Citrus Sinensis ID: 016917

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380
Protein Sequence
MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSHLFRATK
Secondary Structure (PSIPRED)
ccccHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEEccccEEEEEEccccccHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEccccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHccccccccccHHHHHHHHHHHcccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHcccccccccccccEEcccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccEcHHHHHHHHccccHHccccccccccEEEEEcccccEEEEEEcccccHHHHHHHHHHHHHHHcHcHHHEEEEEEccccEEEEEEEcccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHccccEEEEcccHcHEEccccccccHcHccHHEEcccccccEEEEEEEEccccccHHHHHccccEcccHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHcccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MSVTLAAIFGAAAGAVALMGIIFFLSWFCLyrnrsvsrtsetgssepsvqpgrnvgIELSIREARRFQMEELSLATknfsdknligegkfgEVYKGLLQDGMLVAikkrpgaptqefIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEyipngsvsihlygpsqvsrqklEFKHRLSIALGAAKGLAhlhslsprvvhkdfktanvlVDEDFIAKVADAGLrnflgrtdvagpssqvtaDEIFLASEVKEFRrfseksdvySFGVFLLELVSgreassslspdssQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCldpsserrpsmsdVVTELDRTLDKEMNlttvmgegtptvtlgshlfratk
Flexible Loop (DISEMBL)
MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSvsrtsetgssepsvqpgrnvGIELSIREARRFQMEELSLAtknfsdknligeGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFlgrtdvagpssqvtadEIFLASEVKEFRrfseksdvYSFGVFLLELVSGREAssslspdssqDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLdpsserrpsmsdvVTELDRTLDKEMnlttvmgegtptvtlgshlfratk
Low Complexity Region (SEG)
MSVTLaaifgaaagavalmgiiFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIalgaakglahlhslsPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAssslspdssqdlVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSHLFRATK
Disordered region (IsUnstruct)
***********************************************************************LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV*******************LVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCL*************************************************
Disordered Region (DISOPRED)
**VTLAAIFGAAAGAVALMGIIFFLSWFC************************************RFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP*AP*QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAS******S**DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT*****************************
Disordered Region (DISEMBL)
MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRS****************GRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG**************LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSHLFRATK
Disordered Region (DISPRO)
*SVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNR****************************EARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT*****************************
Transmembrane Helix (TMHMM)
iiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSHLFRATK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	380	2.2.26 [Sep-21-2011]
Q8LKZ1	924	Nodulation receptor kinas	N/A	no	0.918	0.377	0.373	9e-58
Q8L4H4	925	Nodulation receptor kinas	N/A	no	0.923	0.379	0.370	6e-56
Q9LX66	830	Receptor-like protein kin	no	no	0.942	0.431	0.347	4e-52
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.776	0.433	0.379	3e-51
C0LGV0	895	Probable LRR receptor-lik	no	no	0.860	0.365	0.362	5e-51
Q9SA72	849	Probable receptor-like pr	no	no	0.897	0.401	0.334	6e-51
Q9SR05	850	Receptor-like protein kin	no	no	0.889	0.397	0.347	2e-50
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.744	0.398	0.386	5e-50
Q9FID8	873	Putative receptor-like pr	no	no	0.802	0.349	0.362	5e-50
Q9LK03	717	Proline-rich receptor-lik	no	no	0.786	0.417	0.363	2e-49

>sp|Q8LKZ1|NORK_PEA Nodulation receptor kinase OS=Pisum sativum GN=NORK PE=1 SV=1

 Score =  224 bits (571), Expect = 9e-58,   Method: Compositional matrix adjust.
 Identities = 137/367 (37%), Positives = 205/367 (55%), Gaps = 18/367 (4%)

Query: 8   IFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIRE---- 63
           + GA      L+ +   + +FC YR++S++     G + P      N+   L  ++    
Sbjct: 521 MIGAITSGSILITLAVVILFFCRYRHKSITLEGFGGKTYPM---ATNIIFSLPSKDDFFI 577

Query: 64  ----ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---E 116
                + F +E + LAT+ +  K LIGEG FG VY+G L DG  VA+K R    TQ   E
Sbjct: 578 KSVSVKPFTLEYIELATEKY--KTLIGEGGFGSVYRGTLDDGQEVAVKVRSATSTQGTRE 635

Query: 117 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 176
           F +E+  L++IQH NLV LLGYC E + Q L+Y ++ NGS+   LYG     R+ L++  
Sbjct: 636 FDNELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYG-EPAKRKILDWPT 694

Query: 177 RLSIALGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 235
           RLSIALGAA+GLA+LH+   R V+H+D K++N+L+D    AKVAD G   +  +   +  
Sbjct: 695 RLSIALGAARGLAYLHTFPGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSYV 754

Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 295
           S +V     +L  E  + ++ SEKSDV+SFGV LLE+VSGRE  +   P     LVE  +
Sbjct: 755 SLEVRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRVEWSLVEWAK 814

Query: 296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 355
                S + +I+D  +   +  E +   +++ ++CL+P S  RP M D+V EL+  L  E
Sbjct: 815 PYIRASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIE 874

Query: 356 MNLTTVM 362
            N +  M
Sbjct: 875 NNASEYM 881

Involved in the perception of symbiotic fungi and bacteria and required for the calcium spiking. Part of the perception/transduction system leading to nodulation or mycorrhizal infection.
Pisum sativum (taxid: 3888)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8L4H4|NORK_MEDTR Nodulation receptor kinase OS=Medicago truncatula GN=NORK PE=1 SV=2

 Score =  218 bits (555), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 135/364 (37%), Positives = 207/364 (56%), Gaps = 13/364 (3%)

Query: 8   IFGAAAGAVALMGIIFFLSWFCLYRNRSVS-----RTSETGSSEPSVQPGRNVGIELSIR 62
           + GA      L+ +   + +FC YR++S++     +T    ++     P ++     S+ 
Sbjct: 523 VIGAITSGSLLITLAVGILFFCRYRHKSITLEGFGKTYPMATNIIFSLPSKDDFFIKSV- 581

Query: 63  EARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFID 119
             + F +E +  AT+ +  K LIGEG FG VY+G L DG  VA+K R    TQ   EF +
Sbjct: 582 SVKPFTLEYIEQATEQY--KTLIGEGGFGSVYRGTLDDGQEVAVKVRSSTSTQGTREFDN 639

Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E+  L++IQH NLV LLGYC E + Q L+Y ++ NGS+   LYG +   R+ L++  RLS
Sbjct: 640 ELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEAS-KRKILDWPTRLS 698

Query: 180 IALGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ 238
           IALGAA+GLA+LH+   R V+H+D K++N+L+D+   AKVAD G   +  +   +  S +
Sbjct: 699 IALGAARGLAYLHTFPGRSVIHRDVKSSNILLDQSMCAKVADFGFSKYAPQEGDSYVSLE 758

Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 298
           V     +L  E  + ++ SEKSDV+SFGV LLE+VSGRE  +   P     LVE  +   
Sbjct: 759 VRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRIEWSLVEWAKPYI 818

Query: 299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL 358
             S + +I+D  +   +  E +   +++ ++CL+P S  RP M D+V EL+  L  E N 
Sbjct: 819 RASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIENNA 878

Query: 359 TTVM 362
           +  M
Sbjct: 879 SEYM 882

Involved in the perception of symbiotic fungi and bacteria. Part of the perception/transduction system leading to nodulation or mycorrhizal infection.

Medicago truncatula (taxid: 3880)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1

 Score =  205 bits (522), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 135/389 (34%), Positives = 198/389 (50%), Gaps = 31/389 (7%)

Query: 5   LAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVG-------- 56
           L  I G+A G+  L+ ++F  S F LY+ R   +   + +  P    G ++G        
Sbjct: 404 LGLIVGSAIGS--LLAVVFLGSCFVLYKKRKRGQDGHSKTWMPFSINGTSMGSKYSNGTT 461

Query: 57  -IELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ 115
              ++     R     +  AT NF +   IG G FG+VYKG L DG  VA+K+  G P  
Sbjct: 462 LTSITTNANYRIPFAAVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKR--GNPKS 519

Query: 116 -----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQ 170
                EF  E+  L+  +HR+LV+L+GYC ENN   LIYEY+ NG+V  HLYG    S  
Sbjct: 520 QQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPS-- 577

Query: 171 KLEFKHRLSIALGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
            L +K RL I +GAA+GL +LH+   + V+H+D K+AN+L+DE+F+AKVAD GL      
Sbjct: 578 -LTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPE 636

Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD 289
            D    S+ V     +L  E    ++ ++KSDVYSFGV L E++  R       P    +
Sbjct: 637 LDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPREMVN 696

Query: 290 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
           L E     +    L +I+D+ L      + + +F +   +CL      RPSM DV+  L+
Sbjct: 697 LAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAETGEKCLADYGVDRPSMGDVLWNLE 756

Query: 350 RTL---------DKEMNLTTVMGEGTPTV 369
             L         + E N T ++GE  P +
Sbjct: 757 YALQLQEAVIDGEPEDNSTNMIGELPPQI 785

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  202 bits (514), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 117/308 (37%), Positives = 179/308 (58%), Gaps = 13/308 (4%)

Query: 67  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCF 123
           F  +ELS  T  FS+KNL+GEG FG VYKG+L DG  VA+K+     +Q   EF  EV  
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386

Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 183
           ++ + HR+LVTL+GYC     + L+Y+Y+PN ++  HL+ P    R  + ++ R+ +A G
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAP---GRPVMTWETRVRVAAG 443

Query: 184 AAKGLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-AGPSSQVTA 241
           AA+G+A+LH    PR++H+D K++N+L+D  F A VAD GL       D+    S++V  
Sbjct: 444 AARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMG 503

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE----LVQNS 297
              ++A E     + SEK+DVYS+GV LLEL++GR+   +  P   + LVE    L+  +
Sbjct: 504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQA 563

Query: 298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 357
            +     +++D RL   F    M   ++    C+  S+ +RP MS VV  LD TL++  +
Sbjct: 564 IENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALD-TLEEATD 622

Query: 358 LTTVMGEG 365
           +T  M  G
Sbjct: 623 ITNGMRPG 630

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGV0|Y5487_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g48740 OS=Arabidopsis thaliana GN=At5g48740 PE=2 SV=1

 Score =  201 bits (512), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 127/350 (36%), Positives = 201/350 (57%), Gaps = 23/350 (6%)

Query: 5   LAAIFGAAAGAVALMGIIF-FLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIRE 63
           +A + G + GA+    ++F F+S   ++  R  ++  +   ++  +Q         +   
Sbjct: 545 IAILLGVSGGALFATFLVFVFMS---IFTRRQRNKERDITRAQLKMQ---------NWNA 592

Query: 64  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK---KRPGAPTQEFIDE 120
           +R F  +E+  AT+NF  K +IG G FG VY+G L DG  VA+K    R       FI+E
Sbjct: 593 SRIFSHKEIKSATRNF--KEVIGRGSFGAVYRGKLPDGKQVAVKVRFDRTQLGADSFINE 650

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
           V  L+ I+H+NLV+  G+C E   Q L+YEY+  GS++ HLYGP +  R  L +  RL +
Sbjct: 651 VHLLSQIRHQNLVSFEGFCYEPKRQILVYEYLSGGSLADHLYGP-RSKRHSLNWVSRLKV 709

Query: 181 ALGAAKGLAHLHSLS-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
           A+ AAKGL +LH+ S PR++H+D K++N+L+D+D  AKV+D GL     + D +  ++ V
Sbjct: 710 AVDAAKGLDYLHNGSEPRIIHRDVKSSNILLDKDMNAKVSDFGLSKQFTKADASHITTVV 769

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQDLVELVQNSR 298
                +L  E     + +EKSDVYSFGV LLEL+ GRE  S S SPDS   ++    N +
Sbjct: 770 KGTAGYLDPEYYSTLQLTEKSDVYSFGVVLLELICGREPLSHSGSPDSFNLVLWARPNLQ 829

Query: 299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +   +I+D+ L  TF    M++   + +RC+   +  RPS+++V+T+L
Sbjct: 830 --AGAFEIVDDILKETFDPASMKKAASIAIRCVGRDASGRPSIAEVLTKL 877

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1

 Score =  201 bits (512), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 123/368 (33%), Positives = 197/368 (53%), Gaps = 27/368 (7%)

Query: 8   IFGAAAGAVALMGIIFFLSWF--CLYRNRSVSRTSETGSSEPSVQP-----------GRN 54
           I+ +    +A++    FL     CL + R  S++ E+ ++ P  +P            + 
Sbjct: 431 IWISVGAGIAIIIFFVFLGILVVCLCKKRR-SKSDESKNNPPGWRPLFLHVNNSTANAKA 489

Query: 55  VGIELSIRE------ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK 108
            G  L +         R+F + E+  ATKNF D   IG G FG+VY+G L+DG L+AIK+
Sbjct: 490 TGGSLRLNTLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKR 549

Query: 109 RPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPS 165
                 Q   EF  E+  L+ ++HR+LV+L+G+C E+N   L+YEY+ NG++  HL+G +
Sbjct: 550 ATPHSQQGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSN 609

Query: 166 QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLR 224
                 L +K RL   +G+A+GL +LH+ S R ++H+D KT N+L+DE+F+AK++D GL 
Sbjct: 610 ---LPPLSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLS 666

Query: 225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
                 D    S+ V     +L  E    ++ +EKSDVYSFGV L E V  R   +   P
Sbjct: 667 KAGPSMDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLP 726

Query: 285 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
               +L E   + +   NL  I+D  L   ++ E +E++ ++  +CL    + RP M +V
Sbjct: 727 KDQINLAEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEV 786

Query: 345 VTELDRTL 352
           +  L+  L
Sbjct: 787 LWSLEYVL 794

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SR05|ANX1_ARATH Receptor-like protein kinase ANXUR1 OS=Arabidopsis thaliana GN=ANX1 PE=2 SV=1

 Score =  200 bits (508), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 129/371 (34%), Positives = 194/371 (52%), Gaps = 33/371 (8%)

Query: 6   AAIFGAAAGAVA-LMGIIFFL----------------SWFCLYRNRSVSRTSETGSSEPS 48
           A I G+A G +A L+G + F                 SW  +Y N + S T  T S +  
Sbjct: 430 AFIIGSAGGVLAVLIGALCFTAYKKKQGYQGGDSHTSSWLPIYGNSTTSGTKSTISGK-- 487

Query: 49  VQPGRNVGIELSIREA---RRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVA 105
                N G  LS   A   RRF + E+   T+NF D N+IG G FG+VYKG++     VA
Sbjct: 488 ----SNNGSHLSNLAAGLCRRFSLPEIKHGTQNFDDSNVIGVGGFGKVYKGVIDGTTKVA 543

Query: 106 IKKRPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY 162
           +KK      Q   EF  E+  L+ ++H++LV+L+GYC E     L+Y+Y+  G++  HLY
Sbjct: 544 VKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLVYDYMAFGTLREHLY 603

Query: 163 GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADA 221
                 + +L +K RL IA+GAA+GL +LH+ +   ++H+D KT N+LVDE+++AKV+D 
Sbjct: 604 ---NTKKPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILVDENWVAKVSDF 660

Query: 222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS 281
           GL       +    ++ V     +L  E    ++ +EKSDVYSFGV L E++  R A + 
Sbjct: 661 GLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNP 720

Query: 282 LSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 341
             P     L +   N +   NL  I+D  L      E +++F     +CL+ S   RP+M
Sbjct: 721 SLPKEQVSLGDWAMNCKRKGNLEDIIDPNLKGKINAECLKKFADTAEKCLNDSGLERPTM 780

Query: 342 SDVVTELDRTL 352
            DV+  L+  L
Sbjct: 781 GDVLWNLEFAL 791

Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  198 bits (504), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 114/295 (38%), Positives = 174/295 (58%), Gaps = 12/295 (4%)

Query: 67  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK---RPGAPTQEFIDEVCF 123
           F  EEL+  T+ FS  N++GEG FG VYKG L DG LVA+K+     G   +EF  EV  
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400

Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 183
           ++ + HR+LV+L+GYC  ++ + LIYEY+PN ++  HL+G     R  LE+  R+ IA+G
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG---KGRPVLEWARRVRIAIG 457

Query: 184 AAKGLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
           +AKGLA+LH    P+++H+D K+AN+L+D++F A+VAD GL      T     S++V   
Sbjct: 458 SAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTH-VSTRVMGT 516

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE----LVQNSR 298
             +LA E  +  + +++SDV+SFGV LLEL++GR+      P   + LVE    L+  + 
Sbjct: 517 FGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAI 576

Query: 299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
           +  +  +++D RL   +    +   I+    C+  S  +RP M  VV  LD   D
Sbjct: 577 ETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGD 631

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FID8|Y5900_ARATH Putative receptor-like protein kinase At5g39000 OS=Arabidopsis thaliana GN=At5g39000 PE=3 SV=1

 Score =  198 bits (504), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 115/317 (36%), Positives = 182/317 (57%), Gaps = 12/317 (3%)

Query: 43  GSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDG- 101
           G+   + +P +++  +L     RRF + E+  AT +F DK +IG G FG VYKG +  G 
Sbjct: 486 GTDSTNTKPAKSLPADL----CRRFSIFEIKSATNDFEDKLIIGVGGFGSVYKGQIDGGA 541

Query: 102 MLVAIKKRPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS 158
            LVA+K+      Q   EF  E+  L+ ++H +LV+L+GYC E+N   L+YEY+P+G++ 
Sbjct: 542 TLVAVKRLEITSNQGAKEFETELEMLSKLRHVHLVSLIGYCDEDNEMVLVYEYMPHGTLK 601

Query: 159 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAK 217
            HL+   + S   L +K RL I +GAA+GL +LH+ +   ++H+D KT N+L+DE+F+ K
Sbjct: 602 DHLFRRDKTSDPPLSWKRRLEICIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVTK 661

Query: 218 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSG 275
           V+D GL   +G T  +           F   + + +RR   +EKSDVYSFGV LLE++  
Sbjct: 662 VSDFGLSR-VGPTSASQTHVSTVVKGTFGYLDPEYYRRQVLTEKSDVYSFGVVLLEVLCC 720

Query: 276 REASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSS 335
           R       P    DL+  V+++     + +I+D  L +  T+  +E+F ++ VRC+    
Sbjct: 721 RPIRMQSVPPEQADLIRWVKSNYRRGTVDQIIDSDLSADITSTSLEKFCEIAVRCVQDRG 780

Query: 336 ERRPSMSDVVTELDRTL 352
             RP M+DVV  L+  L
Sbjct: 781 MERPPMNDVVWALEFAL 797

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  196 bits (499), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 114/314 (36%), Positives = 180/314 (57%), Gaps = 15/314 (4%)

Query: 47  PSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAI 106
           P   PG  +G  L I +   F  EELS AT  FS+ NL+G+G FG V+KG+L++G  VA+
Sbjct: 325 PPPSPGLALG--LGIYQGT-FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAV 381

Query: 107 KKRPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG 163
           K+     +Q   EF  EV  ++ + HR+LV L+GYC  +  + L+YE++PN ++  HL+G
Sbjct: 382 KQLKEGSSQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHG 441

Query: 164 PSQVSRQKLEFKHRLSIALGAAKGLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAG 222
                R  +E+  RL IA+G+AKGL++LH + +P+++H+D K +N+L+D  F AKVAD G
Sbjct: 442 K---GRPTMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFG 498

Query: 223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL 282
           L      T+    S++V     +LA E     + +EKSDV+SFGV LLEL++GR      
Sbjct: 499 LAKIASDTNTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVN 557

Query: 283 SPDSSQDLVE----LVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 338
           +  +   LV+    L+    +  N   ++D++L + +  E M   +     C+  ++ RR
Sbjct: 558 NVHADNSLVDWARPLLNQVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRR 617

Query: 339 PSMSDVVTELDRTL 352
           P M  V   L+  +
Sbjct: 618 PRMDQVARVLEGNI 631

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	380
255543513	381	serine/threonine protein kinase, putativ	1.0	0.997	0.790	1e-174
224069640	378	predicted protein [Populus trichocarpa]	0.994	1.0	0.742	1e-163
351727579	379	protein kinase family protein [Glycine m	0.944	0.947	0.766	1e-157
356571643	379	PREDICTED: probable receptor-like protei	0.944	0.947	0.769	1e-157
225451635	381	PREDICTED: nodulation receptor kinase [V	0.947	0.944	0.745	1e-157
147805741	414	hypothetical protein VITISV_039777 [Viti	0.947	0.869	0.745	1e-156
388494484	380	unknown [Lotus japonicus]	0.944	0.944	0.752	1e-154
357508461	379	Nodulation receptor kinase [Medicago tru	0.944	0.947	0.725	1e-150
449452038	379	PREDICTED: nodulation receptor kinase-li	0.997	1.0	0.697	1e-149
30688460	380	protein kinase family protein [Arabidops	0.952	0.952	0.703	1e-147

>gi|255543513|ref|XP_002512819.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223547830|gb|EEF49322.1| serine/threonine protein kinase, putative [Ricinus communis]

 Score =  618 bits (1593), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 301/381 (79%), Positives = 339/381 (88%), Gaps = 1/381 (0%)

Query: 1   MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQ-PGRNVGIEL 59
           MS TLAAI G AAG VAL+GI+ FL WFCL   +SVSRTSETGSS+PS+Q PGR+VG+EL
Sbjct: 1   MSKTLAAILGGAAGVVALVGIVIFLIWFCLSHKKSVSRTSETGSSDPSIQAPGRHVGVEL 60

Query: 60  SIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFID 119
           S+REARRF+M+ELS ATKNF DKNLIG GKFGEVYKGLL DGMLVAIKKR GA +QEF+D
Sbjct: 61  SLREARRFEMDELSHATKNFVDKNLIGIGKFGEVYKGLLNDGMLVAIKKRSGASSQEFVD 120

Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           EV +L+ IQHRN+VTLLGYCQENNLQFL+YEYIP+GSVS HLYGPSQ S  KLEFKHRLS
Sbjct: 121 EVRYLSPIQHRNIVTLLGYCQENNLQFLVYEYIPSGSVSSHLYGPSQFSDGKLEFKHRLS 180

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
           IALGAAKGLAHLHSLSPR+VHKDFKTANVLVDE+FIAKVADAGL NFLGR DVAGPSSQV
Sbjct: 181 IALGAAKGLAHLHSLSPRLVHKDFKTANVLVDENFIAKVADAGLPNFLGRVDVAGPSSQV 240

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD 299
           TADEIF A EV+EFRRFS+K DV+SFGVFLLEL+SGREA+ S SPDSSQ+LVE VQN++D
Sbjct: 241 TADEIFQAPEVREFRRFSDKGDVFSFGVFLLELLSGREATESPSPDSSQNLVEWVQNTQD 300

Query: 300 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT 359
           +S    ++D+RL + FT EGMEEFIQLI++CL+PSSERRPSMS VV ELDR L+KEM LT
Sbjct: 301 YSAFSSVVDQRLGTRFTAEGMEEFIQLIIQCLEPSSERRPSMSYVVMELDRILEKEMTLT 360

Query: 360 TVMGEGTPTVTLGSHLFRATK 380
           TVMGEGTPTVTLGS LF+A+K
Sbjct: 361 TVMGEGTPTVTLGSQLFKASK 381

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224069640|ref|XP_002303015.1| predicted protein [Populus trichocarpa] gi|222844741|gb|EEE82288.1| predicted protein [Populus trichocarpa]

 Score =  581 bits (1497), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 282/380 (74%), Positives = 332/380 (87%), Gaps = 2/380 (0%)

Query: 1   MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELS 60
           MS TLAAI G AAG +AL G++ F+ W CLY  ++VSRTSETGSSE S+Q GR+ GIELS
Sbjct: 1   MSRTLAAILGGAAGVMALAGVVIFVLW-CLYHKKTVSRTSETGSSETSIQVGRHAGIELS 59

Query: 61  IREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE 120
            +EARRF+MEEL LATK FS+KNLIG GKFGEVYKGLL +GM+VAIKKRPGAP+ EF+DE
Sbjct: 60  SQEARRFEMEELGLATKGFSEKNLIGLGKFGEVYKGLLNNGMIVAIKKRPGAPSPEFVDE 119

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
           V +L+SIQHRNLVTLLGYCQENNLQFL+YEYI +GSVS HLYG  Q    KLEFK+RL I
Sbjct: 120 VRYLSSIQHRNLVTLLGYCQENNLQFLVYEYISSGSVSNHLYGVGQTLEGKLEFKNRLPI 179

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
           ALGAAKGLAHLHS +PR++HK+FKTANVLVDE+FIAKVADAGLRNFLGR D+AGPS+QVT
Sbjct: 180 ALGAAKGLAHLHSQTPRLLHKNFKTANVLVDENFIAKVADAGLRNFLGRVDIAGPSTQVT 239

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 300
           ADEIFLA EV+EFR+FSEKSDV+SFGVFLLEL+SG+EA+   SP++SQ+LVE VQN++D+
Sbjct: 240 ADEIFLAPEVREFRQFSEKSDVFSFGVFLLELLSGKEATEP-SPETSQNLVEWVQNTQDY 298

Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTT 360
           +N   I+D RL S+FT EGMEEFIQL+++C++PSS+RRP MS VV ELDR L+KE NLTT
Sbjct: 299 TNFSSIVDHRLGSSFTAEGMEEFIQLMLQCVEPSSDRRPLMSYVVMELDRILEKERNLTT 358

Query: 361 VMGEGTPTVTLGSHLFRATK 380
           VMGEGTPTVTLGS LFRAT+
Sbjct: 359 VMGEGTPTVTLGSQLFRATR 378

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351727579|ref|NP_001235374.1| protein kinase family protein [Glycine max] gi|223452478|gb|ACM89566.1| protein kinase family protein [Glycine max]

 Score =  562 bits (1448), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 276/360 (76%), Positives = 312/360 (86%), Gaps = 1/360 (0%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFS 80
           I   L WFCL R R+VSRTSETGSS+PS Q GR+  +EL IR+ RRF+MEELSLATKNFS
Sbjct: 21  IAIILIWFCLSRQRNVSRTSETGSSDPS-QVGRHGAMELPIRDTRRFEMEELSLATKNFS 79

Query: 81  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           DKNLIGEGKFGEVYKGLLQDGMLVAIKKR G  +QEF+DEV +L+SI HRNLV+LLGYCQ
Sbjct: 80  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRRGLASQEFVDEVRYLSSIHHRNLVSLLGYCQ 139

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
           ENNLQFLIYEY+PNGSVS HLYG  Q  R+KLEFKHRL IA GAAKGLAHLHSLSPR+VH
Sbjct: 140 ENNLQFLIYEYVPNGSVSSHLYGAGQQPREKLEFKHRLPIAQGAAKGLAHLHSLSPRLVH 199

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKS 260
           K+FKTANVLVDE+FIAKVADAGLRNFLGR D+AG SSQV  DEIFLASEV+EFRRFSEKS
Sbjct: 200 KNFKTANVLVDENFIAKVADAGLRNFLGRVDIAGSSSQVATDEIFLASEVREFRRFSEKS 259

Query: 261 DVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGM 320
           DVYSFGVFLLEL+SG++A+ S  PDS+Q+LVE V +++D   +  I+D RL S+FT EGM
Sbjct: 260 DVYSFGVFLLELLSGKQATESPFPDSNQNLVEWVLSNQDRGMMSYIIDRRLESSFTAEGM 319

Query: 321 EEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSHLFRATK 380
           EE+I LI+RCLDPSSERRP+MS V  EL R LDKEMNLTT+MGEGTPTVTLGS LF++TK
Sbjct: 320 EEYIMLIIRCLDPSSERRPAMSYVEMELVRILDKEMNLTTIMGEGTPTVTLGSQLFKSTK 379

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356571643|ref|XP_003553985.1| PREDICTED: probable receptor-like protein kinase At1g30570-like [Glycine max]

 Score =  561 bits (1445), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 277/360 (76%), Positives = 311/360 (86%), Gaps = 1/360 (0%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFS 80
           I   L WFCL R R+VSRTSETGSS+PS Q GR+  IEL IR+ RRF+MEELSLATKNFS
Sbjct: 21  IAIILIWFCLSRQRNVSRTSETGSSDPS-QVGRHGAIELPIRDTRRFEMEELSLATKNFS 79

Query: 81  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           DKNLIGEGKFGEVYKGLLQDGMLVAIKKR G  +QEF+DEV +L+SI HRNLV+LLGYCQ
Sbjct: 80  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRRGLASQEFVDEVHYLSSIHHRNLVSLLGYCQ 139

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
           ENNLQFLIYEY+PNGSVS HLYG  Q  ++KLEFKHRLSIA GAAKGLAHLHSLSPR+VH
Sbjct: 140 ENNLQFLIYEYVPNGSVSSHLYGAGQNPQEKLEFKHRLSIAQGAAKGLAHLHSLSPRLVH 199

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKS 260
           K+FKT NVLVDE+FIAKVADAGLRNFLGR D+AG SSQV  DEIFLASEV+EFRRFSEKS
Sbjct: 200 KNFKTTNVLVDENFIAKVADAGLRNFLGRVDIAGSSSQVATDEIFLASEVREFRRFSEKS 259

Query: 261 DVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGM 320
           DVYSFGVFLLEL+SG+EA     PDS+Q+LVE V +++D   +  I+D RL S+FT EGM
Sbjct: 260 DVYSFGVFLLELLSGKEAIEPPFPDSNQNLVEWVLSNQDRGMMSYIIDRRLESSFTAEGM 319

Query: 321 EEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSHLFRATK 380
           EE+I LI+RCLDPSSERRP+MS V  ELDR L+KEMNLTTVMGEGTPTVTLGS LF++TK
Sbjct: 320 EEYILLIIRCLDPSSERRPAMSYVEMELDRILEKEMNLTTVMGEGTPTVTLGSQLFKSTK 379

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225451635|ref|XP_002277073.1| PREDICTED: nodulation receptor kinase [Vitis vinifera] gi|296082255|emb|CBI21260.3| unnamed protein product [Vitis vinifera]

 Score =  560 bits (1442), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 269/361 (74%), Positives = 318/361 (88%), Gaps = 1/361 (0%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFS 80
           I+  + WFCL  NRSVSRTSETGSS+PSVQ GRNVG+EL++REAR F+M ELSLATKNFS
Sbjct: 21  IVILIIWFCLSHNRSVSRTSETGSSDPSVQVGRNVGVELALREARHFEMAELSLATKNFS 80

Query: 81  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           D +LIGEGKFGEVYKGLL DGM VAIKKR G P+Q+F+DEV +L++I+HRNLVTLLGYCQ
Sbjct: 81  DISLIGEGKFGEVYKGLLHDGMFVAIKKRFGGPSQDFVDEVRYLSAIEHRNLVTLLGYCQ 140

Query: 141 ENNLQFLIYEYIPNGSVSIHLYG-PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
           EN  QFLIYE+IP+GS+S +LYG  +QVS++KLEFK+RL IALGAAKGLAHLH+LSPR+V
Sbjct: 141 ENGQQFLIYEHIPSGSISSYLYGTAAQVSQEKLEFKNRLQIALGAAKGLAHLHTLSPRLV 200

Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEK 259
           HKDFKTANVLVDE+FI KVADAGLRNFLGR D+AGPSSQV ADEIFLA EV+EFRRFS+K
Sbjct: 201 HKDFKTANVLVDENFIPKVADAGLRNFLGRIDIAGPSSQVVADEIFLAPEVREFRRFSDK 260

Query: 260 SDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG 319
           SDVYSFGVFLLEL+SG+EA++ LSPDS+ +LVE+VQN +D SN+  I+D+RL + FT EG
Sbjct: 261 SDVYSFGVFLLELLSGQEANTLLSPDSNLNLVEMVQNYQDHSNISTIIDQRLGNRFTAEG 320

Query: 320 MEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSHLFRAT 379
           MEEFIQLI+RC+D SSERRPSMS V+ ELDR L+KE  LTT++GEG P V LGS LF+A+
Sbjct: 321 MEEFIQLIIRCVDTSSERRPSMSYVLMELDRILEKETTLTTLVGEGIPNVILGSQLFKAS 380

Query: 380 K 380
           K
Sbjct: 381 K 381

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147805741|emb|CAN73905.1| hypothetical protein VITISV_039777 [Vitis vinifera]

 Score =  558 bits (1438), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 269/361 (74%), Positives = 318/361 (88%), Gaps = 1/361 (0%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFS 80
           I+  + WFCL  NRSVSRTSETGSS+PSVQ GRNVG+EL++REAR F+M ELSLATKNFS
Sbjct: 54  IVILIIWFCLSHNRSVSRTSETGSSDPSVQVGRNVGVELALREARHFEMAELSLATKNFS 113

Query: 81  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           D +LIGEGKFGEVYKGLL DGM VAIKKR G P+Q+F+DEV +L++I+HRNLVTLLGYCQ
Sbjct: 114 DISLIGEGKFGEVYKGLLHDGMFVAIKKRFGGPSQDFVDEVRYLSAIEHRNLVTLLGYCQ 173

Query: 141 ENNLQFLIYEYIPNGSVSIHLYG-PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
           EN  QFLIYE+IP+GS+S +LYG  +QVS++KLEFK+RL IALGAAKGLAHLH+LSPR+V
Sbjct: 174 ENGQQFLIYEHIPSGSISSYLYGTAAQVSQEKLEFKNRLQIALGAAKGLAHLHTLSPRLV 233

Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEK 259
           HKDFKTANVLVDE+FI KVADAGLRNFLGR D+AGPSSQV ADEIFLA EV+EFRRFS+K
Sbjct: 234 HKDFKTANVLVDENFIPKVADAGLRNFLGRIDIAGPSSQVVADEIFLAPEVREFRRFSDK 293

Query: 260 SDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG 319
           SDVYSFGVFLLEL+SG+EA++ LSPDS+ +LVE+VQN +D SN+  I+D+RL + FT EG
Sbjct: 294 SDVYSFGVFLLELLSGQEANTLLSPDSNLNLVEMVQNYQDHSNISTIIDQRLGNRFTAEG 353

Query: 320 MEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSHLFRAT 379
           MEEFIQLI+RC+D SSERRPSMS V+ ELDR L+KE  LTT++GEG P V LGS LF+A+
Sbjct: 354 MEEFIQLIIRCVDTSSERRPSMSYVLMELDRILEKETTLTTLVGEGIPNVILGSQLFKAS 413

Query: 380 K 380
           K
Sbjct: 414 K 414

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388494484|gb|AFK35308.1| unknown [Lotus japonicus]

 Score =  551 bits (1421), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 271/360 (75%), Positives = 311/360 (86%), Gaps = 1/360 (0%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFS 80
           I   L WFCL R RSVSRTSETGSS+PS Q GR+  IEL IR+ RRF MEELSLATKNF+
Sbjct: 22  ISIILLWFCLCRQRSVSRTSETGSSDPS-QVGRHGAIELQIRDTRRFAMEELSLATKNFN 80

Query: 81  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           D NLIG+GKFGEVY GLLQDG+LVAIKKR G P+QEF+DEV +L+SIQHRN+VTL+GYCQ
Sbjct: 81  DGNLIGQGKFGEVYNGLLQDGVLVAIKKRFGTPSQEFVDEVRYLSSIQHRNIVTLIGYCQ 140

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
           ENNLQFLIYEY+PNGSVS HLYG  Q S++KLEFK RLSIA GAAKGLAH+HSLSPR+VH
Sbjct: 141 ENNLQFLIYEYVPNGSVSSHLYGAGQQSQEKLEFKLRLSIAQGAAKGLAHIHSLSPRLVH 200

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKS 260
           KDFKTANVLVDE+FIAKVADAGL++FLGR D+ G SSQV ADEIFLA EV+EFRRFSEKS
Sbjct: 201 KDFKTANVLVDENFIAKVADAGLKHFLGRVDIVGSSSQVAADEIFLAPEVREFRRFSEKS 260

Query: 261 DVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGM 320
           DVYS+GVFLLEL+SG+EA+ S SPDS+ +LVE V  ++D   + KI+D RL S+FT EGM
Sbjct: 261 DVYSYGVFLLELLSGKEATESPSPDSNLNLVEWVLRNQDRHLMSKIIDRRLESSFTAEGM 320

Query: 321 EEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSHLFRATK 380
           E +I L++RCLD SSERRP+MS V TELDR L+KEMNLTT+MGEGTPTVTLGS LF+ATK
Sbjct: 321 EAYILLVIRCLDLSSERRPAMSYVETELDRILEKEMNLTTIMGEGTPTVTLGSQLFKATK 380

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357508461|ref|XP_003624519.1| Nodulation receptor kinase [Medicago truncatula] gi|355499534|gb|AES80737.1| Nodulation receptor kinase [Medicago truncatula]

 Score =  538 bits (1387), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 261/360 (72%), Positives = 307/360 (85%), Gaps = 1/360 (0%)

Query: 21  IIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFS 80
           I   L WF L+R  SVSRTSETGSS+PS Q GR+ GIEL +R+ RRF MEELS ATKNF+
Sbjct: 21  ISIILIWFYLFRQTSVSRTSETGSSDPS-QVGRHGGIELQMRDTRRFAMEELSHATKNFN 79

Query: 81  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           DKNLIGEGKFGEVYKGLLQDGMLVAIKKR G  +QEF+DEV +L+SIQHRNLVTL+GYCQ
Sbjct: 80  DKNLIGEGKFGEVYKGLLQDGMLVAIKKRRGVTSQEFVDEVRYLSSIQHRNLVTLIGYCQ 139

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
           ENNLQFLIYEY+PNGSVS HLYG SQ  R+KLEFKHRLSIA GAAKGLAHLHSLSPR+VH
Sbjct: 140 ENNLQFLIYEYVPNGSVSSHLYGASQQPREKLEFKHRLSIAQGAAKGLAHLHSLSPRLVH 199

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKS 260
           K+FKT+NVLVDE+FI+KVADAGLRNFL R ++ G SSQV  DEIFLA EV+EFR+FSEKS
Sbjct: 200 KNFKTSNVLVDENFISKVADAGLRNFLARVEIVGTSSQVATDEIFLAPEVREFRQFSEKS 259

Query: 261 DVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGM 320
           D YSFGVFLLEL+SG+EA+ S  P+++Q+LVE V ++++ S +  I+D+R+   FT EGM
Sbjct: 260 DAYSFGVFLLELLSGKEATESPHPNTNQNLVESVLSNQNNSTMNTIIDQRMECRFTAEGM 319

Query: 321 EEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSHLFRATK 380
           E +I L++RCLDPSSERRP+MS V  ELDR ++KEMNLTT+MGE TPTVTLGS LF++ K
Sbjct: 320 ESYILLLIRCLDPSSERRPAMSYVEMELDRIIEKEMNLTTMMGERTPTVTLGSQLFKSNK 379

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452038|ref|XP_004143767.1| PREDICTED: nodulation receptor kinase-like [Cucumis sativus] gi|449529349|ref|XP_004171662.1| PREDICTED: nodulation receptor kinase-like [Cucumis sativus]

 Score =  535 bits (1379), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 265/380 (69%), Positives = 321/380 (84%), Gaps = 1/380 (0%)

Query: 1   MSVTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELS 60
           MS  LAAI G +AGAVAL+G+I  L  F L R+R+ +RTSETGSS+PSVQ GR+VGIEL+
Sbjct: 1   MSKVLAAILGGSAGAVALVGLIIILLRF-LARSRNTARTSETGSSDPSVQVGRHVGIELT 59

Query: 61  IREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE 120
           +R+ARRF+M EL LAT +FSDKNLIGEGKFGEVYKG+LQDGM VAIKKR GAP+Q+F+DE
Sbjct: 60  LRDARRFEMAELVLATNDFSDKNLIGEGKFGEVYKGMLQDGMFVAIKKRHGAPSQDFVDE 119

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
           V +L+SIQHRNLVTLLGYCQENNLQFLI++YIPNGSVS H+YG  Q S +KLEFK RLSI
Sbjct: 120 VHYLSSIQHRNLVTLLGYCQENNLQFLIFDYIPNGSVSSHIYGTEQRSAEKLEFKIRLSI 179

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
           ALGAAKGL+HLHS+SPR+ H++FKT+NVLVDE+FIAKVADAGL N + R DV+  SS+ T
Sbjct: 180 ALGAAKGLSHLHSMSPRLTHRNFKTSNVLVDENFIAKVADAGLHNVMRRFDVSESSSRAT 239

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 300
           ADEIFLA EVKEFR+FSEKSDVYSFGVFLLELVSG++A+ +   + +  LV+ +QN++  
Sbjct: 240 ADEIFLAPEVKEFRQFSEKSDVYSFGVFLLELVSGQKATDAPVSNPNYTLVDWIQNNQRK 299

Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTT 360
           S++  I D RL  +FT EGM E + LI++C++ SSERRP MS VVTEL+R L+KEMNLTT
Sbjct: 300 SDIGSITDPRLGKSFTEEGMGELMDLILQCVEYSSERRPVMSYVVTELERILEKEMNLTT 359

Query: 361 VMGEGTPTVTLGSHLFRATK 380
           VMGEG+PTVTLGS LF+ TK
Sbjct: 360 VMGEGSPTVTLGSQLFKTTK 379

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|30688460|ref|NP_189304.2| protein kinase family protein [Arabidopsis thaliana] gi|332643680|gb|AEE77201.1| protein kinase family protein [Arabidopsis thaliana]

 Score =  528 bits (1359), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 256/364 (70%), Positives = 315/364 (86%), Gaps = 2/364 (0%)

Query: 18  LMGIIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATK 77
           L+ +  FL WFC++R +++SRTSETGSS+PS Q GRNV IELS+REARRF+MEEL+ ATK
Sbjct: 18  LIALFVFLLWFCVFRRKNLSRTSETGSSDPSTQEGRNVAIELSMREARRFEMEELAQATK 77

Query: 78  NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           +F++K+LIG GKFGEVYKGLLQDG+LVAIKKRPG PTQEF++EV +L+SI HRNLVTLLG
Sbjct: 78  SFTNKSLIGIGKFGEVYKGLLQDGVLVAIKKRPGLPTQEFVNEVRYLSSIHHRNLVTLLG 137

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGP-SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
           +CQE+N QFL+YEY+PNGSVS HLYG   +V   +LEF+HRL+I++GAAKGLAHLHSLSP
Sbjct: 138 FCQESNTQFLVYEYVPNGSVSSHLYGAGGKVPGNRLEFRHRLAISIGAAKGLAHLHSLSP 197

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R++HKDFKTANVLVDE+FIAKVADAG+RNFLGR DV G SS + AD+IFL+ EV+EF+RF
Sbjct: 198 RLIHKDFKTANVLVDENFIAKVADAGVRNFLGREDV-GTSSHIVADQIFLSPEVQEFKRF 256

Query: 257 SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT 316
           SEKSDVY+FGVFLLELVSGREAS      S+Q LV+ +QN  D++++  ++DERL  T+T
Sbjct: 257 SEKSDVYAFGVFLLELVSGREASEPSPSSSTQTLVDWMQNLTDYADIPMMIDERLGGTYT 316

Query: 317 NEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSHLF 376
            EG+EE I L +RC+D SSE+RP+MS VVTEL+R LDKE++LTTVMGEGTPTVTLGS LF
Sbjct: 317 AEGVEELITLTLRCVDVSSEKRPTMSFVVTELERILDKEVSLTTVMGEGTPTVTLGSQLF 376

Query: 377 RATK 380
           +ATK
Sbjct: 377 KATK 380

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	380
TAIR|locus:2090797	380	AT3G26700 [Arabidopsis thalian	0.997	0.997	0.632	8.9e-125
TAIR|locus:2156992	946	AT5G49770 [Arabidopsis thalian	0.844	0.339	0.333	2.2e-43
TAIR|locus:2019863	971	AT1G79620 [Arabidopsis thalian	0.842	0.329	0.331	5.1e-43
TAIR|locus:2157042	953	AT5G49760 [Arabidopsis thalian	0.839	0.334	0.335	8e-43
TAIR|locus:2157002	857	AT5G49780 [Arabidopsis thalian	0.747	0.331	0.346	8.8e-42
TAIR|locus:2159873	681	PERK8 "proline-rich extensin-l	0.786	0.439	0.349	9.2e-42
TAIR|locus:2012325	466	AT1G09440 [Arabidopsis thalian	0.834	0.680	0.330	2.2e-41
TAIR|locus:2156549	895	AT5G48740 [Arabidopsis thalian	0.763	0.324	0.345	5.8e-41
TAIR|locus:2091980	432	CDG1 "CONSTITUTIVE DIFFERENTIA	0.85	0.747	0.342	5.9e-41
UNIPROTKB|O24585	901	CR4 "Putative receptor protein	0.892	0.376	0.327	1.2e-40

TAIR|locus:2090797 AT3G26700 [Arabidopsis thaliana (taxid:3702)]

 Score = 1226 (436.6 bits), Expect = 8.9e-125, P = 8.9e-125
 Identities = 241/381 (63%), Positives = 295/381 (77%)

Query:     1 MSVTLXXXXXXXXXXXXXXXXXFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELS 60
             MS  L                  FL WFC++R +++SRTSETGSS+PS Q GRNV IELS
Sbjct:     1 MSAILAAAIGGAVGALALIALFVFLLWFCVFRRKNLSRTSETGSSDPSTQEGRNVAIELS 60

Query:    61 IREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE 120
             +REARRF+MEEL+ ATK+F++K+LIG GKFGEVYKGLLQDG+LVAIKKRPG PTQEF++E
Sbjct:    61 MREARRFEMEELAQATKSFTNKSLIGIGKFGEVYKGLLQDGVLVAIKKRPGLPTQEFVNE 120

Query:   121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPS-QVSRQKLEFKHRLS 179
             V +L+SI HRNLVTLLG+CQE+N QFL+YEY+PNGSVS HLYG   +V   +LEF+HRL+
Sbjct:   121 VRYLSSIHHRNLVTLLGFCQESNTQFLVYEYVPNGSVSSHLYGAGGKVPGNRLEFRHRLA 180

Query:   180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
             I               PR++HKDFKTANVLVDE+FIAKVADAG+RNFLGR DV G SS +
Sbjct:   181 ISIGAAKGLAHLHSLSPRLIHKDFKTANVLVDENFIAKVADAGVRNFLGREDV-GTSSHI 239

Query:   240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRD 299
              AD+IFL+ EV+EF+RFSEKSDVY+FGVFLLELVSGREA            V+ +QN  D
Sbjct:   240 VADQIFLSPEVQEFKRFSEKSDVYAFGVFLLELVSGREASEPSPSSSTQTLVDWMQNLTD 299

Query:   300 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT 359
             ++++  ++DERL  T+T EG+EE I L +RC+D SSE+RP+MS VVTEL+R LDKE++LT
Sbjct:   300 YADIPMMIDERLGGTYTAEGVEELITLTLRCVDVSSEKRPTMSFVVTELERILDKEVSLT 359

Query:   360 TVMGEGTPTVTLGSHLFRATK 380
             TVMGEGTPTVTLGS LF+ATK
Sbjct:   360 TVMGEGTPTVTLGSQLFKATK 380

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)]

 Score = 467 (169.5 bits), Expect = 2.2e-43, P = 2.2e-43
 Identities = 110/330 (33%), Positives = 174/330 (52%)

Query:    28 FCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGE 87
             + L + +   R ++  +       G+N      +   + F  EELS  T NFSD N +G 
Sbjct:   583 YALRQKKRAQRATDQMNPFAKWDAGKNEMDAPQLMGTKAFTFEELSKCTNNFSDANDVGG 642

Query:    88 GKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYCQENNL 144
             G +G+VYKG L +G ++AIK+      Q   EF  E+  L+ + H+N+V LLG+C +   
Sbjct:   643 GGYGQVYKGTLPNGQVIAIKRAQQGSMQGAFEFKTEIELLSRVHHKNVVKLLGFCFDQKE 702

Query:   145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX-PRVVHKDF 203
             Q L+YEYIPNGS+   L G + V   KL++  RL I                P ++H+D 
Sbjct:   703 QMLVYEYIPNGSLRDGLSGKNGV---KLDWTRRLKIALGSGKGLAYLHELADPPIIHRDV 759

Query:   204 KTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVY 263
             K+ N+L+DE   AKVAD GL   +G  + A  ++QV     +L  E     + +EKSDVY
Sbjct:   760 KSNNILLDEHLTAKVADFGLSKLVGDPEKAHVTTQVKGTMGYLDPEYYMTNQLTEKSDVY 819

Query:   264 SFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTN-EGMEE 322
              FGV +LEL++G+               ++   SR+  +L ++LD  +     N +G E+
Sbjct:   820 GFGVVMLELLTGKSPIDRGSYVVKEVKKKM-DKSRNLYDLQELLDTTIIQNSGNLKGFEK 878

Query:   323 FIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             ++ + ++C++P    RP+MS+VV EL+  L
Sbjct:   879 YVDVALQCVEPEGVNRPTMSEVVQELESIL 908

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)]

 Score = 464 (168.4 bits), Expect = 5.1e-43, P = 5.1e-43
 Identities = 110/332 (33%), Positives = 178/332 (53%)

Query:    25 LSWFCLYRNRSVSRTSETGSSEPSVQ---PGRNVGIELSIREARRFQMEELSLATKNFSD 81
             L  + +++ R   +    G S P V     G++ G    ++ AR F  EEL   T NFS 
Sbjct:   583 LGIYAMWQKRRAEQA--IGLSRPFVSWASSGKDSGGAPQLKGARWFSYEELKKITNNFSV 640

Query:    82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLASIQHRNLVTLLGY 138
              + +G G +G+VYKG+LQDG +VAIK+     TQ   EF  E+  L+ + H+NLV L+G+
Sbjct:   641 SSELGYGGYGKVYKGMLQDGHMVAIKRAQQGSTQGGLEFKTEIELLSRVHHKNLVGLVGF 700

Query:   139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX-PR 197
             C E   Q L+YEY+ NGS+   L G S ++   L++K RL +                P 
Sbjct:   701 CFEQGEQILVYEYMSNGSLKDSLTGRSGIT---LDWKRRLRVALGSARGLAYLHELADPP 757

Query:   198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
             ++H+D K+ N+L+DE+  AKVAD GL   +        S+QV     +L  E    ++ +
Sbjct:   758 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDCTKGHVSTQVKGTLGYLDPEYYTTQKLT 817

Query:   258 EKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTN 317
             EKSDVYSFGV ++EL++ ++             + + ++  DF  L   +D  L    T 
Sbjct:   818 EKSDVYSFGVVMMELITAKQPIEKGKYIVREIKLVMNKSDDDFYGLRDKMDRSLRDVGTL 877

Query:   318 EGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
               +  +++L ++C+D +++ RP+MS+VV E++
Sbjct:   878 PELGRYMELALKCVDETADERPTMSEVVKEIE 909

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0042546 "cell wall biogenesis" evidence=RCA

GO:0044036 "cell wall macromolecule metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)]

 Score = 462 (167.7 bits), Expect = 8.0e-43, P = 8.0e-43
 Identities = 111/331 (33%), Positives = 174/331 (52%)

Query:    30 LYRNRSVSRTSE-TGSSEPSVQ-PGRNVGIEL-SIREARRFQMEELSLATKNFSDKNLIG 86
             +Y  R   R    TG + P  +       I+   +  A+ F  EEL   T NFS+ N +G
Sbjct:   579 IYALRQKKRAERATGQNNPFAKWDTSKSSIDAPQLMGAKAFTFEELKKCTDNFSEANDVG 638

Query:    87 EGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYCQENN 143
              G +G+VY+G+L +G L+AIK+      Q   EF  E+  L+ + H+N+V LLG+C + N
Sbjct:   639 GGGYGKVYRGILPNGQLIAIKRAQQGSLQGGLEFKTEIELLSRVHHKNVVRLLGFCFDRN 698

Query:   144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX-PRVVHKD 202
              Q L+YEYI NGS+   L G S +   +L++  RL I                P ++H+D
Sbjct:   699 EQMLVYEYISNGSLKDSLSGKSGI---RLDWTRRLKIALGSGKGLAYLHELADPPIIHRD 755

Query:   203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDV 262
              K+ N+L+DE+  AKVAD GL   +G  +    ++QV     +L  E     + +EKSDV
Sbjct:   756 IKSNNILLDENLTAKVADFGLSKLVGDPEKTHVTTQVKGTMGYLDPEYYMTNQLTEKSDV 815

Query:   263 YSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTN-EGME 321
             Y FGV LLEL++GR               ++   SR   +L ++LD  + ++  N +G E
Sbjct:   816 YGFGVVLLELLTGRSPIERGKYVVREVKTKM-NKSRSLYDLQELLDTTIIASSGNLKGFE 874

Query:   322 EFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             +++ L +RC++     RPSM +VV E++  +
Sbjct:   875 KYVDLALRCVEEEGVNRPSMGEVVKEIENIM 905

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006569 "tryptophan catabolic process" evidence=RCA

GO:0009684 "indoleacetic acid biosynthetic process" evidence=RCA

GO:0030003 "cellular cation homeostasis" evidence=RCA

GO:0044242 "cellular lipid catabolic process" evidence=RCA

GO:0070838 "divalent metal ion transport" evidence=RCA

TAIR|locus:2157002 AT5G49780 [Arabidopsis thaliana (taxid:3702)]

 Score = 451 (163.8 bits), Expect = 8.8e-42, P = 8.8e-42
 Identities = 102/294 (34%), Positives = 163/294 (55%)

Query:    65 RRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGA--PTQEFIDEV 121
             + F  EE+     NFS  N +G G +G+VYKG+L  G L+AIK+ +PG+     EF  E+
Sbjct:   520 KAFTFEEMRKCANNFSVANDVGGGGYGQVYKGILPSGQLIAIKRAQPGSLQGALEFKTEI 579

Query:   122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 181
               L+ + H+N+V LLG+C +   Q L+YEYIPNGS+   L G S +   +L++  RL I 
Sbjct:   580 ELLSRVHHKNVVKLLGFCFDRGEQMLVYEYIPNGSLRDSLSGKSGI---RLDWTRRLRIA 636

Query:   182 XXXXXXXXXXXXXX-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                            P ++H+D K++NVL+DE   AKVAD GL   +   + A  ++QV 
Sbjct:   637 LGSGKGLAYLHELADPPIIHRDVKSSNVLLDESLTAKVADFGLSQLVEDAEKANVTAQVK 696

Query:   241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
                 +L  E     + +EKSDVY FGV +LEL++G+              +++   S++ 
Sbjct:   697 GTMGYLDPEYYMTNQLTEKSDVYGFGVMMLELLTGKIPIENGKYVVKEMKMKM-NKSKNL 755

Query:   301 SNLLKILDERLWSTFTN--EGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
              +L   LD  + +T     +G E+++ + +RC+DP   +RPSM++VV E++  +
Sbjct:   756 YDLQDFLDTTISATSNRNLKGFEKYVDVALRCVDPEGVKRPSMNEVVKEIENIM 809

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 446 (162.1 bits), Expect = 9.2e-42, P = 9.2e-42
 Identities = 109/312 (34%), Positives = 166/312 (53%)

Query:    67 FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQ-EFIDEVCF 123
             F  +ELS  T  FS+KNL+GEG FG VYKG+L DG  VA+K  K  G+  + EF  EV  
Sbjct:   327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386

Query:   124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
             ++ + HR+LVTL+GYC     + L+Y+Y+PN ++  HL+ P    R  + ++ R+ +   
Sbjct:   387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPG---RPVMTWETRVRVAAG 443

Query:   184 XXXXXXXXXXX-XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-AGPSSQVTA 241
                          PR++H+D K++N+L+D  F A VAD GL       D+    S++V  
Sbjct:   444 AARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMG 503

Query:   242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVE----LVQNS 297
                ++A E     + SEK+DVYS+GV LLEL++GR+             VE    L+  +
Sbjct:   504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQA 563

Query:   298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 357
              +     +++D RL   F    M   ++    C+  S+ +RP MS VV  LD TL++  +
Sbjct:   564 IENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALD-TLEEATD 622

Query:   358 LTTVMGEGTPTV 369
             +T  M  G   V
Sbjct:   623 ITNGMRPGQSQV 634

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005199 "structural constituent of cell wall" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)]

 Score = 439 (159.6 bits), Expect = 2.2e-41, P = 2.2e-41
 Identities = 108/327 (33%), Positives = 170/327 (51%)

Query:    27 WFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIG 86
             + C+  NRS S   E  +  PS   G     E  +     F + +L +AT  FS +N+IG
Sbjct:   109 YLCV-ANRSTSSLYEMATPSPSPLSGLP---ESHLGWGHWFTLRDLEIATNRFSKENVIG 164

Query:    87 EGKFGEVYKGLLQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN 143
             EG +G VY+G L +G LVA+KK     G   +EF  EV  +  ++H+NLV LLGYC E  
Sbjct:   165 EGGYGVVYRGELVNGSLVAVKKILNHLGQAEKEFRVEVDAIGHVRHKNLVRLLGYCIEGT 224

Query:   144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX-PRVVHKD 202
              + L+YEY+ NG++   L+G  +     L ++ R+ +                P+VVH+D
Sbjct:   225 NRILVYEYMNNGNLEEWLHGAMK-HHGYLTWEARMKVLTGTSKALAYLHEAIEPKVVHRD 283

Query:   203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDV 262
              K++N+L+D+ F AK++D GL   LG    +  +++V     ++A E       +EKSDV
Sbjct:   284 IKSSNILIDDRFNAKISDFGLAKLLG-DGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDV 342

Query:   263 YSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGMEE 322
             YSFGV +LE ++GR+             VE ++       L +++D  +        ++ 
Sbjct:   343 YSFGVLVLEAITGRDPVDYARPANEVNLVEWLKMMVGSKRLEEVIDPNIAVRPATRALKR 402

Query:   323 FIQLIVRCLDPSSERRPSMSDVVTELD 349
              +   +RC+DP SE+RP MS VV  L+
Sbjct:   403 VLLTALRCIDPDSEKRPKMSQVVRMLE 429

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2156549 AT5G48740 [Arabidopsis thaliana (taxid:3702)]

 Score = 444 (161.4 bits), Expect = 5.8e-41, P = 5.8e-41
 Identities = 103/298 (34%), Positives = 159/298 (53%)

Query:    64 ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK---KRPGAPTQEFIDE 120
             +R F  +E+  AT+NF  K +IG G FG VY+G L DG  VA+K    R       FI+E
Sbjct:   593 SRIFSHKEIKSATRNF--KEVIGRGSFGAVYRGKLPDGKQVAVKVRFDRTQLGADSFINE 650

Query:   121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
             V  L+ I+H+NLV+  G+C E   Q L+YEY+  GS++ HLYGP    R  L +  RL +
Sbjct:   651 VHLLSQIRHQNLVSFEGFCYEPKRQILVYEYLSGGSLADHLYGPRS-KRHSLNWVSRLKV 709

Query:   181 XXXXXXXXXXXXXXX-PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                             PR++H+D K++N+L+D+D  AKV+D GL     + D +  ++ V
Sbjct:   710 AVDAAKGLDYLHNGSEPRIIHRDVKSSNILLDKDMNAKVSDFGLSKQFTKADASHITTVV 769

Query:   240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRD 299
                  +L  E     + +EKSDVYSFGV LLEL+ GRE             V   + +  
Sbjct:   770 KGTAGYLDPEYYSTLQLTEKSDVYSFGVVLLELICGREPLSHSGSPDSFNLVLWARPNLQ 829

Query:   300 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 357
              +   +I+D+ L  TF    M++   + +RC+   +  RPS+++V+T+L      +++
Sbjct:   830 -AGAFEIVDDILKETFDPASMKKAASIAIRCVGRDASGRPSIAEVLTKLKEAYSLQLS 886

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2091980 CDG1 "CONSTITUTIVE DIFFERENTIAL GROWTH 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 435 (158.2 bits), Expect = 5.9e-41, P = 5.9e-41
 Identities = 116/339 (34%), Positives = 179/339 (52%)

Query:    32 RNRSVSRTSETGSSEPSVQPGRNVGI--ELSIREARRFQMEELSLATKNFSDKNLIGEGK 89
             RN++ S +++   +   V    +  +  + S    + F   EL++AT +F +++LIG G 
Sbjct:    25 RNQTSSSSAQPAGTAKEVDSSSSQTVVQDSSRYRCQIFSYRELAIATNSFRNESLIGRGG 84

Query:    90 FGEVYKGLLQDGMLVAIKKRPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYCQENNLQF 146
             FG VYKG L  G  +A+K    +  Q   EF+ EV  L+ + HRNLV L GYC E + + 
Sbjct:    85 FGTVYKGRLSTGQNIAVKMLDQSGIQGDKEFLVEVLMLSLLHHRNLVHLFGYCAEGDQRL 144

Query:   147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX-PRVVHKDFKT 205
             ++YEY+P GSV  HLY  S+  ++ L++K R+ I                P V+++D KT
Sbjct:   145 VVYEYMPLGSVEDHLYDLSE-GQEALDWKTRMKIALGAAKGLAFLHNEAQPPVIYRDLKT 203

Query:   206 ANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSF 265
             +N+L+D D+  K++D GL  F    D++  S++V     + A E     + + KSD+YSF
Sbjct:   204 SNILLDHDYKPKLSDFGLAKFGPSDDMSHVSTRVMGTHGYCAPEYANTGKLTLKSDIYSF 263

Query:   266 GVFLLELVSGREAXXXXXXXXXXXXVELVQNSRD-FSN--LLKILDERLWST--FTNEGM 320
             GV LLEL+SGR+A              LV  +R  F N  + +I+D RL     F+N  +
Sbjct:   264 GVVLLELISGRKALMPSSECVGNQSRYLVHWARPLFLNGRIRQIVDPRLARKGGFSNILL 323

Query:   321 EEFIQLIVRCLDPSSERRPSMSDVVTEL----DRTLDKE 355
                I++   CL   +  RPS+S VV  L    D T+ KE
Sbjct:   324 YRGIEVAFLCLAEEANARPSISQVVECLKYIIDHTIRKE 362

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0040007 "growth" evidence=IMP

GO:0004672 "protein kinase activity" evidence=IDA

GO:1900459 "positive regulation of brassinosteroid mediated signaling pathway" evidence=IMP

UNIPROTKB|O24585 CR4 "Putative receptor protein kinase CRINKLY4" [Zea mays (taxid:4577)]

 Score = 441 (160.3 bits), Expect = 1.2e-40, P = 1.2e-40
 Identities = 117/357 (32%), Positives = 182/357 (50%)

Query:    29 CLYRNRSVSRTSETGSS----EPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNL 84
             C   NR +     T  S       +QP      +L IR A+ F  EEL  AT  FS+ + 
Sbjct:   454 CQCSNRELRLAKSTAYSFRKDNMKIQPDME---DLKIRRAQEFSYEELEQATGGFSEDSQ 510

Query:    85 IGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYC 139
             +G+G F  V+KG+L+DG +VA+K+   A      ++EF +E+  L+ + H +L+ LLGYC
Sbjct:   511 VGKGSFSCVFKGILRDGTVVAVKRAIKASDVKKSSKEFHNELDLLSRLNHAHLLNLLGYC 570

Query:   140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX-PRV 198
             ++ + + L+YE++ +GS+  HL+G     +++L +  R++I                P V
Sbjct:   571 EDGSERLLVYEFMAHGSLYQHLHGKDPNLKKRLNWARRVTIAVQAARGIEYLHGYACPPV 630

Query:   199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFS 257
             +H+D K++N+L+DED  A+VAD GL + LG  D   P S++ A  + +L  E       +
Sbjct:   631 IHRDIKSSNILIDEDHNARVADFGL-SILGPADSGTPLSELPAGTLGYLDPEYYRLHYLT 689

Query:   258 EKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTN 317
              KSDVYSFGV LLE++SGR+A            VE         ++  ILD  L      
Sbjct:   690 TKSDVYSFGVVLLEILSGRKAIDMQFEEGNI--VEWAVPLIKAGDIFAILDPVLSPPSDL 747

Query:   318 EGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPT-VTLGS 373
             E +++   +  +C+    + RPSM  V T L+  L   M    +     PT V LGS
Sbjct:   748 EALKKIASVACKCVRMRGKDRPSMDKVTTALEHALALLMGSPCIEQPILPTEVVLGS 804

GO:0042803 "protein homodimerization activity" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	380
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-49
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-48
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-47
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-45
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-39
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-39
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-38
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-32
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-28
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-28
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-27
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-26
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-25
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-24
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-24
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-22
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-21
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-21
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-19
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-19
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-18
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-17
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-17
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-15
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-14
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-14
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-13
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-13
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-13
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-13
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	8e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-12
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-09
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-09
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-08
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-07
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-06
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-06
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-06
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-06
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	9e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-05
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-05
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-05
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-05
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-05
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-04
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-04
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-04
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-04
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-04
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-04
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	0.001
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.001
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	0.001
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.004
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	0.004
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.004
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  166 bits (422), Expect = 4e-49
 Identities = 82/275 (29%), Positives = 129/275 (46%), Gaps = 35/275 (12%)

Query: 85  IGEGKFGEVYKGLLQD-----GMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 135
           +GEG FGEVYKG L+       + VA+K  +  A  Q   EF+ E   +  + H N+V L
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           LG C E    +++ EY+  G +  +L    + +R KL     LS AL  A+G+ +L S  
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYLESK- 121

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVKEFR 254
              +H+D    N LV E+ + K++D GL   L   D      +     I  +A E  +  
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY--RKRGGKLPIRWMAPESLKEG 178

Query: 255 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 314
           +F+ KSDV+SFGV L E+ +           S+++++E ++N             RL   
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTL--GEQPYPGMSNEEVLEYLKN-----------GYRLPQP 225

Query: 315 FTNEGM-EEFIQLIVRCLDPSSERRPSMSDVVTEL 348
                   E   L+++C     E RP+ S++V  L
Sbjct: 226 ---PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  162 bits (413), Expect = 9e-48
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 42/279 (15%)

Query: 85  IGEGKFGEVYKGLLQDG-----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 135
           +GEG FGEVYKG L+       + VA+K  +  A  Q   EF+ E   +  + H N+V L
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           LG C E     ++ EY+P G +  +L    +   ++L     LS AL  A+G+ +L S  
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYL---RKNRPKELSLSDLLSFALQIARGMEYLESK- 122

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----LASEVK 251
              +H+D    N LV E+ + K++D GL   L   D                  +A E  
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-----YKVKGGKLPIRWMAPESL 176

Query: 252 EFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 310
           +  +F+ KSDV+SFGV L E+ + G E    +S     +++E ++              R
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN---AEVLEYLKK-----------GYR 222

Query: 311 LWSTFTNEGM-EEFIQLIVRCLDPSSERRPSMSDVVTEL 348
           L           E  +L+++C     E RP+ S++V  L
Sbjct: 223 LPKP---PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  161 bits (411), Expect = 1e-47
 Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 40/278 (14%)

Query: 85  IGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAP---TQEFIDEVCFLASIQHRNLVTL 135
           +GEG FGEVYKG L          VA+K  + GA     +EF++E   +  + H N+V L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           LG C +    +++ EY+P G +   L    +   +KL  K  L +AL  AKG+ +L S  
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFL----RKHGEKLTLKDLLQMALQIAKGMEYLESK- 121

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----LASEVK 251
              VH+D    N LV E+ + K++D GL   +   D      +           +A E  
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD----YYRKRGGGKLPIKWMAPESL 176

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 311
           +  +F+ KSDV+SFGV L E+ +           S+++++EL+++             RL
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTL--GEQPYPGMSNEEVLELLED-----------GYRL 223

Query: 312 WSTFTNEGMEEFI-QLIVRCLDPSSERRPSMSDVVTEL 348
                 E   + + +L+++C     E RP+ S++V +L
Sbjct: 224 ---PRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  157 bits (399), Expect = 1e-45
 Identities = 80/284 (28%), Positives = 124/284 (43%), Gaps = 39/284 (13%)

Query: 83  NLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVT 134
             +GEG FGEVYKG L+        VA+K  +  A  +   +F+ E   +  + H N+V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 135 LLGYCQENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           LLG C E    +L+ EY+  G     +           +  L  K  LS A+  AKG+ +
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----L 246
           L S   + VH+D    N LV ED + K++D G    L R        +           +
Sbjct: 121 LASK--KFVHRDLAARNCLVGEDLVVKISDFG----LSRDVYDDDYYRKKTGGKLPIRWM 174

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK 305
           A E  +   F+ KSDV+SFGV L E+ + G      LS    ++++E ++          
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRK--------- 222

Query: 306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
               RL         +E  +L++ C     E RP+ S++V  L+
Sbjct: 223 --GYRL--PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  139 bits (353), Expect = 2e-39
 Identities = 72/268 (26%), Positives = 109/268 (40%), Gaps = 63/268 (23%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG FG VY     + G  VAIK    +   +  +E + E+  L  + H N+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
           ++ N  +L+ EY   GS+   L    + +  KL     L I L   +GL +LHS    ++
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL----KENEGKLSEDEILRILLQILEGLEYLHSN--GII 114

Query: 200 HKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FS 257
           H+D K  N+L+D D    K+AD GL   L        +   T    ++A EV   +  +S
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT--PAYMAPEVLLGKGYYS 172

Query: 258 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 317
           EKSD++S GV L E                                              
Sbjct: 173 EKSDIWSLGVILYE---------------------------------------------- 186

Query: 318 EGMEEFIQLIVRCLDPSSERRPSMSDVV 345
             + E   LI + L    E+RPS  +++
Sbjct: 187 --LPELKDLIRKMLQKDPEKRPSAKEIL 212

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  139 bits (352), Expect = 7e-39
 Identities = 69/273 (25%), Positives = 114/273 (41%), Gaps = 32/273 (11%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLV 133
           +     +GEG FG+VY     + G LVAIK     +     +  + E+  L  ++H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            L    ++ +  +L+ EY   G +   L       R +L               L +LHS
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL-----KKRGRLSEDEARFYLRQILSALEYLHS 115

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +VH+D K  N+L+DED   K+AD GL   L   +    +   T +  ++A EV   
Sbjct: 116 K--GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT-TFVGTPE--YMAPEVLLG 170

Query: 254 RRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELVQNSRDFSNLLKILDERLW 312
           + + +  D++S GV L EL++G+       P      L+EL +         KI   +  
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK------PPFPGDDQLLELFK---------KIGKPKPP 215

Query: 313 STFTNEGM-EEFIQLIVRCLDPSSERRPSMSDV 344
                  +  E   LI + L    E+R +  + 
Sbjct: 216 FPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  138 bits (351), Expect = 1e-38
 Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 26/268 (9%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIK--KRPGAP---TQEFIDEVCFLASIQHRNLVTLLGY 138
           +G G FG VYK   +  G +VA+K  K+        Q    E+  L  + H N+V L+  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
            ++ +  +L+ EY   G +  +L          L       IAL   +GL +LHS    +
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILRGLEYLHSN--GI 119

Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-KEFRRFS 257
           +H+D K  N+L+DE+ + K+AD GL   L ++      +       ++A EV      + 
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSS--SSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 258 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 317
            K DV+S GV L EL++G+      S ++  D     Q       L   L+        +
Sbjct: 178 PKVDVWSLGVILYELLTGK---PPFSGENILD-----QLQLIRRILGPPLEFDEP--KWS 227

Query: 318 EGMEEFIQLIVRCLDPSSERRPSMSDVV 345
            G EE   LI +CL+    +RP+  +++
Sbjct: 228 SGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  121 bits (305), Expect = 4e-32
 Identities = 67/203 (33%), Positives = 98/203 (48%), Gaps = 24/203 (11%)

Query: 82  KNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
              IG+G+FG+V  G  + G  VA+K  K      Q F+ E   + +++H NLV LLG  
Sbjct: 11  GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
            + N  +++ EY+  GS+  +L       R  +    +L  AL   +G+ +L       V
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLE--EKNFV 124

Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----ASEVKEFR 254
           H+D    NVLV ED +AKV+D GL             +    D   L     A E    +
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGL----------AKEASQGQDSGKLPVKWTAPEALREK 174

Query: 255 RFSEKSDVYSFGVFLLELVS-GR 276
           +FS KSDV+SFG+ L E+ S GR
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  115 bits (289), Expect = 1e-29
 Identities = 79/289 (27%), Positives = 129/289 (44%), Gaps = 37/289 (12%)

Query: 83  NLIGEGKFGEVYKGLL-----QDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLV 133
             +GEG FG+V            G  VA+K            +F  E+  L ++ H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 134 TLLGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
              G C+     +L+ LI EY+P+GS+  +L    Q  R ++  K  L  +    KG+ +
Sbjct: 70  KYKGVCEKPGGRSLR-LIMEYLPSGSLRDYL----QRHRDQINLKRLLLFSSQICKGMDY 124

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASE 249
           L S   R +H+D    N+LV+ + + K++D GL   L          +     IF  A E
Sbjct: 125 LGSQ--RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 308
                +FS  SDV+SFGV L EL + G     S SP    + + ++  ++    + ++L 
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGD---PSQSP--PAEFLRMIGIAQGQMIVTRLL- 236

Query: 309 ERLWSTFTNEGM-------EEFIQLIVRCLDPSSERRPSMSDVVTELDR 350
           E L      E +       +E   L+  C +   + RPS +D++  +DR
Sbjct: 237 ELLKE---GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  111 bits (280), Expect = 1e-28
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQ-EFIDEVCFLASIQHRNLV 133
           + F+ +  +G G FGEV++GL ++ + VAIK  K      Q +F  EV  L  ++H++L+
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
           +L   C      ++I E +  GS+   L  P     Q L     + +A   A+G+A+L  
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEE 122

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEV 250
                +H+D    N+LV ED + KVAD GL   + + DV   S +    +I   + A E 
Sbjct: 123 --QNSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDK----KIPYKWTAPEA 175

Query: 251 KEFRRFSEKSDVYSFGVFLLELVS 274
                FS KSDV+SFG+ L E+ +
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  110 bits (276), Expect = 5e-28
 Identities = 85/267 (31%), Positives = 133/267 (49%), Gaps = 26/267 (9%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
           +   L++E++ +G +S +L    +  R K   +  L + L   +G+A+L S +  V+H+D
Sbjct: 72  SPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRD 125

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 261
               N LV E+ + KV+D G+  F+   D    SS  T   +  +S EV  F ++S KSD
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFV--LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183

Query: 262 VYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGME 321
           V+SFGV + E+ S  E  +     S+ ++VE        +   ++   RL S    E M+
Sbjct: 184 VWSFGVLMWEVFS--EGKTPYENRSNSEVVE------TINAGFRLYKPRLASQSVYELMQ 235

Query: 322 EFIQLIVRCLDPSSERRPSMSDVVTEL 348
                   C     E RPS S ++ +L
Sbjct: 236 H-------CWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  107 bits (270), Expect = 4e-27
 Identities = 73/281 (25%), Positives = 121/281 (43%), Gaps = 45/281 (16%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVT 134
           F     IG+G FGEVYK    + G  VAIK          ++ I+E+  L   +H N+V 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 135 LLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAAKG 187
             G Y +++ L +++ E+   GS+         + +        L+      +     KG
Sbjct: 62  YYGSYLKKDEL-WIVMEFCSGGSLK-------DLLK---STNQTLTESQIAYVCKELLKG 110

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           L +LHS    ++H+D K AN+L+  D   K+ D GL   L  T      + +     ++A
Sbjct: 111 LEYLHSN--GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT---KARNTMVGTPYWMA 165

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 307
            EV   + +  K+D++S G+  +EL  G+   S L P  +  L ++  N      L    
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA--LFKIATN--GPPGLRNP- 220

Query: 308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
               WS        EF   + +CL  + E+RP+      +L
Sbjct: 221 --EKWSD-------EFKDFLKKCLQKNPEKRPT----AEQL 248

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  105 bits (265), Expect = 3e-26
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 31/210 (14%)

Query: 83  NLIGEGKFGEVYKGLLQD-GMLVAIKK-RPGAPTQEFID----EVCFLASIQHRNLVTLL 136
            L+G G FG VY  L +D G L+A+K       ++E ++    E+  L+S+QH N+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 137 GYCQENNLQFL-IY-EYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIALGAAK 186
           G  ++     L I+ EY+  GS+S  +  +G        + +RQ LE             
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE------------- 112

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 246
           GLA+LHS    +VH+D K AN+LVD D + K+AD G    LG  +    +  V     ++
Sbjct: 113 GLAYLHSN--GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           A EV     +   +D++S G  ++E+ +G+
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 5e-26
 Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 40/222 (18%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASI 127
           E L L  K       +G G+FGEV+ G       VA+K  +PG  + E F+ E   +  +
Sbjct: 6   ESLKLERK-------LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL 58

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           +H  LV L   C E    +++ EY+  GS+   L        +KL     + +A   A+G
Sbjct: 59  RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEG 115

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           +A+L S     +H+D    N+LV E+ + K+AD GL             +++  D+ + A
Sbjct: 116 MAYLESR--NYIHRDLAARNILVGENLVCKIADFGL-------------ARLIEDDEYTA 160

Query: 248 SE-----VK-------EFRRFSEKSDVYSFGVFLLELVS-GR 276
            E     +K        + RF+ KSDV+SFG+ L E+V+ GR
Sbjct: 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  106 bits (265), Expect = 1e-25
 Identities = 68/283 (24%), Positives = 111/283 (39%), Gaps = 25/283 (8%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH-R 130
           ++     +GEG FGEVY    +D  LVA+K             + F+ E+  LAS+ H  
Sbjct: 1   SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           N+V L  + Q+    +L+ EY+  GS+   L       +  L     L I       L +
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSALEY 116

Query: 191 LHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEI----F 245
           LHS    ++H+D K  N+L+D D  + K+ D GL   L           + +  +    +
Sbjct: 117 LHSK--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 246 LASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 302
           +A EV         S  SD++S G+ L EL++G          S+      +       +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234

Query: 303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
           L   L             +    L+ + L    + R S S  +
Sbjct: 235 LASPLSPS----NPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 1e-25
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 31/273 (11%)

Query: 84  LIGEGKFGEVYKGLLQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
            IG+G FG+VYKG+L+    VA+K      P    ++F+ E   L    H N+V L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
            +    +++ E +P GS+   L         +L  K  L ++L AA G+ +L S +   +
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN--CI 115

Query: 200 HKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           H+D    N LV E+ + K++D G+      G   V+    Q+     + A E   + R++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK--WTAPEALNYGRYT 173

Query: 258 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 317
            +SDV+S+G+ L E  S      +  P  S       Q +R+         E  +     
Sbjct: 174 SESDVWSYGILLWETFSL---GDTPYPGMSN------QQTRERI-------ESGYRMPAP 217

Query: 318 EGM-EEFIQLIVRCLDPSSERRPSMSDVVTELD 349
           +   EE  +L+++C     E RPS S++  EL 
Sbjct: 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  104 bits (260), Expect = 2e-25
 Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 35/216 (16%)

Query: 85  IGEGKFGEVYKGLL------QDGMLVAIK--KRPGAPT--QEFIDEVCFLASIQHRNLVT 134
           +GEG FG+V+ G         D  LVA+K  K   +    ++F  E   L + QH N+V 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQVS-------RQKLEFKHRLSIALGAA 185
             G C E +   +++EY+ +G ++  L  +GP             +L     L IA+  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAG----PSSQ 238
            G+ +L S     VH+D  T N LV  D + K+ D G+   +  TD   V G    P   
Sbjct: 133 SGMVYLASQ--HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRW 190

Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +  + I        +R+F+ +SDV+SFGV L E+ +
Sbjct: 191 MPPESIM-------YRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 2e-25
 Identities = 71/213 (33%), Positives = 109/213 (51%), Gaps = 31/213 (14%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRN 131
           N+   +LIG G FG VYKGL L+ G  VAIK     K      +  + E+  L +++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGP---SQVSR---QKLEFKHRLSIALG 183
           +V  +G  + ++  ++I EY  NGS+   I  +GP   S V+    Q L+          
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ---------- 110

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
              GLA+LH     V+H+D K AN+L  +D + K+AD G+   L   DV+   + V    
Sbjct: 111 ---GLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTP 163

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            ++A EV E    S  SD++S G  ++EL++G 
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 2e-25
 Identities = 67/194 (34%), Positives = 103/194 (53%), Gaps = 11/194 (5%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V+ G  +  + VAIK  R GA +++ FI+E   +  + H NLV L G C + 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
              F++ EY+ NG +  +L    +  + KL  +  L +     + + +L S     +H+D
Sbjct: 72  RPIFIVTEYMANGCLLNYL----RERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRD 125

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 261
               N LV ED + KV+D GL  ++   D    SSQ T   +  A  EV ++ RFS KSD
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYV--LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183

Query: 262 VYSFGVFLLELVSG 275
           V+SFGV + E+ S 
Sbjct: 184 VWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  100 bits (251), Expect = 2e-24
 Identities = 66/281 (23%), Positives = 117/281 (41%), Gaps = 43/281 (15%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEF-IDEVCFLASIQHRN 131
            +     IG+G FG+VY      DG L  +K+          +E  ++EV  L  + H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR-----LSIALGAAK 186
           ++      +E     ++ EY   G +S  +       +QK E K       L   +    
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKI------KKQKKEGKPFPEEQILDWFVQLCL 114

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 246
            L +LHS   +++H+D K  N+ +  + + K+ D G+   L  T     +   T    +L
Sbjct: 115 ALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTP--YYL 170

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 306
           + E+ + + ++ KSD++S G  L EL + +       P   ++L+EL           KI
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLK------HPFEGENLLELAL---------KI 215

Query: 307 LD---ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           L      + S ++     E   L+   L    E RPS++ +
Sbjct: 216 LKGQYPPIPSQYS----SELRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  100 bits (249), Expect = 2e-24
 Identities = 76/273 (27%), Positives = 130/273 (47%), Gaps = 34/273 (12%)

Query: 84  LIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYC 139
           L+G+G FGEV+KG L+D   VA+K  +   P +   +F+ E   L    H N+V L+G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
            +    +++ E +P G     L    +  + +L+ K  +  AL AA G+A+L   S   +
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFL----RKKKDELKTKQLVKFALDAAAGMAYLE--SKNCI 115

Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEVKEFRRF 256
           H+D    N LV E+ + K++D G    + R +  G  S     +I   + A E   + R+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171

Query: 257 SEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 315
           S +SDV+S+G+ L E  S G      ++   +++ VE  +  R               + 
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE--KGYR--------------MSC 215

Query: 316 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +  ++  +++ RC D   E RP  S++  EL
Sbjct: 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 99.8 bits (249), Expect = 5e-24
 Identities = 85/305 (27%), Positives = 137/305 (44%), Gaps = 52/305 (17%)

Query: 71  ELSLATKNFSDKNLIGEGKFGEVYKG-LLQDG-----MLVAIK----KRPGAPTQEFIDE 120
           E+ L+   F ++  +GEG FG+VYKG L           VAIK           QEF  E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS-----------R 169
              ++ +QH N+V LLG C +     +++EY+ +G +   L   S  S           +
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
             L+    L IA+  A G+ +L   S   VH+D    N LV E    K++D GL   +  
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLS--SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176

Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD---S 286
            D     S+      ++  E   + +F+ +SD++SFGV L E+      S  L P    S
Sbjct: 177 ADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIF-----SYGLQPYYGFS 231

Query: 287 SQDLVELVQNSRDFSNLLKILDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 343
           +Q+++E+++ SR    LL   ++   R+++            L++ C +    RRP   D
Sbjct: 232 NQEVIEMIR-SR---QLLPCPEDCPARVYA------------LMIECWNEIPARRPRFKD 275

Query: 344 VVTEL 348
           + T L
Sbjct: 276 IHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 98.7 bits (246), Expect = 1e-23
 Identities = 76/299 (25%), Positives = 119/299 (39%), Gaps = 59/299 (19%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIK---KRPGAPTQ-EFIDEVCFLASI 127
           N  +   +G G+FGEV+    +         LV +K   K      Q EF  E+     +
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL----YGPSQVSRQKLEFKHRLSIALG 183
            H+N+V LLG C+E    ++I EY   G +   L        ++    L  K ++++   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
            A G+ HL +   R VH+D    N LV      KV+   L            S  V   E
Sbjct: 126 IALGMDHLSNA--RFVHRDLAARNCLVSSQREVKVSLLSL------------SKDVYNSE 171

Query: 244 IF-----------LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE 292
            +           LA E  +   FS KSDV+SFGV + E+ +  E      P       E
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGEL-----PFYGLSDEE 226

Query: 293 LVQNSRDFSNLLKILD---ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
           ++   +     L + +    RL+            +L+ RC   + + RPS S++V+ L
Sbjct: 227 VLNRLQAGKLELPVPEGCPSRLY------------KLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 1e-23
 Identities = 72/281 (25%), Positives = 131/281 (46%), Gaps = 43/281 (15%)

Query: 85  IGEGKFGEVYKGL-LQDG----MLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +G G FG VYKG+ + +G    + VAIK    +      +E +DE   +AS+ H ++V L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           LG C  + +Q LI + +P G +  ++       +  +  ++ L+  +  AKG+++L    
Sbjct: 75  LGICLSSQVQ-LITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEE-- 127

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE-----IFLASEV 250
            R+VH+D    NVLV      K+ D GL   L   +      +  A+       ++A E 
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE-----KEYHAEGGKVPIKWMALES 182

Query: 251 KEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 309
              R ++ KSDV+S+GV + EL++ G +    +              + +  +LL+   E
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-------------PAVEIPDLLEK-GE 228

Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 350
           RL          +   ++V+C    +E RP+  +++ E  +
Sbjct: 229 RLPQPPICT--IDVYMVLVKCWMIDAESRPTFKELINEFSK 267

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 98.4 bits (245), Expect = 1e-23
 Identities = 75/276 (27%), Positives = 133/276 (48%), Gaps = 34/276 (12%)

Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
           C      ++I E++  G++  +L    + +RQ++     L +A   +  + +L   +   
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKN--F 125

Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 183

Query: 258 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 317
            KSDV++FGV L E+     A+  +SP    DL          S + ++L++     +  
Sbjct: 184 IKSDVWAFGVLLWEI-----ATYGMSPYPGIDL----------SQVYELLEK----GYRM 224

Query: 318 EGME----EFIQLIVRCLDPSSERRPSMSDVVTELD 349
           E  E    +  +L+  C   +   RPS +++    +
Sbjct: 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 98.7 bits (246), Expect = 1e-23
 Identities = 82/279 (29%), Positives = 130/279 (46%), Gaps = 21/279 (7%)

Query: 84  LIGEGKFGEVYK---GLLQD--GMLVAIKK-RPGAPT--QEFIDEVCFLASIQHRNLVTL 135
            +G+G FG V       LQD  G +VA+KK +       ++F  E+  L S+QH N+V  
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 136 LGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
            G C      NL+ L+ EY+P GS+  +L    Q  R++L+ +  L  A    KG+ +L 
Sbjct: 71  KGVCYSAGRRNLR-LVMEYLPYGSLRDYL----QKHRERLDHRKLLLYASQICKGMEYLG 125

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVK 251
           S   R VH+D  T N+LV+ +   K+ D GL   L +        +     IF  A E  
Sbjct: 126 SK--RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 311
              +FS  SDV+SFGV L EL +  + S S   +  + +    Q      +L+++L    
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN- 242

Query: 312 WSTFTNEGM-EEFIQLIVRCLDPSSERRPSMSDVVTELD 349
                  G   E   ++  C +    +RPS S++  +++
Sbjct: 243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 97.8 bits (244), Expect = 2e-23
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 26/206 (12%)

Query: 83  NLIGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQEFIDEVCFL--ASI----QHRN 131
            +IG G+FGEV +G L+      + VAIK  + G+  ++ +D   FL  ASI     H N
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD---FLTEASIMGQFDHPN 66

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           ++ L G   ++    +I EY+ NGS    L    + +  K      + +  G A G+ +L
Sbjct: 67  IIRLEGVVTKSRPVMIITEYMENGS----LDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLAS 248
             ++   VH+D    N+LV+ + + KV+D GL   L  ++    +      +I   + A 
Sbjct: 123 SEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE---ATYTTKGGKIPIRWTAP 177

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS 274
           E   +R+F+  SDV+SFG+ + E++S
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 96.6 bits (241), Expect = 4e-23
 Identities = 75/269 (27%), Positives = 124/269 (46%), Gaps = 28/269 (10%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVTLL 136
           F     +GEG +G VYK +  + G +VAIK  P     QE I E+  L       +V   
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYY 64

Query: 137 G-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           G Y +  +L +++ EY   GSVS  +    +++ + L  +   +I     KGL +LHS  
Sbjct: 65  GSYFKNTDL-WIVMEYCGAGSVSDIM----KITNKTLTEEEIAAILYQTLKGLEYLHSN- 118

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
            + +H+D K  N+L++E+  AK+AD G+   L  TD     + V     ++A EV +   
Sbjct: 119 -KKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNTVIGTPFWMAPEVIQEIG 175

Query: 256 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN-SRDFSNLLKILDERLWST 314
           ++ K+D++S G+  +E+  G+   S + P   + +  +        S+  K      WS 
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSDIHP--MRAIFMIPNKPPPTLSDPEK------WS- 226

Query: 315 FTNEGMEEFIQLIVRCLDPSSERRPSMSD 343
                  EF   + +CL    E RPS   
Sbjct: 227 ------PEFNDFVKKCLVKDPEERPSAIQ 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 94.8 bits (236), Expect = 2e-22
 Identities = 62/195 (31%), Positives = 102/195 (52%), Gaps = 9/195 (4%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPG-APTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV++GL  +   VA+K  +PG    ++F+ E   +  ++H  L+ L   C   
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
              +++ E +  GS+  +L G +    + L+    + +A   A G+A+L + +   +H+D
Sbjct: 74  EPIYIVTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEAQN--YIHRD 128

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDV 262
               NVLV E+ I KVAD GL   +   D+            + A E   + RFS KSDV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187

Query: 263 YSFGVFLLELVS-GR 276
           +SFG+ L E+V+ GR
Sbjct: 188 WSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 94.6 bits (235), Expect = 2e-22
 Identities = 73/212 (34%), Positives = 111/212 (52%), Gaps = 18/212 (8%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN 143
           IGEG+FG V +G    G  VA+K  +     Q F++E   +  + H+NLV LLG    N 
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG 72

Query: 144 LQFLIYEYIPNGSVSIHLY--GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHK 201
           L +++ E +  G++   L   G + VS  +L     L  +L  A+G+ +L S   ++VH+
Sbjct: 73  L-YIVMELMSKGNLVNFLRTRGRALVSVIQL-----LQFSLDVAEGMEYLES--KKLVHR 124

Query: 202 DFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSD 261
           D    N+LV ED +AKV+D GL   +G   V      V     + A E  + ++FS KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVK----WTAPEALKHKKFSSKSD 179

Query: 262 VYSFGVFLLELVS-GREASSSLSPDSSQDLVE 292
           V+S+GV L E+ S GR     +S    ++ VE
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE 211

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 94.7 bits (235), Expect = 3e-22
 Identities = 72/214 (33%), Positives = 107/214 (50%), Gaps = 23/214 (10%)

Query: 67  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-KRPGAPTQEFIDEVCFLA 125
             M+EL L          IG+G+FG+V  G  + G  VA+K  +  A  Q F+ E   + 
Sbjct: 3   LNMKELKL-------LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMT 54

Query: 126 SIQHRNLVTLLGY-CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
            ++H NLV LLG   +E    +++ EY+  GS+  +L       R  L     L  +L  
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDV 111

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQVTADE 243
            + + +L + +   VH+D    NVLV ED +AKV+D GL      T D      + TA E
Sbjct: 112 CEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPE 169

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GR 276
                 ++E ++FS KSDV+SFG+ L E+ S GR
Sbjct: 170 -----ALRE-KKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 94.7 bits (235), Expect = 4e-22
 Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 22/219 (10%)

Query: 85  IGEGKFGEVY----KGLL--QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V+      LL  QD MLVA+K    A     Q+F  E   L  +QH+++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHL--YGP--------SQVSRQKLEFKHRLSIALGAA 185
            G C E     +++EY+ +G ++  L  +GP          V+  +L     L+IA   A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 245
            G+ +L SL    VH+D  T N LV +  + K+ D G+   +  TD      +      +
Sbjct: 133 SGMVYLASL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS 283
           +  E   +R+F+ +SD++SFGV L E+ + G++    LS
Sbjct: 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 94.1 bits (234), Expect = 5e-22
 Identities = 79/294 (26%), Positives = 123/294 (41%), Gaps = 46/294 (15%)

Query: 85  IGEGKFGEVYK----GLL--QDGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVT 134
           IG+G FG V++    GLL  +   +VA+K  +  A      +F  E   +A   H N+V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHL-----YGPSQVSRQKLEFK------------HR 177
           LLG C       L++EY+  G ++  L          +S      +             +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 178 LSIALGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 236
           L IA   A G+A+   LS R  VH+D  T N LV E+ + K+AD GL   +   D    S
Sbjct: 133 LCIAKQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 296
                   ++  E   + R++ +SDV+++GV L E+      S  + P       E++  
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF-----SYGMQPYYGMAHEEVIYY 244

Query: 297 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 350
            RD  N+L   D        N  +E +  L+  C       RPS + +   L R
Sbjct: 245 VRD-GNVLSCPD--------NCPLELY-NLMRLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 93.9 bits (233), Expect = 6e-22
 Identities = 71/219 (32%), Positives = 116/219 (52%), Gaps = 17/219 (7%)

Query: 84  LIGEGKFGEVYKGL-LQDG----MLVAIK---KRPGAPT-QEFIDEVCFLASIQHRNLVT 134
           L+G G FG V+KG+ + +G    + VAIK    R G  T QE  D +  + S+ H  +V 
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           LLG C   +LQ L+ +  P GS+  H+    +  R  L+ +  L+  +  AKG+ +L   
Sbjct: 74  LLGICPGASLQ-LVTQLSPLGSLLDHV----RQHRDSLDPQRLLNWCVQIAKGMYYLEE- 127

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
             R+VH++    N+L+  D I ++AD G+ + L   D     S+      ++A E   F 
Sbjct: 128 -HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 255 RFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE 292
           R++ +SDV+S+GV + E++S G E  + + P    DL+E
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 92.7 bits (230), Expect = 2e-21
 Identities = 77/277 (27%), Positives = 124/277 (44%), Gaps = 23/277 (8%)

Query: 85  IGEGKFGEV----YKGLLQD-GMLVAIK--KRPGAP--TQEFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V    Y       G +VA+K  KR      T  +  E+  L ++ H N+V  
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 136 LGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            G C E   +   LI EY+P GS+  +L       + KL     L  A    +G+A+LHS
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL------PKHKLNLAQLLLFAQQICEGMAYLHS 125

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVKE 252
                +H+D    NVL+D D + K+ D GL   +          +     +F  A E  +
Sbjct: 126 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-QDLVELVQNSRDFSNLLKILDERL 311
             +FS  SDV+SFGV L EL++     S  SP    ++++   Q       L+++L+  +
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT--HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241

Query: 312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
                    +E   L+  C +  ++ RP+   ++  L
Sbjct: 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 92.8 bits (230), Expect = 3e-21
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 41/297 (13%)

Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL ++       VA+K      T+    + I E+  +  I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y P+QV  ++L FK  +S 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
           A   A+G+ +L   S + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 146 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 203

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV L E+      +   SP     + E        
Sbjct: 204 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF-----TLGGSPYPGVPVEE-------- 250

Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 357
             L K+L E       +    E   ++  C      +RP+   +V +LDR L    N
Sbjct: 251 --LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 90.6 bits (225), Expect = 7e-21
 Identities = 73/277 (26%), Positives = 120/277 (43%), Gaps = 47/277 (16%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRN 131
           +F   N IG+G FG V+K + + D  + A+K     K      +E IDE   LA +    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE---FKHRLSIALGAAKGL 188
           ++       +     ++ EY  NG +  H     Q  R   E   ++  + I LG    L
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDL--HKLLKMQRGRPLPEDQVWRFFIQILLG----L 114

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG------RTDVAGPSSQVTAD 242
           AHLHS   +++H+D K+ N+ +D     K+ D G+   L        T V  P       
Sbjct: 115 AHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTP------- 165

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 302
             +L+ E+ E + ++EKSDV++ GV L E  +G+       P  + +   L+        
Sbjct: 166 -YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKH------PFDANNQGALI-------- 210

Query: 303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP 339
            LKI+    +   +    ++  QLI +CL     +RP
Sbjct: 211 -LKIIRGV-FPPVSQMYSQQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 90.6 bits (225), Expect = 1e-20
 Identities = 76/310 (24%), Positives = 131/310 (42%), Gaps = 50/310 (16%)

Query: 67  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKK-RPGAPTQEFID 119
              + L+L          +GEG FG+V K              VA+K  +  A  ++  D
Sbjct: 9   LPRDRLTLG-------KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD 61

Query: 120 ---EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGP 164
              E+  +  I +H+N++ LLG C +    +++ EY  +G++   L              
Sbjct: 62  LVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121

Query: 165 SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR 224
            +   + L  K  +S A   A+G+  L S   + +H+D    NVLV ED + K+AD GL 
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTEDHVMKIADFGLA 179

Query: 225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSL 282
             +   D    ++       ++A E    R ++ +SDV+SFGV L E+ +  G       
Sbjct: 180 RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG------- 232

Query: 283 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 342
           SP     + EL +  ++       +++    T      +E   L+  C      +RP+  
Sbjct: 233 SPYPGIPVEELFKLLKEG----YRMEKPQNCT------QELYHLMRDCWHEVPSQRPTFK 282

Query: 343 DVVTELDRTL 352
            +V +LDR L
Sbjct: 283 QLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 63/279 (22%), Positives = 120/279 (43%), Gaps = 41/279 (14%)

Query: 78  NFSDKNLIGEGKFGEVYK-GLLQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 131
           +F     +G+G +G VYK   L D    A+K+           ++ ++E+  LAS+ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL--SIALGAAKGLA 189
           +++      + N   ++ EY P G +S      S+  +++     +    I +   +GL 
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLS---KAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIF 245
            LH    +++H+D K+AN+L+  + + K+ D G    L+  + +T +  P         +
Sbjct: 118 ALHEQ--KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTP--------HY 167

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 305
           +A EV + R +S KSD++S G  L E+ +           S QDL   VQ  +       
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFA---PPFEARSMQDLRYKVQRGK------- 217

Query: 306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
                +   ++    ++    I   L    + RP+   +
Sbjct: 218 --YPPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 89.2 bits (221), Expect = 2e-20
 Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 50/279 (17%)

Query: 83  NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT---------QEFIDEVCFLASIQHRNLV 133
            ++G+G +G VY GL   G L+A+K+     +         ++  +EV  L S++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIALGAA 185
             LG C ++N   +  E++P GS+S  ++ +GP       + ++Q L+            
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD------------ 113

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ----VTA 241
            G+A+LH+    VVH+D K  NV++  + I K+ D G    L    + G  S     +  
Sbjct: 114 -GVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 301
              ++A EV     +  KSD++S G  + E+ +G+   +S+   ++   +  +   R   
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---MFYIGAHR--- 224

Query: 302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 340
            L+  L +              I  +  CL      RPS
Sbjct: 225 GLMPRLPDSF--------SAAAIDFVTSCLTRDQHERPS 255

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 89.1 bits (221), Expect = 2e-20
 Identities = 77/266 (28%), Positives = 121/266 (45%), Gaps = 40/266 (15%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VAIK  + G+ + E F+ E   +  +QH  LV L     + 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
            + ++I EY+ NGS+   L  P  +   KL     + +A   A+G+A +   +   +H+D
Sbjct: 74  PI-YIITEYMENGSLVDFLKTPEGI---KLTINKLIDMAAQIAEGMAFIERKN--YIHRD 127

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV E    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 128 LRAANILVSETLCCKIADFGLARLI-------EDNEYTAREGAKFPIKWTAPEAINYGTF 180

Query: 257 SEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 315
           + KSDV+SFG+ L E+V+ GR       P       E++QN            ER +   
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR------IPYPGMTNPEVIQNL-----------ERGYRMP 223

Query: 316 TNEGM-EEFIQLIVRCLDPSSERRPS 340
             +   EE  +L+  C     E RP+
Sbjct: 224 RPDNCPEELYELMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 88.6 bits (220), Expect = 5e-20
 Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 18/202 (8%)

Query: 82  KNLIGEGKFGEVYKGLLQD----GMLVAIK--KRPGAP--TQEFIDEVCFLASIQHRNLV 133
              IGEG+FG+VY+G+        + VA+K  K   +P   ++F+ E   +    H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            L+G   EN + +++ E  P G +  +L    QV++  L+    +  +   +  LA+L S
Sbjct: 71  KLIGVITENPV-WIVMELAPLGELRSYL----QVNKYSLDLASLILYSYQLSTALAYLES 125

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKE 252
              R VH+D    NVLV      K+ D GL  +L        S       I ++A E   
Sbjct: 126 K--RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS--KGKLPIKWMAPESIN 181

Query: 253 FRRFSEKSDVYSFGVFLLELVS 274
           FRRF+  SDV+ FGV + E++ 
Sbjct: 182 FRRFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 88.5 bits (219), Expect = 7e-20
 Identities = 67/238 (28%), Positives = 115/238 (48%), Gaps = 26/238 (10%)

Query: 82  KNLIGEGKFGEVYKGL------LQDGMLVAIK--KRPG-APTQEFIDEVCFLASIQHRNL 132
           K  +GEG FG+V+          +D MLVA+K  K P  A  ++F  E   L ++QH ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQV---------SRQKLEFKHRLSIA 181
           V   G C + +   +++EY+ +G ++  L  +GP  +         ++ +L     L IA
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
              A G+ +L   S   VH+D  T N LV  + + K+ D G+   +  TD          
Sbjct: 130 SQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR 298
              ++  E   +R+F+ +SDV+SFGV L E+ + G++    LS     +++E +   R
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEVIECITQGR 242

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 87.8 bits (217), Expect = 8e-20
 Identities = 61/196 (31%), Positives = 104/196 (53%), Gaps = 12/196 (6%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  +PG  + E F++E   +  ++H  LV L     E 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
            + +++ EY+  GS+   L        + L+  + + +A   A G+A++  ++   +H+D
Sbjct: 74  PI-YIVTEYMSKGSLLDFL---KDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRD 127

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            ++AN+LV +  + K+AD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 262 VYSFGVFLLELVS-GR 276
           V+SFG+ L ELV+ GR
Sbjct: 186 VWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 68/239 (28%), Positives = 113/239 (47%), Gaps = 23/239 (9%)

Query: 78  NFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQ 128
           N   K  +GEG FG+V+          QD +LVA+K    A     ++F  E   L ++Q
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQV------SRQKLEFKHRLSI 180
           H ++V   G C E +   +++EY+ +G ++  L  +GP  V         +L     L I
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
           A   A G+ +L   S   VH+D  T N LV E+ + K+ D G+   +  TD         
Sbjct: 126 AQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR 298
               ++  E   +R+F+ +SDV+S GV L E+ + G++    L   S+ +++E +   R
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL---SNNEVIECITQGR 239

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 42/233 (18%)

Query: 78  NFSDKNLIGEGKFGEVY------------KGLLQDGM-----LVAIKK-RPGAPT---QE 116
           NF +K  +GEG+FGEV+            K   ++       LVA+K  RP A     ++
Sbjct: 8   NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65

Query: 117 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPS 165
           F+ EV  L+ +   N+  LLG C  +    +I EY+ NG ++  L               
Sbjct: 66  FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 166 QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN 225
            +S   L     L +A   A G+ +L SL+   VH+D  T N LV +++  K+AD G+  
Sbjct: 126 SLSFSTL-----LYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSR 178

Query: 226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GRE 277
            L  +D      +      ++A E     +F+ KSDV++FGV L E+++  RE
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 75/290 (25%), Positives = 132/290 (45%), Gaps = 50/290 (17%)

Query: 82  KNLIGEGKFGEVYKGLLQ----DGMLVAIKK-RPG---APTQEFIDEVCFLASIQHRNLV 133
           + +IG G+FGEV++G+L+      + VAIK  +PG      Q+F+ E   +    H N++
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLSIALGAAKG 187
            L G   +     +I EY+ NG++  +L      +   Q+          + +  G A G
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL----------VGMLRGIAAG 119

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--- 244
           + +L  ++   VH+D    N+LV+ +   KV+D GL   L   D    +   +  +I   
Sbjct: 120 MKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIR 175

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN-- 302
           + A E   +R+F+  SDV+SFG+ + E++S  E                 +   D SN  
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE-----------------RPYWDMSNHE 218

Query: 303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           ++K +++        +      QL+++C      RRP   D+V  LD+ L
Sbjct: 219 VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 86.8 bits (215), Expect = 2e-19
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 20/210 (9%)

Query: 83  NLIGEGKFGEVYKGLLQDGML-------VAIKK-RPGAPTQE---FIDEVCFLASIQHRN 131
           N +G G FGEVY+G   D +        VA+K  R GA  QE   F+ E   +++  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK--LEFKHRLSIALGAAKGLA 189
           +V LLG C  N  Q++I E +  G +  +L            L  K  L I L  AKG  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 190 HLHSLSPRVVHKDFKTANVLVDE-----DFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
           +L  +    +H+D    N LV E     D + K+ D GL   + ++D      +      
Sbjct: 121 YLEQM--HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           ++A E     +F+ +SDV+SFGV + E+++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 86.6 bits (214), Expect = 2e-19
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 20/198 (10%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G   +   VA+K  +PG    Q F++E   + ++QH  LV L     + 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
              ++I EY+  GS+   L         K+     +  +   A+G+A++       +H+D
Sbjct: 74  EPIYIITEYMAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIER--KNYIHRD 128

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + ANVLV E  + K+AD GL   +         ++ TA E       + A E   F  F
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVI-------EDNEYTAREGAKFPIKWTAPEAINFGSF 181

Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSDV+SFG+ L E+V+
Sbjct: 182 TIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 86.3 bits (213), Expect = 3e-19
 Identities = 65/196 (33%), Positives = 101/196 (51%), Gaps = 12/196 (6%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
            + +++ EY+  GS+   L G      + L     + +A   A G+A++  ++   VH+D
Sbjct: 74  PI-YIVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERMN--YVHRD 127

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 262 VYSFGVFLLELVS-GR 276
           V+SFG+ L EL + GR
Sbjct: 186 VWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 86.1 bits (214), Expect = 4e-19
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 29/207 (14%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IGEG +G+VYK    + G LVA+KK      + G P    I E+  L  ++H N+V L  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPIT-AIREIKLLQKLRHPNIVRLKE 65

Query: 138 Y---CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
                 + ++ ++++EY+ +    +      + +  ++  K          +GL +LHS 
Sbjct: 66  IVTSKGKGSI-YMVFEYMDHDLTGLLDSPEVKFTESQI--KC---YMKQLLEGLQYLHS- 118

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT----ADEIFLASE 249
              ++H+D K +N+L++ D + K+AD GL R +  R      +  +T      E+ L + 
Sbjct: 119 -NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGR 276
                R+  + D++S G  L EL  G+
Sbjct: 178 -----RYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 85.5 bits (212), Expect = 6e-19
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 21/209 (10%)

Query: 82  KNLIGEGKFGEVYKGLLQDG-------MLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNL 132
            +L+ EG FG ++ G+L D        + V   K   +  Q    + E C L  + H+N+
Sbjct: 11  SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70

Query: 133 VTLLGYCQEN-NLQFLIYEYIPNGSVSIHL----YGPSQVSRQKLEFKHRLSIALGAAKG 187
           + +L  C E+    F++Y Y+  G++ + L     G +    Q L  +  + +A+  A G
Sbjct: 71  LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNP-QALSTQQLVHMAIQIACG 129

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RN-FLGRTDVAGPSSQVTADEIF 245
           +++LH     V+HKD    N ++DE+   K+ D  L R+ F       G +       + 
Sbjct: 130 MSYLHKR--GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMA 187

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           L S V +   +S  SDV+SFGV L EL++
Sbjct: 188 LESLVNKE--YSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 85.4 bits (211), Expect = 8e-19
 Identities = 87/302 (28%), Positives = 131/302 (43%), Gaps = 46/302 (15%)

Query: 71  ELSLATKNFSDKNLIGEGKFGEVYKG-LLQDGM----LVAIK--KRPGAPTQ--EFIDEV 121
           EL L+   F ++  +GE  FG++YKG L   GM    LVAIK  K    P Q  EF  E 
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS------------R 169
             +A + H N+V LLG   +     +++EY+  G +   L   S  S            +
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
             L+    L IA+  A G+ +L   S   VHKD    N+L+ E    K++D GL   +  
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176

Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD---S 286
            D      +      ++  E   + +FS  SD++SFGV L E+      S  L P    S
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF-----SFGLQPYYGFS 231

Query: 287 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 346
           +Q+++E+V+  R      +    R++S            L+  C      RRP   D+ T
Sbjct: 232 NQEVIEMVRK-RQLLPCSEDCPPRMYS------------LMTECWQEGPSRRPRFKDIHT 278

Query: 347 EL 348
            L
Sbjct: 279 RL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 58/193 (30%), Positives = 95/193 (49%), Gaps = 11/193 (5%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VAIK  K       EFI+E   +  + H  LV L G C + 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
              +++ EY+ NG +  +L    +   ++ +    L +     +G+A+L   S + +H+D
Sbjct: 72  RPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEGMAYLE--SKQFIHRD 125

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
               N LVD+    KV+D GL  ++   D    SS  +   + +   EV  + +FS KSD
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183

Query: 262 VYSFGVFLLELVS 274
           V++FGV + E+ S
Sbjct: 184 VWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 84/302 (27%), Positives = 133/302 (44%), Gaps = 46/302 (15%)

Query: 71  ELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK----KRPGAPTQEFIDE 120
           E++L+T  F ++  +GE +FG+VYKG L      +    VAIK    K  G   +EF  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS-----------R 169
               + +QH N+V LLG   +     +I+ Y  +  +   L   S  S           +
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
             LE    + I    A G+  L   S  VVHKD  T NVLV +    K++D GL   +  
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLS--SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DS 286
            D             +++ E   + +FS  SD++S+GV L E+      S  L P    S
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF-----SYGLQPYCGYS 231

Query: 287 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 346
           +QD++E+++N +    +L   D+     +T         L++ C +    RRP   D+ +
Sbjct: 232 NQDVIEMIRNRQ----VLPCPDDCPAWVYT---------LMLECWNEFPSRRPRFKDIHS 278

Query: 347 EL 348
            L
Sbjct: 279 RL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 72/281 (25%), Positives = 129/281 (45%), Gaps = 34/281 (12%)

Query: 84  LIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTL 135
           +IG G+FGEV +G L+      + VAIK      T+    +F+ E   +    H N++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
            G   ++    +I E++ NG++   L    + +  +      + +  G A G+ +L  ++
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFL----RQNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADEI-FLASEVKE 252
              VH+D    N+LV+ + + KV+D GL  FL    +D    SS      I + A E   
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 253 FRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 311
           +R+F+  SDV+S+G+ + E++S G      +   S+QD++  ++            D RL
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPYWDM---SNQDVINAIEQ-----------DYRL 230

Query: 312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
                 +      QL++ C       RP    +V+ LD+ +
Sbjct: 231 PPPM--DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 76/272 (27%), Positives = 120/272 (44%), Gaps = 32/272 (11%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FGEV+ G L+ D   VA+K  R   P     +F+ E   L    H N+V L+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
            +    +++ E +  G     L    +    +L+ K  + +   AA G+ +L S     +
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFL----RTEGPRLKVKELIQMVENAAAGMEYLES--KHCI 116

Query: 200 HKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           H+D    N LV E  + K++D G+      G     G   Q+     + A E   + R+S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK--WTAPEALNYGRYS 174

Query: 258 EKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT 316
            +SDV+SFG+ L E  S G    ++LS   +++ +E  Q  R     L   +        
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE--QGVR-----LPCPE-------- 219

Query: 317 NEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
               +   +L+ RC +    +RPS S V  EL
Sbjct: 220 -LCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 77/300 (25%), Positives = 133/300 (44%), Gaps = 55/300 (18%)

Query: 82  KNLIGEGKFGEVYKGLL-QDG--MLVAIKKRPGAPTQE----FIDEVCFLASI-QHRNLV 133
           +++IGEG FG+V K  + +DG  M  AIK+     +++    F  E+  L  +  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIAL 182
            LLG C+     +L  EY P+G++   L           +  +  +   L  +  L  A 
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGRTDVAG 234
             A+G+ +L     + +H+D    N+LV E+++AK+AD GL        +  +GR  V  
Sbjct: 132 DVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR- 188

Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 294
                     ++A E   +  ++  SDV+S+GV L E+V     S   +P       EL 
Sbjct: 189 ----------WMAIESLNYSVYTTNSDVWSYGVLLWEIV-----SLGGTPYCGMTCAELY 233

Query: 295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 354
           +       L K L+            +E   L+ +C       RPS + ++  L+R L++
Sbjct: 234 EKLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 45/220 (20%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT-------------QEFIDEVCFLASIQH 129
           LIG+G +G VY  L +  G ++A+K+     T             +    E+  L  + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIA 181
            N+V  LG+        +  EY+P GS+   +  YG          + Q LE        
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE-------- 119

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
                GLA+LHS    ++H+D K  N+LVD D I K++D G+     ++D    + Q  +
Sbjct: 120 -----GLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISK---KSDDIYDNDQNMS 169

Query: 242 --DEIF-LASEVKEFRR--FSEKSDVYSFGVFLLELVSGR 276
               +F +A EV       +S K D++S G  +LE+ +GR
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 86.1 bits (213), Expect = 4e-18
 Identities = 77/307 (25%), Positives = 131/307 (42%), Gaps = 32/307 (10%)

Query: 62  REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDG----MLVAIKKRPGAPTQEF 117
           + ++   + ++  + K   ++N+I  GK G  YKG         ++  I      P+ E 
Sbjct: 678 KVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEI 734

Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 177
            D    +  +QH N+V L+G C+     +LI+EYI   ++S  L   S   R+K      
Sbjct: 735 AD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRK------ 784

Query: 178 LSIALGAAKGLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 236
             IA+G AK L  LH   SP VV  +     +++D      +    L   L        S
Sbjct: 785 --IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS 841

Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 296
           S       ++A E +E +  +EKSD+Y FG+ L+EL++G+ + +         +VE  + 
Sbjct: 842 SA------YVAPETRETKDITEKSDIYGFGLILIELLTGK-SPADAEFGVHGSIVEWARY 894

Query: 297 SRDFSNLLKILDERLW---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
                +L   +D  +    S   NE + E + L + C       RP  +DV+  L+    
Sbjct: 895 CYSDCHLDMWIDPSIRGDVSVNQNE-IVEVMNLALHCTATDPTARPCANDVLKTLESASR 953

Query: 354 KEMNLTT 360
              +  T
Sbjct: 954 SSSSCVT 960

Length = 968

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 82.6 bits (204), Expect = 4e-18
 Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 30/270 (11%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V+ G  +  + VAIK    GA ++E FI+E   +  + H  LV L G C + 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71

Query: 143 NLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
              +++ E++ NG +  +L    G  ++S+  L     LS+     +G+ +L   S   +
Sbjct: 72  KPLYIVTEFMENGCLLNYLRQRQG--KLSKDML-----LSMCQDVCEGMEYLERNS--FI 122

Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEK 259
           H+D    N LV    + KV+D G+  ++   D    SS       +   EV  F ++S K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 260 SDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG 319
           SDV+SFGV + E+ +  E        S+ ++VE++  SR F    ++   +L S    E 
Sbjct: 182 SDVWSFGVLMWEVFT--EGKMPFEKKSNYEVVEMI--SRGF----RLYRPKLASMTVYEV 233

Query: 320 MEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
           M         C     E RP+ ++++  + 
Sbjct: 234 M-------YSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 83.5 bits (206), Expect = 5e-18
 Identities = 74/297 (24%), Positives = 130/297 (43%), Gaps = 41/297 (13%)

Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
               A+G+ +L   S + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 143 TYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGR 200

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV + E+      +   SP     + E        
Sbjct: 201 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF-----TLGGSPYPGIPVEE-------- 247

Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 357
             L K+L E            E   ++  C       RP+   +V +LDR L    N
Sbjct: 248 --LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 83.3 bits (206), Expect = 5e-18
 Identities = 75/280 (26%), Positives = 124/280 (44%), Gaps = 38/280 (13%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQE----FIDEVCFLASIQH 129
           K F+D   IG G FG VY    ++   +VAIKK    G  + E     I EV FL  ++H
Sbjct: 15  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            N +   G     +  +L+ EY   GS S  L    +V ++ L+     +I  GA +GLA
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEYCL-GSASDIL----EVHKKPLQEVEIAAICHGALQGLA 129

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +LHS     +H+D K  N+L+ E    K+AD       G   +  P++       ++A E
Sbjct: 130 YLHSHE--RIHRDIKAGNILLTEPGTVKLAD------FGSASLVSPANSFVGTPYWMAPE 181

Query: 250 V---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 306
           V    +  ++  K DV+S G+  +EL   +    +++  S+  L  + QN          
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNDSP------- 232

Query: 307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 346
                 +  +N+  + F   +  CL    + RPS  +++ 
Sbjct: 233 ------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 6e-18
 Identities = 77/268 (28%), Positives = 118/268 (44%), Gaps = 37/268 (13%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLLGYCQ 140
           IG G +G+VYK   +  G LVAIK     P  +F     E+  L   +H N+V   G   
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL---GAAKGLAHLHSLSPR 197
             +  +++ EY   GS+   +Y   QV+R  L     L IA       KGLA+LH     
Sbjct: 71  RRDKLWIVMEYCGGGSLQ-DIY---QVTRGPLS---ELQIAYVCRETLKGLAYLHET--G 121

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV-----TADEIFLASEVKE 252
            +H+D K AN+L+ ED   K+AD G+   L  T +A   S +      A E+   + V+ 
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-IAKRKSFIGTPYWMAPEV---AAVER 177

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 312
              +  K D+++ G+  +EL   +     L P     +  L   S+      K+ D+  W
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLHP-----MRALFLISKSNFPPPKLKDKEKW 232

Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPS 340
           S         F   I +CL    ++RP+
Sbjct: 233 SP-------VFHDFIKKCLTKDPKKRPT 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 82.2 bits (203), Expect = 7e-18
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 32/214 (14%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK------------KRPGAPTQEFIDEVCFLASIQHR 130
           LIG G FG VY G+    G L+A+K             R  +       E+  L  +QH 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQVSRQKLEFKHRLSIALGAAKGL 188
           N+V  LG   + +   +  EY+P GSV+  L  YG  + +  +   +  L       KGL
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-------KGL 119

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL------GRTDVAGPSSQVTAD 242
            +LH  +  ++H+D K AN+LVD     K++D G+   L       +T+ A PS Q +  
Sbjct: 120 NYLH--NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV- 176

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             ++A EV +   ++ K+D++S G  ++E+++G+
Sbjct: 177 -FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 82.3 bits (204), Expect = 7e-18
 Identities = 69/270 (25%), Positives = 116/270 (42%), Gaps = 31/270 (11%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEF----IDEVCFLASIQHRNLVTLLG-Y 138
           +G+G  G VYK   +  G + A+KK      +EF    + E+  L S +   +V   G +
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
            +E  +  ++ EY+  GS++  L    ++    L +     IA    KGL +LH+    +
Sbjct: 69  YKEGEI-SIVLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQILKGLDYLHTKR-HI 121

Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSE 258
           +H+D K +N+L++     K+AD G+   L  T     +   T    +++ E  +   +S 
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTV--TYMSPERIQGESYSY 179

Query: 259 KSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNE 318
            +D++S G+ LLE   G+       P       EL+Q   D       L    +S     
Sbjct: 180 AADIWSLGLTLLECALGK---FPFLPPGQPSFFELMQAICDGPPPS--LPAEEFS----- 229

Query: 319 GMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
              EF   I  CL    ++RPS      EL
Sbjct: 230 --PEFRDFISACLQKDPKKRPS----AAEL 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 82.0 bits (202), Expect = 8e-18
 Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 12/196 (6%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG    E F+ E   +  ++H  LV L     E 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
            + +++ E++  GS+   L    +   + L+    + +A   A G+A++  ++   +H+D
Sbjct: 74  PI-YIVTEFMGKGSLLDFL---KEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRD 127

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV ++ + K+AD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 262 VYSFGVFLLELVS-GR 276
           V+SFG+ L ELV+ GR
Sbjct: 186 VWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 82.3 bits (203), Expect = 8e-18
 Identities = 77/308 (25%), Positives = 126/308 (40%), Gaps = 64/308 (20%)

Query: 85  IGEGKFGEVYKGL------LQDGMLVAIKK-RPGAPTQEFID---EVCFLASIQHRNLVT 134
           +GEG+FG+V K              VA+K  +  A + E  D   E   L  + H +++ 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHL-----YGPSQVSR--------------QKLEFK 175
           L G C ++    LI EY   GS+   L      GPS +                + L   
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 176 HRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 235
             +S A   ++G+ +L  +   +VH+D    NVLV E    K++D GL   +   D    
Sbjct: 128 DLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185

Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELV 294
            S+      ++A E      ++ +SDV+SFGV L E+V+ G      ++P          
Sbjct: 186 RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP---------- 235

Query: 295 QNSRDFSNLLKILDERLWSTF-TNEGM-------EEFIQLIVRCLDPSSERRPSMSDVVT 346
                         ERL++   T   M       EE   L++ C     ++RP+ +D+  
Sbjct: 236 --------------ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281

Query: 347 ELDRTLDK 354
           EL++ + K
Sbjct: 282 ELEKMMVK 289

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 80/296 (27%), Positives = 132/296 (44%), Gaps = 40/296 (13%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           K FSD   IG G FG VY    +++  +VAIKK      +     Q+ I EV FL  ++H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            N +   G     +  +L+ EY   GS S  L    +V ++ L+     ++  GA +GLA
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAVTHGALQGLA 129

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +LHS +  ++H+D K  N+L+ E  + K+ D       G   +  P++       ++A E
Sbjct: 130 YLHSHN--MIHRDVKAGNILLSEPGLVKLGD------FGSASIMAPANXFVGTPYWMAPE 181

Query: 250 V---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 306
           V    +  ++  K DV+S G+  +EL          + ++   L  + QN          
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIAQNES------PA 233

Query: 307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVM 362
           L    WS       E F   +  CL    + RP+ S+V+ +  R + +E   T +M
Sbjct: 234 LQSGHWS-------EYFRNFVDSCLQKIPQDRPT-SEVLLK-HRFVLRERPPTVIM 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 29/206 (14%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IGEG  G V+K    + G  VA+KK        G P Q  + E+  L + QH  +V LL 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQ-ALREIKALQACQHPYVVKLLD 66

Query: 138 YCQENNLQFLIYEYIPNG--SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
                +   L+ EY+P+    V      P   ++ K   +  L       KG+A++H+  
Sbjct: 67  VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLL-------KGVAYMHAN- 118

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-----ADEIFLASEV 250
             ++H+D K AN+L+  D + K+AD GL       +    S QV      A E+   +  
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA-- 175

Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGR 276
              R++    D+++ G    EL++G 
Sbjct: 176 ---RKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 74/286 (25%), Positives = 123/286 (43%), Gaps = 45/286 (15%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ 128
             NF  +  IG+G+F  VYK + L DG +VA+KK            Q+ + E+  L  + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
           H N++  L    ENN   ++ E    G +S  +    +  ++ +  +      +     L
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLS-RMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA------D 242
            H+HS   R++H+D K ANV +    + K+ D GL  F         SS+ TA       
Sbjct: 120 EHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFF--------SSKTTAAHSLVGT 169

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP--DSSQDLVELVQN--SR 298
             +++ E      ++ KSD++S G  L E+ + +      SP      +L  L +     
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------SPFYGDKMNLYSLCKKIEKC 223

Query: 299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           D+  L        +S       EE   L+ RC++P  E+RP +S V
Sbjct: 224 DYPPLPA----DHYS-------EELRDLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 79/312 (25%), Positives = 138/312 (44%), Gaps = 45/312 (14%)

Query: 85  IGEGKFGEVYK----GLLQD----GMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V +    G+ +      + VA+K      T     + I E+  +  I +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLY-----GP------SQVSRQKLEFKHRLSI 180
           ++ LLG C +    ++I EY   G++   L      GP      ++V  ++L FK  +S 
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
           A   A+G+ +L S   R +H+D    NVLV ED + K+AD GL   +   D    +S   
Sbjct: 140 AYQVARGMEYLES--RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGR 197

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 300
               ++A E    R ++ +SDV+SFG+ + E+ +   +     P                
Sbjct: 198 LPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---------------V 242

Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL----DKEM 356
             L K+L E       +    E   L+  C      +RP+   +V  LD+ L    ++ +
Sbjct: 243 EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYL 302

Query: 357 NLTTVMGEGTPT 368
           +L+    + +P+
Sbjct: 303 DLSMPFEQYSPS 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 80.3 bits (198), Expect = 4e-17
 Identities = 72/279 (25%), Positives = 130/279 (46%), Gaps = 37/279 (13%)

Query: 81  DKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQE---FIDEVCFLASIQHRNLVTLL 136
           ++ ++G+G +G VY    L   + +AIK+ P   ++      +E+   + ++HRN+V  L
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 137 GYCQENNLQFLIY-EYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           G   EN   F I+ E +P GS+S  L   +GP + + Q + F  +  +     +GL +LH
Sbjct: 72  GSDSENGF-FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLH 125

Query: 193 SLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV- 250
               ++VH+D K  NVLV+    + K++D G    L   +    +   T    ++A EV 
Sbjct: 126 DN--QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVI 181

Query: 251 -KEFRRFSEKSDVYSFGVFLLELVSGREASSSL-SPDSSQDLVELVQNSRDFSNLLKILD 308
            K  R +   +D++S G  ++E+ +G+     L  P ++   V           + KI  
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV----------GMFKIHP 231

Query: 309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 347
           E            E    I+RC +P  ++R S  D++ +
Sbjct: 232 E-----IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 80.4 bits (198), Expect = 4e-17
 Identities = 77/280 (27%), Positives = 136/280 (48%), Gaps = 39/280 (13%)

Query: 84  LIGEGKFGEVYKGL-LQDG----MLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           ++G G FG VYKG+ + DG    + VAIK       P A  +E +DE   +A +    + 
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA-NKEILDEAYVMAGVGSPYVC 72

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            LLG C  + +Q L+ + +P G +  ++    + ++ ++  +  L+  +  AKG+++L  
Sbjct: 73  RLLGICLTSTVQ-LVTQLMPYGCLLDYV----RENKDRIGSQDLLNWCVQIAKGMSYLEE 127

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG--RTDVAGPSSQVTADEIFLASEVK 251
           +  R+VH+D    NVLV      K+ D GL   L    T+      +V    + L S + 
Sbjct: 128 V--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185

Query: 252 EFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 310
             RRF+ +SDV+S+GV + EL++ G +    +              +R+  +LL+   ER
Sbjct: 186 --RRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-------------AREIPDLLE-KGER 229

Query: 311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 350
           L        ++ ++ ++V+C    SE RP   ++V E  R
Sbjct: 230 L-PQPPICTIDVYM-IMVKCWMIDSECRPRFRELVDEFSR 267

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 75/317 (23%), Positives = 138/317 (43%), Gaps = 54/317 (17%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----------------QEFIDEVCFLASI- 127
           +GEG FG+V   ++ + + +  K +P  P                  + + E+  +  I 
Sbjct: 20  LGEGCFGQV---VMAEAIGID-KDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKH 176
           +H+N++ LLG C ++   +++ EY   G++  +L           +   ++  ++L FK 
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 177 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 236
            +S A   A+G+ +L   S + +H+D    NVLV ED + K+AD GL   +   D    +
Sbjct: 136 LVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193

Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 296
           +       ++A E    R ++ +SDV+SFGV L E+      +   SP     + E    
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF-----TLGGSPYPGIPVEE---- 244

Query: 297 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL---- 352
                 L K+L E            E   ++  C      +RP+   +V +LDR L    
Sbjct: 245 ------LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298

Query: 353 -DKEMNLTTVMGEGTPT 368
            D+ ++L+    + +P 
Sbjct: 299 TDEYLDLSVPFEQYSPG 315

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 80.5 bits (198), Expect = 5e-17
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 28/206 (13%)

Query: 84  LIGEGKFGEVYKGL-LQDG----MLVAIK--KRPGAPTQ--EFIDEVCFLASIQHRNLVT 134
           ++G G FG VYKG+ + +G    + VAIK       P    EF+DE   +AS+ H +LV 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-GPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
           LLG C    +Q L+ + +P+G +  +++     +  Q L     L+  +  AKG+ +L  
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLE- 126

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE-----IFLAS 248
              R+VH+D    NVLV      K+ D GL   L      G   +  AD       ++A 
Sbjct: 127 -ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----EGDEKEYNADGGKMPIKWMAL 180

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS 274
           E   +R+F+ +SDV+S+GV + EL++
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 80.4 bits (198), Expect = 5e-17
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 40/220 (18%)

Query: 82  KNLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRNLV 133
           +++IGEG FG+V + +++ DG  M  AIK      ++    +F  E+  L  +  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIAL 182
            LLG C+     ++  EY P G++   L           +     +   L  +  L  A 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGRTDVAG 234
             A G+ +L     + +H+D    NVLV E+  +K+AD GL        +  +GR  V  
Sbjct: 127 DVATGMQYLSE--KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR- 183

Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                     ++A E   +  ++ KSDV+SFGV L E+VS
Sbjct: 184 ----------WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 79.8 bits (197), Expect = 5e-17
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 36/211 (17%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIKKRP----GAPTQEFI----DEVCFLASIQHRNLVT 134
           L+G G FG VY+GL L DG   A+K+      G   QE +     E+  L+ +QH N+V 
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHL--YGP------SQVSRQKLEFKHRLSIALGAAK 186
            LG  +E +  ++  E +P GS++  L  YG          +RQ L              
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-------------L 113

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 246
           GL +LH      VH+D K AN+LVD + + K+AD G+   +     A           ++
Sbjct: 114 GLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA---KSFKGSPYWM 168

Query: 247 ASEV-KEFRRFSEKSDVYSFGVFLLELVSGR 276
           A EV  +   +   +D++S G  +LE+ +G+
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 79.8 bits (198), Expect = 6e-17
 Identities = 75/299 (25%), Positives = 119/299 (39%), Gaps = 58/299 (19%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEF----IDEVCFLASIQHRNL 132
           +     +GEG +G VYK    + G +VA+KK R     +      + E+  L  ++H N+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           V LL         +L++EY         L          L      SI     +GLA+ H
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-----DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFL--GRT---DVAGPSSQVT----AD 242
           S   R++H+D K  N+L++ D + K+AD GL R F    RT   +V      VT    A 
Sbjct: 116 S--HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV------VTLWYRAP 167

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE---ASSSLS-----------PDSSQ 288
           EI L S     + +S   D++S G    E+++G+      S +            P    
Sbjct: 168 EILLGS-----KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222

Query: 289 --DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCL--DPSSERRPSMSD 343
              + +L      F        E++      EG    I L+ + L  +P   +R S  +
Sbjct: 223 WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEG----IDLLSKMLQYNP--AKRISAKE 275

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 78.9 bits (195), Expect = 9e-17
 Identities = 69/267 (25%), Positives = 111/267 (41%), Gaps = 25/267 (9%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           IG G    VY  + L +   VAIK+    +      E   EV  ++   H N+V      
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 140 QENNLQFLIYEYIPNGSV-SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
              +  +L+  Y+  GS+  I         R  L+     ++     KGL +LHS     
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSS---YPRGGLDEAIIATVLKEVLKGLEYLHS--NGQ 123

Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADEIFLASEVKEFRR- 255
           +H+D K  N+L+ ED   K+AD G+   L  G                ++A EV E    
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183

Query: 256 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 315
           +  K+D++SFG+  +EL +G    S   P   + L+  +QN  D  +L    D + +S  
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYPP--MKVLMLTLQN--DPPSLETGADYKKYS-- 237

Query: 316 TNEGMEEFIQLIVRCLDPSSERRPSMS 342
                + F ++I  CL     +RP+  
Sbjct: 238 -----KSFRKMISLCLQKDPSKRPTAE 259

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 31/276 (11%)

Query: 85  IGEGKFGEVYKGLLQDGMLVA---IKK-RPGAPTQE---FIDEVCFLASIQHRNLVTLLG 137
           IG G FG+V  G    GM  A   +K+ R  A   E   F+ EV     + H N++  LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
            C E+    L+ E+ P G +  +L     +  Q  +      +A   A GL  LH     
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR--- 254
            +H D    N  +  D   K+ D GL       D             +LA E+ E R   
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD 180

Query: 255 ----RFSEKSDVYSFGVFLLELVSGREASSSLSPD-SSQDLVELVQNSRDFSNLLKILDE 309
                 ++KS+++S GV + EL     A+    PD S + +++ V   +D    +K+   
Sbjct: 181 LLPKDQTKKSNIWSLGVTMWELF---TAADQPYPDLSDEQVLKQVVREQD----IKLPKP 233

Query: 310 RLWSTFTNEGMEEFIQLIVRC-LDPSSERRPSMSDV 344
           +L   ++    + + +++  C LDP  E RP+  +V
Sbjct: 234 QLDLKYS----DRWYEVMQFCWLDP--ETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 70/281 (24%), Positives = 124/281 (44%), Gaps = 40/281 (14%)

Query: 84  LIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTL 135
           +IG G+FGEV  G L+      + VAIK      T+    +F+ E   +    H N++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK--HRLSIALGAAKGLAHLHS 193
            G   ++    ++ EY+ NGS+   L       +   +F     + +  G A G+ +L  
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFL------RKHDGQFTVIQLVGMLRGIASGMKYLSD 124

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEV 250
           +    VH+D    N+LV+ + + KV+D GL   L   D    +      +I   + A E 
Sbjct: 125 MG--YVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTAPEA 180

Query: 251 KEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 309
             +R+F+  SDV+S+G+ + E++S G      +   S+QD+++ ++              
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM---SNQDVIKAIEEGY----------- 226

Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 350
           RL +           QL++ C       RP    +V+ LD+
Sbjct: 227 RLPAPMDCPAA--LHQLMLDCWQKDRNERPKFEQIVSILDK 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 77.5 bits (191), Expect = 3e-16
 Identities = 75/280 (26%), Positives = 127/280 (45%), Gaps = 36/280 (12%)

Query: 83  NLIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVT 134
            +IG+G FG VY G L D     +  A+K           ++F+ E   +    H N+++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 135 LLGYCQENN-LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
           LLG C  +     ++  Y+ +G +   +   +         K  +   L  AKG+ +L  
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYL-- 114

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVK 251
            S + VH+D    N ++DE F  KVAD GL R+   +        +       ++A E  
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER- 310
           + ++F+ KSDV+SFGV L EL++ R A     PD          +S D +  L  L  R 
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT-RGAPP--YPDV---------DSFDITVYL--LQGRR 220

Query: 311 -LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
            L   +  + + E   +++ C  P  E RP+ S++V+ ++
Sbjct: 221 LLQPEYCPDPLYE---VMLSCWHPKPEMRPTFSELVSRIE 257

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 71/303 (23%)

Query: 82  KNLIGEGKFGEVY----KGLL---------QDG--MLVAIKK-RPGAPT---QEFIDEVC 122
           K  +GEG+FGEV+    +GL           DG  +LVA+K  R         +F+ E+ 
Sbjct: 10  KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69

Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG-------------PSQVSR 169
            ++ +++ N++ LLG C  ++   +I EY+ NG ++  L               PS VS 
Sbjct: 70  IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS-VSI 128

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
             L     L +A+  A G+ +L SL+   VH+D  T N LV   +  K+AD G+   L  
Sbjct: 129 ANL-----LYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181

Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQ 288
            D      +      ++A E     +F+  SDV++FGV L E+ +  +E   SL  D   
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239

Query: 289 DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFI-----------QLIVRCLDPSSER 337
              ++++N+ +F              F N+G + ++           +L++RC     + 
Sbjct: 240 ---QVIENTGEF--------------FRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKD 282

Query: 338 RPS 340
           RP+
Sbjct: 283 RPT 285

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 77.0 bits (190), Expect = 4e-16
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 27/204 (13%)

Query: 85  IGEGKFGEVYKGLLQ--DG--MLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLL 136
           +G G FG V KG+     G  + VA+K    +   A  +EF+ E   +A + H  +V L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
           G C+   L  L+ E  P G +  +L    ++    L       +A   A G+A+L S   
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLES--K 114

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------FLASEV 250
             VH+D    NVL+     AK++D G+   LG    AG S    A         + A E 
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALG----AG-SDYYRATTAGRWPLKWYAPEC 169

Query: 251 KEFRRFSEKSDVYSFGVFLLELVS 274
             + +FS KSDV+S+GV L E  S
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 77/276 (27%), Positives = 130/276 (47%), Gaps = 25/276 (9%)

Query: 85  IGEGKFGEVY------KGLLQDGMLVAIKK-RPGAPTQEFID---EVCFLASIQHRNLVT 134
           +GEG FG+V       +G    G  VA+K  +P +      D   E+  L ++ H N+V 
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 135 LLGYCQEN--NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
             G C E+  N   LI E++P+GS+  +L  P   +  K+  K +L  A+   KG+ +L 
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKN--KINLKQQLKYAVQICKGMDYLG 126

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE--IFLASEV 250
           S   + VH+D    NVLV+ +   K+ D GL   +  TD    + +   D    + A E 
Sbjct: 127 S--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-QDLVELVQNSRDFSNLLKILDE 309
               +F   SDV+SFGV L EL++  ++ S  SP +    ++         + L+++L+E
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLTYCDSES--SPMTLFLKMIGPTHGQMTVTRLVRVLEE 241

Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                      EE  QL+ +C +    +R +  +++
Sbjct: 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 77.8 bits (191), Expect = 5e-16
 Identities = 77/282 (27%), Positives = 127/282 (45%), Gaps = 38/282 (13%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           K F+D   IG G FG VY    ++   +VAIKK      +     Q+ I EV FL  I+H
Sbjct: 25  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            N +   G     +  +L+ EY   GS S  L    +V ++ L+     +I  GA +GLA
Sbjct: 85  PNSIEYKGCYLREHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAITHGALQGLA 139

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +LHS +  ++H+D K  N+L+ E    K+AD       G   +A P++       ++A E
Sbjct: 140 YLHSHN--MIHRDIKAGNILLTEPGQVKLAD------FGSASIASPANSFVGTPYWMAPE 191

Query: 250 V---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 306
           V    +  ++  K DV+S G+  +EL   +    +++  S+  L  + QN          
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNES------PT 243

Query: 307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
           L    WS +       F   +  CL    + RP+  +++  +
Sbjct: 244 LQSNEWSDY-------FRNFVDSCLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 77.0 bits (189), Expect = 6e-16
 Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 40/219 (18%)

Query: 83  NLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRNLVT 134
           ++IGEG FG+V K  ++ DG  M  AIK+     ++    +F  E+  L  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIALG 183
           LLG C+     +L  EY P+G++   L           +  +  +   L  +  L  A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGRTDVAGP 235
            A+G+ +L     + +H+D    N+LV E+++AK+AD GL        +  +GR  V   
Sbjct: 121 VARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-- 176

Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                    ++A E   +  ++  SDV+S+GV L E+VS
Sbjct: 177 ---------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 76.7 bits (189), Expect = 6e-16
 Identities = 72/298 (24%), Positives = 122/298 (40%), Gaps = 46/298 (15%)

Query: 73  SLATKNFSDKNLIGEGKFGEVYKGLL--QDG----MLVAIKKRPGAPTQE----FIDEVC 122
            +   + +    +G G FGEVY+GL   +DG    + VA+K  P + +++    F+ E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG--PSQVSRQKLEFKHRLSI 180
            ++   H+N+V L+G   E   +F++ E +  G +   L    P       L  K  L  
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDV----- 232
           A   AKG  +L       +H+D    N L+       +AK+AD G+   + R        
Sbjct: 122 ARDVAKGCKYLEEN--HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179

Query: 233 -AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDL 290
            A    +    E FL         F+ K+DV+SFGV L E+ S G          ++Q++
Sbjct: 180 RAMLPIKWMPPEAFLDG------IFTSKTDVWSFGVLLWEIFSLGYMPYPGR---TNQEV 230

Query: 291 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
           +E V               RL       G     +++  C   + E RP+ + ++  +
Sbjct: 231 MEFV-----------TGGGRLDPPKGCPG--PVYRIMTDCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 76.9 bits (189), Expect = 8e-16
 Identities = 78/316 (24%), Positives = 135/316 (42%), Gaps = 80/316 (25%)

Query: 82  KNLIGEGKFGEVY--------------------KGLLQDGMLVAIK-KRPGAPTQ---EF 117
           K  +GEG+FGEV+                    KG     +LVA+K  RP A      +F
Sbjct: 10  KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG---RPLLVAVKILRPDANKNARNDF 66

Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY--------GPSQVSR 169
           + EV  L+ ++  N++ LLG C + +   +I EY+ NG ++  L              + 
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 170 QK------LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 223
                   + +   L +AL  A G+ +L SL+   VH+D  T N LV E+   K+AD G 
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIADFG- 183

Query: 224 RNFLGRTDVAGPSSQVTADEI----FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAS 279
              + R   AG   ++    +    ++A E     +F+  SDV++FGV L E++   +  
Sbjct: 184 ---MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE- 239

Query: 280 SSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFI-----------QLIV 328
               P       ++++N+ +F              F ++G + ++           +L++
Sbjct: 240 ---QPYGELTDEQVIENAGEF--------------FRDQGRQVYLFRPPPCPQGLYELML 282

Query: 329 RCLDPSSERRPSMSDV 344
           +C       RPS SD+
Sbjct: 283 QCWSRDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 9e-16
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 26/204 (12%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEF----IDEVCFLASIQHRNLVTLLGY 138
           IGEG +G VYK      G +VAIKK +    ++      + E+  L  + H N++ LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
            +     +L++E++        LY   +  ++ L      S      +GLA  HS    +
Sbjct: 67  FRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS--HGI 119

Query: 199 VHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT-----ADEIFLASEVKE 252
           +H+D K  N+L++ + + K+AD GL R+F   + V   +  V      A E+ L      
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGD---- 173

Query: 253 FRRFSEKSDVYSFGVFLLELVSGR 276
            + +S   D++S G    EL+S R
Sbjct: 174 -KGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.0 bits (189), Expect = 9e-16
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 16/210 (7%)

Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIK--KRPGAP--TQEFIDEVCFL 124
           L    F    ++G G FG VYKGL + +G    + VAIK  +   +P   +E +DE   +
Sbjct: 4   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63

Query: 125 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
           AS+ + ++  LLG C  + +Q LI + +P G +  ++    +  +  +  ++ L+  +  
Sbjct: 64  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQI 118

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
           AKG+ +L     R+VH+D    NVLV      K+ D GL   LG  +    +        
Sbjct: 119 AKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 77.0 bits (189), Expect = 9e-16
 Identities = 75/277 (27%), Positives = 127/277 (45%), Gaps = 38/277 (13%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP--GAPT----QEFIDEVCFLASIQHRN 131
           F   + IG G FG VY         +VA+KK    G  T    Q+ I EV FL  ++H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
            +   G   + +  +L+ EY   GS S  L    +V ++ L+     +I  GA +GLA+L
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAITHGALQGLAYL 137

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV- 250
           HS +  ++H+D K  N+L+ E    K+AD       G    + P++       ++A EV 
Sbjct: 138 HSHN--MIHRDIKAGNILLTEPGQVKLAD------FGSASKSSPANSFVGTPYWMAPEVI 189

Query: 251 --KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 308
              +  ++  K DV+S G+  +EL   +    +++  S+  L  + QN    S  L+   
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQND---SPTLQ--- 241

Query: 309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                  +NE  + F   +  CL    + RP+ ++++
Sbjct: 242 -------SNEWTDSFRGFVDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 76.1 bits (187), Expect = 1e-15
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 30/211 (14%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQE-----FIDEVCFLASIQHRNLV 133
            +G G F   Y+   ++ G L+A+K+    R  +  QE        E+  +A + H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIA--LGAAKGLA 189
            +LG   E++   L  E++  GSVS  +  YG          FK  + I       +GL+
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---------FKEAVIINYTEQLLRGLS 117

Query: 190 HLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGP---SSQVTADEIF 245
           +LH    +++H+D K AN+L+D      ++AD G    L      G      Q+     F
Sbjct: 118 YLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA-AKGTGAGEFQGQLLGTIAF 174

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           +A EV    ++    DV+S G  ++E+ + +
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 33/278 (11%)

Query: 78  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 130
           NF  +  IG G+F EVY+   L DG+ VA+KK             + I E+  L  + H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           N++       E+N   ++ E    G +S    H     ++  +K  +K+ + +       
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SA 118

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           L H+HS   RV+H+D K ANV +    + K+ D GL  F      A  S  +     +++
Sbjct: 119 LEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 307
            E      ++ KSD++S G  L E+ + +      SP           +  +  +L K +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQ------SP--------FYGDKMNLYSLCKKI 220

Query: 308 DERLWSTF-TNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           ++  +    ++   EE  QL+  C++P  E+RP ++ V
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 69/282 (24%), Positives = 113/282 (40%), Gaps = 45/282 (15%)

Query: 84  LIGEGKFGEVYKG----LLQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
            +G+G FG V +G         + VA+K     +      +F+ E   + S+ H NL+ L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 136 LGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            G    + L  ++ E  P GS+   +            L        A+  A G+ +L S
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTL-----CDYAVQIANGMRYLES 115

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEV 250
              R +H+D    N+L+  D   K+ D GL   L + +   V     +V     + A E 
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF--AWCAPES 171

Query: 251 KEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD- 308
              R FS  SDV+ FGV L E+ + G E  + LS                 S +LK +D 
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----------------SQILKKIDK 215

Query: 309 --ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             ERL         ++   ++++C   +   RP+ + +   L
Sbjct: 216 EGERL--ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 66/260 (25%), Positives = 119/260 (45%), Gaps = 28/260 (10%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+         VA+K  +PG+ + E F+ E   + ++QH  LV L     + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
            + ++I E++  GS+ +      + S+Q L     +  +   A+G+A +   +   +H+D
Sbjct: 74  PI-YIITEFMAKGSL-LDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN--YIHRD 127

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTD-VAGPSSQVTADEIFLASEVKEFRRFSEKSD 261
            + AN+LV    + K+AD GL   +   +  A   ++      + A E   F  F+ KSD
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK--WTAPEAINFGSFTIKSD 185

Query: 262 VYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGM 320
           V+SFG+ L+E+V+ GR     +S                   +++ L+            
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSN----------------PEVIRALERGYRMPRPENCP 229

Query: 321 EEFIQLIVRCLDPSSERRPS 340
           EE   +++RC     E RP+
Sbjct: 230 EELYNIMMRCWKNRPEERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 43/216 (19%)

Query: 83  NLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAP--TQEFID-----EVCFLASIQHRNLV 133
             +GEG +  VYK    + G +VAIKK + G     ++ I+     E+  L  ++H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 134 TLLG-YCQENNLQFLIYEY--------IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
            LL  +  ++N+  L++E+        I + S+   +  P+ +           S  L  
Sbjct: 66  GLLDVFGHKSNIN-LVFEFMETDLEKVIKDKSI---VLTPADIK----------SYMLMT 111

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---- 240
            +GL +LHS    ++H+D K  N+L+  D + K+AD GL    G  +       VT    
Sbjct: 112 LRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR 169

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           A E+   +     R +    D++S G    EL+   
Sbjct: 170 APELLFGA-----RHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 27/210 (12%)

Query: 85  IGEGKFGEVYKGLLQD------GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+GL +          VAIK      +     EF++E   +      ++V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY----------GPSQVSRQKLEFKHRLSIALGA 184
           LLG         ++ E +  G +  +L           G    + QK      + +A   
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF-----IQMAAEI 128

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
           A G+A+L +   + VH+D    N +V ED   K+ D G+   +  TD      +      
Sbjct: 129 ADGMAYLAAK--KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           ++A E  +   F+ KSDV+SFGV L E+ +
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 73/287 (25%), Positives = 125/287 (43%), Gaps = 39/287 (13%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIK---KRPG-APTQEFIDEVCFLASIQHRN 131
           +   + + +GEG  G V K  L   GM+ A+K     P     ++ + E+    S +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 132 LVTLLGYC---QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
           +V   G       +++  +  EY   GS+   +Y   +    ++  K    IA    KGL
Sbjct: 61  IVKYYGAFLDESSSSIG-IAMEYCEGGSLD-SIYKKVKKRGGRIGEKVLGKIAESVLKGL 118

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
           ++LHS   +++H+D K +N+L+      K+ D G+   L    +AG     T    ++A 
Sbjct: 119 SYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV-NSLAG---TFTGTSFYMAP 172

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGR-----EASSSLSPDSSQDLVELVQNSRDFSNL 303
           E  + + +S  SDV+S G+ LLE+   R     E    L P    +L+  + N  +    
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP---IELLSYIVNMPNP--- 226

Query: 304 LKILDE----RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 346
            ++ DE      WS       EEF   I +CL+    RRP+  D++ 
Sbjct: 227 -ELKDEPGNGIKWS-------EEFKDFIKQCLEKDPTRRPTPWDMLE 265

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 37/217 (17%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP--------TQEFIDEVCFLASIQ 128
           N+    L+G+G FG VY     D G  +A+K+ P  P              E+  L ++Q
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 129 HRNLVTLLGYCQENNLQFLIY-EYIPNGSVSIHL--YGP------SQVSRQKLEFKHRLS 179
           H  +V   G C  ++    I+ EY+P GSV   L  YG        + +RQ LE      
Sbjct: 63  HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE------ 115

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG--RTDVAGPSS 237
                  G+ +LH  S  +VH+D K AN+L D     K+ D G    L    +   G  S
Sbjct: 116 -------GVEYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS 166

Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            VT    +++ EV     +  K+DV+S G  ++E+++
Sbjct: 167 -VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 73/287 (25%), Positives = 123/287 (42%), Gaps = 42/287 (14%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-------HR 130
           F    +IGEG +G+VYK    + G LVAIK       ++  +E+              H 
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD--IIEDEEEEI--KEEYNILRKYSNHP 63

Query: 131 NLVTLLG-------YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 183
           N+ T  G          ++ L +L+ E    GSV   L    +   ++L+ +    I   
Sbjct: 64  NIATFYGAFIKKNPPGNDDQL-WLVMELCGGGSV-TDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQV 239
             +GLA+LH    +V+H+D K  N+L+ ++   K+ D G    L + LGR +    +   
Sbjct: 122 TLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD 299
            A E+    E  +   +  +SDV+S G+  +EL  G+     + P  +     L +  R+
Sbjct: 180 MAPEVIACDEQPD-ASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-----LFKIPRN 233

Query: 300 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 346
               LK      WS       ++F   I  CL  + E+RP M +++ 
Sbjct: 234 PPPTLK--SPENWS-------KKFNDFISECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 22/203 (10%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IGEG +G VYKG   + G +VA+KK        G P+   I E+  L  +QH N+V L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA-IREISLLKELQHPNIVCLQD 66

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
              + +  +LI+E++   S+ +  Y  S    Q ++ +   S      +G+   HS   R
Sbjct: 67  VLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS--RR 121

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKEF 253
           V+H+D K  N+L+D   + K+AD GL    G          VT    A E+ L S     
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP---- 177

Query: 254 RRFSEKSDVYSFGVFLLELVSGR 276
            R+S   D++S G    E+ + +
Sbjct: 178 -RYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 74.2 bits (183), Expect = 6e-15
 Identities = 67/279 (24%), Positives = 118/279 (42%), Gaps = 47/279 (16%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNL 132
            + + +   IGEG  GEVYK      G  VAIKK R     +E  I+E+  +   +H N+
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           V         +  +++ EY+  GS++  +      +  ++       +     +GL +LH
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTDIITQ----NFVRMNEPQIAYVCREVLQGLEYLH 133

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----RNFLGRTDVAGPSSQVTADEIFLA 247
           S    V+H+D K+ N+L+ +D   K+AD G      +    R  V G     T    ++A
Sbjct: 134 SQ--NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVG-----TP--YWMA 184

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD------SSQDLVELVQNSRDFS 301
            EV + + +  K D++S G+  +E+  G        P       +++ +  L +N   +S
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPL-KNPEKWS 243

Query: 302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 340
              K                +F+    +CL    E+RPS
Sbjct: 244 PEFK----------------DFLN---KCLVKDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 74.0 bits (182), Expect = 7e-15
 Identities = 75/286 (26%), Positives = 115/286 (40%), Gaps = 65/286 (22%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLL-GYC 139
           +G+G FG+VYK    + G+  A K          ++F+ E+  L+  +H N+V L   Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 140 QENNLQFLIYEYIPNGSV-SI-----HLYGPSQ---VSRQKLEFKHRLSIALGAAKGLAH 190
            EN L  LI E+   G++ SI           Q   V RQ LE              L  
Sbjct: 73  YENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQMLE-------------ALNF 118

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFL 246
           LHS   +V+H+D K  N+L+  D   K+AD G+      T     +   T    A E+ +
Sbjct: 119 LHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV-V 175

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 306
           A E  +   +  K+D++S G+ L+EL         L+P                  LLKI
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---------------MRVLLKI 220

Query: 307 LDE--------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           L            WS+        F   +  CL    + RP+ +++
Sbjct: 221 LKSEPPTLDQPSKWSS-------SFNDFLKSCLVKDPDDRPTAAEL 259

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 74.1 bits (182), Expect = 7e-15
 Identities = 84/298 (28%), Positives = 120/298 (40%), Gaps = 66/298 (22%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 130
           NF     IGEG +G VYK      G +VA+KK        G P+   I E+  L  + H 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNHP 59

Query: 131 NLVTLLGYCQENNLQFLIYEYI-----------PNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           N+V LL      N  +L++E++           P   + + L             K  L 
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPL------------IKSYLF 107

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
             L   +GLA  H  S RV+H+D K  N+L++ +   K+AD GL    G          V
Sbjct: 108 QLL---QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 162

Query: 240 T----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 295
           T    A EI L       + +S   D++S G    E+V+ R    +L P  S    E+ Q
Sbjct: 163 TLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR----ALFPGDS----EIDQ 209

Query: 296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTELDRT 351
             R F   L   DE +W   T+  + ++         PS  +  R   S VV  LD  
Sbjct: 210 LFRIF-RTLGTPDEVVWPGVTS--LPDY--------KPSFPKWARQDFSKVVPPLDED 256

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 15/211 (7%)

Query: 79  FSDKNLIGEGKFGEVYKGLL-QDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           F+    IG+G FGEVYKG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
              G   +    ++I EY+  GS ++ L  P       LE  +  +I     KGL +LHS
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGS-ALDLLKPG-----PLEETYIATILREILKGLDYLHS 119

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
              R +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 120 --ERKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 254 RRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
             +  K+D++S G+  +EL  G   +S L P
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHP 206

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 53/270 (19%), Positives = 122/270 (45%), Gaps = 35/270 (12%)

Query: 85  IGEGKFGE--VYKGLLQDGMLVAIK----KRPGAPTQEF-IDEVCFLASIQHRNLVTLLG 137
           +G+G FGE  +Y+   +D  LV  K     R     +   ++E+  L+ +QH N++    
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL--GAAKGLAHLHSLS 195
           +  ++N   +  EY   G++   +     V ++   F+  + +         ++++H   
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKI-----VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
             ++H+D KT N+ + +  + K+ D G+   LG ++ +   + V     +++ E+ +  +
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAET-VVGTPYYMSPELCQGVK 177

Query: 256 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 315
           ++ KSD+++ G  L EL++ +    + +P                 NL+  + +  ++  
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNP----------------LNLVVKIVQGNYTPV 221

Query: 316 TNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
            +    E I L+   L    E+RP+  +V+
Sbjct: 222 VSVYSSELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 72.2 bits (177), Expect = 3e-14
 Identities = 60/232 (25%), Positives = 109/232 (46%), Gaps = 43/232 (18%)

Query: 77  KNFSDKNLIGEGKFGEVY----KGLLQ-------------DGMLVAIKK-RPGA---PTQ 115
           K  + K  +GEG+FGEV+    +G+ +               +LVA+K  R  A      
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64

Query: 116 EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY------GPSQVSR 169
           +F+ E+  ++ ++  N++ LL  C  ++   +I EY+ NG ++  L          +   
Sbjct: 65  DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
             + +   + +A   A G+ +L SL+   VH+D  T N LV +++  K+AD G+   L  
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 230 TD---VAG----PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            D   + G    P   ++ + I L        +F+  SDV++FGV L E+++
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLG-------KFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 71.5 bits (176), Expect = 4e-14
 Identities = 60/281 (21%), Positives = 108/281 (38%), Gaps = 52/281 (18%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG+G FG V K     DG ++  K            Q+ + EV  L  ++H N+V    Y
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64

Query: 139 CQ-----ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
                   N   +++ EY   G ++  L    +  R+ +E +    I       L   H+
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLA-QLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 194 L---SPRVVHKDFKTANVLVDEDFIAKVADAGL------RNFLGRTDVAGPSSQVTADEI 244
                  V+H+D K AN+ +D +   K+ D GL       +   +T V  P         
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTP--------Y 175

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD--FSN 302
           +++ E      + EKSD++S G  + EL +         P ++++ ++L    ++  F  
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALS------PPFTARNQLQLASKIKEGKFRR 229

Query: 303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 343
           +       L              +I   L+   ++RPS  +
Sbjct: 230 IPYRYSSELNE------------VIKSMLNVDPDKRPSTEE 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 70.8 bits (173), Expect = 5e-14
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 20/207 (9%)

Query: 78  NFSDKNLIGEGKFGEVY--KGLLQDGMLV----AIKKRPGAPTQEFIDEVCFLASIQHRN 131
            +     IGEG FG++Y  K        V     + K P    +    EV  LA ++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK---LEFKHRLSIALGAAKGL 188
           +VT     QEN   F++ EY   G +        +++RQ+         LS  +  + GL
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLM------KRINRQRGVLFSEDQILSWFVQISLGL 114

Query: 189 AHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
            H+H    +++H+D K+ N+ + ++  +AK+ D G+   L   D    +        +L+
Sbjct: 115 KHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLS 170

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E+ + R ++ K+D++S G  L EL +
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 72/275 (26%), Positives = 113/275 (41%), Gaps = 52/275 (18%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTLLGYC 139
           +G G  G V K L +  G ++A+K       +      + E+  L       +V   G  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 140 QENNLQFLIYEYIPNGSV-SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
             N    +  EY+  GS+  I      ++  + L       IA+   KGL +LH    ++
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK-----IAVAVLKGLTYLHE-KHKI 122

Query: 199 VHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
           +H+D K +N+LV+     K+ D G    L N L +T V G SS       ++A E  +  
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-GTSS-------YMAPERIQGN 174

Query: 255 RFSEKSDVYSFGVFLLELVSGR--EASSSLSPDSSQDLVELVQNSRDFSNLLKILDE--- 309
            +S KSD++S G+ L+EL +GR      +  PD              F  L  I++E   
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG------------IFELLQYIVNEPPP 222

Query: 310 RL----WSTFTNEGMEEFIQLIVRCLDPSSERRPS 340
           RL    +S        +F   +  CL      RPS
Sbjct: 223 RLPSGKFS-------PDFQDFVNLCLIKDPRERPS 250

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 70.7 bits (173), Expect = 7e-14
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 21/212 (9%)

Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQE---FIDEVCFLA 125
           L  K+   + ++G G+FGE+ +G L+      + VAI   R G   ++   F+ E   L 
Sbjct: 2   LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLG 61

Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG-PSQVSRQKLEFKHRLSIALGA 184
              H N+V L G     N   ++ EY+ NG++   L     Q+   +L     + +  G 
Sbjct: 62  QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL-----MGMLPGL 116

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
           A G+ +L  +    VHK      VLV+ D + K++  G R  L         + ++    
Sbjct: 117 ASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKIS--GFRR-LQEDKSEAIYTTMSGKSP 171

Query: 245 FL--ASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            L  A E  ++  FS  SDV+SFG+ + E++S
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 70.8 bits (174), Expect = 8e-14
 Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 34/228 (14%)

Query: 84  LIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-----EVCFLASIQHRNLVTLLG 137
           ++GEG +G V K   +  G +VAIKK   +   E +      EV  L  ++H N+V L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
             +     +L++EY+     ++       P  +    +      S      + +A+ HS 
Sbjct: 68  AFRRKGRLYLVFEYVER---TLLELLEASPGGLPPDAVR-----SYIWQLLQAIAYCHSH 119

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT----ADEIFLASE 249
              ++H+D K  N+LV E  + K+ D G  R    R          T    A E+ +   
Sbjct: 120 --NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELVQN 296
                 + +  DV++ G  + EL+ G      L P DS  D + L+Q 
Sbjct: 178 -----NYGKPVDVWAIGCIMAELLDGE----PLFPGDSDIDQLYLIQK 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 46/219 (21%)

Query: 83  NLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFI-DEVCFLASIQHRNLVTLL 136
           N IG G FG+VY  + L  G L+A+K    +     T + I DE+  L  ++H NLV   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 137 G-------------YCQENNL-QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
           G             YC    L + L +  I +  V I +Y     + Q LE         
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV-IRVY-----TLQLLE--------- 110

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTA 241
               GLA+LHS    +VH+D K AN+ +D + + K+ D G    L   T   G   Q  A
Sbjct: 111 ----GLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA 164

Query: 242 -DEIFLASEVKEFRRFSEK---SDVYSFGVFLLELVSGR 276
               ++A EV    +       +D++S G  +LE+ +G+
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 35/221 (15%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID----EVCFLASIQHRNLV 133
           F+    IG+G FGEVYK +  +   +VAIK       ++ I+    E+ FL+  +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
              G   + +  ++I EY   GS    L  P      KL+  +   I      GL +LH 
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPG-----KLDETYIAFILREVLLGLEYLHE 116

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--------- 244
                +H+D K AN+L+ E+   K+AD G         V+G   Q+T+            
Sbjct: 117 --EGKIHRDIKAANILLSEEGDVKLADFG---------VSG---QLTSTMSKRNTFVGTP 162

Query: 245 -FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
            ++A EV +   + EK+D++S G+  +EL  G    S L P
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 69.9 bits (172), Expect = 1e-13
 Identities = 53/233 (22%), Positives = 90/233 (38%), Gaps = 47/233 (20%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIK---KRPGAPTQE------FIDEVCFLAS 126
            +F    +IGEG F  V     +      AIK   KR     +E       I++      
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58

Query: 127 IQHRNLVTLLGYCQ-ENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHRLSIALG 183
             H  ++ L    Q E NL + + EY PNG +   I  YG        L+ K     A  
Sbjct: 59  NGHPGIIKLYYTFQDEENL-YFVLEYAPNGELLQYIRKYG-------SLDEKCTRFYAAE 110

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV---- 239
               L +LHS    ++H+D K  N+L+D+D   K+ D G    L        +       
Sbjct: 111 ILLALEYLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168

Query: 240 ----------------TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                           TA+  +++ E+   +   + SD+++ G  + ++++G+
Sbjct: 169 DSQIEKNRRRFASFVGTAE--YVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 15/211 (7%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
              G   ++   ++I EY+  GS ++ L  P  +   ++      +I     KGL +LHS
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIA-----TILREILKGLDYLHS 119

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
              + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 120 --EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 254 RRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
             +  K+D++S G+  +EL  G    S L P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHP 206

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 65/271 (23%), Positives = 114/271 (42%), Gaps = 36/271 (13%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQH---RNLVTL 135
           LIG G +G VY+G  +  G +VA+K      P     +   EV  L+ ++     N+   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 136 LG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
            G Y +   L ++I EY   GSV       + +    +  K+   I       L ++H +
Sbjct: 68  YGSYLKGPRL-WIIMEYAEGGSVR------TLMKAGPIAEKYISVIIREVLVALKYIHKV 120

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-KEF 253
              V+H+D K AN+LV      K+ D G+   L     +   S       ++A EV  E 
Sbjct: 121 G--VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 254 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 313
           + +  K+D++S G+ + E+ +G    S +    +  L+   +  R        L++  +S
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPR--------LEDNGYS 228

Query: 314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
                 + EF+     CLD   + R S  ++
Sbjct: 229 KL----LREFVAA---CLDEEPKERLSAEEL 252

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 40/277 (14%)

Query: 85  IGEGKFGEVYK----GLLQDG--MLVAIKK-RPGA---PTQEFIDEVCFLASI-QHRNLV 133
           +G G FG+V +    GL +    M VA+K  +P A     +  + E+  ++ +  H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            LLG C       +I EY   G +   L    +     L  +  LS +   AKG+A L S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLR---RKRESFLTLEDLLSFSYQVAKGMAFLAS 159

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----AS 248
            +   +H+D    NVL+    I K+ D GL       D+   S+ V      L     A 
Sbjct: 160 KN--CIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAP 212

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 308
           E      ++ +SDV+S+G+ L E+ S     S+  P        +  +S+ F  L+K   
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS---LGSNPYPG-------MPVDSK-FYKLIKEGY 261

Query: 309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                      + + ++    C D    +RP+   +V
Sbjct: 262 RMAQPEHAPAEIYDIMK---TCWDADPLKRPTFKQIV 295

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 31/277 (11%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 130
           NF  +  IG G+F EVY+   L D   VA+KK            Q+ + E+  L  + H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           N++  L    E+N   ++ E    G +S    +     ++  ++  +K+ + +       
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SA 118

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           + H+HS   RV+H+D K ANV +    + K+ D GL  F      A  S  +     +++
Sbjct: 119 VEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 307
            E      ++ KSD++S G  L E+       ++L      D + L      FS   KI 
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM-------AALQSPFYGDKMNL------FSLCQKIE 221

Query: 308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
                   T    E+  +L+  C+ P  ++RP +  V
Sbjct: 222 QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 70/270 (25%), Positives = 129/270 (47%), Gaps = 31/270 (11%)

Query: 85  IGEGKFGEVYKGLLQD-GMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLG-YC 139
           +G+G FG+VYK   ++ G L A   I+ +     ++++ E+  LA+  H  +V LLG + 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
            +  L  +I E+ P G+V   +    ++ R   E + ++ I     + L +LHS+  +++
Sbjct: 80  WDGKLWIMI-EFCPGGAVDAIML---ELDRGLTEPQIQV-ICRQMLEALQYLHSM--KII 132

Query: 200 HKDFKTANVLVDEDFIAKVADAGL--RNF--LGRTDVAGPSSQVTADEIFLASEVKEFRR 255
           H+D K  NVL+  D   K+AD G+  +N   L R D    +    A E+ +   +K+   
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD-TP 191

Query: 256 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 315
           +  K+D++S G+ L+E+         L+P   + L+++ +     S    +     WS  
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIAK-----SEPPTLSQPSKWSM- 243

Query: 316 TNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                 EF   +   LD   E RPS + ++
Sbjct: 244 ------EFRDFLKTALDKHPETRPSAAQLL 267

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 66/282 (23%), Positives = 120/282 (42%), Gaps = 49/282 (17%)

Query: 80  SDKNLIGEGKFGEVYKGLLQDGMLVAIK------KRPGAPTQEFIDEVCFLASIQHRNLV 133
           +D+N I +G F         +   V I+      K          +E+  L  I   N++
Sbjct: 31  NDQNSIYKGIF---------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNIL 81

Query: 134 TLLGY----CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            + G+      +     LI EY   G +   L        + L FK +L +A+   KGL 
Sbjct: 82  KIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD-----KEKDLSFKTKLDMAIDCCKGLY 136

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +L+  + +  +K+  + + LV E++  K+   GL   L     + P   V     F    
Sbjct: 137 NLYKYTNKP-YKNLTSVSFLVTENYKLKIICHGLEKILS----SPPFKNVNFMVYFSYKM 191

Query: 250 VKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI-L 307
           + + F  ++ K D+YS GV L E+ +G+    +L   +++++ +L+ N    +N LK+ L
Sbjct: 192 LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL---TTKEIYDLIINK---NNSLKLPL 245

Query: 308 DERLWSTFTNEGMEEFIQLIV-RCLDPSSERRPSMSDVVTEL 348
           D  L            I+ IV  C    S +RP++ +++  L
Sbjct: 246 DCPL-----------EIKCIVEACTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 67.8 bits (165), Expect = 9e-13
 Identities = 70/273 (25%), Positives = 119/273 (43%), Gaps = 33/273 (12%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID----EVCFLASIQHRNLV 133
           F+    IG+G FGEV+KG+  +   +VAIK       ++ I+    E+  L+      + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 134 TLLGYCQENNLQFLIYEYIPNGS-VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
              G   +    ++I EY+  GS + +   GP    +     K  L       KGL +LH
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL-------KGLDYLH 118

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 252
           S   + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV +
Sbjct: 119 S--EKKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIQ 174

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 312
              +  K+D++S G+  +EL  G   +S + P                  +L ++ +   
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPNSDMHP----------------MRVLFLIPKNNP 218

Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
            T T E  + F + I  CL+     RP+  +++
Sbjct: 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 67.4 bits (164), Expect = 9e-13
 Identities = 73/277 (26%), Positives = 124/277 (44%), Gaps = 37/277 (13%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASI-QHRNLVTLLG-Y 138
           L+G G +G+VYKG  ++ G L AIK     G   +E   E+  L     HRN+ T  G +
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 139 CQEN-----NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            ++N     +  +L+ E+   GSV+  L   ++ +  K E+   +   +   +GL+HLH 
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTKGNTLKEEWIAYICREI--LRGLSHLHQ 129

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV--- 250
              +V+H+D K  NVL+ E+   K+ D G+   L RT   G  +       ++A EV   
Sbjct: 130 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIAC 185

Query: 251 --KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 308
                  +  KSD++S G+  +E+  G      + P  +  L+      R        L 
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR--------LK 237

Query: 309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
            + WS       ++F   I  CL  +  +RP+   ++
Sbjct: 238 SKKWS-------KKFQSFIESCLVKNHSQRPTTEQLM 267

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 9e-13
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 47/215 (21%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IGEG +G VYK      G +VA+KK        G P+   I E+  L  + H N+V LL 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA-IREISLLKELNHPNIVRLLD 65

Query: 138 YCQENNLQFLIYEYIPNG------SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
                N  +L++E++         S  +    P  +      + ++L       +G+A+ 
Sbjct: 66  VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKS----YLYQL------LQGIAYC 115

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG---RT---DVAGPSSQVT----A 241
           H  S RV+H+D K  N+L+D +   K+AD GL    G   RT   +V      VT    A
Sbjct: 116 H--SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV------VTLWYRA 167

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            EI L S     R++S   D++S G    E+V+ R
Sbjct: 168 PEILLGS-----RQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 70/255 (27%), Positives = 117/255 (45%), Gaps = 36/255 (14%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTLL-GYC 139
           +G+G FG+VYK   ++  ++A  K     ++E    ++ E+  LAS  H N+V LL  + 
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 140 QENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
            ENNL  LI E+   G+V    + L  P    + ++  K  L       + L +LH    
Sbjct: 73  YENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-------EALNYLHE--N 122

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEVKE 252
           +++H+D K  N+L   D   K+AD G+       + R D    +    A E+ +    K+
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPD------SSQDLVELVQNSR---DFSNL 303
            R +  K+DV+S G+ L+E+         L+P       +  +   L Q SR   +F + 
Sbjct: 183 -RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241

Query: 304 LKILDER----LWST 314
           LK   E+     W+T
Sbjct: 242 LKKCLEKNVDARWTT 256

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 70/290 (24%), Positives = 122/290 (42%), Gaps = 43/290 (14%)

Query: 84  LIGEGKFGEVYKGLL--QDGML--VAIK--KRPG---APTQEFIDEVCFLASIQHRNLVT 134
           ++GEG+FG V +G L   DG    VA+K  K      +  +EF+ E   +    H N++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 135 LLGYC-QENNLQ-----FLIYEYIPNGSVSIHLY------GPSQVSRQKLEFKHRLSIAL 182
           L+G C + ++LQ      +I  ++ +G +   L        P ++  Q L     L   +
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTL-----LKFMV 120

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
             A G+ +L +     +H+D    N ++ ED    VAD GL   +   D           
Sbjct: 121 DIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 302
             ++A E    R ++ KSDV++FGV + E+     A+   +P         V+N   +  
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEI-----ATRGQTPYPG------VENHEIYDY 227

Query: 303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           L      RL      + ++E   L+  C     + RP+ + +   L+  L
Sbjct: 228 LRH--GNRLKQ--PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 66.0 bits (162), Expect = 3e-12
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 46/214 (21%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFID--EVCFLASIQ-HRNLVTLLGY 138
           +G+G FG VY     + G LVAIK  K+     +E ++  EV  L  +  H N+V L   
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL-------SIALGAAKGLAHL 191
            +EN+  + ++EY     +  +LY   Q+ + +   K +        SI     +GLAH+
Sbjct: 67  FRENDELYFVFEY-----MEGNLY---QLMKDR---KGKPFSESVIRSIIYQILQGLAHI 115

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGL----RNFLGRTD-VAGPSSQVT----AD 242
           H       H+D K  N+LV    + K+AD GL    R+    TD V+      T    A 
Sbjct: 116 HKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS------TRWYRAP 167

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           EI L S       +S   D+++ G  + EL + R
Sbjct: 168 EILLRSTS-----YSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 32/164 (19%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           +GEG FGEVYK   ++ G +VA+KK      + G P      E+  L  ++H N+V L+ 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-REIKILKKLKHPNVVPLID 74

Query: 138 YCQENNLQFLIYEYIPNGS---VSIHLYGPSQVS---------RQKLEFKHRLSIALGAA 185
                    +  E          S+++  P               KL         L   
Sbjct: 75  ---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLG 228
           +G+ +LH     ++H+D K AN+L+D   I K+AD GL R + G
Sbjct: 126 EGINYLHE--NHILHRDIKAANILIDNQGILKIADFGLARPYDG 167

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 49/168 (29%), Positives = 68/168 (40%), Gaps = 46/168 (27%)

Query: 83  NLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ---HRNL 132
             IGEG +G VYK   L  G  VA+KK        G P    + E+  L  ++   H N+
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP-LSTLREIALLKQLESFEHPNI 63

Query: 133 VTLLGYCQENNLQ-----FLIYEYIPNGSVSIHLY---------GPSQ---VSRQKLEFK 175
           V LL  C            L++E++      +  Y          P     + RQ L   
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVDQ---DLATYLSKCPKPGLPPETIKDLMRQLL--- 117

Query: 176 HRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 223
                     +G+  LH  S R+VH+D K  N+LV  D   K+AD GL
Sbjct: 118 ----------RGVDFLH--SHRIVHRDLKPQNILVTSDGQVKIADFGL 153

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 69/258 (26%), Positives = 114/258 (44%), Gaps = 47/258 (18%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
             F   N IGEG +G VY+      G +VA+KK      R G P    + E+  L +++H
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS-LREITLLLNLRH 65

Query: 130 RNLVTLLGYCQENNLQ--FLIYEYIPN--GSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 185
            N+V L       +L   FL+ EY      S+  ++  P   S+ K        + L   
Sbjct: 66  PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVK-------CLMLQLL 118

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ--VT-- 240
           +GL +LH     ++H+D K +N+L+ +    K+AD GL R +      A P +   VT  
Sbjct: 119 RGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY---GLPAKPMTPKVVTLW 173

Query: 241 --ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-DLVELVQNS 297
             A E+ L         ++   D+++ G  L EL++ +     L P  S+ + ++L+   
Sbjct: 174 YRAPELLLGCTT-----YTTAIDMWAVGCILAELLAHK----PLLPGKSEIEQLDLI--- 221

Query: 298 RDFSNLLKILDERLWSTF 315
                LL   +E +W  F
Sbjct: 222 ---IQLLGTPNESIWPGF 236

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 17/205 (8%)

Query: 85  IGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY    KG+++D     VAIK    A +     EF++E   +      ++V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYG-----PSQVSRQKLEFKHRLSIALGAAKGLA 189
           LLG   +     +I E +  G +  +L        +   +     K  + +A   A G+A
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +L++   + VH+D    N +V EDF  K+ D G+   +  TD      +      +++ E
Sbjct: 134 YLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SDV+SFGV L E+ +
Sbjct: 192 SLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 64.7 bits (157), Expect = 8e-12
 Identities = 70/285 (24%), Positives = 120/285 (42%), Gaps = 36/285 (12%)

Query: 85  IGEGKFGEVYKGLL-QDG---------MLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT 134
           +GEG+FG V +G L QD          M +AI  R  +  ++F+ E   +    H N++ 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR--SEMEDFLSEAVCMKEFDHPNVMR 64

Query: 135 LLGYCQENNLQ------FLIYEYIPNGSV-SIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           L+G C +           +I  ++ +G + S  LY       Q L  +  +      A G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           + +L S     +H+D    N +++E+    VAD GL   +   D             ++A
Sbjct: 125 MEYLSS--KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 307
            E    R ++ KSDV+SFGV + E+     A+   +P         V+NS  +  L +  
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEI-----ATRGQTPYPG------VENSEIYDYLRQ-- 229

Query: 308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             RL      + ++    L+  C   + + RPS   +  EL++ L
Sbjct: 230 GNRLKQ--PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 65.3 bits (160), Expect = 9e-12
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 38/213 (17%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PT--QEFIDEVCFLASI-QHRNLVTLLG 137
           +G+G +G V+K +  +   +VA+KK   A    T  Q    E+ FL  +  H N+V LL 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74

Query: 138 -YCQENNLQ-FLIYEYIPNGSVSIHLYGPSQVSRQK-LEFKHRLSIALGAAKGLAHLHSL 194
               EN+   +L++EY+      +H      V R   LE  H+  I     K L ++HS 
Sbjct: 75  VIKAENDKDIYLVFEYM---ETDLH-----AVIRANILEDVHKRYIMYQLLKALKYIHS- 125

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTAD----------E 243
              V+H+D K +N+L++ D   K+AD GL R+         P + V  D          E
Sbjct: 126 -GNVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLTDYVATRWYRAPE 182

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           I L S      R+++  D++S G  L E++ G+
Sbjct: 183 ILLGS-----TRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 29/205 (14%)

Query: 85  IGEGKFGEVYKG---LLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHR----NLVTLLG 137
           +G G FG V KG   + +  + VAIK       +   DE+   A I H+     +V ++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
            C+   L  L+ E    G ++  L G          +E  H++S+      G+ +L    
Sbjct: 63  VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM------GMKYLEG-- 113

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------FLASE 249
              VH+D    NVL+     AK++D GL   LG  D     S   A         + A E
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-----SYYKARSAGKWPLKWYAPE 168

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
              FR+FS +SDV+S+G+ + E  S
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 64.1 bits (156), Expect = 1e-11
 Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 28/206 (13%)

Query: 85  IGEGKFGEVYKGLLQDGM---LVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           IGEG +G VYK   +D +    +A+KK        G P+   I E+  L  +QH N+V L
Sbjct: 10  IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTA-IREISLLKEMQHGNIVRL 66

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
                     +L++EY+ +  +  H+      ++     K  L   L   +G+A+ H  S
Sbjct: 67  QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL---RGIAYCH--S 120

Query: 196 PRVVHKDFKTANVLVDEDFIA-KVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEV 250
            RV+H+D K  N+L+D    A K+AD GL    G          VT    A EI L S  
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS-- 178

Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGR 276
              R +S   D++S G    E+V+ +
Sbjct: 179 ---RHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 64/280 (22%), Positives = 120/280 (42%), Gaps = 37/280 (13%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRN 131
            +    ++G G FG V+      D  LV IK+ P             +E   L  + H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           ++       E+    ++ EY P G+++ ++    +     L+    L   +     L H+
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYI---QKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 192 HSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 250
           H+    ++H+D KT N+L+D+   + K+ D G+   L     A     V     +++ E+
Sbjct: 118 HT--KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISPEL 172

Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 310
            E + +++KSD+++ G  L EL S + A        + +L  LV         LKI+   
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAF------EAANLPALV---------LKIMS-- 215

Query: 311 LWSTF---TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 347
              TF   ++    +  QLI+  L+    +RP +S ++ +
Sbjct: 216 --GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 64.1 bits (157), Expect = 2e-11
 Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 45/223 (20%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRN 131
           +     IG G +G V   +  + G  VAIKK       + ID      E+  L  ++H N
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS-NVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 132 LVTLLGYCQENNLQFLIYEYIPN-GSVSI--HLYGP--SQV--SRQKLEFKHRLSIALGA 184
           ++ LL          L      +   V I   L      +V  S Q L   H        
Sbjct: 61  IIGLL--------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQI 112

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ------ 238
            +GL +LHS +  V+H+D K +N+LV+ +   K+ D G    L R        +      
Sbjct: 113 LRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFG----LARGVDPDEDEKGFLTEY 166

Query: 239 -VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            VT    A E+ L+S      R+++  D++S G    EL++ +
Sbjct: 167 VVTRWYRAPELLLSSS-----RYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 23/210 (10%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 131
           NF     +GEG +  VYKG  +  G +VA+K+       G P+   I E+  +  ++H N
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA-IREISLMKELKHEN 59

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           +V L       N   L++EY+      +  Y  +   R  L+     S      KG+A  
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDK---DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-----ADEIFL 246
           H    RV+H+D K  N+L+++    K+AD GL    G   V   S++V      A ++ L
Sbjct: 117 HE--NRVLHRDLKPQNLLINKRGELKLADFGLARAFG-IPVNTFSNEVVTLWYRAPDVLL 173

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            S     R +S   D++S G  + E+++GR
Sbjct: 174 GS-----RTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 79/291 (27%), Positives = 126/291 (43%), Gaps = 33/291 (11%)

Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYK-GLLQDGMLVAIK-KRPGAPTQEFID-EVCFLA 125
           +E L   T  +     IG+G +G+VYK    +DG L A+K   P +   E I+ E   L 
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQ 73

Query: 126 SI-QHRNLVTLLG------YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL 178
           S+  H N+V   G            L +L+ E    GSV+  + G      Q+L+     
Sbjct: 74  SLPNHPNVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELVKGLLICG-QRLDEAMIS 131

Query: 179 SIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ 238
            I  GA  GL HLH  + R++H+D K  N+L+  +   K+ D G+   L  T +   +S 
Sbjct: 132 YILYGALLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189

Query: 239 VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 294
            T    A E+ +A E +    +  + DV+S G+  +EL  G      + P   + L ++ 
Sbjct: 190 GTPFWMAPEV-IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTLFKIP 246

Query: 295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
           +N         +L    W          F   I +CL    E RPS++ ++
Sbjct: 247 RNPPP-----TLLHPEKWC-------RSFNHFISQCLIKDFEARPSVTHLL 285

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 64/294 (21%), Positives = 124/294 (42%), Gaps = 47/294 (15%)

Query: 79  FSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPG-----APTQEFIDEVCFLASIQH 129
           F+   ++G+G+FG V +  L+        VA+K         +  +EF+ E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 130 RNLVTLLGYCQENNLQ------FLIYEYIPNGSVSIHLY------GPSQVSRQKLEFKHR 177
            N++ L+G    +  +       +I  ++ +G +   L        P  +  Q L     
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL----- 115

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV--AGP 235
           +   +  A G+ +L S     +H+D    N +++E+    VAD GL   +   D    G 
Sbjct: 116 VRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173

Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 295
           +S++    + L S       ++  SDV++FGV + E+++             Q     V+
Sbjct: 174 ASKLPVKWLALESLADNV--YTTHSDVWAFGVTMWEIMT-----------RGQTPYAGVE 220

Query: 296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
           NS  ++ L+K    RL      + +E+  +L+ +C  P  + RPS   +  +L+
Sbjct: 221 NSEIYNYLIK--GNRLKQPP--DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 61.9 bits (150), Expect = 8e-11
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 17/205 (8%)

Query: 85  IGEGKFGEVYKGLLQD------GMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D         VA+K    + +     EF++E   +      ++V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIALGAAKGLA 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +A   A G+A
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +L++   + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 134 YLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 192 SLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 62.0 bits (151), Expect = 8e-11
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 40/166 (24%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IG+G FGEV+K    +   +VA+KK      + G P    + E+  L  ++H N+V L+ 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIE 78

Query: 138 YC-----QENNLQ---FLIYEY--------IPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
            C       N  +   +L++E+        + N +V   L      S  K   K  L+  
Sbjct: 79  ICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL------SEIKKVMKMLLN-- 130

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNF 226
                GL ++H    +++H+D K AN+L+ +D I K+AD GL R F
Sbjct: 131 -----GLYYIHR--NKILHRDMKAANILITKDGILKLADFGLARAF 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 61.6 bits (149), Expect = 9e-11
 Identities = 72/273 (26%), Positives = 120/273 (43%), Gaps = 39/273 (14%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYC 139
           ++G G +G+VYKG  ++ G L AIK         +E   E+  L     HRN+ T  G  
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 140 -------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
                   ++ L +L+ E+   GSV+  L   ++ +  K ++   +   +   +GLAHLH
Sbjct: 83  IKKSPPGHDDQL-WLVMEFCGAGSVT-DLVKNTKGNALKEDWIAYICREI--LRGLAHLH 138

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-- 250
           +   +V+H+D K  NVL+ E+   K+ D G+   L RT   G  +       ++A EV  
Sbjct: 139 A--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIA 194

Query: 251 ---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 307
                   +  +SD++S G+  +E+  G      + P  +  L+          N    L
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------RNPPPKL 246

Query: 308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 340
             + WS       ++FI  I  CL  +   RPS
Sbjct: 247 KSKKWS-------KKFIDFIEGCLVKNYLSRPS 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 44/221 (19%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 130
            +   N I EG +G VY+    + G +VA+KK      + G P    + E+  L  +QH 
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS-LREINILLKLQHP 64

Query: 131 NLVTLLGYCQE----NNLQ--FLIYEYIPNGSVSI--HLYGPSQVSRQKLEFKHRLSIAL 182
           N+VT+    +E    +NL   +++ EY+ +   S+   +  P   S  K      LS   
Sbjct: 65  NIVTV----KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLS--- 117

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ--V 239
               G+AHLH     ++H+D KT+N+L++   I K+ D GL R +        P +Q  V
Sbjct: 118 ----GVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREY---GSPLKPYTQLVV 168

Query: 240 T----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           T    A E+ L +     + +S   D++S G    EL++ +
Sbjct: 169 TLWYRAPELLLGA-----KEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 61/216 (28%), Positives = 90/216 (41%), Gaps = 41/216 (18%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRN-LVTLL 136
           IGEG +G+VYK      G LVA+KK        G P    + E+  L  +     +V LL
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA-LREISLLQMLSESIYIVRLL 67

Query: 137 G--YCQENN---LQFLIYEYIPNGSVS-IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
              + +E N     +L++EY+ +     +   G      + L  K   S      KG+AH
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRG--PGRPLPAKTIKSFMYQLLKGVAH 125

Query: 191 LHSLSPRVVHKDFKTANVLVDED-FIAKVADAGL-RNFLGRTDVAGPSSQVT-------- 240
            H     V+H+D K  N+LVD+   + K+AD GL R F      + P    T        
Sbjct: 126 CHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF------SIPVKSYTHEIVTLWY 177

Query: 241 -ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            A E+ L S       +S   D++S G    E+   
Sbjct: 178 RAPEVLLGS-----THYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 59/230 (25%), Positives = 107/230 (46%), Gaps = 27/230 (11%)

Query: 64  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFI---D 119
           +RR   E+  L  +       IG G +G+VYK   +  G L AIK     P ++F     
Sbjct: 3   SRRNPQEDFELIQR-------IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ 55

Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHR 177
           E+  +   +H N+V   G     +  ++  E+   GS+    H+ GP  +S  ++ +  R
Sbjct: 56  EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSR 113

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
            ++     +GL +LHS     +H+D K AN+L+ ++   K+AD G+   +  T +A   S
Sbjct: 114 ETL-----QGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKRKS 165

Query: 238 QVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASSSLSP 284
            +     ++A EV    R   +++  D+++ G+  +EL   +     L P
Sbjct: 166 FI-GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 23/203 (11%)

Query: 85  IGEGKFGEVYKGLLQD-GMLVA--------IKKRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +G+G FGEV    ++  G + A        +KKR G   Q  ++E   L  +  R +V+L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG--EQMALNEKKILEKVSSRFIVSL 58

Query: 136 LGYCQENNLQF-LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
             Y  E      L+   +  G +  H+Y    V          +  A     GL HLH  
Sbjct: 59  -AYAFETKDDLCLVMTLMNGGDLKYHIY---NVGEPGFPEARAIFYAAQIICGLEHLHQR 114

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLR-NFLGRTDVAGPSSQVTADEIFLASEVKEF 253
             R+V++D K  NVL+D+    +++D GL     G   + G +        ++A EV + 
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG----YMAPEVLQG 168

Query: 254 RRFSEKSDVYSFGVFLLELVSGR 276
             +    D ++ G  L E+++GR
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 51/233 (21%), Positives = 88/233 (37%), Gaps = 55/233 (23%)

Query: 83  NLIGEGKFGEVYKGL-LQDGMLVAIKK-------RPGAPTQEFIDEVCF----------L 124
             +GEG +G+V K      G +VAIKK             ++ +               +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 125 ASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIA 181
             I+H N++ L+  Y +         ++I N  + I      +V   + +L       I 
Sbjct: 75  NEIKHENIMGLVDVYVEG--------DFI-NLVMDIMASDLKKVVDRKIRLTESQVKCIL 125

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ--- 238
           L    GL  LH      +H+D   AN+ ++   I K+AD GL    G    +   S+   
Sbjct: 126 LQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183

Query: 239 -----------VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                      VT    A E+ + +E     ++    D++S G    EL++G+
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAE-----KYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 26/207 (12%)

Query: 85  IGEGKFGEVYKGLLQDGM---LVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVTLLG 137
           IG G FG+V  G +  G     V +K+ R  A  QE   F++E     S+QH NL+  LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
            C E     L+ E+ P G +  +L    +      +      +A   A GL HLH     
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--KNN 120

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF---------LAS 248
            +H D    N L+  D   K+ D GL +   + D       VT D+++         L  
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-----YVTPDQLWVPLRWIAPELVD 175

Query: 249 EVKE---FRRFSEKSDVYSFGVFLLEL 272
           EV         +++S+V+S GV + EL
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 69/303 (22%), Positives = 119/303 (39%), Gaps = 70/303 (23%)

Query: 84  LIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-----EVCFLASIQHRNLVTLLG 137
           L+GEG +G V K   ++ G +VAIKK   +   + +      E+  L  ++H NLV L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 138 YCQENNLQFLIYEYI-----------PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 186
             +     +L++E++           PNG                L+            +
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNG----------------LDESRVRKYLFQILR 111

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
           G+   HS +  ++H+D K  N+LV +  + K+ D G    L     A P    T   A  
Sbjct: 112 GIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTL-----AAPGEVYTDYVATR 164

Query: 244 IFLASE--VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 301
            + A E  V +  ++    D+++ G  + E+++G      L P  S D+ +L    +   
Sbjct: 165 WYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTG----EPLFPGDS-DIDQLYHIIKCLG 218

Query: 302 NLLKILDE-----------RLWSTFTNEGME--------EFIQLIVRCLDPSSERRPSMS 342
           NL+    E           RL      E +E          + L  +CL    + RPS S
Sbjct: 219 NLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS 278

Query: 343 DVV 345
            ++
Sbjct: 279 QLL 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 16/150 (10%)

Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IGEG +G V+K   ++   +VA+K+        G P+     E+C L  ++H+N+V L  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-REICLLKELKHKNIVRLYD 66

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
               +    L++EY       +  Y  S      ++ +   S      KGLA  H  S  
Sbjct: 67  VLHSDKKLTLVFEYCDQ---DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCH--SHN 119

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGL-RNF 226
           V+H+D K  N+L++++   K+AD GL R F
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAF 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 58.4 bits (141), Expect = 8e-10
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 43/212 (20%)

Query: 85  IGEGKFGEVYKGLLQ---DGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLL 136
           +G G FG V KG+ +       VA+K         A   E + E   +  + +  +V ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIALGAAKGLAHLHSLS 195
           G C+  +   L+ E    G ++  L     V+ + + E  H++S+      G+ +L   +
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLEETN 115

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL--------- 246
              VH+D    NVL+     AK++D GL            S  + ADE +          
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGL------------SKALGADENYYKAKTHGKWP 161

Query: 247 ----ASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               A E   + +FS KSDV+SFGV + E  S
Sbjct: 162 VKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 8e-10
 Identities = 72/296 (24%), Positives = 105/296 (35%), Gaps = 70/296 (23%)

Query: 84  LIGEGKFGEVYKGLL---QDGMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNL 132
           +IG G FGEV+  L+     G + A+K        KR          E   LA      +
Sbjct: 8   VIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRN--QIAHVRAERDILADADSPWI 63

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH-RLSIA-LGAAKGLAH 190
           V L    Q+    +L+ EY+P G +   L     + +     +  R  IA L  A  L  
Sbjct: 64  VKLYYSFQDEEHLYLVMEYMPGGDLMNLL-----IRKDVFPEETARFYIAELVLA--LDS 116

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------------------RNFLGRTD 231
           +H L    +H+D K  N+L+D D   K+AD GL                     F     
Sbjct: 117 VHKL--GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174

Query: 232 VAGPSSQV----------TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS 281
           V     +           T D  ++A EV     +  + D +S GV L E++ G      
Sbjct: 175 VRRRDHKQRRVRANSTVGTPD--YIAPEVLRGTPYGLECDWWSLGVILYEMLYGF----- 227

Query: 282 LSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER 337
             P  S  L E      ++   L+   +   S        E I LI R L    +R
Sbjct: 228 -PPFYSDTLQETYNKIINWKESLRFPPDPPVS-------PEAIDLICRLLCDPEDR 275

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 23/211 (10%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP-TQEFIDEV----C---FLASIQ 128
           N+    L+G G FGEVY     D G  +A+K+ P  P +QE   EV    C    L +++
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 129 HRNLVTLLGYC----QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
           H  +V   G C    +E  L   + EY+P GS+   L     ++ + +  ++   I    
Sbjct: 63  HDRIVQYYG-CLRDPEEKKLSIFV-EYMPGGSIKDQLKAYGALT-ENVTRRYTRQIL--- 116

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS-SQVTADE 243
            +G+++LHS    +VH+D K AN+L D     K+ D G    +    ++G     VT   
Sbjct: 117 -QGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            +++ EV     +  K+DV+S    ++E+++
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 35/216 (16%)

Query: 83  NLIGEGKFGEVYKGLLQD-GMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTL 135
             IGEG +G+VYK   +D G LVA+KK      + G P    I E+  L  + HRN+V L
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA-IREIKILRQLNHRNIVNL 71

Query: 136 ----------LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 185
                     L + ++    +L++EY+ +      L G  +         H  S      
Sbjct: 72  KEIVTDKQDALDFKKDKGAFYLVFEYMDH-----DLMGLLESGLVHFSEDHIKSFMKQLL 126

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA---- 241
           +GL + H  +   +H+D K +N+L++     K+AD GL       +    +++V      
Sbjct: 127 EGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184

Query: 242 -DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             E+ L  E     R+    DV+S G  L EL + +
Sbjct: 185 PPELLLGEE-----RYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 66/273 (24%), Positives = 120/273 (43%), Gaps = 32/273 (11%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           +G G +G+VYK   L  G L A   IK  PG        E+  +   +H N+V   G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 141 ENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
                ++  EY   GS+    H+ GP  +S  ++ +  R ++     +GLA+LHS     
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETL-----QGLAYLHSKGK-- 127

Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR--- 255
           +H+D K AN+L+ ++   K+AD G+   +  T              ++A EV    +   
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKI--TATIAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 256 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 315
           +++  D+++ G+  +EL   +     L P     +  L   S+      K+ D+  WS+ 
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHP-----MRALFLMSKSNFQPPKLKDKTKWSS- 239

Query: 316 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
                  F+++    L  + ++RP+   ++T L
Sbjct: 240 ---TFHNFVKI---SLTKNPKKRPTAERLLTHL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 66/272 (24%), Positives = 116/272 (42%), Gaps = 44/272 (16%)

Query: 82  KNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEF----IDEVCFLASIQHRNLVTLL 136
           + ++G G  G VYK   L    ++A+K  P   T E     + E+  L       ++   
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 137 G-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           G +  EN +  +  E++  GS+ ++   P  V  +         IA+   KGL +L SL 
Sbjct: 66  GAFFVENRIS-ICTEFMDGGSLDVYRKIPEHVLGR---------IAVAVVKGLTYLWSL- 114

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
            +++H+D K +N+LV+     K+ D G+   L    V   +        ++A E     +
Sbjct: 115 -KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQ 169

Query: 256 FSEKSDVYSFGVFLLELVSGR-------EASSSLSPDSSQDLVELVQNSRDFSNLLKILD 308
           +   SDV+S G+  +EL  GR       +   SL P      ++L+Q          I+D
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP------LQLLQC---------IVD 214

Query: 309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 340
           E        +  E+F+  I +C+    + RP+
Sbjct: 215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 57.9 bits (141), Expect = 1e-09
 Identities = 67/271 (24%), Positives = 104/271 (38%), Gaps = 53/271 (19%)

Query: 85  IGEGKFGEVYK-GLLQDGMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +G+G FG+V        G L A+K        KR        + E   L+ I H  +V L
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEH--TLTERNILSRINHPFIVKL 58

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK--------G 187
               Q     +L+ EY P G +  HL                   +   A+         
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLS-------------KEGRFSEERARFYAAEIVLA 105

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           L +LHSL   ++++D K  N+L+D D   K+ D GL   L        +   T +  +LA
Sbjct: 106 LEYLHSL--GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE--YLA 161

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 307
            EV   + + +  D +S GV L E+++G+       P  ++D  E+ +         KIL
Sbjct: 162 PEVLLGKGYGKAVDWWSLGVLLYEMLTGK------PPFYAEDRKEIYE---------KIL 206

Query: 308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERR 338
            + L   F      E   LI   L     +R
Sbjct: 207 KDPL--RFPEFLSPEARDLISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 37/212 (17%)

Query: 85  IGEGKFGEVYKGLL----QDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           IGEG FG   K +L    +DG    IK     K      +E   EV  L++++H N+V  
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQV---SRQKLEFKHRLSIALGAAKGLAHLH 192
               +EN   +++ +Y   G +   +     V     Q L++  ++ +AL       H+H
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVH 118

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF------LGRTDVAGPSSQVTADEIFL 246
               +++H+D K+ N+ + +D   K+ D G+         L RT +  P         +L
Sbjct: 119 D--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTP--------YYL 168

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
           + E+ E R ++ KSD+++ G  L E+ + + A
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 63/273 (23%), Positives = 121/273 (44%), Gaps = 28/273 (10%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 132
           K ++    IG+G  G VY  + +  G  VAIK+      P +E I +E+  +   ++ N+
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           V  L      +  +++ EY+  GS++        V+   ++     ++     + L  LH
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALDFLH 132

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 252
           S   +V+H+D K+ N+L+  D   K+ D G    +  T      S +     ++A EV  
Sbjct: 133 S--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVT 188

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 312
            + +  K D++S G+  +E+V G     + +P  +  L+     + +  N      ERL 
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN-----PERLS 242

Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
           + F +         + RCL+   +RR S  +++
Sbjct: 243 AVFRD--------FLNRCLEMDVDRRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 57.4 bits (138), Expect = 2e-09
 Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 46/254 (18%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKK---RPGAP-TQEFID----EVCFLASIQ 128
           N+    L+G+G FG VY     D G  +A K+    P +P T + +     E+  L ++Q
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 129 HRNLVTLLGYCQENNLQFL--IYEYIPNGSVSIHL--YGP------SQVSRQKLEFKHRL 178
           H  +V   G  ++   + L    EY+P GSV   L  YG        + +RQ LE     
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE----- 117

Query: 179 SIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS-S 237
                   G+++LHS    +VH+D K AN+L D     K+ D G    L    ++G    
Sbjct: 118 --------GMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR 167

Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR------EASSSL-----SPDS 286
            VT    +++ EV     +  K+DV+S G  ++E+++ +      EA +++      P +
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN 227

Query: 287 SQDLVELVQNSRDF 300
            Q    + +++RDF
Sbjct: 228 PQLPSHISEHARDF 241

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 64/274 (23%), Positives = 122/274 (44%), Gaps = 28/274 (10%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 132
           K ++    IG+G  G VY  + +  G  VAIK+      P +E I +E+  +   +H N+
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           V  L      +  +++ EY+  GS++        V+   ++     ++     + L  LH
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLH 132

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 252
           S   +V+H+D K+ N+L+  D   K+ D G    +  T      S +     ++A EV  
Sbjct: 133 S--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVT 188

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 312
            + +  K D++S G+  +E+V G     + +P  +  L+     + +  N      E+L 
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN-----PEKLS 242

Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 346
           + F      +F+    RCL+   E+R S  +++ 
Sbjct: 243 AIF-----RDFLN---RCLEMDVEKRGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 61/273 (22%), Positives = 121/273 (44%), Gaps = 28/273 (10%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 132
           K ++    IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           V  L      +  +++ EY+  GS++        V+   ++     ++     + L  LH
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLH 133

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 252
           S   +V+H+D K+ N+L+  D   K+ D G    +  T      S +     ++A EV  
Sbjct: 134 S--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVT 189

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 312
            + +  K D++S G+  +E++ G     + +P  +  L+     + +  N      E+L 
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQN-----PEKLS 243

Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
           + F +         + RCLD   E+R S  +++
Sbjct: 244 AIFRD--------FLNRCLDMDVEKRGSAKELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 56.2 bits (135), Expect = 5e-09
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 37/220 (16%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKK---RPGAP-TQEFID----EVCFLASIQ 128
           N+    L+G+G FG VY     D G  +A+K+    P +P T + ++    E+  L ++ 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 129 HRNLVTLLGYC---QENNLQFLIYEYIPNGSVSIHL--YGP------SQVSRQKLEFKHR 177
           H  +V   G      E  L   + E++P GS+   L  YG        + +RQ LE    
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFM-EHMPGGSIKDQLKSYGALTENVTRKYTRQILE---- 117

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS- 236
                    G+++LHS    +VH+D K AN+L D     K+ D G    L    ++G   
Sbjct: 118 ---------GVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166

Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             VT    +++ EV     +  K+D++S G  ++E+++ +
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 53/237 (22%), Positives = 107/237 (45%), Gaps = 21/237 (8%)

Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IGEG  G V    ++  G LVA+KK   R     +   +EV  +   QH N+V +     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
             +  +++ E++  G+++        V+  ++  +   ++ L   K L+ LH+    V+H
Sbjct: 88  VGDELWVVMEFLEGGALT------DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG--VIH 139

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRRFSEK 259
           +D K+ ++L+  D   K++D G   F  +     P  + +     ++A E+     +  +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196

Query: 260 SDVYSFGVFLLELVSGREASSSLSPDSSQDLVE-----LVQNSRDFSNLLKILDERL 311
            D++S G+ ++E+V G     +  P  +  ++       ++N    S  LK   +RL
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRL 253

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 71/268 (26%), Positives = 113/268 (42%), Gaps = 44/268 (16%)

Query: 84  LIGEGKFGEVY----KGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTL 135
           ++G+G FG+V+    KG  Q   + A+KK       +     +++     + +H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
               Q     F + EY+  G +  H+      S  K +       A     GL  LHS  
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDLMFHIQ-----SCHKFDLPRATFYAAEIICGLQFLHSKG 116

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLG--RTDVAGPSSQVTADEIFLASEVK 251
             +V++D K  N+L+D D   K+AD G+   N LG  +T     +    A EI L     
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG---- 170

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 311
             ++++   D +SFGV L E++ G+      SP    D  EL Q+ R        +D   
Sbjct: 171 --QKYNTSVDWWSFGVLLYEMLIGQ------SPFHGHDEEELFQSIR--------MDNPC 214

Query: 312 WSTF-TNEGMEEFIQLIVRCLDPSSERR 338
           +  + T E  +  ++L VR      ERR
Sbjct: 215 YPRWLTREAKDILVKLFVR----EPERR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 71/282 (25%), Positives = 123/282 (43%), Gaps = 47/282 (16%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEV-----CFLASIQHRNLVTLLGY 138
           IG+G +G+V+K L  ++G   A+K     P  +  +E+        A   H N+V   G 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD--PIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 139 CQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAAKG 187
             + +++     +L+ E    GSV+        + +  L+   R+       I   A  G
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVT-------DLVKGFLKRGERMEEPIIAYILHEALMG 136

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADE 243
           L HLH    + +H+D K  N+L+  +   K+ D G+   L  T +   +S  T    A E
Sbjct: 137 LQHLHV--NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 303
           + +A E +    +  + DV+S G+  +EL  G    + L P   + L ++ +N       
Sbjct: 195 V-IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP--MRALFKIPRNPPP---- 247

Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
             +    LWS        EF   I +CL    E+RP++SD++
Sbjct: 248 -TLHQPELWSN-------EFNDFIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 34/211 (16%)

Query: 85  IGEGKFGEVY---KGLLQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTL 135
           I +G +G V+   K    D  + AIK    A         + + E   L+  Q   +V L
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 136 L-GYCQENNLQFLIYEYIPNGSVS--IHLYG--PSQVSRQKLEFKHRLSIALGAAKGLAH 190
              +  + NL +L+ EY+P G ++  +   G     V+R  +       I L     L +
Sbjct: 59  YYSFQGKKNL-YLVMEYLPGGDLASLLENVGSLDEDVARIYIA-----EIVLA----LEY 108

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL------RNFLGRTDVAGPSSQVTADEI 244
           LHS    ++H+D K  N+L+D +   K+ D GL      R  +   D      ++     
Sbjct: 109 LHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           ++A EV   +  S+  D +S G  L E + G
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 53.6 bits (128), Expect = 5e-08
 Identities = 62/273 (22%), Positives = 121/273 (44%), Gaps = 28/273 (10%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFI-DEVCFLASIQHRNL 132
           K ++    IG+G  G V+  + +  G  VAIK+      P +E I +E+  +  +++ N+
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           V  L      +  F++ EY+  GS++        V+   ++     ++     + L  LH
Sbjct: 79  VNFLDSFLVGDELFVVMEYLAGGSLT------DVVTETCMDEAQIAAVCRECLQALEFLH 132

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 252
           +   +V+H+D K+ NVL+  D   K+ D G    +  T      S +     ++A EV  
Sbjct: 133 A--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVT 188

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 312
            + +  K D++S G+  +E+V G     + +P  +  L+     + +  N      E+L 
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN-----PEKLS 242

Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
             F +         + RCL+   E+R S  +++
Sbjct: 243 PIFRD--------FLNRCLEMDVEKRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 5e-08
 Identities = 49/169 (28%), Positives = 70/169 (41%), Gaps = 48/169 (28%)

Query: 85  IGEGKFGEVYKGLLQ---DGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTL 135
           IG G +G VYK   +   DG   AIKK  G         Q    E+  L  ++H N+V+L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 136 LGYCQENNLQ--FLIYEYIP------------NGSVSIHLYGPSQVSR---QKLEFKHRL 178
           +    E+  +  +L+++Y                 VSI    PS V     Q L      
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIP---PSMVKSLLWQILN----- 119

Query: 179 SIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGL 223
                   G+ +LH  S  V+H+D K AN+LV     E  + K+ D GL
Sbjct: 120 --------GVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 27/211 (12%)

Query: 79  FSDKNLIGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQH 129
           F    ++G+G FGEV    ++  G + A        IKKR G      ++E   L  +  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
           R +V+L    +  +   L+   +  G +  H+Y    +     E    +  A     GL 
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY---HMGEAGFEEGRAVFYAAEICCGLE 116

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI----F 245
            LH    R+V++D K  N+L+D+    +++D GL        V  P  Q     +    +
Sbjct: 117 DLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLA-------VHVPEGQTIKGRVGTVGY 167

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           +A EV +  R++   D ++ G  L E+++G+
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 30/214 (14%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG G FG V+     +DG  VA+KK P         +    E+  L   +H N+++ L  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
            Q  ++      Y+    +   L+    VS Q L   H         +GL +LHS    +
Sbjct: 68  LQPPHIDPFEEIYVVTELMQSDLH-KIIVSPQPLSSDHVKVFLYQILRGLKYLHS--AGI 124

Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---------ADEIFLASE 249
           +H+D K  N+LV+ + + K+ D G    L R +    S  +T         A EI + S 
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFG----LARVEEPDESKHMTQEVVTQYYRAPEILMGS- 179

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGR---EASS 280
               R ++   D++S G    EL+  R   +A S
Sbjct: 180 ----RHYTSAVDIWSVGCIFAELLGRRILFQAQS 209

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 53.3 bits (128), Expect = 8e-08
 Identities = 74/277 (26%), Positives = 117/277 (42%), Gaps = 39/277 (14%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQD---GMLVAIK--KRPGAPTQE---FIDEVCFLASIQ 128
           K+F  K+L+G G FGEV   ++++   G + A+K  K+     QE   F +E   + SI 
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58

Query: 129 HRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           +   +  L Y  Q+ +  +L+ EY P G +       S ++R + +F   ++    A   
Sbjct: 59  NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL------SLLNRYEDQFDEDMAQFYLAELV 112

Query: 188 LAHLHSLSPR-VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 246
           LA +HS+     VH+D K  NVL+D     K+AD G    L    +      V   + ++
Sbjct: 113 LA-IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD-YI 170

Query: 247 ASEVKEFRRFSEKS------DVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 300
           A EV        K       D +S GV   E++ GR      SP       +   N  +F
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR------SPFHEGTSAKTYNNIMNF 224

Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER 337
              LK  ++   S        +F+ LI   L    ER
Sbjct: 225 QRFLKFPEDPKVS-------SDFLDLIQSLLCGQKER 254

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 52.5 bits (126), Expect = 9e-08
 Identities = 45/178 (25%), Positives = 84/178 (47%), Gaps = 33/178 (18%)

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGP 235
           IA+   +GL +L+++  R++H+D K +N+LV+     K+ D G    L N +  T V G 
Sbjct: 108 IAVAVVEGLTYLYNVH-RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-GT 165

Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR-----EASSSLSPDSSQDL 290
           S+       +++ E  +  +++ KSDV+S G+ ++EL  G+             D    +
Sbjct: 166 ST-------YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI 218

Query: 291 VELVQNSRDFSNLLKILDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
           ++L+Q         +I+ E   RL S+   E + +F+     CL      RP+   + 
Sbjct: 219 LDLLQ---------QIVQEPPPRLPSSDFPEDLRDFVD---ACLLKDPTERPTPQQLC 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 30/199 (15%)

Query: 164 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 223
             ++ ++ L  +  +S +   A+G+  L S   + +H+D    N+L+ E+ + K+ D GL
Sbjct: 162 GDELYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGL 219

Query: 224 R-------NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                   +++ + D   P   +  + IF        + ++ +SDV+SFGV L E+ S  
Sbjct: 220 ARDIYKDPDYVRKGDARLPLKWMAPESIF-------DKVYTTQSDVWSFGVLLWEIFS-- 270

Query: 277 EASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSE 336
              +S  P         VQ   +F   LK   E            E   +++ C   + E
Sbjct: 271 -LGASPYPG--------VQIDEEFCRRLK---EGTRMRAPEYATPEIYSIMLDCWHNNPE 318

Query: 337 RRPSMSDVVTELDRTLDKE 355
            RP+ S++V  L   L + 
Sbjct: 319 DRPTFSELVEILGDLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 37/220 (16%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEF----IDEVCFLASIQHRN 131
             + + + IGEG +G V        G+ VAIKK      Q F    + E+  L   +H N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 132 LVTLLGYCQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 186
           ++ +L   +  + +     +++ E +        LY    +  Q L   H         +
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMET-----DLY--KLIKTQHLSNDHIQYFLYQILR 117

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT----- 240
           GL ++HS +  V+H+D K +N+L++ +   K+ D GL R      D    +  +T     
Sbjct: 118 GLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD---HTGFLTEYVAT 172

Query: 241 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               A EI L S     + +++  D++S G  L E++S R
Sbjct: 173 RWYRAPEIMLNS-----KGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 41/211 (19%)

Query: 85  IGEGKFGEVYKGL--LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           +GEG +  VYKG   L D  LVA+K+       GAP    I EV  L  ++H N+VTL  
Sbjct: 14  LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHD 71

Query: 138 YCQENNLQFLIYEYIP--------NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
                    L++EY+         +   SI+++       Q L             +GL 
Sbjct: 72  IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLL-------------RGLN 118

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIF 245
           + H    +V+H+D K  N+L++E    K+AD GL            +  VT      +I 
Sbjct: 119 YCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDIL 176

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           L S       +S + D++  G    E+ +GR
Sbjct: 177 LGST-----DYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 27/204 (13%)

Query: 85  IGEGKFGEVYKGL--LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           +GEG +  V+KG   L +  LVA+K+       GAP    I EV  L  ++H N+VTL  
Sbjct: 14  LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHD 71

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL-GAAKGLAHLHSLSP 196
               +    L++EY+      +  Y     +   +   H + I L    +GLA+ H    
Sbjct: 72  IVHTDKSLTLVFEYLDK---DLKQYMDDCGNIMSM---HNVKIFLYQILRGLAYCH--RR 123

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKE 252
           +V+H+D K  N+L++E    K+AD GL            +  VT      ++ L S    
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS--- 180

Query: 253 FRRFSEKSDVYSFGVFLLELVSGR 276
              +S + D++  G    E+ SGR
Sbjct: 181 --EYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 36/220 (16%)

Query: 75  ATKNFSD---KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLAS 126
           A K+ S+    N IG G  G VYK + +  G L A+K   G       ++   E+  L  
Sbjct: 69  AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128

Query: 127 IQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQ----VSRQKLEFKHRLSIA 181
           + H N+V     +     +Q L+ E++  GS+        Q    V+RQ L         
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSLEGTHIADEQFLADVARQILS-------- 179

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-----DVAGPS 236
                G+A+LH     +VH+D K +N+L++     K+AD G+   L +T        G  
Sbjct: 180 -----GIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTI 232

Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           + ++ + I   +++          D++S GV +LE   GR
Sbjct: 233 AYMSPERI--NTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 50.5 bits (121), Expect = 4e-07
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 10/102 (9%)

Query: 180 IALGAAKGLAHLHS-LSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAG 234
           IA+   K L +LHS LS  V+H+D K +NVL++ +   K+ D G    L + + +T  AG
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAG 165

Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               +  + I      K +     KSDV+S G+ ++EL +GR
Sbjct: 166 CKPYMAPERINPELNQKGY---DVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 3/155 (1%)

Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E+  LA+  H  +V      + ++   LI EY   G ++  +    Q  ++ L F+    
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI---KQRLKEHLPFQEYEV 171

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
             L     LA     S +++H+D K+AN+ +    I K+ D G       +     +S  
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                +LA E+ E +R+S+K+D++S GV L EL++
Sbjct: 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 67/293 (22%), Positives = 120/293 (40%), Gaps = 65/293 (22%)

Query: 85  IGEGKFGEVYKGL---LQDG--------MLVAIKKRPGAPTQEFIDEVCFLASIQHRNLV 133
           +G+G F +++KG+   + D         +L  + K     ++ F +    ++ + H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH-LH 192
              G C   +   ++ EY+  GS+  +L        +K +    +S  L  AK LA  LH
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL--------KKNKNLINISWKLEVAKQLAWALH 114

Query: 193 SLSPR-VVHKDFKTANVLV--DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL--- 246
            L  + + H +    NVL+  +ED        G   F+  +D  G S  V   EI L   
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREED-----RKTGNPPFIKLSD-PGISITVLPKEILLERI 168

Query: 247 ---ASE-VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 302
                E ++  +  S  +D +SFG  L E+ SG                +   ++ D   
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG---------------GDKPLSALDSQK 213

Query: 303 LLKILDERL------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
            L+  ++R       W+        E   LI +C+D   + RPS   ++ +L+
Sbjct: 214 KLQFYEDRHQLPAPKWT--------ELANLINQCMDYEPDFRPSFRAIIRDLN 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 64/273 (23%), Positives = 111/273 (40%), Gaps = 40/273 (14%)

Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVC-------FLASIQHRNLVTLL 136
           +G+G +G+V+    +D G +VA+K R        ++EV         L + +   LV LL
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALK-RMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF-KHRLSIALGAAKGLAHLHSLS 195
              Q++   +L  EY+P G     L     +S     F    +  A+ A      LH L 
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA------LHELG 121

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
              +H+D K  N L+D     K+ D GL +  +   +     S V + + ++A EV   +
Sbjct: 122 --YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN-----SVVGSPD-YMAPEVLRGK 173

Query: 255 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL---KILDERL 311
            +    D +S G  L E + G    S  +P+ +            + NL    + L   +
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------------WENLKYWKETLQRPV 221

Query: 312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           +        +E   LI + ++  S R  S+ D+
Sbjct: 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDI 254

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 19/209 (9%)

Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81

Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           H+N++ LL  +  + +L+     YI    +  +L    QV + +L+ +    +      G
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHERMSYLLYQMLCG 138

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           + HLHS    ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 139 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRA 193

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            EV     + E  D++S G  + E++ G 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 49.4 bits (118), Expect = 9e-07
 Identities = 61/281 (21%), Positives = 119/281 (42%), Gaps = 44/281 (15%)

Query: 84  LIGEGKFGEVYKGLLQDG--MLVAIK-------------KRPGAPTQEFIDEVCFL-ASI 127
            +G G FG VYK   ++    L+A+K             +       + + EV  +   +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           +H N+V       EN+  +++ + I    +  H     +  +Q+   +   +I +     
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLA 125

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE---I 244
           L +LH    R+VH+D    N+++ ED    + D GL           P S++T+     +
Sbjct: 126 LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGL------AKQKQPESKLTSVVGTIL 178

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD-SSQDLVELVQNSRDFSNL 303
           +   E+ +   + EK+DV++FG  L ++        +L P   S +++ L   ++    +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMC-------TLQPPFYSTNMLSLA--TKIVEAV 229

Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
            + L E ++S       E+   +I  CL P +E RP +  V
Sbjct: 230 YEPLPEGMYS-------EDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 49.7 bits (118), Expect = 9e-07
 Identities = 43/196 (21%), Positives = 91/196 (46%), Gaps = 16/196 (8%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IGEG  G V     +  G  VA+KK   R     +   +EV  +    H N+V +     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
             +  +++ E++  G+++        V+  ++  +   ++ L   + L++LH+    V+H
Sbjct: 90  VGDELWVVMEFLEGGALT------DIVTHTRMNEEQIATVCLSVLRALSYLHNQG--VIH 141

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRRFSEK 259
           +D K+ ++L+  D   K++D G   F  +     P  + +     ++A EV     +  +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198

Query: 260 SDVYSFGVFLLELVSG 275
            D++S G+ ++E++ G
Sbjct: 199 VDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 35/209 (16%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83

Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIALGAAKGL 188
                   +E N  +L+           HL G    + V  QKL   H   +     +GL
Sbjct: 84  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 133

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
            ++HS    ++H+D K +N+ V+ED   K+ D GL             +   A   + A 
Sbjct: 134 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAP 186

Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 56/243 (23%), Positives = 106/243 (43%), Gaps = 16/243 (6%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IGEG  G V     +  G  VA+K    R     +   +EV  +   QH+N+V +     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
                +++ E++  G+++        VS+ +L  +   ++     + L +LHS    V+H
Sbjct: 89  VGEELWVLMEFLQGGALT------DIVSQTRLNEEQIATVCESVLQALCYLHSQG--VIH 140

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKS 260
           +D K+ ++L+  D   K++D G    + + DV    S V     ++A EV     +  + 
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKSLV-GTPYWMAPEVISRTPYGTEV 198

Query: 261 DVYSFGVFLLELVSGREASSSLSPDSSQDLV--ELVQNSRDFSNLLKILDERLWSTFTNE 318
           D++S G+ ++E+V G     S SP  +   +        ++   +  +L + L    T E
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTRE 258

Query: 319 GME 321
             E
Sbjct: 259 PQE 261

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 64/279 (22%), Positives = 119/279 (42%), Gaps = 52/279 (18%)

Query: 85  IGEGKFGEVYKGLL---QDGMLVAIKK----------RPGAPTQEFIDEVCFLASIQHRN 131
           +G+G +GEV   L+    DG    IKK          R  A       E   L+ ++H N
Sbjct: 8   VGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAE-----QEAQLLSQLKHPN 60

Query: 132 LVTLLGYCQ-ENNLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIALGAAKG 187
           +V      + E+ L +++  +   G +   L    G      Q +E+  ++++AL     
Sbjct: 61  IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL----- 115

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFL 246
             +LH     ++H+D KT NV +    I KV D G+   L  + D+A   S +     ++
Sbjct: 116 -QYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA---STLIGTPYYM 169

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 306
           + E+   + ++ KSDV++ G  + E+ + + A                 N++D ++L+  
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEMATLKHAF----------------NAKDMNSLVYR 213

Query: 307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
           + E        +   E  +LI   L    E+RPS+  ++
Sbjct: 214 IIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 59/286 (20%), Positives = 105/286 (36%), Gaps = 67/286 (23%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQDGMLV----------AIKKRPGAPTQEFIDEVCFLASI 127
           +F    +IG+G FG+V     +D   +           ++K      +  ++E   L  +
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGS---VRNVLNERRILQEL 57

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH---RLSIALGA 184
            H  LV L    Q+    +L+ + +  G +  HL        QK++F     +  I    
Sbjct: 58  NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-------SQKVKFSEEQVKFWIC-EI 109

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
              L +LHS    ++H+D K  N+L+DE     + D  +            +++VT D +
Sbjct: 110 VLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNI------------ATKVTPDTL 155

Query: 245 ---------FLASEVKEFRRFSEKSDVYSFGVFLLELVSGR---EASSSLSPDSSQDLVE 292
                    ++A EV   + +S   D +S GV   E + G+      S       Q   +
Sbjct: 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQIRAK 213

Query: 293 LVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 338
                  +           WST       E I  I + L+   ++R
Sbjct: 214 QETADVLYPA--------TWST-------EAIDAINKLLERDPQKR 244

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 22/147 (14%)

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFL----GRTDVAGPSSQVTADEIFLASEVKEF 253
           V+H+D K +N+L+D     K+ D G+   L     +T  AG ++ +  + I         
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERI---DPPDPN 192

Query: 254 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 313
            ++  ++DV+S G+ L+EL +G+       P              +F  L KIL E   S
Sbjct: 193 PKYDIRADVWSLGISLVELATGQ------FP--------YKNCKTEFEVLTKILQEEPPS 238

Query: 314 TFTNEGME-EFIQLIVRCLDPSSERRP 339
              NEG   +F   +  CL     +RP
Sbjct: 239 LPPNEGFSPDFCSFVDLCLTKDHRKRP 265

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)

Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L     VAIKK  RP       +    E+  +  + 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74

Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           H+N+++LL  +  + +L+     Y+    +  +L    QV + +L+ +    +      G
Sbjct: 75  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQMLCG 131

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           + HLHS    ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 132 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRA 186

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELV 273
            EV     + E  D++S G  + E+V
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 25/203 (12%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           +GEG +  V+KG  +    LVA+K+       GAP    I EV  L +++H N+VTL   
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA-IREVSLLKNLKHANIVTLHDI 71

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL-GAAKGLAHLHSLSPR 197
                   L++EY+ +  +  +L          L   H + I +    +GL++ H    +
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCH--KRK 123

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKEF 253
           ++H+D K  N+L++E    K+AD GL            +  VT      ++ L S     
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST---- 179

Query: 254 RRFSEKSDVYSFGVFLLELVSGR 276
             +S   D++  G  L E+ +GR
Sbjct: 180 -EYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 26/205 (12%)

Query: 84  LIGEGKFGEV----------YKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLV 133
           L+G+G FG+V          Y  +      V I K   A T   + E   L + +H  L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHT---LTESRVLKNTRHPFLT 58

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLAHL 191
           +L    Q  +    + EY+  G +  HL      SR+++ F    +   GA     L +L
Sbjct: 59  SLKYSFQTKDRLCFVMEYVNGGELFFHL------SRERV-FSEDRTRFYGAEIVSALDYL 111

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 251
           HS   ++V++D K  N+++D+D   K+ D GL    G TD A   +     E +LA EV 
Sbjct: 112 HS--GKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPE-YLAPEVL 167

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGR 276
           E   +    D +  GV + E++ GR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 24/205 (11%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +G+G FGEV    ++  G L A        +KKR G   +  + E   LA +  R +V+L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKG--YEGAMVEKRILAKVHSRFIVSL 58

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA--KGLAHLHS 193
               Q      L+   +  G +  H+Y    V  +   F    +    A    GL HLH 
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIY---NVDEENPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADEIFLASEVK 251
              R++++D K  NVL+D D   +++D GL   L  G++   G +        F+A E+ 
Sbjct: 116 --RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPG----FMAPELL 169

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGR 276
           +   +    D ++ GV L E+++ R
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 67/287 (23%), Positives = 122/287 (42%), Gaps = 42/287 (14%)

Query: 47  PSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY------------ 94
           P+++  +N+   LS  E    ++ +L +  ++F    +IG G FGEV             
Sbjct: 13  PALRKNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYA 72

Query: 95  -KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 153
            K L +  M+    KR  +    F +E   +A      +V L    Q++   +++ EY+P
Sbjct: 73  MKLLSKFEMI----KRSDSAF--FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMP 126

Query: 154 NGSVSIHLYGPSQVSRQKLEF-KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE 212
            G + ++L     +  +   F    + +AL A      +HS+    +H+D K  N+L+D+
Sbjct: 127 GGDL-VNLMSNYDIPEKWARFYTAEVVLALDA------IHSMG--FIHRDVKPDNMLLDK 177

Query: 213 DFIAKVADAGLRNFLGRTDVAGPSSQV-TADEIFLASEVKEFRR----FSEKSDVYSFGV 267
               K+AD G    +    +    + V T D  +++ EV + +     +  + D +S GV
Sbjct: 178 SGHLKLADFGTCMKMDANGMVRCDTAVGTPD--YISPEVLKSQGGDGYYGRECDWWSVGV 235

Query: 268 FLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 314
           FL E++ G       +P  +  LV       D  N L   D+   S 
Sbjct: 236 FLYEMLVGD------TPFYADSLVGTYSKIMDHKNSLTFPDDIEISK 276

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 23/221 (10%)

Query: 84  LIGEGKFGEVYKGLLQ-DGMLVAIK---KRPGAPTQE----FIDEVCFLASIQHRNLVTL 135
           +IG+G FG+V     + +    A+K   K+     +E      +    L +++H  LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
               Q  +  + + +YI  G +  HL    Q  R  LE + R   A   A  L +LHSL+
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARF-YAAEIASALGYLHSLN 116

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
             +V++D K  N+L+D      + D GL       +  G +S       +LA EV   + 
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 256 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 296
           +    D +  G  L E++ G      L P  S++  E+  N
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG------LPPFYSRNTAEMYDN 207

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 47/222 (21%), Positives = 92/222 (41%), Gaps = 42/222 (18%)

Query: 104 VAIKKRPGAPTQEFID---------EVCFLASIQHRNLVTLLGYCQENNLQFLI------ 148
           V +  +PG P    +          E   L ++ H +++ +        +  ++      
Sbjct: 82  VFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS 141

Query: 149 --YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA 206
             Y Y+   S  + +     + +Q LE             GL +LH+   R++H+D KT 
Sbjct: 142 DLYTYLTKRSRPLPIDQALIIEKQILE-------------GLRYLHAQ--RIIHRDVKTE 186

Query: 207 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKEFRRFSEKSDVYSF 265
           N+ +++     + D G   F     V  P+    A  +   A EV    +++ K+D++S 
Sbjct: 187 NIFINDVDQVCIGDLGAAQF----PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSA 242

Query: 266 GVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 307
           G+ L E+++     S++  D      E V++    S+LLKI+
Sbjct: 243 GIVLFEMLA---YPSTIFEDPPSTPEEYVKSCH--SHLLKII 279

Length = 357

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 20/202 (9%)

Query: 84  LIGEGKFGEVY---KGLLQD-GMLVAIKKRPGAPTQEFIDEV------CFLASIQHRNLV 133
           ++G+G FG+V+   K    D G L A+K    A T +  D V        LA + H  +V
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA-TLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            L    Q     +LI +++  G +   L      + + ++F +   +AL     L HLHS
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALA----LDHLHS 116

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
           L   ++++D K  N+L+DE+   K+ D GL       +    S   T +  ++A EV   
Sbjct: 117 LG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE--YMAPEVVNR 172

Query: 254 RRFSEKSDVYSFGVFLLELVSG 275
           R  ++ +D +SFGV + E+++G
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 46/203 (22%), Positives = 91/203 (44%), Gaps = 16/203 (7%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLV 133
              +   IGEG  G V        G  VA+KK   R     +   +EV  +   QH N+V
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            +       +  +++ E++  G+++        V+  ++  +   ++ L   K L+ LH+
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIATVCLAVLKALSFLHA 133

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKE 252
               V+H+D K+ ++L+  D   K++D G   F  +     P  + +     ++A EV  
Sbjct: 134 --QGVIHRDIKSDSILLTSDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPEVIS 188

Query: 253 FRRFSEKSDVYSFGVFLLELVSG 275
              +  + D++S G+ ++E+V G
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 42/155 (27%), Positives = 61/155 (39%), Gaps = 27/155 (17%)

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIF 245
           G+  LH     ++H+D K  N+L+D+    K+ D GL RN L      G     T D  +
Sbjct: 109 GVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVG-----TPD--Y 159

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 305
           LA E        + SD +S G  + E + G     + +PD+  D                
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD---------------N 204

Query: 306 ILDERL-WSTFTNEGME-EFIQLIVRCLDPSSERR 338
           IL  R+ W     E    E + LI R L     +R
Sbjct: 205 ILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 49/214 (22%), Positives = 87/214 (40%), Gaps = 33/214 (15%)

Query: 79  FSDKNLIGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQH 129
           F    ++G+G FGEV    ++  G + A        IKKR G      ++E   L  +  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
           + +V L    +  +   L+   +  G +  H+Y    +     E +  L  A     GL 
Sbjct: 60  QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY---NMGNPGFEEERALFYAAEILCGLE 116

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGPSSQVTAD 242
            LH      V++D K  N+L+D+    +++D GL        +  GR    G        
Sbjct: 117 DLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVG-------- 166

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             ++A EV   +R++   D +  G  + E++ G+
Sbjct: 167 --YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 36/200 (18%)

Query: 138 YC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA--KGLAHLHS 193
           +C  Q     F + EY+  G +  H+       +    F    +    A    GL  LH 
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHI-------QSSGRFDEARARFYAAEIICGLQFLHK 114

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVK 251
               ++++D K  NVL+D+D   K+AD G+   N  G     G +S       ++A E+ 
Sbjct: 115 KG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----GKASTFCGTPDYIAPEIL 168

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 311
           + ++++E  D +SFGV L E++ G+      SP   +D  EL  +         IL++R 
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQ------SPFHGEDEDELFDS---------ILNDRP 213

Query: 312 W--STFTNEGMEEFIQLIVR 329
                 + E  +   +L  R
Sbjct: 214 HFPRWISKEAKDCLSKLFER 233

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 67/240 (27%), Positives = 110/240 (45%), Gaps = 37/240 (15%)

Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLV 133
             K++   N+IG G FG VY+ +  D    VAIKK    P Q    E+  + ++ H N++
Sbjct: 64  PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNLNHINII 122

Query: 134 TLLGY----CQENNLQ--FL--IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL--- 182
            L  Y    C + N +  FL  + E+IP    ++H Y     +R      H L + L   
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQ---TVHKY-MKHYARN----NHALPLFLVKL 174

Query: 183 ---GAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAG-LRNFL-GRTDVAGPS 236
                 + LA++H  S  + H+D K  N+L+D +    K+ D G  +N L G+  V+   
Sbjct: 175 YSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232

Query: 237 SQV-TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 295
           S+   A E+ L +       ++   D++S G  + E++ G    S  S  S   LV ++Q
Sbjct: 233 SRFYRAPELMLGAT-----NYTTHIDLWSLGCIIAEMILGYPIFSGQS--SVDQLVRIIQ 285

Length = 440

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 42/179 (23%)

Query: 132 LVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK--HRLSIALGAAKGL 188
            +T L  C Q  +  + + EY+  G +   +    QV R    FK  H +  A   A GL
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI---QQVGR----FKEPHAVFYAAEIAIGL 114

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSS 237
             LHS    ++++D K  NV++D +   K+AD G+           + F G  D      
Sbjct: 115 FFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD------ 166

Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 296
                  ++A E+  ++ + +  D ++FGV L E+++G+      +P   +D  EL Q+
Sbjct: 167 -------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ------APFEGEDEDELFQS 212

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 23/207 (11%)

Query: 78  NFSDKNLIGEGKFGEV----YKGLLQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHR 130
           +F     +G G FG V    +KG  +   +  +KKR        Q    E   L  + H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA- 189
            +V ++   Q+ N  + + E++  G +  HL       R+   F + ++    A   LA 
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHL-------RKAGRFPNDVAKFYHAELVLAF 131

Query: 190 -HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
            +LHS    ++++D K  N+L+D     KV D G   F  +  V   +  +     +LA 
Sbjct: 132 EYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFG---FAKK--VPDRTFTLCGTPEYLAP 184

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSG 275
           EV + +   +  D ++ GV L E ++G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 34/212 (16%)

Query: 85  IGEGKFGEVYKG--LLQDGMLVAIKK------RPGAPTQEFIDEVCFL---ASIQHRNLV 133
           IGEG +G+V+K   L   G  VA+K+        G P    I EV  L    + +H N+V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-IREVAVLRHLETFEHPNVV 67

Query: 134 TLLGYC------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
            L   C      +E  L  L++E++ +  ++ +L    +V    +  +    +     +G
Sbjct: 68  RLFDVCTVSRTDRETKLT-LVFEHV-DQDLTTYL---DKVPEPGVPTETIKDMMFQLLRG 122

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR---NFLGRTDVAGPSSQVTADEI 244
           L  LHS   RVVH+D K  N+LV      K+AD GL    +F         +    A E+
Sbjct: 123 LDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            L S       ++   D++S G    E+   +
Sbjct: 181 LLQSS------YATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 47.3 bits (113), Expect = 6e-06
 Identities = 41/155 (26%), Positives = 67/155 (43%), Gaps = 34/155 (21%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEF--IDEVCFLASIQ-------HRNLVT 134
           IGEG F EV K    + G   AIK       + F  +++V  L  IQ       H N++ 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCM----KKHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 135 LLGYCQENNLQFLIYEYIPNGSVS-------IHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           L+          ++++    G ++       ++LY   +  ++ L  K   S      K 
Sbjct: 63  LIE---------VLFD-RKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKS 112

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 222
           L H+H     + H+D K  N+L+ +D I K+AD G
Sbjct: 113 LDHMHRNG--IFHRDIKPENILIKDD-ILKLADFG 144

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 47.0 bits (112), Expect = 8e-06
 Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 36/209 (17%)

Query: 85  IGEGKFGEV----YKGLLQDGMLVAIKKRPGAPTQEFI---DEV--------CFLA--SI 127
           +G G FG+V    YK     G L AIK    A  +  I   DEV         F    S 
Sbjct: 7   LGRGHFGKVLLAEYKK---TGELYAIK----ALKKGDIIARDEVESLMCEKRIFETANSE 59

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           +H  LV L    Q  +    + EY   G + +H++     S  +  F      A     G
Sbjct: 60  RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVF-----YAACVVLG 113

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFL 246
           L +LH    ++V++D K  N+L+D +   K+AD GL +  +G  D    +S       FL
Sbjct: 114 LQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFL 168

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           A EV     ++   D +  GV + E++ G
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 46.6 bits (111), Expect = 8e-06
 Identities = 48/160 (30%), Positives = 69/160 (43%), Gaps = 44/160 (27%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           +GEG +  VYKG  +  G LVA+K+       GAP    I E   L  ++H N+VTL   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA-IREASLLKDLKHANIVTLHDI 71

Query: 139 CQENNLQFLIYEYI-----------PNG----SVSIHLYGPSQVSRQKLEFKHRLSIALG 183
                   L++EY+             G    +V + L+   Q+ R              
Sbjct: 72  IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLF---QLLR-------------- 114

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 223
              GLA+ H    RV+H+D K  N+L+ E    K+AD GL
Sbjct: 115 ---GLAYCH--QRRVLHRDLKPQNLLISERGELKLADFGL 149

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 46.9 bits (111), Expect = 9e-06
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 30/207 (14%)

Query: 84  LIGEGKFGEVYKGLLQD---GMLVAIK---------KRPGAPTQEFIDEVCFLASIQHRN 131
           L+G+G FG+V   L+++   G   A+K         K   A T   + E   L + +H  
Sbjct: 2   LLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTRHPF 56

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLA 189
           L  L    Q ++    + EY   G +  HL      SR+++ F    +   GA     L 
Sbjct: 57  LTALKYAFQTHDRLCFVMEYANGGELFFHL------SRERV-FTEERARFYGAEIVSALE 109

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +LHS    VV++D K  N+++D+D   K+ D GL    G +D A   +     E +LA E
Sbjct: 110 YLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE-YLAPE 165

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGR 276
           V E   +    D +  GV + E++ GR
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.9 bits (111), Expect = 9e-06
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 15/206 (7%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQHR 130
           K +     IG G  G V        G+ VA+KK  RP       +    E+  L  + H+
Sbjct: 21  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 80

Query: 131 NLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
           N+++LL  +  + +L+     Y+    +  +L    QV   +L+ +    +      G+ 
Sbjct: 81  NIISLLNVFTPQKSLEEFQDVYLVMELMDANL---CQVIHMELDHERMSYLLYQMLCGIK 137

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           HLHS    ++H+D K +N++V  D   K+ D GL        +  P         + A E
Sbjct: 138 HLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP---YVVTRYYRAPE 192

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSG 275
           V     + E  D++S G  + ELV G
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 25/222 (11%)

Query: 84  LIGEGKFGEVYKGLLQ-DGMLVAIK---KRPGAPTQE----FIDEVCFLASIQHRNLVTL 135
           +IG+G FG+V     + DG   A+K   K+     +E      +    L +++H  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
               Q     + + +++  G +  HL    Q  R   E + R   A   A  L +LHS+ 
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHL----QRERSFPEPRARFYAA-EIASALGYLHSI- 115

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
             +V++D K  N+L+D      + D GL +  + ++D    ++       +LA EV   +
Sbjct: 116 -NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT---TTTFCGTPEYLAPEVIRKQ 171

Query: 255 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 296
            +    D +  G  L E++ G      L P   +D+ E+  N
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG------LPPFYCRDVAEMYDN 207

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 63/252 (25%), Positives = 99/252 (39%), Gaps = 29/252 (11%)

Query: 84  LIGEGKFGEVYKGLLQD-GMLVAIK-------KRPGAPTQEFIDEVCF-LASIQHRNLVT 134
           +IG G FGEVY     D G + A+K       K     T    + +   L S      + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 135 LLGYC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
            + Y     + L F I + +  G +  HL      S  ++ F +   I LG    L H+H
Sbjct: 61  CMSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILG----LEHMH 114

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-K 251
           +    VV++D K AN+L+DE    +++D GL     +     P + V     ++A EV +
Sbjct: 115 NRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV-GTHGYMAPEVLQ 168

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ--DLVELVQNSR---DFSNLLKI 306
           +   +   +D +S G  L +L+ G               D + L         FS  L+ 
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228

Query: 307 LDERLWSTFTNE 318
           L E L     N 
Sbjct: 229 LLEGLLQRDVNR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 25/204 (12%)

Query: 85  IGEGKFGEVYKGLLQD-GMLVA--------IKKRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +G+G FGEV    +++ G + A        +KK+ G        E+  L  +    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 136 LGYCQENNLQF-LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
             Y  E+     L+   +  G +  H+Y    V  + LE +  +  +     G+ HLHS+
Sbjct: 59  -AYAFESKTHLCLVMSLMNGGDLKYHIY---NVGERGLEMERVIHYSAQITCGILHLHSM 114

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG--PSSQVTADEIFLASEVKE 252
              +V++D K  NVL+D+    +++D GL       ++      +Q      ++A E+ +
Sbjct: 115 --DIVYRDMKPENVLLDDQGNCRLSDLGL-----AVELKDGKTITQRAGTNGYMAPEILK 167

Query: 253 FRRFSEKSDVYSFGVFLLELVSGR 276
              +S   D ++ G  + E+V+GR
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 55/246 (22%), Positives = 113/246 (45%), Gaps = 32/246 (13%)

Query: 47  PSVQPGRNVG-----IELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY------- 94
           P+++  +N+       E  +R+ R+ QM+      +++    +IG G FGEV        
Sbjct: 13  PALRKNKNIDNFLNRYEKIVRKIRKLQMK-----AEDYDVVKVIGRGAFGEVQLVRHKSS 67

Query: 95  KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN 154
           + +    +L   +    + +  F +E   +A      +V L    Q++   +++ EY+P 
Sbjct: 68  QKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG 127

Query: 155 GSVSIHLYGPSQVSRQKLEF-KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED 213
           G + ++L     V  +  +F    + +AL A      +HS+   ++H+D K  N+L+D+ 
Sbjct: 128 GDL-VNLMSNYDVPEKWAKFYTAEVVLALDA------IHSMG--LIHRDVKPDNMLLDKH 178

Query: 214 FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR----RFSEKSDVYSFGVFL 269
              K+AD G    +  T +    + V   + +++ EV + +     +  + D +S GVFL
Sbjct: 179 GHLKLADFGTCMKMDETGMVRCDTAVGTPD-YISPEVLKSQGGDGYYGRECDWWSVGVFL 237

Query: 270 LELVSG 275
            E++ G
Sbjct: 238 FEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 29/224 (12%)

Query: 84  LIGEGKFGEVYKGLL----QDGMLVAIK---KRPGAPTQE----FIDEVCFLASIQHRNL 132
           +IG+G FG+V   LL     DG   A+K   K+     +E      +    L +++H  L
Sbjct: 2   VIGKGSFGKV---LLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFL 58

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           V L    Q     + + +Y+  G +  HL    Q  R  LE + R   A   A  + +LH
Sbjct: 59  VGLHYSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARF-YAAEVASAIGYLH 113

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 252
           SL+  ++++D K  N+L+D      + D GL       +    +S       +LA EV  
Sbjct: 114 SLN--IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLR 169

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 296
              +    D +  G  L E++ G      L P  S+D+ ++  N
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYG------LPPFYSRDVSQMYDN 207

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 54/204 (26%), Positives = 82/204 (40%), Gaps = 21/204 (10%)

Query: 85  IGEGKFGEVYKGLLQDGMLVA------IKKRPGAPTQ-EFIDEVCFLASIQHRNLVTLLG 137
           IG G FG+V    +     VA      +K    +  Q EF+ +      +QH N++  LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR--QKLEFKHRLSIALGAAKGLAHLHSLS 195
            C E     L++EY   G +  +L       R  Q L  +    +A   A G+ H+H  +
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMHKHN 119

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE-VKEFR 254
              +H D    N  +  D   KV D G+     + D             +LA E V EF 
Sbjct: 120 --FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177

Query: 255 ------RFSEKSDVYSFGVFLLEL 272
                   ++ S+V++ GV L EL
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 37/216 (17%)

Query: 79  FSDKNLIGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQH 129
           F    ++G+G FGEV    ++  G + A        IKKR G      ++E   L  +  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY--GPSQVSRQKLEFKHRLSIALGAAKG 187
           R +V+L    +  +   L+   +  G +  H+Y  G      ++  F      A     G
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-----YAAEITCG 114

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGPSSQVT 240
           L  LH    R+V++D K  N+L+D+    +++D GL           GR    G      
Sbjct: 115 LEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVG------ 166

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               ++A EV +  R++   D +  G  + E++ G+
Sbjct: 167 ----YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 16/198 (8%)

Query: 84  LIGEGKFGE--VYKGLLQDGMLVAIKKR---PGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           ++GEG FG   + + +  D      + R     +  ++   E   LA ++H N+V     
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR--LSIALGAAKGLAHLHSLSP 196
            + +   +++ EY   G     L    ++ R KL F     L   +    G+ H+H    
Sbjct: 67  FEADGHLYIVMEYCDGGD----LMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIHE--K 119

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           RV+H+D K+ N+ + ++   K+ D G    L  T     +        ++  E+ E   +
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL--TSPGAYACTYVGTPYYVPPEIWENMPY 177

Query: 257 SEKSDVYSFGVFLLELVS 274
           + KSD++S G  L EL +
Sbjct: 178 NNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 16/95 (16%)

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF--------LGRTDVAGPSSQV 239
           LA  H  S  ++H+D K+AN+L+  + + K+ D G            +GRT    P    
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP---- 209

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++A E+   + +S+K+D++S GV L EL++
Sbjct: 210 ----YYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240

Length = 496

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 39/146 (26%), Positives = 66/146 (45%), Gaps = 11/146 (7%)

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           LV L    Q  +  FL+ EY+  G +  H+       ++KL  +H    A      L  L
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYAAEICIALNFL 112

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEV 250
           H     ++++D K  NVL+D D   K+ D G+ +  LG  D    +S       ++A E+
Sbjct: 113 HERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT---TSTFCGTPNYIAPEI 167

Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGR 276
                +    D ++ GV + E+++GR
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 37/161 (22%), Positives = 65/161 (40%), Gaps = 29/161 (18%)

Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-------------EVCFLASIQHR 130
           IGEG +G V+K   ++ G +VAIKK        F++             E+  L  ++H 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKK--------FVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           NLV L+   +      L++EY  +  ++     P  V    ++      I     + +  
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-----KIIWQTLQAVNF 115

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
            H  +   +H+D K  N+L+ +    K+ D G    L    
Sbjct: 116 CHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 27/211 (12%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           +GEG +  VYKG+ + +G LVA+K        G P    I E   L  ++H N+V L   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA-IREASLLKGLKHANIVLLHDI 71

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-FKHRLSIALGAAKGLAHLHSLSPR 197
                    ++EY+        +  P  +    +  F  +L       +GLA++H     
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL------LRGLAYIHG--QH 123

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-----ADEIFLASEVKE 252
           ++H+D K  N+L+      K+AD GL            S  VT      D +  A++   
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD--- 180

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLS 283
              +S   D++  G   +E++ G+ A   +S
Sbjct: 181 ---YSSALDIWGAGCIFIEMLQGQPAFPGVS 208

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 17/209 (8%)

Query: 74  LATKNFSDKNLIGEGKFGEVYK------GLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           L   +F   + +G G  G V K      GL+    L+ ++ +P    Q  I E+  L   
Sbjct: 2   LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ-IIRELQVLHEC 60

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
               +V   G    +    +  E++  GS+   L    +  R   E   ++SIA+   +G
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAV--LRG 115

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           LA+L     +++H+D K +N+LV+     K+ D G+   L    +   ++       +++
Sbjct: 116 LAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMS 170

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            E  +   +S +SD++S G+ L+EL  GR
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 65/284 (22%), Positives = 116/284 (40%), Gaps = 60/284 (21%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK--RPGAPT---QEFIDEVCFLASIQH 129
           T  + D   +G G FG V     Q  G  VAIKK  +P +     +    E+  L  ++H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 130 RNLVTLLG-YCQENNLQFLIYEYIPNGSVSIH-LYGPSQVSRQKLEFKHRLSIALGAAKG 187
            N+++L   +       + + E +      +H L     + +Q +++           +G
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQY-----FLYQILRG 120

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT------- 240
           L ++HS    VVH+D K +N+L++E+   K+ D GL              Q+T       
Sbjct: 121 LKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARI--------QDPQMTGYVSTRY 170

Query: 241 --ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 298
             A EI L      ++++  + D++S G    E++ G+     L P   +D V       
Sbjct: 171 YRAPEIMLT-----WQKYDVEVDIWSAGCIFAEMLEGK----PLFP--GKDHVN------ 213

Query: 299 DFSNLLKIL---DERLWSTFTNEGMEEFIQLIVRCLDPSSERRP 339
            FS +  +L    + + +T  +E    F+Q +     P  E  P
Sbjct: 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSL-----PKREPVP 252

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 45.1 bits (106), Expect = 3e-05
 Identities = 46/193 (23%), Positives = 85/193 (44%), Gaps = 26/193 (13%)

Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
           F  +  H  LV L    Q  +  F + EY+  G +  H+       ++KL  +H    + 
Sbjct: 49  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSA 103

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTA 241
             +  L +LH     ++++D K  NVL+D +   K+ D G+ +  L   D    +S    
Sbjct: 104 EISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCG 158

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE----ASSSLSPDSSQDLVELVQNS 297
              ++A E+     +    D ++ GV + E+++GR       SS +PD         QN+
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD---------QNT 209

Query: 298 RDFSNLLKILDER 310
            D+  L +++ E+
Sbjct: 210 EDY--LFQVILEK 220

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 44.8 bits (107), Expect = 3e-05
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 39/216 (18%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT----QE--FIDEVCFLASIQH 129
            +F     +G G FG V     +  G   A+K    A      Q    ++E   L SI+H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL--YG--PSQVSR----QKLEFKHRLSIA 181
             LV L G  Q+++  +L+ EY+P G +  HL   G  P  V+R    Q         + 
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ---------VV 111

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRT-DVAGPSSQV 239
           L     L +LHSL   +V++D K  N+L+D D   K+ D G    + GRT  + G     
Sbjct: 112 L----ALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCG----- 160

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           T +  +LA E+   + + +  D ++ G+ + E+++G
Sbjct: 161 TPE--YLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 49/180 (27%), Positives = 76/180 (42%), Gaps = 31/180 (17%)

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
           LS     A+G+  L   S   VH+D    NVL+ +  I K+ D GL       D+   S+
Sbjct: 240 LSFTYQVARGMEFL--ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-----DIMHDSN 292

Query: 238 QVTADEIFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLV 291
            V+    FL     A E      ++  SDV+S+G+ L E+ S G      +  DS+    
Sbjct: 293 YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---- 348

Query: 292 ELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS---MSDVVTEL 348
                   F N +K           +   +E   ++V+C +   E+RPS   +SD+V  L
Sbjct: 349 --------FYNKIK---SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 66/290 (22%), Positives = 115/290 (39%), Gaps = 60/290 (20%)

Query: 85  IGEGKFGEVYKGLLQ-------------DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN 131
           +G+G F  +YKG+L+               +++ +       +  F +    ++ + H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 132 LVTLLGYC--QENNLQFLIYEYIPNGSVSIHLY-GPSQVSRQKLEFKHRLSIALGAAKGL 188
           LV L G C   EN    ++ EY+  G + + L+   + VS         L   L  AK L
Sbjct: 63  LVKLYGVCVRDEN---IMVEEYVKFGPLDVFLHREKNNVS---------LHWKLDVAKQL 110

Query: 189 AH-LHSL-SPRVVHKDFKTANVLVDED--------FIAKVADAGLRNFLGRTDVAGPSSQ 238
           A  LH L   ++VH +    N+LV           FI K++D G+   +   +       
Sbjct: 111 ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFI-KLSDPGIPITVLSREERVERIP 169

Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 298
             A E  + +        ++K   +SFG  LLE+ S  E      P S+    E  +  +
Sbjct: 170 WIAPE-CIRNGQASLTIAADK---WSFGTTLLEICSNGEE-----PLSTLSSSEKERFYQ 220

Query: 299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
           D  + L + D    +   N        LI +C      +RPS   ++ +L
Sbjct: 221 D-QHRLPMPD---CAELAN--------LINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 33/214 (15%)

Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAP---TQEFIDEVCFLASIQHRNL 132
           + D   +G G +G V   L  + G  VAIKK  RP       +    E+  L  ++H N+
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76

Query: 133 VTLLG-YCQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 186
           + LL  +  + +L      +L+  ++  G+    L    ++S  +++F     +     K
Sbjct: 77  IGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQF-----LVYQMLK 129

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----AD 242
           GL ++H+    ++H+D K  N+ V+ED   K+ D GL     +TD       VT    A 
Sbjct: 130 GLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAP 184

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           E+ L      +  +++  D++S G  + E+++G+
Sbjct: 185 EVIL-----NWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 29/223 (13%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           IG+G FG+V       DG   A+K        K+         +    L +++H  LV L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ-KHIMAERNVLLKNVKHPFLVGL 61

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
               Q  +  + + +Y+  G +  HL    Q  R   E + R   A   A  L +LHSL+
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHL----QRERSFPEPRARF-YAAEIASALGYLHSLN 116

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT--ADEIFLASEVKEF 253
             ++++D K  N+L+D      + D G    L +  +    +  T      +LA EV   
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFG----LCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170

Query: 254 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 296
           + +    D +  G  L E++ G      L P  S+D  E+  N
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG------LPPFYSRDTAEMYDN 207

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 17/209 (8%)

Query: 74  LATKNFSDKNLIGEGKFGEVYK------GLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           L   +F   + +G G  G V+K      GL+    L+ ++ +P    Q  I E+  L   
Sbjct: 2   LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ-IIRELQVLHEC 60

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
               +V   G    +    +  E++  GS+   L    ++  Q L    ++SIA+   KG
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL---GKVSIAV--IKG 115

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           L +L     +++H+D K +N+LV+     K+ D G+   L    +   ++       +++
Sbjct: 116 LTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMS 170

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            E  +   +S +SD++S G+ L+E+  GR
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 44.7 bits (105), Expect = 4e-05
 Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 14/145 (9%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           +GEG +  VYKG  + +G LVA+K     +  G P    I E   L  ++H N+V L   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHANIVLLHDI 71

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
                   L++EY+           P  +  + ++            +GL+++H     +
Sbjct: 72  IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-----FLFQLLRGLSYIHQ--RYI 124

Query: 199 VHKDFKTANVLVDEDFIAKVADAGL 223
           +H+D K  N+L+ +    K+AD GL
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGL 149

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 21/165 (12%)

Query: 138 YC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           YC  Q     F + E++  G +  H+    +    +  F      A     GL  LHS  
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQFLHSKG 116

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
             ++++D K  NV++D D   K+AD G+   N  G       +S       ++A E+ + 
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR----ASTFCGTPDYIAPEILQG 170

Query: 254 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 298
            +++   D +SFGV L E++ G+      SP    D  EL ++ R
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQ------SPFHGDDEDELFESIR 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 66/268 (24%), Positives = 116/268 (43%), Gaps = 33/268 (12%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +G+G +G VYK L +  G+ +A+K+       +   + I E+  L       +V   G  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
                 ++  EY+  GS+   LY     +    E   R  I     KGL  L      ++
Sbjct: 69  FIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLR-RITYAVVKGLKFLKE-EHNII 125

Query: 200 HKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
           H+D K  NVLV+ +   K+ D G    L   L +T++   S    A E   +    +   
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS--YMAPERIKSGGPNQNPT 183

Query: 256 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD---ERLW 312
           ++ +SDV+S G+ +LE+  GR       P++  ++         F+ L  I+D     L 
Sbjct: 184 YTVQSDVWSLGLSILEMALGR---YPYPPETYANI---------FAQLSAIVDGDPPTLP 231

Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPS 340
           S ++++  ++F+     CL+    RRP+
Sbjct: 232 SGYSDDA-QDFVAK---CLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 25/209 (11%)

Query: 79  FSDKNLI---GEGKFGEVYKGLLQDGML--VAIKK--RPGAPTQEFIDEVC----FLASI 127
           + D N I   G G FG V     ++     VAIK+  +     Q+ +D V      L  I
Sbjct: 29  YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
            H   V L G  ++ +  +L+ E++  G     L       R+   F + +     A   
Sbjct: 89  NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-------RRNKRFPNDVGCFYAAQIV 141

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFL 246
           L   +  S  +V++D K  N+L+D+D   K+ D G    +  RT     + +  A EI L
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILL 201

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
                      + +D ++ G+F+ E++ G
Sbjct: 202 NVG------HGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 43.8 bits (104), Expect = 8e-05
 Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 59/223 (26%)

Query: 83  NLIGEGKFGEVYKGLLQD-GMLVAIKK--RPGAPTQEFID------EVCFLASIQHRNLV 133
           + +G G +G+V        G  VAIKK  RP    Q  I       E+  L  + H N++
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP---FQSAIHAKRTYRELRLLKHMDHENVI 77

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVS--------IHLYGP--SQVSR-QKLEFKHRLSIAL 182
            LL              + P  S+          HL G   + + + QKL   H   +  
Sbjct: 78  GLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVY 125

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
              +GL ++HS    ++H+D K +N+ V+ED   K+ D GL             ++ T D
Sbjct: 126 QILRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFGL-------------ARHTDD 170

Query: 243 EI--------FLASEVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+        + A E+   +  +++  D++S G  + EL++G+
Sbjct: 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 35/144 (24%)

Query: 146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFK--HRLSIALGAAKGLAHLHSLSPRVVHKDF 203
           + + EY+  G +  H+    QV +    FK  H +  A   A GL  LHS    ++++D 
Sbjct: 77  YFVMEYVNGGDLMYHI---QQVGK----FKEPHAVFYAAEIAIGLFFLHSKG--IIYRDL 127

Query: 204 KTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQVTADEIFLASEVKE 252
           K  NV++D +   K+AD G+           R F G  D             ++A E+  
Sbjct: 128 KLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD-------------YIAPEIIA 174

Query: 253 FRRFSEKSDVYSFGVFLLELVSGR 276
           ++ + +  D ++FGV L E+++G+
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 43.7 bits (103), Expect = 9e-05
 Identities = 57/250 (22%), Positives = 106/250 (42%), Gaps = 31/250 (12%)

Query: 84  LIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLA-----SIQHRN-LVTLL 136
           ++G+G FG+V    L + G L A+K        +  D  C +      S+   +  +T L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 137 GYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
             C Q  +  F + E++  G +  H+    Q SR+  E + R   A      L  LH   
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAA-EITSALMFLHDKG 116

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
             ++++D K  NVL+D +   K+AD G+            +   T D  ++A E+ +   
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPD--YIAPEILQEML 172

Query: 256 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 315
           +    D ++ GV L E++ G    +    ++  DL E + N           DE ++ T+
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGH---APFEAENEDDLFEAILN-----------DEVVYPTW 218

Query: 316 TNEGMEEFIQ 325
            ++   + ++
Sbjct: 219 LSQDAVDILK 228

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 43.9 bits (103), Expect = 9e-05
 Identities = 52/242 (21%), Positives = 108/242 (44%), Gaps = 24/242 (9%)

Query: 47  PSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY-------KGLLQ 99
           P+++  +N+   L+  +    ++ +L +  +++    +IG G FGEV        + +  
Sbjct: 13  PALRKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYA 72

Query: 100 DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSI 159
             +L   +    + +  F +E   +A      +V L    Q++   +++ EY+P G + +
Sbjct: 73  MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-V 131

Query: 160 HLYGPSQVSRQKLEF-KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV 218
           +L     V  +   F    + +AL A      +HS+    +H+D K  N+L+D+    K+
Sbjct: 132 NLMSNYDVPEKWARFYTAEVVLALDA------IHSMG--FIHRDVKPDNMLLDKSGHLKL 183

Query: 219 ADAGL-----RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV 273
           AD G      +  + R D A  +    + E+  +     +  +  + D +S GVFL E++
Sbjct: 184 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY--YGRECDWWSVGVFLYEML 241

Query: 274 SG 275
            G
Sbjct: 242 VG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 43.5 bits (102), Expect = 9e-05
 Identities = 46/200 (23%), Positives = 88/200 (44%), Gaps = 16/200 (8%)

Query: 84  LIGEGKFGEVYKGLLQDGM-LVAIKKRPGAPTQEFIDEVCF-----LASIQHRNLVTLLG 137
           ++GEG +G V K   ++   +VAIKK   +   E + E        L +++  N+V L  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
             +     +L++EY+    + +    P+ V  +K+      S      K +   H     
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-----SYIYQLIKAIHWCHK--ND 120

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           +VH+D K  N+L+  + + K+ D G  RN    ++     ++  A   + + E+     +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--YTEYVATRWYRSPELLLGAPY 178

Query: 257 SEKSDVYSFGVFLLELVSGR 276
            +  D++S G  L EL  G+
Sbjct: 179 GKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 30/119 (25%), Positives = 56/119 (47%), Gaps = 16/119 (13%)

Query: 163 GPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 222
               + ++ L  +  +  +   AKG+  L   S + +H+D    N+L+ E+ + K+ D G
Sbjct: 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFG 224

Query: 223 LR-------NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           L        +++ + D   P   +  + IF        R ++ +SDV+SFGV L E+ S
Sbjct: 225 LARDIYKDPDYVRKGDARLPLKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 56/240 (23%), Positives = 101/240 (42%), Gaps = 49/240 (20%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVC------FLASIQHR 130
           +F+   ++G+G FG+V     +    L AIK        +  D  C       LA     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 131 NLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKG 187
             +T L  C Q  +  + + EY+  G +  H+       +Q  +FK   ++   A  + G
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-------QQVGKFKEPQAVFYAAEISVG 113

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPS 236
           L  LH     ++++D K  NV++D +   K+AD G+           R F G  D     
Sbjct: 114 LFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD----- 166

Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 296
                   ++A E+  ++ + +  D +++GV L E+++G+       P   +D  EL Q+
Sbjct: 167 --------YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ------PPFDGEDEDELFQS 212

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 38/218 (17%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFIDEVCFLASIQHRNLV 133
           + ++    +G G +G V   +  + G  VAIKK  RP      F  E+   A   +R L 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRP------FQSEI--FAKRAYREL- 65

Query: 134 TLLGYCQENNLQFLIYEYIP----NGSVSIHLYGP-SQVSRQKLEFKHRLS------IAL 182
           TLL + Q  N+  L+  +      +     +L  P  Q   QK+   H LS      +  
Sbjct: 66  TLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI-MGHPLSEDKVQYLVY 124

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-- 240
               GL ++HS    ++H+D K  N+ V+ED   K+ D GL       D       VT  
Sbjct: 125 QMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRW 179

Query: 241 --ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             A E+ L      +  +++  D++S G  + E+++G+
Sbjct: 180 YRAPEVIL-----NWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 45/218 (20%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PT--QEFIDEVCFLASIQHRNLVTLLG- 137
           IG G +G V   +  + G  VAIKK P A   PT  +  + E+  L   +H N++ +   
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72

Query: 138 -----------YC----QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
                      Y      E++L  +I+                  S Q L  +H      
Sbjct: 73  LRPPGADFKDVYVVMDLMESDLHHIIH------------------SDQPLTEEHIRYFLY 114

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR--TDVAGPSSQVT 240
              +GL ++HS    V+H+D K +N+LV+ED   ++ D G+   L    T+     ++  
Sbjct: 115 QLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 241 ADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVSGRE 277
           A   + A E+      ++   D++S G    E++  R+
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 24/204 (11%)

Query: 84  LIGEGKFGEVYKGLLQD-GMLVAI----KKRPGAPTQEF--IDEVCFLASIQHRN--LVT 134
           +IG G FGEVY     D G + A+    KKR      E   ++E   L+ +   +   + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 135 LLGYC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
            + Y     + L F I + +  G +  HL      S +++ F +   I L    GL H+H
Sbjct: 61  CMTYAFHTPDKLCF-ILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIIL----GLEHMH 114

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-K 251
           +    VV++D K AN+L+DE    +++D GL     +     P + V     ++A EV +
Sbjct: 115 NRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV-GTHGYMAPEVLQ 168

Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
           +   +   +D +S G  L +L+ G
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 32/208 (15%)

Query: 84  LIGEGKFGEVYKGLLQD---GMLVAIKKRPGAPTQEFI---DEVC-------FLASIQHR 130
           L+G+G FG+V   L+++   G   A+K       +E I   DEV         L + +H 
Sbjct: 2   LLGKGTFGKVI--LVREKATGKYYAMK----ILKKEVIIAKDEVAHTLTESRVLQNTRHP 55

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGL 188
            L  L    Q ++    + EY   G +  HL      S  +  F        GA     L
Sbjct: 56  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSAL 108

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
            +LHS    VV++D K  N+++D+D   K+ D GL    G +D A   +     E +LA 
Sbjct: 109 GYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE-YLAP 164

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           EV E   +    D +  GV + E++ GR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 36/112 (32%), Positives = 56/112 (50%), Gaps = 5/112 (4%)

Query: 168 SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNF 226
           S Q L   H  S       GL ++HS +  V+H+D K  N+LV+ D   K+ D GL R F
Sbjct: 98  SGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGF 155

Query: 227 -LGRTDVAGPSSQVTADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
                + AG  ++  A   + A E+   F+ +++  DV+S G  L EL+  +
Sbjct: 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 39/217 (17%)

Query: 79  FSDKNLIGEGKFGEVYKGLLQ-DGMLVA--------IKKRPGAPTQEFIDEVCFLASIQH 129
           F    ++G+G FGEV    ++  G + A        IKKR G      ++E   L  +  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNS 59

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNG-SVSIHLY--GPSQVSRQKLEFKHRLSIALGAAK 186
           R +V+L  Y  E      +   I NG  +  H+Y  G      Q+  F      A     
Sbjct: 60  RFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF-----YAAELCC 113

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGPSSQV 239
           GL  L     R+V++D K  N+L+D+    +++D GL           GR    G     
Sbjct: 114 GLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVG----- 166

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                ++A EV    +++   D +  G  + E++ G+
Sbjct: 167 -----YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 43/188 (22%), Positives = 76/188 (40%), Gaps = 30/188 (15%)

Query: 172 LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------R 224
           L+ +  LS +   AKG++ L   S   +H+D    N+L+    I K+ D GL        
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268

Query: 225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
           N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S     SS  P
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCV-------YTFESDVWSYGILLWEIFS---LGSSPYP 318

Query: 285 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
               D           S   K++ E            E   ++  C D    +RP+   +
Sbjct: 319 GMPVD-----------SKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367

Query: 345 VTELDRTL 352
           V  +++ L
Sbjct: 368 VQLIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 14/148 (9%)

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA-AKGLAH 190
           LVTL    Q +    LI +Y+  G +  HLY      R+    +  + + +      L H
Sbjct: 67  LVTLHYAFQTDTKLHLILDYVNGGELFTHLY-----QREHFT-ESEVRVYIAEIVLALDH 120

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASE 249
           LH L   ++++D K  N+L+D +    + D GL + FL   +    S   T +  ++A E
Sbjct: 121 LHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIE--YMAPE 176

Query: 250 V--KEFRRFSEKSDVYSFGVFLLELVSG 275
           V         +  D +S GV   EL++G
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 39/165 (23%), Positives = 67/165 (40%), Gaps = 37/165 (22%)

Query: 146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKT 205
           F + EY+  G +  H+    Q S  + +       A     GL  LH     ++++D K 
Sbjct: 72  FFVMEYVNGGDLMFHI----QRSG-RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKL 124

Query: 206 ANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
            NVL+D +   K+AD G+             F G  D             ++A E+  ++
Sbjct: 125 DNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD-------------YIAPEILSYQ 171

Query: 255 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD 299
            +    D ++ GV L E+++G+      SP    D  EL Q+  +
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQ------SPFEGDDEDELFQSILE 210

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 11/93 (11%)

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
           G+ HLHS    ++H+D K +N++V  D   K+ D G    L RT  AG S  +T      
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG----LART--AGTSFMMTPYVVTR 181

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            + A EV     + E  D++S G  + E++ G 
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 36/154 (23%), Positives = 69/154 (44%), Gaps = 22/154 (14%)

Query: 121 VCFLAS-IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           V F AS ++      +  YC+  +L   + E    G         +QV     E+  +L 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT----LSENQV----CEWFIQLL 116

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQ 238
           +      G+ ++H    R++H+D K  N+ +  + + K+ D G+   L G  D+A   + 
Sbjct: 117 L------GVHYMHQ--RRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLA---TT 164

Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL 272
            T    +++ E  + + +  KSD++S G  L E+
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 40.9 bits (96), Expect = 2e-04
 Identities = 32/146 (21%), Positives = 54/146 (36%), Gaps = 19/146 (13%)

Query: 80  SDKNLIGEGKFGEVYKGLLQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVT--L 135
           S   L+  G    VY  LL       +           +   EV  L  +  + L    +
Sbjct: 1   SSIKLLKGGLTNRVY--LLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKV 58

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           L   + +   +L+ E+I   ++             ++  + +  IA   A+ LA LH L 
Sbjct: 59  LASGESDGWSYLLMEWIEGETLD------------EVSEEEKEDIAEQLAELLAKLHQLP 106

Query: 196 PRVV-HKDFKTANVLVDEDFIAKVAD 220
             V+ H D    N+LVD+  I  + D
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIID 132

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 53/202 (26%), Positives = 80/202 (39%), Gaps = 36/202 (17%)

Query: 99  QDGMLVAIK-KRPGAPTQE-----FIDEVCFLASIQHRNLVTLL--GYCQENNLQFLIYE 150
             G  VAIK  R  AP +E     F  E    A + H N+V LL  G      L F ++E
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59

Query: 151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA------LGAAKGLAHLHSLSPRVVHKDFK 204
           Y+P  ++           R+ L     L         L     LA  H+    +VH+D K
Sbjct: 60  YVPGRTL-----------REVLAADGALPAGETGRLMLQVLDALACAHNQG--IVHRDLK 106

Query: 205 TANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-----FLASEVKEFRRF 256
             N++V        AKV D G+   L     A  ++     E+     + A E       
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166

Query: 257 SEKSDVYSFGVFLLELVSGREA 278
           +  SD+Y++G+  LE ++G+  
Sbjct: 167 TPNSDLYAWGLIFLECLTGQRV 188

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 69/314 (21%), Positives = 113/314 (35%), Gaps = 61/314 (19%)

Query: 72  LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-----RPGAPTQEFIDEVCFLAS 126
           L+L  K F D           + K       LVA+KK           +    E+     
Sbjct: 3   LTLIGKCFED------LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQ 55

Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS---IAL- 182
           +QH N++  +     ++  +++   +  GS    L         K  F   L    IA  
Sbjct: 56  LQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL---------KTHFPEGLPELAIAFI 106

Query: 183 --GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG-------RTDVA 233
                  L ++HS     +H+  K +++L+  D   KV  +GLR  +        +  V 
Sbjct: 107 LKDVLNALDYIHSKG--FIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVH 162

Query: 234 GPSSQVTADEIFLASEVKE--FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV 291
                   +  +L+ EV +   + ++EKSD+YS G+   EL +G      +   ++Q L+
Sbjct: 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM--PATQMLL 220

Query: 292 E----LVQNSRDFSNLLKILDERLWSTFTNEG---------------MEEFIQLIVRCLD 332
           E     V    D S      D    S  +NE                 E F Q +  CL 
Sbjct: 221 EKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQ 280

Query: 333 PSSERRPSMSDVVT 346
              E RPS S ++ 
Sbjct: 281 RDPESRPSASQLLN 294

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 47/210 (22%), Positives = 92/210 (43%), Gaps = 27/210 (12%)

Query: 85  IGEGKFGEVYKGLLQDG---MLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTL--LGY 138
           +G G +G VYK   +DG      A+K+  G   +     E+  L  ++H N++ L  +  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 139 CQENNLQFLIYEYIPNGSVS-IHLYGPSQVSRQKLEFKHRL--SIALGAAKGLAHLHSLS 195
              +   +L+++Y  +     I  +  S+ +++ ++    +  S+      G+ +LH  +
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH--A 126

Query: 196 PRVVHKDFKTANVLV----DEDFIAKVADAGLRNF-------LGRTDVAGPSSQVTADEI 244
             V+H+D K AN+LV     E    K+AD G           L   D    +    A E+
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            L +     R +++  D+++ G    EL++
Sbjct: 187 LLGA-----RHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 11/146 (7%)

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           LVTL    Q      LI +Y+  G +  HLY     S  ++ F +   I L     L HL
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF-YSGEIILA----LEHL 121

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEV 250
           H L   +V++D K  N+L+D +    + D GL + FL        S   T +  ++A E+
Sbjct: 122 HKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE--YMAPEI 177

Query: 251 KEFRRFSEKS-DVYSFGVFLLELVSG 275
              +    K+ D +S G+ + EL++G
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 43/155 (27%), Positives = 68/155 (43%), Gaps = 24/155 (15%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ---HRNLVT 134
           IG G +G VYK      G  VA+K         G P    + EV  L  ++   H N+V 
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLST-VREVALLKRLEAFDHPNIVR 66

Query: 135 LLGYC------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
           L+  C      +E  +  L++E++ +  +  +L    +V    L  +    +     +GL
Sbjct: 67  LMDVCATSRTDRETKVT-LVFEHV-DQDLRTYL---DKVPPPGLPAETIKDLMRQFLRGL 121

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 223
             LH+    +VH+D K  N+LV      K+AD GL
Sbjct: 122 DFLHA--NCIVHRDLKPENILVTSGGQVKLADFGL 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 47/210 (22%), Positives = 93/210 (44%), Gaps = 27/210 (12%)

Query: 85  IGEGKFGEVYKGLLQDG---MLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTL--LGY 138
           +G G +G VYK   +DG      A+K+  G   +     E+  L  ++H N+++L  +  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 139 CQENNLQFLIYEYIPNGSVS-IHLYGPSQVSRQKLEFKHRL--SIALGAAKGLAHLHSLS 195
              +   +L+++Y  +     I  +  S+ +++ ++    +  S+      G+ +LH  +
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--A 126

Query: 196 PRVVHKDFKTANVLV----DEDFIAKVADAGLRNF-------LGRTDVAGPSSQVTADEI 244
             V+H+D K AN+LV     E    K+AD G           L   D    +    A E+
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            L +     R +++  D+++ G    EL++
Sbjct: 187 LLGA-----RHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 46/186 (24%), Positives = 75/186 (40%), Gaps = 26/186 (13%)

Query: 172 LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L +   +  +   A G+  L   S   VH+D    NVL+ E  + K+ D GL       D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-----D 288

Query: 232 VAGPSSQVTADEIFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS 286
           +   S+ ++    FL     A E      ++  SDV+SFG+ L E+ +      +  P  
Sbjct: 289 IMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT---LGGTPYP-- 343

Query: 287 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 346
                EL  N + F N +K           ++ + E +Q   +C +   E RP  S +V 
Sbjct: 344 -----ELPMNEQ-FYNAIKRGYRMAKPAHASDEIYEIMQ---KCWEEKFEIRPDFSQLVH 394

Query: 347 ELDRTL 352
            +   L
Sbjct: 395 LVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 41.0 bits (96), Expect = 6e-04
 Identities = 45/194 (23%), Positives = 83/194 (42%), Gaps = 28/194 (14%)

Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQ-KLEFKHRLSIA 181
           F  +  H  LV L    Q  +  F + E++  G +  H+       RQ KL  +H    +
Sbjct: 49  FETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM------QRQRKLPEEHARFYS 102

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT 240
              +  L  LH     ++++D K  NVL+D +   K+ D G+ +  +   D    +S   
Sbjct: 103 AEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT---TSTFC 157

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE----ASSSLSPDSSQDLVELVQN 296
               ++A E+     +    D ++ GV + E+++GR        S +PD         QN
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD---------QN 208

Query: 297 SRDFSNLLKILDER 310
           + D+  L +++ E+
Sbjct: 209 TEDY--LFQVILEK 220

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 41.2 bits (96), Expect = 6e-04
 Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 29/207 (14%)

Query: 84  LIGEGKFGEVY------------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN 131
           L+G+G FG+V               +L+  ++VA  +     T+  +     L + +H  
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV-----LQNSRHPF 56

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLA 189
           L  L    Q ++    + EY   G +  HL      S  +  F        GA     L 
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSALD 109

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +LHS    VV++D K  N+++D+D   K+ D GL    G  D A   +     E +LA E
Sbjct: 110 YLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPE-YLAPE 166

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGR 276
           V E   +    D +  GV + E++ GR
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 57/237 (24%), Positives = 100/237 (42%), Gaps = 54/237 (22%)

Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLV--TLLGYC-- 139
           IG+G FG+VY+   +D   + A+K       +E + +     +I  RN++  TLL     
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKV---LSKKEIVAKKEVAHTIGERNILVRTLLDESPF 57

Query: 140 --------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK-HRLSIALGAAKGLAH 190
                   Q ++  +L+ +Y+  G +  HL    + S  + +F    L +AL       H
Sbjct: 58  IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLAL------EH 111

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQV 239
           LH     +V++D K  N+L+D      + D GL             F G T+   P  +V
Sbjct: 112 LHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAP--EV 167

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 296
             DE          + +++  D +S GV + E+  G       SP  ++D  ++ +N
Sbjct: 168 LLDE----------KGYTKHVDFWSLGVLVFEMCCG------WSPFYAEDTQQMYRN 208

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 41.3 bits (96), Expect = 7e-04
 Identities = 54/237 (22%), Positives = 96/237 (40%), Gaps = 62/237 (26%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEF-------------------IDEVCFLA 125
           IG G+FGEV+        LV  K+     TQEF                   + EV  + 
Sbjct: 21  IGNGRFGEVF--------LVKHKR-----TQEFFCWKAISYRGLKEREKSQLVIEVNVMR 67

Query: 126 SIQHRNLVTLLG--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 183
            ++H+N+V  +     + N   +++ E+   G +S ++    ++   K+E    + I   
Sbjct: 68  ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF-GKIEEHAIVDITRQ 126

Query: 184 AAKGLAHLHSLS-----PRVVHKDFKTANVLVDEDF-----------------IAKVADA 221
               LA+ H+L       RV+H+D K  N+ +                     IAK+ D 
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186

Query: 222 GLRNFLGRTDVAGPSSQVTADEIFLASEV--KEFRRFSEKSDVYSFGVFLLELVSGR 276
           GL   +G   +A           + + E+   E + + +KSD+++ G  + EL SG+
Sbjct: 187 GLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 40.5 bits (95), Expect = 9e-04
 Identities = 46/205 (22%), Positives = 88/205 (42%), Gaps = 31/205 (15%)

Query: 84  LIGEGKFGEVYKGLLQD---GMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVT 134
            +G G FG V+  L++D       A+K             Q   +E   L  + H  ++ 
Sbjct: 8   TVGTGTFGRVH--LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIR 65

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLAHLH 192
           L     +    +++ EY+P G +  +L       R    F +   +   +     L +LH
Sbjct: 66  LFWTEHDQRFLYMLMEYVPGGELFSYL-------RNSGRFSNSTGLFYASEIVCALEYLH 118

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEV 250
           S    +V++D K  N+L+D++   K+ D G  +    RT  + G     T +  +LA EV
Sbjct: 119 SKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG-----TPE--YLAPEV 169

Query: 251 KEFRRFSEKSDVYSFGVFLLELVSG 275
            + +  ++  D ++ G+ + E++ G
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 18/189 (9%)

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK-HRLSIALGA-AKGLA 189
           LVTL    Q +    LI +YI  G +  HL        Q+  FK   + I  G     L 
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHL-------SQRERFKEQEVQIYSGEIVLALE 119

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           HLH L   ++++D K  N+L+D +    + D GL       +V    S     E      
Sbjct: 120 HLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177

Query: 250 VKEFRRFSEKS-DVYSFGVFLLELVSGREASSSLSPDSSQ-DLVELVQNS-----RDFSN 302
           V+      +K+ D +S GV + EL++G    +     +SQ ++   +  S     ++ S 
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237

Query: 303 LLKILDERL 311
           L K + +RL
Sbjct: 238 LAKDIIQRL 246

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 23/203 (11%)

Query: 85  IGEGKFGEV---YKGLLQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTL 135
           +G G +G V   Y   L+    VA+KK    P Q  I       E+  L  ++H N++ L
Sbjct: 23  VGSGAYGSVCSAYDTRLRQK--VAVKKL-SRPFQSLIHARRTYRELRLLKHMKHENVIGL 79

Query: 136 LG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L  +    +++     Y+    +   L   + V  QKL  +H   +     +GL ++HS 
Sbjct: 80  LDVFTPATSIENFNEVYLVTNLMGADL--NNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA 137

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK-EF 253
              ++H+D K +NV V+ED   ++ D GL     + D     +   A   + A E+   +
Sbjct: 138 G--IIHRDLKPSNVAVNEDCELRILDFGLAR---QAD--DEMTGYVATRWYRAPEIMLNW 190

Query: 254 RRFSEKSDVYSFGVFLLELVSGR 276
             +++  D++S G  + EL+ G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 39.7 bits (93), Expect = 0.001
 Identities = 43/185 (23%), Positives = 72/185 (38%), Gaps = 48/185 (25%)

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-------DF---------IAKVADAGL 223
           IA+   K L +L     +++H+D K +N+L+D        DF         IAK  DAG 
Sbjct: 112 IAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGC 170

Query: 224 RNFLG--RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS 281
           R ++   R D     S     ++              +SDV+S G+ L E+ +G+     
Sbjct: 171 RPYMAPERID----PSARDGYDV--------------RSDVWSLGITLYEVATGKFPYPK 212

Query: 282 LSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 341
            +    Q L ++V+          IL       F+      F+  I  CL     +RP  
Sbjct: 213 WNSVFDQ-LTQVVKGDP------PILSNSEEREFS----PSFVNFINLCLIKDESKRPKY 261

Query: 342 SDVVT 346
            +++ 
Sbjct: 262 KELLE 266

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 33/232 (14%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDG-MLVAIK--------KRPGAPTQEFIDEVCFLASI 127
           ++F    +IG G FGEV    L++   + A+K        KR  A T  F +E   L + 
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR--AETACFREERDVLVNG 58

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA--LGAA 185
            ++ + TL    Q+ N  +L+ +Y   G +   L   S+   +  E   R  +A  + A 
Sbjct: 59  DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVIAI 115

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG-----LRNFLGRTDVAGPSSQVT 240
             +  LH      VH+D K  N+L+D +   ++AD G     + +   ++ VA  +    
Sbjct: 116 DSVHQLH-----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 170

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE 292
           + EI  A E  +  ++  + D +S GV + E++ G       +P  ++ LVE
Sbjct: 171 SPEILQAMEDGK-GKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVE 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 6/92 (6%)

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTD-VAGPSSQVTAD 242
           A+G+  L   S + +H+D    N+L+ E+ + K+ D GL R+     D V   S+++   
Sbjct: 184 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             ++A E    + ++ +SDV+SFGV L E+ S
Sbjct: 242 --WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 33/134 (24%), Positives = 64/134 (47%), Gaps = 24/134 (17%)

Query: 150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL---HSLSPRVVHKDFKTA 206
           E++  GS+   L    +  R       ++SIA+   +GL +L   H     ++H+D K +
Sbjct: 79  EHMDGGSLDQVL---KKAGRIPENILGKISIAV--LRGLTYLREKHK----IMHRDVKPS 129

Query: 207 NVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDV 262
           N+LV+     K+ D G    L + +  + V   S        +++ E  +   ++ +SD+
Sbjct: 130 NILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--------YMSPERLQGTHYTVQSDI 181

Query: 263 YSFGVFLLELVSGR 276
           +S G+ L+E+  GR
Sbjct: 182 WSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 28/112 (25%), Positives = 51/112 (45%), Gaps = 16/112 (14%)

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL------ 223
             L+    L  +   A+G+  L S     +H+D    NVL+ +  +AK+ D GL      
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264

Query: 224 -RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 50/242 (20%), Positives = 97/242 (40%), Gaps = 39/242 (16%)

Query: 117 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 176
           F +    +  + H+++V L G C  +    ++ E++  G + + ++  S V     +FK 
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK- 109

Query: 177 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP- 235
              +A   A  L++L      +VH +  T N+L+  + I    D     F+  +D   P 
Sbjct: 110 ---VAKQLASALSYLE--DKDLVHGNVCTKNILLAREGI----DGECGPFIKLSDPGIPI 160

Query: 236 ---SSQVTADEI-FLASE-VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL 290
              S Q   + I ++A E V++ +  S  +D +SFG  L E+    E      P   + L
Sbjct: 161 TVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEI-----PLKDKTL 215

Query: 291 VELVQNSRDFSNLLKILDERLWST---FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 347
            E                ER +           +E   L+  C++    +RP    ++ +
Sbjct: 216 AE---------------KERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260

Query: 348 LD 349
           ++
Sbjct: 261 IN 262

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	380
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
PRK10345	210	hypothetical protein; Provisional	99.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.81
smart00090	237	RIO RIO-like kinase.	99.81
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.57
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.5
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.45
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.42
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.41
KOG1243	690	consensus Protein kinase [General function predict	99.37
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.32
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.28
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.27
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.25
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.21
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.11
KOG3087	229	consensus Serine/threonine protein kinase [General	99.07
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.95
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.93
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.92
COG4248	637	Uncharacterized protein with protein kinase and he	98.91
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.84
PRK09902	216	hypothetical protein; Provisional	98.63
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.6
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.59
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.53
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.46
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.46
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.38
PF01636	239	APH: Phosphotransferase enzyme family This family	98.35
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.34
PLN02876	822	acyl-CoA dehydrogenase	98.26
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.14
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.04
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.04
PRK10593	297	hypothetical protein; Provisional	98.01
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.01
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.96
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.95
PRK05231	319	homoserine kinase; Provisional	97.91
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.87
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.86
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.85
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.85
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.85
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.69
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.5
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.43
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.36
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.36
PLN02756	418	S-methyl-5-thioribose kinase	97.1
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.09
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.02
KOG2270	520	consensus Serine/threonine protein kinase involved	96.9
PLN02236	344	choline kinase	96.85
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.59
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.57
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.52
COG2334	331	Putative homoserine kinase type II (protein kinase	96.34
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	96.29
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.29
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.27
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.13
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.59
PRK11768	325	serine/threonine protein kinase; Provisional	95.58
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.35
PRK12396	409	5-methylribose kinase; Reviewed	95.35
COG3231	266	Aph Aminoglycoside phosphotransferase [Translation	95.04
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	94.87
PRK06148	1013	hypothetical protein; Provisional	94.84

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-52  Score=389.62  Aligned_cols=285  Identities=44%  Similarity=0.733  Sum_probs=246.9

Q ss_pred             hhcccCHHHHHHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccce
Q 016917           63 EARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYC  139 (380)
Q Consensus        63 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~  139 (380)
                      ..+.|.+.++..++++|...+.||+|+||.||+|...++..||||+.....   ..+|.+|++++.+++|||+++++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            466789999999999999999999999999999999999999999866543   45799999999999999999999999


Q ss_pred             ecCC-eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCCeeeCCCCceE
Q 016917          140 QENN-LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-SPRVVHKDFKTANVLVDEDFIAK  217 (380)
Q Consensus       140 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivHrDikp~Nili~~~~~~k  217 (380)
                      .+.+ ..+||+||+++|+|.++|+.....   .++|..+++|+.++|.||.|||.. .+.||||||||+|||+|+++++|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            9988 599999999999999999754321   789999999999999999999984 34799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccc-cCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh
Q 016917          218 VADAGLRNFLGRTDVAGPSSQV-TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  296 (380)
Q Consensus       218 l~DFgla~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  296 (380)
                      |+|||+|+.....  ....... .||.+|+|||+......+.++|||||||+|.|++||+.|.....+.....+.+|...
T Consensus       218 lsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  218 LSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             ccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            9999999654331  1111122 789999999999988999999999999999999999998887665555668888877


Q ss_pred             hhcccchhhhcccccc-cCCCH-HHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          297 SRDFSNLLKILDERLW-STFTN-EGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       297 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                      ......+.+++|+.+. ..++. .....+..+..+|++.+|++||+|.++++.|+...
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            7777789999999987 56664 57777999999999999999999999999885544

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-53  Score=374.73  Aligned_cols=250  Identities=26%  Similarity=0.369  Sum_probs=210.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeC----CCCChHHHHHHHHHHhcCCCCceeeeccceecCC-eeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKR----PGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN-LQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  150 (380)
                      .+.+..+.||+|..|+||++.++ +++.+|+|..    .....+++.+|+++++..+|||||.++|.|..++ ..+++||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            35566789999999999999965 6889999986    3344567899999999999999999999999998 5999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      ||++|+|++++.     ..+.+++...-.++.++++||.|||+. .+||||||||+|+|++..|++||||||.+..+.++
T Consensus       159 YMDgGSLd~~~k-----~~g~i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  159 YMDGGSLDDILK-----RVGRIPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             hcCCCCHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            999999999983     347789999999999999999999963 67999999999999999999999999999987664


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                          ......||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+. ..+..+.         +..++++.
T Consensus       233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~L---------l~~Iv~~p  298 (364)
T KOG0581|consen  233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFEL---------LCAIVDEP  298 (364)
T ss_pred             ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHHH---------HHHHhcCC
Confidence                346778999999999999999999999999999999999999999875211 1111111         12222221


Q ss_pred             cccCCCHH-HHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          311 LWSTFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       311 ~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       .+..|.. +++++++|+..||++||.+|||+.|+++|
T Consensus       299 -pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  299 -PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             -CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             1344454 88999999999999999999999999987

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1e-51  Score=382.91  Aligned_cols=256  Identities=32%  Similarity=0.504  Sum_probs=217.1

Q ss_pred             CCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCC-eeEEEEEee
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN-LQFLIYEYI  152 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~  152 (380)
                      +...+.||+|+||+||+|.++....||+|+.....     .+.|.+|+.+|.+++|||||+|+|++.+.. ..++||||+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            34456699999999999999865559999866443     458999999999999999999999999887 789999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCCeeeCCCC-ceEEcccccccccCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRT  230 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-ivHrDikp~Nili~~~~-~~kl~DFgla~~~~~~  230 (380)
                      ++|+|.+++...   ....+++..++.++.||+.||.|||+  ++ ||||||||+|+|++.++ ++||+|||+++....+
T Consensus       123 ~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~--~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  123 PGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHS--EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc--CCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            999999999543   46789999999999999999999999  56 99999999999999997 9999999999877553


Q ss_pred             CCCCCCccccCccceecccccc--cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          231 DVAGPSSQVTADEIFLASEVKE--FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      .  .......||..|||||++.  ...|+.++||||||++||||+||+.||....+.  +             -...+..
T Consensus       198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--~-------------~~~~v~~  260 (362)
T KOG0192|consen  198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--Q-------------VASAVVV  260 (362)
T ss_pred             c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--H-------------HHHHHHh
Confidence            2  2233478999999999999  669999999999999999999999999987641  1             1112223


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                      ...+..++..+++.+..++..||..||..||++.+++..|+.+.....
T Consensus       261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            344556666788999999999999999999999999999998877643

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-52  Score=388.11  Aligned_cols=254  Identities=29%  Similarity=0.480  Sum_probs=222.0

Q ss_pred             CCCCCCeeccCCceEEEEEEECCCcEEEEEeCCC--CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCC
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  155 (380)
                      .++..+.||+|.||.||+|.++....||+|....  ...+.|.+|+++|++|+|+|||+++++|..++.+||||||++.|
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            3445688999999999999999888999997554  45578999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016917          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (380)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~  235 (380)
                      +|.++|..   .....+...+.+.++.|||+||+||++  +++|||||.++|||++++..+||+|||+|+.+.++ ....
T Consensus       287 sLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes--~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~  360 (468)
T KOG0197|consen  287 SLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLES--KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTA  360 (468)
T ss_pred             cHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHh--CCccchhhhhhheeeccCceEEEcccccccccCCC-ceee
Confidence            99999954   346778899999999999999999999  66999999999999999999999999999965543 3334


Q ss_pred             CccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      .....-|..|.|||++....++.+||||||||+||||+| |+.||.....                .++.+.++...+.+
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----------------~ev~~~le~GyRlp  424 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----------------EEVLELLERGYRLP  424 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH----------------HHHHHHHhccCcCC
Confidence            455567888999999999999999999999999999999 8888887652                23445556666778


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhh
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  353 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~  353 (380)
                      .|..||+++.++|..||+.+|++|||++.+...|+++..
T Consensus       425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            889999999999999999999999999999988887764

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-52  Score=370.69  Aligned_cols=252  Identities=23%  Similarity=0.320  Sum_probs=204.7

Q ss_pred             HhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCC----------ChHHHHHHHHHHhcCCCCceeeeccceecCC
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA----------PTQEFIDEVCFLASIQHRNLVTLLGYCQENN  143 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  143 (380)
                      ..+.|.+.+.||+|+||.|-+|. .++++.||||+....          ......+|+++|++|+|||||++.++++..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            34567888999999999999999 567999999974321          1223579999999999999999999999999


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---CceEEcc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVAD  220 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~---~~~kl~D  220 (380)
                      ..||||||++||+|.+++.     ..+.+.+.....++.|++.|+.|||+  .||+||||||+|||++.+   ..+||+|
T Consensus       250 s~YmVlE~v~GGeLfd~vv-----~nk~l~ed~~K~~f~Qll~avkYLH~--~GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVV-----ANKYLREDLGKLLFKQLLTAVKYLHS--QGIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             ceEEEEEEecCccHHHHHH-----hccccccchhHHHHHHHHHHHHHHHH--cCcccccCCcceEEeccCCcceEEEecc
Confidence            9999999999999999993     45666777788999999999999999  779999999999999766   7899999


Q ss_pred             cccccccCCCCCCCCCccccCccceecccccccCCC---CcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhh
Q 016917          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF---SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS  297 (380)
Q Consensus       221 Fgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  297 (380)
                      ||+|+..+..   ......+||+.|.|||++.+..+   ..++|+||+||+||-+++|.+||+....+.  .+.+.+...
T Consensus       323 FGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~~G  397 (475)
T KOG0615|consen  323 FGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQILKG  397 (475)
T ss_pred             cchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHhcC
Confidence            9999988643   34567899999999999987654   347899999999999999999999754321  122221111


Q ss_pred             hcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      .      ..+    .+..-.+.+++..+||.+||..||++|||+.|+|++-
T Consensus       398 ~------y~f----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp  438 (475)
T KOG0615|consen  398 R------YAF----GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP  438 (475)
T ss_pred             c------ccc----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence            1      000    1122235678899999999999999999999999873

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.3e-53  Score=358.84  Aligned_cols=255  Identities=25%  Similarity=0.397  Sum_probs=209.4

Q ss_pred             CCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeC-----CCCChHHHHHHHHHHhcCCCCceeeeccc-eecCCe-eEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR-----PGAPTQEFIDEVCFLASIQHRNLVTLLGY-CQENNL-QFLI  148 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~-~~lv  148 (380)
                      .+|++.++||+|.||+||++. ..+|..+|.|..     +....+.+..|+.+|++|+|||||+++++ +.+++. +++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            357778999999999999999 668999999963     34456778999999999999999999994 444444 8999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR--VVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~--ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      ||||+.|+|...+...+. ..+.+++..+|.++.|++.||.++|..-+.  |+||||||.||+++.+|.+||+|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            999999999988854433 467799999999999999999999984334  99999999999999999999999999998


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      +....  .....++||++||+||.+...+|+.+|||||+||++|||+.-++||.+.      ++.+...+..+       
T Consensus       178 l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~q-------  242 (375)
T KOG0591|consen  178 LSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQ-------  242 (375)
T ss_pred             hcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHc-------
Confidence            86532  2345688999999999999999999999999999999999999999875      23333222221       


Q ss_pred             cccccccCCC-HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHh
Q 016917          307 LDERLWSTFT-NEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  350 (380)
Q Consensus       307 ~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~  350 (380)
                         ...++.| .-.+.++..|+..|+..||+.||+.-.+++.+..
T Consensus       243 ---gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  243 ---GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             ---CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence               1223444 5677889999999999999999986666655544

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-51  Score=365.28  Aligned_cols=247  Identities=24%  Similarity=0.425  Sum_probs=204.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+...     ..+.+..|+.+|+.++|||||++++++..++.+||||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            457888889999999999999954 6789999976544     3445788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC------CceEEccccc
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED------FIAKVADAGL  223 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~------~~~kl~DFgl  223 (380)
                      |||.||+|.+++     ...+.+++.....++.|++.||++||+  ++||||||||+|||++.+      -.+||+|||+
T Consensus        89 EyC~gGDLs~yi-----~~~~~l~e~t~r~Fm~QLA~alq~L~~--~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   89 EYCNGGDLSDYI-----RRRGRLPEATARHFMQQLASALQFLHE--NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EeCCCCCHHHHH-----HHcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            999999999999     355689999999999999999999999  789999999999999765      5689999999


Q ss_pred             ccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      |+.+.+..   .....+|++.|||||++....|+.|+|+||+|++||+|++|+.||....+.   ++...++..      
T Consensus       162 AR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~---eL~~~~~k~------  229 (429)
T KOG0595|consen  162 ARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK---ELLLYIKKG------  229 (429)
T ss_pred             hhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH---HHHHHHhcc------
Confidence            99987533   345678999999999999999999999999999999999999999875532   222222211      


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT  346 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~  346 (380)
                           .......+...++...+++...++.+|.+|.+..+-..
T Consensus       230 -----~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~  267 (429)
T KOG0595|consen  230 -----NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD  267 (429)
T ss_pred             -----ccccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence                 11223344445556677888888888888887776654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.7e-51  Score=379.86  Aligned_cols=245  Identities=23%  Similarity=0.387  Sum_probs=213.5

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      .+|...+.||+|||++||.++. .+|..||+|+.+      ...++...+|+++.+.|+|||||+++++|++.++.|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688899999999999999996 789999999754      345677899999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      |+|+.++|..++     ..++.+.+..+..+..||+.||.|||+  .+|+|||||..|+|++++.++||+|||||..+..
T Consensus        98 ELC~~~sL~el~-----Krrk~ltEpEary~l~QIv~GlkYLH~--~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELL-----KRRKPLTEPEARYFLRQIVEGLKYLHS--LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHH-----HhcCCCCcHHHHHHHHHHHHHHHHHHh--cCceecccchhheeecCcCcEEecccceeeeecC
Confidence            999999999888     357889999999999999999999999  6699999999999999999999999999998865


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ..  ......+||+-|.|||++....++..+||||+||+||-|+.|++||+.....   +.+..+...            
T Consensus       171 ~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk---ety~~Ik~~------------  233 (592)
T KOG0575|consen  171 DG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK---ETYNKIKLN------------  233 (592)
T ss_pred             cc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH---HHHHHHHhc------------
Confidence            32  2346789999999999999999999999999999999999999999975421   111111110            


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .  -.+|...+.+.++||.++|+.||.+|||+++++.+
T Consensus       234 ~--Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  234 E--YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             C--cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0  13455777889999999999999999999999976

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.5e-50  Score=390.55  Aligned_cols=266  Identities=29%  Similarity=0.470  Sum_probs=225.3

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCC
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENN  143 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  143 (380)
                      +...+.+..+.||+|.||+||+|+..      +.+.||||.++...    .++|++|++++..|+|||||+|+|+|..++
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            44555666788999999999999832      35789999866443    457999999999999999999999999999


Q ss_pred             eeEEEEEeecCCCccccccCCCCCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVS---------RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF  214 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~  214 (380)
                      .++||+||+..|||.+||+......         ...++..+.+.|+.|||.||.||.+  ..+|||||..+|+||.++.
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~--~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS--HHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--Ccccccchhhhhceeccce
Confidence            9999999999999999996544322         2338899999999999999999999  5699999999999999999


Q ss_pred             ceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHH
Q 016917          215 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVEL  293 (380)
Q Consensus       215 ~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~  293 (380)
                      .|||+|||+++.+-..++........-+..||+||.+..++|+++||||||||+|||+++ |+.||.+...   ++.++.
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~EVIe~  717 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---QEVIEC  717 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---HHHHHH
Confidence            999999999998877776665555567888999999999999999999999999999998 9999987663   233333


Q ss_pred             HHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcc
Q 016917          294 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  357 (380)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~  357 (380)
                      ++            ..++ .+.|.+||.+++.||..||+.+|.+||+++||-..|+...+....
T Consensus       718 i~------------~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~  768 (774)
T KOG1026|consen  718 IR------------AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK  768 (774)
T ss_pred             HH------------cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence            32            2222 467889999999999999999999999999999999887766544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-49  Score=351.75  Aligned_cols=240  Identities=22%  Similarity=0.312  Sum_probs=202.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      ..+|++.++||+|+||+||.++. .+++.+|+|.+.+      ........|..+|.+++||.||+++-.|++...+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            45789999999999999999995 4688999996432      3456688999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      +||+.||.|...|     .+++.+++..+..++..|+.||.|||+  ++||||||||+|||+|.+|+++|+|||+++...
T Consensus       104 ld~~~GGeLf~hL-----~~eg~F~E~~arfYlaEi~lAL~~LH~--~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  104 LDYLNGGELFYHL-----QREGRFSEDRARFYLAEIVLALGYLHS--KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EeccCCccHHHHH-----HhcCCcchhHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            9999999999988     467889999999999999999999999  779999999999999999999999999998543


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ...  ......+||+.|||||++.+.+|+..+|+||||+++|||++|.+||...+..   ...+            ++..
T Consensus       177 ~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~---~~~~------------~I~~  239 (357)
T KOG0598|consen  177 KDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK---KMYD------------KILK  239 (357)
T ss_pred             cCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH---HHHH------------HHhc
Confidence            322  2345589999999999999999999999999999999999999999875421   1111            1111


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCC
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS  340 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt  340 (380)
                      .+ ....+.-.+.+.++++.++|+.||++|..
T Consensus       240 ~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  240 GK-LPLPPGYLSEEARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             Cc-CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence            11 12333346678999999999999999963

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=379.70  Aligned_cols=276  Identities=26%  Similarity=0.458  Sum_probs=238.4

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECC----CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCee
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      +......+.++||.|.||.|++|+.+.    ...||||.++...    +.+|+.|..||.+++||||++|.|+.......
T Consensus       626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv  705 (996)
T KOG0196|consen  626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV  705 (996)
T ss_pred             cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence            344456778999999999999999643    4579999866443    45699999999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++|+|||++|+|+.||+    .+++.+.+.++.-+.++|+.||+||.+++  +|||||..+|||++.+..+|++|||+++
T Consensus       706 MIiTEyMENGsLDsFLR----~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSR  779 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLR----QNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSR  779 (996)
T ss_pred             EEEhhhhhCCcHHHHHh----hcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEecccccee
Confidence            99999999999999995    34567899999999999999999999965  9999999999999999999999999999


Q ss_pred             ccCCCC-CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          226 FLGRTD-VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       226 ~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      .++++. .......-..+..|.|||.+...+++.+|||||||++|||.++ |..||.....                +++
T Consensus       780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN----------------QdV  843 (996)
T KOG0196|consen  780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----------------QDV  843 (996)
T ss_pred             ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch----------------HHH
Confidence            886643 2333445566889999999999999999999999999999776 9999987653                345


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcccccccCCCC-ccccc
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGT-PTVTL  371 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~~~~~~~~~~-~~~~~  371 (380)
                      .+.+++.++.+.|.+|+..+.+||+.||++|-.+||.+.|++..|++++.++.+++......+ |...+
T Consensus       844 IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~~l  912 (996)
T KOG0196|consen  844 IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQPL  912 (996)
T ss_pred             HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCcccc
Confidence            556667778889999999999999999999999999999999999999999999888877653 44333

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4e-48  Score=333.63  Aligned_cols=267  Identities=19%  Similarity=0.304  Sum_probs=206.6

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCCh-----HHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT-----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      +.|+...++|+|+||.||+|+++ +|+.||||++.....     +-.++|+.+|++|+|+|+|.++++|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            35777889999999999999965 699999998654433     346789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      ||+..-| +.|.    .....++...+.++..|++.|+.|+|+  +++|||||||+||||+.+|.+||||||+|+.+..+
T Consensus        82 ~~dhTvL-~eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk--~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   82 YCDHTVL-HELE----RYPNGVPSELVKKYLYQLLKAIHFCHK--NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             ecchHHH-HHHH----hccCCCCHHHHHHHHHHHHHHhhhhhh--cCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            9988444 3442    234567888999999999999999999  66999999999999999999999999999988642


Q ss_pred             CCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc-cchhhhcc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF-SNLLKILD  308 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  308 (380)
                        ......+.+|..|+|||.+.| ..|+..+||||+||++.||++|.+.|.+...  .+++.......-+. +....++.
T Consensus       155 --gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD--iDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  155 --GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD--IDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             --cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch--HHHHHHHHHHHcccCHHHHHHhc
Confidence              223457889999999999888 6899999999999999999999998887543  23333222211111 11111111


Q ss_pred             ccc-----ccC----------CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--HHhhhhh
Q 016917          309 ERL-----WST----------FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRTLDK  354 (380)
Q Consensus       309 ~~~-----~~~----------~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~--L~~~~~~  354 (380)
                      .+.     ..+          .-+..+.-+.++++.||+.||.+|++.++++.+  +++.+++
T Consensus       231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er  293 (396)
T KOG0593|consen  231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER  293 (396)
T ss_pred             cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence            110     000          012234568999999999999999999999965  4444444

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-48  Score=347.08  Aligned_cols=255  Identities=27%  Similarity=0.370  Sum_probs=205.6

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCC--eeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENN--LQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~  151 (380)
                      ++...+.||+|+||+||++... +|...|||......   .+.+.+|+.+|++++|||||+++|......  .+++.|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            4566788999999999999954 48999999765444   456899999999999999999999855444  68999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEcccccccccCC-
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGR-  229 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~-~~~~kl~DFgla~~~~~-  229 (380)
                      +++|+|.+++...    ...+++..+..+..|++.||.|||+  +|||||||||+|||++. ++.+||+|||++..... 
T Consensus        98 ~~~GsL~~~~~~~----g~~l~E~~v~~ytr~iL~GL~ylHs--~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   98 APGGSLSDLIKRY----GGKLPEPLVRRYTRQILEGLAYLHS--KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             cCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999432    1268999999999999999999998  78999999999999999 79999999999987653 


Q ss_pred             CCCCCCCccccCccceecccccccCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ...........||+.|||||++.... .+.++|||||||++.||+||+.||.... . .   .+         .+..+..
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-~-~---~~---------~~~~ig~  237 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-E-E---AE---------ALLLIGR  237 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-c-h---HH---------HHHHHhc
Confidence            11222344678999999999998632 3359999999999999999999998741 0 0   11         1112222


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                      ....+.+|...+++.++++.+|++.||++|||++++|++.--..
T Consensus       238 ~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  238 EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence            22233677778899999999999999999999999998865433

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-48  Score=355.56  Aligned_cols=268  Identities=19%  Similarity=0.261  Sum_probs=217.6

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCC------CCChHHHHHHHHHHhcC-CCCceeeeccceecCCee
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP------GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  145 (380)
                      ....+|...+.||.|+|++|++|+ ..+++.||||+..      +...+.+..|-++|.+| .||.|++|+-.|.+...+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            345679999999999999999999 4578999999743      33345577899999999 899999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      |+|+||+++|+|.+++     ..-+.+.+.....++.+|+.||+|||+  +|||||||||+|||+|+|+++||+|||.|+
T Consensus       150 YFvLe~A~nGdll~~i-----~K~Gsfde~caR~YAAeIldAleylH~--~GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLI-----KKYGSFDETCARFYAAEILDALEYLHS--NGIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             EEEEEecCCCcHHHHH-----HHhCcchHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeEcCCCcEEEeeccccc
Confidence            9999999999999999     355788999999999999999999999  779999999999999999999999999999


Q ss_pred             ccCCCCCC---------CC--CccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH
Q 016917          226 FLGRTDVA---------GP--SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  294 (380)
Q Consensus       226 ~~~~~~~~---------~~--~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~  294 (380)
                      .+.+....         ..  ....+||..|.+||++.....+..+|+|+|||+||+|+.|.+||....+-.      . 
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------i-  295 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------I-  295 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH------H-
Confidence            88542211         11  145889999999999999999999999999999999999999999765311      0 


Q ss_pred             HhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcccccccCCCCcc
Q 016917          295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPT  368 (380)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~~~~~~~~~~~~  368 (380)
                           +.++.+   -  --.+++..++.+.+|+.+.|..||.+|+|+++|-+|.   .-+...|++.-+-++|.
T Consensus       296 -----FqkI~~---l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp---FF~~Vdw~nlw~~~PP~  356 (604)
T KOG0592|consen  296 -----FQKIQA---L--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP---FFEGVDWENLWQQTPPK  356 (604)
T ss_pred             -----HHHHHH---h--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc---ccccCChhhhhhcCCCc
Confidence                 111111   1  1245566668899999999999999999998887762   22334455544444443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-46  Score=352.38  Aligned_cols=264  Identities=22%  Similarity=0.383  Sum_probs=205.9

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEE------CCCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeeeccceecC
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQEN  142 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  142 (380)
                      +..++|++.+.||+|+||.||+|..      .++..||+|......    ...+.+|+.++..+ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            3456799999999999999999974      234679999865432    34588899999999 899999999988754


Q ss_pred             -CeeEEEEEeecCCCccccccCCCCC------------------------------------------------------
Q 016917          143 -NLQFLIYEYIPNGSVSIHLYGPSQV------------------------------------------------------  167 (380)
Q Consensus       143 -~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------  167 (380)
                       +..++||||+++|+|.+++......                                                      
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4678999999999999888532110                                                      


Q ss_pred             ---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccc
Q 016917          168 ---SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI  244 (380)
Q Consensus       168 ---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~  244 (380)
                         ....+.+..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...............++..
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               02347788889999999999999999  7899999999999999999999999999986543222112223345678


Q ss_pred             eecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHH
Q 016917          245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEF  323 (380)
Q Consensus       245 ~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  323 (380)
                      |+|||++.+..++.++|||||||++|||++ |..||......  .........             ......+..+++++
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~~~-------------~~~~~~~~~~~~~l  306 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFCQRLKD-------------GTRMRAPENATPEI  306 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHhc-------------CCCCCCCCCCCHHH
Confidence            999999999999999999999999999997 99998764321  111111110             01112234456789


Q ss_pred             HHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          324 IQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       324 ~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      .+++.+||+.||.+|||+.++++.|++++.+
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-47  Score=326.68  Aligned_cols=235  Identities=22%  Similarity=0.334  Sum_probs=204.4

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      ..++|+..+.||.|+||+|.+++.+ +|..+|+|.++...      .+...+|..+|+.+.||.++++++.+.+.+.+||
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            4457888999999999999999954 68899999866443      3457789999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||.+||.|..++     .+.+++++.....++.+|+.||+|||+  .+|++|||||+|||+|.+|.+||+|||+|+..
T Consensus       122 vmeyv~GGElFS~L-----rk~~rF~e~~arFYAAeivlAleylH~--~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  122 VMEYVPGGELFSYL-----RKSGRFSEPHARFYAAEIVLALEYLHS--LDIIYRDLKPENLLLDQNGHIKITDFGFAKRV  194 (355)
T ss_pred             EEeccCCccHHHHH-----HhcCCCCchhHHHHHHHHHHHHHHHHh--cCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence            99999999999999     355778999999999999999999999  66999999999999999999999999999976


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      ..     .....+||+.|+|||++...+|+.++|+|||||++|||+.|.+||....+.   .            ...+++
T Consensus       195 ~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~---~------------iY~KI~  254 (355)
T KOG0616|consen  195 SG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI---Q------------IYEKIL  254 (355)
T ss_pred             cC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH---H------------HHHHHH
Confidence            43     356789999999999999999999999999999999999999999876541   1            112233


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCC
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERR  338 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  338 (380)
                      ...+  .+|...++++++|++.+|+.|-.+|
T Consensus       255 ~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  255 EGKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             hCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            3322  5677777889999999999999999

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=349.42  Aligned_cols=246  Identities=22%  Similarity=0.378  Sum_probs=209.0

Q ss_pred             CCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCC---CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeec
Q 016917           78 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      .|....+||+|+.|.||.+. ..+++.||+|.+.   +...+-+.+|+.+|+..+|+|||++++.+...+.++.||||++
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~  353 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME  353 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence            47778899999999999999 5678899999733   3344557899999999999999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                      ||+|.|.+      ....+.+.++..+++.++.||+|||.  ++|+|||||.+|||++.+|.+||+|||++..+..... 
T Consensus       354 ggsLTDvV------t~~~~~E~qIA~Icre~l~aL~fLH~--~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  354 GGSLTDVV------TKTRMTEGQIAAICREILQGLKFLHA--RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             CCchhhhh------hcccccHHHHHHHHHHHHHHHHHHHh--cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            99999988      34558899999999999999999999  7899999999999999999999999999988765332 


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  313 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (380)
                       ......||++|||||++....|++++||||||++++||+-|.+||-...+...  ++-...            ......
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA--lyLIa~------------ng~P~l  489 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIAT------------NGTPKL  489 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH--HHHHhh------------cCCCCc
Confidence             45678899999999999999999999999999999999999999986443211  111000            112223


Q ss_pred             CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       314 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..+...++.+++|+.+||+.|+++|+++.++|++
T Consensus       490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            4556678899999999999999999999999986

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-46  Score=341.29  Aligned_cols=264  Identities=23%  Similarity=0.312  Sum_probs=203.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecC--CeeEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFL  147 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  147 (380)
                      ...|+.+++||+|.||.||+|+ ..+|+.||+|+..-.     ......+|+.+|++|+||||+++.+...+.  +.+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3457778899999999999999 678999999974322     233457899999999999999999998776  78999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      |+|||+. +|.-++.    ...-.+++.++..++.|++.||+|+|+  +||+|||||.+|||||++|.+||+|||||+++
T Consensus       196 VFeYMdh-DL~GLl~----~p~vkft~~qIKc~mkQLl~Gl~~cH~--~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLS----SPGVKFTEPQIKCYMKQLLEGLEYCHS--RGVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEecccc-hhhhhhc----CCCcccChHHHHHHHHHHHHHHHHHhh--cCeeeccccccceEEcCCCCEEeccccceeec
Confidence            9999988 6766663    235678999999999999999999999  78999999999999999999999999999987


Q ss_pred             CCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhh-----hccc
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS-----RDFS  301 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-----~~~~  301 (380)
                      .... .......+.|..|+|||.+.| ..|+..+|+||.||||.||+.|++.|.+..+.+.-..+..+...     |...
T Consensus       269 ~~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  269 TPSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             cCCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            5533 223456678999999999877 48999999999999999999999999887643222222211111     1100


Q ss_pred             chhhhcccccccCCC-------HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 NLLKILDERLWSTFT-------NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ++......+....+.       ...++...+|+..+|..||.+|.|+.++|+.
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            111000000000111       1234668899999999999999999999864

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.3e-46  Score=345.38  Aligned_cols=268  Identities=22%  Similarity=0.293  Sum_probs=210.1

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      +..++|+.+++||+|+||.||+|+. .+|..+|+|++++.      ....++.|..+|..-++|+||+++-.|++..++|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            3456799999999999999999995 46999999986644      3456889999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      |||||++||++...|     .+.+.+++.....++.+++.|+.-||+  .|+|||||||+|+|||..|++||+||||+..
T Consensus       218 LiMEylPGGD~mTLL-----~~~~~L~e~~arfYiaE~vlAI~~iH~--~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLL-----MRKDTLTEDWARFYIAETVLAIESIHQ--LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEEecCCccHHHHH-----HhcCcCchHHHHHHHHHHHHHHHHHHH--cCcccccCChhheeecCCCCEeeccccccch
Confidence            999999999999988     567889999999999999999999999  6699999999999999999999999999854


Q ss_pred             cCCC----------------------CCCC-----------------------CCccccCccceecccccccCCCCcchh
Q 016917          227 LGRT----------------------DVAG-----------------------PSSQVTADEIFLASEVKEFRRFSEKSD  261 (380)
Q Consensus       227 ~~~~----------------------~~~~-----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~D  261 (380)
                      +...                      ....                       ......|||.|+|||++.+.+|+..+|
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence            3210                      0000                       012357999999999999999999999


Q ss_pred             hHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCC-
Q 016917          262 VYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-  340 (380)
Q Consensus       262 vwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-  340 (380)
                      +||||||+|||+.|.+||....+.+-      .++...+..       .+..+-...++++..|||.+|+. ||++|.. 
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~~T------~rkI~nwr~-------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQET------YRKIVNWRE-------TLKFPEEVDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHHHhh-------hccCCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence            99999999999999999998765311      111111111       11112223455889999999998 9999986 


Q ss_pred             --HHHHHHHHHhhhhhhcccccccCCC
Q 016917          341 --MSDVVTELDRTLDKEMNLTTVMGEG  365 (380)
Q Consensus       341 --~~~ll~~L~~~~~~~~~~~~~~~~~  365 (380)
                        ++||-++   =.-+...|+.+....
T Consensus       437 ~G~~EIK~H---PfF~~v~W~~l~~~~  460 (550)
T KOG0605|consen  437 KGAEEIKKH---PFFKGVDWDHLREMP  460 (550)
T ss_pred             ccHHHHhcC---CccccCCcchhhcCC
Confidence              4444332   112234455555444

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.7e-46  Score=346.94  Aligned_cols=244  Identities=26%  Similarity=0.402  Sum_probs=208.2

Q ss_pred             CCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCCChH-----HHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQ-----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-----~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ++|.+.+.||+|+||+||+|+ ..+.+.||+|..++..+.     .+.+|+++++.++||||+.++++|+....+++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            467778899999999999999 556889999976554443     48899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+.| +|..++     ..+..++++.+..++.+++.||.|||+  .+|+|||+||+|||++.++++|+||||+|+.+...
T Consensus        82 ~a~g-~L~~il-----~~d~~lpEe~v~~~a~~LVsaL~yLhs--~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   82 YAVG-DLFTIL-----EQDGKLPEEQVRAIAYDLVSALYYLHS--NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhh-hHHHHH-----HhccCCCHHHHHHHHHHHHHHHHHHHh--cCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            9988 999988     567889999999999999999999999  67999999999999999999999999999987542


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                        ........||+.|||||...+.+|+..+|+||+||++||+++|++||....      ..+.+..         +..+.
T Consensus       154 --t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~---------I~~d~  216 (808)
T KOG0597|consen  154 --TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKS---------ILKDP  216 (808)
T ss_pred             --ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHH---------HhcCC
Confidence              223456789999999999999999999999999999999999999997533      2222221         11111


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .  ..|...+..+..++...|.+||.+|.|-.+++.+
T Consensus       217 v--~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  217 V--KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             C--CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            1  2344677889999999999999999999999876

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=344.70  Aligned_cols=248  Identities=23%  Similarity=0.293  Sum_probs=207.2

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCC--------ChHHHHHHHHHHhcCC-CCceeeeccceecCC
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--------PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENN  143 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  143 (380)
                      ...+.|.+.+.||+|+||+|+.|. ..++..||+|+.+..        ..+.+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            346789999999999999999998 456899999974442        2334567999999998 999999999999999


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CceEEcccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAG  222 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~-~~~kl~DFg  222 (380)
                      ..|+||||+.+|+|.+++.     ....+.+.....++.|++.|++|+|+  +||+||||||+|+|++.+ +++||+|||
T Consensus        94 ~~~ivmEy~~gGdL~~~i~-----~~g~l~E~~ar~~F~Qlisav~y~H~--~gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIV-----NKGRLKEDEARKYFRQLISAVAYCHS--RGIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             eEEEEEEecCCccHHHHHH-----HcCCCChHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            9999999999999999993     35778889999999999999999999  779999999999999999 999999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccCC-CC-cchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF  300 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  300 (380)
                      ++....  .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||.....   ..+...       
T Consensus       167 ~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~---~~l~~k-------  234 (370)
T KOG0583|consen  167 LSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV---PNLYRK-------  234 (370)
T ss_pred             cccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH---HHHHHH-------
Confidence            999874  2223456788999999999999988 85 789999999999999999999997321   111111       


Q ss_pred             cchhhhcccccccCCCHHH-HHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 SNLLKILDERLWSTFTNEG-MEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                           +...  ...+|... ++++++++.+||..||.+|+|+.+++.+
T Consensus       235 -----i~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  235 -----IRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             -----HhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence                 1111  11344444 7889999999999999999999999954

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=9.6e-46  Score=313.66  Aligned_cols=260  Identities=22%  Similarity=0.343  Sum_probs=205.5

Q ss_pred             CCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      .+|...++||+|.||.||+|+ ..+|+.||||+..-..     .....+|+..|+.++|+||+.+++.|...+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            357778899999999999999 6789999999754332     3457899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |++. +|+..+.    .+...++..++..++.++++|++|+|.  +.|+||||||.|+||+.+|.+||+|||+|+.+...
T Consensus        82 fm~t-dLe~vIk----d~~i~l~pa~iK~y~~m~LkGl~y~H~--~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIK----DKNIILSPADIKSYMLMTLKGLAYCHS--KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhc----ccccccCHHHHHHHHHHHHHHHHHHHh--hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9987 8888874    456778899999999999999999999  66999999999999999999999999999988654


Q ss_pred             CCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh-----hhcccchh
Q 016917          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN-----SRDFSNLL  304 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~  304 (380)
                      ....  ...+.|..|+|||.+-| ..|+..+||||.||++.||+-|.+-|.+...  .+++....+.     ...++++.
T Consensus       155 ~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD--idQL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  155 NRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD--IDQLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             Cccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch--HHHHHHHHHHcCCCCcccCcccc
Confidence            4322  23378899999998765 5899999999999999999999877776543  2333222211     11112222


Q ss_pred             hhccccc--------ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          305 KILDERL--------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...|-..        ....-..++++..+|+.+||.+||.+|+|+.|++++
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            2111111        111223455677999999999999999999999976

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-47  Score=342.90  Aligned_cols=261  Identities=24%  Similarity=0.357  Sum_probs=207.1

Q ss_pred             HhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCC--ChHHH--HHHHHHHhcCC-CCceeeeccceecCC-eeEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA--PTQEF--IDEVCFLASIQ-HRNLVTLLGYCQENN-LQFL  147 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~--~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l  147 (380)
                      ...+|...++||.|+||.||+|+ ..++..||||+++..  ..++.  .+|+..|++|+ ||||+++.+++.+++ .+|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            45678889999999999999999 557899999975533  23333  57999999998 999999999999888 8999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      |||||+. +|.+.+.    .+++.+++..+..|+.||+.||+|+|.  +|+.|||+||+|||+.....+||+|||+|+.+
T Consensus        88 VfE~Md~-NLYqLmK----~R~r~fse~~irnim~QilqGL~hiHk--~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMK----DRNRLFSESDIRNIMYQILQGLAHIHK--HGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eHHhhhh-hHHHHHh----hcCCcCCHHHHHHHHHHHHHHHHHHHh--cCcccccCChhheEecccceeEeccccccccc
Confidence            9999987 7888874    347889999999999999999999999  67999999999999999999999999999987


Q ss_pred             CCCCCCCCCccccCccceecccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH--hhhccc---
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ--NSRDFS---  301 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~---  301 (380)
                      ..   ..+...++.|..|+|||++. ..-|+.+.||||+|||++|+.+-++.|.+..+.  +++.....  ......   
T Consensus       161 ~S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~--Dqi~KIc~VLGtP~~~~~~  235 (538)
T KOG0661|consen  161 RS---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI--DQIYKICEVLGTPDKDSWP  235 (538)
T ss_pred             cc---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH--HHHHHHHHHhCCCccccch
Confidence            44   34566788999999999865 567899999999999999999999999876532  22222211  111000   


Q ss_pred             ---chhhhcccccc-------cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 ---NLLKILDERLW-------STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 ---~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         .+...++-.+.       ...-+.++.+..+++.+|+++||.+|||+.+++++
T Consensus       236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence               01111111110       01112377889999999999999999999999987

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=347.83  Aligned_cols=250  Identities=24%  Similarity=0.402  Sum_probs=212.2

Q ss_pred             HHHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        72 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +++.......++-||+|+.|.||+|+.+ ++.||||+....    -..+++.|++|+||||+.|.|+|.....+||||||
T Consensus       119 WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el----kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf  193 (904)
T KOG4721|consen  119 WEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL----KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF  193 (904)
T ss_pred             ccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhh----hhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence            3444444455678999999999999986 678999986432    23578999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      |..|-|...|     ...+.+.......+..+||.|+.|||.  ..|||||||.-||||+.+..|||+|||.++...+. 
T Consensus       194 Ca~GqL~~VL-----ka~~~itp~llv~Wsk~IA~GM~YLH~--hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-  265 (904)
T KOG4721|consen  194 CAQGQLYEVL-----KAGRPITPSLLVDWSKGIAGGMNYLHL--HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-  265 (904)
T ss_pred             cccccHHHHH-----hccCccCHHHHHHHHHHhhhhhHHHHH--hhHhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence            9999999999     345667778889999999999999999  45999999999999999999999999999877543 


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                        .....+.||..|||||++.+.+.+.|+|||||||+||||+||..||...+..               .-+..+-...+
T Consensus       266 --STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---------------AIIwGVGsNsL  328 (904)
T KOG4721|consen  266 --STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---------------AIIWGVGSNSL  328 (904)
T ss_pred             --hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---------------eeEEeccCCcc
Confidence              3345678999999999999999999999999999999999999999865421               11222233445


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                      ..+.|..|++.+.-|+++||+..|..||++.+++.+|+-.
T Consensus       329 ~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  329 HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            5678889999999999999999999999999999999743

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-46  Score=370.99  Aligned_cols=263  Identities=29%  Similarity=0.468  Sum_probs=220.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECC--C----cEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQD--G----MLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~--~----~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      ....+..+.||+|.||.||.|...+  +    ..||+|.....    ...+|.+|..+|++++||||++++|++.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4445667899999999999999543  3    34899976544    345799999999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      ++++|||++|+|..+|+..+..  ....+...+.+.++.|||+|+.||++  ++.|||||..+|+|++....+||+|||+
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~--~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES--KHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh--CCCcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999999755332  25678899999999999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccc
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN  302 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (380)
                      |+.+.+.++........-+..|||||.+....+++|+|||||||+|||++| |..||...+..               +-
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---------------~v  913 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---------------EV  913 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH---------------HH
Confidence            997766555444444456778999999999999999999999999999999 88999876532               11


Q ss_pred             hhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                      +..+.... +.+.|..|++.++++|.+||+.+|++||++..+++.+..+.+...
T Consensus       914 ~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  914 LLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             HHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence            11122222 557788999999999999999999999999999999988776643

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=332.98  Aligned_cols=265  Identities=25%  Similarity=0.304  Sum_probs=212.0

Q ss_pred             HHHHHhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCC----CCChHHHHHHHHHHhcCCCCceeeeccceecCCee
Q 016917           71 ELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        71 ~~~~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      .++...+.|++..+||.|..++||+|. ...+..||||+..    ....+.+.+|+..|+.++||||++++..|..+..+
T Consensus        20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            344567789999999999999999999 5568999999854    22356789999999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      |+||.||.+|++.+.+...   -...+.+..+..|.+++++||.|||+  +|.||||||+.||||+.+|.|||+|||.+.
T Consensus       100 WvVmpfMa~GS~ldIik~~---~~~Gl~E~~Ia~iLre~LkaL~YLH~--~G~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTY---YPDGLEEASIATILREVLKALDYLHQ--NGHIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             EEeehhhcCCcHHHHHHHH---ccccccHHHHHHHHHHHHHHHHHHHh--cCceecccccccEEEcCCCcEEEcCceeee
Confidence            9999999999999998544   23458899999999999999999999  789999999999999999999999999876


Q ss_pred             ccCCCCCCC-CC-ccccCccceeccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc
Q 016917          226 FLGRTDVAG-PS-SQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       226 ~~~~~~~~~-~~-~~~~~~~~~~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                      .+.+..... .. ....||++|||||++..  .+|+.|+||||||++..||.+|..||....+-  +.+...+++..+..
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvLl~tLqn~pp~~  252 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--KVLLLTLQNDPPTL  252 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--HHHHHHhcCCCCCc
Confidence            664433211 11 56789999999999543  58999999999999999999999999987652  22222222222211


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      . ....+..    .....+..+++++..||++||.+|||+++++++
T Consensus       253 ~-t~~~~~d----~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  253 L-TSGLDKD----EDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             c-cccCChH----HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            1 1111111    112233579999999999999999999999965

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-46  Score=336.94  Aligned_cols=246  Identities=28%  Similarity=0.398  Sum_probs=207.8

Q ss_pred             CCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCC----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      ..|+....||+|.||.||+|. ..+++.||+|+.+-    ...+.+.+|+.+|.+++++||.++|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            346667889999999999999 55789999998542    3345678899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +.||++.+.|..     ...+.+..+.-+.++++.|+.|||.  .+.+|||||+.|||+..+|.+||+|||.+..+..+.
T Consensus        93 ~~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~--~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   93 CGGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHS--EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             hcCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhh--cceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            999999999832     2333666667789999999999999  669999999999999999999999999998876644


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                      ..  .....||+.|||||++.+..|+.++||||||++.+||.+|.+|+....+..                ..-++-+..
T Consensus       166 ~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~  227 (467)
T KOG0201|consen  166 KR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSA  227 (467)
T ss_pred             hc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCC
Confidence            33  367899999999999999999999999999999999999999999877521                122222222


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .+.....+++.+++|+..||.+||+.||++.+++++
T Consensus       228 PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  228 PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            334444677889999999999999999999999986

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=342.52  Aligned_cols=264  Identities=28%  Similarity=0.448  Sum_probs=214.3

Q ss_pred             HHHHHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCe
Q 016917           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (380)
Q Consensus        70 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  144 (380)
                      +++++..+...+...||+|+||+||+|.+.  ..||||.+...     ..+.|.+|+..+++-+|.||+-|.|+|.....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            666777777888899999999999999975  35999975433     34679999999999999999999999999887


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                       .+|+.+|+|-+|..+++    ..+..+.+...+.|+.|++.|+.|||.  ++|||||||..||++.+++.|||+|||++
T Consensus       463 -AIiTqwCeGsSLY~hlH----v~etkfdm~~~idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLH----VQETKFDMNTTIDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             -eeeehhccCchhhhhcc----chhhhhhHHHHHHHHHHHHHhhhhhhh--hhhhhhhccccceEEccCCcEEEecccce
Confidence             89999999999999995    456788999999999999999999999  78999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCccceeccccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                      ..-.............|...|||||++.-   .+|++.+||||||+++|||++|..||.....+..   +-.+-..    
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI---ifmVGrG----  608 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI---IFMVGRG----  608 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe---EEEeccc----
Confidence            76544333333445567788999999863   5899999999999999999999999994332211   1000000    


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                          .+.+++ ......++.++.+|+..||.+++++||.+.+++..|+.++..
T Consensus       609 ----~l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  609 ----YLMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             ----ccCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence                001111 123346778999999999999999999999999999888874

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.1e-44  Score=329.47  Aligned_cols=243  Identities=22%  Similarity=0.346  Sum_probs=198.9

Q ss_pred             CeeccCCceEEEEEEECCCcEEEEEeCCCCC------hHHHHHHHHHHhcCCCCceeeeccceec----CCeeEEEEEee
Q 016917           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQFLIYEYI  152 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  152 (380)
                      ..||+|++|.||+|.. +|+.||+|......      .+.+.+|+.+|++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999998 58899999865432      3557799999999999999999999876    45679999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++|+|.+++.     ....+++.....++.+++.||.|||+. .+++||||||+|||+++++.+||+|||+++...... 
T Consensus       105 ~~g~L~~~l~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLD-----KEKDLSFKTKLDMAIDCCKGLYNLYKY-TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHh-----hCCCCChhHHHHHHHHHHHHHHHHHhc-CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            9999999984     345678899999999999999999973 368899999999999999999999999988654321 


Q ss_pred             CCCCccccCccceeccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          233 AGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                          ....++..|+|||++.+  ..|+.++|||||||++|||++|+.||.....   .+....+.            ...
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~~~i~------------~~~  238 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIYDLII------------NKN  238 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHHHHHH------------hcC
Confidence                23457788999999876  6899999999999999999999999986532   11111111            111


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                      .....+..+++.+.+++.+||+.||++|||++++++.|+++.
T Consensus       239 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            122344456788999999999999999999999999998875

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=329.16  Aligned_cols=256  Identities=25%  Similarity=0.317  Sum_probs=206.3

Q ss_pred             HhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCCC-----------------hHHHHHHHHHHhcCCCCceeeec
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP-----------------TQEFIDEVCFLASIQHRNLVTLL  136 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l~  136 (380)
                      ..++|++.+.||+|.||.|-+|. ..+++.||||++++..                 .+...+|+.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            45679999999999999999999 5578999999744321                 24688999999999999999999


Q ss_pred             cceecC--CeeEEEEEeecCCCccccccCCCCCCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC
Q 016917          137 GYCQEN--NLQFLIYEYIPNGSVSIHLYGPSQVSRQK-LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED  213 (380)
Q Consensus       137 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~  213 (380)
                      ++..+.  +.+|||+|||..|.+...-      .... +.+.+.+.++.+++.||+|||.  +|||||||||+|+|++++
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p------~d~~els~~~Ar~ylrDvv~GLEYLH~--QgiiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP------PDKPELSEQQARKYLRDVVLGLEYLHY--QGIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC------CCcccccHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEEcCC
Confidence            999764  5789999999998875332      2333 8999999999999999999999  779999999999999999


Q ss_pred             CceEEcccccccccCCCCCCC---CCccccCccceecccccccC---CC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 016917          214 FIAKVADAGLRNFLGRTDVAG---PSSQVTADEIFLASEVKEFR---RF-SEKSDVYSFGVFLLELVSGREASSSLSPDS  286 (380)
Q Consensus       214 ~~~kl~DFgla~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~---~~-~~~~DvwSlG~il~el~tg~~p~~~~~~~~  286 (380)
                      |++||+|||.+.....+....   ......||+.|+|||...+.   .| +.+.||||+||+||.|+.|+.||.....  
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--  324 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--  324 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence            999999999988663322111   12346799999999987762   33 5789999999999999999999986432  


Q ss_pred             cccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhh
Q 016917          287 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  353 (380)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~  353 (380)
                                   ..-..++.+..+..+..++..+.+++||++||.+||++|.+..++..+..-...
T Consensus       325 -------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  325 -------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             -------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence                         112334445555444444677889999999999999999999999888765443

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.7e-44  Score=332.17  Aligned_cols=263  Identities=26%  Similarity=0.393  Sum_probs=201.5

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECC-----------------CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQD-----------------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVT  134 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~  134 (380)
                      .++|++.++||+|+||.||+|..++                 +..||+|......    ...+.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4578889999999999999997532                 3469999865432    346889999999999999999


Q ss_pred             eccceecCCeeEEEEEeecCCCccccccCCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 016917          135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQ--------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH  200 (380)
Q Consensus       135 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivH  200 (380)
                      +++++.+.+..++||||+++|+|.+++.....              .....+++..+..++.|++.||.|||+  .+|+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~ivH  161 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS--LNFVH  161 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH--CCccc
Confidence            99999999999999999999999988743211              112356788899999999999999999  67999


Q ss_pred             cCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc--CCCC
Q 016917          201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREA  278 (380)
Q Consensus       201 rDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t--g~~p  278 (380)
                      |||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986543322222223345778999999988899999999999999999986  5567


Q ss_pred             CCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          279 SSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                      |......   +...........      .........+..+++.+.+++.+||+.||.+|||+.++.+.|+
T Consensus       242 ~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDE---QVIENAGEFFRD------QGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHH---HHHHHHHHHhhh------ccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            7654321   111111111000      0001111223455678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.4e-44  Score=343.35  Aligned_cols=260  Identities=23%  Similarity=0.372  Sum_probs=203.8

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE------CCCcEEEEEeCCCC----ChHHHHHHHHHHhcC-CCCceeeeccceecCC
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQENN  143 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  143 (380)
                      ..++|++.+.||+|+||.||+|+.      .++..||+|.....    ..+.+.+|+.+++.+ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            345688899999999999999973      23568999986532    234578899999999 8999999999999999


Q ss_pred             eeEEEEEeecCCCccccccCCCC---------------------------------------------------------
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQ---------------------------------------------------------  166 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  166 (380)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            99999999999999888753211                                                         


Q ss_pred             -------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          167 -------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       167 -------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                                   .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++........
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                         011247788899999999999999999  77999999999999999999999999999876443221


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                      .......++..|+|||.+.+..++.++|||||||++|||++ |..||......  ......+.             ....
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~~-------------~~~~  335 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMIK-------------EGYR  335 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHHH-------------hCcc
Confidence            12222345667999999999999999999999999999998 88888754321  11111111             1111


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                      ...+...+.++.+++.+||+.||++|||+.++++.|++.
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            122233457799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-45  Score=342.93  Aligned_cols=245  Identities=23%  Similarity=0.305  Sum_probs=210.8

Q ss_pred             CCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      +-|+..+.||.|+.|.|.+|+ ..+|+.+|||+....      ....+.+|+-+|+.+.|||++++|+++++...+|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            457888999999999999999 468999999986544      2446789999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|.|.+++     ...+.+++....+++.||+.|+.|+|.  -+|+||||||+|+|+|..+++||+|||+|..-.+
T Consensus        92 Eyv~gGELFdyl-----v~kG~l~e~eaa~ff~QIi~gv~yCH~--~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYL-----VRKGPLPEREAAHFFRQILDGVSYCHA--FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EecCCchhHHHH-----HhhCCCCCHHHHHHHHHHHHHHHHHhh--hcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            999999999999     567889999999999999999999999  5599999999999999999999999999987543


Q ss_pred             CCCCCCCccccCccceecccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      +   ......+|.+.|.+||++.|.+| +.++||||+|||||.|+||+.||++.+   ...++..++...          
T Consensus       165 g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV~~G~----------  228 (786)
T KOG0588|consen  165 G---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKVQRGV----------  228 (786)
T ss_pred             C---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHHHcCc----------
Confidence            2   23456789999999999999999 578999999999999999999999432   222322222111          


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                          -+.|.+.+.+.++|+.+||..||++|.|+++|++|-
T Consensus       229 ----f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  229 ----FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             ----ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence                245677889999999999999999999999999984

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.7e-44  Score=342.43  Aligned_cols=262  Identities=23%  Similarity=0.368  Sum_probs=204.4

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeeeccceecC
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQEN  142 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  142 (380)
                      ...++|++.+.||+|+||.||+|...      ++..||+|......    .+.+.+|+++++.+ +|+||+++++++...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            34457888999999999999998842      23579999865432    34578899999999 899999999999999


Q ss_pred             CeeEEEEEeecCCCccccccCCCC--------------------------------------------------------
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQ--------------------------------------------------------  166 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------  166 (380)
                      +..++||||+++|+|.+++.....                                                        
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            999999999999999988743210                                                        


Q ss_pred             ---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016917          167 ---------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  237 (380)
Q Consensus       167 ---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~  237 (380)
                               .....+++..++.++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++............
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                     012347788899999999999999999  779999999999999999999999999987654322111112


Q ss_pred             cccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCC
Q 016917          238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT  316 (380)
Q Consensus       238 ~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (380)
                      ...++..|+|||++.+..++.++|||||||++|||++ |+.||.......  .......             .......+
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~~~-------------~~~~~~~~  337 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKMVK-------------RGYQMSRP  337 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHHHH-------------cccCccCC
Confidence            2334567999999998899999999999999999997 999997643211  1111111             11111222


Q ss_pred             HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          317 NEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       317 ~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                      ...++++.+++.+||+.||.+|||+.++++.|++++
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            234578999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-45  Score=323.63  Aligned_cols=263  Identities=23%  Similarity=0.338  Sum_probs=206.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCC-----CCChHHHHHHHHHHhcCCCCceeeeccceec-----CCe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQE-----NNL  144 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  144 (380)
                      ...|...+.||+|+||.|..+. ..+|..||+|+..     ....++..+|+.+|+.++|+||+.+.+.+..     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            3456667899999999999999 5578999999854     2234567899999999999999999998865     356


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .|+|+|+|+. +|...+     ..++.+.......+..|++.||+|+|+  .+++||||||+|+|++.++.+||||||+|
T Consensus       101 vYiV~elMet-DL~~ii-----k~~~~L~d~H~q~f~YQiLrgLKyiHS--AnViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  101 VYLVFELMET-DLHQII-----KSQQDLTDDHAQYFLYQILRGLKYIHS--ANVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eEEehhHHhh-HHHHHH-----HcCccccHHHHHHHHHHHHHhcchhhc--ccccccccchhheeeccCCCEEeccccce
Confidence            8999999965 888888     344558899999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCccceeccccc-ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      +.............+..|..|+|||.+ ....|+...||||+|||+.||++|++.|.+.+.-+.-.++-........+.+
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            988654333445678899999999975 4579999999999999999999999999887643332222222111111111


Q ss_pred             hhhcccc--------------c-ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 LKILDER--------------L-WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ~~~~~~~--------------~-~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..+-.+.              . ...++ ..++...+|+.+||..||.+|+|++|+|++
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            1111110              0 11122 455789999999999999999999999987

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.9e-44  Score=323.57  Aligned_cols=253  Identities=24%  Similarity=0.401  Sum_probs=203.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC----CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      .++|++.+.||+|+||.||+|..+    .+..||+|......    ...+.+|+.++++++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            456888999999999999999853    35689999865432    2357889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+++|+|.+++..    ....+++..++.++.|++.||+|||+  ++++||||||+|||++.++.++++|||.+...
T Consensus        84 v~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~i~~al~~lH~--~~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          84 VTEYMSNGALDSFLRK----HEGQLVAGQLMGMLPGLASGMKYLSE--MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEeCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            9999999999988842    23468899999999999999999999  77999999999999999999999999987654


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      ..... .......++..|+|||.+.+..++.++|||||||++||+++ |..||......   +....+.           
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~-----------  222 (266)
T cd05064         158 KSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAVE-----------  222 (266)
T ss_pred             cccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHH-----------
Confidence            22111 11122334567999999999999999999999999999775 99999765321   1111111           


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                        .......+..++..+.+++.+||+.||.+||+++++++.|.++
T Consensus       223 --~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         223 --DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --CCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence              1111233455678899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7e-44  Score=325.80  Aligned_cols=256  Identities=30%  Similarity=0.488  Sum_probs=206.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEECC------CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      ++|++.+.||+|+||.||+|....      ...|++|......    ...+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467888999999999999998532      2579999765433    345788999999999999999999999989999


Q ss_pred             EEEEeecCCCccccccCCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVS-----------RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI  215 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~  215 (380)
                      ++|||+++++|.+++.......           ...+++..++.++.|++.||.|||+  ++++|+||||+||++++++.
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccccceEEEcCCCc
Confidence            9999999999998885432211           1567888999999999999999999  77999999999999999999


Q ss_pred             eEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHH
Q 016917          216 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELV  294 (380)
Q Consensus       216 ~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~  294 (380)
                      ++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......   +....+
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~~i  239 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIEMI  239 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence            99999999876543332222333456778999999988899999999999999999998 99998765431   111111


Q ss_pred             HhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHh
Q 016917          295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  350 (380)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~  350 (380)
                      .             .......+..+++++.+++.+||+.||.+||++.+++++|++
T Consensus       240 ~-------------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         240 R-------------SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             H-------------cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            1             111223445677889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-45  Score=342.88  Aligned_cols=264  Identities=27%  Similarity=0.416  Sum_probs=215.3

Q ss_pred             HHHHHHhCCCCCCCeeccCCceEEEEEEECC--C---cEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccc
Q 016917           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQD--G---MLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGY  138 (380)
Q Consensus        70 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~--~---~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~  138 (380)
                      +.+++...+....++||+|+||.||+|+.+.  +   ..||+|....      ....++.+|.++|++++||||+++||+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3445555566667999999999999999543  2   2389997553      224568999999999999999999999


Q ss_pred             eecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEE
Q 016917          139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV  218 (380)
Q Consensus       139 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl  218 (380)
                      +.....+++|||+|.||+|.++|..    ....++..++..++.+.+.||+|||+  ++++||||..+|+|++.++.+||
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k----~~~~v~~~ek~~~~~~AA~Gl~YLh~--k~~IHRDIAARNcL~~~~~~vKI  303 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKK----NKKSLPTLEKLRFCYDAARGLEYLHS--KNCIHRDIAARNCLYSKKGVVKI  303 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHhHHHHHHH--CCCcchhHhHHHheecCCCeEEe
Confidence            9999999999999999999999942    23368999999999999999999999  66999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhh
Q 016917          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNS  297 (380)
Q Consensus       219 ~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~  297 (380)
                      +|||+++.-..  +........-+..|+|||.+....|++++|||||||++||+++ |..||.+....   +.       
T Consensus       304 SDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v-------  371 (474)
T KOG0194|consen  304 SDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EV-------  371 (474)
T ss_pred             CccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HH-------
Confidence            99999876431  1111112357788999999999999999999999999999999 88898876532   11       


Q ss_pred             hcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                           ..++.....+...+...+.++..++.+||..||++||+|.++.+.|+.+.....
T Consensus       372 -----~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  372 -----KAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             -----HHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                 112223344456666778889999999999999999999999999998887754

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.1e-44  Score=327.45  Aligned_cols=261  Identities=18%  Similarity=0.243  Sum_probs=199.7

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC-----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|+...     ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36889999999999999999965 678899997442     224567889999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |++++++..+.     .....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~-----~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLE-----EMPNGVPPEKVRSYIYQLIKAIHWCHK--NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            99987776543     223468889999999999999999999  67999999999999999999999999999876432


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc----------
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF----------  300 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------  300 (380)
                      .. .......++..|+|||++.+..++.++|||||||++|||++|+.||......+  .+..........          
T Consensus       154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         154 SN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID--QLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             cc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhhCCCCHHHHHhhhc
Confidence            21 12234568889999999998899999999999999999999999998654211  111110000000          


Q ss_pred             -cchhhhcccc------cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 -SNLLKILDER------LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 -~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       ........+.      .........+.++.+++.+||+.||++|||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             0000000000      0001112355779999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-44  Score=340.06  Aligned_cols=242  Identities=23%  Similarity=0.322  Sum_probs=205.7

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC------CCChHHHHHHHHHHhcC-CCCceeeeccceecCCe
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP------GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNL  144 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  144 (380)
                      ....++|...++||+|+||+|+++.. .+++.+|||..+      ....+..+.|..++... +||.+++++..|.+..+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            45567899999999999999999995 468899999644      34556778898888877 59999999999999999


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      +|.||||+.||++..+.      ..+.+++.....++..|+.||+|||+  ++||+||||.+|||+|.+|++||+|||++
T Consensus       444 l~fvmey~~Ggdm~~~~------~~~~F~e~rarfyaAev~l~L~fLH~--~~IIYRDlKLdNiLLD~eGh~kiADFGlc  515 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI------HTDVFSEPRARFYAAEVVLGLQFLHE--NGIIYRDLKLDNLLLDTEGHVKIADFGLC  515 (694)
T ss_pred             EEEEEEecCCCcEEEEE------ecccccHHHHHHHHHHHHHHHHHHHh--cCceeeecchhheEEcccCcEEecccccc
Confidence            99999999999966554      45778999999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      +....  .....+..+||+.|+|||++.+..|+..+|+|||||+||||+.|..||.+.++++.   .+-           
T Consensus       516 Ke~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~---Fds-----------  579 (694)
T KOG0694|consen  516 KEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV---FDS-----------  579 (694)
T ss_pred             cccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH-----------
Confidence            86432  22346778999999999999999999999999999999999999999998664322   111           


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM  341 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  341 (380)
                       ++...  ..+|..++.+...++.++|++||++|..+
T Consensus       580 -I~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  580 -IVNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -HhcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence             11111  24677788999999999999999999866

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.2e-44  Score=326.33  Aligned_cols=249  Identities=19%  Similarity=0.291  Sum_probs=199.8

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      .|+..+.||+|+||.||+|.. .+++.||+|.....      ....+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367789999999999999995 57899999975422      12346789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++|+|.+.+...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||+++++.++|+|||++......
T Consensus        81 ~~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          81 IMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             ecCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            99999998777422   23457889999999999999999999  77999999999999999999999999998765432


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      .   ......|+..|+|||++.+..++.++|||||||++|||++|+.||.........   +......          ..
T Consensus       156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~----------~~  219 (285)
T cd05631         156 E---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRV----------KE  219 (285)
T ss_pred             C---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHh----------hc
Confidence            1   123446889999999999999999999999999999999999999865432111   1111000          00


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  347 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~~ll~~  347 (380)
                      ....++...++++.+|+.+||+.||.+||+     +++++++
T Consensus       220 ~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         220 DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            111234445678999999999999999997     7888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-44  Score=331.10  Aligned_cols=242  Identities=21%  Similarity=0.266  Sum_probs=200.6

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||.||+|... +++.||+|.....      ..+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999964 6889999975422      2345788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++.     ....+++.....++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLR-----NSGRFSNSTGLFYASEIVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            9999999998883     34567888999999999999999999  7799999999999999999999999999886543


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      .     .....|++.|+|||++.+..++.++|||||||++|+|++|+.||......   .....+..            .
T Consensus       154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~~i~~------------~  213 (291)
T cd05612         154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYEKILA------------G  213 (291)
T ss_pred             C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh------------C
Confidence            1     22346888999999999999999999999999999999999999764321   11111110            0


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~~ll~~  347 (380)
                        ...++...++.+.+++.+||+.||.+||+     +++++++
T Consensus       214 --~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         214 --KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             --CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence              11233444678999999999999999995     8888876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=7e-44  Score=330.63  Aligned_cols=263  Identities=29%  Similarity=0.396  Sum_probs=214.1

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ..+...+.++||+|-||.|.+|....+..||+|+.....    +.+|.+|+++|.+|+||||+.++|+|..++.+++|+|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            344567789999999999999998888999999876543    4678999999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++|+|.+++.....   ..+......+|+.||+.||+||.+  -++|||||.++|+|++.++++||+|||+++.+-..
T Consensus       616 YmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes--~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLES--LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHh--hchhhccccccceeecCcccEEecCcccccccccC
Confidence            9999999999954322   224455667899999999999999  45999999999999999999999999999977665


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ++........-+..|||+|.+..+++++++|+|+||+++||+++  ...||+....+.   .++......+.      -.
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~------~~  761 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRD------QG  761 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCC------CC
Confidence            55544445566788999999999999999999999999999775  778888665321   11111111111      11


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                      .......|.-|+..+.+++..||+.|-++||+++++..+|.+.
T Consensus       762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1223456777889999999999999999999999999988764

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-44  Score=349.33  Aligned_cols=265  Identities=20%  Similarity=0.271  Sum_probs=213.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCC-cEEEEEeCCC---CChHHHHHHHHHHhcCC-CCceeeecc-ceec------CC
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDG-MLVAIKKRPG---APTQEFIDEVCFLASIQ-HRNLVTLLG-YCQE------NN  143 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~-~~vavK~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~------~~  143 (380)
                      ..++++.+.|.+|||+.||+|+...+ ..||+|++-.   ...+.+.+|+++|++|+ |+|||.+++ ....      .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            34567889999999999999996655 9999997433   33456789999999996 999999999 3321      13


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      +.+|+||||.||.|-|++....   ...|.+..+++|+.|+++|+.+||....+|||||||-+||||+.+++.||||||.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            5689999999999999995432   3449999999999999999999999888999999999999999999999999999


Q ss_pred             ccccCCCCCC-C------CCccccCccceeccccc---ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHH
Q 016917          224 RNFLGRTDVA-G------PSSQVTADEIFLASEVK---EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL  293 (380)
Q Consensus       224 a~~~~~~~~~-~------~~~~~~~~~~~~aPE~~---~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~  293 (380)
                      |.-....... .      ..-.-..|+.|+|||++   .+.++++|+|||+|||+||-|+....||+....         
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------  263 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------  263 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------
Confidence            8754321110 0      01122368889999975   577899999999999999999999999987532         


Q ss_pred             HHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhccccccc
Q 016917          294 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVM  362 (380)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~~~~~~  362 (380)
                                ..+++.++..+-.+.++..+.+||..||+.||.+||++-+++..+.++...+-...+..
T Consensus       264 ----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  264 ----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY  322 (738)
T ss_pred             ----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence                      23344444434445788999999999999999999999999999999888875544444

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.1e-44  Score=314.45  Aligned_cols=262  Identities=22%  Similarity=0.312  Sum_probs=203.5

Q ss_pred             CCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCCCh-H----HHHHHHHHHhcCCCCceeeecccee--cCCeeEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT-Q----EFIDEVCFLASIQHRNLVTLLGYCQ--ENNLQFLI  148 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~----~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv  148 (380)
                      ++|+.++.|++|+||.||+|+ .+++..||+|+.+.... +    ...+|+++|.+++|||||.+-.+..  +.+.+|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            457778999999999999999 56789999998654332 2    3579999999999999999988765  44679999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||++. +|...+...    .+.+...++..+..|++.|++|||+  +.|+|||||++|+|++..|.+||+|||+|+.++
T Consensus       156 Me~~Eh-DLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH~--~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLHD--NWILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHHHh-hHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHhh--ceeEecccchhheeeccCCcEEecccchhhhhc
Confidence            999988 787777432    3678999999999999999999999  669999999999999999999999999999886


Q ss_pred             CCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc---ccch-
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD---FSNL-  303 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~-  303 (380)
                      ..  .......+.|..|+|||.+.+ ..|++..|+||+|||+.||+++++.|.+..+.+.-+.+........   ++.. 
T Consensus       229 sp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  229 SP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             CC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            54  233456778999999998876 5789999999999999999999999988764333222211111110   0000 


Q ss_pred             -hhhc---------ccccccCCCHH-HHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 -LKIL---------DERLWSTFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 -~~~~---------~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       ....         -..++..|+.. .++.-.+|+..+|.+||.+|.|+++.|++
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence             0000         01122223322 45778999999999999999999999986

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.8e-43  Score=328.50  Aligned_cols=259  Identities=25%  Similarity=0.424  Sum_probs=205.5

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCc----EEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      ..+|+..+.||+|+||.||+|.+. ++.    .||+|......    .+.+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            457899999999999999999853 333    48999865332    35688899999999999999999998765 467


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +|+||+++|+|.+++..    ....+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~--~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          85 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeecCCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEecCCCcEEEcccccccc
Confidence            99999999999998843    23457888899999999999999999  7799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ...............+..|+|||.+.+..++.++|||||||++|||++ |..||......   +.....           
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~~~-----------  224 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSIL-----------  224 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH-----------
Confidence            654322212222334667999999999999999999999999999997 99998754321   111111           


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcc
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  357 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~  357 (380)
                        ........+..++.++.+++.+||..||.+||++.+++..|..+..++..
T Consensus       225 --~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~  274 (316)
T cd05108         225 --EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR  274 (316)
T ss_pred             --hCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCch
Confidence              11111223344557799999999999999999999999999998877643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.2e-43  Score=325.36  Aligned_cols=263  Identities=20%  Similarity=0.265  Sum_probs=197.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ..+|++.+.||+|+||.||+|... ++..||+|....    .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            356899999999999999999954 688999997542    223467789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++ +|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~~~-~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          84 YLDS-DLKQYLDN----CGNLMSMHNVKIFMFQLLRGLSYCHK--RKILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             CCCc-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            9985 88777732    23457888999999999999999999  77999999999999999999999999998765322


Q ss_pred             CCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc---------c
Q 016917          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD---------F  300 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------~  300 (380)
                      .  .......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||......+.............         .
T Consensus       157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         157 T--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             C--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence            1  12234467888999998865 5689999999999999999999999976543211111100000000         0


Q ss_pred             cchhhhcccccc----cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 SNLLKILDERLW----STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 ~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ........+...    .......+++..+++.+||+.||.+|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000000101000    00111245678999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-44  Score=332.85  Aligned_cols=249  Identities=23%  Similarity=0.348  Sum_probs=212.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC-----CCChHHHHHHHHHHhcCCCCceeeeccceecCCe-eEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNL-QFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv  148 (380)
                      ..+|...+++|+|+||.+++++++ ++..+++|+..     ...+....+|+.++++++|||||.+.+.+..++. .++|
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            356888999999999999999954 57789999633     2233467899999999999999999999998887 9999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |+|++||++.+.+...   +...+++..+..++.|++.|+.|||+  ++|+|||||+.||+++.++.|+|+|||+|+.+.
T Consensus        83 m~Y~eGg~l~~~i~~~---k~~~f~E~~i~~~~~Q~~~av~ylH~--~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQ---KGVLFPEERILKWFVQILLAVNYLHE--NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             EeecCCCCHHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHh--hhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence            9999999999988543   24678999999999999999999997  789999999999999999999999999999986


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ...  .......||+.|+.||.+.+.+|+.++|||||||++|||++-+++|...+..   .++..             +.
T Consensus       158 ~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~k-------------i~  219 (426)
T KOG0589|consen  158 PED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILK-------------IN  219 (426)
T ss_pred             Cch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHH-------------Hh
Confidence            543  2456788999999999999999999999999999999999999999876531   11111             11


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .....+.+...+.+++.+++.|++.+|..||++.++|.+
T Consensus       220 ~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  220 RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            222356677788999999999999999999999999986

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.7e-45  Score=323.22  Aligned_cols=266  Identities=24%  Similarity=0.370  Sum_probs=201.6

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCChHHHHHHHHHHhcCCCCceeeeccceecCC-----eeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----LQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~  151 (380)
                      .|...+++|+|+||.||+|.. .++..||||+.-+... .-.+|+++|+.++|||||++.-+|....     ...+||||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley  103 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY  103 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence            366679999999999999995 4578999998543322 2247999999999999999998875332     34579999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CceEEcccccccccCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRT  230 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~-~~~kl~DFgla~~~~~~  230 (380)
                      ++. +|...++... ..+..++...+.-+..|+.+||.|||+  .+|+||||||+|+|+|.+ |.+||||||+|+.+..+
T Consensus       104 mP~-tL~~~~r~~~-~~~~~mp~~~iKLYt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  104 MPE-TLYRVIRHYT-RANQRMPLLEIKLYTYQLFRGLAYLHS--HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             chH-HHHHHHHHHh-hcCCCCceeeeHHHHHHHHHHHHHHHh--cCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence            988 8887775322 235667777888899999999999999  679999999999999976 89999999999998653


Q ss_pred             CCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh--hhcccchhhh-
Q 016917          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN--SRDFSNLLKI-  306 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-  306 (380)
                      .   +...+..+..|+|||.+.| ..|+.+.||||.||++.||+-|++.|.+.+.  .+++.+.+.-  .+..+++... 
T Consensus       180 e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  180 E---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             C---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCCCHHHHhhcC
Confidence            3   4567889999999998776 5899999999999999999999999998543  3333333221  1111111110 


Q ss_pred             ----------cccccc-cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--HHhhhh
Q 016917          307 ----------LDERLW-STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRTLD  353 (380)
Q Consensus       307 ----------~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~--L~~~~~  353 (380)
                                +....+ .-+....+++..+|+.++|+++|.+|.++.|++.+  ++++..
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence                      011111 12445567889999999999999999999999965  444443

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.2e-44  Score=334.44  Aligned_cols=243  Identities=22%  Similarity=0.296  Sum_probs=200.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      ..+|++.+.||+|+||.||+|+.. +++.||+|....      ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            356888999999999999999964 688999997532      2345678999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+.+|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        97 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         97 LEFVVGGELFTHLR-----KAGRFPNDVAKFYHAELVLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             EcCCCCChHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            99999999998883     34567888889999999999999999  779999999999999999999999999998664


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ..     .....|++.|+|||++.+..++.++|||||||++|||++|..||....+   ....+.+.            .
T Consensus       170 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~------------~  229 (329)
T PTZ00263        170 DR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRIYEKIL------------A  229 (329)
T ss_pred             CC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHHHHHHh------------c
Confidence            32     2235688999999999999999999999999999999999999975432   11111111            1


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~~ll~~  347 (380)
                      ..  ..++...+..+.+++.+||+.||.+||+     +++++.+
T Consensus       230 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        230 GR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             CC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            11  1233345577899999999999999997     6888765

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-44  Score=300.08  Aligned_cols=247  Identities=23%  Similarity=0.322  Sum_probs=208.5

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      ..++|++.+.||+|-||.||+|+. +++-.||+|+..+      ....++.+|+++-..|+||||.++|++|.+....||
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            345788999999999999999994 5677899997432      334578899999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ++||..+|++...|...   ....+.+.....+..|+|.|+.|+|.  ++++||||||+|+|++.++.+|++|||.+-..
T Consensus       100 ilEya~~gel~k~L~~~---~~~~f~e~~~a~Yi~q~A~Al~y~h~--k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEG---RMKRFDEQRAATYIKQLANALLYCHL--KRVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEecCCchHHHHHHhc---ccccccccchhHHHHHHHHHHHHhcc--CCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            99999999999988532   34557777788899999999999999  78999999999999999999999999987653


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      .    .......+||..|.+||...+..++..+|+|++|++.||++.|.+||....   ..+.+..+...          
T Consensus       175 p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~----------  237 (281)
T KOG0580|consen  175 P----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKV----------  237 (281)
T ss_pred             C----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHc----------
Confidence            2    234567899999999999999999999999999999999999999998754   22222222211          


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                          ...+|...+.+..++|.+|+..+|.+|.+..|++++
T Consensus       238 ----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  238 ----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ----cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                123456677889999999999999999999999876

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-43  Score=318.96  Aligned_cols=270  Identities=27%  Similarity=0.394  Sum_probs=217.3

Q ss_pred             CCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcC--CCCceeeeccceecCC----eeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQENN----LQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~lv~e~  151 (380)
                      ..+..+.||+|+||.||+|+.. ++.||||+++....+.|..|-+|.+..  +|+||++|++.-....    .++||++|
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f  289 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF  289 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence            3455678999999999999986 589999999999999999999998764  8999999999876554    78999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-------SPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .+.|+|.++|      ....++|....+++..+++||+|||+.       .++|+|||||.+|||+.+|+++.|+|||+|
T Consensus       290 h~kGsL~dyL------~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  290 HPKGSLCDYL------KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             ccCCcHHHHH------HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            9999999999      456789999999999999999999974       467999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCccceecccccccCC-CC-----cchhhHHHHHHHHHHHcCCCCCCCCCCCCccc-HHHHHHhh
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FS-----EKSDVYSFGVFLLELVSGREASSSLSPDSSQD-LVELVQNS  297 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-----~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~  297 (380)
                      ..+..+...+......||..|||||++.+.. ..     .+.||||+|.+||||+++...+....+.+.+- ..+.+...
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            9988766666666789999999999988641 11     35899999999999999876654322222222 22244444


Q ss_pred             hcccchhhhc-ccccccCCCHH-----HHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          298 RDFSNLLKIL-DERLWSTFTNE-----GMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       298 ~~~~~~~~~~-~~~~~~~~~~~-----~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      +..+++...+ .++.++.++..     ...-+++.+..||..||+.|.|+.=+-+++.++..-
T Consensus       444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence            4444444432 33444444443     335689999999999999999999999998876643

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.2e-43  Score=336.59  Aligned_cols=264  Identities=23%  Similarity=0.363  Sum_probs=207.4

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcCC-CCceeeeccceec
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQ-HRNLVTLLGYCQE  141 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~  141 (380)
                      ....++|++.+.||+|+||.||+|+..      .+..||+|......    .+.+.+|+++++++. ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            344668899999999999999999853      13469999865432    356889999999996 9999999999999


Q ss_pred             CCeeEEEEEeecCCCccccccCCCC-------------------------------------------------------
Q 016917          142 NNLQFLIYEYIPNGSVSIHLYGPSQ-------------------------------------------------------  166 (380)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  166 (380)
                      .+..|+||||+++|+|.+++.....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            9999999999999999887743210                                                       


Q ss_pred             ------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 016917          167 ------------------------------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (380)
Q Consensus       167 ------------------------------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili  210 (380)
                                                          .....+++..+..++.|++.||.|||+  ++|+||||||+|||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dikp~Nill  270 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHhEEE
Confidence                                                001247788889999999999999999  779999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCccc
Q 016917          211 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQD  289 (380)
Q Consensus       211 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~  289 (380)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......  ..
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~  348 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--ST  348 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HH
Confidence            9999999999999886643222222233446678999999998899999999999999999997 88998754321  11


Q ss_pred             HHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhh
Q 016917          290 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  353 (380)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~  353 (380)
                      ....+.             .......+..++.++.+++.+||+.||++|||+.++.+.|+++++
T Consensus       349 ~~~~~~-------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         349 FYNKIK-------------SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHHHh-------------cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            111111             111122344566789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3e-43  Score=321.03  Aligned_cols=256  Identities=27%  Similarity=0.457  Sum_probs=205.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECC------CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      .++|.+.+.||+|+||.||+|...+      +..||+|......    .+.+.+|+++++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3467888999999999999998532      4789999865432    35688999999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCce
Q 016917          146 FLIYEYIPNGSVSIHLYGPS---------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  216 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~  216 (380)
                      ++||||+++++|.+++....         ......+++..+..++.|++.|+.|||+  ++++||||||+||+++.++.+
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS--QHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeeccccccceEEEcCCCeE
Confidence            99999999999999885432         1223557888999999999999999999  779999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHH
Q 016917          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ  295 (380)
Q Consensus       217 kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~  295 (380)
                      +|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......   ...+.+.
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~~~  238 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIECIT  238 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHH
Confidence            9999999876543322222233345678999999999999999999999999999998 99998754321   1222111


Q ss_pred             hhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                                   .......+...+..+.+++.+||+.||.+||++.|+++.|+
T Consensus       239 -------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         239 -------------QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -------------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                         11111223345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.4e-43  Score=329.63  Aligned_cols=260  Identities=20%  Similarity=0.273  Sum_probs=203.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      .++|++.+.||+|+||.||++... ++..+|+|.....    ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            467999999999999999999964 6788999975533    23468899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++++|.+++.     ....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          84 HMDGGSLDQVLK-----EAKRIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             cCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            999999999883     334578899999999999999999972 35999999999999999999999999998765432


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh-c----------
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-D----------  299 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~----------  299 (380)
                          ......++..|+|||.+.+..++.++|||||||++|||++|+.||......+   +...+.... .          
T Consensus       158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (331)
T cd06649         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSIS  230 (331)
T ss_pred             ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccC
Confidence                1234568889999999999999999999999999999999999997543211   111110000 0          


Q ss_pred             ----------------------ccchhhhcccccccCC-CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          300 ----------------------FSNLLKILDERLWSTF-TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       300 ----------------------~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                                            ...+...+........ ....++++.+|+.+||+.||++|||+++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                  0000000000001111 123567899999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.3e-43  Score=318.02  Aligned_cols=254  Identities=26%  Similarity=0.440  Sum_probs=205.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC--hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ..+|.+.+.||+|+||.||+|..+ .+..+++|......  ...+.+|+++++.++||||+++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            345778899999999999999954 58889999865443  356889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++...   ....+++..++.++.|++.||.|||+  ++++||||||+||++++++.+||+|||++........
T Consensus        85 ~~~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          85 TYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            999999988432   23567889999999999999999999  7799999999999999999999999999887654221


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                      . .......+..|+|||.+.+..++.++|||||||++|||++ |..||......   +......             ...
T Consensus       160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~~~-------------~~~  222 (263)
T cd05052         160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLE-------------KGY  222 (263)
T ss_pred             e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH-------------CCC
Confidence            1 1122234567999999999999999999999999999998 88998754321   1111111             111


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                      ....+..++.++.+++.+||+.||++|||+.++++.|+.+
T Consensus       223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            2233445668899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-43  Score=316.81  Aligned_cols=255  Identities=25%  Similarity=0.442  Sum_probs=207.0

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ..++|++.+.||+|++|.||+|...++..||+|.....  ..+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            34568889999999999999999877888999986543  3467889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++...   ....+++..+..++.|++.|+.|||+  ++++||||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          84 KYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEA--QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999988432   23467899999999999999999999  7799999999999999999999999999987653221


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                      . .......+..|+|||...+..++.++|+||||+++|||++ |+.||.....   ......+.             ...
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~-------------~~~  221 (261)
T cd05068         159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQVD-------------QGY  221 (261)
T ss_pred             c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH-------------cCC
Confidence            1 1122223457999999998999999999999999999999 9999875432   11111111             111


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                      ....+..++..+.+++.+||+.||.+||++.++++.|+++
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            1123344567899999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.4e-43  Score=315.92  Aligned_cols=249  Identities=24%  Similarity=0.419  Sum_probs=201.7

Q ss_pred             CCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      ++|++.+.||+|+||.||++..+++..+|+|.....  ....+.+|++++++++||||+++++++...+..++||||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            457788999999999999999888889999975533  346788999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |+|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||.++........ 
T Consensus        84 ~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          84 GCLLNYLRQ----RQGKLSKDMLLSMCQDVCEGMEYLER--NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            999988742    22457889999999999999999999  77999999999999999999999999998865432221 


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccccc
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  313 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (380)
                      ......++..|+|||.+.+..++.++|+||||+++|||++ |+.||.....   .+....+....             +.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~~~-------------~~  220 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISRGF-------------RL  220 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCC-------------CC
Confidence            1122335567999999998899999999999999999999 8999875432   11222211110             11


Q ss_pred             CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       314 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      ..+...+..+.+++.+||+.||.+||+++++++.|
T Consensus       221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            12223346799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.7e-43  Score=329.91  Aligned_cols=263  Identities=24%  Similarity=0.383  Sum_probs=204.9

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeeeccceec-C
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQE-N  142 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~  142 (380)
                      ..++|++.+.||+|+||.||+|...      +++.||+|+.....    .+.+.+|++++.++ +|+||+++++++.. .
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            4457899999999999999999632      24789999865432    23567899999999 89999999998764 4


Q ss_pred             CeeEEEEEeecCCCccccccCCCCC-------------------------------------------------------
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQV-------------------------------------------------------  167 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------  167 (380)
                      ...++++||+++++|.+++......                                                       
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            5678999999999998887432110                                                       


Q ss_pred             -CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccee
Q 016917          168 -SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL  246 (380)
Q Consensus       168 -~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~  246 (380)
                       ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||++..+.............++..|+
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             01367889999999999999999999  779999999999999999999999999998764322222222344567799


Q ss_pred             cccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHH
Q 016917          247 ASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQ  325 (380)
Q Consensus       247 aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  325 (380)
                      |||++.+..++.++|||||||++|||++ |..||......+  .+...+.             .......+...++++.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~~~~-------------~~~~~~~~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRRLK-------------EGTRMRAPEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHHHHh-------------ccCCCCCCccCCHHHHH
Confidence            9999999999999999999999999998 999987643221  1111111             11111223344577999


Q ss_pred             HHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          326 LIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       326 li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      ++.+||+.+|++||++.+++++|+++++.
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.8e-44  Score=332.27  Aligned_cols=239  Identities=23%  Similarity=0.270  Sum_probs=195.7

Q ss_pred             CeeccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCC
Q 016917           83 NLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  155 (380)
                      +.||+|+||.||+|.. .+++.||+|.....      ....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999995 56889999975432      2345678999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016917          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (380)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~  235 (380)
                      +|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~  151 (323)
T cd05571          81 ELFFHLS-----RERVFSEDRARFYGAEIVSALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GAT  151 (323)
T ss_pred             cHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCc
Confidence            9988883     34568899999999999999999999  67999999999999999999999999998753221  112


Q ss_pred             CccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCC
Q 016917          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF  315 (380)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (380)
                      .....||..|+|||++.+..|+.++|||||||++|||++|+.||.....   ......+.            ..  ...+
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~~~------------~~--~~~~  214 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELIL------------ME--EIRF  214 (323)
T ss_pred             ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHHHH------------cC--CCCC
Confidence            2345689999999999999999999999999999999999999975432   11111111            00  0133


Q ss_pred             CHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          316 TNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       316 ~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                      +...++++.+++.+||+.||++||     ++.+++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            445567899999999999999999     79998865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.9e-43  Score=317.97  Aligned_cols=255  Identities=26%  Similarity=0.450  Sum_probs=206.8

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ..++|++.++||+|+||.||+|...++..|++|.....  ..+.+.+|+.+++.++|+||+++++.+...+..+++|||+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            34578889999999999999999888889999976533  3467889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++...   ....+++..+..++.|++.||+|||+  .+++||||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          84 AKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            999999988432   23567888899999999999999999  7799999999999999999999999999987654322


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                      . ......++..|+|||...+..++.++|||||||++|+|++ |..||......   .....+....             
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~-------------  221 (261)
T cd05072         159 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQRGY-------------  221 (261)
T ss_pred             e-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHHHcCC-------------
Confidence            1 1223345667999999988889999999999999999998 99998754321   1111111111             


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                      ..+....++.++.+++.+||+.||++||+++++.+.|+++
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         222 RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            1122233557799999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.2e-43  Score=317.57  Aligned_cols=253  Identities=29%  Similarity=0.492  Sum_probs=208.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ..+|++.+.||+|+||.||+|...++..+++|......   .+.+..|+.+++.++||||+++++++...+..++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            45688889999999999999998889999999865443   456889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++...   ....+++..+..++.|++.|+.|||+  ++++|+||||+||++++++.+||+|||++........
T Consensus        85 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          85 EKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            999999998532   23567899999999999999999999  7799999999999999999999999999987644222


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                      .  .....++..|+|||...+..++.++||||||+++|+|++ |+.||.....   .+......             ...
T Consensus       160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~-------------~~~  221 (261)
T cd05148         160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQIT-------------AGY  221 (261)
T ss_pred             c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHH-------------hCC
Confidence            1  123345678999999988899999999999999999998 8999875431   11111111             111


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                      ....+..+++.+.+++.+||+.||.+|||++++++.|+.+
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            2233455667899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=331.94  Aligned_cols=250  Identities=23%  Similarity=0.335  Sum_probs=202.2

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||.||+|... +++.||+|.....      ....+..|++++..++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46888999999999999999965 5889999975432      2345788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLN-----NLGVLSEDHARFYMAEMFEAVDALHE--LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            9999999999883     34567889999999999999999999  6799999999999999999999999999876533


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                           ......||..|+|||++.+..++.++|||||||++|||++|..||......   +....+....   .   .+..
T Consensus       154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~---~---~~~~  219 (333)
T cd05600         154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN---ETWENLKYWK---E---TLQR  219 (333)
T ss_pred             -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH---HHHHHHHhcc---c---cccC
Confidence                 234456889999999999999999999999999999999999999764421   1111111100   0   0000


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..........++++.+++.+||..+|.+||++.+++++
T Consensus       220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            00011112346789999999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-43  Score=315.86  Aligned_cols=254  Identities=22%  Similarity=0.246  Sum_probs=207.7

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCCh------HHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      +..+.|+..+.||+|.-|+||+++.+ ++..+|+|.+++...      .+...|-+||+.++||.++.||..++..+..|
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC  153 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence            34456777899999999999999965 468999998765432      34667999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +|||||+||+|...+.   ....+.+++..+..++..++.||+|||.  -|||+|||||+||||-++|++.|+||.++..
T Consensus       154 l~meyCpGGdL~~Lrq---kQp~~~fse~~aRFYaAEvl~ALEYLHm--lGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQ---KQPGKRFSESAARFYAAEVLLALEYLHM--LGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             EEEecCCCccHHHHHh---hCCCCccchhhHHHHHHHHHHHHHHHHh--hceeeccCCcceeEEecCCcEEeeecccccc
Confidence            9999999999987763   2356789999999999999999999999  5699999999999999999999999998643


Q ss_pred             cCC---------------------------------CCC---------------------CCCCccccCccceecccccc
Q 016917          227 LGR---------------------------------TDV---------------------AGPSSQVTADEIFLASEVKE  252 (380)
Q Consensus       227 ~~~---------------------------------~~~---------------------~~~~~~~~~~~~~~aPE~~~  252 (380)
                      ..-                                 ...                     .......+||..|+|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            210                                 000                     01123567999999999999


Q ss_pred             cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccC
Q 016917          253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLD  332 (380)
Q Consensus       253 ~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  332 (380)
                      |.+.+.++|+|+||++||||++|..||.+....               +.+..++...+.-+..++.+..++|||.++|.
T Consensus       309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~---------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLv  373 (459)
T KOG0610|consen  309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK---------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLV  373 (459)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch---------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhc
Confidence            999999999999999999999999999987642               23344444444334444677889999999999


Q ss_pred             CCCCCCCC----HHHHHHH
Q 016917          333 PSSERRPS----MSDVVTE  347 (380)
Q Consensus       333 ~dp~~Rpt----~~~ll~~  347 (380)
                      +||++|..    +.||.+|
T Consensus       374 KdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  374 KDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             cChhhhhccccchHHhhcC
Confidence            99999998    6666554

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1e-42  Score=319.36  Aligned_cols=259  Identities=27%  Similarity=0.425  Sum_probs=205.2

Q ss_pred             CCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      +|++.+.||+|+||.||+|...      ....+++|......    ...+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999853      22468888765432    2457889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 016917          148 IYEYIPNGSVSIHLYGPSQ-------------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~-------------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Ni  208 (380)
                      ++||+.+++|.+++.....                   .....+++..++.++.|++.||.|||+  .+++||||||+||
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~ivH~dikp~ni  158 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE--MKLVHRDLAARNV  158 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH--CCeehhhhhhheE
Confidence            9999999999988753211                   112457889999999999999999998  7799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCc
Q 016917          209 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSS  287 (380)
Q Consensus       209 li~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~  287 (380)
                      |+++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....+.  
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--  236 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE--  236 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence            999999999999999876543222112223345667999999988899999999999999999998 99998754321  


Q ss_pred             ccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          288 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                       .+.+..             ........+..++.++.+++.+||+.||++||++.++++.|++++.+
T Consensus       237 -~~~~~~-------------~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         237 -RLFNLL-------------KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             -HHHHHH-------------hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence             111111             11112223344567899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8.7e-43  Score=319.60  Aligned_cols=261  Identities=26%  Similarity=0.438  Sum_probs=207.1

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      ..+|.+.+.||+|+||.||++...      ++..+++|......   .+.+.+|++++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            456888899999999999999842      34568899765433   346889999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEE
Q 016917          147 LIYEYIPNGSVSIHLYGPSQ--------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV  218 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl  218 (380)
                      +||||+++++|.+++.....        .....+++..++.++.|++.||.|||+  ++++||||||+||++++++.++|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~--~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCCcEEe
Confidence            99999999999988853221        123458999999999999999999999  77999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhh
Q 016917          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNS  297 (380)
Q Consensus       219 ~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~  297 (380)
                      +|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......   .....+...
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~~i~~~  238 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECITQG  238 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC
Confidence            99999886643322222223345678999999998999999999999999999998 89988754421   111111111


Q ss_pred             hcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      .             ....+...+.++.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       239 ~-------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         239 R-------------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             C-------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            0             0112223456799999999999999999999999999888754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-42  Score=314.77  Aligned_cols=255  Identities=27%  Similarity=0.468  Sum_probs=205.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECC----CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      .++|++.+.||+|+||.||+|....    ...|++|......    ...+.+|+.+++.++||||+++++.+...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3568889999999999999998642    4579999865432    3467889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+++++|.+++..    ....+++..+..++.|++.|+.|||+  ++|+|+||||+||++++++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          83 ITEYMENGSLDKFLRE----NDGKFTVGQLVGMLRGIASGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEcCCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            9999999999998843    23468899999999999999999999  77999999999999999999999999999877


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ......+..          
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~----------  223 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVED----------  223 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHc----------
Confidence            52221111223345677999999998999999999999999999998 9999865432   111111111          


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                         ....+.+..+++.+.+++.+||+.||++||++.+++++|++++
T Consensus       224 ---~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         224 ---GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence               1111223445678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.5e-43  Score=332.58  Aligned_cols=261  Identities=19%  Similarity=0.212  Sum_probs=198.4

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeec
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      ...+|++.+.||+|+||.||+|.. .+++.||+|...   ...+.+|++++++++||||+++++++......++|+|++.
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  166 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK  166 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence            346799999999999999999995 568899999743   3457789999999999999999999999999999999986


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                       ++|..++.     ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus       167 -~~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~ylH~--~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~  237 (391)
T PHA03212        167 -TDLYCYLA-----AKRNIAICDILAIERSVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A  237 (391)
T ss_pred             -CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence             57777763     33567899999999999999999999  679999999999999999999999999987543211 1


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcc-----cHHHHHHhhhc----c----
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-----DLVELVQNSRD----F----  300 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~----~----  300 (380)
                      .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.........     .+...+.....    +    
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            1223457899999999999999999999999999999999999887543321111     11111110000    0    


Q ss_pred             -cchhhhc----c-----cccccC--CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 -SNLLKIL----D-----ERLWST--FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 -~~~~~~~----~-----~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       ..+....    .     +..+..  .....+.++.+++.+||+.||.+|||++|++++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             0000000    0     000000  001345689999999999999999999999975

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.2e-42  Score=319.07  Aligned_cols=261  Identities=25%  Similarity=0.432  Sum_probs=208.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCCh---HHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      .++|.+.+.||+|+||.||+|...      ++..+++|.......   +.+.+|++++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            345778899999999999999842      345688898665443   46889999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI  215 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~  215 (380)
                      +||||+++++|.+++.....           .....+++..++.++.|++.|+.|||+  ++|+||||||+||+++.++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS--QHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCCc
Confidence            99999999999998854321           123458899999999999999999999  77999999999999999999


Q ss_pred             eEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHH
Q 016917          216 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELV  294 (380)
Q Consensus       216 ~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~  294 (380)
                      ++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......   ...+..
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~  238 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIECI  238 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence            99999999876544322222233456778999999999999999999999999999998 99998764421   111111


Q ss_pred             HhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      .             .......+..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       239 ~-------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         239 T-------------QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             h-------------CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            1             1111122334567799999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2e-43  Score=330.94  Aligned_cols=243  Identities=19%  Similarity=0.258  Sum_probs=199.9

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECC--CcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQD--GMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~--~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      .++|++.+.||+|+||.||+|....  +..||+|...      ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4568889999999999999998543  3689999743      2234567889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++...
T Consensus       109 v~Ey~~~g~L~~~i~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        109 VLEFVIGGEFFTFLR-----RNKRFPNDVGCFYAAQIVLIFEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            999999999999883     34568899999999999999999999  77999999999999999999999999999865


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      ...     .....||+.|+|||++.+..++.++|||||||++|||++|..||....+.   .....+.            
T Consensus       182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~~i~------------  241 (340)
T PTZ00426        182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIYQKIL------------  241 (340)
T ss_pred             CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHHHHHh------------
Confidence            331     23456899999999999989999999999999999999999999864321   1111111            


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                      ...  ..++...++.+.+++.+||+.||.+|+     ++++++++
T Consensus       242 ~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        242 EGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             cCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            110  123344556789999999999999995     88888876

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.7e-43  Score=342.07  Aligned_cols=251  Identities=20%  Similarity=0.238  Sum_probs=201.6

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-C-CcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-D-GMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~-~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      .|.+.+.||+|+||.||+|... + +..|++|......   ...+..|+.+++.++||||+++++++...+..|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3888899999999999999843 3 5778888654332   234678999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++|+|.+++.... .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.......
T Consensus       148 ~gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            9999988774321 124467888999999999999999999  7799999999999999999999999999987654332


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ......+.            .. ..
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~~~~~------------~~-~~  288 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---REIMQQVL------------YG-KY  288 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH------------hC-CC
Confidence            2233456689999999999999999999999999999999999999975331   11111110            00 11


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..++..++.++.+++.+||+.||++||++.+++.+
T Consensus       289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            12334456789999999999999999999998753

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.6e-43  Score=318.10  Aligned_cols=257  Identities=24%  Similarity=0.387  Sum_probs=202.4

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCe
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  144 (380)
                      ..++|++.+.||+|+||.||+|...      .+..||+|......    ..++.+|+.+++.++||||+++++++..+..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567899999999999999998753      24679999764322    2357889999999999999999999999999


Q ss_pred             eEEEEEeecCCCccccccCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQV-----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  219 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~  219 (380)
                      .++||||+++++|.+++......     ....+++..+..++.|++.||.|||+  ++++||||||+||++++++.++|+
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCcchheEEEcCCCCEEEC
Confidence            99999999999999888432211     12345778889999999999999999  779999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhh
Q 016917          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR  298 (380)
Q Consensus       220 DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  298 (380)
                      |||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.....   .........  
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~~~~~--  236 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLRFVME--  236 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc--
Confidence            9999876544332222223345678999999998899999999999999999999 6888875432   111111111  


Q ss_pred             cccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                                 ......+..+++.+.+++.+||+.||++|||+.++++.|+
T Consensus       237 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         237 -----------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -----------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                       0111233445678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.5e-42  Score=317.12  Aligned_cols=256  Identities=29%  Similarity=0.461  Sum_probs=202.9

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-----CCCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      .+|++.+.||+|+||.||+|..     ..+..+++|......    ...+.+|+++++.++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4677889999999999999984     245789999865332    2457889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc
Q 016917          148 IYEYIPNGSVSIHLYGPSQ------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI  215 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~  215 (380)
                      ||||+++++|.+++.....            .....+++...+.++.|++.||.|||+  ++++||||||+|||+++++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--cCeehhccccceEEEcCCCc
Confidence            9999999999988742211            112357888899999999999999999  77999999999999999999


Q ss_pred             eEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHH
Q 016917          216 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELV  294 (380)
Q Consensus       216 ~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~  294 (380)
                      +||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.....   ....+.+
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~~  239 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEMV  239 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH
Confidence            99999999987643322222233445677999999988889999999999999999998 8889875432   1111111


Q ss_pred             HhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHh
Q 016917          295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  350 (380)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~  350 (380)
                      ..             ......+..+++.+.+++.+||+.||.+||++.+++++|..
T Consensus       240 ~~-------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         240 RK-------------RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             Hc-------------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11             11122334556789999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2e-42  Score=310.76  Aligned_cols=245  Identities=28%  Similarity=0.453  Sum_probs=195.7

Q ss_pred             CeeccCCceEEEEEEE-CCCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCc
Q 016917           83 NLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  157 (380)
                      +.||+|+||.||+|.. .+++.+|+|......    ...+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            3699999999999995 478899999754332    34688999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016917          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  237 (380)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~  237 (380)
                      .+++..    ....+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++.............
T Consensus        81 ~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRT----EGPRLKVKELIQMVENAAAGMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            998832    23457889999999999999999999  779999999999999999999999999987654322111111


Q ss_pred             cccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCC
Q 016917          238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT  316 (380)
Q Consensus       238 ~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (380)
                      ....+..|+|||.+.+..++.++|||||||++|||++ |..||......   .....             .........+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~~-------------~~~~~~~~~~  218 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTREA-------------IEQGVRLPCP  218 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHHH-------------HHcCCCCCCc
Confidence            2223456999999998899999999999999999998 88888654321   11111             1111122334


Q ss_pred             HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          317 NEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       317 ~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                      ..++..+.+++.+||+.||++|||+.++++.|+
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            455678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=331.11  Aligned_cols=265  Identities=25%  Similarity=0.426  Sum_probs=229.7

Q ss_pred             HHHHHHhCCCCCCCeeccCCceEEEEEEECC-CcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        70 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      ++++....+....++||-|.||.||.|.|+. ...||||.++..  ..++|+.|..+|+.++|||+|+++|+|.....+|
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            5666666677778999999999999999764 668999976654  5678999999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      ||+|||..|+|.++|+..   ++..++.-.++.++.||..||.||..  +++|||||..+|+|+.++..+|++|||+++.
T Consensus       340 IiTEfM~yGNLLdYLRec---nr~ev~avvLlyMAtQIsSaMeYLEk--knFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLREC---NRSEVPAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEecccCccHHHHHHHh---chhhcchhHHHHHHHHHHHHHHHHHH--hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            999999999999999643   45667777788999999999999999  7799999999999999999999999999999


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      +..+ .........-+..|.|||.+..+.++.++|||+|||+|||+.| |-.||.+.+                ...+..
T Consensus       415 MtgD-TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid----------------lSqVY~  477 (1157)
T KOG4278|consen  415 MTGD-TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID----------------LSQVYG  477 (1157)
T ss_pred             hcCC-ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc----------------HHHHHH
Confidence            8663 3333455566788999999999999999999999999999998 778888755                234455


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                      ++....+...|..|++.+++||..||+++|.+||++.|+-+.++.++....
T Consensus       478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS  528 (1157)
T KOG4278|consen  478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS  528 (1157)
T ss_pred             HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence            566667778889999999999999999999999999999999999886643

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.2e-43  Score=329.70  Aligned_cols=262  Identities=19%  Similarity=0.301  Sum_probs=193.8

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC-----CChHHHHHHHHHHhcCCCCceeeeccceecC-----CeeE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NLQF  146 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  146 (380)
                      +|++.+.||+|+||.||+|.. .++..||+|....     .....+.+|+++++.++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            478889999999999999995 4689999997542     2234578899999999999999999987543     3479


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +||||+. ++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIK-----ANDDLTPEHHQFFLYQLLRALKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHH-----hcccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999996 57887773     34568899999999999999999999  6799999999999999999999999999876


Q ss_pred             cCCCCC-CCCCccccCccceeccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc--
Q 016917          227 LGRTDV-AGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS--  301 (380)
Q Consensus       227 ~~~~~~-~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--  301 (380)
                      ...... ........+|..|+|||++.+  ..++.++|||||||++|||++|+.||......................  
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            533221 112234578999999999875  678999999999999999999999997644211100000000000000  


Q ss_pred             ---------chhhhcccccccCCC---HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 ---------NLLKILDERLWSTFT---NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 ---------~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                               .............+.   ...++.+.+++.+||+.||++|||+++++++
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                     000000000000000   1234678999999999999999999999976

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3e-42  Score=313.15  Aligned_cols=254  Identities=23%  Similarity=0.389  Sum_probs=197.2

Q ss_pred             CCCCeeccCCceEEEEEEECCC---cEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecC------Cee
Q 016917           80 SDKNLIGEGKFGEVYKGLLQDG---MLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------NLQ  145 (380)
Q Consensus        80 ~~~~~ig~G~~g~V~~~~~~~~---~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  145 (380)
                      .+.+.||+|+||.||+|.....   ..+|+|.....     ..+.+.+|.++++.++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            4568899999999999996543   26899975432     234678899999999999999999987432      246


Q ss_pred             EEEEEeecCCCccccccCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPS-QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      +++|||+.+|+|.+++.... ......+++.....++.|++.||.|||+  ++|+||||||+|||+++++.++|+|||++
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhheEEcCCCCEEECCCCcc
Confidence            89999999999988774322 1233457899999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      +...............++..|+|||...+..++.++|||||||++|||++ |..||.....   ....+.+....     
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~-----  231 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYLRQGN-----  231 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHcCC-----
Confidence            87654332222223345677999999999999999999999999999999 7888875332   12222111111     


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                              ....+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus       232 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 --------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                    1122334567799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.6e-43  Score=320.29  Aligned_cols=261  Identities=27%  Similarity=0.465  Sum_probs=206.8

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeeeccceecC
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQEN  142 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  142 (380)
                      ...++|+..+.||+|+||.||++...      ....+|+|......    ...+.+|+++++++ +|+||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            34456888899999999999999853      23678999765432    23577899999999 899999999999999


Q ss_pred             CeeEEEEEeecCCCccccccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD  211 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~  211 (380)
                      +..+++|||+++|+|..++.....           .....+++..++.++.|++.||+|||+  ++|+||||||+||+++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~Nil~~  166 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLVT  166 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCccccccceeeEEEc
Confidence            999999999999999988853210           234568899999999999999999998  7799999999999999


Q ss_pred             CCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccH
Q 016917          212 EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDL  290 (380)
Q Consensus       212 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~  290 (380)
                      .++.+||+|||+++.+.............++..|+|||...+..++.++|||||||++|||++ |..||......   +.
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~  243 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---EL  243 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---HH
Confidence            999999999999987654332222222334567999999988899999999999999999998 88888754321   11


Q ss_pred             HHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          291 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                      ....             ........+..++..+.+++.+||..||++|||+.++++.|+.++
T Consensus       244 ~~~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         244 FKLL-------------KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHH-------------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            1111             111112334455678999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.5e-41  Score=359.64  Aligned_cols=264  Identities=26%  Similarity=0.453  Sum_probs=208.5

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCC
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  155 (380)
                      ..|...+.||+|+||.||+|.. .++..||+|....... ....|++.+++++||||+++++++.+.+..++||||+++|
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g  768 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK  768 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCC
Confidence            4577888999999999999996 5789999998654322 2345789999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      +|.+++.        .++|..+..++.|++.|++|||.. .++|+||||||+||+++.++..++. ||.......     
T Consensus       769 ~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----  834 (968)
T PLN00113        769 NLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----  834 (968)
T ss_pred             cHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence            9999882        378899999999999999999943 3689999999999999998888775 665443211     


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccccc-
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS-  313 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  313 (380)
                       .....++..|+|||++.+..|+.++|||||||++|||+||+.||..... ......++.+............++.... 
T Consensus       835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCC
Confidence             1223577889999999999999999999999999999999999854322 2334455544333223333444444422 


Q ss_pred             -CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcc
Q 016917          314 -TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  357 (380)
Q Consensus       314 -~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~  357 (380)
                       ..+.....++.+++.+||+.||++|||+.++++.|+++.+....
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~  957 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS  957 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccc
Confidence             33455667889999999999999999999999999988765443

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.8e-42  Score=314.84  Aligned_cols=256  Identities=27%  Similarity=0.425  Sum_probs=201.3

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCc----EEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      ++|++.+.||+|+||.||+|... ++.    .+++|......    ..++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46788899999999999999953 343    47788754332    2456677888999999999999998764 45688


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ++||+++|+|.+++..    ....+++..+..++.|++.||.|||+  ++++||||||+|||++.++.+||+|||+++..
T Consensus        86 i~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ----HRDSLDPQRLLNWCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            9999999999999842    23568899999999999999999999  77999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      .............++..|+|||.+.+..++.++|||||||++|||++ |..||....+..   ..+.+..          
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~----------  226 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDLLEK----------  226 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHC----------
Confidence            43322222234456778999999998899999999999999999998 999987654211   1111111          


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                         ......+..++.++.+++.+||..||.+|||+.++++.|..+.++.
T Consensus       227 ---~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         227 ---GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             ---CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence               1111122234567899999999999999999999999998887654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-42  Score=312.28  Aligned_cols=249  Identities=28%  Similarity=0.446  Sum_probs=201.8

Q ss_pred             CCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      .+|++.+.||+|+||.||+|..+++..+++|.....  ..+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            357788999999999999999877788999986543  345788999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      ++|.+++..    ....+++..++.++.|++.|+.|||+  ++++||||||+||++++++.+||+|||+++...+.... 
T Consensus        84 ~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-  156 (256)
T cd05059          84 GCLLNYLRE----RKGKLGTEWLLDMCSDVCEAMEYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-  156 (256)
T ss_pred             CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence            999998842    23367899999999999999999999  77999999999999999999999999998765432211 


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccccc
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  313 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (380)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......   +....+.             .....
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~-------------~~~~~  220 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVESVS-------------AGYRL  220 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHHHH-------------cCCcC
Confidence            1112223457999999998999999999999999999999 88898754321   1111111             11112


Q ss_pred             CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       314 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      ..+..++.++.+++.+||..+|++|||+.++++.|
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            23334667899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.1e-43  Score=341.85  Aligned_cols=254  Identities=20%  Similarity=0.317  Sum_probs=203.6

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCC-----
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----  143 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  143 (380)
                      ..++|++.+.||+|+||+||+|.. .+++.||+|.....     ....+.+|+.++..++|+||+++.+.+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            346899999999999999999984 57899999975432     2345778999999999999999988765332     


Q ss_pred             ---eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcc
Q 016917          144 ---LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  220 (380)
Q Consensus       144 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~D  220 (380)
                         ..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~--~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHS--KHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEeCCCCEEEEe
Confidence               36899999999999988854322 34568899999999999999999999  7799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc
Q 016917          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF  300 (380)
Q Consensus       221 Fgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  300 (380)
                      ||+++...............||+.|+|||++.+..|+.++|||||||++|||++|+.||.....      .+.....   
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~---  257 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKT---  257 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHH---
Confidence            9999876543322333456789999999999999999999999999999999999999975431      1111111   


Q ss_pred             cchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                            .. ......+...++++.+++.+||+.||.+||++.+++++
T Consensus       258 ------~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        258 ------LA-GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ------hc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                  00 11123445567889999999999999999999999875

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-42  Score=312.76  Aligned_cols=249  Identities=27%  Similarity=0.441  Sum_probs=201.1

Q ss_pred             CCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      ++|++.+.||+|+||.||+|...++..+|+|.....  ..+.+.+|+.++++++||||+++++++...+..++||||+.+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            457888999999999999999877777999976543  345789999999999999999999999988889999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |+|.+++..    ....+++..++.++.|++.||.|||+  ++++|+||||+||+++.++.+||+|||.++........ 
T Consensus        84 ~~l~~~i~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          84 GCLLNYLRE----HGKRFQPSQLLEMCKDVCEGMAYLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            999998842    22367899999999999999999999  77999999999999999999999999998765432211 


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccccc
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  313 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (380)
                      ......++..|+|||...+..++.++||||||+++|+|++ |..||......   .....+...             .+.
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~-------------~~~  220 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKVSQG-------------LRL  220 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHhcC-------------CCC
Confidence            1122345667999999998889999999999999999998 99998754421   111111110             111


Q ss_pred             CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       314 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      ..+...+..+.+++.+||+.||.+||++.++++.|
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence            12223457899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.1e-43  Score=326.97  Aligned_cols=239  Identities=23%  Similarity=0.277  Sum_probs=194.6

Q ss_pred             CeeccCCceEEEEEEE-CCCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCC
Q 016917           83 NLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  155 (380)
                      +.||+|+||.||++.. .++..||+|....      .....+.+|+.+++.++||||+++++.+...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999995 4689999997542      22345678999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016917          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (380)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~  235 (380)
                      +|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||++.......  ..
T Consensus        81 ~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  151 (323)
T cd05595          81 ELFFHLS-----RERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT  151 (323)
T ss_pred             cHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence            9988773     34568899999999999999999999  779999999999999999999999999987532211  11


Q ss_pred             CccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCC
Q 016917          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF  315 (380)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (380)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......   .....+.            ...  ..+
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~~~------------~~~--~~~  214 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELIL------------MEE--IRF  214 (323)
T ss_pred             cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHh------------cCC--CCC
Confidence            23456889999999999999999999999999999999999999764321   1111110            000  123


Q ss_pred             CHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          316 TNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       316 ~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                      +...++++.+++.+||+.||++||     ++.+++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            445567899999999999999998     88888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.5e-42  Score=316.18  Aligned_cols=256  Identities=24%  Similarity=0.379  Sum_probs=202.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      .++|++.+.||+|++|.||+|...      .+..|++|......    ...+..|+.+++.++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            456888999999999999999964      35688999765332    23588899999999999999999999988899


Q ss_pred             EEEEEeecCCCccccccCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC---ceEEcc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVAD  220 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~---~~kl~D  220 (380)
                      ++||||+++++|.+++.....  .....+++..+..++.|++.||.|||+  ++++||||||+||+++.++   .+||+|
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE--NHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchheEEEeccCCCcceEecc
Confidence            999999999999998854321  122358899999999999999999999  6799999999999998654   699999


Q ss_pred             cccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhc
Q 016917          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRD  299 (380)
Q Consensus       221 Fgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  299 (380)
                      ||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |..||......   .....+.    
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~~----  235 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFVT----  235 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH----
Confidence            999987643322222222233567999999998899999999999999999997 99998754321   1111111    


Q ss_pred             ccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          300 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                               .......+..++..+.+++.+||+.||++||++.+++++|.
T Consensus       236 ---------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 ---------GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ---------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                     11112334455678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.3e-43  Score=326.25  Aligned_cols=249  Identities=22%  Similarity=0.271  Sum_probs=197.5

Q ss_pred             CCCCCCeeccCCceEEEEEEE----CCCcEEEEEeCCC-------CChHHHHHHHHHHhcC-CCCceeeeccceecCCee
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPG-------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~-------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  145 (380)
                      +|++.+.||+|+||.||+++.    .++..||+|....       ...+.+..|+++++.+ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999985    3578999997532       1234577899999999 589999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLY-----QRDNFSEDEVRFYSGEIILALEHLHK--LGIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999998883     34568899999999999999999999  679999999999999999999999999987


Q ss_pred             ccCCCCCCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ....... .......||..|+|||++.+. .++.++|||||||++|||++|+.||............  ......     
T Consensus       154 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~-----  225 (332)
T cd05614         154 EFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILK-----  225 (332)
T ss_pred             cccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhc-----
Confidence            6533221 122345689999999998865 4788999999999999999999999754322111111  010000     


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                            ....++...++.+.+++.+||+.||++||     ++++++++
T Consensus       226 ------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 ------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                  01133344567899999999999999999     77788765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.5e-42  Score=318.91  Aligned_cols=261  Identities=20%  Similarity=0.258  Sum_probs=195.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ..+|++.+.||+|+||.||+|... ++..||+|.....    ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            357899999999999999999965 6889999975432    23457789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+.+ +|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          84 YVHT-DLCQYMDK----HPGGLHPENVKLFLFQLLRGLSYIHQ--RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CCCc-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            9964 67666632    23557888899999999999999999  77999999999999999999999999998754321


Q ss_pred             CCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc------ch
Q 016917          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS------NL  303 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~  303 (380)
                      .  .......++..|+|||++.+ ..++.++|||||||++|||++|..||.....  .....+.+.......      ..
T Consensus       157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccch
Confidence            1  12234567889999998865 4688999999999999999999999986432  111111111100000      00


Q ss_pred             hh--hccc-ccccCCC---------HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 LK--ILDE-RLWSTFT---------NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ~~--~~~~-~~~~~~~---------~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..  ...+ ......+         ...++++.+++.+||+.||++|||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            00  0000 0000000         0123568899999999999999999999974

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-44  Score=299.19  Aligned_cols=266  Identities=21%  Similarity=0.287  Sum_probs=208.3

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCC---ChHHHHHHHHHHhcCCCCceeeeccceecC-----C
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-----N  143 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  143 (380)
                      .+..++|++.+.+|+|||+-||+++ ..++..+|+|+....   ..+..++|++.-++++|||+++++++....     .
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            3566789999999999999999999 567889999985443   345678999999999999999999987533     3


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      ..|++++|...|+|.+.+..... ....+++.+++.++.++++||++||+..+++.||||||.|||+++++.++|.|||+
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence            58999999999999998865433 44578999999999999999999999656699999999999999999999999999


Q ss_pred             ccccCCCCCC-------CCCccccCccceecccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHH
Q 016917          224 RNFLGRTDVA-------GPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL  293 (380)
Q Consensus       224 a~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~  293 (380)
                      ++...-.-..       ........|..|+|||.+.   +...++++|||||||+||+|+.|..||+.... .+.++   
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSl---  251 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSL---  251 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeE---
Confidence            8764211000       1112234567799999875   34568899999999999999999999985432 11111   


Q ss_pred             HHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          294 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                               ...+.+..+..+-....++.+.++++.|++.||.+||++.+++..++.++
T Consensus       252 ---------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  252 ---------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ---------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                     01111222222223336788999999999999999999999999998765

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-43  Score=324.89  Aligned_cols=237  Identities=20%  Similarity=0.269  Sum_probs=192.7

Q ss_pred             eccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCc
Q 016917           85 IGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        85 ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  157 (380)
                      ||+|+||.||+|... ++..||+|....      .....+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999964 578999997542      2334577899999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016917          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  237 (380)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~  237 (380)
                      .+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||+++......  ....
T Consensus        81 ~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  151 (312)
T cd05585          81 FHHLQ-----REGRFDLSRARFYTAELLCALENLHK--FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTN  151 (312)
T ss_pred             HHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccc
Confidence            98883     34568899999999999999999999  779999999999999999999999999987543211  1223


Q ss_pred             cccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCH
Q 016917          238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  317 (380)
Q Consensus       238 ~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (380)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||.....      .+......         ..  ...++.
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~---------~~--~~~~~~  214 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKIL---------QE--PLRFPD  214 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHH---------cC--CCCCCC
Confidence            45689999999999999999999999999999999999999975431      11111111         11  113344


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCC---HHHHHHH
Q 016917          318 EGMEEFIQLIVRCLDPSSERRPS---MSDVVTE  347 (380)
Q Consensus       318 ~~~~~l~~li~~cl~~dp~~Rpt---~~~ll~~  347 (380)
                      ..++++.+++.+||+.||.+||+   +.+++.+
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            56678999999999999999985   5666654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-43  Score=316.23  Aligned_cols=246  Identities=21%  Similarity=0.310  Sum_probs=208.1

Q ss_pred             CCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      -+|++.+.||+|.||.|-+|. +..|+.||||.+.+.      ..-.+++|++||..|+||||+.++.+|++.+.+.+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            457888999999999999999 578999999964332      2335789999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||..+|.|.|++     ..++.+++.....+++||+.|+.|+|+  ++++|||||.+|||+|.++++||+|||++..+.+
T Consensus       133 EYaS~GeLYDYi-----Ser~~LsErEaRhfFRQIvSAVhYCHk--nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  133 EYASGGELYDYI-----SERGSLSEREARHFFRQIVSAVHYCHK--NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EecCCccHHHHH-----HHhccccHHHHHHHHHHHHHHHHHHhh--ccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            999999999999     456789999999999999999999999  7799999999999999999999999999988765


Q ss_pred             CCCCCCCccccCccceecccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ..   ....++|++.|.+||++.|.+| ++.+|-|||||+||-|..|..||++.+.   ..++..+.            .
T Consensus       206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQIs------------~  267 (668)
T KOG0611|consen  206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQIS------------R  267 (668)
T ss_pred             cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHHhh------------c
Confidence            43   3456789999999999999999 6889999999999999999999998652   12222111            1


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHh
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  350 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~  350 (380)
                      ..++   .++.+.+..-||.+||..||++|-|+.++..+-.-
T Consensus       268 GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  268 GAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             cccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence            1111   11223557889999999999999999999988654

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.8e-42  Score=326.58  Aligned_cols=245  Identities=23%  Similarity=0.302  Sum_probs=192.7

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      .+|+..+.||+|+||.||+|... +++.||+|......    ...+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45667789999999999999954 68999999864332    34578999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++|+|....         ...+..+..++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++.+....
T Consensus       154 ~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        154 MDGGSLEGTH---------IADEQFLADVARQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             CCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            9999886432         23466778899999999999999  679999999999999999999999999998764322


Q ss_pred             CCCCCccccCccceeccccccc-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          232 VAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      .  ......|+..|+|||.+..     ..++.++|||||||++|||++|+.||......+   .........        
T Consensus       223 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~--------  289 (353)
T PLN00034        223 D--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAIC--------  289 (353)
T ss_pred             c--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHh--------
Confidence            1  1234568899999998743     234568999999999999999999998432211   111111000        


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                        .......+..++.++.+++.+||+.||++|||+.|++++
T Consensus       290 --~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        290 --MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             --ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              001122334556789999999999999999999999986

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.3e-42  Score=321.35  Aligned_cols=262  Identities=27%  Similarity=0.440  Sum_probs=207.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC--------CCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeeeccceecC
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQEN  142 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  142 (380)
                      ..+|.+.+.||+|+||.||++...        +...+|+|......    ...+..|+++++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            457889999999999999999742        23569999866432    24577899999999 799999999999999


Q ss_pred             CeeEEEEEeecCCCccccccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD  211 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~  211 (380)
                      +..++||||+.+|+|.+++.....           .....+++..++.++.|++.||+|||+  .+++||||||+||+++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Nill~  174 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVT  174 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHHheEEc
Confidence            999999999999999999854321           122458889999999999999999999  6799999999999999


Q ss_pred             CCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccH
Q 016917          212 EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDL  290 (380)
Q Consensus       212 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~  290 (380)
                      .++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.....   .+.
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---~~~  251 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EEL  251 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHH
Confidence            999999999999876643222222222334567999999998899999999999999999998 8888864331   111


Q ss_pred             HHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          291 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      ...+.             .......+..++.++.+++.+||..+|.+|||+.++++.|++++...
T Consensus       252 ~~~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         252 FKLLK-------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             HHHHH-------------cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            11111             11122334455678999999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-43  Score=331.45  Aligned_cols=250  Identities=24%  Similarity=0.284  Sum_probs=202.3

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||.||+|... +++.||+|....      .....+..|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888999999999999999965 689999997542      33456788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLI-----RKDVFPEETARFYIAELVLALDSVHK--LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            9999999999883     33568899999999999999999999  7799999999999999999999999999886644


Q ss_pred             CC---------------------------CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 016917          230 TD---------------------------VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (380)
Q Consensus       230 ~~---------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~  282 (380)
                      ..                           .........||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            22                           001223456899999999999999999999999999999999999999865


Q ss_pred             CCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCC-HHHHHHH
Q 016917          283 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-MSDVVTE  347 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~~ll~~  347 (380)
                      ...      ..........       .....+.....++++.+++.+||. ||.+||+ +++++++
T Consensus       234 ~~~------~~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         234 TLQ------ETYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CHH------HHHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            421      1111111100       111111112246789999999997 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.2e-43  Score=326.91  Aligned_cols=239  Identities=22%  Similarity=0.274  Sum_probs=195.2

Q ss_pred             CeeccCCceEEEEEEE-CCCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCC
Q 016917           83 NLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  155 (380)
                      +.||+|+||.||++.. .++..||+|....      .....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999995 4689999997543      22345778999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016917          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (380)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~  235 (380)
                      +|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  151 (328)
T cd05593          81 ELFFHLS-----RERVFSEDRTRFYGAEIVSALDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--AT  151 (328)
T ss_pred             CHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cc
Confidence            9988873     34568899999999999999999999  779999999999999999999999999987542211  12


Q ss_pred             CccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCC
Q 016917          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF  315 (380)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (380)
                      .....||..|+|||++.+..++.++|||||||++|+|++|+.||......   .....+.            ..  ...+
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~~~~------------~~--~~~~  214 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELIL------------ME--DIKF  214 (328)
T ss_pred             cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHHHhc------------cC--CccC
Confidence            23456899999999999999999999999999999999999999754321   1111110            00  1123


Q ss_pred             CHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          316 TNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       316 ~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                      +...++++.+++.+||+.||++||     ++.+++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            445567899999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.2e-42  Score=316.02  Aligned_cols=265  Identities=27%  Similarity=0.411  Sum_probs=203.4

Q ss_pred             CCCCCeeccCCceEEEEEEE-----CCCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceec--CCeeEE
Q 016917           79 FSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFL  147 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  147 (380)
                      |+..+.||+|+||+||++..     .++..||+|.....    ....+.+|++++++++||||+++++++..  ....++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            48889999999999988652     35778999986543    23567889999999999999999998765  346789


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+++++|.+++.      ...+++..+..++.|++.||.|||+  ++|+||||||+|||+++++.++|+|||++...
T Consensus        86 v~e~~~~~~l~~~~~------~~~l~~~~~~~i~~~l~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          86 IMEYVPLGSLRDYLP------KHKLNLAQLLLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EecCCCCCCHHHHHH------HcCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            999999999998883      2358999999999999999999999  77999999999999999999999999998876


Q ss_pred             CCCCCC-CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          228 GRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       228 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      ...... .......++..|+|||.+.+..++.++||||||+++|||++|..||....... .................+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhh
Confidence            432211 11122345667999999988889999999999999999999999986543211 0111000000111111222


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                      .+.....+.+..++.++.+++.+||+.||++|||++++++.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            2222233445566788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-42  Score=315.96  Aligned_cols=257  Identities=24%  Similarity=0.393  Sum_probs=205.8

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCe
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  144 (380)
                      ..++|++.+.||+|+||.||+|...      .+..|++|......    ...+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            4567888999999999999999854      23689999865332    2357889999999999999999999999999


Q ss_pred             eEEEEEeecCCCccccccCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQV-----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  219 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~  219 (380)
                      .++||||+++|+|.+++......     ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccChheEEEcCCCCEEEC
Confidence            99999999999999988543221     12346788999999999999999998  779999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhh
Q 016917          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR  298 (380)
Q Consensus       220 DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  298 (380)
                      |||+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |..||......   .......   
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~~---  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLKFVI---  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHHHHh---
Confidence            9999887654333222333456778999999988889999999999999999998 88898754321   1111111   


Q ss_pred             cccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                                .......+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus       236 ----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 ----------DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                      11112334445788999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-42  Score=319.58  Aligned_cols=265  Identities=25%  Similarity=0.436  Sum_probs=208.9

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEEC--------CCcEEEEEeCCCC----ChHHHHHHHHHHhcC-CCCceeeecccee
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQ  140 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~  140 (380)
                      ....+|.+.+.||+|+||.||+|+..        ++..|++|.....    ....+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34556888899999999999999731        2457999986532    234678899999999 8999999999999


Q ss_pred             cCCeeEEEEEeecCCCccccccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 016917          141 ENNLQFLIYEYIPNGSVSIHLYGPSQV-----------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL  209 (380)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nil  209 (380)
                      ..+..++||||+.+|+|.+++......           ....+++..+..++.|++.||.|||+  ++++||||||+||+
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Nil  169 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS--QKCIHRDLAARNVL  169 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH--CCeeecccccceEE
Confidence            999999999999999999988543211           13457888999999999999999999  77999999999999


Q ss_pred             eCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcc
Q 016917          210 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQ  288 (380)
Q Consensus       210 i~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~  288 (380)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.....   .
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~  246 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---E  246 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---H
Confidence            99999999999999987654332222333445677999999988899999999999999999998 7788765431   1


Q ss_pred             cHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          289 DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                      .....+.             .......+..++.++.+++.+||+.+|.+|||+.++++.|.+++.-.+
T Consensus       247 ~~~~~~~-------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         247 ELFKLLK-------------EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             HHHHHHH-------------cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence            1111111             111122334566789999999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.2e-42  Score=325.08  Aligned_cols=260  Identities=19%  Similarity=0.264  Sum_probs=200.9

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ..++|++.+.||+|+||.||++... ++..+|+|.....    ....+.+|+++++.++||||+++++++...+..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            3468999999999999999999965 6788899875433    2346889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          83 EHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             ecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            9999999999883     334578888999999999999999972 3699999999999999999999999999876533


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc----------
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD----------  299 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------  299 (380)
                      .    ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.......   ..........          
T Consensus       157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  229 (333)
T cd06650         157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE---LELMFGCPVEGDPAESETSP  229 (333)
T ss_pred             h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH---HHHHhcCcccCCccccccCc
Confidence            1    1234468889999999999899999999999999999999999997543211   1110000000          


Q ss_pred             ------------------ccch---hhhcccccccCCC-HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 ------------------FSNL---LKILDERLWSTFT-NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 ------------------~~~~---~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                                        ....   ............+ ...+.++.+|+.+||+.||++|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                              0000   0000000001111 1245679999999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-43  Score=326.82  Aligned_cols=253  Identities=27%  Similarity=0.476  Sum_probs=216.1

Q ss_pred             CCCCCCeeccCCceEEEEEEECC---C--cEEEEEeCCC----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQD---G--MLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~~---~--~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .....+.||.|-||.||.|.+.+   |  -.||||..+.    ..++.|..|.-+|++++||||++++|.|.+. ..++|
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence            34455789999999999998432   2  3588886433    4467899999999999999999999999876 46999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      ||+++.|.|..+|.    .+...++......++.|++.||.|||+  +..|||||..+|||+.....+||+|||+++.+.
T Consensus       469 mEL~~~GELr~yLq----~nk~sL~l~tL~ly~~Qi~talaYLeS--krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  469 MELAPLGELREYLQ----QNKDSLPLRTLTLYCYQICTALAYLES--KRFVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EecccchhHHHHHH----hccccchHHHHHHHHHHHHHHHHHHHh--hchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            99999999999993    455678888999999999999999999  779999999999999999999999999999998


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      +..+...+ ...-+..|||||.+....++++||||.|||++||++. |..||.+....                ++...+
T Consensus       543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----------------DVI~~i  605 (974)
T KOG4257|consen  543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----------------DVIGHI  605 (974)
T ss_pred             ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------------ceEEEe
Confidence            76654433 4455778999999999999999999999999999987 99999876532                233334


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      ....+.+.|+.|++.++.|+.+||.+||.+||++.++...|+++++.
T Consensus       606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence            55556788999999999999999999999999999999999998874

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-42  Score=312.19  Aligned_cols=255  Identities=23%  Similarity=0.407  Sum_probs=200.5

Q ss_pred             CCCCCeeccCCceEEEEEEECC----CcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCe-----
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL-----  144 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  144 (380)
                      |++.+.||+|+||.||+|....    +..||+|......     ...+.+|++.++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5677899999999999998532    3679999754321     2467889999999999999999998865443     


Q ss_pred             -eEEEEEeecCCCccccccCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 016917          145 -QFLIYEYIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       145 -~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFg  222 (380)
                       .++++||+++|+|..++..... .....+++..+..++.|++.||.|||+  ++++||||||+||++++++.+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchheEEECCCCeEEECCcc
Confidence             6899999999999888743321 123468899999999999999999999  779999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhccc
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                      +++................+..|+|||.+.+..++.++|||||||++|||++ |..||.....   ....+....     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~~-----  230 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLRH-----  230 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc-----
Confidence            9987644332222222334667999999988899999999999999999999 8888865432   111111111     


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                              ......+..++.++.+++.+||+.||.+|||+.++++.|+++
T Consensus       231 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 --------GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             --------CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    111223445667899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.8e-42  Score=330.17  Aligned_cols=264  Identities=23%  Similarity=0.366  Sum_probs=206.5

Q ss_pred             HHHHhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcCC-CCceeeecccee
Q 016917           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQ-HRNLVTLLGYCQ  140 (380)
Q Consensus        72 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~  140 (380)
                      +.+..++|.+.+.||+|+||.||+|++.      .+..||+|+.....    .+.+.+|++++.++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3344556788899999999999999853      34679999865432    246788999999997 999999999999


Q ss_pred             cCCeeEEEEEeecCCCccccccCCCC------------------------------------------------------
Q 016917          141 ENNLQFLIYEYIPNGSVSIHLYGPSQ------------------------------------------------------  166 (380)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  166 (380)
                      ..+..++||||+++|+|.+++.....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999988854311                                                      


Q ss_pred             ---------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 016917          167 ---------------------------------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTAN  207 (380)
Q Consensus       167 ---------------------------------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~N  207 (380)
                                                             .....+++..++.++.|++.||.|||+  ++++||||||+|
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrdlkp~N  269 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS--KNCVHRDLAARN  269 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCcCcccCCcce
Confidence                                                   011246777889999999999999998  779999999999


Q ss_pred             eeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCC
Q 016917          208 VLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDS  286 (380)
Q Consensus       208 ili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~  286 (380)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... 
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~-  348 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN-  348 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch-
Confidence            9999999999999999986543221111223346778999999998889999999999999999998 88888654321 


Q ss_pred             cccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          287 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                       ......+             ........+..++.++.+++.+||..||.+||+++++++.|++++
T Consensus       349 -~~~~~~~-------------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 -EQFYNAI-------------KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -HHHHHHH-------------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence             1111111             111112233445678999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5e-42  Score=310.22  Aligned_cols=254  Identities=27%  Similarity=0.445  Sum_probs=204.1

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeec
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      .++|++.++||+|+||.||+|...+...|++|.....  ..+.+.+|+++++.++||||+++++.+.. +..++||||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            4568899999999999999999777778999986643  34578899999999999999999998754 45789999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                      +|+|.+++...   ....+++..+..++.|++.||.|||+  ++++||||||+||++++++.++|+|||.+.........
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          84 KGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            99999988432   23457889999999999999999999  77999999999999999999999999999876543221


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                       ......++..|+|||...+..++.++||||||+++|||++ |..||......   .......             ....
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~~~~-------------~~~~  221 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVE-------------RGYR  221 (262)
T ss_pred             -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHHHHh-------------cCCC
Confidence             1223346677999999988899999999999999999999 88888654321   1111110             0111


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                      ...+...+..+.+++.+||+.||.+||+++++++.|++.+
T Consensus       222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            1233456678999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2e-42  Score=316.28  Aligned_cols=255  Identities=29%  Similarity=0.414  Sum_probs=201.9

Q ss_pred             CCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      +|++.+.||+|+||.||+|...      .+..||+|......    .+.+..|..++..++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4666788999999999999853      24789999866443    2457789999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCce
Q 016917          148 IYEYIPNGSVSIHLYGPS-----------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  216 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~  216 (380)
                      ++||+.+++|.+++....           ......+++..+..++.|++.||.|||+  ++|+||||||+||++++++.+
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS--HHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--cCccccccchhheEecCCCce
Confidence            999999999988874211           0112457888899999999999999999  679999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHH
Q 016917          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ  295 (380)
Q Consensus       217 kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~  295 (380)
                      ||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....   .+..+.+.
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~i~  240 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIEMIR  240 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH
Confidence            9999999887644332222233345678999999988889999999999999999998 8888875432   11121111


Q ss_pred             hhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHh
Q 016917          296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  350 (380)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~  350 (380)
                      .             ......+..++..+.+++.+||+.||.+||+++++++.|..
T Consensus       241 ~-------------~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         241 N-------------RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             c-------------CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1             11123345567889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.9e-42  Score=313.12  Aligned_cols=259  Identities=26%  Similarity=0.421  Sum_probs=203.5

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCc----EEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCee
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGM----LVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      ...+|+..+.||+|+||+||+|++ .++.    +||+|......    ...+.+|..+++.++||||+++++++... ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   83 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV   83 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence            345788899999999999999984 3443    58999765332    34577899999999999999999998754 46


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++++||+++|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++
T Consensus        84 ~l~~~~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGMSYLEE--VRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             EEEEEcCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEEcCCCcEEECCCCcee
Confidence            899999999999988842    23468899999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ...............++..|+|||...+..++.++|||||||++|||++ |..||.....   ......+.         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~---------  225 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLE---------  225 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH---------
Confidence            7643222111222334667999999998899999999999999999998 8899875432   11111111         


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                          .......+..++.++.+++.+||+.||++||++.++++.|.++..++.
T Consensus       226 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05109         226 ----KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS  273 (279)
T ss_pred             ----CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence                111112233456789999999999999999999999999988876653

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.4e-43  Score=317.38  Aligned_cols=246  Identities=31%  Similarity=0.540  Sum_probs=192.8

Q ss_pred             CCeeccCCceEEEEEEEC-----CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           82 KNLIGEGKFGEVYKGLLQ-----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      .+.||.|.||.||+|.+.     .+..|+||......    .+.+.+|++.+++++||||++++|++...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            478999999999999966     35789999875432    357889999999999999999999999888899999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++|+|.+++...   ....+++..+..++.|++.||.|||+  ++++|+||+++||+++.++.+||+|||++........
T Consensus        84 ~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~--~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   84 PGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHS--NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHH--TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccc---cccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccc
Confidence            999999999532   24678999999999999999999999  6799999999999999999999999999887633222


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                      .........+..|+|||.+.+..++.++||||||+++|||++ |+.||.....   .+..+.+.             ...
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~~-------------~~~  222 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKLK-------------QGQ  222 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHHH-------------TTE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccc-------------ccc
Confidence            222233446678999999999999999999999999999999 6788765431   12222111             111


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      ....+..++..+.+++.+||..||++|||+.++++.|
T Consensus       223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            2234445667899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.5e-42  Score=318.15  Aligned_cols=259  Identities=22%  Similarity=0.308  Sum_probs=192.8

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC--CCcEEEEEeCCCC-----ChHHHHHHHHHHhcC---CCCceeeecccee-----c
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ--DGMLVAIKKRPGA-----PTQEFIDEVCFLASI---QHRNLVTLLGYCQ-----E  141 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~  141 (380)
                      ++|++.+.||+|+||.||+|...  ++..||+|.....     ....+.+|+++++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            46889999999999999999853  4678999964321     233566777777665   6999999999875     3


Q ss_pred             CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccc
Q 016917          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (380)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DF  221 (380)
                      ....++||||+. ++|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence            456899999997 4888777422   23457899999999999999999999  77999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc--
Q 016917          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD--  299 (380)
Q Consensus       222 gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--  299 (380)
                      |++......   .......++..|+|||.+.+..++.++|||||||++|||++|++||......+   ....+.....  
T Consensus       155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~  228 (290)
T cd07862         155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLP  228 (290)
T ss_pred             cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCC
Confidence            998765432   22334568889999999988899999999999999999999999998654311   1111111000  


Q ss_pred             ----ccchh----hhcccccc---cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 ----FSNLL----KILDERLW---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 ----~~~~~----~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                          .....    ..+.....   .......++.+.+++.+||+.||++|||+.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence                00000    00000000   01112345678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-43  Score=331.35  Aligned_cols=250  Identities=23%  Similarity=0.301  Sum_probs=197.9

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||.||+|+.. +++.||+|....      .....+.+|+++++.++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36889999999999999999964 688999997542      22345678999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||++..+..
T Consensus        81 E~~~~g~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLM-----KKDTFTEEETRFYIAETILAIDSIHK--LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            9999999999883     34568899999999999999999999  6799999999999999999999999999876432


Q ss_pred             CCCCC------------------------------------CCccccCccceecccccccCCCCcchhhHHHHHHHHHHH
Q 016917          230 TDVAG------------------------------------PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV  273 (380)
Q Consensus       230 ~~~~~------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~  273 (380)
                      .....                                    ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            11000                                    011245899999999999999999999999999999999


Q ss_pred             cCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCC---HHHHHHH
Q 016917          274 SGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS---MSDVVTE  347 (380)
Q Consensus       274 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---~~~ll~~  347 (380)
                      +|..||......   .....+   ....       ..+..+.....++++.+++.+|+. +|.+|++   +.+++++
T Consensus       234 ~G~~Pf~~~~~~---~~~~~i---~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         234 VGYPPFCSDNPQ---ETYRKI---INWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             cCCCCCCCCCHH---HHHHHH---HcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            999999764421   111111   1000       000001111345778999999996 9999998   8888875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.5e-42  Score=310.78  Aligned_cols=253  Identities=26%  Similarity=0.460  Sum_probs=203.9

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ..++|++.++||+|+||.||+|...++..||+|.....  ....+.+|+++++.++|+||+++++++. .+..+++|||+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            45678899999999999999999888899999975543  3467899999999999999999999874 45689999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      .+++|.+++...   ....+++..+..++.|++.||+|||+  .+++||||||+||+++.++.++|+|||++........
T Consensus        83 ~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          83 ENGSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIER--KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            999999887432   23467889999999999999999999  6799999999999999999999999999876653221


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                      . ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ........             ...
T Consensus       158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~-------------~~~  220 (260)
T cd05067         158 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNLE-------------RGY  220 (260)
T ss_pred             c-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHH-------------cCC
Confidence            1 1123345667999999988889999999999999999999 9999975432   11111111             111


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHh
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  350 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~  350 (380)
                      ....+...+.++.+++.+||+.||++|||+++++..|+.
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            112333455789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.1e-43  Score=332.03  Aligned_cols=253  Identities=21%  Similarity=0.260  Sum_probs=200.4

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCee
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      .....+|++.+.||+|+||.||++... ++..||+|....      .....+.+|+.+++.++||||+++++++.+++..
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            344567999999999999999999954 688999997542      2234577899999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++||||+++|+|.+++.      ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.
T Consensus       119 ~lv~Ey~~gg~L~~~l~------~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         119 YMVMEYMPGGDLVNLMS------NYDIPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EEEEcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence            99999999999998873      2357788888999999999999999  779999999999999999999999999988


Q ss_pred             ccCCCCCCCCCccccCccceecccccccC----CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFR----RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                      ....... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||......   .....+....   
T Consensus       191 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~---  263 (370)
T cd05596         191 KMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMDHK---  263 (370)
T ss_pred             eccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---HHHHHHHcCC---
Confidence            6643221 112345689999999998653    4789999999999999999999999864421   1111111000   


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE  347 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~~ll~~  347 (380)
                             ..+..+.....+.++.+++.+||+.+|.+  |+++.+++++
T Consensus       264 -------~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         264 -------NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -------CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                   00111111235678999999999999988  9999999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.3e-42  Score=310.15  Aligned_cols=252  Identities=25%  Similarity=0.460  Sum_probs=202.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeec
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      .++|++.+.||+|+||.||+|...++..+|+|.....  ..+.+.+|++++++++|+|++++++++.. +..+++|||++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS   83 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence            4568889999999999999999888888999976532  34678899999999999999999998754 55789999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                      +++|.+++...   ....+++..+..++.|++.||.|||+  ++++||||||+||++++++.++|+|||++.........
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          84 KGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIER--MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            99999988432   23457899999999999999999999  67999999999999999999999999999766442211


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                       ......++..|+|||...+..++.++|+||||+++|+|++ |..||.....   .+..+.+.             ....
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~-------------~~~~  221 (260)
T cd05070         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQVE-------------RGYR  221 (260)
T ss_pred             -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH-------------cCCC
Confidence             1122335567999999988899999999999999999999 8888875431   11111111             1111


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHh
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  350 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~  350 (380)
                      .+.+...+..+.+++.+||..||.+|||+.++.+.|++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            22334556789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.2e-42  Score=313.65  Aligned_cols=262  Identities=25%  Similarity=0.423  Sum_probs=207.7

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECC-----CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceec-CCe
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE-NNL  144 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  144 (380)
                      ..++|++.+.||+|+||.||+|....     +..|++|......    ...+.+|+.+++.++||||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45678889999999999999999665     6889999765432    3457789999999999999999998765 567


Q ss_pred             eEEEEEeecCCCccccccCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQV---SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DF  221 (380)
                      .+++++|+.+++|.+++......   ....+++..++.++.|++.||.|||+  ++++||||||+||++++++.+||+||
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK--RGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCHhhEEEcCCCcEEECCC
Confidence            89999999999999888443211   12568899999999999999999999  67999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcc
Q 016917          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDF  300 (380)
Q Consensus       222 gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  300 (380)
                      |+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |+.||....+   .+....+..    
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~----  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLKD----  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHHc----
Confidence            99986644332222223345667999999998899999999999999999999 9999876432   111111111    


Q ss_pred             cchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                               ......+..+++++.+++.+||+.||++|||+.++++.|+.+.++
T Consensus       235 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         235 ---------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             ---------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                     111122334567899999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-42  Score=322.81  Aligned_cols=239  Identities=19%  Similarity=0.274  Sum_probs=193.8

Q ss_pred             CeeccCCceEEEEEEE----CCCcEEEEEeCCC-------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           83 NLIGEGKFGEVYKGLL----QDGMLVAIKKRPG-------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~----~~~~~vavK~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +.||+|+||.||++..    .+++.||+|....       .....+..|+++++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    3578899997542       1234567899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++.     ....+.+..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLE-----REGIFMEDTACFYLSEISLALEHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            99999998883     34567788888999999999999999  679999999999999999999999999987542211


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                        .......|+..|+|||++.+..++.++|||||||++|||++|+.||......   .....+            ...  
T Consensus       155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~~~~~------------~~~--  215 (323)
T cd05584         155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KTIDKI------------LKG--  215 (323)
T ss_pred             --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HHHHHH------------HcC--
Confidence              1223456899999999999889999999999999999999999999764321   111111            111  


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                      ....+...++++.+++.+||+.||++||     ++++++++
T Consensus       216 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         216 KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            1123444567899999999999999999     78888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-42  Score=315.38  Aligned_cols=249  Identities=20%  Similarity=0.291  Sum_probs=199.9

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      +|+..++||+|+||.||++.. .++..||+|......      ...+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            477889999999999999995 468899999754321      2346789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++|+|.+++...   ....+++..+..++.|++.||.|||+  ++++||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999998877432   23468899999999999999999999  67999999999999999999999999998765432


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      .   ......++..|+|||++.+..++.++||||+||++|||++|..||.......   ..+.+...         +. .
T Consensus       156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~---------~~-~  219 (285)
T cd05605         156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERR---------VK-E  219 (285)
T ss_pred             C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHH---------hh-h
Confidence            2   1223467889999999998899999999999999999999999998643221   11111100         00 0


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                      ....++...+..+.+++.+||+.||.+||     ++++++++
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         220 DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            11223445667899999999999999999     78888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.8e-42  Score=329.89  Aligned_cols=250  Identities=21%  Similarity=0.264  Sum_probs=195.0

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      .|+..+.||+|+||+||+|.. .+++.||+|+....      ....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578889999999999999985 56789999975432      23457889999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~gg~L~~~l~-----~~~~~~e~~~~~~~~qi~~aL~~LH~--~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLI-----RMEVFPEVLARFYIAELTLAIESVHK--MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            999999998883     33567888899999999999999999  77999999999999999999999999997643110


Q ss_pred             CC---------------------------------------------CCCCccccCccceecccccccCCCCcchhhHHH
Q 016917          231 DV---------------------------------------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSF  265 (380)
Q Consensus       231 ~~---------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSl  265 (380)
                      ..                                             ........||..|+|||++.+..|+.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                             000123468999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhH--ccCCCCCCCCCHHH
Q 016917          266 GVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVR--CLDPSSERRPSMSD  343 (380)
Q Consensus       266 G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dp~~Rpt~~~  343 (380)
                      ||++|||++|..||.......   ....+.   ..       ......+.....++++.+++.+  |+..+|..||++.+
T Consensus       235 G~il~elltG~~Pf~~~~~~~---~~~~i~---~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~  301 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTE---TQLKVI---NW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD  301 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHH---HHHHHH---cc-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence            999999999999998654211   110000   00       0001111112345778899988  44556666999999


Q ss_pred             HHHH
Q 016917          344 VVTE  347 (380)
Q Consensus       344 ll~~  347 (380)
                      ++.+
T Consensus       302 ~l~h  305 (381)
T cd05626         302 IKAH  305 (381)
T ss_pred             HhcC
Confidence            9986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.2e-42  Score=313.93  Aligned_cols=261  Identities=24%  Similarity=0.387  Sum_probs=203.9

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCC
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENN  143 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  143 (380)
                      ....+|++.+.||+|+||.||+|..+      .+..||+|......    ...+.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34567899999999999999999743      24579999765332    235678999999999999999999999999


Q ss_pred             eeEEEEEeecCCCccccccCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEE
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQV-----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV  218 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl  218 (380)
                      ..++||||+++|+|.+++......     ......+..+..++.|++.||.|||+  ++|+||||||+||+++.++.++|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999998532211     12345677888999999999999999  77999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhh
Q 016917          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNS  297 (380)
Q Consensus       219 ~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~  297 (380)
                      +|||+++...............++..|+|||.+.+..++.++|+|||||++|||++ |..||......   +....+.  
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~--  235 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLKFVM--  235 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH--
Confidence            99999886544332222222334667999999998899999999999999999998 78888654321   1111111  


Q ss_pred             hcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                                + ......+..+++.+.+++.+||+.||++|||+.++++.|...+
T Consensus       236 ----------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         236 ----------D-GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             ----------c-CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence                      0 1111233345578999999999999999999999999888765

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.3e-42  Score=317.13  Aligned_cols=258  Identities=24%  Similarity=0.381  Sum_probs=203.6

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeeeccceecC
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQEN  142 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  142 (380)
                      ...++|.+.+.||+|+||.||++...      .+..+|+|......    .+.+.+|+++++++ +||||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            34456888999999999999999742      34579999765432    34578899999999 799999999999999


Q ss_pred             CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFg  222 (380)
                      +..++||||+.+|+|.+++...   ....+++.++..++.|++.||.|||+  ++|+|+||||+|||++.++.++++|||
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeehhhhccceEEEcCCCeEEECCCc
Confidence            9999999999999999888432   12337899999999999999999999  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhccc
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                      ++................++..|+|||.+.+..++.++|||||||++|||++ |..||......  ........      
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~~~------  258 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKLIK------  258 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHHHH------
Confidence            9886643221111222345678999999998899999999999999999998 99998764421  11111111      


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                             .......+...++++.+++.+||..+|++|||+.++++.|+++
T Consensus       259 -------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         259 -------EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -------cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                   1111122233457799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8e-42  Score=307.93  Aligned_cols=244  Identities=23%  Similarity=0.391  Sum_probs=195.2

Q ss_pred             eeccCCceEEEEEEE---CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCC
Q 016917           84 LIGEGKFGEVYKGLL---QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (380)
Q Consensus        84 ~ig~G~~g~V~~~~~---~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  155 (380)
                      .||+|+||.||+|.+   .++..+|+|+.....     .+.+.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999974   357889999865332     3467889999999999999999998864 4568999999999


Q ss_pred             CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC-C
Q 016917          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA-G  234 (380)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~-~  234 (380)
                      +|.+++.     ....+++..+..++.|++.||.|||+  ++++||||||+||++++++.+||+|||++......... .
T Consensus        81 ~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQ-----KNKHVTEKNITELVHQVSMGMKYLEE--TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            9998883     33467899999999999999999999  77999999999999999999999999999876443211 1


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccccc
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  313 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (380)
                      ......++..|+|||.+.+..++.++|+|||||++|||++ |..||.....   ......+.             .....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i~-------------~~~~~  217 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMIE-------------SGERM  217 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH-------------CCCCC
Confidence            1122234567999999988889999999999999999998 9999976432   12222221             11122


Q ss_pred             CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       314 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                      ..+..+++++.+++.+||+.||++||++.+|.+.|++.
T Consensus       218 ~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         218 ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            34445668899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.4e-42  Score=326.93  Aligned_cols=249  Identities=22%  Similarity=0.288  Sum_probs=194.9

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||+||+|... +++.||+|+....      ....+..|+.++..++||||+++++.+.+.+..|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            36888999999999999999854 6889999986432      2345778999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~--~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLM-----KKDTLTEEETQFYIAETVLAIDSIHQ--LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            9999999999883     34568899999999999999999999  7799999999999999999999999999876532


Q ss_pred             CCCC---------------------------------CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCC
Q 016917          230 TDVA---------------------------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR  276 (380)
Q Consensus       230 ~~~~---------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~  276 (380)
                      ....                                 .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            1100                                 0012346899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCC--HHHHHHHHHHHhHccC--CCCCCCCCHHHHHHH
Q 016917          277 EASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT--NEGMEEFIQLIVRCLD--PSSERRPSMSDVVTE  347 (380)
Q Consensus       277 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~--~dp~~Rpt~~~ll~~  347 (380)
                      .||......   .....+....          ..  ..++  ...++++.+++.+++.  .++..||++++++++
T Consensus       234 ~Pf~~~~~~---~~~~~i~~~~----------~~--~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         234 PPFCSETPQ---ETYKKVMNWK----------ET--LIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCCHH---HHHHHHHcCc----------Cc--ccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            999764321   1111111000          00  0111  1234678888887554  233356899999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.8e-42  Score=314.04  Aligned_cols=258  Identities=27%  Similarity=0.447  Sum_probs=202.8

Q ss_pred             CCCCCCCeeccCCceEEEEEEECC-C--cEEEEEeCCCC----ChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQD-G--MLVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~-~--~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  148 (380)
                      ++|++.+.||+|+||.||+|..++ +  ..+++|.....    ..+.+.+|++++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            478889999999999999998643 3  34688876532    234678899999999 799999999999999999999


Q ss_pred             EEeecCCCccccccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceE
Q 016917          149 YEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  217 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~k  217 (380)
                      +||+++++|.+++.....           .....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+|
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCcCCcceEEECCCCeEE
Confidence            999999999988854221           012358889999999999999999999  7799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHh
Q 016917          218 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQN  296 (380)
Q Consensus       218 l~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~  296 (380)
                      |+|||++.......   .......+..|+|||...+..++.++|||||||++|||++ |..||......   +....   
T Consensus       160 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~~~---  230 (297)
T cd05089         160 IADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELYEK---  230 (297)
T ss_pred             ECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH---
Confidence            99999986432110   1111223456999999998899999999999999999997 99999764421   11111   


Q ss_pred             hhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          297 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                                .........+..++..+.+++.+||+.||.+||+++++++.|..+++..
T Consensus       231 ----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         231 ----------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             ----------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                      1111112233445678999999999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=331.04  Aligned_cols=250  Identities=20%  Similarity=0.267  Sum_probs=195.1

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||.||++.. .+++.||+|.....      ..+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3688899999999999999985 57889999975322      2345778999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++.     ....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~ql~~aL~~LH~--~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLI-----KYDTFSEDVTRFYMAECVLAIEAVHK--LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999998883     34567888899999999999999999  7799999999999999999999999999864321


Q ss_pred             CCC------------CC---------------------------------CCccccCccceecccccccCCCCcchhhHH
Q 016917          230 TDV------------AG---------------------------------PSSQVTADEIFLASEVKEFRRFSEKSDVYS  264 (380)
Q Consensus       230 ~~~------------~~---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwS  264 (380)
                      ...            ..                                 ......||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            100            00                                 001246899999999999999999999999


Q ss_pred             HHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCC---CCH
Q 016917          265 FGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR---PSM  341 (380)
Q Consensus       265 lG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---pt~  341 (380)
                      |||++|||++|..||......   +....+.   ...       ..+..+.....+.++.+++.+||. +|.+|   +++
T Consensus       234 lGvil~elltG~~Pf~~~~~~---~~~~~i~---~~~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~  299 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSH---ETYRKII---NWR-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA  299 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHH---HHHHHHH---ccC-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence            999999999999999754321   1111111   000       000001111345778999999997 66665   599


Q ss_pred             HHHHHH
Q 016917          342 SDVVTE  347 (380)
Q Consensus       342 ~~ll~~  347 (380)
                      .+++.+
T Consensus       300 ~~~l~h  305 (377)
T cd05629         300 HEIKSH  305 (377)
T ss_pred             HHHhcC
Confidence            999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-44  Score=301.83  Aligned_cols=249  Identities=22%  Similarity=0.309  Sum_probs=204.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEe-----CCCCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ...|++.++||+|.|+.||++.+ .+|+.+|+|+     +.....+++.+|+.|-+.|+||||+++.+.+...+..|||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            44677788999999999999985 4688888774     44556788999999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCceEEcccccccc
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNF  226 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~---~~~~~kl~DFgla~~  226 (380)
                      |++.|++|...+     ..+..+++..+-...+||++||.|+|.  ++|||||+||+|+|+.   ..--+||+|||+|..
T Consensus        90 e~m~G~dl~~eI-----V~R~~ySEa~aSH~~rQiLeal~yCH~--n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   90 DLVTGGELFEDI-----VAREFYSEADASHCIQQILEALAYCHS--NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             ecccchHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999987655     344667888888999999999999999  8899999999999994   344699999999998


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      +..   .....+..||+.|||||++...+|+..+|||+.||+||-++.|.+||.+.+.   ..+.+.+....      .-
T Consensus       163 l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rlye~I~~g~------yd  230 (355)
T KOG0033|consen  163 VND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYEQIKAGA------YD  230 (355)
T ss_pred             eCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHHHHHHhccc------cC
Confidence            863   2345677899999999999999999999999999999999999999997432   22333222111      01


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ++++.|.    ..+++.++|+.+||..||.+|.|+.|+|++
T Consensus       231 ~~~~~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  231 YPSPEWD----TVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             CCCcccC----cCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            1222333    344678999999999999999999999876

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-42  Score=308.62  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=201.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC--------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      ++|++.+.||+|++|.||.|.. .++..+++|.....        ..+.+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688899999999999999985 46889999974322        12457789999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      |+||+++++|.+++.     ....+++.....++.|++.||.|||+  .+++||||+|+||++++++.++|+|||+++..
T Consensus        82 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLK-----AYGALTETVTRKYTRQILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            999999999998873     33457888889999999999999999  77999999999999999999999999998765


Q ss_pred             CCCCCCC-CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          228 GRTDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       228 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......      ....         ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~---------~~  219 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIF---------KI  219 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHH---------HH
Confidence            4322111 113345778899999999999999999999999999999999998754221      1111         11


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .........+...+..+.+++.+||..||.+|||+.+++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         220 ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             hccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            11111223455566789999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.2e-42  Score=322.21  Aligned_cols=242  Identities=24%  Similarity=0.336  Sum_probs=193.2

Q ss_pred             CCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC------CChHHHHHHHHHH---hcCCCCceeeeccceecCCeeEEE
Q 016917           79 FSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFL---ASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      |++.+.||+|+||.||+|.. .+++.||+|....      ...+.+..|..++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            56788999999999999995 4688999997542      2234456666554   567899999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++++|...+.      ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++....
T Consensus        81 ~E~~~~~~L~~~~~------~~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIH------TDVFSEPRAVFYAACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            99999999987762      3468899999999999999999999  779999999999999999999999999987532


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ...  .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......   +....+.            .
T Consensus       153 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~~~i~------------~  215 (324)
T cd05589         153 GFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVFDSIV------------N  215 (324)
T ss_pred             CCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH------------h
Confidence            211  1223456889999999999999999999999999999999999999764321   1111111            0


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                      .  ...++...++.+.+++.+||+.||.+||     ++.+++++
T Consensus       216 ~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         216 D--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            0  0123344567789999999999999999     57777664

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=9.8e-42  Score=308.89  Aligned_cols=258  Identities=22%  Similarity=0.338  Sum_probs=205.1

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||.||+|+. .++..||+|....      .....+.+|+++++.++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5788999999999999999995 4789999996432      12245788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++.... .....++...+..++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFK-KQKRLIPERTVWKYFVQLCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999988774321 133557888999999999999999999  7799999999999999999999999999887643


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|||++|+.||...... .......+...            
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~------------  223 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKIEQC------------  223 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHHHhcC------------
Confidence            221  122345778899999998888999999999999999999999998653321 11111111100            


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                      ......+...+..+.+++.+||+.||.+||+++++++.|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            0011112345577999999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.1e-42  Score=313.24  Aligned_cols=245  Identities=24%  Similarity=0.306  Sum_probs=194.7

Q ss_pred             eccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCc
Q 016917           85 IGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        85 ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  157 (380)
                      ||+|+||+||++.. .+++.+|+|.....      ..+.+..|+++++.++|+||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999995 46889999975432      124567899999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016917          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  237 (380)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~  237 (380)
                      .+.+.... .....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            87764322 234568899999999999999999999  7799999999999999999999999999876543221  123


Q ss_pred             cccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCH
Q 016917          238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  317 (380)
Q Consensus       238 ~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (380)
                      ...+++.|+|||.+.+..++.++|||||||++|||++|+.||.........  .....         .....  ...++.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~---------~~~~~--~~~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQ---------RILND--SVTYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHH---------hhccc--CCCCcc
Confidence            456888999999999999999999999999999999999999764322110  00000         00111  112334


Q ss_pred             HHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          318 EGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       318 ~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                      ..++++.+++.+||+.||++||     ++++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            4667899999999999999999     67778765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.2e-42  Score=329.35  Aligned_cols=252  Identities=22%  Similarity=0.295  Sum_probs=199.4

Q ss_pred             HHHHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCe
Q 016917           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (380)
Q Consensus        72 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  144 (380)
                      +....++|++.+.||+|+||.||++... +++.+|+|....      .....+.+|+.+++.++||||+++++.+.+++.
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3444577999999999999999999964 578999997532      223457789999999999999999999999999


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .|+||||+++|+|.+++.      ...+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       118 ~~lv~Ey~~gg~L~~~l~------~~~~~~~~~~~~~~qil~aL~~LH~--~~IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMS------NYDVPEKWAKFYTAEVVLALDAIHS--MGLIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             EEEEEcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEEecccc
Confidence            999999999999998883      2357888899999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCccceecccccccCC----CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRR----FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF  300 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  300 (380)
                      ........ .......||+.|+|||++.+..    ++.++|||||||++|||++|+.||......   ....        
T Consensus       190 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~---~~~~--------  257 (370)
T cd05621         190 MKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV---GTYS--------  257 (370)
T ss_pred             eecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH---HHHH--------
Confidence            87643221 1123456899999999987643    788999999999999999999999764321   1111        


Q ss_pred             cchhhhcccccccCCC--HHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 016917          301 SNLLKILDERLWSTFT--NEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE  347 (380)
Q Consensus       301 ~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~--Rpt~~~ll~~  347 (380)
                          .+.+......++  ...+..+.+++..||+.++.+  |+++.+++++
T Consensus       258 ----~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         258 ----KIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ----HHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                111111011112  234677899999999866544  8999999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.1e-42  Score=327.31  Aligned_cols=261  Identities=23%  Similarity=0.339  Sum_probs=196.2

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCC-----eeE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----LQF  146 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  146 (380)
                      +|++.+.||+|+||.||++.. .+++.||+|+....     ....+.+|+++++.++||||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999995 57899999986432     2346788999999999999999999998766     789


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +|+||+.+ +|.+.+.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~~-~l~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQS-DLHKIIV-----SPQPLSSDHVKVFLYQILRGLKYLHS--AGILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeecccc-CHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHHEEECCCCCEEeccccceee
Confidence            99999975 6766662     34568899999999999999999999  6799999999999999999999999999876


Q ss_pred             cCCCCCCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch--
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL--  303 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  303 (380)
                      ...... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||....+......+...........+  
T Consensus       153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            543221 122334578889999998774 5799999999999999999999999865432111111000000000000  


Q ss_pred             -----hhhc-ccccc-------cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 -----LKIL-DERLW-------STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 -----~~~~-~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                           ...+ .....       .......++++.+++.+||+.||++|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                 0000 00000       01122345778999999999999999999999976

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.7e-42  Score=335.15  Aligned_cols=263  Identities=23%  Similarity=0.309  Sum_probs=194.8

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCChHHHHHHHHHHhcCCCCceeeeccceec--------CCee
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQE--------NNLQ  145 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~~~  145 (380)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|+.... .....+|+.+++.++||||+++++++..        ....
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            345799999999999999999996 46889999976433 2334579999999999999999887632        1246


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEcccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLR  224 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~-~~kl~DFgla  224 (380)
                      ++||||+++ ++.+++.... .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++ .+||+|||++
T Consensus       143 ~lvmE~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~--~~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        143 NVVMEFIPQ-TVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHS--KFICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             EEEEecCCc-cHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            789999986 5655553211 234568899999999999999999999  7799999999999998664 7999999999


Q ss_pred             cccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhh--hccc
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--RDFS  301 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~  301 (380)
                      +.+....   ......+|+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+....  ..+...+...  ...+
T Consensus       219 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        219 KNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRIIQVLGTPTED  293 (440)
T ss_pred             hhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHH
Confidence            8664322   1234567889999998765 46899999999999999999999999865432  1111111110  0000


Q ss_pred             ch------------hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 NL------------LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 ~~------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..            .......+...++...++++.+|+.+||+.||.+|||+.+++++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            00            00011112222344456789999999999999999999999966

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-41  Score=311.81  Aligned_cols=265  Identities=28%  Similarity=0.421  Sum_probs=200.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-----CCCcEEEEEeCCCCCh---HHHHHHHHHHhcCCCCceeeeccceec--CCeeE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQF  146 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  146 (380)
                      +.|++.+.||+|+||.||++..     .++..|++|.......   +.+.+|+++++.++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4688889999999999999974     3578899998655433   467889999999999999999998653  34679


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +|+||+++++|.+++..    ....+++..+..++.|++.||.|||+  ++++||||||+||++++++.++|+|||++..
T Consensus        84 lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~aL~~LH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          84 LVMEYLPYGSLRDYLQK----HRERLDHRKLLLYASQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEecCCCCHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHhhEEECCCCeEEECCCccccc
Confidence            99999999999998842    23457899999999999999999999  7799999999999999999999999999987


Q ss_pred             cCCCCCC-CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc----cc
Q 016917          227 LGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD----FS  301 (380)
Q Consensus       227 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~  301 (380)
                      ....... .......++..|+|||...+..++.++|||||||++|||++|..|+......    ..........    ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  233 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVY  233 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchH
Confidence            6432211 1111222445699999999889999999999999999999988765432211    0000000000    00


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                      .+.+.+........+..++.++.+++.+||..||++|||+.++++.|+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            01111222222233445667899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.2e-42  Score=320.99  Aligned_cols=246  Identities=20%  Similarity=0.288  Sum_probs=193.7

Q ss_pred             CeeccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|+||.||+|.. .++..||+|.....      ..+.+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999995 46889999975432      234577899999888 799999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 g~L~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~  151 (329)
T cd05588          81 GDLMFHMQ-----RQRKLPEEHARFYSAEISLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GD  151 (329)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEECcCccccccccC--CC
Confidence            99988773     34568999999999999999999999  77999999999999999999999999998753211  11


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC--cccHHHHHHhhhcccchhhhcccccc
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS--SQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                      ......||..|+|||++.+..++.++|+|||||++|+|++|+.||.......  .....+.....        +....  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------~~~~~--  221 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV--------ILEKQ--  221 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH--------HHcCC--
Confidence            2234578999999999999999999999999999999999999997433221  11111111100        01111  


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCC------HHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPS------MSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt------~~~ll~~  347 (380)
                      ...+...+.++.+++.+||+.||.+||+      +++++++
T Consensus       222 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         222 IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            1234445677999999999999999997      5677654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.1e-41  Score=316.31  Aligned_cols=262  Identities=27%  Similarity=0.452  Sum_probs=205.8

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC--------CCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeeeccceec
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQE  141 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~  141 (380)
                      ...+|.+.+.||+|+||.||+|+..        ....+|+|......    ...+..|+++++.+ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3457888999999999999999742        24578999755332    23577899999999 69999999999999


Q ss_pred             CCeeEEEEEeecCCCccccccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 016917          142 NNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (380)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili  210 (380)
                      .+..++||||+++|+|.+++.....           .....+++..+..++.|++.||.|||+  ++++||||||+|||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Nill  167 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDLAARNVLV  167 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeeccccceeEEE
Confidence            9999999999999999998854321           123458899999999999999999999  779999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCccc
Q 016917          211 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQD  289 (380)
Q Consensus       211 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~  289 (380)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ..
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~  244 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EE  244 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HH
Confidence            9999999999999987644222222222234457999999998899999999999999999999 8888865432   11


Q ss_pred             HHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          290 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      .......             ......+..++.++.+++.+||+.||++|||+.++++.|.++...
T Consensus       245 ~~~~~~~-------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         245 LFKLLRE-------------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             HHHHHHc-------------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            2221111             111123345567899999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.3e-41  Score=312.82  Aligned_cols=263  Identities=26%  Similarity=0.396  Sum_probs=203.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECC-----------------CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQD-----------------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVT  134 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~  134 (380)
                      .++|++.+.||+|+||.||+|....                 +..||+|......    .+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578999999999999999998532                 2458899865432    346788999999999999999


Q ss_pred             eccceecCCeeEEEEEeecCCCccccccCCCCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 016917          135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQV------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (380)
Q Consensus       135 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Ni  208 (380)
                      +++++..++..+++|||+++++|.+++......      ....+++..++.++.|++.||.|||+  .+++||||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~--~~i~H~dlkp~Ni  161 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES--LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH--cCccccccchhce
Confidence            999999999999999999999999988543311      12368899999999999999999999  6799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCCCC
Q 016917          209 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSLSPDS  286 (380)
Q Consensus       209 li~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t--g~~p~~~~~~~~  286 (380)
                      +++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++  |..||.....  
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~--  239 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD--  239 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence            999999999999999886544332222334456778999999988889999999999999999998  6677765431  


Q ss_pred             cccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          287 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                       ...........      ...........+..++.++.+++.+||+.||.+|||+.++++.|.
T Consensus       240 -~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 -QQVIENAGHFF------RDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             -HHHHHHHHhcc------ccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence             11111111100      000111111223345578999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.9e-42  Score=318.72  Aligned_cols=238  Identities=24%  Similarity=0.340  Sum_probs=190.2

Q ss_pred             CeeccCCceEEEEEEE-CCCcEEEEEeCCC------CChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|+||.||+|.. .++..||+|....      ...+....|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999995 4578999997542      2234455677777654 899999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 g~L~~~~~-----~~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~  151 (316)
T cd05592          81 GDLMFHIQ-----SSGRFDEARARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G  151 (316)
T ss_pred             CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence            99988873     34568889999999999999999999  779999999999999999999999999987543222  2


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      ......||..|+|||.+.+..++.++|||||||++|||++|+.||.....   ......+..              ....
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~--------------~~~~  214 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSILN--------------DRPH  214 (316)
T ss_pred             ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHc--------------CCCC
Confidence            23345689999999999999999999999999999999999999986432   111111110              0123


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHH-HHHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMS-DVVT  346 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~-~ll~  346 (380)
                      ++...+.++.+++.+||+.||.+||++. ++++
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            3444567789999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.5e-42  Score=312.12  Aligned_cols=256  Identities=27%  Similarity=0.445  Sum_probs=201.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      .++|+..++||+|+||.||++...      ++..+++|......   .+.+.+|+++++.++|+||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            346778899999999999999732      35678888765443   346889999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCce
Q 016917          147 LIYEYIPNGSVSIHLYGPSQ----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  216 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~  216 (380)
                      ++|||+++++|.+++.....          .....+++..+..++.|++.|++|||+  ++++||||||+|||+++++.+
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS--LHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH--CCeecccccHhhEEEcCCCCE
Confidence            99999999999988854321          112457889999999999999999999  779999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHH
Q 016917          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ  295 (380)
Q Consensus       217 kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~  295 (380)
                      +|+|||++................++..|+|||...+..++.++|||||||++|||++ |.+||......   .......
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~  238 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIECIT  238 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHHHHH
Confidence            9999999876543222112223335678999999999999999999999999999998 89998654321   1111111


Q ss_pred             hhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                                   .......+..+++.+.+++.+||+.||.+||+++++++.|+
T Consensus       239 -------------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         239 -------------QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -------------cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                         11111223345677999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8e-42  Score=320.89  Aligned_cols=263  Identities=24%  Similarity=0.371  Sum_probs=202.1

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE------CCCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeeeccceec-C
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQE-N  142 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~  142 (380)
                      ..++|++.+.||+|+||.||+|..      .+++.||+|......    ...+.+|++++.++ +||||+++++++.. +
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            345799999999999999999973      346789999865432    34577899999999 68999999998865 4


Q ss_pred             CeeEEEEEeecCCCccccccCCCCC-------------------------------------------------------
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQV-------------------------------------------------------  167 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------  167 (380)
                      ...++||||+++|+|.+++......                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            5678999999999999887532100                                                       


Q ss_pred             -------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCcccc
Q 016917          168 -------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT  240 (380)
Q Consensus       168 -------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~  240 (380)
                             ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++................
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   01246788889999999999999999  779999999999999999999999999987653322211122234


Q ss_pred             CccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHH
Q 016917          241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG  319 (380)
Q Consensus       241 ~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (380)
                      ++..|+|||.+.+..++.++||||||+++|+|++ |..||......  ......+...             .....+...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~-------------~~~~~~~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEG-------------TRMRAPDYT  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHHHhcc-------------CCCCCCCCC
Confidence            5567999999988899999999999999999997 88998754321  1111111111             111122233


Q ss_pred             HHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          320 MEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       320 ~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      ++++.+++..||+.||.+|||+.+++++|+++++.
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            46789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.8e-42  Score=305.87  Aligned_cols=262  Identities=23%  Similarity=0.320  Sum_probs=199.0

Q ss_pred             CCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCC-----CChHHHHHHHHHHhcCCCCc-eeeeccceecCC------e
Q 016917           78 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRN-LVTLLGYCQENN------L  144 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~  144 (380)
                      .|...++||+|+||+||+|+ ..+|+.||+|+..-     .......+|+.+|+.++|+| |+.+++++.+.+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            45556779999999999999 56789999997331     24556789999999999999 999999998776      7


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .++|+||++. +|..++....... ..++...+..++.|++.||+|||+  ++|+||||||+|+||+++|.+||+|||+|
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~--~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS--HGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCcceEEECCCCcEeeeccchH
Confidence            8999999987 8888885432211 456678899999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh--h---h
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN--S---R  298 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~---~  298 (380)
                      +...-.  ........+|..|+|||++.+. .|++..||||+||+++||+++++.|.+..+  .+++....+.  .   .
T Consensus       168 ra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  168 RAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             HHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCCcc
Confidence            865421  1224455688889999998887 899999999999999999999998887654  2222211111  1   1


Q ss_pred             cccchhhhccccc--ccCC-C----H---HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          299 DFSNLLKILDERL--WSTF-T----N---EGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       299 ~~~~~~~~~~~~~--~~~~-~----~---~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .++.+....+.+.  .... +    .   ...++..+++.+||+.||.+|.|++.++.+
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            1111111111110  0000 1    1   111478999999999999999999999987

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.7e-42  Score=330.24  Aligned_cols=249  Identities=21%  Similarity=0.243  Sum_probs=194.4

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      .|+..+.||+|+||.||+|.. .+++.||+|.....      ....+.+|+++++.++||||+++++.+.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            578889999999999999995 46889999986532      23457789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++|+|.+.+.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~gg~L~~~l~-----~~~~~~e~~~~~~~~qi~~al~~lH~--~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLI-----RMGIFPEDLARFYIAELTCAVESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            999999998883     23467888899999999999999999  67999999999999999999999999997533110


Q ss_pred             CC---------------------------------------------CCCCccccCccceecccccccCCCCcchhhHHH
Q 016917          231 DV---------------------------------------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSF  265 (380)
Q Consensus       231 ~~---------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSl  265 (380)
                      ..                                             ........||+.|+|||++.+..|+.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            00                                             000123468999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCC---HH
Q 016917          266 GVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS---MS  342 (380)
Q Consensus       266 G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---~~  342 (380)
                      ||++|||++|+.||....+.      +........       ......+.....++++.+++.+|+ .||.+|++   +.
T Consensus       235 Gvil~elltG~~Pf~~~~~~------~~~~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~  300 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPL------ETQMKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD  300 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHH------HHHHHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence            99999999999999865421      111100000       001111112234567888888876 59999997   88


Q ss_pred             HHHHH
Q 016917          343 DVVTE  347 (380)
Q Consensus       343 ~ll~~  347 (380)
                      +++++
T Consensus       301 ei~~h  305 (382)
T cd05625         301 EIKAH  305 (382)
T ss_pred             HHhcC
Confidence            87765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-42  Score=314.32  Aligned_cols=264  Identities=25%  Similarity=0.383  Sum_probs=200.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECC---------------CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeec
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQD---------------GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLL  136 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~---------------~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~  136 (380)
                      .++|++.+.||+|+||.||+|....               ...||+|......    .+.+.+|++++++++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4578999999999999999987532               2358999865432    34588899999999999999999


Q ss_pred             cceecCCeeEEEEEeecCCCccccccCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 016917          137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQ-------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL  209 (380)
Q Consensus       137 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nil  209 (380)
                      +++...+..++||||+++++|.+++.....       .....+++..++.++.|++.||.|||+  .+++||||||+||+
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil  161 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS--LNFVHRDLATRNCL  161 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh--cCeeccccChhhEE
Confidence            999999999999999999999988743211       011246788999999999999999999  67999999999999


Q ss_pred             eCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCCCCc
Q 016917          210 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSLSPDSS  287 (380)
Q Consensus       210 i~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t--g~~p~~~~~~~~~  287 (380)
                      +++++.+||+|||++................++..|+|||...+..++.++|+|||||++|+|++  |..||......  
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~--  239 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE--  239 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence            99999999999999876543222222223345678999999988899999999999999999998  56676654321  


Q ss_pred             ccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHh
Q 016917          288 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  350 (380)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~  350 (380)
                       +.........      ...........+...++.+.+++.+||+.||++||++.++++.|.+
T Consensus       240 -~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         240 -QVIENTGEFF------RNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             -HHHHHHHHhh------hhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence             1111111000      0000111112233345789999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-41  Score=306.75  Aligned_cols=251  Identities=25%  Similarity=0.432  Sum_probs=201.0

Q ss_pred             CCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      .+|++.+.||+|++|.||+|....+..+++|.....  ..+.+.+|+.+++.++|||++++++++.. +..++||||+.+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~   84 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGK   84 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence            457888999999999999999877778999975533  34568899999999999999999988754 557899999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      ++|.+++...   ....+++..+..++.|++.||.|||+  .+++|+||||+||++++++.++|+|||++......... 
T Consensus        85 ~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          85 GSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIER--MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            9999988532   23447889999999999999999999  67999999999999999999999999999766432211 


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccccc
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  313 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (380)
                      ......++..|+|||...+..++.++||||||+++|||++ |..||......   .......             .....
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~-------------~~~~~  222 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQVE-------------RGYRM  222 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH-------------cCCCC
Confidence            1223345677999999988899999999999999999999 88998754321   1111111             01111


Q ss_pred             CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHh
Q 016917          314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  350 (380)
Q Consensus       314 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~  350 (380)
                      ..+...+..+.+++.+||+.||.+||+++++++.|++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            2334556789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.5e-41  Score=312.57  Aligned_cols=263  Identities=24%  Similarity=0.382  Sum_probs=201.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-----------------CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-----------------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVT  134 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~  134 (380)
                      .++|++.+.||+|+||.||++...                 ++..+|+|......    .+.+.+|+++++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356899999999999999998632                 23468999865432    356889999999999999999


Q ss_pred             eccceecCCeeEEEEEeecCCCccccccCCCCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 016917          135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQV------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (380)
Q Consensus       135 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Ni  208 (380)
                      +++++...+..++||||+++++|.+++......      ....+++..+..++.|++.||.|||+  .+++||||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dlkp~Ni  161 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS--LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCeecccCChheE
Confidence            999999999999999999999999888543211      12347788899999999999999999  6799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCCCC
Q 016917          209 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS--GREASSSLSPDS  286 (380)
Q Consensus       209 li~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t--g~~p~~~~~~~~  286 (380)
                      |++.++.++|+|||++..+.............++..|++||...+..++.++|+|||||++|||++  |..||......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999886643322121222334667999999888889999999999999999998  678886543211


Q ss_pred             cccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          287 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                         .........      .........+.+..+++.+.+++.+||+.||++||++.++++.|+
T Consensus       242 ---~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 ---VIENTGEFF------RDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             ---HHHHHHHHH------hhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence               111100000      000001111223345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.3e-41  Score=303.44  Aligned_cols=244  Identities=29%  Similarity=0.490  Sum_probs=196.6

Q ss_pred             CeeccCCceEEEEEEECCCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCcc
Q 016917           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS  158 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  158 (380)
                      ++||+|+||.||+|...++..+|+|......    ...+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3689999999999998888999999865443    235778999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCcc
Q 016917          159 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ  238 (380)
Q Consensus       159 ~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~  238 (380)
                      +++..    ....+.+..+..++.|++.||.|+|+  ++++||||||+||+++.++.++|+|||++......... ....
T Consensus        81 ~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~  153 (250)
T cd05085          81 SFLRK----KKDELKTKQLVKFALDAAAGMAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGL  153 (250)
T ss_pred             HHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCC
Confidence            88742    23457889999999999999999999  77999999999999999999999999998765432211 1112


Q ss_pred             ccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCH
Q 016917          239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  317 (380)
Q Consensus       239 ~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (380)
                      ..++..|+|||++.+..++.++||||||+++|++++ |..||......   .....+.             .......+.
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~~-------------~~~~~~~~~  217 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQVE-------------KGYRMSCPQ  217 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHH-------------cCCCCCCCC
Confidence            234567999999998889999999999999999998 99998754321   1111111             111122334


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          318 EGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       318 ~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                      .++.++.+++.+||+.+|++||++.++++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            45678999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.2e-42  Score=313.04  Aligned_cols=257  Identities=27%  Similarity=0.437  Sum_probs=203.1

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      .++|++.+.||+|+||.||+|...      ++..||+|......    ...+.+|+.+++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457889999999999999999853      46789999865443    34588899999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQ-----------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Ni  208 (380)
                      ++||||+++|+|.+++.....                 .....+++..++.++.|++.||.|||+  ++++||||||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~--~~i~H~dl~p~ni  161 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRDLATRNC  161 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCeecccccHhhe
Confidence            999999999999988853211                 112357888899999999999999999  7899999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCc
Q 016917          209 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSS  287 (380)
Q Consensus       209 li~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~  287 (380)
                      +++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||......  
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~--  239 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE--  239 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            999999999999999876543322222223334567999999998999999999999999999997 88888654321  


Q ss_pred             ccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHh
Q 016917          288 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  350 (380)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~  350 (380)
                       +....+.            +.. ....+...+.++.+++.+||+.||.+|||+.|+++.|++
T Consensus       240 -~~~~~~~------------~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 -EVIYYVR------------DGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -HHHHHHh------------cCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence             1111111            011 112233456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.3e-41  Score=305.08  Aligned_cols=245  Identities=24%  Similarity=0.415  Sum_probs=194.5

Q ss_pred             eeccCCceEEEEEEEC---CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCC
Q 016917           84 LIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS  156 (380)
Q Consensus        84 ~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  156 (380)
                      .||+|+||.||+|...   .+..||+|......    .+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999753   35579999865443    3457899999999999999999998864 46799999999999


Q ss_pred             ccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC-CC
Q 016917          157 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA-GP  235 (380)
Q Consensus       157 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~-~~  235 (380)
                      |.+++..    ....+++..++.++.|++.||.|||+  ++++||||||+|||++.++.+||+|||++......... ..
T Consensus        81 L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--cCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            9988842    24568899999999999999999999  77999999999999999999999999998765432211 11


Q ss_pred             CccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      .....++..|+|||.+.+..++.++|||||||++||+++ |..||......   +....+             .......
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~-------------~~~~~~~  218 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSFI-------------EQGKRLD  218 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH-------------HCCCCCC
Confidence            122233567999999988889999999999999999996 99998765321   111111             1111223


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                      .+..+++++.+++.+||..||++||++.++.+.|..+
T Consensus       219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            4455678899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=8.6e-42  Score=315.31  Aligned_cols=260  Identities=27%  Similarity=0.459  Sum_probs=203.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCc--EEEEEeCCCC----ChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM--LVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  147 (380)
                      .++|++.+.||+|+||.||+|..+ ++.  .+++|.....    ....+.+|++++.++ +||||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            457888899999999999999964 343  4577765432    234577899999999 89999999999999999999


Q ss_pred             EEEeecCCCccccccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCce
Q 016917          148 IYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  216 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~  216 (380)
                      ||||+++++|.+++.....           .....+++..++.++.|++.|++|||+  ++++||||||+|||++.++.+
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEecCCCcE
Confidence            9999999999998854321           112357899999999999999999998  779999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHH
Q 016917          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ  295 (380)
Q Consensus       217 kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~  295 (380)
                      ||+|||++.......   .......+..|+|||.+.+..++.++|||||||++|||+| |..||......   +....+.
T Consensus       164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~  237 (303)
T cd05088         164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLP  237 (303)
T ss_pred             EeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHHHHh
Confidence            999999986432111   1111234567999999988889999999999999999998 99998754321   1111110


Q ss_pred             hhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                                   .......+...++++.+++.+||+.||++||++.++++.|.++++..-
T Consensus       238 -------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         238 -------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             -------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence                         111112233355779999999999999999999999999998887754

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-41  Score=318.21  Aligned_cols=265  Identities=26%  Similarity=0.447  Sum_probs=208.2

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEEC--------CCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeeeccce
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYC  139 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~  139 (380)
                      ++...+|++.+.||+|+||.||+|...        .+..||+|......    .+.+.+|+++++++ +||||+++++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            344557889999999999999999742        12368999765332    34688899999999 799999999999


Q ss_pred             ecCCeeEEEEEeecCCCccccccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 016917          140 QENNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (380)
Q Consensus       140 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Ni  208 (380)
                      ...+..++++||+.+|+|.+++.....           .....+++..+..++.|++.||.|||+  ++++||||||+||
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Ni  165 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS--QKCIHRDLAARNV  165 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceE
Confidence            999999999999999999998854221           123457889999999999999999999  7799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCc
Q 016917          209 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSS  287 (380)
Q Consensus       209 li~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~  287 (380)
                      |++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....   
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---  242 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---  242 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---
Confidence            999999999999999887644322222222334567999999999999999999999999999998 8888865432   


Q ss_pred             ccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          288 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      ......+.             .......+..++.++.+++.+||+.+|.+|||+.++++.|+++....
T Consensus       243 ~~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         243 EELFKLLK-------------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHHHHHHH-------------cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            11111111             11112233445678999999999999999999999999999888544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.3e-42  Score=323.91  Aligned_cols=240  Identities=23%  Similarity=0.269  Sum_probs=194.3

Q ss_pred             CeeccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCC
Q 016917           83 NLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  155 (380)
                      +.||+|+||.||++.. .++..||+|.....      ....+..|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999995 56889999975432      2345678999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016917          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (380)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~  235 (380)
                      +|..++.     ....+++..+..++.|++.||.|||+. ++|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~~-~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLS-----RERVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            9988773     345688999999999999999999962 479999999999999999999999999987542211  11


Q ss_pred             CccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCC
Q 016917          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF  315 (380)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (380)
                      .....||..|+|||++.+..++.++|||||||++|||++|..||......   .....+.            ..  ...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~i~------------~~--~~~~  215 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELIL------------ME--EIRF  215 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHHHh------------cC--CCCC
Confidence            23456899999999999999999999999999999999999999754321   1111111            00  0123


Q ss_pred             CHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          316 TNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       316 ~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                      +...++++.+++.+||+.||++|+     ++.+++++
T Consensus       216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            344567899999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.6e-42  Score=329.77  Aligned_cols=250  Identities=22%  Similarity=0.248  Sum_probs=196.8

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||.||+|+. .+++.||+|....      .....+.+|+++++.++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3688999999999999999995 4688999997543      23455778999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||++..+..
T Consensus        81 E~~~~g~L~~~i~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLI-----RLGIFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            9999999999883     34567888889999999999999999  6799999999999999999999999999753310


Q ss_pred             CC-----------------------------------------CCCCCccccCccceecccccccCCCCcchhhHHHHHH
Q 016917          230 TD-----------------------------------------VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVF  268 (380)
Q Consensus       230 ~~-----------------------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~i  268 (380)
                      ..                                         .........||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            00                                         0000123468999999999999999999999999999


Q ss_pred             HHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCC---CHHHHH
Q 016917          269 LLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP---SMSDVV  345 (380)
Q Consensus       269 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---t~~~ll  345 (380)
                      +|||++|+.||....+.+   ....+.   ...       ...........++++.+++.+|+ .+|.+|+   ++.+++
T Consensus       234 lyell~G~~Pf~~~~~~~---~~~~i~---~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell  299 (376)
T cd05598         234 LYEMLVGQPPFLADTPAE---TQLKVI---NWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK  299 (376)
T ss_pred             eeehhhCCCCCCCCCHHH---HHHHHh---ccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence            999999999998654211   111110   000       00111112234567888999876 5999999   899998


Q ss_pred             HH
Q 016917          346 TE  347 (380)
Q Consensus       346 ~~  347 (380)
                      ++
T Consensus       300 ~h  301 (376)
T cd05598         300 AH  301 (376)
T ss_pred             CC
Confidence            77

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-41  Score=325.24  Aligned_cols=263  Identities=19%  Similarity=0.208  Sum_probs=202.2

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC---CCcEEEEEeCCCCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      ...+|++.+.||+|+||.||+|...   .+..|++|.....  ....+|++++++++||||+++++++...+..++|||+
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~  167 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK  167 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence            3457999999999999999999743   3578999986543  3456899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +. ++|.+++     .....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||++.......
T Consensus       168 ~~-~~l~~~l-----~~~~~l~~~~~~~i~~ql~~aL~~LH~--~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        168 YK-CDLFTYV-----DRSGPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             cC-CCHHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            86 4777777     234668999999999999999999999  779999999999999999999999999998765433


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc---------
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN---------  302 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  302 (380)
                      .........||..|+|||++.+..|+.++|||||||++|||++|+.||.+............+........         
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence            33333456789999999999999999999999999999999999999977654332221111111100000         


Q ss_pred             -hhh---hcccccccCCC-------HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          303 -LLK---ILDERLWSTFT-------NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       303 -~~~---~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       +.+   ......+..+.       ...+.++.+++.+||+.||++|||+.+++.+
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence             000   00000111111       1234678899999999999999999999987

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-41  Score=306.35  Aligned_cols=255  Identities=27%  Similarity=0.490  Sum_probs=206.4

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCC--CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +..++|++.+.||+|+||.||+|..+++..+++|....  .....+.+|++++++++|+||+++++++......++||||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            34567899999999999999999988888999997653  3456789999999999999999999999988899999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++...   ....+++..+..++.+++.|+.|||+  ++++|+||||+||++++++.++|+|||++.......
T Consensus        83 ~~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          83 MSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             cCCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999988432   23467899999999999999999999  679999999999999999999999999988764321


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      . ........+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.....   ........             ..
T Consensus       158 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~-------------~~  220 (261)
T cd05034         158 Y-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVE-------------RG  220 (261)
T ss_pred             h-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH-------------cC
Confidence            1 11122234567999999998899999999999999999998 9999865432   11111111             11


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHh
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  350 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~  350 (380)
                      .....+...+.++.+++.+||+.||.+||+++++.+.|+.
T Consensus       221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         221 YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1112233346789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5e-42  Score=319.26  Aligned_cols=239  Identities=21%  Similarity=0.309  Sum_probs=191.9

Q ss_pred             CeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|+||.||+|..+ +++.||+|....      .....+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 578999997542      2334567788888876 799999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 g~L~~~i~-----~~~~l~~~~~~~~~~ql~~~L~~lH~--~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~  151 (320)
T cd05590          81 GDLMFHIQ-----KSRRFDEARARFYAAEITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--K  151 (320)
T ss_pred             chHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--C
Confidence            99988873     34568899999999999999999999  779999999999999999999999999987532211  1


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......   .....+..            .  ...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~~i~~------------~--~~~  214 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAILN------------D--EVV  214 (320)
T ss_pred             cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHhc------------C--CCC
Confidence            223456899999999999999999999999999999999999999864421   11111110            0  012


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCH------HHHHHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSM------SDVVTE  347 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~------~~ll~~  347 (380)
                      .+...++++.+++.+||+.||.+||++      ++++++
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            233456789999999999999999998      555544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.4e-41  Score=306.62  Aligned_cols=255  Identities=27%  Similarity=0.486  Sum_probs=202.5

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CC---cEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DG---MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~---~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      .++|+..+.||+|+||.||+|... ++   ..+++|......    .+.+..|+++++.++||||+++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            346778899999999999999964 33   378999865432    3467889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+++++|.+++..    ....+++..+..++.|++.|++|||+  .+++||||||+||+++.++.++|+|||++...
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          84 ITEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSD--MNYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEEcCCCcEEECCCccceec
Confidence            9999999999988832    23567889999999999999999999  77999999999999999999999999998766


Q ss_pred             CCCCCCC-CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          228 GRTDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       228 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.....   ......+.          
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~----------  224 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAIN----------  224 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHh----------
Confidence            4322111 1112223457999999998899999999999999999997 9999875432   11111111          


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                         .....+.+..++.++.+++.+||+.||++||++.++++.|.+++
T Consensus       225 ---~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         225 ---DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             ---cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence               11112223345678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.6e-41  Score=305.71  Aligned_cols=249  Identities=29%  Similarity=0.425  Sum_probs=199.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC-ChHHHHHHHHHHhcCCCCceeeecccee-cCCeeEEEEEeec
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQ-ENNLQFLIYEYIP  153 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  153 (380)
                      ..+|++.+.||+|+||.||++... +..+++|..... ..+.+.+|+.+++.++|+|++++++++. ..+..++++||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            457888999999999999999865 778999976543 3456889999999999999999999764 5567899999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                      +++|.+++...   ....+++..++.++.|++.||.|||+  ++++||||||+||++++++.+||+|||++.......  
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          84 KGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            99999988432   23357889999999999999999999  779999999999999999999999999987643311  


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                         .....+..|+|||++.+..++.++|||||||++|||++ |+.||.....   .+....+..             ...
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~-------------~~~  217 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEK-------------GYK  217 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhc-------------CCC
Confidence               22234557999999998899999999999999999997 9998865331   111111111             111


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                      ...+..+++.+.+++.+||+.||++|||+.++++.|+++
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            123344567899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.2e-42  Score=319.24  Aligned_cols=244  Identities=21%  Similarity=0.294  Sum_probs=195.2

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCC-CceeeeccceecCCeeEEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  149 (380)
                      +|++.+.||+|+||.||+|... +++.||+|....      ...+.+..|.+++..++| ++|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999954 578899997542      234567789999999976 56888999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQ-----QVGKFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            9999999988883     34567889999999999999999999  7799999999999999999999999999864321


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ..  .......||..|+|||++.+..++.++|||||||++|||++|+.||.....   ......+..            .
T Consensus       154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~~------------~  216 (324)
T cd05587         154 GG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQSIME------------H  216 (324)
T ss_pred             CC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHc------------C
Confidence            11  122345689999999999999999999999999999999999999975432   111111110            0


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM-----SDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~~ll~~  347 (380)
                        ...++...++++.+++.+||+.||.+|++.     ++++++
T Consensus       217 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         217 --NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              112334456778999999999999999986     566544

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-42  Score=324.66  Aligned_cols=250  Identities=23%  Similarity=0.263  Sum_probs=198.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||.||++.. .++..||+|.....      ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4688899999999999999995 46889999975432      2345778999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~qi~~aL~~lH~--~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNR----YEDQFDEDMAQFYLAELVLAIHSVHQ--MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            99999999998842    23568899999999999999999999  7799999999999999999999999999987643


Q ss_pred             CCCCCCCccccCccceecccccc------cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          230 TDVAGPSSQVTADEIFLASEVKE------FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      .... ......+|+.|+|||++.      +..++.++|||||||++|||++|+.||......      ........... 
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~-  226 (330)
T cd05601         155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQR-  226 (330)
T ss_pred             CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCC-
Confidence            2211 122346888999999986      456789999999999999999999999764321      11111111100 


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                            ....+.....++++.+++.+||+ ||.+|||+++++++
T Consensus       227 ------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         227 ------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             ------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                  00011112345779999999998 99999999999865

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-42  Score=330.21  Aligned_cols=274  Identities=26%  Similarity=0.410  Sum_probs=229.2

Q ss_pred             CCCCeeccCCceEEEEEEEC-C----CcEEEEEeCC----CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           80 SDKNLIGEGKFGEVYKGLLQ-D----GMLVAIKKRP----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        80 ~~~~~ig~G~~g~V~~~~~~-~----~~~vavK~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      +..++||+|+||+||+|.+- .    +.+||+|.+.    .....++.+|.-+|.+++|||+++++++|.... +.||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            34589999999999999852 2    4578888643    234678999999999999999999999998776 789999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |++.|+|.++++    ..+..+.....+.+..||++||.|||.  +++|||||..+|||+.....+|++|||+++.....
T Consensus       778 ~mP~G~LlDyvr----~hr~~igsq~lLnw~~QIAkgM~YLe~--qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  778 LMPLGCLLDYVR----EHRDNIGSQDLLNWCYQIAKGMKYLEE--QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             hcccchHHHHHH----HhhccccHHHHHHHHHHHHHHHHHHHh--cchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            999999999994    456788889999999999999999998  77999999999999999999999999999998776


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ..........-++.|||-|.+....|+.++|||||||++||++| |..||.+....                ++.+.+..
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~----------------eI~dlle~  915 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE----------------EIPDLLEK  915 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----------------HhhHHHhc
Confidence            65555555666778999999999999999999999999999998 99999887643                34444555


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcccccccCCCCcccccccccc
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSHLF  376 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (380)
                      ..+...|+.++.++..++.+||..|+..||+++++...+.++.+.+..--.+.....+-+++.+..|
T Consensus       916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl~i~~~~~~~~s~~~~~~  982 (1177)
T KOG1025|consen  916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYLVIQDERMILPSPESSLF  982 (1177)
T ss_pred             cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEeeehhhcCCCCCCCcchH
Confidence            5566788899999999999999999999999999999999998887654444443344444444433

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.4e-42  Score=318.45  Aligned_cols=238  Identities=21%  Similarity=0.312  Sum_probs=190.3

Q ss_pred             CeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|+||.||+|..+ ++..||+|....      ........|..++... +||||+++++++.+.+..|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999964 688999997542      2334566777787754 899999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |+|..++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.++|+|||+++.....  ..
T Consensus        81 g~L~~~i~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  151 (316)
T cd05620          81 GDLMFHIQ-----DKGRFDLYRATFYAAEIVCGLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DN  151 (316)
T ss_pred             CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CC
Confidence            99988873     34567888999999999999999999  67999999999999999999999999998743211  11


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      ......||..|+|||++.+..++.++|||||||++|||++|+.||.....   ....+.+...              ...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~~~~--------------~~~  214 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESIRVD--------------TPH  214 (316)
T ss_pred             ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhC--------------CCC
Confidence            23345689999999999999999999999999999999999999975432   1111111100              112


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHH-HHHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMS-DVVT  346 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~-~ll~  346 (380)
                      ++...+.++.+++.+||+.||++||++. ++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         215 YPRWITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            3334557799999999999999999985 5553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.4e-41  Score=305.58  Aligned_cols=253  Identities=25%  Similarity=0.455  Sum_probs=202.0

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC----CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .+|++.+.||+|+||.||+|...    .+..+|+|......    ...+.+|+.+++.++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999853    23478999765432    34678899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++++|.+++..    ....+++..+..++.|++.|+.|||+  ++++||||||+|||++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            999999999998842    23457889999999999999999999  779999999999999999999999999998764


Q ss_pred             CCCCCC-CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          229 RTDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       229 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      ...... ......++..|+|||.+.+..++.++|+|||||++||+++ |..||......   +....+...         
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~---------  225 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIEEG---------  225 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHhCC---------
Confidence            322111 1122233567999999998899999999999999999886 99998765421   111111110         


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                          ...+.+..+++.+.+++.+||+.+|.+||++.++++.|+++
T Consensus       226 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 ----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                11122334567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.9e-41  Score=306.30  Aligned_cols=253  Identities=25%  Similarity=0.463  Sum_probs=201.2

Q ss_pred             CCCCCCCeeccCCceEEEEEEECC-C---cEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQD-G---MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~-~---~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      ++|++.+.||+|+||.||+|.... +   ..|++|......    ...+..|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457788999999999999999542 3   369999865432    34688999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++++|.+++..    ....+++..+..++.|++.|+.|||+  ++++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~l~~al~~lH~--~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            999999999988843    23467889999999999999999999  779999999999999999999999999987664


Q ss_pred             CCCCCCCC---ccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          229 RTDVAGPS---SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       229 ~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ........   .....+..|+|||.+.+..++.++|||||||++|||++ |..||......   +....+.         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~---------  225 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE---------  225 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH---------
Confidence            32211111   11112457999999999999999999999999999886 99998754321   1111111         


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                          .....+.+.+++..+.+++.+||+.+|.+||++++++..|+++
T Consensus       226 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         226 ----QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ----cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                0111223345567799999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.4e-41  Score=317.49  Aligned_cols=246  Identities=20%  Similarity=0.283  Sum_probs=192.2

Q ss_pred             CeeccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|+||.||+|.. .+++.+|+|.....      ....+..|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999995 46789999975432      223467788888776 899999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 ~~L~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~  151 (329)
T cd05618          81 GDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D  151 (329)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--C
Confidence            99988773     34568899999999999999999999  679999999999999999999999999987532211  1


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCc--ccHHHHHHhhhcccchhhhcccccc
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS--QDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                      ......||..|+|||++.+..++.++|||||||++|||++|+.||........  ..........        +...  .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------i~~~--~  221 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------ILEK--Q  221 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH--------HhcC--C
Confidence            22345689999999999999999999999999999999999999964322111  1111111110        0111  1


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCH------HHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSM------SDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~------~~ll~~  347 (380)
                      ..++...+..+.+++.+||+.||.+||++      .+++++
T Consensus       222 ~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         222 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            13444556778999999999999999984      566554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.5e-42  Score=318.68  Aligned_cols=239  Identities=20%  Similarity=0.284  Sum_probs=192.7

Q ss_pred             CeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|+||.||+|+.. +++.||+|....      ...+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999964 578999997543      2234567788888866 799999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |+|...+.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.......  .
T Consensus        81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~  151 (321)
T cd05591          81 GDLMFQIQ-----RSRKFDEPRSRFYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V  151 (321)
T ss_pred             CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence            99988873     34567888999999999999999999  679999999999999999999999999987543211  1


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||.....   ....+.+..            ..  ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~~~~i~~------------~~--~~  214 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLFESILH------------DD--VL  214 (321)
T ss_pred             cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHHHHHHHc------------CC--CC
Confidence            22345688999999999999999999999999999999999999986442   111111110            00  12


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCC-------CHHHHHHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRP-------SMSDVVTE  347 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rp-------t~~~ll~~  347 (380)
                      ++...+.++.+++.+||+.||++||       ++++++++
T Consensus       215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            2333557899999999999999999       78888765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.6e-41  Score=303.27  Aligned_cols=257  Identities=25%  Similarity=0.409  Sum_probs=207.1

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||.||+|... +++.|++|....      .....+.+|++++++++|+|++++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999965 789999996432      22456889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++++|..++.... .....+++..+..++.+++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999998874322 234557899999999999999999999  6799999999999999999999999999876543


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ..  .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.....    ...+....          ...
T Consensus       159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~----------~~~  222 (267)
T cd08224         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK----------IEK  222 (267)
T ss_pred             CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhh----------hhc
Confidence            21  112334577889999999988999999999999999999999999865431    11111111          011


Q ss_pred             ccccCCCH-HHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          310 RLWSTFTN-EGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       310 ~~~~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                      ......+. ..+..+.+++.+||..+|.+|||+.++++.|.++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            11122233 55678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=317.91  Aligned_cols=248  Identities=22%  Similarity=0.287  Sum_probs=206.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcCC-CCceeeeccceecCCeeEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  147 (380)
                      ...|++.+.||+|.||.||+++.+ +|..+|+|..++.      ....+.+|+.+|+++. ||||+.+.+.+++....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            446888899999999999999965 4999999975433      2357899999999998 9999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC----CCceEEccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE----DFIAKVADAGL  223 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~----~~~~kl~DFgl  223 (380)
                      |||++.||.|.+.+...      .+++.....++.|++.++.|||+  .||+||||||+|+|+..    ++.+|++|||+
T Consensus       114 vmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            99999999999998432      38999999999999999999999  67999999999999953    35799999999


Q ss_pred             ccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      +.....   .......+||+.|+|||++...+|+..+||||+||++|.|++|.+||.........  ........     
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~--~~i~~~~~-----  255 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF--LAILRGDF-----  255 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH--HHHHcCCC-----
Confidence            998765   33456788999999999999999999999999999999999999999976532111  11111000     


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                        .++.    +.-...+..+.+++..|+..||..|+|+.++|++
T Consensus       256 --~f~~----~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 --DFTS----EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             --CCCC----CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence              1111    2223456789999999999999999999999996

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-41  Score=304.27  Aligned_cols=248  Identities=29%  Similarity=0.470  Sum_probs=203.1

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC--hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeec
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      .++|++.+.||+|+||.||+|... ++.|++|......  .+.+.+|+.+++.++|+||+++++++...+..++||||++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            457888999999999999999875 7889999865443  4678899999999999999999999998899999999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                      +++|.+++...   ....+++..+..++.|++.|+.|||+  ++++|+||||+||+++.++.++|+|||.++....... 
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          84 KGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            99999988432   22368899999999999999999999  7799999999999999999999999999887633211 


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                          ....+..|+|||.+.+..++.++|+||||+++|||++ |..||.....   .++...+..             ...
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~-------------~~~  217 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVEK-------------GYR  217 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhc-------------CCC
Confidence                2234567999999988889999999999999999997 9999875432   111111111             111


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHh
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  350 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~  350 (380)
                      ...+...++.+.+++.+||..+|.+|||+.++++.|.+
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            12233456789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-43  Score=321.61  Aligned_cols=252  Identities=20%  Similarity=0.273  Sum_probs=202.9

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeC-----CCCChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEE
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKR-----PGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~-----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  147 (380)
                      +....|++.+.||+||.+.||++...+.+.+|+|+.     +....+.|.+|+++|.+| .|.+|+++++|-..++.+||
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            445679999999999999999999888888888863     334456799999999999 58999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||-+. +|..+|...    ....+...+..+..|++.|+.++|+  .||||.||||+|+|+-. |.+||+|||+|..+
T Consensus       438 vmE~Gd~-DL~kiL~k~----~~~~~~~~lk~ywkqML~aV~~IH~--~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  438 VMECGDI-DLNKILKKK----KSIDPDWFLKFYWKQMLLAVKTIHQ--HGIVHSDLKPANFLLVK-GRLKLIDFGIANAI  509 (677)
T ss_pred             Eeecccc-cHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHHH--hceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence            9998655 899888432    2333434788999999999999999  56999999999999875 68999999999998


Q ss_pred             CCCCCCCCCccccCccceecccccccC-----------CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFR-----------RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  296 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  296 (380)
                      ......-.....+||.-||+||.+...           ..+.++||||||||||+|+.|++||.....            
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------------  577 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------------  577 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------------
Confidence            776555556678899999999987543           246899999999999999999999885321            


Q ss_pred             hhcccchhhhcccccccCCCHH-HHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          297 SRDFSNLLKILDERLWSTFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                        ...++..+.++.-..+|+.- ...++.++++.||.+||++|||+.++|++
T Consensus       578 --~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  578 --QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             --HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence              12234455555443344331 11339999999999999999999999986

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.4e-41  Score=316.07  Aligned_cols=239  Identities=21%  Similarity=0.313  Sum_probs=193.0

Q ss_pred             CeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|+||.||+|... ++..||+|....      .....+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 578999997542      2334567888898888 799999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||+++++.++|+|||+++......  .
T Consensus        81 ~~L~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~  151 (318)
T cd05570          81 GDLMFHIQ-----RSGRFDEPRARFYAAEIVLGLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V  151 (318)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence            99988873     34568899999999999999999999  779999999999999999999999999986532211  1


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      ......++..|+|||++.+..++.++|||||||++|+|++|+.||.....   ......+.            ..  ...
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~~i~------------~~--~~~  214 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQSIL------------ED--EVR  214 (318)
T ss_pred             cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHHHHH------------cC--CCC
Confidence            12334688899999999999999999999999999999999999975432   11111111            00  012


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSM-----SDVVTE  347 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~~ll~~  347 (380)
                      ++...+..+.+++.+||+.||.+||++     .+++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            334456789999999999999999999     777764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-43  Score=302.28  Aligned_cols=247  Identities=28%  Similarity=0.408  Sum_probs=212.6

Q ss_pred             CCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC-CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCC
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS  156 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  156 (380)
                      |.++++||+|+||.||++.++ .|+.+|+|..+ ....+++..|+.++++++.|++|++||.+..+..+++|||||..|+
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS  114 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS  114 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence            456788999999999999954 69999999876 4567899999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCC
Q 016917          157 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS  236 (380)
Q Consensus       157 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~  236 (380)
                      ..+.++    .+++.+.+..+..+.++.+.||+|||.+.  -+|||||..|||++.+|.+||+|||.|..+.++.  ...
T Consensus       115 iSDI~R----~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKR  186 (502)
T KOG0574|consen  115 ISDIMR----ARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKR  186 (502)
T ss_pred             HHHHHH----HhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhH--Hhh
Confidence            999984    46788999999999999999999999954  7999999999999999999999999998876543  234


Q ss_pred             ccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCC
Q 016917          237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT  316 (380)
Q Consensus       237 ~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (380)
                      +...||+.|||||++..-+|+.++||||||++..||.-|++||....+-..-              ..--..+......|
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------------FMIPT~PPPTF~KP  252 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------------FMIPTKPPPTFKKP  252 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee--------------EeccCCCCCCCCCh
Confidence            5678999999999999999999999999999999999999999976642110              00001222223456


Q ss_pred             HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          317 NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       317 ~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..++.++.++++.||.+.|++|-|+.+++++
T Consensus       253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            7889999999999999999999999999886

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-41  Score=310.34  Aligned_cols=265  Identities=26%  Similarity=0.404  Sum_probs=200.8

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-----CCCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecC--Cee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQ  145 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  145 (380)
                      +.|++.+.||+|+||.||++..     .++..||+|......    ...+.+|+++++.++||||+++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578899999999999999973     357889999865332    34678899999999999999999998765  567


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++||||+++++|.+++..    ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~~i~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPR----NKNKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccchheEEEcCCCCEEECCCcccc
Confidence            999999999999998832    22357899999999999999999999  789999999999999999999999999988


Q ss_pred             ccCCCCCC-CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh---hhccc
Q 016917          226 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN---SRDFS  301 (380)
Q Consensus       226 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~  301 (380)
                      .+...... .......++..|+|||++.+..++.++|||||||++|||++++.|.......    .......   .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~----~~~~~~~~~~~~~~~  233 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL----FLKMIGPTHGQMTVT  233 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch----hhhhcccccccccHH
Confidence            76432211 1122345677799999998888999999999999999999987664321100    0000000   00000


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                      ...+......+.+.+..++..+.+++.+||+.||++|||++++++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         234 RLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            00111111112223344667899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.3e-42  Score=317.13  Aligned_cols=238  Identities=24%  Similarity=0.344  Sum_probs=190.3

Q ss_pred             CeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhc-CCCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLAS-IQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|+||.||+|... ++..||+|....      ........|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 578999997542      223456677888876 4899999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.......  .
T Consensus        81 g~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  151 (316)
T cd05619          81 GDLMFHIQ-----SCHKFDLPRATFYAAEIICGLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A  151 (316)
T ss_pred             CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence            99998883     33567888999999999999999999  779999999999999999999999999987532211  1


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      ......||..|+|||++.+..++.++|||||||++|||++|+.||.....   ......+...              ...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~--------------~~~  214 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIRMD--------------NPC  214 (316)
T ss_pred             ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhC--------------CCC
Confidence            22345688999999999999999999999999999999999999976432   1111111100              012


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHH-HHHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMS-DVVT  346 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~-~ll~  346 (380)
                      ++...+.++.+++.+||+.||++||++. ++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            2334557789999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.1e-41  Score=303.86  Aligned_cols=254  Identities=24%  Similarity=0.450  Sum_probs=203.8

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +..++|++.+.||+|+||.||++....+..+++|.....  ..+.+.+|+++++.++|+||+++.+.+.. ...+++|||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            345678999999999999999999877888999976543  34578899999999999999999999887 678999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++...   ....+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          82 MAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             CCCCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            9999999988432   23457788899999999999999998  779999999999999999999999999987664322


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      .. ......++..|+|||.+.+..++.++|+|||||++|++++ |..||.....   ......+..             .
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~-------------~  219 (260)
T cd05073         157 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALER-------------G  219 (260)
T ss_pred             cc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhC-------------C
Confidence            21 1122334567999999998889999999999999999998 8999875432   111111111             1


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHh
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  350 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~  350 (380)
                      .....+...+.++.+++.+||+.||++||++.++.+.|+.
T Consensus       220 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         220 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1112233455779999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-41  Score=302.24  Aligned_cols=249  Identities=32%  Similarity=0.512  Sum_probs=202.5

Q ss_pred             CeeccCCceEEEEEEECC----CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|+||.||+|....    +..+++|......    .+.+.+|++.++.++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999653    7889999865433    45788899999999999999999999999999999999999


Q ss_pred             CCccccccCCCCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          155 GSVSIHLYGPSQV----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       155 g~L~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      ++|.+++......    ....+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||.+......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc--CCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            9999998432110    13678999999999999999999999  77999999999999999999999999999877543


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ..........++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .+..+....             
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~-------------  222 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRK-------------  222 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHc-------------
Confidence            32222334556778999999988899999999999999999999 6999886532   111111111             


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                      ......+..++.++.+++.+||+.||.+|||+.+++++|+
T Consensus       223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            1122344555788999999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.5e-41  Score=316.89  Aligned_cols=241  Identities=20%  Similarity=0.259  Sum_probs=190.6

Q ss_pred             CeeccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|+||.||+|.. .+++.||+|.....      ..+.+..|..++.++ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999995 45789999975532      234477899998888 699999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.......  .
T Consensus        81 ~~L~~~~~-----~~~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~  151 (327)
T cd05617          81 GDLMFHMQ-----RQRKLPEEHARFYAAEICIALNFLHE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--D  151 (327)
T ss_pred             CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--C
Confidence            99988773     34568999999999999999999999  779999999999999999999999999987532211  1


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      ......||..|+|||++.+..++.++|||||||++|||++|..||............+......        ...  ...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~--~~~  221 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--------LEK--PIR  221 (327)
T ss_pred             ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH--------HhC--CCC
Confidence            2234568999999999999999999999999999999999999997543322222111111111        001  112


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMS  342 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~  342 (380)
                      .+...+..+.+++.+||+.||.+|+++.
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            3444557789999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.7e-41  Score=306.08  Aligned_cols=252  Identities=21%  Similarity=0.280  Sum_probs=198.5

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC---ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      .++|++.+.||+|+||.||+|.. .++..||+|.....   ....+.+|+.++++++||||+++++.+...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35789999999999999999995 56889999975432   334577899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++.     ....+++..+..++.|++.|+.|||+  .+|+||||||+||+++.++.++|+|||++.......
T Consensus        88 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          88 CGGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLAYLHS--KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            99999998873     23567889999999999999999999  779999999999999999999999999988664321


Q ss_pred             CCCCCccccCccceecccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          232 VAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                        .......++..|+|||.+.   ...++.++|+|||||++|||++|+.||....+.......      .     .....
T Consensus       161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~------~-----~~~~~  227 (267)
T cd06646         161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------S-----KSNFQ  227 (267)
T ss_pred             --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee------e-----cCCCC
Confidence              1123446788899999874   345788999999999999999999998654321110000      0     00000


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      . .........+..+.+++.+||+.||++|||+++++++|
T Consensus       228 ~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         228 P-PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             C-CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0 00011223457899999999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.4e-41  Score=310.57  Aligned_cols=259  Identities=26%  Similarity=0.439  Sum_probs=202.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCc----EEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      ..+|+..+.||+|+||.||+|... ++.    .+|+|......    ...+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            456788899999999999999853 343    57888765432    23578899999999999999999998754 467


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +++||+++|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          85 LVTQLMPHGCLLDYVHE----HKDNIGSQLLLNWCVQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eeehhcCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHhh--cCeeccccccceeeecCCCceEEcccccccc
Confidence            89999999999988742    23457888999999999999999999  7799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ..............++..|+|||.+.+..++.++|||||||++|||++ |+.||.....   ......+..         
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~~~~---------  226 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDLLEK---------  226 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHC---------
Confidence            643222212223345667999999999999999999999999999997 8899875432   111111111         


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcc
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  357 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~  357 (380)
                          ......+..++..+.+++..||..||++||++.++++.|..+.+.+.+
T Consensus       227 ----~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~  274 (303)
T cd05110         227 ----GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQR  274 (303)
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhh
Confidence                111122233456789999999999999999999999999998766543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.2e-42  Score=318.26  Aligned_cols=238  Identities=20%  Similarity=0.288  Sum_probs=191.8

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      +|++.+.||+|+||.||+|... ++..||+|.....      ....+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999954 5789999975422      223456677888777 5899999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+.+.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQ-----QVGRFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            9999999988873     33567889999999999999999999  6799999999999999999999999999875432


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+...+..            .
T Consensus       154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~------------~  216 (323)
T cd05616         154 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIME------------H  216 (323)
T ss_pred             CC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHHh------------C
Confidence            11  122345689999999999999999999999999999999999999976432   111111111            0


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM  341 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  341 (380)
                        ...++...+.++.+++.+||+.||.+|++.
T Consensus       217 --~~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         217 --NVAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence              112344556789999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.9e-41  Score=313.88  Aligned_cols=262  Identities=21%  Similarity=0.287  Sum_probs=196.0

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      .+|.+.+.||+|+||.||+|+.+ ++..||+|.....    ....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999954 6788999975422    234577899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++ +|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.......
T Consensus        86 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LDK-DLKQYMDD----CGNIMSMHNVKIFLYQILRGLAYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCC-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            986 77766632    23457888899999999999999999  779999999999999999999999999987643221


Q ss_pred             CCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc---ch---h
Q 016917          232 VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS---NL---L  304 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~---~  304 (380)
                        .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......+...............   ..   .
T Consensus       159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence              11223456788999998765 468999999999999999999999997654322111111100000000   00   0


Q ss_pred             hhcccccc-------cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          305 KILDERLW-------STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...+....       .......++++.+++.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            00000000       00112345778999999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-41  Score=300.95  Aligned_cols=245  Identities=29%  Similarity=0.487  Sum_probs=197.2

Q ss_pred             CeeccCCceEEEEEEECCCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCcc
Q 016917           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS  158 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  158 (380)
                      ++||.|+||.||++...+++.|++|......    ...+.+|++++++++|+||+++++++......++||||+.+++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            4699999999999997669999999755432    346889999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCcc
Q 016917          159 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ  238 (380)
Q Consensus       159 ~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~  238 (380)
                      +++..    ....+++..+..++.+++.|+.|||+  ++++||||||+||+++.++.++|+|||++..............
T Consensus        81 ~~l~~----~~~~~~~~~~~~~~~~~~~~l~~lH~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRK----KKNRLTVKKLLQMSLDAAAGMEYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            88843    23457888999999999999999998  7799999999999999999999999999886643222211122


Q ss_pred             ccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCH
Q 016917          239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  317 (380)
Q Consensus       239 ~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (380)
                      ...+..|+|||.+.+..++.++|+|||||++|||++ |..||......   .....+.             .......+.
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~~~~-------------~~~~~~~~~  218 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRERIE-------------SGYRMPAPQ  218 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHHHHh-------------cCCCCCCCc
Confidence            234567999999988899999999999999999999 88888665421   1111111             111112334


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          318 EGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       318 ~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                      ..+.++.+++.+||+.+|.+|||+.++++.|+
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            55678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.6e-41  Score=308.10  Aligned_cols=244  Identities=22%  Similarity=0.289  Sum_probs=191.0

Q ss_pred             eccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCc
Q 016917           85 IGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        85 ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  157 (380)
                      ||+|+||.||++.. .+++.||+|.....      .......|++++++++||||+++++.+......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999995 46899999975422      123456799999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016917          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  237 (380)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~  237 (380)
                      .+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.++|+|||++.......   ...
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~  152 (277)
T cd05607          81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT  152 (277)
T ss_pred             HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHH--CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence            8877432   23457888889999999999999999  779999999999999999999999999987664321   122


Q ss_pred             cccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCH
Q 016917          238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  317 (380)
Q Consensus       238 ~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (380)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||........  ..+.....         ...... ....
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~---------~~~~~~-~~~~  220 (277)
T cd05607         153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRT---------LEDEVK-FEHQ  220 (277)
T ss_pred             ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHh---------hccccc-cccc
Confidence            34578889999999988999999999999999999999999975432111  11111111         011110 0112


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          318 EGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       318 ~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      ..++++.+++.+||+.||++||+++|+++.+
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            3457799999999999999999997766433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-41  Score=305.06  Aligned_cols=249  Identities=28%  Similarity=0.472  Sum_probs=194.4

Q ss_pred             CeeccCCceEEEEEEECC-Cc--EEEEEeCCCC----ChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLLQD-GM--LVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~-~~--~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|+||.||+|.... +.  .+++|.....    ..+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999643 43  4688876532    234678899999999 899999999999999999999999999


Q ss_pred             CCccccccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          155 GSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       155 g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      |+|.+++.....           .....+++..+..++.|++.|++|||+  ++++||||||+||+++.++.+||+|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccccceEEEcCCCeEEECCCCC
Confidence            999988854321           112357889999999999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccc
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN  302 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (380)
                      +.......   .......+..|+|||++.+..++.++|||||||++|||++ |..||......   +....+        
T Consensus       159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~--------  224 (270)
T cd05047         159 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKL--------  224 (270)
T ss_pred             ccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHHHH--------
Confidence            86432110   1111223556999999988899999999999999999997 99998654321   111111        


Q ss_pred             hhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                           ........+..++.++.+++.+||+.||.+|||+.++++.|.+++
T Consensus       225 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         225 -----PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -----hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                 111111223345577999999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-41  Score=305.30  Aligned_cols=258  Identities=26%  Similarity=0.423  Sum_probs=205.1

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CC----cEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DG----MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~----~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      ..+|++.+.||+|+||.||+|..+ ++    ..+++|......    ...+.+|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            356788899999999999999854 23    368999765443    3467889999999999999999999887 6789


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +|+||+++|+|.+++..    ....+++..+..++.|++.|+.|||+  ++++||||||+||+++.++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          85 LITQLMPLGCLLDYVRN----HKDNIGSQYLLNWCVQIAKGMSYLEE--KRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEecCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecccCcceEEEcCCCeEEECCCccccc
Confidence            99999999999998842    23458899999999999999999999  7799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ..............++..|+|||......++.++|+||||+++||+++ |+.||......   +....+.          
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~----------  225 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDLLE----------  225 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHh----------
Confidence            653322211222334567999999988899999999999999999998 99998765421   1111111          


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                         .......+..++..+.+++.+||..||.+||++.++++.|+++.+++.
T Consensus       226 ---~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05057         226 ---KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ  273 (279)
T ss_pred             ---CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence               111122333455678999999999999999999999999999876544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.8e-41  Score=302.89  Aligned_cols=247  Identities=25%  Similarity=0.381  Sum_probs=201.6

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC-----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +|++.+.||+|++|.||+|..+ ++..|++|....     .....+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999954 688999997432     2345688899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++...   ....+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~--~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            9999999988532   23567889999999999999999998  779999999999999999999999999988765422


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                      .  ......++..|+|||+..+..++.++|+||||+++|+|++|+.||.....   ......+             ....
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~-------------~~~~  217 (256)
T cd08529         156 N--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILKI-------------IRGV  217 (256)
T ss_pred             c--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH-------------HcCC
Confidence            1  12334577889999999999999999999999999999999999975441   1111110             0111


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....+...+.++.+++.+||+.+|++||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         218 FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            123333566789999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.5e-41  Score=304.06  Aligned_cols=253  Identities=25%  Similarity=0.353  Sum_probs=190.5

Q ss_pred             CeeccCCceEEEEEEECC---CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCC
Q 016917           83 NLIGEGKFGEVYKGLLQD---GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  155 (380)
                      +.||+|+||.||+|...+   +..+++|......    ...+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998543   4578999755332    235778999999999999999999999888999999999999


Q ss_pred             CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016917          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (380)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~  235 (380)
                      +|.+++...........++..+..++.|++.|+.|||+  ++++||||||+||+++.++.++|+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            99999854332223445677788899999999999999  7799999999999999999999999999876543332222


Q ss_pred             CccccCccceecccccccC-------CCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          236 SSQVTADEIFLASEVKEFR-------RFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~-------~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      .....++..|+|||++.+.       .++.++|+||||+++|||++ |..||......   +.......    .......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~~~~----~~~~~~~  231 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---QVLTYTVR----EQQLKLP  231 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHhh----cccCCCC
Confidence            2334567789999987642       35789999999999999996 99999754321   11111000    0001111


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                      .+    ......++.+.+++..|| .+|++|||++++++.|+
T Consensus       232 ~~----~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KP----RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CC----ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11    112234466889999999 68999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.2e-41  Score=304.75  Aligned_cols=258  Identities=24%  Similarity=0.365  Sum_probs=205.9

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      .+|++.+.||+|+||.||++.. .++..+++|.....      ....+.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999994 57899999964321      2346788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++++|.+++.... .....+++..++.++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999998874321 134568899999999999999999999  7799999999999999999999999999876643


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .......+.            ..
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~------------~~  223 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIE------------QC  223 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhh------------cC
Confidence            221  123346788899999999889999999999999999999999998754321 111111110            00


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                      ......+...++++.+++.+||+.||++|||+.++++.+.++.
T Consensus       224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            0011112346678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.6e-42  Score=323.66  Aligned_cols=258  Identities=21%  Similarity=0.278  Sum_probs=200.5

Q ss_pred             HHHHHHHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceec
Q 016917           69 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQE  141 (380)
Q Consensus        69 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  141 (380)
                      ..+.....++|++.+.||+|+||.||+|..+ +++.+|+|....      .....+.+|..+++.++||||+++++.+.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3445556688999999999999999999964 678999997542      123446789999999999999999999999


Q ss_pred             CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccc
Q 016917          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (380)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DF  221 (380)
                      ++..++||||+++|+|.+++.      ...++...+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHEEECCCCCEEEEeC
Confidence            999999999999999998873      2347888888999999999999999  77999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCccceecccccccCC----CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhh
Q 016917          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR----FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS  297 (380)
Q Consensus       222 gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  297 (380)
                      |++........ .......||+.|+|||++.+..    ++.++|||||||++|||++|..||.....      .......
T Consensus       187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i  259 (371)
T cd05622         187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKI  259 (371)
T ss_pred             CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHH
Confidence            99987643221 1123456899999999987543    78999999999999999999999986432      1111111


Q ss_pred             hcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHHH
Q 016917          298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTEL  348 (380)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~~ll~~L  348 (380)
                      ....       .....+.....+..+.+++..||..++.+  |+++++++++.
T Consensus       260 ~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         260 MNHK-------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HcCC-------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            1000       00111112245677999999999844443  78999998864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-42  Score=295.65  Aligned_cols=247  Identities=21%  Similarity=0.326  Sum_probs=201.1

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC-------CCh----HHHHHHHHHHhcC-CCCceeeeccceecC
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-------APT----QEFIDEVCFLASI-QHRNLVTLLGYCQEN  142 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~-------~~~----~~~~~E~~~l~~l-~h~niv~l~~~~~~~  142 (380)
                      ...|...+.||.|..+.|.++.+ .++..+|+|+...       ...    +.-.+|+.+|+++ .||||+.+.++++.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            45677889999999999999884 4678888886321       111    3356799999998 699999999999999


Q ss_pred             CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFg  222 (380)
                      ...++|+|.++.|.|.|+|     .+.-.++++...+|++|+.+|++|||.  +.||||||||+|||++++.+++|+|||
T Consensus        96 sF~FlVFdl~prGELFDyL-----ts~VtlSEK~tR~iMrqlfegVeylHa--~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYL-----TSKVTLSEKETRRIMRQLFEGVEYLHA--RNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             chhhhhhhhcccchHHHHh-----hhheeecHHHHHHHHHHHHHHHHHHHH--hhhhhcccChhheeeccccceEEeccc
Confidence            9999999999999999999     456778999999999999999999999  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCccceeccccccc------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEF------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  296 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  296 (380)
                      +++.+.++.   .....+||++|+|||.+.-      .+|+..+|+||+||+||-++.|.+||.....     +.     
T Consensus       169 Fa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----ml-----  235 (411)
T KOG0599|consen  169 FACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----ML-----  235 (411)
T ss_pred             eeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----HH-----
Confidence            999886643   3567899999999998753      4788999999999999999999999985321     00     


Q ss_pred             hhcccchhhhccccc--ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          297 SRDFSNLLKILDERL--WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       297 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                           .+.-+...+.  ..+.=.+.+.+.++||.+||+.||.+|.|++|+|++
T Consensus       236 -----MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  236 -----MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             -----HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence                 0111111111  111112456789999999999999999999999976

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.4e-42  Score=323.72  Aligned_cols=250  Identities=22%  Similarity=0.292  Sum_probs=195.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|+..+.||+|+||.||++... ++..||+|....      .....+..|+.++..++||||+++++.+.+.+..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888899999999999999954 688999997542      23456778999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||++.....
T Consensus        81 E~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~~L~~lH~--~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLM-----KKDTLSEEATQFYIAETVLAIDAIHQ--LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            9999999999883     34568899999999999999999999  7799999999999999999999999999875432


Q ss_pred             CCCC---------------------------------CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCC
Q 016917          230 TDVA---------------------------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR  276 (380)
Q Consensus       230 ~~~~---------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~  276 (380)
                      ....                                 .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            1100                                 0012346899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCC---HHHHHHH
Q 016917          277 EASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS---MSDVVTE  347 (380)
Q Consensus       277 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---~~~ll~~  347 (380)
                      .||....+.   .....+..   ..       .....+.....++++.+++.+|+. ||.+|++   +.+++++
T Consensus       234 ~Pf~~~~~~---~~~~~i~~---~~-------~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         234 PPFCSETPQ---ETYRKVMN---WK-------ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCCHH---HHHHHHHc---CC-------CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            999765431   11111110   00       000000011245678899998774 9999985   5666655

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.2e-41  Score=319.97  Aligned_cols=259  Identities=20%  Similarity=0.290  Sum_probs=194.1

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC-----CChHHHHHHHHHHhcCCCCceeeeccceecCC-----
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----  143 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  143 (380)
                      ..++|++.+.||+|+||.||++.. .++..||+|....     .....+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            357899999999999999999985 4688999997542     22456778999999999999999999886443     


Q ss_pred             -eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 016917          144 -LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       144 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFg  222 (380)
                       ..|+||||+++ ++...+       ...++...+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~-------~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVI-------HMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHH-------hccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEecCC
Confidence             46999999976 454444       1246788888999999999999999  779999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc-cc
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-FS  301 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~  301 (380)
                      +++......   ......+|..|+|||++.+..++.++|||||||++|+|++|+.||...+...  ........... ..
T Consensus       169 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~  243 (359)
T cd07876         169 LARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID--QWNKVIEQLGTPSA  243 (359)
T ss_pred             CccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCcH
Confidence            987543211   2234567889999999999999999999999999999999999998654211  11100000000 00


Q ss_pred             --------chhhhcccc---------------c---ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          302 --------NLLKILDER---------------L---WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       302 --------~~~~~~~~~---------------~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                              .........               .   ........++++++++.+||+.||++|||+.|++++-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence                    000000000               0   0001112346789999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-41  Score=301.13  Aligned_cols=245  Identities=27%  Similarity=0.445  Sum_probs=194.6

Q ss_pred             CeeccCCceEEEEEEEC-C---CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLLQ-D---GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~-~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|+||.||+|... .   +..+|+|......    .+.+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            46999999999999743 2   2689999865443    3467889999999999999999998764 467999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC-
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA-  233 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~-  233 (380)
                      |+|.+++.     ....+++..+..++.|++.||.|||+  .+++|+||||+|||++.++.+||+|||+++........ 
T Consensus        80 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLK-----KRREIPVSDLKELAHQVAMGMAYLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHhh--cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            99999984     23467899999999999999999999  77999999999999999999999999998876432211 


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                      .......++..|+|||...+..++.++||||||+++|+|++ |..||.....   .+....+....             .
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~~-------------~  216 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESGE-------------R  216 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCC-------------c
Confidence            11112223457999999998899999999999999999998 9999876432   22222221111             1


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                      ...+..++..+.+++.+||..||++||++.++++.|+..
T Consensus       217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            123344567899999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.9e-41  Score=301.44  Aligned_cols=249  Identities=29%  Similarity=0.478  Sum_probs=200.3

Q ss_pred             CCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      .+|++.+.||+|+||.||++...++..+++|.....  ....+.+|++++++++|||++++++++......++|+||+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            467788999999999999999877888999986543  346789999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      ++|.+++..    ....+++..+..++.+++.|+.|||+  .+++|+||||+||+++.++.++|+|||++........ .
T Consensus        84 ~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~  156 (256)
T cd05112          84 GCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLES--SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-T  156 (256)
T ss_pred             CcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccccceEEEcCCCeEEECCCcceeecccCcc-c
Confidence            999988742    23457888999999999999999999  6799999999999999999999999999876543221 1


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccccc
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  313 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (380)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ....+....             ....
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~-------------~~~~  220 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETINA-------------GFRL  220 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHhC-------------CCCC
Confidence            1122334567999999998899999999999999999998 8999875432   111111110             0011


Q ss_pred             CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       314 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      ..+...++++.+++.+||+.+|++|||+.++++.|
T Consensus       221 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            11222357799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.2e-42  Score=318.91  Aligned_cols=235  Identities=22%  Similarity=0.270  Sum_probs=191.1

Q ss_pred             CeeccCCceEEEEEEE----CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeec
Q 016917           83 NLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      +.||+|+||.||++..    .++..+|+|.....     ....+..|++++++++||||+++++++..++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999874    35789999975432     23446789999999999999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                      +|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.......  
T Consensus        82 ~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--  152 (318)
T cd05582          82 GGDLFTRLS-----KEVMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--  152 (318)
T ss_pred             CCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence            999988883     34568899999999999999999999  679999999999999999999999999987653321  


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  313 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (380)
                      .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.....   ......+.            ..  ..
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~i~------------~~--~~  215 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETMTMIL------------KA--KL  215 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHHHHHH------------cC--CC
Confidence            122345688999999999988999999999999999999999999975432   11111111            00  11


Q ss_pred             CCCHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 016917          314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSD  343 (380)
Q Consensus       314 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~  343 (380)
                      .++...++++.+++.+||+.||++||++.+
T Consensus       216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            234445678999999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7e-41  Score=303.94  Aligned_cols=256  Identities=26%  Similarity=0.452  Sum_probs=203.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECC----CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      ..+|.+.+.||+|+||.||+|...+    ...|++|......    .+.+.+|+.++++++||||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            4467888999999999999998543    3578999755432    3468889999999999999999998876 45689


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+++++|.+++..    ....+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||+++..
T Consensus        84 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          84 VMELAPLGELRSYLQV----NKYSLDLASLILYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEcCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccChheEEEecCCCeEEccCceeeec
Confidence            9999999999999843    23357899999999999999999999  77999999999999999999999999998876


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      ....... .....++..|+|||.+.+..++.++||||||+++||+++ |..||......   .....+..          
T Consensus       158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~~----------  223 (270)
T cd05056         158 EDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIEN----------  223 (270)
T ss_pred             cccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHc----------
Confidence            4432211 122234567999999988899999999999999999986 99999765421   11111110          


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                         ......+..++.++.+++.+|+..+|.+|||+.++++.|+++..++
T Consensus       224 ---~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         224 ---GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             ---CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence               1111234456678999999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.8e-41  Score=308.30  Aligned_cols=249  Identities=20%  Similarity=0.306  Sum_probs=198.5

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      .|+..+.||+|+||.||++.. .+++.||+|......      ...+..|+.++++++|+||+.+++.+...+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            367778999999999999995 468899999754321      2346789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++++|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          81 LMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             ecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            99999999887432   23458889999999999999999999  77999999999999999999999999998765332


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      .   ......|+..|+|||++.+..++.++|||||||++|+|++|+.||................             ..
T Consensus       156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-------------~~  219 (285)
T cd05630         156 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-------------KE  219 (285)
T ss_pred             c---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-------------hh
Confidence            1   1123468889999999999999999999999999999999999998643221111110000             00


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  347 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~~ll~~  347 (380)
                      ....++...++++.+++.+||+.||++|||     +++++++
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         220 VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            011233345577999999999999999999     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.1e-41  Score=322.85  Aligned_cols=262  Identities=17%  Similarity=0.187  Sum_probs=197.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      ..+|.+.+.||+|+||.||+|... .++.||+|...   ...+.+|++++++++|+||+++++++...+..++|||++. 
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-  243 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-  243 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence            346999999999999999999964 57889999643   2346789999999999999999999999999999999995 


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      ++|..++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||+++.........
T Consensus       244 ~~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        244 SDLYTYLGA----RLRPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            577777632    23468999999999999999999999  779999999999999999999999999998764322222


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC-----cccHHHHHHhhhcc-cch-----
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS-----SQDLVELVQNSRDF-SNL-----  303 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~-~~~-----  303 (380)
                      ......||..|+|||++.+..++.++|||||||+||||++|..|+.......     ...+...+...... ...     
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            2334568999999999999999999999999999999999887654322111     11122222211100 000     


Q ss_pred             ---hhhcc----cccccCCC-------HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 ---LKILD----ERLWSTFT-------NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ---~~~~~----~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         .....    ......+.       ...+..+.+|+.+||+.||.+|||+.|+|++
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence               00000    00000000       0223568999999999999999999999986

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.8e-41  Score=315.94  Aligned_cols=234  Identities=21%  Similarity=0.282  Sum_probs=186.5

Q ss_pred             CeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHH-HHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVC-FLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|+||+||+|... +++.||+|.....      ....+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999964 6899999975432      1233445544 56789999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.......  .
T Consensus        81 g~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~  151 (323)
T cd05575          81 GELFFHLQ-----RERSFPEPRARFYAAEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--K  151 (323)
T ss_pred             CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--C
Confidence            99988873     34567889999999999999999999  779999999999999999999999999987532211  1


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      ......||..|+|||++.+..++.++|||||||++|||++|+.||.....   .+..+.+.            ...  ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~------------~~~--~~  214 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---AEMYDNIL------------NKP--LR  214 (323)
T ss_pred             ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---HHHHHHHH------------cCC--CC
Confidence            23345689999999999999999999999999999999999999976432   11111111            110  11


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMS  342 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~  342 (380)
                      .+...++.+.+++.+||+.||.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         215 LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            2233467799999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.5e-40  Score=303.36  Aligned_cols=247  Identities=22%  Similarity=0.339  Sum_probs=195.4

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      +|++.+.||+|+||.||+|.. .++..||+|.....    ....+.+|++++++++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            578889999999999999984 57889999975432    2345788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|..+         ..+++..+..++.|++.||.|||+  .+|+|+||||+|||++.++.++|+|||++......  
T Consensus        82 ~~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          82 DGGSLDVY---------RKIPEHVLGRIAVAVVKGLTYLWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCChHHh---------hcCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            99988643         235677888999999999999999  77999999999999999999999999998765432  


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                        ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||..................        +.+....
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~~  218 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC--------IVDEDPP  218 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH--------HhccCCC
Confidence              123456888999999999999999999999999999999999999764432211111000000        0000000


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .......++++.+++.+||+.||++||++++++++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         219 VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            01112244678999999999999999999999976

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1e-40  Score=302.02  Aligned_cols=249  Identities=25%  Similarity=0.414  Sum_probs=199.9

Q ss_pred             CCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC---------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      +|+..+.||+|+||.||+|...++..+|+|......         ...+.+|+++++.++|+||+++.+++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998888999999754221         13477899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      +||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILN-----RFGPLPEPVFCKYTKQILDGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            99999999999883     23457888999999999999999999  679999999999999999999999999987653


Q ss_pred             CCCC----CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          229 RTDV----AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       229 ~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ....    ........++..|+|||.+.+..++.++|+|||||++|+|++|..||.......  .... ....       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~-~~~~-------  223 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFY-IGAH-------  223 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHH-hhhc-------
Confidence            2111    112234457888999999998899999999999999999999999997543211  0000 0000       


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                          .......+...+.++.+++.+||+.||.+||++.+++++
T Consensus       224 ----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         224 ----RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             ----cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                001122334456779999999999999999999999863

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.6e-41  Score=303.18  Aligned_cols=252  Identities=24%  Similarity=0.333  Sum_probs=188.6

Q ss_pred             CeeccCCceEEEEEEECC---CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCC
Q 016917           83 NLIGEGKFGEVYKGLLQD---GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  155 (380)
                      +.||+|+||.||+|....   ...+++|......    ...+.+|+++++.++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999997432   3578888754332    235778999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016917          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (380)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~  235 (380)
                      +|.+++............+.....++.|++.|++|||+  ++|+||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh--cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            99999865433333445677888999999999999999  6799999999999999999999999999875433222112


Q ss_pred             CccccCccceeccccccc-------CCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          236 SSQVTADEIFLASEVKEF-------RRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~-------~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      .....++..|+|||+...       ..++.++|||||||++|||++ |..||......+  .+.......     ..+..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~~~-----~~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VLKQVVREQ-----DIKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHHhhcc-----CccCC
Confidence            233345667999998643       356889999999999999999 778886543210  111111100     00011


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      .    ...+...++.+.+++..|| .||.+|||++++++.|
T Consensus       232 ~----~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         232 K----PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             C----CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            1    1223345577888999999 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.6e-40  Score=300.10  Aligned_cols=249  Identities=25%  Similarity=0.457  Sum_probs=191.1

Q ss_pred             CeeccCCceEEEEEEEC----CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeecccee-cCCeeEEEEEeec
Q 016917           83 NLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQ-ENNLQFLIYEYIP  153 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  153 (380)
                      +.||+|+||.||+|...    .+..+|+|......    .+.+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    24579999764322    346778999999999999999999775 4556789999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                      +|+|.+++...    .....+..+..++.|++.||.|||+  .+++||||||+|||+++++.+||+|||+++........
T Consensus        81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLAS--KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            99999988422    2345677888999999999999999  67999999999999999999999999998765432211


Q ss_pred             --CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          234 --GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG-REASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       234 --~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                        .......++..|+|||.+.+..++.++|||||||++|||++| .+||.....   .+....+..             .
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~-------------~  218 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLLQ-------------G  218 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhc-------------C
Confidence              111233456679999999888999999999999999999995 555553321   111111110             0


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhh
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  353 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~  353 (380)
                      .....+...++.+.+++.+||+.+|++||++.++++.|+++..
T Consensus       219 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            0112223345679999999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.8e-41  Score=310.05  Aligned_cols=258  Identities=20%  Similarity=0.279  Sum_probs=199.9

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      ++|++.+.||+|+||.||++... ++..+++|......    ...+.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999954 57888888754332    24577899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++.     ....+++..+..++.|++.||.|||+. .+++||||||+|||++.++.++|+|||++...... 
T Consensus        81 ~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLK-----KAGRIPENILGKISIAVLRGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhh-CCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            99999999983     335678899999999999999999972 36999999999999999999999999998765332 


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc----------
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS----------  301 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  301 (380)
                         ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.......   ............          
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  227 (308)
T cd06615         154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVS  227 (308)
T ss_pred             ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCccccc
Confidence               1234567888999999988889999999999999999999999986543211   111110000000          


Q ss_pred             --------------chhhhcccccccCCC-HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          302 --------------NLLKILDERLWSTFT-NEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       302 --------------~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                                    ........ .....+ ...+.++.+++.+||..||++|||+.+++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         228 GHPPDSPRPMAIFELLDYIVNE-PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCCCCccchhhHHHHHHHHhcC-CCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                          00000000 001111 12456799999999999999999999999873

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.9e-40  Score=308.29  Aligned_cols=263  Identities=19%  Similarity=0.284  Sum_probs=187.5

Q ss_pred             CCeeccCCceEEEEEEEC---CCcEEEEEeCCCC-ChHHHHHHHHHHhcCCCCceeeeccceec--CCeeEEEEEeecCC
Q 016917           82 KNLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLIYEYIPNG  155 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g  155 (380)
                      .++||+|+||.||+|..+   +++.+|+|..... ....+.+|++++++++||||+++++++..  ....++||||+.+ 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence            367999999999999854   4678999986543 34567889999999999999999998854  4567899999865 


Q ss_pred             CccccccCCCC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----CCCCceEEccccccccc
Q 016917          156 SVSIHLYGPSQ----VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFL  227 (380)
Q Consensus       156 ~L~~~l~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili----~~~~~~kl~DFgla~~~  227 (380)
                      +|.+++.....    .....+++..+..++.|++.||.|||+  ++|+||||||+|||+    +.++.+||+|||+++..
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07868          85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence            66665532111    123358889999999999999999999  779999999999999    45678999999999876


Q ss_pred             CCCCC-CCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcc------cHHHHHHhhhc
Q 016917          228 GRTDV-AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ------DLVELVQNSRD  299 (380)
Q Consensus       228 ~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~------~~~~~~~~~~~  299 (380)
                      ..... ........+|..|+|||++.+ ..++.++||||+||++|||++|++||.........      .....+.....
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (317)
T cd07868         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG  242 (317)
T ss_pred             CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence            43221 112234568899999999876 45899999999999999999999999754422110      00111100000


Q ss_pred             ------cc---------chhhhccccccc---------CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 ------FS---------NLLKILDERLWS---------TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 ------~~---------~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                            ..         ...+........         ......+..+.+++.+||+.||.+|||++|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h  314 (317)
T cd07868         243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  314 (317)
T ss_pred             CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                  00         000000000000         0000112457899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=9.1e-41  Score=302.87  Aligned_cols=249  Identities=28%  Similarity=0.458  Sum_probs=196.4

Q ss_pred             CeeccCCceEEEEEEECC-------CcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           83 NLIGEGKFGEVYKGLLQD-------GMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~-------~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +.||+|+||.||+|+..+       +..+++|.....    ....+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998542       257888865432    345688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-----ceEEcccccc
Q 016917          152 IPNGSVSIHLYGPSQV--SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-----IAKVADAGLR  224 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~-----~~kl~DFgla  224 (380)
                      +++++|.+++......  ....+++..+..++.|++.||.|||+  ++++|+||||+||+++.++     .++|+|||++
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh--CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999988543211  23447889999999999999999998  6799999999999999877     8999999998


Q ss_pred             cccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      .................+..|+|||.+.+..++.++|||||||++|||++ |..||.....   .+....+.        
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~--------  227 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVT--------  227 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHh--------
Confidence            76643322222223345667999999998899999999999999999998 9999875432   11111111        


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                           .......+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus       228 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         228 -----AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -----cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                 11111233455678999999999999999999999998875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.4e-41  Score=315.46  Aligned_cols=237  Identities=22%  Similarity=0.280  Sum_probs=187.3

Q ss_pred             CeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHH-HHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEV-CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|+||.||+|... +++.||+|.....      ....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999964 5788999975432      122334444 456788999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |+|.+++.     ....+.+..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 ~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~lH~--~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~  151 (325)
T cd05602          81 GELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NG  151 (325)
T ss_pred             CcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CC
Confidence            99998883     34557788888899999999999999  67999999999999999999999999998754221  12


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..||......   .....+..            ..  ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~------------~~--~~  214 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNILN------------KP--LQ  214 (325)
T ss_pred             CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHHHHh------------CC--cC
Confidence            234456899999999999999999999999999999999999999754321   11111110            00  12


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVV  345 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll  345 (380)
                      .+...+..+.+++.+||+.||.+||++.+.+
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            2334557799999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.7e-41  Score=337.11  Aligned_cols=265  Identities=21%  Similarity=0.216  Sum_probs=205.3

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.++||+|+||.||+|... +++.||+|+....      ..+.+.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999954 5889999975432      1346889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          150 EYIPNGSVSIHLYGPSQ------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      ||+++|+|.+++.....      ......++..++.++.|++.||+|||+  ++|+||||||+|||++.++.++|+|||+
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs--~GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH--CCccccCCchheEEEcCCCCEEEEecCc
Confidence            99999999988743211      112345677888999999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCC----------------CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCc
Q 016917          224 RNFLGRTDV----------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS  287 (380)
Q Consensus       224 a~~~~~~~~----------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~  287 (380)
                      +........                ........||+.|+|||.+.+..++.++|||||||++|||+||+.||........
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            986621100                0111234689999999999999999999999999999999999999976332110


Q ss_pred             ccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHHHhhhhhhcc
Q 016917          288 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTLDKEMN  357 (380)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~~ll~~L~~~~~~~~~  357 (380)
                         ..   . .      ...++... ......++.+.+++.+||+.||++|| +++++++.|+..++....
T Consensus       240 ---~~---~-~------~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~  296 (932)
T PRK13184        240 ---SY---R-D------VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE  296 (932)
T ss_pred             ---hh---h-h------hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence               00   0 0      00000000 00123456789999999999999996 677788888888765443

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-42  Score=321.13  Aligned_cols=241  Identities=29%  Similarity=0.439  Sum_probs=200.5

Q ss_pred             CCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCCCh------HHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           79 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      |...+.||.|+||.||.|+ .++...||||++.-...      +++..|+.+|++++|||++.+-|+|......+|||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            6667889999999999999 56788999998654332      3578899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      |-| +-.|.+.    .-.+.+.+..+..|..+.+.||.|||++  +.||||||..|||+++.|.|||+|||.|....+  
T Consensus       108 ClG-SAsDlle----VhkKplqEvEIAAi~~gaL~gLaYLHS~--~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--  178 (948)
T KOG0577|consen  108 CLG-SASDLLE----VHKKPLQEVEIAAITHGALQGLAYLHSH--NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--  178 (948)
T ss_pred             Hhc-cHHHHHH----HHhccchHHHHHHHHHHHHHHHHHHHHh--hHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence            966 7777773    3456788888999999999999999995  499999999999999999999999999987643  


Q ss_pred             CCCCCccccCccceecccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          232 VAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                          ...++||++|||||++.   .+.|+-++||||||++..|+.-.++|+...+.  ...++...++..          
T Consensus       179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--MSALYHIAQNes----------  242 (948)
T KOG0577|consen  179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNES----------  242 (948)
T ss_pred             ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--HHHHHHHHhcCC----------
Confidence                56789999999999875   46899999999999999999999999765432  111111111111          


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         ..-..+++++.++.|+..||++-|.+|||.++++++
T Consensus       243 ---PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  243 ---PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             ---CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence               112356788999999999999999999999999876

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.9e-41  Score=306.81  Aligned_cols=259  Identities=22%  Similarity=0.283  Sum_probs=191.2

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcC---CCCceeeeccceec-----CC
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASI---QHRNLVTLLGYCQE-----NN  143 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  143 (380)
                      +|++.+.||+|+||.||+|... +++.||+|.....     ......+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999954 6889999975422     223456777777665   79999999998754     34


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      ..++||||+.+ +|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECccCc
Confidence            57999999985 777776322   23458899999999999999999999  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhh-----h
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS-----R  298 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-----~  298 (380)
                      +.......   ......++..|+|||++.+..++.++|||||||++|+|++|++||......+  .+.......     .
T Consensus       155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~  229 (288)
T cd07863         155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLPPED  229 (288)
T ss_pred             cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHHHhCCCChh
Confidence            88664321   1223457888999999998999999999999999999999999987543211  111111100     0


Q ss_pred             cccchhh----hccccc---ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          299 DFSNLLK----ILDERL---WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       299 ~~~~~~~----~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .......    ...+..   ........++.+.+++.+||+.||++|||+.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000000    000000   001112345678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-41  Score=301.72  Aligned_cols=263  Identities=24%  Similarity=0.433  Sum_probs=211.2

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhc--CCCCceeeeccceecCC----eeEE
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLAS--IQHRNLVTLLGYCQENN----LQFL  147 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~l  147 (380)
                      ...++.++.+.||+|.||.||+|.++ |..||||++.....+.+.+|.++.+.  |+|+||..|++.-..++    +++|
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc-CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            34556788899999999999999997 88999999998888999999999986  49999999998865432    5799


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCeeeCCCCceEEccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL------SPRVVHKDFKTANVLVDEDFIAKVADA  221 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~ivHrDikp~Nili~~~~~~kl~DF  221 (380)
                      |++|.+.|+|.|+|      .+..+.....++++..+|.||+|||..      .+.|.|||||+.|||+.+++.+.|+|+
T Consensus       287 vTdYHe~GSL~DyL------~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYL------NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             eeecccCCcHHHHH------hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            99999999999999      457788899999999999999999974      367999999999999999999999999


Q ss_pred             ccccccCCC--CCCCCCccccCccceecccccccC----CCC--cchhhHHHHHHHHHHHcCC----------CCCCCCC
Q 016917          222 GLRNFLGRT--DVAGPSSQVTADEIFLASEVKEFR----RFS--EKSDVYSFGVFLLELVSGR----------EASSSLS  283 (380)
Q Consensus       222 gla~~~~~~--~~~~~~~~~~~~~~~~aPE~~~~~----~~~--~~~DvwSlG~il~el~tg~----------~p~~~~~  283 (380)
                      |+|-.....  ...-+.+..+||..|||||++...    .++  ..+||||||.++||+..+.          .||....
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            998665432  223456678899999999998643    221  3589999999999998532          5655443


Q ss_pred             CCCcccHHHHHHhhhcccchhhhc-ccccccCCCH-----HHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          284 PDSSQDLVELVQNSRDFSNLLKIL-DERLWSTFTN-----EGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      +.           .+.++++.+++ .+++++..|.     ++...+.++|+.||..+|.-|.|+-.+.+.|.++.+.
T Consensus       441 p~-----------DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  441 PS-----------DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             CC-----------CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            32           22334444433 3344444443     4557799999999999999999999999999888753

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.5e-41  Score=305.66  Aligned_cols=268  Identities=28%  Similarity=0.398  Sum_probs=204.0

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-----CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceec--CCee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQ  145 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  145 (380)
                      +.|+..+.||+|+||.||+|...     ++..+|+|......    ...+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999853     36789999865443    3568899999999999999999999877  5578


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++||||+++++|.+++...    ...+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            9999999999999998432    2358899999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCC-CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          226 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       226 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ....... ........++..|+|||...+..++.++||||||+++|||++|..|+............. .........+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~  236 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLL  236 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHH
Confidence            7653211 111122345566999999988899999999999999999999999876533211100000 00000001111


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                      ..+........+..++.++.+++.+||+.||++|||+.++++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11222222233445567899999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.9e-41  Score=305.45  Aligned_cols=250  Identities=29%  Similarity=0.447  Sum_probs=197.6

Q ss_pred             CCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCChHH-----HHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQE-----FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      |++.+.||+|+||+||++... +++.+|+|.........     ...|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567789999999999999965 46689999866554432     234899999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++.     ....+++..+..++.|++.||.+||+  .+|+|+||||+||++++++.++|+|||.+....  ..
T Consensus        81 ~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~Lh~--~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~  151 (260)
T PF00069_consen   81 PGGSLQDYLQ-----KNKPLSEEEILKIAYQILEALAYLHS--KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--EN  151 (260)
T ss_dssp             TTEBHHHHHH-----HHSSBBHHHHHHHHHHHHHHHHHHHH--TTEEESSBSGGGEEESTTSEEEESSGTTTEEST--ST
T ss_pred             cccccccccc-----cccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccc--cc
Confidence            9999999883     45678999999999999999999999  679999999999999999999999999987541  11


Q ss_pred             CCCCccccCccceecccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          233 AGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                      ........++..|+|||+.. +..++.++||||+|+++|+|++|..||.....   .+............ ..    ...
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~---~~~~~~~~~~~~~~-~~----~~~  223 (260)
T PF00069_consen  152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS---DDQLEIIEKILKRP-LP----SSS  223 (260)
T ss_dssp             TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH---HHHHHHHHHHHHTH-HH----HHT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---hhhhhhhhhccccc-cc----ccc
Confidence            22334566788899999998 88899999999999999999999999986521   11111111111000 00    000


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                        ........++.+++.+||+.||++||++.+++++
T Consensus       224 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  224 --QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             --TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             --cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0001112779999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.8e-41  Score=300.66  Aligned_cols=247  Identities=20%  Similarity=0.316  Sum_probs=199.6

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      +|++.+.||+|+||.||++... ++..+++|....    ...+.+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999954 688999997432    23456788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++...   ....+++.....++.|++.||.|||+  ++|+|+||||+||++++++.++++|||++........
T Consensus        81 ~~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          81 DGGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            999998877421   23457888899999999999999999  7799999999999999999999999999876543221


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                        ......++..|+|||++.+..++.++|+||||+++|+|++|..||.....   ......+.             ....
T Consensus       156 --~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---~~~~~~~~-------------~~~~  217 (255)
T cd08219         156 --YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---KNLILKVC-------------QGSY  217 (255)
T ss_pred             --ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH---HHHHHHHh-------------cCCC
Confidence              12345678889999999988999999999999999999999999975431   11111111             0111


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...+...+..+.+++.+||+.||.+|||+.+++..
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            22344456779999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.9e-41  Score=308.95  Aligned_cols=260  Identities=20%  Similarity=0.288  Sum_probs=196.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      .++|++.+.||+|+||.||+|... ++..||+|....    .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            357889999999999999999854 678999997542    223457789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++ +|.+++..    ....+++..+..++.|++.||.|||+  ++|+|+||||+||+++.++.++|+|||++......
T Consensus        85 ~~~~-~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          85 YLDK-DLKQYLDD----CGNSINMHNVKLFLFQLLRGLNYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             cccc-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            9975 78777632    23457888999999999999999999  77999999999999999999999999998764322


Q ss_pred             CCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc---ccchhhh
Q 016917          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD---FSNLLKI  306 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  306 (380)
                      .  .......++..|+|||.+.+ ..++.++|||||||++|||++|++||...+..+   ....+.....   .......
T Consensus       158 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~  232 (301)
T cd07873         158 T--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGI  232 (301)
T ss_pred             C--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhh
Confidence            1  11223456788999998765 457889999999999999999999998654321   1111111000   0000000


Q ss_pred             ccc---------ccc----cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDE---------RLW----STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~---------~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .+.         ...    .......++.+.+++.+||+.||.+|||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000         000    01112345678999999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.2e-41  Score=313.40  Aligned_cols=238  Identities=19%  Similarity=0.281  Sum_probs=191.5

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC------CChHHHHHHHHHHhcCC-CCceeeeccceecCCeeEEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  149 (380)
                      +|+..+.||+|+||.||+|.. .++..||+|....      ...+.+..|..++..+. |++|+++.+++...+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            367789999999999999995 4688999997542      22345677888888885 578889999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus        81 Ey~~~g~L~~~i~-----~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQ-----QVGKFKEPQAVFYAAEISVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            9999999988873     34568899999999999999999999  7799999999999999999999999999875432


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ..  .......||..|+|||++.+..++.++|||||||++|||++|+.||.....   ......+.            ..
T Consensus       154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~------------~~  216 (323)
T cd05615         154 DG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIM------------EH  216 (323)
T ss_pred             CC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH------------hC
Confidence            11  122345688999999999999999999999999999999999999986432   11111111            00


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM  341 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  341 (380)
                        ...++...+.++.+++.+||+.||.+|++.
T Consensus       217 --~~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         217 --NVSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              012334456778999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8e-41  Score=315.70  Aligned_cols=261  Identities=17%  Similarity=0.249  Sum_probs=194.0

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ....+|++.+.||+|+||.||+|... ++..||+|.....   ....|+.++++++||||+++++++...+..++|+||+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            34567999999999999999999964 5778999975433   3356999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      .+ +|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.....  
T Consensus       140 ~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  210 (357)
T PHA03209        140 SS-DLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--  210 (357)
T ss_pred             CC-cHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence            64 77777632    34568899999999999999999999  67999999999999999999999999998754321  


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCccc--------HHHHHHhhh----cc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD--------LVELVQNSR----DF  300 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~--------~~~~~~~~~----~~  300 (380)
                       .......||..|+|||++.+..++.++|||||||++|||+++..|+....+.....        +...+....    .+
T Consensus       211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  289 (357)
T PHA03209        211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF  289 (357)
T ss_pred             -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence             11234568899999999999999999999999999999998665543332222111        111111000    00


Q ss_pred             c-----ch-hhhccc--ccccCC-------CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 S-----NL-LKILDE--RLWSTF-------TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 ~-----~~-~~~~~~--~~~~~~-------~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .     .. ....+.  .....+       ....+.++.++|.+||+.||.+|||+.|++++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            0     00 000000  000000       01234567789999999999999999999976

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.7e-41  Score=315.21  Aligned_cols=256  Identities=21%  Similarity=0.297  Sum_probs=192.7

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecC------
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------  142 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  142 (380)
                      ..++|++.+.||+|+||.||+|.. .++..||+|.....     ....+.+|+++++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            356799999999999999999985 56789999986532     224567899999999999999999987543      


Q ss_pred             CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFg  222 (380)
                      ...+++++++ +++|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK------CQKLSDEHVQFLIYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCChhhEEECCCCCEEEcCCc
Confidence            3468999987 668877662      3468899999999999999999999  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc-
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF-  300 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-  300 (380)
                      ++......     .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||......+   ....+...... 
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~  235 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGTP  235 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCC
Confidence            98865432     234568889999999876 578999999999999999999999997643211   11111000000 


Q ss_pred             -cc-hhhhcc-------cccc-------cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 -SN-LLKILD-------ERLW-------STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 -~~-~~~~~~-------~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       .. ...+..       ..+.       .......++.+.+++.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             00 000000       0000       00001123568899999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.6e-40  Score=305.91  Aligned_cols=247  Identities=22%  Similarity=0.352  Sum_probs=200.1

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC---ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      .+|+..+.||+|+||.||+|.. .++..+++|.....   ..+.+.+|+.+++.++||||+++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            4788889999999999999985 46889999975432   3456788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++.      ...+++.++..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++....... 
T Consensus       100 ~~~~L~~~~~------~~~~~~~~~~~i~~ql~~aL~~LH~--~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-  170 (296)
T cd06654         100 AGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (296)
T ss_pred             CCCCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence            9999998873      2347888999999999999999999  679999999999999999999999999987653321 


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                       .......++..|+|||.+.+..++.++|||||||++|+|++|+.||....+..  .......            .....
T Consensus       171 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~~~------------~~~~~  235 (296)
T cd06654         171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIAT------------NGTPE  235 (296)
T ss_pred             -cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHHhc------------CCCCC
Confidence             11233467888999999998889999999999999999999999997544211  1111000            00011


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...+...+..+.+++.+||..||++|||+.+++++
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            12234455779999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.7e-40  Score=305.83  Aligned_cols=247  Identities=22%  Similarity=0.341  Sum_probs=200.7

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC---CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG---APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ++|++.+.||+|+||.||+|.. .++..||+|....   ...+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5788999999999999999995 5789999997542   23356788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++.      ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~------~~~~~~~~~~~~~~~l~~~L~~LH~--~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          99 AGGSLTDVVT------ETCMDEGQIAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             CCCCHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            9999998873      2456888999999999999999999  6799999999999999999999999999876543221


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                        ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+....  ...            .......
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--~~~------------~~~~~~~  234 (297)
T cd06656         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YLI------------ATNGTPE  234 (297)
T ss_pred             --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--eee------------ccCCCCC
Confidence              123346788899999999888999999999999999999999999764431110  000            0000111


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...+...+..+.+++.+||+.||.+||++++++++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            12234455778999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.2e-41  Score=314.06  Aligned_cols=234  Identities=21%  Similarity=0.275  Sum_probs=186.4

Q ss_pred             CeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHH-HHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVC-FLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      ++||+|+||.||+|+.. ++..||+|.....      ....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 6889999975422      2233445554 67889999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |+|...+.     ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++.....  ..
T Consensus        81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~  151 (321)
T cd05603          81 GELFFHLQ-----RERCFLEPRARFYAAEVASAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EE  151 (321)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CC
Confidence            99987773     34567888899999999999999999  77999999999999999999999999998753221  12


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      ......|+..|+|||.+.+..++.++|||||||++|||++|..||...+.   ....+.+.            ..  ...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~------------~~--~~~  214 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQMYDNIL------------HK--PLQ  214 (321)
T ss_pred             ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHHHHHHh------------cC--CCC
Confidence            23345688999999999999999999999999999999999999976431   11111111            11  112


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMS  342 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~  342 (380)
                      .+...+..+.+++.+||+.||.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            3344557799999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.5e-40  Score=300.60  Aligned_cols=245  Identities=27%  Similarity=0.405  Sum_probs=201.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      ..|+..+.||.|+||.||+|... ++..||+|......    ...+.+|+.+++.++||||+++++.+.+++..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35777889999999999999964 58899999754332    34678899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++.      ...+++..+..++.|++.|+.|||+  ++++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~i~------~~~l~~~~~~~~~~~l~~~l~~lh~--~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          84 LGGGSALDLLR------AGPFDEFQIATMLKEILKGLDYLHS--EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            99999998873      2457888899999999999999999  779999999999999999999999999987664322


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                      .  ......++..|+|||.+.+..++.++|+|||||++|||++|..||....+..   ....             .....
T Consensus       156 ~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~-------------~~~~~  217 (277)
T cd06640         156 I--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLFL-------------IPKNN  217 (277)
T ss_pred             c--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hhhh-------------hhcCC
Confidence            1  1233457778999999988889999999999999999999999987544211   0100             01111


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....+...+..+.+++.+||+.||.+||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            234455677889999999999999999999999877

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3e-41  Score=329.56  Aligned_cols=263  Identities=17%  Similarity=0.213  Sum_probs=190.1

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCC------CceeeeccceecC-
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA--PTQEFIDEVCFLASIQH------RNLVTLLGYCQEN-  142 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~-  142 (380)
                      ....++|++.+.||+|+||+||+|.. ..++.||||+....  .......|+++++.++|      .+++++++++... 
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            34567899999999999999999995 45788999986432  23345667777776654      4588898888754 


Q ss_pred             CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC--------
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF--------  214 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~--------  214 (380)
                      +..++|||++ +++|.+++.     ....+++..+..++.|++.||.|||+. .+||||||||+|||++.++        
T Consensus       205 ~~~~iv~~~~-g~~l~~~l~-----~~~~l~~~~~~~i~~qi~~aL~yLH~~-~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        205 GHMCIVMPKY-GPCLLDWIM-----KHGPFSHRHLAQIIFQTGVALDYFHTE-LHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             ceEEEEEecc-CCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEecCCcccccccc
Confidence            5678999988 667877773     345688999999999999999999972 3799999999999998665        


Q ss_pred             --------ceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 016917          215 --------IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS  286 (380)
Q Consensus       215 --------~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~  286 (380)
                              .+||+|||++.....     ......||..|+|||++.+..|+.++|||||||++|||++|+.||......+
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             cccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                    499999998764322     2234678999999999999999999999999999999999999998654321


Q ss_pred             cccHHHHHHhhh--------cccchhhhc----------ccccc-------cCCCHHHHHHHHHHHhHccCCCCCCCCCH
Q 016917          287 SQDLVELVQNSR--------DFSNLLKIL----------DERLW-------STFTNEGMEEFIQLIVRCLDPSSERRPSM  341 (380)
Q Consensus       287 ~~~~~~~~~~~~--------~~~~~~~~~----------~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  341 (380)
                      ............        .......+.          ++...       ........+.+.+||.+||++||++|||+
T Consensus       353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta  432 (467)
T PTZ00284        353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA  432 (467)
T ss_pred             HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence            111111100000        000000000          00000       00000123568899999999999999999


Q ss_pred             HHHHHH
Q 016917          342 SDVVTE  347 (380)
Q Consensus       342 ~~ll~~  347 (380)
                      +|++++
T Consensus       433 ~e~L~H  438 (467)
T PTZ00284        433 RQMTTH  438 (467)
T ss_pred             HHHhcC
Confidence            999985

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.3e-40  Score=302.35  Aligned_cols=251  Identities=27%  Similarity=0.409  Sum_probs=196.5

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC--CChHHHHHHHHHHhcC-CCCceeeeccceecC------Ce
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG--APTQEFIDEVCFLASI-QHRNLVTLLGYCQEN------NL  144 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~~  144 (380)
                      +.+.|+..+.||+|+||.||+|.. .+++.+|+|....  .....+..|+.+++++ +||||+++++++...      ..
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            345688889999999999999995 4688899997543  3345688999999998 799999999998643      45


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .++||||+.+++|.+++...   ....+++..+..++.|++.|+.|||+  ++|+||||||+||++++++.++|+|||++
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            79999999999999988432   23467899999999999999999999  67999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCccceecccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD  299 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  299 (380)
                      .......  .......++..|+|||++.     +..++.++|||||||++|||++|+.||.......     .... ...
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~~-~~~  230 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALFL-IPR  230 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHHH-Hhc
Confidence            7654321  2233456888899999875     3468889999999999999999999986543211     0000 000


Q ss_pred             ccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                               ..........++.++.+++.+||..||.+|||+.+++++
T Consensus       231 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         231 ---------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             ---------CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                     000111122345679999999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.5e-40  Score=299.71  Aligned_cols=247  Identities=25%  Similarity=0.440  Sum_probs=198.4

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC------------hHHHHHHHHHHhcCCCCceeeeccceecCCe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------------TQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  144 (380)
                      +|.+.+.||+|++|.||+|.. .++..+++|......            .+.+.+|++++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            367788999999999999985 467899999643211            1347789999999999999999999999999


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .++|+||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++||||+|+||++++++.++|+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~~l~~~l~~lH~--~~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLN-----NYGAFEETLVRNFVRQILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHH-----hccCccHHHHHHHHHHHHHHHHHHHh--cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence            999999999999998883     33567888899999999999999999  67999999999999999999999999998


Q ss_pred             cccCCCCCC----CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc
Q 016917          225 NFLGRTDVA----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF  300 (380)
Q Consensus       225 ~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  300 (380)
                      +........    .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||......      ..+....  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~--  225 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFKIG--  225 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHHHh--
Confidence            876532111    1122345788899999999888999999999999999999999999754311      1111000  


Q ss_pred             cchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                              .......+...+..+.+++.+||+.||.+||++.+++++
T Consensus       226 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         226 --------ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             --------ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                    011223444566789999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.2e-40  Score=298.35  Aligned_cols=246  Identities=25%  Similarity=0.383  Sum_probs=195.7

Q ss_pred             CeeccCCceEEEEEEECC--C--cEEEEEeCCCCCh----HHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLLQD--G--MLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~--~--~~vavK~~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|++|.||+|.+..  +  ..||+|.......    +.+.+|+.++++++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998543  2  3689998665433    467889999999999999999999988 888999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC-C
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-A  233 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~-~  233 (380)
                      ++|.+++.....   ..+++..++.++.|++.||.|||+  ++++|+||||+||+++.++.+||+|||++........ .
T Consensus        80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHh--CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999998854311   467899999999999999999999  7799999999999999999999999999987644221 1


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                      .......++..|+|||.+.+..++.++|||||||++|||++ |..||......   +.......            ....
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~------------~~~~  219 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKIDK------------EGER  219 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHh------------cCCc
Confidence            11223456778999999998899999999999999999998 99998654321   11111110            0011


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                      ...+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            1223345678999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1e-40  Score=305.44  Aligned_cols=248  Identities=20%  Similarity=0.285  Sum_probs=196.5

Q ss_pred             CCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           79 FSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      |+..+.||+|+||+||++.. .+++.+|+|.....      ....+.+|+++++.++|+||+.+.+.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778999999999999995 46889999975432      123467899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~--~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            9999998877432   23468999999999999999999999  779999999999999999999999999987653211


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                         ......++..|+|||.+.+..++.++|+|||||++|+|++|..||........   .+.+.....        ..  
T Consensus       157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~--------~~--  220 (285)
T cd05632         157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVL--------ET--  220 (285)
T ss_pred             ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhh--------cc--
Confidence               12334688899999999989999999999999999999999999986432111   111110000        00  


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  347 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~~ll~~  347 (380)
                      ...++...+.++.+++..||+.||++||+     +.+++.+
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         221 EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            01223344567899999999999999999     6677654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.1e-41  Score=317.10  Aligned_cols=258  Identities=19%  Similarity=0.271  Sum_probs=193.9

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecC------
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------  142 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  142 (380)
                      ..++|++.+.||+|+||.||++.. ..++.||+|+....     ....+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            356899999999999999999995 46888999986432     234677899999999999999999987543      


Q ss_pred             CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFg  222 (380)
                      ...|+||||+++ +|.+.+.       ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEECCCCcEEEEeCC
Confidence            357999999976 5655551       246788889999999999999999  779999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh-ccc
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-DFS  301 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~  301 (380)
                      +++......   ......+|..|+|||++.+..++.++|||||||++|+|++|+.||...+..+.  ....+.... ...
T Consensus       172 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~  246 (364)
T cd07875         172 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCP  246 (364)
T ss_pred             CccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCH
Confidence            998654321   22345688899999999999999999999999999999999999976542111  111110000 000


Q ss_pred             ch--------hhhccc--------------cc----ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 NL--------LKILDE--------------RL----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 ~~--------~~~~~~--------------~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..        ......              ..    ..........++++++.+||+.||.+|||+.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00        000000              00    000111234578999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.1e-41  Score=320.33  Aligned_cols=259  Identities=22%  Similarity=0.293  Sum_probs=201.0

Q ss_pred             CCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCCC--hHHHHHHHHHHhcCC-C-----CceeeeccceecCCeeEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-H-----RNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~lv  148 (380)
                      +|.+.+.||+|+||.|.+|. .++++.||||+.+...  ..+...|+.+|..|+ |     -|+|+++++|...+..|||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            57888999999999999999 5679999999876543  355677999999986 3     4899999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC--CceEEcccccccc
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED--FIAKVADAGLRNF  226 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~--~~~kl~DFgla~~  226 (380)
                      +|.++. +|.+++...   +...++...+..++.||+.||.+||+  .+|||+||||+|||+.+.  ..+||+|||+++.
T Consensus       267 fELL~~-NLYellK~n---~f~Glsl~~ir~~~~Qil~~L~~L~~--l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  267 FELLST-NLYELLKNN---KFRGLSLPLVRKFAQQILTALLFLHE--LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             ehhhhh-hHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            999976 899999543   44668999999999999999999998  679999999999999643  4799999999997


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH-----------
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ-----------  295 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~-----------  295 (380)
                      ..+.     ...+..+..|+|||++.|.+|+.+.||||||||+.||++|.+.|.+.++.+.-..+-.+.           
T Consensus       341 ~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  341 ESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            6553     236778889999999999999999999999999999999988888765422211111100           


Q ss_pred             -hhhcc-cc---------hhh----------------hcccc--------cccCCCHHHHHHHHHHHhHccCCCCCCCCC
Q 016917          296 -NSRDF-SN---------LLK----------------ILDER--------LWSTFTNEGMEEFIQLIVRCLDPSSERRPS  340 (380)
Q Consensus       296 -~~~~~-~~---------~~~----------------~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt  340 (380)
                       +...+ ..         ...                ..+..        +...........+.+++++||.+||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence             00000 00         000                00000        000111234467899999999999999999


Q ss_pred             HHHHHHH
Q 016917          341 MSDVVTE  347 (380)
Q Consensus       341 ~~~ll~~  347 (380)
                      +.++++|
T Consensus       496 p~qal~H  502 (586)
T KOG0667|consen  496 PAQALNH  502 (586)
T ss_pred             HHHHhcC
Confidence            9999987

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.3e-40  Score=299.39  Aligned_cols=245  Identities=29%  Similarity=0.489  Sum_probs=197.7

Q ss_pred             CCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC-ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCC
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  155 (380)
                      ++|++.+.||+|+||.||++.. .+..+++|..... ..+.+.+|+.+++.++|||++++++++..++ .++||||+.++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~   83 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKG   83 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCC
Confidence            5688899999999999999875 5778999986543 4467889999999999999999999987654 69999999999


Q ss_pred             CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016917          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (380)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~  235 (380)
                      +|.+++...   ....+++..+..++.|++.|+.|||+  ++++||||||+||+++.++.++|+|||++......     
T Consensus        84 ~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~--~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          84 NLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            999998532   23457888999999999999999999  77999999999999999999999999998764321     


Q ss_pred             CccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      ......+..|+|||.+.+..++.++|+||||+++|||++ |+.||......   .......             ......
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~-------------~~~~~~  217 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKECVE-------------KGYRME  217 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHHh-------------CCCCCC
Confidence            112233567999999988899999999999999999997 99998754421   1111111             111112


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                      .+..++..+.+++.+||+.+|++||+++++++.|+
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            23345678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.2e-40  Score=297.91  Aligned_cols=249  Identities=28%  Similarity=0.427  Sum_probs=203.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEECC-CcEEEEEeCCCCC-hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAP-TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      ++|+..+.||+|+||.||+|.... +..+++|...... .+.+.+|+++++.++||||+++++++......++++||+.+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   82 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA   82 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence            578889999999999999999764 7899999865432 66789999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      ++|.+++..    ....+++..+..++.|++.|+.|||+  .+++|+||+|+||++++++.++|+|||++........  
T Consensus        83 ~~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          83 GSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            999998832    24567899999999999999999999  6799999999999999999999999999887654321  


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....+...   ....   ..        .......
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~---~~~~---~~--------~~~~~~~  220 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA---IFMI---PN--------KPPPTLS  220 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh---hhhh---cc--------CCCCCCC
Confidence            12334577789999999989999999999999999999999999876433211   0000   00        0001112


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .+...+.++.+++.+||+.||++|||+.+++++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            234456789999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2e-40  Score=303.17  Aligned_cols=261  Identities=23%  Similarity=0.314  Sum_probs=194.6

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +|++.+.||+|++|.||+|... ++..||+|.....     ....+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999964 6889999975422     235678899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      ++ ++|.+++...  .....+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcC--CCCCcCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 4777776332  123568899999999999999999999  779999999999999999999999999987653221


Q ss_pred             CCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc-----------
Q 016917          232 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-----------  299 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----------  299 (380)
                        .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||......  ............           
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd07861         156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFRIFRILGTPTEDVWPGVTS  231 (285)
T ss_pred             --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhcchh
Confidence              111233567789999987654 5789999999999999999999999754321  111111000000           


Q ss_pred             ccchhhhccc---ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 FSNLLKILDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 ~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..........   ..........++++.+++.+||..||.+|||+++++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0000000000   00001112245778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.3e-40  Score=299.44  Aligned_cols=236  Identities=19%  Similarity=0.367  Sum_probs=183.6

Q ss_pred             CeeccCCceEEEEEEECC-------------CcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           83 NLIGEGKFGEVYKGLLQD-------------GMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~-------------~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      +.||+|+||.||+|....             ...+++|......   ...+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            358999999999998432             2358888755433   235778899999999999999999999988999


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc-------eEEc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI-------AKVA  219 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~-------~kl~  219 (380)
                      +||||+++|+|..++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhh--CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            99999999999887732    23458889999999999999999999  77999999999999987654       8999


Q ss_pred             ccccccccCCCCCCCCCccccCccceecccccc-cCCCCcchhhHHHHHHHHHHH-cCCCCCCCCCCCCcccHHHHHHhh
Q 016917          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELV-SGREASSSLSPDSSQDLVELVQNS  297 (380)
Q Consensus       220 DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwSlG~il~el~-tg~~p~~~~~~~~~~~~~~~~~~~  297 (380)
                      |||++.....      .....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+.   .. .   
T Consensus       155 d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~-~---  221 (262)
T cd05077         155 DPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK---ER-F---  221 (262)
T ss_pred             CCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH---HH-H---
Confidence            9999865432      12334667799999886 567899999999999999998 58888765332111   00 0   


Q ss_pred             hcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      .         ....  ......++++.+++.+||+.||++||++.++++.|
T Consensus       222 ~---------~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         222 Y---------EGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             H---------hcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            0         0000  01112246789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.8e-41  Score=316.63  Aligned_cols=258  Identities=19%  Similarity=0.283  Sum_probs=193.9

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecC------
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------  142 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  142 (380)
                      ..++|++.+.||+|+||.||++.. ..++.||+|.....     ....+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            456899999999999999999985 46889999976432     234577899999999999999999988543      


Q ss_pred             CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFg  222 (380)
                      ...++||||+++ ++.+.+       ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVI-------QMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHH-------hhcCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEECCCCCEEEeeCc
Confidence            356999999976 555554       1246788889999999999999999  779999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh-cc-
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-DF-  300 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~-  300 (380)
                      +++......   ......+|..|+|||++.+..++.++|||||||++|+|++|+.||......+.  ....+.... .. 
T Consensus       165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~  239 (355)
T cd07874         165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCP  239 (355)
T ss_pred             ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCH
Confidence            998654321   22345688899999999999999999999999999999999999976442111  110000000 00 


Q ss_pred             -------cchhhhcc----------c-----ccc---cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 -------SNLLKILD----------E-----RLW---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 -------~~~~~~~~----------~-----~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                             .......+          +     ...   ...+...+.++++++.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                   00000000          0     000   01112234678999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.7e-41  Score=314.16  Aligned_cols=235  Identities=20%  Similarity=0.273  Sum_probs=186.5

Q ss_pred             CeeccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHH-HHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVC-FLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|+||.||+|.. .+++.+|+|.....      ....+..|.. +++.++||||+++++.+...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999995 46889999975422      2234455554 56788999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~  151 (325)
T cd05604          81 GELFFHLQ-----RERSFPEPRARFYAAEIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD  151 (325)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence            99988773     34568899999999999999999999  77999999999999999999999999998753221  11


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      ......|+..|+|||++.+..++.++|||||||++|||++|..||......   .....+   .         ...  ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~~---~---------~~~--~~  214 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMYDNI---L---------HKP--LV  214 (325)
T ss_pred             CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HHHHHH---H---------cCC--cc
Confidence            233456899999999999999999999999999999999999999764321   111111   1         000  11


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMSD  343 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~~  343 (380)
                      .+...+..+.+++.+||+.||.+||++.+
T Consensus       215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         215 LRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            22234567889999999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-40  Score=300.72  Aligned_cols=245  Identities=27%  Similarity=0.384  Sum_probs=200.2

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      ++|+..+.||.|++|.||+|... ++..+++|.....    ....+.+|+++++.++|+||+++.+++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36788899999999999999954 6889999975433    234678899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++..      ..+++..+..++.|++.|+.|||+  ++++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            999999988832      267899999999999999999999  679999999999999999999999999998775432


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                        .......++..|+|||.+.+..++.++||||||+++|+|++|..||....+.   .....+...             .
T Consensus       153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~-------------~  214 (274)
T cd06609         153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RVLFLIPKN-------------N  214 (274)
T ss_pred             --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HHHHHhhhc-------------C
Confidence              1223446778899999999888999999999999999999999999764421   111111100             1


Q ss_pred             ccCCCHH-HHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          312 WSTFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       312 ~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....+.. .++.+.+++.+||..||++|||+++++++
T Consensus       215 ~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         215 PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            1111112 55679999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.5e-40  Score=296.93  Aligned_cols=247  Identities=22%  Similarity=0.325  Sum_probs=198.0

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceec-CCeeEEEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYE  150 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  150 (380)
                      +|++.+.||+|++|.||++..+ +++.+++|.....     ..+.+.+|++++++++|+|++++.+.+.. .+..+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999954 5788999975322     23457889999999999999999988764 456799999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++++|.+++...   ....+++.++..++.+++.|+.+||+  ++++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~--~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            99999999888432   23457899999999999999999999  77999999999999999999999999998866432


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      .  .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.      ........          ..
T Consensus       156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~----------~~  217 (257)
T cd08223         156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRII----------EG  217 (257)
T ss_pred             C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHH----------hc
Confidence            2  122345578889999999999999999999999999999999999875331      11111100          00


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .....+...++.+.+++.+||+.||++|||+.+++++
T Consensus       218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         218 KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            1112344566789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2e-40  Score=302.19  Aligned_cols=244  Identities=28%  Similarity=0.406  Sum_probs=198.2

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      .|+..+.||+|+||.||+|.. .++..||+|......    .+.+.+|+++++.++||||+++++.+..++..++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            355667899999999999985 457889999755322    345788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++.      ...+++..+..++.|++.|+.|||+  ++++|+||+|+||++++++.++|+|||++..+.....
T Consensus        85 ~~~~L~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~--~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          85 GGGSALDLLK------PGPLEETYIATILREILKGLDYLHS--ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHhc--CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            9999988873      2457888999999999999999999  7799999999999999999999999999876643221


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                        ......++..|+|||.+.+..++.++|+|||||++|||++|+.||....+...   ...             ......
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~-------------~~~~~~  218 (277)
T cd06642         157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFL-------------IPKNSP  218 (277)
T ss_pred             --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhh-------------hhcCCC
Confidence              12234577889999999998999999999999999999999999875432110   100             111111


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...+...+.++.+++.+||+.+|.+||++.+++++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            22334456779999999999999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=311.43  Aligned_cols=252  Identities=23%  Similarity=0.264  Sum_probs=194.9

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||.||++.. .+++.||+|....      ...+.+.+|..++..++|+||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            3688899999999999999995 4688999998542      23345788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++..    ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVLAIDSVHQ--LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            99999999998832    23567889999999999999999999  7799999999999999999999999999876543


Q ss_pred             CCCCCCCccccCccceeccccccc-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ... .......||..|+|||++..     ..++.++|||||||++|||++|+.||.....      .+............
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~  227 (331)
T cd05597         155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHF  227 (331)
T ss_pred             CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcc
Confidence            221 11223468999999999863     4578899999999999999999999975432      11111111000000


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~~ll~~  347 (380)
                      .      ........++.+.+++.+|+..++++  |+++++++++
T Consensus       228 ~------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         228 Q------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             c------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0      01111235677899999988654443  7899999987

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4e-40  Score=296.48  Aligned_cols=248  Identities=21%  Similarity=0.354  Sum_probs=201.1

Q ss_pred             CCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCC-----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +|+..+.||.|+||.||.++ ..++..+++|....     .....+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            47888999999999999998 45688899996332     2345688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++...   ....+++..+..++.|++.|+.|||+  .+++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHK--AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            9999999988432   23567889999999999999999999  679999999999999999999999999987664422


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                      .  ......++..|+|||...+..++.++|+||||+++|||++|..||......   +....+.            . ..
T Consensus       156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~~~~------------~-~~  217 (256)
T cd08221         156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIV------------Q-GN  217 (256)
T ss_pred             c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH------------c-CC
Confidence            1  223456788999999998888999999999999999999999998753321   1111111            0 11


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      ....+...+.++.+++.+||..||.+||+++++++++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         218 YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            1122344567799999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.4e-40  Score=300.15  Aligned_cols=255  Identities=27%  Similarity=0.437  Sum_probs=200.5

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      .+|++.+.||+|+||.||+|+.+      +...+++|......    .+.+.+|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888899999999999999954      24678999765432    346889999999999999999999999989999


Q ss_pred             EEEEeecCCCccccccCCCCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQV----SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFg  222 (380)
                      +||||+++|+|.+++......    ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.++++|||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~~~~  162 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN--ARFVHRDLAARNCLVSSQREVKVSLLS  162 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh--cCcccCcCccceEEEeCCCcEEEcccc
Confidence            999999999999988533211    12268999999999999999999999  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhccc
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                      ++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .......      
T Consensus       163 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~~~------  232 (275)
T cd05046         163 LSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNRLQ------  232 (275)
T ss_pred             cccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHHHH------
Confidence            9875432221 11223345677999999988888999999999999999998 77888654321   1111110      


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                            ........+..++..+.+++.+||+.||.+|||+.++++.|.
T Consensus       233 ------~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         233 ------AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             ------cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                  011111223345578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.7e-40  Score=297.92  Aligned_cols=248  Identities=23%  Similarity=0.334  Sum_probs=195.1

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC--------ChHHHHHHHHHHhcCCCCceeeeccceec--CCee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQ  145 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  145 (380)
                      .+|+..+.||+|+||.||+|.. .++..|++|.....        ....+.+|+.+++.++||||+++++++..  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3688899999999999999985 46889999974321        12357789999999999999999998865  3677


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++++||+++++|.+++.     ....+++...+.++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++.
T Consensus        82 ~l~~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~LH~--~~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLK-----AYGALTESVTRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            89999999999998883     23457888899999999999999998  779999999999999999999999999987


Q ss_pred             ccCCCCC-CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          226 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       226 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ....... ........++..|+|||.+.+..++.++|+|||||++|||++|+.||......      ..+.         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~---------  219 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIF---------  219 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHH---------
Confidence            6533111 11122345788899999999889999999999999999999999999754321      1111         


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..........++...++.+.+++ .||..||++||++++++.+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         220 KIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             HHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            11111112234455567788888 6777899999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.8e-40  Score=300.76  Aligned_cols=250  Identities=21%  Similarity=0.317  Sum_probs=196.7

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ++|++.+.||+|+||.||+|.. .++..||+|......   ...+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            3577778999999999999985 468899999754332   345678999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++.     ....+++..+..++.|++.|+.|||+  .+++|+||||+||+++.++.++|+|||++....... 
T Consensus        89 ~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06645          89 GGGSLQDIYH-----VTGPLSESQIAYVSRETLQGLYYLHS--KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-  160 (267)
T ss_pred             CCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence            9999999873     34568899999999999999999999  679999999999999999999999999987654321 


Q ss_pred             CCCCccccCccceecccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          233 AGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                       .......++..|+|||.+.   ...++.++|+|||||++|+|++|..||....+...  ......  ..       ..+
T Consensus       161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~~~~--~~-------~~~  228 (267)
T cd06645         161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMTK--SN-------FQP  228 (267)
T ss_pred             -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHhhhc--cC-------CCC
Confidence             2223456888999999874   45688999999999999999999999865432110  000000  00       000


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ... .....++..+.+++.+||+.||++||++++++++
T Consensus       229 ~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         229 PKL-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             Ccc-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            000 0011244678999999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=305.74  Aligned_cols=245  Identities=22%  Similarity=0.276  Sum_probs=208.3

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      +-|...+.||+|.|+.|-+|++ -+|.+||||+.++.     .+..+.+|+..|+..+|||||++|++......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            3477789999999999999994 57999999976544     34568899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee-CCCCceEEcccccccccCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV-DEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili-~~~~~~kl~DFgla~~~~~  229 (380)
                      +-++|+|.|++-.    ....+.+....+++.||+.|+.|+|+  -++|||||||+||.+ .+-|.+||+|||++..+.+
T Consensus        98 LGD~GDl~DyImK----He~Gl~E~La~kYF~QI~~AI~YCHq--LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   98 LGDGGDLFDYIMK----HEEGLNEDLAKKYFAQIVHAISYCHQ--LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             ecCCchHHHHHHh----hhccccHHHHHHHHHHHHHHHHHHhh--hhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            9999999999842    35668889999999999999999999  459999999999976 4668999999999987755


Q ss_pred             CCCCCCCccccCccceecccccccCCCC-cchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      +.   .....+|...|.|||++.|..|+ +++||||||||||.|.+|++||+..+..               +.+..++|
T Consensus       172 G~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------------ETLTmImD  233 (864)
T KOG4717|consen  172 GK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------------ETLTMIMD  233 (864)
T ss_pred             cc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---------------hhhhhhhc
Confidence            32   34566899999999999999996 5799999999999999999999865532               23334444


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      -++  ..|...+.+.++||..||..||++|.+.+++...
T Consensus       234 CKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  234 CKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            433  4677788999999999999999999999998753

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-40  Score=311.35  Aligned_cols=252  Identities=22%  Similarity=0.246  Sum_probs=195.3

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||.||++..+ +++.+|+|....      .....+..|..++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36888999999999999999954 577899997542      22334778999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.....
T Consensus        81 ey~~~g~L~~~l~~----~~~~l~~~~~~~~~~qi~~al~~lH~--~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            99999999999842    23467888999999999999999999  6799999999999999999999999999876533


Q ss_pred             CCCCCCCccccCccceecccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          230 TDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ... .......||..|+|||++.     ...++.++|||||||++|||++|+.||.....      .+..........  
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~--  225 (332)
T cd05623         155 DGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKE--  225 (332)
T ss_pred             CCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCc--
Confidence            211 1123456899999999986     34688999999999999999999999975432      111111110000  


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~~ll~~  347 (380)
                          ..........+++++.+++.+|+..++.+  |+++++++++
T Consensus       226 ----~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         226 ----RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ----cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                00011112345678999999988665544  6899999887

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.2e-40  Score=305.85  Aligned_cols=262  Identities=19%  Similarity=0.276  Sum_probs=187.2

Q ss_pred             CeeccCCceEEEEEEEC---CCcEEEEEeCCCC-ChHHHHHHHHHHhcCCCCceeeecccee--cCCeeEEEEEeecCCC
Q 016917           83 NLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQ--ENNLQFLIYEYIPNGS  156 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~~g~  156 (380)
                      .+||+|+||.||+|..+   ++..||+|..... ....+.+|++++++++||||+++++++.  .+...++|+||+.+ +
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~   85 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-D   85 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-c
Confidence            57999999999999964   3578999976543 3446788999999999999999999885  35677999999876 6


Q ss_pred             ccccccCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----CCCCceEEcccccccccC
Q 016917          157 VSIHLYGPS----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       157 L~~~l~~~~----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili----~~~~~~kl~DFgla~~~~  228 (380)
                      |.+++....    ......+++..+..++.|++.||.|||+  .+|+||||||+|||+    +.++.+||+|||+++...
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07867          86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence            655553211    1123457888999999999999999999  679999999999999    566799999999998764


Q ss_pred             CCCC-CCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcc-------cHHHHHHh---
Q 016917          229 RTDV-AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-------DLVELVQN---  296 (380)
Q Consensus       229 ~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~~---  296 (380)
                      .... ........+|..|+|||.+.+ ..++.++|||||||++|||+||++||.....+...       ........   
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T cd07867         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF  243 (317)
T ss_pred             CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCC
Confidence            4321 112234567889999999876 45799999999999999999999999754432111       00000000   


Q ss_pred             -----------hhcccchhhhccccc---------ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          297 -----------SRDFSNLLKILDERL---------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       297 -----------~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                                 ...............         ...........+.+++.+||+.||.+|||++|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             CChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence                       000000000000000         000111123568899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.5e-40  Score=300.20  Aligned_cols=235  Identities=20%  Similarity=0.374  Sum_probs=183.5

Q ss_pred             eeccCCceEEEEEEECC-------------------------CcEEEEEeCCCCCh---HHHHHHHHHHhcCCCCceeee
Q 016917           84 LIGEGKFGEVYKGLLQD-------------------------GMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTL  135 (380)
Q Consensus        84 ~ig~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~---~~~~~E~~~l~~l~h~niv~l  135 (380)
                      .||+|+||.||+|....                         ...|++|.......   ..+.+|..+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999997421                         13588887654432   357788999999999999999


Q ss_pred             ccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-
Q 016917          136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-  214 (380)
Q Consensus       136 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~-  214 (380)
                      ++++...+..++||||+++|+|..++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLED--KNLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHc--CCccCCCCCcccEEEeccCc
Confidence            9999999999999999999999888742    24567889999999999999999999  7899999999999997643 


Q ss_pred             ------ceEEcccccccccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHH-cCCCCCCCCCCCC
Q 016917          215 ------IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELV-SGREASSSLSPDS  286 (380)
Q Consensus       215 ------~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~-tg~~p~~~~~~~~  286 (380)
                            .++++|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+..
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                  4899999987643221      12345667999998865 56899999999999999985 6899987654321


Q ss_pred             cccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          287 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      .   ......             .  ...+....+++.+++.+||+.+|++|||+.++++.|
T Consensus       230 ~---~~~~~~-------------~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         230 K---ERFYEK-------------K--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             H---HHHHHh-------------c--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            1   111110             0  011222235689999999999999999999999877

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-40  Score=303.15  Aligned_cols=253  Identities=20%  Similarity=0.295  Sum_probs=200.9

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ..+|++.+.||+|+||+||++... ++..+|+|.....    ....+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            346778899999999999999954 6888999964322    24568899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++++|.+++.     ....+++..+..++.+++.||.|||+. .+++||||||+||++++++.++|+|||++......
T Consensus        84 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          84 FMDCGSLDRIYK-----KGGPIPVEILGKIAVAVVEGLTYLYNV-HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             cCCCCCHHHHHH-----hccCCCHHHHHHHHHHHHHHHHHHHHh-cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            999999988873     234678999999999999999999962 46999999999999999999999999998654321


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcc-----cHHHHHHhhhcccchhh
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-----DLVELVQNSRDFSNLLK  305 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  305 (380)
                          ......++..|+|||++.+..++.++|+|||||++|+|++|..||.........     ...+....         
T Consensus       158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  224 (284)
T cd06620         158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ---------  224 (284)
T ss_pred             ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH---------
Confidence                122446788899999998889999999999999999999999999865432111     11111111         


Q ss_pred             hcccccccCCCH-HHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          306 ILDERLWSTFTN-EGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       306 ~~~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      ..... ....+. ..+.++.+++.+||+.||.+|||+.+++++.
T Consensus       225 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         225 IVQEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             Hhhcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            11111 111122 2567799999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.4e-40  Score=300.15  Aligned_cols=250  Identities=22%  Similarity=0.339  Sum_probs=198.6

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      +|++.+.||+|+||.||++... ++..+|+|.....    ....+.+|++++++++||||+++++.+...+..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5788899999999999999965 7889999975432    1346888999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|..++...  .....+++..+..++.|++.||.|||+. .+++||||||+||+++.++.++|+|||++....... 
T Consensus        82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          82 DAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKEE-HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             CCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhc-CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            999998887432  1134689999999999999999999962 479999999999999999999999999987653321 


Q ss_pred             CCCCccccCccceecccccccC------CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          233 AGPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~------~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                         .....++..|+|||.+.+.      .++.++|+|||||++|+|++|+.||......   ......         ..+
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~---------~~~  222 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQL---------SAI  222 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHH---------HHH
Confidence               2233567789999988544      3588999999999999999999999754321   111111         111


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .+ ......+..++.++.+++.+||+.||.+||++++++.+
T Consensus       223 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         223 VD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             hh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            11 11123445577889999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.2e-40  Score=301.75  Aligned_cols=259  Identities=21%  Similarity=0.262  Sum_probs=194.0

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +|+..+.||+|+||.||+|... +|..+++|.....     ....+.+|+++++.++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999964 6889999975422     234577899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++ +|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CDQ-DLKKYFDS----CNGDIDPEIVKSFMFQLLKGLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CCC-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            975 67666632    23558899999999999999999999  679999999999999999999999999987653321


Q ss_pred             CCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc------cchh
Q 016917          232 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF------SNLL  304 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~  304 (380)
                        .......++..|+|||.+.+. .++.++|||||||++|+|++|+.|+.....  .......+......      ....
T Consensus       154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07839         154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPGVS  229 (284)
T ss_pred             --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHHhh
Confidence              112234567789999988764 478999999999999999999988654322  11111111110000      0000


Q ss_pred             hhccccc---------ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          305 KILDERL---------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...+...         +.......++++.+++.+||+.||.+|||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            0000000         011122356788999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5e-40  Score=300.29  Aligned_cols=247  Identities=24%  Similarity=0.361  Sum_probs=195.9

Q ss_pred             CCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      |++.+.||+|+||.||+|... ++..+++|......   .+.+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            567788999999999999965 57788888765433   34578899999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      ++|..++..    ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++.......  .
T Consensus        87 ~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~--~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~  158 (282)
T cd06643          87 GAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHE--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  158 (282)
T ss_pred             CcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence            999887632    23568899999999999999999999  679999999999999999999999999987653321  1


Q ss_pred             CCccccCccceecccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          235 PSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ......++..|+|||++.     +..++.++|||||||++|||++|++||......  ........ ..           
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~-~~-----------  224 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKIAK-SE-----------  224 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHHHhh-cC-----------
Confidence            223456788899999873     456788999999999999999999998754321  01111100 00           


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ......+..++.++.+++.+||+.||.+||++.+++++
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         225 PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00112233456789999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.8e-40  Score=301.47  Aligned_cols=250  Identities=24%  Similarity=0.336  Sum_probs=198.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      .+.|++.+.||.|+||.||+|... ++..+++|......   .+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            356889999999999999999964 58899999865443   34577899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|..++..    ....+++..+..++.|++.|+.|||+  .+++||||||+||+++.++.++|+|||++.......
T Consensus        91 ~~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          91 CPGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             CCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhc--CCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence            999999877632    23457899999999999999999999  679999999999999999999999999887543221


Q ss_pred             CCCCCccccCccceecccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          232 VAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                        .......++..|+|||.+.     ...++.++|+|||||++|||++|..||....+.      .........      
T Consensus       165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~------  230 (292)
T cd06644         165 --QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKS------  230 (292)
T ss_pred             --cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhcC------
Confidence              1123445778899999874     345788999999999999999999998754321      111100000      


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                        .......+..++.++.+++.+||..||++||++++++++
T Consensus       231 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         231 --EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             --CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence              000112233455679999999999999999999999864

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.9e-40  Score=297.10  Aligned_cols=252  Identities=24%  Similarity=0.401  Sum_probs=196.7

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      .+...+.....||+|+||.||+|.. .++..|++|......   .+.+.+|+++++.++|+||+++++++..++..++|+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            3445555667899999999999994 467889999765443   346789999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEcccccccc
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKL--EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNF  226 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~-~~~~kl~DFgla~~  226 (380)
                      ||+++++|.+++...    ...+  ....+..++.|++.||.|||+  ++|+||||||+||+++. ++.++|+|||++..
T Consensus        85 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          85 EQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHD--NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             ecCCCCCHHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            999999999988432    1223  677888899999999999998  77999999999999976 67999999999876


Q ss_pred             cCCCCCCCCCccccCccceecccccccC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ......  ......++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.........     ..         
T Consensus       159 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-----~~---------  222 (268)
T cd06624         159 LAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-----MF---------  222 (268)
T ss_pred             cccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-----Hh---------
Confidence            543221  12234578889999998654  3789999999999999999999998754321100     00         


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...........+...++++.+++.+||+.+|.+|||+.+++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         223 KVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             hhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            0000011123444566789999999999999999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1e-40  Score=311.92  Aligned_cols=252  Identities=21%  Similarity=0.255  Sum_probs=195.1

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||.||+++.. +++.||+|....      .....+.+|..++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999954 678899997543      12334778899999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.....
T Consensus        81 Ey~~gg~L~~~l~~----~~~~l~~~~~~~~~~qi~~~L~~lH~--~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSK----FEDRLPEDMARFYIAEMVLAIHSIHQ--LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999998842    23567888999999999999999999  7799999999999999999999999999876643


Q ss_pred             CCCCCCCccccCccceeccccccc-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ... .......|+..|+|||++.+     ..++.++|||||||++|||++|+.||......   .....+....   .  
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~i~~~~---~--  225 (331)
T cd05624         155 DGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHE---E--  225 (331)
T ss_pred             CCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH---HHHHHHHcCC---C--
Confidence            221 11233568999999999875     46789999999999999999999999754321   1111111000   0  


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~~ll~~  347 (380)
                          ...........++++.+++.+|+..++++  |+++++++++
T Consensus       226 ----~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         226 ----RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ----cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence                00001111234578999999999876554  4688888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.8e-40  Score=294.46  Aligned_cols=248  Identities=30%  Similarity=0.500  Sum_probs=198.4

Q ss_pred             CCCCCeeccCCceEEEEEEECC-----CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      +++.+.||.|+||.||++....     +..+|+|......    ...+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999999653     3789999865443    457889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++++|.+++...   ....+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~--~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKN---RPKELSLSDLLSFALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhh---hhccCCHHHHHHHHHHHHHHHHHHhc--CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            999999999888432   11228999999999999999999999  6799999999999999999999999999887654


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ....... ...++..|+|||...+..++.++|+||+|+++|+|++ |..||.....   ....+.+..            
T Consensus       156 ~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~------------  219 (258)
T smart00219      156 DDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLKK------------  219 (258)
T ss_pred             ccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhc------------
Confidence            3222211 2236778999999988889999999999999999998 7888765321   111111111            


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                       ......+...+.++.+++.+||..||++|||+.++++.|
T Consensus       220 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      220 -GYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -CCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence             111223334667899999999999999999999998754

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-41  Score=317.48  Aligned_cols=247  Identities=26%  Similarity=0.380  Sum_probs=209.5

Q ss_pred             CCCCCeeccCCceEEEEEEECC----CcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      .+..++||+|.||.|++|.|..    ...||||.+...    ..++|++|+.+|.+|+|+|+++|||+..+ ....||||
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            3455789999999999999753    357899975533    45789999999999999999999999988 66789999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      +++.|+|.+.|+.   .....+.....-.++.|||.||.||..  ++.|||||..+|+|+.....+||+|||+.+-++..
T Consensus       191 LaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLes--krlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLES--KRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            9999999999965   245667788888999999999999999  88999999999999999999999999999988654


Q ss_pred             CC-CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          231 DV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       231 ~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      +. ........-+..|.|||.+....++.++|||+|||++|||+| |..||.+...                ..+.+.+|
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----------------~qIL~~iD  329 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----------------IQILKNID  329 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----------------HHHHHhcc
Confidence            32 223334455667999999999999999999999999999998 7789887653                23445566


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .+.+..-+..|+++++++++.||..+|.+|||+..+.+.
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            666778888999999999999999999999999999743

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.6e-40  Score=297.48  Aligned_cols=255  Identities=21%  Similarity=0.391  Sum_probs=196.7

Q ss_pred             CCCCCeeccCCceEEEEEEEC----CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCC------
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN------  143 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  143 (380)
                      |.+.+.||+|+||.||+|...    ++..+|+|.....     ..+.+.+|+++++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566789999999999999843    3688999975533     2345788999999999999999999875432      


Q ss_pred             eeEEEEEeecCCCccccccCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPS-QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFg  222 (380)
                      ..++++||+.+|+|.+++.... ......+++.....++.|++.|++|||+  ++|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccchhhEEEcCCCCEEECccc
Confidence            2478899999999987764321 1123357888999999999999999998  779999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhccc
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                      +++...............++..|++||.+.+..++.++|||||||++|||++ |+.||.....   .+.........   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~---  232 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLIKGN---  232 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHHcCC---
Confidence            9887643322222233345667999999988889999999999999999999 8888875432   11111111100   


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                                ....+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       233 ----------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 ----------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                      0112234457899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.1e-40  Score=302.46  Aligned_cols=247  Identities=23%  Similarity=0.370  Sum_probs=200.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC---CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG---APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      .+|+..+.||.|++|.||+|.. .+++.|++|....   ...+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4588899999999999999984 5788999997432   23456788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|..++.      ...+++.++..++.|++.|+.|||+  .+++|+||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~------~~~l~~~~~~~i~~~l~~al~~LH~--~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          99 AGGSLTDVVT------ETCMDEAQIAAVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             CCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            9999998872      3457899999999999999999999  6799999999999999999999999999876543221


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                        ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||....+..  ... ....           .....
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~--~~~-~~~~-----------~~~~~  234 (296)
T cd06655         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALY-LIAT-----------NGTPE  234 (296)
T ss_pred             --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH-HHHh-----------cCCcc
Confidence              1233457788999999998889999999999999999999999997644211  010 0000           00001


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...+...++.+.+++.+||..||.+||++.+++++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            12233456779999999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.8e-40  Score=307.60  Aligned_cols=260  Identities=18%  Similarity=0.199  Sum_probs=192.2

Q ss_pred             CCCeeccC--CceEEEEEEE-CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           81 DKNLIGEG--KFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        81 ~~~~ig~G--~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      +.++||+|  +|++||++.. .++..||+|......     ...+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  7899999985 578999999865432     234667999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++|+|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.++++||+..........
T Consensus        82 ~~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            999999988432   22457889999999999999999999  6799999999999999999999999986544322111


Q ss_pred             -----CCCCccccCccceeccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc------
Q 016917          233 -----AGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD------  299 (380)
Q Consensus       233 -----~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------  299 (380)
                           ........++..|+|||++.+  ..|+.++|||||||++|||++|+.||.......  ...........      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~  234 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTT  234 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCcccccccc
Confidence                 011123346677999999876  468999999999999999999999997543211  01110000000      


Q ss_pred             ---ccch-------------h---------hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 ---FSNL-------------L---------KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 ---~~~~-------------~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         .+..             .         ...............++++.+++.+||+.||++|||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence               0000             0         0000000111223456789999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.8e-40  Score=302.51  Aligned_cols=260  Identities=25%  Similarity=0.358  Sum_probs=200.3

Q ss_pred             HHHHHHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC--ChHHHHHHHHHHhcC-CCCceeeecccee-----
Q 016917           70 EELSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGYCQ-----  140 (380)
Q Consensus        70 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----  140 (380)
                      +.+....++|++.+.||+|+||.||+|.. .++..+++|.....  ....+..|+.+++.+ +||||+++++++.     
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            34445677899999999999999999985 45789999976542  235678899999999 6999999999873     


Q ss_pred             cCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcc
Q 016917          141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  220 (380)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~D  220 (380)
                      .++..++||||+++++|.+++.... .....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~kl~d  167 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHV--NKTIHRDVKGNNILLTTEGGVKLVD  167 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHh--CCccccCCCHHhEEECCCCCEEEcc
Confidence            3456899999999999988774321 234567888999999999999999999  6799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCccceeccccccc-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH
Q 016917          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  295 (380)
Q Consensus       221 Fgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~  295 (380)
                      ||++........  ......++..|+|||.+..     ..++.++|||||||++|||++|+.||.......  ...    
T Consensus       168 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~----  239 (286)
T cd06638         168 FGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALF----  239 (286)
T ss_pred             CCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHh----
Confidence            999876643221  1233458888999998753     457899999999999999999999987543210  000    


Q ss_pred             hhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      ....      .  .......+..++.++.+++.+||+.||++|||+.++++++
T Consensus       240 ~~~~------~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 KIPR------N--PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             hccc------c--CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            0000      0  0000112223456799999999999999999999999764

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=294.41  Aligned_cols=251  Identities=25%  Similarity=0.362  Sum_probs=200.8

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC---ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ++|++.+.||.|+||.||+|... ++..+++|.....   ..+.+.+|+++++.++||||+++++++...+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888899999999999999954 5788999975433   3467889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      .+++|.+++..    ....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        83 ~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  155 (262)
T cd06613          83 GGGSLQDIYQV----TRGPLSELQIAYVCRETLKGLAYLHE--TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-  155 (262)
T ss_pred             CCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh--CCceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence            99999988732    22568899999999999999999999  679999999999999999999999999987654321 


Q ss_pred             CCCCccccCccceecccccccC---CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFR---RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                       .......++..|+|||.+.+.   .++.++|+||||+++|+|++|+.||....+...  ......  ...        .
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~~~~--~~~--------~  222 (262)
T cd06613         156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFLISK--SNF--------P  222 (262)
T ss_pred             -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh--ccC--------C
Confidence             112334677789999998776   889999999999999999999999976442111  110000  000        0


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ......+...+.++.+++.+||..||.+|||+++++.+
T Consensus       223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00112234456789999999999999999999999853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.4e-40  Score=337.06  Aligned_cols=255  Identities=22%  Similarity=0.328  Sum_probs=196.5

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceec--CCe
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE--NNL  144 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~  144 (380)
                      +....+|++.+.||+|+||+||+|... ++..+|+|.....     ....+..|+.+++.|+||||+++++++..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            345578999999999999999999954 5678888875422     23468889999999999999999998854  457


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCeEecCCCCCCeeeCC-------
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS-----PRVVHKDFKTANVLVDE-------  212 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~ivHrDikp~Nili~~-------  212 (380)
                      +|+||||+++|+|.+++.... .....+++..++.++.||+.||.|||+.+     ++||||||||+|||++.       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~-~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCY-KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            899999999999998884321 12356899999999999999999999842     45999999999999964       


Q ss_pred             ----------CCceEEcccccccccCCCCCCCCCccccCccceeccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCC
Q 016917          213 ----------DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASS  280 (380)
Q Consensus       213 ----------~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~p~~  280 (380)
                                .+.+||+|||++..+....   ......+|+.|+|||++.+  ..++.++|||||||+||||++|..||.
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                      2358999999998664322   1234568999999999854  458899999999999999999999997


Q ss_pred             CCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          281 SLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....  ...+...+....           .  .+ ....+.++.+||..||+.+|.+||++.+++++
T Consensus       245 ~~~~--~~qli~~lk~~p-----------~--lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        245 KANN--FSQLISELKRGP-----------D--LP-IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             cCCc--HHHHHHHHhcCC-----------C--CC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            5331  111111111100           0  00 11235779999999999999999999999954

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.2e-40  Score=300.78  Aligned_cols=256  Identities=27%  Similarity=0.401  Sum_probs=198.4

Q ss_pred             HHHHHHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC--ChHHHHHHHHHHhcC-CCCceeeeccceec----
Q 016917           70 EELSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGYCQE----  141 (380)
Q Consensus        70 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----  141 (380)
                      .++....+.|++.+.||+|+||.||+|.. .+++.+|+|.....  ....+..|+.+++++ +|+||+++++++..    
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636           9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence            34444567899999999999999999995 56889999975433  345678899999998 79999999999853    


Q ss_pred             --CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEc
Q 016917          142 --NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  219 (380)
Q Consensus       142 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~  219 (380)
                        .+..+++|||+.+|+|.+++...   ....+++..+..++.|++.|+.|||+  .+|+|+||+|+||++++++.++|+
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHA--HKVIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEe
Confidence              45789999999999999888432   23457788889999999999999999  679999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCccceecccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH
Q 016917          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  294 (380)
Q Consensus       220 DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~  294 (380)
                      |||++.......  .......++..|+|||.+.     ...++.++|+|||||++|||++|..||....+...  ... .
T Consensus       164 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~~~-~  238 (282)
T cd06636         164 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--LFL-I  238 (282)
T ss_pred             eCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--hhh-H
Confidence            999987653211  1223456788899999875     35688899999999999999999999975432100  000 0


Q ss_pred             HhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                                  ............++.++.+++.+||+.||.+|||+.+++++
T Consensus       239 ------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         239 ------------PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             ------------hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                        00000111122456789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-41  Score=314.99  Aligned_cols=242  Identities=27%  Similarity=0.447  Sum_probs=202.7

Q ss_pred             eeccCCceEEEEEEEC-CCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCccc
Q 016917           84 LIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSI  159 (380)
Q Consensus        84 ~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  159 (380)
                      +||+|.||+||-|+.. +...+|||..+...   .+-+.+|+.+-++|+|.|||+++|.+.+++.+-+.||-.+||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999954 45678999766443   4557889999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCceEEcccccccccCCCCCCCCC
Q 016917          160 HLYGPSQVSRQKL--EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPS  236 (380)
Q Consensus       160 ~l~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~-~~~~~kl~DFgla~~~~~~~~~~~~  236 (380)
                      .|++.    -+++  .+...-.+.+||++||.|||+  +.|||||||-+||||+ -.|.+||+|||.++.+..  .....
T Consensus       662 LLrsk----WGPlKDNEstm~fYtkQILeGLkYLHe--n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~T  733 (1226)
T KOG4279|consen  662 LLRSK----WGPLKDNESTMNFYTKQILEGLKYLHE--NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCT  733 (1226)
T ss_pred             HHHhc----cCCCccchhHHHHHHHHHHHHhhhhhh--cceeeccccCCcEEEeeccceEEecccccchhhcc--CCccc
Confidence            99532    3333  677788899999999999999  6799999999999996 578999999999987753  22334


Q ss_pred             ccccCccceeccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          237 SQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       237 ~~~~~~~~~~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      ....||..|||||++..  .+|+.++|||||||++.||.||++||........              .+-++-.-+..++
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------------AMFkVGmyKvHP~  799 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------------AMFKVGMYKVHPP  799 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------------hhhhhcceecCCC
Confidence            56789999999999875  4789999999999999999999999987653211              1222223344568


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .|.+.+.+.+.+|.+|+..||.+||+++++|+.
T Consensus       800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             CcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            899999999999999999999999999999864

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-39  Score=295.11  Aligned_cols=251  Identities=22%  Similarity=0.361  Sum_probs=201.0

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC---------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP---------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      +|+..+.||+|++|.||++.. .++..+|+|......         .+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999984 568899999754322         3467889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEcccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNF  226 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~-~~kl~DFgla~~  226 (380)
                      |+||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++++|+||+|+||+++.++ .++|+|||++..
T Consensus        81 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~ql~~al~~LH~--~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLS-----KYGAFKEAVIINYTEQLLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            999999999999883     23467889999999999999999999  7799999999999998775 699999999877


Q ss_pred             cCCCCCC--CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          227 LGRTDVA--GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       227 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      .......  .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||........   .....         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~---------  221 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIF---------  221 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHH---------
Confidence            6543211  112234578889999999888999999999999999999999999875432211   11110         


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...........+...++++.+++.+||..||.+||++.+++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         222 KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            1111111234455667889999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.7e-39  Score=294.09  Aligned_cols=248  Identities=22%  Similarity=0.303  Sum_probs=195.6

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC--------ChHHHHHHHHHHhcCCCCceeeeccceecC--Cee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQ  145 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  145 (380)
                      .+|++.+.||+|+||.||.|.. .++..|++|.....        ..+.+.+|+.+++.++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4688899999999999999995 45889999964311        123577899999999999999999988653  567


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++||||+++++|.+++.     ....+++.....++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||++.
T Consensus        82 ~~v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLK-----SYGALTENVTRKYTRQILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            89999999999998883     23457788889999999999999999  779999999999999999999999999987


Q ss_pred             ccCCCCC-CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          226 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       226 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ....... ........++..|+|||.+.+..++.++|+|||||++|||++|+.||......      ....         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~---------  219 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIF---------  219 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHH---------
Confidence            6543211 11223345788899999998888999999999999999999999998754211      1011         


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...........+...+..+.+++.+|+. +|++||++++++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         220 KIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             HHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            0011111223455666788999999994 99999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-39  Score=295.76  Aligned_cols=252  Identities=23%  Similarity=0.381  Sum_probs=196.2

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----C--------hHHHHHHHHHHhcCCCCceeeeccceecCC
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----P--------TQEFIDEVCFLASIQHRNLVTLLGYCQENN  143 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  143 (380)
                      +|...+.||.|+||.||+|.. .+++.+|+|.....     .        .+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999985 46889999964321     0        134678999999999999999999999999


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      ..++||||+++++|.+++..     ...+++..+..++.|++.||.|||+  ++++||||+|+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT-----YGRFEEQLVRFFTEQVLEGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHhh--CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence            99999999999999998832     3567888899999999999999999  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCccceecccccccCC--CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                      +................++..|+|||.+....  ++.++|+||||+++|++++|..||.....     ... ....... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~-~~~~~~~-  227 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAA-MFKLGNK-  227 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHH-HHHhhcc-
Confidence            87654322222233456788899999987654  78999999999999999999999864321     111 1100000 


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...    ..........++..+.+++.+||+.||.+|||+++++++
T Consensus       228 ~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         228 RSA----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ccC----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            000    000111222346789999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-39  Score=297.76  Aligned_cols=260  Identities=20%  Similarity=0.275  Sum_probs=197.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ++|+..+.||+|+||.||+|..+ +++.||+|.....     ..+.+.+|+++++.++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36888899999999999999965 5889999964321     23457889999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++++|..++.     ....+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEK-----NPRGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            999988877662     33458899999999999999999999  67999999999999999999999999999876442


Q ss_pred             CCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc-cchhhhcc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF-SNLLKILD  308 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  308 (380)
                      ..  ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+....+.  +.......... .......+
T Consensus       154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07847         154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ--LYLIRKTLGDLIPRHQQIFS  229 (286)
T ss_pred             cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCChHHhhhcc
Confidence            21  1223456778999999876 4678999999999999999999999986543211  11111100000 00000000


Q ss_pred             ----------cccccCC-----CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ----------ERLWSTF-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ----------~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                                +......     ....+..+.+++.+||+.||++||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                      0000000     11235778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=311.72  Aligned_cols=237  Identities=22%  Similarity=0.292  Sum_probs=184.6

Q ss_pred             eccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcC---CCCceeeeccceecCCeeEEEEEeecC
Q 016917           85 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI---QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        85 ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      ||+|+||+||+|... ++..||+|.....      .......|..++...   +||||+++++.+...+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999954 6899999975432      122345566666655   699999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||++.......  .
T Consensus        81 g~L~~~l~-----~~~~~~~~~~~~~~~qil~al~~LH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~  151 (330)
T cd05586          81 GELFWHLQ-----KEGRFSEDRAKFYIAELVLALEHLHK--YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K  151 (330)
T ss_pred             ChHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence            99988873     34568899999999999999999999  779999999999999999999999999987542211  1


Q ss_pred             CCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccccc
Q 016917          235 PSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  313 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (380)
                      ......||..|+|||.+.+. .++.++|||||||++|+|++|+.||.....   ......+.    .        ...  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---~~~~~~i~----~--------~~~--  214 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---QQMYRNIA----F--------GKV--  214 (330)
T ss_pred             CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---HHHHHHHH----c--------CCC--
Confidence            23345689999999998754 589999999999999999999999975432   11111111    0        000  


Q ss_pred             CCC-HHHHHHHHHHHhHccCCCCCCCC----CHHHHHHH
Q 016917          314 TFT-NEGMEEFIQLIVRCLDPSSERRP----SMSDVVTE  347 (380)
Q Consensus       314 ~~~-~~~~~~l~~li~~cl~~dp~~Rp----t~~~ll~~  347 (380)
                      .++ ...++++.+++.+||+.||.+||    ++.+++++
T Consensus       215 ~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         215 RFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            111 12456789999999999999998    56666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.3e-40  Score=294.11  Aligned_cols=245  Identities=26%  Similarity=0.425  Sum_probs=198.3

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC--------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      +|+..+.||+|++|.||+|... ++..|++|.....        ..+.+.+|+.+++.++|+||+++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999965 7899999964321        234678899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      +||+++++|.+++.     ....+++..+..++.|++.|+.|||+  .+++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLK-----KYGSFPEPVIRLYTRQILLGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            99999999998883     23457888999999999999999999  779999999999999999999999999987654


Q ss_pred             CCCCCCCCccccCccceecccccccCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      ...   ......++..|++||.+.... ++.++|+||||+++|+|++|+.||.....      ........         
T Consensus       154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~---------  215 (258)
T cd06632         154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIG---------  215 (258)
T ss_pred             ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHH---------
Confidence            322   123455788899999987766 89999999999999999999999876431      11111000         


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ........+...++.+.+++.+||+.||.+||++.+++.+
T Consensus       216 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         216 RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             hcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            0001123344456789999999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=289.81  Aligned_cols=263  Identities=22%  Similarity=0.260  Sum_probs=213.8

Q ss_pred             HhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      ..++|..+++||+|.||.|-+++ ..+++.+|+|++++.      ....-..|-.+|+..+||.+..+--.|+.++.+|.
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            45678888999999999999999 457899999975543      33445679999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||..||.|.-+|     ...+.+++.....+...|+.||.|||+  ++||.||||.+|.|+|++|++||+|||+++.-
T Consensus       246 VMeyanGGeLf~HL-----srer~FsE~RtRFYGaEIvsAL~YLHs--~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  246 VMEYANGGELFFHL-----SRERVFSEDRTRFYGAEIVSALGYLHS--RNIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEEEccCceEeeeh-----hhhhcccchhhhhhhHHHHHHhhhhhh--CCeeeeechhhhheeccCCceEeeecccchhc
Confidence            99999999999888     346778888888999999999999999  77999999999999999999999999999753


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      -  .........+||+.|+|||++....|+..+|+|.+||++|||++|+.||...+.+   .+.+.+....         
T Consensus       319 I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLFeLIl~ed---------  384 (516)
T KOG0690|consen  319 I--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLFELILMED---------  384 (516)
T ss_pred             c--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHHHHHHhhh---------
Confidence            2  2234456789999999999999999999999999999999999999999876533   2333222111         


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCC--CHHHHHHHHHhhhhhhcccccccC
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRP--SMSDVVTELDRTLDKEMNLTTVMG  363 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp--t~~~ll~~L~~~~~~~~~~~~~~~  363 (380)
                           ..||...+++...|+..+|.+||.+|.  ...++.+...--.-...+|.+...
T Consensus       385 -----~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~  437 (516)
T KOG0690|consen  385 -----LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYR  437 (516)
T ss_pred             -----ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHH
Confidence                 246777788999999999999999996  445555444333333445544443

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.8e-40  Score=298.13  Aligned_cols=236  Identities=22%  Similarity=0.386  Sum_probs=184.8

Q ss_pred             CeeccCCceEEEEEEECC--------CcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           83 NLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +.||+|+||.||+|....        ...+++|......   .+.+.+|..+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999998532        2347788755432   34678899999999999999999999998899999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc--------eEEccccc
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--------AKVADAGL  223 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~--------~kl~DFgl  223 (380)
                      +++|+|.+++...    ...+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.        ++++|||+
T Consensus        81 ~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            9999999988432    2357888999999999999999999  77999999999999987664        69999998


Q ss_pred             ccccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCC-CCCCCCCCCCcccHHHHHHhhhccc
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGR-EASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                      +.....      .....++..|+|||++.+ ..++.++|||||||++|||++|. .||.......   .....       
T Consensus       155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~~~~-------  218 (258)
T cd05078         155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFY-------  218 (258)
T ss_pred             ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HHHHH-------
Confidence            765432      223456778999999876 45799999999999999999985 5554332210   00000       


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                            ..  ....+...+.++.+++.+||+.||++|||++++++.|
T Consensus       219 ------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         219 ------ED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             ------Hc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                  00  1122333446799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-40  Score=299.20  Aligned_cols=261  Identities=21%  Similarity=0.305  Sum_probs=199.5

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC-----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ++|++.+.||+|+||.||+|..+ +++.|++|....     ...+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999965 578999997542     234568899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |++++.+....     .....+++..+..++.|++.|+.|||+  ++++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLE-----ASPGGLPPDAVRSYIWQLLQAIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            99987776554     233457899999999999999999999  67999999999999999999999999998876543


Q ss_pred             CCCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc-------
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN-------  302 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  302 (380)
                      .. .......++..|+|||++.+. .++.++|+||||+++|+|++|+.||......  ..+............       
T Consensus       154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhcc
Confidence            22 122345677889999999888 8899999999999999999999998754321  111110000000000       


Q ss_pred             ---------hhhhccc-ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          303 ---------LLKILDE-RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       303 ---------~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                               .....+. .....++..++.++.+++.+||..||++|||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence                     0000000 00011233346889999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.5e-39  Score=293.55  Aligned_cols=251  Identities=24%  Similarity=0.336  Sum_probs=185.6

Q ss_pred             eeccCCceEEEEEEECCC---cEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCC
Q 016917           84 LIGEGKFGEVYKGLLQDG---MLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS  156 (380)
Q Consensus        84 ~ig~G~~g~V~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  156 (380)
                      .||+|+||.||+|...++   ..+++|.....    ..+.+.+|+++++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999974332   34667754322    23568899999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCC
Q 016917          157 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS  236 (380)
Q Consensus       157 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~  236 (380)
                      |.+++..... ......+..+..++.|++.||+|||+  .+++||||||+|||++.++.++|+|||++............
T Consensus        82 L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHK--HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHH--CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9998854321 23445677788899999999999999  67999999999999999999999999997643222221222


Q ss_pred             ccccCccceeccccccc-------CCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          237 SQVTADEIFLASEVKEF-------RRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       237 ~~~~~~~~~~aPE~~~~-------~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ....++..|+|||++..       ..++.++|||||||++|||++ |..||.....   .+....+....    .....+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~----~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLNHVIKDQ----QVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhhc----ccccCC
Confidence            34557788999998743       245789999999999999997 5667764332   11111111110    011111


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                      +    ..+...++.+.+++..|| .+|++||+++++++.|.
T Consensus       232 ~----~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 P----QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             C----ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1    222234567889999999 68999999999998773

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1e-39  Score=299.51  Aligned_cols=242  Identities=23%  Similarity=0.333  Sum_probs=199.8

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||.||++... +++.+|+|....      ...+.+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888899999999999999954 688999997542      23456788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~-----~~~~l~~~~~~~~~~qil~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLR-----KSGRFPEPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            9999999998883     34568899999999999999999999  7799999999999999999999999999887643


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      .     .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.....   ......+.            ..
T Consensus       154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~------------~~  213 (290)
T cd05580         154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQIYEKIL------------EG  213 (290)
T ss_pred             C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHh------------cC
Confidence            2     2344678889999999888889999999999999999999999875441   11111110            00


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                        ...++...+..+.+++.+||..||.+|+     ++++++++
T Consensus       214 --~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         214 --KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             --CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence              1123344467899999999999999999     77888755

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-39  Score=293.37  Aligned_cols=235  Identities=25%  Similarity=0.436  Sum_probs=185.2

Q ss_pred             CeeccCCceEEEEEEECCC-----------cEEEEEeCCCCC--hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           83 NLIGEGKFGEVYKGLLQDG-----------MLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~-----------~~vavK~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      +.||+|+||.||+|.....           ..+++|......  ...+.+|+.+++.++||||+++++++.. +..++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            4689999999999996532           257788654333  5678899999999999999999999988 7789999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-------ceEEcccc
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-------IAKVADAG  222 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~-------~~kl~DFg  222 (380)
                      ||+++|+|.+++...    ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++       .+||+|||
T Consensus        80 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          80 EYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLED--KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh--CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999988432    2267889999999999999999998  7799999999999999887       79999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccC--CCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhc
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRD  299 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  299 (380)
                      ++.....      .....++..|+|||.+.+.  .++.++||||||+++|||++ |..||........   .....    
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~~~~----  220 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ERFYQ----  220 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HHHHh----
Confidence            9886543      1223355669999998876  78999999999999999999 5777765532111   11000    


Q ss_pred             ccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          300 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                              ...   ..+......+.+++.+||..||.+|||+.++++.|
T Consensus       221 --------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         221 --------DQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             --------cCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                    000   00111116789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=302.16  Aligned_cols=251  Identities=22%  Similarity=0.256  Sum_probs=199.6

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|+..+.||+|++|.||+|... ++..+|+|.....      ....+..|+++++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999965 5899999975433      2235788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+.+++|.+++...   ....+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            999999999987421   23568889999999999999999999  6799999999999999999999999999875432


Q ss_pred             CCCC---------------------------CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 016917          230 TDVA---------------------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL  282 (380)
Q Consensus       230 ~~~~---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~  282 (380)
                      ....                           .......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            1110                           0112346788899999999889999999999999999999999999754


Q ss_pred             CCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCC----HHHHHHH
Q 016917          283 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS----MSDVVTE  347 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt----~~~ll~~  347 (380)
                      ...  ...             ..+.............++.+.+++.+||..||++|||    +++++++
T Consensus       236 ~~~--~~~-------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         236 NRD--ETF-------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             chH--HHH-------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            421  011             1111111111111225688999999999999999999    7777764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-40  Score=299.01  Aligned_cols=249  Identities=22%  Similarity=0.323  Sum_probs=198.8

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ++|++.+.||.|+||.||++.. .++..+++|......   .+.+..|++++++++||||+++++.+..++..++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            4588889999999999999996 468899999755433   346788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++..    ....+++..+..++.|++.||.|||+  ++|+|+||||+||+++.++.++|+|||++........
T Consensus        85 ~~~~L~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          85 DGGALDSIMLE----LERGLTEPQIRYVCRQMLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             CCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            99999988732    23468899999999999999999999  7799999999999999999999999998776533211


Q ss_pred             CCCCccccCccceecccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          233 AGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                        ......++..|+|||.+.     +..++.++|+||||+++|+|++|+.||......      .........       
T Consensus       159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-------  223 (280)
T cd06611         159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKILKS-------  223 (280)
T ss_pred             --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHhcC-------
Confidence              123445788899999874     345788999999999999999999999764321      111111000       


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       .......+..++.++.+++.+||+.||.+||++.+++++
T Consensus       224 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         224 -EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence             000112233456779999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.1e-40  Score=321.09  Aligned_cols=269  Identities=15%  Similarity=0.213  Sum_probs=189.8

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECC--CcEEEE------------------EeCCC--CChHHHHHHHHHHhcCCCCce
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQD--GMLVAI------------------KKRPG--APTQEFIDEVCFLASIQHRNL  132 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~--~~~vav------------------K~~~~--~~~~~~~~E~~~l~~l~h~ni  132 (380)
                      ..++|++.+.||+|+||+||+|..+.  +...+.                  |....  .....+.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            35689999999999999999987432  111111                  11111  123457889999999999999


Q ss_pred             eeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC
Q 016917          133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE  212 (380)
Q Consensus       133 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~  212 (380)
                      +++++++...+..|+|++++.+ +|..++..................++.|++.||.|||+  ++|+||||||+|||++.
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~--~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD--KKLIHRDIKLENIFLNC  302 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECC
Confidence            9999999999999999999865 56655543222222334456777899999999999999  67999999999999999


Q ss_pred             CCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCC-CCCCCCCCcccHH
Q 016917          213 DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQDLV  291 (380)
Q Consensus       213 ~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p-~~~~~~~~~~~~~  291 (380)
                      ++.+||+|||+++.+..... .......||..|+|||++.+..|+.++|||||||++|||++|..+ +..........+.
T Consensus       303 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            99999999999987644221 122346789999999999999999999999999999999998754 4433322222222


Q ss_pred             HHHHhhh----ccc----chhhhccccccc----CCC-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          292 ELVQNSR----DFS----NLLKILDERLWS----TFT-----NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       292 ~~~~~~~----~~~----~~~~~~~~~~~~----~~~-----~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      +.+....    .+.    .+.+.++.....    .++     ...+..+.+++.+||+.||.+|||+.|++++
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            2221100    000    011111100000    000     0123567888999999999999999999976

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-39  Score=300.63  Aligned_cols=267  Identities=21%  Similarity=0.309  Sum_probs=196.9

Q ss_pred             CCCCCCeeccCCceEEEEEEEC---CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecC--CeeE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ---DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQF  146 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  146 (380)
                      +|++.+.||+|+||.||+|...   ++..||+|....      ...+.+.+|+.+++.++||||+++++++...  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999964   478999997654      2245678899999999999999999999887  7899


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC----CCceEEcccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE----DFIAKVADAG  222 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~----~~~~kl~DFg  222 (380)
                      +||||+++ ++.+.+..........+++..++.++.|++.||.|||+  ++|+||||||+||+++.    ++.+||+|||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            99999976 56555533322233478899999999999999999999  77999999999999999    8999999999


Q ss_pred             cccccCCCCC-CCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcc-------cHHHH
Q 016917          223 LRNFLGRTDV-AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-------DLVEL  293 (380)
Q Consensus       223 la~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~-------~~~~~  293 (380)
                      ++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.........       .+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9887644322 112234467888999998766 46799999999999999999999999866543310       00000


Q ss_pred             HHhhh-----------cccchhhhcccccccCCC---------H--HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          294 VQNSR-----------DFSNLLKILDERLWSTFT---------N--EGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       294 ~~~~~-----------~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      +....           .........+......++         .  ..+.++.+++.+||+.||++|||+.+++++
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00000           000000000000001111         1  334578999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.4e-39  Score=293.81  Aligned_cols=251  Identities=22%  Similarity=0.350  Sum_probs=200.3

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeecccee--cCCeeEEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQ--ENNLQFLIY  149 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~  149 (380)
                      +|++.+.||+|+||.||++.. .++..+++|.....     ..+.+..|+++++.++||||+++++++.  .....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999984 56788999975422     2345778999999999999999999775  345679999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---CCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL---SPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~---~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      ||+++++|.+++.... .....+++..++.++.|++.||.|||..   +.+++|+||+|+||++++++.+||+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            9999999998885332 1245688999999999999999999921   27799999999999999999999999999887


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      ......  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....   ....+.+            
T Consensus       160 ~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~------------  222 (265)
T cd08217         160 LGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASKI------------  222 (265)
T ss_pred             ccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHHH------------
Confidence            654321  12234578889999999988899999999999999999999999986441   1111111            


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       ........+...+.++.+++.+||+.+|.+||++.+++++
T Consensus       223 -~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         223 -KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence             1111223445566889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3e-39  Score=294.42  Aligned_cols=244  Identities=26%  Similarity=0.405  Sum_probs=198.8

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      -|+..+.||+|+||.||+|.. .++..+|+|......    ...+.+|++++++++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            367788999999999999985 467899999754322    345788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++.      ...+++..+..++.|++.|+.|||+  ++++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~l~~~i~------~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          85 GGGSALDLLE------PGPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHcc--CCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            9999998873      2457889999999999999999999  7899999999999999999999999999876543221


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                        ......++..|+|||.+.+..++.++|+|||||++|+|++|..||......   .....+             .....
T Consensus       157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~-------------~~~~~  218 (277)
T cd06641         157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---KVLFLI-------------PKNNP  218 (277)
T ss_pred             --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---HHHHHH-------------hcCCC
Confidence              122345777899999998888899999999999999999999998754321   111111             01111


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...+...+.++.+++.+||+.||.+||++.+++++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            22334556779999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.7e-39  Score=292.36  Aligned_cols=247  Identities=21%  Similarity=0.354  Sum_probs=199.2

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC-----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +|++.+.||+|+||.||++.. .+++.+++|....     .....+.+|+.++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478889999999999999994 4688999997432     2334688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +.+++|.+++...   ....+++..+..++.|++.|+.|||+  ++++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999998887421   22357888999999999999999999  779999999999999999999999999987654322


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                      ..  .....++..|+|||...+..++.++|+|||||++|+|++|+.||.....      .+....         +.. ..
T Consensus       156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~---------~~~-~~  217 (256)
T cd08218         156 EL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLK---------IIR-GS  217 (256)
T ss_pred             hh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHH---------Hhc-CC
Confidence            11  1234577789999999988899999999999999999999999874321      111110         000 01


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....+...+.++.+++.+||+.+|.+||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         218 YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            122344556789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.5e-39  Score=297.01  Aligned_cols=250  Identities=21%  Similarity=0.320  Sum_probs=191.1

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC----hHHHHHHHHH-HhcCCCCceeeeccceecCCeeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCF-LASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ++|++.+.||+|+||.||++... ++..||+|......    ...+..|++. ++.++||||+++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36888899999999999999964 68999999754332    2345556664 566799999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |++ |+|.+++..... ....+++..++.++.|++.||.|||+. .+++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSK-LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 477766643222 235689999999999999999999982 27999999999999999999999999998865432


Q ss_pred             CCCCCCccccCccceeccccccc----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          231 DVAGPSSQVTADEIFLASEVKEF----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      .   ......++..|+|||.+.+    ..++.++|+|||||++|+|++|+.||......     .+...         ..
T Consensus       158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~---------~~  220 (283)
T cd06617         158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLK---------QV  220 (283)
T ss_pred             c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHH---------HH
Confidence            1   1122456778999998765    45788999999999999999999998643211     01110         00


Q ss_pred             cccccccCCC-HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFT-NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ... .....+ ...++++.+++.+||..||.+||++.+++++
T Consensus       221 ~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         221 VEE-PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             Hhc-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000 011111 2345789999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.5e-39  Score=291.81  Aligned_cols=255  Identities=25%  Similarity=0.340  Sum_probs=202.1

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      ++|++.+.||.|+||+||+|.. .++..+++|.....    ..+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4688899999999999999995 46788999975432    345688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++....  ....+++..+..++.|++.|+.|||+  .+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh~--~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            99999998884321  12467889999999999999999998  779999999999999999999999999987765432


Q ss_pred             CC--CCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          232 VA--GPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       232 ~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ..  .......++..|+|||.+... .++.++|+|||||++|+|++|+.||.......  .........          .
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~----------~  224 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQND----------P  224 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhcCC----------C
Confidence            22  123445688899999998766 78999999999999999999999997554321  111111100          0


Q ss_pred             cccccC-CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWST-FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      +..... .....++.+.+++.+||..||++||++++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            001000 112456789999999999999999999999874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.4e-39  Score=293.58  Aligned_cols=252  Identities=21%  Similarity=0.345  Sum_probs=197.6

Q ss_pred             CCCCCCeeccCCceEEEEEEECC--CcEEEEEeCCCC-------------ChHHHHHHHHHHhc-CCCCceeeeccceec
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQD--GMLVAIKKRPGA-------------PTQEFIDEVCFLAS-IQHRNLVTLLGYCQE  141 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~~--~~~vavK~~~~~-------------~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  141 (380)
                      +|++.+.||+|+||.||+|....  +..+|+|.....             ....+..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999654  678999964311             12346678887765 799999999999999


Q ss_pred             CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccc
Q 016917          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (380)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DF  221 (380)
                      ++..+++|||+++++|.+.+.... .....+++..++.++.|++.||.|||+. ++++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKE-KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccC-CceeecCCCHHHEEECCCCcEEEecc
Confidence            999999999999999988774321 2345688899999999999999999962 57999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc
Q 016917          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       222 gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                      |.+.......   ......++..|++||...+..++.++|+||||+++|+|++|+.||......   .....+.      
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~------  226 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLATKIV------  226 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HHHHHHh------
Confidence            9988754432   223456788899999999888999999999999999999999998754321   1111110      


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                            +...........++.+.+++.+||+.||++||++.++..++.
T Consensus       227 ------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         227 ------EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ------hccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                  111111111134577999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.6e-39  Score=290.93  Aligned_cols=246  Identities=23%  Similarity=0.397  Sum_probs=198.6

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +|+..+.||+|+||.||++.. .++..+++|.....     ....+.+|+++++.++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478889999999999999985 46889999974432     245688899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CceEEcccccccccCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRT  230 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~-~~~kl~DFgla~~~~~~  230 (380)
                      +++++|.+++...   ....+++..+..++.+++.|+.|||+  ++++|+||+|+||+++++ +.++|+|||++......
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            9999999988432   23457889999999999999999999  779999999999999855 46899999998876432


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      .   ......++..|+|||.+.+..++.++||||||+++|+|++|+.||......   .......             ..
T Consensus       156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~-------------~~  216 (256)
T cd08220         156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKIM-------------SG  216 (256)
T ss_pred             c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHHH-------------hc
Confidence            2   123345788899999999888999999999999999999999998754321   1111110             01


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .....+...++++.+++.+||+.||.+|||+.+++++
T Consensus       217 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         217 TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            1112333456789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1e-39  Score=298.73  Aligned_cols=260  Identities=20%  Similarity=0.339  Sum_probs=196.5

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ++|+..+.||+|+||.||+|... +++.||+|.....     ..+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36888899999999999999965 5889999974322     23457889999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++++|..+..     ....+.+..+..++.|++.||.|||+  .+++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEK-----YPNGLDESRVRKYLFQILRGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            999988877652     23447899999999999999999999  67999999999999999999999999998765432


Q ss_pred             CCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc-chhhhcc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS-NLLKILD  308 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  308 (380)
                      .  .......++..|+|||...+ ..++.++||||||+++|||++|++||......  .............. ......+
T Consensus       154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI--DQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH--HHHHHHHHHhCCCchhhHHHhc
Confidence            2  11233457888999998875 35788999999999999999999998754321  11111110000000 0000000


Q ss_pred             ----------ccc-----ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ----------ERL-----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ----------~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                                +..     ........+..+.+++.+||+.||++||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence                      000     000112345779999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.9e-39  Score=299.89  Aligned_cols=253  Identities=20%  Similarity=0.230  Sum_probs=197.1

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      .+|+..+.||+|+||.||++... +++.|++|......      .+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888899999999999999964 57889999754332      345778999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.++|+|||+++....
T Consensus        81 e~~~g~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLK-----NIGALPVDMARMYFAETVLALEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            9999999999983     33567888999999999999999999  6799999999999999999999999998864211


Q ss_pred             CCC-------------CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh
Q 016917          230 TDV-------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  296 (380)
Q Consensus       230 ~~~-------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  296 (380)
                      ...             ........++..|+|||.+.+..++.++|+|||||++|||++|..||.....   .+.......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~~~~~~~~~  230 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVIS  230 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh
Confidence            000             0011123567789999999888999999999999999999999999975432   111111100


Q ss_pred             hhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHh
Q 016917          297 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  350 (380)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~  350 (380)
                      .    .       ..........++++.+++.+||+.||++||+..++++.|+.
T Consensus       231 ~----~-------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         231 D----D-------IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             c----c-------cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            0    0       00011112355778999999999999999997666665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=324.38  Aligned_cols=266  Identities=29%  Similarity=0.446  Sum_probs=215.0

Q ss_pred             HHHHhCCCCCCCeeccCCceEEEEEEEC--------CCcEEEEEeCCCC----ChHHHHHHHHHHhcC-CCCceeeeccc
Q 016917           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGY  138 (380)
Q Consensus        72 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~  138 (380)
                      ++...++..+.+.||+|.||.|++|...        ....||||..+..    ..+.+..|+++|+.+ +|+||+.++|.
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            4444555566679999999999999832        1457999985543    345788999999999 69999999999


Q ss_pred             eecCCeeEEEEEeecCCCccccccCCC---------CCCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 016917          139 CQENNLQFLIYEYIPNGSVSIHLYGPS---------QVSRQ--KLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTAN  207 (380)
Q Consensus       139 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~N  207 (380)
                      |...+..++|+||+..|+|..+|+..+         .....  .+.....++++.||+.|++||++  +++|||||..+|
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~--~~~vHRDLAaRN  448 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS--VPCVHRDLAARN  448 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh--CCccchhhhhhh
Confidence            999999999999999999999997665         11122  38999999999999999999999  779999999999


Q ss_pred             eeeCCCCceEEcccccccccCCCCCCC-CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 016917          208 VLVDEDFIAKVADAGLRNFLGRTDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPD  285 (380)
Q Consensus       208 ili~~~~~~kl~DFgla~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~  285 (380)
                      ||++++..+||+|||+|+...+..... ......-+..|||||.+....|+.++||||||++|||++| |..||.+... 
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-  527 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-  527 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence            999999999999999999765543322 1111114667999999999999999999999999999999 8899876321 


Q ss_pred             CcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          286 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                       ..++.             +.+.+..+...|..|+++++++|+.||+.+|++||++.++.+.++.++..
T Consensus       528 -~~~l~-------------~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~  582 (609)
T KOG0200|consen  528 -TEELL-------------EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD  582 (609)
T ss_pred             -HHHHH-------------HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence             11122             22334444567778889999999999999999999999999999997654

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.1e-39  Score=293.95  Aligned_cols=245  Identities=20%  Similarity=0.265  Sum_probs=200.2

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      +|++.+.||.|+||.||+|... ++..+++|....      ...+.+.+|++++++++||||+++++.+..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999965 688999997542      234578899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+.+++|.+++.     ....+++..+..++.|++.||.|||+  .+++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~-----~~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLS-----QKVKFSEEQVKFWICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHH-----hcCCcCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            999999998883     23567889999999999999999999  67999999999999999999999999998766432


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      .   ......++..|+|||.+.+..++.++|+||||+++|+|++|..||................             . 
T Consensus       154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------~-  216 (258)
T cd05578         154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE-------------T-  216 (258)
T ss_pred             c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc-------------c-
Confidence            2   1233457778999999988889999999999999999999999998655321111111100             0 


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCH--HHHHH
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSM--SDVVT  346 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~--~~ll~  346 (380)
                      .....+...+..+.+++.+||+.||.+||++  +++++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            1123444566889999999999999999999  65543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2e-39  Score=297.70  Aligned_cols=259  Identities=27%  Similarity=0.385  Sum_probs=199.9

Q ss_pred             HHHHHHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC--ChHHHHHHHHHHhcC-CCCceeeeccceecC---
Q 016917           70 EELSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGYCQEN---  142 (380)
Q Consensus        70 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~---  142 (380)
                      .++....++|++.+.||+|+||.||++.. .+++.+|+|.....  ....+.+|+.+++++ +|||++++++++...   
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL   94 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence            33334567899999999999999999995 56889999986543  345677899999998 899999999998643   


Q ss_pred             --CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcc
Q 016917          143 --NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  220 (380)
Q Consensus       143 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~D  220 (380)
                        +..++||||+++++|.+++.... .....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.++|+|
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~nili~~~~~~kl~d  171 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHN--NRIIHRDVKGNNILLTTEGGVKLVD  171 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEee
Confidence              35799999999999988774321 134567899999999999999999999  7799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCccceecccccccC-----CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH
Q 016917          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-----RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  295 (380)
Q Consensus       221 Fgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~  295 (380)
                      ||++.........  .....++..|+|||.+...     .++.++|||||||++|||++|+.||......  .....   
T Consensus       172 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~~---  244 (291)
T cd06639         172 FGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLFK---  244 (291)
T ss_pred             cccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHHH---
Confidence            9998865432211  1234577889999987543     3688999999999999999999999764321  11111   


Q ss_pred             hhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       ....        .......+...+..+.+++.+||+.||++||++.+++++
T Consensus       245 -~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         245 -IPRN--------PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             -HhcC--------CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence             0000        000011223345679999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-39  Score=292.52  Aligned_cols=244  Identities=23%  Similarity=0.368  Sum_probs=195.5

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC----CChHHHHHHHHHHhcCC---CCceeeeccceecCCeeEEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG----APTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  149 (380)
                      .|+..+.||+|+||.||+|.. .++..+++|....    .....+.+|+++++.++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477788999999999999995 5688999997543    23456788999999986   999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++++|.+++.      ...+++..++.++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~------~~~l~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMK------AGPIAEKYISVIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHH------ccCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            9999999998873      2367889999999999999999999  7799999999999999999999999999887654


Q ss_pred             CCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ..  .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||........   .....             
T Consensus       154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~-------------  215 (277)
T cd06917         154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MMLIP-------------  215 (277)
T ss_pred             Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhccc-------------
Confidence            32  11233467888999998764 4578999999999999999999999975432110   00000             


Q ss_pred             cccccCCCH-HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTN-EGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .......+. ..+.++.+++.+||+.||.+||++.+++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         216 KSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             cCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            000011111 145679999999999999999999999864

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=6.8e-39  Score=294.57  Aligned_cols=247  Identities=23%  Similarity=0.356  Sum_probs=199.5

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC---CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG---APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ++|.+.+.||+|+||.||++.. .++..+++|....   ...+.+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5788899999999999999984 4678899997542   23456788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++.      ...+++..+..++.|++.|+.|||+  ++++|+||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~------~~~l~~~~~~~i~~~l~~al~~LH~--~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          99 AGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCcHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHh--CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            9999998883      2356788899999999999999999  7799999999999999999999999998876543221


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                        ......++..|+|||.+.+..++.++|+|||||++|++++|+.||........  ... ..           ......
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~-~~-----------~~~~~~  234 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL-IA-----------TNGTPE  234 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eee-hh-----------cCCCCC
Confidence              12334678889999999888899999999999999999999999975432111  000 00           000111


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...+...+..+.+++.+||..||++||++.+++.+
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11223455679999999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.3e-39  Score=289.78  Aligned_cols=248  Identities=25%  Similarity=0.393  Sum_probs=198.1

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +|+..+.||+|+||.||+|.. .++..+++|.....     ..+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            478889999999999999985 46889999974432     345678999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++.     ....+++..+..++.+++.|+.|||+  .+++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLE-----HGRILDEHVIRVYTLQLLEGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHh-----hcCCCChHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            99999999883     23457788899999999999999999  679999999999999999999999999988765432


Q ss_pred             CCCC--CccccCccceecccccccCC---CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          232 VAGP--SSQVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       232 ~~~~--~~~~~~~~~~~aPE~~~~~~---~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      ....  .....++..|+|||.+.+..   ++.++||||||+++|++++|+.||......  .........          
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~~~~----------  221 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFHVGA----------  221 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHHHhc----------
Confidence            2111  22356778899999988766   889999999999999999999999754311  000000000          


Q ss_pred             cccccccCCCH--HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFTN--EGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         ......+.  ..++.+.+++.+||+.||++|||+.+++.+
T Consensus       222 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         222 ---GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             ---CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence               00111222  236778999999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.1e-39  Score=295.40  Aligned_cols=258  Identities=21%  Similarity=0.303  Sum_probs=195.2

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC--------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      +|+..+.||+|++|.||+|... +++.|++|......        ...+..|+++++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999954 68899999754332        23467899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+ +++|.+++...    ...+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 88999888422    1368899999999999999999999  679999999999999999999999999988764


Q ss_pred             CCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh---------
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR---------  298 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------  298 (380)
                      ....  ......++..|+|||.+.+ ..++.++|+|||||++|||++|.+||......   ..........         
T Consensus       154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  228 (298)
T cd07841         154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWP  228 (298)
T ss_pred             CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhh
Confidence            4221  1222345677999998754 46789999999999999999998877654321   1111111000         


Q ss_pred             cccchhhhcccccccC-----CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          299 DFSNLLKILDERLWST-----FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       299 ~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ................     .....+..+.+++.+||+.||++|||+.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000000000001     112345789999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6.2e-39  Score=296.76  Aligned_cols=244  Identities=27%  Similarity=0.374  Sum_probs=193.0

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      +.|+..+.||+|+||.||+|... +++.|++|.....      ..+.+.+|+++++.++||||+++.+++...+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999954 6889999975422      1245788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+.+ ++.+.+..    ....+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~g-~l~~~~~~----~~~~l~~~~~~~~~~ql~~~L~~LH~--~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCLG-SASDILEV----HKKPLQEVEIAAICHGALQGLAYLHS--HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhCC-CHHHHHHH----cccCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99975 66555521    23458899999999999999999999  6799999999999999999999999999876532


Q ss_pred             CCCCCCCccccCccceecccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          230 TDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      .      ....++..|+|||++.   ...++.++||||||+++|||++|..||......      .......        
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~~~--------  227 (307)
T cd06607         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA--------  227 (307)
T ss_pred             C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHHHh--------
Confidence            1      2345677899999874   456889999999999999999999998754321      1000000        


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                       ........+..++..+.+++.+||+.||++||++.+++.+.
T Consensus       228 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         228 -QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             -cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence             00001111234567899999999999999999999999763

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-39  Score=292.55  Aligned_cols=254  Identities=28%  Similarity=0.407  Sum_probs=198.2

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC--ChHHHHHHHHHHhcC-CCCceeeeccceecCC------e
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGYCQENN------L  144 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------~  144 (380)
                      ..++|++.+.||+|++|.||+|..+ +++.+++|.....  ..+.+.+|+++++++ +|+||+++++++....      .
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            3578999999999999999999964 5788999985543  345688999999999 7999999999986544      4


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .++||||+++++|.+++.... .....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEEccCCeEEECCCccc
Confidence            899999999999988874321 124568899999999999999999999  67999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCccceeccccccc-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD  299 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  299 (380)
                      .......  .......++..|+|||.+..     ..++.++|||||||++|+|++|+.||......  ......    ..
T Consensus       161 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~----~~  232 (275)
T cd06608         161 AQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFKI----PR  232 (275)
T ss_pred             eecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHHh----hc
Confidence            7654322  12234457888999998753     35678999999999999999999999754321  111110    00


Q ss_pred             ccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                              ........+...++++.+++.+||..||++|||+.+++++
T Consensus       233 --------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         233 --------NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             --------cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                    0000111223356789999999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.1e-38  Score=286.77  Aligned_cols=249  Identities=28%  Similarity=0.420  Sum_probs=204.6

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecC--CeeEEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFLIY  149 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  149 (380)
                      +|+..+.||+|++|.||+|... ++..+++|......     .+.+.+|++++++++||||+++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999965 68899999755443     56788999999999999999999999888  8899999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++++|.+++.     ....+++..+..++.|++.|+.|||+  .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLK-----KFGKLPEPVIRKYTRQILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            9999999999883     23378899999999999999999999  7799999999999999999999999999887655


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ...........++..|+|||...+..++.++||||||+++|+|++|..||.....     ......         .....
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~---------~~~~~  219 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALY---------KIGSS  219 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHH---------hcccc
Confidence            3322123345678889999999888899999999999999999999999986541     111111         11111


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ......+...+..+.+++.+||..||.+||++.+++++
T Consensus       220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            12233445557889999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.1e-38  Score=292.89  Aligned_cols=262  Identities=20%  Similarity=0.241  Sum_probs=192.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      .++|++.+.||+|+||.||+|.. .++..|++|.....    ....+.+|+++++.++|+||+++.+++...+..++|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            46789999999999999999985 46889999975432    22357789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+. +++.+++..    ....+.+..+..++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||+++.....
T Consensus        84 ~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          84 YMH-TDLAQYMIQ----HPGGLHPYNVRLFMFQLLRGLAYIHG--QHILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             ccc-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            996 566655532    23456778888999999999999999  67999999999999999999999999998764332


Q ss_pred             CCCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh-ccc-------
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-DFS-------  301 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~-------  301 (380)
                      ..  ......++..|+|||.+.+. .++.++|||||||++|+|++|..||...... .+.+.+...... ...       
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-FEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-HHHHHHHHHHcCCCChhhhhhhh
Confidence            11  12233467789999998754 5789999999999999999999999754421 111111100000 000       


Q ss_pred             chhhhcccccccCCC---------HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 NLLKILDERLWSTFT---------NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .+.+..........+         ...+..+.+++.+|++.||.+|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            000000000000000         0124678999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.9e-39  Score=290.48  Aligned_cols=240  Identities=21%  Similarity=0.271  Sum_probs=195.1

Q ss_pred             eccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCc
Q 016917           85 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        85 ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  157 (380)
                      ||.|++|.||+|... ++..+++|.....      ..+.+.+|+.+++.++||||+++++.+.+++..++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999964 5889999975432      235688899999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016917          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  237 (380)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~  237 (380)
                      .+++.     ....++...+..++.|++.||.|||+  ++++|+||+|+||+++.++.++|+|||++.......   ...
T Consensus        81 ~~~l~-----~~~~l~~~~~~~~~~~i~~~l~~lH~--~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~  150 (262)
T cd05572          81 WTILR-----DRGLFDEYTARFYIACVVLAFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW  150 (262)
T ss_pred             HHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence            99883     23457889999999999999999999  779999999999999999999999999988765422   123


Q ss_pred             cccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCH
Q 016917          238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  317 (380)
Q Consensus       238 ~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (380)
                      ...++..|++||.+.+..++.++|+||||+++|+|++|..||.....+.    .+...         .+........++.
T Consensus       151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~---------~~~~~~~~~~~~~  217 (262)
T cd05572         151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYN---------DILKGNGKLEFPN  217 (262)
T ss_pred             cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHH---------HHhccCCCCCCCc
Confidence            3457788999999988889999999999999999999999998654311    11111         1111111233444


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016917          318 EGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  347 (380)
Q Consensus       318 ~~~~~l~~li~~cl~~dp~~Rpt-----~~~ll~~  347 (380)
                      ..++++.+++.+||+.||.+||+     ++|++++
T Consensus       218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            55788999999999999999999     7777763

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=9.8e-39  Score=288.42  Aligned_cols=249  Identities=24%  Similarity=0.324  Sum_probs=203.5

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      +|++.+.||+|++|.||+|... ++..+++|+....    ....+.+|+..+..++|+||+++++++...+..++|+||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            6788899999999999999965 5899999985543    2467889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++.     ....+++..++.++.|++.|+.|||+. .+++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~L~~~l~-----~~~~l~~~~~~~~~~~l~~~l~~lh~~-~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          82 DGGSLADLLK-----KVGKIPEPVLAYIARQILKGLDYLHTK-RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             CCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHhcc-CCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999999983     236688999999999999999999971 3599999999999999999999999999887643222


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                      .  .....++..|+|||...+..++.++|+||||+++|+|++|..||.........+....+.             ....
T Consensus       156 ~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------------~~~~  220 (264)
T cd06623         156 Q--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-------------DGPP  220 (264)
T ss_pred             c--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-------------cCCC
Confidence            1  123457788999999998899999999999999999999999997765311111211111             1111


Q ss_pred             cCCCHH-HHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          313 STFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...+.. .+..+.+++.+||..+|++||++.+++++
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            122333 56789999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7e-39  Score=292.90  Aligned_cols=260  Identities=24%  Similarity=0.325  Sum_probs=194.5

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +|+..+.||+|++|.||+|... ++..|++|.....     ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999854 6889999975432     234688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +. ++|..++...   ....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 5787777432   23567899999999999999999999  679999999999999999999999999987654321


Q ss_pred             CCCCCccccCccceecccccccCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc-cch------
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF-SNL------  303 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~------  303 (380)
                        .......++..|+|||.+.+.. ++.++||||||+++|||+||+.||......  ............. ...      
T Consensus       155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         155 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             --cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhH
Confidence              1122334577899999887644 588999999999999999999999754321  1111111111000 000      


Q ss_pred             ----hhhccc---ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 ----LKILDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ----~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                          ......   ..........++++.+++.+||+.||.+|||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                000000   00000112244678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.1e-39  Score=297.78  Aligned_cols=242  Identities=18%  Similarity=0.308  Sum_probs=193.9

Q ss_pred             CCeeccCCceEEEEEEE-CCCcEEEEEeCCCC---ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCc
Q 016917           82 KNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  157 (380)
                      ...||+|+||.||++.. .++..||+|.....   ..+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            46699999999999985 46889999975432   234578899999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016917          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  237 (380)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~  237 (380)
                      .+++.      ...+++..+..++.|++.||.|||+  ++|+||||||+||++++++.++|+|||++.......  ....
T Consensus       107 ~~~~~------~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~  176 (292)
T cd06658         107 TDIVT------HTRMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRK  176 (292)
T ss_pred             HHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCc
Confidence            88772      2457889999999999999999999  679999999999999999999999999987653321  1123


Q ss_pred             cccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCH
Q 016917          238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  317 (380)
Q Consensus       238 ~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (380)
                      ...++..|+|||...+..++.++|+||||+++|||++|+.||......   .....+..         ......  ....
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~---------~~~~~~--~~~~  242 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMRRIRD---------NLPPRV--KDSH  242 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh---------cCCCcc--cccc
Confidence            356788899999998889999999999999999999999998754321   11111110         011110  1112


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          318 EGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       318 ~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..+..+.+++.+||..||.+|||+++++++
T Consensus       243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         243 KVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            345678999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-40  Score=295.63  Aligned_cols=250  Identities=21%  Similarity=0.301  Sum_probs=205.9

Q ss_pred             HHHHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCe
Q 016917           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (380)
Q Consensus        72 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  144 (380)
                      .+...+.|+.-++||+|+||.||-++.+ +|+.+|.|+..+.      ...-..+|-.+|.+++.+.||.+--.+.+.+.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            4555677899999999999999999954 6888998864322      22346789999999999999999999999999


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      +++|+..|.||+|.-+++..   ....+++..++.++.+|+.||++||+  .+||.||+||+|||+|+.|++.|+|+|+|
T Consensus       260 LClVLtlMNGGDLkfHiyn~---g~~gF~e~ra~FYAAEi~cGLehlH~--~~iVYRDLKPeNILLDd~GhvRISDLGLA  334 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNH---GNPGFDEQRARFYAAEIICGLEHLHR--RRIVYRDLKPENILLDDHGHVRISDLGLA  334 (591)
T ss_pred             eEEEEEeecCCceeEEeecc---CCCCCchHHHHHHHHHHHhhHHHHHh--cceeeccCChhheeeccCCCeEeeccceE
Confidence            99999999999999998654   34689999999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ..+.+..   +.....||.+|||||++.+..|+...|+|||||+||||+.|+.||.........+-++            
T Consensus       335 vei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd------------  399 (591)
T KOG0986|consen  335 VEIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD------------  399 (591)
T ss_pred             EecCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH------------
Confidence            9876543   3345589999999999999999999999999999999999999998654432221111            


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS  342 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~  342 (380)
                      +.+-. ....++...+++.+++....|++||++|....
T Consensus       400 rr~~~-~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  400 RRTLE-DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHhc-chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            10000 01245566778899999999999999998655

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.5e-39  Score=293.73  Aligned_cols=259  Identities=23%  Similarity=0.280  Sum_probs=197.3

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +|++.+.||+|++|.||+|.. .++..|++|.....     ....+.+|+.++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            478889999999999999995 46889999975432     235688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      + +++|.+++..    ....+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRD----EERPLPEAQVKSYMRMLLKGVAYMHA--NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 9999988742    23568899999999999999999999  679999999999999999999999999988764422


Q ss_pred             CCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc---------cc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD---------FS  301 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------~~  301 (380)
                      . .......++..|+|||.+.+. .++.++||||+||++|||++|.+||......   .....+.....         ..
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07832         154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLT  229 (286)
T ss_pred             C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhcc
Confidence            1 122344678889999988654 4689999999999999999998877654321   11111111000         00


Q ss_pred             chhh---hcccc----cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 NLLK---ILDER----LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 ~~~~---~~~~~----~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .+..   .....    .......+.+..+.+++.+||+.||++|||+++++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000   00000    0001112345789999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-39  Score=293.66  Aligned_cols=261  Identities=21%  Similarity=0.293  Sum_probs=192.9

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      .++|+..+.||+|++|.||+|..+ ++..||+|.....    ....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            357888999999999999999965 6789999975422    23456789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+.+ +|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||+++.....
T Consensus        84 ~~~~-~L~~~~~~----~~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          84 YLDT-DLKQYMDD----CGGGLSMHNVRLFLFQLLRGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             cCCC-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            9985 88877742    23467889999999999999999999  67999999999999999999999999998754321


Q ss_pred             CCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc--cc----h
Q 016917          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF--SN----L  303 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~----~  303 (380)
                      .  .......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||......  .+...........  ..    .
T Consensus       157 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07844         157 S--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGV  232 (291)
T ss_pred             C--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhh
Confidence            1  11122345778999998865 45889999999999999999999999754311  1111111000000  00    0


Q ss_pred             hh---hcc--------cccccCCC-HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 LK---ILD--------ERLWSTFT-NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ~~---~~~--------~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..   ...        .......+ .....++.+++.+||+.||++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            00   000        00000000 0112667899999999999999999998864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-38  Score=291.66  Aligned_cols=256  Identities=25%  Similarity=0.334  Sum_probs=197.6

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceec--CCeeEEEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLIYE  150 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  150 (380)
                      +|...+.||.|++|.||+|.. .+++.+|+|.....    ....+.+|++++++++||||+++++++..  .+..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            577889999999999999996 46788999975532    23468899999999999999999998854  346899999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++++|.+++..... ....++...+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999887643211 34567888999999999999999999  67999999999999999999999999998765332


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC--CcccHHHHHHhhhcccchhhhcc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD--SSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      .    .....++..|+|||.+.+..++.++|||||||++|+|++|..||......  ...+.......... ..+    .
T Consensus       159 ~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~----~  229 (287)
T cd06621         159 L----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-PEL----K  229 (287)
T ss_pred             c----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc-hhh----c
Confidence            1    12345677899999999889999999999999999999999999865321  11111111111000 000    0


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..  .......++.+.+++.+||+.||.+|||+.|++++
T Consensus       230 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         230 DE--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             cC--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            00  01112345789999999999999999999999985

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.7e-39  Score=297.76  Aligned_cols=245  Identities=20%  Similarity=0.306  Sum_probs=195.7

Q ss_pred             CCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC---CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           79 FSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG---APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      |.....||+|+||.||++.. .++..|++|....   ...+.+.+|+.+++.++||||+++++.+..++..++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            34456799999999999985 4688999997532   3345678899999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      ++|..++      ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++.......  .
T Consensus       103 ~~L~~~~------~~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~  172 (297)
T cd06659         103 GALTDIV------SQTRLNEEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P  172 (297)
T ss_pred             CCHHHHH------hhcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--c
Confidence            9998866      23457889999999999999999999  679999999999999999999999999987654322  1


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      ......++..|+|||.+.+..++.++|||||||++|||++|+.||......   ..........           .....
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~-----------~~~~~  238 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLRDSP-----------PPKLK  238 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhccC-----------CCCcc
Confidence            123456788999999999889999999999999999999999998754321   1111111000           00011


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .....++.+.+++.+||+.||++||++++++++
T Consensus       239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         239 NAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            112344678999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.5e-39  Score=291.76  Aligned_cols=250  Identities=24%  Similarity=0.326  Sum_probs=199.7

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      +|+..+.||+|++|.||++..+ +++.+++|.....    ....+.+|+++++.++||||+++++.+...+..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5777889999999999999965 6889999975433    2345788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++...    ...+++..+..++.|++.|+.|||+. .+++|+||||+||++++++.++|+|||.+........
T Consensus        82 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~-~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          82 DGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHEK-HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             CCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcCC-CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            999999988432    26678899999999999999999982 4599999999999999999999999999876533211


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                          ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+......         ... .
T Consensus       157 ----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~---------~~~-~  221 (265)
T cd06605         157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIV---------NEP-P  221 (265)
T ss_pred             ----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHh---------cCC-C
Confidence                1256778899999999999999999999999999999999998765321 111122111111         110 1


Q ss_pred             cCCCHH-HHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          313 STFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...+.. .+.++.+++.+||..||++|||+.+++.+
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            122222 66789999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-39  Score=302.92  Aligned_cols=263  Identities=21%  Similarity=0.305  Sum_probs=193.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecC-----Cee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  145 (380)
                      .++|++.+.||+|+||.||+|.. .++..||+|.....    ....+.+|+.+++.++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            35799999999999999999984 56899999976432    234577899999999999999999987543     357


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++|+||+.+ +|...+      ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~-~l~~~~------~~~~l~~~~~~~i~~ql~~aL~~LH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELMET-DLYKLI------KTQHLSNDHIQYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhccc-CHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEECccccee
Confidence            999999975 666655      23568899999999999999999999  679999999999999999999999999987


Q ss_pred             ccCCCCCC-CCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          226 FLGRTDVA-GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       226 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      ........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.................+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            66432211 12234567888999998654 56899999999999999999999999754321100000000000000001


Q ss_pred             hhhcccc-----------cc---cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 LKILDER-----------LW---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ~~~~~~~-----------~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..+.+..           ..   .......++++.+++.+||+.||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000000           00   00111235679999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=310.36  Aligned_cols=246  Identities=24%  Similarity=0.359  Sum_probs=200.7

Q ss_pred             CCCCCeeccCCceEEEEEEECC-CcEEEEEeC---CCCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKR---PGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      |.+++.||.|+||.||+|..+. +...|-|.+   .....+.++-|++||..++||+|+++++.|...+.++++.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            4566789999999999999764 334455543   334566788999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |..+..+.    .-...+.+.++.-+++|++.||.|||+  +.|||||||..|||++-+|.++|+|||.+.....+  ..
T Consensus       114 GAVDaiml----EL~r~LtE~QIqvvc~q~ldALn~LHs--~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~q  185 (1187)
T KOG0579|consen  114 GAVDAIML----ELGRVLTEDQIQVVCYQVLDALNWLHS--QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQ  185 (1187)
T ss_pred             chHhHHHH----HhccccchHHHHHHHHHHHHHHHHHhh--cchhhhhccccceEEEecCcEeeecccccccchhH--Hh
Confidence            99988774    335678999999999999999999999  77999999999999999999999999987654332  23


Q ss_pred             CCccccCccceeccccc-----ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc-
Q 016917          235 PSSQVTADEIFLASEVK-----EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD-  308 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~-----~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  308 (380)
                      ....+.||++|||||+.     ...+|+.++||||||++|.||..+.+|.....+-      .         -+.++.. 
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------R---------VllKiaKS  250 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------R---------VLLKIAKS  250 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------H---------HHHHHhhc
Confidence            34578899999999985     3569999999999999999999999997755431      0         1111111 


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      +......|..++..+.|+++.||..||..||++.+++++
T Consensus       251 ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  251 EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            112234566788899999999999999999999999986

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8e-39  Score=292.03  Aligned_cols=239  Identities=21%  Similarity=0.283  Sum_probs=186.4

Q ss_pred             eeccCCceEEEEEEE-CCCcEEEEEeCCCCC------hHHHHHHHHHHh---cCCCCceeeeccceecCCeeEEEEEeec
Q 016917           84 LIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLA---SIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        84 ~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      .||+|+||.||++.. .++..+|+|......      ...+.+|..+++   ..+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999995 468899999643221      122344444333   3479999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                      +++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||+++++.++|+|||++.......  
T Consensus        81 ~~~L~~~i~-----~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLS-----QHGVFSEKEMRFYATEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            999988873     34568999999999999999999999  779999999999999999999999999987553321  


Q ss_pred             CCCccccCccceecccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          234 GPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                        .....++..|+|||... +..++.++|+|||||++|+|++|..||.............    ..          ....
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~----------~~~~  215 (279)
T cd05633         152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MT----------LTVN  215 (279)
T ss_pred             --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH----Hh----------hcCC
Confidence              22346888999999886 4668999999999999999999999997654322111110    00          0011


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                      ...+...++++.+++.+||+.||.+||     |+++++++
T Consensus       216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            233445667899999999999999999     59999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=289.22  Aligned_cols=266  Identities=24%  Similarity=0.352  Sum_probs=222.9

Q ss_pred             HHHHHHHhCCCCCCCeeccCCceEEEEEEECC------CcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccc
Q 016917           69 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGY  138 (380)
Q Consensus        69 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~  138 (380)
                      ..++.....+++....+-+|.||+||.|.+++      .+.|.+|..+..    ....+..|...+..+.|||+....++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            44556666678888899999999999996543      345566654333    23457889999999999999999999


Q ss_pred             eec-CCeeEEEEEeecCCCccccccCC---CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC
Q 016917          139 CQE-NNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF  214 (380)
Q Consensus       139 ~~~-~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~  214 (380)
                      +.. ....+.++.+..-|+|..||...   +....+.+...+...++.|++.|+.|||+  .++||.||..+|++||+..
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~--~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN--HGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh--cCcccchhhhhcceehhhe
Confidence            864 45678899999999999999522   22345667888899999999999999999  6699999999999999999


Q ss_pred             ceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHH
Q 016917          215 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVEL  293 (380)
Q Consensus       215 ~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~  293 (380)
                      ++||+|=.+++.+-+.++.........+..||+||.+....|+..+|+|||||+||||+| |+.||...++.        
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf--------  505 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF--------  505 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH--------
Confidence            999999999999988888877777788899999999999999999999999999999998 99999877653        


Q ss_pred             HHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          294 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                              ++...+.+..+...|.+||+++..+|..||+.+|++||+++|+..-|.+..
T Consensus       506 --------Em~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  506 --------EMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             --------HHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence                    233444555666788899999999999999999999999999998887654

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=288.32  Aligned_cols=248  Identities=22%  Similarity=0.317  Sum_probs=197.1

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC--------CChHHHHHHHHHHhcCCCCceeeeccceecC--Cee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG--------APTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQ  145 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  145 (380)
                      .+|++.+.||+|+||.||+|.. .++..|++|....        .....+.+|++++++++|+||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688899999999999999995 4688999997431        1123577899999999999999999998654  567


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++++||+++++|.+++.     ....+++.....++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~-----~~~~l~~~~~~~~~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLK-----AYGALTENVTRRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            89999999999998873     23457888899999999999999998  779999999999999999999999999988


Q ss_pred             ccCCCCC-CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          226 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       226 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ....... ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||......      ..+         .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~---------~  219 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAI---------F  219 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHH---------H
Confidence            6543111 11122345788899999999888999999999999999999999999754211      111         1


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      +.........++...++.+.+++.+||+ +|..||++.+++.+
T Consensus       220 ~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         220 KIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             HHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            1111112234556677889999999998 57999999988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.1e-39  Score=294.75  Aligned_cols=259  Identities=24%  Similarity=0.325  Sum_probs=195.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecC--CeeEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFLI  148 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  148 (380)
                      ++|++.+.||+|+||.||+|..+ ++..+++|.....     ....+.+|++++++++||||+++++++...  +..|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999965 5788999975422     123467899999999999999999998776  889999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      +||+++ +|.+.+..    ....+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||++....
T Consensus        85 ~e~~~~-~L~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVEH-DLKSLMET----MKQPFLQSEVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcCc-CHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            999975 88777732    22368899999999999999999999  679999999999999999999999999988765


Q ss_pred             CCCCCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc--------
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD--------  299 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------  299 (380)
                      ...  .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.......   ....+.....        
T Consensus       158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~  232 (293)
T cd07843         158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID---QLNKIFKLLGTPTEKIWP  232 (293)
T ss_pred             CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchHHHH
Confidence            422  112234567789999988754 46899999999999999999999997654211   1111100000        


Q ss_pred             -ccchh--------hhcccccccCCCHH-HHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 -FSNLL--------KILDERLWSTFTNE-GMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 -~~~~~--------~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       ...+.        ......+...++.. .++.+.+++.+||+.||++|||+.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence             00000        00011111223332 46779999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9e-39  Score=293.78  Aligned_cols=264  Identities=24%  Similarity=0.307  Sum_probs=193.6

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCC-CCceeeeccceecCCe-----
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNL-----  144 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  144 (380)
                      ++|++.+.||+|+||.||+|... ++..||+|.....     ....+.+|+.+++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888899999999999999954 6889999974422     2346788999999995 6999999999876655     


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGL  223 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~-~~~~kl~DFgl  223 (380)
                      .|+||||+++ +|.+++..........+++..++.++.|++.||.|||+  ++|+||||||+||+++. ++.++|+|||+
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEecCCCeEEEeeccc
Confidence            7999999986 78777754332224568999999999999999999999  77999999999999998 88999999999


Q ss_pred             ccccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc---
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD---  299 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---  299 (380)
                      +.......  .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......  ..+.........   
T Consensus       158 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~  233 (295)
T cd07837         158 GRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL--QQLLHIFKLLGTPTE  233 (295)
T ss_pred             ceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHhCCCCh
Confidence            87653221  11122345777999998765 46799999999999999999999999764321  111111110000   


Q ss_pred             --ccchhhhcc--------cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 --FSNLLKILD--------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 --~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                        .........        +..........++++.+++.+||+.||.+||++.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence              000000000        000000112355779999999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.1e-38  Score=290.78  Aligned_cols=242  Identities=23%  Similarity=0.307  Sum_probs=191.1

Q ss_pred             eccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCc
Q 016917           85 IGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        85 ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  157 (380)
                      ||+|+||+||+|.. .++..+++|.....      ....+..|+++++.++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999985 46889999975422      233467899999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016917          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  237 (380)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~  237 (380)
                      .+++...   ....+++..+..++.|++.||.|||+  ++++||||+|+||++++++.++|+|||.+.......   ...
T Consensus        81 ~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~  152 (277)
T cd05577          81 KYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQ--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK  152 (277)
T ss_pred             HHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccc
Confidence            9888432   22468899999999999999999999  779999999999999999999999999987654311   122


Q ss_pred             cccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCH
Q 016917          238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  317 (380)
Q Consensus       238 ~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (380)
                      ...++..|+|||...+..++.++|+|||||++|+|++|+.||..........   .+....        .  ......+.
T Consensus       153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~--------~--~~~~~~~~  219 (277)
T cd05577         153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKRRT--------L--EMAVEYPD  219 (277)
T ss_pred             cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHhcc--------c--cccccCCc
Confidence            3456778999999988889999999999999999999999997654321111   010000        0  00112333


Q ss_pred             HHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          318 EGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       318 ~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                      ..++++.+++.+||+.||.+||     ++.+++.+
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            4567899999999999999999     66666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-40  Score=308.38  Aligned_cols=243  Identities=25%  Similarity=0.404  Sum_probs=194.6

Q ss_pred             CCCCeeccCCceEEEEEEE-CCCcEEE---EEe--C--CCCChHHHHHHHHHHhcCCCCceeeeccceecCCe--eEEEE
Q 016917           80 SDKNLIGEGKFGEVYKGLL-QDGMLVA---IKK--R--PGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNL--QFLIY  149 (380)
Q Consensus        80 ~~~~~ig~G~~g~V~~~~~-~~~~~va---vK~--~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  149 (380)
                      +...+||+|+|-+||+|.. .+|..||   +|.  +  .....+.|..|+++|+.|+||||+++++++.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            4457899999999999995 4566665   332  2  23344789999999999999999999999976554  78999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEcccccccccC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLG  228 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~-~~~~kl~DFgla~~~~  228 (380)
                      |.+..|+|..++.     +.+......+.++++||++||.|||++.++|+|||||.+||+|+. .|.|||+|+|+|....
T Consensus       123 EL~TSGtLr~Y~k-----k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  123 ELFTSGTLREYRK-----KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ecccCCcHHHHHH-----HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            9999999999983     456678889999999999999999999999999999999999985 4899999999999875


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ...    .....||+.|||||+.. ..|+..+||||||+++.||.|+..||+.-..  ..+.+..+-......       
T Consensus       198 ~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiKP~-------  263 (632)
T KOG0584|consen  198 KSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIKPA-------  263 (632)
T ss_pred             ccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCCHH-------
Confidence            432    23478999999999998 8999999999999999999999999985331  112222222111111       


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                           .+..--.+++++||.+||.. ..+|||+.|+|++
T Consensus       264 -----sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  264 -----ALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             -----HhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                 11111236799999999999 9999999999974

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3e-38  Score=286.41  Aligned_cols=247  Identities=20%  Similarity=0.218  Sum_probs=191.0

Q ss_pred             HHHhCCCCCCCee--ccCCceEEEEEEE-CCCcEEEEEeCCCCChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEE
Q 016917           73 SLATKNFSDKNLI--GEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        73 ~~~~~~~~~~~~i--g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  148 (380)
                      ....++|.+.+.+  |+|+||.||++.. .++..+++|..........  |......+ +||||+++++.+...+..++|
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence            3345567777666  9999999999995 4678899998654332222  23332223 799999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEccccccccc
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFL  227 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~-~~kl~DFgla~~~  227 (380)
                      |||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++ .++|+|||++...
T Consensus        88 ~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         88 MDYIKDGDLFDLLK-----KEGKLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             EEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence            99999999999883     23478999999999999999999999  6799999999999999988 9999999998765


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      ...      ....++..|+|||++.+..++.++||||||+++|+|++|+.||....... .+........          
T Consensus       161 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~----------  223 (267)
T PHA03390        161 GTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ----------  223 (267)
T ss_pred             CCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh----------
Confidence            432      23457788999999999999999999999999999999999998443221 1111111100          


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCC-HHHHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-MSDVVTE  347 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~~ll~~  347 (380)
                      ..  ........++.+.+++.+||+.||.+||+ +++++++
T Consensus       224 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        224 QK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             cc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            00  11223356678999999999999999996 6988854

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.9e-38  Score=291.68  Aligned_cols=257  Identities=14%  Similarity=0.170  Sum_probs=182.1

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECC----CcEEEEEeCCCCCh----H----------HHHHHHHHHhcCCCCceeeec
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----Q----------EFIDEVCFLASIQHRNLVTLL  136 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~----~----------~~~~E~~~l~~l~h~niv~l~  136 (380)
                      ..++|++.+.||+|+||.||+|...+    +..+++|.......    +          ....+...+..++|+|+++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            34679999999999999999999654    34566765321111    0          112233445667899999999


Q ss_pred             cceecCC----eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC
Q 016917          137 GYCQENN----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE  212 (380)
Q Consensus       137 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~  212 (380)
                      +.+....    ..+++++++.. ++.+.+.     .....++..+..++.|++.||.|||+  ++|+||||||+|||++.
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiHrDiKp~Nill~~  161 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFK-----RIKCKNKKLIKNIMKDMLTTLEYIHE--HGISHGDIKPENIMVDG  161 (294)
T ss_pred             EeeeEecCCceEEEEEEehhcc-CHHHHHH-----hhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcC
Confidence            8765443    34677777644 4444441     12234677788999999999999999  67999999999999999


Q ss_pred             CCceEEcccccccccCCCCC-----CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCc
Q 016917          213 DFIAKVADAGLRNFLGRTDV-----AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS  287 (380)
Q Consensus       213 ~~~~kl~DFgla~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~  287 (380)
                      ++.++|+|||+++.......     ........||..|+|||+..+..++.++|||||||++|||++|+.||....... 
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-  240 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-  240 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch-
Confidence            99999999999986632211     111233468999999999999999999999999999999999999998653211 


Q ss_pred             ccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          288 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                       ........    +....+.....   ....+++++.+++..||+.+|++||+++++++.|
T Consensus       241 -~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        241 -NLIHAAKC----DFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             -HHHHHhHH----HHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence             11111100    00011111111   1123457799999999999999999999999876

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9.9e-39  Score=287.36  Aligned_cols=247  Identities=23%  Similarity=0.380  Sum_probs=197.6

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC-----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +|++.+.||+|+||.||+|..+ ++..+|+|....     ...+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4777899999999999999954 578899997532     2345678999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEcccccccccCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRT  230 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~-~~kl~DFgla~~~~~~  230 (380)
                      +++++|.+++...   ....+++..+..++.|++.||.|||+  .+++|+||||+||++++++ .++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999888432   22357889999999999999999999  6799999999999998875 5699999998776432


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      ..  ......++..|+|||...+..++.++|+||||+++|||++|..||.....      .+......         ...
T Consensus       156 ~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~---------~~~  218 (257)
T cd08225         156 ME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKIC---------QGY  218 (257)
T ss_pred             cc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHh---------ccc
Confidence            21  12234578889999999888899999999999999999999999865331      11111111         010


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       ....+...+.++.+++.+||..+|++|||+.+++++
T Consensus       219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         219 -FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence             112233445779999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.7e-39  Score=300.44  Aligned_cols=266  Identities=19%  Similarity=0.263  Sum_probs=196.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecC-----Ce
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NL  144 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  144 (380)
                      .++|.+.+.||+|+||+||+|.. .++..||+|.....     ....+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35788999999999999999995 56899999975432     234567899999999999999999988644     34


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .++|+||+. ++|.+++.     ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR-----SSQTLSDDHCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999996 57777773     34568899999999999999999999  77999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc-
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN-  302 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  302 (380)
                      .......  .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+................... 
T Consensus       156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL  233 (337)
T ss_pred             cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence            8664321  11233457788999998764 4689999999999999999999999975432111000000000000000 


Q ss_pred             -------hhhhcc---cccc---cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--HHhh
Q 016917          303 -------LLKILD---ERLW---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRT  351 (380)
Q Consensus       303 -------~~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~--L~~~  351 (380)
                             ..+...   ....   .......++++.+++.+||+.||++|||+++++++  +..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                   000000   0000   01112356778999999999999999999999987  5544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.1e-39  Score=293.95  Aligned_cols=254  Identities=20%  Similarity=0.275  Sum_probs=192.1

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC----ChHHHHHHHHHHhcCC-CCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +|+..+.||+|+||.||++.. .++..+|+|.....    ....+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            455567899999999999995 45889999975432    2345788999999995 99999999999988899999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +.. ++.++...........+++..+..++.+++.||+|||+. .+++||||||+||+++.++.++|+|||++.......
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc-CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            865 444332110011235688999999999999999999972 379999999999999999999999999987654322


Q ss_pred             CCCCCccccCccceecccccccC---CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFR---RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                         ......++..|+|||.+.+.   .++.++|||||||++|+|++|+.||....     ...+.+......      ..
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~------~~  228 (288)
T cd06616         163 ---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG------DP  228 (288)
T ss_pred             ---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC------CC
Confidence               11233577789999998766   68999999999999999999999987543     111111111100      00


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      +.+....+..++.++.+++.+||+.||.+|||+++++++
T Consensus       229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111122223466789999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2e-38  Score=290.36  Aligned_cols=250  Identities=24%  Similarity=0.367  Sum_probs=201.1

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC--hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      .+.|+..+.||+|++|.||+|... ++..+++|......  .+.+.+|++.++.++|+|++++++.+...+..++|+||+
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   97 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYM   97 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEecc
Confidence            455788899999999999999965 68899999865443  567889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++...    ...+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        98 ~~~~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~lH~--~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-  170 (286)
T cd06614          98 DGGSLTDIITQN----FVRMNEPQIAYVCREVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-  170 (286)
T ss_pred             CCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence            999999998432    1378899999999999999999999  779999999999999999999999999876554321 


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                       .......++..|++||.+.+..++.++|+|||||++|+|++|+.||....+.   .......   ..        ....
T Consensus       171 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~~~~---~~--------~~~~  235 (286)
T cd06614         171 -SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALFLIT---TK--------GIPP  235 (286)
T ss_pred             -hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH---hc--------CCCC
Confidence             1122345677899999998888999999999999999999999998754321   0010000   00        0000


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...+..++..+.+++.+||+.+|.+||++.+++.+
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            11122356789999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-40  Score=324.45  Aligned_cols=278  Identities=26%  Similarity=0.291  Sum_probs=221.9

Q ss_pred             HHHHHHHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceec
Q 016917           69 MEELSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQE  141 (380)
Q Consensus        69 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  141 (380)
                      ..++.....+|.++++||+|+||.|.++++ .+++.||+|++.      ...+.-|+.|..+|..-+.+.|+++.-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            456667778899999999999999999995 568899999744      3455678999999999999999999999999


Q ss_pred             CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccc
Q 016917          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (380)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DF  221 (380)
                      ++++|+||||++||+|...+.     +...++++....+...|+.||.-||++  |+|||||||+|||+|.+|++||+||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlS-----k~~~~pE~~ArFY~aEiVlAldslH~m--gyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLS-----KFDRLPEDWARFYTAEIVLALDSLHSM--GYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ccceEEEEecccCchHHHHHh-----hcCCChHHHHHHHHHHHHHHHHHHHhc--cceeccCCcceeEecccCcEeeccc
Confidence            999999999999999998883     233789999999999999999999995  5999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCccceeccccccc-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh
Q 016917          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  296 (380)
Q Consensus       222 gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  296 (380)
                      |.+-.+..++. -.....+|||.|++||++..     +.|+..+|+||+||++|||++|..||-...      +.+.   
T Consensus       220 GsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveT---  289 (1317)
T KOG0612|consen  220 GSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVET---  289 (1317)
T ss_pred             hhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHH---
Confidence            99888765332 23456789999999998752     578999999999999999999999987432      2322   


Q ss_pred             hhcccchhhhcccccccCCC--HHHHHHHHHHHhHccCCCCCCCCC---HHHHHHHHHhhhhhhcccccccCCCCccccc
Q 016917          297 SRDFSNLLKILDERLWSTFT--NEGMEEFIQLIVRCLDPSSERRPS---MSDVVTELDRTLDKEMNLTTVMGEGTPTVTL  371 (380)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rpt---~~~ll~~L~~~~~~~~~~~~~~~~~~~~~~~  371 (380)
                            ..++.+......||  ..++++.++||.+.+ -+|+.|..   ++++-.|.   ......|.++-...+|.++.
T Consensus       290 ------Y~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~Hp---FF~g~~W~~iR~~~pP~vPe  359 (1317)
T KOG0612|consen  290 ------YGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHP---FFEGIDWDNIRESVPPVVPE  359 (1317)
T ss_pred             ------HHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCc---cccCCChhhhhhcCCCCCCc
Confidence                  22333333334555  468899999999887 56888887   77776552   23344565555555555554


Q ss_pred             cc
Q 016917          372 GS  373 (380)
Q Consensus       372 ~~  373 (380)
                      +|
T Consensus       360 vs  361 (1317)
T KOG0612|consen  360 VS  361 (1317)
T ss_pred             CC
Confidence            43

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=289.91  Aligned_cols=259  Identities=24%  Similarity=0.305  Sum_probs=193.6

Q ss_pred             CCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           79 FSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      |++.+.||.|++|.||+|.. .+|..|++|+....     ....+.+|+++++.++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            56778999999999999985 47899999975422     2356788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      + ++|.+++...   ....+++..+..++.|++.||.|||+  ++++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~--~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            5 5888877322   12468899999999999999999999  6799999999999999999999999999876532211


Q ss_pred             CCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc----------
Q 016917          233 AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS----------  301 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  301 (380)
                        ......++..|+|||++.+. .++.++|+||||+++|+|++|+.||......  ..............          
T Consensus       155 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         155 --TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             --ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhc
Confidence              11223457789999987654 5789999999999999999999999764321  11111111100000          


Q ss_pred             -chhhhccc---ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 -NLLKILDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 -~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       ........   ..........+..+.+++.+||+.||.+|||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             00000000   00011122344678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.7e-38  Score=294.10  Aligned_cols=260  Identities=22%  Similarity=0.299  Sum_probs=193.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecC--CeeEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFL  147 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  147 (380)
                      ..+|++.+.||+|+||.||+|.. .++..||+|......     ...+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            45789999999999999999995 468999999753221     23456899999999999999999998654  56899


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+++ +|.+++..    ....+++..+..++.|++.||.|||+  .+++||||||+||++++++.+||+|||++...
T Consensus        86 v~e~~~~-~l~~~l~~----~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCEQ-DLASLLDN----MPTPFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCCC-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            9999975 77777632    23568899999999999999999999  67999999999999999999999999998876


Q ss_pred             CCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc--cchh
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF--SNLL  304 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~  304 (380)
                      ....  .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......   +....+......  ....
T Consensus       159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~  233 (309)
T cd07845         159 GLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI---EQLDLIIQLLGTPNESIW  233 (309)
T ss_pred             CCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChhhc
Confidence            4322  11222345677999998865 56799999999999999999999999754321   111111111000  0000


Q ss_pred             ----h------h-cccccccC---CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          305 ----K------I-LDERLWST---FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       305 ----~------~-~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                          .      . ........   .....++++.+++.+||+.||++|||+++++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                0      0 00000000   001235778999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9.4e-39  Score=299.07  Aligned_cols=263  Identities=21%  Similarity=0.318  Sum_probs=195.6

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceec----CCeeE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQF  146 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  146 (380)
                      .+|++.+.||+|+||.||+|.. .++..|++|.....     ....+.+|+.+++.++||||+++.+++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            6788899999999999999994 46899999975432     23457789999999999999999998753    35679


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +||||+. ++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++..
T Consensus        85 lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          85 VVMDLME-SDLHHIIH-----SDQPLTEEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEehhh-hhHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            9999996 58888773     34558999999999999999999999  6799999999999999999999999999876


Q ss_pred             cCCCCCC--CCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc---
Q 016917          227 LGRTDVA--GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF---  300 (380)
Q Consensus       227 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---  300 (380)
                      .......  .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.................   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            6432211  11223467888999998765 46899999999999999999999999765432111000000000000   


Q ss_pred             -----cchhhhcc---ccc---ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 -----SNLLKILD---ERL---WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 -----~~~~~~~~---~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                           ........   ...   +.......++++.+++.+||+.||++|||+.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                 00000000   000   001112346789999999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.5e-38  Score=299.95  Aligned_cols=258  Identities=20%  Similarity=0.312  Sum_probs=194.5

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecC------
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------  142 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  142 (380)
                      ..++|+..+.||+|+||.||+|.. .++..||+|.....     ....+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457799999999999999999995 47899999986432     234577899999999999999999987643      


Q ss_pred             CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFg  222 (380)
                      ...|+||||+.+ +|.+.+.       ..++...+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQ-------MDLDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccCc
Confidence            346999999965 7766662       127888889999999999999999  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhh-hccc
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS-RDFS  301 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~  301 (380)
                      ++........   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+....  ........ ....
T Consensus       164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~  238 (353)
T cd07850         164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ--WNKIIEQLGTPSD  238 (353)
T ss_pred             cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhcCCCCH
Confidence            9986543221   2234577889999999999999999999999999999999999975432110  00000000 0000


Q ss_pred             c-----------------------hhhhcccccc----cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 N-----------------------LLKILDERLW----STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 ~-----------------------~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .                       ..........    ...+...++.+.+++.+||+.||++|||+.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0                       0001001000    01122346678999999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.2e-38  Score=289.95  Aligned_cols=245  Identities=20%  Similarity=0.315  Sum_probs=195.3

Q ss_pred             CCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC---ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           79 FSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      |...+.||+|++|.||++.. .++..+++|.....   ..+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            44457899999999999985 56889999975322   234578899999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      ++|.+++..      ..+++..+..++.|++.|+.|||+  .+++||||+|+||+++.++.++|+|||.+........  
T Consensus       101 ~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648         101 GALTDIVTH------TRMNEEQIATVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             CCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            999988832      457888999999999999999999  6799999999999999999999999998775533211  


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      ......++..|+|||...+..++.++|+|||||++|+|++|+.||....+      ...........      .+  ...
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~~------~~--~~~  236 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDNL------PP--KLK  236 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhcC------CC--CCc
Confidence            12234578889999999888899999999999999999999999875332      11111111100      00  001


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .+...+..+.+++.+||+.||++|||+.+++++
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            122245779999999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.1e-38  Score=292.60  Aligned_cols=248  Identities=27%  Similarity=0.373  Sum_probs=195.1

Q ss_pred             CCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           79 FSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      |...+.||+|+||.||++.. .++..+|+|.....      ....+.+|+++++.++|||++++++++...+..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            67778999999999999995 46889999975422      123577899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +.+ ++.+.+..    ....+++..+..++.|++.|+.|||+  ++++||||+|+||+++.++.++|+|||++.....  
T Consensus       107 ~~g-~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~--~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         107 CLG-SASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             CCC-CHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            975 66666532    23457899999999999999999999  7799999999999999999999999998875432  


Q ss_pred             CCCCCccccCccceecccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          232 VAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                          .....++..|+|||.+.   ...++.++|||||||++|||++|+.||......   ......            ..
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~------------~~  238 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHI------------AQ  238 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHH------------Hh
Confidence                22345777899999873   456889999999999999999999998753211   111100            00


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      ..........+++.+.+++.+||+.+|.+||++.++++++.....+
T Consensus       239 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         239 NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            1111112234567799999999999999999999999876554433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3e-38  Score=288.62  Aligned_cols=261  Identities=25%  Similarity=0.340  Sum_probs=195.7

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      +|+..+.||.|++|.||+|+.. ++..||+|.....    ....+.+|+++++.++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999965 6889999975432    2456778999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++ +|.+++....  ....+++..+..++.|++.||.|||+  .+++||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~-~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-  154 (284)
T cd07836          81 DK-DLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-  154 (284)
T ss_pred             Cc-cHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence            86 7777764321  23468999999999999999999998  679999999999999999999999999987653321 


Q ss_pred             CCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh-cccc-hhhhcc-
Q 016917          233 AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-DFSN-LLKILD-  308 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~-  308 (380)
                       .......++..|++||.+.+ ..++.++|+|||||++|+|++|+.||......+.  ......... .... .....+ 
T Consensus       155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIFRIMGTPTESTWPGISQL  231 (284)
T ss_pred             -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhHHHHhcC
Confidence             11223346778999998765 4578999999999999999999999976543211  111110000 0000 000000 


Q ss_pred             cc-----------cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ER-----------LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~-----------~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      +.           ......+..++.+.+++.+||+.||.+||++.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00           0011112345778999999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.3e-38  Score=289.02  Aligned_cols=255  Identities=20%  Similarity=0.254  Sum_probs=189.9

Q ss_pred             CCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC----ChHHHHHHHHHHhcCC-CCceeeeccceecC--CeeEEEEE
Q 016917           79 FSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQ-HRNLVTLLGYCQEN--NLQFLIYE  150 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  150 (380)
                      |++.+.||+|+||.||+|.. .++..+|+|.....    ......+|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            56778999999999999995 46889999975432    1223457888898885 99999999999877  88999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++ ++.+.+..    ....+++..+..++.|++.||.|||+  ++++||||+|+||+++. +.+||+|||++......
T Consensus        81 ~~~~-~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMDM-NLYELIKG----RKRPLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCCc-cHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            9975 77666632    23568899999999999999999999  77999999999999999 99999999999876432


Q ss_pred             CCCCCCccccCccceecccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc--ccchhhhc
Q 016917          231 DVAGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD--FSNLLKIL  307 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  307 (380)
                      .   ......++..|+|||.+. +..++.++|||||||++|||++|..||...+..+   ..........  ........
T Consensus       153 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07831         153 P---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKF  226 (282)
T ss_pred             C---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhh
Confidence            2   112345778899999764 4567889999999999999999999997654321   1111111000  00000000


Q ss_pred             c---------ccc----ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          308 D---------ERL----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       308 ~---------~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .         +..    ........+.++.+++.+||+.||++||++++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0         000    001112456889999999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-39  Score=304.20  Aligned_cols=270  Identities=23%  Similarity=0.353  Sum_probs=207.4

Q ss_pred             CCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCC----CChHHHHHHHHHHhcCCCCceeeeccceecCC------eeEE
Q 016917           79 FSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENN------LQFL  147 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l  147 (380)
                      +...+.||+|+||.||+++ ..+|+.||||....    ...+.+.+|+++|++++|+|||++++.-.+..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            3445789999999999999 56799999997543    45677889999999999999999999865443      4589


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC--CCC--ceEEccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--EDF--IAKVADAGL  223 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~--~~~--~~kl~DFgl  223 (380)
                      |||||.+|+|...|..+  .+...+++...+.+..+++.||.|||+  ++|+||||||.||++-  .+|  ..||+|||.
T Consensus        95 vmEyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrE--n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRE--NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEeecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHH--cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999655  556789999999999999999999998  7799999999999983  333  579999999


Q ss_pred             ccccCCCCCCCCCccccCccceecccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  302 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (380)
                      |+.+.++.   .-....||+.|.+||... ...|+..+|.|||||++|++.||..||..........-..+.....+...
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            99887644   445678999999999998 48889999999999999999999999987665432211211111111111


Q ss_pred             hhhhcccc------------cccCCCHHHHHHHHHHHhHccCCCCCCCC--CHHHHHHHHHhhhhhh
Q 016917          303 LLKILDER------------LWSTFTNEGMEEFIQLIVRCLDPSSERRP--SMSDVVTELDRTLDKE  355 (380)
Q Consensus       303 ~~~~~~~~------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rp--t~~~ll~~L~~~~~~~  355 (380)
                      ..-...+.            ...+........+-.++..+|..+|++|-  ...+....++.+++..
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence            00000000            01122233445677888889999999999  8888888888777664

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=331.10  Aligned_cols=248  Identities=23%  Similarity=0.361  Sum_probs=202.9

Q ss_pred             CCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCC-----CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +++....||.|.||.||.|. ..+|...|+|...     ....+.+.+|..+|..|+|||+|+++|+-...+..+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            46667889999999999998 5678889998532     22345578899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      |++|+|.+.+.     ..+..++.....+..|++.|+.|||+  .|||||||||+||+++.+|.+|++|||.|..+....
T Consensus      1316 C~~GsLa~ll~-----~gri~dE~vt~vyt~qll~gla~LH~--~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1316 CEGGSLASLLE-----HGRIEDEMVTRVYTKQLLEGLAYLHE--HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             hccCcHHHHHH-----hcchhhhhHHHHHHHHHHHHHHHHHh--cCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            99999999883     33345555566688899999999999  669999999999999999999999999998876532


Q ss_pred             --CCCCCccccCccceecccccccC---CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          232 --VAGPSSQVTADEIFLASEVKEFR---RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       232 --~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                        ..+....+.||+.|||||++.+.   +...+.||||+||+..||+||+.||...+.+              +.-+.++
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--------------~aIMy~V 1454 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--------------WAIMYHV 1454 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--------------hHHHhHH
Confidence              23344578899999999999764   4567899999999999999999999976632              1111111


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      . -.-.+++|...+++-++++..||..||++|.++.|++++
T Consensus      1455 ~-~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 A-AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             h-ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            1 112356788899999999999999999999999988875

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.4e-38  Score=281.02  Aligned_cols=247  Identities=27%  Similarity=0.413  Sum_probs=200.3

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC---ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeec
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      +|+..+.||+|++|.||++... ++..+++|.....   ..+.+.+|++.++.++|+|++++++.+...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4777899999999999999965 6889999986544   34678899999999999999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                      +++|.+++...    ...+++..+..++.|++.|+.+||+  .+++|+||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          81 GGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhc--CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            99999888432    2568999999999999999999999  7799999999999999999999999999887654321 


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  313 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (380)
                        .....++..|++||.+.+..++.++|+||||+++|+|++|+.||......   ........ .   ....       .
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~-~---~~~~-------~  217 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFKIAT-N---GPPG-------L  217 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHHh-c---CCCC-------c
Confidence              23456778899999998888999999999999999999999998754321   11111100 0   0000       0


Q ss_pred             CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       314 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..+..++.++.+++.+||+.||++|||+.+++++
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1111235779999999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.2e-38  Score=284.77  Aligned_cols=247  Identities=23%  Similarity=0.372  Sum_probs=201.9

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC-----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +|++.+.||+|++|.||++.. .++..+++|....     .....+.+|+++++.++|+||+++.+++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477889999999999999984 4678999997543     2234577899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++.... .....+++..++.++.|++.||.|||+  .+++|+||+|+||+++.++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~--~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHE--QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999998874321 123567889999999999999999999  67999999999999999999999999998876543 


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                         ......++..|++||...+..++.++|+||||+++|+|++|+.||...+..   .....             .....
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~-------------~~~~~  217 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYK-------------VQRGK  217 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH-------------HhcCC
Confidence               122345778899999999889999999999999999999999999765421   11111             11112


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....+...+.++.+++.+||+.+|.+||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            223444667889999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.3e-38  Score=292.93  Aligned_cols=265  Identities=18%  Similarity=0.269  Sum_probs=191.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCC------
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN------  143 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  143 (380)
                      .++|++.+.||+|+||.||+|... ++..||+|.....     ....+.+|++++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457889999999999999999954 6889999974321     1234568999999999999999999876543      


Q ss_pred             --eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccc
Q 016917          144 --LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (380)
Q Consensus       144 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DF  221 (380)
                        ..++||||+.+ +|.+.+..    ....+++..++.++.|++.||.|||+  ++++|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHR--NKILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEECCCCcEEECcC
Confidence              45999999975 67666632    23468899999999999999999999  67999999999999999999999999


Q ss_pred             ccccccCCCCCC--CCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh
Q 016917          222 GLRNFLGRTDVA--GPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR  298 (380)
Q Consensus       222 gla~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  298 (380)
                      |++.........  .......++..|+|||.+.+. .++.++||||||+++|||++|..||..............+....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            998766432211  112234567789999987664 47889999999999999999999997654321111111111000


Q ss_pred             ccc---chh--hhcc----c-ccccCC-----CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          299 DFS---NLL--KILD----E-RLWSTF-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       299 ~~~---~~~--~~~~----~-~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..+   ...  ...+    + ......     +...+..+.+++.+||..||.+|||+++++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000   000  0000    0 000000     00123567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=277.42  Aligned_cols=246  Identities=21%  Similarity=0.332  Sum_probs=190.9

Q ss_pred             CCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEee
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      .+.+..||+|+.|.|++++.+ +|...|||......    .+++...+.++... +.|+||+.+|+|..+...++.||.+
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            344567999999999999965 58899999865443    33455666665554 4899999999999999999999988


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      .. .++..+.    ...+.+++..+-++...++.||.||.+. .+|+|||+||+|||+|+.|++||||||++..+.+...
T Consensus       174 s~-C~ekLlk----rik~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  174 ST-CAEKLLK----RIKGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HH-HHHHHHH----HhcCCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEEccCCCEEeecccccceeecccc
Confidence            54 4554442    2345678888888999999999999874 5799999999999999999999999999988765433


Q ss_pred             CCCCccccCccceeccccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          233 AGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      .   ....|-+.|||||.+..   ..|+..+||||||+.|+||.||+.||.....+              ++.+.++++.
T Consensus       248 h---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--------------Fe~ltkvln~  310 (391)
T KOG0983|consen  248 H---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--------------FEVLTKVLNE  310 (391)
T ss_pred             c---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--------------HHHHHHHHhc
Confidence            2   33346667999998764   47899999999999999999999999875432              3333344432


Q ss_pred             cc-ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RL-WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .. ........++.+++++..||++|+.+||.+.+++++
T Consensus       311 ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  311 EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            21 112222367889999999999999999999999986

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-38  Score=298.91  Aligned_cols=252  Identities=22%  Similarity=0.288  Sum_probs=209.6

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      +.....|.+.+.||+|.|+.|.++++ .++..||+|..++..     .+.+.+|+++|+.++|||||+++.+......+|
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            44567799999999999999999995 468999999865443     345789999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +||||+.+|.+.+++.     +.....+.....++.|+.+|++|+|+  +.|||||||++|+|++.+.++||+|||++..
T Consensus       132 lV~eya~~ge~~~yl~-----~~gr~~e~~ar~~F~q~vsaveYcH~--k~ivHrdLk~eNilL~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLV-----KHGRMKEKEARAKFRQIVSAVEYCHS--KNIVHRDLKAENILLDENMNIKIADFGFSTF  204 (596)
T ss_pred             EEEEeccCchhHHHHH-----hcccchhhhhhhhhHHHHHHHHHHhh--cceeccccchhhcccccccceeeecccccee
Confidence            9999999999999994     44555667788899999999999999  7799999999999999999999999999998


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      +..   .......+|++.|.|||+..+..| ++.+|+||+|++||-|+.|..||.+..-.+..               .+
T Consensus       205 ~~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr---------------~r  266 (596)
T KOG0586|consen  205 FDY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR---------------PR  266 (596)
T ss_pred             ecc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------------ch
Confidence            753   334567789999999999999988 57899999999999999999999975532111               11


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                      .+-.+++  .+...+-+..+++.++|..+|.+|++++++-++-...
T Consensus       267 vl~gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n  310 (596)
T KOG0586|consen  267 VLRGKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN  310 (596)
T ss_pred             heeeeec--ccceeechhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence            1222222  2233445688999999999999999999998764433

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.9e-38  Score=296.16  Aligned_cols=261  Identities=23%  Similarity=0.351  Sum_probs=193.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC-----CChHHHHHHHHHHhcC-CCCceeeeccceecC--CeeE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASI-QHRNLVTLLGYCQEN--NLQF  146 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~  146 (380)
                      .++|++.+.||+|+||.||+|... ++..+++|+...     .....+.+|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            457888899999999999999964 578999997532     2234567899999999 999999999988643  4679


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +||||+++ +|..++.      ...+.+..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++..
T Consensus        86 lv~e~~~~-~L~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~--~~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          86 LVFEYMET-DLHAVIR------ANILEDVHKRYIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEeccccc-CHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999975 8877762      1267788888999999999999999  7799999999999999999999999999886


Q ss_pred             cCCCCCC---CCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc---
Q 016917          227 LGRTDVA---GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD---  299 (380)
Q Consensus       227 ~~~~~~~---~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---  299 (380)
                      .......   .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||........  ..........   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~  234 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ--LEKIIEVIGPPSA  234 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCH
Confidence            6432221   12234567889999998754 4678899999999999999999999975432211  0000000000   


Q ss_pred             ----------ccchhhhcc-cc--cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 ----------FSNLLKILD-ER--LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 ----------~~~~~~~~~-~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                                ...+..... ..  .........+.++.+++.+||+.||.+|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                      000000000 00  0001112246789999999999999999999999976

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.7e-38  Score=285.38  Aligned_cols=239  Identities=21%  Similarity=0.283  Sum_probs=186.4

Q ss_pred             eeccCCceEEEEEEE-CCCcEEEEEeCCCCCh------HHHHHHH---HHHhcCCCCceeeeccceecCCeeEEEEEeec
Q 016917           84 LIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT------QEFIDEV---CFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        84 ~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      .||+|+||.||++.. .+++.||+|.......      ..+..|.   ..++...||||+.+.+++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999985 4688999997543211      1233343   34455689999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                      +|+|.+++.     ....+++..+..++.|++.|+.|||+  .+++||||||+||+++.++.++|+|||++.......  
T Consensus        81 g~~L~~~l~-----~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLS-----QHGVFSEAEMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            999988873     34568999999999999999999999  779999999999999999999999999987553321  


Q ss_pred             CCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          234 GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                        .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||..............    .          ....
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~----~----------~~~~  215 (278)
T cd05606         152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----T----------LTMA  215 (278)
T ss_pred             --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH----h----------hccC
Confidence              223468889999999874 4689999999999999999999999986533211111100    0          0011


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                      ...+...+.++.+++.+||..||.+||     ++.+++++
T Consensus       216 ~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            123334567899999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.9e-39  Score=278.35  Aligned_cols=270  Identities=21%  Similarity=0.294  Sum_probs=201.1

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-C--C--CcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceec-CCe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-Q--D--GMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE-NNL  144 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~--~--~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  144 (380)
                      ...|+.++.||+|.+|.||+|.- +  +  ...+|+|++..+     .....-+|+.+++.++|||++.+..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            45689999999999999999962 2  2  237899976544     23457789999999999999999999877 778


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC----CceEEcc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED----FIAKVAD  220 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~----~~~kl~D  220 (380)
                      .+|++||.+. +|...+.-.+....+.++...+.+|+.||+.|+.|||+  +=|+||||||+|||+..+    |.|||+|
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--NWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh--hheeeccCCcceEEEeccCCccCeeEeec
Confidence            9999999988 67777755555555789999999999999999999999  449999999999999877    8999999


Q ss_pred             cccccccCCCCC-CCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcc-------cHH
Q 016917          221 AGLRNFLGRTDV-AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-------DLV  291 (380)
Q Consensus       221 Fgla~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~-------~~~  291 (380)
                      ||+++.+.+.-. .......+.|..|+|||.+.| ..|+.+.||||.|||+.||+|-.+.|.+.......       ++.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            999998865422 223455677889999999876 57899999999999999999999888765432211       111


Q ss_pred             HHHHh-----hhcccchhhhccc---------ccccCC--------CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          292 ELVQN-----SRDFSNLLKILDE---------RLWSTF--------TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       292 ~~~~~-----~~~~~~~~~~~~~---------~~~~~~--------~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      ....-     ..+++.+.+..+-         ..+...        ...-++...+|+.++|++||.+|.|+++++++.
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            11100     0011111111111         001000        001124478999999999999999999999763

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.2e-38  Score=282.31  Aligned_cols=249  Identities=22%  Similarity=0.363  Sum_probs=202.5

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +|++.+.||+|+||.||++... ++..+++|.....     ....+.+|+++++.++|||++++.+.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999954 6889999975432     345688899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++..... ....+++..+..++.+++.||.|||+  .+++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999988854321 23678999999999999999999999  679999999999999999999999999987764432


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                        .......++..|+|||...+..++.++|+||+|+++|+|++|+.||......   ......   .          ...
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~---~----------~~~  219 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELALKI---L----------KGQ  219 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHHHH---h----------cCC
Confidence              1223346788899999998888999999999999999999999998754321   111111   0          011


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....+...+.++.+++.+||..||.+|||+.+++++
T Consensus       220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            122333556789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.2e-38  Score=289.70  Aligned_cols=262  Identities=23%  Similarity=0.303  Sum_probs=193.7

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCC----
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN----  143 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  143 (380)
                      ...++|++.+.||+|+||.||+|..+ ++..|++|.....     ....+.+|+++++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34567899999999999999999965 5889999975422     2245678999999999999999999887654    


Q ss_pred             ------eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceE
Q 016917          144 ------LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  217 (380)
Q Consensus       144 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~k  217 (380)
                            ..++|+||+++ ++...+..    ....+++..+..++.|++.||.|||+  .+|+|+||||+||++++++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHK--KNFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCcEE
Confidence                  78999999986 56555532    23468899999999999999999999  6799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh
Q 016917          218 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  296 (380)
Q Consensus       218 l~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  296 (380)
                      |+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|++||......   .....+..
T Consensus       157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~  232 (302)
T cd07864         157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISR  232 (302)
T ss_pred             eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHH
Confidence            999999887644221 11222345677999998764 45788999999999999999999999754321   11111111


Q ss_pred             hhcc------cchhhh-----cc------cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          297 SRDF------SNLLKI-----LD------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       297 ~~~~------~~~~~~-----~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....      ..+...     .+      .... ......+..+.+++.+||+.||.+||++++++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HhCCCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1000      000000     00      0000 0111235779999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-38  Score=281.04  Aligned_cols=245  Identities=27%  Similarity=0.439  Sum_probs=200.2

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +|++.+.||+|++|.||++... ++..+++|......     .+.+.+|++++++++|||++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999854 67899999754332     35688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++.     ....+++..+..++.|++.|+.|||+  .+|+||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIK-----KFGPFPESLVAVYVYQVLQGLAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHH-----hccCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            99999998883     33568899999999999999999998  779999999999999999999999999998765432


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                      ..  .....++..|+|||...+..++.++|+||+|+++|+|++|..||......  .....    ..          ...
T Consensus       154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--~~~~~----~~----------~~~  215 (254)
T cd06627         154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--AALFR----IV----------QDD  215 (254)
T ss_pred             cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--HHHHH----Hh----------ccC
Confidence            21  23446788899999998888899999999999999999999998754310  00100    00          011


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....+...++.+.+++.+||..+|++|||+.+++.+
T Consensus       216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            123344456789999999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-38  Score=287.81  Aligned_cols=258  Identities=22%  Similarity=0.324  Sum_probs=196.4

Q ss_pred             CCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           79 FSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      |+..+.||+|++|.||+|.. .++..+++|......     ...+..|+++++.++|+||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            56778999999999999995 468899999754332     346788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++ ++.+++..    ....+++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||.+....... 
T Consensus        81 ~~-~l~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 DT-DLYKLIKD----RQRGLPESLIKSYLYQLLQGLAFCHS--HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             CC-CHHHHHHh----hcccCCHHHHHHHHHHHHHHHHHHHH--CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            76 77777632    23568899999999999999999999  679999999999999999999999999987765432 


Q ss_pred             CCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh-----cccchhh-
Q 016917          233 AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-----DFSNLLK-  305 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~-  305 (380)
                       .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+  ..........     ....... 
T Consensus       153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCchHhcccchhh
Confidence             112234577789999998776 78999999999999999999999987654211  1111000000     0000000 


Q ss_pred             -------hccc--ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          306 -------ILDE--RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       306 -------~~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                             ....  ........+.+.++.+++.+||+.||.+||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                   0000  00011223467889999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.7e-38  Score=288.47  Aligned_cols=261  Identities=21%  Similarity=0.277  Sum_probs=192.2

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ++|++.+.||+|++|.||+|..+ +++.|++|.....     ..+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999954 6889999975432     23567889999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEcccccccccCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGR  229 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~-~~~~kl~DFgla~~~~~  229 (380)
                      |+++ +|.+++...   ....+++..+..++.|++.||.|||+  ++++|+||+|+||+++. ++.+||+|||++.....
T Consensus        82 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLDL-DLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             cccc-cHHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            9965 676666321   22335778888999999999999999  77999999999999985 56799999999876533


Q ss_pred             CCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh-cccch----
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-DFSNL----  303 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~----  303 (380)
                      ..  .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||......  ........... .....    
T Consensus       156 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        156 PV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI--DELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             Cc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChhhcccc
Confidence            21  11123356778999998865 45789999999999999999999999764321  11111111000 00000    


Q ss_pred             ---hhhc--cccccc----CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 ---LKIL--DERLWS----TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ---~~~~--~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         ....  .+....    ......++++.+++.+||+.||++||++.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0000  000000    0112345678999999999999999999999874

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1e-37  Score=291.39  Aligned_cols=258  Identities=22%  Similarity=0.290  Sum_probs=190.5

Q ss_pred             CeeccC--CceEEEEEEE-CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEG--KFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G--~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      ..||+|  +||+||++.. .+++.||+|......     .+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  9999999995 478999999854322     24577899999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC-
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA-  233 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~-  233 (380)
                      +++.+++...   ....+++..+..++.|++.||.|||+  ++++||||||+|||++.++.++++||+.+......... 
T Consensus        84 ~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTY---FPEGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            9999887432   12457888899999999999999998  77999999999999999999999999865433221110 


Q ss_pred             ----CCCccccCccceecccccccC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc--------
Q 016917          234 ----GPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD--------  299 (380)
Q Consensus       234 ----~~~~~~~~~~~~~aPE~~~~~--~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------  299 (380)
                          .......++..|+|||++.+.  .++.++|||||||++|||++|+.||......  ............        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCcccccc
Confidence                111122345669999998763  5789999999999999999999999765321  111110000000        


Q ss_pred             -------------c-----------cchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 -------------F-----------SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 -------------~-----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                                   .           .......+.......+..+++.+.+++.+||+.||++|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                         0           00000111112222334577889999999999999999999999966

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-38  Score=286.64  Aligned_cols=258  Identities=23%  Similarity=0.325  Sum_probs=194.1

Q ss_pred             CCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecC--CeeEEEEE
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFLIYE  150 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  150 (380)
                      |++.+.||+|++|.||+|... ++..+++|.....     ....+.+|+++++.++|||++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999965 5789999986543     234678899999999999999999999887  88999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++ +|..++..    ....+++..++.++.|++.||+|||+  .+++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~--~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDS----PEVKFTESQIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9975 77777632    22468899999999999999999999  67999999999999999999999999998876543


Q ss_pred             CCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc------ccch
Q 016917          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD------FSNL  303 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~  303 (380)
                      .. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......   ....+.....      ....
T Consensus       154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGV  229 (287)
T ss_pred             Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhcccc
Confidence            21 11223345677999997765 467899999999999999999999997654321   1111111000      0000


Q ss_pred             hhh-----------cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 LKI-----------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ~~~-----------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...           ........+...++..+.+++.+||+.||.+||++++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            000           00000001111136789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.8e-38  Score=287.10  Aligned_cols=260  Identities=21%  Similarity=0.263  Sum_probs=199.8

Q ss_pred             CCCCCCeeccCCceEEEEEEE----CCCcEEEEEeCCCC-------ChHHHHHHHHHHhcC-CCCceeeeccceecCCee
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  145 (380)
                      +|++.+.||+|++|.||++..    .++..||+|.....       ..+.+..|++++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            367788999999999999984    25678999975422       234577899999999 599999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.++|+|||+++
T Consensus        81 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~lH~--~~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLY-----QREHFTESEVRVYIAEIVLALDHLHQ--LGIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHh-----hcCCcCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            99999999999998883     23457888999999999999999998  779999999999999999999999999987


Q ss_pred             ccCCCCCCCCCccccCccceecccccccCC--CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      ....... .......++..|+|||...+..  ++.++|+||||+++|||++|..||.......  ...+.......    
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~----  226 (288)
T cd05583         154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILK----  226 (288)
T ss_pred             ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHc----
Confidence            6543221 1122345788899999987654  7889999999999999999999986432211  11111111000    


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhccc
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL  358 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~~  358 (380)
                           .  ....+...+..+.+++.+||+.||++|||+.++.+.|.--.-+...+
T Consensus       227 -----~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         227 -----S--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             -----c--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence                 0  11233345577899999999999999999988877665544344334

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-38  Score=283.06  Aligned_cols=238  Identities=20%  Similarity=0.231  Sum_probs=184.8

Q ss_pred             CeeccCCceEEEEEEE-CCCcEEEEEeCCCCCh------HHHHHHHHHH-hcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT------QEFIDEVCFL-ASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|+||.||+|.. .+++.||+|.......      ..+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5699999999999995 4688999998654321      1234454443 455899999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      ++|.+++.     ....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.....     
T Consensus        82 ~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIK-----TLGGLPEDWAKQYIAEVVLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            99999883     33467889999999999999999999  6799999999999999999999999999875432     


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                       .....++..|+|||...+..++.++||||||+++|+|++|..||.....   ...........          ......
T Consensus       150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~----------~~~~~~  215 (260)
T cd05611         150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNILSRR----------INWPEE  215 (260)
T ss_pred             -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcc----------cCCCCc
Confidence             2234567789999999888899999999999999999999999975432   11111111000          000111


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT  346 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~  346 (380)
                      ....+++++.+++.+||+.||++||++.++.+
T Consensus       216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             ccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence            22245678999999999999999997754444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6.1e-38  Score=293.72  Aligned_cols=260  Identities=20%  Similarity=0.265  Sum_probs=192.4

Q ss_pred             CCCC-CCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCCh-----------------HHHHHHHHHHhcCCCCceeeecc
Q 016917           77 KNFS-DKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT-----------------QEFIDEVCFLASIQHRNLVTLLG  137 (380)
Q Consensus        77 ~~~~-~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----------------~~~~~E~~~l~~l~h~niv~l~~  137 (380)
                      ++|. +.+.||+|+||.||+|.. .+++.||+|.......                 ..+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 457799999999999995 4688999997543211                 13678999999999999999999


Q ss_pred             ceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceE
Q 016917          138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  217 (380)
Q Consensus       138 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~k  217 (380)
                      ++...+..++||||+. |+|.+++.     ....+++.....++.|++.||.|||+  .+++|+||+|+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~-----~~~~~~~~~~~~~~~ql~~aL~~LH~--~~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVD-----RKIRLTESQVKCILLQILNGLNVLHK--WYFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHeEECCCCCEE
Confidence            9999999999999997 48887773     34568899999999999999999999  7799999999999999999999


Q ss_pred             EcccccccccCCCCC------------CCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 016917          218 VADAGLRNFLGRTDV------------AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSP  284 (380)
Q Consensus       218 l~DFgla~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~  284 (380)
                      |+|||++........            ........++..|+|||.+.+. .++.++|+|||||++|||++|+.||...+.
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999876542110            0111223457789999998764 468999999999999999999999986543


Q ss_pred             CCcccHHHHHHhhhc------ccchhhhc--c------cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          285 DSSQDLVELVQNSRD------FSNLLKIL--D------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       285 ~~~~~~~~~~~~~~~------~~~~~~~~--~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .+   ....+.....      +.......  .      +..........++++.+++.+||+.||++|||+++++.+
T Consensus       240 ~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        240 ID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            21   1111111000      00000000  0      000001112335778999999999999999999999974

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.3e-38  Score=286.68  Aligned_cols=247  Identities=20%  Similarity=0.272  Sum_probs=200.7

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcCC-CCceeeeccceecCCeeEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  148 (380)
                      ++|.+.+.||+|+||.||+|... ++..+++|.....      ....+..|.+++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888899999999999999954 6899999975431      2345778999999998 99999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIR-----KYGSLDEKCTRFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            99999999999883     33478999999999999999999999  679999999999999999999999999987664


Q ss_pred             CCCCC------------------CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccH
Q 016917          229 RTDVA------------------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL  290 (380)
Q Consensus       229 ~~~~~------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~  290 (380)
                      .....                  .......++..|+|||...+..++.++|+||||+++|++++|..||......   ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~  230 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LT  230 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HH
Confidence            42211                  1223345778899999988888999999999999999999999999865411   11


Q ss_pred             HHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCH----HHHHHH
Q 016917          291 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM----SDVVTE  347 (380)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~----~~ll~~  347 (380)
                      .   ....           .....++...++.+.+++.+||+.||.+||++    ++++++
T Consensus       231 ~---~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         231 F---QKIL-----------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             H---HHHH-----------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            1   1000           01123344456789999999999999999999    777654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.1e-37  Score=286.06  Aligned_cols=249  Identities=22%  Similarity=0.282  Sum_probs=194.4

Q ss_pred             CCCCCCeeccCCceEEEEEEE----CCCcEEEEEeCCCC-------ChHHHHHHHHHHhcC-CCCceeeeccceecCCee
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  145 (380)
                      +|++.+.||+|+||.||++..    .+|..||+|.....       ..+.+.+|+.+++.+ +|+||+++++.+..++..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999985    36889999975432       235577899999999 589999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++|+||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+++||||+|+|||++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLS-----QRERFKEQEVQIYSGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            99999999999999883     33457888889999999999999999  779999999999999999999999999987


Q ss_pred             ccCCCCCCCCCccccCccceecccccccC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      ....... .......++..|+|||.+.+.  .++.++||||||+++|+|++|..||......  ....+.......    
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~----  226 (290)
T cd05613         154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILK----  226 (290)
T ss_pred             ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhc----
Confidence            6543221 122334578889999998653  4678999999999999999999998743221  111111111100    


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                             ....++...++.+.+++.+||+.||.+||     ++.+++.+
T Consensus       227 -------~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         227 -------SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             -------cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                   01123444567899999999999999997     66776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.2e-37  Score=287.24  Aligned_cols=241  Identities=27%  Similarity=0.373  Sum_probs=189.1

Q ss_pred             CCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           79 FSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      |...+.||+|+||.||+|.. .++..|++|......      ...+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            55567899999999999995 468899999754221      23577899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +.+ ++.+++..    ....+++..+..++.|++.|+.|||+  ++++|+||+|+||+++.++.++|+|||++.....  
T Consensus       103 ~~~-~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         103 CLG-SASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             CCC-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            965 66666632    23457889999999999999999999  7799999999999999999999999998764322  


Q ss_pred             CCCCCccccCccceecccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          232 VAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                          .....++..|+|||.+.   +..++.++|||||||++|+|++|..||......   .......   .         
T Consensus       174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---~~~~~~~---~---------  234 (313)
T cd06633         174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIA---Q---------  234 (313)
T ss_pred             ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHH---h---------
Confidence                22345778899999974   456889999999999999999999998764321   1111000   0         


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...........+..+.+++.+||+.+|.+||++.+++.+
T Consensus       235 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         235 NDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000011122344678999999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6e-38  Score=293.11  Aligned_cols=259  Identities=21%  Similarity=0.310  Sum_probs=198.4

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCC-----eeE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----LQF  146 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  146 (380)
                      +|++.+.||+|++|.||+|... ++..+++|.....     ..+.+.+|+++++.++||||+++.+++...+     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999964 5889999975432     3456889999999999999999999988765     789


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +||||+.+ +|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.++|+|||++..
T Consensus        81 lv~e~~~~-~l~~~l~-----~~~~l~~~~~~~i~~~l~~~l~~LH~--~gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELMET-DLHKVIK-----SPQPLTDDHIQYFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchhh-hHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99999985 7877773     23478899999999999999999999  6799999999999999999999999999887


Q ss_pred             cCCCCC-CCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc-----
Q 016917          227 LGRTDV-AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-----  299 (380)
Q Consensus       227 ~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----  299 (380)
                      ...... ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+.   ...+.....     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~  229 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEE  229 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChh
Confidence            654321 0122344578889999999887 889999999999999999999999976653211   111110000     


Q ss_pred             ------ccchhhhcc---c---ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 ------FSNLLKILD---E---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 ------~~~~~~~~~---~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                            .......+.   .   ..........+.++.+++.+||+.||.+|||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                  000000000   0   00011122346779999999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7.8e-38  Score=282.42  Aligned_cols=240  Identities=23%  Similarity=0.320  Sum_probs=190.9

Q ss_pred             eccCCceEEEEEEEC-CCcEEEEEeCCCCC------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCc
Q 016917           85 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        85 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  157 (380)
                      ||+|+||.||++... +++.+++|......      ...+.+|++++++++||||+++++.+...+..|+++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 48999999865432      34678899999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC-----
Q 016917          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-----  232 (380)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~-----  232 (380)
                      .+++.     ....+++..+..++.|++.||.|||+  ++++|+||+|+||++++++.++|+|||++........     
T Consensus        81 ~~~l~-----~~~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLE-----NVGSLDEDVARIYIAEIVLALEYLHS--NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            98883     23468899999999999999999999  7799999999999999999999999999876433211     


Q ss_pred             -CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          233 -AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       233 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                       ........++..|++||......++.++|+||||+++|++++|..||......   ........            .. 
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~------------~~-  217 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQNILN------------GK-  217 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhc------------CC-
Confidence             11223445777899999998888999999999999999999999999754421   11111100            00 


Q ss_pred             ccCCCHH--HHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          312 WSTFTNE--GMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       312 ~~~~~~~--~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                       ...+..  .+..+.+++.+||+.+|.+|||+..+.+.|
T Consensus       218 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         218 -IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             -cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence             011222  267899999999999999999995554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8.4e-38  Score=287.13  Aligned_cols=241  Identities=19%  Similarity=0.336  Sum_probs=192.7

Q ss_pred             CeeccCCceEEEEEEE-CCCcEEEEEeCCCC---ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCcc
Q 016917           83 NLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS  158 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  158 (380)
                      .+||+|+||.||++.. .++..||+|.....   ....+.+|+.+++.++|+||+++++.+..++..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            5799999999999986 56889999975432   2345788999999999999999999999999999999999999998


Q ss_pred             ccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCcc
Q 016917          159 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ  238 (380)
Q Consensus       159 ~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~  238 (380)
                      +++.      ...+++..+..++.|++.|++|||+  .+++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus       106 ~~~~------~~~~~~~~~~~~~~ql~~~l~~lH~--~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~  175 (292)
T cd06657         106 DIVT------HTRMNEEQIAAVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS  175 (292)
T ss_pred             HHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence            8762      2357888999999999999999999  679999999999999999999999999887653321  11233


Q ss_pred             ccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHH
Q 016917          239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNE  318 (380)
Q Consensus       239 ~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (380)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||......   ..........         ...  ......
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~~---------~~~--~~~~~~  241 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNL---------PPK--LKNLHK  241 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhC---------Ccc--cCCccc
Confidence            56788899999998888999999999999999999999998754321   1111111000         000  011123


Q ss_pred             HHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          319 GMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       319 ~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .+..+.+++.+||+.||.+||++.+++++
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            45678999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.4e-38  Score=294.23  Aligned_cols=263  Identities=21%  Similarity=0.308  Sum_probs=195.6

Q ss_pred             HHHHHHHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecC
Q 016917           69 MEELSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN  142 (380)
Q Consensus        69 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~  142 (380)
                      ..++....++|++.+.||+|+||.||+|.. .++..||+|+.....     .+.+.+|++++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            455566778899999999999999999984 578899999865321     34577899999999999999999987543


Q ss_pred             ------CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCce
Q 016917          143 ------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  216 (380)
Q Consensus       143 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~  216 (380)
                            ...+++++++ +++|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+||++++++.+
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEcCCCCE
Confidence                  3467888876 678877662      2457899999999999999999999  679999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH
Q 016917          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  295 (380)
Q Consensus       217 kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~  295 (380)
                      +|+|||++......     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......  .......
T Consensus       160 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~  232 (345)
T cd07877         160 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILR  232 (345)
T ss_pred             EEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence            99999998764321     233467788999998766 568899999999999999999999996543211  1111100


Q ss_pred             hh-hcccchhh-h-----------cccccc---cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          296 NS-RDFSNLLK-I-----------LDERLW---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       296 ~~-~~~~~~~~-~-----------~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .. ........ +           +.....   .......++++.+++.+||+.||.+||++.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            00 00000000 0           000000   00011235678999999999999999999999976

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.4e-37  Score=286.25  Aligned_cols=247  Identities=27%  Similarity=0.369  Sum_probs=192.4

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      .|+..+.||+|+||.||+|... ++..+++|.....      ....+.+|+++++.++|+|++++.+++...+..++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3666788999999999999954 5788999974321      12357789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+. |++.+.+..    ....+++..+..++.|++.|+.|||+  ++++||||+|+||+++.++.++|+|||++..... 
T Consensus        96 ~~~-~~l~~~~~~----~~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-  167 (308)
T cd06634          96 YCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (308)
T ss_pred             ccC-CCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence            997 477666532    23457888999999999999999998  7799999999999999999999999999876533 


Q ss_pred             CCCCCCccccCccceecccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          231 DVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                           .....++..|+|||.+.   ...++.++|||||||++|+|++|..||.......  ......             
T Consensus       168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~-------------  227 (308)
T cd06634         168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIA-------------  227 (308)
T ss_pred             -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--HHHHHh-------------
Confidence                 22345777899999874   3567889999999999999999999986542110  000000             


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                      ........+...+..+.+++.+||+.+|++||++.+++++.....
T Consensus       228 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             hcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence            000011112345577999999999999999999999998754443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.1e-37  Score=284.99  Aligned_cols=250  Identities=20%  Similarity=0.324  Sum_probs=190.7

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECC-CcEEEEEeCCCC----ChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  148 (380)
                      ..++|++.+.||+|+||.||+|..+. ++.||+|.....    ....+..|+.++.+. .||||+++++++......++|
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            44678889999999999999999764 889999986432    233456677766666 599999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+.+ ++.+.+..    ....+++..+..++.|++.|+.|||+. .+|+||||+|+||++++++.++|+|||++..+.
T Consensus        93 ~e~~~~-~l~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          93 MELMST-CLDKLLKR----IQGPIPEDILGKMTVAIVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eeccCc-CHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhh-CCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            999854 66555522    234688899999999999999999962 479999999999999999999999999987654


Q ss_pred             CCCCCCCCccccCccceecccccccCC----CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRR----FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ....   .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......     .+...         
T Consensus       167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~---------  229 (296)
T cd06618         167 DSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLT---------  229 (296)
T ss_pred             CCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHH---------
Confidence            3221   12234677899999987554    788999999999999999999998653211     11111         


Q ss_pred             hhccccc-ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          305 KILDERL-WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....... .......+++++.+++.+||+.||.+||++++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         230 KILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1111100 001111345779999999999999999999999976

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=271.31  Aligned_cols=250  Identities=18%  Similarity=0.237  Sum_probs=195.4

Q ss_pred             hCCCCCC-CeeccCCceEEEEEEE-CCCcEEEEEeCCCCChHHHHHHHHHHhcC-CCCceeeeccceec----CCeeEEE
Q 016917           76 TKNFSDK-NLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQE----NNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~-~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv  148 (380)
                      +++|++. ++||-|-.|.|..+.+ ++++++|+|.+...  +..++|+++--.. .|||||.+++++.+    ...+.+|
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV  137 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV  137 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence            4456654 6899999999999985 57899999986433  3456788764444 69999999999864    3466789


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCceEEccccccc
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRN  225 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~---~~~~~kl~DFgla~  225 (380)
                      ||.++||.|...+..   ...+.+.+..+-.|+.||+.|+.|||+++  |.||||||+|+|..   .|..+||+|||+|+
T Consensus       138 mE~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK  212 (400)
T KOG0604|consen  138 MECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAK  212 (400)
T ss_pred             eecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEeccccccc
Confidence            999999999988843   24566899999999999999999999955  99999999999995   45689999999999


Q ss_pred             ccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ....   .......+-|++|.|||++....|+..+|+||+||++|-|++|.+||-.......   ..        +.-.+
T Consensus       213 ~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---sp--------gMk~r  278 (400)
T KOG0604|consen  213 ETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SP--------GMKRR  278 (400)
T ss_pred             ccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---Ch--------hHHhH
Confidence            7543   2334556789999999999999999999999999999999999999976543111   00        00011


Q ss_pred             hcccccccCCCH----HHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          306 ILDERLWSTFTN----EGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       306 ~~~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      +.....  .||.    .+++..+++|+.+|+.+|.+|.|+.++..+-
T Consensus       279 I~~gqy--~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp  323 (400)
T KOG0604|consen  279 IRTGQY--EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP  323 (400)
T ss_pred             hhccCc--cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence            111111  2332    4678899999999999999999999998763

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.3e-37  Score=286.01  Aligned_cols=257  Identities=19%  Similarity=0.217  Sum_probs=188.4

Q ss_pred             CeeccCCceEEEEEEECCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCc
Q 016917           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  157 (380)
                      +.+|.|+++.|+++.. ++..||+|+....     ..+.+.+|+++++.++|+||+++++++...+..+++|||+++|+|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3445555555555544 6889999975432     335688999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC-----
Q 016917          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-----  232 (380)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~-----  232 (380)
                      .+++...   ....+++.....++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||.+........     
T Consensus        87 ~~~l~~~---~~~~~~~~~~~~~~~~l~~~L~~LH~--~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          87 EDLLKTH---FPEGLPELAIAFILKDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            9888432   23457888899999999999999999  6799999999999999999999999998865532211     


Q ss_pred             CCCCccccCccceeccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc-------c---
Q 016917          233 AGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-------F---  300 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------~---  300 (380)
                      ........++..|+|||.+..  ..|+.++|+|||||++|||++|+.||......  ....+.......       .   
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhhh
Confidence            111233456778999999865  46889999999999999999999999864321  111111110000       0   


Q ss_pred             -cchh--------hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 -SNLL--------KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 -~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       ....        ...............+.++.+++.+||+.||.+|||+++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence             0000        0000001112233456789999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.4e-37  Score=290.24  Aligned_cols=260  Identities=20%  Similarity=0.275  Sum_probs=193.4

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC-----CChHHHHHHHHHHhcCCCCceeeeccceec-CCeeE
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQF  146 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~  146 (380)
                      ...++|++.+.||.|+||.||+|.. .++..||+|....     .....+..|+++++.++||||+++.+++.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            3567899999999999999999984 4788999997432     234567889999999999999999998865 56789


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +++||+. ++|..++.      ...+++.....++.|++.||.|||+  ++|+||||+|+||++++++.++|+|||++..
T Consensus        87 lv~e~~~-~~L~~~~~------~~~~~~~~~~~~~~ql~~aL~~LH~--~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          87 FVTELLG-TDLHRLLT------SRPLEKQFIQYFLYQILRGLKYVHS--AGVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEeehhc-cCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            9999984 57877762      3456788888999999999999999  6799999999999999999999999999875


Q ss_pred             cCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH-H-------hh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV-Q-------NS  297 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~-~-------~~  297 (380)
                      ....     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||............... .       ..
T Consensus       158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            4321     123456778999998765 57899999999999999999999999765421111000000 0       00


Q ss_pred             hcccchhhhc-ccccccCCC-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          298 RDFSNLLKIL-DERLWSTFT-----NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       298 ~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .......+.. .-......+     ...++.+.+++.+||+.||++|||+++++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000000 000000111     1245789999999999999999999999865

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.9e-37  Score=278.57  Aligned_cols=248  Identities=18%  Similarity=0.274  Sum_probs=192.8

Q ss_pred             CCCCCCeeccCCceEEEEEEECC-CcEEEEEeCC--------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRP--------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      +|.+.+.||+|+||.||++.... +..+++|...        ......+..|..+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999998543 3344444322        12233466789999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      +||+++++|.+++.... .....+++..++.++.|++.|+.|||+  .+++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMHQ--RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHH--cCccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999988774321 234568899999999999999999999  77999999999999975 569999999987654


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ....  ......++..|+|||...+..++.++|+||||+++|+|++|..||....      .........          
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~----------  218 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIV----------  218 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHH----------
Confidence            3221  1223456778999999988889999999999999999999999986432      111111110          


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .......+..++.++.+++.+||+.||++||++.+++++
T Consensus       219 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         219 EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            111123345667889999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=281.32  Aligned_cols=258  Identities=24%  Similarity=0.329  Sum_probs=191.4

Q ss_pred             CCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcC---CCCceeeeccceecCCe-----
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASI---QHRNLVTLLGYCQENNL-----  144 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  144 (380)
                      |++.+.||+|+||.||+|..+ ++..+|+|.....     ....+.+|+.+++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999976 4889999975422     123456787777655   69999999999987776     


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .+++|||+.+ +|.+++...   ....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~--~~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHS--HRIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhccc-CHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence            8999999975 787777422   22358899999999999999999999  67999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc-----
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-----  299 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----  299 (380)
                      .......   ......++..|+|||.+.+..++.++|+|||||++|||++|.+||......+  ...........     
T Consensus       155 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  229 (287)
T cd07838         155 RIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEE  229 (287)
T ss_pred             eeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHh
Confidence            7764321   1223346778999999998999999999999999999999999987543211  11111110000     


Q ss_pred             ccch----hhhccccc---ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 FSNL----LKILDERL---WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 ~~~~----~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....    ........   ........++.+.+++.+||+.||.+||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            0000    00000000   011122455778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.3e-37  Score=290.65  Aligned_cols=260  Identities=18%  Similarity=0.285  Sum_probs=189.6

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC---ChHHHHHHHHHHhcCCCCceeeeccceecC----------
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQEN----------  142 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----------  142 (380)
                      ++|++.+.||.|+||.||+|.. .++..|++|.....   ..+.+.+|+++++.++||||+++++.+...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            6788999999999999999995 46889999975432   345678899999999999999999876543          


Q ss_pred             ----CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCceE
Q 016917          143 ----NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAK  217 (380)
Q Consensus       143 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~-~~~~~k  217 (380)
                          ...++|+||+++ +|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+||+++ .++.++
T Consensus        85 ~~~~~~~~lv~e~~~~-~L~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~--~givH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          85 LTELNSVYIVQEYMET-DLANVLE------QGPLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccceEEEEeecccc-cHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCceEE
Confidence                357899999974 7777662      3457899999999999999999999  6799999999999997 456789


Q ss_pred             EcccccccccCCCCCC-CCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH
Q 016917          218 VADAGLRNFLGRTDVA-GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  295 (380)
Q Consensus       218 l~DFgla~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~  295 (380)
                      |+|||++......... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||....+..  .......
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~~~~~~~  233 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE--QMQLILE  233 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence            9999998765432111 11123356778999997643 568899999999999999999999997554211  0110000


Q ss_pred             hhh-----cccchh----hhcc-cccc-----cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          296 NSR-----DFSNLL----KILD-ERLW-----STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       296 ~~~-----~~~~~~----~~~~-~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...     ......    .... ....     .......+.++.+++.+||+.||++|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            000     000000    0000 0000     00112344678999999999999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.1e-37  Score=286.67  Aligned_cols=265  Identities=22%  Similarity=0.310  Sum_probs=190.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecC-------
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN-------  142 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  142 (380)
                      .++|++.+.||+|+||.||+|..+ ++..+++|.....     ....+.+|+++++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999954 6889999964321     223567899999999999999999987543       


Q ss_pred             -CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccc
Q 016917          143 -NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (380)
Q Consensus       143 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DF  221 (380)
                       ...++|+||+.+ ++...+..    ....+++..+..++.|++.||.|||+  .+|+|+||||+||++++++.++|+||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~--~~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHE--NHILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECcC
Confidence             346999999876 55555522    23468999999999999999999999  67999999999999999999999999


Q ss_pred             ccccccCCCCCCC---------CCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHH
Q 016917          222 GLRNFLGRTDVAG---------PSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV  291 (380)
Q Consensus       222 gla~~~~~~~~~~---------~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~  291 (380)
                      |++..........         ......++..|+|||.+.+ ..++.++|||||||++|||++|++||............
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9987654322111         1123356778999998765 45799999999999999999999999754432111111


Q ss_pred             HHHHhhhc------ccchhhhcccccccCCC-------HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          292 ELVQNSRD------FSNLLKILDERLWSTFT-------NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       292 ~~~~~~~~------~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ........      ...+....+.......+       ....+.+.+++.+||+.||.+|||+.+++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            00000000      00000000000000000       1123668899999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-37  Score=280.40  Aligned_cols=260  Identities=25%  Similarity=0.342  Sum_probs=191.6

Q ss_pred             CCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC----hHHHHHHHHHHhcCC-CCceeeeccceecCCeeEEEEEee
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      |++.+.||+|++|.||+|... +++.|++|......    .....+|+..+++++ ||||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567789999999999999965 57889999754332    223456899999998 999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                       +|+|.+.+...   ....+++..+..++.|++.+|.|||+  ++++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 -~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-  153 (283)
T cd07830          81 -EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHK--HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-  153 (283)
T ss_pred             -CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence             77888777432   12467899999999999999999999  779999999999999999999999999987654322 


Q ss_pred             CCCCccccCccceecccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCccc-HHHHHHhhhc--c---cchhh
Q 016917          233 AGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD-LVELVQNSRD--F---SNLLK  305 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~--~---~~~~~  305 (380)
                        ......++..|+|||.+. +..++.++|+||||+++|||++|+.||......+... ..........  .   .....
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence              122345778899999874 4567899999999999999999999987553211100 0000000000  0   00000


Q ss_pred             hcccccc-------cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          306 ILDERLW-------STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       306 ~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..+....       .......+..+.+++.+||+.||++|||++|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0000000       00011124679999999999999999999999764

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.9e-37  Score=288.77  Aligned_cols=259  Identities=22%  Similarity=0.256  Sum_probs=189.7

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-C--CcEEEEEeCCCC-----ChHHHHHHHHHHhcC-CCCceeeeccceec----CCe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-D--GMLVAIKKRPGA-----PTQEFIDEVCFLASI-QHRNLVTLLGYCQE----NNL  144 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~--~~~vavK~~~~~-----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  144 (380)
                      +|++.+.||+|+||.||++... .  +..||+|.....     ..+.+.+|+++++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4777889999999999999954 3  678999975432     234678899999999 59999999987532    245


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .+++++|+. ++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIR-----SGQPLTDAHFQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            688889886 57887773     34568899999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCCC--CCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh---
Q 016917          225 NFLGRTDVA--GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR---  298 (380)
Q Consensus       225 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---  298 (380)
                      .........  .......++..|+|||...+ ..++.++|+|||||++|+|++|..||.......   ....+....   
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~  229 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTP  229 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCC
Confidence            866432211  11233467888999998765 578999999999999999999999987644211   111000000   


Q ss_pred             cccchhhh-----------cccccc---cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          299 DFSNLLKI-----------LDERLW---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       299 ~~~~~~~~-----------~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .......+           ......   .......+..+.+++.+||+.||++|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000           000000   00111235679999999999999999999999865

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-38  Score=273.02  Aligned_cols=252  Identities=21%  Similarity=0.344  Sum_probs=197.6

Q ss_pred             CeeccCCceEEEEEE-ECCCcEEEEEeCCCC---ChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEeecCCCc
Q 016917           83 NLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA---PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  157 (380)
                      +.||+|+++.|-.+. ..++..||||+..+.   .+.+..+|++++.+. .|+||++++++|+++..+|||||-+.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            679999999999998 678999999985543   467789999999999 599999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---CceEEcccccccccCCCCCC-
Q 016917          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVADAGLRNFLGRTDVA-  233 (380)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~---~~~kl~DFgla~~~~~~~~~-  233 (380)
                      ...+     ..+.-+++.....+.++|+.||.|||.  +||.|||+||+|||....   .-+|||||.+...+.....- 
T Consensus       164 LshI-----~~~~~F~E~EAs~vvkdia~aLdFlH~--kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  164 LSHI-----QKRKHFNEREASRVVKDIASALDFLHT--KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             HHHH-----HHhhhccHHHHHHHHHHHHHHHHHHhh--cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            8888     456778899999999999999999999  889999999999998644   35899999998765432211 


Q ss_pred             ----CCCccccCccceecccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCc----ccHHHHHHhhhcc
Q 016917          234 ----GPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS----QDLVELVQNSRDF  300 (380)
Q Consensus       234 ----~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~----~~~~~~~~~~~~~  300 (380)
                          ......+|+..|||||+..     ...|+.++|.|||||+||-|++|.+||.+....+-    .+.....++    
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~----  312 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN----  312 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH----
Confidence                1223456888999999853     34789999999999999999999999998764221    111111110    


Q ss_pred             cchhhhcccccccCCCH----HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 SNLLKILDERLWSTFTN----EGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 ~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       .+-+.+.+.. -.||.    ..+.+..+++..+|..|+.+|.++.+++.+
T Consensus       313 -~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  313 -KLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             -HHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence             0111111111 13443    356788999999999999999999999874

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-37  Score=290.23  Aligned_cols=261  Identities=20%  Similarity=0.327  Sum_probs=192.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecC------C
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------N  143 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  143 (380)
                      ..+|...+.||+|+||.||+|.. .++..||+|.....     ....+.+|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            46788999999999999999995 46899999975432     234577899999999999999999988654      3


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      ..++|+||+.. +|....       ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||+
T Consensus        94 ~~~lv~e~~~~-~l~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-------GHPLSEDKVQYLVYQMLCGLKYIHS--AGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEeccccc-CHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            46899999864 555443       2357888999999999999999999  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhh-hccc
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS-RDFS  301 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~  301 (380)
                      +.....     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......  ......... ....
T Consensus       164 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~  236 (342)
T cd07879         164 ARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGP  236 (342)
T ss_pred             CcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCH
Confidence            875432     1233456778999999866 468999999999999999999999998643211  111100000 0000


Q ss_pred             chhhhccc------------cccc---CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--HHhhhh
Q 016917          302 NLLKILDE------------RLWS---TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRTLD  353 (380)
Q Consensus       302 ~~~~~~~~------------~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~--L~~~~~  353 (380)
                      ...+....            ....   ...+..+..+.+++.+||+.||++||++++++.+  ++++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            00000000            0000   0011234678999999999999999999999966  655543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=289.94  Aligned_cols=242  Identities=24%  Similarity=0.339  Sum_probs=199.0

Q ss_pred             CCeeccCCceEEEEEEE-CCCcEEEEEeCC-----CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCC
Q 016917           82 KNLIGEGKFGEVYKGLL-QDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~-~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  155 (380)
                      .++||+|.||+||-|.+ ++|+.||||.++     ....+.+++|+.||+++.||.||.+...|+..+..+.|||-+.|+
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            37899999999999995 579999999643     344567899999999999999999999999999999999999886


Q ss_pred             CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEcccccccccCCCCC
Q 016917          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~---~~~~kl~DFgla~~~~~~~~  232 (380)
                      -|+.+|.    ...+++++..-..+..||+.||+|||.  ++|+|+||||+|||+..   ..++||||||+|+.+++.. 
T Consensus       649 MLEMILS----sEkgRL~er~TkFlvtQIL~ALr~LH~--knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-  721 (888)
T KOG4236|consen  649 MLEMILS----SEKGRLPERITKFLVTQILVALRYLHF--KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-  721 (888)
T ss_pred             HHHHHHH----hhcccchHHHHHHHHHHHHHHHHHhhh--cceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence            6666663    245778888888899999999999999  77999999999999954   3589999999999997643 


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                        ......||+.|+|||++..++|+..-|+||.||++|--++|..||.....     ..+.++++.      -..-+..|
T Consensus       722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQIQNAa------FMyPp~PW  788 (888)
T KOG4236|consen  722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQIQNAA------FMYPPNPW  788 (888)
T ss_pred             --hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHhhccc------cccCCCch
Confidence              34567899999999999999999999999999999999999999986432     222222111      11122223


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .    +.+++..+||..+|+..-++|.|..+.+.+
T Consensus       789 ~----eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  789 S----EISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             h----hcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            2    445678999999999999999999887765

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-37  Score=290.10  Aligned_cols=257  Identities=19%  Similarity=0.314  Sum_probs=192.6

Q ss_pred             HhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCC-----
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----  143 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  143 (380)
                      ..++|++.+.||+|+||.||++. ..++..||+|.....     ....+.+|+++++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            45679999999999999999998 457899999975422     1245778999999999999999999886543     


Q ss_pred             -eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 016917          144 -LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       144 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFg  222 (380)
                       ..++||||+ +++|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~--~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK------HEKLSEDRIQFLVYQMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecc
Confidence             358999998 668877762      3467899999999999999999999  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc--
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD--  299 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--  299 (380)
                      ++......     .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||......  ............  
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~  236 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQLMEIMKVTGTPS  236 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCC
Confidence            98765331     223456778999998875 45889999999999999999999999754321  111111000000  


Q ss_pred             --------ccchhhhcc------cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 --------FSNLLKILD------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 --------~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                              .........      ..........+++.+.+++.+|++.||++|||+.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                    000000000      000001112345678999999999999999999999954

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=294.18  Aligned_cols=241  Identities=20%  Similarity=0.276  Sum_probs=195.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEeec
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      ...|.....+|.|+|+.|-.+.. .+++..++|+.... ..+..+|+.++... +||||+++.+.+.++...|+|||++.
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~  399 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD  399 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence            45677778899999999999984 56788999987655 33345677666555 79999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee-CCCCceEEcccccccccCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV-DEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili-~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++.+.+.+.     ....+. ..+..++.+|+.|+.|||.  +|+|||||||+|||+ ++.++++|+|||.++...+.  
T Consensus       400 g~ell~ri~-----~~~~~~-~e~~~w~~~lv~Av~~LH~--~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  400 GGELLRRIR-----SKPEFC-SEASQWAAELVSAVDYLHE--QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             ccHHHHHHH-----hcchhH-HHHHHHHHHHHHHHHHHHh--cCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            998877773     222233 5667799999999999999  789999999999999 68899999999999877553  


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                         ....+-|..|.|||+....+|+.++||||||++||+|++|+.||.....+  .++...+                ..
T Consensus       470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i----------------~~  528 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRI----------------QM  528 (612)
T ss_pred             ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhh----------------cC
Confidence               22334566799999999999999999999999999999999999876543  1111111                11


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      ..+....+++.++|+.+||+.||.+||++.++..+-
T Consensus       529 ~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~  564 (612)
T KOG0603|consen  529 PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP  564 (612)
T ss_pred             CccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence            234467889999999999999999999999999763

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-37  Score=278.56  Aligned_cols=256  Identities=24%  Similarity=0.319  Sum_probs=194.0

Q ss_pred             CCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      |+..+.||+|++|.||+|... +++.+++|.....     ..+.+..|+++++.++|+|++++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            556788999999999999965 5899999975432     2346778999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++ +|.+++...    ...+++..+..++.|++.||.|||+  .+|+||||+|+||++++++.++|+|||++........
T Consensus        81 ~~-~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 DM-DLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             Cc-CHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            85 888888421    1468899999999999999999999  6799999999999999999999999999876643221


Q ss_pred             CCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc---------ccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD---------FSN  302 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~  302 (380)
                        ......++..|+|||.+.+. .++.++|+||||+++|||++|..||......+   ....+.....         ...
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhcc
Confidence              12233456679999998766 88999999999999999999999987644211   1111100000         000


Q ss_pred             h-------hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          303 L-------LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       303 ~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      +       ...........+ +..+..+.+++.+||..||++||++++++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         229 LPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            0       000000000111 1225679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-37  Score=290.94  Aligned_cols=256  Identities=20%  Similarity=0.304  Sum_probs=193.3

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCe----
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL----  144 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  144 (380)
                      ..++|++.+.||+|++|.||+|... ++..||+|.....     ....+.+|+.+++.++||||+++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3567999999999999999999964 5789999985432     22456789999999999999999998866554    


Q ss_pred             --eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 016917          145 --QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       145 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFg  222 (380)
                        .++|+||+ +++|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~------~~~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVK------CQKLSDDHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEcccc
Confidence              89999998 558888773      2468899999999999999999999  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc-
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF-  300 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-  300 (380)
                      ++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......   .....+...... 
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~~~~~  235 (343)
T cd07851         164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---DQLKRIMNLVGTP  235 (343)
T ss_pred             cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCC
Confidence            98865432     233456778999998765 46789999999999999999999999754321   111111110000 


Q ss_pred             -cc---------hhhhcc---cccccC---CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 -SN---------LLKILD---ERLWST---FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 -~~---------~~~~~~---~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       +.         ......   ......   .....++++.+++.+||+.||++|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence             00         000000   000000   011235789999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=272.43  Aligned_cols=233  Identities=24%  Similarity=0.308  Sum_probs=189.9

Q ss_pred             eccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCc
Q 016917           85 IGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        85 ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  157 (380)
                      ||.|+||.||++... ++..+++|.....      ....+..|+++++.++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999965 5889999975432      234678899999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCc
Q 016917          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS  237 (380)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~  237 (380)
                      .+++.     ....+++..+..++.|++.|+.|||+  .+++|+||+|+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lh~--~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~  151 (250)
T cd05123          81 FSHLS-----KEGRFSEERARFYAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN  151 (250)
T ss_pred             HHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence            98883     23467899999999999999999999  779999999999999999999999999987764422  1123


Q ss_pred             cccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCH
Q 016917          238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  317 (380)
Q Consensus       238 ~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (380)
                      ...++..|++||...+..++.++|+||||+++|++++|..||...+.   ......+.            .  ....++.
T Consensus       152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~------------~--~~~~~~~  214 (250)
T cd05123         152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKIL------------K--DPLRFPE  214 (250)
T ss_pred             CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHh------------c--CCCCCCC
Confidence            44577789999999888889999999999999999999999975432   11111111            0  1123344


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCCHHH
Q 016917          318 EGMEEFIQLIVRCLDPSSERRPSMSD  343 (380)
Q Consensus       318 ~~~~~l~~li~~cl~~dp~~Rpt~~~  343 (380)
                      ..+..+.+++.+||..||++||++.+
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            44678999999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3e-37  Score=307.47  Aligned_cols=251  Identities=23%  Similarity=0.359  Sum_probs=180.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecC--------
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--------  142 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  142 (380)
                      ..+|++...||+||||.||+++++ +|+.||||+++-..    .....+|+.+|.+|+|||||+++..+.+.        
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            456778899999999999999955 89999999865442    23477899999999999999997633110        


Q ss_pred             --------------------------------------------------------------------------------
Q 016917          143 --------------------------------------------------------------------------------  142 (380)
Q Consensus       143 --------------------------------------------------------------------------------  142 (380)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             -------------------------------CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 016917          143 -------------------------------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL  191 (380)
Q Consensus       143 -------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~L  191 (380)
                                                     ..+|+-||||+..++.+++......    -.....++++++|++||.|+
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHHHHHH
Confidence                                           0135666777665555555221110    03567789999999999999


Q ss_pred             hcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC----C------------CCCCCCCccccCccceecccccccC-
Q 016917          192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG----R------------TDVAGPSSQVTADEIFLASEVKEFR-  254 (380)
Q Consensus       192 H~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~----~------------~~~~~~~~~~~~~~~~~aPE~~~~~-  254 (380)
                      |+  .|||||||||.||+++++..|||+|||+|+...    .            ....+......||..|+|||.+.+. 
T Consensus       714 H~--~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  714 HD--QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             Hh--CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            99  679999999999999999999999999998721    0            0111234467899999999998765 


Q ss_pred             --CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccC
Q 016917          255 --RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLD  332 (380)
Q Consensus       255 --~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  332 (380)
                        .|+.|+|+||||++++||+.   ||.+.     .+....+.+.+. ..+     +.. ..+.....+.-..+|.+|++
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-----MERa~iL~~LR~-g~i-----P~~-~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTS-----MERASILTNLRK-GSI-----PEP-ADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCch-----HHHHHHHHhccc-CCC-----CCC-cccccccchHHHHHHHHHhc
Confidence              49999999999999999986   34432     111111111111 110     000 12233333556889999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 016917          333 PSSERRPSMSDVVTE  347 (380)
Q Consensus       333 ~dp~~Rpt~~~ll~~  347 (380)
                      .||.+|||+.|+|..
T Consensus       857 hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  857 HDPSKRPTATELLNS  871 (1351)
T ss_pred             CCCccCCCHHHHhhc
Confidence            999999999999863

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-38  Score=277.87  Aligned_cols=262  Identities=21%  Similarity=0.255  Sum_probs=201.3

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC--ChHHHHHHHHHHhcCC-C-C----ceeeeccceecCCee
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA--PTQEFIDEVCFLASIQ-H-R----NLVTLLGYCQENNLQ  145 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~  145 (380)
                      ..++|.+.+.+|+|.||.|-.+.. ..+..||+|+.+..  ..+..+-|+++|+++. + |    -++.+.++|+..+..
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            467899999999999999999984 45789999986533  3456678999999994 2 2    378889999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-------------
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-------------  212 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~-------------  212 (380)
                      |+|+|.+ |-++.++|..   .+...++...+..++.|+++++++||+  .+++|-||||+|||+.+             
T Consensus       167 Civfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~--~kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHD--LKLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             EEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHh--cceeecCCChheEEEeccceEEEeccCCcc
Confidence            9999988 4489999943   356778999999999999999999999  66999999999999821             


Q ss_pred             -------CCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 016917          213 -------DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD  285 (380)
Q Consensus       213 -------~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~  285 (380)
                             +..++++|||.|....+.     .+....|..|+|||++.+.+++.++||||+||||+|+++|...|.+.+..
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                   346999999999875442     35677899999999999999999999999999999999999999987643


Q ss_pred             CcccHHHHHHhhhcccchhhh----------cc---------------cc--c--ccCCCHHHHHHHHHHHhHccCCCCC
Q 016917          286 SSQDLVELVQNSRDFSNLLKI----------LD---------------ER--L--WSTFTNEGMEEFIQLIVRCLDPSSE  336 (380)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~----------~~---------------~~--~--~~~~~~~~~~~l~~li~~cl~~dp~  336 (380)
                      +.-.+.+.+....+...+.+.          +|               ..  +  ..........++.||+.+||.+||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            332232222211100000000          00               00  0  0011123346699999999999999


Q ss_pred             CCCCHHHHHHH
Q 016917          337 RRPSMSDVVTE  347 (380)
Q Consensus       337 ~Rpt~~~ll~~  347 (380)
                      +|+|+.|++++
T Consensus       396 ~RiTl~EAL~H  406 (415)
T KOG0671|consen  396 RRITLREALSH  406 (415)
T ss_pred             ccccHHHHhcC
Confidence            99999999976

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-37  Score=246.74  Aligned_cols=261  Identities=21%  Similarity=0.310  Sum_probs=200.3

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC-----CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +|.-.++||+|.+|+||+|+. .++..||+|...     ........+|+.+|+.++|.||+++++....++.+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            355567899999999999994 568899999632     33456789999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      |+. +|..+..    ..++.+....+.+++.|+++||.++|+  .++.|||+||.|.||+.+|++|++|||+++-.+-. 
T Consensus        83 cdq-dlkkyfd----slng~~d~~~~rsfmlqllrgl~fchs--hnvlhrdlkpqnllin~ngelkladfglarafgip-  154 (292)
T KOG0662|consen   83 CDQ-DLKKYFD----SLNGDLDPEIVRSFMLQLLRGLGFCHS--HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-  154 (292)
T ss_pred             hhH-HHHHHHH----hcCCcCCHHHHHHHHHHHHhhhhhhhh--hhhhhccCCcceEEeccCCcEEecccchhhhcCCc-
Confidence            976 6776663    235677888999999999999999999  55999999999999999999999999999866431 


Q ss_pred             CCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHH---hhhcccchhhh
Q 016917          232 VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ---NSRDFSNLLKI  306 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  306 (380)
                       ....+....|..|++|.++-| +-|++..|+||.||++.|+.. |++.|.+.+.++.-..+.+..   ....++.+.+.
T Consensus       155 -vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             -eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence             112344567888999998766 578999999999999999997 555566654332222222221   12233344444


Q ss_pred             cccccccCCCH---------HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFTN---------EGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~~---------~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .|....+.++.         .....-++++++.|.-+|.+|.++++.+++
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            45444444432         233456899999999999999999998875

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.8e-36  Score=269.91  Aligned_cols=220  Identities=17%  Similarity=0.180  Sum_probs=176.1

Q ss_pred             CCceEEEEEEE-CCCcEEEEEeCCCCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCccccccCCCC
Q 016917           88 GKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQ  166 (380)
Q Consensus        88 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~  166 (380)
                      |.+|.||++.. .+++.+|+|......  .+..|...+....||||+++++++...+..++||||+++|+|.+++.    
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS----   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH----
Confidence            89999999995 568899999875442  23445555556679999999999999999999999999999998883    


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcccee
Q 016917          167 VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL  246 (380)
Q Consensus       167 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~  246 (380)
                       ....+++..+..++.|++.||.|||+  ++++||||||+||+++.++.++++|||.+.......     ....++..|+
T Consensus        78 -~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~  149 (237)
T cd05576          78 -KFLNIPEECVKRWAAEMVVALDALHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYC  149 (237)
T ss_pred             -HhcCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcccc
Confidence             23458899999999999999999999  779999999999999999999999999876654321     2233456799


Q ss_pred             cccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHH
Q 016917          247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQL  326 (380)
Q Consensus       247 aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  326 (380)
                      |||...+..++.++|+||+|+++|||++|..|+.......                     ........+...++.++++
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~l  208 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------------NTHTTLNIPEWVSEEARSL  208 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------------ccccccCCcccCCHHHHHH
Confidence            9999988889999999999999999999998865322100                     0000012333455779999


Q ss_pred             HhHccCCCCCCCCCHH
Q 016917          327 IVRCLDPSSERRPSMS  342 (380)
Q Consensus       327 i~~cl~~dp~~Rpt~~  342 (380)
                      +.+||+.||.+||++.
T Consensus       209 i~~~l~~dp~~R~~~~  224 (237)
T cd05576         209 LQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHccCCHHHhcCCC
Confidence            9999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-38  Score=266.33  Aligned_cols=264  Identities=20%  Similarity=0.329  Sum_probs=193.8

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeC-----CCCChHHHHHHHHHHhcCCCCceeeeccceec--------C
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKR-----PGAPTQEFIDEVCFLASIQHRNLVTLLGYCQE--------N  142 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  142 (380)
                      +.|.-..+||+|.||.||+|+. +++++||+|+.     +..-.....+|+.+|..|+|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            3455567899999999999994 56788899862     23334557899999999999999999998853        2


Q ss_pred             CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFg  222 (380)
                      ..+|+||++|+. +|.-.|.    ....+++...+..++.+++.||.|+|.  ..|+|||+||+|+||+.++.+||+|||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLs----n~~vr~sls~Ikk~Mk~Lm~GL~~iHr--~kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLS----NRKVRFSLSEIKKVMKGLMNGLYYIHR--NKILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhc----CccccccHHHHHHHHHHHHHHHHHHHH--hhHHhhcccHhhEEEcCCceEEeeccc
Confidence            357999999987 6666662    234678999999999999999999999  569999999999999999999999999


Q ss_pred             cccccCCCC--CCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh---
Q 016917          223 LRNFLGRTD--VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN---  296 (380)
Q Consensus       223 la~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---  296 (380)
                      +++.+.-..  ..........|..|++||.+.| ..|+++.|||..||++.||+||.+-+++......-.++..+..   
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            997664322  2222344567889999998776 5899999999999999999999988877653322222221110   


Q ss_pred             -----hhcccchhhhcccc-ccc-C---C-----CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          297 -----SRDFSNLLKILDER-LWS-T---F-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       297 -----~~~~~~~~~~~~~~-~~~-~---~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                           ..+.-.+...+... +.. .   .     +-.-.++..+|+..++..||.+|+++.+++.+
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence                 00000011111000 000 0   0     00112578899999999999999999999876

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.3e-36  Score=304.51  Aligned_cols=143  Identities=27%  Similarity=0.317  Sum_probs=127.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|.+.+.||+|+||.||+|... +++.||+|+.....      ...+..|+.+++.++||||+++++.+...+..|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            357889999999999999999965 68899999865332      25678899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      |||+.+++|.+++.     ....+.+..++.++.||+.||.|||.  ++|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~-----~~~~l~~~~~~~i~~qil~aL~yLH~--~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLH-----IYGYFDEEMAVKYISEVALALDYLHR--HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999883     23457888899999999999999999  679999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=280.10  Aligned_cols=260  Identities=23%  Similarity=0.316  Sum_probs=201.6

Q ss_pred             HHHHhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeC--CCCCh--------HHHHHHHHHHhcCCCCceeeecccee
Q 016917           72 LSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPT--------QEFIDEVCFLASIQHRNLVTLLGYCQ  140 (380)
Q Consensus        72 ~~~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~--~~~~~--------~~~~~E~~~l~~l~h~niv~l~~~~~  140 (380)
                      .++..++|-.+..||+|||+.||+|. ....+.||+|+.  .+..+        ....+|-.|-+.|+||.||++|+++.
T Consensus       458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs  537 (775)
T KOG1151|consen  458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS  537 (775)
T ss_pred             CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence            34444567778899999999999998 556789999972  23332        23457889999999999999999996


Q ss_pred             -cCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCce
Q 016917          141 -ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIA  216 (380)
Q Consensus       141 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~---~~~~~  216 (380)
                       +.+.+|-|+|||+|.+|+-+|     ...+.++++...+|+.||+.||.||...+.+|||-||||.|||+-   ..|.+
T Consensus       538 lDtdsFCTVLEYceGNDLDFYL-----KQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeI  612 (775)
T KOG1151|consen  538 LDTDSFCTVLEYCEGNDLDFYL-----KQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEI  612 (775)
T ss_pred             eccccceeeeeecCCCchhHHH-----HhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCccccee
Confidence             567889999999999999888     345678899999999999999999999888999999999999994   45789


Q ss_pred             EEcccccccccCCCCCC-----CCCccccCccceeccccccc----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCc
Q 016917          217 KVADAGLRNFLGRTDVA-----GPSSQVTADEIFLASEVKEF----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS  287 (380)
Q Consensus       217 kl~DFgla~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~----~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~  287 (380)
                      ||+|||+++.+.+..+.     ...+...||..|++||++.-    ...+.++||||+|||+|.++.|+.||.....  .
T Consensus       613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--Q  690 (775)
T KOG1151|consen  613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--Q  690 (775)
T ss_pred             EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--H
Confidence            99999999998765443     23455679999999998643    3568899999999999999999999986432  1


Q ss_pred             ccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          288 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ++.++.       ..+.+...  ...+..+.++.+..++|.+||++--++|....++..+
T Consensus       691 QdILqe-------NTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  691 QDILQE-------NTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             HHHHhh-------hchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            111111       11111100  0112223566789999999999999999998888753

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=269.76  Aligned_cols=242  Identities=21%  Similarity=0.293  Sum_probs=197.2

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC------hHHHHHHHHHHhcC-CCCceeeeccceecCCee
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  145 (380)
                      +...+|..+.+||+|+||.|.++.. .+...+|||++++..      .+--+.|-.+|... +-|.++++...+...+.+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            3455788899999999999999984 456789999755432      22234566777666 467899999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      |.||||+.||+|--.+     ..-+.+.+.....++..|+.||-+||+  +||+.||||.+|||+|.+|++||+|||+++
T Consensus       426 yFVMEyvnGGDLMyhi-----QQ~GkFKEp~AvFYAaEiaigLFFLh~--kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHI-----QQVGKFKEPVAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             eeEEEEecCchhhhHH-----HHhcccCCchhhhhhHHHHHHhhhhhc--CCeeeeeccccceEeccCCceEeeeccccc
Confidence            9999999999998777     345667788889999999999999999  889999999999999999999999999987


Q ss_pred             ccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      .---  ........+||+.|+|||++..++|+.++|+|||||+||||+.|++||.+.++++   +...+           
T Consensus       499 Eni~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---lF~aI-----------  562 (683)
T KOG0696|consen  499 ENIF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQAI-----------  562 (683)
T ss_pred             cccc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHH-----------
Confidence            5321  1234567899999999999999999999999999999999999999999866431   11111           


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCH
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM  341 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  341 (380)
                       .+.+  ..+|...+.+...+.+..|.+.|.+|...
T Consensus       563 -~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  563 -MEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLGC  595 (683)
T ss_pred             -HHcc--CcCcccccHHHHHHHHHHhhcCCccccCC
Confidence             1111  25677788889999999999999999643

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=269.86  Aligned_cols=255  Identities=21%  Similarity=0.270  Sum_probs=188.4

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +.+.+..||.|+||+|++-.++ .|+..|||+.....    .++++.|.+...+- +.||||++||.+..++..++.||+
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            3455678999999999999854 68999999754332    34678888765554 789999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      |+- +++.+...--......+++..+-.|..-.+.||.||... -.|||||+||+|||++..|.+||||||++..+.++-
T Consensus       145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI  222 (361)
T ss_pred             Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence            965 555433111112456678888888888999999999874 469999999999999999999999999987765422


Q ss_pred             CCCCCccccCccceeccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      . .  ..-.|-..|||||.+..  .+|+.+|||||||++|||+.||..||...+. .-+++...+....     ..+.  
T Consensus       223 A-k--T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-vfeql~~Vv~gdp-----p~l~--  291 (361)
T KOG1006|consen  223 A-K--TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-VFEQLCQVVIGDP-----PILL--  291 (361)
T ss_pred             H-h--hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-HHHHHHHHHcCCC-----Ceec--
Confidence            1 1  22234555999998864  4699999999999999999999999986542 1111111111000     0000  


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                        ...-..+.+..+..++..||.+|-.+||.+.+++++
T Consensus       292 --~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  292 --FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             --CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence              011122356789999999999999999999999865

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-37  Score=280.61  Aligned_cols=249  Identities=16%  Similarity=0.223  Sum_probs=205.4

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECCC-cEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQDG-MLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~~-~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      ...+++.+..||-|+||+|=++..+.. ..+|+|+++      ....+....|-++|..++.|.||++|-.|.+....|+
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm  497 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM  497 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence            345566778899999999999986543 347777533      2334567889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      +||-|-||.+...|     ..++.+.......++..+++|++|||+  ++||+|||||+|.+++.+|-+||.|||+|+.+
T Consensus       498 LmEaClGGElWTiL-----rdRg~Fdd~tarF~~acv~EAfeYLH~--k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki  570 (732)
T KOG0614|consen  498 LMEACLGGELWTIL-----RDRGSFDDYTARFYVACVLEAFEYLHR--KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI  570 (732)
T ss_pred             hHHhhcCchhhhhh-----hhcCCcccchhhhhHHHHHHHHHHHHh--cCceeccCChhheeeccCCceEEeehhhHHHh
Confidence            99999999999998     356677778888899999999999999  77999999999999999999999999999988


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      ...   ......+||+.|.|||++.+++.+.++|.||||+++|||++|.+||++.++-...+   .+....         
T Consensus       571 ~~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn---~ILkGi---------  635 (732)
T KOG0614|consen  571 GSG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN---LILKGI---------  635 (732)
T ss_pred             ccC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH---HHHhhh---------
Confidence            653   34567899999999999999999999999999999999999999999877532211   111111         


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTEL  348 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~~ll~~L  348 (380)
                         -...+|........++++++.+.+|.+|..     +.++-+|-
T Consensus       636 ---d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  636 ---DKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             ---hhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence               113556666778899999999999999976     66666653

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=287.74  Aligned_cols=252  Identities=27%  Similarity=0.405  Sum_probs=208.3

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCC--CChHHHHHHHHHHhcC-CCCceeeecccee-----cCCe
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG--APTQEFIDEVCFLASI-QHRNLVTLLGYCQ-----ENNL  144 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~~~  144 (380)
                      ..+..|++..+||.|.+|.||+++ .++++..|+|+...  ...++...|.++|+.. .|||++.++|++.     .++.
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            345568888999999999999999 55688889998554  3456677888999988 6999999999985     3578


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      ++||||||.+|+..|......   ...+.|..+..|+..++.|+.|||.  +.++|||||-.|||++.++.|||+|||.+
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~--nkviHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHN--NKVIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhh--cceeeecccCceEEEeccCcEEEeeeeee
Confidence            999999999999999986543   6778899999999999999999999  67999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCccceecccccccC-----CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFR-----RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD  299 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  299 (380)
                      ..+..+.  .......||++|||||++.-.     .|+..+|+||||++..||--|.+|+....+-.             
T Consensus       171 aQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-------------  235 (953)
T KOG0587|consen  171 AQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-------------  235 (953)
T ss_pred             eeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------------
Confidence            8775433  345667899999999998643     56789999999999999999999988766420             


Q ss_pred             ccchhhh-cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 FSNLLKI-LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 ~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                        .+-.+ -++.....-+..+++++.++|..||.+|..+||+..+++++
T Consensus       236 --aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  236 --ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             --hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence              00011 12233334467788999999999999999999999999865

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.3e-34  Score=286.18  Aligned_cols=265  Identities=18%  Similarity=0.177  Sum_probs=168.5

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-C----CcEEEEEeCCCCChHHHHHHHHHHhcCCCCceeeeccc------eecCC
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-D----GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGY------CQENN  143 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~~~~  143 (380)
                      ..++|++.+.||+|+||.||+|... +    +..||+|+.......+...+ +.++...+.++..+...      .....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~-e~l~~~~~~~~~~~~~~~~~~~~~~~~~  208 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMN-ERVRRACPNSCADFVYGFLEPVSSKKED  208 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHH-HHHHhhchhhHHHHHHhhhcccccccCC
Confidence            4568999999999999999999964 4    68999998654332222111 12222223333333222      24556


Q ss_pred             eeEEEEEeecCCCccccccCCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQV---------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Ni  208 (380)
                      ..++|+||+.+++|.+++......               .........+..++.|++.||.|||+  ++|+||||||+||
T Consensus       209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~--~gIiHRDLKP~NI  286 (566)
T PLN03225        209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS--TGIVHRDVKPQNI  286 (566)
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH--CCEEeCcCCHHHE
Confidence            789999999999998887432110               00111234456799999999999999  7799999999999


Q ss_pred             eeCC-CCceEEcccccccccCCCCCCCCCccccCccceecccccccC----------------------CCCcchhhHHH
Q 016917          209 LVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR----------------------RFSEKSDVYSF  265 (380)
Q Consensus       209 li~~-~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------------------~~~~~~DvwSl  265 (380)
                      |++. ++.+||+|||+++.+.... ........+++.|+|||.+...                      .++.++|||||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            9985 5799999999998654322 1223445678899999965322                      23456799999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCcccHHHHHHhh-hcccchhhhcccccccC----C--CHHHHHHHHHHHhHccCCCCCCC
Q 016917          266 GVFLLELVSGREASSSLSPDSSQDLVELVQNS-RDFSNLLKILDERLWST----F--TNEGMEEFIQLIVRCLDPSSERR  338 (380)
Q Consensus       266 G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~----~--~~~~~~~l~~li~~cl~~dp~~R  338 (380)
                      ||+||||+++..|+...    ...+...+... .+.........+.....    +  .........+|+.+||+.||++|
T Consensus       366 GviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        366 GLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             HHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            99999999976553311    01111111100 00000011111110000    0  00012345689999999999999


Q ss_pred             CCHHHHHHH
Q 016917          339 PSMSDVVTE  347 (380)
Q Consensus       339 pt~~~ll~~  347 (380)
                      ||+.+++++
T Consensus       442 ~ta~e~L~H  450 (566)
T PLN03225        442 ISAKAALAH  450 (566)
T ss_pred             CCHHHHhCC
Confidence            999999986

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=257.87  Aligned_cols=264  Identities=22%  Similarity=0.344  Sum_probs=202.2

Q ss_pred             CCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCC-----ee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN-----LQ  145 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  145 (380)
                      .+.+..+.||-|+||.||.++ -++|+.|++|++...     ....+.+|+.+|..++|.|+...++...-.+     ++
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            345667899999999999999 568999999986643     3457889999999999999999998776443     45


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      |.++|++.. +|..++     .+.+.++.+.+.-+..||++||+|||+  .+|.||||||.|.|++.+..+||||||+++
T Consensus       133 YV~TELmQS-DLHKII-----VSPQ~Ls~DHvKVFlYQILRGLKYLHs--A~ILHRDIKPGNLLVNSNCvLKICDFGLAR  204 (449)
T KOG0664|consen  133 YVLTELMQS-DLHKII-----VSPQALTPDHVKVFVYQILRGLKYLHT--ANILHRDIKPGNLLVNSNCILKICDFGLAR  204 (449)
T ss_pred             HHHHHHHHh-hhhhee-----ccCCCCCcchhhhhHHHHHhhhHHHhh--cchhhccCCCccEEeccCceEEeccccccc
Confidence            788998876 787777     466778888999999999999999999  779999999999999999999999999999


Q ss_pred             ccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ..+... .........|.+|+|||.+.| ..|+...||||.||++.|++.++..|....+.+.-+++..+......+.+.
T Consensus       205 vee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr  283 (449)
T KOG0664|consen  205 TWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMK  283 (449)
T ss_pred             ccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHH
Confidence            765432 222334567889999999887 478999999999999999999999998877655544443332222222221


Q ss_pred             hhcc--------ccccc---------CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          305 KILD--------ERLWS---------TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       305 ~~~~--------~~~~~---------~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                      ...+        ...+.         .-+..-..+..++...++..||+.|.+..+.+.++.
T Consensus       284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            1111        00000         111122245677888899999999999999988754

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.1e-35  Score=245.71  Aligned_cols=258  Identities=21%  Similarity=0.337  Sum_probs=200.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCCChHHHHHHHHHHhcCC-CCceeeeccceecC--CeeEEEEEe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQEN--NLQFLIYEY  151 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~  151 (380)
                      ..+|++.+++|+|-++.||.|. ..++.+++||++++.....+.+|+.+|+.|. ||||+++++...+.  ....||+||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~  116 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY  116 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence            4568899999999999999999 5568899999999999999999999999996 99999999998765  456899999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CceEEcccccccccCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRT  230 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~-~~~kl~DFgla~~~~~~  230 (380)
                      ..+.+.....        ..++...+..++.+++.||.|+|+  .||+|||+||.|++||.. -.++|+|+|+|.+....
T Consensus       117 v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS--~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  117 VNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHS--MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHh--cCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            9887766543        456667788899999999999999  669999999999999854 57999999999887653


Q ss_pred             CCCCCCccccCccceecccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH------------Hh-
Q 016917          231 DVAGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV------------QN-  296 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~------------~~-  296 (380)
                      .   ..+...++.+|-.||.+- ...|+.+-|+|||||+|..|+..+.||...... .++++..+            .. 
T Consensus       187 ~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  187 K---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             c---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHHHHH
Confidence            2   234456788899999764 567899999999999999999999998765532 22333221            11 


Q ss_pred             ----hhcccchhhhcccccccCCCH-----HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          297 ----SRDFSNLLKILDERLWSTFTN-----EGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       297 ----~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                          .+++.++........|..|-.     -.+++..+++.+.|+.|..+|||+.|+..+
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence                011111111112222222211     134789999999999999999999999875

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.2e-33  Score=251.18  Aligned_cols=233  Identities=26%  Similarity=0.343  Sum_probs=188.1

Q ss_pred             CceEEEEEEEC-CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCccccccC
Q 016917           89 KFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG  163 (380)
Q Consensus        89 ~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  163 (380)
                      +||.||+|... ++..+++|......    .+.+.+|++.+++++|+|++++++.+......++++||+++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 48999999865433    57889999999999999999999999999999999999999999988732


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCcc
Q 016917          164 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE  243 (380)
Q Consensus       164 ~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~  243 (380)
                           ...+++..++.++.+++.++.|||+  .+++|+||+|+||++++++.++|+|||.+.......   ......++.
T Consensus        81 -----~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~  150 (244)
T smart00220       81 -----RGRLSEDEARFYARQILSALEYLHS--NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP  150 (244)
T ss_pred             -----ccCCCHHHHHHHHHHHHHHHHHHHH--cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence                 2227889999999999999999999  679999999999999999999999999988765432   223445677


Q ss_pred             ceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCH--HHHH
Q 016917          244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN--EGME  321 (380)
Q Consensus       244 ~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  321 (380)
                      .|++||...+..++.++|+||||+++|++++|..||.....  .....+...             .........  ..+.
T Consensus       151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~-------------~~~~~~~~~~~~~~~  215 (244)
T smart00220      151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIG-------------KPKPPFPPPEWKISP  215 (244)
T ss_pred             CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHh-------------ccCCCCccccccCCH
Confidence            89999999888899999999999999999999999876321  111111111             000000001  1457


Q ss_pred             HHHHHHhHccCCCCCCCCCHHHHHH
Q 016917          322 EFIQLIVRCLDPSSERRPSMSDVVT  346 (380)
Q Consensus       322 ~l~~li~~cl~~dp~~Rpt~~~ll~  346 (380)
                      ++.+++.+||..||++||++.++++
T Consensus       216 ~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      216 EAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHHccCCchhccCHHHHhh
Confidence            7999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-35  Score=272.79  Aligned_cols=242  Identities=23%  Similarity=0.280  Sum_probs=187.3

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      .-|..++.||-|+||.|.+++.. +...||+|.+.+.      .......|..||..-+++.||+||-.|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            34677789999999999999854 4667898864332      3345778999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC-
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG-  228 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~-  228 (380)
                      +|++||++-..|.     ..+.+.+.....++..+..|+++.|.+  |+|||||||+|||||.+|++||+||||+..+. 
T Consensus       709 dYIPGGDmMSLLI-----rmgIFeE~LARFYIAEltcAiesVHkm--GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLI-----RMGIFEEDLARFYIAELTCAIESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             eccCCccHHHHHH-----HhccCHHHHHHHHHHHHHHHHHHHHhc--cceecccCccceEEccCCceeeeecccccccee
Confidence            9999999988883     456788888889999999999999995  59999999999999999999999999985431 


Q ss_pred             --CCCC-------------------------------------CCCCccccCccceecccccccCCCCcchhhHHHHHHH
Q 016917          229 --RTDV-------------------------------------AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFL  269 (380)
Q Consensus       229 --~~~~-------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il  269 (380)
                        +..+                                     ......++||+-|+|||++...+|+..+|+||.||||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence              1000                                     0011246799999999999999999999999999999


Q ss_pred             HHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCC
Q 016917          270 LELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP  339 (380)
Q Consensus       270 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp  339 (380)
                      |||+.|+.||-...+.+-+..+.      .+..       .+...+..+.+.+..++|.++. -+++.|.
T Consensus       862 ~em~~g~~pf~~~tp~~tq~kv~------nw~~-------~l~~~~~~~ls~e~~~li~kLc-~sad~RL  917 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADTPGETQYKVI------NWRN-------FLHIPYQGNLSKEALDLIQKLC-CSADSRL  917 (1034)
T ss_pred             HHHhhCCCCccCCCCCcceeeee------ehhh-------ccccccccccCHHHHHHHHHHh-cChhhhh
Confidence            99999999998776644332111      0111       1112333455566777776643 3455564

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-35  Score=280.80  Aligned_cols=248  Identities=25%  Similarity=0.338  Sum_probs=189.6

Q ss_pred             CCCCCeeccCCceE-EEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEeecCCC
Q 016917           79 FSDKNLIGEGKFGE-VYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGS  156 (380)
Q Consensus        79 ~~~~~~ig~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~  156 (380)
                      |...+++|.|+.|+ ||+|... ++.||||.+-....+...+|+..|+.- +||||+++++.-.+.+..|+..|.|.. +
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s  588 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S  588 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence            45557889999886 6899885 789999998777777788999999988 699999999999999999999999977 8


Q ss_pred             ccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---C--CceEEcccccccccCCCC
Q 016917          157 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---D--FIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       157 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~---~--~~~kl~DFgla~~~~~~~  231 (380)
                      |.+++... ........-...+....|++.|++|||+  -+||||||||.||||+.   +  ..++|+|||+++.+....
T Consensus       589 L~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHs--l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  589 LQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHS--LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHh--cccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            99998653 1111111113346788999999999999  56999999999999975   2  479999999999886543


Q ss_pred             C-CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          232 V-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG-REASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       232 ~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      . ........||.+|+|||.+....-+.++||+|+||++|+.++| ..||...-.-+.+    .+   .....+..    
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N----Il---~~~~~L~~----  734 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN----IL---TGNYTLVH----  734 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh----hh---cCccceee----
Confidence            2 2235667799999999999998888899999999999999986 7888753211000    00   00000000    


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         ..-..++  +..+||.+|++.||..||++.+++.|
T Consensus       735 ---L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  735 ---LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             ---eccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence               0011112  78999999999999999999999865

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.4e-33  Score=271.01  Aligned_cols=264  Identities=19%  Similarity=0.257  Sum_probs=178.6

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-----------------CCCcEEEEEeCCCCC---hHH--------------HHHH
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-----------------QDGMLVAIKKRPGAP---TQE--------------FIDE  120 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~---~~~--------------~~~E  120 (380)
                      ..++|++.++||+|+||.||+|..                 ..++.||||+.....   .++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            466899999999999999999963                 235679999854321   122              2346


Q ss_pred             HHHHhcCCCCce-----eeeccceec--------CCeeEEEEEeecCCCccccccCCCC-------------------CC
Q 016917          121 VCFLASIQHRNL-----VTLLGYCQE--------NNLQFLIYEYIPNGSVSIHLYGPSQ-------------------VS  168 (380)
Q Consensus       121 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~-------------------~~  168 (380)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.+++.....                   ..
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            666777766544     677777753        3567999999999999988854211                   01


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecc
Q 016917          169 RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS  248 (380)
Q Consensus       169 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aP  248 (380)
                      ...+.+..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++......... ......+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~--~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR--IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence            2235677888999999999999999  67999999999999999999999999998765332111 11223347789999


Q ss_pred             cccccCC--------------------CC--cchhhHHHHHHHHHHHcCCC-CCCCCCCCCcccHHH--HHHhhhcccch
Q 016917          249 EVKEFRR--------------------FS--EKSDVYSFGVFLLELVSGRE-ASSSLSPDSSQDLVE--LVQNSRDFSNL  303 (380)
Q Consensus       249 E~~~~~~--------------------~~--~~~DvwSlG~il~el~tg~~-p~~~~~~~~~~~~~~--~~~~~~~~~~~  303 (380)
                      |.+....                    |+  .+.||||+||++|+|++|.. ||........ +...  .....+.    
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~~~~~~~~~~r----  454 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELRQYDNDLNRWR----  454 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHhhccchHHHHH----
Confidence            9875322                    22  34799999999999999875 6643211100 0000  0000000    


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCC---CCCCCHHHHHHH
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSS---ERRPSMSDVVTE  347 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~Rpt~~~ll~~  347 (380)
                       ...............++...+++.+||..+|   .+|+|++|+|+|
T Consensus       455 -~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        455 -MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             -hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence             0000011111122345778999999999766   689999999986

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=245.75  Aligned_cols=250  Identities=19%  Similarity=0.261  Sum_probs=197.6

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCC------ChHHHHHHHHHHhcC-CCCceeeeccceecCCe
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNL  144 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  144 (380)
                      .+..++|...++||+|++++|.+++ .++.+.+|+|+.+++      ..+=...|-.++.+- +||.+|.+..+|.....
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr  325 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR  325 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence            3456789999999999999999999 456789999964432      222245677777666 79999999999999999


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      +++|.||..||+|--.+     ...+.+++.....+...|+.||.|||+  +||+.||||..|+|+|..|++||+|+|++
T Consensus       326 lffvieyv~ggdlmfhm-----qrqrklpeeharfys~ei~lal~flh~--rgiiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  326 LFFVIEYVNGGDLMFHM-----QRQRKLPEEHARFYSAEICLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             EEEEEEEecCcceeeeh-----hhhhcCcHHHhhhhhHHHHHHHHHHhh--cCeeeeeccccceEEccCCceeecccchh
Confidence            99999999999998777     456789999999999999999999999  88999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCccc-HHHHHHhhhcccch
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD-LVELVQNSRDFSNL  303 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~  303 (380)
                      +.--.  .....+..+||+.|.|||.+.+..|+..+|+|+|||+++||+.|+.||.....+..+. ..+++-        
T Consensus       399 ke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf--------  468 (593)
T KOG0695|consen  399 KEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF--------  468 (593)
T ss_pred             hcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH--------
Confidence            75322  2334577899999999999999999999999999999999999999998544322211 111110        


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCH
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM  341 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  341 (380)
                      .-++.+..  ..|...+-....+++.-|++||.+|...
T Consensus       469 qvilekqi--riprslsvkas~vlkgflnkdp~erlgc  504 (593)
T KOG0695|consen  469 QVILEKQI--RIPRSLSVKASHVLKGFLNKDPKERLGC  504 (593)
T ss_pred             HHHhhhcc--cccceeehhhHHHHHHhhcCCcHHhcCC
Confidence            01112222  2334444556778899999999999644

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.3e-33  Score=259.37  Aligned_cols=263  Identities=21%  Similarity=0.252  Sum_probs=200.5

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCCh--HHHHHHHHHHhcCC------CCceeeeccceecCC
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT--QEFIDEVCFLASIQ------HRNLVTLLGYCQENN  143 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~------h~niv~l~~~~~~~~  143 (380)
                      ++...+|.+....|+|-|++|..|.. ..|..||||++.....  ..-..|+++|++|+      --|+++|+-.|...+
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            45667888889999999999999994 4578999998654432  33568999999995      358999999999999


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CceEEcccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAG  222 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~-~~~kl~DFg  222 (380)
                      ++|||||-+.- +|.+.|....  ..-.+....+..++.|+..||.+|..  .+|+|.||||.|||+++. ..+||||||
T Consensus       508 HLClVFE~Lsl-NLRevLKKyG--~nvGL~ikaVRsYaqQLflALklLK~--c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  508 HLCLVFEPLSL-NLREVLKKYG--RNVGLHIKAVRSYAQQLFLALKLLKK--CGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             eeEEEehhhhc-hHHHHHHHhC--cccceeehHHHHHHHHHHHHHHHHHh--cCeeecccCccceEeccCcceeeeccCc
Confidence            99999998755 7888885443  35667889999999999999999999  569999999999999876 468999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh-hhccc
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN-SRDFS  301 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~  301 (380)
                      .|....+..    ...+..+..|.|||++.|.+|+...|+||+||+|||++||+..|.+....   +++.+... .-.++
T Consensus       583 SA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN---~MLrl~me~KGk~p  655 (752)
T KOG0670|consen  583 SASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN---QMLRLFMELKGKFP  655 (752)
T ss_pred             ccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH---HHHHHHHHhcCCCc
Confidence            998876543    23455667799999999999999999999999999999999998876532   22211100 00000


Q ss_pred             c-----------------------hhh-----------hccc------cccc--CCC---HHHHHHHHHHHhHccCCCCC
Q 016917          302 N-----------------------LLK-----------ILDE------RLWS--TFT---NEGMEEFIQLIVRCLDPSSE  336 (380)
Q Consensus       302 ~-----------------------~~~-----------~~~~------~~~~--~~~---~~~~~~l~~li~~cl~~dp~  336 (380)
                      .                       ...           .+.+      .+..  .++   .....++.+|+.+||..||+
T Consensus       656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~  735 (752)
T KOG0670|consen  656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE  735 (752)
T ss_pred             HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence            0                       000           0000      0000  112   23447899999999999999


Q ss_pred             CCCCHHHHHHH
Q 016917          337 RRPSMSDVVTE  347 (380)
Q Consensus       337 ~Rpt~~~ll~~  347 (380)
                      +|.|.+++|++
T Consensus       736 KRit~nqAL~H  746 (752)
T KOG0670|consen  736 KRITVNQALKH  746 (752)
T ss_pred             hcCCHHHHhcC
Confidence            99999999976

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.1e-32  Score=248.78  Aligned_cols=131  Identities=21%  Similarity=0.306  Sum_probs=109.5

Q ss_pred             HhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCC--CChHHHHHHHHHHhcCC-----C---Cceeeecccee---
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG--APTQEFIDEVCFLASIQ-----H---RNLVTLLGYCQ---  140 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~---  140 (380)
                      ..++|.+.++||-|.|++||+|. ..+.+.||+|+.+.  ..++..+.|+++|++++     |   .+||+|++.|.   
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            34678899999999999999999 56788999998653  34677889999999873     2   46999999996   


Q ss_pred             -cCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 016917          141 -ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (380)
Q Consensus       141 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili  210 (380)
                       ++..+|||+|++.. +|..++..   ..-+.++...+..|++||+.||.|||.. .||||-||||+|||+
T Consensus       156 pNG~HVCMVfEvLGd-nLLklI~~---s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVLGD-NLLKLIKY---SNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhhhh-HHHHHHHH---hCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeee
Confidence             45688999999844 66666643   2456789999999999999999999985 689999999999998

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=4.3e-33  Score=228.62  Aligned_cols=202  Identities=21%  Similarity=0.275  Sum_probs=160.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC----ChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      .........||+|++|.|=+-++ .+|...|+|.....    ...+..+|+++..+. .+|.+|.|||.....+..++.|
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            33444457799999999988884 57899999975433    233466788776555 7899999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      |.++. +|+.+...- -.....+++..+-+|+..+++||.|||+. -.++|||+||+||||+.+|++|+||||++..+.+
T Consensus       125 E~M~t-Sldkfy~~v-~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  125 ELMDT-SLDKFYRKV-LKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             HHhhh-hHHHHHHHH-HhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            99976 776554221 13467788999999999999999999984 3599999999999999999999999999887765


Q ss_pred             CCCCCCCccccCccceeccccccc----CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEF----RRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~DvwSlG~il~el~tg~~p~~~~~  283 (380)
                      +-..   .-..|-..|||||.+..    ..|+.++||||||+.+.||.+++.||....
T Consensus       202 SiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  202 SIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             hhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            3211   11234445999998753    489999999999999999999999988644

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-32  Score=238.93  Aligned_cols=258  Identities=21%  Similarity=0.295  Sum_probs=187.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCC-----CChHHHHHHHHHHhcCCCCceeeeccceecC------C
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQEN------N  143 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  143 (380)
                      ..+|.-.+.+|.|.- .|..+. .-.+++||+|+...     ....+..+|..++..++|+||++++.++.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            346667788888888 555554 34578999997332     2334567899999999999999999998644      3


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      ..|+||||+.. +|...+.       -.+.=..+..++.|++.|++|||+  .+|+||||||+||++..++.+||.|||+
T Consensus        95 e~y~v~e~m~~-nl~~vi~-------~elDH~tis~i~yq~~~~ik~lhs--~~IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVIL-------MELDHETISYILYQMLCGIKHLHS--AGIIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHH-------HhcchHHHHHHHHHHHHHHHHHHh--cceeecccCcccceecchhheeeccchh
Confidence            56999999976 6665552       223445677899999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHH------------
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV------------  291 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~------------  291 (380)
                      |+.-..+   .....+..|.+|.|||++.+..|...+||||+||++.||++|+-.|.+.+..+.....            
T Consensus       165 ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  165 ARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             hcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            9864332   3456788999999999999999999999999999999999999888755422111110            


Q ss_pred             ----HHHHh----hhcc--cchhhhccccccc---CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          292 ----ELVQN----SRDF--SNLLKILDERLWS---TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       292 ----~~~~~----~~~~--~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                          ...+.    ..+.  -...+.+....+.   ..+.--...+++++.+||..||++|.+++++|++
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                00000    0000  0001111111111   1111223568999999999999999999999986

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-32  Score=252.28  Aligned_cols=194  Identities=22%  Similarity=0.365  Sum_probs=166.1

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECC-CcEEEEEeCCCCCh--H---------HHHHHHHHHhcCC---CCceeeecccee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT--Q---------EFIDEVCFLASIQ---HRNLVTLLGYCQ  140 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~---------~~~~E~~~l~~l~---h~niv~l~~~~~  140 (380)
                      ..+|...+.+|.|+||.|++|.++. ...|++|...++..  +         ..-.|+.||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3458889999999999999999654 56788886443321  1         1346999999997   999999999999


Q ss_pred             cCCeeEEEEEee-cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEc
Q 016917          141 ENNLQFLIYEYI-PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  219 (380)
Q Consensus       141 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~  219 (380)
                      +++++||+||-- ++.+|.+++     +....+.+.....|++|++.|++|||+  .+|||||||-+|+.++.+|-+||+
T Consensus       640 ddd~yyl~te~hg~gIDLFd~I-----E~kp~m~E~eAk~IFkQV~agi~hlh~--~~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFI-----EFKPRMDEPEAKLIFKQVVAGIKHLHD--QGIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhh-----hccCccchHHHHHHHHHHHhccccccc--cCceecccccccEEEecCCeEEEe
Confidence            999999999965 456788888     456778899999999999999999999  779999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCccceecccccccCCC-CcchhhHHHHHHHHHHHcCCCCCC
Q 016917          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASS  280 (380)
Q Consensus       220 DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~p~~  280 (380)
                      |||.+.....    ++-....||..|.|||++.|..| +..-|||++|++||-++....||-
T Consensus       713 dfgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999887544    34567789999999999999999 667899999999999999988874

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.9e-30  Score=224.94  Aligned_cols=207  Identities=34%  Similarity=0.524  Sum_probs=179.2

Q ss_pred             eccCCceEEEEEEECC-CcEEEEEeCCCCCh----HHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCccc
Q 016917           85 IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSI  159 (380)
Q Consensus        85 ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  159 (380)
                      ||+|++|.||++.... +..+++|.......    +.+.+|++.++.++|++++++++++......++++||+.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999654 88999998766544    678999999999999999999999999899999999999999999


Q ss_pred             cccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEcccccccccCCCCCCCCCcc
Q 016917          160 HLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQ  238 (380)
Q Consensus       160 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~-~~~~kl~DFgla~~~~~~~~~~~~~~  238 (380)
                      ++...    ...+++..+..++.+++.++.+||+  .+++|+||+|.||+++. ++.++|+|||.+........  ....
T Consensus        81 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~--~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (215)
T cd00180          81 LLKEN----EGKLSEDEILRILLQILEGLEYLHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT  152 (215)
T ss_pred             HHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence            88321    1467889999999999999999999  67999999999999999 89999999999876544221  1233


Q ss_pred             ccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCH
Q 016917          239 VTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN  317 (380)
Q Consensus       239 ~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (380)
                      ..+...|++||..... .++.++|+|++|+++++|                                             
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence            4566779999998877 888999999999999999                                             


Q ss_pred             HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          318 EGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       318 ~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         ..+.+++.+|++.||.+||++.++++.
T Consensus       188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ---PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence               347899999999999999999999865

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=5.6e-32  Score=255.16  Aligned_cols=251  Identities=21%  Similarity=0.295  Sum_probs=200.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCC---CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      ..+|....++|+|.+|.||+++ .+.+...|+|..+   ........+|+-+++..+||||+.++|.+...+..+++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            3468888999999999999999 5568888888644   44455567899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      |.+|+|.+..+     ....+++.++...++..+.|++|||+  .+-+|||||-.|||+++.|.+|++|||.+..+..+-
T Consensus        94 cgggslQdiy~-----~TgplselqiayvcRetl~gl~ylhs--~gk~hRdiKGanilltd~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   94 CGGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLKYLHS--QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             cCCCcccceee-----ecccchhHHHHHHHhhhhccchhhhc--CCcccccccccceeecccCceeecccCchhhhhhhh
Confidence            99999998873     45778889999999999999999999  568999999999999999999999999987665422


Q ss_pred             CCCCCccccCccceeccccc---ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          232 VAGPSSQVTADEIFLASEVK---EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~---~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                        .......||++|||||+.   ....|..++|+|++|+...|+---++|.....+-     .........       .-
T Consensus       167 --~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-----r~l~LmTkS-------~~  232 (829)
T KOG0576|consen  167 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-----RALFLMTKS-------GF  232 (829)
T ss_pred             --hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-----HHHHHhhcc-------CC
Confidence              234577899999999975   3568999999999999999998877775443321     111111110       01


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ......-+..+++.+.+|++.|+.++|++||+++.++++
T Consensus       233 qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  233 QPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             CCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence            111112234566789999999999999999999988764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=2.6e-30  Score=233.03  Aligned_cols=267  Identities=22%  Similarity=0.303  Sum_probs=196.6

Q ss_pred             HHHHHHhCCCCCCCeeccCCceEEEEEEEC----CCcEEEEEeCC-CCChHHHHHHHHHHhcC-CCCceeeeccceecCC
Q 016917           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRP-GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENN  143 (380)
Q Consensus        70 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  143 (380)
                      +..+...+.|..+++||.|.|++||++...    ....||+|.+. .........|+++|..+ .+.||+++.+.+..++
T Consensus        29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            344556677999999999999999999843    46789999754 45677899999999999 5899999999999999


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEcccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAG  222 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~-~~~~kl~DFg  222 (380)
                      ...+|+||++.....+++        ..++...+..++..+..||.++|.  +|||||||||+|+|.+. .+.-.|.|||
T Consensus       109 ~v~ivlp~~~H~~f~~l~--------~~l~~~~i~~Yl~~ll~Al~~~h~--~GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLY--------RSLSLAEIRWYLRNLLKALAHLHK--NGIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eeEEEecccCccCHHHHH--------hcCCHHHHHHHHHHHHHHhhhhhc--cCccccCCCccccccccccCCceEEech
Confidence            999999999998887776        234577888999999999999999  88999999999999984 4677899999


Q ss_pred             cccccCCC---------------C----------C-----------------CCCCccccCccceecccccccC-CCCcc
Q 016917          223 LRNFLGRT---------------D----------V-----------------AGPSSQVTADEIFLASEVKEFR-RFSEK  259 (380)
Q Consensus       223 la~~~~~~---------------~----------~-----------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~  259 (380)
                      +|......               .          .                 ........||++|+|||++... ..+++
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            98621100               0          0                 0001234589999999998654 45889


Q ss_pred             hhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH--------hh---------h-------------cccchh-hhcc
Q 016917          260 SDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ--------NS---------R-------------DFSNLL-KILD  308 (380)
Q Consensus       260 ~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~--------~~---------~-------------~~~~~~-~~~~  308 (380)
                      +||||.||++..+++++.||-....+ ...+.+.+.        +.         +             .+..+. ..+.
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd-~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~  337 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDD-ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY  337 (418)
T ss_pred             cceeeccceeehhhccccccccCccc-cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence            99999999999999999998654322 222221110        00         0             000010 0000


Q ss_pred             c--c--cc-cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 E--R--LW-STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~--~--~~-~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      +  .  .. .......+..+.+++.+|+..||.+|.|++++|++
T Consensus       338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            0  0  00 11112233478999999999999999999999986

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=3.3e-29  Score=220.27  Aligned_cols=195  Identities=32%  Similarity=0.454  Sum_probs=167.1

Q ss_pred             CCCCCeeccCCceEEEEEEECC-CcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeec
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      |.+.+.||+|++|.||++.... +..+++|.....    ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999999764 889999986654    35678899999999999999999999999899999999999


Q ss_pred             CCCccccccCCCCCCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQK-LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      +++|.+++...     .. +++..+..++.+++.++.+||+  .+++|+||+|.||+++.++.++|+|||.+....... 
T Consensus        81 ~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-  152 (225)
T smart00221       81 GGDLFDYLRKK-----GGKLSEEEARFYLRQILEALEYLHS--LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-  152 (225)
T ss_pred             CCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-
Confidence            99999888422     22 7889999999999999999999  679999999999999999999999999988765432 


Q ss_pred             CCCCccccCccceeccccc-ccCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 016917          233 AGPSSQVTADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~-~~~~~~~~~DvwSlG~il~el~tg~~p~~~  281 (380)
                      ........++..|++||.. ....++.++|+||||+++|+|++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            1122344567779999998 677888899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.8e-30  Score=217.90  Aligned_cols=248  Identities=17%  Similarity=0.289  Sum_probs=180.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC--ChHHHHHHHHHHhcC-CCCceeeeccc-eecCCeeEEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASI-QHRNLVTLLGY-CQENNLQFLIYE  150 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~e  150 (380)
                      ...|.+.+.+|+|.||.+-++.++ .++.+++|..+..  ...+|.+|...--.| .|.||+.-|+. |+..+.++.++|
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            346888999999999999999976 4678899976543  456799998877777 58999988876 566778889999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC--CCCceEEcccccccccC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGLRNFLG  228 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~--~~~~~kl~DFgla~~~~  228 (380)
                      |++.|+|..-+      ....+.+.....++.|+++|+.|||+  +.+||||||.+||||-  +...+||||||+.+..+
T Consensus       103 ~aP~gdL~snv------~~~GigE~~~K~v~~ql~SAi~fMHs--knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  103 FAPRGDLRSNV------EAAGIGEANTKKVFAQLLSAIEFMHS--KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             cCccchhhhhc------CcccccHHHHHHHHHHHHHHHHHhhc--cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999998766      34567788889999999999999999  7799999999999994  44589999999987654


Q ss_pred             CCCCCCCCccccCccceecccccccC-----CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFR-----RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      .+     -....-+..|.+||.....     ..++.+|+|.||+++|.++||+.||+..... .....++.  .+.....
T Consensus       175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~--~w~~rk~  246 (378)
T KOG1345|consen  175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWE--QWLKRKN  246 (378)
T ss_pred             ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHH--HHhcccC
Confidence            32     1222233448899875422     3478899999999999999999999843322 22222221  1111111


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV  345 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll  345 (380)
                      .  .-++....+    ++.+..+.++-|..+|++|=-..++.
T Consensus       247 ~--~~P~~F~~f----s~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  247 P--ALPKKFNPF----SEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             c--cCchhhccc----CHHHHHHHHHhcCCcccccchhHHHH
Confidence            1  111122222    35578889999999999994444433

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.1e-29  Score=262.71  Aligned_cols=197  Identities=16%  Similarity=0.162  Sum_probs=138.9

Q ss_pred             cCCC-Cceeeecccee-------cCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 016917          126 SIQH-RNLVTLLGYCQ-------ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR  197 (380)
Q Consensus       126 ~l~h-~niv~l~~~~~-------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~  197 (380)
                      .++| +||.++++++.       ....++.++||+ +++|.+++..    ....+++..++.++.||+.||.|||+  ++
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN----PDRSVDAFECFHVFRQIVEIVNAAHS--QG  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc----ccccccHHHHHHHHHHHHHHHHHHHh--CC
Confidence            4556 68888888872       334567788887 5599999842    23558899999999999999999998  78


Q ss_pred             eEecCCCCCCeeeCCC-------------------CceEEcccccccccCCCCC--------------CCCCccccCccc
Q 016917          198 VVHKDFKTANVLVDED-------------------FIAKVADAGLRNFLGRTDV--------------AGPSSQVTADEI  244 (380)
Q Consensus       198 ivHrDikp~Nili~~~-------------------~~~kl~DFgla~~~~~~~~--------------~~~~~~~~~~~~  244 (380)
                      |+||||||+|||++..                   +.+|++|||+++.......              ........+|+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            9999999999999653                   4556666666653211000              000112457888


Q ss_pred             eecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHH
Q 016917          245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFI  324 (380)
Q Consensus       245 ~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  324 (380)
                      |+|||++.+..|+.++|||||||+||||++|.+|+....     ........        ....+     ......+...
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~--------~~~~~-----~~~~~~~~~~  242 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRH--------RVLPP-----QILLNWPKEA  242 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHH--------hhcCh-----hhhhcCHHHH
Confidence            999999999999999999999999999999888754211     01110000        00000     0011124467


Q ss_pred             HHHhHccCCCCCCCCCHHHHHHH
Q 016917          325 QLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       325 ~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      +++.+||+.||.+||++.+++++
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhhc
Confidence            88999999999999999999875

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=7.9e-28  Score=204.10  Aligned_cols=171  Identities=20%  Similarity=0.260  Sum_probs=127.2

Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      |+|.+++..    ....+++..++.++.|++.||.|||+  ++      ||+|||++.++.+++  ||++.......   
T Consensus         1 GsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~lH~--~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEV----RGRPLNEEEIWAVCLQCLRALRELHR--QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHh--cC------CcccEeEcCccceee--ccceEeecccc---
Confidence            577777732    24568999999999999999999998  44      999999999999999  99988654321   


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                          ..++..|+|||++.+..|+.++|||||||++|||++|+.||......  ..............      ... ...
T Consensus        64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~------~~~-~~~  130 (176)
T smart00750       64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPAD------DPR-DRS  130 (176)
T ss_pred             ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccC------Ccc-ccc
Confidence                25788999999999999999999999999999999999998654321  11111111110000      000 001


Q ss_pred             CCHHHHH--HHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          315 FTNEGME--EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       315 ~~~~~~~--~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      .+.....  ++.+++.+||+.||.+||++.++++++..+..+.
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~  173 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET  173 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence            1223333  6999999999999999999999999998776543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=5e-26  Score=199.46  Aligned_cols=265  Identities=17%  Similarity=0.236  Sum_probs=216.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCC-CCChHHHHHHHHHHhcCC-CCceeeeccceecCCeeEEEEEee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-GAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      .-.|++.++||+|+||..+.|+ .-++++||||..+ +....++..|-...+.|. .++|...+-+...+..=.||+|++
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            4468999999999999999999 5679999999854 445677889999999884 689999988888777778999988


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-----CceEEccccccccc
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-----FIAKVADAGLRNFL  227 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~-----~~~kl~DFgla~~~  227 (380)
                       |.+|+|...    .+.+.++.+.+..++.|++.-++|+|+  +.+|.|||||+|+||...     ..+.++|||+|+..
T Consensus       107 -GPSLEDLFD----~CgR~FSvKTV~miA~Qmi~rie~vH~--k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  107 -GPSLEDLFD----LCGRRFSVKTVAMIAKQMITRIEYVHE--KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             -CcCHHHHHH----HhcCcccHHhHHHHHHHHHHHHHHHHh--cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence             668988773    567889999999999999999999999  669999999999999643     36899999999988


Q ss_pred             CCCCCC-----CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc
Q 016917          228 GRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  302 (380)
Q Consensus       228 ~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (380)
                      .+....     .......||..||+-....|.+-+...|+-|||-++++.+.|..||.+.......+.++.+....+...
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~  259 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP  259 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence            654432     234567899999999999999999999999999999999999999999887666666665544443332


Q ss_pred             hhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                      +..+         ....|.++..-+.-.-+.+-.+-|..+-+...+..++.+..
T Consensus       260 i~~L---------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g  304 (449)
T KOG1165|consen  260 IEVL---------CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG  304 (449)
T ss_pred             HHHH---------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence            2222         22344667777777777888999999999999999888753

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-26  Score=193.95  Aligned_cols=263  Identities=17%  Similarity=0.230  Sum_probs=208.6

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEE-ECCCcEEEEEeCCCC-ChHHHHHHHHHHhcCCC-CceeeeccceecCCeeEEEEE
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  150 (380)
                      +..+.|.++++||+|+||.+|+|. ..+|..||+|..... .-.++.-|..+.+.|++ ..|..+..+..+...-.+||+
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            345789999999999999999999 667999999985544 34567889999999975 788888888888888899999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---CceEEccccccccc
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVADAGLRNFL  227 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~---~~~kl~DFgla~~~  227 (380)
                      .+ |.+|++.+    +.+.+.++.+.++-++-|++.-++|+|.  ++.+||||||+|+|+.-+   ..+.++|||+|+..
T Consensus        92 LL-GPsLEdLf----nfC~R~ftmkTvLMLaDQml~RiEyvH~--r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   92 LL-GPSLEDLF----NFCSRRFTMKTVLMLADQMLSRIEYVHL--RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             cc-CccHHHHH----HHHhhhhhHHhHHHHHHHHHHHHHHHHh--hccccccCCccceeeccccccceEEEEeccchhhh
Confidence            88 66998887    3577889999999999999999999999  779999999999999633   46899999999877


Q ss_pred             CCCCC-----CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc
Q 016917          228 GRTDV-----AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  302 (380)
Q Consensus       228 ~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (380)
                      -+...     ........||..|.+-....+...+...|+-|+|.+|.++-.|..||++.......+..+.+......-.
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~  244 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP  244 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence            54322     2334577899999988888888889999999999999999999999999887666555555443322111


Q ss_pred             hhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                      +     +    ..+...|.++...+.-|-..--++-|...-+.+.+.-+.
T Consensus       245 i-----e----~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf  285 (341)
T KOG1163|consen  245 I-----E----VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF  285 (341)
T ss_pred             H-----H----HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence            1     1    122233466788888888888888898887766654433

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-25  Score=209.16  Aligned_cols=269  Identities=20%  Similarity=0.201  Sum_probs=201.4

Q ss_pred             CCCCCCeeccCCceEEEEEEECCC--cEEEEEeCCCC---ChHHHHHHHHHHhcCCC----Cceeeeccce-ecCCeeEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQDG--MLVAIKKRPGA---PTQEFIDEVCFLASIQH----RNLVTLLGYC-QENNLQFL  147 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~~~--~~vavK~~~~~---~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  147 (380)
                      +|.+.+.||+|+||.||.|.....  ..+|+|.....   ....+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999996543  57888864432   12267789999988862    6899999998 57778899


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-----CceEEcccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-----FIAKVADAG  222 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~-----~~~kl~DFg  222 (380)
                      ||+.+ |.+|.+.....   ..+.++......++.|++.+|++||+  .|++||||||+|+++...     ..+.|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH~--~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLHS--KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHHh--cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99987 66888866322   25789999999999999999999999  779999999999999754     469999999


Q ss_pred             ccc--ccCCCCC-----CCC-CccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH
Q 016917          223 LRN--FLGRTDV-----AGP-SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  294 (380)
Q Consensus       223 la~--~~~~~~~-----~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~  294 (380)
                      +++  .......     ... .....||..|.++.+..+...+.+.|+||++.++.|+..|..||...............
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~  252 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD  252 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence            998  3322111     111 23456999999999999999999999999999999999999999765532221111111


Q ss_pred             HhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh-cccccccCC
Q 016917          295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE-MNLTTVMGE  364 (380)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~-~~~~~~~~~  364 (380)
                      .....       ..     ......+.++.++...+-..+..++|....+...|.++..+. ....++..+
T Consensus       253 ~~~~~-------~~-----~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw  311 (322)
T KOG1164|consen  253 PRKLL-------TD-----RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDW  311 (322)
T ss_pred             hhhhc-------cc-----cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcc
Confidence            10000       00     022233456777777777799999999999999999888775 444444443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=2e-25  Score=207.36  Aligned_cols=162  Identities=19%  Similarity=0.219  Sum_probs=125.5

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC--CCcEEEEEeCCCC--------ChHHHHHHHHHHhcCCCCceee-eccceecCC
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ--DGMLVAIKKRPGA--------PTQEFIDEVCFLASIQHRNLVT-LLGYCQENN  143 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~  143 (380)
                      ...+|.+.+.||+|+||+||+|...  +++.+|+|+....        ....+.+|+++|++++|+|++. ++++    +
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence            4567999999999999999999864  5777899974322        1345889999999999999985 5432    4


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeeeCCCCceEEcccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF-KTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDi-kp~Nili~~~~~~kl~DFg  222 (380)
                      ..|+||||+++++|....      ...      ...++.+++.||.|||+  +||+|||| ||+|||++.++.+||+|||
T Consensus        92 ~~~LVmE~~~G~~L~~~~------~~~------~~~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLAR------PHG------DPAWFRSAHRALRDLHR--AGITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             CcEEEEEccCCCCHHHhC------ccc------hHHHHHHHHHHHHHHHH--CCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence            579999999999886221      011      13578899999999999  77999999 9999999999999999999


Q ss_pred             cccccCCCCCCCC------CccccCccceecccccccC
Q 016917          223 LRNFLGRTDVAGP------SSQVTADEIFLASEVKEFR  254 (380)
Q Consensus       223 la~~~~~~~~~~~------~~~~~~~~~~~aPE~~~~~  254 (380)
                      +|+..........      .....++..|+|||.+...
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9997755332111      1245577789999987654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.2e-26  Score=196.61  Aligned_cols=246  Identities=23%  Similarity=0.353  Sum_probs=192.5

Q ss_pred             CCCeeccCCceEEEEEEECCCcEEEEEeCC-----CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCC
Q 016917           81 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (380)
Q Consensus        81 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  155 (380)
                      ...+|.....|..|+|+++.+..| .|+..     .....+|..|.-.|+-+.||||...++.|....++.++..|++.|
T Consensus       194 l~tkl~e~hsgelwrgrwqgndiv-akil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQGNDIV-AKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCcccccccccCcchh-hhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            345688899999999999855443 44322     223456888999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016917          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (380)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~  235 (380)
                      +|...|+...   .-...-.+..+++.++++|+.|||+..+-|.---|....++||++.+.+|+=       .+......
T Consensus       273 slynvlhe~t---~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism-------ad~kfsfq  342 (448)
T KOG0195|consen  273 SLYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-------ADTKFSFQ  342 (448)
T ss_pred             HHHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-------ccceeeee
Confidence            9999996542   3345567888999999999999999865555557899999999998877641       11111111


Q ss_pred             CccccCccceecccccccCCCC---cchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          236 SSQVTADEIFLASEVKEFRRFS---EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~---~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                      .....-.+.|++||.+...+-+   ..+|+|||++++||+.|+.-||....+-+               --.++.-+.++
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme---------------cgmkialeglr  407 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME---------------CGMKIALEGLR  407 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh---------------hhhhhhhcccc
Confidence            1223345669999999876554   47899999999999999999998776522               12345556777


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                      ...|+..+.++.+++.-|...||.+||.+..++-.|+.+.
T Consensus       408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            8899999999999999999999999999999999998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=2.4e-25  Score=219.93  Aligned_cols=252  Identities=21%  Similarity=0.226  Sum_probs=184.6

Q ss_pred             CCCCeeccCCceEEEEEEEC-CCcEEEEEeC-----CCCChH----HHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           80 SDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKR-----PGAPTQ----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        80 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~-----~~~~~~----~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ....++|.|.+|.|+.+... .....+.|..     +.....    .+..|..+-..++|||++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999977777633 2332333321     111111    1456777778899999999888887776666669


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      |||++ +|..++     .....+....+-.++.|++.|++|+|+  .||.|||+|++|++++.+|.+||+|||.+....-
T Consensus       401 E~~~~-Dlf~~~-----~~~~~~~~~e~~c~fKqL~~Gv~y~h~--~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLV-----MSNGKLTPLEADCFFKQLLRGVKYLHS--MGLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHH-----hcccccchhhhhHHHHHHHHHHHHHHh--cCceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99999 988887     233467777888899999999999999  6699999999999999999999999999876533


Q ss_pred             CCCC--CCCccccCccceecccccccCCCCc-chhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          230 TDVA--GPSSQVTADEIFLASEVKEFRRFSE-KSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       230 ~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~-~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      ....  ......+|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||......+... .+. ..      ....
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~~-~~------~~~~  544 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KTN-NY------SDQR  544 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hhh-cc------cccc
Confidence            2222  3455778888999999999999976 5899999999999999999998665443321 000 00      0000


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      -........-...+.+.+.++.+||+.||.+|.|++++++.
T Consensus       545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            00011112233456778999999999999999999999864

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=3.2e-23  Score=191.76  Aligned_cols=258  Identities=26%  Similarity=0.344  Sum_probs=192.7

Q ss_pred             CCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCC-ceeeeccceecCCeeEEEEEe
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHR-NLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  151 (380)
                      |.....||.|+||.||.+...  ..+++|.....      ....+.+|..++..+.|+ +++++.+.+......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999976  77888864322      245688999999999887 799999999877778999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEcccccccccCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRT  230 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~-~~kl~DFgla~~~~~~  230 (380)
                      +.++++.+++......  ..+.......+..|++.++.|+|+  .+++|||+||+||+++..+ .++++|||++......
T Consensus        80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~--~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999998665321110  367888999999999999999999  6699999999999999988 7999999999865443


Q ss_pred             CCCC----CCccccCccceeccccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC-CcccHHHHHHhhhcccc
Q 016917          231 DVAG----PSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPD-SSQDLVELVQNSRDFSN  302 (380)
Q Consensus       231 ~~~~----~~~~~~~~~~~~aPE~~~~---~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~  302 (380)
                      ....    ......++..|++||.+.+   ..++...|+||+|++++++++|..||...... ........+...... .
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~  234 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-S  234 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-c
Confidence            3221    3456789999999999987   57889999999999999999999996654421 011111111111100 0


Q ss_pred             hhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..    ..............+.+++..|+..+|..|.+..+....
T Consensus       235 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         235 LA----SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cc----cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00    000000001223568899999999999999999887765

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=8.3e-23  Score=174.79  Aligned_cols=136  Identities=19%  Similarity=0.140  Sum_probs=104.5

Q ss_pred             CCeeccCCceEEEEEEECCCcEEEEEeCCCCCh------------HHH-----------------HHHHHHHhcCCCCce
Q 016917           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT------------QEF-----------------IDEVCFLASIQHRNL  132 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~------------~~~-----------------~~E~~~l~~l~h~ni  132 (380)
                      .+.||+|+||.||+|...+|+.||+|+......            ..|                 ..|.+.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            467999999999999987899999997543210            112                 348899999987766


Q ss_pred             eeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCCeeeC
Q 016917          133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL-HSLSPRVVHKDFKTANVLVD  211 (380)
Q Consensus       133 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~ivHrDikp~Nili~  211 (380)
                      .....+..  ...++||||++++++.....     ....++......++.|++.+|.++ |+  .+|+||||||+|||++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~l~H~--~giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL-----KDAPLSESKARELYLQVIQIMRILYQD--CRLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh-----hcCCCCHHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEE
Confidence            43332222  22389999999877654431     234678888999999999999999 67  6799999999999998


Q ss_pred             CCCceEEccccccccc
Q 016917          212 EDFIAKVADAGLRNFL  227 (380)
Q Consensus       212 ~~~~~kl~DFgla~~~  227 (380)
                       ++.++|+|||+|...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=9.6e-24  Score=199.91  Aligned_cols=230  Identities=22%  Similarity=0.252  Sum_probs=182.9

Q ss_pred             eeccCCceEEEEEEE----CCCcEEEEEeCCC-----CChHHHHHHHHHHhcCC-CCceeeeccceecCCeeEEEEEeec
Q 016917           84 LIGEGKFGEVYKGLL----QDGMLVAIKKRPG-----APTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        84 ~ig~G~~g~V~~~~~----~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      ++|+|.||.|+++..    ..+..+|+|....     ........|..++...+ ||.++++...+......++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998863    3356677774322     12224566888888886 9999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                      +|++...+     .....+.+.....+...++.++.++|+  .+|+|||+|++||+++.+|++++.|||+++..-+... 
T Consensus        81 gg~lft~l-----~~~~~f~~~~~~~~~aelaLald~lh~--l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-  152 (612)
T KOG0603|consen   81 GGDLFTRL-----SKEVMFDELDVAFYLAELALALDHLHK--LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-  152 (612)
T ss_pred             cchhhhcc-----ccCCchHHHHHHHHHHHHHHHHhhcch--hHHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence            99998777     345566777778888899999999999  6799999999999999999999999999987644221 


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  313 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (380)
                           .+||..|||||++.  +....+|+||||++++||+||..||..          +..         ..++.  ...
T Consensus       153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~---------~~Il~--~~~  204 (612)
T KOG0603|consen  153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTM---------KRILK--AEL  204 (612)
T ss_pred             -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHH---------HHHhh--hcc
Confidence                 18899999999997  678899999999999999999999886          111         11111  113


Q ss_pred             CCCHHHHHHHHHHHhHccCCCCCCCCCH--HHHHHHHH
Q 016917          314 TFTNEGMEEFIQLIVRCLDPSSERRPSM--SDVVTELD  349 (380)
Q Consensus       314 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~--~~ll~~L~  349 (380)
                      ..|.+.+..+++++..++..+|..|...  ..+.++..
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~  242 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ  242 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence            5677888999999999999999999865  34444433

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.88  E-value=1.5e-22  Score=191.70  Aligned_cols=216  Identities=25%  Similarity=0.386  Sum_probs=163.5

Q ss_pred             HhcCCCCceeeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe-EecC
Q 016917          124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV-VHKD  202 (380)
Q Consensus       124 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~i-vHrD  202 (380)
                      |+.+.|.|+.+|+|.+.++...+.|.+||..|+|.|.+..    ....+.+.....+.++++.||.|||.  ..| .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeee
Confidence            4678999999999999999999999999999999999953    35667888889999999999999998  334 9999


Q ss_pred             CCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCC-------CCcchhhHHHHHHHHHHHcC
Q 016917          203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR-------FSEKSDVYSFGVFLLELVSG  275 (380)
Q Consensus       203 ikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~DvwSlG~il~el~tg  275 (380)
                      ++++|++++..+.+||+|||+.....+...........-...|.|||.+.+..       .+.+.|+||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            99999999999999999999987764311111112222344699999987642       35679999999999999999


Q ss_pred             CCCCCCCCCCCcc-cHHHHHHhhhcccchhhhcccccccCCC--HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          276 REASSSLSPDSSQ-DLVELVQNSRDFSNLLKILDERLWSTFT--NEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       276 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                      +.||......... +....+..   .      -.+..++...  .+..+++..++.+||..+|.+||+++++-..++.+.
T Consensus       155 ~~~~~~~~~~~~~~eii~~~~~---~------~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  155 SGPFDLRNLVEDPDEIILRVKK---G------GSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             cCccccccccCChHHHHHHHHh---c------CCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            9999875433222 22222222   0      0011111111  144457999999999999999999999998887766


Q ss_pred             hh
Q 016917          353 DK  354 (380)
Q Consensus       353 ~~  354 (380)
                      ..
T Consensus       226 ~~  227 (484)
T KOG1023|consen  226 KG  227 (484)
T ss_pred             cc
Confidence            54

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=1.4e-22  Score=175.53  Aligned_cols=170  Identities=13%  Similarity=0.131  Sum_probs=130.2

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC--hHH----------HHHHHHHHhcCCCCceeeecccee
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQE----------FIDEVCFLASIQHRNLVTLLGYCQ  140 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~----------~~~E~~~l~~l~h~niv~l~~~~~  140 (380)
                      ....++|+..+++|.|+||.||+... ++..+|+|...+..  .+.          +.+|+..+.++.|++|....+++.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            34578899999999999999999766 57789999864322  111          578888999999999999988865


Q ss_pred             cC--------CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC
Q 016917          141 EN--------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE  212 (380)
Q Consensus       141 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~  212 (380)
                      ..        +..++||||++|.+|.++..         ++.    ....+++.++..+|+  .|++|||++|+|+++++
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~--~gi~H~Dikp~Nili~~  170 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQ--HGMVSGDPHKGNFIVSK  170 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHH--cCCccCCCChHHEEEeC
Confidence            33        35789999999999877631         112    245689999999999  77999999999999999


Q ss_pred             CCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHH
Q 016917          213 DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV  273 (380)
Q Consensus       213 ~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~  273 (380)
                      ++ ++|+|||..........              .........|+.++|+||||+.+....
T Consensus       171 ~g-i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CC-EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence            88 99999998765422110              011334456778999999999876554

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.5e-21  Score=165.77  Aligned_cols=185  Identities=19%  Similarity=0.098  Sum_probs=135.6

Q ss_pred             CCCCeeccCCceEEEEEEECCCcEEEEEeCCCCCh--H-----HHHHHHHHHhcCC-CCceeeeccceecCCeeEEEEEe
Q 016917           80 SDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT--Q-----EFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        80 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--~-----~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      .+...|++|+||+||.+.. .+.+++.+.......  .     .+.+|+++|++|. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3457899999999997766 677888776544332  2     4678999999995 5889999886    346999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeeeCCCCceEEcccccccccCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF-KTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDi-kp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      +.|.+|...+.      ..      ...++.|++.+|.++|+  .||+|||| ||+|||++.++.++|+|||++....+.
T Consensus        80 I~G~~L~~~~~------~~------~~~~~~qi~~~L~~lH~--~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         80 LAGAAMYQRPP------RG------DLAYFRAARRLLQQLHR--CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ecCccHHhhhh------hh------hHHHHHHHHHHHHHHHH--CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            99988864331      11      13467899999999999  77999999 799999999999999999999865432


Q ss_pred             CCC----CC-------CccccCccceecccccccC-CCC-cchhhHHHHHHHHHHHcCCCCCCCCC
Q 016917          231 DVA----GP-------SSQVTADEIFLASEVKEFR-RFS-EKSDVYSFGVFLLELVSGREASSSLS  283 (380)
Q Consensus       231 ~~~----~~-------~~~~~~~~~~~aPE~~~~~-~~~-~~~DvwSlG~il~el~tg~~p~~~~~  283 (380)
                      ...    ..       ......++.|++|+-..-. ..+ ...++++.|+-+|.++|++.++.+..
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            210    00       0112245556777643322 334 56799999999999999998866544

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=1.7e-21  Score=167.19  Aligned_cols=139  Identities=18%  Similarity=0.135  Sum_probs=106.5

Q ss_pred             CCeeccCCceEEEEEEECCCcEEEEEeCCCCCh-----------------------------HHHHHHHHHHhcCCCCce
Q 016917           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT-----------------------------QEFIDEVCFLASIQHRNL  132 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------------------------~~~~~E~~~l~~l~h~ni  132 (380)
                      .+.||+|++|.||+|...+|+.||+|.......                             ..+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            478999999999999977899999997443210                             113468888999988887


Q ss_pred             eeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC
Q 016917          133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE  212 (380)
Q Consensus       133 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~  212 (380)
                      .....+....  .++||||++++++.....     ....++......++.|++.++.++|+. .||+||||||+|||++ 
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l-----~~~~~~~~~~~~i~~~l~~~l~~lH~~-~givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRL-----KDVPLEEEEAEELYEQVVEQMRRLYQE-AGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhh-----hhccCCHHHHHHHHHHHHHHHHHHHHh-CCEecCCCChhhEEEE-
Confidence            4433333222  389999999875543321     234466788899999999999999982 4699999999999999 


Q ss_pred             CCceEEcccccccccCC
Q 016917          213 DFIAKVADAGLRNFLGR  229 (380)
Q Consensus       213 ~~~~kl~DFgla~~~~~  229 (380)
                      ++.++|+|||++....+
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            78999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=2.4e-22  Score=199.83  Aligned_cols=244  Identities=19%  Similarity=0.236  Sum_probs=172.6

Q ss_pred             CCCCCCeeccCCceEEEEEEECCCcEEEEEeC----CCCChHHHHHHHHH--HhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKR----PGAPTQEFIDEVCF--LASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~----~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      ++...+.||++.|=+|.+|++..|. |++|.+    +......+.++++-  ...++|||.+.+.-+...+...|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5667789999999999999998887 777753    23334455544433  4455899999999888888888999898


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc--CC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GR  229 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~--~~  229 (380)
                      ... +|.|++     ..+..+......-|+.|++.|+.-+|.  .||+|+|||.+||||+.-.=+.|+||..-+..  ..
T Consensus       103 vkh-nLyDRl-----STRPFL~~iEKkWiaFQLL~al~qcH~--~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  103 VKH-NLYDRL-----STRPFLVLIEKKWIAFQLLKALSQCHK--LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             Hhh-hhhhhh-----ccchHHHHHHHHHHHHHHHHHHHHHHH--cCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            866 888888     345556666777799999999999999  77999999999999998777899999764322  11


Q ss_pred             CCCCCCC---ccccCccceecccccccC----------C-CCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHH
Q 016917          230 TDVAGPS---SQVTADEIFLASEVKEFR----------R-FSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELV  294 (380)
Q Consensus       230 ~~~~~~~---~~~~~~~~~~aPE~~~~~----------~-~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~  294 (380)
                      +......   .....-.+|.|||.+-..          . .+++-||||+||++.|+++ |++||.-      .++..+-
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr  248 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYR  248 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHh
Confidence            1111111   111223469999975431          1 4578899999999999998 5776652      2222221


Q ss_pred             Hhh-hcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          295 QNS-RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       295 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ... ...+.+.+.+.           ...+++++..|++.||.+|.++++.|+.
T Consensus       249 ~~~~~~~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  249 SGNADDPEQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ccCccCHHHHHHhCc-----------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence            111 00111111110           1247899999999999999999999987

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=1.7e-21  Score=173.90  Aligned_cols=230  Identities=22%  Similarity=0.255  Sum_probs=142.0

Q ss_pred             CCCCCeeccCCceEEEEEEEC-CCcEEEEEeC--CCC----ChHHHHHHHHHHhcCCC----------Cceeeecccee-
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKR--PGA----PTQEFIDEVCFLASIQH----------RNLVTLLGYCQ-  140 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~--~~~----~~~~~~~E~~~l~~l~h----------~niv~l~~~~~-  140 (380)
                      +...+.||.|+++.||.++.. +++.+|+|..  ...    ..+++.+|.-....+.+          -.++.-++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            344578999999999999965 5899999962  222    22345555444433322          11222222111 


Q ss_pred             --------cC---C-----eeEEEEEeecCCCccccccC---CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 016917          141 --------EN---N-----LQFLIYEYIPNGSVSIHLYG---PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHK  201 (380)
Q Consensus       141 --------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHr  201 (380)
                              ..   .     +.+++|+-+.+ +|.+.+..   ... ....+....++.+..|++..+++||+  .|+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~-~~~~l~~~arl~lT~Q~I~lvA~Lh~--~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQ-THSPLAFAARLSLTVQMIRLVANLHS--YGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTT-TSHHHHHHHHHHHHHHHHHHHHHHHH--TTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhccc-ccchhHHHHHHHHHHHHHHHHHHHhh--cceEec
Confidence                    11   1     23667777744 77665421   111 12334456667788999999999999  679999


Q ss_pred             CCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceeccccccc--------CCCCcchhhHHHHHHHHHHH
Q 016917          202 DFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF--------RRFSEKSDVYSFGVFLLELV  273 (380)
Q Consensus       202 Dikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~DvwSlG~il~el~  273 (380)
                      ||+|+|++++.+|.++|+||+.....+....     ....+..|.+||....        -.++.+.|.|+||+++|.|+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            9999999999999999999987765443211     1334466899997543        25788999999999999999


Q ss_pred             cCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCC
Q 016917          274 SGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR  338 (380)
Q Consensus       274 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  338 (380)
                      +|..||....+......                    ...... +.++.+++||..+|+.||.+|
T Consensus       245 C~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999986543222111                    112222 778899999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=5.3e-21  Score=193.13  Aligned_cols=254  Identities=19%  Similarity=0.291  Sum_probs=188.9

Q ss_pred             HHHHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcCC---CCceeeeccceecCCeeEE
Q 016917           71 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        71 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  147 (380)
                      +.+.....|.+.+.||+|+||.||+|...+|+.||+|..++...-+|.--.+++.+|+   -+.|..+...+...+.-++
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            4445566788889999999999999998889999999988777766655556666665   2345555555566677789


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-------CCCceEEcc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-------EDFIAKVAD  220 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~-------~~~~~kl~D  220 (380)
                      |+||.+.|+|.+.+.     ..+...+..+..+..|++..+++||.  .+|||+||||+|+||.       ++..++|+|
T Consensus       772 v~ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~--~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHA--MGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHh--cceecccCCcceeEeecccCCCCcccceEEEe
Confidence            999999999999994     56778889999999999999999999  5699999999999993       345799999


Q ss_pred             cccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc
Q 016917          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF  300 (380)
Q Consensus       221 Fgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  300 (380)
                      ||-+-.+.--.....-.....|..+--+|+..|++++.+.|.|.++.+++-|+.|+.--              ..+....
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--------------~~~g~~~  910 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--------------VKNGSSW  910 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--------------hcCCcce
Confidence            99886654322222334556777888999999999999999999999999999997321              0000000


Q ss_pred             ---cchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          301 ---SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       301 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                         ..+.+..+.           +-..+++..+|+.|...=|...++...|++.+.+..
T Consensus       911 ~~~~~~~Ry~~~-----------~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~  958 (974)
T KOG1166|consen  911 MVKTNFPRYWKR-----------DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHF  958 (974)
T ss_pred             eccccchhhhhH-----------HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHH
Confidence               001111111           224566777777666666888888888888776643

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=2.7e-20  Score=160.81  Aligned_cols=133  Identities=19%  Similarity=0.252  Sum_probs=101.2

Q ss_pred             CCCCeeccCCceEEEEEEECCCcEEEEEeCCCC---ChHHHHHHHHHHhcC-----CCCceeeeccceecCC---eeE-E
Q 016917           80 SDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA---PTQEFIDEVCFLASI-----QHRNLVTLLGYCQENN---LQF-L  147 (380)
Q Consensus        80 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-l  147 (380)
                      ...+.||+|+||.||. ...++.. +||+....   ..+.+.+|+.+++.+     +||||++++|++.++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3457899999999996 3334444 68875433   456789999999999     5799999999998763   433 7


Q ss_pred             EEEe--ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCCCeeeCC----CCceEEcc
Q 016917          148 IYEY--IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL-AHLHSLSPRVVHKDFKTANVLVDE----DFIAKVAD  220 (380)
Q Consensus       148 v~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~ivHrDikp~Nili~~----~~~~kl~D  220 (380)
                      |+||  +.+++|.+++..      ..+.+.  ..++.+++.++ +|||+  .+|+||||||+|||++.    ++.++|+|
T Consensus        83 I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~--~~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLD--NRIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            8999  557899999932      234444  35577888777 99999  67999999999999974    34899999


Q ss_pred             cccc
Q 016917          221 AGLR  224 (380)
Q Consensus       221 Fgla  224 (380)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5544

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.81  E-value=1.4e-20  Score=187.12  Aligned_cols=215  Identities=21%  Similarity=0.220  Sum_probs=148.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      ..+|..++.|..|++|.||.++++ +.+.+|+|+.++...-  ++   ++..-.+|.+|                     
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~lil--Rn---ilt~a~npfvv---------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLIL--RN---ILTFAGNPFVV---------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccchhh--hc---cccccCCccee---------------------
Confidence            356888999999999999999966 4667787654322110  00   22222233222                     


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC---
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---  231 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~---  231 (380)
                      |+-...+.     ..+.++.        +++.+++|+|+  .+|+|||+||+|.+|+.-|++|++|||+.+..-...   
T Consensus       136 gDc~tllk-----~~g~lPv--------dmvla~Eylh~--ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 GDCATLLK-----NIGPLPV--------DMVLAVEYLHS--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             chhhhhcc-----cCCCCcc--------hhhHHhHhhcc--CCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence            34443442     2233332        22779999999  779999999999999999999999999976532110   


Q ss_pred             ----------CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc
Q 016917          232 ----------VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       232 ----------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                                ........+||+.|+|||++.-.+|+..+|+|++|+++||.+-|..||.+..+++.   ...+.      
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel---fg~vi------  271 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL---FGQVI------  271 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH---Hhhhh------
Confidence                      01123456899999999999999999999999999999999999999998765322   11110      


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV  345 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll  345 (380)
                           -|.-.|.+.....+++.++++.++|+.+|..|.-....+
T Consensus       272 -----sd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~  310 (1205)
T KOG0606|consen  272 -----SDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGAL  310 (1205)
T ss_pred             -----hhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence                 112223333445568899999999999999996443333

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=1.5e-19  Score=159.85  Aligned_cols=139  Identities=18%  Similarity=0.133  Sum_probs=107.8

Q ss_pred             CCCCCCeeccCCceEEEEEE--ECCCcEEEEEeCCCCCh---------------------------HHHHHHHHHHhcCC
Q 016917           78 NFSDKNLIGEGKFGEVYKGL--LQDGMLVAIKKRPGAPT---------------------------QEFIDEVCFLASIQ  128 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~--~~~~~~vavK~~~~~~~---------------------------~~~~~E~~~l~~l~  128 (380)
                      .|++.+.||+|+||.||+|.  ..+|+.||+|.......                           ..+..|.+.++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48889999999999999998  56899999997442210                           12457999999986


Q ss_pred             C--CceeeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCC
Q 016917          129 H--RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR-VVHKDFKT  205 (380)
Q Consensus       129 h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-ivHrDikp  205 (380)
                      +  ..+.+.+++    ...++||||++++++.....     ............++.|++.++.+||+  .+ ++||||||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~g~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL-----KDVEPEEEEEFELYDDILEEMRKLYK--EGELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccc-----ccCCcchHHHHHHHHHHHHHHHHHHh--cCCEEeCCCCh
Confidence            5  334444443    23489999999988876542     22334455667899999999999999  77 99999999


Q ss_pred             CCeeeCCCCceEEcccccccccC
Q 016917          206 ANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       206 ~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      +||+++ ++.++|+|||.+....
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccC
Confidence            999999 8899999999987543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.80  E-value=2.8e-19  Score=160.83  Aligned_cols=198  Identities=18%  Similarity=0.207  Sum_probs=138.8

Q ss_pred             CCCceeeeccceecC---------------------------CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHH
Q 016917          128 QHRNLVTLLGYCQEN---------------------------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI  180 (380)
Q Consensus       128 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i  180 (380)
                      +|||||++.+.|.+.                           ..+|+||..++. +|..++..      +..+.....-+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~------~~~s~r~~~~~  346 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT------RHRSYRTGRVI  346 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc------CCCchHHHHHH
Confidence            599999998877422                           245899988766 88888842      33455566678


Q ss_pred             HHHHHHHHHHHhcCCCCeEecCCCCCCeee--CCC--CceEEcccccccccCCC----CCCCCCccccCccceecccccc
Q 016917          181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLV--DED--FIAKVADAGLRNFLGRT----DVAGPSSQVTADEIFLASEVKE  252 (380)
Q Consensus       181 ~~~i~~~l~~LH~~~~~ivHrDikp~Nili--~~~--~~~kl~DFgla~~~~~~----~~~~~~~~~~~~~~~~aPE~~~  252 (380)
                      ..|+++|+.|||+  .||.|||+|++|||+  |+|  ..+.++|||.+---+..    .+..-.-...|....||||+..
T Consensus       347 laQlLEav~hL~~--hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  347 LAQLLEAVTHLHK--HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHH--ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            8999999999999  569999999999998  333  36789999975322111    1111112334666789999876


Q ss_pred             cCCC------CcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHH
Q 016917          253 FRRF------SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQL  326 (380)
Q Consensus       253 ~~~~------~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  326 (380)
                      ..+-      -.++|.|+.|.+.||+++...||-...+-.. +...              ..+...+..+..+++.++++
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~r~--------------Yqe~qLPalp~~vpp~~rql  489 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DTRT--------------YQESQLPALPSRVPPVARQL  489 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-chhh--------------hhhhhCCCCcccCChHHHHH
Confidence            4321      2589999999999999999999986332110 0000              11111245667788899999


Q ss_pred             HhHccCCCCCCCCCHHHHHHHHH
Q 016917          327 IVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       327 i~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                      +...|+.||.+|++..-....|.
T Consensus       490 V~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHhcCCccccCCccHHHhHHH
Confidence            99999999999998876555443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=1.3e-18  Score=151.92  Aligned_cols=131  Identities=21%  Similarity=0.293  Sum_probs=108.4

Q ss_pred             CeeccCCceEEEEEEECCCcEEEEEeCCCCC-----------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +.||+|++|.||+|.. .+..+++|......           ...+.+|++++..+.|+++.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 57788898643221           12467899999999999888777777677778999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      ++|++|.+.+...        .. .+..++.+++.+|.++|+  .+++|+|++|+|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~--~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHS--AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHh--CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999887321        11 677899999999999999  7799999999999999 78899999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=3.8e-18  Score=147.47  Aligned_cols=135  Identities=21%  Similarity=0.134  Sum_probs=105.2

Q ss_pred             CCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC-------------------------hHHHHHHHHHHhcCCCCc
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-------------------------TQEFIDEVCFLASIQHRN  131 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~E~~~l~~l~h~n  131 (380)
                      ..|.+.+.||+|+||.||++...+|+.||+|......                         ......|..++..+.|++
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            3478889999999999999998889999999633211                         112566888888887764


Q ss_pred             --eeeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 016917          132 --LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL  209 (380)
Q Consensus       132 --iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nil  209 (380)
                        +...++    ....++||||+++++|.....     .      .....++.+++.++.++|+  .+++||||||+||+
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-----~------~~~~~~~~~i~~~l~~lh~--~gi~H~Dl~p~Nil  157 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV-----L------EDPEEVLDEILEEIVKAYK--HGIIHGDLSEFNIL  157 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhccc-----c------ccHHHHHHHHHHHHHHHHH--CCCCcCCCCcccEE
Confidence              444443    234589999999998876541     0      2345688899999999999  77999999999999


Q ss_pred             eCCCCceEEcccccccccC
Q 016917          210 VDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       210 i~~~~~~kl~DFgla~~~~  228 (380)
                      +++++.++|+|||.+....
T Consensus       158 l~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         158 VDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             EcCCCcEEEEECCccccCC
Confidence            9999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=3.3e-18  Score=148.03  Aligned_cols=128  Identities=22%  Similarity=0.308  Sum_probs=101.7

Q ss_pred             eeccCCceEEEEEEECCCcEEEEEeCCCCC-----------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           84 LIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        84 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      .||+|+||.||+|.. ++..+++|......           ...+.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999995 46789999733211           134667999999998876655544555566678999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      +|++|.+.+...     ..       .++.+++.+|.+||+  .+++|+|++|.||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~-----~~-------~~~~~i~~~l~~lH~--~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEG-----ND-------ELLREIGRLVGKLHK--AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhc-----HH-------HHHHHHHHHHHHHHH--CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999998876211     10       688999999999999  7799999999999999 789999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=2.6e-19  Score=166.94  Aligned_cols=174  Identities=21%  Similarity=0.348  Sum_probs=128.1

Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      .+|+.|++|..++|.+|+.....  ....++...+.++.|++.|+.|     ++.+|||+||.||+...+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhh
Confidence            46899999999999999965433  3445677788899999999999     4599999999999999999999999999


Q ss_pred             ccccCCCC----CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCCcccHHHHHHhhh
Q 016917          224 RNFLGRTD----VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG-REASSSLSPDSSQDLVELVQNSR  298 (380)
Q Consensus       224 a~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~  298 (380)
                      ........    .........||..||+||.+.+..|+.++||||||++|+|+++- ..++..            ..   
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------------~~---  467 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------------IA---  467 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------------HH---
Confidence            87765433    12234567799999999999999999999999999999999972 211110            00   


Q ss_pred             cccchhh-hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHH
Q 016917          299 DFSNLLK-ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV  344 (380)
Q Consensus       299 ~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~l  344 (380)
                      ...++.+ .+.+.....+     +.-..|+.+++...|.+||++.+.
T Consensus       468 t~~d~r~g~ip~~~~~d~-----p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  468 TLTDIRDGIIPPEFLQDY-----PEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hhhhhhcCCCChHHhhcC-----cHHHHHHHHhcCCCcccCchHHHH
Confidence            0011111 1111111112     334689999999999999954443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=4.9e-18  Score=168.36  Aligned_cols=134  Identities=23%  Similarity=0.282  Sum_probs=107.8

Q ss_pred             CCCCCCCeeccCCceEEEEEEECCCcEEEEEe-CCC----C------ChHHHHHHHHHHhcCCCCceeeeccceecCCee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPG----A------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~-~~~----~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      ..|...+.||+|+||+||+|.+.... +++|+ ...    .      ..+.+.+|+++++.++|++++....++......
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34566789999999999999875443 33332 111    1      123577899999999999998887777777778


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++||||+++++|.+++.             ....++.+++.+|.+||+  .+++||||||+|||+ .++.++|+|||+++
T Consensus       412 ~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~--~giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK--AGIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             EEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh--CCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            99999999999988772             346789999999999999  779999999999999 67789999999987


Q ss_pred             cc
Q 016917          226 FL  227 (380)
Q Consensus       226 ~~  227 (380)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            53

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=4.7e-18  Score=168.34  Aligned_cols=254  Identities=19%  Similarity=0.200  Sum_probs=186.5

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC--CCcEEEEEeCCCCC--h---HHHHHHHHHHhcCC-CCceeeeccceecCCeeEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ--DGMLVAIKKRPGAP--T---QEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~--~---~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  148 (380)
                      ..|.+.+.||+|+|+.|-.....  ....+|.|......  .   .....|..+-+.+. |+|++.+++...+.+..++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            35677788999999999888753  34556666533222  1   22334666666776 99999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeeCCCC-ceEEcccccccc
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH-SLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNF  226 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~ivHrDikp~Nili~~~~-~~kl~DFgla~~  226 (380)
                      ++|.+++++.+.+...   .....+....-.++.|+..++.|+| .  .++.||||||+|.+++..+ ..+++|||+|..
T Consensus       100 ~~~s~g~~~f~~i~~~---~~~~~~~~~~~~~~~ql~s~l~~~H~~--~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHP---DSTGTSSSSASRYLPQLNSGLSYLHPE--NGVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             cCcccccccccccccC---CccCCCCcchhhhhhhhccCccccCcc--cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            9999999988777211   1113344555678999999999999 6  7899999999999999999 999999999988


Q ss_pred             cCC-CCCCCCCccccC-ccceecccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          227 LGR-TDVAGPSSQVTA-DEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       227 ~~~-~~~~~~~~~~~~-~~~~~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      ... ...........| +..|.|||...+..| ....|+||.|+++.-+++|..|+........ ....+....      
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~------  247 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK------  247 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc------
Confidence            766 444444556667 899999999988544 6789999999999999999999886654321 111111100      


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       ....    ............+++.+++..+|..|.+.+++-..
T Consensus       248 -~~~~----~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  248 -GRFT----QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             -cccc----cCccccCChhhhhcccccccCCchhcccccccccc
Confidence             0000    11112334567889999999999999999988654

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=4.6e-16  Score=127.79  Aligned_cols=133  Identities=23%  Similarity=0.274  Sum_probs=111.0

Q ss_pred             CCCeeccCCceEEEEEEECCCcEEEEEeCCCCC-hHHHHHHHHHHhcCCC--CceeeeccceecCCeeEEEEEeecCCCc
Q 016917           81 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-TQEFIDEVCFLASIQH--RNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        81 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L  157 (380)
                      +.+.||+|.++.||++.... ..+++|...... ...+..|...++.++|  .++++++++....+..++++||++++.+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            45779999999999999754 778999865443 3578899999999976  5899999988888889999999988766


Q ss_pred             cccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS-PRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      ...            +......++.+++.++.++|... .+++|+|++|+||++++++.++++|||.+..
T Consensus        81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          81 DEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            533            44566778999999999999842 3699999999999999989999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.67  E-value=2.6e-16  Score=134.67  Aligned_cols=135  Identities=22%  Similarity=0.219  Sum_probs=93.5

Q ss_pred             CCeeccCCceEEEEEEECCCcEEEEEeCCCCCh-----HHH----------------------HHHHHHHhcCCCC--ce
Q 016917           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT-----QEF----------------------IDEVCFLASIQHR--NL  132 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~----------------------~~E~~~l~~l~h~--ni  132 (380)
                      .+.||+|+||+||+|...+++.||+|.......     ...                      ..|.+.+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999987899999997443211     111                      2344444444332  23


Q ss_pred             eeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC
Q 016917          133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE  212 (380)
Q Consensus       133 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~  212 (380)
                      .+.++.    ...++||||++++.+.......     .... .....++.+++.++.++|.. .+|+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~-----~~~~-~~~~~~~~~~~~~l~~lh~~-~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD-----VRLL-EDPEELYDQILELMRKLYRE-AGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhh-----hhhc-ccHHHHHHHHHHHHHHHhhc-cCcCcCCCChhhEEEE-
Confidence            333332    2358999999996543222110     0001 45678899999999999982 4599999999999999 


Q ss_pred             CCceEEcccccccccC
Q 016917          213 DFIAKVADAGLRNFLG  228 (380)
Q Consensus       213 ~~~~kl~DFgla~~~~  228 (380)
                      ++.++++|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8999999999987553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=6.5e-16  Score=136.94  Aligned_cols=131  Identities=16%  Similarity=0.131  Sum_probs=99.2

Q ss_pred             Ceec-cCCceEEEEEEECCCcEEEEEeCCC----------------CChHHHHHHHHHHhcCCCCce--eeeccceecC-
Q 016917           83 NLIG-EGKFGEVYKGLLQDGMLVAIKKRPG----------------APTQEFIDEVCFLASIQHRNL--VTLLGYCQEN-  142 (380)
Q Consensus        83 ~~ig-~G~~g~V~~~~~~~~~~vavK~~~~----------------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~-  142 (380)
                      ..|| .|+.|+||.+... +..+++|....                .....+.+|++++.+|+|++|  +..+++.... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5687 8899999999875 66788885421                122456789999999988774  6666664332 


Q ss_pred             C---eeEEEEEeecC-CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEE
Q 016917          143 N---LQFLIYEYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV  218 (380)
Q Consensus       143 ~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl  218 (380)
                      .   ..++|||++++ .+|.+++..      ..++..    .+.+++.++.+||+  .||+||||||+|||++.++.++|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~--~GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHD--AGVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHH--CCCCCCCCCchhEEEcCCCCEEE
Confidence            2   23599999997 588777621      233432    35789999999999  78999999999999999899999


Q ss_pred             cccccccc
Q 016917          219 ADAGLRNF  226 (380)
Q Consensus       219 ~DFgla~~  226 (380)
                      +|||.+..
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99998765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.57  E-value=1.2e-14  Score=139.74  Aligned_cols=138  Identities=19%  Similarity=0.157  Sum_probs=94.3

Q ss_pred             CCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHH------------------------------------------
Q 016917           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFID------------------------------------------  119 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~------------------------------------------  119 (380)
                      .+.||+|++|.||+|+.++|+.||||+..+...+.+..                                          
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36799999999999999999999999866554333332                                          


Q ss_pred             -HHHHHhcC----CCCceeeeccce-ecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHH-HHHHHh
Q 016917          120 -EVCFLASI----QHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK-GLAHLH  192 (380)
Q Consensus       120 -E~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~-~l~~LH  192 (380)
                       |...+.++    +|.+-+.+-..+ ......+|||||++|++|.+.....    ....   ....++..++. .+..+|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~----~~~~---~~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD----EAGL---DRKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH----hcCC---CHHHHHHHHHHHHHHHHH
Confidence             33222222    222222222222 2233468999999999998875311    1111   12345666665 467888


Q ss_pred             cCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       193 ~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      .  .|++|+|++|.||++++++.++++|||++..+.
T Consensus       275 ~--~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       275 R--DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             h--CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8  679999999999999999999999999987664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.50  E-value=1.1e-14  Score=128.60  Aligned_cols=204  Identities=21%  Similarity=0.275  Sum_probs=141.2

Q ss_pred             HhcCCCCceeeeccceecCC-----eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 016917          124 LASIQHRNLVTLLGYCQENN-----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV  198 (380)
Q Consensus       124 l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~i  198 (380)
                      |-++.|.||+++..|+.+.+     ...++.||+..|++..+|..... +...+......+++.||..||.|||+..+.|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            33456999999999987554     46789999999999999965433 4566788888999999999999999999999


Q ss_pred             EecCCCCCCeeeCCCCceEEccccccc--ccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCC
Q 016917          199 VHKDFKTANVLVDEDFIAKVADAGLRN--FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR  276 (380)
Q Consensus       199 vHrDikp~Nili~~~~~~kl~DFgla~--~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~  276 (380)
                      +|+++..+-|++..+|.+|+.--.-..  ...............+-++|.+||.-.....+..+|||+||....||..+.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            999999999999999988875321111  000000111122344567799999877777788999999999999998876


Q ss_pred             CCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          277 EASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       277 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      -.-....  ......+.+.      ...-.+..           ..-++++.+|++-+|..||++.+++.+
T Consensus       280 iq~tnse--S~~~~ee~ia------~~i~~len-----------~lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  280 IQSTNSE--SKVEVEENIA------NVIIGLEN-----------GLQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             eccCCCc--ceeehhhhhh------hheeeccC-----------ccccCcCcccccCCCCCCcchhhhhcC
Confidence            3211110  0000000000      00000000           113568899999999999999999876

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.45  E-value=9.9e-14  Score=132.12  Aligned_cols=249  Identities=22%  Similarity=0.235  Sum_probs=178.7

Q ss_pred             HhCCCCCCCeecc--CCceEEEEEEE---CCCcEEEEEeCC-----CCChHHHHHHHHHHhcC-CCCceeeeccceecCC
Q 016917           75 ATKNFSDKNLIGE--GKFGEVYKGLL---QDGMLVAIKKRP-----GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENN  143 (380)
Q Consensus        75 ~~~~~~~~~~ig~--G~~g~V~~~~~---~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  143 (380)
                      ....+.+.+.+|.  |.+|.||.+..   .++..+|+|+.+     ......=.+|+...+++ .|+|.++.+..+...+
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            3455777888999  99999999885   457788888622     12223335677777777 5999999999999999


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCeEecCCCCCCeeeCCC-CceEE
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK----GLAHLHSLSPRVVHKDFKTANVLVDED-FIAKV  218 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~ivHrDikp~Nili~~~-~~~kl  218 (380)
                      ..++-+|++. .+|..+-...    ...++....+....+...    |+.++|.  ++++|-|+||.||++..+ ...++
T Consensus       192 ~lfiqtE~~~-~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~hs--~~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  192 ILFIQTELCG-ESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLHS--NNIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             cceeeecccc-chhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccCC--Ccccccccchhheecccccceeec
Confidence            9999999986 4666555322    233566667777777778    9999999  789999999999999999 88999


Q ss_pred             cccccccccCCCCCCC---CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH
Q 016917          219 ADAGLRNFLGRTDVAG---PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  295 (380)
Q Consensus       219 ~DFgla~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~  295 (380)
                      +|||+...+.......   ......+...|++||... ..++..+|+||+|.+..+-.++..+....-..          
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~----------  333 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS----------  333 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC----------
Confidence            9999988886644322   122335667799999977 56788999999999999998887654432100          


Q ss_pred             hhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         .+..+....   +..++....+.++...+..|++.+|..|++.+.+..+
T Consensus       334 ---~W~~~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  334 ---SWSQLRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ---Ccccccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence               011111111   1112222233445668889999999999999887643

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.42  E-value=8.8e-13  Score=110.83  Aligned_cols=128  Identities=16%  Similarity=0.076  Sum_probs=94.0

Q ss_pred             CCeeccCCceEEEEEEECCCcEEEEEeCCCCC--hHHHHHHHHHHhcCCCCce-eeeccceecCCeeEEEEEeecCCCcc
Q 016917           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIPNGSVS  158 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~  158 (380)
                      .+.|+.|.++.||+++.. +..+++|......  ...+..|..+++.+.+.++ .+++.+..  ...++||||+++.++.
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~   79 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL   79 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence            356889999999999875 7789999865443  3346789999998865443 44554433  2357999999998775


Q ss_pred             ccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---CCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          159 IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS---PRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       159 ~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      ...          .   .....+.+++.++..||+.+   .+++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            421          0   01235678999999999842   1259999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.41  E-value=2.2e-13  Score=132.69  Aligned_cols=141  Identities=16%  Similarity=0.097  Sum_probs=88.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEECC-CcEEEEEeCCCCChHH-------------------------------------HH
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQE-------------------------------------FI  118 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~-------------------------------------~~  118 (380)
                      ..|.. +.||+|++|.||+|+.++ |+.||||+..+...+.                                     +.
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34666 789999999999999877 9999999865442211                                     11


Q ss_pred             HHHHHHhcCCCCceeeeccceec-------------CCeeEEEEEeecCCCccccccCCC-CCCCCCCCHHHHHHHHHHH
Q 016917          119 DEVCFLASIQHRNLVTLLGYCQE-------------NNLQFLIYEYIPNGSVSIHLYGPS-QVSRQKLEFKHRLSIALGA  184 (380)
Q Consensus       119 ~E~~~l~~l~h~niv~l~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~i~~~i  184 (380)
                      +|+++.+..  +|+.++...+.+             ....+|||||++|+.+.+.-.-.. ......+....+..++.|+
T Consensus       199 ~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        199 DELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence            222222211  233333322222             234579999999999976421100 0011123333333344444


Q ss_pred             HHHHHHHhcCCCCeEecCCCCCCeeeCCCC----ceEEcccccccccCC
Q 016917          185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADAGLRNFLGR  229 (380)
Q Consensus       185 ~~~l~~LH~~~~~ivHrDikp~Nili~~~~----~~kl~DFgla~~~~~  229 (380)
                      .       .  .|++|+|++|.||+++.++    .++++|||++..+.+
T Consensus       277 f-------~--~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 F-------R--DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             H-------h--CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3       3  5799999999999999888    999999999877644

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.37  E-value=1.1e-11  Score=119.45  Aligned_cols=163  Identities=20%  Similarity=0.177  Sum_probs=118.2

Q ss_pred             ECCCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCH
Q 016917           98 LQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF  174 (380)
Q Consensus        98 ~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  174 (380)
                      ..++.+|.|...+...   .+...+-++.|+.++||||+++++.....+..|+|+|-+.  .|...+..        +..
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~~  103 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LGK  103 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hHH
Confidence            3456677666533222   3456778899999999999999999999999999999874  34444421        123


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccC
Q 016917          175 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR  254 (380)
Q Consensus       175 ~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  254 (380)
                      ..+.-.+.||+.||.|||+. .+++|++|.-+.|+++..|..||++|.++........  +.....--..|..|+.+...
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d-~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDD-CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhcc-CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence            44555788999999999863 6799999999999999999999999998765433221  11112222235666654332


Q ss_pred             CCCcchhhHHHHHHHHHHHcC
Q 016917          255 RFSEKSDVYSFGVFLLELVSG  275 (380)
Q Consensus       255 ~~~~~~DvwSlG~il~el~tg  275 (380)
                      .  ...|.|-|||+++|++.|
T Consensus       181 ~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCc
Confidence            2  456999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.32  E-value=2.2e-11  Score=103.51  Aligned_cols=134  Identities=17%  Similarity=0.091  Sum_probs=94.1

Q ss_pred             CCeeccCCceEEEEEEECC-------CcEEEEEeCCC-------------------------CChHHH----HHHHHHHh
Q 016917           82 KNLIGEGKFGEVYKGLLQD-------GMLVAIKKRPG-------------------------APTQEF----IDEVCFLA  125 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~-------~~~vavK~~~~-------------------------~~~~~~----~~E~~~l~  125 (380)
                      ...||.|--+.||.|...+       +..+|+|+...                         .....+    .+|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999998543       47899994110                         001122    27888888


Q ss_pred             cCC--CCceeeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCeEecC
Q 016917          126 SIQ--HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL-HSLSPRVVHKD  202 (380)
Q Consensus       126 ~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~ivHrD  202 (380)
                      ++.  .-++++.+++    ...++||||+.++.+....     .....++......+..+++.+|..| |+  .++||+|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~-----Lkd~~~~~~~~~~i~~~i~~~l~~l~H~--~glVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK-----LKDAKLNDEEMKNAYYQVLSMMKQLYKE--CNLVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh-----hhccccCHHHHHHHHHHHHHHHHHHHHh--CCeecCC
Confidence            884  3456666654    3458999999875442211     1122334455667789999999999 77  6799999


Q ss_pred             CCCCCeeeCCCCceEEccccccccc
Q 016917          203 FKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       203 ikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      |++.|||+++ +.+.++|||-+-..
T Consensus       151 Ls~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         151 LSEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             CCHHHEEEEC-CcEEEEECCCceeC
Confidence            9999999974 67999999977654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.28  E-value=2.3e-12  Score=122.85  Aligned_cols=245  Identities=23%  Similarity=0.284  Sum_probs=172.2

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEEC--CCcEEEEEeCCCCCh---HH--HHHHHHHHhcC-CCCceeeeccceecCCe
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ--DGMLVAIKKRPGAPT---QE--FIDEVCFLASI-QHRNLVTLLGYCQENNL  144 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~~---~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~  144 (380)
                      .....+|..+..||.|.|+.|+.+..+  ++..|++|...+...   ++  -..|+-+...+ .|.++++++..+.....
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            344567888999999999999998844  577888885433221   11  23455555555 58899998888887777


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CceEEccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGL  223 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~-~~~kl~DFgl  223 (380)
                      .|+=-||++++++....     .....+.+..++++..|++.++.++|+  +.++|+|+||+||++..+ +..+++|||.
T Consensus       341 ~~ip~e~~~~~s~~l~~-----~~~~~~d~~~~~~~~~q~~~~l~~i~s--~~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRS-----VTSQMLDEDPRLRLTAQILTALNVIHS--KLFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             ccCchhhhcCcchhhhh-----HHHHhcCcchhhhhHHHHHhccccccc--hhhhcccccccceeeccchhhhhcccccc
Confidence            88999999999887666     344566777888999999999999998  669999999999999886 7889999998


Q ss_pred             ccccCCCCCCCCCccccCccce-ecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc
Q 016917          224 RNFLGRTDVAGPSSQVTADEIF-LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  302 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~-~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (380)
                      +..+.-...    ...-....| .+|.......+..+.|++|||.-+.+.+++...-....     +.            
T Consensus       414 ~t~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-----~~------------  472 (524)
T KOG0601|consen  414 WTRLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-----QS------------  472 (524)
T ss_pred             ccccceecc----cccccccccccchhhccccccccccccccccccccccccCcccCcccc-----cc------------
Confidence            864322111    111122234 35666666788899999999999999999864211110     00            


Q ss_pred             hhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                       .. +........+..- .++..+.+.+...|+..||.+.++..+.
T Consensus       473 -~~-i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  473 -LT-IRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             -ee-eecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccc
Confidence             00 0011111122222 6688899999999999999998876553

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.27  E-value=9.2e-11  Score=102.90  Aligned_cols=138  Identities=22%  Similarity=0.350  Sum_probs=105.2

Q ss_pred             CeeccCCceEEEEEEECCCcEEEEEeCCCC----ChHHHHHHHHHHhcCCC--CceeeeccceecC---CeeEEEEEeec
Q 016917           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA----PTQEFIDEVCFLASIQH--RNLVTLLGYCQEN---NLQFLIYEYIP  153 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~~  153 (380)
                      +.|+.|..+.||++...+|..+++|.....    ....+..|.++++.+.+  .++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            568999999999999876788999985543    24578899999999965  4467777776654   35689999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL---------------------------------------  194 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~---------------------------------------  194 (380)
                      |.++.+.+.      ...++......++.+++.+|..||+.                                       
T Consensus        84 G~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          84 GRVLRDRLL------RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CEecCCCCC------CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            988876551      13355666677777888888888752                                       


Q ss_pred             ---------------CCCeEecCCCCCCeeeCC--CCceEEcccccccc
Q 016917          195 ---------------SPRVVHKDFKTANVLVDE--DFIAKVADAGLRNF  226 (380)
Q Consensus       195 ---------------~~~ivHrDikp~Nili~~--~~~~kl~DFgla~~  226 (380)
                                     ...++|+|+.|.||+++.  ++.+.++||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           134699999999999998  66789999997763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.25  E-value=3.2e-12  Score=128.31  Aligned_cols=246  Identities=21%  Similarity=0.225  Sum_probs=168.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEe---CC---CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK---RP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~---~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      ...+.+.+.+.+|.++.++.+.-. .+...+.|.   .+   ....+....+-.++-.-.+|-++...--+......+|+
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            345666678889999999987733 232222221   11   11122233333333334456677666666667778999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      ++|+.+++|...|....     .............+..+.+|||.  ..+.|||++|.|.++..++..+++|||......
T Consensus       883 ~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s--~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHS--SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhcccc--chhhcccccccchhhcccCCcccCccccccccc
Confidence            99999999988875432     22333334456677889999998  559999999999999999999999998432221


Q ss_pred             C------C---------------C---C-----CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCC
Q 016917          229 R------T---------------D---V-----AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAS  279 (380)
Q Consensus       229 ~------~---------------~---~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~  279 (380)
                      -      .               .   .     ........+|+.|.+||...+......+|+|++|++++|.++|.+||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            0      0               0   0     01122456899999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccHHHHHHhhhcccchhhhcc-cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 016917          280 SSLSPDSSQDLVELVQNSRDFSNLLKILD-ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD  343 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~  343 (380)
                      ....+....               ..++. .-.|...+...+.+.++++...+..+|.+|..+.-
T Consensus      1036 na~tpq~~f---------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~ 1085 (1205)
T KOG0606|consen 1036 NAETPQQIF---------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKG 1085 (1205)
T ss_pred             CCcchhhhh---------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCccc
Confidence            876653221               11111 11234556677788999999999999999988773

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=9e-11  Score=96.67  Aligned_cols=128  Identities=21%  Similarity=0.291  Sum_probs=94.0

Q ss_pred             CeeccCCceEEEEEEECCCcEEEEEeCCCC-C----------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-P----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      ..+++|+-+.+|.+.+. |..+++|...+. .          .....+|..++.++.--.|..-+=+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            45789999999999774 445777753222 1          12356788888887543333333344455566799999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      ++|..|.+.+...            ...++..+-.-+.-||.  .||+|+||.++|++++.+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~--~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHK--AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc------------chHHHHHHHHHHHHHHh--cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999998888322            24567777788889999  7899999999999998765 89999999874

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.11  E-value=2.5e-09  Score=100.55  Aligned_cols=217  Identities=17%  Similarity=0.207  Sum_probs=149.8

Q ss_pred             CceEEEEEE-ECCCcEEEEEeCC---CCChHHHHHHHHHHhcCCCCceeeecccee----cCCeeEEEEEeecC-CCccc
Q 016917           89 KFGEVYKGL-LQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQ----ENNLQFLIYEYIPN-GSVSI  159 (380)
Q Consensus        89 ~~g~V~~~~-~~~~~~vavK~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-g~L~~  159 (380)
                      ...+.|++. ..+|..|++|+..   .........-++.++++.|+|+|+|.+++.    .+..+++|++|+++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            446789998 5678899999862   222333455688999999999999999886    34567899999876 34544


Q ss_pred             cccCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          160 HLYGPSQ----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       160 ~l~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      .-.....          ......++..+|.++.|+..||.++|+  .|.--+-|.|.+||++.+.+++|+..|....+..
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs--sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS--SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh--cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            3322211          234567889999999999999999999  7788899999999999999999998888766544


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ..         +       +.+   .--.+-|.=.||.++..|.||..--...+.  .++.           .       
T Consensus       446 d~---------~-------~~l---e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~--~~~s-----------~-------  486 (655)
T KOG3741|consen  446 DP---------T-------EPL---ESQQQNDLRDLGLLLLALATGTENSNRTDS--TQSS-----------H-------  486 (655)
T ss_pred             CC---------C-------cch---hHHhhhhHHHHHHHHHHHhhcccccccccc--hHHH-----------H-------
Confidence            22         0       011   112357999999999999999642110000  0000           0       


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                        ........+.++++++.-....++++ -++.+++.++-
T Consensus       487 --~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~  523 (655)
T KOG3741|consen  487 --LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIG  523 (655)
T ss_pred             --HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHH
Confidence              01122344566778888777777776 67777776543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.07  E-value=8.4e-10  Score=90.64  Aligned_cols=140  Identities=20%  Similarity=0.231  Sum_probs=97.5

Q ss_pred             CCCeeccCCceEEEEEEECCCcEEEEEeCCCC-----------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           81 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        81 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ....|.+|+-++|+++.+. |+...||.....           .+.+..+|...|.++.--.|..---++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4577889999999999985 777778853221           1234667898888875433333333344444557899


Q ss_pred             EeecC-CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC---ceEEccccccc
Q 016917          150 EYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVADAGLRN  225 (380)
Q Consensus       150 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~---~~kl~DFgla~  225 (380)
                      ||+++ .++.+++.....  ... .......++..+-..+.-||.  ++|+|+||..+||++..++   .+.++|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~--~~~-~d~~~~~~~~~iG~~igklH~--ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTME--DES-EDEGLAELARRIGELIGKLHD--NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHcc--Ccc-cchhHHHHHHHHHHHHHHhhh--CCeecccccccceEEecCCCcCceEEEeecchh
Confidence            99977 366777644322  111 112225788889999999999  7899999999999996554   45899999976


Q ss_pred             c
Q 016917          226 F  226 (380)
Q Consensus       226 ~  226 (380)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            4

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=6.7e-09  Score=88.03  Aligned_cols=122  Identities=20%  Similarity=0.209  Sum_probs=76.9

Q ss_pred             EEEEEEECCCcEEEEEeCCCCC-----------------------------hHHHHHHHHHHhcCCCC--ceeeecccee
Q 016917           92 EVYKGLLQDGMLVAIKKRPGAP-----------------------------TQEFIDEVCFLASIQHR--NLVTLLGYCQ  140 (380)
Q Consensus        92 ~V~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~~l~~l~h~--niv~l~~~~~  140 (380)
                      .||.|...+|..+|+|......                             .....+|.+.|.++..-  ++++.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998889999999522110                             01246799999999654  566666443 


Q ss_pred             cCCeeEEEEEeec--CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCCeeeCCCCceE
Q 016917          141 ENNLQFLIYEYIP--NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL-HSLSPRVVHKDFKTANVLVDEDFIAK  217 (380)
Q Consensus       141 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~ivHrDikp~Nili~~~~~~k  217 (380)
                         .-++||||++  |..+.... .      ..+.......++.+++..+..+ |.  .||+|+||.+.|||++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~-~------~~~~~~~~~~~~~~il~~~~~~~~~--~givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLK-D------VDLSPEEPKELLEEILEEIIKMLHK--AGIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHH-H------CGGGGSTHHHHHHHHHHHHHHHHHC--TTEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHH-h------ccccchhHHHHHHHHHHHHHHHHHh--cCceecCCChhhEEeecc-eEE
Confidence               2379999998  54443322 1      1111223345677777766664 67  679999999999999987 899


Q ss_pred             Eccccccccc
Q 016917          218 VADAGLRNFL  227 (380)
Q Consensus       218 l~DFgla~~~  227 (380)
                      ++|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.93  E-value=1.4e-08  Score=91.31  Aligned_cols=137  Identities=14%  Similarity=0.087  Sum_probs=93.5

Q ss_pred             eeccCCceEEEEEEECCCcEEEEEeCCCCC--------------hHHHHHHHHHHhcCCC--Cceeeeccceec-----C
Q 016917           84 LIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--------------TQEFIDEVCFLASIQH--RNLVTLLGYCQE-----N  142 (380)
Q Consensus        84 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~h--~niv~l~~~~~~-----~  142 (380)
                      .+-......|+++.. .|+.+.+|......              ...+.+|...+.+|..  -..+..+++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            343334445667665 46789999643222              1146788888877732  223334444432     2


Q ss_pred             CeeEEEEEeecCC-CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-------CC
Q 016917          143 NLQFLIYEYIPNG-SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-------DF  214 (380)
Q Consensus       143 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~-------~~  214 (380)
                      ...++|+|++++. +|.+++...   ............++.+++..+.-||+  .||+|+|++++|||++.       ++
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~---~~~~~~~~~~~~ll~~la~~i~~LH~--~Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADW---ATNPPDPRLKRMLIKRVATMVRDMHA--AGINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH--CcCccCCCChhhEEEeccccCCCCCc
Confidence            3568999999875 687776321   12333456677899999999999999  77999999999999975       46


Q ss_pred             ceEEcccccccc
Q 016917          215 IAKVADAGLRNF  226 (380)
Q Consensus       215 ~~kl~DFgla~~  226 (380)
                      .+.++||+.+..
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            899999998753

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.92  E-value=3.4e-10  Score=109.87  Aligned_cols=150  Identities=21%  Similarity=0.217  Sum_probs=105.0

Q ss_pred             HHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC-CCCC------CCCccccCccceecccccccCC
Q 016917          183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVA------GPSSQVTADEIFLASEVKEFRR  255 (380)
Q Consensus       183 ~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~-~~~~------~~~~~~~~~~~~~aPE~~~~~~  255 (380)
                      +++.|+.|+|.. .++||++|.|++|.++.++..||+.|+++-.... ..+.      ...........|.|||++.+..
T Consensus       107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             cccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            455899999985 6899999999999999999999999998765433 1111      1111223445699999999888


Q ss_pred             CCcchhhHHHHHHHHHHHcCCCC-CCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCC
Q 016917          256 FSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPS  334 (380)
Q Consensus       256 ~~~~~DvwSlG~il~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  334 (380)
                      -+.++|++|+||++|.+..|..+ +.........             ......+..-...++.+.++++.+-+.+++..|
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-------------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~  252 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-------------SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGD  252 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchh-------------hhhhcccccccccccccCcHHHHHHHHHHhcCC
Confidence            89999999999999999954443 3332211110             011111111123445677888999999999999


Q ss_pred             CCCCCCHHHHHH
Q 016917          335 SERRPSMSDVVT  346 (380)
Q Consensus       335 p~~Rpt~~~ll~  346 (380)
                      +.-||++.+++.
T Consensus       253 ~~~rp~~~~l~~  264 (700)
T KOG2137|consen  253 SAVRPTLDLLLS  264 (700)
T ss_pred             cccCcchhhhhc
Confidence            999997766653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.91  E-value=1.2e-07  Score=87.53  Aligned_cols=265  Identities=15%  Similarity=0.138  Sum_probs=155.0

Q ss_pred             CCCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcC-CCCceeeeccc------eecCC-eeEEEEEee
Q 016917           81 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGY------CQENN-LQFLIYEYI  152 (380)
Q Consensus        81 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~~-~~~lv~e~~  152 (380)
                      ..+.||+|+-+.+|-.-.- +..| -|+...-....-.+.++.|..- .||-+..-+.+      .-+.+ ..-++|..+
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d~V-AKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v   92 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RDQV-AKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV   92 (637)
T ss_pred             CCccccCCccceeeecchh-hchh-heeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence            4577999999999955421 1122 3433222222222334444444 56544331211      11222 255677776


Q ss_pred             cCCC-ccccccCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          153 PNGS-VSIHLYGPS-QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       153 ~~g~-L~~~l~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      .+-. ..+++.... +.+-....|...++.++.++.+..-||.  .|.+-+|+.++|+|+++++.+.|.|=..-....+ 
T Consensus        93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~--~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n-  169 (637)
T COG4248          93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE--HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN-  169 (637)
T ss_pred             CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh--cCCcccccCccceeeecCceEEEEcccceeeccC-
Confidence            6532 222222111 1223456789999999999999999999  5689999999999999999999998553322211 


Q ss_pred             CCCCCCccccCccceecccccc-----cCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCCc-ccHHH-HHHhhhcccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSG-REASSSLSPDSS-QDLVE-LVQNSRDFSN  302 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg-~~p~~~~~~~~~-~~~~~-~~~~~~~~~~  302 (380)
                        ........|...|.+||.-.     +-.-+...|-|.||+++++++.| +.||++...... ....+ .+-. -.+-.
T Consensus       170 --g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~-g~f~y  246 (637)
T COG4248         170 --GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH-GRFAY  246 (637)
T ss_pred             --CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc-ceeee
Confidence              11123445777899999644     33456789999999999999986 899987532111 00111 0000 00000


Q ss_pred             hhh---hcccccccCCC-HHHHHHHHHHHhHccCC--CCCCCCCHHHHHHHHHhhhhh
Q 016917          303 LLK---ILDERLWSTFT-NEGMEEFIQLIVRCLDP--SSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       303 ~~~---~~~~~~~~~~~-~~~~~~l~~li~~cl~~--dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      -.+   -..+.. ...| .-.++.++.+..+|+..  ++.-|||++.++.-|..+-.+
T Consensus       247 a~~~~~g~~p~P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         247 ASDQRRGLKPPP-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             chhccCCCCCCC-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            000   000000 0111 12457788999999865  467899999998888776555

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.84  E-value=1.9e-08  Score=87.94  Aligned_cols=130  Identities=21%  Similarity=0.145  Sum_probs=91.2

Q ss_pred             CCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC-------------------------hHHHHHHHHHHhcCCCC--c
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-------------------------TQEFIDEVCFLASIQHR--N  131 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~E~~~l~~l~h~--n  131 (380)
                      ..+...||-|--+.||.|....|.++|+|......                         .....+|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45668899999999999999999999999422111                         11346789999988644  5


Q ss_pred             eeeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC
Q 016917          132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD  211 (380)
Q Consensus       132 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~  211 (380)
                      +.+-+++    +...+||||++|-.|...-.          .....-.++..|+.-+..+-.  .||||+|+.+-||+++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~----------~~en~~~il~~il~~~~~~~~--~GiVHGDlSefNIlV~  236 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRL----------DVENPDEILDKILEEVRKAYR--RGIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccC----------cccCHHHHHHHHHHHHHHHHH--cCccccCCchheEEEe
Confidence            6665543    44579999999865543210          111122344445555554444  6799999999999999


Q ss_pred             CCCceEEcccccc
Q 016917          212 EDFIAKVADAGLR  224 (380)
Q Consensus       212 ~~~~~kl~DFgla  224 (380)
                      +||.+.++||--+
T Consensus       237 ~dg~~~vIDwPQ~  249 (304)
T COG0478         237 EDGDIVVIDWPQA  249 (304)
T ss_pred             cCCCEEEEeCccc
Confidence            9999999999543

>PRK09902 hypothetical protein; Provisional

Probab=98.63  E-value=3.7e-07  Score=78.08  Aligned_cols=141  Identities=11%  Similarity=0.042  Sum_probs=100.1

Q ss_pred             CCCCCeeccCCceEEEEEEECCCcEEEEEeCC---------CCChHHHHHHHHHHhcCCC--Cceeeecccee---c--C
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP---------GAPTQEFIDEVCFLASIQH--RNLVTLLGYCQ---E--N  142 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~---------~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~---~--~  142 (380)
                      +-..---|+||-+-|+...... ..+.+|.-.         +.....|.+|...+.+|..  -++.+.. ++.   .  .
T Consensus        20 wve~pN~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~   97 (216)
T PRK09902         20 WVEEPNYRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGE   97 (216)
T ss_pred             eecCCCcCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCc
Confidence            3333445778999999987654 368888522         3456779999999998843  2344444 332   1  1


Q ss_pred             CeeEEEEEeecC-CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc--eEEc
Q 016917          143 NLQFLIYEYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--AKVA  219 (380)
Q Consensus       143 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~--~kl~  219 (380)
                      ...+||+|-+++ -+|.+++...   .....+...+..+..+++..+.-||+  .|+.|+|+-+.||+++.++.  ++++
T Consensus        98 ~rA~LVTe~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH~--~Gv~Hgdly~khIll~~~g~~~v~lI  172 (216)
T PRK09902         98 WRALLVTEDMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMHS--VNRQHGCCYVRHIYVKTEGKAEAGFL  172 (216)
T ss_pred             eEEEEEEEeCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHhheeecCCCCeeEEEE
Confidence            235899997753 4677776321   12344666777899999999999999  77999999999999986666  9999


Q ss_pred             ccccccc
Q 016917          220 DAGLRNF  226 (380)
Q Consensus       220 DFgla~~  226 (380)
                      ||.-++.
T Consensus       173 DlEk~r~  179 (216)
T PRK09902        173 DLEKSRR  179 (216)
T ss_pred             Ehhccch
Confidence            9986553

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.60  E-value=1.5e-07  Score=81.74  Aligned_cols=106  Identities=22%  Similarity=0.233  Sum_probs=78.5

Q ss_pred             hHHHHHHHHHHhcCC--CCceeeeccceecC----CeeEEEEEeecCC-CccccccCCCCCCCCCCCHHHHHHHHHHHHH
Q 016917          114 TQEFIDEVCFLASIQ--HRNLVTLLGYCQEN----NLQFLIYEYIPNG-SVSIHLYGPSQVSRQKLEFKHRLSIALGAAK  186 (380)
Q Consensus       114 ~~~~~~E~~~l~~l~--h~niv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~  186 (380)
                      .....+|...+..|.  .-..++.+++....    ...++|+|++++. +|.+++...     ...+......++.+++.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~~ll~~l~~  129 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRRELLRALAR  129 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHHHHHHHHHH
Confidence            445777888777763  22344445554432    2458999999874 688777321     12455667789999999


Q ss_pred             HHHHHhcCCCCeEecCCCCCCeeeCCCC---ceEEcccccccc
Q 016917          187 GLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVADAGLRNF  226 (380)
Q Consensus       187 ~l~~LH~~~~~ivHrDikp~Nili~~~~---~~kl~DFgla~~  226 (380)
                      .+.-||+  .||+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       130 ~i~~lH~--~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  130 LIAKLHD--AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHH--CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999  7799999999999999887   899999997664

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.59  E-value=1.6e-07  Score=91.43  Aligned_cols=138  Identities=19%  Similarity=0.169  Sum_probs=86.6

Q ss_pred             CeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHH-------------------------------------------
Q 016917           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFID-------------------------------------------  119 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~-------------------------------------------  119 (380)
                      ..|+.++-|.||+|+.++|+.||||+..+.-.+.+..                                           
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6799999999999999999999999755544333222                                           


Q ss_pred             HHHHHhcC----C-CCceeeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHH-HHHHhc
Q 016917          120 EVCFLASI----Q-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG-LAHLHS  193 (380)
Q Consensus       120 E~~~l~~l----~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~-l~~LH~  193 (380)
                      |..-+.++    + .+++.--.=|.+..+...|+|||++|-.+.+...-.    ....+.+.   ++..++.+ +..+-.
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~----~~g~d~k~---ia~~~~~~f~~q~~~  283 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK----SAGIDRKE---LAELLVRAFLRQLLR  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH----hcCCCHHH---HHHHHHHHHHHHHHh
Confidence            22222222    1 122111111122234458999999999888874211    12223222   22222222 122222


Q ss_pred             CCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       194 ~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                        .|++|.|.-|.||+++.+|.+.+.|||+...+.+
T Consensus       284 --dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         284 --DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             --cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence              4699999999999999999999999999876643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.53  E-value=1.3e-06  Score=76.79  Aligned_cols=139  Identities=17%  Similarity=0.112  Sum_probs=84.0

Q ss_pred             CeeccCCceEEEEEEECCCcEEEEEeCCCC-ChHHHHHHHHHHhcCCCC--ceeeeccceecCCeeEEEEEeecCCC-cc
Q 016917           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHR--NLVTLLGYCQENNLQFLIYEYIPNGS-VS  158 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~-L~  158 (380)
                      ..||+|..+.||+.   .+..+++|..... ......+|.++++.+..-  .+.+.+++....+...+|||+++|.. +.
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~   83 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS   83 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence            56899999999984   2456788886543 355678899999888533  35677777777777889999999863 21


Q ss_pred             ccccCCC------------------CCCCCCCCHHHHH-HHHH----------HHHH-HHHHHhc--CCCCeEecCCCCC
Q 016917          159 IHLYGPS------------------QVSRQKLEFKHRL-SIAL----------GAAK-GLAHLHS--LSPRVVHKDFKTA  206 (380)
Q Consensus       159 ~~l~~~~------------------~~~~~~~~~~~~~-~i~~----------~i~~-~l~~LH~--~~~~ivHrDikp~  206 (380)
                      ..+....                  ............. .+..          .+.. ...+|..  ....++|+|+.|.
T Consensus        84 ~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~  163 (226)
T TIGR02172        84 RIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIG  163 (226)
T ss_pred             hhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCC
Confidence            1110000                  0000000110000 0000          0011 1222221  1245789999999


Q ss_pred             CeeeCCCCceEEccccccc
Q 016917          207 NVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       207 Nili~~~~~~kl~DFgla~  225 (380)
                      |+++++++ +.++||+.+.
T Consensus       164 Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       164 NLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             cEEEcCCC-cEEEechhcC
Confidence            99999888 9999998765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.46  E-value=1.8e-06  Score=77.06  Aligned_cols=74  Identities=19%  Similarity=0.255  Sum_probs=54.5

Q ss_pred             eccCCc-eEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcCC-CCceeeeccceecCCeeEEEEEeecCCCccc
Q 016917           85 IGEGKF-GEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSI  159 (380)
Q Consensus        85 ig~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  159 (380)
                      |..|.+ ..||+.... +..+.+|...........+|.++++.+. +--+.+++++....+..++|||+++|.++..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444555 789999765 4788899876554556778999988883 4456677777776667899999999877653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.46  E-value=2.6e-08  Score=96.11  Aligned_cols=189  Identities=21%  Similarity=0.130  Sum_probs=135.9

Q ss_pred             CCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcCCCCc-eeeeccceecCCeeEEEEEeecCC
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIYEYIPNG  155 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g  155 (380)
                      +.+...+-.++|+.+.+++.+-...+....+.....  ....-++++|.+++||| .+..++-++.+...+++++++.++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~  319 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG  319 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence            334445667889999999887332222334443333  44566899999999999 777777777788889999999887


Q ss_pred             -CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          156 -SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       156 -~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                       +-....    ......+...+...+.+.-.++++++|+.  .=+|+|    ||+.++ +..+..||+....+.+..   
T Consensus       320 rs~~~~~----~~se~~~~~~~~~~~~r~et~~l~~l~~~--~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---  385 (829)
T KOG0576|consen  320 RSSALEM----TVSEIALEQYQFAYPLRKETRPLAELHSS--YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---  385 (829)
T ss_pred             ccccccC----ChhhHhhhhhhhhhhhhhhcccccccccc--cccCcc----cccccc-cccccccccCCcccCccc---
Confidence             322222    12233334444555666777889999983  248998    887766 578999999988776643   


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSS  281 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~  281 (380)
                      ......+++.|+|||+...+.+....|.||+|+--.+|--|-+|-..
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            34566789999999999999999999999999887888888776443

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.38  E-value=4.4e-06  Score=72.66  Aligned_cols=134  Identities=19%  Similarity=0.225  Sum_probs=86.6

Q ss_pred             CeeccCCceEEEEEEECCCcEEEEEeCCCCChH----------------------H-----HHHHHHHHhcCC--CCcee
Q 016917           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------------------E-----FIDEVCFLASIQ--HRNLV  133 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~-----~~~E~~~l~~l~--h~niv  133 (380)
                      ..|++|--+.||+|...++..+|+|+.......                      +     ..+|..-|+++.  +-.+.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            456778888999999888999999974432211                      0     124555555552  22333


Q ss_pred             eeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC
Q 016917          134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED  213 (380)
Q Consensus       134 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~  213 (380)
                      +-+++..    -.|||||+.......     ...+.-.+.......+..+++..+.-|-.. .++||+||+.=|||+. +
T Consensus       134 ~Pi~~~~----nVLvMEfIg~~g~pA-----P~LkDv~~e~~e~~~~~~~~v~~~~~l~~~-a~LVHgDLSEyNiL~~-~  202 (268)
T COG1718         134 EPIAFRN----NVLVMEFIGDDGLPA-----PRLKDVPLELEEAEGLYEDVVEYMRRLYKE-AGLVHGDLSEYNILVH-D  202 (268)
T ss_pred             CceeecC----CeEEEEeccCCCCCC-----CCcccCCcCchhHHHHHHHHHHHHHHHHHh-cCcccccchhhheEEE-C
Confidence            3333322    269999986542111     011222223334566777888888887763 5799999999999999 8


Q ss_pred             CceEEccccccccc
Q 016917          214 FIAKVADAGLRNFL  227 (380)
Q Consensus       214 ~~~kl~DFgla~~~  227 (380)
                      +.+.++|||-|-..
T Consensus       203 ~~p~iID~~QaV~~  216 (268)
T COG1718         203 GEPYIIDVSQAVTI  216 (268)
T ss_pred             CeEEEEECcccccc
Confidence            89999999976544

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.35  E-value=2e-06  Score=75.80  Aligned_cols=76  Identities=18%  Similarity=0.273  Sum_probs=55.4

Q ss_pred             CeeccCCceEEEEEEECCCcEEEEEeCCCC-ChHHHHHHHHHHhcCCC--Cceeeeccce---ecCCeeEEEEEeecCCC
Q 016917           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQH--RNLVTLLGYC---QENNLQFLIYEYIPNGS  156 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~h--~niv~l~~~~---~~~~~~~lv~e~~~~g~  156 (380)
                      +.++.|..+.||++...+ ..+++|..... ....+..|..+++.+..  ..+.+++.+.   ......+++|+++++..
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~   81 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP   81 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence            568999999999999887 58999986555 45567789888888742  2355666543   23345689999999987


Q ss_pred             ccc
Q 016917          157 VSI  159 (380)
Q Consensus       157 L~~  159 (380)
                      +..
T Consensus        82 ~~~   84 (239)
T PF01636_consen   82 LDD   84 (239)
T ss_dssp             HHH
T ss_pred             ccc
Confidence            766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.34  E-value=4.7e-06  Score=71.65  Aligned_cols=135  Identities=14%  Similarity=0.117  Sum_probs=86.5

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCChH--H----------HHHHHHHHhcCCC---Cceeeeccc
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ--E----------FIDEVCFLASIQH---RNLVTLLGY  138 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~----------~~~E~~~l~~l~h---~niv~l~~~  138 (380)
                      ...++|...+++.......|.+-... |..+++|........  +          ..+++..+.+++.   -....++-.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            45677888888887777777666654 688999975443321  1          1223333333322   222222222


Q ss_pred             ee-----cCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC
Q 016917          139 CQ-----ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED  213 (380)
Q Consensus       139 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~  213 (380)
                      ..     -....+++|||++|..|.+...         +..    .+...++.++.-||+  .|+.|+|..|.|++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~--~G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHK--HGFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHH--cCCccCCCCcCcEEEECC
Confidence            22     2234568999999988766541         111    245667788999999  679999999999999966


Q ss_pred             CceEEccccccc
Q 016917          214 FIAKVADAGLRN  225 (380)
Q Consensus       214 ~~~kl~DFgla~  225 (380)
                      + ++++||+..+
T Consensus       172 ~-i~iID~~~k~  182 (229)
T PF06176_consen  172 G-IRIIDTQGKR  182 (229)
T ss_pred             c-EEEEECcccc
Confidence            5 8999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PLN02876 acyl-CoA dehydrogenase

Probab=98.26  E-value=1.5e-05  Score=83.34  Aligned_cols=77  Identities=17%  Similarity=0.336  Sum_probs=56.9

Q ss_pred             CCeeccCCceEEEEEEECCC---cEEEEEeCCCC----ChHHHHHHHHHHhcCC-CCce--eeeccceecC---CeeEEE
Q 016917           82 KNLIGEGKFGEVYKGLLQDG---MLVAIKKRPGA----PTQEFIDEVCFLASIQ-HRNL--VTLLGYCQEN---NLQFLI  148 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  148 (380)
                      .+.++.|.+..+|+.....+   ..+++|+.+..    ....+.+|.++++.+. |.++  .+.+.++.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999886553   46778875432    2346789999999995 6654  7788887664   467899


Q ss_pred             EEeecCCCcc
Q 016917          149 YEYIPNGSVS  158 (380)
Q Consensus       149 ~e~~~~g~L~  158 (380)
                      |||++|..+.
T Consensus       123 ME~v~G~~~~  132 (822)
T PLN02876        123 MEYLEGRIFV  132 (822)
T ss_pred             EEecCCcccC
Confidence            9999986543

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.14  E-value=1.8e-05  Score=77.10  Aligned_cols=137  Identities=17%  Similarity=0.171  Sum_probs=86.9

Q ss_pred             CeeccCCceEEEEEEECCCcEEEEEeCCCCChHH----------------------------------------HHHHHH
Q 016917           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQE----------------------------------------FIDEVC  122 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~E~~  122 (380)
                      +.||.-+.|.||+|+.++|+.||||...+.-.+.                                        |.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6799999999999999999999999644332211                                        222322


Q ss_pred             ----HHhcCCCCc------eeeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 016917          123 ----FLASIQHRN------LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH  192 (380)
Q Consensus       123 ----~l~~l~h~n------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH  192 (380)
                          +.+.+.|-+      |.+++-.+.  ....|+|||++|..+.|.-.    .....++...   ++..+.++...+=
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~----i~~~gi~~~~---i~~~l~~~~~~qI  317 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDA----IDKRGISPHD---ILNKLVEAYLEQI  317 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHH----HHHcCCCHHH---HHHHHHHHHHHHH
Confidence                122233444      444443332  34689999999988876542    1233344433   3333333322221


Q ss_pred             cCCCCeEecCCCCCCeeeCC----CCceEEcccccccccCC
Q 016917          193 SLSPRVVHKDFKTANVLVDE----DFIAKVADAGLRNFLGR  229 (380)
Q Consensus       193 ~~~~~ivHrDikp~Nili~~----~~~~kl~DFgla~~~~~  229 (380)
                      - ..|.+|+|--|.||++..    ++.+.+-|||+...+..
T Consensus       318 f-~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  318 F-KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             H-hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            1 146999999999999983    67899999999876643

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.04  E-value=2.2e-05  Score=64.75  Aligned_cols=128  Identities=20%  Similarity=0.258  Sum_probs=84.9

Q ss_pred             CCCCeeccCCceEEEEEEECCCcEEEEEe-CCCCChHHHHHHHHHHhcCCCCcee-eeccceecCCeeEEEEEeecCCCc
Q 016917           80 SDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLV-TLLGYCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        80 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~-~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L  157 (380)
                      +..+.|++|++|.||+|.+. |..+|+|. .....+..+..|.++|..+.-.++. +++.|..+    ++.|||++|-.|
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L   99 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcch
Confidence            45578999999999999987 45788886 4455677899999999998765544 34444433    355999998777


Q ss_pred             cccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC-CCeeeCCCCceEEcccccccc
Q 016917          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKT-ANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp-~Nili~~~~~~kl~DFgla~~  226 (380)
                      .+.-...        .-.+    ...++++---|-.  .||-|..|.- ...++.++..+.|+||..|+.
T Consensus       100 ~~~~~~~--------~rk~----l~~vlE~a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         100 GKLEIGG--------DRKH----LLRVLEKAYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcc--------cHHH----HHHHHHHHHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            6544211        1122    2334444223333  4688888764 444444445899999998874

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.04  E-value=7.1e-05  Score=64.07  Aligned_cols=126  Identities=17%  Similarity=0.208  Sum_probs=85.4

Q ss_pred             CCCeeccCCceEEEEEEECCCcEEEEEeCCCCC-------------------hHHHHHHHHHHhcCC------CCceeee
Q 016917           81 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-------------------TQEFIDEVCFLASIQ------HRNLVTL  135 (380)
Q Consensus        81 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------~~~~~~E~~~l~~l~------h~niv~l  135 (380)
                      ....||+|+.=.||.  +.+.....||+.....                   ..+..+|+.....+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            346799999988884  4445556777655444                   456777777666555      7899999


Q ss_pred             ccceecCCeeEEEEEeecC--C----CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 016917          136 LGYCQENNLQFLIYEYIPN--G----SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL  209 (380)
Q Consensus       136 ~~~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nil  209 (380)
                      +|+.+++...-+|+|.+.+  |    +|.+++      ....+.. .   +...+-.-.+||-+  .+|+.+|++|.||+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l------~~~~~~~-~---~~~~L~~f~~~l~~--~~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYL------KEGGLTE-E---LRQALDEFKRYLLD--HHIVIRDLNPHNIV  150 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHH------HcCCccH-H---HHHHHHHHHHHHHH--cCCeecCCCcccEE
Confidence            9999999888999998754  2    344444      2233333 2   22333344556666  55999999999999


Q ss_pred             eCCC---C-ceEEcc
Q 016917          210 VDED---F-IAKVAD  220 (380)
Q Consensus       210 i~~~---~-~~kl~D  220 (380)
                      +...   . .+.|+|
T Consensus       151 ~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  151 VQRRDSGEFRLVLID  165 (199)
T ss_pred             EEecCCCceEEEEEe
Confidence            9532   2 577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=98.01  E-value=0.00011  Score=67.43  Aligned_cols=77  Identities=16%  Similarity=0.096  Sum_probs=57.6

Q ss_pred             CCCCeeccCCceEEEEEEECCCcEEEEEeCCCC-ChHHHHHHHHHHhcCCC---Cceeeeccceec---CCeeEEEEEee
Q 016917           80 SDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQH---RNLVTLLGYCQE---NNLQFLIYEYI  152 (380)
Q Consensus        80 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e~~  152 (380)
                      ...+.||.|..+.||.....++ .+.+|..+.. ....+..|.+.|+.+..   -.+.+.++++..   .+..++|||++
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            3346799999999999986655 4666765542 45688999999988842   367788877654   36689999999


Q ss_pred             cCCCc
Q 016917          153 PNGSV  157 (380)
Q Consensus       153 ~~g~L  157 (380)
                      +++++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.01  E-value=6.4e-05  Score=66.61  Aligned_cols=73  Identities=11%  Similarity=0.218  Sum_probs=46.6

Q ss_pred             CeeccCCce-EEEEEEECCCcEEEEEeCCCC-ChHHHHHHHHHHhcCCCC---ceeeeccceecC---CeeEEEEEeecC
Q 016917           83 NLIGEGKFG-EVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHR---NLVTLLGYCQEN---NLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g-~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~~~  154 (380)
                      ..|+.|+.. .||+.    +..+++|..... ....+..|.+++..+...   .+.+.++.....   ...+++|++++|
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G   78 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG   78 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence            457777666 58876    235777875443 345788899999877421   344444444332   245889999999


Q ss_pred             CCccc
Q 016917          155 GSVSI  159 (380)
Q Consensus       155 g~L~~  159 (380)
                      .++.+
T Consensus        79 ~~l~~   83 (235)
T cd05155          79 ETATA   83 (235)
T ss_pred             CCCCc
Confidence            77753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.96  E-value=9.7e-05  Score=67.82  Aligned_cols=143  Identities=16%  Similarity=0.082  Sum_probs=85.5

Q ss_pred             CCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcCCCC--ceeeeccce------ecCCeeEEEEEeec
Q 016917           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHR--NLVTLLGYC------QENNLQFLIYEYIP  153 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~------~~~~~~~lv~e~~~  153 (380)
                      .+.|..|....+|+....+ ..+++|............|.+++..+.+.  .+.+.+...      ...+..++|+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~   97 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLA   97 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCC
Confidence            4567778888999987654 46888987655556677888888887432  244544321      23345689999999


Q ss_pred             CCCcccc----c----------c----CCCCC--CCCCCCHHHHH----------HHHHHHHHHHHHHhc-----CCCCe
Q 016917          154 NGSVSIH----L----------Y----GPSQV--SRQKLEFKHRL----------SIALGAAKGLAHLHS-----LSPRV  198 (380)
Q Consensus       154 ~g~L~~~----l----------~----~~~~~--~~~~~~~~~~~----------~i~~~i~~~l~~LH~-----~~~~i  198 (380)
                      |..+...    .          +    .....  ......|....          .....+..++.++.+     ...++
T Consensus        98 G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l  177 (296)
T cd05153          98 GEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGV  177 (296)
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcC
Confidence            8766430    0          0    00000  00111111100          011122333444432     22469


Q ss_pred             EecCCCCCCeeeCCCCceEEccccccc
Q 016917          199 VHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       199 vHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      +|+|+.|.|+|+++++.+.|+||+.+.
T Consensus       178 ~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         178 IHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CccCcCcccEEEeCCceEEEeehhhhc
Confidence            999999999999998778899998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.95  E-value=8.3e-05  Score=66.81  Aligned_cols=135  Identities=13%  Similarity=0.115  Sum_probs=76.0

Q ss_pred             eccCCceEEEEEEECCCcEEEEEeCCCCCh---HHHHHHHHHHhcCCCCce-eeeccceecCCeeEEEEEeecCCCcccc
Q 016917           85 IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIPNGSVSIH  160 (380)
Q Consensus        85 ig~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~~~  160 (380)
                      +..|-...+|+... ++..+++|.......   -...+|.++++.+....+ .+++....    -++|+||++|..+...
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            55677889998874 466788887543321   135778889988853322 33333322    2689999998766532


Q ss_pred             -----------------ccCCCCCCCCCCCHHH-HHHHHHHH---------HHHHHHHhcC------CCCeEecCCCCCC
Q 016917          161 -----------------LYGPSQVSRQKLEFKH-RLSIALGA---------AKGLAHLHSL------SPRVVHKDFKTAN  207 (380)
Q Consensus       161 -----------------l~~~~~~~~~~~~~~~-~~~i~~~i---------~~~l~~LH~~------~~~ivHrDikp~N  207 (380)
                                       ++.... ....+.... ...+..++         ...+..+-..      ...++|+|+.|.|
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPR-FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence                             011100 011111111 11111111         1112222110      1358999999999


Q ss_pred             eeeCCCCceEEcccccccc
Q 016917          208 VLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       208 ili~~~~~~kl~DFgla~~  226 (380)
                      |++++++ +.++||+.+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999987753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.91  E-value=0.0002  Score=66.47  Aligned_cols=143  Identities=14%  Similarity=0.068  Sum_probs=77.9

Q ss_pred             CCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcCCC--Cceeeeccc------eecCCeeEEEEEeec
Q 016917           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQH--RNLVTLLGY------CQENNLQFLIYEYIP  153 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~------~~~~~~~~lv~e~~~  153 (380)
                      .+.|+.|....+|+....+| .+++|+......+....|...++.|..  -.+.+.+..      ....+..+++++|++
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~  105 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFLE  105 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEecC
Confidence            35567777789999987655 678887643344455556666665531  123333321      123456789999999


Q ss_pred             CCCcccc----c----------cCCCC----C--CCCCCCH-HHHHH------------HHHH-HHHHHHHHhc-----C
Q 016917          154 NGSVSIH----L----------YGPSQ----V--SRQKLEF-KHRLS------------IALG-AAKGLAHLHS-----L  194 (380)
Q Consensus       154 ~g~L~~~----l----------~~~~~----~--~~~~~~~-~~~~~------------i~~~-i~~~l~~LH~-----~  194 (380)
                      |..+...    .          +....    .  ....+.+ .....            ...+ +...+..+..     .
T Consensus       106 G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l  185 (319)
T PRK05231        106 GKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPAL  185 (319)
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccccC
Confidence            8754311    0          00000    0  0001111 11100            1111 1112223321     2


Q ss_pred             CCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       195 ~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ..++||+|+.|.||+++++...-++||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            3579999999999999977666899998765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.87  E-value=4.4e-05  Score=79.08  Aligned_cols=196  Identities=22%  Similarity=0.239  Sum_probs=134.1

Q ss_pred             HHHHHHHHhcCCCCceeeeccceecCCee----EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 016917          117 FIDEVCFLASIQHRNLVTLLGYCQENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH  192 (380)
Q Consensus       117 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH  192 (380)
                      ..-|.+.+.++.|+|++.++.|.......    .+..+++..-++...+     ..-...+....+.+..+..+|+.|+|
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~-----q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL-----QSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH-----hhccccCHHHHHHHHHHHhhhHHHHH
Confidence            34577788889999999999887654332    2345677766666666     34566778888889999999999999


Q ss_pred             cCCCCeEecCCCCC---CeeeCCCCceEEc--ccccccccCCCCCCCCCccccCccceecccccccCCCCcc--hhhHHH
Q 016917          193 SLSPRVVHKDFKTA---NVLVDEDFIAKVA--DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEK--SDVYSF  265 (380)
Q Consensus       193 ~~~~~ivHrDikp~---Nili~~~~~~kl~--DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~--~DvwSl  265 (380)
                      +.  ...|.-+..+   +.-.+.++.+..+  ||+..........   ......+..+.+||....+.+..+  .|+|.+
T Consensus       304 ~~--~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  304 SL--SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             Hh--ccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHH
Confidence            94  3555555555   4455667777777  9988776644322   223344556888988877766554  799999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 016917          266 GVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV  345 (380)
Q Consensus       266 G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll  345 (380)
                      |..+..+..|..+-....                  .....        .+........+...+|+..|+++|+++.+++
T Consensus       379 gll~~~~~~~~~i~~~~~------------------~~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll  432 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSA------------------VPVSL--------LDVLSTSELLDALPKCLDEDSEERLSALELL  432 (1351)
T ss_pred             HHHHhhhhhcCccccccc------------------chhhh--------hccccchhhhhhhhhhcchhhhhccchhhhh
Confidence            999999998765311100                  00000        0111112577889999999999999999999


Q ss_pred             HHH
Q 016917          346 TEL  348 (380)
Q Consensus       346 ~~L  348 (380)
                      .+.
T Consensus       433 ~~~  435 (1351)
T KOG1035|consen  433 THP  435 (1351)
T ss_pred             hch
Confidence            764

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.86  E-value=0.00035  Score=64.52  Aligned_cols=143  Identities=17%  Similarity=0.079  Sum_probs=82.5

Q ss_pred             CCeeccCCceEEEEEEECCCcEEEEEeCCCC-ChHHHHHHHHHHhcCCC--Cceeeeccce------ecCCeeEEEEEee
Q 016917           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQH--RNLVTLLGYC------QENNLQFLIYEYI  152 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~h--~niv~l~~~~------~~~~~~~lv~e~~  152 (380)
                      .+.++.|....+|+....++ .+++|..... ..+....|.+++..|..  -++++.+...      ...+..+++++|+
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i  105 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL  105 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence            45677777789999886555 5778875433 34556677777777732  2244444422      2245678999999


Q ss_pred             cCCCcccc--------------ccCCCC---CCC-C---CCCHHHHH------------HHHHHHHHHHHHHhc-----C
Q 016917          153 PNGSVSIH--------------LYGPSQ---VSR-Q---KLEFKHRL------------SIALGAAKGLAHLHS-----L  194 (380)
Q Consensus       153 ~~g~L~~~--------------l~~~~~---~~~-~---~~~~~~~~------------~i~~~i~~~l~~LH~-----~  194 (380)
                      +|..+...              ++....   ... .   .-.|....            .....+...+.++..     .
T Consensus       106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~  185 (307)
T TIGR00938       106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL  185 (307)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            98654311              000000   000 0   00111000            011122334555532     2


Q ss_pred             CCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       195 ~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ..+++|+|+.+.|+++++++...|+||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            3679999999999999988877899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.85  E-value=9.9e-05  Score=62.82  Aligned_cols=104  Identities=23%  Similarity=0.167  Sum_probs=79.5

Q ss_pred             HHHHHHHhcCCC-CceeeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-C
Q 016917          118 IDEVCFLASIQH-RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-S  195 (380)
Q Consensus       118 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~  195 (380)
                      ..|.-+++.+.+ +++++++|+|-.    ++|.||...+++.......  ..-...+|..+.+|+.++++.+.+++.. .
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l--~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPL--SQFLQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccc--ccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            357888888866 699999999943    6789999877654221000  1123458999999999999999999873 1


Q ss_pred             CCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       196 ~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ..+.-.|++++|+-+++++.+|++|.+.+...
T Consensus        81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            23778899999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.85  E-value=0.00018  Score=63.69  Aligned_cols=72  Identities=18%  Similarity=0.176  Sum_probs=47.3

Q ss_pred             CeeccCCceEEEEEEECC--CcEEEEEeCCCCChH--HHHHHHHHHhcCCCCc-eeeeccceecCCeeEEEEEeecCCCc
Q 016917           83 NLIGEGKFGEVYKGLLQD--GMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~--~~~vavK~~~~~~~~--~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g~L  157 (380)
                      +.|..|-...+|++...+  +..+++|........  ...+|..+++.+...+ .+++++... +   .+||||++|.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCcC
Confidence            567788888999998664  678889976543221  2346888888874322 344443332 1   379999998766


Q ss_pred             c
Q 016917          158 S  158 (380)
Q Consensus       158 ~  158 (380)
                      .
T Consensus        80 ~   80 (235)
T cd05157          80 E   80 (235)
T ss_pred             C
Confidence            4

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.85  E-value=0.00024  Score=67.44  Aligned_cols=71  Identities=17%  Similarity=0.159  Sum_probs=52.5

Q ss_pred             CeeccCCceEEEEEEECCC-cEEEEEeCC----------CCChHHHHHHHHHHhcCC---CCceeeeccceecCCeeEEE
Q 016917           83 NLIGEGKFGEVYKGLLQDG-MLVAIKKRP----------GAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~-~~vavK~~~----------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  148 (380)
                      +.||.|.+..||++...+| +.++||.-.          +...++...|.+.|+.+.   ..++++++.+..  ...++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence            5789999999999998776 489999732          123456778888888763   246777777644  446899


Q ss_pred             EEeecCC
Q 016917          149 YEYIPNG  155 (380)
Q Consensus       149 ~e~~~~g  155 (380)
                      |||+++.
T Consensus       110 ME~L~~~  116 (401)
T PRK09550        110 MEDLSDH  116 (401)
T ss_pred             EecCCCc
Confidence            9999864

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.69  E-value=0.00048  Score=58.69  Aligned_cols=122  Identities=20%  Similarity=0.295  Sum_probs=85.3

Q ss_pred             CCCCCCCeeccCCc-eEEEEEEECCCcEEEEEe---CCC---------------------CChHHHHHHHHHHhcCC---
Q 016917           77 KNFSDKNLIGEGKF-GEVYKGLLQDGMLVAIKK---RPG---------------------APTQEFIDEVCFLASIQ---  128 (380)
Q Consensus        77 ~~~~~~~~ig~G~~-g~V~~~~~~~~~~vavK~---~~~---------------------~~~~~~~~E~~~l~~l~---  128 (380)
                      .+++..+.||.|.- |.||+++.. |+.+|+|.   ...                     ...+.|..|.....+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888899999999 999999986 67999997   110                     01124677888777763   


Q ss_pred             CCce--eeeccceecCC------------------eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 016917          129 HRNL--VTLLGYCQENN------------------LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL  188 (380)
Q Consensus       129 h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l  188 (380)
                      +.++  ++.+||..-..                  ...||.||.+...              .+..    .-+.++.+-+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~----~~~~~~~~dl  177 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQI----RDIPQMLRDL  177 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccch----hHHHHHHHHH
Confidence            4566  89999873220                  1245666654422              1222    2345677778


Q ss_pred             HHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       189 ~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      ..+|.  .||+-+|+++.|..     .-+|+|||.+
T Consensus       178 ~~~~k--~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  178 KILHK--LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHH--CCeeeccCcccccc-----CCEEEecccC
Confidence            88999  67999999999986     3489999864

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.50  E-value=0.00033  Score=63.68  Aligned_cols=74  Identities=18%  Similarity=0.266  Sum_probs=50.5

Q ss_pred             CCCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcCC---CCceeeeccceecCCeeEEEEEeecCC
Q 016917           81 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFLIYEYIPNG  155 (380)
Q Consensus        81 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  155 (380)
                      ..+.++.|....+|+.. .++..+.+|.........|..|.+-|+.|.   --.+++.+++....+..+||+||++.+
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            34678889999999988 567889999877666677889988888873   346788888887777779999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.43  E-value=0.00084  Score=61.82  Aligned_cols=73  Identities=26%  Similarity=0.266  Sum_probs=47.1

Q ss_pred             CeeccCCceEEEEEEECC-------CcEEEEEeCCCCC--hHHHHHHHHHHhcCCCCc-eeeeccceecCCeeEEEEEee
Q 016917           83 NLIGEGKFGEVYKGLLQD-------GMLVAIKKRPGAP--TQEFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~-------~~~vavK~~~~~~--~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~  152 (380)
                      +.+..|-...+|+....+       +..+++|......  ......|.++++.+...+ ..++++.+. +   .+|+||+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i   79 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI   79 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence            456667777999988654       5789999855432  234567888888874322 334444443 2   3589999


Q ss_pred             cCCCccc
Q 016917          153 PNGSVSI  159 (380)
Q Consensus       153 ~~g~L~~  159 (380)
                      +|..+..
T Consensus        80 ~G~~l~~   86 (302)
T cd05156          80 PSRTLTT   86 (302)
T ss_pred             CCCcCCH
Confidence            8876653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.36  E-value=0.002  Score=58.51  Aligned_cols=69  Identities=14%  Similarity=0.089  Sum_probs=40.5

Q ss_pred             eccCCceEEEEEEECCCcEEEEEeCCCC-ChHHHHHHHHHHhcCC-C-C-ceeeeccceecCCeeEEEEEeecCCCc
Q 016917           85 IGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQ-H-R-NLVTLLGYCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        85 ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~-h-~-niv~l~~~~~~~~~~~lv~e~~~~g~L  157 (380)
                      .++|-...|+.....+|..+++|.-+.. ......+|..+|+.+. + | -+.++...  ..  -+++|+++.|..+
T Consensus        19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~--~~--~~~~y~~i~G~p~   91 (276)
T cd05152          19 NESGLDFQVVFAKDTDGVPWVLRIPRRPDVSERAAAEKRVLALVRKHLPVQVPDWRVH--TP--ELIAYPKLPGVPA   91 (276)
T ss_pred             cCCcceeEEEEEEcCCCCeEEEEecCCHHHHHHHHHHHHHHHHHHhcCCCCCCceeee--cC--ceEEEeccCCCcc
Confidence            3455556677665566888998876532 3456788999998884 2 2 12222211  11  2466777766544

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.36  E-value=0.00022  Score=64.55  Aligned_cols=128  Identities=17%  Similarity=0.149  Sum_probs=88.5

Q ss_pred             CCCCCeeccCCceEEEEEEECCCcEEEEEeCCC--C-------C----------------hHHHHHHHHHHhcCC-C-Cc
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG--A-------P----------------TQEFIDEVCFLASIQ-H-RN  131 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~--~-------~----------------~~~~~~E~~~l~~l~-h-~n  131 (380)
                      +.+.+.||-|--+.||.+-...|.+.++|...-  .       .                +-...+|...|+.|. | =-
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            567789999999999999999999999884110  0       0                012346788887773 2 23


Q ss_pred             eeeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC
Q 016917          132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD  211 (380)
Q Consensus       132 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~  211 (380)
                      +.+-++    .+..++|||++.+-.|...-.        ....   ..+...++.-+.-|-.  .|+||+|..--||+++
T Consensus       174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~--------v~d~---~~ly~~lm~~Iv~la~--~GlIHgDFNEFNimv~  236 (465)
T KOG2268|consen  174 VPKPID----HNRHCVVMELVDGYPLRQVRH--------VEDP---PTLYDDLMGLIVRLAN--HGLIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCccc----ccceeeHHHhhcccceeeeee--------cCCh---HHHHHHHHHHHHHHHH--cCceecccchheeEEe
Confidence            444443    345689999998877654321        1111   2234445555556666  6799999999999999


Q ss_pred             CCCceEEccccc
Q 016917          212 EDFIAKVADAGL  223 (380)
Q Consensus       212 ~~~~~kl~DFgl  223 (380)
                      +++.++++||--
T Consensus       237 dd~~i~vIDFPQ  248 (465)
T KOG2268|consen  237 DDDKIVVIDFPQ  248 (465)
T ss_pred             cCCCEEEeechH
Confidence            999999999963

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.10  E-value=0.0081  Score=57.03  Aligned_cols=70  Identities=14%  Similarity=0.161  Sum_probs=49.8

Q ss_pred             CCeeccCCceEEEEEEECCCcEEEEEeCC------C----CChHHHHHHHHHHhcCC---CCceeeeccceecCCeeEEE
Q 016917           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRP------G----APTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~------~----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  148 (380)
                      .+.||.|....||+.... +..++||.-.      .    ....+-..|.+.|+.+.   ..++++++.++.+.  .+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEE
Confidence            467899999999998874 4568899633      1    13344455677776653   24788888888744  5789


Q ss_pred             EEeecC
Q 016917          149 YEYIPN  154 (380)
Q Consensus       149 ~e~~~~  154 (380)
                      |||+++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.09  E-value=0.011  Score=54.34  Aligned_cols=134  Identities=22%  Similarity=0.280  Sum_probs=80.5

Q ss_pred             CCeeccCCceEEEEEEECCCcEEEEEeCCC-----CChHHHHHHHHHHhcCCC--CceeeeccceecCC--eeEEEEEee
Q 016917           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPG-----APTQEFIDEVCFLASIQH--RNLVTLLGYCQENN--LQFLIYEYI  152 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~  152 (380)
                      .+.+..|..-.+|..... ++.+++. .+.     .......+|..+++.+.-  --+..-+++|.++.  ..+.||+|+
T Consensus        30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            344434443444444433 7778887 331     223345567778877642  34555677776655  679999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHH-HHHHHHHHHHhcCC------------------------------------
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIA-LGAAKGLAHLHSLS------------------------------------  195 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~-~~i~~~l~~LH~~~------------------------------------  195 (380)
                      +|..+...+.....      .    ..++ ..++..|.-||+..                                    
T Consensus       108 eGe~~~~~~~~~~~------~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~  177 (321)
T COG3173         108 EGEVVWSALPPESL------G----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI  177 (321)
T ss_pred             cceeccCcCCcccc------h----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence            98644433311100      0    0111 23444444444321                                    


Q ss_pred             --------------------CCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          196 --------------------PRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       196 --------------------~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                                          ..++|+|+.+.|+++++++-+-+.||+++..-
T Consensus       178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                                35899999999999999888999999988653

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.02  E-value=7.7e-05  Score=79.30  Aligned_cols=159  Identities=13%  Similarity=0.060  Sum_probs=111.5

Q ss_pred             HHHHHHHhcCCCCceeeeccceec--CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-
Q 016917          118 IDEVCFLASIQHRNLVTLLGYCQE--NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-  194 (380)
Q Consensus       118 ~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-  194 (380)
                      ..|.+-++...|+++.....-...  ....+.+++|+.+|.+.+.+...... ...+...-+.....+...+..-+|.. 
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee-~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEE-SPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcccc-CCcchhchHHHHHHHHHhccchhhhcc
Confidence            345555566789988877665543  34558899999999998887544322 22222222333333335666666653 


Q ss_pred             --CCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHH
Q 016917          195 --SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL  272 (380)
Q Consensus       195 --~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el  272 (380)
                        +.--+|+++|+.|.+|..+..+|++++|+.+...+.  ........+++.|++|+....-.++.++|+|+.|+-+|+.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence              334689999999999999999999999999843221  1122345677889999988888888889999999999998


Q ss_pred             HcCCCCC
Q 016917          273 VSGREAS  279 (380)
Q Consensus       273 ~tg~~p~  279 (380)
                      .-|..+|
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            8877654

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.90  E-value=0.0053  Score=56.79  Aligned_cols=137  Identities=17%  Similarity=0.141  Sum_probs=91.1

Q ss_pred             CCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC------------------------hH---H--HHHHHHHHhcCCCC
Q 016917           80 SDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP------------------------TQ---E--FIDEVCFLASIQHR  130 (380)
Q Consensus        80 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~------------------------~~---~--~~~E~~~l~~l~h~  130 (380)
                      .+...|..|--+.||.++..+|..+|||+.+...                        +.   .  ...|+.-|++++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            3456788899999999999999999999533211                        00   0  23466666666544


Q ss_pred             ceeeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 016917          131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (380)
Q Consensus       131 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili  210 (380)
                      .|.--.-...  ....|||+++.......-.     .....++...+..+-.+++.-|.-|.+. .++||.||.--|+|+
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPk-----LKd~~ls~~ka~~~Y~~~v~~MR~lY~~-c~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPK-----LKDASLSTSKARELYQQCVRIMRRLYQK-CRLVHADLSEFNLLY  298 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCcc-----cccccCChHHHHHHHHHHHHHHHHHHHH-hceeccchhhhhheE
Confidence            4322111111  1237999999654332211     3455667777778888888888888764 579999999999987


Q ss_pred             CCCCceEEccccccc
Q 016917          211 DEDFIAKVADAGLRN  225 (380)
Q Consensus       211 ~~~~~~kl~DFgla~  225 (380)
                      .+ |.+.++|-+-+-
T Consensus       299 hd-G~lyiIDVSQSV  312 (520)
T KOG2270|consen  299 HD-GKLYIIDVSQSV  312 (520)
T ss_pred             EC-CEEEEEEccccc
Confidence            64 678899987543

>PLN02236 choline kinase

Probab=96.85  E-value=0.0085  Score=56.26  Aligned_cols=139  Identities=15%  Similarity=0.137  Sum_probs=76.7

Q ss_pred             CeeccCCceEEEEEEECC-----CcEEEEEeCCCCChH--HHHHHHHHHhcCCCCcee-eeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNLV-TLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~--~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      ..+..|-.-.+|++...+     +..+++|........  .-.+|..+++.+..-++. ++++.+.. +   .|.+|+++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g  117 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA  117 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence            445567888999987532     367899986544321  125688888887433332 44444432 2   57999987


Q ss_pred             CCcccc-c----------------cCCCCCCCC-CCCHHHHHHHHHH-----------------HHHHHHHH----hc--
Q 016917          155 GSVSIH-L----------------YGPSQVSRQ-KLEFKHRLSIALG-----------------AAKGLAHL----HS--  193 (380)
Q Consensus       155 g~L~~~-l----------------~~~~~~~~~-~~~~~~~~~i~~~-----------------i~~~l~~L----H~--  193 (380)
                      .++... +                +........ ...+..+..+..+                 +...+..|    ..  
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            666421 1                111101111 1112222222111                 11112222    11  


Q ss_pred             CCCCeEecCCCCCCeeeCC-CCceEEccccccc
Q 016917          194 LSPRVVHKDFKTANVLVDE-DFIAKVADAGLRN  225 (380)
Q Consensus       194 ~~~~ivHrDikp~Nili~~-~~~~kl~DFgla~  225 (380)
                      ....++|+|+++.|||+++ ++.+.++||..+.
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            1235899999999999986 4789999998765

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.59  E-value=0.036  Score=51.14  Aligned_cols=29  Identities=21%  Similarity=0.276  Sum_probs=25.2

Q ss_pred             CCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          196 PRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       196 ~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57999999999999987 568899998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.57  E-value=0.022  Score=49.34  Aligned_cols=75  Identities=15%  Similarity=0.230  Sum_probs=54.6

Q ss_pred             CeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcC---CCCceeeeccceecCCeeEEEEEeecCCCcc
Q 016917           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI---QHRNLVTLLGYCQENNLQFLIYEYIPNGSVS  158 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  158 (380)
                      +.+.-|.--..|.... ...++-+|.........|..|+.-|..|   +.-++.+.+.+....+..|+|+||++.+.+.
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            3444444444454443 3567889987777777888888777666   3456888898999999999999999987665

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.52  E-value=0.025  Score=52.88  Aligned_cols=69  Identities=13%  Similarity=0.149  Sum_probs=45.6

Q ss_pred             eeccCCceEEEEEEECCC-cEEEEEe-------CC---CCChHHHHHHHHHHhcCC--CC-ceeeeccceecCCeeEEEE
Q 016917           84 LIGEGKFGEVYKGLLQDG-MLVAIKK-------RP---GAPTQEFIDEVCFLASIQ--HR-NLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        84 ~ig~G~~g~V~~~~~~~~-~~vavK~-------~~---~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~  149 (380)
                      .||.|....||++...++ ..++||.       ..   +...++..-|.+.|+...  -| .+++++.+-  .....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--TEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--cccceehH
Confidence            479999999999997654 5899994       11   223445567778887663  24 455555443  33446899


Q ss_pred             EeecC
Q 016917          150 EYIPN  154 (380)
Q Consensus       150 e~~~~  154 (380)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.34  E-value=0.048  Score=50.61  Aligned_cols=140  Identities=18%  Similarity=0.202  Sum_probs=82.6

Q ss_pred             eeccCCceEEEEEEECCCcEEEEEeCCCC-ChHHHHHHHHHHhcCC-C--Cc---eeeeccce--ecCC--eeEEEEEee
Q 016917           84 LIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQ-H--RN---LVTLLGYC--QENN--LQFLIYEYI  152 (380)
Q Consensus        84 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~-h--~n---iv~l~~~~--~~~~--~~~lv~e~~  152 (380)
                      .|.+ .-..+|+....+|.. ++|..... ...+...|...+..|. +  +-   +..+-|-.  .-.+  ..+-|++|+
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l  110 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL  110 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence            3444 456799999887777 89987664 6667788888888873 1  11   22222211  1223  677899999


Q ss_pred             cCCCccc-cc------------------cCC---CCCCCCCCCHHH-------------HHHHHHHHHHHHHHHhcC---
Q 016917          153 PNGSVSI-HL------------------YGP---SQVSRQKLEFKH-------------RLSIALGAAKGLAHLHSL---  194 (380)
Q Consensus       153 ~~g~L~~-~l------------------~~~---~~~~~~~~~~~~-------------~~~i~~~i~~~l~~LH~~---  194 (380)
                      +|..+.. ..                  .+.   .+.......|..             -.....++...+..+.+.   
T Consensus       111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~  190 (331)
T COG2334         111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA  190 (331)
T ss_pred             CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence            9988773 11                  000   000111122220             011233334444444332   


Q ss_pred             ---CCC--eEecCCCCCCeeeCCCCc-eEEccccccc
Q 016917          195 ---SPR--VVHKDFKTANVLVDEDFI-AKVADAGLRN  225 (380)
Q Consensus       195 ---~~~--ivHrDikp~Nili~~~~~-~kl~DFgla~  225 (380)
                         .-+  +||+|+-|.||+++.+.. +-+.||+-+.
T Consensus       191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               123  999999999999998874 8999998654

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=96.29  E-value=0.006  Score=47.30  Aligned_cols=34  Identities=29%  Similarity=0.358  Sum_probs=21.1

Q ss_pred             cchhhHHHHHHHHHHHHHHHHHHHHHHHHhcCCC
Q 016917            3 VTLAAIFGAAAGAVALMGIIFFLSWFCLYRNRSV   36 (380)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~   36 (380)
                      +.-+++++|++||++.+++++++++||.+|++++
T Consensus        61 fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk   94 (122)
T PF01102_consen   61 FSEPAIIGIIFGVMAGVIGIILLISYCIRRLRKK   94 (122)
T ss_dssp             SS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred             ccccceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence            3446788888888876666666666665555554

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.29  E-value=0.039  Score=50.98  Aligned_cols=31  Identities=19%  Similarity=0.189  Sum_probs=27.8

Q ss_pred             CCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       196 ~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      .+++|+|+.+.|+|+++++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4799999999999999999999999987653

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.27  E-value=0.0023  Score=61.46  Aligned_cols=165  Identities=24%  Similarity=0.322  Sum_probs=90.2

Q ss_pred             HHHHHHHHHHhcCCCCceeeeccceecC-CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 016917          115 QEFIDEVCFLASIQHRNLVTLLGYCQEN-NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS  193 (380)
Q Consensus       115 ~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~  193 (380)
                      .+......+++.+.|+|...++++.... ....+|+|++.. +|.+.+...      .+....      ..+        
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~------~l~~~s------~~~--------   85 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTG------NLKDES------LLA--------   85 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhc------ccchhh------hcc--------
Confidence            3456678889999999999999988644 346789999855 888777321      111100      001        


Q ss_pred             CCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHH
Q 016917          194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV  273 (380)
Q Consensus       194 ~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~  273 (380)
                        +++.|-     |+       .+.+|    .....               |  |     ....+|+||||+|.++.|+.
T Consensus        86 --~~~~~~-----~~-------~~~td----~~~t~---------------~--~-----~~~~pKsdVwsl~~i~~el~  125 (725)
T KOG1093|consen   86 --HGVLHL-----NI-------IYITD----HFLTK---------------Y--P-----SPIGPKSDVWSLGFIILELY  125 (725)
T ss_pred             --ccccee-----hh-------hhccc----ccccc---------------C--C-----CCCCcchhhhhHHHHHHHHH
Confidence              223331     22       23333    11000               0  1     01114999999999999999


Q ss_pred             cCCCCCCCCCCCCcccHHHHHHhh-hcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 016917          274 SGREASSSLSPDSSQDLVELVQNS-RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT  346 (380)
Q Consensus       274 tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~  346 (380)
                      -|...+......+.   ...+... ...........+.   .+.-+++..++++.+.|+-..|..||...++.+
T Consensus       126 L~~~l~~~~~~s~~---l~~i~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k  193 (725)
T KOG1093|consen  126 LGISLEAELTESEY---LEILLKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK  193 (725)
T ss_pred             HhhHHHHHHHHHHH---HHHHHHhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence            98765443221100   0000000 0000001111111   222345677889999999999999987666553

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.13  E-value=0.039  Score=51.50  Aligned_cols=71  Identities=15%  Similarity=0.186  Sum_probs=43.3

Q ss_pred             CeeccCCceEEEEEEECC----CcEEEEEeCCCCChH--HHHHHHHHHhcCCCCce-eeeccceecCCeeEEEEEeecCC
Q 016917           83 NLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIPNG  155 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~--~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g  155 (380)
                      +.|..|-.-.+|+....+    +..|++|........  .-.+|..+++.+..-++ .++++++. ++   +|.+|+++.
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~   95 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR   95 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence            445557778899887543    237889976543221  23568888888854333 34454443 22   588998776


Q ss_pred             Cc
Q 016917          156 SV  157 (380)
Q Consensus       156 ~L  157 (380)
                      .+
T Consensus        96 ~l   97 (330)
T PLN02421         96 TL   97 (330)
T ss_pred             CC
Confidence            55

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.59  E-value=0.085  Score=45.62  Aligned_cols=113  Identities=17%  Similarity=0.122  Sum_probs=68.2

Q ss_pred             CCceEEEEEEECCCcEEEEEeCCC---C-ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCccccccC
Q 016917           88 GKFGEVYKGLLQDGMLVAIKKRPG---A-PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG  163 (380)
Q Consensus        88 G~~g~V~~~~~~~~~~vavK~~~~---~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  163 (380)
                      ++.++.-.+..+-| +..+|+...   . ...-|..+..++.++.  .|+++..=  ++...-++.|+|-...       
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------  140 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------
Confidence            34444444443333 334444332   2 2334667778887775  46666522  3334567888874311       


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          164 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       164 ~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                             ....    .+..-=+.+|.-.|+.+.+.+|+|..|+||+-|..|.+||.|=+.
T Consensus       141 -------i~~~----N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  141 -------INFS----NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             -------cchh----HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence                   0111    111112456778897668899999999999999999999999653

The function of this family is unknown.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.58  E-value=0.37  Score=44.87  Aligned_cols=70  Identities=17%  Similarity=0.212  Sum_probs=44.9

Q ss_pred             CCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCC--ceeeec---c--ceecCCeeEEEEEeecCCCc
Q 016917           88 GKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHR--NLVTLL---G--YCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        88 G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~--niv~l~---~--~~~~~~~~~lv~e~~~~g~L  157 (380)
                      +.-..||+....++..+++|.....  .......|.+.+..|...  .++...   |  ....++..+.|+++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            4556799999888888999986533  455677888888776321  122211   1  12224567889999987654

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.35  E-value=0.035  Score=52.19  Aligned_cols=122  Identities=20%  Similarity=0.142  Sum_probs=71.2

Q ss_pred             CeeccCCceEEEEEEEC----------------CCcEEEEEeCCCCChHHHHHHHHHHhcCC-CCceee-----------
Q 016917           83 NLIGEGKFGEVYKGLLQ----------------DGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVT-----------  134 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~----------------~~~~vavK~~~~~~~~~~~~E~~~l~~l~-h~niv~-----------  134 (380)
                      ..||+|+-+.||+|..+                ..+.+|+|...+.....+...+.+|.... -+|++.           
T Consensus       195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~ir~Dl~Il~f~Akl~~~vP~l~wL~l~~~v  274 (565)
T KOG1236|consen  195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQIRLDLGILGFGAKLINNVPDLSWLSLPLEV  274 (565)
T ss_pred             cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHHHHHHHHHhhhhhhhhhcCccccccCcchH
Confidence            46999999999998632                13578999876666555555555444331 112221           


Q ss_pred             ----------------------ecccee-------------cCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHH
Q 016917          135 ----------------------LLGYCQ-------------ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS  179 (380)
Q Consensus       135 ----------------------l~~~~~-------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~  179 (380)
                                            +..-+.             ......|+=+|..|.++..++.      ....++..+..
T Consensus       275 kqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~------~~~~pe~l~kk  348 (565)
T KOG1236|consen  275 KQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVK------WKSQPEALVKK  348 (565)
T ss_pred             HHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhh------cccChHHHHHH
Confidence                                  111111             0111245556777777776663      23334445555


Q ss_pred             HHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC
Q 016917          180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVD  211 (380)
Q Consensus       180 i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~  211 (380)
                      ++.-.+.|+--+--. .+.+|.|+.|.||++-
T Consensus       349 va~lg~~AllkMl~v-DNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  349 VAKLGVNALLKMLIV-DNFVHADLHPGNVLIR  379 (565)
T ss_pred             HHHHHHHHHHHHHHh-hcceecccCCCcEEEE
Confidence            666556665544332 4599999999999994

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.35  E-value=0.055  Score=51.24  Aligned_cols=71  Identities=14%  Similarity=0.144  Sum_probs=47.5

Q ss_pred             CCeeccCCceEEEEEEECC-CcEEEEEe------CC---CCChHHHHHHHHHHhcCC--CC-ceeeeccceecCCeeEEE
Q 016917           82 KNLIGEGKFGEVYKGLLQD-GMLVAIKK------RP---GAPTQEFIDEVCFLASIQ--HR-NLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~-~~~vavK~------~~---~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv  148 (380)
                      .+.||.|.-..||++...+ +..++||.      ..   +...++..-|.+.|+...  -| .+++++.+-.  ....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~--e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS--VMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc--HHhhHH
Confidence            4678999999999999743 56799994      11   223456677888888763  24 4556664443  334678


Q ss_pred             EEeecC
Q 016917          149 YEYIPN  154 (380)
Q Consensus       149 ~e~~~~  154 (380)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888854

>COG3231 Aph Aminoglycoside phosphotransferase [Translation, ribosomal structure and biogenesis]

Probab=95.04  E-value=0.33  Score=42.04  Aligned_cols=129  Identities=21%  Similarity=0.218  Sum_probs=88.1

Q ss_pred             eccCCc-eEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcCCC--CceeeeccceecCCeeEEEEEeecCCCccccc
Q 016917           85 IGEGKF-GEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQH--RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL  161 (380)
Q Consensus        85 ig~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l  161 (380)
                      +..|.. +.||+.....+--+.+|+........+..|.+.++-+.-  -...+..++..+.+.-+|+|+-++|.++..--
T Consensus        26 v~~geS~~~v~rl~a~~r~g~~~k~~~~~~~a~L~~Ea~RlrWla~~~l~~P~V~~~~~~~~~~wLl~salpG~~~s~~~  105 (266)
T COG3231          26 VTEGESGAGVFRLFADSRPGLYLKIASSGPAAELEGEAARLRWLAGQGLGCPRVLGLEDDADQAWLLMSALPGEDASHPR  105 (266)
T ss_pred             eeccCCCCeEEEEeccCCCceEEEEecCcchhhhhhHHHHHHHhcccCCCCCceEeeccCcchhHHhhhhcCCCcccchh
Confidence            444443 468877655555677888777777889999999987632  23444455556677789999999997765322


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------------
Q 016917          162 YGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS----------------------------------------------  195 (380)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------------  195 (380)
                              ..++.+.   .+--++.+|+.||...                                              
T Consensus       106 --------~~~~p~r---~v~~la~aLR~LH~l~~~aCPFd~rl~~rl~~a~~r~~a~~vdesdfd~e~qgr~~~El~d~  174 (266)
T COG3231         106 --------YALDPKR---AVPLLAEALRRLHELPVEACPFDRRLARRLAKARARVRAGLVDESDFDEERQGRTAEELFDE  174 (266)
T ss_pred             --------hcCCHHH---HHHHHHHHHHHHhcCChhhCCcchHHHHHHHHHHHHHhccCCChhhcChhhcCCCHHHHHHH
Confidence                    1233333   4455778888888752                                              


Q ss_pred             ----------CCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          196 ----------PRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       196 ----------~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                                --+.|+|-+.-|++++....-=.+|+|-.
T Consensus       175 L~~~rp~~edLVv~HGDACLPN~i~d~~rf~GfIDlGrl  213 (266)
T COG3231         175 LEARRPAVEDLVVTHGDACLPNFILDGWRFSGFIDLGRL  213 (266)
T ss_pred             HHhcCCchhhceeecCcccCcceEecCCceEEeeecCcc
Confidence                      12589999999999998866667777754

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=94.87  E-value=0.15  Score=46.70  Aligned_cols=30  Identities=30%  Similarity=0.260  Sum_probs=24.6

Q ss_pred             CCeEecCCCCCCeeeCCC--C---ceEEccccccc
Q 016917          196 PRVVHKDFKTANVLVDED--F---IAKVADAGLRN  225 (380)
Q Consensus       196 ~~ivHrDikp~Nili~~~--~---~~kl~DFgla~  225 (380)
                      +-++|+|++..|||+..+  |   .+++.||..++
T Consensus       215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~  249 (294)
T PF02958_consen  215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR  249 (294)
T ss_pred             eEEEcCccCHHhEeEccccccccccceeecccccc
Confidence            348999999999999654  3   68999998765

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PRK06148 hypothetical protein; Provisional

Probab=94.84  E-value=0.29  Score=52.80  Aligned_cols=143  Identities=18%  Similarity=0.216  Sum_probs=78.3

Q ss_pred             CeeccCCceEEEEEEECCCcEEEEEeCCCC-ChHHHHHHHHHHhcC-------CCCceeeec-cc----eec-CC--eeE
Q 016917           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASI-------QHRNLVTLL-GY----CQE-NN--LQF  146 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l-------~h~niv~l~-~~----~~~-~~--~~~  146 (380)
                      +.|+ |..-.+|+.+..++..+++|+.... .......|...|..|       .-|.+++-. |-    ... .+  ..+
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~v  109 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRLL  109 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEEE
Confidence            4564 4557789998878889999997644 333444565666544       223333322 11    111 22  456


Q ss_pred             EEEEeecCCCcccccc---------------------CCCCC-CCCCCCHH-----------------HHHHHHHHHHHH
Q 016917          147 LIYEYIPNGSVSIHLY---------------------GPSQV-SRQKLEFK-----------------HRLSIALGAAKG  187 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~---------------------~~~~~-~~~~~~~~-----------------~~~~i~~~i~~~  187 (380)
                      -+++|++|..+.+...                     ..... ....+.|.                 ....++.++...
T Consensus       110 rLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~~  189 (1013)
T PRK06148        110 RLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLAR  189 (1013)
T ss_pred             EEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHHH
Confidence            7899999877654110                     00000 01111121                 111222233322


Q ss_pred             HH-----HHhcCCCCeEecCCCCCCeeeCCCC--ceE-Ecccccccc
Q 016917          188 LA-----HLHSLSPRVVHKDFKTANVLVDEDF--IAK-VADAGLRNF  226 (380)
Q Consensus       188 l~-----~LH~~~~~ivHrDikp~Nili~~~~--~~k-l~DFgla~~  226 (380)
                      ..     .+.+...++||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       190 ~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        190 FERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            22     2333335699999999999999875  454 999997653

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	380
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-38
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-38
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-35
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-35
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-21
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-21
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-20
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-17
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		9e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-11
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		9e-07
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-06
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-06
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-06
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-06
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-06
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-06
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		9e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-05
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-05
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-05
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-05
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-05
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-05
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-05
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-05
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-05
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-05
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-05
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-05
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-05
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-05
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-05
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-05
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-04
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-04
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-04
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-04
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-04
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-04
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-04
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-04
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-04
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-04
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-04
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-04
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-04
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-04
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-04
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-04
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-04
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-04
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-04
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-04
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-04
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-04
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-04
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-04
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-04
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-04
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-04
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-04
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-04
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-04
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-04
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-04
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-04
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-04
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		9e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-04
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-04

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 103/293 (35%), Positives = 151/293 (51%), Gaps = 6/293 (2%)
Query: 63  EARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFID 119
           E+ R  + +L  AT NF  K LIG G FG+VYKG+L+DG  VA+K+R    +Q   EF  
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E+  L+  +H +LV+L+G+C E N   LIY+Y+ NG++  HLYG S +    + ++ RL 
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQRLE 143
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
           I                 ++H+D K+ N+L+DE+F+ K+ D G+       D       V
Sbjct: 144 ICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVV 201
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRD 299
                ++  E     R +EKSDVYSFGV L E++  R A             E    S +
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 300 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
              L +I+D  L      E + +F    V+CL  SSE RPSM DV+ +L+  L
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 105/296 (35%), Positives = 155/296 (52%), Gaps = 12/296 (4%)
Query: 63  EARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ---EFID 119
           E+ R  + +L  AT NF  K LIG G FG+VYKG+L+DG  VA+K+R    +Q   EF  
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E+  L+  +H +LV+L+G+C E N   LIY+Y+ NG++  HLYG S +    + ++ RL 
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQRLE 143
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNF---LGRTDVAGPS 236
           I                 ++H+D K+ N+L+DE+F+ K+ D G+      LG+T +    
Sbjct: 144 ICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLX--- 198
Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQN 296
             V     ++  E     R +EKSDVYSFGV L E++  R A             E    
Sbjct: 199 XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 297 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           S +   L +I+D  L      E + +F    V+CL  SSE RPSM DV+ +L+  L
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 98/299 (32%), Positives = 154/299 (51%), Gaps = 9/299 (3%)
Query: 58  ELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ-- 115
           E+ + + +RF + EL +A+ NF +KN++G G FG+VYKG L DG LVA+K+     TQ  
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGG 70
Query: 116 --EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
             +F  EV  ++   HRNL+ L G+C     + L+Y Y+ NGSV+  L    + S+  L+
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLD 129
Query: 174 FKHRLSIXXXXXXXXXXXXXX-XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
           +  R  I                P+++H+D K AN+L+DE+F A V D GL   +   D 
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX 189
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA--XXXXXXXXXXXX 290
               + V      +A E     + SEK+DV+ +GV LLEL++G+ A              
Sbjct: 190 HVXXA-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 291 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
           ++ V+       L  ++D  L   + +E +E+ IQ+ + C   S   RP MS+VV  L+
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 98/299 (32%), Positives = 154/299 (51%), Gaps = 9/299 (3%)
Query: 58  ELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK----RPGAP 113
           E+ + + +RF + EL +A+ NFS+KN++G G FG+VYKG L DG LVA+K+    R    
Sbjct: 19  EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGG 78
Query: 114 TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
             +F  EV  ++   HRNL+ L G+C     + L+Y Y+ NGSV+  L    + S+  L+
Sbjct: 79  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLD 137
Query: 174 FKHRLSIXXXXXXXXXXXXXX-XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
           +  R  I                P+++H+D K AN+L+DE+F A V D GL   +   D 
Sbjct: 138 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX 197
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA--XXXXXXXXXXXX 290
               + V      +A E     + SEK+DV+ +GV LLEL++G+ A              
Sbjct: 198 HVXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 256
Query: 291 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
           ++ V+       L  ++D  L   + +E +E+ IQ+ + C   S   RP MS+VV  L+
Sbjct: 257 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/238 (31%), Positives = 111/238 (46%), Gaps = 19/238 (7%)
Query: 54  NVGIELSIREARRFQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIK 107
           N  +E+S      F   EL   T NF ++      N +GEG FG VYKG + +   VA+K
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVK 60
Query: 108 KRPGAP-------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIH 160
           K             Q+F  E+  +A  QH NLV LLG+  + +   L+Y Y+PNGS+   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 161 LYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVAD 220
           L          L +  R  I                  +H+D K+AN+L+DE F AK++D
Sbjct: 121 L--SCLDGTPPLSWHMRCKIAQGAANGINFLHEN--HHIHRDIKSANILLDEAFTAKISD 176
Query: 221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
            GL     +       S++     ++A E       + KSD+YSFGV LLE+++G  A
Sbjct: 177 FGLARASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA 233

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 110/238 (46%), Gaps = 19/238 (7%)
Query: 54  NVGIELSIREARRFQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIK 107
           N  +E+S      F   EL   T NF ++      N +GEG FG VYKG + +   VA+K
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVK 60
Query: 108 KRPGAP-------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIH 160
           K             Q+F  E+  +A  QH NLV LLG+  + +   L+Y Y+PNGS+   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 161 LYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVAD 220
           L          L +  R  I                  +H+D K+AN+L+DE F AK++D
Sbjct: 121 L--SCLDGTPPLSWHMRCKIAQGAANGINFLHEN--HHIHRDIKSANILLDEAFTAKISD 176
Query: 221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
            GL     +        ++     ++A E       + KSD+YSFGV LLE+++G  A
Sbjct: 177 FGLARASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA 233

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 105/225 (46%), Gaps = 19/225 (8%)
Query: 67  FQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP------- 113
           F   EL   T NF ++      N +GEG FG VYKG + +   VA+KK            
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 114 TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
            Q+F  E+  +A  QH NLV LLG+  + +   L+Y Y+PNGS+   L          L 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPPLS 125
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           +  R  I                  +H+D K+AN+L+DE F AK++D GL     +    
Sbjct: 126 WHMRCKIAQGAANGINFLHEN--HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
               ++     ++A E       + KSD+YSFGV LLE+++G  A
Sbjct: 184 VMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA 227

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 102/225 (45%), Gaps = 19/225 (8%)
Query: 67  FQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP------- 113
           F   EL   T NF ++      N  GEG FG VYKG + +   VA+KK            
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 114 TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
            Q+F  E+   A  QH NLV LLG+  + +   L+Y Y PNGS+   L          L 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL--SCLDGTPPLS 122
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           +  R  I                  +H+D K+AN+L+DE F AK++D GL     +    
Sbjct: 123 WHXRCKIAQGAANGINFLHEN--HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
              S++     + A E       + KSD+YSFGV LLE+++G  A
Sbjct: 181 VXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPA 224

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 11/223 (4%)
Query: 56  GIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGA 112
           G++L         M++  +   + + K+ +G G++GEVY G+ +   + VA+K  K    
Sbjct: 11  GVDLGTENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM 70
Query: 113 PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL 172
             +EF+ E   +  I+H NLV LLG C      +++ EY+P G++  +L    + +R+  
Sbjct: 71  EVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL---RECNRE-- 125
Query: 173 EFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTD 231
           E    + +                  +H+D    N LV E+ + KVAD GL   + G T 
Sbjct: 126 EVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTY 185
Query: 232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            A   ++      + A E   +  FS KSDV++FGV L E+ +
Sbjct: 186 TAHAGAKFPIK--WTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFL 124
           +++ +   + + K  IG G FG V++     G  VA+K             EF+ EV  +
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIM 88
Query: 125 ASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIX 181
             ++H N+V  +G   Q  NL  ++ EY+  GS+   +H  G    +R++L+ + RLS+ 
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLS-IVTEYLSRGSLYRLLHKSG----AREQLDERRRLSMA 143
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
                         P +VH++ K+ N+LVD+ +  KV D GL      T ++  S+  T 
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTP 203
Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +  ++A EV      +EKSDVYSFGV L EL +
Sbjct: 204 E--WMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLA 125
           +++  +   + + K+ +G G+FGEVY+G+ +   + VA+K  K      +EF+ E   + 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 62
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
            I+H NLV LLG C      ++I E++  G++  +L    + +RQ  E    + +     
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQ 117
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEI 244
                        +H+D    N LV E+ + KVAD GL   + G T  A   ++      
Sbjct: 118 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-- 175
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + A E   + +FS KSDV++FGV L E+ +
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 118/267 (44%), Gaps = 26/267 (9%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
               L++E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 75  APICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRD 128
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 261
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 262 VYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGME 321
           V+SFGV + E+ S  E             VE      D S   ++   RL ST       
Sbjct: 187 VWSFGVLMWEVFS--EGKIPYENRSNSEVVE------DISTGFRLYKPRLASTHV----- 233
Query: 322 EFIQLIVRCLDPSSERRPSMSDVVTEL 348
              Q++  C     E RP+ S ++ +L
Sbjct: 234 --YQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 118/267 (44%), Gaps = 26/267 (9%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
               L++E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 73  APICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 126
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 261
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 262 VYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGME 321
           V+SFGV + E+ S  E             VE      D S   ++   RL ST       
Sbjct: 185 VWSFGVLMWEVFS--EGKIPYENRSNSEVVE------DISTGFRLYKPRLASTHV----- 231
Query: 322 EFIQLIVRCLDPSSERRPSMSDVVTEL 348
              Q++  C     E RP+ S ++ +L
Sbjct: 232 --YQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 118/267 (44%), Gaps = 26/267 (9%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
               L++E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 75  APICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 128
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 261
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 262 VYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGME 321
           V+SFGV + E+ S  E             VE      D S   ++   RL ST       
Sbjct: 187 VWSFGVLMWEVFS--EGKIPYENRSNSEVVE------DISTGFRLYKPRLASTHV----- 233
Query: 322 EFIQLIVRCLDPSSERRPSMSDVVTEL 348
              Q++  C     E RP+ S ++ +L
Sbjct: 234 --YQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLA 125
           +++  +   + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   + 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 62
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
            I+H NLV LLG C      ++I E++  G++  +L    + +RQ  E    + +     
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQ 117
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEI 244
                        +H+D    N LV E+ + KVAD GL   + G T  A   ++      
Sbjct: 118 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-- 175
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + A E   + +FS KSDV++FGV L E+ +
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 129/295 (43%), Gaps = 41/295 (13%)
Query: 82  KNLIGEGKFGEVYKGLLQDG-----MLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNL 132
           + +IG G+FGEVYKG+L+       + VAIK      T+    +F+ E   +    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-LEFKHRLSIXXXXXXXXXXX 191
           + L G   +     +I EY+ NG++   L       R+K  EF     +           
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL-------REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLAS 248
                  VH+D    N+LV+ + + KV+D GL   L   D    +   +  +I   + A 
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTTSGGKIPIRWTAP 219
Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN--LLKI 306
           E   +R+F+  SDV+SFG+ + E+++  E                 +   + SN  ++K 
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGE-----------------RPYWELSNHEVMKA 262
Query: 307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 361
           +++        +      QL+++C      RRP  +D+V+ LD+ +    +L T+
Sbjct: 263 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 317

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 118/267 (44%), Gaps = 26/267 (9%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
               L++E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 78  APICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 131
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 261
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 189
Query: 262 VYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGME 321
           V+SFGV + E+ S  E             VE      D S   ++   RL ST       
Sbjct: 190 VWSFGVLMWEVFS--EGKIPYENRSNSEVVE------DISTGFRLYKPRLASTHV----- 236
Query: 322 EFIQLIVRCLDPSSERRPSMSDVVTEL 348
              Q++  C     E RP+ S ++ +L
Sbjct: 237 --YQIMNHCWRERPEDRPAFSRLLRQL 261

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK--WTAPESLAYNKFS 191
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 192 IKSDVWAFGVLLWEIAT 208

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK--WTAPESLAYNKFS 195
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFL 124
           +++ +   + + K  IG G FG V++     G  VA+K             EF+ EV  +
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIM 88
Query: 125 ASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIX 181
             ++H N+V  +G   Q  NL  ++ EY+  GS+   +H  G    +R++L+ + RLS+ 
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLS-IVTEYLSRGSLYRLLHKSG----AREQLDERRRLSMA 143
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
                         P +VH+D K+ N+LVD+ +  KV D GL        +    +  T 
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTP 203
Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +  ++A EV      +EKSDVYSFGV L EL +
Sbjct: 204 E--WMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 195
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 195
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK--WTAPESLAYNKFS 191
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 192 IKSDVWAFGVLLWEIAT 208

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 192
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 190
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 190
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK--WTAPESLAYNKFS 192
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 192
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 190
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 190
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQISSAMEYLEKKNF 137
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 195
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLA 125
           +++  +   + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   + 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 62
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
            I+H NLV LLG C      ++I E++  G++  +L    + +RQ  E    + +     
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQ 117
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEI 244
                        +H+D    N LV E+ + KVAD GL   + G T  A   ++      
Sbjct: 118 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIK-- 175
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + A E   + +FS KSDV++FGV L E+ +
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 190
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 136
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 194
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 195 IKSDVWAFGVLLWEIAT 211

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 195
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 190
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 31  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 145
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 203
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 204 IKSDVWAFGVLLWEIAT 220

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 117/267 (43%), Gaps = 26/267 (9%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           IG G+FG V+ G   +   VAIK  R GA ++E FI+E   +  + H  LV L G C E 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
               L+ E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 76  APICLVTEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 129
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 261
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 262 VYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGME 321
           V+SFGV + E+ S  E             VE      D S   ++   RL ST       
Sbjct: 188 VWSFGVLMWEVFS--EGKIPYENRSNSEVVE------DISTGFRLYKPRLASTHV----- 234
Query: 322 EFIQLIVRCLDPSSERRPSMSDVVTEL 348
              Q++  C     E RP+ S ++ +L
Sbjct: 235 --YQIMNHCWRERPEDRPAFSRLLRQL 259

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 114/267 (42%), Gaps = 26/267 (9%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           IG G+FG V+ G   +   VAIK  K       +FI+E   +  + H  LV L G C E 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQ 94
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
               L++E++ +G +S +L        Q+  F     +                 V+H+D
Sbjct: 95  APICLVFEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 148
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-EVKEFRRFSEKSD 261
               N LV E+ + KV+D G+  F+   D    SS  T   +  AS EV  F R+S KSD
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 262 VYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGME 321
           V+SFGV + E+ S  E             VE      D S   ++   RL ST       
Sbjct: 207 VWSFGVLMWEVFS--EGKIPYENRSNSEVVE------DISTGFRLYKPRLASTHV----- 253
Query: 322 EFIQLIVRCLDPSSERRPSMSDVVTEL 348
              Q++  C     E RP+ S ++ +L
Sbjct: 254 --YQIMNHCWKERPEDRPAFSRLLRQL 278

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVSAVVLLYMATQISSAMEYLEKKNF 339
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H++    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 397
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 398 IKSDVWAFGVLLWEIAT 414

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E   +  I+H NLV LLG 
Sbjct: 264 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           C      ++I E++  G++  +L    + +RQ  E    + +                  
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYL---RECNRQ--EVNAVVLLYMATQISSAMEYLEKKNF 378
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL-GRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H++    N LV E+ + KVAD GL   + G T  A   ++      + A E   + +FS
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFS 436
Query: 258 EKSDVYSFGVFLLELVS 274
            KSDV++FGV L E+ +
Sbjct: 437 IKSDVWAFGVLLWEIAT 453

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 26/272 (9%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IG G FG VYKG     + V +     APT    Q F +EV  L   +H N++  +GY  
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 78
Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVH 200
           +  L  ++ ++    S+  HL+     S  K E K  + I                 ++H
Sbjct: 79  KPQLA-IVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKS--IIH 131
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRFS 257
           +D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +S
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 191
Query: 258 EKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTN 317
            +SDVY+FG+ L EL++G+              +E+V       +L K+          +
Sbjct: 192 FQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGSLSPDLSKV---------RS 240
Query: 318 EGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
              +   +L+  CL    + RPS   ++ E++
Sbjct: 241 NCPKRMKRLMAECLKKKRDERPSFPRILAEIE 272

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IG G FG VYKG     + V I K    PT    Q F +EV  L   +H N++  +GY  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVH 200
           ++NL  ++ ++    S+  HL+       Q+ +F+    I                 ++H
Sbjct: 103 KDNLA-IVTQWCEGSSLYKHLH------VQETKFQMFQLIDIARQTAQGMDYLHAKNIIH 155
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRFS 257
           +D K+ N+ + E    K+ D GL     R   +    Q T   +++A EV   ++   FS
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215
Query: 258 EKSDVYSFGVFLLELVSG 275
            +SDVYS+G+ L EL++G
Sbjct: 216 FQSDVYSYGIVLYELMTG 233

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 119/275 (43%), Gaps = 32/275 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IG G FG VYKG     + V +     APT    Q F +EV  L   +H N++  +GY  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVH 200
           +  L  ++ ++    S+  HL+     S  K E K  + I                 ++H
Sbjct: 91  KPQLA-IVTQWCEGSSLYHHLH----ASETKFEMKKLIDIARQTARGMDYLHAKS--IIH 143
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRFS 257
           +D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +S
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 258 EKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQN---SRDFSNLLKILDERLWST 314
            +SDVY+FG+ L EL++G+              +E+V     S D S +     +R+   
Sbjct: 204 FQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM--- 258
Query: 315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
                     +L+  CL    + RPS   ++ E++
Sbjct: 259 ---------KRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 118/275 (42%), Gaps = 32/275 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IG G FG VYKG     + V +     APT    Q F +EV  L   +H N++  +GY  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVH 200
              L  ++ ++    S+  HL+     S  K E K  + I                 ++H
Sbjct: 91  APQLA-IVTQWCEGSSLYHHLH----ASETKFEMKKLIDIARQTARGMDYLHAKS--IIH 143
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRFS 257
           +D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +S
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 258 EKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQN---SRDFSNLLKILDERLWST 314
            +SDVY+FG+ L EL++G+              +E+V     S D S +     +R+   
Sbjct: 204 FQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM--- 258
Query: 315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
                     +L+  CL    + RPS   ++ E++
Sbjct: 259 ---------KRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 83  NLIGEGKFGEVYKGL-LQDG----MLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNL 132
            ++G G FG VYKG+ + +G    + VAIK       P A   EF+DE   +AS+ H +L
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA-NVEFMDEALIMASMDHPHL 102
Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
           V LLG C    +Q L+ + +P+G +         V   K     +L +            
Sbjct: 103 VRLLGVCLSPTIQ-LVTQLMPHGCLL------EYVHEHKDNIGSQLLLNWCVQIAKGMMY 155
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE-----IFLA 247
               R+VH+D    NVLV      K+ D GL   L      G   +  AD       ++A
Sbjct: 156 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----EGDEKEYNADGGKMPIKWMA 210
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   +R+F+ +SDV+S+GV + EL++
Sbjct: 211 LECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  I+H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSEE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 85  IGEGKFGEVY----KGLL--QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V+      LL  QD MLVA+K    A     Q+F  E   L  +QH+++V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHL--YGPS--------QVSRQKLEFKHRLSIXXXXX 185
            G C E     +++EY+ +G ++  L  +GP          V+   L     L++     
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 245
                        VH+D  T N LV +  + K+ D G+   +  TD      +      +
Sbjct: 146 AGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 203
Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +  E   +R+F+ +SDV+SFGV L E+ +
Sbjct: 204 MPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 85  IGEGKFGEVY----KGLL--QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V+      LL  QD MLVA+K    A     Q+F  E   L  +QH+++V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHL--YGPS--------QVSRQKLEFKHRLSIXXXXX 185
            G C E     +++EY+ +G ++  L  +GP          V+   L     L++     
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 245
                        VH+D  T N LV +  + K+ D G+   +  TD      +      +
Sbjct: 140 AGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 197
Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +  E   +R+F+ +SDV+SFGV L E+ +
Sbjct: 198 MPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 83  NLIGEGKFGEVYKGL-LQDG----MLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNL 132
            ++G G FG VYKG+ + +G    + VAIK       P A   EF+DE   +AS+ H +L
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA-NVEFMDEALIMASMDHPHL 79
Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
           V LLG C    +Q L+ + +P+G +         V   K     +L +            
Sbjct: 80  VRLLGVCLSPTIQ-LVTQLMPHGCLL------EYVHEHKDNIGSQLLLNWCVQIAKGMMY 132
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE-----IFLA 247
               R+VH+D    NVLV      K+ D GL   L      G   +  AD       ++A
Sbjct: 133 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----EGDEKEYNADGGKMPIKWMA 187
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   +R+F+ +SDV+S+GV + EL++
Sbjct: 188 LECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 15/212 (7%)
Query: 78  NFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQ 128
           N   K  +GEG FG+V+          QD +LVA+K    A     ++F  E   L ++Q
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 73
Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQV----SRQKLEFKHRLSIXX 182
           H ++V   G C E +   +++EY+ +G ++  +  +GP  V         E      +  
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                           VH+D  T N LV E+ + K+ D G+   +  TD           
Sbjct: 134 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 193
Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             ++  E   +R+F+ +SDV+S GV L E+ +
Sbjct: 194 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 26/201 (12%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G   +   VA+K  +PG    Q F++E   + ++QH  LV L       
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTRE 80
Query: 143 NLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
              ++I EY+  GS+   L    G   +  + ++F  +++                   +
Sbjct: 81  EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA--------EGMAYIERKNYI 132
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEF 253
           H+D + ANVLV E  + K+AD GL   +         ++ TA E       + A E   F
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVI-------EDNEYTAREGAKFPIKWTAPEAINF 185
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
             F+ KSDV+SFG+ L E+V+
Sbjct: 186 GCFTIKSDVWSFGILLYEIVT 206

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVIEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 85  IGEGKFGEVY----KGLL--QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V+      LL  QD MLVA+K    A     Q+F  E   L  +QH+++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHL--YGPS--------QVSRQKLEFKHRLSIXXXXX 185
            G C E     +++EY+ +G ++  L  +GP          V+   L     L++     
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 245
                        VH+D  T N LV +  + K+ D G+   +  TD      +      +
Sbjct: 169 AGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226
Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +  E   +R+F+ +SDV+SFGV L E+ +
Sbjct: 227 MPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 82
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 83  PI-YIVTEYMNKGSLLDFLKGETG---KYLRLPQLVDMSAQIASGMAYVERM--NYVHRD 136
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 137 LRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L EL +
Sbjct: 195 VWSFGILLTELTT 207

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 252 PI-YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 305
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L EL +
Sbjct: 364 VWSFGILLTELTT 376

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 252 PI-YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 305
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L EL +
Sbjct: 364 VWSFGILLTELTT 376

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 78
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 79  PI-YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 132
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ KSD
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L EL +
Sbjct: 191 VWSFGILLTELTT 203

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 15/220 (6%)
Query: 64  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFID 119
            RR   ++  +     +    IG G FG VYKG     + V +     APT    Q F +
Sbjct: 23  GRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVT-APTPQQLQAFKN 81
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           EV  L   +H N++  +GY  +  L  ++ ++    S+  HL+    +   K E    + 
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLID 136
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
           I                 ++H+D K+ N+ + ED   K+ D GL     R   +    Q+
Sbjct: 137 IARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 194
Query: 240 TADEIFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGR 276
           +   +++A EV   ++   +S +SDVY+FG+ L EL++G+
Sbjct: 195 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 82  KNLIGEGKFGEVYKGLL------QDGMLVAIK--KRPG-APTQEFIDEVCFLASIQHRNL 132
           K  +GEG FG+V+          +D MLVA+K  K P  A  ++F  E   L ++QH ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGP-------SQVSRQKLEFKHRLSIXXX 183
           V   G C + +   +++EY+ +G ++  +  +GP        Q  + K E      +   
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                          VH+D  T N LV  + + K+ D G+   +  TD            
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++  E   +R+F+ +SDV+SFGV L E+ +
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 17/221 (7%)
Query: 64  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFI 118
            RR   ++  +     +    IG G FG VYKG       VA+K     APT    Q F 
Sbjct: 22  GRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFK 79
Query: 119 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL 178
           +EV  L   +H N++  +GY  +  L  ++ ++    S+  HL+    +   K E    +
Sbjct: 80  NEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLI 134
Query: 179 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ 238
            I                 ++H+D K+ N+ + ED   K+ D GL     R   +    Q
Sbjct: 135 DIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 192
Query: 239 VTADEIFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGR 276
           ++   +++A EV   ++   +S +SDVY+FG+ L EL++G+
Sbjct: 193 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVIEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 335 PI-YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 388
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ KSD
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L EL +
Sbjct: 447 VWSFGILLTELTT 459

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FG VYKG       VA+K     APT    Q F +EV  L   +H N++  +GY 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
            +  L  ++ ++    S+  HL+    +   K E    + I                 ++
Sbjct: 79  TKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--II 131
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRF 256
           H+D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 257 SEKSDVYSFGVFLLELVSGR 276
           S +SDVY+FG+ L EL++G+
Sbjct: 192 SFQSDVYAFGIVLYELMTGQ 211

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FG VYKG       VA+K     APT    Q F +EV  L   +H N++  +GY 
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
            +  L  ++ ++    S+  HL+    +   K E    + I                 ++
Sbjct: 76  TKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--II 128
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRF 256
           H+D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 188
Query: 257 SEKSDVYSFGVFLLELVSGR 276
           S +SDVY+FG+ L EL++G+
Sbjct: 189 SFQSDVYAFGIVLYELMTGQ 208

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVCEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 76
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 77  PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 128
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 187 SDVWSFGILLTELTT 201

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 252 PI-YIVGEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 305
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L EL +
Sbjct: 364 VWSFGILLTELTT 376

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 74
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 75  PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 126
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 185 SDVWSFGILLTELTT 199

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IG G FG VYKG     + V +     APT    Q F +EV  L   +H N++  +GY  
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 79
Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVH 200
           +  L  ++ ++    S+  HL+    +   K E    + I                 ++H
Sbjct: 80  KPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--IIH 132
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRFS 257
           +D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +S
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 258 EKSDVYSFGVFLLELVSGR 276
            +SDVY+FG+ L EL++G+
Sbjct: 193 FQSDVYAFGIVLYELMTGQ 211

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 82
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + +++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 83  PI-YIVTEYMNKGSLLDFLKGETG---KYLRLPQLVDMSAQIASGMAYVERM--NYVHRD 136
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ KSD
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L EL +
Sbjct: 195 VWSFGILLTELTT 207

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FG VYKG       VA+K     APT    Q F +EV  L   +H N++  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
            +  L  ++ ++    S+  HL+    +   K E    + I                 ++
Sbjct: 74  TKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--II 126
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRF 256
           H+D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 257 SEKSDVYSFGVFLLELVSGR 276
           S +SDVY+FG+ L EL++G+
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 101/233 (43%), Gaps = 24/233 (10%)
Query: 46  EPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVA 105
           +P V  G     +   R      M+EL L          IG+G+FG+V  G  + G  VA
Sbjct: 169 KPKVMEGTVAAQDEFYRSGWALNMKELKLL-------QTIGKGEFGDVMLGDYR-GNKVA 220
Query: 106 IKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGY-CQENNLQFLIYEYIPNGSVSIHLYG 163
           +K  +  A  Q F+ E   +  ++H NLV LLG   +E    +++ EY+  GS+  +L  
Sbjct: 221 VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR- 279
Query: 164 PSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL 223
               SR +        +                  VH+D    NVLV ED +AKV+D GL
Sbjct: 280 ----SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335
Query: 224 RNFLGRTDVAG--PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                 T   G  P         + A E    ++FS KSDV+SFG+ L E+ S
Sbjct: 336 TKEASSTQDTGKLPVK-------WTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 82
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 83  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 136
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIE-------DNEXTAREGAKFPIKWTAPEAINYGTF 189
Query: 257 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 315
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 190 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 233
Query: 316 TNEGMEEFIQLIVRCLDPSSERRPS 340
            +   EE  QL+  C     E RP+
Sbjct: 234 PDNCPEELYQLMRLCWKERPEDRPT 258

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 88
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 89  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 142
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLIE-------DNEXTAREGAKFPIKWTAPEAINYGTF 195
Query: 257 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 315
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 196 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 239
Query: 316 TNEGMEEFIQLIVRCLDPSSERRPS 340
            +   EE  QL+  C     E RP+
Sbjct: 240 PDNCPEELYQLMRLCWKERPEDRPT 264

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 89
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 90  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 143
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLIE-------DNEXTAREGAKFPIKWTAPEAINYGTF 196
Query: 257 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 315
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 197 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 240
Query: 316 TNEGMEEFIQLIVRCLDPSSERRPS 340
            +   EE  QL+  C     E RP+
Sbjct: 241 PDNCPEELYQLMRLCWKERPEDRPT 265

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 86
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 87  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 140
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIE-------DNEYTAREGAKFPIKWTAPEAINYGTF 193
Query: 257 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 315
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 194 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 237
Query: 316 TNEGMEEFIQLIVRCLDPSSERRPS 340
            +   EE  QL+  C     E RP+
Sbjct: 238 PDNCPEELYQLMRLCWKERPEDRPT 262

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 86  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 139
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLIE-------DNEYTAREGAKFPIKWTAPEAINYGTF 192
Query: 257 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 315
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 193 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 236
Query: 316 TNEGMEEFIQLIVRCLDPSSERRPS 340
            +   EE  QL+  C     E RP+
Sbjct: 237 PDNCPEELYQLMRLCWKERPEDRPT 261

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 81
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 82  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 135
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLI-------EDNEXTAREGAKFPIKWTAPEAINYGTF 188
Query: 257 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 315
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 189 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 232
Query: 316 TNEGMEEFIQLIVRCLDPSSERRPS 340
            +   EE  QL+  C     E RP+
Sbjct: 233 PDNCPEELYQLMRLCWKERPEDRPT 257

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 134
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLI-------EDNEXTAREGAKFPIKWTAPEAINYGTF 187
Query: 257 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 315
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 188 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 231
Query: 316 TNEGMEEFIQLIVRCLDPSSERRPS 340
            +   EE  QL+  C     E RP+
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPT 256

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 86
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 87  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 140
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIE-------DNEXTAREGAKFPIKWTAPEAINYGTF 193
Query: 257 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 315
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 194 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 237
Query: 316 TNEGMEEFIQLIVRCLDPSSERRPS 340
            +   EE  QL+  C     E RP+
Sbjct: 238 PDNCPEELYQLMRLCWKERPEDRPT 262

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FG VYKG       VA+K     APT    Q F +EV  L   +H N++  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
               L  ++ ++    S+  HL+    +   K E    + I                 ++
Sbjct: 74  TAPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--II 126
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRF 256
           H+D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 257 SEKSDVYSFGVFLLELVSGR 276
           S +SDVY+FG+ L EL++G+
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 90
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 91  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 144
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLIE-------DNEYTAREGAKFPIKWTAPEAINYGTF 197
Query: 257 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 315
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 198 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 241
Query: 316 TNEGMEEFIQLIVRCLDPSSERRPS 340
            +   EE  QL+  C     E RP+
Sbjct: 242 PDNCPEELYQLMRLCWKERPEDRPT 266

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 134
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIE-------DNEXTAREGAKFPIKWTAPEAINYGTF 187
Query: 257 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 315
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 188 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 231
Query: 316 TNEGMEEFIQLIVRCLDPSSERRPS 340
            +   EE  QL+  C     E RP+
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPT 256

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 252
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 253 PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 304
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ K
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 363 SDVWSFGILLTELTT 377

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 134
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLI-------EDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 257 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 315
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 188 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 231
Query: 316 TNEGMEEFIQLIVRCLDPSSERRPS 340
            +   EE  QL+  C     E RP+
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPT 256

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 90/193 (46%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 75
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            +  ++ EY+  GS+   L G +    + L     + +                  VH+D
Sbjct: 76  PIX-IVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM--NYVHRD 129
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            + AN+LV E+ + KVAD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 130 LRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L EL +
Sbjct: 188 VWSFGILLTELTT 200

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 17/221 (7%)
Query: 64  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFI 118
            RR   ++  +     +    IG G FG VYKG       VA+K     APT    Q F 
Sbjct: 23  GRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFK 80
Query: 119 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL 178
           +EV  L   +H N++  +GY  +  L  ++ ++    S+  HL+    +   K E    +
Sbjct: 81  NEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLI 135
Query: 179 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ 238
            I                 ++H+D K+ N+ + ED   K+ D GL     R   +    Q
Sbjct: 136 DIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 193
Query: 239 VTADEIFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGR 276
           ++   +++A EV   ++   +S +SDVY+FG+ L EL++G+
Sbjct: 194 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 75
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 76  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 129
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLI-------EDNEYTAREGAKFPIKWTAPEAINYGTF 182
Query: 257 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 315
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 183 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 226
Query: 316 TNEGMEEFIQLIVRCLDPSSERRPS 340
            +   EE  QL+  C     E RP+
Sbjct: 227 PDNCPEELYQLMRLCWKERPEDRPT 251

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  GS+   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D   AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 17/221 (7%)
Query: 64  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFI 118
            RR   ++  +     +    IG G FG VYKG       VA+K     APT    Q F 
Sbjct: 15  GRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFK 72
Query: 119 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL 178
           +EV  L   +H N++  +GY  +  L  ++ ++    S+  HL+    +   K E    +
Sbjct: 73  NEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLI 127
Query: 179 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ 238
            I                 ++H+D K+ N+ + ED   K+ D GL     R   +    Q
Sbjct: 128 DIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 185
Query: 239 VTADEIFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGR 276
           ++   +++A EV   ++   +S +SDVY+FG+ L EL++G+
Sbjct: 186 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  G +   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVMEYMSKGCLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FG VYKG       VA+K     APT    Q F +EV  L   +H N++  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
            +  L  ++ ++    S+  HL+    +   K E    + I                 ++
Sbjct: 74  TKPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS--II 126
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV---KEFRRF 256
           H+D K+ N+ + ED   K+ D GL     R   +    Q++   +++A EV   ++   +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 257 SEKSDVYSFGVFLLELVSGR 276
           S +SDVY+FG+ L EL++G+
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 11/193 (5%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VAIK  +PG  + E F++E   +  ++H  LV L     E 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEE 76
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + +++ EY+  GS+   L        + L+  + + +                  +H+D
Sbjct: 77  PI-YIVTEYMNKGSLLDFL---KDGEGRALKLPNLVDMAAQVAAGMAYIERM--NYIHRD 130
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEKSD 261
            ++AN+LV    I K+AD GL   +   D    + Q     I + A E   + RF+ KSD
Sbjct: 131 LRSANILVGNGLICKIADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L ELV+
Sbjct: 189 VWSFGILLTELVT 201

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV--VH 200
            + +++ EY+  G +   L G       ++    RL                  R+  VH
Sbjct: 86  PI-YIVTEYMSKGCLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 137
Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFSEK 259
           +D + AN+LV E+ + KVAD GL   +   +    + Q     I + A E   + RF+ K
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 260 SDVYSFGVFLLELVS 274
           SDV+SFG+ L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 96/219 (43%), Gaps = 17/219 (7%)
Query: 60  SIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFI 118
           S+     F     +L  K       IG+G+FG+V  G  + G  VA+K  +  A  Q F+
Sbjct: 4   SVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFL 62
Query: 119 DEVCFLASIQHRNLVTLLGY-CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 177
            E   +  ++H NLV LLG   +E    +++ EY+  GS+  +L      SR +      
Sbjct: 63  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGD 117
Query: 178 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG--P 235
             +                  VH+D    NVLV ED +AKV+D GL      T   G  P
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 177
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                    + A E    ++FS KSDV+SFG+ L E+ S
Sbjct: 178 VK-------WTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 122/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++TLLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 116/282 (41%), Gaps = 19/282 (6%)
Query: 85  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 76  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 128
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 189 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 248
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 354
               +   +E   ++  C + +  +RPS  D+   +D+  D+
Sbjct: 249 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 290

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 85  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 96  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 209 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 268
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 269 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 309

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 116/282 (41%), Gaps = 19/282 (6%)
Query: 85  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 109 GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 281
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 354
               +   +E   ++  C + +  +RPS  D+   +D+  D+
Sbjct: 282 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 197 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 254
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 255 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 300
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 301 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 26/201 (12%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G   +   VA+K  +PG    Q F++E   + ++QH  LV L     + 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 79
Query: 143 NLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
              ++I E++  GS+   L    G   +  + ++F  +++                   +
Sbjct: 80  EPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA--------EGMAYIERKNYI 131
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEF 253
           H+D + ANVLV E  + K+AD GL   +         ++ TA E       + A E   F
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVI-------EDNEYTAREGAKFPIKWTAPEAINF 184
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
             F+ KS+V+SFG+ L E+V+
Sbjct: 185 GCFTIKSNVWSFGILLYEIVT 205

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 90/194 (46%), Gaps = 17/194 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGY-CQEN 142
           IG+G+FG+V  G  + G  VA+K  +  A  Q F+ E   +  ++H NLV LLG   +E 
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
              +++ EY+  GS+  +L      SR +        +                  VH+D
Sbjct: 73  GGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 127
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAG--PSSQVTADEIFLASEVKEFRRFSEKS 260
               NVLV ED +AKV+D GL      T   G  P         + A E    ++FS KS
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-------WTAPEALREKKFSTKS 180
Query: 261 DVYSFGVFLLELVS 274
           DV+SFG+ L E+ S
Sbjct: 181 DVWSFGILLWEIYS 194

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 85  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 96  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 209 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 268
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 269 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 309

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 85  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 85  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 156 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 213
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 259
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 260 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 85  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 85  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 137
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 198 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 257
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 258 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 298

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 85  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 77  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 129
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 190 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 249
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 250 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 290

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 149 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 206
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 207 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 252
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 253 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 303

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 156 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 213
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 259
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 260 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 85  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 83  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 135
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 196 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 255
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 256 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 296

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 156 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 213
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 259
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 260 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 145 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 202
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 203 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 248
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 249 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 299

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 19/197 (9%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 198
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 92  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 199 VHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           +H+D    N LV++  + KV+D GL R  L   + +   S+      +   EV  + +FS
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR--WSPPEVLMYSKFS 199
Query: 258 EKSDVYSFGVFLLELVS 274
            KSD+++FGV + E+ S
Sbjct: 200 SKSDIWAFGVLMWEIYS 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 85  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 81  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 194 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 254 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 294

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 148 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 205
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 206 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 251
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 252 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 302

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 85  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 84  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 136
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 197 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 256
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 257 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 297

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 85  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 82  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 134
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 195 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 254
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 255 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 295

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y PS    ++L  K  +S 
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 141 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 198
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 199 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 244
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 245 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 19/197 (9%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 198
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 77  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 126
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFRRFS 257
           +H+D    N LV++  + KV+D GL  ++   D    SS+ +   + +   EV  + +FS
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSRGSKFPVRWSPPEVLMYSKFS 184
Query: 258 EKSDVYSFGVFLLELVS 274
            KSD+++FGV + E+ S
Sbjct: 185 SKSDIWAFGVLMWEIYS 201

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 76
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H++
Sbjct: 77  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRN 130
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLI-------EDNEYTAREGAKFPIKWTAPEAINYGTF 183
Query: 257 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 315
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 184 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 227
Query: 316 TNEGMEEFIQLIVRCLDPSSERRPS 340
            +   EE  QL+  C     E RP+
Sbjct: 228 PDNCPEELYQLMRLCWKERPEDRPT 252

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+E     + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 91/224 (40%), Gaps = 22/224 (9%)
Query: 62  REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGAPTQ-- 115
           R  R F  E   +       + +IG G  GEV  G L    Q  + VAIK      T+  
Sbjct: 37  RAGRSFTRE---IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ 93
Query: 116 --EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
             +F+ E   +    H N++ L G      L  ++ EY+ NGS+   L           +
Sbjct: 94  RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL------RTHDGQ 147
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F     +                  VH+D    NVLVD + + KV+D GL   L   D  
Sbjct: 148 FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL--EDDP 205
Query: 234 GPSSQVTADEI---FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             +   T  +I   + A E   FR FS  SDV+SFGV + E+++
Sbjct: 206 DAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 34/283 (12%)
Query: 82  KNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLV 133
           + +IG G+FGEV  G L+      + VAIK      T+    +F+ E   +    H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            L G   ++    +I E++ NGS+       S + +   +F     +             
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLD------SFLRQNDGQFTVIQLVGMLRGIAAGMKYL 151
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS-SQVTADEI---FLASE 249
                VH+D    N+LV+ + + KV+D GL  FL   D + P+ +     +I   + A E
Sbjct: 152 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL-EDDTSDPTYTSALGGKIPIRWTAPE 210
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 309
             ++R+F+  SDV+S+G+ + E++S  E                   ++D  N ++  D 
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD------------MTNQDVINAIE-QDY 257
Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           RL      +      QL++ C       RP    +V  LD+ +
Sbjct: 258 RLPPPM--DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 298

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 110/265 (41%), Gaps = 38/265 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+ GEV+ G       VA+K  K+       F+ E   +  +QH+ LV L     + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
            + ++I EY+ NGS+   L  PS +   KL     L +                  +H+D
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER--NYIHRD 134
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEFRRF 256
            + AN+LV +    K+AD GL   +         ++ TA E       + A E   +  F
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIE-------DAEXTAREGAKFPIKWTAPEAINYGTF 187
Query: 257 SEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTF 315
           + KSDV+SFG+ L E+V+ GR               E++QN      +++          
Sbjct: 188 TIKSDVWSFGILLTEIVTHGR------IPYPGMTNPEVIQNLERGYRMVR---------- 231
Query: 316 TNEGMEEFIQLIVRCLDPSSERRPS 340
            +   EE  QL+  C     E RP+
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPT 256

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 75
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 198
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 76  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 125
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLASEVKEFRR 255
           +H+D    N LV++  + KV+D GL  ++     T   G    V     +   EV  + +
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSK 181
Query: 256 FSEKSDVYSFGVFLLELVS 274
           FS KSD+++FGV + E+ S
Sbjct: 182 FSSKSDIWAFGVLMWEIYS 200

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 91/224 (40%), Gaps = 22/224 (9%)
Query: 62  REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGAPTQ-- 115
           R  R F  E   +       + +IG G  GEV  G L    Q  + VAIK      T+  
Sbjct: 37  RAGRSFTRE---IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ 93
Query: 116 --EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
             +F+ E   +    H N++ L G      L  ++ EY+ NGS+   L           +
Sbjct: 94  RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL------RTHDGQ 147
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F     +                  VH+D    NVLVD + + KV+D GL   L   D  
Sbjct: 148 FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL--EDDP 205
Query: 234 GPSSQVTADEI---FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             +   T  +I   + A E   FR FS  SDV+SFGV + E+++
Sbjct: 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 130/312 (41%), Gaps = 46/312 (14%)
Query: 61  IREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK----KRP 110
           I + ++ +++E+SL+   F ++  +GE +FG+VYKG L      +    VAIK    K  
Sbjct: 12  INQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE 69
Query: 111 GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS-- 168
           G   +EF  E    A +QH N+V LLG   ++    +I+ Y  +G +   L   S  S  
Sbjct: 70  GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDV 129
Query: 169 ---------RQKLE---FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIA 216
                    +  LE   F H ++                  VVHKD  T NVLV +    
Sbjct: 130 GSTDDDRTVKSALEPPDFVHLVA-----QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV 184
Query: 217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           K++D GL   +   D             ++A E   + +FS  SD++S+GV L E+ S  
Sbjct: 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS-- 242
Query: 277 EAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSE 336
                         VE+++N +    +L   D+     +          L++ C +    
Sbjct: 243 YGLQPYCGYSNQDVVEMIRNRQ----VLPCPDDCPAWVYA---------LMIECWNEFPS 289
Query: 337 RRPSMSDVVTEL 348
           RRP   D+ + L
Sbjct: 290 RRPRFKDIHSRL 301

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 82
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 198
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 83  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 132
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLASEVKEFRR 255
           +H+D    N LV++  + KV+D GL  ++     T   G    V     +   EV  + +
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSK 188
Query: 256 FSEKSDVYSFGVFLLELVS 274
           FS KSD+++FGV + E+ S
Sbjct: 189 FSSKSDIWAFGVLMWEIYS 207

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 198
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 92  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLASEVKEFRR 255
           +H+D    N LV++  + KV+D GL  ++     T   G    V     +   EV  + +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSK 197
Query: 256 FSEKSDVYSFGVFLLELVS 274
           FS KSD+++FGV + E+ S
Sbjct: 198 FSSKSDIWAFGVLMWEIYS 216

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 198
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 77  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 126
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLASEVKEFRR 255
           +H+D    N LV++  + KV+D GL  ++     T   G    V     +   EV  + +
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSK 182
Query: 256 FSEKSDVYSFGVFLLELVS 274
           FS KSD+++FGV + E+ S
Sbjct: 183 FSSKSDIWAFGVLMWEIYS 201

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 117/276 (42%), Gaps = 32/276 (11%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 153
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL R+ L +  D     +       ++A E  +
Sbjct: 154 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 259
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 260 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 292

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV L G C + 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS----IXXXXXXXXXXXXXXXPRV 198
              F+I EY+ NG +  +L           E +HR      +                + 
Sbjct: 72  RPIFIITEYMANGCLLNYL----------REMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLASEVKEFRR 255
           +H+D    N LV++  + KV+D GL  ++     T   G    V     +   EV  + +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSK 177
Query: 256 FSEKSDVYSFGVFLLELVS 274
           FS KSD+++FGV + E+ S
Sbjct: 178 FSSKSDIWAFGVLMWEIYS 196

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 85  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 78  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 251 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 81/338 (23%), Positives = 135/338 (39%), Gaps = 35/338 (10%)
Query: 25  LSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQ-MEELSLATKNF--SD 81
           L   C     S S   + GS     Q    V I+LS       Q ++ + +   +     
Sbjct: 34  LDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHF 93
Query: 82  KNLIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLV 133
             +IG G FG VY G L D     +  A+K            +F+ E   +    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 134 TLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
           +LLG C +      ++  Y+ +G +   +   +     K      L +            
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-- 211
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEV 250
               + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E 
Sbjct: 212 ----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDER 310
            + ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------L 315
Query: 311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
           L   +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 316 LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 350

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVYK----GLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V      GL +D       VA+K      T+    + I E+  +  I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           + PS    ++L  K  +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV ED + K+AD GL   +   D    ++   
Sbjct: 156 AYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGR 213
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV L E+ +                VE        
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYPGVPVE-------- 259
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 260 -ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 118/281 (41%), Gaps = 19/281 (6%)
Query: 85  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L    Q   ++++  H   +             
Sbjct: 81  GVCYSAGRRNLK-LIMEYLPYGSLRDYL----QAHAERID--HIKLLQYTSQICKGMEYL 133
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 194 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 254 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 294

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 122/304 (40%), Gaps = 56/304 (18%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTL 135
           +IG G+FGEV +G L+        VAIK   G  T+    EF+ E   +   +H N++ L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 136 LGYCQENNLQFLIYEYIPNGSVS------------IHLYGPSQVSRQKLEFKHRLSIXXX 183
            G    +    ++ E++ NG++             I L G  +     + +   +S    
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMS---- 138
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                          VH+D    N+LV+ + + KV+D GL  FL         +     +
Sbjct: 139 --------------YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 244 I---FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
           I   + A E   FR+F+  SD +S+G+ + E++S  E                  +++D 
Sbjct: 185 IPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD------------MSNQDV 232
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTT 360
            N ++  D RL      +      QL++ C       RP    VV+ LD+ +    +L  
Sbjct: 233 INAIE-QDYRL--PPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKI 289
Query: 361 VMGE 364
           V  E
Sbjct: 290 VARE 293

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 122/304 (40%), Gaps = 56/304 (18%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTL 135
           +IG G+FGEV +G L+        VAIK   G  T+    EF+ E   +   +H N++ L
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 136 LGYCQENNLQFLIYEYIPNGSVS------------IHLYGPSQVSRQKLEFKHRLSIXXX 183
            G    +    ++ E++ NG++             I L G  +     + +   +S    
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMS---- 136
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                          VH+D    N+LV+ + + KV+D GL  FL         +     +
Sbjct: 137 --------------YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 244 I---FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
           I   + A E   FR+F+  SD +S+G+ + E++S  E                  +++D 
Sbjct: 183 IPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD------------MSNQDV 230
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTT 360
            N ++  D RL      +      QL++ C       RP    VV+ LD+ +    +L  
Sbjct: 231 INAIE-QDYRL--PPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKI 287
Query: 361 VMGE 364
           V  E
Sbjct: 288 VARE 291

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/299 (22%), Positives = 123/299 (41%), Gaps = 34/299 (11%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 30  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 89
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 90  QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 143
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 144 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 203
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN-- 302
           + + E   +R+F+  SDV+S+G+ L E++S  E                 +   + SN  
Sbjct: 204 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----------------RPYWEMSNQD 246
Query: 303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 361
           ++K +DE        +      QL++ C       RP    +V+ LD+ +    +L  +
Sbjct: 247 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 305

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 30/297 (10%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 304
           + + E   +R+F+  SDV+S+G+ L E++S  E                        +++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------QDVI 260
Query: 305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 361
           K +DE        +      QL++ C       RP    +V+ LD+ +    +L  +
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 317

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 30/297 (10%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 304
           + + E   +R+F+  SDV+S+G+ L E++S  E                        +++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------QDVI 260
Query: 305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 361
           K +DE        +      QL++ C       RP    +V+ LD+ +    +L  +
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 317

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 117/288 (40%), Gaps = 30/288 (10%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 40  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 99
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 100 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 153
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 154 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 213
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 304
           + + E   +R+F+  SDV+S+G+ L E++S  E                        +++
Sbjct: 214 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------QDVI 258
Query: 305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           K +DE        +      QL++ C       RP    +V+ LD+ +
Sbjct: 259 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 306

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 85  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI E++P GS+  +L       + K    H   +             
Sbjct: 81  GVCYSAGRRNLK-LIMEFLPYGSLREYL------QKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H+D  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 194 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 253
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 254 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 294

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 120/290 (41%), Gaps = 34/290 (11%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN-- 302
           + + E   +R+F+  SDV+S+G+ L E++S  E                 +   + SN  
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----------------RPYWEMSNQD 258
Query: 303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           ++K +DE        +      QL++ C       RP    +V+ LD+ +
Sbjct: 259 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 120/290 (41%), Gaps = 34/290 (11%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 13  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 72
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 126
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 127 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN-- 302
           + + E   +R+F+  SDV+S+G+ L E++S  E                 +   + SN  
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----------------RPYWEMSNQD 229
Query: 303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           ++K +DE        +      QL++ C       RP    +V+ LD+ +
Sbjct: 230 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 155 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 212
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 213 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 258
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 259 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 309

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 117/288 (40%), Gaps = 30/288 (10%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 304
           + + E   +R+F+  SDV+S+G+ L E++S  E                        +++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------QDVI 260
Query: 305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           K +DE        +      QL++ C       RP    +V+ LD+ +
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 117/288 (40%), Gaps = 30/288 (10%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 304
           + + E   +R+F+  SDV+S+G+ L E++S  E                        +++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------QDVI 260
Query: 305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           K +DE        +      QL++ C       RP    +V+ LD+ +
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/299 (22%), Positives = 123/299 (41%), Gaps = 34/299 (11%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN-- 302
           + + E   +R+F+  SDV+S+G+ L E++S  E                 +   + SN  
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----------------RPYWEMSNQD 258
Query: 303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 361
           ++K +DE        +      QL++ C       RP    +V+ LD+ +    +L  +
Sbjct: 259 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 317

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 152 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 209
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 210 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 255
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 256 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 306

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 209 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 267 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 312
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 313 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 150 TYQLARGMEYLASQ--KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 207
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 208 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 253
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 254 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 304

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/299 (22%), Positives = 123/299 (41%), Gaps = 34/299 (11%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ EY+ NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN-- 302
           + + E   +R+F+  SDV+S+G+ L E++S  E                 +   + SN  
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----------------RPYWEMSNQD 258
Query: 303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 361
           ++K +DE        +      QL++ C       RP    +V+ LD+ +    +L  +
Sbjct: 259 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 317

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 89/193 (46%), Gaps = 15/193 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGY-CQEN 142
           IG+G+FG+V  G  + G  VA+K  +  A  Q F+ E   +  ++H NLV LLG   +E 
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 78
Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKD 202
              +++ EY+  GS+  +L      SR +        +                  VH+D
Sbjct: 79  GGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 133
Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQVTADEIFLASEVKEFRRFSEKSD 261
               NVLV ED +AKV+D GL      T D      + TA E    +       FS KSD
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREAA------FSTKSD 187
Query: 262 VYSFGVFLLELVS 274
           V+SFG+ L E+ S
Sbjct: 188 VWSFGILLWEIYS 200

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 123/310 (39%), Gaps = 39/310 (12%)
Query: 43  GSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG-LLQDG 101
           G   P  QP          ++A R  M   +LA  NF  +  IG G+F EVY+   L DG
Sbjct: 10  GPPVPQFQP----------QKALRPDMGYNTLA--NFRIEKKIGRGQFSEVYRAACLLDG 57
Query: 102 MLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 155
           + VA+KK             + I E+  L  + H N++       E+N   ++ E    G
Sbjct: 58  VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 117
Query: 156 SVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFI 215
            +S  +       +QK     R                   RV+H+D K ANV +    +
Sbjct: 118 DLSRMI---KHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV 174
Query: 216 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            K+ D GL  F      A  S  +     +++ E      ++ KSD++S G  L E+ + 
Sbjct: 175 VKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232
Query: 276 REAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGM-EEFIQLIVRCLDPS 334
           +                   +  +  +L K +++  +    ++   EE  QL+  C++P 
Sbjct: 233 QSP--------------FYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPD 278
Query: 335 SERRPSMSDV 344
            E+RP ++ V
Sbjct: 279 PEKRPDVTYV 288

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 126/305 (41%), Gaps = 65/305 (21%)
Query: 82  KNLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAPTQE----FIDEVCFLASI-QHRNLV 133
           +++IGEG FG+V K  ++ DG  M  AIK+     +++    F  E+  L  +  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 134 TLLGYCQENNLQFLIYEYIPNGSV----------------SIHLYGPSQVSRQKLEFKHR 177
            LLG C+     +L  EY P+G++                +I     S +S Q+L     
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL----- 144
Query: 178 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGR 229
             +                + +H+D    N+LV E+++AK+AD GL        +  +GR
Sbjct: 145 --LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 202
Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXX 289
             V            ++A E   +  ++  SDV+S+GV L E+VS               
Sbjct: 203 LPVR-----------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----LGGTPYCGMT 246
Query: 290 XVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
             EL +       L K L+            +E   L+ +C       RPS + ++  L+
Sbjct: 247 CAELYEKLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLN 296
Query: 350 RTLDK 354
           R L++
Sbjct: 297 RMLEE 301

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I EY   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + ++AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 151
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD--EIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 152 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQ 209
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 257
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 258 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 290

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 126/305 (41%), Gaps = 65/305 (21%)
Query: 82  KNLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAPTQE----FIDEVCFLASI-QHRNLV 133
           +++IGEG FG+V K  ++ DG  M  AIK+     +++    F  E+  L  +  H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 134 TLLGYCQENNLQFLIYEYIPNGSV----------------SIHLYGPSQVSRQKLEFKHR 177
            LLG C+     +L  EY P+G++                +I     S +S Q+L     
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL----- 134
Query: 178 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGR 229
             +                + +H+D    N+LV E+++AK+AD GL        +  +GR
Sbjct: 135 --LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 192
Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXX 289
             V            ++A E   +  ++  SDV+S+GV L E+VS               
Sbjct: 193 LPVR-----------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----LGGTPYCGMT 236
Query: 290 XVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
             EL +       L K L+            +E   L+ +C       RPS + ++  L+
Sbjct: 237 CAELYEKLPQGYRLEKPLN----------CDDEVYDLMRQCWREKPYERPSFAQILVSLN 286
Query: 350 RTLDK 354
           R L++
Sbjct: 287 RMLEE 291

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 115/281 (40%), Gaps = 19/281 (6%)
Query: 85  IGEGKFGEV---YKGLLQD--GMLVAIKKRPGAPTQEFID---EVCFLASIQHRNLVTLL 136
           +G+G FG V       LQD  G +VA+KK   +  +   D   E+  L S+QH N+V   
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 137 GYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           G C      NL+ LI EY+P GS+  +L       + K    H   +             
Sbjct: 79  GVCYSAGRRNLK-LIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKGMEYL 131
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKE 252
              R +H++  T N+LV+ +   K+ D GL   L +        +     IF  A E   
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
             +FS  SDV+SFGV L EL +  E                 Q      +L+++L     
Sbjct: 192 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 251
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
               +   +E   ++  C + +  +RPS  D+   +D+  D
Sbjct: 252 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 292

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 144
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD--EIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 145 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 202
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 203 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 250
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 251 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 283

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 170
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD--EIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 171 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 228
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 229 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 276
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 277 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 309

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 152
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E  +
Sbjct: 153 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 258
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 259 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 291

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 150
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD--EIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 151 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 208
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 256
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 257 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 289

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 150
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E  +
Sbjct: 151 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 208
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 256
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 257 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 289

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 152
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD--EIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 153 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 258
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 259 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 157
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E  +
Sbjct: 158 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 215
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 216 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 263
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 264 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 296

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 147
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD--EIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 148 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 253
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 254 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 286

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 151
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD--EIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 152 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 209
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 257
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 258 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 290

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 171
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD--EIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 172 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 229
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 230 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 277
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 278 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 310

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 126/305 (41%), Gaps = 46/305 (15%)
Query: 68  QMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK----KRPGAPTQEF 117
           +++E+SL+   F ++  +GE +FG+VYKG L      +    VAIK    K  G   +EF
Sbjct: 2   KLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF 59
Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS--------- 168
             E    A +QH N+V LLG   ++    +I+ Y  +G +   L   S  S         
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 169 --RQKLE---FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL 223
             +  LE   F H ++                  VVHKD  T NVLV +    K++D GL
Sbjct: 120 TVKSALEPPDFVHLVA-----QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
Query: 224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXX 283
              +   D             ++A E   + +FS  SD++S+GV L E+ S         
Sbjct: 175 FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS--YGLQPYC 232
Query: 284 XXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 343
                  VE+++N +    +L   D+     +          L++ C +    RRP   D
Sbjct: 233 GYSNQDVVEMIRNRQ----VLPCPDDCPAWVYA---------LMIECWNEFPSRRPRFKD 279
Query: 344 VVTEL 348
           + + L
Sbjct: 280 IHSRL 284

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/294 (22%), Positives = 124/294 (42%), Gaps = 36/294 (12%)
Query: 59  LSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE- 116
           +S +  + ++ +   +  ++   +  +G G+FGEV+         VA+K  +PG+ + E 
Sbjct: 164 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA 223
Query: 117 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 176
           F+ E   + ++QH  LV L     +  + ++I E++  GS+ +      + S+Q L    
Sbjct: 224 FLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSL-LDFLKSDEGSKQPLP--- 278
Query: 177 RLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 236
           +L I                  +H+D + AN+LV    + K+AD GL     +  +    
Sbjct: 279 KL-IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK--- 334
Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQ 295
                   + A E   F  F+ KSDV+SFG+ L+E+V+ GR                +  
Sbjct: 335 --------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR----------------IPY 370
Query: 296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
                  +++ L+            EE   +++RC     E RP+   + + LD
Sbjct: 371 PGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 424

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 152
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD--EIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 153 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 258
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 259 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 291

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---- 149
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD--EIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL   +   +     ++  A     ++A E  +
Sbjct: 150 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 207
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 255
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 256 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 288

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 153
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E  +
Sbjct: 154 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 259
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 260 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 292

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 84  LIGEGKFGEVYKGLLQDG----MLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           +IG G FG VY G L D     +  A+K            +F+ E   +    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 136 LGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LG C +      ++  Y+ +G +   +   +     K      L +              
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 152
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT-DVAGPSSQVTADEIFLASEVKE 252
             + VH+D    N ++DE F  KVAD GL R+   +  D     +       ++A E  +
Sbjct: 153 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
            ++F+ KSDV+SFGV L EL++ R A            V L+Q  R            L 
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRR-----------LLQ 258
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +  + + E   ++++C  P +E RPS S++V+ +
Sbjct: 259 PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRI 291

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/278 (23%), Positives = 113/278 (40%), Gaps = 30/278 (10%)
Query: 84  LIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTL 135
           +IG G+FGEV  G L+      + VAIK      T+    +F+ E   +    H N++ L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
            G   ++    ++ EY+ NGS+   L       +   +F     +               
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFL------KKNDGQFTVIQLVGMLRGISAGMKYLSD 142
Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFR 254
              VH+D    N+L++ + + KV+D GL   L     A  +++     I + A E   FR
Sbjct: 143 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 255 RFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWST 314
           +F+  SDV+S+G+ + E+VS  E                        +++K ++E     
Sbjct: 203 KFTSASDVWSYGIVMWEVVSYGERPYWEMTN---------------QDVIKAVEEGYRLP 247
Query: 315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
              +      QL++ C       RP   ++V  LD+ +
Sbjct: 248 SPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLI 285

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/300 (23%), Positives = 128/300 (42%), Gaps = 38/300 (12%)
Query: 59  LSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE- 116
           +S +  + ++ +   +  ++   +  +G G+FGEV+         VA+K  +PG+ + E 
Sbjct: 170 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA 229
Query: 117 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 176
           F+ E   + ++QH  LV L     +  + ++I E++  GS+ +      + S+Q L    
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSL-LDFLKSDEGSKQPLP--- 284
Query: 177 RLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 236
           +L I                  +H+D + AN+LV    + K+AD GL   +         
Sbjct: 285 KL-IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI-------ED 336
Query: 237 SQVTADE------IFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXX 289
           ++ TA E       + A E   F  F+ KSDV+SFG+ L+E+V+ GR             
Sbjct: 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR------------- 383
Query: 290 XVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
              +         +++ L+            EE   +++RC     E RP+   + + LD
Sbjct: 384 ---IPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 119/283 (42%), Gaps = 34/283 (12%)
Query: 82  KNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLV 133
           + +IG G+FGEV  G L+      + VAIK      T+    +F+ E   +    H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            L G   ++    +I E++ NGS+       S + +   +F     +             
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLD------SFLRQNDGQFTVIQLVGMLRGIAAGMKYL 125
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS-SQVTADEI---FLASE 249
                VH+     N+LV+ + + KV+D GL  FL   D + P+ +     +I   + A E
Sbjct: 126 ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFL-EDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 309
             ++R+F+  SDV+S+G+ + E++S  E                   ++D  N ++  D 
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD------------MTNQDVINAIE-QDY 231
Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           RL      +      QL++ C       RP    +V  LD+ +
Sbjct: 232 RLPPPM--DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 272

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I  Y   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 118/277 (42%), Gaps = 44/277 (15%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+         VA+K  +PG+ + E F+ E   + ++QH  LV L     + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 82
Query: 143 NLQFLIYEYIPNGSVSIHLY---GPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
            + ++I E++  GS+   L    G  Q   + ++F  +++                   +
Sbjct: 83  PI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA--------EGMAFIEQRNYI 133
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE------IFLASEVKEF 253
           H+D + AN+LV    + K+AD GL   +         ++ TA E       + A E   F
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIE-------DNEYTAREGAKFPIKWTAPEAINF 186
Query: 254 RRFSEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLW 312
             F+ KSDV+SFG+ L+E+V+ GR                +         +++ L+    
Sbjct: 187 GSFTIKSDVWSFGILLMEIVTYGR----------------IPYPGMSNPEVIRALERGYR 230
Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
                   EE   +++RC     E RP+   + + LD
Sbjct: 231 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 267

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 15/197 (7%)
Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FGEV+ G L+ D  LVA+K      P     +F+ E   L    H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
            +    +++ E +  G     L    +    +L  K  L +                  +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLESKC--CI 235
Query: 200 HKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           H+D    N LV E  + K++D G+      G    +G   QV     + A E   + R+S
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVK--WTAPEALNYGRYS 293
Query: 258 EKSDVYSFGVFLLELVS 274
            +SDV+SFG+ L E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVY--------KGLLQDGMLVAIKKRPGAPTQ----EFIDEVCFLASI-QHRN 131
           +GEG FG+V         K   ++ + VA+K      T+    + + E+  +  I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSI 180
           ++ LLG C ++   ++I  Y   G++  +L           Y  ++V  +++ FK  +S 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
                           + +H+D    NVLV E+ + K+AD GL   +   D    ++   
Sbjct: 163 TYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDF 300
               ++A E    R ++ +SDV+SFGV + E+ +                VE        
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYPGIPVE-------- 266
Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
             L K+L E            E   ++  C      +RP+   +V +LDR L
Sbjct: 267 -ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 126/305 (41%), Gaps = 65/305 (21%)
Query: 82  KNLIGEGKFGEVYKGLLQ-DG--MLVAIKKRPGAPTQE----FIDEVCFLASI-QHRNLV 133
           +++IGEG FG+V K  ++ DG  M  AIK+     +++    F  E+  L  +  H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 134 TLLGYCQENNLQFLIYEYIPNGSV----------------SIHLYGPSQVSRQKLEFKHR 177
            LLG C+     +L  EY P+G++                +I     S +S Q+L     
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL----- 141
Query: 178 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL--------RNFLGR 229
             +                + +H++    N+LV E+++AK+AD GL        +  +GR
Sbjct: 142 --LHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 199
Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXX 289
             V            ++A E   +  ++  SDV+S+GV L E+VS               
Sbjct: 200 LPVR-----------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----LGGTPYCGMT 243
Query: 290 XVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
             EL +       L K L+            +E   L+ +C       RPS + ++  L+
Sbjct: 244 CAELYEKLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLN 293
Query: 350 RTLDK 354
           R L++
Sbjct: 294 RMLEE 298

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 34/206 (16%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +GEG +G VYK + ++ G +VAIK+ P  +  QE I E+  +      ++V   G   +N
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96
Query: 143 NLQFLIYEYIPNGSVS--IHLYGPS----------QVSRQKLEFKHRLSIXXXXXXXXXX 190
              +++ EY   GSVS  I L   +          Q + + LE+ H +            
Sbjct: 97  TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM------------ 144
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 250
                 R +H+D K  N+L++ +  AK+AD G+   L  TD     + V     ++A EV
Sbjct: 145 ------RKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEV 196
Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGR 276
            +   ++  +D++S G+  +E+  G+
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 15/197 (7%)
Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FGEV+ G L+ D  LVA+K      P     +F+ E   L    H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
            +    +++ E +  G     L    +    +L  K  L +                  +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLESKC--CI 235
Query: 200 HKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           H+D    N LV E  + K++D G+      G    +G   QV     + A E   + R+S
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK--WTAPEALNYGRYS 293
Query: 258 EKSDVYSFGVFLLELVS 274
            +SDV+SFG+ L E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 15/195 (7%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VA+K  K       EF  E   +  + H  LV   G C + 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 143 NLQFLIYEYIPNGSVSIHL--YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVH 200
              +++ EYI NG +  +L  +G      Q LE  + +                  + +H
Sbjct: 76  YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVC--------EGMAFLESHQFIH 127
Query: 201 KDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEK 259
           +D    N LVD D   KV+D G+ R  L    V+   ++      + A EV  + ++S K
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK--WSAPEVFHYFKYSSK 185
Query: 260 SDVYSFGVFLLELVS 274
           SDV++FG+ + E+ S
Sbjct: 186 SDVWAFGILMWEVFS 200

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/288 (22%), Positives = 116/288 (40%), Gaps = 30/288 (10%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ E + NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 304
           + + E   +R+F+  SDV+S+G+ L E++S  E                        +++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------QDVI 260
Query: 305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           K +DE        +      QL++ C       RP    +V+ LD+ +
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 34/290 (11%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 13  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 72
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ E + NGS+       S + +   +F     +     
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD------SFLRKHDAQFTVIQLVGMLRG 126
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 127 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN-- 302
           + + E   +R+F+  SDV+S+G+ L E++S  E                 +   + SN  
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----------------RPYWEMSNQD 229
Query: 303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           ++K +DE        +      QL++ C       RP    +V+ LD+ +
Sbjct: 230 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 34/290 (11%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
           L   N S   ++G G+FGEV  G L+      + VAIK      T+    +F+ E   + 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXX 185
              H N++ L G   ++    ++ E + NGS+       S + +   +F     +     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD------SFLRKHDAQFTVIQLVGMLRG 155
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI- 244
                        VH+D    N+L++ + + KV+D GL   L     A  +++     I 
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN-- 302
           + + E   +R+F+  SDV+S+G+ L E++S  E                 +   + SN  
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-----------------RPYWEMSNQD 258
Query: 303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           ++K +DE        +      QL++ C       RP    +V+ LD+ +
Sbjct: 259 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 127/294 (43%), Gaps = 42/294 (14%)
Query: 73  SLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPT----------QEFIDEV 121
           +LA      +  IG+G FG V+KG L++D  +VAIK      +          QEF  EV
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 181
             ++++ H N+V L G    +N   ++ E++P G +   L   +   +  ++ +  L I 
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLV---DED--FIAKVADAGL--RNFLGRTDVAG 234
                         P +VH+D ++ N+ +   DE+    AKVAD GL  ++    + + G
Sbjct: 133 LGIEYMQNQN----PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLG 188
Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELV 294
            + Q  A E   A E      ++EK+D YSF + L  +++G                E  
Sbjct: 189 -NFQWMAPETIGAEE----ESYTEKADTYSFAMILYTILTGEGPFD-----------EYS 232
Query: 295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
                F N+++  +E L  T   +       +I  C     ++RP  S +V EL
Sbjct: 233 YGKIKFINMIR--EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        M VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 130
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 189
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/306 (22%), Positives = 122/306 (39%), Gaps = 43/306 (14%)
Query: 67  FQMEELSLATKNFSDK---------NLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP 113
           F  E+ + A + F+ +          +IG G+FGEV  G L+      + VAIK      
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 114 T----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR 169
           T    ++F+ E   +    H N++ L G   +     +I EY+ NGS+   L       +
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL------RK 123
Query: 170 QKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
               F     +                  VH+D    N+LV+ + + KV+D G+   L  
Sbjct: 124 NDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLED 183
Query: 230 TDVAGPSSQVTADEI-FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXX 288
              A  +++     I + A E   +R+F+  SDV+S+G+ + E++S  E           
Sbjct: 184 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE----------- 232
Query: 289 XXVELVQNSRDFSN--LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 346
                 +   D SN  ++K ++E        +      QL++ C       RP    +V 
Sbjct: 233 ------RPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVN 286
Query: 347 ELDRTL 352
            LD+ +
Sbjct: 287 MLDKLI 292

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        M VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL----QVRKFSLDLASL--ILYAYQLSTALAYLESK 130
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++        +S+      ++A E   FRRF
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 114/282 (40%), Gaps = 34/282 (12%)
Query: 82  KNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLV 133
           + +IG G+FGEV  G L+      + VAIK      T    ++F+ E   +    H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            L G   +     +I EY+ NGS+   L       +    F     +             
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFL------RKNDGRFTVIQLVGMLRGIGSGMKYL 126
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKE 252
                VH+D    N+LV+ + + KV+D G+   L     A  +++     I + A E   
Sbjct: 127 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN--LLKILDER 310
           +R+F+  SDV+S+G+ + E++S  E                 +   D SN  ++K ++E 
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMSYGE-----------------RPYWDMSNQDVIKAIEEG 229
Query: 311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
                  +      QL++ C       RP    +V  LD+ +
Sbjct: 230 YRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 271

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/278 (21%), Positives = 122/278 (43%), Gaps = 33/278 (11%)
Query: 80  SDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTL 135
            D+ ++G+G +G VY G  L + + +AIK+ P      +Q   +E+     ++H+N+V  
Sbjct: 25  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
           LG   EN    +  E +P GS+S  L   +GP + + Q + F  +  +            
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--- 141
Query: 193 XXXPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV- 250
               ++VH+D K  NVL++    + K++D G    L   +    +   T    ++A E+ 
Sbjct: 142 ----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEII 195
Query: 251 -KEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 309
            K  R + + +D++S G  ++E+ +G+                  +     + + K+   
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPP--------------FYELGEPQAAMFKVGMF 241
Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 347
           ++          E    I++C +P  ++R   +D++ +
Sbjct: 242 KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/278 (21%), Positives = 122/278 (43%), Gaps = 33/278 (11%)
Query: 80  SDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTL 135
            D+ ++G+G +G VY G  L + + +AIK+ P      +Q   +E+     ++H+N+V  
Sbjct: 11  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 70
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
           LG   EN    +  E +P GS+S  L   +GP + + Q + F  +  +            
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--- 127
Query: 193 XXXPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV- 250
               ++VH+D K  NVL++    + K++D G    L   +    +   T    ++A E+ 
Sbjct: 128 ----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEII 181
Query: 251 -KEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 309
            K  R + + +D++S G  ++E+ +G+                  +     + + K+   
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPP--------------FYELGEPQAAMFKVGMF 227
Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE 347
           ++          E    I++C +P  ++R   +D++ +
Sbjct: 228 KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 265

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 114/282 (40%), Gaps = 34/282 (12%)
Query: 82  KNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLV 133
           + +IG G+FGEV  G L+      + VAIK      T    ++F+ E   +    H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            L G   +     +I EY+ NGS+   L       +    F     +             
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFL------RKNDGRFTVIQLVGMLRGIGSGMKYL 132
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKE 252
                VH+D    N+LV+ + + KV+D G+   L     A  +++     I + A E   
Sbjct: 133 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN--LLKILDER 310
           +R+F+  SDV+S+G+ + E++S  E                 +   D SN  ++K ++E 
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMSYGE-----------------RPYWDMSNQDVIKAIEEG 235
Query: 311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
                  +      QL++ C       RP    +V  LD+ +
Sbjct: 236 YRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 277

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 73
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL------DYVREHKDNIGSQYLLNWC 126
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 127 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 74
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 127
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 128 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 187
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 106 GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 158
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 217
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 218 TSASDVWMFGVCMWEIL 234

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 83  NLIGEGKFGEVYKGL-LQDG-------MLVAIKKRPGAPT-QEFIDEVCFLASIQHRNLV 133
            ++G G FG V+KG+ + +G        +  I+ + G  + Q   D +  + S+ H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            LLG C  ++LQ L+ +Y+P GS+  H      V + +     +L +             
Sbjct: 79  RLLGLCPGSSLQ-LVTQYLPLGSLLDH------VRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +VH++    NVL+      +VAD G+ + L   D     S+      ++A E   F
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
            +++ +SDV+S+GV + EL++
Sbjct: 192 GKYTHQSDVWSYGVTVWELMT 212

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL------DYVREHKDNIGSQYLLNWC 123
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 109/282 (38%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G V   L        QKL +F  + +       
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--------QKLSKFDEQRTATYITEL 122
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 175
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 226
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 227 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 260

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 71
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL------DYVREHKDNIGSQYLLNWC 124
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 125 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 72
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL------DYVREHKDNIGSQYLLNWC 125
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 81  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 133
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 192
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 193 TSASDVWMFGVCMWEIL 209

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 116
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 117 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 169
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 170 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 223
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 224 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 254

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 83  NLIGEGKFGEVYKGL-LQDG-------MLVAIKKRPGAPT-QEFIDEVCFLASIQHRNLV 133
            ++G G FG V+KG+ + +G        +  I+ + G  + Q   D +  + S+ H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            LLG C  ++LQ L+ +Y+P GS+  H      V + +     +L +             
Sbjct: 97  RLLGLCPGSSLQ-LVTQYLPLGSLLDH------VRQHRGALGPQLLLNWGVQIAKGMYYL 149
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               +VH++    NVL+      +VAD G+ + L   D     S+      ++A E   F
Sbjct: 150 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 209
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
            +++ +SDV+S+GV + EL++
Sbjct: 210 GKYTHQSDVWSYGVTVWELMT 230

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 18  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 76
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 77  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 129
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 130 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 189
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 77
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 130
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 131 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTXLCGTL 170
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 224
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 225 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 130
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 189
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 72
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 125
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 133/310 (42%), Gaps = 40/310 (12%)
Query: 83  NLIGEGKFGEVYKGL-LQDG----MLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNL 132
            ++G G FG VYKG+ + DG    + VAIK       P A  +E +DE   +A +    +
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA-NKEILDEAYVMAGVGSPYV 81
Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
             LLG C  + +Q L+ + +P G +  H+    + +R +L  +  L+             
Sbjct: 82  SRLLGICLTSTVQ-LVTQLMPYGCLLDHV----RENRGRLGSQDLLNWCMQIAKGMSYLE 136
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQVTADEIFLASEV 250
               R+VH+D    NVLV      K+ D GL   L    T+      +V    + L S +
Sbjct: 137 DV--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 251 KEFRRFSEKSDVYSFGVFLLELVS-GREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 309
           +  RRF+ +SDV+S+GV + EL++ G +                   +R+  +LL+   E
Sbjct: 195 R--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-------------AREIPDLLE-KGE 238
Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGT-PT 368
           RL          +   ++V+C    SE RP   ++V+E  R          +  E   P 
Sbjct: 239 RLPQPPIC--TIDVYMIMVKCWMIDSECRPRFRELVSEFSRMARDPQRFVVIQNEDLGPA 296
Query: 369 VTLGSHLFRA 378
             L S  +R+
Sbjct: 297 SPLDSTFYRS 306

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 135
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 194
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 123
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 80  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 132
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 191
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 73
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 126
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 127 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 114
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 115 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 167
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 168 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 221
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 222 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 252

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 22  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 80
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 81  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 133
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 134 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 193
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 194 KWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 73
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 126
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 127 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 121
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 122 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 174
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 228
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 229 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 259

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 64
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 65  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 117
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 118 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 71
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLL------DYVREHKDNIGSQYLLNWC 124
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 125 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 85  IGEGKFGEVYK----GLL--QDGMLVAIK---KRPGAPTQ-EFIDEVCFLASIQHRNLVT 134
           IGEG FG V++    GLL  +   +VA+K   +   A  Q +F  E   +A   + N+V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 135 LLGYCQENNLQFLIYEYIPNGSV-----SIHLYGPSQVSRQKLEFKHRLS---------- 179
           LLG C       L++EY+  G +     S+  +    +S   L  + R+S          
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 180 --IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
             +                + VH+D  T N LV E+ + K+AD GL   +   D      
Sbjct: 175 EQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADG 234
Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                  ++  E   + R++ +SDV+++GV L E+ S
Sbjct: 235 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 73
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 126
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 127 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 9   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 67
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 68  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 120
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 121 VQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 180
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 181 KWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 173
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 227
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 228 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        + VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 75  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASL--ILYAYQLSTALAYLESK 127
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 186
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 123
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 37  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 95
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 96  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 148
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 149 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 208
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 209 KWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 124/300 (41%), Gaps = 54/300 (18%)
Query: 73  SLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPT----------QEFIDEV 121
           +LA      +  IG+G FG V+KG L++D  +VAIK      +          QEF  EV
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 181
             ++++ H N+V L G    +N   ++ E++P G +   L   +   +  ++ +  L I 
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLV---DED--FIAKVADAG--------LRNFLG 228
                         P +VH+D ++ N+ +   DE+    AKVAD G        +   LG
Sbjct: 133 LGIEYMQNQN----PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLG 188
Query: 229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXX 288
                 P + + A+E            ++EK+D YSF + L  +++G             
Sbjct: 189 NFQWMAPET-IGAEE----------ESYTEKADTYSFAMILYTILTGEGPFD-------- 229
Query: 289 XXVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
              E       F N+++  +E L  T   +       +I  C     ++RP  S +V EL
Sbjct: 230 ---EYSYGKIKFINMIR--EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLL------DYVREHKDNIGSQYLLNWC 123
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 170
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 221
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 222 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        M VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL----QVRKFSLDLASL--ILYAYQLSTALAYLESK 130
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV      K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 189
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA---DE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+  A     
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRAALCGTL 170
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 224
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 225 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        M VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFL----QVRKFSLDLASL--ILYAYQLSTALAYLESK 510
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 569
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 112/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG---RTDVAGPSSQVTADE 243
                     RV+H+D K  N+L+      K+AD G         RTD+ G     T D 
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG-----TLD- 171
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 172 -YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 224
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 225 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 122
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 175
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 226
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 227 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 260

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTELCGTL 170
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 221
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 222 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 122
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTDLCGTL 175
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 226
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 227 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 260

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 173
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 224
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 225 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 118
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG---RTDVAGPSSQVTADE 243
                     RV+H+D K  N+L+      K+AD G         RTD+ G     T D 
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG-----TLD- 172
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 173 -YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 222
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 223 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 256

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 112/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG---RTDVAGPSSQVTADE 243
                     RV+H+D K  N+L+      K+AD G         RTD+ G     T D 
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG-----TLD- 171
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 172 -YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 224
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 225 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 71  ELSLATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVC 122
           +  +A ++     ++GEG FGEVY+G+  +     + VA+K      T    ++F+ E  
Sbjct: 18  QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 77
Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 182
            + ++ H ++V L+G  +E    ++I E  P G +  +L       R K   K    +  
Sbjct: 78  IMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYL------ERNKNSLKVLTLVLY 130
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                           VH+D    N+LV      K+ D GL  ++   D    S  VT  
Sbjct: 131 SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--VTRL 188
Query: 243 EI-FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            I +++ E   FRRF+  SDV+ F V + E++S
Sbjct: 189 PIKWMSPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRDDLCGTL 173
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 227
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 228 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 118 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRXXLCGTL 170
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 224
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 225 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 109/282 (38%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G V   L        QKL +F  + +       
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--------QKLSKFDEQRTATYITEL 122
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRXXLXGTL 175
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 226
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 227 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 260

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 100/243 (41%), Gaps = 31/243 (12%)
Query: 45  SEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY-------KGL 97
           S P   P   +  +    E+++ Q      A ++F     +G+GKFG VY       K +
Sbjct: 7   SAPENNPEEELASKQKNEESKKRQW-----ALEDFEIGRPLGKGKFGNVYLAREKQSKFI 61
Query: 98  LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV 157
           L   +L   +        +   EV   + ++H N++ L GY  +    +LI EY P G+V
Sbjct: 62  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 121
Query: 158 SIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIA 216
              L        QKL +F  + +                 RV+H+D K  N+L+      
Sbjct: 122 YREL--------QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGEL 173
Query: 217 KVADAGLRNFLGRTDVAGPSSQVT---ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV 273
           K+AD G         V  PSS+ T       +L  E+ E R   EK D++S GV   E +
Sbjct: 174 KIADFGW-------SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 226
Query: 274 SGR 276
            G+
Sbjct: 227 VGK 229

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRXXLCGTL 173
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 227
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 228 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 109/282 (38%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 122
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 175
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E  E R   EK D++S GV   E + G+              +  V         
Sbjct: 176 DYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 226
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 227 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPXLREVL 260

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA---DE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+  A     
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRAALCGTL 173
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 224
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 225 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 71  ELSLATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVC 122
           +  +A ++     ++GEG FGEVY+G+  +     + VA+K      T    ++F+ E  
Sbjct: 6   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65
Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 182
            + ++ H ++V L+G  +E    ++I E  P G +  +L       R K   K    +  
Sbjct: 66  IMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYL------ERNKNSLKVLTLVLY 118
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                           VH+D    N+LV      K+ D GL  ++   D    S  VT  
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--VTRL 176
Query: 243 EI-FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            I +++ E   FRRF+  SDV+ F V + E++S
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 126/294 (42%), Gaps = 42/294 (14%)
Query: 73  SLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPT----------QEFIDEV 121
           +LA      +  IG+G FG V+KG L++D  +VAIK      +          QEF  EV
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 181
             ++++ H N+V L G    +N   ++ E++P G +   L   +   +  ++ +  L I 
Sbjct: 75  FIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLV---DED--FIAKVADAGL--RNFLGRTDVAG 234
                         P +VH+D ++ N+ +   DE+    AKVAD  L  ++    + + G
Sbjct: 133 LGIEYMQNQN----PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLG 188
Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELV 294
            + Q  A E   A E      ++EK+D YSF + L  +++G                E  
Sbjct: 189 -NFQWMAPETIGAEE----ESYTEKADTYSFAMILYTILTGEGPFD-----------EYS 232
Query: 295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
                F N+++  +E L  T   +       +I  C     ++RP  S +V EL
Sbjct: 233 YGKIKFINMIR--EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 24/209 (11%)
Query: 77  KNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQH 129
           ++F     +G+GKFG VY       K +L   +L   +        +   EV   + ++H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXX 189
            N++ L GY  +    +LI EY P G+V   L   S+   Q+       +          
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQR-------TATYITELANA 124
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADEIFL 246
                  RV+H+D K  N+L+  +   K+AD G         V  PSS+ T       +L
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW-------SVHAPSSRRTTLCGTLDYL 177
Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
             E+ E R   EK D++S GV   E + G
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 71  ELSLATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVC 122
           +  +A ++     ++GEG FGEVY+G+  +     + VA+K      T    ++F+ E  
Sbjct: 2   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 61
Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 182
            + ++ H ++V L+G  +E    ++I E  P G +  +L       R K   K    +  
Sbjct: 62  IMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYL------ERNKNSLKVLTLVLY 114
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                           VH+D    N+LV      K+ D GL  ++   D    S  VT  
Sbjct: 115 SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--VTRL 172
Query: 243 EI-FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            I +++ E   FRRF+  SDV+ F V + E++S
Sbjct: 173 PIKWMSPESINFRRFTTASDVWMFAVCMWEILS 205

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 111/274 (40%), Gaps = 31/274 (11%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           K    + ++G G FG V K   +    VAIK+    +  + FI E+  L+ + H N+V L
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL 66
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
            G C   N   L+ EY   GS+   L+G   +        H +S                
Sbjct: 67  YGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTA--AHAMSWCLQCSQGVAYLHSMQ 122
Query: 196 PR-VVHKDFKTANVL-VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
           P+ ++H+D K  N+L V    + K+ D G        D+    +       ++A EV E 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEG 177
Query: 254 RRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRD--FSNLLKILDERL 311
             +SEK DV+S+G+ L E+++ R+               +   +R     NL K ++   
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE--- 234
Query: 312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                         L+ RC      +RPSM ++V
Sbjct: 235 -------------SLMTRCWSKDPSQRPSMEEIV 255

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 111/274 (40%), Gaps = 31/274 (11%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTL 135
           K    + ++G G FG V K   +    VAIK+    +  + FI E+  L+ + H N+V L
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL 67
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
            G C   N   L+ EY   GS+   L+G   +        H +S                
Sbjct: 68  YGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTA--AHAMSWCLQCSQGVAYLHSMQ 123
Query: 196 PR-VVHKDFKTANVL-VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
           P+ ++H+D K  N+L V    + K+ D G        D+    +       ++A EV E 
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEG 178
Query: 254 RRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRD--FSNLLKILDERL 311
             +SEK DV+S+G+ L E+++ R+               +   +R     NL K ++   
Sbjct: 179 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE--- 235
Query: 312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                         L+ RC      +RPSM ++V
Sbjct: 236 -------------SLMTRCWSKDPSQRPSMEEIV 256

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 134
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+ T      
Sbjct: 135 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRTTLCGTL 187
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +L  E+ E R   EK D++S GV   E + G+
Sbjct: 188 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 119
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 120 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRXXLCGTL 172
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 223
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 224 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 257

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 112/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  ++   +LI EY P G+V   L        QKL +F  + +       
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 117
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA---DE 243
                     +V+H+D K  N+L+      K+AD G         V  PSS+  A     
Sbjct: 118 ANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRAALCGTL 170
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFT------ 224
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 225 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 118
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADE 243
                     RV+H+D K  N+L+      K+AD G         V  PSS+   +    
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSSRRDTLCGTL 171
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 222
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 223 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 256

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 16/210 (7%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK------KRPGAP--TQEFIDEVCFL 124
           L    F    ++G G FG VYKGL + +G  V I       +   +P   +E +DE   +
Sbjct: 46  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVM 105
Query: 125 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXX 184
           AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +    
Sbjct: 106 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWCV 158
Query: 185 XXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
                       R+VH+D    NVLV      K+ D GL   LG  +    +        
Sbjct: 159 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 219 WMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 16/197 (8%)
Query: 85  IGEGKFGEVYKGLLQD----GMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        M VAIK      +    ++F+ E   +    H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           G   EN + ++I E    G +   L    QV +  L+      I                
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFL----QVRKFSLDLASL--ILYAYQLSTALAYLESK 510
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
           R VH+D    NVLV      K+ D GL  ++  +     S      + ++A E   FRRF
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRF 569
Query: 257 SEKSDVYSFGVFLLELV 273
           +  SDV+ FGV + E++
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 24/209 (11%)
Query: 77  KNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQH 129
           ++F     +G+GKFG VY       K +L   +L   +        +   EV   + ++H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXX 189
            N++ L GY  +    +LI EY P G+V   L   S+   Q+       +          
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQR-------TATYITELANA 124
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ---VTADEIFL 246
                  RV+H+D K  N+L+  +   K+AD G         V  PSS+   +     +L
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW-------SVHAPSSRRDTLCGTLDYL 177
Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
             E+ E R   EK D++S GV   E + G
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 100/243 (41%), Gaps = 31/243 (12%)
Query: 45  SEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY-------KGL 97
           S P   P   +  +    E+++ Q      A ++F     +G+GKFG VY       K +
Sbjct: 7   SAPENNPEEELASKQKNEESKKRQW-----ALEDFEIGRPLGKGKFGNVYLAREKQSKFI 61
Query: 98  LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV 157
           L   +L   +        +   EV   + ++H N++ L GY  +    +LI EY P G+V
Sbjct: 62  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 121
Query: 158 SIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIA 216
              L        QKL +F  + +                 RV+H+D K  N+L+      
Sbjct: 122 YREL--------QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGEL 173
Query: 217 KVADAGLRNFLGRTDVAGPSSQ---VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV 273
           K+AD G         V  PSS+   +     +L  E+ E R   EK D++S GV   E +
Sbjct: 174 KIADFGW-------SVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 226
Query: 274 SGR 276
            G+
Sbjct: 227 VGK 229

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 113/281 (40%), Gaps = 42/281 (14%)
Query: 84  LIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFID-------EVCFLASIQHRNLVTLL 136
           +IG G FG+VY+     G  VA+K     P ++          E    A ++H N++ L 
Sbjct: 14  IIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 137 GYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
           G C +E NL  L+ E+   G ++  L G     R   +     ++               
Sbjct: 73  GVCLKEPNL-CLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 196 PRVVHKDFKTANVLVDEDF--------IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
           P ++H+D K++N+L+ +          I K+ D GL     RT     +        ++A
Sbjct: 128 P-IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA----WMA 182
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKIL 307
            EV     FS+ SDV+S+GV L EL++G               V +              
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM-------------- 228
Query: 308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
             +L     +   E F +L+  C +P    RPS ++++ +L
Sbjct: 229 -NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 120
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+A+ G         V  PSS+ T      
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW-------SVHAPSSRRTTLCGTL 173
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V+ +      
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------ 227
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                   +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 228 --------FPDFVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 113/282 (40%), Gaps = 38/282 (13%)
Query: 84  LIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTL 135
           +IG G+FGEV  G L+      + VAIK      T+    +F+ E   +    H N+V L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
            G         ++ E++ NG++   L       +   +F     +               
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFL------RKHDGQFTVIQLVGMLRGIAAGMRYLAD 163
Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEVKE 252
              VH+D    N+LV+ + + KV+D GL   +   D        T  +I   + A E  +
Sbjct: 164 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVI--EDDPEAVYTTTGGKIPVRWTAPEAIQ 221
Query: 253 FRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN--LLKILDER 310
           +R+F+  SDV+S+G+ + E++S  E                 +   D SN  ++K ++E 
Sbjct: 222 YRKFTSASDVWSYGIVMWEVMSYGE-----------------RPYWDMSNQDVIKAIEEG 264
Query: 311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
                  +      QL++ C       RP    +V  LD+ +
Sbjct: 265 YRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMI 306

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 109/282 (38%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 118
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+AD G            PSS+ T      
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-------SCHAPSSRRTTLSGTL 171
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 222
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 223 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 256

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTLL-GYC 139
           +G+G FG+VYK   ++  ++A  K     ++E    ++ E+  LAS  H N+V LL  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 140 QENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
            ENNL  LI E+   G+V    + L  P   S+ ++  K  L                  
Sbjct: 105 YENNLWILI-EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--------- 154
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEVKE 252
           +++H+D K  N+L   D   K+AD G+       + R D    +    A E+ +    K+
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 253 FRRFSEKSDVYSFGVFLLELV 273
            R +  K+DV+S G+ L+E+ 
Sbjct: 215 -RPYDYKADVWSLGITLIEMA 234

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 72
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 125
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTLL-GYC 139
           +G+G FG+VYK   ++  ++A  K     ++E    ++ E+  LAS  H N+V LL  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 140 QENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
            ENNL  LI E+   G+V    + L  P   S+ ++  K  L                  
Sbjct: 105 YENNLWILI-EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--------- 154
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEVKE 252
           +++H+D K  N+L   D   K+AD G+       + R D    +    A E+ +    K+
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 253 FRRFSEKSDVYSFGVFLLELV 273
            R +  K+DV+S G+ L+E+ 
Sbjct: 215 -RPYDYKADVWSLGITLIEMA 234

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++  G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 77
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 130
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 131 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 72
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDY------VREHKDNIGSQYLLNWC 125
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 74
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL------DYVREHKDNIGSQYLLNWC 127
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 128 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 187
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 25/202 (12%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTLL-GYC 139
           +G+G FG+VYK   ++  ++A  K     ++E    ++ E+  LAS  H N+V LL  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 140 QENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
            ENNL  LI E+   G+V    + L  P   S+ ++  K  L                  
Sbjct: 105 YENNLWILI-EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN--------- 154
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGL-----RNFLGRTDVAGPSSQVTADEIFLASEVK 251
           +++H+D K  N+L   D   K+AD G+     R    R    G +    A E+ +    K
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG-TPYWMAPEVVMCETSK 213
Query: 252 EFRRFSEKSDVYSFGVFLLELV 273
           + R +  K+DV+S G+ L+E+ 
Sbjct: 214 D-RPYDYKADVWSLGITLIEMA 234

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 110/282 (39%), Gaps = 43/282 (15%)
Query: 75  ATKNFSDKNLIGEGKFGEVY-------KGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI 127
           A ++F     +G+GKFG VY       K +L   +L   +        +   EV   + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXX 186
           +H N++ L GY  +    +LI EY P G+V   L        QKL +F  + +       
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--------QKLSKFDEQRTATYITEL 119
Query: 187 XXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT---ADE 243
                     RV+H+D K  N+L+      K+A+ G         V  PSS+ T      
Sbjct: 120 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW-------SVHAPSSRRTTLCGTL 172
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            +L  E+ E R   EK D++S GV   E + G+              +  V         
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------- 223
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                E  +  F  EG  +   LI R L  +  +RP + +V+
Sbjct: 224 -----EFTFPDFVTEGARD---LISRLLKHNPSQRPMLREVL 257

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 72
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 125
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 126 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 77
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 130
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 131 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 190
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++  G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 77
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 130
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 131 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++G G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +  +      V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY------VREHKDNIGSQYLLNWC 123
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D G    LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 183
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKGL-LQDG----MLVAIKK-----RPGAPTQEFIDEVCF 123
           L    F    ++  G FG VYKGL + +G    + VAIK+      P A  +E +DE   
Sbjct: 12  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYV 70
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           +AS+ + ++  LLG C  + +Q LI + +P G +         V   K     +  +   
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL------DYVREHKDNIGSQYLLNWC 123
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        R+VH+D    NVLV      K+ D GL   LG  +    +       
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
            ++A E    R ++ +SDV+S+GV + EL++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 86/207 (41%), Gaps = 21/207 (10%)
Query: 78  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK---KRPGAPT--QEFIDEVCFLASIQHRN 131
           N+     IG+G F +V     +  G  VAIK   K    PT  Q+   EV  +  + H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXX 191
           +V L    +     +LI EY   G V  +L    ++  ++   K R  +           
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK-- 130
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLAS 248
                R+VH+D K  N+L+D D   K+AD G  N     G+ D    S    A E+F   
Sbjct: 131 -----RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGK 185
Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSG 275
           +         + DV+S GV L  LVSG
Sbjct: 186 KYD-----GPEVDVWSLGVILYTLVSG 207

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 86/207 (41%), Gaps = 21/207 (10%)
Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPT--QEFIDEVCFLASIQHRN 131
           N+     IG+G F +V     +  G  VAIK   K    PT  Q+   EV  +  + H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXX 191
           +V L    +     +LI EY   G V  +L    ++  ++   K R  +           
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK-- 133
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLAS 248
                R+VH+D K  N+L+D D   K+AD G  N     G+ D    +    A E+F   
Sbjct: 134 -----RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGK 188
Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSG 275
           +         + DV+S GV L  LVSG
Sbjct: 189 KYD-----GPEVDVWSLGVILYTLVSG 210

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 75/325 (23%), Positives = 127/325 (39%), Gaps = 42/325 (12%)
Query: 57  IELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK--K 108
           + LS+   +  +  +     KN      +GEG+FG+V K              VA+K  K
Sbjct: 3   LSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK 62
Query: 109 RPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL----- 161
              +P++  + + E   L  + H +++ L G C ++    LI EY   GS+   L     
Sbjct: 63  ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
Query: 162 YGPSQVSRQKLEFKHRLS------------IXXXXXXXXXXXXXXXPRVVHKDFKTANVL 209
            GP  +          L             I                ++VH+D    N+L
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182
Query: 210 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFL 269
           V E    K++D GL   +   D     SQ      ++A E      ++ +SDV+SFGV L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 270 LELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVR 329
            E+V+                   +   R F NLLK    R+     +   EE  +L+++
Sbjct: 243 WEIVT-----------LGGNPYPGIPPERLF-NLLKT-GHRM--ERPDNCSEEMYRLMLQ 287
Query: 330 CLDPSSERRPSMSDVVTELDRTLDK 354
           C     ++RP  +D+  +L++ + K
Sbjct: 288 CWKQEPDKRPVFADISKDLEKMMVK 312

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 110/274 (40%), Gaps = 38/274 (13%)
Query: 84  LIGEGKFGEVYKGLLQDGMLVAIKK---RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYC 139
           ++G+G FG+  K   ++   V + K   R    TQ  F+ EV  +  ++H N++  +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVV 199
            ++     I EYI  G+    L G  +    +  +  R+S                  ++
Sbjct: 77  YKDKRLNFITEYIKGGT----LRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM--NII 130
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFL--------GRTDVAGPSSQ----VTADEIFLA 247
           H+D  + N LV E+    VAD GL   +        G   +  P  +    V  +  ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFS-NLLKI 306
            E+   R + EK DV+SFG+ L E++    A             + +  + DF  N+   
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP-----------DYLPRTMDFGLNVRGF 239
Query: 307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 340
           LD              F  + VRC D   E+RPS
Sbjct: 240 LDRYCPPNCP----PSFFPITVRCCDLDPEKRPS 269

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/325 (23%), Positives = 127/325 (39%), Gaps = 42/325 (12%)
Query: 57  IELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK--K 108
           + LS+   +  +  +     KN      +GEG+FG+V K              VA+K  K
Sbjct: 3   LSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK 62
Query: 109 RPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL----- 161
              +P++  + + E   L  + H +++ L G C ++    LI EY   GS+   L     
Sbjct: 63  ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
Query: 162 YGPSQVSRQKLEFKHRLS------------IXXXXXXXXXXXXXXXPRVVHKDFKTANVL 209
            GP  +          L             I                ++VH+D    N+L
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182
Query: 210 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFL 269
           V E    K++D GL   +   D     SQ      ++A E      ++ +SDV+SFGV L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 270 LELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVR 329
            E+V+                   +   R F NLLK    R+     +   EE  +L+++
Sbjct: 243 WEIVT-----------LGGNPYPGIPPERLF-NLLKT-GHRM--ERPDNCSEEMYRLMLQ 287
Query: 330 CLDPSSERRPSMSDVVTELDRTLDK 354
           C     ++RP  +D+  +L++ + K
Sbjct: 288 CWKQEPDKRPVFADISKDLEKMMVK 312

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 75/325 (23%), Positives = 126/325 (38%), Gaps = 42/325 (12%)
Query: 57  IELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIK--K 108
           + LS+   +  +  +     KN      +GEG+FG+V K              VA+K  K
Sbjct: 3   LSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK 62
Query: 109 RPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL----- 161
              +P++  + + E   L  + H +++ L G C ++    LI EY   GS+   L     
Sbjct: 63  ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
Query: 162 YGPSQVSRQKLEFKHRLS------------IXXXXXXXXXXXXXXXPRVVHKDFKTANVL 209
            GP  +          L             I                 +VH+D    N+L
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNIL 182
Query: 210 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFL 269
           V E    K++D GL   +   D     SQ      ++A E      ++ +SDV+SFGV L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 270 LELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVR 329
            E+V+                   +   R F NLLK    R+     +   EE  +L+++
Sbjct: 243 WEIVT-----------LGGNPYPGIPPERLF-NLLKT-GHRM--ERPDNCSEEMYRLMLQ 287
Query: 330 CLDPSSERRPSMSDVVTELDRTLDK 354
           C     ++RP  +D+  +L++ + K
Sbjct: 288 CWKQEPDKRPVFADISKDLEKMMVK 312

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 21/201 (10%)
Query: 85  IGEGKFGEVYKGLL---QDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           +G G FG V +G+    +  + VAIK        A T+E + E   +  + +  +V L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQ---VSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
            CQ   L  L+ E    G +   L G  +   VS    E  H++S+              
Sbjct: 78  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVA-ELLHQVSMGMKYLEEK------ 129
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEF 253
               VH+D    NVL+     AK++D GL   LG  D    +       + + A E   F
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
           R+FS +SDV+S+GV + E +S
Sbjct: 188 RKFSSRSDVWSYGVTMWEALS 208

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 118
Query: 180 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX 178
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 179 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 127
Query: 180 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX 187
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 188 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 21/228 (9%)
Query: 64  ARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ-- 115
           A  F  +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +   
Sbjct: 3   ADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 62
Query: 116 --EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
             EF++E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E
Sbjct: 63  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEME 118
Query: 174 FKHRLS-------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNF 226
               L+       I                + VH+D    N +V EDF  K+ D G+   
Sbjct: 119 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 178
Query: 227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +  TD      +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 179 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 18/206 (8%)
Query: 80  SDKNLIGEGKFGEVYKG----LLQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRN 131
           SD+ +IG+G FG VY G      Q+ +  AIK           + F+ E   +  + H N
Sbjct: 25  SDR-VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 132 LVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 190
           ++ L+G       L  ++  Y+ +G +   +  P +    K      L +          
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEI-FLAS 248
                 + VH+D    N ++DE F  KVAD GL R+ L R   +    +     + + A 
Sbjct: 144 ------KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS 274
           E  +  RF+ KSDV+SFGV L EL++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 120
Query: 180 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 180
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 23/202 (11%)
Query: 85  IGEGKFGEVYKGLLQDGML---VAIKKRPGAPTQE------FIDEVCFLASIQHRNLVTL 135
           +G G    VY  L +D +L   VAIK     P ++      F  EV   + + H+N+V++
Sbjct: 19  LGGGGMSTVY--LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 136 LGYCQENNLQFLIYEYI--PNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
           +   +E++  +L+ EYI  P  S  I  +GP  V           +I             
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDT---------AINFTNQILDGIKHA 127
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
              R+VH+D K  N+L+D +   K+ D G+   L  T +   ++ V     + + E  + 
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKG 186
Query: 254 RRFSEKSDVYSFGVFLLELVSG 275
               E +D+YS G+ L E++ G
Sbjct: 187 EATDECTDIYSIGIVLYEMLVG 208

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 21/232 (9%)
Query: 60  SIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAP 113
           S   A  +  +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A 
Sbjct: 2   SFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 61
Query: 114 TQ----EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR 169
           +     EF++E   +      ++V LLG   +     +I E +  G +  +L    +  R
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLR 117
Query: 170 QKLEFKHRLS-------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAG 222
            ++E    L+       I                + VH+D    N +V EDF  K+ D G
Sbjct: 118 PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 177
Query: 223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           +   +  TD      +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 178 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 35/206 (16%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           +G+G FG+VYK   ++ G L A   I+ +     +++I E+  LA+  H  +V LLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 141 ENNLQFLIYEYIPNGSVSIHLY----GPSQ-----VSRQKLEFKHRLSIXXXXXXXXXXX 191
            +   +++ E+ P G+V   +     G ++     V RQ LE  + L             
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH------------ 126
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAG-----LRNFLGRTDVAGPSSQVTADEIFL 246
                R++H+D K  NVL+  +   ++AD G     L+    R    G +    A E+ +
Sbjct: 127 ---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG-TPYWMAPEVVM 182
Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLEL 272
              +K+   +  K+D++S G+ L+E+
Sbjct: 183 CETMKD-TPYDYKADIWSLGITLIEM 207

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 126
Query: 180 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 187 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           +G+G FG+VYK   ++ G L A   I+ +     +++I E+  LA+  H  +V LLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 141 ENNLQFLIYEYIPNGSVSIHLY----GPSQ-----VSRQKLEFKHRLSIXXXXXXXXXXX 191
            +   +++ E+ P G+V   +     G ++     V RQ LE  + L             
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH------------ 134
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAG-----LRNFLGRTDVAGPSSQVTADEIFL 246
                R++H+D K  NVL+  +   ++AD G     L+    R    G +    A E+ +
Sbjct: 135 ---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG-TPYWMAPEVVM 190
Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELV 273
              +K+   +  K+D++S G+ L+E+ 
Sbjct: 191 CETMKD-TPYDYKADIWSLGITLIEMA 216

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C  A + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 126
Query: 180 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 186
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 187 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 27/212 (12%)
Query: 83  NLIGEGKFGEVYKGLL--QDG--MLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLV 133
            ++GEG+FG V +G L  +DG  + VA+K            +EF+ E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 134 TLLGYCQENNLQ-----FLIYEYIPNGSVSIHLY------GPSQVSRQKLEFKHRLSIXX 182
            LLG C E + Q      +I  ++  G +  +L       GP  +  Q L  K  + I  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL-LKFMVDIAL 158
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                           +H+D    N ++ +D    VAD GL   +   D           
Sbjct: 159 GMEYLSNR------NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             ++A E    R ++ KSDV++FGV + E+ +
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/288 (21%), Positives = 117/288 (40%), Gaps = 40/288 (13%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           +GEG +G VYK     G +VA+K+        G P+   I E+  L  + H N+V+L+  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA-IREISLLKELHHPNIVSLIDV 87
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
                   L++E++      +     ++   Q  + K  L                  R+
Sbjct: 88  IHSERCLTLVFEFMEKDLKKV--LDENKTGLQDSQIKIYL-----YQLLRGVAHCHQHRI 140
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKEFR 254
           +H+D K  N+L++ D   K+AD GL    G    +     VT    A ++ + S     +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS-----K 195
Query: 255 RFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELV---QNSRDFSNL-------- 303
           ++S   D++S G    E+++G+              +  +    N R++  +        
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 304 --LKILDERLWSTFTNEGMEEFIQLI--VRCLDPSSERRPSMSDVVTE 347
              ++ +++ WS+      +E I L+  + C DP+  +R S  D +  
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN--KRISARDAMNH 301

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/288 (21%), Positives = 117/288 (40%), Gaps = 40/288 (13%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           +GEG +G VYK     G +VA+K+        G P+   I E+  L  + H N+V+L+  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA-IREISLLKELHHPNIVSLIDV 87
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
                   L++E++      +     ++   Q  + K  L                  R+
Sbjct: 88  IHSERCLTLVFEFMEKDLKKV--LDENKTGLQDSQIKIYL-----YQLLRGVAHCHQHRI 140
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVKEFR 254
           +H+D K  N+L++ D   K+AD GL    G    +     VT    A ++ + S     +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS-----K 195
Query: 255 RFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELV---QNSRDFSNL-------- 303
           ++S   D++S G    E+++G+              +  +    N R++  +        
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 304 --LKILDERLWSTFTNEGMEEFIQLI--VRCLDPSSERRPSMSDVVTE 347
              ++ +++ WS+      +E I L+  + C DP+  +R S  D +  
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN--KRISARDAMNH 301

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 110/264 (41%), Gaps = 29/264 (10%)
Query: 28  FCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGE 87
           +  +R R+ SR    G    SV P      ++ + +      E+++++ +       +G+
Sbjct: 6   YVFHRKRNNSRLG-NGVLYASVNPEYFSAADVYVPDEWEVAREKITMSRE-------LGQ 57
Query: 88  GKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFIDEVCFLASIQHRNLVTLLG 137
           G FG VY    KG+++D     VAIK    A +     EF++E   +      ++V LLG
Sbjct: 58  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 117
Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS-------IXXXXXXXXXX 190
              +     +I E +  G +  +L    +  R ++E    L+       I          
Sbjct: 118 VVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 173
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 250
                 + VH+D    N +V EDF  K+ D G+   +  TD      +      +++ E 
Sbjct: 174 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 233
Query: 251 KEFRRFSEKSDVYSFGVFLLELVS 274
            +   F+  SDV+SFGV L E+ +
Sbjct: 234 LKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 85  IGEGKFGEVYKGLL---QDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           +G G FG V +G+    +  + VAIK        A T+E + E   +  + +  +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL------EFKHRLSIXXXXXXXXXXX 191
            CQ   L  L+ E    G +   L G     R+++      E  H++S+           
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEK--- 455
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEV 250
                  VH++    NVL+     AK++D GL   LG  D    +       + + A E 
Sbjct: 456 -----NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510
Query: 251 KEFRRFSEKSDVYSFGVFLLELVS 274
             FR+FS +SDV+S+GV + E +S
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 15/219 (6%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 67
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG--PSQVSRQKLEFKHR 177
           E   +      ++V LLG   +     +I E +  G +  +L    P+  +   L     
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA-PPS 126
Query: 178 LS--IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 235
           LS  I                + VH+D    N +V EDF  K+ D G+   +  TD    
Sbjct: 127 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 186
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 187 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 133
Query: 180 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
                  I                + VH+D    N +V EDF  K+ D G+   +  TD 
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 82/200 (41%), Gaps = 21/200 (10%)
Query: 85  IGEGKFGEVYKG-LLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG+G F +V     +  G  VA+K     +   +  Q+   EV  +  + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
            +     +L+ EY   G V  +L    ++  ++   K R  +                 +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF-------I 134
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
           VH+D K  N+L+D D   K+AD G  N   F  + D    S    A E+F   +      
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD---- 190
Query: 256 FSEKSDVYSFGVFLLELVSG 275
              + DV+S GV L  LVSG
Sbjct: 191 -GPEVDVWSLGVILYTLVSG 209

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 82/200 (41%), Gaps = 21/200 (10%)
Query: 85  IGEGKFGEVYKG-LLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG+G F +V     +  G  VA+K     +   +  Q+   EV  +  + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
            +     +L+ EY   G V  +L    ++  ++   K R  +                 +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF-------I 134
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
           VH+D K  N+L+D D   K+AD G  N   F  + D    S    A E+F   +      
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD---- 190
Query: 256 FSEKSDVYSFGVFLLELVSG 275
              + DV+S GV L  LVSG
Sbjct: 191 -GPEVDVWSLGVILYTLVSG 209

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 15/219 (6%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG--PSQVSRQKLEFKHR 177
           E   +      ++V LLG   +     +I E +  G +  +L    P+  +   L     
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA-PPS 136
Query: 178 LS--IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP 235
           LS  I                + VH+D    N +V EDF  K+ D G+   +  TD    
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           K FSD   IG G FG VY    +++  +VAIKK      +     Q+ I EV FL  ++H
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXX 189
            N +   G     +  +L+ EY   GS S  L    +V ++ L+     ++         
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYC-LGSASDLL----EVHKKPLQEVEIAAVTHGALQGLA 168
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                   ++H+D K  N+L+ E  + K+ D       G   +  P++       ++A E
Sbjct: 169 YLHSH--NMIHRDVKAGNILLSEPGLVKLGD------FGSASIMAPANXFVGTPYWMAPE 220
Query: 250 V---KEFRRFSEKSDVYSFGVFLLELV 273
           V    +  ++  K DV+S G+  +EL 
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELA 247

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 21/207 (10%)
Query: 78  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK---KRPGAPT--QEFIDEVCFLASIQHRN 131
           N+  +  IG+G F +V     +  G  VA+K   K    PT  Q+   EV  +  + H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXX 191
           +V L    +     +L+ EY   G V  +L    ++  ++   K R  +           
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY- 134
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL---GRTDVAGPSSQVTADEIFLAS 248
                 +VH+D K  N+L+D D   K+AD G  N      + D    S    A E+F   
Sbjct: 135 ------IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGK 188
Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSG 275
           +         + DV+S GV L  LVSG
Sbjct: 189 KYD-----GPEVDVWSLGVILYTLVSG 210

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 84/211 (39%), Gaps = 21/211 (9%)
Query: 74  LATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASI 127
           L   N+     IG+G F +V     +  G  VA+K     +   +  Q+   EV  +  +
Sbjct: 4   LHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVL 63
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
            H N+V L    +     +L+ EY   G V  +L     +  ++   K R  +       
Sbjct: 64  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCH 123
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADEI 244
                     +VH+D K  N+L+D D   K+AD G  N   F  + D    S    A E+
Sbjct: 124 QKF-------IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPEL 176
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           F   +         + DV+S GV L  LVSG
Sbjct: 177 FQGKKYD-----GPEVDVWSLGVILYTLVSG 202

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 60
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 116
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 117 LAFCH------------------SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 158
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 61
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLS 117
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 118 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCHSH------------------RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 160
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           K FSD   IG G FG VY    +++  +VAIKK      +     Q+ I EV FL  ++H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXX 189
            N +   G     +  +L+ EY   GS S  L    +V ++ L+     ++         
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYC-LGSASDLL----EVHKKPLQEVEIAAVTHGALQGLA 129
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                   ++H+D K  N+L+ E  + K+ D       G   +  P++       ++A E
Sbjct: 130 YLHSH--NMIHRDVKAGNILLSEPGLVKLGD------FGSASIMAPANXFVGTPYWMAPE 181
Query: 250 V---KEFRRFSEKSDVYSFGVFLLELV 273
           V    +  ++  K DV+S G+  +EL 
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELA 208

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 61
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ----LLQG 117
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 118 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 61
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 117
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 118 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 59
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 115
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 116 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 158 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 60
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 116
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 117 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 158
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 RTYTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 60
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 116
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 117 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 158
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 21/222 (9%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVY----KGLLQDG--MLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY    KG+++D     VAIK    A +     EF++
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E   +      ++V LLG   +     +I E +  G +  +L    +  R ++E    L+
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLA 120
Query: 180 -------IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
                  I                + VH+D    N  V EDF  K+ D G+   +  TD 
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDY 180
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                +      +++ E  +   F+  SDV+SFGV L E+ +
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 61
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 117
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 118 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 59
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 115
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 116 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 158 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 59
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQ----LLQG 115
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 116 LAFCH------------------SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 157
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 158 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 32/216 (14%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-----EVCFLASIQ 128
           + + + +  L+GEG +G V K   +D G +VAIKK   +   + +      E+  L  ++
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXX 188
           H NLV LL  C++    +L++E++ +  +      P+ +  Q ++ K+   I        
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQ-KYLFQIINGIGFCH 141
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---- 244
                    ++H+D K  N+LV +  + K+ D G      RT +A P  +V  DE+    
Sbjct: 142 SH------NIIHRDIKPENILVSQSGVVKLCDFG----FART-LAAP-GEVYDDEVATRW 189
Query: 245 -----FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
                 L  +VK    + +  DV++ G  + E+  G
Sbjct: 190 YRAPELLVGDVK----YGKAVDVWAIGCLVTEMFMG 221

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 61
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 117
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 118 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 61
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 117
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 118 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 59
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 115
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 116 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 158 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 61
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 117
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 118 LAFCHSH------------------RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 159
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 60
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 116
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 117 LAFCH------------------SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 158
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 68
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 124
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 125 FCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 166
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 167 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 61
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 117
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 118 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 YTHEVVTLWYRAPEILLGX-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 82/200 (41%), Gaps = 21/200 (10%)
Query: 85  IGEGKFGEVYKG-LLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG+G F +V     +  G  VA+K     +   +  Q+   EV  +  + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
            +     +L+ EY   G V  +L    ++  ++   K R  +                 +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF-------I 134
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
           VH+D K  N+L+D D   K+AD G  N   F  + D    +    A E+F   +      
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD---- 190
Query: 256 FSEKSDVYSFGVFLLELVSG 275
              + DV+S GV L  LVSG
Sbjct: 191 -GPEVDVWSLGVILYTLVSG 209

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 59
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 115
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 116 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 158 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 82/200 (41%), Gaps = 21/200 (10%)
Query: 85  IGEGKFGEVYKG-LLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG+G F +V     +  G  VA++     +   +  Q+   EV  +  + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
            +     +L+ EY   G V  +L    ++  ++   K R  +                 +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF-------I 134
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
           VH+D K  N+L+D D   K+AD G  N   F  + D    S    A E+F   +      
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD---- 190
Query: 256 FSEKSDVYSFGVFLLELVSG 275
              + DV+S GV L  LVSG
Sbjct: 191 -GPEVDVWSLGVILYTLVSG 209

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 68
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 124
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 125 FCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 166
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 167 YTHEVVTLWYRAPEILLGX-----KYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 63
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 119
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 120 LAFCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 161
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 162 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 65
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 121
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 122 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 163
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 164 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 85  IGEGKFGEV----YKGLLQD-GMLVAIKK-RPGAPTQEFID---EVCFLASIQHRNLVTL 135
           +GEG FG+V    Y     + G  VA+K  +P +      D   E+  L ++ H N+V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 136 LGYCQEN--NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            G C E+  N   LI E++P+GS+  +L      ++ K+  K +L               
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE--IFLASEVK 251
              + VH+D    NVLV+ +   K+ D GL   +  TD    + +   D    + A E  
Sbjct: 145 R--QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
              +F   SDV+SFGV L EL++
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 85  IGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAPTQEFID---EVCFLASIQHRNLVTL 135
           +GEG FG+V            G  VA+K  +P +      D   E+  L ++ H N+V  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 136 LGYCQEN--NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            G C E+  N   LI E++P+GS+  +L      ++ K+  K +L               
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGMDYLGS 132
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE--IFLASEVK 251
              + VH+D    NVLV+ +   K+ D GL   +  TD    + +   D    + A E  
Sbjct: 133 R--QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
              +F   SDV+SFGV L EL++
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLT 212

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 55/229 (24%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASI 127
           + +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKEL 62
Query: 128 QHRNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQK 171
            H N+V LL      N  +L++E+                IP   +  +L+       Q 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQ----LLQG 118
Query: 172 LEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L F H                    RV+H+D K  N+L++ +   K+AD GL    G   
Sbjct: 119 LAFCHSH------------------RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 232 VAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 RTYXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+KK        G P+   I E+  L  + H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNH 62
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 118
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 119 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 160
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 161 YXHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 73  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 123
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 183 HAEPVDVWSCGIVLTAMLAG 202

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 82/200 (41%), Gaps = 21/200 (10%)
Query: 85  IGEGKFGEVYKG-LLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG+G F +V     +  G  VA++     +   +  Q+   EV  +  + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
            +     +L+ EY   G V  +L    ++  ++   K R  +                 +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF-------I 134
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
           VH+D K  N+L+D D   K+AD G  N   F  + D    S    A E+F   +      
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYD---- 190
Query: 256 FSEKSDVYSFGVFLLELVSG 275
              + DV+S GV L  LVSG
Sbjct: 191 -GPEVDVWSLGVILYTLVSG 209

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 119/292 (40%), Gaps = 41/292 (14%)
Query: 85  IGEGKFGEVYKGLLQD-----GMLVAIK--KRPGAPTQE--FIDEVCFLASIQHRNLVTL 135
           +GEG FG+V            G +VA+K  K    P     +  E+  L ++ H +++  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 136 LGYCQEN---NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
            G C++    +LQ L+ EY+P GS+  +L   S    Q L F  ++              
Sbjct: 99  KGCCEDAGAASLQ-LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC--------EGMAY 149
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN--------FLGRTDVAGPSSQVTADEI 244
                 +H+D    NVL+D D + K+ D GL          +  R D   P         
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV-------F 202
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 304
           + A E  +  +F   SDV+SFGV L EL++  ++            + + Q       L 
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDS-SQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 305 KILD--ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 354
           ++L+  ERL     ++   E   L+  C +  +  RP+  +++  L    +K
Sbjct: 262 ELLERGERL--PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 112/281 (39%), Gaps = 28/281 (9%)
Query: 85  IGEGKFGEV----YKGLLQD-GMLVAIKK-RPGAPTQE--FIDEVCFLASIQHRNLVTLL 136
           +G+G FG V    Y  L  + G LVA+K+ +   P Q+  F  E+  L ++    +V   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 137 G--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           G  Y        L+ EY+P+G +   L    Q  R +L+    L                
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLGSR 134
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKEF 253
             R VH+D    N+LV+ +   K+AD GL   L          +     IF  A E    
Sbjct: 135 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 192
Query: 254 RRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLK-----ILD 308
             FS +SDV+SFGV L EL +                + ++   RD   L +        
Sbjct: 193 NIFSRQSDVWSFGVVLYELFT----YCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEG 248
Query: 309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
           +RL +        E  +L+  C  PS + RPS S +  +LD
Sbjct: 249 QRLPAPPACPA--EVHELMKLCWAPSPQDRPSFSALGPQLD 287

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 112/281 (39%), Gaps = 28/281 (9%)
Query: 85  IGEGKFGEV----YKGLLQD-GMLVAIKK-RPGAPTQE--FIDEVCFLASIQHRNLVTLL 136
           +G+G FG V    Y  L  + G LVA+K+ +   P Q+  F  E+  L ++    +V   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 137 G--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           G  Y        L+ EY+P+G +   L    Q  R +L+    L                
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLGSR 130
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKEF 253
             R VH+D    N+LV+ +   K+AD GL   L          +     IF  A E    
Sbjct: 131 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSD 188
Query: 254 RRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLK-----ILD 308
             FS +SDV+SFGV L EL +                + ++   RD   L +        
Sbjct: 189 NIFSRQSDVWSFGVVLYELFT----YCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEG 244
Query: 309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
           +RL +        E  +L+  C  PS + RPS S +  +LD
Sbjct: 245 QRLPAPPACPA--EVHELMKLCWAPSPQDRPSFSALGPQLD 283

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 113/281 (40%), Gaps = 28/281 (9%)
Query: 85  IGEGKFGEV----YKGLLQD-GMLVAIKK-RPGAPTQE--FIDEVCFLASIQHRNLVTLL 136
           +G+G FG V    Y  L  + G LVA+K+ +   P Q+  F  E+  L ++    +V   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 137 G--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           G  Y        L+ EY+P+G +   L    Q  R +L+    L                
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLGSR 133
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKEF 253
             R VH+D    N+LV+ +   K+AD GL   L          +     IF  A E    
Sbjct: 134 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 191
Query: 254 RRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLK-----ILD 308
             FS +SDV+SFGV L EL +                + ++ + RD   L +        
Sbjct: 192 NIFSRQSDVWSFGVVLYELFT----YCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEG 247
Query: 309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
           +RL +        E  +L+  C  PS + RPS S +  +LD
Sbjct: 248 QRLPAPPACPA--EVHELMKLCWAPSPQDRPSFSALGPQLD 286

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 35/225 (15%)
Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFIDEVCFLASIQH----- 129
           +F +  ++G+G FG+V K     D    AIKK           + EV  LAS+ H     
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 130 --------RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 181
                   RN V  +   ++ +  F+  EY  NG++   L     +++Q+ E+  RL   
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL-YDLIHSENLNQQRDEY-WRL--- 121
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT---------DV 232
                           ++H+D K  N+ +DE    K+ D GL   + R+         ++
Sbjct: 122 -FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 233 AGPSSQVTA---DEIFLASEVKEFR-RFSEKSDVYSFGVFLLELV 273
            G S  +T+     +++A+EV +    ++EK D+YS G+   E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 89/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+ K        G P+   I E+  L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTA-IREISLLKELNH 61
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 117
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 118 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 160 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 89/227 (39%), Gaps = 55/227 (24%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           +NF     IGEG +G VYK   +  G +VA+ K        G P+   I E+  L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTA-IREISLLKELNH 60
Query: 130 RNLVTLLGYCQENNLQFLIYEY----------------IPNGSVSIHLYGPSQVSRQKLE 173
            N+V LL      N  +L++E+                IP   +  +L+       Q L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LLQGLA 116
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
           F H                    RV+H+D K  N+L++ +   K+AD GL    G     
Sbjct: 117 FCH------------------SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 234 GPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                VT    A EI L       + +S   D++S G    E+V+ R
Sbjct: 159 YTHEVVTLWYRAPEILLGC-----KYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/319 (20%), Positives = 132/319 (41%), Gaps = 35/319 (10%)
Query: 59  LSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL--QDGMLVAIKKR------- 109
           L I +  + ++E++ +  + F+   ++G+G+FG V +  L  +DG  V +  +       
Sbjct: 5   LGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII 64
Query: 110 PGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN------LQFLIYEYIPNGSVSIHLYG 163
             +  +EF+ E   +    H ++  L+G    +       +  +I  ++ +G +   L  
Sbjct: 65  ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA 124
Query: 164 PSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL 223
            S++         +  +                  +H+D    N ++ ED    VAD GL
Sbjct: 125 -SRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL 183
Query: 224 --RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXX 281
             + + G     G +S++     +LA E      ++  SDV++FGV + E+++  +    
Sbjct: 184 SRKIYSGDYYRQGCASKLPVK--WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241
Query: 282 XXXXXXXXXVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 341
                       ++N+  ++ L  I   RL      E MEE   L+ +C     ++RPS 
Sbjct: 242 G-----------IENAEIYNYL--IGGNRL--KQPPECMEEVYDLMYQCWSADPKQRPSF 286
Query: 342 SDVVTELDRTLDKEMNLTT 360
           + +  EL+  L     L+T
Sbjct: 287 TCLRMELENILGHLSVLST 305

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 14  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 72
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 73  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 130
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 131 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENXYKAQTHGKWPVKWYA 182
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 183 PECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 142 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE 199
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 200 SLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 36/210 (17%)
Query: 85  IGEGKFGEVYKGLLQD-----GMLVAIK--KRPGAPTQE--FIDEVCFLASIQHRNLVTL 135
           +GEG FG+V            G +VA+K  K    P     +  E+  L ++ H +++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 136 LGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
            G C+   E +LQ L+ EY+P GS+  +L   S    Q L F  ++              
Sbjct: 82  KGCCEDQGEKSLQ-LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC--------EGMAY 132
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN--------FLGRTDVAGPSSQVTADEI 244
                 +H++    NVL+D D + K+ D GL          +  R D   P         
Sbjct: 133 LHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-------F 185
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + A E  +  +F   SDV+SFGV L EL++
Sbjct: 186 WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE 202
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 36/210 (17%)
Query: 85  IGEGKFGEVYKGLLQD-----GMLVAIK--KRPGAPTQE--FIDEVCFLASIQHRNLVTL 135
           +GEG FG+V            G +VA+K  K    P     +  E+  L ++ H +++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 136 LGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
            G C+   E +LQ L+ EY+P GS+  +L   S    Q L F  ++              
Sbjct: 82  KGCCEDQGEKSLQ-LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC--------EGMAY 132
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN--------FLGRTDVAGPSSQVTADEI 244
                 +H++    NVL+D D + K+ D GL          +  R D   P         
Sbjct: 133 LHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-------F 185
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + A E  +  +F   SDV+SFGV L EL++
Sbjct: 186 WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE 202
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG  GEV   +    ++ + V I   KR     +    E+C    + H N+V   G+ 
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 112/281 (39%), Gaps = 28/281 (9%)
Query: 85  IGEGKFGEV----YKGLLQD-GMLVAIKK-RPGAPTQE--FIDEVCFLASIQHRNLVTLL 136
           +G+G FG V    Y  L  + G LVA+K+ +   P Q+  F  E+  L ++    +V   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 137 G--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           G  Y        L+ EY+P+G +   L    Q  R +L+    L                
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-ASEVKEF 253
             R VH+D    N+LV+ +   K+AD GL   L          +     IF  A E    
Sbjct: 147 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 254 RRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLK-----ILD 308
             FS +SDV+SFGV L EL +                + ++   RD   L +        
Sbjct: 205 NIFSRQSDVWSFGVVLYELFT----YCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260
Query: 309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
           +RL +        E  +L+  C  PS + RPS S +  +LD
Sbjct: 261 QRLPAPPACPA--EVHELMKLCWAPSPQDRPSFSALGPQLD 299

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 20  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 78
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 79  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 136
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 137 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 188
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 30  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 88
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 89  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 146
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 147 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 198
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 199 PECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 30  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 88
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 89  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 146
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 147 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 198
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 199 PECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 28  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 86
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 87  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 144
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 145 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 196
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 197 PECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 10  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 68
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 69  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 126
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 127 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 178
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 8   LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 66
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 67  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 124
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 125 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 176
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 177 PECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 14  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 72
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 73  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 130
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 131 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 182
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 183 PECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 85/205 (41%), Gaps = 22/205 (10%)
Query: 81  DKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHRNL 132
           DK L G G FG V KG  Q         +  +K     P    E + E   +  + +  +
Sbjct: 374 DKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXXXX 191
           V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+           
Sbjct: 433 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES--- 488
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLASE 249
                  VH+D    NVL+     AK++D GL   L R D     +Q        + A E
Sbjct: 489 -----NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPE 542
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
              + +FS KSDV+SFGV + E  S
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 80/200 (40%), Gaps = 21/200 (10%)
Query: 85  IGEGKFGEVYKG-LLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG+G F +V     +  G  VA+K     +   +  Q+   EV     + H N+V L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
            +     +L+ EY   G V  +L    +   ++   K R  +                 +
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF-------I 134
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRN---FLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
           VH+D K  N+L+D D   K+AD G  N   F  + D    +    A E+F   +      
Sbjct: 135 VHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD---- 190
Query: 256 FSEKSDVYSFGVFLLELVSG 275
              + DV+S GV L  LVSG
Sbjct: 191 -GPEVDVWSLGVILYTLVSG 209

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHR 130
             DK L G G FG V KG  Q         +  +K     P    E + E   +  + + 
Sbjct: 373 LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 431
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIXXXXXXXXX 189
            +V ++G C+  +   L+ E    G ++ +L     V  + + E  H++S+         
Sbjct: 432 YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 489
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--FLA 247
                    VH+D    NVL+     AK++D GL   L R D     +Q        + A
Sbjct: 490 -------NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYA 541
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS 274
            E   + +FS KSDV+SFGV + E  S
Sbjct: 542 PECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 15/202 (7%)
Query: 79  FSDKNLIGEGKFGEVYKGLLQDGM-LVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           F+  + IG+G FGEVYKG+      +VAIK    +      ++   E+  L+      + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
              G   ++   ++I EY+  GS ++ L  P  +    +    R  +             
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGS-ALDLLKPGPLEETYIATILREILKGLDYLHSE---- 135
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
              R +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 136 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQ 190
Query: 254 RRFSEKSDVYSFGVFLLELVSG 275
             +  K+D++S G+  +EL  G
Sbjct: 191 SAYDFKADIWSLGITAIELAKG 212

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 84  LIGEGKFGEVYKG-LLQDGMLVAIK--KRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYC 139
           L+G G +G+VYKG  ++ G L AIK     G   +E   E+  L     HRN+ T  G  
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 140 QENNLQ------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
            + N        +L+ E+   GSV+  L   ++ +  K E+   +               
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTKGNTLKEEWIAYIC----REILRGLSHL 145
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV--- 250
              +V+H+D K  NVL+ E+   K+ D G+   L RT   G  +       ++A EV   
Sbjct: 146 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIAC 203
Query: 251 --KEFRRFSEKSDVYSFGVFLLELVSG 275
                  +  KSD++S G+  +E+  G
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 79/205 (38%), Gaps = 30/205 (14%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           +GEG +GEVYK +       VAIK+        G P    I EV  L  +QHRN++ L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA-IREVSLLKELQHRNIIELKS 100
Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPR 197
               N+   LI+EY  N         P    R    F ++L                  R
Sbjct: 101 VIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL--------INGVNFCHSRR 152
Query: 198 VVHKDFKTANVLV-----DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 252
            +H+D K  N+L+      E  + K+ D GL    G      P  Q T + I L     E
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-----PIRQFTHEIITLWYRPPE 207
Query: 253 F----RRFSEKSDVYSFGVFLLELV 273
                R +S   D++S      E++
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 144 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 201
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 202 SLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + VH+D    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 202
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 71  ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQ 128
           E SL   N     LIG G++G VYKG L D   VA+K    A  Q FI+E  +  +  ++
Sbjct: 7   EPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLME 65
Query: 129 HRNLVTLL----GYCQENNLQF-LIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIX 181
           H N+   +        +  +++ L+ EY PNGS+   + L+    VS  +L       + 
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGL- 124
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
                         P + H+D  + NVLV  D    ++D GL   L    +  P  +  A
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 242 --DEI----FLASEV-------KEFRRFSEKSDVYSFGVFLLEL 272
              E+    ++A EV       ++     ++ D+Y+ G+   E+
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 22/214 (10%)
Query: 75  ATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKK-----RPGAPTQEFIDEVCFLASIQ 128
           ++  F     +G G +  VYKGL +  G+ VA+K+       G P+   I E+  +  ++
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA-IREISLMKELK 61
Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIXXXXXXX 187
           H N+V L       N   L++E++ N    +  Y  S+ V       +  L         
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDN---DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-----AD 242
                    +++H+D K  N+L+++    K+ D GL    G   V   SS+V      A 
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVVTLWYRAP 177
Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           ++ + S     R +S   D++S G  L E+++G+
Sbjct: 178 DVLMGS-----RTYSTSIDIWSCGCILAEMITGK 206

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 85  IGEGKFGEVYKGLL----QDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           IGEG FG   K +L    +DG    IK     +      +E   EV  LA+++H N+V  
Sbjct: 32  IGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-LEFKHRLSIXXXXXXXXXXXXXX 194
               +EN   +++ +Y   G +        +++ QK + F+    +              
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLF------KRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
             +++H+D K+ N+ + +D   ++ D G+   L  T     +        +L+ E+ E +
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIGTPYYLSPEICENK 200
Query: 255 RFSEKSDVYSFGVFLLELVSGREA 278
            ++ KSD+++ G  L EL + + A
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHA 224

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 35/225 (15%)
Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFIDEVCFLASIQH----- 129
           +F +  ++G+G FG+V K     D    AIKK           + EV  LAS+ H     
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 130 --------RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 181
                   RN V  +   ++ +  F+  EY  N ++   L     +++Q+ E+  RL   
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTL-YDLIHSENLNQQRDEY-WRL--- 121
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT---------DV 232
                           ++H+D K  N+ +DE    K+ D GL   + R+         ++
Sbjct: 122 -FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 233 AGPSSQVTA---DEIFLASEVKEFR-RFSEKSDVYSFGVFLLELV 273
            G S  +T+     +++A+EV +    ++EK D+YS G+   E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 36/214 (16%)
Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 132
           K ++    IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 133 VTLLGYCQENNLQFLIYEYIPNGS----VSIHLYGPSQVSR------QKLEFKHRLSIXX 182
           V  L      +  +++ EY+  GS    V+       Q++       Q LEF H      
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH------ 133
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTA 241
                         +V+H+D K+ N+L+  D   K+ D G   F  + T      S++  
Sbjct: 134 ------------SNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSEMVG 178
Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
              ++A EV   + +  K D++S G+  +E++ G
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 73  SLAT------KNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------RPGAPTQEFID 119
           SLAT      ++F   NL+G+G F  VY+   +  G+ VAIK             Q   +
Sbjct: 1   SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHR 177
           EV     ++H +++ L  Y +++N  +L+ E   NG ++ +L    +     +   F H+
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 178 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
           +                   ++H+D   +N+L+  +   K+AD GL      T +  P  
Sbjct: 121 IITGMLYLHSHG--------ILHRDLTLSNLLLTRNMNIKIADFGL-----ATQLKMPHE 167
Query: 238 Q---VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           +   +     +++ E+        +SDV+S G     L+ GR
Sbjct: 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + VH++    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 146 YLNAK--KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 203
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 204 SLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 125
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 185 HAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 85  IGEGKFGEVYKGL---LQDGMLVAI--KKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +GEG +GEV   +    ++ + V I   KR     +    E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 140 QENNLQFLIYEYIPNGSVSIHL---YGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
           +E N+Q+L  EY   G +   +    G  +   Q+  F H+L                  
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHGIG------- 124
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF 256
            + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ + R F
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 257 -SEKSDVYSFGVFLLELVSG 275
            +E  DV+S G+ L  +++G
Sbjct: 184 HAEPVDVWSCGIVLTAMLAG 203

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/205 (21%), Positives = 81/205 (39%), Gaps = 17/205 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + VH++    N +V  DF  K+ D G+   +  TD      +      ++A E
Sbjct: 145 YLNAK--KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 202
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
              G   ++   ++I EY+  GS ++ L  P  +   ++    R  +             
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSE---- 123
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
              + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 124 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQ 178
Query: 254 RRFSEKSDVYSFGVFLLELVSG 275
             +  K+D++S G+  +EL  G
Sbjct: 179 SAYDSKADIWSLGITAIELARG 200

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 38/234 (16%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 119
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 120 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQV 167
           E+  ++ + QH N+V LLG C       +I EY   G +   L           Y PS  
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHN 158
Query: 168 SRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL---- 223
             ++L  +  L                    +H+D    NVL+    +AK+ D GL    
Sbjct: 159 PEEQLSSRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDI 216
Query: 224 ---RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
               N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 217 MNDSNYIVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 263

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
              G   ++   ++I EY+  GS ++ L  P  +   ++    R  +             
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSE---- 123
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
              + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 124 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 178
Query: 254 RRFSEKSDVYSFGVFLLELVSG 275
             +  K+D++S G+  +EL  G
Sbjct: 179 SAYDSKADIWSLGITAIELARG 200

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
              G   ++   ++I EY+  GS ++ L  P  +   ++    R  +             
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSE---- 138
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
              + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQ 193
Query: 254 RRFSEKSDVYSFGVFLLELVSG 275
             +  K+D++S G+  +EL  G
Sbjct: 194 SAYDSKADIWSLGITAIELARG 215

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 120/295 (40%), Gaps = 47/295 (15%)
Query: 85  IGEGKFGEVYKGLLQD-----GMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V            G +VA+K  + G   Q    +  E+  L ++ H ++V  
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 136 LGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
            G C+   E ++Q L+ EY+P GS+  +L        Q L F  ++              
Sbjct: 77  KGCCEDQGEKSVQ-LVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQIC--------EGMAY 127
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN--------FLGRTDVAGPSSQVTADEI 244
                 +H+     NVL+D D + K+ D GL          +  R D   P         
Sbjct: 128 LHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-------F 180
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 304
           + A E  +  +F   SDV+SFGV L EL++  ++             EL+ +++    +L
Sbjct: 181 WYAPECLKECKFYYASDVWSFGVTLYELLTYCDS----NQSPHTKFTELIGHTQGQMTVL 236
Query: 305 KILD-----ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 354
           ++ +     ERL     +    E   L+  C +  +  RP+  ++V  L    +K
Sbjct: 237 RLTELLERGERL--PRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEK 289

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXX 193
              G   ++   ++I EY+  GS ++ L  P  +   ++    R  +             
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILREILKGLDYLHSE---- 143
Query: 194 XXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
              + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A EV + 
Sbjct: 144 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 198
Query: 254 RRFSEKSDVYSFGVFLLELVSG 275
             +  K+D++S G+  +EL  G
Sbjct: 199 SAYDSKADIWSLGITAIELARG 220

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 120/295 (40%), Gaps = 47/295 (15%)
Query: 85  IGEGKFGEVYKGLLQD-----GMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V            G +VA+K  + G   Q    +  E+  L ++ H ++V  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 136 LGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXX 192
            G C+   E ++Q L+ EY+P GS+  +L        Q L F  ++              
Sbjct: 76  KGCCEDQGEKSVQ-LVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQIC--------EGMAY 126
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN--------FLGRTDVAGPSSQVTADEI 244
                 +H+     NVL+D D + K+ D GL          +  R D   P         
Sbjct: 127 LHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-------F 179
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLL 304
           + A E  +  +F   SDV+SFGV L EL++  ++             EL+ +++    +L
Sbjct: 180 WYAPECLKECKFYYASDVWSFGVTLYELLTYCDS----NQSPHTKFTELIGHTQGQMTVL 235
Query: 305 KILD-----ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 354
           ++ +     ERL     +    E   L+  C +  +  RP+  ++V  L    +K
Sbjct: 236 RLTELLERGERL--PRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEK 288

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 36/214 (16%)
Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 132
           K ++    IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 133 VTLLGYCQENNLQFLIYEYIPNGS----VSIHLYGPSQVSR------QKLEFKHRLSIXX 182
           V  L      +  +++ EY+  GS    V+       Q++       Q LEF H      
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH------ 133
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTA 241
                         +V+H+D K+ N+L+  D   K+ D G   F  + T      S +  
Sbjct: 134 ------------SNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSXMVG 178
Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
              ++A EV   + +  K D++S G+  +E++ G
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 36/214 (16%)
Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 132
           K ++    IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 133 VTLLGYCQENNLQFLIYEYIPNGS----VSIHLYGPSQVSR------QKLEFKHRLSIXX 182
           V  L      +  +++ EY+  GS    V+       Q++       Q LEF H      
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH------ 134
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTA 241
                         +V+H+D K+ N+L+  D   K+ D G   F  + T      S +  
Sbjct: 135 ------------SNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSXMVG 179
Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
              ++A EV   + +  K D++S G+  +E++ G
Sbjct: 180 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 36/214 (16%)
Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 132
           K ++    IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 133 VTLLGYCQENNLQFLIYEYIPNGS----VSIHLYGPSQVSR------QKLEFKHRLSIXX 182
           V  L      +  +++ EY+  GS    V+       Q++       Q LEF H      
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH------ 133
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTA 241
                         +V+H+D K+ N+L+  D   K+ D G   F  + T      S +  
Sbjct: 134 ------------SNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVG 178
Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
              ++A EV   + +  K D++S G+  +E++ G
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 49/223 (21%)
Query: 76  TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID--------EVCFLAS 126
            K +   + +GEG+F  VYK   ++   +VAIKK       E  D        E+  L  
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 127 IQHRNLVTLL-GYCQENNLQFLIYEY--------IPNGSVSI---HLYGPSQVSRQKLEF 174
           + H N++ LL  +  ++N+  L++++        I + S+ +   H+     ++ Q LE+
Sbjct: 69  LSHPNIIGLLDAFGHKSNIS-LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 175 KHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 234
            H+  I                  +H+D K  N+L+DE+ + K+AD GL    G  + A 
Sbjct: 128 LHQHWI------------------LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169
Query: 235 PSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELV 273
               VT    A E+   +     R +    D+++ G  L EL+
Sbjct: 170 XHQVVTRWYRAPELLFGA-----RMYGVGVDMWAVGCILAELL 207

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 112/289 (38%), Gaps = 37/289 (12%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASIQHR-NLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 134 TLLGYC-QENNLQFLIYEYIPNGSVSIHL---------YGPSQVSRQKLEFKHRLSIXXX 183
            LLG C +      +I E+   G++S +L         Y P  + +  L  +H +     
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        + +H+D    N+L+ E  + K+ D GL   + +              
Sbjct: 157 VAKGMEFLASR--KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            ++A E    R ++ +SDV+SFGV L E+ S                   V+   +F   
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCRR 263
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 264 LKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 79  FSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRNLV 133
           F+    IG+G FGEV+KG+  +   +VAIK    +      ++   E+  L+      + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 134 TLLGYCQENNLQFLIYEYIPNGS-VSIHLYGPS---QVSRQKLEFKHRLSIXXXXXXXXX 189
              G   + +  ++I EY+  GS + +   GP    Q++    E    L           
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE----- 139
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + +H+D K ANVL+ E    K+AD G+   L  TD     +       ++A E
Sbjct: 140 -------KKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPE 190
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSG 275
           V +   +  K+D++S G+  +EL  G
Sbjct: 191 VIQQSAYDSKADIWSLGITAIELAKG 216

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/205 (21%), Positives = 80/205 (39%), Gaps = 17/205 (8%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ----------EFIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G  +D +    + R    T           EF++E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEFKHRLSIXXXXXXXXX 189
           LLG   +     ++ E + +G +  +L        +   R     +  + +         
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 190 XXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                  + VH+D    N +V  DF  K+ D G+   +  T       +      ++A E
Sbjct: 145 YLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPE 202
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS 274
             +   F+  SD++SFGV L E+ S
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 51/297 (17%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 134 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 182
            LLG C +      +I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 190
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGP 235
                         + +H+D    N+L+ E  + K+ D GL        +++ + D   P
Sbjct: 191 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 295
              +  + IF        R ++ +SDV+SFGV L E+ S                   V+
Sbjct: 251 LKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVK 292
Query: 296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
              +F   LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 293 IDEEFCRRLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 17/174 (9%)
Query: 109 RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ--FLIYEYIPNGSV-SIHLYGPS 165
           +P  P ++   E+  L  + H N+V L+    + N    ++++E +  G V  +    P 
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPL 134
Query: 166 QVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRN 225
              + +  F+  +                  +++H+D K +N+LV ED   K+AD G+ N
Sbjct: 135 SEDQARFYFQDLIK---------GIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 226 FLGRTDVAGPSSQVTADEIFLASE-VKEFRR-FSEKS-DVYSFGVFLLELVSGR 276
               +D     S       F+A E + E R+ FS K+ DV++ GV L   V G+
Sbjct: 186 EFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 25/203 (12%)
Query: 85  IGEGKFGEVYKGLLQDGMLVA------IKKRPGAPTQE---FIDEVCFLASIQHRNLVTL 135
           +G G +GEV   L +D +  A      IKK     T      +DEV  L  + H N++ L
Sbjct: 12  LGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
             + ++    +L+ E    G +   +     + RQK  F    +                
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEI-----ILRQK--FSEVDAAVIMKQVLSGTTYLHK 122
Query: 196 PRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 252
             +VH+D K  N+L++    D + K+ D GL       +V G   +      ++A EV  
Sbjct: 123 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYYIAPEVLR 179
Query: 253 FRRFSEKSDVYSFGVFLLELVSG 275
            +++ EK DV+S GV L  L+ G
Sbjct: 180 -KKYDEKCDVWSCGVILYILLCG 201

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 51/297 (17%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 134 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 182
            LLG C +      +I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 144
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGP 235
                         + +H+D    N+L+ E  + K+ D GL        +++ + D   P
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 295
              +  + IF        R ++ +SDV+SFGV L E+ S                   V+
Sbjct: 205 LKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVK 246
Query: 296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
              +F   LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 300

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 51/297 (17%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 134 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 182
            LLG C +      +I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 144
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGP 235
                         + +H+D    N+L+ E  + K+ D GL        +++ + D   P
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 295
              +  + IF        R ++ +SDV+SFGV L E+ S                   V+
Sbjct: 205 LKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVK 246
Query: 296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
              +F   LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 300

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 25/203 (12%)
Query: 85  IGEGKFGEVYKGLLQDGMLVA------IKKRPGAPTQE---FIDEVCFLASIQHRNLVTL 135
           +G G +GEV   L +D +  A      IKK     T      +DEV  L  + H N++ L
Sbjct: 29  LGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
             + ++    +L+ E    G +   +     + RQK  F    +                
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEI-----ILRQK--FSEVDAAVIMKQVLSGTTYLHK 139
Query: 196 PRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 252
             +VH+D K  N+L++    D + K+ D GL       +V G   +      ++A EV  
Sbjct: 140 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYYIAPEVLR 196
Query: 253 FRRFSEKSDVYSFGVFLLELVSG 275
            +++ EK DV+S GV L  L+ G
Sbjct: 197 -KKYDEKCDVWSCGVILYILLCG 218

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 51/297 (17%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 134 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 182
            LLG C +      +I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 153
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGP 235
                         + +H+D    N+L+ E  + K+ D GL        +++ + D   P
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 295
              +  + IF        R ++ +SDV+SFGV L E+ S                   V+
Sbjct: 214 LKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVK 255
Query: 296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
              +F   LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/302 (20%), Positives = 111/302 (36%), Gaps = 50/302 (16%)
Query: 85  IGEGKFGEVYK----GLLQD--GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    GL++    M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIXX 182
            LLG C       +I EY   G +   L             P+ +   +L       +  
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGP 235
                           +H+D    N+L+    I K+ D GL        N++ + +   P
Sbjct: 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 295
              +  + IF          ++ +SDV+S+G+FL EL S   +                 
Sbjct: 211 VKWMAPESIFNCV-------YTFESDVWSYGIFLWELFSLGSSPYPGMPVD--------- 254
Query: 296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 355
                S   K++ E            E   ++  C D    +RP+   +V  +++ + + 
Sbjct: 255 -----SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
Query: 356 MN 357
            N
Sbjct: 310 TN 311

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/302 (20%), Positives = 111/302 (36%), Gaps = 50/302 (16%)
Query: 85  IGEGKFGEVYK----GLLQD--GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    GL++    M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIXX 182
            LLG C       +I EY   G +   L             P+ +   +L       +  
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGP 235
                           +H+D    N+L+    I K+ D GL        N++ + +   P
Sbjct: 167 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 226
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 295
              +  + IF          ++ +SDV+S+G+FL EL S   +                 
Sbjct: 227 VKWMAPESIFNCV-------YTFESDVWSYGIFLWELFSLGSSPYPGMPVD--------- 270
Query: 296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 355
                S   K++ E            E   ++  C D    +RP+   +V  +++ + + 
Sbjct: 271 -----SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 325
Query: 356 MN 357
            N
Sbjct: 326 TN 327

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/302 (20%), Positives = 111/302 (36%), Gaps = 50/302 (16%)
Query: 85  IGEGKFGEVYK----GLLQD--GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    GL++    M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIXX 182
            LLG C       +I EY   G +   L             P+ +   +L       +  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGP 235
                           +H+D    N+L+    I K+ D GL        N++ + +   P
Sbjct: 174 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 233
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 295
              +  + IF          ++ +SDV+S+G+FL EL S   +                 
Sbjct: 234 VKWMAPESIFNCV-------YTFESDVWSYGIFLWELFSLGSSPYPGMPVD--------- 277
Query: 296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 355
                S   K++ E            E   ++  C D    +RP+   +V  +++ + + 
Sbjct: 278 -----SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 332
Query: 356 MN 357
            N
Sbjct: 333 TN 334

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/302 (20%), Positives = 111/302 (36%), Gaps = 50/302 (16%)
Query: 85  IGEGKFGEVYK----GLLQD--GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    GL++    M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIXX 182
            LLG C       +I EY   G +   L             P+ +   +L       +  
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGP 235
                           +H+D    N+L+    I K+ D GL        N++ + +   P
Sbjct: 169 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 228
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 295
              +  + IF          ++ +SDV+S+G+FL EL S   +                 
Sbjct: 229 VKWMAPESIFNCV-------YTFESDVWSYGIFLWELFSLGSSPYPGMPVD--------- 272
Query: 296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 355
                S   K++ E            E   ++  C D    +RP+   +V  +++ + + 
Sbjct: 273 -----SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 327
Query: 356 MN 357
            N
Sbjct: 328 TN 329

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/302 (20%), Positives = 111/302 (36%), Gaps = 50/302 (16%)
Query: 85  IGEGKFGEVYK----GLLQD--GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    GL++    M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHRLSIXX 182
            LLG C       +I EY   G +   L             P+ +   +L       +  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRTDVAGP 235
                           +H+D    N+L+    I K+ D GL        N++ + +   P
Sbjct: 174 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLP 233
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQ 295
              +  + IF          ++ +SDV+S+G+FL EL S   +                 
Sbjct: 234 VKWMAPESIFNCV-------YTFESDVWSYGIFLWELFSLGSSPYPGMPVD--------- 277
Query: 296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 355
                S   K++ E            E   ++  C D    +RP+   +V  +++ + + 
Sbjct: 278 -----SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 332
Query: 356 MN 357
            N
Sbjct: 333 TN 334

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 82/202 (40%), Gaps = 26/202 (12%)
Query: 85  IGEGKFGEVYKGLLQDG-MLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTLL 136
           +G+GKFG VY    +    +VA+K       ++ G   Q    E+   A + H N++ L 
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQ-LRREIEIQAHLHHPNILRLY 89
Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
            Y  +    +LI EY P G     LY   Q S     F  + +                 
Sbjct: 90  NYFYDRRRIYLILEYAPRGE----LYKELQKS---CTFDEQRTATIMEELADALMYCHGK 142
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS---SQVTADEIFLASEVKEF 253
           +V+H+D K  N+L+      K+AD G         V  PS     +     +L  E+ E 
Sbjct: 143 KVIHRDIKPENLLLGLKGELKIADFGW-------SVHAPSLRRKTMCGTLDYLPPEMIEG 195
Query: 254 RRFSEKSDVYSFGVFLLELVSG 275
           R  +EK D++  GV   EL+ G
Sbjct: 196 RMHNEKVDLWCIGVLCYELLVG 217

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 32/228 (14%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 119
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 31  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 90
Query: 120 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-----LE 173
           E+  ++ + QH N+V LLG C       +I EY   G +   L   ++    K     LE
Sbjct: 91  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLE 150
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNF 226
            +  L                    +H+D    NVL+    +AK+ D GL        N+
Sbjct: 151 LRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 208
Query: 227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 209 IVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 249

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 36/214 (16%)
Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKR--PGAPTQEFI-DEVCFLASIQHRNL 132
           K ++    IG+G  G VY  + +  G  VAI++      P +E I +E+  +   ++ N+
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 133 VTLLGYCQENNLQFLIYEYIPNGS----VSIHLYGPSQVSR------QKLEFKHRLSIXX 182
           V  L      +  +++ EY+  GS    V+       Q++       Q LEF H      
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH------ 134
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVTA 241
                         +V+H++ K+ N+L+  D   K+ D G   F  + T      S +  
Sbjct: 135 ------------SNQVIHRNIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVG 179
Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
              ++A EV   + +  K D++S G+  +E++ G
Sbjct: 180 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 32/228 (14%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 119
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 120 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-----LE 173
           E+  ++ + QH N+V LLG C       +I EY   G +   L   ++    K     LE
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLE 158
Query: 174 FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNF 226
            +  L                    +H+D    NVL+    +AK+ D GL        N+
Sbjct: 159 LRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 216
Query: 227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           + + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 217 IVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 257

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 116/290 (40%), Gaps = 37/290 (12%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 134 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 182
            LLG C +      +I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 144
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                         + +H+D    N+L+ E  + K+ D GL   + +             
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN 302
             ++A E    R ++ +SDV+SFGV L E+ S                   V+   +F  
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCR 253
Query: 303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
            LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 254 RLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 300

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 116/290 (40%), Gaps = 37/290 (12%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 134 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 182
            LLG C +      +I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 144
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                         + +H+D    N+L+ E  + K+ D GL   + +             
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN 302
             ++A E    R ++ +SDV+SFGV L E+ S                   V+   +F  
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCR 253
Query: 303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
            LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 254 RLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 300

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
           + H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 91  LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 148
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 149 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 206
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 207 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 116/290 (40%), Gaps = 37/290 (12%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 134 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 182
            LLG C +      +I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 153
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                         + +H+D    N+L+ E  + K+ D GL   + +             
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN 302
             ++A E    R ++ +SDV+SFGV L E+ S                   V+   +F  
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCR 262
Query: 303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
            LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 263 RLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 74/152 (48%), Gaps = 13/152 (8%)
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVT--ADEIFLASEVKE-FR 254
           +H+D K  N+L+ ED   ++AD G+  FL    D+     + T      ++A EV E  R
Sbjct: 138 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR 197
Query: 255 RFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL-LKILDERLWS 313
            +  K+D++SFG+  +EL +G  A            +  +QN  D  +L   + D+ +  
Sbjct: 198 GYDFKADIWSFGITAIELATG--AAPYHKYPPMKVLMLTLQN--DPPSLETGVQDKEMLK 253
Query: 314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
            +     + F ++I  CL    E+RP+ ++++
Sbjct: 254 KYG----KSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 68/298 (22%), Positives = 115/298 (38%), Gaps = 53/298 (17%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 134 TLLGYC-QENNLQFLIYEYIPNGSVSIHLY-----------GPSQVSRQKLEFKHRLSIX 181
            LLG C +      +I E+   G++S +L             P  + +  L  +H +   
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAG 234
                          + +H+D    N+L+ E  + K+ D GL        +++ + D   
Sbjct: 157 FQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 214
Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELV 294
           P   +  + IF        R ++ +SDV+SFGV L E+ S                   V
Sbjct: 215 PLKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGV 256
Query: 295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           +   +F   LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 257 KIDEEFCRRLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 311

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/204 (20%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 73  SLATKNFSDKNLIGEGKFGEVYK-GLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN 131
           +L T +F   +LI     G  Y   +L+  ++V +K+      +   DE   L+ + H  
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-----VEHTNDERLMLSIVTHPF 67
Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXX 191
           ++ + G  Q+    F+I +YI  G +   L       R+   F + ++            
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLL-------RKSQRFPNPVAKFYAAEVCLALE 120
Query: 192 XXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 251
                 ++++D K  N+L+D++   K+ D G   +     V   +  +     ++A EV 
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDYIAPEVV 175
Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
             + +++  D +SFG+ + E+++G
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAG 199

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 98/232 (42%), Gaps = 41/232 (17%)
Query: 77  KNFSDKNLIGEGKFGEVYK----GLLQDG--MLVAIK----KRPGAPTQEFIDEVCFLAS 126
           +N     ++G G FG+V      G+ + G  + VA+K    K   +  +  + E+  +  
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 127 I-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL------YGPSQV---SRQKLEFKH 176
           +  H N+V LLG C  +   +LI+EY   G +  +L      +   ++   ++++LE + 
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 177 RLSIXX-------XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL------ 223
            L++                         VH+D    NVLV    + K+ D GL      
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 224 -RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
             N++ R +   P   +  + +F          ++ KSDV+S+G+ L E+ S
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGI-------YTIKSDVWSYGILLWEIFS 269

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 74/152 (48%), Gaps = 13/152 (8%)
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGR-TDVAGPSSQVT--ADEIFLASEVKE-FR 254
           +H+D K  N+L+ ED   ++AD G+  FL    D+     + T      ++A EV E  R
Sbjct: 143 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR 202
Query: 255 RFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL-LKILDERLWS 313
            +  K+D++SFG+  +EL +G  A            +  +QN  D  +L   + D+ +  
Sbjct: 203 GYDFKADIWSFGITAIELATG--AAPYHKYPPMKVLMLTLQN--DPPSLETGVQDKEMLK 258
Query: 314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
            +     + F ++I  CL    E+RP+ ++++
Sbjct: 259 KYG----KSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/216 (21%), Positives = 88/216 (40%), Gaps = 21/216 (9%)
Query: 71  ELSLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPTQEFIDEVCFLA---- 125
           ++ L  ++F    ++G+G FG+V+     +     AIK           D  C +     
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 126 ---SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 182
              + +H  L  +    Q     F + EY+  G +  H+    +    +  F     I  
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 131
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVAGPSSQVT 240
                          +V++D K  N+L+D+D   K+AD G+   N LG       +++  
Sbjct: 132 LQFLHSKG-------IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----DAKTNEFC 180
Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               ++A E+   ++++   D +SFGV L E++ G+
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 40/288 (13%)
Query: 78  NFSDKNLIGEGKFGEVYKGLLQDGMLVA----IKKRPGAPTQEFIDEVCFLASIQHRNLV 133
           NF  K  + E   GE++KG  Q   +V     ++      +++F +E   L    H N++
Sbjct: 13  NFLTK--LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 134 TLLGYCQENNLQF--LIYEYIPNGSVSIHLY-GPSQVSRQKLEFKHRLSIXXXXXXXXXX 190
            +LG CQ        LI  ++P GS+   L+ G + V  Q    K  L +          
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM----ARGMAF 126
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-NFLGRTDVAGPSSQVTADEIFLASE 249
                P +      + +V++DED  A+++ A ++ +F     +  P+    A E      
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPA--WVAPEALQKKP 184
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL---LKI 306
               RR    +D++SF V L ELV+ RE                     D SN+   +K+
Sbjct: 185 EDTNRR---SADMWSFAVLLWELVT-REVPFA-----------------DLSNMEIGMKV 223
Query: 307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 354
             E L  T          +L+  C++    +RP    +V  L++  DK
Sbjct: 224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 117/294 (39%), Gaps = 45/294 (15%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 134 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQVSRQKLEFKHRLS----IXX 182
            LLG C +      +I E+   G++S +L      + P +V+ + L +K  L+    I  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL-YKDFLTLEHLICY 153
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                         + +H+D    N+L+ E  + K+ D G    L R     P      D
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG----LARDIYKDPDXVRKGD 209
Query: 243 E----IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSR 298
                 ++A E    R ++ +SDV+SFGV L E+ S                   V+   
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDE 258
Query: 299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           +F   LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 259 EFCRRLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 88  GKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQHRNLVTLLGYCQE-NNL 144
           G+FG V+K  L +   VA+K  P    Q +  E  +     ++H NL+  +   +  +NL
Sbjct: 26  GRFGCVWKAQLMND-FVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNL 84
Query: 145 Q---FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS---IXXXXXXXXXXXXXXXPRV 198
           +   +LI  +   GS++ +L G      +       +S                   P +
Sbjct: 85  EVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSI 144
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE----FR 254
            H+DFK+ NVL+  D  A +AD GL          G +        ++A EV E    F+
Sbjct: 145 AHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQ 204
Query: 255 RFS-EKSDVYSFGVFLLELVS 274
           R +  + D+Y+ G+ L ELVS
Sbjct: 205 RDAFLRIDMYAMGLVLWELVS 225

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
           + H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 105 LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 162
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 163 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 220
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 221 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/239 (23%), Positives = 93/239 (38%), Gaps = 41/239 (17%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 119
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 24  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 83
Query: 120 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSV-------SIHLYGPSQVSRQK 171
           E+  ++ + QH N+V LLG C       +I EY   G +       +  + GPS    Q 
Sbjct: 84  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQD 143
Query: 172 LE---------FKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAG 222
            E          + R  +                  +H+D    NVL+    +AK+ D G
Sbjct: 144 PEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 203
Query: 223 L-------RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           L        N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 204 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 255

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLL-----G 137
           IG+G++GEV+ G  + G  VA+K         +  E     ++  +H N++  +     G
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKG 103
Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPR 197
                 L +LI +Y  NGS+  +L   +  ++  L+  +                   P 
Sbjct: 104 TGSWTQL-YLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA 162
Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLR-NFLGRTD-VAGPSSQVTADEIFLASEV----- 250
           + H+D K+ N+LV ++    +AD GL   F+  T+ V  P +     + ++  EV     
Sbjct: 163 IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL 222
Query: 251 --KEFRRFSEKSDVYSFGVFLLELV 273
               F+ +   +D+YSFG+ L E+ 
Sbjct: 223 NRNHFQSYI-MADMYSFGLILWEVA 246

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 148
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 149 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCA 206
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 207 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 83/204 (40%), Gaps = 29/204 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IGEG +G VYK     G   A+KK        G P+   I E+  L  ++H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IREISILKELKHSNIVKLYDV 68
Query: 139 CQENNLQFLIYEYIPNGS---VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
                   L++E++       + +   G   V+ +    +    I               
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--------- 119
Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-- 253
            RV+H+D K  N+L++ +   K+AD GL    G      P  + T + + L     +   
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGI-----PVRKYTHEVVTLWYRAPDVLM 173
Query: 254 --RRFSEKSDVYSFGVFLLELVSG 275
             +++S   D++S G    E+V+G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 111/290 (38%), Gaps = 38/290 (13%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 134 TLLGYC-QENNLQFLIYEYIPNGSVSIHLYG----------PSQVSRQKLEFKHRLSIXX 182
            LLG C +      +I E+   G++S +L            P  + +  L  +H +    
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD 242
                         + +H+D    N+L+ E  + K+ D GL   + +             
Sbjct: 156 QVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSN 302
             ++A E    R ++ +SDV+SFGV L E+ S                   V+   +F  
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCR 262
Query: 303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
            LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 263 RLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 90/230 (39%), Gaps = 32/230 (13%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 119
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 120 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF---- 174
           E+  ++ + QH N+V LLG C       +I EY   G +   L   S+V      F    
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 175 ---KHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------R 224
                R  +                  +H+D    NVL+    +AK+ D GL        
Sbjct: 159 STLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 261

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 83/204 (40%), Gaps = 29/204 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IGEG +G VYK     G   A+KK        G P+   I E+  L  ++H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IREISILKELKHSNIVKLYDV 68
Query: 139 CQENNLQFLIYEYIPNGS---VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
                   L++E++       + +   G   V+ +    +    I               
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--------- 119
Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-- 253
            RV+H+D K  N+L++ +   K+AD GL    G      P  + T + + L     +   
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGI-----PVRKYTHEVVTLWYRAPDVLM 173
Query: 254 --RRFSEKSDVYSFGVFLLELVSG 275
             +++S   D++S G    E+V+G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 47  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 106
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 107 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 164
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 165 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 222
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 223 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 90/230 (39%), Gaps = 32/230 (13%)
Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGML-VAIKK-RPGAPTQE---FID 119
           E+      N      +G G FG+V +        +D +L VA+K  +  A   E    + 
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 120 EVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF---- 174
           E+  ++ + QH N+V LLG C       +I EY   G +   L   S+V      F    
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 175 ---KHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-------R 224
                R  +                  +H+D    NVL+    +AK+ D GL        
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           N++ + +   P   +  + IF          ++ +SDV+S+G+ L E+ S
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFS 261

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 148
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 149 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 206
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 207 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 25/218 (11%)
Query: 71  ELSLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPTQEFIDEVCFLA---- 125
           ++ L  ++F    ++G+G FG+V+     +     AIK           D  C +     
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 126 ---SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 182
              + +H  L  +    Q     F + EY+  G +  H+    +    +  F     I  
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG 130
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL--RNFLG--RTDVAGPSSQ 238
                          +V++D K  N+L+D+D   K+AD G+   N LG  +T+    +  
Sbjct: 131 LQFLHSKG-------IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPD 183
Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             A EI L       ++++   D +SFGV L E++ G+
Sbjct: 184 YIAPEILLG------QKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 83/204 (40%), Gaps = 29/204 (14%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IGEG +G VYK     G   A+KK        G P+   I E+  L  ++H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IREISILKELKHSNIVKLYDV 68
Query: 139 CQENNLQFLIYEYIPNGS---VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
                   L++E++       + +   G   V+ +    +    I               
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--------- 119
Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----ADEIFLASEVK 251
            RV+H+D K  N+L++ +   K+AD GL    G          VT    A ++ + S   
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS--- 175
Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
             +++S   D++S G    E+V+G
Sbjct: 176 --KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 57  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 116
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 117 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 174
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 175 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 232
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 233 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 37  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 96
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 97  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 154
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 155 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 212
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 213 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 142
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 108
Query: 143 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 109 NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 168
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 250
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 169 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 226
Query: 251 ---KEFRRFSEKSDVYSFGVFLLELV 273
              K F  F +++D+Y+ G+   E+ 
Sbjct: 227 INMKHFESF-KRADIYAMGLVFWEIA 251

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 147
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 148 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 205
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 142
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 72
Query: 143 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 73  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 132
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 250
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 133 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 190
Query: 251 ---KEFRRFSEKSDVYSFGVFLLELV 273
              K F  F +++D+Y+ G+   E+ 
Sbjct: 191 INMKHFESF-KRADIYAMGLVFWEIA 215

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 147
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 148 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 205
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 22  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 81
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 82  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 139
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 140 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 197
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 198 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 48  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 107
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 108 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 165
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 166 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 223
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 224 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 142
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 95
Query: 143 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 96  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 155
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 250
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 156 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 213
Query: 251 ---KEFRRFSEKSDVYSFGVFLLELV 273
              K F  F +++D+Y+ G+   E+ 
Sbjct: 214 INMKHFESF-KRADIYAMGLVFWEIA 238

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 142
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 70
Query: 143 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 71  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 130
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 250
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 131 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 188
Query: 251 ---KEFRRFSEKSDVYSFGVFLLELV 273
              K F  F +++D+Y+ G+   E+ 
Sbjct: 189 INMKHFESF-KRADIYAMGLVFWEIA 213

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 142
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 75
Query: 143 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 76  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 135
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 250
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 136 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 193
Query: 251 ---KEFRRFSEKSDVYSFGVFLLELV 273
              K F  F +++D+Y+ G+   E+ 
Sbjct: 194 INMKHFESF-KRADIYAMGLVFWEIA 218

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 162
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 163 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 220
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 221 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 188
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 189 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 246
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN 142
           IG+G+FGEV++G  + G  VA+K       + +  E     ++  +H N++  +    ++
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 143 NLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
           N  +    L+ +Y  +GS+  +L   +      ++     +                P +
Sbjct: 70  NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 129
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLR----NFLGRTDVAGPSSQVTADEIFLASEV---- 250
            H+D K+ N+LV ++    +AD GL     +     D+A P+ +V     ++A EV    
Sbjct: 130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-PNHRVGTKR-YMAPEVLDDS 187
Query: 251 ---KEFRRFSEKSDVYSFGVFLLELV 273
              K F  F +++D+Y+ G+   E+ 
Sbjct: 188 INMKHFESF-KRADIYAMGLVFWEIA 212

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPTQE----FIDEVCFLAS 126
           KN +    +G G FGEVY+G +         + VA+K  P   +++    F+ E   ++ 
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISK 104
Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG----PSQVSRQKLEFKHRLSIXX 182
             H+N+V  +G   ++  +F++ E +  G +   L      PSQ S   L     L +  
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVAR 162
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
                           +H+D    N L+       +AK+ D G+   + R          
Sbjct: 163 DIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 220
Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                ++  E      F+ K+D +SFGV L E+ S
Sbjct: 221 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ-----EFIDEVCFLASIQHRNLVT 134
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 132
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 251
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF--AWCAPESL 190
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
           + R FS  SD + FGV L E+ +
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 86/219 (39%), Gaps = 26/219 (11%)
Query: 68  QMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFID 119
           +M +      +F     +G+GKFG VY     Q+  ++A+K       ++ G   Q    
Sbjct: 6   EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRR 64
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E+   + ++H N++ +  Y  +    +L+ E+ P G +   L    +   Q+       S
Sbjct: 65  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR-------S 117
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS--- 236
                            +V+H+D K  N+L+      K+AD G         V  PS   
Sbjct: 118 ATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW-------SVHAPSLRR 170
Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
             +     +L  E+ E +   EK D++  GV   E + G
Sbjct: 171 RXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 88/220 (40%), Gaps = 44/220 (20%)
Query: 77  KNFSDKNLIGEGKFGEVYKGLLQD---GMLVAIKKRPGAPTQ----EFIDEVCFLASIQH 129
           K F  K  +G G F EV   L ++   G L A+K  P    +       +E+  L  I+H
Sbjct: 22  KIFEFKETLGTGAFSEVV--LAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKH 79
Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQKLE---FKHRL 178
            N+V L    +  N  +L+ + +  G      V    Y     S   RQ L+   + HR+
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRM 139
Query: 179 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGP 235
            I                  VH+D K  N+L    DE+    ++D GL    G+ DV   
Sbjct: 140 GI------------------VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMST 181
Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           +        ++A EV   + +S+  D +S GV    L+ G
Sbjct: 182 ACGTPG---YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ-----EFIDEVCFLASIQHRNLVT 134
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 132
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 251
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF--AWCAPESL 190
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
           + R FS  SD + FGV L E+ +
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ-----EFIDEVCFLASIQHRNLVT 134
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 251
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF--AWCAPESL 186
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
           + R FS  SD + FGV L E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ-----EFIDEVCFLASIQHRNLVT 134
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 251
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF--AWCAPESL 186
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
           + R FS  SD + FGV L E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ-----EFIDEVCFLASIQHRNLVT 134
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 251
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF--AWCAPESL 186
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
           + R FS  SD + FGV L E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ-----EFIDEVCFLASIQHRNLVT 134
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 251
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF--AWCAPESL 196
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
           + R FS  SD + FGV L E+ +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ-----EFIDEVCFLASIQHRNLVT 134
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           L G      ++ ++ E  P GS+        ++ + +  F                    
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLL------DRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 195 XPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQVTADEIFLASEVK 251
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     + A E  
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF--AWCAPESL 196
Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
           + R FS  SD + FGV L E+ +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 86/219 (39%), Gaps = 26/219 (11%)
Query: 68  QMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFID 119
           +M +      +F     +G+GKFG VY     Q+  ++A+K       ++ G   Q    
Sbjct: 5   EMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRR 63
Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           E+   + ++H N++ +  Y  +    +L+ E+ P G +   L    +   Q+       S
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR-------S 116
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS--- 236
                            +V+H+D K  N+L+      K+AD G         V  PS   
Sbjct: 117 ATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW-------SVHAPSLRR 169
Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
             +     +L  E+ E +   EK D++  GV   E + G
Sbjct: 170 RXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 81/206 (39%), Gaps = 32/206 (15%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID-----EVCFLASIQHRNLVTLLGY 138
           IGEG +G V+K   +D G +VAIKK   +     I      E+  L  ++H NLV LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
            +      L++EY  +  +        ++ R +      L                    
Sbjct: 71  FRRKRRLHLVFEYCDHTVL-------HELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123
Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR---- 254
           +H+D K  N+L+ +  + K+ D G    L      GPS     DE+      + +R    
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLL-----TGPSDYYD-DEV----ATRWYRSPEL 173
Query: 255 -----RFSEKSDVYSFGVFLLELVSG 275
                ++    DV++ G    EL+SG
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 83/201 (41%), Gaps = 14/201 (6%)
Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG G +G   K   + DG ++  K+        A  Q  + EV  L  ++H N+V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 139 C--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
              + N   +++ EY   G ++  +   ++  RQ L+ +  L +                
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 197 ---RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               V+H+D K ANV +D     K+ D GL   L   +    + +      +++ E    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE--DFAKEFVGTPYYMSPEQMNR 190
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
             ++EKSD++S G  L EL +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCA 211

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 28/216 (12%)
Query: 76  TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEF----IDEVCFLASIQHR 130
           + +F  K+L+GEG +G V     +  G +VAIKK        F    + E+  L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 190
           N++T+    + ++ +     YI    +   L+    +S Q L   H              
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLH--RVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT--DVAGPSSQVT-------- 240
                  V+H+D K +N+L++ +   KV D GL   +  +  D + P+ Q +        
Sbjct: 128 LHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVAT 185
Query: 241 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL 272
               A E+ L S      ++S   DV+S G  L EL
Sbjct: 186 RWYRAPEVMLTSA-----KYSRAMDVWSCGCILAEL 216

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 18/218 (8%)
Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEV 121
           +E   +    F D  ++G G FGEV+   ++  G L A KK            Q  + E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-VSIHLYGPSQVSRQKLEFKHRLSI 180
             LA +  R +V+L  Y  E      +   I NG  +  H+Y    V      F+   +I
Sbjct: 237 KILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIY---NVDEDNPGFQEPRAI 292
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQ 238
                            ++++D K  NVL+D+D   +++D GL   L  G+T   G    
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG---- 348
Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                 F+A E+     +    D ++ GV L E+++ R
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/159 (23%), Positives = 67/159 (42%), Gaps = 28/159 (17%)
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQVTADEIFLASE 249
           + +H+D    N+L+ E+ + K+ D GL        +++ + D   P   +  + IF    
Sbjct: 219 KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIF---- 274
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 309
               + +S KSDV+S+GV L E+ S                   VQ   DF + L+   E
Sbjct: 275 ---DKIYSTKSDVWSYGVLLWEIFS-----------LGGSPYPGVQMDEDFCSRLR---E 317
Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
            +          E  Q+++ C     + RP  +++V +L
Sbjct: 318 GMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 18/211 (8%)
Query: 76  TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEF----IDEVCFLASIQHR 130
           + +F  K+L+GEG +G V     +  G +VAIKK        F    + E+  L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 190
           N++T+    + ++ +     YI    +   L+    +S Q L   H              
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLH--RVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT--DVAGPSSQ------VTAD 242
                  V+H+D K +N+L++ +   KV D GL   +  +  D + P+ Q        A 
Sbjct: 128 LHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVAT 185
Query: 243 EIFLASEVK-EFRRFSEKSDVYSFGVFLLEL 272
             + A EV     ++S   DV+S G  L EL
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 117/294 (39%), Gaps = 49/294 (16%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 134 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQ-VSRQKLEFKHRLSIXXXXX 185
            LLG C +      +I E+   G++S +L      + P + + +  L  +H +       
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQ 238
                      + +H+D    N+L+ E  + K+ D GL        +++ + D   P   
Sbjct: 155 KGMEFLASR--KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSR 298
           +  + IF        R ++ +SDV+SFGV L E+ S                   V+   
Sbjct: 213 MAPETIF-------DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDE 254
Query: 299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           +F   LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 255 EFCRRLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 305

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 18/218 (8%)
Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEV 121
           +E   +    F D  ++G G FGEV+   ++  G L A KK            Q  + E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-VSIHLYGPSQVSRQKLEFKHRLSI 180
             LA +  R +V+L  Y  E      +   I NG  +  H+Y    V      F+   +I
Sbjct: 237 KILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIY---NVDEDNPGFQEPRAI 292
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQ 238
                            ++++D K  NVL+D+D   +++D GL   L  G+T   G    
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG---- 348
Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                 F+A E+     +    D ++ GV L E+++ R
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 28/216 (12%)
Query: 76  TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEF----IDEVCFLASIQHR 130
           + +F  K+L+GEG +G V     +  G +VAIKK        F    + E+  L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 190
           N++T+    + ++ +     YI    +   L+    +S Q L   H              
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLH--RVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT--DVAGPSSQVT-------- 240
                  V+H+D K +N+L++ +   KV D GL   +  +  D + P+ Q +        
Sbjct: 128 LHGS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 241 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL 272
               A E+ L S      ++S   DV+S G  L EL
Sbjct: 186 RWYRAPEVMLTSA-----KYSRAMDVWSCGCILAEL 216

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 18/218 (8%)
Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEV 121
           +E   +    F D  ++G G FGEV+   ++  G L A KK            Q  + E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-VSIHLYGPSQVSRQKLEFKHRLSI 180
             LA +  R +V+L  Y  E      +   I NG  +  H+Y    V      F+   +I
Sbjct: 237 KILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIY---NVDEDNPGFQEPRAI 292
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQ 238
                            ++++D K  NVL+D+D   +++D GL   L  G+T   G    
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG---- 348
Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                 F+A E+     +    D ++ GV L E+++ R
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 18/218 (8%)
Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEV 121
           +E   +    F D  ++G G FGEV+   ++  G L A KK            Q  + E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-VSIHLYGPSQVSRQKLEFKHRLSI 180
             LA +  R +V+L  Y  E      +   I NG  +  H+Y    V      F+   +I
Sbjct: 237 KILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIY---NVDEDNPGFQEPRAI 292
Query: 181 XXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL--GRTDVAGPSSQ 238
                            ++++D K  NVL+D+D   +++D GL   L  G+T   G    
Sbjct: 293 FYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG---- 348
Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                 F+A E+     +    D ++ GV L E+++ R
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/273 (21%), Positives = 107/273 (39%), Gaps = 43/273 (15%)
Query: 31  YRNRSVSRTSETGSSEPSVQ---------PGRNVGIELSIREARRFQMEELSLATKNFSD 81
           + N SV+R++      P            P +  G     RE +R   E+   A +   D
Sbjct: 86  FENMSVTRSNSLRRDSPPPPARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVD 145
Query: 82  KN----------LIGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASI 127
                        IGEG  G V    ++  G LVA+KK   R     +   +EV  +   
Sbjct: 146 PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY 205
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           QH N+V +       +  +++ E++  G+    V+       Q++   L     LS+   
Sbjct: 206 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHA 265
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTAD 242
                         V+H+D K+ ++L+  D   K++D G   F  +     P  + +   
Sbjct: 266 QG------------VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGT 310
Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
             ++A E+     +  + D++S G+ ++E+V G
Sbjct: 311 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 51/223 (22%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPT--QEFIDEVCFLASIQHRNLVTL- 135
           K  +G G FG V + + QD G  VAIK  ++  +P   + +  E+  +  + H N+V+  
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 136 -----LGYCQENNLQFLIYEYIPNGSVSIHLY----------GP-----SQVSRQKLEFK 175
                L     N+L  L  EY   G +  +L           GP     S +S   L + 
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS-SALRYL 137
Query: 176 HRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDV 232
           H                    R++H+D K  N+++    +  I K+ D G    L + ++
Sbjct: 138 HE------------------NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
               ++      +LA E+ E ++++   D +SFG    E ++G
Sbjct: 180 C---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 51/223 (22%)
Query: 82  KNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPT--QEFIDEVCFLASIQHRNLVTL- 135
           K  +G G FG V + + QD G  VAIK  ++  +P   + +  E+  +  + H N+V+  
Sbjct: 20  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 79
Query: 136 -----LGYCQENNLQFLIYEYIPNGSVSIHLY----------GP-----SQVSRQKLEFK 175
                L     N+L  L  EY   G +  +L           GP     S +S   L + 
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS-SALRYL 138
Query: 176 HRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDV 232
           H                    R++H+D K  N+++    +  I K+ D G    L + ++
Sbjct: 139 HE------------------NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 180
Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
               ++      +LA E+ E ++++   D +SFG    E ++G
Sbjct: 181 C---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 14/84 (16%)
Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLG-----RTDVAGPSSQVTADEIFLASEVKE 252
           VVH+D K  NVL+D    AK+AD GL N +      RT    P+        + A EV  
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN--------YAAPEVIS 183
Query: 253 FRRFS-EKSDVYSFGVFLLELVSG 275
            R ++  + D++S GV L  L+ G
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 84/201 (41%), Gaps = 14/201 (6%)
Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG G +G   K   + DG ++  K+        A  Q  + EV  L  ++H N+V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 139 C--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
              + N   +++ EY   G ++  +   ++  RQ L+ +  L +                
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 197 ---RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               V+H+D K ANV +D     K+ D GL   L   D +   + V     +++ E    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKTFV-GTPYYMSPEQMNR 190
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
             ++EKSD++S G  L EL +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCA 211

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/271 (21%), Positives = 106/271 (39%), Gaps = 35/271 (12%)
Query: 76  TKN-FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEF------IDEVCFLASI 127
           TKN F    ++G+G FGEV    ++  G + A KK      ++       ++E   L  +
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
             R +V+L    +  +   L+   +  G +  H+Y   Q       F    ++       
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-----FPEARAVFYAAEIC 296
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--- 244
                    R+V++D K  N+L+D+    +++D GL        V  P  Q     +   
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL-------AVHVPEGQTIKGRVGTV 349
Query: 245 -FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNL 303
            ++A EV +  R++   D ++ G  L E+++G+              VE          L
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---------RL 400
Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPS 334
           +K + E     F+ +      QL+  C DP+
Sbjct: 401 VKEVPEEYSERFSPQARSLCSQLL--CKDPA 429

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 24/213 (11%)
Query: 76  TKN-FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEF------IDEVCFLASI 127
           TKN F    ++G+G FGEV    ++  G + A KK      ++       ++E   L  +
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
             R +V+L    +  +   L+   +  G +  H+Y   Q       F    ++       
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-----FPEARAVFYAAEIC 296
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--- 244
                    R+V++D K  N+L+D+    +++D GL        V  P  Q     +   
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL-------AVHVPEGQTIKGRVGTV 349
Query: 245 -FLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            ++A EV +  R++   D ++ G  L E+++G+
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 84/201 (41%), Gaps = 14/201 (6%)
Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG G +G   K   + DG ++  K+        A  Q  + EV  L  ++H N+V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 139 C--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
              + N   +++ EY   G ++  +   ++  RQ L+ +  L +                
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 197 ---RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
               V+H+D K ANV +D     K+ D GL   L   D +   + V     +++ E    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFV-GTPYYMSPEQMNR 190
Query: 254 RRFSEKSDVYSFGVFLLELVS 274
             ++EKSD++S G  L EL +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCA 211

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 86/200 (43%), Gaps = 24/200 (12%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IGEG  G V    ++  G LVA+KK   R     +   +EV  +   QH N+V +     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 141 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
             +  +++ E++  G+    V+       Q++   L     LS+                
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG----------- 145
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRR 255
            V+H+D K+ ++L+  D   K++D G   F  +     P  + +     ++A E+     
Sbjct: 146 -VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 201
Query: 256 FSEKSDVYSFGVFLLELVSG 275
           +  + D++S G+ ++E+V G
Sbjct: 202 YGPEVDIWSLGIMVIEMVDG 221

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 88/218 (40%), Gaps = 55/218 (25%)
Query: 85  IGEGKFGEVYKGL--LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           +GEG +  VYKG   L D  LVA+K+       GAP    I EV  L  ++H N+VTL  
Sbjct: 10  LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHD 67
Query: 138 YCQENNLQFLIYEYIPNG---------------SVSIHLYGPSQVSRQKLEFKHRLSIXX 182
                    L++EY+                  +V + L+   Q+ R  L + HR     
Sbjct: 68  IIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLF---QLLR-GLAYCHR----- 118
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-- 240
                         +V+H+D K  N+L++E    K+AD GL            +  VT  
Sbjct: 119 -------------QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW 165
Query: 241 --ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               +I L S       +S + D++  G    E+ +GR
Sbjct: 166 YRPPDILLGST-----DYSTQIDMWGVGCIFYEMATGR 198

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 118/294 (40%), Gaps = 49/294 (16%)
Query: 85  IGEGKFGEVYK----GLLQDGML--VAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +    G+ +      VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 134 TLLGYC-QENNLQFLIYEYIPNGSVSIHL------YGPSQ-VSRQKLEFKHRLSIXXXXX 185
            LLG C +      +I E+   G++S +L      + P + + +  L  +H   I     
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEH--LIXYSFQ 152
Query: 186 XXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQ 238
                      + +H+D    N+L+ E  + K+ D GL        +++ + D   P   
Sbjct: 153 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSR 298
           +  + IF        R ++ +SDV+SFGV L E+ S                   V+   
Sbjct: 213 MAPETIF-------DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDE 254
Query: 299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
           +F   LK         +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 255 EFXRRLKEGTRMRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 305

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 86/200 (43%), Gaps = 24/200 (12%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IGEG  G V    ++  G LVA+KK   R     +   +EV  +   QH N+V +     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 141 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
             +  +++ E++  G+    V+       Q++   L     LS+                
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG----------- 136
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRR 255
            V+H+D K+ ++L+  D   K++D G   F  +     P  + +     ++A E+     
Sbjct: 137 -VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 192
Query: 256 FSEKSDVYSFGVFLLELVSG 275
           +  + D++S G+ ++E+V G
Sbjct: 193 YGPEVDIWSLGIMVIEMVDG 212

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 86/200 (43%), Gaps = 24/200 (12%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IGEG  G V    ++  G LVA+KK   R     +   +EV  +   QH N+V +     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 141 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
             +  +++ E++  G+    V+       Q++   L     LS+                
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG----------- 140
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRR 255
            V+H+D K+ ++L+  D   K++D G   F  +     P  + +     ++A E+     
Sbjct: 141 -VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 196
Query: 256 FSEKSDVYSFGVFLLELVSG 275
           +  + D++S G+ ++E+V G
Sbjct: 197 YGPEVDIWSLGIMVIEMVDG 216

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 86/200 (43%), Gaps = 24/200 (12%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           IGEG  G V    ++  G LVA+KK   R     +   +EV  +   QH N+V +     
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 141 ENNLQFLIYEYIPNGS----VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXP 196
             +  +++ E++  G+    V+       Q++   L     LS+                
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG----------- 147
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRR 255
            V+H+D K+ ++L+  D   K++D G   F  +     P  + +     ++A E+     
Sbjct: 148 -VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLP 203
Query: 256 FSEKSDVYSFGVFLLELVSG 275
           +  + D++S G+ ++E+V G
Sbjct: 204 YGPEVDIWSLGIMVIEMVDG 223

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/244 (21%), Positives = 98/244 (40%), Gaps = 34/244 (13%)
Query: 51  PGRNVGIELSIREARRFQMEELSLATKNFSDKN----------LIGEGKFGEVYKGLLQD 100
           P +  G     RE +R   E+   A +   D             IGEG  G V    ++ 
Sbjct: 38  PEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRS 97
Query: 101 -GMLVAIKK---RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS 156
            G LVA+KK   R     +   +EV  +   QH N+V +       +  +++ E++  G+
Sbjct: 98  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 157
Query: 157 ----VSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDE 212
               V+       Q++   L     LS+                 V+H+D K+ ++L+  
Sbjct: 158 LTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG------------VIHRDIKSDSILLTH 205
Query: 213 DFIAKVADAGLRNFLGRTDVAGPSSQ-VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLE 271
           D   K++D G   F  +     P  + +     ++A E+     +  + D++S G+ ++E
Sbjct: 206 DGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 262
Query: 272 LVSG 275
           +V G
Sbjct: 263 MVDG 266

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 106/275 (38%), Gaps = 43/275 (15%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVAIK---KRPGAPTQEF---IDEVCFLASIQHRNLVTLLG 137
           IG+G FG+V      D   + A+K   K+      E      E+  +  ++H  LV L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPR 197
             Q+    F++ + +  G +  HL       +Q + FK                     R
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHL-------QQNVHFKEETVKLFICELVMALDYLQNQR 135
Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGR----TDVAGPSSQVTADEIFLASEVKEF 253
           ++H+D K  N+L+DE     + D  +   L R    T +AG          ++A E+   
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKP-------YMAPEMFSS 188
Query: 254 RR---FSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDER 310
           R+   +S   D +S GV   EL+ GR              V   + +             
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV------------ 236
Query: 311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPS-MSDV 344
              T+ +   +E + L+ + L+P+ ++R S +SDV
Sbjct: 237 --VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDV 269

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 35/225 (15%)
Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFIDEVCFLASIQH----- 129
           +F +  ++G+G FG+V K     D    AIKK           + EV  LAS+ H     
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 130 --------RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 181
                   RN V      ++ +  F+  EY  N ++   L     +++Q+ E+  RL   
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTL-YDLIHSENLNQQRDEY-WRL--- 121
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT---------DV 232
                           ++H++ K  N+ +DE    K+ D GL   + R+         ++
Sbjct: 122 -FRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 233 AGPSSQVTA---DEIFLASEVKEFR-RFSEKSDVYSFGVFLLELV 273
            G S  +T+      ++A+EV +    ++EK D YS G+   E +
Sbjct: 181 PGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 29/210 (13%)
Query: 85  IGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLG---YC 139
           +G+G++GEV++GL   G  VA+K       Q +  E     ++  +H N++  +      
Sbjct: 16  VGKGRYGEVWRGLWH-GESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTS 74
Query: 140 QENNLQ-FLIYEYIPNGSVSIHLYGPSQVSRQKLE--FKHRLSIXXXXXXXXXXX----X 192
           + ++ Q +LI  Y  +GS+   L       RQ LE     RL++                
Sbjct: 75  RNSSTQLWLITHYHEHGSLYDFL------QRQTLEPHLALRLAVSAACGLAHLHVEIFGT 128
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGLR--NFLGRTDVAGPSSQVTADEIFLASEV 250
              P + H+DFK+ NVLV  +    +AD GL   +  G   +   ++     + ++A EV
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEV 188
Query: 251 KE-------FRRFSEKSDVYSFGVFLLELV 273
            +       F  + + +D+++FG+ L E+ 
Sbjct: 189 LDEQIRTDCFESY-KWTDIWAFGLVLWEIA 217

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ DAGL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI    +  +L   SQV   ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVI--QMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S GV + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI    +  +L   SQV   ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVI--QMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S GV + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 70  EELSLATKNFSD----KNLIGEGKFGE----VYKGLLQDGMLVAIKKRPGAPTQEFIDEV 121
           E L   +  FSD    K  IG G + E    V+K    +  +  I K    P++E   E+
Sbjct: 16  ENLYFQSMVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEI--EI 73
Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIX 181
             L   QH N++TL     +    +L+ E +  G +        ++ RQK  F  R +  
Sbjct: 74  -LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELL------DKILRQKF-FSEREASF 125
Query: 182 XXXXXXXXXXXXXXPRVVHKDFKTANVL-VDEDF---IAKVADAGLRNFLGRTDVAGPSS 237
                           VVH+D K +N+L VDE       ++ D G    L   +    + 
Sbjct: 126 VLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP 185
Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
             TA+  F+A EV + + + E  D++S G+ L  +++G
Sbjct: 186 CYTAN--FVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 84/198 (42%), Gaps = 14/198 (7%)
Query: 115 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 174
           +E  +E+  L S+ H N++ L    ++    +L+ E+   G +   +     ++R K + 
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-----INRHKFDE 145
Query: 175 KHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDED---FIAKVADAGLRNFLGRTD 231
               +I                 +VH+D K  N+L++        K+ D GL +F  + D
Sbjct: 146 CDAANIMKQILSGICYLHK--HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK-D 202
Query: 232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXV 291
                   TA   ++A EV + ++++EK DV+S GV +  L+ G               V
Sbjct: 203 YKLRDRLGTA--YYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259
Query: 292 ELVQNSRDFSNLLKILDE 309
           E  +   DF++   I DE
Sbjct: 260 EKGKYYFDFNDWKNISDE 277

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 41/88 (46%), Gaps = 22/88 (25%)
Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFL----------GRTDVAGPSSQVTADEIFLA 247
           VVH+D K  NVL+D    AK+AD GL N +          G  + A P  +V +  ++  
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAP--EVISGRLYAG 194
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV          D++S GV L  L+ G
Sbjct: 195 PEV----------DIWSSGVILYALLCG 212

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 27/287 (9%)
Query: 88  GKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQHRNLVTLLGYCQENNLQ 145
           G+FG V+K  L +   VA+K  P    Q + +E  V  L  ++H N++  +G  +     
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93
Query: 146 ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS--IXXXXXXXXXXXXXXXPRVV 199
               +LI  +   GS+S  L        +       ++  +               P + 
Sbjct: 94  DVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAIS 153
Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE----FRR 255
           H+D K+ NVL+  +  A +AD GL         AG +        ++A EV E    F+R
Sbjct: 154 HRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQR 213
Query: 256 FS-EKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDER---- 310
            +  + D+Y+ G+ L EL S   A             E +       ++ +++  +    
Sbjct: 214 DAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRP 273
Query: 311 ----LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV---VTELDR 350
                W    + GM    + I  C D  +E R S   V   +T++ R
Sbjct: 274 VLRDYWQ--KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 96  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL         A   +   A   + A 
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH-----TADEMTGYVATRWYRAP 198
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI    +  +L   SQV   ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVI--QMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 79  FSD----KNLIGEGKFGE----VYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHR 130
           FSD    K  IG G + E    V+K    +  +  I K    P++E   E+  L   QH 
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEI--EI-LLRYGQHP 81
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 190
           N++TL     +    +L+ E +  G +        ++ RQK  F  R +           
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELL------DKILRQKF-FSEREASFVLHTIGKTV 134
Query: 191 XXXXXPRVVHKDFKTANVL-VDEDF---IAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 246
                  VVH+D K +N+L VDE       ++ D G    L   +    +   TA+  F+
Sbjct: 135 EYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN--FV 192
Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           A EV + + + E  D++S G+ L  +++G
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 96  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL         A   +   A   + A 
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH-----TADEMTGYVATRWYRAP 198
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 41/88 (46%), Gaps = 22/88 (25%)
Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFL----------GRTDVAGPSSQVTADEIFLA 247
           VVH+D K  NVL+D    AK+AD GL N +          G  + A P  +V +  ++  
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAP--EVISGRLYAG 189
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV          D++S GV L  L+ G
Sbjct: 190 PEV----------DIWSCGVILYALLCG 207

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/146 (23%), Positives = 65/146 (44%), Gaps = 10/146 (6%)
Query: 132 LVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 190
            +T L  C Q  +  + + EY+  G +  H+    QV R    FK   ++          
Sbjct: 82  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGR----FKEPHAVFYAAEIAIGL 134
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 250
                  ++++D K  NV++D +   K+AD G+        V       T D  ++A E+
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPD--YIAPEI 192
Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGR 276
             ++ + +  D ++FGV L E+++G+
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/159 (22%), Positives = 70/159 (44%), Gaps = 14/159 (8%)
Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 177
           ++E   L ++    LV L    ++N+  +++ EY+P G +  HL    + S     F   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 178 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPS 236
             +                 ++++D K  N+L+D+    KVAD G  +   GRT     +
Sbjct: 149 QIVLTFEYLHSLD-------LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGT 201
Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            +  A EI L+      + +++  D ++ GV + E+ +G
Sbjct: 202 PEYLAPEIILS------KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 96  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL         A   +   A   + A 
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH-----TADEMTGYVATRWYRAP 198
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI    +  +L   SQV   ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVI--QMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 25/211 (11%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI      + L   +     ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYI-----VMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI--- 244
                     ++H+D K +N++V  D   K+ D G    L RT  AG S  +T + +   
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LART--AGTSFMMTPEVVTRY 190
Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           + A EV     + E  D++S G  + E++ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/146 (23%), Positives = 65/146 (44%), Gaps = 10/146 (6%)
Query: 132 LVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXX 190
            +T L  C Q  +  + + EY+  G +  H+    QV R    FK   ++          
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGR----FKEPHAVFYAAEIAIGL 455
Query: 191 XXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 250
                  ++++D K  NV++D +   K+AD G+        V       T D  ++A E+
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPD--YIAPEI 513
Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGR 276
             ++ + +  D ++FGV L E+++G+
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/241 (19%), Positives = 100/241 (41%), Gaps = 22/241 (9%)
Query: 47  PSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY-------KGLLQ 99
           P+++  +N+   LS  +    ++ +L +  +++    +IG G FGEV        + +  
Sbjct: 44  PALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYA 103
Query: 100 DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSI 159
             +L   +    + +  F +E   +A      +V L    Q++   +++ EY+P G + +
Sbjct: 104 MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-V 162
Query: 160 HLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVA 219
           +L     V  +   F     +                  +H+D K  N+L+D+    K+A
Sbjct: 163 NLMSNYDVPEKWARFYTAEVVLALDAIHSMG-------FIHRDVKPDNMLLDKSGHLKLA 215
Query: 220 DAGL-----RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           D G      +  + R D A  +    + E+  +     +  +  + D +S GVFL E++ 
Sbjct: 216 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY--YGRECDWWSVGVFLYEMLV 273
Query: 275 G 275
           G
Sbjct: 274 G 274

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 75  ATKNFSDK----NLIGEGKFGEVY----KGLLQDGMLVAIKKRP---GAPTQEFIDEVCF 123
           +T  FSD+     ++G+G FGEV     K   Q+  +  I KR        +  + EV  
Sbjct: 20  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           L  + H N++ L  + ++    +L+ E    G +   +     +SR++  F    +    
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-----ISRKR--FSEVDAARII 132
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        ++VH+D K  N+L++    +K  DA +R           +S+   D+
Sbjct: 133 RQVLSGITYMHKNKIVHRDLKPENLLLE----SKSKDANIRIIDFGLSTHFEASKKMKDK 188
Query: 244 I----FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           I    ++A EV     + EK DV+S GV L  L+SG
Sbjct: 189 IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/241 (19%), Positives = 100/241 (41%), Gaps = 22/241 (9%)
Query: 47  PSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY-------KGLLQ 99
           P+++  +N+   LS  +    ++ +L +  +++    +IG G FGEV        + +  
Sbjct: 39  PALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYA 98
Query: 100 DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSI 159
             +L   +    + +  F +E   +A      +V L    Q++   +++ EY+P G + +
Sbjct: 99  MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-V 157
Query: 160 HLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVA 219
           +L     V  +   F     +                  +H+D K  N+L+D+    K+A
Sbjct: 158 NLMSNYDVPEKWARFYTAEVVLALDAIHSMG-------FIHRDVKPDNMLLDKSGHLKLA 210
Query: 220 DAGL-----RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           D G      +  + R D A  +    + E+  +     +  +  + D +S GVFL E++ 
Sbjct: 211 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY--YGRECDWWSVGVFLYEMLV 268
Query: 275 G 275
           G
Sbjct: 269 G 269

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 75  ATKNFSDK----NLIGEGKFGEVY----KGLLQDGMLVAIKKRP---GAPTQEFIDEVCF 123
           +T  FSD+     ++G+G FGEV     K   Q+  +  I KR        +  + EV  
Sbjct: 26  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 85
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           L  + H N++ L  + ++    +L+ E    G +   +     +SR++  F    +    
Sbjct: 86  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-----ISRKR--FSEVDAARII 138
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        ++VH+D K  N+L++    +K  DA +R           +S+   D+
Sbjct: 139 RQVLSGITYMHKNKIVHRDLKPENLLLE----SKSKDANIRIIDFGLSTHFEASKKMKDK 194
Query: 244 I----FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           I    ++A EV     + EK DV+S GV L  L+SG
Sbjct: 195 IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 229

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 57/144 (39%), Gaps = 30/144 (20%)
Query: 144 LQFLIYEYIPNGSVS--IHLYGPSQVSR---------QKLEFKHRLSIXXXXXXXXXXXX 192
           L +++ EY+   ++   +H  GP    R         Q L F H+  I            
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI------------ 137
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVK 251
                 +H+D K AN+L+      KV D G+ R      +    ++ V     +L+ E  
Sbjct: 138 ------IHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
                  +SDVYS G  L E+++G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/159 (22%), Positives = 70/159 (44%), Gaps = 14/159 (8%)
Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 177
           ++E   L ++    LV L    ++N+  +++ EY+P G +  HL    + S     F   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAA 148
Query: 178 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPS 236
             +                 ++++D K  N+L+D+    KVAD G  +   GRT     +
Sbjct: 149 QIVLTFEYLHSLD-------LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGT 201
Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            +  A EI L+      + +++  D ++ GV + E+ +G
Sbjct: 202 PEYLAPEIILS------KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/241 (19%), Positives = 100/241 (41%), Gaps = 22/241 (9%)
Query: 47  PSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY-------KGLLQ 99
           P+++  +N+   LS  +    ++ +L +  +++    +IG G FGEV        + +  
Sbjct: 44  PALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYA 103
Query: 100 DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSI 159
             +L   +    + +  F +E   +A      +V L    Q++   +++ EY+P G + +
Sbjct: 104 MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-V 162
Query: 160 HLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVA 219
           +L     V  +   F     +                  +H+D K  N+L+D+    K+A
Sbjct: 163 NLMSNYDVPEKWARFYTAEVVLALDAIHSMG-------FIHRDVKPDNMLLDKSGHLKLA 215
Query: 220 DAGL-----RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           D G      +  + R D A  +    + E+  +     +  +  + D +S GVFL E++ 
Sbjct: 216 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY--YGRECDWWSVGVFLYEMLV 273
Query: 275 G 275
           G
Sbjct: 274 G 274

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/159 (22%), Positives = 70/159 (44%), Gaps = 14/159 (8%)
Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 177
           ++E   L ++    LV L    ++N+  +++ EY+P G +  HL    + S     F   
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAA 148
Query: 178 LSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPS 236
             +                 ++++D K  N+L+D+    KVAD G  +   GRT     +
Sbjct: 149 QIVLTFEYLHSLD-------LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGT 201
Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            +  A EI L+      + +++  D ++ GV + E+ +G
Sbjct: 202 PEYLAPEIILS------KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 75  ATKNFSDK----NLIGEGKFGEVY----KGLLQDGMLVAIKKRP---GAPTQEFIDEVCF 123
           +T  FSD+     ++G+G FGEV     K   Q+  +  I KR        +  + EV  
Sbjct: 43  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 102
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           L  + H N++ L  + ++    +L+ E    G +   +     +SR++  F    +    
Sbjct: 103 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-----ISRKR--FSEVDAARII 155
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        ++VH+D K  N+L++    +K  DA +R           +S+   D+
Sbjct: 156 RQVLSGITYMHKNKIVHRDLKPENLLLE----SKSKDANIRIIDFGLSTHFEASKKMKDK 211
Query: 244 I----FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           I    ++A EV     + EK DV+S GV L  L+SG
Sbjct: 212 IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           IG G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 94  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR---HTD--DEMTGYVATRWYRAP 196
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 75  ATKNFSDK----NLIGEGKFGEVY----KGLLQDGMLVAIKKRP---GAPTQEFIDEVCF 123
           +T  FSD+     ++G+G FGEV     K   Q+  +  I KR        +  + EV  
Sbjct: 44  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 103
Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXX 183
           L  + H N++ L  + ++    +L+ E    G +   +     +SR++  F    +    
Sbjct: 104 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-----ISRKR--FSEVDAARII 156
Query: 184 XXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
                        ++VH+D K  N+L++    +K  DA +R           +S+   D+
Sbjct: 157 RQVLSGITYMHKNKIVHRDLKPENLLLE----SKSKDANIRIIDFGLSTHFEASKKMKDK 212
Query: 244 I----FLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           I    ++A EV     + EK DV+S GV L  L+SG
Sbjct: 213 IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI    +  +L   SQV   ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVI--QMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/165 (21%), Positives = 69/165 (41%), Gaps = 32/165 (19%)
Query: 124 LASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXX 182
           LA +     +T L  C Q  +  + + EY+  G +  H+    QV +    FK   ++  
Sbjct: 73  LALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI---QQVGK----FKEPQAVFY 125
Query: 183 XXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTD 231
                          ++++D K  NV++D +   K+AD G+           R F G  D
Sbjct: 126 AAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPD 185
Query: 232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                        ++A E+  ++ + +  D +++GV L E+++G+
Sbjct: 186 -------------YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI    +  +L   SQV   ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVI--QMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI      + L   +     ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYI-----VMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/249 (20%), Positives = 92/249 (36%), Gaps = 49/249 (19%)
Query: 57  IELSIREARRFQ---------MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGM---LV 104
           + LS+  AR F          ++E  +  +      LIG+G+FG+VY G     +   L+
Sbjct: 4   MNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLI 63
Query: 105 AIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI---------YEYIPNG 155
            I++      + F  EV      +H N+V  +G C       +I         Y  + + 
Sbjct: 64  DIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA 123
Query: 156 SVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFI 215
            + + +    Q++++ ++    L                   ++HKD K+ NV  D   +
Sbjct: 124 KIVLDVNKTRQIAQEIVKGMGYLHAKG---------------ILHKDLKSKNVFYDNGKV 168
Query: 216 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR------------FSEKSDVY 263
             + D GL +  G         ++     +L     E  R            FS+ SDV+
Sbjct: 169 V-ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227
Query: 264 SFGVFLLEL 272
           + G    EL
Sbjct: 228 ALGTIWYEL 236

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI      + L   +     ++E  H           
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYI-----VMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRA 193
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S G  + E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI      + L   +     ++E  H           
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYI-----VMELMDANLCQVIQMELDHERMSYLLYQML 137
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRA 194
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S G  + E++ G
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 39/175 (22%), Positives = 67/175 (38%), Gaps = 34/175 (19%)
Query: 117 FIDEVCFLASIQHRNLVTLLGYCQENN----LQFLIYEYIPNGSVS--IHLYGPSQVSR- 169
           F  E    A++ H  +V +    +       L +++ EY+   ++   +H  GP    R 
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 170 --------QKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADA 221
                   Q L F H+  I                  +H+D K AN+++      KV D 
Sbjct: 119 IEVIADACQALNFSHQNGI------------------IHRDVKPANIMISATNAVKVMDF 160
Query: 222 GL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
           G+ R      +    ++ V     +L+ E         +SDVYS G  L E+++G
Sbjct: 161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGY 138
           L+GEG + +V   + LQ+G   A+K   K+ G        EV  L   Q ++N++ L+ +
Sbjct: 20  LLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEF 79
Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRV 198
            +++   +L++E +  GS+  H      + +QK  F  R +                  +
Sbjct: 80  FEDDTRFYLVFEKLQGGSILAH------IQKQK-HFNEREASRVVRDVAAALDFLHTKGI 132
Query: 199 VHKDFKTANVLVDED---FIAKVADAGLRNFLGRTDVAGPSSQVTADEI--------FLA 247
            H+D K  N+L +        K+ D  L + +   +   P   +T  E+        ++A
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTP---ITTPELTTPCGSAEYMA 189
Query: 248 SEVKEF-----RRFSEKSDVYSFGVFLLELVSG 275
            EV E        + ++ D++S GV L  ++SG
Sbjct: 190 PEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 69/152 (45%), Gaps = 21/152 (13%)
Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFL----GRTDVAGPSSQVTADEIFLASEVKEF 253
           V+H+D K +NVL++     K+ D G+  +L     +T  AG    +  + I    E+ + 
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERI--NPELNQ- 231
Query: 254 RRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDERLWS 313
           + +S KSD++S G+ ++EL   R                       F  L ++++E    
Sbjct: 232 KGYSVKSDIWSLGITMIELAILRFPYDSW--------------GTPFQQLKQVVEEPSPQ 277
Query: 314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
              ++   EF+    +CL  +S+ RP+  +++
Sbjct: 278 LPADKFSAEFVDFTSQCLKKNSKERPTYPELM 309

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL-SKPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 101 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 203
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 45/165 (27%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IG+G FGEV+K   +  G  VA+KK      + G P    + E+  L  ++H N+V L+ 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIE 84
Query: 138 YCQE-----NNLQ---FLIYEYIPN---GSVSIHL--YGPSQVSR------QKLEFKHRL 178
            C+      N  +   +L++++  +   G +S  L  +  S++ R        L + HR 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR- 143
Query: 179 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL 223
                             +++H+D K ANVL+  D + K+AD GL
Sbjct: 144 -----------------NKILHRDMKAANVLITRDGVLKLADFGL 171

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 28/163 (17%)
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQVTADEIFLASE 249
           + +H+D    N+L+ E  + K+ D GL        +++ + D   P   +  + IF    
Sbjct: 213 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---- 268
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 309
               R ++ +SDV+SFGV L E+ S                   V+   +F   LK    
Sbjct: 269 ---DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCRRLKEGTR 314
Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
                +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 315 MRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 45/165 (27%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IG+G FGEV+K   +  G  VA+KK      + G P    + E+  L  ++H N+V L+ 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIE 83
Query: 138 YCQE-----NNLQ---FLIYEYIPN---GSVSIHL--YGPSQVSR------QKLEFKHRL 178
            C+      N  +   +L++++  +   G +S  L  +  S++ R        L + HR 
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR- 142
Query: 179 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL 223
                             +++H+D K ANVL+  D + K+AD GL
Sbjct: 143 -----------------NKILHRDMKAANVLITRDGVLKLADFGL 170

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 44/90 (48%), Gaps = 22/90 (24%)
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFL----------GRTDVAGPSSQVTADEIFL 246
           ++VH+D K  N+L+D++   K+AD GL N +          G  + A P  +V   +++ 
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP--EVINGKLYA 185
Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             EV          DV+S G+ L  ++ GR
Sbjct: 186 GPEV----------DVWSCGIVLYVMLVGR 205

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 59/227 (25%)
Query: 78  NFSDKNLIGEGKFGEV----YKGLLQDGMLVAIKKRPGAPT--QEFID-EVCFLASIQHR 130
           N+     +GEG FG+V    +    Q   L  I K+  A +  Q  I+ E+ +L  ++H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-----------LEFKHRLS 179
           +++ L    +  +   ++ EY  N  +  ++    ++S Q+           +E+ HR  
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR-- 131
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL----------GR 229
                            ++VH+D K  N+L+DE    K+AD GL N +          G 
Sbjct: 132 ----------------HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGS 175
Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            + A P  +V + +++   EV          DV+S GV L  ++  R
Sbjct: 176 PNYAAP--EVISGKLYAGPEV----------DVWSCGVILYVMLCRR 210

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 28/163 (17%)
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQVTADEIFLASE 249
           + +H+D    N+L+ E  + K+ D GL        +++ + D   P   +  + IF    
Sbjct: 211 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---- 266
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 309
               R ++ +SDV+SFGV L E+ S                   V+   +F   LK    
Sbjct: 267 ---DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCRRLKEGTR 312
Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
                +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 313 MRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 352

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 101 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 203
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 109 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 211
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/240 (20%), Positives = 103/240 (42%), Gaps = 20/240 (8%)
Query: 47  PSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY-------KGLLQ 99
           P+++  +N+   L+  E    ++  L +  +++    +IG G FGEV        + +  
Sbjct: 45  PALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYA 104
Query: 100 DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSI 159
             +L   +    + +  F +E   +A      +V L    Q++   +++ EY+P G + +
Sbjct: 105 MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL-V 163
Query: 160 HLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVA 219
           +L     V  +  +F     +                 ++H+D K  N+L+D+    K+A
Sbjct: 164 NLMSNYDVPEKWAKFYTAEVVLALDAIHSMG-------LIHRDVKPDNMLLDKHGHLKLA 216
Query: 220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR----RFSEKSDVYSFGVFLLELVSG 275
           D G    +  T +    + V   + +++ EV + +     +  + D +S GVFL E++ G
Sbjct: 217 DFGTCMKMDETGMVHCDTAVGTPD-YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 101 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 203
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 59/227 (25%)
Query: 78  NFSDKNLIGEGKFGEV----YKGLLQDGMLVAIKKRPGAPT--QEFID-EVCFLASIQHR 130
           N+     +GEG FG+V    +    Q   L  I K+  A +  Q  I+ E+ +L  ++H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-----------LEFKHRLS 179
           +++ L    +  +   ++ EY  N  +  ++    ++S Q+           +E+ HR  
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR-- 130
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL----------GR 229
                            ++VH+D K  N+L+DE    K+AD GL N +          G 
Sbjct: 131 ----------------HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGS 174
Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            + A P  +V + +++   EV          DV+S GV L  ++  R
Sbjct: 175 PNYAAP--EVISGKLYAGPEV----------DVWSCGVILYVMLCRR 209

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGXVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 94  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 196
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 45/165 (27%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IG+G FGEV+K   +  G  VA+KK      + G P    + E+  L  ++H N+V L+ 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIE 84
Query: 138 YCQE-----NNLQFLIY------EYIPNGSVSIHL--YGPSQVSR------QKLEFKHRL 178
            C+      N  +  IY      E+   G +S  L  +  S++ R        L + HR 
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR- 143
Query: 179 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL 223
                             +++H+D K ANVL+  D + K+AD GL
Sbjct: 144 -----------------NKILHRDMKAANVLITRDGVLKLADFGL 171

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 95  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 197
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 28/163 (17%)
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQVTADEIFLASE 249
           + +H+D    N+L+ E  + K+ D GL        +++ + D   P   +  + IF    
Sbjct: 220 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---- 275
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 309
               R ++ +SDV+SFGV L E+ S                   V+   +F   LK    
Sbjct: 276 ---DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCRRLKEGTR 321
Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
                +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 322 MRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 361

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 91  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 193
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 94  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR---HTD--DEMTGYVATRWYRAP 196
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 94  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 196
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 87
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 88  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 137
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 138 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 190
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 107
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 108 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 210
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 28/163 (17%)
Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLR-------NFLGRTDVAGPSSQVTADEIFLASE 249
           + +H+D    N+L+ E  + K+ D GL        +++ + D   P   +  + IF    
Sbjct: 218 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---- 273
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREAXXXXXXXXXXXXVELVQNSRDFSNLLKILDE 309
               R ++ +SDV+SFGV L E+ S                   V+   +F   LK    
Sbjct: 274 ---DRVYTIQSDVWSFGVLLWEIFS-----------LGASPYPGVKIDEEFCRRLKEGTR 319
Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
                +T     E  Q ++ C      +RP+ S++V  L   L
Sbjct: 320 MRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 359

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 99
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 100 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 202
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 91  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 193
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKSQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGL---CRHTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 99
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 100 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR---HTD--DEMTGYVATRWYRAP 202
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 45/165 (27%)
Query: 85  IGEGKFGEVYKGLLQD-GMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IG+G FGEV+K   +  G  VA+KK      + G P    + E+  L  ++H N+V L+ 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIE 84
Query: 138 YCQE-----NNLQ---FLIYEYIPN---GSVSIHL--YGPSQVSR------QKLEFKHRL 178
            C+      N  +   +L++++  +   G +S  L  +  S++ R        L + HR 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR- 143
Query: 179 SIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGL 223
                             +++H+D K ANVL+  D + K+AD GL
Sbjct: 144 -----------------NKILHRDMKAANVLITRDGVLKLADFGL 171

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 96  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 198
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 85
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 86  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 188
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 91  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 193
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 86
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 87  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 136
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 137 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 189
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 111
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 112 VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 161
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 162 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 214
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 59/227 (25%)
Query: 78  NFSDKNLIGEGKFGEV----YKGLLQDGMLVAIKKRPGAPT--QEFID-EVCFLASIQHR 130
           N+     +GEG FG+V    +    Q   L  I K+  A +  Q  I+ E+ +L  ++H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-----------LEFKHRLS 179
           +++ L    +  +   ++ EY  N  +  ++    ++S Q+           +E+ HR  
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR-- 121
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL----------GR 229
                            ++VH+D K  N+L+DE    K+AD GL N +          G 
Sbjct: 122 ----------------HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGS 165
Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            + A P  +V + +++   EV          DV+S GV L  ++  R
Sbjct: 166 PNYAAP--EVISGKLYAGPEV----------DVWSCGVILYVMLCRR 200

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 57/144 (39%), Gaps = 30/144 (20%)
Query: 144 LQFLIYEYIPNGSVS--IHLYGPSQVSR---------QKLEFKHRLSIXXXXXXXXXXXX 192
           L +++ EY+   ++   +H  GP    R         Q L F H+  I            
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI------------ 137
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVK 251
                 +H+D K AN+++      KV D G+ R      +    ++ V     +L+ E  
Sbjct: 138 ------IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
                  +SDVYS G  L E+++G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 57/144 (39%), Gaps = 30/144 (20%)
Query: 144 LQFLIYEYIPNGSVS--IHLYGPSQVSR---------QKLEFKHRLSIXXXXXXXXXXXX 192
           L +++ EY+   ++   +H  GP    R         Q L F H+  I            
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI------------ 137
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVK 251
                 +H+D K AN+++      KV D G+ R      +    ++ V     +L+ E  
Sbjct: 138 ------IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
                  +SDVYS G  L E+++G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 85
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 86  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 188
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 85  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 187
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 19/208 (9%)
Query: 77  KNFSDKNLIGEGKFGEV---YKGLLQDGMLVAIKK--RP---GAPTQEFIDEVCFLASIQ 128
           K + +   IG G  G V   Y  +L+    VAIKK  RP       +    E+  +  + 
Sbjct: 26  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 83
Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXX 187
           H+N++ LL  +  + +L+     YI      + L   +     ++E  H           
Sbjct: 84  HKNIIGLLNVFTPQKSLEEFQDVYI-----VMELMDANLCQVIQMELDHERMSYLLYQML 138
Query: 188 XXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
                     ++H+D K +N++V  D   K+ D GL    G + +  P         + A
Sbjct: 139 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVP---FVVTRYYRA 195
Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EV     + E  D++S G  + E++ G
Sbjct: 196 PEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 57/144 (39%), Gaps = 30/144 (20%)
Query: 144 LQFLIYEYIPNGSVS--IHLYGPSQVSR---------QKLEFKHRLSIXXXXXXXXXXXX 192
           L +++ EY+   ++   +H  GP    R         Q L F H+  I            
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI------------ 137
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVK 251
                 +H+D K AN+++      KV D G+ R      +    ++ V     +L+ E  
Sbjct: 138 ------IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
                  +SDVYS G  L E+++G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 59/227 (25%)
Query: 78  NFSDKNLIGEGKFGEV----YKGLLQDGMLVAIKKRPGAPT--QEFID-EVCFLASIQHR 130
           N+     +GEG FG+V    +    Q   L  I K+  A +  Q  I+ E+ +L  ++H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-----------LEFKHRLS 179
           +++ L    +  +   ++ EY  N  +  ++    ++S Q+           +E+ HR  
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR-- 125
Query: 180 IXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL----------GR 229
                            ++VH+D K  N+L+DE    K+AD GL N +          G 
Sbjct: 126 ----------------HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGS 169
Query: 230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            + A P  +V + +++   EV          DV+S GV L  ++  R
Sbjct: 170 PNYAAP--EVISGKLYAGPEV----------DVWSCGVILYVMLCRR 204

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 96/237 (40%), Gaps = 28/237 (11%)
Query: 48  SVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAI 106
           S + G  +G+  S R           L   NF    ++G+G FG+V    +++ G L A+
Sbjct: 5   SSKEGNGIGVNSSNR-----------LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAV 53
Query: 107 KKRPGAPTQEFIDEVC------FLASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSI 159
           K        +  D  C       L+  ++   +T L  C Q  +  F + E++  G +  
Sbjct: 54  KVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMF 113
Query: 160 HLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXXPRVVHKDFKTANVLVDEDFIAKVA 219
           H+    Q SR+  E + R                    ++++D K  NVL+D +   K+A
Sbjct: 114 HI----QKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLA 166
Query: 220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           D G+        V   +   T D  ++A E+ +   +    D ++ GV L E++ G 
Sbjct: 167 DFGMCKEGICNGVTTATFCGTPD--YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 57/144 (39%), Gaps = 30/144 (20%)
Query: 144 LQFLIYEYIPNGSVS--IHLYGPSQVSR---------QKLEFKHRLSIXXXXXXXXXXXX 192
           L +++ EY+   ++   +H  GP    R         Q L F H+  I            
Sbjct: 107 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGI------------ 154
Query: 193 XXXPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVK 251
                 +H+D K AN+++      KV D G+ R      +    ++ V     +L+ E  
Sbjct: 155 ------IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 208
Query: 252 EFRRFSEKSDVYSFGVFLLELVSG 275
                  +SDVYS G  L E+++G
Sbjct: 209 RGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G  VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL       ++AG      A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMAG----FVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 95  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL      TD     +   A   + A 
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTD--DEMTGYVATRWYRAP 197
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 81/201 (40%), Gaps = 15/201 (7%)
Query: 83  NLIGEGKFGEVY----KGLLQDGMLVAIKKRPGAPTQEF---IDEVCFLASIQHRNLVTL 135
            L+G+G FG+V     K   +   +  +KK       E    + E   L + +H  L  L
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 216
Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXXX 195
               Q ++    + EY   G +  HL      SR+++  + R                  
Sbjct: 217 KYSFQTHDRLCFVMEYANGGELFFHL------SRERVFSEDRARFYGAEIVSALDYLHSE 270
Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
             VV++D K  N+++D+D   K+ D GL    G  D A   +     E +LA EV E   
Sbjct: 271 KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPE-YLAPEVLEDND 328
Query: 256 FSEKSDVYSFGVFLLELVSGR 276
           +    D +  GV + E++ GR
Sbjct: 329 YGRAVDWWGLGVVMYEMMCGR 349

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 44/206 (21%), Positives = 85/206 (41%), Gaps = 21/206 (10%)
Query: 84  LIGEGKFGEVYKGLLQD-GMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           +IG+G F  V + + ++ G   A+K          PG  T++   E      ++H ++V 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIXXXXXXXXXXXXXX 194
           LL     + + ++++E++    +   +     V R    F +  ++              
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEI-----VKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 195 XP--RVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
                ++H+D K  NVL+   +     K+ D G+   LG + +       T    F+A E
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPH--FMAPE 203
Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSG 275
           V +   + +  DV+  GV L  L+SG
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 35/209 (16%)
Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG 137
           +G G +G V      + G  VA+KK    P Q  I       E+  L  ++H N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 138 Y------CQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIXXXXXXXX 188
                   +E N  +L+           HL G    + V  QKL   H   +        
Sbjct: 89  VFTPARSLEEFNDVYLV----------THLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 189 XXXXXXXPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
                    ++H+D K +N+ V+ED   K+ D GL       ++AG      A   + A 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMAG----FVATRWYRAP 191
Query: 249 EVK-EFRRFSEKSDVYSFGVFLLELVSGR 276
           E+   +  +++  D++S G  + EL++GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	380
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-102
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-96
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-88
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-69
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-57
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-56
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-56
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-54
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-53
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-50
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-50
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-50
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-50
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-48
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-43
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-41
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-40
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-39
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-39
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-38
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-38
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-38
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-36
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-35
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-35
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-34
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-34
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-32
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-32
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-32
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-31
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-30
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-30
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-29
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-29
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-28
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-28
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-26
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-24
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-24
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-23
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-23
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-23
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-22
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-21
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-21
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-21
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-20
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-20
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-20
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-20
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-19
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-19
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-19
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-19
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-19
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-18
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-18
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-18
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-18
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-17
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-17
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-17
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-17
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-17
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-17
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-17
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-16
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-16
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-16
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-16
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-16
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-16
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-16
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-05
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-15
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-15
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-15
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-14
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-14
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-14
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-14
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-14
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-14
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-14
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-14
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-14
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-14
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-14
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-13
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-13
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-13
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-13
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-13
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-13
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-13
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-13
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-13
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-13
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-13
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-12
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-12
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-11
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-11
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-11
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-10
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-10
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-10
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-09
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-09
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-09
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-09
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-09
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-09
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-08
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-08
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-08
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-07
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-07
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-06
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-05
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-05
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-05
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-04
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-04
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-04
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  305 bits (783), Expect = e-102
 Identities = 115/318 (36%), Positives = 173/318 (54%), Gaps = 17/318 (5%)

Query: 37  SRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG 96
             +  T S   ++     V  E     + R  + +L  AT NF  K LIG G FG+VYKG
Sbjct: 4   KYSKATNSINDALSSSYLVPFE-----SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKG 58

Query: 97  LLQDGMLVAIKKRPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP 153
           +L+DG  VA+K+R    +Q   EF  E+  L+  +H +LV+L+G+C E N   LIY+Y+ 
Sbjct: 59  VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118

Query: 154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED 213
           NG++  HLYG        + ++ RL I +GAA+GL +LH+    ++H+D K+ N+L+DE+
Sbjct: 119 NGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDEN 175

Query: 214 FIAKVADAGL-RNF--LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLL 270
           F+ K+ D G+ +    L +T +   S+ V     ++  E     R +EKSDVYSFGV L 
Sbjct: 176 FVPKITDFGISKKGTELDQTHL---STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232

Query: 271 ELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRC 330
           E++  R A     P    +L E    S +   L +I+D  L      E + +F    V+C
Sbjct: 233 EVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKC 292

Query: 331 LDPSSERRPSMSDVVTEL 348
           L  SSE RPSM DV+ +L
Sbjct: 293 LALSSEDRPSMGDVLWKL 310

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  290 bits (744), Expect = 1e-96
 Identities = 113/307 (36%), Positives = 173/307 (56%), Gaps = 25/307 (8%)

Query: 58  ELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ-- 115
           E+ + + +RF + EL +A+ NFS+KN++G G FG+VYKG L DG LVA+K+     TQ  
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG 70

Query: 116 --EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
             +F  EV  ++   HRNL+ L G+C     + L+Y Y+ NGSV+  L    + S+  L+
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLD 129

Query: 174 FKHRLSIALGAAKGLAHLH-SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR--- 229
           +  R  IALG+A+GLA+LH    P+++H+D K AN+L+DE+F A V D GL   +     
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 189

Query: 230 ---TDVAGPSSQVTADEIF--LASEVKEFRRFSEKSDVYSFGVFLLELVSGREA--SSSL 282
              T V G     T       +A E     + SEK+DV+ +GV LLEL++G+ A   + L
Sbjct: 190 HVTTAVRG-----T----IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240

Query: 283 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 342
           + D    L++ V+       L  ++D  L   + +E +E+ IQ+ + C   S   RP MS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300

Query: 343 DVVTELD 349
           +VV  L+
Sbjct: 301 EVVRMLE 307

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  267 bits (686), Expect = 3e-88
 Identities = 92/313 (29%), Positives = 144/313 (46%), Gaps = 35/313 (11%)

Query: 57  IELSIREARRFQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIKKRP 110
           +E+S      F   EL   T NF ++      N +GEG FG VYKG + +   VA+KK  
Sbjct: 5   LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLA 63

Query: 111 GAPT-------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG 163
                      Q+F  E+  +A  QH NLV LLG+  + +   L+Y Y+PNGS+   L  
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123

Query: 164 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 223
                   L +  R  IA GAA G+  LH      +H+D K+AN+L+DE F AK++D GL
Sbjct: 124 LD--GTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGL 179

Query: 224 RNFLGRTDVAGPSSQV------TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE 277
                +      +S++       A E             + KSD+YSFGV LLE+++G  
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEALRG-------EITPKSDIYSFGVVLLEIITGLP 232

Query: 278 ASSSLSPDSSQDLVELVQNS-RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSE 336
           A         Q L+++ +    +   +   +D+++ +   +  +E    +  +CL     
Sbjct: 233 AVDEHREP--QLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKN 289

Query: 337 RRPSMSDVVTELD 349
           +RP +  V   L 
Sbjct: 290 KRPDIKKVQQLLQ 302

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  219 bits (559), Expect = 5e-69
 Identities = 71/318 (22%), Positives = 119/318 (37%), Gaps = 35/318 (11%)

Query: 67  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFL 124
              E L   +       +   G+FG V+K  L     VA+K  P    Q + +E  V  L
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSL 72

Query: 125 ASIQHRNLVTLLGYCQENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
             ++H N++  +G  +         +LI  +   GS+S  L          + +     I
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL------KANVVSWNELCHI 126

Query: 181 ALGAAKGLAHLHS--------LSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTD 231
           A   A+GLA+LH           P + H+D K+ NVL+  +  A +AD GL   F     
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 232 VAGPSSQV-----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS 286
                 QV      A E+ L   +   R    + D+Y+ G+ L EL S   A+     + 
Sbjct: 187 AGDTHGQVGTRRYMAPEV-LEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

Query: 287 SQDLVELVQNSRDFSNLLKILDERLW------STFTNEGMEEFIQLIVRCLDPSSERRPS 340
                E +       ++ +++  +            + GM    + I  C D  +E R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 341 MSDVVTELDRTLDKEMNL 358
              V   +   + +  N+
Sbjct: 306 AGCVGERIT-QMQRLTNI 322

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  189 bits (481), Expect = 2e-57
 Identities = 84/292 (28%), Positives = 135/292 (46%), Gaps = 39/292 (13%)

Query: 78  NFSD---KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQH 129
            + D   K  IG G FG V++     G  VA+K             EF+ EV  +  ++H
Sbjct: 35  PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            N+V  +G   +     ++ EY+  GS+   L+     +R++L+ + RLS+A   AKG+ 
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMN 151

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----RNFLGRTDVAGPSSQVTADEI 244
           +LH+ +P +VH++ K+ N+LVD+ +  KV D GL       FL     AG     T    
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG-----TP--E 204

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 304
           ++A EV      +EKSDVYSFGV L EL + ++   +L+P  +Q +  +           
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--AQVVAAVGFK-------- 254

Query: 305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 356
               +RL          +   +I  C      +RPS + ++  L R L K  
Sbjct: 255 ---CKRL--EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL-RPLIKSA 300

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  186 bits (475), Expect = 4e-57
 Identities = 63/293 (21%), Positives = 119/293 (40%), Gaps = 37/293 (12%)

Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCF 123
            ++L+  TK       + E   GE++KG  Q G  + +K  +    +    ++F +E   
Sbjct: 9   FKQLNFLTK-------LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPR 60

Query: 124 LASIQHRNLVTLLGYCQENNLQFL--IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
           L    H N++ +LG CQ         I  ++P GS+   L+  +      ++    +  A
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF---VVDQSQAVKFA 117

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
           L  A+G+A LH+L P +      + +V++DED  A+++ A ++           +    A
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY-APAWVA 176

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 301
            E     + K        +D++SF V L ELV+     + LS    +  +++        
Sbjct: 177 PEAL---QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--MEIGMKVALE----- 226

Query: 302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 354
                   R   T          +L+  C++    +RP    +V  L++  DK
Sbjct: 227 ------GLRP--TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  185 bits (471), Expect = 2e-56
 Identities = 72/316 (22%), Positives = 124/316 (39%), Gaps = 55/316 (17%)

Query: 56  GIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------ 108
           G E            E+    +       IG+G FG V+KG L++D  +VAIK       
Sbjct: 5   GSEFPKSRLPTLADNEIEYEKQ-------IGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57

Query: 109 ----RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGP 164
                     QEF  EV  ++++ H N+V L G         ++ E++P G +   L   
Sbjct: 58  EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDK 115

Query: 165 SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-----DFIAKVA 219
           +      +++  +L + L  A G+ ++ + +P +VH+D ++ N+ +          AKVA
Sbjct: 116 AH----PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171

Query: 220 DAGLRNFLGRTDVAGPSSQV-----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
           D G    L +  V   S  +      A E   A E      ++EK+D YSF + L  +++
Sbjct: 172 DFG----LSQQSVHSVSGLLGNFQWMAPETIGAEE----ESYTEKADTYSFAMILYTILT 223

Query: 275 GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPS 334
           G       S    + +  + +              R   T   +       +I  C    
Sbjct: 224 GEGPFDEYSYGKIKFINMIREE-----------GLRP--TIPEDCPPRLRNVIELCWSGD 270

Query: 335 SERRPSMSDVVTELDR 350
            ++RP  S +V EL  
Sbjct: 271 PKKRPHFSYIVKELSE 286

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  186 bits (475), Expect = 2e-56
 Identities = 75/345 (21%), Positives = 123/345 (35%), Gaps = 49/345 (14%)

Query: 67  FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFL 124
               E SL   N     LIG G++G VYKG L D   VA+K    A  Q FI+E  +  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRV 61

Query: 125 ASIQHRNLVTLLGYCQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
             ++H N+   +   +           L+ EY PNGS+  +L      S    ++     
Sbjct: 62  PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL------SLHTSDWVSSCR 115

Query: 180 IALGAAKGLAHLHS-------LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
           +A    +GLA+LH+         P + H+D  + NVLV  D    ++D GL   L    +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 233 AGPSSQVTAD------------EIF-LASEVKEFRRFSEKSDVYSFGVFLLELVSGREAS 279
             P  +  A             E+   A  +++     ++ D+Y+ G+   E+       
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 280 SSLSPDSS-----QDLVELVQNSRDFSNLLKILDERL-----WSTFTNEGMEEFIQLIVR 329
                        Q  V       D   L+    +R      W   +   +    + I  
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS-LAVRSLKETIED 294

Query: 330 CLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTVTLGSH 374
           C D  +E R +           + + M +       +PT     H
Sbjct: 295 CWDQDAEARLTAQXAE----ERMAELMMIWERNKSVSPTAHHHHH 335

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  180 bits (458), Expect = 3e-54
 Identities = 70/269 (26%), Positives = 118/269 (43%), Gaps = 27/269 (10%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN 143
           +G G FG V K   +    VAIK+    +  + FI E+  L+ + H N+V L G C    
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPV 74

Query: 144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR-VVHKD 202
              L+ EY   GS+   L+G   +        H +S  L  ++G+A+LHS+ P+ ++H+D
Sbjct: 75  --CLVMEYAEGGSLYNVLHGAEPLP--YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 203 FKTANVLVDEDF-IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSD 261
            K  N+L+     + K+ D G    +         S       ++A EV E   +SEK D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSA-----AWMAPEVFEGSNYSEKCD 185

Query: 262 VYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGME 321
           V+S+G+ L E+++ R+    +    +  ++  V N             R          +
Sbjct: 186 VFSWGIILWEVITRRKPFDEIG-GPAFRIMWAVHN-----------GTRP--PLIKNLPK 231

Query: 322 EFIQLIVRCLDPSSERRPSMSDVVTELDR 350
               L+ RC      +RPSM ++V  +  
Sbjct: 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTH 260

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  179 bits (456), Expect = 4e-54
 Identities = 76/290 (26%), Positives = 135/290 (46%), Gaps = 35/290 (12%)

Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCF 123
             ++++  +       IG G FG VYKG       VA+K     APT    Q F +EV  
Sbjct: 23  DGQITVGQR-------IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGV 73

Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 183
           L   +H N++  +GY     L  ++ ++    S+  HL      S  K E K  + IA  
Sbjct: 74  LRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHL----HASETKFEMKKLIDIARQ 128

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
            A+G+ +LH+    ++H+D K+ N+ + ED   K+ D GL     R   +    Q++   
Sbjct: 129 TARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186

Query: 244 IFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 300
           +++A EV   ++   +S +SDVY+FG+ L EL++G+   S+++      ++E+V      
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLS 244

Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 350
            +L K+              +   +L+  CL    + RPS   ++ E++ 
Sbjct: 245 PDLSKVRSNCP---------KRMKRLMAECLKKKRDERPSFPRILAEIEE 285

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  173 bits (441), Expect = 1e-51
 Identities = 65/285 (22%), Positives = 114/285 (40%), Gaps = 38/285 (13%)

Query: 82  KNLIGEGKFGEVYKGLL-QDGMLVAIKK--RPGAPTQ-EFIDEVCFLASIQHRNLVTLLG 137
             ++G+G FG+  K    + G ++ +K+  R    TQ  F+ EV  +  ++H N++  +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 138 YC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
              ++  L   I EYI  G++   +    +    +  +  R+S A   A G+A+LHS++ 
Sbjct: 75  VLYKDKRL-NFITEYIKGGTLRGII----KSMDSQYPWSQRVSFAKDIASGMAYLHSMN- 128

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS-------- 248
            ++H+D  + N LV E+    VAD GL   +          +                  
Sbjct: 129 -IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187

Query: 249 ----EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 304
               E+   R + EK DV+SFG+ L E++    A     P +    + +           
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-----R 242

Query: 305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
                             F  + VRC D   E+RPS   +   L+
Sbjct: 243 YC---------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  169 bits (431), Expect = 1e-50
 Identities = 72/300 (24%), Positives = 124/300 (41%), Gaps = 55/300 (18%)

Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT------QEFIDEV 121
             EL+L          IG G FG+VY+     G  VA+K  R           +    E 
Sbjct: 6   FAELTLEEI-------IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEA 57

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
              A ++H N++ L G C +     L+ E+   G ++  L      S +++     ++ A
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL------SGKRIPPDILVNWA 111

Query: 182 LGAAKGLAHLHSLSPR-VVHKDFKTANVLVDEDF--------IAKVADAGLRNFLGRTDV 232
           +  A+G+ +LH  +   ++H+D K++N+L+ +          I K+ D GL     RT  
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK 171

Query: 233 ---AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD 289
              AG  +       ++A EV     FS+ SDV+S+GV L EL++G      +       
Sbjct: 172 MSAAGAYA-------WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG--LAV 222

Query: 290 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
              +  N              L     +   E F +L+  C +P    RPS ++++ +L 
Sbjct: 223 AYGVAMN-----------KLAL--PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  171 bits (435), Expect = 2e-50
 Identities = 63/302 (20%), Positives = 130/302 (43%), Gaps = 35/302 (11%)

Query: 83  NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQHRNLVTLLGYCQ 140
             IG+G+FGEV++G  + G  VA+K       + +  E  +     ++H N++  +    
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106

Query: 141 ENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS--- 193
           ++N      +L+ +Y  +GS+  +L      +R  +  +  + +AL  A GLAHLH    
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 194 ---LSPRVVHKDFKTANVLVDEDFIAKVADAGL---RNFLGRTDVAGPSSQV-----TAD 242
                P + H+D K+ N+LV ++    +AD GL    +    T    P+ +V      A 
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 302
           E+   S   +     +++D+Y+ G+   E+   R +   +  D      +LV +      
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEE 279

Query: 303 LLK-ILDERL-----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 356
           + K + +++L         + E +    +++  C   +   R +   +   L + L ++ 
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ-LSQQE 338

Query: 357 NL 358
            +
Sbjct: 339 GI 340

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  171 bits (434), Expect = 2e-50
 Identities = 65/302 (21%), Positives = 129/302 (42%), Gaps = 35/302 (11%)

Query: 83  NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQHRNLVTLLGYCQ 140
             IG+G++GEV+ G  + G  VA+K         +  E  +     ++H N++  +    
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101

Query: 141 ENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS- 195
           +        +LI +Y  NGS+  +L          L+ K  L +A  +  GL HLH+   
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYL------KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 196 -----PRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVA--GPSSQV-----TAD 242
                P + H+D K+ N+LV ++    +AD GL   F+  T+     P+++V        
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN 302
           E+   S  +   +    +D+YSFG+ L E+   R  S  +  +      +LV +   + +
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPSYED 274

Query: 303 LLK-ILDERL-----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 356
           + + +  ++L         ++E + +  +L+  C   +   R +   V   L   + +  
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL-AKMSESQ 333

Query: 357 NL 358
           ++
Sbjct: 334 DI 335

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  168 bits (428), Expect = 8e-50
 Identities = 61/302 (20%), Positives = 118/302 (39%), Gaps = 50/302 (16%)

Query: 83  NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDE--VCFLASIQHRNLVTLLGYCQ 140
             +G+G++GEV++G  Q G  VA+K       + +  E  +     ++H N++  +    
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72

Query: 141 ENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS- 195
            +       +LI  Y   GS+  +L          L+    L I L  A GLAHLH    
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 196 -----PRVVHKDFKTANVLVDEDFIAKVADAGL---RNFLGRTDVAGPSSQV-----TAD 242
                P + H+D K+ N+LV ++    +AD GL    +        G + +V      A 
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP------------DSSQDL 290
           E+   +   +     ++ D+++FG+ L E+     ++  +               S +D+
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246

Query: 291 VELV--QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
            ++V     R       I +   W   ++  +    +L+  C   +   R +   +   L
Sbjct: 247 RKVVCVDQQR-----PNIPNR--WF--SDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

Query: 349 DR 350
            +
Sbjct: 298 TK 299

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  165 bits (421), Expect = 1e-48
 Identities = 57/293 (19%), Positives = 105/293 (35%), Gaps = 44/293 (15%)

Query: 78  NFSD---KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFLASIQH 129
            F       LIG+G+FG+VY G       VAI+            + F  EV      +H
Sbjct: 31  PFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            N+V  +G C       +I       ++   +       +  L+      IA    KG+ 
Sbjct: 89  ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMG 144

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTAD------- 242
           +LH  +  ++HKD K+ NV  D   +  + D GL +  G         ++          
Sbjct: 145 YLH--AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201

Query: 243 --EIF---LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 297
             EI         ++   FS+ SDV++ G    EL +      +      + ++  +   
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQMGT- 257

Query: 298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 350
                +   L +           +E   +++ C     E RP+ + ++  L++
Sbjct: 258 ----GMKPNLSQIGMG-------KEISDILLFCWAFEQEERPTFTKLMDMLEK 299

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  150 bits (382), Expect = 7e-43
 Identities = 80/334 (23%), Positives = 136/334 (40%), Gaps = 50/334 (14%)

Query: 45  SEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL-----Q 99
           +  ++     +G     R+  +F+   L            +G+G FG V           
Sbjct: 16  TTENLYFQGAMGSAFEDRDPTQFEERHLKF-------LQQLGKGNFGSVEMCRYDPLQDN 68

Query: 100 DGMLVAIKK-RPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENNLQ--FLIYEYIPN 154
            G +VA+KK +        +F  E+  L S+QH N+V   G C     +   LI EY+P 
Sbjct: 69  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 128

Query: 155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF 214
           GS+  +L    Q  +++++    L       KG+ +L +   R +H+D  T N+LV+ + 
Sbjct: 129 GSLRDYL----QKHKERIDHIKLLQYTSQICKGMEYLGTK--RYIHRDLATRNILVENEN 182

Query: 215 IAKVADAGL-RNFLGRTDVAGPSSQVTADE-----IF-LASEVKEFRRFSEKSDVYSFGV 267
             K+ D GL +      +           E     IF  A E     +FS  SDV+SFGV
Sbjct: 183 RVKIGDFGLTKVLPQDKEYY------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 236

Query: 268 FLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGME------ 321
            L EL +  E S S   +  + +    Q      +L+++L         N  +       
Sbjct: 237 VLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN-------NGRLPRPDGCP 289

Query: 322 -EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 354
            E   ++  C + +  +RPS  D+   +D+  D+
Sbjct: 290 DEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  146 bits (370), Expect = 2e-41
 Identities = 76/294 (25%), Positives = 124/294 (42%), Gaps = 43/294 (14%)

Query: 85  IGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAPTQ--EFIDEVCFLASIQHRNLVTLL 136
           +G+G FG V            G +VA+KK +        +F  E+  L S+QH N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 137 GYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           G C     +   LI EY+P GS+  +L    Q  +++++    L       KG+ +L + 
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQICKGMEYLGTK 133

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADE-----IF-LA 247
             R +H+D  T N+LV+ +   K+ D GL +      +           E     IF  A
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF------KVKEPGESPIFWYA 185

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 307
            E     +FS  SDV+SFGV L EL +  E S S   +  + +    Q      +L+++L
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245

Query: 308 DERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 354
                    N  +        E   ++  C + +  +RPS  D+   +D+  D 
Sbjct: 246 KN-------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  143 bits (362), Expect = 8e-40
 Identities = 82/324 (25%), Positives = 130/324 (40%), Gaps = 53/324 (16%)

Query: 60  SIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAP 113
           + ++   F+   L   ++       +G+G FG V            G LVA+K+ +   P
Sbjct: 13  ACQDPTIFEERHLKYISQ-------LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP 65

Query: 114 TQ--EFIDEVCFLASIQHRNLVTLLGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSR 169
            Q  +F  E+  L ++    +V   G       Q   L+ EY+P+G +   L    Q  R
Sbjct: 66  DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHR 121

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLG 228
            +L+    L  +    KG+ +L S   R VH+D    N+LV+ +   K+AD GL +    
Sbjct: 122 ARLDASRLLLYSSQICKGMEYLGSR--RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179

Query: 229 RTDVAGPSSQVTADE-----IF-LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSS 281
             D           E     IF  A E      FS +SDV+SFGV L EL +   ++ S 
Sbjct: 180 DKDYY------VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233

Query: 282 LSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGME-------EFIQLIVRCLDPS 334
            +        E    +   S LL++L+E        + +        E  +L+  C  PS
Sbjct: 234 SAEFLRMMGCERDVPAL--SRLLELLEE-------GQRLPAPPACPAEVHELMKLCWAPS 284

Query: 335 SERRPSMSDVVTELDRTLDKEMNL 358
            + RPS S +  +LD         
Sbjct: 285 PQDRPSFSALGPQLDMLWSGSRGC 308

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  141 bits (358), Expect = 1e-39
 Identities = 71/294 (24%), Positives = 118/294 (40%), Gaps = 51/294 (17%)

Query: 85  IGEGKFGEVYKGLL-----QDGMLVAIKK-RPGAPT---QEFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V            G  VA+K  +P +      +   E+  L ++ H N+V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 136 LGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            G C E+      LI E++P+GS+  +L      ++ K+  K +L  A+   KG+ +L S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGMDYLGS 144

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-LASEVKE 252
              + VH+D    NVLV+ +   K+ D GL   +                +F  A E   
Sbjct: 145 R--QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202

Query: 253 FRRFSEKSDVYSFGVFLLELVS-GREASSSLSPD-----------SSQDLVELVQNSRDF 300
             +F   SDV+SFGV L EL++     SS ++             +   LV  ++     
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE---- 258

Query: 301 SNLLKILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 350
                   +RL              E  QL+ +C +     R S  +++   + 
Sbjct: 259 -------GKRL------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  142 bits (361), Expect = 2e-39
 Identities = 75/284 (26%), Positives = 118/284 (41%), Gaps = 42/284 (14%)

Query: 85  IGEGKFGEVYKGLLQ-DGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYC 139
           IG G FGEV+ G L+ D  LVA+K  R   P     +F+ E   L    H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
            +    +++ E +  G     L    +    +L  K  L +   AA G+ +L S     +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLESK--CCI 235

Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI---FLASEVKEFRRF 256
           H+D    N LV E  + K++D G+            ++     ++   + A E   + R+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALNYGRY 292

Query: 257 SEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLKILDERLW 312
           S +SDV+SFG+ L E  S G        P    S+Q   E V+              RL 
Sbjct: 293 SSESDVWSFGILLWETFSLGAS------PYPNLSNQQTREFVEK-----------GGRLP 335

Query: 313 STFTNEGMEEFI-QLIVRCLDPSSERRPSMSDVVTELDRTLDKE 355
                E   + + +L+ +C      +RPS S +  EL     + 
Sbjct: 336 CP---ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  138 bits (351), Expect = 7e-39
 Identities = 77/291 (26%), Positives = 124/291 (42%), Gaps = 64/291 (21%)

Query: 82  KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYC 139
              IG G+FG V+ G   +   VAIK  R GA + ++FI+E   +  + H  LV L G C
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
            E     L+ E++ +G +S +L    +  R     +  L + L   +G+A+L      V+
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEGMAYLEEA--CVI 126

Query: 200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS----------- 248
           H+D    N LV E+ + KV+D G+             ++   D+ + +S           
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGM-------------TRFVLDDQYTSSTGTKFPVKWAS 173

Query: 249 -EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNL 303
            EV  F R+S KSDV+SFGV + E+ S G+       P    S+ ++VE +         
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGK------IPYENRSNSEVVEDIST------- 220

Query: 304 LKILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 350
                 RL                 Q++  C     E RP+ S ++ +L  
Sbjct: 221 ----GFRL------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  138 bits (351), Expect = 1e-38
 Identities = 66/289 (22%), Positives = 125/289 (43%), Gaps = 50/289 (17%)

Query: 82  KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYC 139
              +G G+FG V  G  +    VAIK  + G+ +  EFI+E   + ++ H  LV L G C
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
            +    F+I EY+ NG +  +L    +  R + + +  L +     + + +L S   + +
Sbjct: 89  TKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLESK--QFL 142

Query: 200 HKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV----TADEIFLASEVKEFR 254
           H+D    N LV++  + KV+D GL R  L     +   S+     +  E+ +      + 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM------YS 196

Query: 255 RFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLKILDER 310
           +FS KSD+++FGV + E+ S G+       P    ++ +  E +               R
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGK------MPYERFTNSETAEHIAQ-----------GLR 239

Query: 311 LWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 355
           L              +   ++  C    ++ RP+   +++ +   +D+E
Sbjct: 240 L------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  142 bits (361), Expect = 1e-38
 Identities = 84/333 (25%), Positives = 133/333 (39%), Gaps = 71/333 (21%)

Query: 46  EPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVA 105
           +P V  G     +   R      M+EL L          IG+G+FG+V  G  + G  VA
Sbjct: 169 KPKVMEGTVAAQDEFYRSGWALNMKELKLLQT-------IGKGEFGDVMLGDYR-GNKVA 220

Query: 106 IKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYG 163
           +K  +  A  Q F+ E   +  ++H NLV LLG   +E    +++ EY+  GS+  +L  
Sbjct: 221 VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 280

Query: 164 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 223
                R  L     L  +L   + + +L       VH+D    NVLV ED +AKV+D GL
Sbjct: 281 RG---RSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGL 335

Query: 224 -RNFLGRTDVAGPSSQV------TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-G 275
            +      + +            TA E          ++FS KSDV+SFG+ L E+ S G
Sbjct: 336 TK------EASSTQDTGKLPVKWTAPEALR------EKKFSTKSDVWSFGILLWEIYSFG 383

Query: 276 REASSSLSP---DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGME-------EFIQ 325
           R       P      +D+V  V+              +         M+           
Sbjct: 384 R------VPYPRIPLKDVVPRVEK-----------GYK---------MDAPDGCPPAVYD 417

Query: 326 LIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL 358
           ++  C    +  RP+   +  +L+     E++L
Sbjct: 418 VMKNCWHLDAATRPTFLQLREQLEHIRTHELHL 450

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  137 bits (348), Expect = 2e-38
 Identities = 67/295 (22%), Positives = 123/295 (41%), Gaps = 64/295 (21%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FG V  G  +    VA+K  + G+ +  EF  E   +  + H  LV   G C + 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
              +++ EYI NG +  +L    +   + LE    L +     +G+A L S   + +H+D
Sbjct: 76  YPIYIVTEYISNGCLLNYL----RSHGKGLEPSQLLEMCYDVCEGMAFLESH--QFIHRD 129

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------EV 250
               N LVD D   KV+D G+             ++   D+ +++S            EV
Sbjct: 130 LAARNCLVDRDLCVKVSDFGM-------------TRYVLDDQYVSSVGTKFPVKWSAPEV 176

Query: 251 KEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLKI 306
             + ++S KSDV++FG+ + E+ S G+       P    ++ ++V  V            
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGK------MPYDLYTNSEVVLKVSQ---------- 220

Query: 307 LDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 357
              RL                 Q++  C     E+RP+   +++ ++   +K+ +
Sbjct: 221 -GHRL------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDKH 268

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  137 bits (347), Expect = 4e-38
 Identities = 76/294 (25%), Positives = 124/294 (42%), Gaps = 58/294 (19%)

Query: 82  KNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC- 139
              IG+G+FG+V  G  + G  VA+K  +  A  Q F+ E   +  ++H NLV LLG   
Sbjct: 26  LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
           +E    +++ EY+  GS+  +L       R  L     L  +L   + + +L       V
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN--NFV 139

Query: 200 HKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV------TADEIFLASEVKE 252
           H+D    NVLV ED +AKV+D GL +      + +            TA E         
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALR------ 187

Query: 253 FRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLKILD 308
            ++FS KSDV+SFG+ L E+ S GR       P      +D+V  V+             
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGR------VPYPRIPLKDVVPRVEK-----------G 230

Query: 309 ERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL 358
            ++      +  +       +++  C    +  RPS   +  +L+     E++L
Sbjct: 231 YKM------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHELHL 278

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  141 bits (357), Expect = 7e-38
 Identities = 73/294 (24%), Positives = 128/294 (43%), Gaps = 42/294 (14%)

Query: 83  NLIGEGKFGEVYKGLLQD-GMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYC 139
           + +G G++GEVY+G+ +   + VA+K  +      E F+ E   +  I+H NLV LLG C
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
                 ++I E++  G++  +L    + +RQ++     L +A   +  + +L       +
Sbjct: 286 TREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NFI 340

Query: 200 HKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSE 258
           H++    N LV E+ + KVAD GL R   G T  A   ++      + A E   + +FS 
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--WTAPESLAYNKFSI 398

Query: 259 KSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 317
           KSDV++FGV L E+ + G      +       + EL++            D R       
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLEK-----------DYR------- 437

Query: 318 EGM-------EEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGE 364
             M       E+  +L+  C   +   RPS +++    +    +      V  E
Sbjct: 438 --MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 489

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  136 bits (345), Expect = 2e-37
 Identities = 68/300 (22%), Positives = 126/300 (42%), Gaps = 58/300 (19%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDG-----MLVAIKK-RPGAPTQ---EFIDE 120
            E             +G G FG VYKGL         + VAIK+ R     +   E +DE
Sbjct: 15  TEFKKIKV-------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
              +AS+ + ++  LLG C  + +Q LI + +P G +  ++    +  +  +  ++ L+ 
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNW 122

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
            +  AKG+ +L     R+VH+D    NVLV      K+ D GL   LG  +      +  
Sbjct: 123 CVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-----KEYH 175

Query: 241 ADEIFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELV 294
           A+   +     A E    R ++ +SDV+S+GV + EL++ G +    +      ++  ++
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSIL 232

Query: 295 QNSRDFSNLLKILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 350
           +             ERL              +   ++ +C    ++ RP   +++ E  +
Sbjct: 233 EK-----------GERL------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 275

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  136 bits (344), Expect = 2e-37
 Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 49/297 (16%)

Query: 85  IGEGKFGEVYKGLLQD-----GMLVAIKK-RPGAPT---QEFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V            G +VA+K  +  A       +  E+  L ++ H +++  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 136 LGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            G C++       L+ EY+P GS+  +L       R  +     L  A    +G+A+LH+
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADE-----IF-L 246
                +H+D    NVL+D D + K+ D GL +      +           E     +F  
Sbjct: 153 Q--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY------RVREDGDSPVFWY 204

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK 305
           A E  +  +F   SDV+SFGV L EL++    + S  +       +   Q       L +
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA--QGQMTVLRLTE 262

Query: 306 ILDERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 355
           +L+         E +        E   L+  C +  +  RP+  +++  L    +K 
Sbjct: 263 LLER-------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  139 bits (351), Expect = 3e-37
 Identities = 67/287 (23%), Positives = 120/287 (41%), Gaps = 58/287 (20%)

Query: 83  NLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYCQ 140
             +G G+FGEV+         VA+K  +PG+ + + F+ E   + ++QH  LV L     
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
           +  + ++I E++  GS+   L         K      +  +   A+G+A +       +H
Sbjct: 254 KEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQR--NYIH 307

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------ 248
           +D + AN+LV    + K+AD GL             ++V  D  + A             
Sbjct: 308 RDLRAANILVSASLVCKIADFGL-------------ARVIEDNEYTAREGAKFPIKWTAP 354

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 307
           E   F  F+ KSDV+SFG+ L+E+V+ GR     +   S+ +++  ++            
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM---SNPEVIRALER----------- 400

Query: 308 DERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 350
             R+         E    E   +++RC     E RP+   + + LD 
Sbjct: 401 GYRM------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  138 bits (349), Expect = 5e-37
 Identities = 72/284 (25%), Positives = 123/284 (43%), Gaps = 52/284 (18%)

Query: 83  NLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQ 140
             +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
           E  + +++ EY+  GS+   L G +    + L     + +A   A G+A++  +    VH
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM--NYVH 303

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------ 248
           +D + AN+LV E+ + KVAD GL             +++  D  + A             
Sbjct: 304 RDLRAANILVGENLVCKVADFGL-------------ARLIEDNEYTARQGAKFPIKWTAP 350

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 307
           E   + RF+ KSDV+SFG+ L EL + GR     +    ++++++ V+            
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVER----------- 396

Query: 308 DERLWSTFTNEGM-EEFIQLIVRCLDPSSERRPSMSDVVTELDR 350
             R+          E    L+ +C     E RP+   +   L+ 
Sbjct: 397 GYRMPCP---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  138 bits (349), Expect = 1e-36
 Identities = 72/284 (25%), Positives = 123/284 (43%), Gaps = 52/284 (18%)

Query: 83  NLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQE-FIDEVCFLASIQHRNLVTLLGYCQ 140
             +G+G FGEV+ G       VAIK  +PG  + E F+ E   +  ++H  LV L     
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
           E  + +++ EY+  GS+   L G +    + L     + +A   A G+A++  +    VH
Sbjct: 333 EEPI-YIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM--NYVH 386

Query: 201 KDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------ 248
           +D + AN+LV E+ + KVAD GL             +++  D  + A             
Sbjct: 387 RDLRAANILVGENLVCKVADFGL-------------ARLIEDNEYTARQGAKFPIKWTAP 433

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 307
           E   + RF+ KSDV+SFG+ L EL + GR     +    ++++++ V+            
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVER----------- 479

Query: 308 DERLWSTFTNEGM-EEFIQLIVRCLDPSSERRPSMSDVVTELDR 350
             R+          E    L+ +C     E RP+   +   L+ 
Sbjct: 480 GYRMPCP---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  132 bits (335), Expect = 2e-36
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 33/204 (16%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGYCQEN 142
           +G G+FGEV+ G       VA+K  + G+ +   F+ E   +  +QH+ LV L     + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
            + ++I EY+ NGS+   L  PS     KL     L +A   A+G+A +       +H+D
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEER--NYIHRD 134

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------------EV 250
            + AN+LV +    K+AD GL             +++  D  + A             E 
Sbjct: 135 LRAANILVSDTLSCKIADFGL-------------ARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 251 KEFRRFSEKSDVYSFGVFLLELVS 274
             +  F+ KSDV+SFG+ L E+V+
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  132 bits (335), Expect = 2e-36
 Identities = 74/306 (24%), Positives = 130/306 (42%), Gaps = 64/306 (20%)

Query: 82  KNLIGEGKFGEVYKGLLQDG-MLVAIKK-RPGAPT-QEFIDEVCFLASIQHRNLVTLLGY 138
           K+ +G G++GEVY+G+ +   + VA+K  +      +EF+ E   +  I+H NLV LLG 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
           C      ++I E++  G++  +L    + +RQ++     L +A   +  + +L       
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK--NF 132

Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS---------- 248
           +H+D    N LV E+ + KVAD GL             S++   + + A           
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGL-------------SRLMTGDTYTAHAGAKFPIKWT 179

Query: 249 --EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSN 302
             E   + +FS KSDV++FGV L E+ + G       SP        + EL++       
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGM------SPYPGIDLSQVYELLEK------ 227

Query: 303 LLKILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL 358
                D R+      E  E    +  +L+  C   +   RPS +++    +    +    
Sbjct: 228 -----DYRM------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 276

Query: 359 TTVMGE 364
             V  E
Sbjct: 277 DEVEKE 282

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  133 bits (336), Expect = 4e-36
 Identities = 77/324 (23%), Positives = 132/324 (40%), Gaps = 60/324 (18%)

Query: 64  ARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGML-----VAIKK-RPGAPTQ-- 115
           AR F+  EL            +G G FG V+KG+           V IK     +  Q  
Sbjct: 7   ARIFKETELRKLKV-------LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 59

Query: 116 -EFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 174
               D +  + S+ H ++V LLG C  ++LQ L+ +Y+P GS+  H+    +  R  L  
Sbjct: 60  QAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHV----RQHRGALGP 114

Query: 175 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 234
           +  L+  +  AKG+ +L      +VH++    NVL+      +VAD G+ + L   D   
Sbjct: 115 QLLLNWGVQIAKGMYYLEEH--GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 172

Query: 235 PSSQV------TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSS 287
             S+        A E         F +++ +SDV+S+GV + EL++ G E  + L     
Sbjct: 173 LYSEAKTPIKWMALESIH------FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--- 223

Query: 288 QDLVELVQNSRDFSNLLKILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSD 343
            ++ +L++             ERL         +    +   ++V+C       RP+  +
Sbjct: 224 AEVPDLLEK-----------GERL------AQPQICTIDVYMVMVKCWMIDENIRPTFKE 266

Query: 344 VVTELDRTLDKEMNLTTVMGEGTP 367
           +  E  R          +  E  P
Sbjct: 267 LANEFTRMARDPPRYLVIKRESGP 290

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  132 bits (334), Expect = 8e-36
 Identities = 76/289 (26%), Positives = 117/289 (40%), Gaps = 58/289 (20%)

Query: 85  IGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVTLL 136
           IG G  GEV  G L+      + VAIK  + G   ++   F+ E   +    H N++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
           G      L  ++ EY+ NGS+   L    +    +      + +  G   G+ +L  L  
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGMLRGVGAGMRYLSDL-- 170

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV------TADEIFLASE 249
             VH+D    NVLVD + + KV+D GL R      D A  ++        TA E      
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA--- 227

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLK 305
              FR FS  SDV+SFGV + E+++ G        P    +++D++  V+          
Sbjct: 228 ---FRTFSSASDVWSFGVVMWEVLAYGE------RPYWNMTNRDVISSVEE--------- 269

Query: 306 ILDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 350
               RL                 QL++ C      +RP  S +V+ LD 
Sbjct: 270 --GYRL------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  132 bits (333), Expect = 1e-35
 Identities = 69/306 (22%), Positives = 130/306 (42%), Gaps = 51/306 (16%)

Query: 85  IGEGKFGEVYKGLLQDG-----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTL 135
           +G G FG VYKGL         + VAIK+ R     +   E +DE   +AS+ + ++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           LG C  + +Q LI + +P G +  ++    +  +  +  ++ L+  +  AKG+ +L    
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----ASEV 250
            R+VH+D    NVLV      K+ D GL   LG  +      +  A+   +     A E 
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-----KEYHAEGGKVPIKWMALES 190

Query: 251 KEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 309
              R ++ +SDV+S+GV + EL++ G +    +      ++  +++             E
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEK-----------GE 236

Query: 310 RLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEG 365
           RL              +   ++V+C    ++ RP   +++ E  +          + G+ 
Sbjct: 237 RL------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDE 290

Query: 366 TPTVTL 371
              +  
Sbjct: 291 RMHLPS 296

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  132 bits (335), Expect = 1e-35
 Identities = 81/355 (22%), Positives = 134/355 (37%), Gaps = 57/355 (16%)

Query: 28  FCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSI---REARRFQMEELSLATKNFSDKNL 84
            C     S S   + GS     Q    V I+LS       +  Q   +  ++       +
Sbjct: 37  ICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEV 96

Query: 85  IGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVTLL 136
           IG G FG VY G L D     +  A+K         E   F+ E   +    H N+++LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156

Query: 137 GYCQENNLQ-FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           G C  +     ++  Y+ +G +   +    +        K  +   L  AKG+  L S  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFLASK- 211

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----ASEV 250
            + VH+D    N ++DE F  KVAD GL   +   +     S        L     A E 
Sbjct: 212 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---FDSVHNKTGAKLPVKWMALES 267

Query: 251 KEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 309
            + ++F+ KSDV+SFGV L EL++ G      ++     D+   +               
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYLLQ-----------GR 313

Query: 310 RLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 357
           R         +           +++++C  P +E RPS S++V+ +       + 
Sbjct: 314 R---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  130 bits (330), Expect = 1e-35
 Identities = 71/294 (24%), Positives = 118/294 (40%), Gaps = 46/294 (15%)

Query: 82  KNLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLV 133
             +IG+G FG VY G   D     +  AIK        Q+   F+ E   +  + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 134 TLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
            L+G       L  ++  Y+ +G +   +    +  ++    K  +S  L  A+G+ +L 
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQVARGMEYLA 141

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----LAS 248
               + VH+D    N ++DE F  KVAD GL   +   +         A         A 
Sbjct: 142 EQ--KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA--RLPVKWTAL 197

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 307
           E  +  RF+ KSDV+SFGV L EL++ G      + P    DL   +   R         
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---FDLTHFLAQGR--------- 245

Query: 308 DERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 357
             RL         E       Q++ +C +     RP+   +V E+++ +   + 
Sbjct: 246 --RL------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  130 bits (329), Expect = 2e-35
 Identities = 66/288 (22%), Positives = 113/288 (39%), Gaps = 52/288 (18%)

Query: 82  KNLIGEGKFGEVYKGLLQDG---MLVAIKK-RPGAP---TQEFIDEVCFLASIQHRNLVT 134
              +G G FG V +G+ +     + VAIK  + G     T+E + E   +  + +  +V 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L+G CQ   L  L+ E    G +   L       R+++   +   +    + G+ +L   
Sbjct: 75  LIGVCQAEAL-MLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLEEK 129

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQV----TADEIFLA 247
               VH+D    NVL+     AK++D GL   LG  D    A  + +      A E    
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN- 186

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI 306
                FR+FS +SDV+S+GV + E +S G++    +      +++  ++           
Sbjct: 187 -----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQ---------- 228

Query: 307 LDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDR 350
             +R+      E       E   L+  C     E RP    V   +  
Sbjct: 229 -GKRM------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  131 bits (332), Expect = 2e-35
 Identities = 74/298 (24%), Positives = 133/298 (44%), Gaps = 47/298 (15%)

Query: 85  IGEGKFGEVYKGLLQDG-----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVTL 135
           IG G+FGEVYKG+L+       + VAIK  + G   ++   F+ E   +    H N++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
            G   +     +I EY+ NG++   L    +    +      + +  G A G+ +L ++ 
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFL----REKDGEFSVLQLVGMLRGIAAGMKYLANM- 166

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLASEVKEFR 254
              VH+D    N+LV+ + + KV+D GL   L     A  ++      I + A E   +R
Sbjct: 167 -NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225

Query: 255 RFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQNSRDFSNLLKILDER 310
           +F+  SDV+SFG+ + E+++ G        P    S+ ++++ + +             R
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGE------RPYWELSNHEVMKAIND-----------GFR 268

Query: 311 LWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGE 364
           L                 QL+++C      RRP  +D+V+ LD+ +    +L T+   
Sbjct: 269 L------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 320

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  130 bits (328), Expect = 3e-35
 Identities = 71/295 (24%), Positives = 116/295 (39%), Gaps = 54/295 (18%)

Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ-----EFIDEVCFLASIQHRNLVT 134
           +G+G FG V +G         + VA+K  +P   +Q     +FI EV  + S+ HRNL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L G      ++ ++ E  P GS+   L    +  +           A+  A+G+ +L S 
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRL----RKHQGHFLLGTLSRYAVQVAEGMGYLESK 140

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD---VAGPSSQV----TADEIFLA 247
             R +H+D    N+L+    + K+ D GL   L + D   V     +V     A E    
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK- 197

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI 306
                 R FS  SD + FGV L E+ + G+E    L+      ++  +            
Sbjct: 198 -----TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDKEG-------- 241

Query: 307 LDERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 357
             ERL         E    +   ++V+C     E RP+   +   L      +M 
Sbjct: 242 --ERL------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  130 bits (328), Expect = 3e-35
 Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 52/292 (17%)

Query: 83  NLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 134
            +IG G FG VY G L D     +  A+K         E   F+ E   +    H N+++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 135 LLGYCQENNLQ-FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
           LLG C  +     ++  Y+ +G +   +    +        K  +   L  AKG+ +L S
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKYLAS 146

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----AS 248
              + VH+D    N ++DE F  KVAD GL   +   +     S        L     A 
Sbjct: 147 K--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---YYSVHNKTGAKLPVKWMAL 201

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 307
           E  + ++F+ KSDV+SFGV L EL++ G      ++     D+   +   R        L
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYLLQGR-------RL 251

Query: 308 D------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
                  + L+            +++++C  P +E RPS S++V+ +     
Sbjct: 252 LQPEYCPDPLY------------EVMLKCWHPKAEMRPSFSELVSRISAIFS 291

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  128 bits (325), Expect = 9e-35
 Identities = 68/305 (22%), Positives = 130/305 (42%), Gaps = 69/305 (22%)

Query: 82  KNLIGEGKFGEVYKGLL------QDGMLVAIKK-RPGAPT--QEFIDEVCFLASIQHRNL 132
           K  +GEG FG+V+          +D MLVA+K  +       ++F  E   L ++QH ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 133 VTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSIA 181
           V   G C + +   +++EY+ +G              I + G  + ++ +L     L IA
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--VAGPSSQV 239
              A G+ +L S     VH+D  T N LV  + + K+ D G+   +  TD    G  + +
Sbjct: 140 SQIASGMVYLASQ--HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197

Query: 240 ----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLV 291
                  E  +      +R+F+ +SDV+SFGV L E+ + G+       P    S+ +++
Sbjct: 198 PIRWMPPESIM------YRKFTTESDVWSFGVILWEIFTYGK------QPWFQLSNTEVI 245

Query: 292 ELVQNSRDFSNLLKILD------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
           E +   R       +L+      + ++             +++ C     ++R ++ ++ 
Sbjct: 246 ECITQGR-------VLERPRVCPKEVY------------DVMLGCWQREPQQRLNIKEIY 286

Query: 346 TELDR 350
             L  
Sbjct: 287 KILHA 291

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  129 bits (326), Expect = 1e-34
 Identities = 72/314 (22%), Positives = 126/314 (40%), Gaps = 68/314 (21%)

Query: 85  IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQ--EFIDEVCFLASIQHRNLVTL 135
           +GEG FG+V+     +       MLVA+K  +  + +   +F  E   L  +QH+++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 136 LGYCQENNLQFLIYEYIPNGS----------VSIHLYGPSQVSRQKLEFKHRLSIALGAA 185
            G C E     +++EY+ +G            +  L G   V+   L     L++A   A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV--AGPSSQV---- 239
            G+ +L  L    VH+D  T N LV +  + K+ D G+   +  TD    G  + +    
Sbjct: 169 AGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQ 295
              E  L      +R+F+ +SDV+SFGV L E+ + G+       P    S+ + ++ + 
Sbjct: 227 MPPESIL------YRKFTTESDVWSFGVVLWEIFTYGK------QPWYQLSNTEAIDCIT 274

Query: 296 NSRDFSNLLKILD------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
             R        L+        ++             ++  C     ++R S+ DV   L 
Sbjct: 275 QGR-------ELERPRACPPEVY------------AIMRGCWQREPQQRHSIKDVHARLQ 315

Query: 350 RTLDKEMNLTTVMG 363
                      V+G
Sbjct: 316 ALAQAPPVYLDVLG 329

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  128 bits (324), Expect = 2e-34
 Identities = 69/319 (21%), Positives = 115/319 (36%), Gaps = 84/319 (26%)

Query: 85  IGEGKFGEVYKGLL------QDGMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +            M VA+K  +P A   E    + E+  L+ +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 134 TLLGYCQENNLQFLIYEYIPNGS-------------VSIHLYGPSQVSRQKLEFKHRLSI 180
            LLG C       +I EY   G               S       +     L+ +  LS 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT 240
           +   AKG+A L S     +H+D    N+L+    I K+ D GL            +  + 
Sbjct: 151 SYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFGL------------ARDIK 196

Query: 241 ADEIFLASE-----VK-------EFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSS 287
            D  ++        VK           ++ +SDV+S+G+FL EL S G      +  D  
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254

Query: 288 QDLVELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSSERR 338
               ++++                      EG  M        E   ++  C D    +R
Sbjct: 255 SKFYKMIK----------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

Query: 339 PSMSDVVTELDRTLDKEMN 357
           P+   +V  +++ + +  N
Sbjct: 293 PTFKQIVQLIEKQISESTN 311

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  129 bits (326), Expect = 3e-34
 Identities = 69/302 (22%), Positives = 124/302 (41%), Gaps = 52/302 (17%)

Query: 85  IGEGKFGEVYKGLLQ----DGMLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLL 136
           +G G+FGEV  G L+      + VAIK  + G   +   +F+ E   +    H N++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
           G   ++    ++ EY+ NGS+   L    +    +      + +  G A G+ +L  +  
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMKYLSDM-- 166

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV------TADEIFLASE 249
             VH+D    N+L++ + + KV+D GL R      + A  +         T+ E      
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--- 223

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 308
              +R+F+  SDV+S+G+ L E++S G      +   S+QD+++ V              
Sbjct: 224 ---YRKFTSASDVWSYGIVLWEVMSYGERPYWEM---SNQDVIKAVDE-----------G 266

Query: 309 ERLWSTFTNEGME----EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGE 364
            RL                 QL++ C       RP    +V+ LD+ +    +L  +   
Sbjct: 267 YRL------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSA 320

Query: 365 GT 366
             
Sbjct: 321 AA 322

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  127 bits (322), Expect = 5e-34
 Identities = 72/384 (18%), Positives = 126/384 (32%), Gaps = 100/384 (26%)

Query: 20  GIIFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNF 79
           G+ +       Y+ R     S  G+S   + P      +L   E   F    L       
Sbjct: 1   GVDYKYKQKPKYQVRWKIIESYEGNSYTFIDPT-----QLPYNEKWEFPRNNLQF----- 50

Query: 80  SDKNLIGEGKFGEVYKGLLQD------GMLVAIKK-RPGAPTQE---FIDEVCFLASI-Q 128
                +G G FG+V +            + VA+K  +  A   E    + E+  ++ + Q
Sbjct: 51  --GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL---------YGPSQVSRQKLEFKHRLS 179
           H N+V LLG C       +I EY   G +   L              ++      +  L 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
            +   A+G+A L S     +H+D    NVL+    +AK+ D GL            +  +
Sbjct: 169 FSSQVAQGMAFLASK--NCIHRDVAARNVLLTNGHVAKIGDFGL------------ARDI 214

Query: 240 TADEIFLASE-----VK-------EFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP-- 284
             D  ++        VK           ++ +SDV+S+G+ L E+ S G       +P  
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL------NPYP 268

Query: 285 --DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDP 333
               +    +LV+                      +G  M            ++  C   
Sbjct: 269 GILVNSKFYKLVK----------------------DGYQMAQPAFAPKNIYSIMQACWAL 306

Query: 334 SSERRPSMSDVVTELDRTLDKEMN 357
               RP+   + + L     ++  
Sbjct: 307 EPTHRPTFQQICSFLQEQAQEDRR 330

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  127 bits (321), Expect = 7e-34
 Identities = 73/308 (23%), Positives = 128/308 (41%), Gaps = 69/308 (22%)

Query: 82  KNLIGEGKFGEVYKGLLQDG---MLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +++IGEG FG+V K  ++     M  AIK+ +  A   +   F  E+  L  +  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 134 TLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSIAL 182
            LLG C+     +L  EY P+G+            +   +  +  +   L  +  L  A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTA 241
             A+G+ +L     + +H+D    N+LV E+++AK+AD GL R      +V         
Sbjct: 150 DVARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSRG----QEVY----VKKT 199

Query: 242 DEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQN 296
                   +A E   +  ++  SDV+S+GV L E+VS G      ++     +L E +  
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLP- 255

Query: 297 SRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSSERRPSMSDVVTE 347
                                +G  +E       E   L+ +C       RPS + ++  
Sbjct: 256 ---------------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294

Query: 348 LDRTLDKE 355
           L+R L++ 
Sbjct: 295 LNRMLEER 302

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  126 bits (318), Expect = 8e-34
 Identities = 76/308 (24%), Positives = 118/308 (38%), Gaps = 76/308 (24%)

Query: 82  KNLIGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRN 131
              +GE +FG+VYKG L           VAIK  +  A      EF  E    A +QH N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSI 180
           +V LLG   ++    +I+ Y  +G              +      +  +  LE    + +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--VAGPSSQ 238
               A G+ +L S    VVHKD  T NVLV +    K++D GL   +   D      +S 
Sbjct: 134 VAQIAAGMEYLSSH--HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 239 V----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDL 290
           +     A E  +      + +FS  SD++S+GV L E+ S G        P    S+QD+
Sbjct: 192 LPIRWMAPEAIM------YGKFSIDSDIWSYGVVLWEVFSYGL------QPYCGYSNQDV 239

Query: 291 VELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSSERRPSM 341
           VE+++                          +            L++ C +    RRP  
Sbjct: 240 VEMIR----------------------NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRF 277

Query: 342 SDVVTELD 349
            D+ + L 
Sbjct: 278 KDIHSRLR 285

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  125 bits (317), Expect = 8e-34
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 26/203 (12%)

Query: 85  IGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLL 136
           +GEG FGEVY+G+  +     + VA+K  +         +F+ E   + ++ H ++V L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
           G  +E    ++I E  P G +  +L    + ++  L+    +  +L   K +A+L S+  
Sbjct: 80  GIIEEEPT-WIIMELYPYGELGHYL----ERNKNSLKVLTLVLYSLQICKAMAYLESI-- 132

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD-VAGPSSQV----TADEIFLASEVK 251
             VH+D    N+LV      K+ D GL  ++   D      +++     + E        
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN----- 187

Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
            FRRF+  SDV+ F V + E++S
Sbjct: 188 -FRRFTTASDVWMFAVCMWEILS 209

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  125 bits (316), Expect = 1e-33
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 26/203 (12%)

Query: 85  IGEGKFGEVYKGLLQDG----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLL 136
           IGEG+FG+V++G+        + VAIK  +         +F+ E   +    H ++V L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
           G   EN + ++I E    G +   L    QV +  L+    +  A   +  LA+L S   
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTALAYLESK-- 135

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD-VAGPSSQV----TADEIFLASEVK 251
           R VH+D    NVLV  +   K+ D GL  ++  +        ++     A E        
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN----- 190

Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
            FRRF+  SDV+ FGV + E++ 
Sbjct: 191 -FRRFTSASDVWMFGVCMWEILM 212

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  125 bits (315), Expect = 2e-33
 Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 33/219 (15%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDG---MLVAIKK-RPGAPTQ----EFIDEV 121
           + L+L  K       +G G FG V KG  Q       VA+K  +  A       E + E 
Sbjct: 16  KLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
             +  + +  +V ++G C+  +   L+ E    G ++ +L     V  + +     + + 
Sbjct: 70  NVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELV 123

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
              + G+ +L       VH+D    NVL+     AK++D GL   L   +     +   A
Sbjct: 124 HQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKA 176

Query: 242 DEI------FLASEVKEFRRFSEKSDVYSFGVFLLELVS 274
                    + A E   + +FS KSDV+SFGV + E  S
Sbjct: 177 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  125 bits (315), Expect = 3e-33
 Identities = 64/301 (21%), Positives = 117/301 (38%), Gaps = 58/301 (19%)

Query: 85  IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 134
           +G+G FG VY+G+ +          VAIK     A  +E   F++E   +      ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHL-----YGPSQVSRQKLEFKHRLSIALGAAKGLA 189
           LLG   +     +I E +  G +  +L        +            + +A   A G+A
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--VAGPSSQV----TADE 243
           +L++   + VH+D    N +V EDF  K+ D G+   +  TD    G    +     + E
Sbjct: 153 YLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN 302
                       F+  SDV+SFGV L E+ +   +    LS    + ++  V        
Sbjct: 211 SLK------DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFVMEGG---- 257

Query: 303 LLKILD------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 356
              +LD      + L+            +L+  C   + + RPS  ++++ +   ++   
Sbjct: 258 ---LLDKPDNCPDMLF------------ELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302

Query: 357 N 357
            
Sbjct: 303 R 303

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  123 bits (312), Expect = 7e-33
 Identities = 62/304 (20%), Positives = 122/304 (40%), Gaps = 66/304 (21%)

Query: 82  KNLIGEGKFGEVYKGLLQDG----MLVAIK--KRPGAPTQE---FIDEVCFLASIQHRNL 132
             ++GEG+FG V +G L+      + VA+K  K   +  +E   F+ E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 133 VTLLGYC-----QENNLQFLIYEYIPNGSVSIHL-YGPSQVSRQKLEFKHRLSIALGAAK 186
           + LLG C     Q      +I  ++  G +  +L Y   +   + +  +  L   +  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV--AGPSSQV----T 240
           G+ +L +     +H+D    N ++ +D    VAD GL   +   D    G  +++     
Sbjct: 159 GMEYLSNR--NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP---DSSQDLVELVQN 296
           A E          R ++ KSDV++FGV + E+ + G       +P     + ++ + + +
Sbjct: 217 AIESLA------DRVYTSKSDVWAFGVTMWEIATRGM------TPYPGVQNHEMYDYLLH 264

Query: 297 SRDFSNLLKILDERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVVTELD 349
                        R         ++       E  +++  C       RP+ S +  +L+
Sbjct: 265 GH-----------R---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304

Query: 350 RTLD 353
           + L+
Sbjct: 305 KLLE 308

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  128 bits (323), Expect = 9e-33
 Identities = 81/340 (23%), Positives = 136/340 (40%), Gaps = 55/340 (16%)

Query: 31  YRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKF 90
            R+ +VS +     +E   +        +        Q E + L          IGEG+F
Sbjct: 354 VRSHTVSVSETDDYAEIIDEEDTY---TMPSTRDYEIQRERIELGRC-------IGEGQF 403

Query: 91  GEVYKGLLQDG----MLVAIKK-RPGAPTQ---EFIDEVCFLASIQHRNLVTLLGYCQEN 142
           G+V++G+        M VAIK  +         +F+ E   +    H ++V L+G   EN
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 463

Query: 143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD 202
            + ++I E    G +   L    QV +  L+    +  A   +  LA+L S   R VH+D
Sbjct: 464 PV-WIIMELCTLGELRSFL----QVRKFSLDLASLILYAYQLSTALAYLESK--RFVHRD 516

Query: 203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-----ASEVKEFRRFS 257
               NVLV  +   K+ D GL  ++  +          A +  L     A E   FRRF+
Sbjct: 517 IAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESINFRRFT 570

Query: 258 EKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT 316
             SDV+ FGV + E++  G +    +      D++  ++N            ERL     
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIEN-----------GERLPMP-- 614

Query: 317 NEGMEEFI-QLIVRCLDPSSERRPSMSDVVTELDRTLDKE 355
                  +  L+ +C      RRP  +++  +L   L++E
Sbjct: 615 -PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  128 bits (322), Expect = 1e-32
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 25/203 (12%)

Query: 85  IGEGKFGEVYKGLLQDG---MLVAIKK-RPGAP---TQEFIDEVCFLASIQHRNLVTLLG 137
           +G G FG V +G+ +     + VAIK  + G     T+E + E   +  + +  +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
            CQ   L  L+ E    G +   L       R+++   +   +    + G+ +L      
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLEEK--N 456

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------FLASEVK 251
            VH++    NVL+     AK++D GL   LG  D     S  TA         + A E  
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLKWYAPECI 511

Query: 252 EFRRFSEKSDVYSFGVFLLELVS 274
            FR+FS +SDV+S+GV + E +S
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  123 bits (310), Expect = 2e-32
 Identities = 62/292 (21%), Positives = 114/292 (39%), Gaps = 48/292 (16%)

Query: 85  IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 134
           +G G FGEVY+G +         + VA+K        Q+   F+ E   ++   H+N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
            +G   ++  +F++ E +  G +   L    P       L     L +A   A G  +L 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 193 SLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTD--VAGPSSQV----TADE 243
                 +H+D    N L+       +AK+ D G+   + R      G  + +       E
Sbjct: 158 EN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN 302
            F+         F+ K+D +SFGV L E+ S G     S    S+Q+++E V +      
Sbjct: 216 AFM------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLEFVTSGG---- 262

Query: 303 LLKILDERLWSTFTNEG-MEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
                  R+      +       +++ +C     E RP+ + ++  ++    
Sbjct: 263 -------RMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  123 bits (310), Expect = 2e-32
 Identities = 60/326 (18%), Positives = 127/326 (38%), Gaps = 61/326 (18%)

Query: 59  LSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDG----MLVAIKK-RPGAP 113
           L I +  + ++E++ +  + F+   ++G+G+FG V +  L+      + VA+K  +    
Sbjct: 5   LGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII 64

Query: 114 T----QEFIDEVCFLASIQHRNLVTLLGYC------QENNLQFLIYEYIPNGSVSIHLYG 163
                +EF+ E   +    H ++  L+G            +  +I  ++ +G +   L  
Sbjct: 65  ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA 124

Query: 164 PS-QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG 222
                +   L  +  +   +  A G+ +L S     +H+D    N ++ ED    VAD G
Sbjct: 125 SRIGENPFNLPLQTLVRFMVDIACGMEYLSSR--NFIHRDLAARNCMLAEDMTVCVADFG 182

Query: 223 LRNFLGRTDV--AGPSSQV----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-G 275
           L   +   D    G +S++     A E            ++  SDV++FGV + E+++ G
Sbjct: 183 LSRKIYSGDYYRQGCASKLPVKWLALESLA------DNLYTVHSDVWAFGVTMWEIMTRG 236

Query: 276 REASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGME-------EFIQLIV 328
           +   + +      ++   +               R         ++       E   L+ 
Sbjct: 237 QTPYAGIEN---AEIYNYLIGGN-----------R---------LKQPPECMEEVYDLMY 273

Query: 329 RCLDPSSERRPSMSDVVTELDRTLDK 354
           +C     ++RPS + +  EL+  L  
Sbjct: 274 QCWSADPKQRPSFTCLRMELENILGH 299

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  122 bits (308), Expect = 3e-32
 Identities = 70/314 (22%), Positives = 114/314 (36%), Gaps = 75/314 (23%)

Query: 85  IGEGKFGEVYKGLLQD------GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLV 133
           +G G FG+V +              VA+K  + GA   E    + E+  L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 134 TLLGYC-QENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSIA 181
            LLG C +      +I E+   G+              +   P  + +  L  +H +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
              AKG+  L S   + +H+D    N+L+ E  + K+ D GL   + +            
Sbjct: 155 FQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKG 208

Query: 242 DEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP----DSSQDLVE 292
           D       +A E    R ++ +SDV+SFGV L E+ S G       SP       ++   
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA------SPYPGVKIDEEFCR 262

Query: 293 LVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSSERRPSMSD 343
            ++                      EG  M        E  Q ++ C      +RP+ S+
Sbjct: 263 RLK----------------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 300

Query: 344 VVTELDRTLDKEMN 357
           +V  L   L     
Sbjct: 301 LVEHLGNLLQANAQ 314

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  122 bits (309), Expect = 3e-32
 Identities = 71/312 (22%), Positives = 130/312 (41%), Gaps = 65/312 (20%)

Query: 82  KNLIGEGKFGEVYKGLLQD--------GMLVAIKK-RPGAPTQE---FIDEVCFLASI-Q 128
              +GEG FG+V                + VA+K  +  A  ++    + E+  +  I +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHR 177
           H+N++ LLG C ++   ++I EY   G+              + Y  ++V  +++ FK  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
           +S     A+G+ +L S   + +H+D    NVLV E+ + K+AD GL   +   D      
Sbjct: 160 VSCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 213

Query: 238 QVTADEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE 292
           + T +       +A E    R ++ +SDV+SFGV + E+ + G      +     ++L +
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EELFK 270

Query: 293 LVQNSRDFSNLLKILDERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDVV 345
           L++              R         M+       E   ++  C      +RP+   +V
Sbjct: 271 LLKEGH-----------R---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

Query: 346 TELDRTLDKEMN 357
            +LDR L    N
Sbjct: 311 EDLDRILTLTTN 322

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  123 bits (311), Expect = 3e-32
 Identities = 82/373 (21%), Positives = 148/373 (39%), Gaps = 77/373 (20%)

Query: 32  RNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDK--------- 82
             R V+ ++E+ SS  S  P   +   LS        +  +S        K         
Sbjct: 26  LRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTP-MLAGVSEYELPEDPKWEFPRDKLT 84

Query: 83  --NLIGEGKFGEVYKGLLQD--------GMLVAIKK-RPGAPTQE---FIDEVCFLASI- 127
               +GEG FG+V                + VA+K  +  A  ++    + E+  +  I 
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGS-----------VSIHLYGPSQVSRQKLEFKH 176
           +H+N++ LLG C ++   ++I EY   G+              + Y  ++V  +++ FK 
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 177 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 236
            +S     A+G+ +L S   + +H+D    NVLV E+ + K+AD GL   +   D     
Sbjct: 205 LVSCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY--- 259

Query: 237 SQVTADEIF----LASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLV 291
            + T +       +A E    R ++ +SDV+SFGV + E+ + G      +     ++L 
Sbjct: 260 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EELF 315

Query: 292 ELVQNSRDFSNLLKILDERLWSTFTNEGME-------EFIQLIVRCLDPSSERRPSMSDV 344
           +L++              R         M+       E   ++  C      +RP+   +
Sbjct: 316 KLLKEGH-----------R---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 355

Query: 345 VTELDRTLDKEMN 357
           V +LDR L    N
Sbjct: 356 VEDLDRILTLTTN 368

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  122 bits (308), Expect = 6e-32
 Identities = 68/331 (20%), Positives = 111/331 (33%), Gaps = 97/331 (29%)

Query: 82  KNLIGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASI-QHR 130
             ++G G FG+V              + VA+K  +  A + E    + E+  +  +  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGS------------------VSIHLYGPSQVSRQKL 172
           N+V LLG C  +   +LI+EY   G                            +     L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 173 EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV 232
            F+  L  A   AKG+  L       VH+D    NVLV    + K+ D GL         
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKVVKICDFGL--------- 218

Query: 233 AGPSSQVTADEIFLASE-----VK-------EFRRFSEKSDVYSFGVFLLELVS-GREAS 279
              +  + +D  ++        VK           ++ KSDV+S+G+ L E+ S G    
Sbjct: 219 ---ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV--- 272

Query: 280 SSLSP----DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQL 326
              +P        +  +L+Q                       G  M+       E   +
Sbjct: 273 ---NPYPGIPVDANFYKLIQ----------------------NGFKMDQPFYATEEIYII 307

Query: 327 IVRCLDPSSERRPSMSDVVTELDRTLDKEMN 357
           +  C    S +RPS  ++ + L   L     
Sbjct: 308 MQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  122 bits (308), Expect = 8e-32
 Identities = 62/292 (21%), Positives = 113/292 (38%), Gaps = 48/292 (16%)

Query: 85  IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 134
           +G G FGEVY+G +         + VA+K        Q+   F+ E   ++   H+N+V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHL--YGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
            +G   ++  +F++ E +  G +   L    P       L     L +A   A G  +L 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 193 SLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTD--VAGPSSQV----TADE 243
                 +H+D    N L+       +AK+ D G+   + R      G  + +       E
Sbjct: 199 EN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 256

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSN 302
            F+         F+ K+D +SFGV L E+ S G     S S    Q+++E V +      
Sbjct: 257 AFM------EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVTSGG---- 303

Query: 303 LLKILDERLWSTFTNEG-MEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
                  R+      +       +++ +C     E RP+ + ++  ++    
Sbjct: 304 -------RMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  121 bits (305), Expect = 8e-32
 Identities = 71/317 (22%), Positives = 123/317 (38%), Gaps = 80/317 (25%)

Query: 85  IGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRNLVT 134
           +GEG+FG+V K              VA+K  +  A   E    + E   L  + H +++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 135 LLGYCQENNLQFLIYEYIPNGS-------------------VSIHLYGPSQVSRQKLEFK 175
           L G C ++    LI EY   GS                    S +         + L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 176 HRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--VA 233
             +S A   ++G+ +L  +  ++VH+D    N+LV E    K++D GL   +   D  V 
Sbjct: 151 DLISFAWQISQGMQYLAEM--KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 208

Query: 234 GPSSQV----TADE-IFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSS 287
               ++     A E +F          ++ +SDV+SFGV L E+V+ G      + P   
Sbjct: 209 RSQGRIPVKWMAIESLF-------DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP--- 258

Query: 288 QDLVELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLDPSSERR 338
           + L  L++                       G  ME       E  +L+++C     ++R
Sbjct: 259 ERLFNLLK----------------------TGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

Query: 339 PSMSDVVTELDRTLDKE 355
           P  +D+  +L++ + K 
Sbjct: 297 PVFADISKDLEKMMVKR 313

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  122 bits (308), Expect = 1e-31
 Identities = 81/354 (22%), Positives = 136/354 (38%), Gaps = 76/354 (21%)

Query: 42  TGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD- 100
           T +             EL          + L L          +GEG FG+V        
Sbjct: 41  TENLYFQGMLAGVSEYELPEDPRWELPRDRLVL-------GKPLGEGAFGQVVLAEAIGL 93

Query: 101 -------GMLVAIKK-RPGAPTQE---FIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI 148
                     VA+K  +  A  ++    I E+  +  I +H+N++ LLG C ++   ++I
Sbjct: 94  DKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 153

Query: 149 YEYIPNGS-----------VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
            EY   G+              + Y PS    ++L  K  +S A   A+G+ +L S   +
Sbjct: 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--K 211

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----LASEVKEF 253
            +H+D    NVLV ED + K+AD GL   +   D      + T +       +A E    
Sbjct: 212 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMAPEALFD 267

Query: 254 RRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 312
           R ++ +SDV+SFGV L E+ + G      +     ++L +L++                 
Sbjct: 268 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EELFKLLK----------------- 307

Query: 313 STFTNEG--ME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 357
                EG  M+       E   ++  C      +RP+   +V +LDR +    N
Sbjct: 308 -----EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  121 bits (305), Expect = 2e-31
 Identities = 72/323 (22%), Positives = 114/323 (35%), Gaps = 86/323 (26%)

Query: 82  KNLIGEGKFGEVYKGLLQDG------MLVAIKK-RPGAPTQE---FIDEVCFLASIQHRN 131
              IGEG FG V++             +VA+K  +  A       F  E   +A   + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGS-------------------VSIHLYGPSQVSRQKL 172
           +V LLG C       L++EY+  G                            S      L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 173 EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTD 231
               +L IA   A G+A+L     + VH+D  T N LV E+ + K+AD GL RN +   D
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIADFGLSRN-IYSAD 228

Query: 232 --VAGPSSQV----TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSP 284
              A  +  +       E         + R++ +SDV+++GV L E+ S G        P
Sbjct: 229 YYKADGNDAIPIRWMPPESIF------YNRYTTESDVWAYGVVLWEIFSYGL------QP 276

Query: 285 ---DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG--ME-------EFIQLIVRCLD 332
               + ++++  V+                      +G  +        E   L+  C  
Sbjct: 277 YYGMAHEEVIYYVR----------------------DGNILACPENCPLELYNLMRLCWS 314

Query: 333 PSSERRPSMSDVVTELDRTLDKE 355
                RPS   +   L R  ++ 
Sbjct: 315 KLPADRPSFCSIHRILQRMCERA 337

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  120 bits (302), Expect = 2e-31
 Identities = 72/330 (21%), Positives = 121/330 (36%), Gaps = 52/330 (15%)

Query: 22  IFFLSWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSD 81
           ++F S    ++ +    +    +SE    PG +       R    FQ        ++F  
Sbjct: 18  LYFQSM---HQLQPRRVSFRGEASETLQSPGYD-----PSRPESFFQ--------QSFQR 61

Query: 82  KNLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQE---FIDEVCFLASI-QHRNLVT 134
            + +G G +GEV+K    +DG L A+K    P    ++    + EV     + QH   V 
Sbjct: 62  LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L    +E  + +L  E     S+  H     +     L               LAHLHS 
Sbjct: 122 LEQAWEEGGILYLQTELC-GPSLQQHC----EAWGASLPEAQVWGYLRDTLLALAHLHSQ 176

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
              +VH D K AN+ +      K+ D GL   LG         Q   D  ++A E+ +  
Sbjct: 177 --GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQE-GDPRYMAPELLQ-G 230

Query: 255 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 314
            +   +DV+S G+ +LE+    E      P   +   +L Q           L     + 
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL-----PHGGEGWQQLRQ---------GYLPPEFTAG 276

Query: 315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
            +     E   ++V  L+P  + R +   +
Sbjct: 277 LS----SELRSVLVMMLEPDPKLRATAEAL 302

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  118 bits (298), Expect = 5e-31
 Identities = 54/300 (18%), Positives = 116/300 (38%), Gaps = 63/300 (21%)

Query: 85  IGEGKFGEVYKGLLQD--------GMLVAIKK-RPGAPTQ--EFIDEVCFLASIQHRNLV 133
           +G+G F +++KG+ ++           V +K            F +    ++ + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
              G C   +   L+ E++  GS+  +L    + ++  +    +L +A   A  +  L  
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYL----KKNKNCINILWKLEVAKQLAAAMHFLEE 131

Query: 194 LSPRVVHKDFKTANVLVDEDF--------IAKVADAGLRNFLGRTDVAGPSSQVTADEIF 245
               ++H +    N+L+  +           K++D G+            S  V   +I 
Sbjct: 132 N--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI------------SITVLPKDIL 177

Query: 246 ------LASE-VKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNS 297
                 +  E ++  +  +  +D +SFG  L E+ S G +  S+L    SQ  ++  ++ 
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL---DSQRKLQFYED- 233

Query: 298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN 357
                       +L      +  E    LI  C+D   + RPS   ++ +L+     ++ 
Sbjct: 234 ----------RHQL---PAPKAAELA-NLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  116 bits (293), Expect = 3e-30
 Identities = 61/290 (21%), Positives = 117/290 (40%), Gaps = 43/290 (14%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPT---QEFIDEVCFLASI-Q 128
           T  F +   IG G+FG V+K +   DG + AIK+  +P A +   Q  + EV   A + Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
           H ++V       E++   +  EY   GS++      +       +      + L   +GL
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLA-DAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA-------GPSSQVTA 241
            ++HS+   +VH D K +N+ +    I   A          ++         G  +++++
Sbjct: 129 RYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 242 DEIF------LASEV-KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 294
            ++       LA+EV +E      K+D+++  + ++             P +     E+ 
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL-----PRNGDQWHEIR 241

Query: 295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           Q       +      ++ S       +EF +L+   + P  ERRPS   +
Sbjct: 242 QG--RLPRI-----PQVLS-------QEFTELLKVMIHPDPERRPSAMAL 277

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  117 bits (294), Expect = 4e-30
 Identities = 59/311 (18%), Positives = 108/311 (34%), Gaps = 43/311 (13%)

Query: 62  REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPTQEFI 118
           RE   FQ   + +  K++     +GEG F  V     L DG   A+K+        +E  
Sbjct: 14  RENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA 73

Query: 119 D-EVCFLASIQHRNLVTLLGYCQENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
             E        H N++ L+ YC          +L+  +   G++   +    +     L 
Sbjct: 74  QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIE-RLKDKGNFLT 132

Query: 174 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
               L + LG  +GL  +H+      H+D K  N+L+ ++    + D G  N        
Sbjct: 133 EDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190

Query: 234 GPSSQVTADEI-------FLASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLS 283
              +    D         + A E+   +      E++DV+S G  L  ++ G        
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE------G 244

Query: 284 P----DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP 339
           P        D V L   ++        L        +        QL+   +     +RP
Sbjct: 245 PYDMVFQKGDSVALAVQNQ--------LSIPQSPRHS----SALWQLLNSMMTVDPHQRP 292

Query: 340 SMSDVVTELDR 350
            +  ++++L+ 
Sbjct: 293 HIPLLLSQLEA 303

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  112 bits (282), Expect = 8e-29
 Identities = 60/276 (21%), Positives = 105/276 (38%), Gaps = 51/276 (18%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
            IG G F  VYKGL  +  + VA       K   +  Q F +E   L  +QH N+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 138 Y----CQENNLQFLIYEYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIALGAA 185
                 +      L+ E + +G++   +  +            RQ L+            
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK------------ 140

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
            GL  LH+ +P ++H+D K  N+ +       K+ D GL      +     +   T +  
Sbjct: 141 -GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPE-- 195

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 304
           F+A E+ E  ++ E  DVY+FG+ +LE+ +     S      +  +   V +        
Sbjct: 196 FMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTS-------- 244

Query: 305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 340
            +           E ++E I+    C+  + + R S
Sbjct: 245 GVKPASFDKVAIPE-VKEIIE---GCIRQNKDERYS 276

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  112 bits (283), Expect = 9e-29
 Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 33/279 (11%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK--RPGAPT----QEFIDEVCFLASIQH 129
            NF  +  IG G+F EVY+   L DG+ VA+KK             + I E+  L  + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR--LSIALGAAKG 187
            N++       E+N   ++ E    G +S  +       +QK     R      +     
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-TADEIF 245
           L H+HS   RV+H+D K ANV +    + K+ D GL R F  +T  A   S V T    +
Sbjct: 149 LEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTP--YY 202

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 305
           ++ E      ++ KSD++S G  L E+ + +            +L  L +         K
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLCK---------K 249

Query: 306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           I         ++   EE  QL+  C++P  E+RP ++ V
Sbjct: 250 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  112 bits (283), Expect = 2e-28
 Identities = 54/279 (19%), Positives = 114/279 (40%), Gaps = 39/279 (13%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 130
           + +     IGEG FG+       +DG    IK+           +E   EV  LA+++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           N+V      +EN   +++ +Y   G +   +   +       +    L   +     L H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKH 140

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-TADEIFLAS 248
           +H    +++H+D K+ N+ + +D   ++ D G+ R      ++A   + + T    +L+ 
Sbjct: 141 VHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA--RACIGTP--YYLSP 194

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 308
           E+ E + ++ KSD+++ G  L EL + +          +  +  LV          KI+ 
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLK------HAFEAGSMKNLVL---------KIIS 239

Query: 309 ---ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
                +   ++     +   L+ +    +   RPS++ +
Sbjct: 240 GSFPPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSI 274

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  110 bits (278), Expect = 4e-28
 Identities = 51/295 (17%), Positives = 95/295 (32%), Gaps = 49/295 (16%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRN 131
            +F     +G G FG V++     D    AIK+          ++ + EV  LA ++H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 132 LVTLLGYCQENNLQ------------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           +V       E N              ++  +     ++   +    + + ++ E    L 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN--GRCTIEERERSVCLH 122

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
           I L  A+ +  LHS    ++H+D K +N+    D + KV D GL   + + +        
Sbjct: 123 IFLQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 240 TADEIFLAS----------EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD 289
                              E      +S K D++S G+ L EL+                
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMER------- 233

Query: 290 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
                         L  +    +     +       ++   L PS   RP   ++
Sbjct: 234 -----------VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  110 bits (276), Expect = 7e-28
 Identities = 55/286 (19%), Positives = 111/286 (38%), Gaps = 49/286 (17%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTL 135
            +F +  LIG G FG+V+K     DG    IK+      ++   EV  LA + H N+V  
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-NEKAEREVKALAKLDHVNIVHY 69

Query: 136 LGYCQENNLQ----------------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
            G     +                  F+  E+   G++   +    +   +KL+    L 
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLDKVLALE 126

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV 239
           +     KG+ ++HS   +++++D K +N+ + +    K+ D GL   L        +   
Sbjct: 127 LFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSK 182

Query: 240 -TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 298
            T    +++ E    + + ++ D+Y+ G+ L EL+   +     +   +           
Sbjct: 183 GTLR--YMSPEQISSQDYGKEVDLYALGLILAELLHVCD-----TAFETSKFFT------ 229

Query: 299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
                  + D  +   F     ++   L+ + L    E RP+ S++
Sbjct: 230 ------DLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEI 265

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  108 bits (272), Expect = 2e-27
 Identities = 62/286 (21%), Positives = 113/286 (39%), Gaps = 44/286 (15%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 130
           +++     IG G +G   K     DG ++  K+        A  Q  + EV  L  ++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 131 NLVTLLG--YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR--LSIALGAAK 186
           N+V        + N   +++ EY   G ++  +   ++ ++++        L +      
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEEFVLRVMTQLTL 122

Query: 187 GLAHLHS---LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQV-TA 241
            L   H        V+H+D K ANV +D     K+ D GL   L      A   + V T 
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KTFVGTP 180

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 301
              +++ E      ++EKSD++S G  L EL +         P ++    EL        
Sbjct: 181 --YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAG------ 226

Query: 302 NLLKILD---ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
              KI +    R+   ++    +E  ++I R L+     RPS+ ++
Sbjct: 227 ---KIREGKFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEI 265

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  109 bits (273), Expect = 4e-27
 Identities = 60/261 (22%), Positives = 102/261 (39%), Gaps = 35/261 (13%)

Query: 32  RNRSVSRTSETGSSEPSVQPGRNVGIE-LSIREARRFQMEELSLATKNFSDKNLIGEGKF 90
              S+++T  +GS++           E + + E  +    E        + +  +G G F
Sbjct: 12  SLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSF 71

Query: 91  GEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY 149
           GEV++    Q G   A+KK      +   +E+   A +    +V L G  +E     +  
Sbjct: 72  GEVHRMKDKQTGFQCAVKKVRLEVFRV--EELVACAGLSSPRIVPLYGAVREGPWVNIFM 129

Query: 150 EYIPNGSVS--IHLYGP------SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHK 201
           E +  GS+   I   G            Q LE             GL +LH+   R++H 
Sbjct: 130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALE-------------GLEYLHTR--RILHG 174

Query: 202 DFKTANVLVDED-FIAKVADAGL-----RNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
           D K  NVL+  D   A + D G       + LG++ + G     T  E  +A EV   + 
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT--ETHMAPEVVMGKP 232

Query: 256 FSEKSDVYSFGVFLLELVSGR 276
              K D++S    +L +++G 
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGC 253

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  107 bits (268), Expect = 2e-26
 Identities = 65/324 (20%), Positives = 107/324 (33%), Gaps = 66/324 (20%)

Query: 62  REARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEF 117
           R+   F  + + L       + ++ EG F  VY+   +  G   A+K          +  
Sbjct: 13  RDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI 72

Query: 118 IDEVCFLASIQ-HRNLVTLLGYC-------QENNLQFLIYEYIPNGSVSIHLYGPSQVSR 169
           I EVCF+  +  H N+V                  +FL+   +  G +   L      SR
Sbjct: 73  IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK--KMESR 130

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
             L     L I     + + H+H   P ++H+D K  N+L+      K+ D G    +  
Sbjct: 131 GPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI-- 188

Query: 230 TDVAGPSSQVTADEIFLASEVKE---------------FRRF--SEKSDVYSFGVFLLEL 272
                P    +A    L  E                  +  F   EK D+++ G  L  L
Sbjct: 189 --SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246

Query: 273 VSGREASSSLSPDSSQDLVELVQNSRDF--SNLLKILDERL----WSTFTNEGMEEFIQL 326
              +       P               F     L+I++ +       T        F  L
Sbjct: 247 CFRQ------HP---------------FEDGAKLRIVNGKYSIPPHDTQY----TVFHSL 281

Query: 327 IVRCLDPSSERRPSMSDVVTELDR 350
           I   L  + E R S+++VV +L  
Sbjct: 282 IRAMLQVNPEERLSIAEVVHQLQE 305

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  102 bits (257), Expect = 4e-25
 Identities = 56/301 (18%), Positives = 104/301 (34%), Gaps = 56/301 (18%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNL 132
             +F +  ++G+G FG+V K     D    AIK  +         + EV  LAS+ H+ +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64

Query: 133 VTLLG-YCQENNLQ------------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS 179
           V     + +  N              F+  EY  NG++   +           +      
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDEYWR 120

Query: 180 IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ 238
           +     + L+++HS    ++H+D K  N+ +DE    K+ D GL +N     D+    SQ
Sbjct: 121 LFRQILEALSYIHSQ--GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 239 VTADEIFLAS-----------EVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDS 286
                    +           EV +     +EK D+YS G+   E++            +
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------FST 230

Query: 287 SQDLVELVQNSRDFSNLLKI---LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 343
             + V +         L  +                 +   ++I   +D    +RP    
Sbjct: 231 GMERVNI------LKKLRSVSIEFPPDFDDNKM----KVEKKIIRLLIDHDPNKRPGART 280

Query: 344 V 344
           +
Sbjct: 281 L 281

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  101 bits (253), Expect = 1e-24
 Identities = 71/287 (24%), Positives = 116/287 (40%), Gaps = 59/287 (20%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID----EVCFLASIQHR 130
            + F+    IG+G FGEV+KG+  +   +VAIK       ++ I+    E+  L+     
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 131 NLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            +    G Y ++  L ++I EY+  GS    L  P       L+     +I     KGL 
Sbjct: 81  YVTKYYGSYLKDTKL-WIIMEYLGGGSAL-DLLEP-----GPLDETQIATILREILKGLD 133

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVAD----AGLRNFLGR--TDVAGPSSQVTADE 243
           +LHS   + +H+D K ANVL+ E    K+AD      L +   +  T V  P        
Sbjct: 134 YLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP-------- 183

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 303
            ++A EV +   +  K+D++S G+  +EL  G    S L P                  L
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---------------MKVL 228

Query: 304 LKI-------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 343
             I       L+   +S       +   + +  CL+     RP+  +
Sbjct: 229 FLIPKNNPPTLEGN-YS-------KPLKEFVEACLNKEPSFRPTAKE 267

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  100 bits (250), Expect = 3e-24
 Identities = 59/283 (20%), Positives = 119/283 (42%), Gaps = 50/283 (17%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRN 131
            K ++    IG+G  G VY  + +  G  VAI++   +     +  I+E+  +   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 132 LVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           +V  L  Y   + L +++ EY+  GS++        V+   ++     ++     + L  
Sbjct: 79  IVNYLDSYLVGDEL-WVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEF 131

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------ 244
           LHS   +V+H+D K+ N+L+  D   K+ D G              +Q+T ++       
Sbjct: 132 LHSN--QVIHRDIKSDNILLGMDGSVKLTDFGF------------CAQITPEQSKRSTMV 177

Query: 245 ----FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 300
               ++A EV   + +  K D++S G+  +E++ G     + +P   + L  +  N    
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIATNGTP- 234

Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 343
               ++ +    S         F   + RCL+   E+R S  +
Sbjct: 235 ----ELQNPEKLS-------AIFRDFLNRCLEMDVEKRGSAKE 266

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  100 bits (250), Expect = 3e-24
 Identities = 64/290 (22%), Positives = 123/290 (42%), Gaps = 35/290 (12%)

Query: 73  SLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASI 127
           S+   ++  + +IG G    V           VAIK+    +      E + E+  ++  
Sbjct: 11  SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70

Query: 128 QHRNLVTLLG-YCQENNLQFLIYEYIPNGSVS---IHLYGPSQVSRQKLEFKHRLSIALG 183
            H N+V+    +  ++ L +L+ + +  GSV     H+    +     L+     +I   
Sbjct: 71  HHPNIVSYYTSFVVKDEL-WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQVTAD 242
             +GL +LH      +H+D K  N+L+ ED   ++AD G+  FL    D+     + T  
Sbjct: 130 VLEGLEYLHKN--GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT-- 185

Query: 243 EIF------LASEV-KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 295
             F      +A EV ++ R +  K+D++SFG+  +EL +G        P   + L+  +Q
Sbjct: 186 --FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP--MKVLMLTLQ 241

Query: 296 NS--RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 343
           N      + +      + +        + F ++I  CL    E+RP+ ++
Sbjct: 242 NDPPSLETGVQDKEMLKKYG-------KSFRKMISLCLQKDPEKRPTAAE 284

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 99.3 bits (248), Expect = 6e-24
 Identities = 71/290 (24%), Positives = 116/290 (40%), Gaps = 57/290 (19%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRN 131
            + +     +G+G FG+VYK    + G L A K    +     +++I E+  LA+  H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 132 LVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           +V LLG Y  +  L +++ E+ P G+V   +        + L       +     + L  
Sbjct: 78  IVKLLGAYYHDGKL-WIMIEFCPGGAVDAIM----LELDRGLTEPQIQVVCRQMLEALNF 132

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLG-RTDVAGPSSQVT----A 241
           LHS   R++H+D K  NVL+  +   ++AD G        L  R    G     T    A
Sbjct: 133 LHSK--RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG-----TPYWMA 185

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 301
            E+ +   +K+   +  K+D++S G+ L+E+         L+P                 
Sbjct: 186 PEVVMCETMKD-TPYDYKADIWSLGITLIEMAQIEPPHHELNP---------------MR 229

Query: 302 NLLKI--------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 343
            LLKI        L    WS        EF   +   LD + E RPS + 
Sbjct: 230 VLLKIAKSDPPTLLTPSKWS-------VEFRDFLKIALDKNPETRPSAAQ 272

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 99.4 bits (248), Expect = 9e-24
 Identities = 77/312 (24%), Positives = 125/312 (40%), Gaps = 64/312 (20%)

Query: 63  EARRFQMEELSLA-----TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP--GAPT 114
           ++    ++E+ L+        F    L+G G +G+VYKG  ++ G L AIK     G   
Sbjct: 5   DSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE 64

Query: 115 QEFIDEVCFLASI-QHRNLVTLLG-YCQENNLQF-----LIYEYIPNGSVSIHLYGPSQV 167
           +E   E+  L     HRN+ T  G + ++N         L+ E+   GSV+  L   ++ 
Sbjct: 65  EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT-DLIKNTK- 122

Query: 168 SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD----AGL 223
               L+ +    I     +GL+HLH    +V+H+D K  NVL+ E+   K+ D    A L
Sbjct: 123 -GNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179

Query: 224 RNFLG-RTDVAGPSSQVT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
              +G R    G     T    A E+    E  +   +  KSD++S G+  +E+  G   
Sbjct: 180 DRTVGRRNTFIG-----TPYWMAPEVIACDENPD-ATYDFKSDLWSLGITAIEMAEGAPP 233

Query: 279 SSSLSPDSSQDLVELVQNSRDFSNLLKI-------LDERLWSTFTNEGMEEFIQLIVRCL 331
              + P                  L  I       L  + WS       ++F   I  CL
Sbjct: 234 LCDMHP---------------MRALFLIPRNPAPRLKSKKWS-------KKFQSFIESCL 271

Query: 332 DPSSERRPSMSD 343
             +  +RP+   
Sbjct: 272 VKNHSQRPATEQ 283

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 98.2 bits (245), Expect = 2e-23
 Identities = 72/305 (23%), Positives = 132/305 (43%), Gaps = 52/305 (17%)

Query: 58  ELSIREARRFQMEELSLA------TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP 110
            + +R   R Q+++L          + F     +GEG +G VYK +  + G +VAIK+ P
Sbjct: 4   TVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP 63

Query: 111 GAP-TQEFIDEVCFLASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVS 168
                QE I E+  +      ++V   G Y +  +L +++ EY   GSVS  +    ++ 
Sbjct: 64  VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL-WIVMEYCGAGSVS-DII---RLR 118

Query: 169 RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 228
            + L      +I     KGL +LH +  R +H+D K  N+L++ +  AK+AD     F  
Sbjct: 119 NKTLTEDEIATILQSTLKGLEYLHFM--RKIHRDIKAGNILLNTEGHAKLAD-----F-- 169

Query: 229 RTDVAGPSSQVTADEI----------FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
                G + Q+T              ++A EV +   ++  +D++S G+  +E+  G+  
Sbjct: 170 -----GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

Query: 279 SSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 338
            + + P   + +  +  N              LWS       + F   + +CL  S E+R
Sbjct: 225 YADIHP--MRAIFMIPTNPPP-----TFRKPELWS-------DNFTDFVKQCLVKSPEQR 270

Query: 339 PSMSD 343
            + + 
Sbjct: 271 ATATQ 275

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 97.8 bits (243), Expect = 6e-23
 Identities = 35/347 (10%), Positives = 80/347 (23%), Gaps = 66/347 (19%)

Query: 37  SRTSETGSSEPSVQPGRNVGIE-LSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYK 95
                   +           ++ L  +  R+ ++ E             +  G    V+ 
Sbjct: 33  PAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEP------------LRVGDRSVVFL 80

Query: 96  GL-LQDGMLVAIK------KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ--- 145
              ++     A+K      +   +  +   +     A +   +        +        
Sbjct: 81  VRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140

Query: 146 -----------------------FLIYEYIP-NGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
                                   L+      +  +         V R          + 
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG-RTDVAGPSSQVT 240
               +  A+L S    +VH  F   N+ +  D    + D      +G R   +       
Sbjct: 201 AQLIRLAANLQSK--GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYA 258

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP--DSSQDLVELVQNSR 298
             E   AS       F+   + +  G+ +  +           P    +  +    +   
Sbjct: 259 PREFLNAST----ATFTHALNAWQLGLSIYRVWCLF------LPFGLVTPGIKGSWKRPS 308

Query: 299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                   L     +       +    LI R L+    RR    + +
Sbjct: 309 LRVPGTDSLAFGSCTPLP----DFVKTLIGRFLNFDRRRRLLPLEAM 351

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 96.7 bits (241), Expect = 7e-23
 Identities = 58/280 (20%), Positives = 109/280 (38%), Gaps = 50/280 (17%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---RPGAPTQEFIDEVCFLASIQHRN 131
                    IGEG  G V        G  VA+K    R     +   +EV  +   QH N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 132 LVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           +V +   Y     L +++ E++  G+++        VS+ +L  +   ++     + LA+
Sbjct: 104 VVEMYKSYLVGEEL-WVLMEFLQGGALT------DIVSQVRLNEEQIATVCEAVLQALAY 156

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------ 244
           LH+    V+H+D K+ ++L+  D   K++D G              +Q++ D        
Sbjct: 157 LHA--QGVIHRDIKSDSILLTLDGRVKLSDFGF------------CAQISKDVPKRKSLV 202

Query: 245 ----FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 300
               ++A EV     ++ + D++S G+ ++E+V G     S SP   Q +  L  +    
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPP- 259

Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 340
               K+ +    S             + R L    + R +
Sbjct: 260 ----KLKNSHKVS-------PVLRDFLERMLVRDPQERAT 288

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 97.6 bits (243), Expect = 9e-23
 Identities = 59/331 (17%), Positives = 120/331 (36%), Gaps = 44/331 (13%)

Query: 33  NRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGE 92
             S  + +     E       ++G +   + +     E +S+  + +S    IG G   +
Sbjct: 13  RGSGMKETAAAKFERQHMDSPDLGTDDDDKASSS-ANECISVKGRIYSILKQIGSGGSSK 71

Query: 93  VYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRNL--VTLLGYCQENNLQ 145
           V++ L +   + AIK     +        + +E+ +L  +Q  +   + L  Y   +   
Sbjct: 72  VFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131

Query: 146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKT 205
           +++ E   N  ++  L       ++ ++   R S      + +  +H     +VH D K 
Sbjct: 132 YMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKP 183

Query: 206 ANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-T----ADEIFL-----ASEVKEFR 254
           AN L+ +  + K+ D G+       T      SQV        E            K   
Sbjct: 184 ANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242

Query: 255 RFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELVQNSRDFSNLLKILDERLWS 313
           + S KSDV+S G  L  +  G+      +P     + +           L  I+D     
Sbjct: 243 KISPKSDVWSLGCILYYMTYGK------TPFQQIINQISK---------LHAIIDPNHEI 287

Query: 314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
            F +   ++   ++  CL    ++R S+ ++
Sbjct: 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 95.8 bits (239), Expect = 9e-23
 Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 35/214 (16%)

Query: 81  DKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRNLVTLL 136
           D+ ++G+G +G VY G  L + + +AIK   +R    +Q   +E+     ++H+N+V  L
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85

Query: 137 GYCQENNLQFLIYEYIPNGSVS---IHLYGPSQVS--------RQKLEFKHRLSIALGAA 185
           G   EN    +  E +P GS+S      +GP + +        +Q LE            
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE------------ 133

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
            GL +LH    ++VH+D K  NVL++    + K++D G    L   +    +   T    
Sbjct: 134 -GLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL--Q 188

Query: 245 FLASEV--KEFRRFSEKSDVYSFGVFLLELVSGR 276
           ++A E+  K  R + + +D++S G  ++E+ +G+
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 96.3 bits (240), Expect = 1e-22
 Identities = 55/287 (19%), Positives = 107/287 (37%), Gaps = 43/287 (14%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFLASIQHRN 131
           + +S    IG G   +V++ L +   + AIK     +        + +E+ +L  +Q  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 132 L--VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
              + L  Y   +   +++ E   N  ++  L       ++ ++   R S      + + 
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVH 122

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-T----ADE 243
            +H     +VH D K AN L+ +  + K+ D G+       T      SQV T      E
Sbjct: 123 TIHQH--GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

Query: 244 IFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDLVELVQNS 297
                       K   + S KSDV+S G  L  +  G+      +P     + +      
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIINQISK---- 229

Query: 298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
                L  I+D      F +   ++   ++  CL    ++R S+ ++
Sbjct: 230 -----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 96.9 bits (241), Expect = 2e-22
 Identities = 55/329 (16%), Positives = 101/329 (30%), Gaps = 63/329 (19%)

Query: 63  EARRFQMEELSLATKNFSDKNLIGEG--KFGEVYKGL-LQDGMLVAIK-----KRPGAPT 114
                 M         +    +IG+G      V        G  V ++            
Sbjct: 11  NLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV 70

Query: 115 QEFIDEVCFLASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE 173
                E+       H N+V     +  +N L +++  ++  GS    L            
Sbjct: 71  TFLQGELHVSKLFNHPNIVPYRATFIADNEL-WVVTSFMAYGSAK-DLI--------CTH 120

Query: 174 FKHRLS---IAL---GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----L 223
           F   ++   IA    G  K L ++H +    VH+  K +++L+  D    ++       +
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178

Query: 224 RNFLGRTDVAGPSSQVTADEIF-LASEV--KEFRRFSEKSDVYSFGVFLLELVSG----- 275
            +   R  V     + +   +  L+ EV  +  + +  KSD+YS G+   EL +G     
Sbjct: 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238

Query: 276 ------------REASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGME-- 321
                             L   S+    EL  +         + D    ST      +  
Sbjct: 239 DMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP 298

Query: 322 ----------EFIQLIVRCLDPSSERRPS 340
                      F   + +CL  + + RPS
Sbjct: 299 SHPYHRTFSPHFHHFVEQCLQRNPDARPS 327

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 56/294 (19%), Positives = 111/294 (37%), Gaps = 43/294 (14%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK-----KRPGAPTQEFIDEVCFL 124
           + +S+  + +S    IG G   +V++ L +   + AIK     +        + +E+ +L
Sbjct: 21  QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 80

Query: 125 ASIQHRNL--VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
             +Q  +   + L  Y   +   +++ E   N  ++  L       ++ ++   R S   
Sbjct: 81  NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWK 134

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-T 240
              + +  +H     +VH D K AN L+ +  + K+ D G+       T      SQV T
Sbjct: 135 NMLEAVHTIHQH--GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 191

Query: 241 ----ADEIFL-----ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-DSSQDL 290
                 E            K   + S KSDV+S G  L  +  G+      +P     + 
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIINQ 245

Query: 291 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           +           L  I+D      F +   ++   ++  CL    ++R S+ ++
Sbjct: 246 ISK---------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 95.2 bits (237), Expect = 4e-22
 Identities = 74/292 (25%), Positives = 120/292 (41%), Gaps = 66/292 (22%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ 128
            K FSD   IG G FG VY    +++  +VAIKK      +     Q+ I EV FL  ++
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 129 HRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKG 187
           H N +   G Y +E+   +L+ EY    +  +      +V ++ L+     ++  GA +G
Sbjct: 113 HPNTIQYRGCYLREHTA-WLVMEYCLGSASDLL-----EVHKKPLQEVEIAAVTHGALQG 166

Query: 188 LAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF-- 245
           LA+LHS    ++H+D K  N+L+ E  + K+ D     F       G +S +     F  
Sbjct: 167 LAYLHSH--NMIHRDVKAGNILLSEPGLVKLGD-----F-------GSASIMAPANSFVG 212

Query: 246 ----LASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR 298
               +A EV    +  ++  K DV+S G+  +EL   +    +++               
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------------- 258

Query: 299 DFSNLLKI-------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 343
             S L  I       L    WS       E F   +  CL    + RP+   
Sbjct: 259 -MSALYHIAQNESPALQSGHWS-------EYFRNFVDSCLQKIPQDRPTSEV 302

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 92.7 bits (230), Expect = 4e-21
 Identities = 45/308 (14%), Positives = 97/308 (31%), Gaps = 42/308 (13%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKG------LLQDGMLVAIKK-RPGAPTQEFI--DE 120
            E  L +K     +L+GEG F +VY+         ++     +K  +P  P + +I    
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
           +  L        +         N   L+ E    G++   +        + +     +S 
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD--------V 232
           A+     +  +H     ++H D K  N ++   F+ +  +  L   L   D        +
Sbjct: 178 AMRMLYMIEQVHDC--EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235

Query: 233 AGPSSQVTAD---EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD 289
               +  TA      F   E+   + ++ + D +     +  ++ G             +
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT------YMKVKNE 289

Query: 290 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
                          + L  RL      +   EF  +++    P     PS+  +  +L 
Sbjct: 290 ---------GGECKPEGLFRRLPHL---DMWNEFFHVMLNI--PDCHHLPSLDLLRQKLK 335

Query: 350 RTLDKEMN 357
           +   +   
Sbjct: 336 KVFQQHYT 343

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 91.1 bits (227), Expect = 4e-21
 Identities = 62/306 (20%), Positives = 115/306 (37%), Gaps = 70/306 (22%)

Query: 84  LIGEGKFGEVYKGLLQDGML---VAIK--KRPGAPTQEFID----EVCFLASIQHRNLVT 134
            +G G    VY    +D +L   VAIK    P    +E +     EV   + + H+N+V+
Sbjct: 18  KLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 135 LLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           ++   +E++  +L+ EYI   ++S  I  +GP       L     ++       G+ H H
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-------LSVDTAINFTNQILDGIKHAH 128

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS---- 248
            +  R+VH+D K  N+L+D +   K+ D G+         A   + +T     L +    
Sbjct: 129 DM--RIVHRDIKPQNILIDSNKTLKIFDFGIA-------KALSETSLTQTNHVLGTVQYF 179

Query: 249 --EVKEFRRFSEKSDVYSFGVFLLELVSGR---------------------EASSSLSPD 285
             E  +     E +D+YS G+ L E++ G                        ++ +  D
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239

Query: 286 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
             Q L  ++  +       K    R  +      ++E    +   L      R +     
Sbjct: 240 IPQSLSNVILRA-----TEKDKANRYKT------IQEMKDDLSSVLHE---NRANEDVYE 285

Query: 346 TELDRT 351
            +  +T
Sbjct: 286 LDKMKT 291

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 92.0 bits (228), Expect = 6e-21
 Identities = 38/359 (10%), Positives = 98/359 (27%), Gaps = 76/359 (21%)

Query: 34  RSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQME-ELSLATKNFSDKNLIGEGKFGE 92
             + + +   +SE       ++         + F++E EL    +      ++G+     
Sbjct: 29  NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYA 88

Query: 93  VYKGL-LQDGMLVAIK-----KRPGAPTQE--------------------------FIDE 120
             +    + G    +      +RP +   +                          FI  
Sbjct: 89  YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148

Query: 121 VCFLASIQHRNLVTLLGYCQ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 177
              +   Q + ++ +    +     +  FL      N      +      + + L    R
Sbjct: 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 208

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-------RNFLGRT 230
           L + L   + LA LH     +VH   +  ++++D+     +                   
Sbjct: 209 LQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSR 266

Query: 231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSS 287
               P  ++ A    ++         +   D ++ G+ +  +           P   D++
Sbjct: 267 GFEPP--ELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD------LPITKDAA 318

Query: 288 QDLVELV-QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
               E + ++ ++    ++                    L+   L    E R      +
Sbjct: 319 LGGSEWIFRSCKNIPQPVR-------------------ALLEGFLRYPKEDRLLPLQAM 358

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 90.4 bits (225), Expect = 8e-21
 Identities = 74/273 (27%), Positives = 114/273 (41%), Gaps = 43/273 (15%)

Query: 83  NLIGEGKFGEVYKG-LLQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVT 134
             +G+GKFG VY     Q   ++A+K       ++ G   Q    EV   + ++H N++ 
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L GY  +    +LI EY P G+V   L         K + +   +     A  L++ HS 
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHSK 128

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGL---RNFLGRTDVAGPSSQVTADEIFLASEVK 251
             RV+H+D K  N+L+      K+AD G         RTD+ G     T D  +L  E+ 
Sbjct: 129 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG-----TLD--YLPPEMI 179

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 311
           E R   EK D++S GV   E + G+       P  +    E  +         +I     
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYK---------RISRVEF 224

Query: 312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
             TF +   E    LI R L  +  +RP + +V
Sbjct: 225 --TFPDFVTEGARDLISRLLKHNPSQRPMLREV 255

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 92.6 bits (230), Expect = 1e-20
 Identities = 51/282 (18%), Positives = 103/282 (36%), Gaps = 54/282 (19%)

Query: 84  LIGEGKFGEVYKG--LLQDGMLVAIKKRPGAPTQEFID----EVCFLASIQHRNLVTLLG 137
            I  G  G +Y       +G  V +K    +   E       E  FLA + H ++V +  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 138 YCQENN-----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           + +  +     + +++ EY+   S+        +   QKL     ++  L     L++LH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLK-------RSKGQKLPVAEAIAYLLEILPALSYLH 199

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD-VAGPSSQVTADEIFLASEVK 251
           S+   +V+ D K  N+++ E+ + K+ D G  + +     + G     T    F A E+ 
Sbjct: 200 SI--GLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFGYLYG-----TPG--FQAPEIV 249

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 311
                +  +D+Y+ G  L  L       +    D   +   +++    +           
Sbjct: 250 R-TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGR--------- 299

Query: 312 WSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTL 352
                         L+ R +DP   +R  +  ++  +L   L
Sbjct: 300 --------------LLRRAIDPDPRQRFTTAEEMSAQLTGVL 327

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 56/282 (19%), Positives = 103/282 (36%), Gaps = 59/282 (20%)

Query: 84  LIGEGKFGEVYKG-LLQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
            +G+G F + ++        + A K        +P    +    E+    S+ H+++V  
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 106

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIALGAAKGLAHLHSL 194
            G+ ++N+  F++ E     S+           R+ L E + R         G  +LH  
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEAR-YYLRQIVLGCQYLHRN 160

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-------- 246
             RV+H+D K  N+ ++ED   K+ D GL            +++V  D            
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGL------------ATKVEYDGERKKVLCGTPN 206

Query: 247 --ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 304
             A EV   +  S + DV+S G  +  L+ G+       P  +  L E            
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKETYL--------- 251

Query: 305 KILDERL-WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
           +I           N        LI + L      RP++++++
Sbjct: 252 RIKKNEYSIPKHINPVAAS---LIQKMLQTDPTARPTINELL 290

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 55/281 (19%), Positives = 103/281 (36%), Gaps = 57/281 (20%)

Query: 84  LIGEGKFGEVYKG-LLQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
            +G+G F + ++        + A K        +P    +    E+    S+ H+++V  
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 80

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKL-EFKHRLSIALGAAKGLAHLHSL 194
            G+ ++N+  F++ E     S+           R+ L E + R         G  +LH  
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEAR-YYLRQIVLGCQYLHRN 134

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-------- 246
             RV+H+D K  N+ ++ED   K+ D GL            +++V  D            
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGL------------ATKVEYDGERKKVLCGTPN 180

Query: 247 --ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 304
             A EV   +  S + DV+S G  +  L+ G+       P  +  L E            
Sbjct: 181 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKETYL--------- 225

Query: 305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
           +I       +           LI + L      RP++++++
Sbjct: 226 RIKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELL 264

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 88.1 bits (219), Expect = 8e-20
 Identities = 60/285 (21%), Positives = 107/285 (37%), Gaps = 34/285 (11%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVC-----F 123
           +      ++  D   IG G +G V K +    G ++A+K+      ++   ++       
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74

Query: 124 LASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 183
           + S     +V   G        ++  E + + S          V    +  +    I L 
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLA 133

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQV 239
             K L HL   + +++H+D K +N+L+D     K+ D G    L + + +T  AG     
Sbjct: 134 TVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRP-- 190

Query: 240 TADEIFLASEV----KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 295
                ++A E        + +  +SDV+S G+ L EL +GR      +    Q    L Q
Sbjct: 191 -----YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ----LTQ 241

Query: 296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 340
             +     L   +ER +S         FI  +  CL     +RP 
Sbjct: 242 VVKGDPPQLSNSEEREFS-------PSFINFVNLCLTKDESKRPK 279

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 57/288 (19%), Positives = 101/288 (35%), Gaps = 52/288 (18%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFL-ASIQHRNLVTLL 136
           +F  K+++G G  G +    + D   VA+K+           EV  L  S +H N++   
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYF 84

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR--LSIALGAAKGLAHLHSL 194
              ++   Q++  E                V ++         +++      GLAHLHSL
Sbjct: 85  CTEKDRQFQYIAIELCAATLQEY-------VEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137

Query: 195 SPRVVHKDFKTANVLVDE------------DF-IAKVADAGLRNFLGRTDVAGPSSQVTA 241
              +VH+D K  N+L+              DF + K    G  +F  R+ V G       
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG---- 191

Query: 242 DEIFLASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP--DSSQDLVELVQN 296
              ++A E+         +   D++S G     ++S         P   S Q    ++  
Sbjct: 192 ---WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-----PFGKSLQRQANILLG 243

Query: 297 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           +     L     E+              +LI + +    ++RPS   V
Sbjct: 244 ACSLDCL---HPEKHED-------VIARELIEKMIAMDPQKRPSAKHV 281

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 54/308 (17%), Positives = 111/308 (36%), Gaps = 47/308 (15%)

Query: 68  QMEELSLATKNFSD----KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCF 123
           ++  +    ++  +    + ++G G  G V       G  VA+K+         + E+  
Sbjct: 2   RIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKL 61

Query: 124 L-ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSI 180
           L  S  H N++        +   ++  E   N ++   +     S  + +  +  + +S+
Sbjct: 62  LTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISL 120

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-------------EDFIAKVADAGLRNFL 227
               A G+AHLHSL  +++H+D K  N+LV              E+    ++D GL   L
Sbjct: 121 LRQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178

Query: 228 GRTDVAGPSSQVT--------ADEIFLAS-EVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
                +  ++           A E+   S  ++  RR +   D++S G     ++S  + 
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

Query: 279 SSSLSP--DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSE 336
                P  D       +++           +      +   E       LI + +D    
Sbjct: 239 -----PFGDKYSRESNIIRGIFSLDE----MKCLHDRSLIAEA----TDLISQMIDHDPL 285

Query: 337 RRPSMSDV 344
           +RP+   V
Sbjct: 286 KRPTAMKV 293

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 64/369 (17%), Positives = 130/369 (35%), Gaps = 80/369 (21%)

Query: 58  ELSIREARRFQMEEL--------SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKK 108
           EL + E +R ++E           L   +F   + +G G  G V+K      G+++A K 
Sbjct: 6   ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL 65

Query: 109 RPGAPTQEFIDEVC----FLASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYG 163
                     +++      L       +V   G +  +  +  +  E++  GS+   L  
Sbjct: 66  IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKK 124

Query: 164 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG- 222
             ++  Q L       +++   KGL +L     +++H+D K +N+LV+     K+ D G 
Sbjct: 125 AGRIPEQILG-----KVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGV 178

Query: 223 ---LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR--- 276
              L + +  + V   S        +++ E  +   +S +SD++S G+ L+E+  GR   
Sbjct: 179 SGQLIDSMANSFVGTRS--------YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

Query: 277 ------------------------EASSSLSPDSSQDLVELVQNSRDFSNLLKI------ 306
                                       +     ++  ++       F  L  I      
Sbjct: 231 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP 290

Query: 307 -LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD------VVTELDRTLDKEMNLT 359
            L   ++S        EF   + +CL  +   R  +        +       +D    L 
Sbjct: 291 KLPSGVFS-------LEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLC 343

Query: 360 TVMGEGTPT 368
           + +G   P+
Sbjct: 344 STIGLNQPS 352

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 87.4 bits (216), Expect = 3e-19
 Identities = 38/362 (10%), Positives = 94/362 (25%), Gaps = 67/362 (18%)

Query: 26  SWFCLYRNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQME-ELSLATKNFSDKNL 84
                     + + +   +SE       ++         + F++E EL    +      +
Sbjct: 26  DVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTV 85

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDE--------------------- 120
           +G+       +    + G    +        P    I +                     
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 121 -------VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-- 171
                     L     +  +  +   + +      +   P    ++  +G   +S     
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 172 --LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
             L    RL + L   + LA LH     +VH   +  ++++D+     +         G 
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263

Query: 230 TDVAGPSSQVTADEIFLASEVKEFRR-----FSEKSDVYSFGVFLLELVSGREASSSLSP 284
           + V+         E   A  +  F +      +   D ++ G+ +  +           P
Sbjct: 264 SAVSPIGRGFAPPE-TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD------LP 316

Query: 285 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGM-EEFIQLIVRCLDPSSERRPSMSD 343
           ++    +   +          I           + + +    L+   L    E R     
Sbjct: 317 NTDDAALGGSE---------WIFRS-------CKNIPQPVRALLEGFLRYPKEDRLLPLQ 360

Query: 344 VV 345
            +
Sbjct: 361 AM 362

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 85.0 bits (211), Expect = 6e-19
 Identities = 64/280 (22%), Positives = 108/280 (38%), Gaps = 59/280 (21%)

Query: 84  LIGEGKFGEVYKG-LLQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
            +G+GKFG VY     Q+  ++A+K       ++ G   Q    E+   + ++H N++ +
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRM 79

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA------AKGLA 189
             Y  +    +L+ E+ P G     LY       ++L+   R      A      A  L 
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGE----LY-------KELQKHGRFDEQRSATFMEELADALH 128

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV-----TADEI 244
           + H    +V+H+D K  N+L+      K+AD G         V  PS +      T D  
Sbjct: 129 YCHER--KVIHRDIKPENLLMGYKGELKIADFGW-------SVHAPSLRRRTMCGTLD-- 177

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 304
           +L  E+ E +   EK D++  GV   E + G        P  S    E  +         
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM------PPFDSPSHTETHR--------- 222

Query: 305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           +I++  L   F     +    LI + L     +R  +  V
Sbjct: 223 RIVNVDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 53/316 (16%), Positives = 107/316 (33%), Gaps = 36/316 (11%)

Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCF 123
           M   S +   +   +++G+G    V++G   + G L AIK         P    + E   
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60

Query: 124 LASIQHRNLVTLLGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
           L  + H+N+V L    +E   +   LI E+ P GS+   L  PS  +   L     L + 
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVL 118

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGRTDVAGPSS 237
                G+ HL      +VH++ K  N++     D   + K+ D G    L   +     S
Sbjct: 119 RDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VS 174

Query: 238 QV-----TADEIF--LASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQD 289
                     +++          +++    D++S GV      +G         P  +++
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 290 LVELVQNSRDFSNLLKILDER-----------LWSTFTNEGMEEFIQLIVRCLDPSSERR 338
           ++  +   +    +  +               +  + +         ++   L+   E+ 
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294

Query: 339 PSMSDVVTELDRTLDK 354
                   E    L +
Sbjct: 295 WGFDQFFAETSDILHR 310

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 84.1 bits (209), Expect = 2e-18
 Identities = 56/244 (22%), Positives = 99/244 (40%), Gaps = 55/244 (22%)

Query: 61  IREARRFQMEELSLATKNFSDK----NLIGEGKFGEVYKGLLQDGMLVAIKK------RP 110
           +           +L  +   +K      +GEG +G VYK     G +VA+K+        
Sbjct: 1   MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE 60

Query: 111 GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP--------NGSVSIHLY 162
           G P+   I E+  L  + H N+V+L+          L++E++              +   
Sbjct: 61  GIPSTA-IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQ-- 117

Query: 163 GPSQV---SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA 219
             SQ+     Q L             +G+AH H    R++H+D K  N+L++ D   K+A
Sbjct: 118 -DSQIKIYLYQLL-------------RGVAHCHQH--RILHRDLKPQNLLINSDGALKLA 161

Query: 220 DAGL-RNFLGRTDVAGPSSQ--VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL 272
           D GL R F          +   VT    A ++ + S     +++S   D++S G    E+
Sbjct: 162 DFGLARAF---GIPVRSYTHEVVTLWYRAPDVLMGS-----KKYSTSVDIWSIGCIFAEM 213

Query: 273 VSGR 276
           ++G+
Sbjct: 214 ITGK 217

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 83.0 bits (206), Expect = 3e-18
 Identities = 60/285 (21%), Positives = 108/285 (37%), Gaps = 66/285 (23%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           L+G+G F  VY+   +  G+ VAIK        + G   +   +EV     ++H +++ L
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILEL 76

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA------AKGLA 189
             Y +++N  +L+ E   NG ++ +L      +R K       S             G+ 
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYL-----KNRVK-----PFSENEARHFMHQIITGML 126

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL--- 246
           +LHS    ++H+D   +N+L+  +   K+AD GL            ++Q+          
Sbjct: 127 YLHSH--GILHRDLTLSNLLLTRNMNIKIADFGL------------ATQLKMPHEKHYTL 172

Query: 247 -------ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD 299
                  + E+        +SDV+S G     L+ GR       P  +  +         
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR------PPFDTDTVKNT------ 220

Query: 300 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
              L K++         +    E   LI + L  +   R S+S V
Sbjct: 221 ---LNKVVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSV 260

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 53/316 (16%), Positives = 107/316 (33%), Gaps = 36/316 (11%)

Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFIDEVCF 123
           M   S +   +   +++G+G    V++G   + G L AIK         P    + E   
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60

Query: 124 LASIQHRNLVTLLGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
           L  + H+N+V L    +E   +   LI E+ P GS+   L  PS  +   L     L + 
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVL 118

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGRTDVAGPSS 237
                G+ HL      +VH++ K  N++     D   + K+ D G    L   +     S
Sbjct: 119 RDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VS 174

Query: 238 QV-----TADEIF--LASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQD 289
                     +++          +++    D++S GV      +G         P  +++
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 290 LVELVQNSRDFSNLLKILDER-----------LWSTFTNEGMEEFIQLIVRCLDPSSERR 338
           ++  +   +    +  +               +  + +         ++   L+   E+ 
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294

Query: 339 PSMSDVVTELDRTLDK 354
                   E    L +
Sbjct: 295 WGFDQFFAETSDILHR 310

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 83.0 bits (205), Expect = 2e-17
 Identities = 62/341 (18%), Positives = 119/341 (34%), Gaps = 68/341 (19%)

Query: 32  RNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDK----NLIGE 87
           + R      E G          +          +++  + + +   +  D       +G 
Sbjct: 108 KRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGT 167

Query: 88  GKFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN 143
           G FG V++      G   A   +     +  +    E+  ++ ++H  LV L    +++N
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227

Query: 144 LQFLIYEYIPNG-------SVSIHL--YGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
              +IYE++  G            +      +  RQ  +             GL H+H  
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK-------------GLCHMHEN 274

Query: 195 SPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDVAGPSSQVTADEIFLA 247
           +   VH D K  N++      + + K+ D GL   L          G     TA+  F A
Sbjct: 275 N--YVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLDPKQSVKVTTG-----TAE--FAA 324

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSSQDLVELVQNSR-DFSNL 303
            EV E +     +D++S GV    L+SG      LSP   ++  + +  V++   +    
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSG------LSPFGGENDDETLRNVKSCDWNM--- 375

Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
               D+  +S  + +G +     I + L      R ++   
Sbjct: 376 ----DDSAFSGISEDGKD----FIRKLLLADPNTRMTIHQA 408

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 53/287 (18%), Positives = 110/287 (38%), Gaps = 43/287 (14%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID----EVCFL 124
           +       +  +   +G G  G+V+K    + G ++A+K+   +  +E       ++  +
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 125 -ASIQHRNLVTLLG-YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
             S     +V   G +    ++ F+  E +   +  +       +     E      + +
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQGPIP----ERILG-KMTV 131

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQ 238
              K L +L      V+H+D K +N+L+DE    K+ D G    L +   +   AG ++ 
Sbjct: 132 AIVKALYYLKEKH-GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAA- 189

Query: 239 VTADEIFLASEVKEFRR-----FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 293
                 ++A E  +        +  ++DV+S G+ L+EL +G+    +   D    L ++
Sbjct: 190 ------YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LTKV 242

Query: 294 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 340
           +Q       LL       +S        +F   +  CL     +RP 
Sbjct: 243 LQEE---PPLLP--GHMGFS-------GDFQSFVKDCLTKDHRKRPK 277

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 30/215 (13%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 131
            F     +G G +  VYKGL    G+ VA+K+       G P+   I E+  +  ++H N
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA-IREISLMKELKHEN 64

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           +V L       N   L++E++ N             + + LE            +GLA  
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ-----VT----A 241
           H    +++H+D K  N+L+++    K+ D GL R F        P +      VT    A
Sbjct: 125 HEN--KILHRDLKPQNLLINKRGQLKLGDFGLARAF------GIPVNTFSSEVVTLWYRA 176

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            ++ + S     R +S   D++S G  L E+++G+
Sbjct: 177 PDVLMGS-----RTYSTSIDIWSCGCILAEMITGK 206

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 63/300 (21%), Positives = 117/300 (39%), Gaps = 65/300 (21%)

Query: 72  LSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEV 121
           ++    + S+       +G G +GEV         +  AIK         +   + ++EV
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
             L  + H N++ L  + ++    +L+ E    G     L+        ++  + + +  
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE----LF-------DEIIHRMKFNEV 136

Query: 182 LGAA------KGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR--- 229
             A        G+ +LH  +  +VH+D K  N+L+   ++D + K+ D GL         
Sbjct: 137 DAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194

Query: 230 -TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---D 285
             +  G     TA   ++A EV   +++ EK DV+S GV L  L++G        P    
Sbjct: 195 MKERLG-----TAY--YIAPEVLR-KKYDEKCDVWSIGVILFILLAGY------PPFGGQ 240

Query: 286 SSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           + Q+++  V+  +  F       D   W   +         LI + L   S+RR S    
Sbjct: 241 TDQEILRKVEKGKYTF-------DSPEWKNVSEGA----KDLIKQMLQFDSQRRISAQQA 289

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 80.2 bits (199), Expect = 3e-17
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 35/216 (16%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 130
           + +     IGEG +G VYK     G   A+KK        G P+   I E+  L  ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IREISILKELKHS 60

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           N+V L           L++E++        L     V    LE     S  L    G+A+
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQD-----LKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ-----VT---- 240
            H    RV+H+D K  N+L++ +   K+AD GL R F        P  +     VT    
Sbjct: 116 CHDR--RVLHRDLKPQNLLINREGELKIADFGLARAF------GIPVRKYTHEIVTLWYR 167

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           A ++ + S     +++S   D++S G    E+V+G 
Sbjct: 168 APDVLMGS-----KKYSTTIDIWSVGCIFAEMVNGT 198

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 59/271 (21%), Positives = 107/271 (39%), Gaps = 40/271 (14%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVC-----FLASIQHRNLVTLLG- 137
           +G G +G V K   +  G ++A+K+       +    +       + ++     VT  G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
             +E ++ ++  E + + S+    Y       Q +       IA+   K L HLHS    
Sbjct: 75  LFREGDV-WICMELM-DTSLD-KFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLS 130

Query: 198 VVHKDFKTANVLVDEDFIAKVADAG----LRNFLGRTDVAGPSSQVTADEIFLASEV--- 250
           V+H+D K +NVL++     K+ D G    L + + +   AG          ++A E    
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKP-------YMAPERINP 183

Query: 251 -KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 309
               + +S KSD++S G+ ++EL   R    S         ++ V            L  
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--QQLKQVVEEPSPQ-----LPA 236

Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 340
             +S        EF+    +CL  +S+ RP+
Sbjct: 237 DKFS-------AEFVDFTSQCLKKNSKERPT 260

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 49/230 (21%), Positives = 88/230 (38%), Gaps = 58/230 (25%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           + +     IGEG +G V+K    +   +VA+K+        G P+   + E+C L  ++H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-LREICLLKELKH 60

Query: 130 RNLVTLLGYCQENNLQFLIYEYIP--------NGSVSIHLYGPSQV---SRQKLEFKHRL 178
           +N+V L      +    L++E+          + +  +    P  V     Q L      
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLL------ 111

Query: 179 SIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSS 237
                  KGL   HS    V+H+D K  N+L++ +   K+A+ GL R F        P  
Sbjct: 112 -------KGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAF------GIPVR 156

Query: 238 QVT---------ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
             +           ++   +     + +S   D++S G    EL +    
Sbjct: 157 CYSAEVVTLWYRPPDVLFGA-----KLYSTSIDMWSAGCIFAELANAGRP 201

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 56/229 (24%), Positives = 100/229 (43%), Gaps = 57/229 (24%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEF-------IDEVCFLASI 127
           K +   + +GEG+F  VYK        +VAIKK + G  ++         + E+  L  +
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 128 QHRNLVTLLG-YCQENNLQFLIYEYIPN------GSVSIHLYGPSQV---SRQKLEFKHR 177
            H N++ LL  +  ++N+  L+++++           S+ L  PS +       L     
Sbjct: 70  SHPNIIGLLDAFGHKSNI-SLVFDFMETDLEVIIKDNSLVL-TPSHIKAYMLMTL----- 122

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGP- 235
                   +GL +LH     ++H+D K  N+L+DE+ + K+AD GL ++F        P 
Sbjct: 123 --------QGLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKSF------GSPN 166

Query: 236 ---SSQV-T----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
              + QV T    A E+   +     R +    D+++ G  L EL+   
Sbjct: 167 RAYTHQVVTRWYRAPELLFGA-----RMYGVGVDMWAVGCILAELLLRV 210

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 66/297 (22%), Positives = 117/297 (39%), Gaps = 67/297 (22%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLA 125
              F+++     ++G+G FGEV K          A+K           T   + EV  L 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 185
            + H N++ L    ++++  +++ E    G     L+        ++  + R S    AA
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LF-------DEIIKRKRFSEH-DAA 124

Query: 186 K-------GLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TD 231
           +       G+ ++H     +VH+D K  N+L+   ++D   K+ D GL     +     D
Sbjct: 125 RIIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182

Query: 232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSSQ 288
             G     TA   ++A EV     + EK DV+S GV L  L+SG        P    +  
Sbjct: 183 RIG-----TAY--YIAPEVLR-GTYDEKCDVWSAGVILYILLSGT------PPFYGKNEY 228

Query: 289 DLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           D+++ V+  +  F       D   W T +++       LI + L      R + +  
Sbjct: 229 DILKRVETGKYAF-------DLPQWRTISDDA----KDLIRKMLTFHPSLRITATQC 274

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 80.3 bits (199), Expect = 4e-17
 Identities = 48/210 (22%), Positives = 80/210 (38%), Gaps = 38/210 (18%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAP-TQEFIDEVCFLASIQHRNLVTLL 136
           IGEG +G V+K      G +VAIKK       P        + E+  L  ++H NLV LL
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA--LREIRMLKQLKHPNLVNLL 68

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
              +      L++EY  +      +       ++ +      SI     + +   H    
Sbjct: 69  EVFRRKRRLHLVFEYCDH-----TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH-- 121

Query: 197 RVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT---------ADEIFL 246
             +H+D K  N+L+ +  + K+ D G  R         GPS             + E+ +
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLL------TGPSDYYDDEVATRWYRSPELLV 175

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                   ++    DV++ G    EL+SG 
Sbjct: 176 GD-----TQYGPPVDVWAIGCVFAELLSGV 200

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 80.9 bits (200), Expect = 5e-17
 Identities = 61/339 (17%), Positives = 115/339 (33%), Gaps = 76/339 (22%)

Query: 43  GSSEPSVQPGRNVG----------IELSIREARRFQMEELSLATKNFSDK----NLIGEG 88
           GS        +  G           +      +++  + + +   +  D       +G G
Sbjct: 3   GSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSG 62

Query: 89  KFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNL 144
            FG V++ +    G +     I            +E+  +  + H  L+ L    ++   
Sbjct: 63  AFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122

Query: 145 QFLIYEYIPNG------SVSIHLYGPSQVS---RQKLEFKHRLSIALGAAKGLAHLHSLS 195
             LI E++  G      +   +    ++V    RQ  E             GL H+H   
Sbjct: 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE-------------GLKHMHEH- 168

Query: 196 PRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGR----TDVAGPSSQVTADEIFLASE 249
             +VH D K  N++    +    K+ D GL   L                TA+  F A E
Sbjct: 169 -SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA-----TAE--FAAPE 220

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSSQDLVELVQNSR-DFSNLLK 305
           + +       +D+++ GV    L+SG      LSP   +   + ++ V+    +F     
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSG------LSPFAGEDDLETLQNVKRCDWEF----- 269

Query: 306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
             DE  +S+ + E  +     I   L     +R ++ D 
Sbjct: 270 --DEDAFSSVSPEAKD----FIKNLLQKEPRKRLTVHDA 302

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 63/310 (20%), Positives = 110/310 (35%), Gaps = 73/310 (23%)

Query: 84  LIGEGKFGEVYKGLLQDGML---VAIK--KRPGAPTQEFID----EVCFLASIQHRNLVT 134
           ++G G   EV+    +D      VA+K  +   A    F      E    A++ H  +V 
Sbjct: 19  ILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 135 LLGYCQENN----LQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
           +    +       L +++ EY+   ++   +H  GP       +  K  + +   A + L
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-------MTPKRAIEVIADACQAL 129

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLA 247
              H     ++H+D K AN+++      KV D G+ R       +A   + VT     + 
Sbjct: 130 NFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIAR------AIADSGNSVTQTAAVIG 181

Query: 248 S------EVKEFRRFSEKSDVYSFGVFLLELVSGR--------------------EASSS 281
           +      E         +SDVYS G  L E+++G                        S+
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 241

Query: 282 LSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 341
                S DL  +V  +     L K  + R  +        E    +VR  +      P  
Sbjct: 242 RHEGLSADLDAVVLKA-----LAKNPENRYQT------AAEMRADLVRVHNG---EPPEA 287

Query: 342 SDVVTELDRT 351
             V+T+ +RT
Sbjct: 288 PKVLTDAERT 297

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 41/259 (15%), Positives = 83/259 (32%), Gaps = 56/259 (21%)

Query: 35  SVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY 94
            +             + G   G          +++  L            +G G  G+VY
Sbjct: 13  GLVPRGSHMDGTAESREGTQFG---------PYRLRRL------------VGRGGMGDVY 51

Query: 95  KGLLQDGML---VAIK--KRPGAPTQEFID----EVCFLASIQHRNLVTLLGYCQENNLQ 145
           +   +D +    VA+K      +    F      E      +Q  ++V +  + + +   
Sbjct: 52  EA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109

Query: 146 FLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF 203
           ++    I    ++  +   GP       L     ++I       L   H+      H+D 
Sbjct: 110 YVDMRLINGVDLAAMLRRQGP-------LAPPRAVAIVRQIGSALDAAHAA--GATHRDV 160

Query: 204 KTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS------EVKEFRRFS 257
           K  N+LV  D  A + D G+         A    ++T     + +      E       +
Sbjct: 161 KPENILVSADDFAYLVDFGIA-------SATTDEKLTQLGNTVGTLYYMAPERFSESHAT 213

Query: 258 EKSDVYSFGVFLLELVSGR 276
            ++D+Y+    L E ++G 
Sbjct: 214 YRADIYALTCVLYECLTGS 232

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 16/157 (10%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 130
            + +  L+GEG +G V K      G +VAIKK               + E+  L  ++H 
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA-MREIKLLKQLRHE 84

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           NLV LL  C++    +L++E+     V   +    ++    L+++           G+  
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNF 226
            HS    ++H+D K  N+LV +  + K+ D G  R  
Sbjct: 140 CHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 79.0 bits (195), Expect = 7e-17
 Identities = 33/249 (13%), Positives = 61/249 (24%), Gaps = 68/249 (27%)

Query: 37  SRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG 96
            R S     +  + PG  +          R+++                G     + ++ 
Sbjct: 10  DRESSAPPDDVQLVPGARIA-------NGRYRLLIF------------HGGVPPLQFWQA 50

Query: 97  LLQDGML---VAIK------KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL 147
              D  L   VA+         P    QE +     L+ I    +  +L          +
Sbjct: 51  --LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108

Query: 148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTAN 207
           + E+I  GS+        +V+         +      A      H     V       + 
Sbjct: 109 VAEWIRGGSLQ-------EVADTSPSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSR 159

Query: 208 VLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGV 267
           V V  D    +A                ++                     + D+   G 
Sbjct: 160 VRVSIDGDVVLAYPA---------TMPDANP--------------------QDDIRGIGA 190

Query: 268 FLLELVSGR 276
            L  L+  R
Sbjct: 191 SLYALLVNR 199

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 67/301 (22%), Positives = 113/301 (37%), Gaps = 66/301 (21%)

Query: 72  LSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFID----E 120
           +  +T  FSD+     ++G+G FGEV        G   A+K   +     +   +    E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
           V  L  + H N++ L  + ++    +L+ E    G     L+        ++  + R S 
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LF-------DEIISRKRFSE 125

Query: 181 ALGAA------KGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR-- 229
              A        G+ ++H     +VH+D K  N+L+    +D   ++ D GL        
Sbjct: 126 VDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183

Query: 230 --TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP--- 284
              D  G     TA   ++A EV     + EK DV+S GV L  L+SG        P   
Sbjct: 184 KMKDKIG-----TAY--YIAPEVLH-GTYDEKCDVWSTGVILYILLSGC------PPFNG 229

Query: 285 DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 343
            +  D+++ V+  +  F       +   W   +         LI + L      R S  D
Sbjct: 230 ANEYDILKKVEKGKYTF-------ELPQWKKVSESA----KDLIRKMLTYVPSMRISARD 278

Query: 344 V 344
            
Sbjct: 279 A 279

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 27/216 (12%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFID-EVCFLASIQHRNL 132
            +  K  +G G FG V + +    G  VAIK   +      +E    E+  +  + H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 133 VTLL------GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQK-LEFKHRLS-IALGA 184
           V+             N+L  L  EY   G +  +L         K    +  LS I+   
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA- 133

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRTDVAGPSSQV-T 240
              L +LH    R++H+D K  N+++    +  I K+ D G    L + ++   +  V T
Sbjct: 134 ---LRYLHEN--RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGT 186

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               +LA E+ E ++++   D +SFG    E ++G 
Sbjct: 187 --LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 51/307 (16%), Positives = 102/307 (33%), Gaps = 72/307 (23%)

Query: 85  IGEGKFGEVYKGLLQDGMLVAIK----------KRPGAPTQEFID----------EVCFL 124
           + +GKF ++     +D    A+K          +       + I           E+  +
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 125 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
             I++   +T  G     +  ++IYEY+ N S+              L+  +   I +  
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-----EYFFVLDKNYTCFIPIQV 152

Query: 185 AK--------GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 236
            K          +++H+    + H+D K +N+L+D++   K++D G              
Sbjct: 153 IKCIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKNGRVKLSDFGE------------- 198

Query: 237 SQVTADEI---------FLASEVKEFRRF--SEKSDVYSFGVFLLELVSGR---EASSSL 282
           S+   D+          F+  E           K D++S G+ L  +           SL
Sbjct: 199 SEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258

Query: 283 SPDSSQDLVELVQNSR-----DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER 337
                 +L   ++        D ++ L  L  +  +   N    E I  +   L  +   
Sbjct: 259 -----VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313

Query: 338 RPSMSDV 344
           R +  D 
Sbjct: 314 RITSEDA 320

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 65/308 (21%), Positives = 118/308 (38%), Gaps = 78/308 (25%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK----------------KRPGAPT 114
                +       +G G +GEV            AIK                K      
Sbjct: 31  EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90

Query: 115 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 174
           +E  +E+  L S+ H N++ L    ++    +L+ E+   G     L+       +++  
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LF-------EQIIN 139

Query: 175 KHRLSIALGAAK-------GLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLR 224
           +H+      AA        G+ +LH  +  +VH+D K  N+L+   +     K+ D GL 
Sbjct: 140 RHKFDEC-DAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLS 196

Query: 225 NFLGR----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASS 280
           +F  +     D  G     TA   ++A EV + ++++EK DV+S GV +  L+ G     
Sbjct: 197 SFFSKDYKLRDRLG-----TAY--YIAPEVLK-KKYNEKCDVWSCGVIMYILLCGY---- 244

Query: 281 SLSP---DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSE 336
              P    + QD+++ V+  +  F       D   W   ++E      +LI   L     
Sbjct: 245 --PPFGGQNDQDIIKKVEKGKYYF-------DFNDWKNISDEA----KELIKLMLTYDYN 291

Query: 337 RRPSMSDV 344
           +R +  + 
Sbjct: 292 KRCTAEEA 299

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 69/340 (20%), Positives = 117/340 (34%), Gaps = 70/340 (20%)

Query: 35  SVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSD------KNLIGEG 88
            V   ++     P      +            F    ++      +         ++G G
Sbjct: 41  EVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGG 100

Query: 89  KFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNL 144
           +FG+V+K      G+ +A   IK R     +E  +E+  +  + H NL+ L    +  N 
Sbjct: 101 RFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKND 160

Query: 145 QFLIYEYIPNGSV------SIHLYGPSQVS---RQKLEFKHRLSIALGAAKGLAHLHSLS 195
             L+ EY+  G +        +           +Q  E             G+ H+H + 
Sbjct: 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE-------------GIRHMHQM- 206

Query: 196 PRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDVAGPSSQVTADEIFLAS 248
             ++H D K  N+L    D   I K+ D GL              G     T +  FLA 
Sbjct: 207 -YILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNFG-----TPE--FLAP 257

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSSQDLVELVQNSR-DFSNLL 304
           EV  +   S  +D++S GV    L+SG      LSP   D+  + +  +   R D     
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSG------LSPFLGDNDAETLNNILACRWDL---- 307

Query: 305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
              ++  +   + E  E     I + L      R S S+ 
Sbjct: 308 ---EDEEFQDISEEAKE----FISKLLIKEKSWRISASEA 340

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 51/224 (22%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 130
           + +   + +GEG +  VYKG       LVA+K+       GAP    I EV  L  ++H 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT-AIREVSLLKDLKHA 60

Query: 131 NLVTLLGYCQENNLQFLIYEYIP--------NGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
           N+VTL           L++EY+         +    I+      V   KL     L    
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIIN---MHNV---KLFLFQLL---- 110

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ--- 238
              +GLA+ H    +V+H+D K  N+L++E    K+AD GL R        + P+     
Sbjct: 111 ---RGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAK------SIPTKTYDN 159

Query: 239 --VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             VT      +I L S       +S + D++  G    E+ +GR
Sbjct: 160 EVVTLWYRPPDILLGS-----TDYSTQIDMWGVGCIFYEMATGR 198

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 77.6 bits (191), Expect = 3e-16
 Identities = 37/240 (15%), Positives = 78/240 (32%), Gaps = 32/240 (13%)

Query: 115 QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEF 174
                ++  +     +N V  L         ++  +     ++   +    + S +  E 
Sbjct: 106 DAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMN--RRCSLEDREH 163

Query: 175 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVA 233
              L I +  A+ +  LHS    ++H+D K +N+    D + KV D GL        +  
Sbjct: 164 GVCLHIFIQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221

Query: 234 GPSSQVTADEIF---------LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP 284
              + + A             ++ E      +S K D++S G+ L EL+           
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-- 279

Query: 285 DSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
                             ++  +    +     +   +   ++   L PS   RP  +D+
Sbjct: 280 ----------------VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 44.1 bits (104), Expect = 4e-05
 Identities = 19/109 (17%), Positives = 33/109 (30%), Gaps = 5/109 (4%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHRN 131
            +F     +G G FG V++     D    AIK+          ++ + EV  LA ++H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSI 180
           +V       E   +    E             P            ++  
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 77.7 bits (192), Expect = 5e-16
 Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 38/216 (17%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLG 137
           IG+G FGEV+K    + G  VA+KK      + G P    + E+  L  ++H N+V L+ 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIE 83

Query: 138 YCQENNLQ--------FLIYEYIPNGSVSIH-LYGPSQVSRQKLEFKHRLSIALGAAKGL 188
            C+             +L++++        H L G       K        +      GL
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCE------HDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 137

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNF--LGRTDVAGPSSQV-T---- 240
            ++H    +++H+D K ANVL+  D + K+AD GL R F     +     +++V T    
Sbjct: 138 YYIHRN--KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 195

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             E+ L       R +    D++  G  + E+ +  
Sbjct: 196 PPELLLGE-----RDYGPPIDLWGAGCIMAEMWTRS 226

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 77.1 bits (190), Expect = 9e-16
 Identities = 47/213 (22%), Positives = 88/213 (41%), Gaps = 29/213 (13%)

Query: 85  IGEGKFGEVYKGLLQD---GMLVAIKK--RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
           +G G +G VYK   +D       A+K+    G        E+  L  ++H N+++L    
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-MSACREIALLRELKHPNVISLQKVF 87

Query: 140 QENNLQ--FLIYEYIPN---GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
             +  +  +L+++Y  +     +  H    +     +L      S+      G+ +LH+ 
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA- 146

Query: 195 SPRVVHKDFKTANVLVDEDF----IAKVADAGL-RNF--LGRTDVAGPSSQVT----ADE 243
              V+H+D K AN+LV  +       K+AD G  R F    +         VT    A E
Sbjct: 147 -NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           + L +     R +++  D+++ G    EL++  
Sbjct: 206 LLLGA-----RHYTKAIDIWAIGCIFAELLTSE 233

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 57/258 (22%), Positives = 89/258 (34%), Gaps = 58/258 (22%)

Query: 50  QPGRNVGIELSIREARRFQMEELSLATK--NFSDKNLIGEGKFGEVYKGL-LQDGMLVAI 106
                  +E   +      +     AT    +     +GEG +GEVYK +       VAI
Sbjct: 5   HHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAI 64

Query: 107 KK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP------- 153
           K+        G P    I EV  L  +QHRN++ L      N+   LI+EY         
Sbjct: 65  KRIRLEHEEEGVPGTA-IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYM 123

Query: 154 NGSVSIHLYGPSQV---SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV 210
           + +  +       +     Q +              G+   H  S R +H+D K  N+L+
Sbjct: 124 DKNPDVS---MRVIKSFLYQLI-------------NGVNFCH--SRRCLHRDLKPQNLLL 165

Query: 211 DEDFIA-----KVADAGL-RNFLGRTDVAGPSSQ--VT----ADEIFLASEVKEFRRFSE 258
                +     K+ D GL R F          +   +T      EI L S     R +S 
Sbjct: 166 SVSDASETPVLKIGDFGLARAF---GIPIRQFTHEIITLWYRPPEILLGS-----RHYST 217

Query: 259 KSDVYSFGVFLLELVSGR 276
             D++S      E++   
Sbjct: 218 SVDIWSIACIWAEMLMKT 235

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 51/330 (15%), Positives = 98/330 (29%), Gaps = 83/330 (25%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFID----EVC 122
                 K      IG+G +G V   +  Q   + AIK     +      + ++    EV 
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80

Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS--IHLYGPSQVSRQKLEFKHRLSI 180
            +  + H N+  L    ++     L+ E    G +   ++++      +  ++       
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140

Query: 181 ALG--------------------------AAK-------GLAHLHSLSPRVVHKDFKTAN 207
                                         +         L +LH+    + H+D K  N
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ--GICHRDIKPEN 198

Query: 208 VLV--DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-----FLASEV--KEFRRFSE 258
            L   ++ F  K+ D GL     + +                  F+A EV       +  
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLN---NGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255

Query: 259 KSDVYSFGVFLLELVSGREASSSLSP---DSSQDLVELVQNSR-DFSNLLKILDERLWST 314
           K D +S GV L  L+ G        P    +  D +  V N +  F       +   ++ 
Sbjct: 256 KCDAWSAGVLLHLLLMGA------VPFPGVNDADTISQVLNKKLCF-------ENPNYNV 302

Query: 315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
            +         L+   L+ + + R      
Sbjct: 303 LSPLA----RDLLSNLLNRNVDERFDAMRA 328

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 74.5 bits (184), Expect = 3e-15
 Identities = 62/299 (20%), Positives = 104/299 (34%), Gaps = 67/299 (22%)

Query: 73  SLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFL 124
           S+ T N         ++G G F EV+       G L A+K   K P        +E+  L
Sbjct: 1   SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVL 60

Query: 125 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYG------PSQVSRQKLEFKH 176
             I+H N+VTL    +     +L+ + +  G +   I   G       S V +Q L    
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS--- 117

Query: 177 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR---T 230
                      + +LH     +VH+D K  N+L    +E+    + D GL         +
Sbjct: 118 ----------AVKYLHEN--GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165

Query: 231 DVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DS 286
              G P         ++A EV   + +S+  D +S GV    L+ G        P   ++
Sbjct: 166 TACGTPG--------YVAPEVLAQKPYSKAVDCWSIGVITYILLCGY------PPFYEET 211

Query: 287 SQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
              L E ++    +F       +   W   +    +     I   L+     R +    
Sbjct: 212 ESKLFEKIKEGYYEF-------ESPFWDDISESAKD----FICHLLEKDPNERYTCEKA 259

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 73.0 bits (180), Expect = 7e-15
 Identities = 64/293 (21%), Positives = 117/293 (39%), Gaps = 59/293 (20%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLA 125
              F+++     ++G+G FGEV K          A+K           T   + EV  L 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHRLSIALG 183
            + H N++ L    ++++  +++ E    G +   I       + R++        I   
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-------IKRKRFSEHDAARIIKQ 129

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDVAGPS 236
              G+ ++H  +  +VH+D K  N+L+   ++D   K+ D GL     +     D  G  
Sbjct: 130 VFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG-- 185

Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP----DSSQDLVE 292
              TA   ++A EV     + EK DV+S GV L  L+SG       +P     +  D+++
Sbjct: 186 ---TA--YYIAPEVLR-GTYDEKCDVWSAGVILYILLSG-------TPPFYGKNEYDILK 232

Query: 293 LVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
            V+  +  F       D   W T +++  +    LI + L      R + +  
Sbjct: 233 RVETGKYAF-------DLPQWRTISDDAKD----LIRKMLTFHPSLRITATQC 274

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 60/310 (19%), Positives = 111/310 (35%), Gaps = 75/310 (24%)

Query: 71  ELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEF 117
           +++     F D      +IG+G F  V + +  + G   A+K          PG  T++ 
Sbjct: 14  DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73

Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG---------SVSIHLYG---PS 165
             E      ++H ++V LL     + + ++++E++            + +  +Y     S
Sbjct: 74  KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133

Query: 166 QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAG 222
              RQ LE              L + H     ++H+D K   VL+   +     K+   G
Sbjct: 134 HYMRQILE-------------ALRYCHDN--NIIHRDVKPHCVLLASKENSAPVKLGGFG 178

Query: 223 LRNFLGR-----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE 277
           +   LG          G     T    F+A EV +   + +  DV+  GV L  L+SG  
Sbjct: 179 VAIQLGESGLVAGGRVG-----TPH--FMAPEVVKREPYGKPVDVWGCGVILFILLSGC- 230

Query: 278 ASSSLSP--DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPS 334
                 P   + + L E +   +          + R WS  +    +    L+ R L   
Sbjct: 231 -----LPFYGTKERLFEGIIKGKYKM-------NPRQWSHISESAKD----LVRRMLMLD 274

Query: 335 SERRPSMSDV 344
              R ++ + 
Sbjct: 275 PAERITVYEA 284

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 60/306 (19%), Positives = 109/306 (35%), Gaps = 73/306 (23%)

Query: 73  SLATKNFSD----KNLIGEGKFGEVYKGL-LQDGMLVAIK---------KRPGAPTQEFI 118
           +   +   D       +G G+F  V K      G+  A K          R G   +E  
Sbjct: 4   TFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE 63

Query: 119 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQ 170
            EV  L  + H N++TL    +      LI E +  G               + +   +Q
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123

Query: 171 KLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNF 226
            L+             G+ +LH+    + H D K  N+++          K+ D GL + 
Sbjct: 124 ILD-------------GVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168

Query: 227 LGR----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL 282
           +       ++ G     T +  F+A E+  +     ++D++S GV    L+SG       
Sbjct: 169 IEDGVEFKNIFG-----TPE--FVAPEIVNYEPLGLEADMWSIGVITYILLSG------A 215

Query: 283 SP---DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 338
           SP   D+ Q+ +  +     DF       DE  +S  +    +     I + L   + +R
Sbjct: 216 SPFLGDTKQETLANITAVSYDF-------DEEFFSQTSELAKD----FIRKLLVKETRKR 264

Query: 339 PSMSDV 344
            ++ + 
Sbjct: 265 LTIQEA 270

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 60/303 (19%), Positives = 109/303 (35%), Gaps = 73/303 (24%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---------KRPGAPTQEFIDEV 121
            +   D       +G G+F  V K      G+  A K          R G   +E   EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQKLE 173
             L  + H N++TL    +      LI E +  G               + +   +Q L+
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126

Query: 174 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGR 229
                        G+ +LH+    + H D K  N+++          K+ D GL + +  
Sbjct: 127 -------------GVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171

Query: 230 ----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP- 284
                ++ G     T +  F+A E+  +     ++D++S GV    L+SG       SP 
Sbjct: 172 GVEFKNIFG-----TPE--FVAPEIVNYEPLGLEADMWSIGVITYILLSG------ASPF 218

Query: 285 --DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 341
             D+ Q+ +  + +   DF       DE  +S  +    +     I + L   + +R ++
Sbjct: 219 LGDTKQETLANITSVSYDF-------DEEFFSHTSELAKD----FIRKLLVKETRKRLTI 267

Query: 342 SDV 344
            + 
Sbjct: 268 QEA 270

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 71.8 bits (177), Expect = 2e-14
 Identities = 60/288 (20%), Positives = 106/288 (36%), Gaps = 69/288 (23%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFID-EVCFLASIQHRNLVTLLGY 138
            +GEG +GEV   +       VA+K    +      E I  E+C    + H N+V   G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLAHL 191
            +E N+Q+L  EY   G +   +          +        F   ++       G+ +L
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA-------GVVYL 121

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL----- 246
           H +   + H+D K  N+L+DE    K++D GL              +    E  L     
Sbjct: 122 HGI--GITHRDIKPENLLLDERDNLKISDFGLATV----------FRYNNRERLLNKMCG 169

Query: 247 -----ASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 300
                A E+ + R F  E  DV+S G+ L  +++G      L  D   D  +        
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE-----LPWDQPSDSCQE------- 217

Query: 301 SNLLKILDERL----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
                  +++     W    +      + L+ + L  +   R ++ D+
Sbjct: 218 --YSDWKEKKTYLNPWKKIDSAP----LALLHKILVENPSARITIPDI 259

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 57/323 (17%), Positives = 117/323 (36%), Gaps = 66/323 (20%)

Query: 57  IELSIREARRF-----QMEELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAI 106
           I LS+   + F      +++ S+  K   D+      +G G  GEV      +    VAI
Sbjct: 106 IALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAI 165

Query: 107 K---KRPGAPTQE--------FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 155
           +   KR  A               E+  L  + H  ++ +  +    +  +++ E +  G
Sbjct: 166 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG 224

Query: 156 SV--SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV--- 210
            +   +       V  ++L+              + +LH     ++H+D K  NVL+   
Sbjct: 225 ELFDKV-------VGNKRLKEATCKLYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQ 275

Query: 211 DEDFIAKVADAGLRNFLGR----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFG 266
           +ED + K+ D G    LG       + G  + + A E+           ++   D +S G
Sbjct: 276 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYL-APEVL---VSVGTAGYNRAVDCWSLG 331

Query: 267 VFLLELVSGREASSSLSP----DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGME 321
           V L   +SG        P     +   L + + + + +F          +W+  + + ++
Sbjct: 332 VILFICLSGY------PPFSEHRTQVSLKDQITSGKYNF-------IPEVWAEVSEKALD 378

Query: 322 EFIQLIVRCLDPSSERRPSMSDV 344
               L+ + L    + R +  + 
Sbjct: 379 ----LVKKLLVVDPKARFTTEEA 397

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 64/303 (21%), Positives = 110/303 (36%), Gaps = 73/303 (24%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---------KRPGAPTQEFIDEV 121
            +N  D       +G G+F  V K      G+  A K          R G   ++   EV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQKLE 173
             L  IQH N++TL    +      LI E +  G               + +   +Q L 
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125

Query: 174 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGR 229
                        G+ +LHSL   + H D K  N+++          K+ D GL + +  
Sbjct: 126 -------------GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170

Query: 230 ----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP- 284
                ++ G     T +  F+A E+  +     ++D++S GV    L+SG       SP 
Sbjct: 171 GNEFKNIFG-----TPE--FVAPEIVNYEPLGLEADMWSIGVITYILLSG------ASPF 217

Query: 285 --DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 341
             D+ Q+ +  V     +F       ++  +S  +    +     I R L    ++R ++
Sbjct: 218 LGDTKQETLANVSAVNYEF-------EDEYFSNTSALAKD----FIRRLLVKDPKKRMTI 266

Query: 342 SDV 344
            D 
Sbjct: 267 QDS 269

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 71.5 bits (176), Expect = 4e-14
 Identities = 55/294 (18%), Positives = 103/294 (35%), Gaps = 65/294 (22%)

Query: 77  KNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQH 129
           K   +K      +G G+FG V++ +          K  K  G        E+  L   +H
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNG-------SVSIHL--YGPSQVSRQKLEFKHRLSI 180
           RN++ L    +      +I+E+I          + +  L          Q  E       
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE------- 113

Query: 181 ALGAAKGLAHLHSLSPRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGR----TDVAG 234
                  L  LHS +  + H D +  N++         K+ + G    L        +  
Sbjct: 114 ------ALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165

Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSSQDLV 291
                  +  + A EV +    S  +D++S G  +  L+SG      ++P   +++Q ++
Sbjct: 166 -----APE--YYAPEVHQHDVVSTATDMWSLGTLVYVLLSG------INPFLAETNQQII 212

Query: 292 ELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           E + N+   F       DE  +   + E M+     + R L    + R + S+ 
Sbjct: 213 ENIMNAEYTF-------DEEAFKEISIEAMD----FVDRLLVKERKSRMTASEA 255

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 70.7 bits (174), Expect = 4e-14
 Identities = 56/290 (19%), Positives = 99/290 (34%), Gaps = 55/290 (18%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASI 127
             + +      N IG G +GEV   +     +  A K   K        F  E+  + S+
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEFKHRLSIALGAA 185
            H N++ L    ++N   +L+ E    G +   +       V ++         I     
Sbjct: 64  DHPNIIRLYETFEDNTDIYLVMELCTGGELFERV-------VHKRVFRESDAARIMKDVL 116

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDVAGPSSQ 238
             +A+ H L   V H+D K  N L      D   K+ D GL              G    
Sbjct: 117 SAVAYCHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG---- 170

Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSSQDLVELVQ 295
            T    +++ +V E   +  + D +S GV +  L+ G        P    +  +++  ++
Sbjct: 171 -TP--YYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGY------PPFSAPTDSEVMLKIR 220

Query: 296 NSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
                F        E+ W   + +       LI R L  S ++R +    
Sbjct: 221 EGTFTF-------PEKDWLNVSPQAES----LIRRLLTKSPKQRITSLQA 259

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 59/232 (25%), Positives = 87/232 (37%), Gaps = 60/232 (25%)

Query: 78  NFSDKNLIGEGKFGEVYKG--LLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ- 128
            +     IGEG +G+V+K   L   G  VA+K+        G P    I EV  L  ++ 
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-IREVAVLRHLET 70

Query: 129 --HRNLVTLL------GYCQENNLQFLIYEYIPN------GSVSIHLYGPSQV---SRQK 171
             H N+V L          +E  L  L++E++          V         +     Q 
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129

Query: 172 LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRT 230
           L             +GL  LHS   RVVH+D K  N+LV      K+AD GL R +    
Sbjct: 130 L-------------RGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIY---- 170

Query: 231 DVAGPSSQ--VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                 +   VT    A E+ L S       ++   D++S G    E+   +
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQS------SYATPVDLWSVGCIFAEMFRRK 216

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 71.1 bits (175), Expect = 5e-14
 Identities = 53/233 (22%), Positives = 82/233 (35%), Gaps = 60/233 (25%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---------RPGAPTQEFIDEVCFLASI 127
            +     IG G +G VYK      G  VA+K            G P    + EV  L  +
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST-VREVALLRRL 68

Query: 128 Q---HRNLVTLLGYCQENNLQ-----FLIYEYIPN------GSVSIHLYGPSQV---SRQ 170
           +   H N+V L+  C  +         L++E++                    +    RQ
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128

Query: 171 KLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGR 229
            L             +GL  LH+    +VH+D K  N+LV      K+AD GL R +   
Sbjct: 129 FL-------------RGLDFLHAN--CIVHRDLKPENILVTSGGTVKLADFGLARIY--- 170

Query: 230 TDVAGPSSQ--VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  +   VT    A E+ L S       ++   D++S G    E+   +
Sbjct: 171 -SYQMALTPVVVTLWYRAPEVLLQS------TYATPVDMWSVGCIFAEMFRRK 216

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 71.7 bits (176), Expect = 5e-14
 Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 53/228 (23%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
             +++D  +IG G FG VY+  L D G LVAIKK          D      E+  +  + 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD 105

Query: 129 HRNLVTLLGYCQENNLQF------LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
           H N+V L  +   +  +       L+ +Y+P       +Y   +V+R     K  L +  
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-----TVY---RVARHYSRAKQTLPVIY 157

Query: 183 G------AAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGP 235
                    + LA++HS    + H+D K  N+L+D D  + K+ D G      +  V G 
Sbjct: 158 VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFG----SAKQLVRGE 211

Query: 236 SSQ---VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +     +    A E+   +       ++   DV+S G  L EL+ G+
Sbjct: 212 PNVSYICSRYYRAPELIFGA-----TDYTSSIDVWSAGCVLAELLLGQ 254

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 71.5 bits (175), Expect = 6e-14
 Identities = 66/288 (22%), Positives = 107/288 (37%), Gaps = 40/288 (13%)

Query: 76  TKNFSDKNLIGE-GKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT 134
           TK      +I E  KFG +   L          K  GA  ++  D V  +     R L +
Sbjct: 96  TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDS 155

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           +       +  F+  + +   S       P  + +  L  +H +  +   AKG+  L S 
Sbjct: 156 ITSSQSSASSGFVEEKSL---SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 212

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
             + +H+D    N+L+ E  + K+ D GL   + +               ++A E    R
Sbjct: 213 --KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 270

Query: 255 RFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 313
            ++ +SDV+SFGV L E+ S G       SP         V+   +F   LK        
Sbjct: 271 VYTIQSDVWSFGVLLWEIFSLGA------SPYPG------VKIDEEFCRRLK-------- 310

Query: 314 TFTNEG--ME-------EFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
               EG  M        E  Q ++ C      +RP+ S++V  L   L
Sbjct: 311 ----EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 38/219 (17%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
            K +     +G G +G V   +  + G  VAIKK    P Q  I       E+  L  +Q
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQ 81

Query: 129 HRNLVTLL------GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
           H N++ LL         +     +L+  ++      +      ++   K   +    +  
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFMQ---TDLQ-----KIMGLKFSEEKIQYLVY 133

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-- 240
              KGL ++HS    VVH+D K  N+ V+ED   K+ D G    L R   A  +  V   
Sbjct: 134 QMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFG----LARHADAEMTGYVVTR 187

Query: 241 ---ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
              A E+ L+     +  +++  D++S G  + E+++G+
Sbjct: 188 WYRAPEVILS-----WMHYNQTVDIWSVGCIMAEMLTGK 221

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 70.3 bits (173), Expect = 7e-14
 Identities = 62/290 (21%), Positives = 108/290 (37%), Gaps = 69/290 (23%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK---------KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           +G G+F  V K      G   A K          R G   +E   EV  L  I+H N++T
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 135 LLGYCQENNLQFLIYEYIPNGS-----VSIHLYGPSQVS---RQKLEFKHRLSIALGAAK 186
           L    +      LI E +  G               + +   +Q L+             
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD------------- 119

Query: 187 GLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLGR----TDVAGPSSQ 238
           G+ +LHS   R+ H D K  N+++      +   K+ D G+ + +       ++ G    
Sbjct: 120 GVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG---- 173

Query: 239 VTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSSQDLVELVQ 295
            T +  F+A E+  +     ++D++S GV    L+SG       SP   ++ Q+ +  + 
Sbjct: 174 -TPE--FVAPEIVNYEPLGLEADMWSIGVITYILLSG------ASPFLGETKQETLTNIS 224

Query: 296 NSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
               DF       DE  +S  +    +     I R L    +RR +++  
Sbjct: 225 AVNYDF-------DEEYFSNTSELAKD----FIRRLLVKDPKRRMTIAQS 263

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 70.9 bits (174), Expect = 8e-14
 Identities = 48/274 (17%), Positives = 101/274 (36%), Gaps = 47/274 (17%)

Query: 32  RNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDK----NLIGE 87
           R+      +    ++            L  +            A K F  K    ++IG 
Sbjct: 45  RDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGR 104

Query: 88  GKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFID--------EVCFLASI-QHRNLVT 134
           G    V + +    G   A+K         + E ++        E   L  +  H +++T
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164

Query: 135 LLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKL-E------FKHRLSIALGAA 185
           L+   + ++  FL+++ +  G +   +         +  L E       +  L       
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGELFDYL-------TEKVALSEKETRSIMRSLLE------ 211

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR----TDVAGPSSQVTA 241
             ++ LH+    +VH+D K  N+L+D++   +++D G    L       ++ G    + A
Sbjct: 212 -AVSFLHAN--NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYL-A 267

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
            EI   S  +    + ++ D+++ GV L  L++G
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 70.4 bits (173), Expect = 8e-14
 Identities = 60/288 (20%), Positives = 106/288 (36%), Gaps = 69/288 (23%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFID-EVCFLASIQHRNLVTLLGY 138
            +GEG +GEV   +       VA+K    +      E I  E+C    + H N+V   G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLAHL 191
            +E N+Q+L  EY   G +   +          +        F   ++       G+ +L
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMA-------GVVYL 121

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL----- 246
           H +   + H+D K  N+L+DE    K++D GL              +    E  L     
Sbjct: 122 HGI--GITHRDIKPENLLLDERDNLKISDFGLATV----------FRYNNRERLLNKMCG 169

Query: 247 -----ASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 300
                A E+ + R F  E  DV+S G+ L  +++G      L  D   D  +        
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE-----LPWDQPSDSCQE------- 217

Query: 301 SNLLKILDERL----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
                  +++     W    +      + L+ + L  +   R ++ D+
Sbjct: 218 --YSDWKEKKTYLNPWKKIDSAP----LALLHKILVENPSARITIPDI 259

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 70.0 bits (172), Expect = 9e-14
 Identities = 57/299 (19%), Positives = 109/299 (36%), Gaps = 57/299 (19%)

Query: 75  ATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPT---------QEF 117
           +T  F +      ++G G    V + +        A+K      G            +  
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 118 IDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLEF 174
           + EV  L  +  H N++ L    + N   FL+++ +  G +   +         +  L  
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-------TEKVTLSE 123

Query: 175 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR----T 230
           K    I     + +  LH L   +VH+D K  N+L+D+D   K+ D G    L       
Sbjct: 124 KETRKIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181

Query: 231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP----DS 286
           +V G  S + A EI   S       + ++ D++S GV +  L++G       SP      
Sbjct: 182 EVCGTPSYL-APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG-------SPPFWHRK 233

Query: 287 SQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
              ++ ++ +    F           W  +++   +    L+ R L    ++R +  + 
Sbjct: 234 QMLMLRMIMSGNYQF-------GSPEWDDYSDTVKD----LVSRFLVVQPQKRYTAEEA 281

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 69.5 bits (171), Expect = 1e-13
 Identities = 64/301 (21%), Positives = 110/301 (36%), Gaps = 74/301 (24%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFLA 125
           +  FSD       +G+G F  V + +    G+  A K     K      Q+   E     
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKL-E------FKH 176
            +QH N+V L    QE +  +L+++ +  G +   I       V+R+   E       + 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI-------VAREFYSEADASHCIQQ 113

Query: 177 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR---- 229
            L         +A+ HS    +VH++ K  N+L+    +    K+AD GL   +      
Sbjct: 114 ILE-------SIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164

Query: 230 TDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---- 284
              AG P         +L+ EV +   +S+  D+++ GV L  L+ G        P    
Sbjct: 165 HGFAGTPG--------YLSPEVLKKDPYSKPVDIWACGVILYILLVG-------YPPFWD 209

Query: 285 DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 343
           +    L   ++    D+           W T T E       LI   L  + ++R +   
Sbjct: 210 EDQHRLYAQIKAGAYDY-------PSPEWDTVTPEA----KSLIDSMLTVNPKKRITADQ 258

Query: 344 V 344
            
Sbjct: 259 A 259

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 69/316 (21%), Positives = 118/316 (37%), Gaps = 96/316 (30%)

Query: 82  KNLIGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEFID------------- 119
           K+ IG+G +G V       D    A+K        ++ G P +                 
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 120 --------EVCFLASIQHRNLVTL---LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVS 168
                   E+  L  + H N+V L   L    E++L ++++E +  G V          +
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVM------EVPT 130

Query: 169 RQKLE-------FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA 221
            + L        F+  +        G+ +LH    +++H+D K +N+LV ED   K+AD 
Sbjct: 131 LKPLSEDQARFYFQDLIK-------GIEYLHYQ--KIIHRDIKPSNLLVGEDGHIKIADF 181

Query: 222 GLRNFLGRTDV-----AG-PSSQVTADEIFLASEV--KEFRRFS-EKSDVYSFGVFLLEL 272
           G+ N    +D       G P+        F+A E   +  + FS +  DV++ GV L   
Sbjct: 182 GVSNEFKGSDALLSNTVGTPA--------FMAPESLSETRKIFSGKALDVWAMGVTLYCF 233

Query: 273 VSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL----WSTFTNEGMEEFIQLIV 328
           V G+       P   + ++ L           KI  + L             E+   LI 
Sbjct: 234 VFGQ-----C-PFMDERIMCL---------HSKIKSQALEFPDQPDIA----EDLKDLIT 274

Query: 329 RCLDPSSERRPSMSDV 344
           R LD + E R  + ++
Sbjct: 275 RMLDKNPESRIVVPEI 290

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 39/220 (17%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
            K + +   IG G  G V           VAIKK    P Q          E+  +  + 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 119

Query: 129 HRNLVTLLG-YCQENNLQFL--IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 185
           H+N+++LL  +  +  L+    +Y  +     ++      QV + +L+ +    +     
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-----QVIQMELDHERMSYLLYQML 174

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT----- 240
            G+ HLHS    ++H+D K +N++V  D   K+ D G    L RT  AG S  +T     
Sbjct: 175 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG----LART--AGTSFMMTPYVVT 226

Query: 241 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               A E+ L         + E  D++S G  + E+V  +
Sbjct: 227 RYYRAPEVILGM------GYKENVDIWSVGCIMGEMVRHK 260

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 60/302 (19%), Positives = 108/302 (35%), Gaps = 69/302 (22%)

Query: 73  SLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVC 122
           ++    F+++      +G+G F  V + + +  G   A       K      Q+   E  
Sbjct: 3   TITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREAR 62

Query: 123 FLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKLEF 174
               ++H N+V L     E    +LI++ +  G +   I           S   +Q LE 
Sbjct: 63  ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE- 121

Query: 175 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR-- 229
                        + H H +   VVH++ K  N+L+    +    K+AD GL   +    
Sbjct: 122 ------------AVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167

Query: 230 ---TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-- 284
                 AG     T    +L+ EV     + +  D+++ GV L  L+ G        P  
Sbjct: 168 QAWFGFAG-----TPG--YLSPEVLRKDPYGKPVDLWACGVILYILLVGY------PPFW 214

Query: 285 -DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 342
            +    L + ++    DF           W T T E  +    LI + L  +  +R + +
Sbjct: 215 DEDQHRLYQQIKAGAYDF-------PSPEWDTVTPEAKD----LINKMLTINPSKRITAA 263

Query: 343 DV 344
           + 
Sbjct: 264 EA 265

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 63/298 (21%), Positives = 110/298 (36%), Gaps = 67/298 (22%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKG-LLQDGMLVAIK----KRPGAPTQEFIDEVCFLAS 126
                D       +G G FG+V+       G+   IK     R   P ++   E+  L S
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS 76

Query: 127 IQHRNLVTLLGYCQENNLQFLIYEY---------IPNGSVSIHLYGPSQVSRQKLEFKHR 177
           + H N++ +    ++ +  +++ E          I +            V+      K  
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL---MKQM 133

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----T 230
           ++        LA+ HS    VVHKD K  N+L          K+ D GL          T
Sbjct: 134 MN-------ALAYFHSQ--HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184

Query: 231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP---DSS 287
           + AG     TA  +++A EV + R  + K D++S GV +  L++G        P    S 
Sbjct: 185 NAAG-----TA--LYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGC------LPFTGTSL 230

Query: 288 QDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           +++ +       ++               T + ++    L+ + L    ERRPS + V
Sbjct: 231 EEVQQKATYKEPNY--------AVECRPLTPQAVD----LLKQMLTKDPERRPSAAQV 276

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 51/220 (23%), Positives = 96/220 (43%), Gaps = 44/220 (20%)

Query: 79  FSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFID-EVCFLASIQHRNLVTLL 136
           +++  +IG G FG V++  L +   VAIKK         F + E+  +  ++H N+V L 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK---RFKNRELQIMRIVKHPNVVDLK 98

Query: 137 GYCQENNLQ------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG------A 184
            +   N  +       L+ EY+P       +Y   + SR   + K  + + L        
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPE-----TVY---RASRHYAKLKQTMPMLLIKLYMYQL 150

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQ---VT 240
            + LA++HS+   + H+D K  N+L+D    + K+ D G      +  +AG  +     +
Sbjct: 151 LRSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFG----SAKILIAGEPNVSYICS 204

Query: 241 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               A E+   +       ++   D++S G  + EL+ G+
Sbjct: 205 RYYRAPELIFGA-----TNYTTNIDIWSTGCVMAELMQGQ 239

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 66/313 (21%), Positives = 117/313 (37%), Gaps = 70/313 (22%)

Query: 76  TKNFSD-----KNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLAS 126
           +  F D     ++++GEG    V   + L      A+K   K+PG        EV  L  
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66

Query: 127 IQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKLEFKHR 177
            Q HRN++ L+ + +E +  +L++E +  GS+   IH          S V +        
Sbjct: 67  CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS---- 122

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAG 234
                     L  LH+    + H+D K  N+L    ++    K+ D  L + +       
Sbjct: 123 ---------ALDFLHNK--GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171

Query: 235 PSSQVTADEI-----FLASEV-----KEFRRFSEKSDVYSFGVFLLELVSG--------- 275
           P S            ++A EV     +E   + ++ D++S GV L  L+SG         
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231

Query: 276 ---REASSSLSPDSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCL 331
                      P     L E +Q  + +F        ++ W+  +    +    LI + L
Sbjct: 232 SDCGWDRGEACPACQNMLFESIQEGKYEF-------PDKDWAHISCAAKD----LISKLL 280

Query: 332 DPSSERRPSMSDV 344
              +++R S + V
Sbjct: 281 VRDAKQRLSAAQV 293

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 56/302 (18%), Positives = 107/302 (35%), Gaps = 72/302 (23%)

Query: 76  TKNFSDK-----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFIDEVCFL 124
            +NF++        +G GKF  V + +    G   A K     +R      E + E+  L
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82

Query: 125 ASIQHR-NLVTLLGYCQENNLQFLIYEYIPNG-------SVSIHLYGPSQVS---RQKLE 173
              +    ++ L    +  +   LI EY   G            +   + V    +Q LE
Sbjct: 83  ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE 142

Query: 174 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLG-- 228
                        G+ +LH     +VH D K  N+L+         K+ D G+   +G  
Sbjct: 143 -------------GVYYLHQN--NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187

Query: 229 --RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP-- 284
               ++ G     T +  +LA E+  +   +  +D+++ G+    L++        SP  
Sbjct: 188 CELREIMG-----TPE--YLAPEILNYDPITTATDMWNIGIIAYMLLTH------TSPFV 234

Query: 285 -DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 342
            + +Q+    +     D+        E  +S+ +    +     I   L  + E+RP+  
Sbjct: 235 GEDNQETYLNISQVNVDY-------SEETFSSVSQLATD----FIQSLLVKNPEKRPTAE 283

Query: 343 DV 344
             
Sbjct: 284 IC 285

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 67/306 (21%), Positives = 112/306 (36%), Gaps = 70/306 (22%)

Query: 69  MEELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK-----KRPGAPTQEFI 118
            E +  A+  FSD       +G+G F  V + +    G+  A K     K      Q+  
Sbjct: 17  SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE 76

Query: 119 DEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS-----VSIHLYG---PSQVSRQ 170
            E      +QH N+V L    QE +  +L+++ +  G      V+   Y     S   +Q
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ 136

Query: 171 KLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFL 227
            LE              +A+ HS    +VH++ K  N+L+    +    K+AD GL   +
Sbjct: 137 ILE-------------SIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181

Query: 228 GR----TDVAG-PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSL 282
                    AG P         +L+ EV +   +S+  D+++ GV L  L+ G       
Sbjct: 182 NDSEAWHGFAGTPG--------YLSPEVLKKDPYSKPVDIWACGVILYILLVGY------ 227

Query: 283 SP---DSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 338
            P   +    L   ++    D+           W T T E       LI   L  + ++R
Sbjct: 228 PPFWDEDQHRLYAQIKAGAYDY-------PSPEWDTVTPEAKS----LIDSMLTVNPKKR 276

Query: 339 PSMSDV 344
            +    
Sbjct: 277 ITADQA 282

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 65/285 (22%), Positives = 114/285 (40%), Gaps = 70/285 (24%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK----KRPGAPTQEFID-EVCFLASIQHRNLVTLLGY 138
           IG+G F +V     +  G  VAIK     +    + + +  EV  +  + H N+V L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLAHL 191
            +     +LI EY   G V  +L     V+  +++       F+  +S        + + 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYL-----VAHGRMKEKEARSKFRQIVS-------AVQYC 130

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI------- 244
           H    R+VH+D K  N+L+D D   K+AD G             S++ T           
Sbjct: 131 HQK--RIVHRDLKAENLLLDADMNIKIADFGF------------SNEFTVGGKLDAFCGA 176

Query: 245 --FLASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 301
             + A E+ + +++   + DV+S GV L  LVSG        P   Q+L EL +      
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS------LPFDGQNLKELRE------ 224

Query: 302 NLLKILDE--RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
              ++L    R+    +     +   L+ R L  +  +R ++  +
Sbjct: 225 ---RVLRGKYRIPFYMS----TDCENLLKRFLVLNPIKRGTLEQI 262

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 68.1 bits (167), Expect = 5e-13
 Identities = 66/336 (19%), Positives = 113/336 (33%), Gaps = 75/336 (22%)

Query: 37  SRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG 96
           S       S   V  G ++     +   +    +E       +    L+G G FG VY G
Sbjct: 3   SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62

Query: 97  L-LQDGMLVAIK--------KRPGAPTQEFID-EVCFLASIQHR--NLVTLLGYCQENNL 144
           + + D + VAIK             P    +  EV  L  +      ++ LL + +  + 
Sbjct: 63  IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122

Query: 145 QFLIYEYI-PNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLAHLHSLSP 196
             LI E   P   +   +       R  L+       F   L         + H H+   
Sbjct: 123 FVLILERPEPVQDLFDFI-----TERGALQEELARSFFWQVLE-------AVRHCHNC-- 168

Query: 197 RVVHKDFKTANVLVDEDFI-AKVADAGLRNFLGR---TDVAG-PSSQVTADEIFLASEVK 251
            V+H+D K  N+L+D +    K+ D G    L     TD  G           +   E  
Sbjct: 169 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV--------YSPPEWI 220

Query: 252 EFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 310
            + R+    + V+S G+ L ++V G        P               F +  +I+  +
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGD------IP---------------FEHDEEIIRGQ 259

Query: 311 LW--STFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           ++     ++E       LI  CL      RP+  ++
Sbjct: 260 VFFRQRVSSECQ----HLIRWCLALRPSDRPTFEEI 291

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 68.1 bits (167), Expect = 5e-13
 Identities = 65/289 (22%), Positives = 97/289 (33%), Gaps = 73/289 (25%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK--------KRPGAPTQEFID-EVCFL----ASIQH 129
           L+G+G FG V+ G  L D + VAIK                     EV  L    A   H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK--- 186
             ++ LL + +      L+ E          L+         +  K  L           
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPA---QDLF-------DYITEKGPLGEGPSRCFFGQ 147

Query: 187 ---GLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGR---TDVAG-PSSQ 238
               + H HS    VVH+D K  N+L+D     AK+ D G    L     TD  G     
Sbjct: 148 VVAAIQHCHSR--GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRV-- 203

Query: 239 VTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 297
                 +   E     ++    + V+S G+ L ++V G        P             
Sbjct: 204 ------YSPPEWISRHQYHALPATVWSLGILLYDMVCGD------IP------------- 238

Query: 298 RDFSNLLKILDERLW--STFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
             F    +IL+  L   +  + +       LI RCL P    RPS+ ++
Sbjct: 239 --FERDQEILEAELHFPAHVSPDC----CALIRRCLAPKPSSRPSLEEI 281

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 68.5 bits (168), Expect = 5e-13
 Identities = 50/225 (22%), Positives = 84/225 (37%), Gaps = 41/225 (18%)

Query: 76  TKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPTQEF--IDEVCFLASIQHRNL 132
              F  + + G+G FG V  G     GM VAIKK    P      +  +  LA + H N+
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI 81

Query: 133 VTLL------GYCQENNL-QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG-- 183
           V L       G     ++   ++ EY+P+   ++H     +  R     +      L   
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVPD---TLH-----RCCRNYYRRQVAPPPILIKV 133

Query: 184 ----AAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQ 238
                 + +  LH  S  V H+D K  NVLV+  D   K+ D G      +       + 
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG----SAKKLSPSEPNV 189

Query: 239 ---VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               +    A E+   +     + ++   D++S G    E++ G 
Sbjct: 190 AYICSRYYRAPELIFGN-----QHYTTAVDIWSVGCIFAEMMLGE 229

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 45/223 (20%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
            K + +   IG G  G V           VAIKK    P Q          E+  +  + 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82

Query: 129 HRNLVTLLG-YCQENNLQ-----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIAL 182
           H+N++ LL  +  + +L+     +++ E +     ++      QV + +L+ +    +  
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMD---ANLC-----QVIQMELDHERMSYLLY 134

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT-- 240
               G+ HLHS    ++H+D K +N++V  D   K+ D G    L RT  AG S  +T  
Sbjct: 135 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG----LART--AGTSFMMTPY 186

Query: 241 -------ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  A E+ L         + E  D++S G  + E++ G 
Sbjct: 187 VVTRYYRAPEVILGM------GYKENVDIWSVGCIMGEMIKGG 223

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 43/206 (20%), Positives = 88/206 (42%), Gaps = 28/206 (13%)

Query: 32  RNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFG 91
           ++ S ++ + +GS +   Q  ++   + +    R     ++      +  ++LIG G +G
Sbjct: 11  QHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYG 67

Query: 92  EVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQHRNLVTLLG-YCQENN 143
            V +     +  +VAIKK      ++ ID      E+  L  + H ++V +L     ++ 
Sbjct: 68  HVCEAYDKLEKRVVAIKKILR-VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126

Query: 144 LQF----LIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
            +F    ++ E               ++  +   L   H  ++      G+ ++HS    
Sbjct: 127 EKFDELYVVLEIAD---SDFK-----KLFRTPVYLTELHIKTLLYNLLVGVKYVHS--AG 176

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGL 223
           ++H+D K AN LV++D   KV D GL
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGL 202

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 68.1 bits (167), Expect = 7e-13
 Identities = 58/344 (16%), Positives = 105/344 (30%), Gaps = 70/344 (20%)

Query: 30  LYRNRSVSRTSETGSSEPSVQPGRNV-GIELSIREARRFQMEELSLATKNFSDK----NL 84
           ++ +   S   + G+     Q   +V         +               SD     + 
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESE 60

Query: 85  IGEGKFGEVYKGL-LQDGMLVA---IKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
           +G G    VY+          A   +KK      +    E+  L  + H N++ L    +
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118

Query: 141 ENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKLEFKHRLSIALGAAKGLAHLH 192
                 L+ E +  G +   I   G       +   +Q LE              +A+LH
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE-------------AVAYLH 165

Query: 193 SLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR----TDVAGPSSQVTADEIF 245
                +VH+D K  N+L      D   K+AD GL   +        V G     T    +
Sbjct: 166 EN--GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG-----TPG--Y 216

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSP----DSSQDLVELVQNSR-DF 300
            A E+     +  + D++S G+    L+ G        P       Q +   + N    F
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIITYILLCGF------EPFYDERGDQFMFRRILNCEYYF 270

Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
                      W   +    +    L+ + +    ++R +    
Sbjct: 271 -------ISPWWDEVSLNAKD----LVRKLIVLDPKKRLTTFQA 303

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 48/217 (22%), Positives = 84/217 (38%), Gaps = 42/217 (19%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
           L+GEG +G+V + L  +     A+K       +R          E+  L  ++H+N++ L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 136 ---LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAA 185
              L   ++  + +++ EY   G   +       V  ++         F   +       
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQEMLDS----VPEKRFPVCQAHGYFCQLID------ 120

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP------SSQV 239
            GL +LHS    +VHKD K  N+L+      K++  G+   L              S   
Sbjct: 121 -GLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
              EI   + +  F  F  K D++S GV L  + +G 
Sbjct: 178 QPPEIA--NGLDTFSGF--KVDIWSAGVTLYNITTGL 210

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 49/236 (20%), Positives = 89/236 (37%), Gaps = 53/236 (22%)

Query: 72  LSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQE------- 116
           +S+  K   D+      +G G  GEV      +    VAIK   KR  A           
Sbjct: 1   MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60

Query: 117 -FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGPSQVSRQKLE 173
               E+  L  + H  ++ +  +    +  +++ E +  G +   +       V  ++L+
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKV-------VGNKRLK 112

Query: 174 -------FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGL 223
                  F   L         + +LH     ++H+D K  NVL+   +ED + K+ D G 
Sbjct: 113 EATCKLYFYQMLL-------AVQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163

Query: 224 RNFLGR----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG 275
              LG       + G  + + A E+ ++        ++   D +S GV L   +SG
Sbjct: 164 SKILGETSLMRTLCGTPTYL-APEVLVS---VGTAGYNRAVDCWSLGVILFICLSG 215

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 52/289 (17%), Positives = 101/289 (34%), Gaps = 75/289 (25%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFID----EVCFLASIQHRNL 132
           +G G FG V+  +  +    V +K                 +     E+  L+ ++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK------ 186
           + +L   +      L+ E   +G   + L+         ++   RL   L +        
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG---LDLF-------AFIDRHPRLDEPLASYIFRQLVS 141

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL----------GRTDVAGPS 236
            + +L      ++H+D K  N+++ EDF  K+ D G   +L          G  +   P 
Sbjct: 142 AVGYLRLK--DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP- 198

Query: 237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 296
            +V     +   E+          +++S GV L  LV         +P            
Sbjct: 199 -EVLMGNPYRGPEL----------EMWSLGVTLYTLVFEE------NP------------ 229

Query: 297 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
              F  L + ++  +         +E + L+   L P  ERR ++  +V
Sbjct: 230 ---FCELEETVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLV 273

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 65.0 bits (159), Expect = 7e-12
 Identities = 48/221 (21%), Positives = 95/221 (42%), Gaps = 37/221 (16%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
              +++ + IGEG +G V       + + VAIKK   +P +          E+  L   +
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFR 83

Query: 129 HRNLVTLL-----GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR-QKLEFKHRLSIAL 182
           H N++ +         ++    +++ + +      ++     ++ + Q L   H      
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLME---TDLY-----KLLKTQHLSNDHICYFLY 135

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQ--V 239
              +GL ++HS +  V+H+D K +N+L++     K+ D GL R      D  G  ++   
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193

Query: 240 T----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           T    A EI L       + +++  D++S G  L E++S R
Sbjct: 194 TRWYRAPEIMLN-----SKGYTKSIDIWSVGCILAEMLSNR 229

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 44/227 (19%), Positives = 80/227 (35%), Gaps = 42/227 (18%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK--------RPGAPTQEFID------EV 121
              ++ +  I  G +G V  G+  +G+ VAIK+        R      +         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 122 CFLASIQHRNLVTLL-----GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 176
             L    H N++ L            +  +L+ E +        L       R  +  +H
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-----DLAQVIHDQRIVISPQH 135

Query: 177 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPS 236
                     GL  LH     VVH+D    N+L+ ++    + D      L R D A  +
Sbjct: 136 IQYFMYHILLGLHVLHE--AGVVHRDLHPGNILLADNNDITICDFN----LAREDTADAN 189

Query: 237 SQ---VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                      A E+ +      F+ F++  D++S G  + E+ + +
Sbjct: 190 KTHYVTHRWYRAPELVMQ-----FKGFTKLVDMWSAGCVMAEMFNRK 231

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 61/304 (20%), Positives = 107/304 (35%), Gaps = 69/304 (22%)

Query: 74  LATKNFSD-------KNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVC 122
           +    F            +GEG F    K +  +     A+K   KR  A TQ+   E+ 
Sbjct: 1   MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EIT 57

Query: 123 FLASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKLE 173
            L   + H N+V L     +    FL+ E +  G +   I           S + R+ + 
Sbjct: 58  ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117

Query: 174 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR- 229
                         ++H+H +   VVH+D K  N+L    +++   K+ D G        
Sbjct: 118 -------------AVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162

Query: 230 ----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG----REASSS 281
                         T    + A E+     + E  D++S GV L  ++SG    +    S
Sbjct: 163 NQPLKTPCF-----TLH--YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRS 215

Query: 282 LSPDSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 340
           L+  S+ ++++ ++     F       +   W   + E       LI   L     +R  
Sbjct: 216 LTCTSAVEIMKKIKKGDFSF-------EGEAWKNVSQEA----KDLIQGLLTVDPNKRLK 264

Query: 341 MSDV 344
           MS +
Sbjct: 265 MSGL 268

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 56/302 (18%), Positives = 113/302 (37%), Gaps = 62/302 (20%)

Query: 69  MEELSLATKNFSD----KNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDE 120
           +++L   +  F+D    K  IG G +    + +     M  A+K   K    PT+E I+ 
Sbjct: 10  VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE-IEI 68

Query: 121 VCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV--SIHLYGP------SQVSRQKL 172
           +      QH N++TL     +    +++ E +  G +   I           S V     
Sbjct: 69  LLRY--GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT 126

Query: 173 EFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLRNFLG 228
           +              + +LH+    VVH+D K +N+L           ++ D G    L 
Sbjct: 127 K-------------TVEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171

Query: 229 R-----TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS 283
                           TA+  F+A EV E + +    D++S GV L  +++G    ++  
Sbjct: 172 AENGLLMTPCY-----TAN--FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224

Query: 284 PDSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 342
            D+ ++++  + + +              W++ ++        L+ + L     +R + +
Sbjct: 225 DDTPEEILARIGSGKFSL-------SGGYWNSVSDTA----KDLVSKMLHVDPHQRLTAA 273

Query: 343 DV 344
            V
Sbjct: 274 LV 275

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 39/220 (17%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
            + + + + +G G +G V      + G+ VA+KK    P Q  I       E+  L  ++
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMK 86

Query: 129 HRNLVTLL------GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR-QKLEFKHRLSIA 181
           H N++ LL         +E N  +L+   +      ++      + + QKL   H   + 
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMG---ADLN-----NIVKCQKLTDDHVQFLI 138

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT- 240
               +GL ++HS    ++H+D K +N+ V+ED   K+ D G    L R      +  V  
Sbjct: 139 YQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFG----LARHTADEMTGYVAT 192

Query: 241 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               A EI L      +  +++  D++S G  + EL++GR
Sbjct: 193 RWYRAPEIMLN-----WMHYNQTVDIWSVGCIMAELLTGR 227

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 62.0 bits (151), Expect = 7e-11
 Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 39/220 (17%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
              + D   +G G +G V   +  + G  VAIKK    P Q  +       E+  L  ++
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMR 82

Query: 129 HRNLVTLLG--YCQENNLQF----LIYEYIPNGSVSIHLYGPSQVSR-QKLEFKHRLSIA 181
           H N++ LL      E    F    L+  ++      +      ++ + +KL       + 
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMG---TDLG-----KLMKHEKLGEDRIQFLV 134

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT- 240
               KGL ++H+    ++H+D K  N+ V+ED   K+ D G    L R   +  +  V  
Sbjct: 135 YQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFG----LARQADSEMTGYVVT 188

Query: 241 ----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
               A E+ L      + R+++  D++S G  + E+++G+
Sbjct: 189 RWYRAPEVILN-----WMRYTQTVDIWSVGCIMAEMITGK 223

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 62.1 bits (151), Expect = 8e-11
 Identities = 47/245 (19%), Positives = 91/245 (37%), Gaps = 46/245 (18%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
             N+  K+LIG G +G VY          VAIKK      ++ ID      E+  L  ++
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-MFEDLIDCKRILREITILNRLK 83

Query: 129 HRNLVTLLGYCQ-ENNLQF----LIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIA 181
              ++ L      ++ L+F    ++ E        +      ++  +   L  +H  +I 
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIAD---SDLK-----KLFKTPIFLTEEHIKTIL 135

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT 240
                G   +H     ++H+D K AN L+++D   KV D GL R      D    +    
Sbjct: 136 YNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193

Query: 241 ADEIFLASEVKE--------------------FRRFSEKSDVYSFGVFLLELVSGREASS 280
            +E    ++  +                       +++  D++S G    EL++  ++  
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253

Query: 281 SLSPD 285
           +   +
Sbjct: 254 NDPTN 258

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 61.5 bits (150), Expect = 9e-11
 Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 44/228 (19%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
           + +F  K+L+GEG +G V        G +VAIKK    P  + +       E+  L   +
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFK 67

Query: 129 HRNLVTLL-----GYCQENNLQFLIYEYIPNGSVSIHLYGPSQV-SRQKLEFKHRLSIAL 182
           H N++T+         +  N  ++I E +      +H     +V S Q L   H      
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQ---TDLH-----RVISTQMLSDDHIQYFIY 119

Query: 183 GAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----RNFLGRTDVAGPSS 237
              + +  LH  +  V+H+D K +N+L++ +   KV D GL      +    ++  G  S
Sbjct: 120 QTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 238 QVT---------ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            +          A E+ L S      ++S   DV+S G  L EL   R
Sbjct: 178 GMVEFVATRWYRAPEVMLTS-----AKYSRAMDVWSCGCILAELFLRR 220

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 61.5 bits (150), Expect = 9e-11
 Identities = 52/304 (17%), Positives = 112/304 (36%), Gaps = 64/304 (21%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQ-HRNL 132
             ++     +G GK+ EV++ + + +   V +K  +P    ++   E+  L +++   N+
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNI 93

Query: 133 VTLLG--YCQENNLQFLIYEYIPNGSVSIH-LYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
           +TL        +    L++E++ N       LY       Q L             K L 
Sbjct: 94  ITLADIVKDPVSRTPALVFEHVNN--TDFKQLY-------QTLTDYDIRFYMYEILKALD 144

Query: 190 HLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVT-------- 240
           + HS+   ++H+D K  NV++D E    ++ D GL  F        P  +          
Sbjct: 145 YCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF------YHPGQEYNVRVASRYF 196

Query: 241 -ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA--------------SSSLSPD 285
              E+ +     +++ +    D++S G  L  ++  +E               +  L  +
Sbjct: 197 KGPELLV-----DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 251

Query: 286 SSQDLVEL--VQNSRDFSNLLKILDERLWSTFTNEGM-----EEFIQLIVRCL--DPSSE 336
              D ++   ++    F+++L     + W  F +         E +  + + L  D    
Sbjct: 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ-- 309

Query: 337 RRPS 340
            R +
Sbjct: 310 SRLT 313

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 53/219 (24%), Positives = 85/219 (38%), Gaps = 54/219 (24%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
            +G G FG+V  G     G  VA+K       +      +    E+  L   +H +++ L
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-REIQNLKLFRHPHIIKL 76

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGL 188
                     F++ EY+  G +  ++         ++E       F+  LS        +
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYI-----CKHGRVEEMEARRLFQQILS-------AV 124

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-- 246
            + H     VVH+D K  NVL+D    AK+AD GL N +             +D  FL  
Sbjct: 125 DYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMM-------------SDGEFLRT 169

Query: 247 --------ASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 276
                   A EV   R ++  + D++S GV L  L+ G 
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 45/223 (20%), Positives = 86/223 (38%), Gaps = 32/223 (14%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
              + D   +G G  G V+  +       VAIKK       +         E+  +  + 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK---IVLTDPQSVKHALREIKIIRRLD 66

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGP------SQVSR-QKLEFKHRLSIA 181
           H N+V +      +  Q            S+++         + V     L  +H     
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFM 126

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGL-RNFLGRTDVAGPSSQ- 238
               +GL ++HS +  V+H+D K AN+ ++ ED + K+ D GL R         G  S+ 
Sbjct: 127 YQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 239 -VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            VT    +  + L+        +++  D+++ G    E+++G+
Sbjct: 185 LVTKWYRSPRLLLSP-----NNYTKAIDMWAAGCIFAEMLTGK 222

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 67/318 (21%), Positives = 103/318 (32%), Gaps = 55/318 (17%)

Query: 45  SEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQD 100
               +   + V   L   E    +++E+ L   +F    +IG G F EV     K     
Sbjct: 29  GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---T 85

Query: 101 GMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC-QENNLQFLIYEY 151
           G + A+K        KR       F +E   L +   R +  L  +  Q+ N  +L+ EY
Sbjct: 86  GQVYAMKIMNKWDMLKR--GEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEY 142

Query: 152 IPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAAKGLAHLHSLSPRVVHKDFKT 205
              G +   L      S+        ++      I +     +  +H L    VH+D K 
Sbjct: 143 YVGGDLLTLL------SKFGERIPAEMARFYLAEIVM----AIDSVHRLG--YVHRDIKP 190

Query: 206 ANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV-TAD----EIFLASEVKEFRRFSEKS 260
            N+L+D     ++AD G    L           V T D    EI  A             
Sbjct: 191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE 250

Query: 261 -DVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEG 319
            D ++ GVF  E+  G       +P  +    E       +   L +             
Sbjct: 251 CDWWALGVFAYEMFYG------QTPFYADSTAETYGKIVHYKEHLSLPLVDEGVP----- 299

Query: 320 MEEFIQLIVRCLDPSSER 337
            EE    I R L P   R
Sbjct: 300 -EEARDFIQRLLCPPETR 316

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 19/229 (8%)

Query: 60  SIREARRFQ---MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQ 115
           S+   R  Q   +E   +    F D  ++G G FGEV+   ++  G L A KK      +
Sbjct: 165 SLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224

Query: 116 EFIDEVC------FLASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVS 168
           +             LA +  R +V+L  Y  +      L+   +  G +  H+Y   + +
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283

Query: 169 RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 228
               E +     A     GL HLH     ++++D K  NVL+D+D   +++D GL     
Sbjct: 284 PGFQEPRAIFYTA-QIVSGLEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAV-EL 339

Query: 229 RTDVAGPSSQV-TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
           +           T    F+A E+     +    D ++ GV L E+++ R
Sbjct: 340 KAGQTKTKGYAGTPG--FMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 52/218 (23%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFID----EVCFLASIQHRNLVTLL 136
            +G G FG+V  G     G  VA+K   R    + + +     E+  L   +H +++ L 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 137 GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGLA 189
                 +  F++ EY+  G +  ++         +L+       F+  LS       G+ 
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYI-----CKNGRLDEKESRRLFQQILS-------GVD 130

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL--- 246
           + H     VVH+D K  NVL+D    AK+AD GL N +             +D  FL   
Sbjct: 131 YCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMM-------------SDGEFLRTS 175

Query: 247 -------ASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 276
                  A EV   R ++  + D++S GV L  L+ G 
Sbjct: 176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 44/247 (17%), Positives = 83/247 (33%), Gaps = 59/247 (23%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLV 133
           +K +S    +G G FG V +    + G   A+KK       +    E+  +  + H N++
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK--NRELDIMKVLDHVNII 63

Query: 134 TLL------GYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFK------------ 175
            L+      G  +    Q         G  +        V     + K            
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123

Query: 176 -HRLSIALGAAK-----------------GLAHLHSLSPRVVHKDFKTANVLVD-EDFIA 216
            H++  +   +                   +  +HSL   + H+D K  N+LV+ +D   
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--GICHRDIKPQNLLVNSKDNTL 181

Query: 217 KVADAGLRNFLGRTDVAGPSSQ---VT----ADEIFLASEVKEFRRFSEKSDVYSFGVFL 269
           K+ D G      +  +    S     +    A E+ L +       ++   D++S G   
Sbjct: 182 KLCDFG----SAKKLIPSEPSVAYICSRFYRAPELMLGA-----TEYTPSIDLWSIGCVF 232

Query: 270 LELVSGR 276
            EL+ G+
Sbjct: 233 GELILGK 239

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.1 bits (142), Expect = 1e-09
 Identities = 50/360 (13%), Positives = 104/360 (28%), Gaps = 93/360 (25%)

Query: 22  IFFLSW-FCLYRNRSVSRTSETG------------SSEPSVQPGRNVGIELSIREARRFQ 68
              L W     +   V +  E               +E   QP     + +  R+ R + 
Sbjct: 64  TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR-QPSMMTRMYIEQRD-RLYN 121

Query: 69  MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ---------DGM-------LVAIKKRPGA 112
             ++      F+  N+     + ++ + LL+         DG+       +         
Sbjct: 122 DNQV------FAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYK 175

Query: 113 PTQEFIDEVCFLASIQHRNLVTLLGYCQE-----NNLQFLIYEYIPNGSVSIHLYGPSQV 167
              +   ++ +L           L  C         LQ L+Y+  PN +        S +
Sbjct: 176 VQCKMDFKIFWLN----------LKNCNSPETVLEMLQKLLYQIDPNWTSRSD--HSSNI 223

Query: 168 SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV----ADAGL 223
             +    +  L   L +     + + L   +V  + + A      +   K+        +
Sbjct: 224 KLRIHSIQAELRRLLKSKP---YENCL---LVLLNVQNAKAWNAFNLSCKILLTTRFKQV 277

Query: 224 RNFLGRTDVAGPSSQVTADEI---FLASEVKEFRRFSEKSDVYSFGVFLLELVSG--REA 278
            +FL     A  ++ ++ D         EVK                +L        RE 
Sbjct: 278 TDFLS----AATTTHISLDHHSMTLTPDEVKSL-----------LLKYLDCRPQDLPREV 322

Query: 279 SSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 338
            +  +P     + E +   RD            W     + +   I+  +  L+P+  R+
Sbjct: 323 LT-TNPRRLSIIAESI---RDGLATWD-----NWKHVNCDKLTTIIESSLNVLEPAEYRK 373

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 67/320 (20%), Positives = 127/320 (39%), Gaps = 59/320 (18%)

Query: 44  SSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQ 99
            +   ++  +N+   L   +    +++++ L  ++F    +IG G FGEV     K    
Sbjct: 41  CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN--- 97

Query: 100 DGMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 151
              + A+K        KR  A T  F +E   L +   + + TL    Q++N  +L+ +Y
Sbjct: 98  ADKVFAMKILNKWEMLKR--AETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155

Query: 152 IPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAAKGLAHLHSLSPRVVHKDFKT 205
              G +   L      S+ +      ++      + +     +  +H L    VH+D K 
Sbjct: 156 YVGGDLLTLL------SKFEDRLPEEMARFYLAEMVI----AIDSVHQLH--YVHRDIKP 203

Query: 206 ANVLVDEDFIAKVADAGL-----RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKS 260
            N+L+D +   ++AD G       +   ++ VA  +    + EI  A E  +  R+  + 
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK-GRYGPEC 262

Query: 261 DVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGM 320
           D +S GV + E++ G       +P  ++ LVE            KI++ +    F  +  
Sbjct: 263 DWWSLGVCMYEMLYG------ETPFYAESLVETYG---------KIMNHKERFQFPTQVT 307

Query: 321 ---EEFIQLIVRCLDPSSER 337
              E    LI R +     R
Sbjct: 308 DVSENAKDLIRRLICSREHR 327

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 61/271 (22%), Positives = 114/271 (42%), Gaps = 42/271 (15%)

Query: 45  SEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQD 100
             P+++  +N+   LS  +    ++ +L +  +++    +IG G FGEV     K     
Sbjct: 37  DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---T 93

Query: 101 GMLVAIK--------KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI 152
             + A+K        KR  + +  F +E   +A      +V L    Q++   +++ EY+
Sbjct: 94  RKVYAMKLLSKFEMIKR--SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 151

Query: 153 PNGSVSIHLYGPSQVSRQKLEFKH-RLSIA-LGAAKGLAHLHSLSPRVVHKDFKTANVLV 210
           P G +   +      S   +  K  R   A +  A  L  +HS+    +H+D K  N+L+
Sbjct: 152 PGGDLVNLM------SNYDVPEKWARFYTAEVVLA--LDAIHSMG--FIHRDVKPDNMLL 201

Query: 211 DEDFIAKVADAGLRNFLGRTDVAGPSSQV-TADEIFLASEV----KEFRRFSEKSDVYSF 265
           D+    K+AD G    + +  +    + V T D  +++ EV         +  + D +S 
Sbjct: 202 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD--YISPEVLKSQGGDGYYGRECDWWSV 259

Query: 266 GVFLLELVSGREASSSLSPDSSQDLVELVQN 296
           GVFL E++ G       +P  +  LV     
Sbjct: 260 GVFLYEMLVG------DTPFYADSLVGTYSK 284

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 52/232 (22%), Positives = 100/232 (43%), Gaps = 42/232 (18%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID------EVCFLASIQ 128
            + +     +G+G +G V+K +  + G +VA+KK      Q   D      E+  L  + 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-AFQNSTDAQRTFREIMILTELS 66

Query: 129 -HRNLVTLLGYCQENNLQ--FLIYEYIPNGSVSIHLYGPSQVSR-QKLEFKHRLSIALGA 184
            H N+V LL   + +N +  +L+++Y+      +H      V R   LE  H+  +    
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYME---TDLH-----AVIRANILEPVHKQYVVYQL 118

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADE 243
            K + +LHS    ++H+D K +N+L++ +   KVAD GL R+F+    V         + 
Sbjct: 119 IKVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 244 IFLASEVKEF-------------------RRFSEKSDVYSFGVFLLELVSGR 276
                + +                      ++++  D++S G  L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 46/220 (20%), Positives = 80/220 (36%), Gaps = 58/220 (26%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFID-----------EVCFLASIQHRN 131
            IG G FG            LVA+K         +I+           E+    S++H N
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVK---------YIERGAAIDENVQREIINHRSLRHPN 77

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGA 184
           +V             +I EY   G +   +      +  +         F+  LS     
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERI-----CNAGRFSEDEARFFFQQLLS----- 127

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA--KVADAGLRNF-----LGRTDVAGPSS 237
             G+++ HS+  ++ H+D K  N L+D       K+ D G           ++ V  P+ 
Sbjct: 128 --GVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 182

Query: 238 QVTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 276
                  ++A EV   + +  + +DV+S GV L  ++ G 
Sbjct: 183 -------YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 56.3 bits (136), Expect = 8e-09
 Identities = 52/240 (21%), Positives = 96/240 (40%), Gaps = 44/240 (18%)

Query: 60  SIREARRFQ---MEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQ 115
           SI   R  Q   +E   +    F    ++G+G FGEV    ++  G + A KK      +
Sbjct: 164 SIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK 223

Query: 116 EFIDEVC------FLASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVS 168
           +   E         L  +  R +V+L  Y  +  +   L+   +  G +  H+Y      
Sbjct: 224 KRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY-----H 277

Query: 169 RQKLEFKHRLSIALGA--AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL--- 223
             +  F    ++   A    GL  LH    R+V++D K  N+L+D+    +++D GL   
Sbjct: 278 MGQAGFPEARAVFYAAEICCGLEDLHRE--RIVYRDLKPENILLDDHGHIRISDLGLAVH 335

Query: 224 -------RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                  +  +G                ++A EV +  R++   D ++ G  L E+++G+
Sbjct: 336 VPEGQTIKGRVGTVG-------------YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 55.3 bits (134), Expect = 9e-09
 Identities = 49/249 (19%), Positives = 95/249 (38%), Gaps = 37/249 (14%)

Query: 43  GSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG-LLQDG 101
           G++        ++       + R+ + E       +F    ++GEG F  V     L   
Sbjct: 3   GTAAEPRPGAGSLQHAQPPPQPRKKRPE-------DFKFGKILGEGSFSTVVLARELATS 55

Query: 102 MLVAIK---KRPGAPTQEF---IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG 155
              AIK   KR      +      E   ++ + H   V L    Q++   +    Y  NG
Sbjct: 56  REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNG 115

Query: 156 SVSIHLYGPSQVSRQKLEFKHRLSIALG---AAK---GLAHLHSLSPRVVHKDFKTANVL 209
            +  ++        +K                A+    L +LH     ++H+D K  N+L
Sbjct: 116 ELLKYI--------RK---IGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENIL 162

Query: 210 VDEDFIAKVADAGL-RNFLGRTDVAGPSSQV-TADEIFLASEVKEFRRFSEKSDVYSFGV 267
           ++ED   ++ D G  +     +  A  +S V TA   +++ E+   +   + SD+++ G 
Sbjct: 163 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ--YVSPELLTEKSACKSSDLWALGC 220

Query: 268 FLLELVSGR 276
            + +LV+G 
Sbjct: 221 IIYQLVAGL 229

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 46/219 (21%), Positives = 89/219 (40%), Gaps = 55/219 (25%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK-------KRPGAPTQEFIDEVCFLASIQHRNLVTL 135
            +GEG FG+V      +    VA+K       K+     +    E+ +L  ++H +++ L
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-REISYLKLLRHPHIIKL 74

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLE-------FKHRLSIALGAAKGL 188
                      ++ EY   G +  ++     V ++++        F+  +         +
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYI-----VEKKRMTEDEGRRFFQQIIC-------AI 121

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL-- 246
            + H    ++VH+D K  N+L+D++   K+AD GL N +              D  FL  
Sbjct: 122 EYCHRH--KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-------------TDGNFLKT 166

Query: 247 --------ASEVKEFRRFS-EKSDVYSFGVFLLELVSGR 276
                   A EV   + ++  + DV+S G+ L  ++ GR
Sbjct: 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 51/314 (16%), Positives = 101/314 (32%), Gaps = 68/314 (21%)

Query: 62  REARRFQMEELSLATKNFSD-----KNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGA 112
                   +         +D     K ++G G  G+V +    + G   A+K     P A
Sbjct: 9   SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA 68

Query: 113 PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ----FLIYEYIPNGSV--SIHLYGP-- 164
             +          +    ++V +L   +  +       +I E +  G +   I   G   
Sbjct: 69  RQEVDH----HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA 124

Query: 165 ------SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFI 215
                 +++ R                  +  LHS +  + H+D K  N+L    ++D +
Sbjct: 125 FTEREAAEIMRDIGT-------------AIQFLHSHN--IAHRDVKPENLLYTSKEKDAV 169

Query: 216 AKVADAGLRNFLGR---TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL 272
            K+ D G      +             T    ++A EV    ++ +  D++S GV +  L
Sbjct: 170 LKLTDFGFAKETTQNALQTPCY-----TPY--YVAPEVLGPEKYDKSCDMWSLGVIMYIL 222

Query: 273 VSGREA-SSSLSPDSSQDLVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRC 330
           + G     S+     S  +   ++  +  F           WS  + +      QLI   
Sbjct: 223 LCGFPPFYSNTGQAISPGMKRRIRLGQYGF-------PNPEWSEVSEDA----KQLIRLL 271

Query: 331 LDPSSERRPSMSDV 344
           L      R +++  
Sbjct: 272 LKTDPTERLTITQF 285

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 54.1 bits (129), Expect = 2e-08
 Identities = 35/194 (18%), Positives = 57/194 (29%), Gaps = 46/194 (23%)

Query: 74  LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP-----------GAPTQEFIDEVC 122
           L T+       IGEG FGEV++ +  D   VAIK                  +E + E+ 
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 123 FL---------ASIQHRNLVTLLGY--CQENNLQFLIYEYI----PNGSVSIHL--YGPS 165
                         +    + L      Q +    L+  +       GS +     +   
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 166 QV----------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL 209
           Q+                  +        SI       LA   + S R  H+D    NVL
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA-SLRFEHRDLHWGNVL 194

Query: 210 VDEDFIAKVADAGL 223
           + +  + K+     
Sbjct: 195 LKKTSLKKLHYTLN 208

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 52/345 (15%), Positives = 111/345 (32%), Gaps = 76/345 (22%)

Query: 33  NRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGE 92
                  +      P+  P                Q+++ ++         ++G G  G+
Sbjct: 18  APPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGK 77

Query: 93  VYKGL-LQDGMLVAIK---KRPGAPTQEFIDEV-CFLASIQHRNLVTLLGYCQENNLQ-- 145
           V +    +     A+K     P     +   EV     + Q  ++V ++   +       
Sbjct: 78  VLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVYENLYAGRK 132

Query: 146 --FLIYEYIPNGSV--SIHLYGP--------SQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
              ++ E +  G +   I   G         S++ +   E              + +LHS
Sbjct: 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE-------------AIQYLHS 179

Query: 194 LSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF----- 245
           ++  + H+D K  N+L      + I K+ D G             + + T+         
Sbjct: 180 IN--IAHRDVKPENLLYTSKRPNAILKLTDFGF------------AKETTSHNSLTTPCY 225

Query: 246 ----LASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQDLVELVQNSR-D 299
               +A EV    ++ +  D++S GV +  L+ G     S+     S  +   ++  + +
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285

Query: 300 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           F           WS  + E       LI   L     +R ++++ 
Sbjct: 286 F-------PNPEWSEVSEEV----KMLIRNLLKTEPTQRMTITEF 319

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 34/236 (14%)

Query: 60  SIREARRFQMEELSLATK----NFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPT 114
           S +  R  Q + + L       +FS   +IG G FGEVY     D G + A+K       
Sbjct: 168 SDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI 227

Query: 115 QEFIDEVCFLA---------SIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGP 164
           +    E   L          +     +V +  Y     +    I + +  G +  HL   
Sbjct: 228 KMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQH 286

Query: 165 SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL- 223
              S   + F +   I LG    L H+H+    VV++D K AN+L+DE    +++D GL 
Sbjct: 287 GVFSEADMRF-YAAEIILG----LEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLA 339

Query: 224 -RNFLGRTDVAGPSSQV-TADEIFLASEV-KEFRRFSEKSDVYSFGVFLLELVSGR 276
                 +       + V T    ++A EV ++   +   +D +S G  L +L+ G 
Sbjct: 340 CDFSKKKP-----HASVGTHG--YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 57/257 (22%), Positives = 108/257 (42%), Gaps = 41/257 (15%)

Query: 37  SRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG 96
           +  ++ GS + SV+       E  +++          L    F     +G G FG V   
Sbjct: 3   AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL--DQFDRIKTLGTGSFGRVM-- 58

Query: 97  LLQ---DGMLVAIK---KRPGAPTQEF---IDEVCFLASIQHRNLVTLLGYCQENNLQFL 147
           L++    G   A+K   K+     ++    ++E   L ++    LV L    ++N+  ++
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118

Query: 148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAAKGLAHLHSLSPRVVHK 201
           + EY+  G +  HL       R+   F    +      I L       +LHSL   ++++
Sbjct: 119 VMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVL----TFEYLHSLD--LIYR 165

Query: 202 DFKTANVLVDEDFIAKVADAGL-RNFLGRTD-VAGPSSQVTADEIFLASEVKEFRRFSEK 259
           D K  N+L+D+    +V D G  +   GRT  + G     T +   LA E+   + +++ 
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPE--ALAPEIILSKGYNKA 218

Query: 260 SDVYSFGVFLLELVSGR 276
            D ++ GV + E+ +G 
Sbjct: 219 VDWWALGVLIYEMAAGY 235

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 66/288 (22%), Positives = 107/288 (37%), Gaps = 63/288 (21%)

Query: 37  SRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKG 96
               +  ++E   + G       +          +  +    F    L+G+G FG+V   
Sbjct: 108 DGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILV 167

Query: 97  LLQD-GMLVAIK---KRPGAPTQEFI---DEV-------CFLASIQHRNLVTLLGYC-QE 141
             +  G   A+K   K       E I   DEV         L + +H  L  L  Y  Q 
Sbjct: 168 KEKATGRYYAMKILKK-------EVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQT 219

Query: 142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLAHLHSLSPRVV 199
           ++    + EY   G +  HL      SR+++ F    +   GA     L +LHS    VV
Sbjct: 220 HDRLCFVMEYANGGELFFHL------SRERV-FSEDRARFYGAEIVSALDYLHSEK-NVV 271

Query: 200 HKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQVTADEIFLAS 248
           ++D K  N+++D+D   K+ D GL           + F G  +             +LA 
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE-------------YLAP 318

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 296
           EV E   +    D +  GV + E++ GR       P  +QD  +L + 
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHEKLFEL 360

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 32/134 (23%), Positives = 51/134 (38%), Gaps = 20/134 (14%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQH-RNLVTLLGYCQE 141
           IG G FG++Y G  +  G  VAIK         +   E      +Q    + T+     E
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 76

Query: 142 NNLQFLIYEYIPNGSVSIHLYGPS-----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
            +   ++ E          L GPS         +K   K  L +A      + ++HS + 
Sbjct: 77  GDYNVMVME----------LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN- 125

Query: 197 RVVHKDFKTANVLV 210
             +H+D K  N L+
Sbjct: 126 -FIHRDVKPDNFLM 138

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 60/294 (20%), Positives = 113/294 (38%), Gaps = 72/294 (24%)

Query: 32  RNRSVSRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFG 91
           R +        G+  P  +    +    +     R ++        +F+   ++G+G FG
Sbjct: 303 RQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLT-------DFNFLMVLGKGSFG 355

Query: 92  EV----YKGLLQDGMLVAIKKRPGAPTQEFI---DEV--------CFLASIQHRNLVTLL 136
           +V     KG      L A+K       ++ +   D+V              +   L  L 
Sbjct: 356 KVMLSERKG---TDELYAVK----ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408

Query: 137 GYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA--AKGLAHLHS 193
             C Q  +  + + EY+  G +  H+        Q   FK   ++   A  A GL  L S
Sbjct: 409 -SCFQTMDRLYFVMEYVNGGDLMYHIQ-------QVGRFKEPHAVFYAAEIAIGLFFLQS 460

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQVTAD 242
               ++++D K  NV++D +   K+AD G+           + F G  D           
Sbjct: 461 KG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD----------- 507

Query: 243 EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 296
             ++A E+  ++ + +  D ++FGV L E+++G+      +P   +D  EL Q+
Sbjct: 508 --YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ------APFEGEDEDELFQS 553

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 34/134 (25%), Positives = 52/134 (38%), Gaps = 20/134 (14%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLV-TLLGYCQE 141
           IG G FGE+Y G  +Q    VAIK         + + E      +Q    +  +  +  E
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74

Query: 142 NNLQFLIYEYIPNGSVSIHLYGPS-----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
            +   L+ +          L GPS         +KL  K  L +A      +  +HS S 
Sbjct: 75  GDYNVLVMD----------LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS- 123

Query: 197 RVVHKDFKTANVLV 210
             +H+D K  N L+
Sbjct: 124 -FLHRDIKPDNFLM 136

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 31/134 (23%), Positives = 51/134 (38%), Gaps = 20/134 (14%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQH-RNLVTLLGYCQE 141
           IGEG FG +++G  L +   VAIK     +   +  DE      +     +  +  + QE
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77

Query: 142 NNLQFLIYEYIPNGSVSIHLYGPS-----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSP 196
                L+ +          L GPS      +  +K   K     A      +  +H  S 
Sbjct: 78  GLHNVLVID----------LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS- 126

Query: 197 RVVHKDFKTANVLV 210
            +V++D K  N L+
Sbjct: 127 -LVYRDIKPDNFLI 139

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 63/258 (24%), Positives = 109/258 (42%), Gaps = 53/258 (20%)

Query: 84  LIGEGKFGEVYKGLLQ---DGMLVAIK---KRPGAPTQEF---IDEVCFLASIQHRNLVT 134
            IG+G FG+V   ++Q      + A+K   K+      E      E+  +  ++H  LV 
Sbjct: 22  AIGKGSFGKVC--IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79

Query: 135 LLGYCQ-ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH---RLSIA-LGAAKGLA 189
           L    Q E ++ F++ + +  G +  HL       +Q + FK    +L I  L  A  L 
Sbjct: 80  LWYSFQDEEDM-FMVVDLLLGGDLRYHL-------QQNVHFKEETVKLFICELVMA--LD 129

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVT--------A 241
           +L +   R++H+D K  N+L+DE     + D  +        +   +   T        A
Sbjct: 130 YLQNQ--RIIHRDMKPDNILLDEHGHVHITDFNI-----AAMLPRETQITTMAGTKPYMA 182

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN----- 296
            E+F +   ++   +S   D +S GV   EL+ GR      S  SS+++V   +      
Sbjct: 183 PEMFSS---RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY 239

Query: 297 ----SRDFSNLLKILDER 310
               S++  +LLK L E 
Sbjct: 240 PSAWSQEMVSLLKKLLEP 257

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 43.7 bits (104), Expect = 5e-05
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 70/244 (28%)

Query: 84  LIGEGKFGEV----YKGLLQDGMLVAIK---KRPGAPTQEFI---DEV-------CFLAS 126
           L+G+G FG+V     K     G   A+K   K       E I   DEV         L +
Sbjct: 12  LLGKGTFGKVILVREKA---TGRYYAMKILRK-------EVIIAKDEVAHTVTESRVLQN 61

Query: 127 IQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA- 184
            +H  L  L  Y  Q ++    + EY   G +  HL        ++  F    +   GA 
Sbjct: 62  TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS-------RERVFTEERARFYGAE 113

Query: 185 -AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDV 232
               L +LHS    VV++D K  N+++D+D   K+ D GL           + F G  + 
Sbjct: 114 IVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE- 170

Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE 292
                       +LA EV E   +    D +  GV + E++ GR       P  +QD   
Sbjct: 171 ------------YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHER 212

Query: 293 LVQN 296
           L + 
Sbjct: 213 LFEL 216

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 43.3 bits (103), Expect = 7e-05
 Identities = 37/162 (22%), Positives = 69/162 (42%), Gaps = 32/162 (19%)

Query: 78  NFSDKNLIGEGKFGEVY----KGLLQDGMLVAIK---KRPGAPTQEF---IDEVCFLASI 127
           +F     +G G FG V+    +    +G   A+K   K      ++     DE   L+ +
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63

Query: 128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IA 181
            H  ++ + G  Q+    F+I +YI  G +   L       R+   F + ++      + 
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL-------RKSQRFPNPVAKFYAAEVC 116

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL 223
           L     L +LHS    ++++D K  N+L+D++   K+ D G 
Sbjct: 117 L----ALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGF 152

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 43.0 bits (102), Expect = 8e-05
 Identities = 48/296 (16%), Positives = 99/296 (33%), Gaps = 67/296 (22%)

Query: 67  FQMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEV- 121
            Q+++ ++         ++G G  G+V +    +     A+K           +   EV 
Sbjct: 8   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVE 62

Query: 122 CFLASIQHRNLVTLLGYCQENNLQ----FLIYEYIPNGSV--SIHLYGPSQVSRQKLEFK 175
               + Q  ++V ++   +          ++ E +  G +   I         R    F 
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-------QDRGDQAFT 115

Query: 176 HR--LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRT 230
            R    I     + + +LHS++  + H+D K  N+L      + I K+ D G        
Sbjct: 116 EREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG-------- 165

Query: 231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQD 289
                           A E     ++ +  D++S GV +  L+ G     S+     S  
Sbjct: 166 ---------------FAKETTG-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 209

Query: 290 LVELVQNSR-DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           +   ++  + +F           WS  + E       LI   L     +R ++++ 
Sbjct: 210 MKTRIRMGQYEF-------PNPEWSEVSEEV----KMLIRNLLKTEPTQRMTITEF 254

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 66/289 (22%), Positives = 107/289 (37%), Gaps = 80/289 (27%)

Query: 41  ETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KG 96
           E  ++ P+  P  +  I L        +         +F    +IG+G FG+V     K 
Sbjct: 9   ELMNANPAPPPAPSQQINLGPSSNPHAKPS-------DFHFLKVIGKGSFGKVLLARHKA 61

Query: 97  LLQDGMLVAIK---KRPGAPTQEFI---DEV--------CFLASIQHRNLVTLLGYC-QE 141
              + +  A+K   K       + I    E           L +++H  LV L  +  Q 
Sbjct: 62  ---EEVFYAVKVLQK-------KAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQT 110

Query: 142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL---SIALGAAKGLAHLHSLSPRV 198
            +  + + +YI  G +  HL    Q  R  LE + R     IA      L +LHSL+  +
Sbjct: 111 ADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASA----LGYLHSLN--I 160

Query: 199 VHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAGPSSQVTADEIFLA 247
           V++D K  N+L+D      + D GL             F G  +             +LA
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPE-------------YLA 207

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 296
            EV   + +    D +  G  L E++ G      L P  S++  E+  N
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYG------LPPFYSRNTAEMYDN 250

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 52/314 (16%), Positives = 102/314 (32%), Gaps = 69/314 (21%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
            +G G F  V+    + +   VA+K  +     T+   DE+  L  +   +         
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 141 ENNLQFLIYEYIPNGSVSIH------LYGPSQVSRQKLEFKHRLSIALGAA------KGL 188
            + L+ L +     G   +H      + G + ++  K      + +            GL
Sbjct: 86  NHILKLLDHFNH-KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 144

Query: 189 AHLHSLSPRVVHKDFKTANVLVDE------DFIAKVADAGLRNFLGR---TDVAGPSSQV 239
            ++H     ++H D K  NVL++           K+AD G   +        +   + + 
Sbjct: 145 DYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI--QTREY 201

Query: 240 TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR---EASSSLSPDSSQD------- 289
            + E+ L +       +   +D++S    + EL++G    E     S     D       
Sbjct: 202 RSPEVLLGA------PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 290 --------LVELVQNSRDF----SNLLKILDERLWST---------FTNEGMEEFIQLIV 328
                   L+   + +R F      L  I   + W           F+ +  +E    + 
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315

Query: 329 RCL--DPSSERRPS 340
             L  DP   +R  
Sbjct: 316 PMLQLDP--RKRAD 327

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 30/135 (22%), Positives = 49/135 (36%), Gaps = 22/135 (16%)

Query: 85  IGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQH-RNLVTLLGYCQ 140
           IG G FGE+  G  L     VAIK         Q    E  F   +     +  +  +  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ-LHLEYRFYKQLGSGDGIPQVYYFGP 75

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPS-----QVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
                 ++ E          L GPS      +  +    K  L IA+     + ++HS +
Sbjct: 76  CGKYNAMVLE----------LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125

Query: 196 PRVVHKDFKTANVLV 210
             ++++D K  N L+
Sbjct: 126 --LIYRDVKPENFLI 138

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 41.8 bits (99), Expect = 2e-04
 Identities = 49/219 (22%), Positives = 84/219 (38%), Gaps = 53/219 (24%)

Query: 84  LIGEGKFGEVY----KGLLQDGMLVAIK---KRPGAPTQEFI---DEV--------CFLA 125
           ++G+G FG+V     K     G L A+K   K       + I   D+V            
Sbjct: 30  VLGKGSFGKVMLARVKE---TGDLYAVKVLKK-------DVILQDDDVECTMTEKRILSL 79

Query: 126 SIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
           +  H  L  L   C Q  +  F + E++  G +  H+        +   F    +    A
Sbjct: 80  ARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ-------KSRRFDEARARFYAA 131

Query: 185 --AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVA----GPSS 237
                L  LH     ++++D K  NVL+D +   K+AD G+ +  +          G   
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCG--- 186

Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
             T D  ++A E+ +   +    D ++ GV L E++ G 
Sbjct: 187 --TPD--YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 41.4 bits (98), Expect = 3e-04
 Identities = 59/253 (23%), Positives = 101/253 (39%), Gaps = 70/253 (27%)

Query: 58  ELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY----KGLLQDGMLVAIK---KRP 110
           E++I    +   E+       F    ++G+G FG+V+            L A+K   K  
Sbjct: 7   EIAITHHVKEGHEKADP--SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-- 62

Query: 111 GAPTQEFI---DEV------CFLASIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIH 160
                  +   D V        L  + H  +V L  Y  Q     +LI +++  G +   
Sbjct: 63  -----ATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTR 116

Query: 161 LYGPSQVSRQKLEFKHRLS------IALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF 214
           L      S++ + F           +AL     L HLHSL   ++++D K  N+L+DE+ 
Sbjct: 117 L------SKEVM-FTEEDVKFYLAELALA----LDHLHSLG--IIYRDLKPENILLDEEG 163

Query: 215 IAKVADAGL-----------RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVY 263
             K+ D GL            +F G           T +  ++A EV   R  ++ +D +
Sbjct: 164 HIKLTDFGLSKESIDHEKKAYSFCG-----------TVE--YMAPEVVNRRGHTQSADWW 210

Query: 264 SFGVFLLELVSGR 276
           SFGV + E+++G 
Sbjct: 211 SFGVLMFEMLTGT 223

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 48/226 (21%), Positives = 80/226 (35%), Gaps = 66/226 (29%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQ------------ 128
           +IG+G FG+V K    +    VA+K  +      ++  +E+  L  ++            
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163

Query: 129 ------HRN---LVT-LLGYCQENNLQFLIYEYI-PNGSVSIHLYGPSQVSRQKLEFKHR 177
                  RN   +   LL      NL    YE I  N      L    + +   L+    
Sbjct: 164 MLENFTFRNHICMTFELLSM----NL----YELIKKNKFQGFSLPLVRKFAHSILQ---- 211

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGRTDVAGP 235
                     L  LH    R++H D K  N+L+ +      KV D G   +  +      
Sbjct: 212 ---------CLDALHKN--RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR----V 256

Query: 236 SSQVT-----ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            + +      A E+ L +      R+    D++S G  L EL++G 
Sbjct: 257 YTYIQSRFYRAPEVILGA------RYGMPIDMWSLGCILAELLTGY 296

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 63/241 (26%)

Query: 84  LIGEGKFGEV----YKGLLQDGMLVAIK---KRPGAPTQEFI---DEV--------CFLA 125
           ++G+G FG+V    +K         AIK   K       + +   D+V            
Sbjct: 24  MLGKGSFGKVFLAEFKK---TNQFFAIKALKK-------DVVLMDDDVECTMVEKRVLSL 73

Query: 126 SIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRL---SIA 181
           + +H  L  +     Q     F + EY+  G +  H+    Q   +    +       I 
Sbjct: 74  AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEII 128

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGL-RNFLGRTDVA----GP 235
           LG    L  LHS    +V++D K  N+L+D+D  I K+AD G+ +  +          G 
Sbjct: 129 LG----LQFLHSKG--IVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCG- 180

Query: 236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ 295
               T D  ++A E+   ++++   D +SFGV L E++ G       SP   QD  EL  
Sbjct: 181 ----TPD--YIAPEILLGQKYNHSVDWWSFGVLLYEMLIG------QSPFHGQDEEELFH 228

Query: 296 N 296
           +
Sbjct: 229 S 229

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 40.3 bits (95), Expect = 6e-04
 Identities = 51/225 (22%), Positives = 91/225 (40%), Gaps = 65/225 (28%)

Query: 84  LIGEGKFGEV----YKGLLQDGMLVAIK---KRPGAPTQEFI---DEV--------CFLA 125
           ++G+G FG+V     KG      L A+K   K       + +   D+V            
Sbjct: 27  VLGKGSFGKVMLSERKG---TDELYAVKILKK-------DVVIQDDDVECTMVEKRVLAL 76

Query: 126 SIQHRNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
             +   L  L   C Q  +  + + EY+  G +  H+        Q   FK   ++   A
Sbjct: 77  PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-------QVGRFKEPHAVFYAA 128

Query: 185 --AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTD 231
             A GL  L S    ++++D K  NV++D +   K+AD G+           + F G  D
Sbjct: 129 EIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD 186

Query: 232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                        ++A E+  ++ + +  D ++FGV L E+++G+
Sbjct: 187 -------------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 40.3 bits (95), Expect = 6e-04
 Identities = 57/266 (21%), Positives = 98/266 (36%), Gaps = 53/266 (19%)

Query: 37  SRTSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVY-- 94
           +        E  +     +        A +  +E       NF    ++G G +G+V+  
Sbjct: 21  TSADGGDGGEQLLTVKHELRTANLTGHAEKVGIE-------NFELLKVLGTGAYGKVFLV 73

Query: 95  --KGLLQDGMLVAIK---KRPGAPTQEFID----EVCFLASIQHRNLVTLLGYC-QENNL 144
                   G L A+K   K       +  +    E   L  I+    +  L Y  Q    
Sbjct: 74  RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133

Query: 145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAAKGLAHLHSLSPRV 198
             LI +YI  G +  HL      S+++  F           I L     L HLH L   +
Sbjct: 134 LHLILDYINGGELFTHL------SQRER-FTEHEVQIYVGEIVLA----LEHLHKLG--I 180

Query: 199 VHKDFKTANVLVDEDFIAKVADAGL--RNFLGRTDVA----GPSSQVTADEIFLASEV-K 251
           +++D K  N+L+D +    + D GL        T+ A    G     T +  ++A ++ +
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG-----TIE--YMAPDIVR 233

Query: 252 EFRRFSEKS-DVYSFGVFLLELVSGR 276
                 +K+ D +S GV + EL++G 
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGA 259

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 40.5 bits (95), Expect = 7e-04
 Identities = 49/230 (21%), Positives = 77/230 (33%), Gaps = 70/230 (30%)

Query: 83  NLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQ----------- 128
           +LIG+G FG+V K     +   VAIK  K   A   +   EV  L  +            
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119

Query: 129 -------HRN---LVT-LLGYCQENNLQFLIYEYI-PNGSVSIHLYGPSQVSRQKLEFKH 176
                   RN   LV  +L Y    NL    Y+ +       + L    + ++Q      
Sbjct: 120 HLKRHFMFRNHLCLVFEMLSY----NL----YDLLRNTNFRGVSLNLTRKFAQQMCT--- 168

Query: 177 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGRTDVAG 234
                      L  L +    ++H D K  N+L+   +    K+ D G            
Sbjct: 169 ----------ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG------------ 206

Query: 235 PSSQVTADEIFL--------ASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
            SS      I+         + EV     +    D++S G  L+E+ +G 
Sbjct: 207 -SSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 40.2 bits (95), Expect = 8e-04
 Identities = 43/222 (19%), Positives = 86/222 (38%), Gaps = 56/222 (25%)

Query: 84  LIGEGKFGEVY---KGLLQD-GMLVAIKKRPGAPTQEFIDEVC-------FLASIQHRNL 132
           ++G+G +G+V+   K    + G + A+K    A       +          L  ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 133 VTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLS------IALGAA 185
           V L+ Y  Q     +LI EY+  G + + L        ++  F    +      I++   
Sbjct: 84  VDLI-YAFQTGGKLYLILEYLSGGELFMQLE-------REGIFMEDTACFYLAEISMA-- 133

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-----------RNFLGRTDVAG 234
             L HLH     ++++D K  N++++     K+ D GL             F G      
Sbjct: 134 --LGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCG------ 183

Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR 276
                T +  ++A E+      +   D +S G  + ++++G 
Sbjct: 184 -----TIE--YMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 40.1 bits (94), Expect = 8e-04
 Identities = 28/172 (16%), Positives = 51/172 (29%), Gaps = 47/172 (27%)

Query: 85  IGEGKFGEVYKGL---------LQDGMLVAIK---------------KRPGAPTQEFIDE 120
                 G +Y+                  ++K               +R   P Q  +++
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQ--VNK 107

Query: 121 VCFLASIQHRNLVTLLGY-CQENNLQFLIYEYIPNGSVSIHLYGPS------QVSRQKLE 173
              L S     + T +G+   ++  +FL+              G S         +  L 
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP----------SLGRSLQSALDVSPKHVLS 157

Query: 174 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV--ADAGL 223
            +  L +A      L  LH      VH +    N+ VD +  ++V  A  G 
Sbjct: 158 ERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGF 207

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	380
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.37
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.19
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.99
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.76
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.6
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.54
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.49
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.43
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.38
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.22
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.03
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.99
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.87
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.75
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.68
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.54
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.52
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.43
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.37
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.37
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.35
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.34
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.98
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.93
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.3
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.72
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	95.38
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	95.21
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	95.0
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	93.47
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.29
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.13
2l34_A	33	TYRO protein tyrosine kinase-binding protein; immu	90.0
2l8s_A	54	Integrin alpha-1; transmembrane region, detergent	89.56
2knc_A	54	Integrin alpha-IIB; transmembrane signaling, prote	89.48
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.51
2klu_A	70	T-cell surface glycoprotein CD4; cell membrane, di	83.25

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.4e-60  Score=437.78  Aligned_cols=262  Identities=26%  Similarity=0.425  Sum_probs=209.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      .+|.+.++||+|+||+||+|+++      ++..||||......   .++|.+|+++|++++|||||+++|+|.+.+..||
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45667789999999999999864      47889999876543   3568999999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceE
Q 016917          148 IYEYIPNGSVSIHLYGPSQ----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  217 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~k  217 (380)
                      ||||+++|+|.+++.....          .....+++..++.++.|++.||.|||+  ++||||||||+|||+++++.+|
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLKp~NILl~~~~~~K  198 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG--LHFVHRDLATRNCLVGQGLVVK  198 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHhhEEECCCCcEE
Confidence            9999999999999865432          123568999999999999999999999  7799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHh
Q 016917          218 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQN  296 (380)
Q Consensus       218 l~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~  296 (380)
                      |+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.....   .+....+..
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i~~  275 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDCITQ  275 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHHHHH
T ss_pred             EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc
Confidence            999999987755444444455679999999999999999999999999999999999 8999986542   122222211


Q ss_pred             hhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          297 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                                   ..+...|..+++++.+|+.+||+.||++|||++|++++|+.+.+.+.
T Consensus       276 -------------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp  322 (329)
T 4aoj_A          276 -------------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP  322 (329)
T ss_dssp             -------------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred             -------------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence                         11234566677899999999999999999999999999999876543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-60  Score=435.37  Aligned_cols=260  Identities=27%  Similarity=0.429  Sum_probs=214.9

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      ++|.+.+.||+|+||+||+|++.      ++..||||......   .++|.+|+++|++++|||||+++|++.+.+..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46778899999999999999864      47789999876543   3568999999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEc
Q 016917          148 IYEYIPNGSVSIHLYGPS--------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  219 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~  219 (380)
                      ||||+++|+|.++|....        ......+++..++.++.|++.||.|||+  ++||||||||+|||+++++.+||+
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDlKp~NILl~~~~~~Ki~  170 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLLVKIG  170 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccCHhhEEECCCCcEEEC
Confidence            999999999999995432        1234578999999999999999999999  779999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhh
Q 016917          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR  298 (380)
Q Consensus       220 DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  298 (380)
                      |||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.....   .++...+..  
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i~~--  245 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECITQ--  245 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHH--
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc--
Confidence            9999987655433333344568999999999999999999999999999999998 8999986542   222222211  


Q ss_pred             cccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                                 ......|..+++++.+|+.+||+.||++|||++++.+.|+++.+.
T Consensus       246 -----------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          246 -----------GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             -----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                       112345666778999999999999999999999999999887654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.5e-60  Score=432.89  Aligned_cols=257  Identities=30%  Similarity=0.406  Sum_probs=214.7

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      .++++.++||+|+||+||+|.+.      +++.||||.....    ..++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34566789999999999999863      4678999986432    3567999999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI  215 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~  215 (380)
                      +||||+++|+|.++|.....           .....+++..++.++.|++.||.|||+  ++||||||||+|||+++++.
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCccccceEECCCCC
Confidence            99999999999999954321           123568999999999999999999999  67999999999999999999


Q ss_pred             eEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHH
Q 016917          216 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELV  294 (380)
Q Consensus       216 ~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~  294 (380)
                      +||+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |..||.+...   .+....+
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~~i  260 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVEMI  260 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHHHH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHHHH
Confidence            99999999987755444444456679999999999999999999999999999999998 8999986542   2222222


Q ss_pred             HhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                      .             .....+.|..+++++.+|+.+||+.||.+|||+.+|+++|+..
T Consensus       261 ~-------------~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          261 R-------------NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             H-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             H-------------cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1             1222345667888999999999999999999999999999764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9.2e-59  Score=424.15  Aligned_cols=259  Identities=25%  Similarity=0.421  Sum_probs=203.8

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      +..+++++.++||+|+||+||+|+++.  .||||..+...     .+.|.+|++++++++|||||+++|++.+ +..+||
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            445678888999999999999998753  58999865322     3468899999999999999999998865 467999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++|+|.+++..    ....+++..+..++.|++.||.|||+  ++||||||||+|||+++++.+||+|||+|+...
T Consensus       110 mEy~~gGsL~~~l~~----~~~~l~~~~~~~i~~qia~gL~yLH~--~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          110 TQWCEGSSLYKHLHV----QETKFQMFQLIDIARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             EECCSSCBHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             EEcCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            999999999999843    34568999999999999999999999  779999999999999999999999999998765


Q ss_pred             CCCCCCCCccccCccceeccccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ............||+.|||||++.+   ..|+.++|||||||+||||+||+.||......  ......+......     
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~~-----  256 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYAS-----  256 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCCC-----
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCC-----
Confidence            5433333456689999999999864   46899999999999999999999999865421  1111111111111     


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                         + .....+.++++++.+|+.+||+.||++|||+.++++.|+.+.
T Consensus       257 ---p-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          257 ---P-DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             ---C-CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             ---C-CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence               1 112344567788999999999999999999999999997664

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.8e-59  Score=424.22  Aligned_cols=267  Identities=16%  Similarity=0.215  Sum_probs=219.6

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||+||+|+. .+++.||+|+..      ....+.+.+|+++|++++||||+++++++.+.+..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4699999999999999999995 468999999753      344567899999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||++||+|.+++.     ..+.+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       112 Ey~~gG~L~~~i~-----~~~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          112 SYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            9999999999983     45678999999999999999999999  7799999999999999999999999999998765


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ..........+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+.   .++...+...            
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~------------  249 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIFAKIIKL------------  249 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT------------
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcC------------
Confidence            4444445567899999999999999999999999999999999999999976431   1222211111            


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhh----hhcccccccCCCCcc
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD----KEMNLTTVMGEGTPT  368 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~----~~~~~~~~~~~~~~~  368 (380)
                      .  ..++...++++++|+.+||+.||++|||++|++.+- .+++    +..+|+.....++|-
T Consensus       250 ~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~-~i~~Hp~F~~idw~~l~~~~pP~  309 (311)
T 4aw0_A          250 E--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG-PLKAHPFFESVTWENLHQQTPPK  309 (311)
T ss_dssp             C--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHH-HHHTSGGGTTCCCTTGGGSCCCC
T ss_pred             C--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCH-HHHCCCCcCCCCHHHhcCCCCCC
Confidence            1  134445667899999999999999999999976432 2222    234566665555443

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.5e-58  Score=425.28  Aligned_cols=258  Identities=21%  Similarity=0.220  Sum_probs=211.3

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCC
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNG  155 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  155 (380)
                      ..|+..++||+|+||.||+|+. .+|+.||||+......  ..+|+.+++.++|||||++++++.+++..||||||++||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG  135 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            4577788999999999999996 4689999998654322  247999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEcccccccccCCCCCC-
Q 016917          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRTDVA-  233 (380)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~-~~kl~DFgla~~~~~~~~~-  233 (380)
                      +|.+++.     ....+++..+..++.|++.||.|||+  ++||||||||+|||++.++ .+||+|||+|+.+...... 
T Consensus       136 ~L~~~l~-----~~~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          136 SLGQLIK-----QMGCLPEDRALYYLGQALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             BHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             cHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            9999983     34678999999999999999999999  7799999999999999987 6999999999887543221 


Q ss_pred             --CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          234 --GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       234 --~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                        ......+||+.|||||++.+..|+.++|||||||++|||+||+.||........   ...+....           ..
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i~~~~-----------~~  274 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLKIASEP-----------PP  274 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHHHHHSC-----------CG
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHHHcCC-----------CC
Confidence              123346799999999999999999999999999999999999999986553321   11111110           11


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcc
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  357 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~  357 (380)
                      ....+..+++++.+++.+||+.||.+|||+.|++++|...+.+...
T Consensus       275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~  320 (336)
T 4g3f_A          275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG  320 (336)
T ss_dssp             GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred             chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence            1234556678899999999999999999999999999988866443

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2e-58  Score=430.66  Aligned_cols=273  Identities=24%  Similarity=0.376  Sum_probs=222.6

Q ss_pred             cCHHHHHHHhCCCCCCCeeccCCceEEEEEEECC------CcEEEEEeCCCCC----hHHHHHHHHHHhcCCC-Cceeee
Q 016917           67 FQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAP----TQEFIDEVCFLASIQH-RNLVTL  135 (380)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~----~~~~~~E~~~l~~l~h-~niv~l  135 (380)
                      +...++++..++|++.+.||+|+||+||+|.+..      ++.||+|......    .+.+.+|+++|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3455677778889999999999999999998542      3579999865443    3458899999999965 999999


Q ss_pred             ccceec-CCeeEEEEEeecCCCccccccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 016917          136 LGYCQE-NNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF  203 (380)
Q Consensus       136 ~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDi  203 (380)
                      +|+|.+ ++.+++|||||++|+|.++|.....           .....+++..++.++.|++.||.|||+  ++||||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~--~~iiHRDL  211 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDL  211 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh--CCeecCcc
Confidence            999865 4568999999999999999954321           123558999999999999999999999  77999999


Q ss_pred             CCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCC
Q 016917          204 KTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL  282 (380)
Q Consensus       204 kp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~  282 (380)
                      ||+|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999997755433333345678999999999999999999999999999999998 89999865


Q ss_pred             CCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          283 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                      ...  ..+...             +....+...|..+++++.+++.+||+.||++|||+.+++++|+++++...
T Consensus       292 ~~~--~~~~~~-------------i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~  350 (353)
T 4ase_A          292 KID--EEFCRR-------------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  350 (353)
T ss_dssp             CCS--HHHHHH-------------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             CHH--HHHHHH-------------HHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence            432  112221             22222345566677889999999999999999999999999999987643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.1e-58  Score=429.68  Aligned_cols=249  Identities=21%  Similarity=0.345  Sum_probs=201.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++...     ..+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            35799999999999999999996 46899999975432     2356889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||++||+|.+++...   ....+++..++.++.||+.||.|||+  ++||||||||+|||++.++.+||+|||+|+....
T Consensus       103 Ey~~gg~L~~~i~~~---~~~~~~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             ECCTTCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH--TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             eCCCCCcHHHHHHHc---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            999999999998422   23457889999999999999999999  7799999999999999999999999999987643


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ..  ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.....   .++...+...            
T Consensus       178 ~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~~~------------  240 (350)
T 4b9d_A          178 TV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNLVLKIISG------------  240 (350)
T ss_dssp             HH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHT------------
T ss_pred             Cc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHcC------------
Confidence            21  112345799999999999999999999999999999999999999986432   1121111111            


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       .....+..+++++.+|+.+||+.||++|||++|++++
T Consensus       241 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          241 -SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0123344566889999999999999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.1e-58  Score=423.52  Aligned_cols=247  Identities=18%  Similarity=0.327  Sum_probs=207.7

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC---CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      +.|+..++||+|+||+||+|+.+ +|+.||||+..   ....+.+.+|+++|++++|||||++++++.+++.+||||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            45899999999999999999964 68999999743   344567899999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++|+|.+++.      ...+++..+..++.||+.||.|||+  ++||||||||+|||++.++.+||+|||+|+.+.... 
T Consensus       154 ~gg~L~~~l~------~~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  224 (346)
T 4fih_A          154 EGGALTDIVT------HTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  224 (346)
T ss_dssp             TTEEHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred             CCCcHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence            9999999883      3568999999999999999999999  779999999999999999999999999998775432 


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                       ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.....   .+....+....           ...
T Consensus       225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~~-----------~~~  289 (346)
T 4fih_A          225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDNL-----------PPR  289 (346)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSS-----------CCC
T ss_pred             -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHcCC-----------CCC
Confidence             223457899999999999999999999999999999999999999976432   11222221110           001


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ......+++++.+|+.+||+.||++|||++|++++
T Consensus       290 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          290 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            12233556789999999999999999999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.6e-57  Score=410.67  Aligned_cols=244  Identities=25%  Similarity=0.381  Sum_probs=196.0

Q ss_pred             CCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceec----CCeeEEEE
Q 016917           80 SDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQFLIY  149 (380)
Q Consensus        80 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  149 (380)
                      ++.++||+|+||+||+|... ++..||+|.....     ..+.+.+|++++++++|||||++++++.+    .+.+||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56678999999999999964 6889999975322     23568899999999999999999999864    35689999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCceEEcccccccccC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLG  228 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~-~~~~~kl~DFgla~~~~  228 (380)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+.+++||||||||+|||++ .++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999993     45678999999999999999999999434499999999999997 47999999999998643


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      .    ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||.....  ...+...+....          
T Consensus       184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~~i~~~~----------  246 (290)
T 3fpq_A          184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGV----------  246 (290)
T ss_dssp             T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTC----------
T ss_pred             C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHHHHHHcCC----------
Confidence            3    22345689999999999875 699999999999999999999999975432  111211111110          


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                        ....++...++++.+|+.+||+.||++|||++|++++
T Consensus       247 --~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          247 --KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             --CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0111223344679999999999999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-56  Score=403.91  Aligned_cols=243  Identities=22%  Similarity=0.290  Sum_probs=191.9

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||+||+|.. .+|+.||+|....      .....+.+|++++++++||||+++++++.+.+..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5899999999999999999995 5689999997532      23456889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+ +|+|.+++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+|+...+
T Consensus        93 Ey~-~g~L~~~l~-----~~~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIV-----QRDKMSEQEARRFFQQIISAVEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHH-----HSCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 578888883     45679999999999999999999999  7799999999999999999999999999987654


Q ss_pred             CCCCCCCccccCccceecccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ..   .....+||+.|+|||++.+..| +.++||||+||++|||+||+.||....   ...+...+...           
T Consensus       165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---~~~~~~~i~~~-----------  227 (275)
T 3hyh_A          165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---IPVLFKNISNG-----------  227 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHT-----------
T ss_pred             CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcC-----------
Confidence            22   2345679999999999998887 579999999999999999999997532   11222211111           


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         ...++...++++.+|+.+||+.||++|||++|++++
T Consensus       228 ---~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          228 ---VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               113344566889999999999999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-56  Score=425.21  Aligned_cols=247  Identities=18%  Similarity=0.330  Sum_probs=207.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC---CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      +.|+..++||+|+||.||+|..+ +|+.||||++.   ....+.+.+|+++|+.++|||||++++++.+.+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            45999999999999999999964 68999999743   344567899999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      +||+|.+++.      ...+++..+..++.||+.||.|||+  ++||||||||+|||++.+|.+||+|||+|+.+.... 
T Consensus       231 ~gG~L~~~i~------~~~l~e~~~~~~~~qil~aL~ylH~--~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-  301 (423)
T 4fie_A          231 EGGALTDIVT------HTRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  301 (423)
T ss_dssp             TTEEHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred             CCCcHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence            9999999883      3468999999999999999999999  779999999999999999999999999998775432 


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.....   .+....+....         .+  .
T Consensus       302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~~---------~~--~  366 (423)
T 4fie_A          302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDNL---------PP--R  366 (423)
T ss_dssp             -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSC---------CC--C
T ss_pred             -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHcCC---------CC--C
Confidence             223457899999999999999999999999999999999999999976432   11222111110         00  1


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ......+++++.+|+.+||+.||++|||+.|++++
T Consensus       367 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          367 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            12233456789999999999999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1e-56  Score=412.48  Aligned_cols=271  Identities=21%  Similarity=0.345  Sum_probs=202.0

Q ss_pred             CCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHH--HHhcCCCCceeeeccceecCC----eeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVC--FLASIQHRNLVTLLGYCQENN----LQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~--~l~~l~h~niv~l~~~~~~~~----~~~lv~e  150 (380)
                      ++|.+.++||+|+||+||+|++ +|+.||||+......+.+..|.+  .+.+++||||+++++++.+.+    .+|||||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            3567778999999999999998 48999999987666666655554  456789999999999997654    5799999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL------SPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      |+++|+|.+++.      ...+++..+..++.|++.||.|||+.      .++||||||||+|||++.++++||+|||+|
T Consensus        82 y~~~gsL~~~l~------~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           82 YHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             CCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCCCCcHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999993      34689999999999999999999973      238999999999999999999999999999


Q ss_pred             cccCCCCC--CCCCccccCccceecccccccC------CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh
Q 016917          225 NFLGRTDV--AGPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  296 (380)
Q Consensus       225 ~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~------~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  296 (380)
                      +.......  ........||+.|+|||++.+.      .|+.++|||||||+||||+||.+||.......... ......
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~~~~  234 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVPS  234 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSCS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhcccc
Confidence            87644322  2223456799999999998764      46789999999999999999988765432211000 000000


Q ss_pred             hhcccchh-hhcccccccCCC-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          297 SRDFSNLL-KILDERLWSTFT-----NEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       297 ~~~~~~~~-~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      ......+. .+.....++..+     .++++.+.+|+.+||+.||++|||+.|+++.|+++.+++
T Consensus       235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence            00000011 111222222222     356678999999999999999999999999999987653

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.5e-57  Score=411.48  Aligned_cols=245  Identities=20%  Similarity=0.250  Sum_probs=197.6

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC----CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      ++|++.+.||+|+||+||+|+..    +++.||+|.....     ....+.+|+++|++++||||+++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            46999999999999999999853    4688999975432     23467889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||++||+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+|+..
T Consensus       104 vmEy~~gg~L~~~l~-----~~~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLS-----KEVMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999983     45678999999999999999999999  77999999999999999999999999999865


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      ....  ......+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+.   .+....+..           
T Consensus       177 ~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~~-----------  240 (304)
T 3ubd_A          177 IDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---KETMTMILK-----------  240 (304)
T ss_dssp             ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH-----------
T ss_pred             cCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---HHHHHHHHc-----------
Confidence            4322  223456899999999999999999999999999999999999999986432   112221111           


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM-----SDVVTE  347 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~~ll~~  347 (380)
                       .  ...++..+++++.+|+.+||+.||++|||+     +|++++
T Consensus       241 -~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          241 -A--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             -C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             -C--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence             1  123455567889999999999999999985     566653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.7e-54  Score=396.14  Aligned_cols=249  Identities=22%  Similarity=0.352  Sum_probs=185.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCC--------
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN--------  143 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  143 (380)
                      ++|++.+.||+|+||+||+|+.+ +++.||+|+....    ..+.+.+|+++|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35888999999999999999964 6899999975422    2346889999999999999999999986544        


Q ss_pred             ----eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEc
Q 016917          144 ----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  219 (380)
Q Consensus       144 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~  219 (380)
                          ..|+||||+++|+|.+++.....  .....+..++.++.|++.||+|||+  ++|+||||||+|||++.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~--~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHH--CcCccccCcHHHeEECCCCcEEEc
Confidence                36999999999999999954322  2334567788999999999999999  779999999999999999999999


Q ss_pred             ccccccccCCCCCC----------CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCccc
Q 016917          220 DAGLRNFLGRTDVA----------GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD  289 (380)
Q Consensus       220 DFgla~~~~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~  289 (380)
                      |||+|+.+......          ......+||+.|||||++.+..|+.++|||||||++|||++   ||....     +
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~  232 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----E  232 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----H
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----H
Confidence            99999887543221          11234579999999999999999999999999999999996   664311     1


Q ss_pred             HHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          290 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....+.....         .. .++.....++...+|+.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~---------~~-~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          233 RVRTLTDVRN---------LK-FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHHHHHHT---------TC-CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHhc---------CC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1111111110         00 011112344667899999999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-52  Score=398.57  Aligned_cols=260  Identities=21%  Similarity=0.298  Sum_probs=199.5

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceec------CCe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQE------NNL  144 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  144 (380)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++....     .+.+.+|+++|+.++||||+++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            4699999999999999999996 479999999865332     2457789999999999999999998753      367


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      +|+||||++ |+|.+++.     ..+.+++..+..++.||+.||.|||+  ++||||||||+|||++.++.+||+|||+|
T Consensus       134 ~~ivmE~~~-g~L~~~i~-----~~~~l~~~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH-----SSQPLTLEHVRYFLYQLLRGLKYMHS--AQVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT-----SSSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeCCC-CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CcCcCCCcCccccccCCCCCEEEeeccee
Confidence            899999996 57888883     45679999999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCC--CCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc
Q 016917          225 NFLGRTD--VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       225 ~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                      +.+....  ........+||+.|+|||++.+. .|+.++||||+||++|||++|++||.+.+..   +....+.......
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~---~~l~~I~~~~g~p  282 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV---HQLQLIMMVLGTP  282 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhcCCC
Confidence            8764422  12234567899999999998875 5699999999999999999999999865421   1222211111000


Q ss_pred             c---h--------hhh---ccccc---ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 N---L--------LKI---LDERL---WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 ~---~--------~~~---~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .   .        ...   +....   +.......++++.+|+.+||+.||.+|||+.|+++|
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0   0        000   00000   000111235778999999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.3e-52  Score=389.01  Aligned_cols=264  Identities=23%  Similarity=0.253  Sum_probs=199.8

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEEC----CCcEEEEEeCC-CCChHHHHHHHHHHhcC-CCCceeeeccceecCCeeE
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRP-GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  146 (380)
                      +...+.|++.+.||+|+||+||+|+.+    +++.||+|... ......+.+|+++|+.+ +||||+++++++.+.+..|
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            334578999999999999999999853    46789999754 44556788999999998 6999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CceEEccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRN  225 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~-~~~kl~DFgla~  225 (380)
                      +||||+++|+|.+++        ..+++..+..++.|++.||.|||+  +||+||||||+|||++.+ +.+||+|||+|+
T Consensus        97 lvmE~~~g~~L~~~~--------~~l~~~~~~~~~~qll~al~ylH~--~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           97 IAMPYLEHESFLDIL--------NSLSFQEVREYMLNLFKALKRIHQ--FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEECCCCCCHHHHH--------TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeCCCcccHHHHH--------cCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            999999999999887        247899999999999999999999  779999999999999876 799999999998


Q ss_pred             ccCCCCCC--------------------------CCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCC
Q 016917          226 FLGRTDVA--------------------------GPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREA  278 (380)
Q Consensus       226 ~~~~~~~~--------------------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p  278 (380)
                      ...+....                          ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            65432210                          112345799999999998875 589999999999999999999999


Q ss_pred             CCCCCCCCcccHHHHHHh--hhc-------------------ccchhhhc------c---cc---------cccCCCHHH
Q 016917          279 SSSLSPDSSQDLVELVQN--SRD-------------------FSNLLKIL------D---ER---------LWSTFTNEG  319 (380)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~--~~~-------------------~~~~~~~~------~---~~---------~~~~~~~~~  319 (380)
                      |.....+ ...+......  ...                   .....+..      +   +.         .........
T Consensus       247 f~~~~~~-~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i  325 (361)
T 4f9c_A          247 FYKASDD-LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV  325 (361)
T ss_dssp             SSCCSSH-HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred             CCCCCCH-HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence            9754321 1111111000  000                   00000000      0   00         000111234


Q ss_pred             HHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          320 MEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       320 ~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ++++.+|+.+||+.||++|||++|+++|
T Consensus       326 s~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          326 PDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            5778999999999999999999999976

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.2e-50  Score=376.01  Aligned_cols=282  Identities=39%  Similarity=0.620  Sum_probs=239.7

Q ss_pred             HHHHHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        70 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      .++....++|+..+.||+|+||.||+|..+++..||+|......   .+.+.+|+.+++.++||||+++++++...+..+
T Consensus        32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            34445678899999999999999999998889999999865433   456889999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +||||+++|+|.+++..... ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++..
T Consensus       112 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  188 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKK  188 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcC--CCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence            99999999999999854322 23468999999999999999999999  7799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      ..............||..|+|||.+.+..++.++|||||||++|||++|+.||....+........+.........+...
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (321)
T 2qkw_B          189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI  268 (321)
T ss_dssp             CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence            55433333334456889999999999999999999999999999999999999987776666666555444444455556


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      +++......+..++..+.+++.+||+.||++|||+.+++++|+.+++.
T Consensus       269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            666666777889999999999999999999999999999999988754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.4e-51  Score=405.96  Aligned_cols=247  Identities=21%  Similarity=0.269  Sum_probs=202.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHH---HHHHHhcCCCCceeeeccceecCCee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFID---EVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      .++|++.++||+|+||.||+|+.+ +|+.||+|++..      .......+   ++.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            457999999999999999999964 689999997532      22233334   46677888999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      |+||||++||+|.+++.     ....+++..+..++.||+.||.|||+  ++||||||||+|||++.+|++||+|||+|+
T Consensus       268 ylVmEy~~GGdL~~~l~-----~~~~l~E~~a~~y~~qIl~aL~yLH~--~gIiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEEECCCCSCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHeEEeCCCCEEecccceee
Confidence            99999999999999983     45678999999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCccceecccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      .+....    ....+||+.|+|||++. +..|+.++|||||||+||||++|.+||......+.   .+.......     
T Consensus       341 ~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i~~-----  408 (689)
T 3v5w_A          341 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLT-----  408 (689)
T ss_dssp             ECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHHHH-----
T ss_pred             ecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhhcC-----
Confidence            765432    34568999999999996 46899999999999999999999999976443222   111111111     


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~~ll~~  347 (380)
                          .  ...++...++++.+|+.+||+.||.+|++     ++|+++|
T Consensus       409 ----~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          409 ----M--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             ----C--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             ----C--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence                0  12345556788999999999999999998     6777765

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.9e-49  Score=368.66  Aligned_cols=286  Identities=37%  Similarity=0.622  Sum_probs=239.4

Q ss_pred             hhcccCHHHHHHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccc
Q 016917           63 EARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGY  138 (380)
Q Consensus        63 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~  138 (380)
                      ....+...++....++|++.+.||+|+||.||+|...++..||+|......    ...+.+|+++++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            345678889999999999999999999999999998889999999865432    2368899999999999999999999


Q ss_pred             eecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCCeeeCCCCceE
Q 016917          139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-SPRVVHKDFKTANVLVDEDFIAK  217 (380)
Q Consensus       139 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivHrDikp~Nili~~~~~~k  217 (380)
                      +...+..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+. ..+|+||||||+|||++.++.+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            9999999999999999999998864322 345589999999999999999999993 11799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCC--CCCcccHHHHHH
Q 016917          218 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS--PDSSQDLVELVQ  295 (380)
Q Consensus       218 l~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~--~~~~~~~~~~~~  295 (380)
                      |+|||++........ .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||....  ........++..
T Consensus       175 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          175 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             eccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            999999987643221 22334558999999999999999999999999999999999999996321  122334455555


Q ss_pred             hhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHh
Q 016917          296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  350 (380)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~  350 (380)
                      ............+.......+...++.+.+++.+||+.||.+|||+.+++++|++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            5555555666667777778888999999999999999999999999999999976

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.3e-50  Score=399.02  Aligned_cols=249  Identities=21%  Similarity=0.269  Sum_probs=205.2

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ++|++.+.||+|+||.||+|.. .+|+.||+|.+....   .+.+.+|+++|+.++||||+++++++.+.+.+|+||||+
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            5789999999999999999996 468999999754433   356789999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC--CceEEcccccccccCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED--FIAKVADAGLRNFLGRT  230 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~--~~~kl~DFgla~~~~~~  230 (380)
                      +||+|.+++..    ....+++..+..++.||+.||.|||+  ++|+||||||+|||++.+  +.+||+|||+|+.+...
T Consensus       237 ~gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          237 SGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             CCCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999988832    34568999999999999999999999  779999999999999854  89999999999987543


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      .   .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+...   .+....+....          ..
T Consensus       311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---~~~~~~i~~~~----------~~  374 (573)
T 3uto_A          311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKSCD----------WN  374 (573)
T ss_dssp             S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHTTC----------CC
T ss_pred             C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHhCC----------CC
Confidence            2   23456799999999999999999999999999999999999999986432   11222111110          00


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ........+++++.+||.+||+.||.+|||+.|+++|
T Consensus       375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0011112345778999999999999999999999985

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.8e-48  Score=368.34  Aligned_cols=262  Identities=26%  Similarity=0.448  Sum_probs=215.9

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC--------CCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeeeccceecC
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQEN  142 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  142 (380)
                      .++|++.+.||+|+||.||+|...        ++..||+|......    .+.+.+|+++++.+ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            457888899999999999999852        35679999876543    24578999999999 899999999999999


Q ss_pred             CeeEEEEEeecCCCccccccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD  211 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~  211 (380)
                      +..|+||||+++|+|.+++.....           .....+++..++.++.|++.||.|||+  ++|+||||||+|||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEC
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchhhEEEC
Confidence            999999999999999999854321           123458899999999999999999999  7799999999999999


Q ss_pred             CCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccH
Q 016917          212 EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDL  290 (380)
Q Consensus       212 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~  290 (380)
                      .++.+||+|||+++...............+|+.|+|||++.+..|+.++|||||||++|||++ |..||.....   .+.
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---~~~  314 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EEL  314 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGH
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence            999999999999987655443333445567888999999999999999999999999999999 9999986542   222


Q ss_pred             HHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          291 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      ...+.             .......+..+++++.+++.+||+.||.+|||+.++++.|+.++...
T Consensus       315 ~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          315 FKLLK-------------EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             HHHHH-------------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHh-------------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            22221             11223445566788999999999999999999999999999988643

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.9e-48  Score=361.44  Aligned_cols=273  Identities=25%  Similarity=0.330  Sum_probs=211.1

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCChH--HHHHHHHHHhcCCCCceeeeccceecCC----eeEEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNLVTLLGYCQENN----LQFLI  148 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv  148 (380)
                      ..++|++.+.||+|+||.||+|+.. ++.||+|+.......  ....|+.++++++||||+++++++....    ..++|
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            3467889999999999999999976 789999987654433  3456788899999999999999998744    46999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CCCeEecCCCCCCeeeCCCCceEEcc
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL--------SPRVVHKDFKTANVLVDEDFIAKVAD  220 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------~~~ivHrDikp~Nili~~~~~~kl~D  220 (380)
                      |||+++|+|.+++.      ...+++..++.++.|++.||.|||+.        +++|+||||||+|||++.++.+||+|
T Consensus       101 ~e~~~~g~L~~~l~------~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          101 TAFHEKGSLSDFLK------ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EECCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EecCCCCCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            99999999999983      24589999999999999999999983        11799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCccceeccccccc-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH
Q 016917          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  295 (380)
Q Consensus       221 Fgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~  295 (380)
                      ||+++...............||..|+|||++.+     ..++.++|||||||++|||++|+.||................
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  254 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG  254 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence            999987765444334445679999999999886     355678999999999999999999998755433222222111


Q ss_pred             hhhcccchhhh-cccccccCC-----CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          296 NSRDFSNLLKI-LDERLWSTF-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       296 ~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      .......+... .........     ....++++.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            11111111111 111111111     224667899999999999999999999999999987653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-48  Score=370.84  Aligned_cols=259  Identities=27%  Similarity=0.431  Sum_probs=213.3

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      +..++|++.+.||+|+||.||+|... ++..||+|......    .+.+.+|++++++++||||+++++++...+..++|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            44567888899999999999999975 78999999866442    23577899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus       191 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          191 MELVQGGDFLTFLRT----EGARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EECCTTCBHHHHHHH----HGGGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            999999999999842    23458899999999999999999999  779999999999999999999999999998654


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      ............+|..|+|||++.+..++.++|||||||++|||++ |..||......   ...+.+             
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~~~-------------  328 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTREFV-------------  328 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHHHH-------------
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH-------------
Confidence            4322222222345678999999998999999999999999999998 99999765421   111111             


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      ........+..+++++.+++.+||+.||++|||+.++++.|+++.++
T Consensus       329 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          329 EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            11122344555678899999999999999999999999999988764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.9e-48  Score=359.20  Aligned_cols=263  Identities=27%  Similarity=0.434  Sum_probs=211.8

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC----CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      ..++|++.+.||+|+||.||+|...    .+..||+|......    .+.+.+|+++++.++||||+++++++.+.+..+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            3457888999999999999999964    35569999865432    345889999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +||||+++|+|.+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++..
T Consensus       127 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEeeCCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            99999999999999842    33568999999999999999999999  7799999999999999999999999999987


Q ss_pred             cCCCCCC-CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          227 LGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       227 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ....... .......+|..|+|||++.+..++.++|||||||++|||++ |..||.....   .+....+.         
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~---------  268 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSVE---------  268 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHH---------
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH---------
Confidence            6543211 11223446778999999999999999999999999999999 9999976432   11111111         


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcccc
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT  359 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~~~  359 (380)
                          .......+..+++++.+++.+||+.||.+|||+.++++.|+.+++...+..
T Consensus       269 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~  319 (325)
T 3kul_A          269 ----EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLR  319 (325)
T ss_dssp             ----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC---
T ss_pred             ----cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccccc
Confidence                112233445667889999999999999999999999999999997765543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.3e-48  Score=348.24  Aligned_cols=257  Identities=28%  Similarity=0.430  Sum_probs=213.4

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ..++|++.+.||+|+||.||+|...++..||+|+....  ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            34578889999999999999999988999999986543  4567899999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++........
T Consensus        88 ~~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           88 EHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             TTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             CCCcHHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHh--CCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            99999999842    34568899999999999999999999  7799999999999999999999999999987644221


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                       .......+|..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ......+..             ..
T Consensus       162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~~~-------------~~  224 (269)
T 4hcu_A          162 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDIST-------------GF  224 (269)
T ss_dssp             -HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHT-------------TC
T ss_pred             -ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhc-------------Cc
Confidence             12233456778999999999999999999999999999999 9999876432   111111111             11


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      ....+...++++.+++.+||+.||.+|||+.+++++|+++.++
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            1223344567899999999999999999999999999998764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.3e-47  Score=351.86  Aligned_cols=248  Identities=21%  Similarity=0.355  Sum_probs=206.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC---CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      .++|++.+.||+|+||+||+|.. .+++.||+|...   ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999994 578999999742   34456788999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++|+|.+++.      ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.......
T Consensus        99 ~~~~~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           99 LAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CTTCBHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            99999999883      3458899999999999999999999  679999999999999999999999999988765422


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                        .......||+.|+|||.+.+..|+.++|||||||++|||++|..||......   .........           ...
T Consensus       171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~-----------~~~  234 (297)
T 3fxz_A          171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLIATN-----------GTP  234 (297)
T ss_dssp             --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHH-----------CSC
T ss_pred             --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhC-----------CCC
Confidence              2234567899999999999999999999999999999999999999764321   111111000           001


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....+...++.+.+++.+||+.||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            112344566789999999999999999999999975

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5e-48  Score=356.55  Aligned_cols=264  Identities=28%  Similarity=0.423  Sum_probs=205.1

Q ss_pred             HHHHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCee
Q 016917           71 ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        71 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      ++.+...+|++.+.||+|+||.||+|+. ++..||+|......     .+.+.+|++++++++||||+++++++...+..
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            3344566889999999999999999987 47889999854332     24578999999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeeCCCCceEEccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR--VVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~--ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      ++||||+++|+|.+++....  ....+++..++.++.|++.||.|||+  ++  |+||||||+|||++.++.+||+|||+
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~--~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHN--RNPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHT--SSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             EEEEecCCCCcHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHc--CCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            99999999999999984321  12348899999999999999999999  66  99999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      ++......  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......   +....+.        
T Consensus       186 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~~~--------  252 (309)
T 3p86_A          186 SRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVAAVG--------  252 (309)
T ss_dssp             ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHHHH--------
T ss_pred             Cccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH--------
Confidence            97654321  1233456899999999999999999999999999999999999999765421   1111110        


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                          ........+..+++++.+++.+||+.||.+|||+.++++.|+.+++...
T Consensus       253 ----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          253 ----FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             ----HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             ----hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence                0111223455566889999999999999999999999999999987643

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.6e-48  Score=352.79  Aligned_cols=259  Identities=25%  Similarity=0.430  Sum_probs=212.4

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +..++|++.+.||+|+||.||+|...++..||+|.....  ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            345678889999999999999999998889999986543  457789999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A          101 MANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             CTTCBHHHHHHC----GGGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             cCCCcHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            999999999843    24568999999999999999999999  779999999999999999999999999998764422


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      . .......+|..|+|||.+.+..++.++||||||+++|+|++ |+.||......   .....+.             ..
T Consensus       175 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~-------------~~  237 (283)
T 3gen_A          175 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIA-------------QG  237 (283)
T ss_dssp             H-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHH-------------TT
T ss_pred             c-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHHHHh-------------cc
Confidence            1 11233456778999999999999999999999999999998 99999865421   1111111             11


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      .....+...++.+.+++.+||+.||.+|||+.+++++|.++++++
T Consensus       238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          238 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence            112233344578999999999999999999999999999998764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.3e-47  Score=352.22  Aligned_cols=260  Identities=25%  Similarity=0.386  Sum_probs=210.9

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      .++|++.+.||+|+||+||+|... ++..||+|......   .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            456888899999999999999964 68899999754433   35688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.......
T Consensus        89 ~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           89 IKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             CTTCBHHHHHHH----CCTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             cCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999842    24568999999999999999999999  679999999999999999999999999998764422


Q ss_pred             CCC------------CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc
Q 016917          232 VAG------------PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD  299 (380)
Q Consensus       232 ~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  299 (380)
                      ...            ......||+.|+|||.+.+..++.++||||||+++|||++|..||............        
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~--------  234 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--------  234 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--------
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--------
Confidence            211            112457899999999999999999999999999999999999998765432211100        


Q ss_pred             ccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          300 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                        .....    .....+..+++++.+++.+||+.||++|||+.++++.|+++....
T Consensus       235 --~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          235 --NVRGF----LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             --CHHHH----HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --hhhcc----ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence              00000    111223445567999999999999999999999999999887653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.7e-47  Score=362.02  Aligned_cols=262  Identities=26%  Similarity=0.447  Sum_probs=203.3

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC----CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      ...+|++.+.||+|+||.||+|+..    ++..||+|......    .+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            3457999999999999999999864    57789999876432    346889999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +||||+++|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       123 lv~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            99999999999999842    23468999999999999999999999  6799999999999999999999999999987


Q ss_pred             cCCCCC-CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          227 LGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       227 ~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||.....   .+....           
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~-----------  262 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKA-----------  262 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHH-----------
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH-----------
Confidence            654221 111223345678999999999999999999999999999998 9999976432   111111           


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhccc
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL  358 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~~  358 (380)
                        +........+..++.++.+++.+||+.||.+||++.++++.|++++.+....
T Consensus       263 --i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~~  314 (373)
T 2qol_A          263 --VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSL  314 (373)
T ss_dssp             --HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGGG
T ss_pred             --HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcccc
Confidence              1122223344556788999999999999999999999999999998776543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.5e-46  Score=343.64  Aligned_cols=280  Identities=32%  Similarity=0.510  Sum_probs=225.7

Q ss_pred             hcccCHHHHHHHhCCCCCC------CeeccCCceEEEEEEECCCcEEEEEeCCCC-------ChHHHHHHHHHHhcCCCC
Q 016917           64 ARRFQMEELSLATKNFSDK------NLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-------PTQEFIDEVCFLASIQHR  130 (380)
Q Consensus        64 ~~~~~~~~~~~~~~~~~~~------~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~h~  130 (380)
                      ...+...++...+++|...      +.||+|+||.||+|.. ++..||+|.....       ..+.+.+|+.+++.++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            3567788888888888776      8999999999999987 5789999975422       245688999999999999


Q ss_pred             ceeeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 016917          131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (380)
Q Consensus       131 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili  210 (380)
                      ||+++++++.+.+..++||||+++++|.+++...  .....+++..++.++.|++.||.|||+  .+|+||||||+||++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nili  166 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANILL  166 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG--GGCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEE
Confidence            9999999999999999999999999999988532  224568999999999999999999999  679999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccH
Q 016917          211 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL  290 (380)
Q Consensus       211 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~  290 (380)
                      +.++.+||+|||++................||..|+|||.+.+ .++.++||||||+++|+|++|..||...........
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            9999999999999987654332222334568999999998875 589999999999999999999999987654332221


Q ss_pred             H-HHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          291 V-ELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       291 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                      . ....  .....+...+++.. ...+...++.+.+++.+||+.||.+|||+.+++++|+++.
T Consensus       246 ~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          246 IKEEIE--DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHH--TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHhh--hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            1 1111  11122333333333 3456788899999999999999999999999999998875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.8e-48  Score=355.56  Aligned_cols=263  Identities=27%  Similarity=0.428  Sum_probs=215.1

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEE------CCCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCC
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENN  143 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  143 (380)
                      ...++|.+.+.||+|+||.||+|..      .++..||+|......    .+.+.+|+++++.++||||+++++++.+.+
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            3456788899999999999999985      235789999876543    245788999999999999999999999999


Q ss_pred             eeEEEEEeecCCCccccccCCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQV-------------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFK  204 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDik  204 (380)
                      ..++||||+++++|.+++......                   ....+++..++.++.|++.||.|||+  ++|+|||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dik  177 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MKLVHRDLA  177 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH--TTEECCCCS
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH--CCCcccccc
Confidence            999999999999999998543211                   12448899999999999999999999  679999999


Q ss_pred             CCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 016917          205 TANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS  283 (380)
Q Consensus       205 p~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~  283 (380)
                      |+|||++.++.+||+|||++................+|..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987654333233344567888999999999999999999999999999999 999997654


Q ss_pred             CCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          284 PDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      ..   .....+..             ......+..+++++.+++.+||+.||.+|||+.+++++|++++.+
T Consensus       258 ~~---~~~~~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          258 PE---RLFNLLKT-------------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GG---GHHHHHHT-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HH---HHHHHhhc-------------CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            32   22222211             112234445668899999999999999999999999999998765

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.5e-47  Score=345.88  Aligned_cols=257  Identities=25%  Similarity=0.413  Sum_probs=212.0

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ..++|++.+.||+|+||.||+|..+++..||+|.....  ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            35678899999999999999999988889999986543  4567899999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++........
T Consensus        86 ~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           86 SNGCLLNYLRS----HGKGLEPSQLLEMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             TTCBHHHHHHH----HGGGCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             CCCcHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            99999998832    23458999999999999999999999  7799999999999999999999999999987654322


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                      . ......+|..|+|||.+.+..++.++||||||+++|+|++ |..||......   .....+..             ..
T Consensus       160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~-------------~~  222 (268)
T 3sxs_A          160 V-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS---EVVLKVSQ-------------GH  222 (268)
T ss_dssp             E-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHT-------------TC
T ss_pred             h-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH---HHHHHHHc-------------CC
Confidence            1 1233446778999999999999999999999999999999 99998754321   11111110             11


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      ....+...++++.+++.+||+.||.+|||+.+++++|+.+.++
T Consensus       223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          223 RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            1122334457799999999999999999999999999988765

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-47  Score=357.65  Aligned_cols=266  Identities=26%  Similarity=0.403  Sum_probs=214.0

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecC
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQEN  142 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~  142 (380)
                      ....++|++.+.||+|+||.||+|+..      ++..||+|......    .+.+.+|+.++++++||||+++++++.+.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            345678999999999999999999964      34789999876543    34578999999999999999999999999


Q ss_pred             CeeEEEEEeecCCCccccccCCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQV-------------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF  203 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDi  203 (380)
                      +..++||||+++|+|.+++......                   ....+++..++.++.|++.||.|||+  ++|+||||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dl  200 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDL  200 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCC
Confidence            9999999999999999988543211                   12568999999999999999999999  67999999


Q ss_pred             CCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCC
Q 016917          204 KTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL  282 (380)
Q Consensus       204 kp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~  282 (380)
                      ||+|||++.++.+||+|||++................+|..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999987654333333345567889999999999999999999999999999999 99999764


Q ss_pred             CCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          283 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                      ..   .+....+..             ......+..+++++.+++.+||+.||.+|||+.++++.|+++.++..
T Consensus       281 ~~---~~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          281 AH---EEVIYYVRD-------------GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             CH---HHHHHHHHT-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             Ch---HHHHHHHhC-------------CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            32   111111111             11123344566789999999999999999999999999999987654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.7e-47  Score=355.70  Aligned_cols=246  Identities=25%  Similarity=0.315  Sum_probs=205.4

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|+....     ..+.+.+|+++++.++||||+++++++...+..|+|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            356799999999999999999996 57899999975322     234578999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++....
T Consensus        93 ~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           93 MEYASGGEVFDYLV-----AHGRMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             ECCCTTCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EECCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            99999999999883     34568999999999999999999999  779999999999999999999999999998664


Q ss_pred             CCCCCCCCccccCccceecccccccCCCC-cchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      ...   ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.....   ......+..           
T Consensus       166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~-----------  228 (328)
T 3fe3_A          166 VGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL---KELRERVLR-----------  228 (328)
T ss_dssp             SSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH-----------
T ss_pred             CCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHh-----------
Confidence            322   23456799999999999988875 789999999999999999999976432   111111111           


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       .  ....+...++++.+++.+||+.||.+|||+++++++
T Consensus       229 -~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          229 -G--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             -C--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             -C--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             0  112334456789999999999999999999999976

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.3e-47  Score=354.33  Aligned_cols=251  Identities=21%  Similarity=0.312  Sum_probs=204.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      .++|++.+.||+|+||.||+|... +++.||+|.....    ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            467899999999999999999965 7899999975322    23568899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           86 YCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             CCTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            999999999883     44568999999999999999999999  77999999999999999999999999999876443


Q ss_pred             CCCCCCccccCccceecccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ..........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ....+..             .
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~-------------~  224 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE-------------K  224 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHT-------------T
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhc-------------c
Confidence            33333445679999999999988776 7789999999999999999999986543211 1111110             0


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..........++++.+|+.+||+.||.+|||+.|++++
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          225 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            00111112345778999999999999999999999876

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.1e-47  Score=354.86  Aligned_cols=258  Identities=26%  Similarity=0.395  Sum_probs=207.1

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCc----EEEEEeCCC----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      .++|++.+.||+|+||.||+|... ++.    +|++|....    .....+.+|+.+++.++||||+++++++.. +..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence            457888999999999999999954 343    378886432    233567789999999999999999999864 5688


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +||||+.+|+|.+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQ----HRGALGPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEECCTTCBSHHHHHS----SGGGSCTTHHHHHHHHHHHHHHHHHH--TTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEeCCCCCHHHHHHH----ccccCCHHHHHHHHHHHHHHHHHHHh--CCCCCCccchheEEECCCCeEEECCCCcccc
Confidence            99999999999998843    23568888999999999999999999  6799999999999999999999999999988


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ..............+|..|+|||.+.+..++.++|||||||++|||++ |..||......   .....+..         
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~---------  232 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EVPDLLEK---------  232 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HHHHHHHT---------
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HHHHHHHc---------
Confidence            765444444455667888999999999999999999999999999999 99999865432   12221111         


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                          ......+..++.++.+++.+||+.||.+|||+.+++++|+++.....
T Consensus       233 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~  279 (325)
T 3kex_A          233 ----GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP  279 (325)
T ss_dssp             ----TCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred             ----CCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence                11223333455678999999999999999999999999999987654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.6e-48  Score=363.41  Aligned_cols=263  Identities=23%  Similarity=0.346  Sum_probs=213.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      .++|++.+.||+|+||.||+|...      ++..||+|......    ...+.+|+.++++++||||+++++++.+.+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467888999999999999999943      46789999875432    23578899999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC---ceEEcc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVAD  220 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~---~~kl~D  220 (380)
                      ++||||+++|+|.+++.....  .....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++   .+||+|
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEEecCCCCceEEECC
Confidence            999999999999998854321  223468999999999999999999999  7799999999999999554   599999


Q ss_pred             cccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhc
Q 016917          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRD  299 (380)
Q Consensus       221 Fgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  299 (380)
                      ||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.....   ......+..   
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~~~i~~---  301 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVTS---  301 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHT---
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc---
Confidence            999986544333333445667889999999999999999999999999999998 9999976432   112221111   


Q ss_pred             ccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          300 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                                ......+..+++++.+++.+||+.||.+|||+.+++++|+.+.+...
T Consensus       302 ----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          302 ----------GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             ----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             ----------CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence                      11223344566789999999999999999999999999999887754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-47  Score=360.78  Aligned_cols=266  Identities=27%  Similarity=0.427  Sum_probs=217.6

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEEC--------CCcEEEEEeCCCCCh----HHHHHHHHHHhcC-CCCceeeecccee
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGYCQ  140 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~----~~~~~E~~~l~~l-~h~niv~l~~~~~  140 (380)
                      +..++|++.+.||+|+||.||+|...        .+..||+|+......    ..+.+|+++++++ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            34567889999999999999999852        235799998654432    4578999999999 9999999999999


Q ss_pred             cCCeeEEEEEeecCCCccccccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 016917          141 ENNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL  209 (380)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nil  209 (380)
                      ..+..++||||+++|+|.+++.....           .....+++..++.++.|++.||.|||+  ++|+||||||+|||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCcceEE
Confidence            99999999999999999998854321           113468999999999999999999999  67999999999999


Q ss_pred             eCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcc
Q 016917          210 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQ  288 (380)
Q Consensus       210 i~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~  288 (380)
                      ++.++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|||++ |..||.....   .
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---~  300 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---E  300 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---H
Confidence            99999999999999987765443344455567889999999999999999999999999999999 9999876432   1


Q ss_pred             cHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcc
Q 016917          289 DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  357 (380)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~  357 (380)
                      +....+.             .......+..+++++.+++.+||+.||++|||+.++++.|++++....+
T Consensus       301 ~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  356 (382)
T 3tt0_A          301 ELFKLLK-------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN  356 (382)
T ss_dssp             HHHHHHH-------------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred             HHHHHHH-------------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            1222111             1112233445667899999999999999999999999999999876543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.4e-48  Score=363.50  Aligned_cols=271  Identities=24%  Similarity=0.377  Sum_probs=216.3

Q ss_pred             cCHHHHHHHhCCCCCCCeeccCCceEEEEEEE------CCCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeee
Q 016917           67 FQMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTL  135 (380)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l  135 (380)
                      +....++...++|++.+.||+|+||.||+|.+      .+++.||+|......    .+.+.+|+++++++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            34456666778899999999999999999973      245789999865533    23588999999999 78999999


Q ss_pred             ccceecCC-eeEEEEEeecCCCccccccCCCCC-----------------------------------------------
Q 016917          136 LGYCQENN-LQFLIYEYIPNGSVSIHLYGPSQV-----------------------------------------------  167 (380)
Q Consensus       136 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~-----------------------------------------------  167 (380)
                      ++++...+ ..++||||+++|+|.+++......                                               
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99987754 489999999999999998654221                                               


Q ss_pred             --------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          168 --------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       168 --------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                                    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.........
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  249 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY  249 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence                          01228899999999999999999999  77999999999999999999999999999876443322


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                      .......+|..|+|||++.+..++.++|||||||++|||++ |..||......  ......+.             ....
T Consensus       250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~-------------~~~~  314 (359)
T 3vhe_A          250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLK-------------EGTR  314 (359)
T ss_dssp             EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHHHHHHH-------------HTCC
T ss_pred             hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--HHHHHHHH-------------cCCC
Confidence            23344567888999999999999999999999999999998 99999765432  11111111             1112


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      ...+..+++++.+++.+||+.||.+|||+.+++++|+++++.
T Consensus       315 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            233445567899999999999999999999999999998864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9.5e-48  Score=356.69  Aligned_cols=267  Identities=22%  Similarity=0.365  Sum_probs=199.0

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEECC-C---cEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCC
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLLQD-G---MLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN  143 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~-~---~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  143 (380)
                      .+..++|++.+.||+|+||.||+|.... +   ..||+|.....     ..+.+.+|++++++++||||+++++++...+
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            3455689999999999999999999543 3   37999986533     2456889999999999999999999998766


Q ss_pred             ee------EEEEEeecCCCccccccCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCce
Q 016917          144 LQ------FLIYEYIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  216 (380)
Q Consensus       144 ~~------~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~  216 (380)
                      ..      ++||||+++|+|.+++..... .....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCE
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc--CCcccCCCCcceEEEcCCCCE
Confidence            55      999999999999998843221 122358999999999999999999999  779999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHH
Q 016917          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ  295 (380)
Q Consensus       217 kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~  295 (380)
                      ||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......   .....+.
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~  253 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYNYLI  253 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHH
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHHHHh
Confidence            9999999987655443333445557788999999999999999999999999999999 89999865432   1222111


Q ss_pred             hhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcc
Q 016917          296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  357 (380)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~  357 (380)
                      .             ......+..+++++.+++.+||+.||++|||+.++++.|++++....-
T Consensus       254 ~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~  302 (323)
T 3qup_A          254 G-------------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV  302 (323)
T ss_dssp             T-------------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred             c-------------CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence            1             111233445667899999999999999999999999999999988653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.8e-47  Score=355.72  Aligned_cols=258  Identities=25%  Similarity=0.425  Sum_probs=207.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCc----EEEEEeCCC----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      .++|++.+.||+|+||+||+|... ++.    +||+|....    ...+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            456888999999999999999954 333    468887543    34567899999999999999999999998765 68


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +|+||+.+|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           93 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCTTCBHHHHHHH----STTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            99999999999998842    34568999999999999999999999  6799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ..............+|..|+|||.+.+..++.++|||||||++|||++ |+.||......   .....+           
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~-----------  232 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSIL-----------  232 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH-----------
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---HHHHHH-----------
Confidence            755443333445567888999999999999999999999999999999 99999865432   122211           


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                        ........+..++.++.+++.+||+.||.+|||+.+++++|+.+.....
T Consensus       233 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~  281 (327)
T 3poz_A          233 --EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  281 (327)
T ss_dssp             --HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHH
T ss_pred             --HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhh
Confidence              1122233445566789999999999999999999999999999887643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.2e-47  Score=349.86  Aligned_cols=266  Identities=20%  Similarity=0.311  Sum_probs=208.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC---CC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG---AP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~---~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|.. .++..||+|....   ..   .+.+.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            45789999999999999999995 4688999997422   11   24678999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++++|.+++.     ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++....
T Consensus        90 ~e~~~g~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           90 MEYIEGPTLSEYIE-----SHGPLSVDTAINFTNQILDGIKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EECCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EeCCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            99999999999983     34568999999999999999999999  679999999999999999999999999998765


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      .... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......      ......... .     .
T Consensus       163 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~-~-----~  229 (294)
T 4eqm_A          163 ETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQD-S-----V  229 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSS-C-----C
T ss_pred             cccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhc-c-----C
Confidence            4321 2233456899999999999999999999999999999999999999764321      111000000 0     0


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHHHhhhhhhcccccc
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTLDKEMNLTTV  361 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~~ll~~L~~~~~~~~~~~~~  361 (380)
                      +......+..+++.+.+++.+||+.||.+|| +++++.+.|..++.+.....+.
T Consensus       230 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~~  283 (294)
T 4eqm_A          230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDV  283 (294)
T ss_dssp             CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCCC
T ss_pred             CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcch
Confidence            0111122334557899999999999999998 9999999999988765544433

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.2e-46  Score=345.51  Aligned_cols=262  Identities=21%  Similarity=0.344  Sum_probs=204.9

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhc--CCCCceeeeccceec----CCeeEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLAS--IQHRNLVTLLGYCQE----NNLQFLIY  149 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~lv~  149 (380)
                      .++|++.+.||+|+||+||+|+. +++.||+|+........+..|.+++..  ++||||+++++++..    ....++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~   85 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT   85 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence            46789999999999999999998 588999999877777777788887776  799999999998653    35679999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCeEecCCCCCCeeeCCCCceEEccc
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH--------SLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~ivHrDikp~Nili~~~~~~kl~DF  221 (380)
                      ||+++|+|.+++.      ...+++..++.++.|++.||.|||        +  ++|+||||||+|||++.++.+||+||
T Consensus        86 e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           86 HYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK--PAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             CCCTTCBHHHHHT------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB--CEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             hhccCCCHHHHHh------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC--CCeecCCCChHhEEEcCCCCEEEeeC
Confidence            9999999999982      346899999999999999999999        7  77999999999999999999999999


Q ss_pred             ccccccCCCCC--CCCCccccCccceecccccccC------CCCcchhhHHHHHHHHHHHcC----------CCCCCCCC
Q 016917          222 GLRNFLGRTDV--AGPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSG----------REASSSLS  283 (380)
Q Consensus       222 gla~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~------~~~~~~DvwSlG~il~el~tg----------~~p~~~~~  283 (380)
                      |++........  ........||+.|+|||++.+.      .++.++|||||||++|||++|          ..||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            99976544221  1122345789999999998876      456799999999999999999          78887654


Q ss_pred             CCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          284 PDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                      ...... .. ............   .......+..+++++.+++.+||+.||++|||+.++++.|+++
T Consensus       238 ~~~~~~-~~-~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          238 PNDPSF-ED-MRKVVCVDQQRP---NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CSSCCH-HH-HHHHHTTSCCCC---CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcch-hh-hhHHHhccCCCC---CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            332211 11 111000000000   0000112345778999999999999999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.8e-48  Score=353.61  Aligned_cols=270  Identities=27%  Similarity=0.418  Sum_probs=208.0

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-----CCCcEEEEEeCCCCCh---HHHHHHHHHHhcCCCCceeeeccceec--CCe
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQE--NNL  144 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~  144 (380)
                      ..++|++.+.||+|+||.||+|+.     .+++.||+|+......   +.+.+|++++++++||||+++++++..  ...
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            346788999999999999999984     3688999998765543   467899999999999999999999854  356


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .++||||+++|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        88 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHH----CGGGCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             eEEEEEeCCCCCHHHHHHh----cccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            8999999999999999842    23458999999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCC-CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc----
Q 016917          225 NFLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD----  299 (380)
Q Consensus       225 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----  299 (380)
                      ........ ........++..|+|||.+.+..++.++||||||+++|||++|..|+......    ..........    
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~  237 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMI  237 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccchh
Confidence            87654321 12233445777899999999999999999999999999999999987643210    0000000000    


Q ss_pred             ccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          300 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      .......+........+..+++++.+++.+||+.||++|||+.++++.|+++.++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            0011112222223345666778899999999999999999999999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.3e-46  Score=350.78  Aligned_cols=246  Identities=23%  Similarity=0.272  Sum_probs=206.1

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|++.+.||+|+||+||+|+.+ +++.||+|...      ......+.+|..+++.++||||+++++++.+.+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            457889999999999999999965 68999999753      34556788999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           84 MEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999999998883     34568899999999999999999999  779999999999999999999999999998643


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ...  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.....   ......+..            
T Consensus       157 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~------------  219 (337)
T 1o6l_A          157 SDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILM------------  219 (337)
T ss_dssp             CTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH------------
T ss_pred             cCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---HHHHHHHHc------------
Confidence            211  223456789999999999999999999999999999999999999975431   111111111            


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                      .  ...++...++++.+++.+||+.||.+||     ++++++++
T Consensus       220 ~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          220 E--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            1  1124445668899999999999999999     89999876

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.2e-47  Score=372.14  Aligned_cols=260  Identities=25%  Similarity=0.444  Sum_probs=217.0

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECC-CcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      +...+|++.+.||+|+||.||+|..+. +..||+|.....  ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            345668888999999999999999764 889999986543  46789999999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++|+|.+++...   ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       297 ~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          297 FMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             CCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             ccCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            99999999998432   33568899999999999999999999  77999999999999999999999999999876542


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      .. .......+|..|+|||++.+..++.++|||||||++|||++ |..||......   ...+.+             ..
T Consensus       372 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~~-------------~~  434 (495)
T 1opk_A          372 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL-------------EK  434 (495)
T ss_dssp             CE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH-------------HT
T ss_pred             ce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH-------------Hc
Confidence            21 12234456778999999999999999999999999999999 99999865432   222221             22


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      ......+..+++++.+|+.+||+.||.+|||+.++++.|+.++...
T Consensus       435 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~  480 (495)
T 1opk_A          435 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  480 (495)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence            2233445567788999999999999999999999999999887553

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6e-47  Score=349.45  Aligned_cols=267  Identities=24%  Similarity=0.397  Sum_probs=215.5

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEE------CCCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeeeccceecC
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQEN  142 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  142 (380)
                      ...++|++.+.||+|+||.||+|+.      .++..||+|......    .+.+.+|+.+++++ +||||+++++++...
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            3456788999999999999999984      346789999865443    35688999999999 999999999999999


Q ss_pred             CeeEEEEEeecCCCccccccCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQ-------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL  209 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nil  209 (380)
                      +..++||||+++|+|.+++.....             .....+++..++.++.|++.||.|||+  ++|+||||||+||+
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil  177 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNIL  177 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEE
Confidence            999999999999999998854321             112358999999999999999999999  67999999999999


Q ss_pred             eCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcc
Q 016917          210 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQ  288 (380)
Q Consensus       210 i~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~  288 (380)
                      ++.++.+||+|||++................+|..|+|||.+.+..++.++||||||+++|||++ |..||......  .
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~  255 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--S  255 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--H
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch--h
Confidence            99999999999999987755432222334456778999999999999999999999999999999 99999765432  1


Q ss_pred             cHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcc
Q 016917          289 DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  357 (380)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~  357 (380)
                      .......             .......+...++++.+++.+||+.||.+|||+.++++.|++++.+..+
T Consensus       256 ~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  311 (313)
T 1t46_A          256 KFYKMIK-------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN  311 (313)
T ss_dssp             HHHHHHH-------------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred             HHHHHhc-------------cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence            1111111             1111223344567899999999999999999999999999999877543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.7e-46  Score=363.90  Aligned_cols=256  Identities=29%  Similarity=0.426  Sum_probs=211.2

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCC-CChHHHHHHHHHHhcCCCCceeeeccceecCC-eeEEEEEe
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG-APTQEFIDEVCFLASIQHRNLVTLLGYCQENN-LQFLIYEY  151 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  151 (380)
                      +..++|++.+.||+|+||.||+|... +..||+|.... ...+.+.+|+.++++++||||+++++++...+ ..++||||
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            44567888999999999999999986 77999998554 35677999999999999999999999987654 78999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++|+|.+++...   ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus       269 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  342 (450)
T ss_dssp             CTTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             cCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence            9999999999432   22347889999999999999999999  77999999999999999999999999999854322 


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                          .....++..|+|||++.+..++.++|||||||++|||++ |..||......   +....+.             ..
T Consensus       343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~-------------~~  402 (450)
T 1k9a_A          343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVE-------------KG  402 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT---THHHHHH-------------TT
T ss_pred             ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH-------------cC
Confidence                122356778999999999999999999999999999998 99999865432   2222211             11


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                      .+...+..+++++.+++.+||+.||.+|||+.++++.|+.+...+.
T Consensus       403 ~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l  448 (450)
T 1k9a_A          403 YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL  448 (450)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence            2234556677889999999999999999999999999998876543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.4e-47  Score=368.41  Aligned_cols=260  Identities=24%  Similarity=0.434  Sum_probs=213.8

Q ss_pred             HHHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCC--CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        72 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      +.+..++|++.+.||+|+||.||+|..+++..||+|....  ...+.+.+|+.++++++||||+++++++. .+..++||
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence            3445667888999999999999999998889999998654  34678999999999999999999999987 56689999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++...   ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus       262 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             CCCTTCBHHHHHHSH---HHHTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             eecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            999999999998432   22367888999999999999999999  6799999999999999999999999999987644


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      .... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||.....   .+....+.             
T Consensus       337 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~-------------  399 (454)
T 1qcf_A          337 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALE-------------  399 (454)
T ss_dssp             HHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHH-------------
T ss_pred             Ccee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH-------------
Confidence            2211 1223446778999999999999999999999999999999 9999976432   11111111             


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      .......+..+++++.+++.+||+.||++|||++++++.|+++...
T Consensus       400 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          400 RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            1122334556678899999999999999999999999999988754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-46  Score=354.02  Aligned_cols=249  Identities=20%  Similarity=0.284  Sum_probs=203.5

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC---------ChHHHHHHHHHHhcCCCCceeeeccceecCCee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      .+.|++.+.||+|+||.||+|..+ +|..||+|.....         ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            356889999999999999999965 6899999974322         246789999999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC----ceEEccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADA  221 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~----~~kl~DF  221 (380)
                      ++||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~gg~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           91 VLILELVSGGELFDFLA-----QKESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHT-----TCSCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            99999999999999983     34568999999999999999999999  6799999999999998776    7999999


Q ss_pred             ccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc
Q 016917          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       222 gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                      |++.......   ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.....   ......+.... . 
T Consensus       164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~-~-  235 (361)
T 2yab_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANITAVS-Y-  235 (361)
T ss_dssp             SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHTTC-C-
T ss_pred             CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcC-C-
Confidence            9998765422   23455799999999999999999999999999999999999999976432   11111111100 0 


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                          ..++..+    ...++++.+|+.+||..||.+|||+.+++++
T Consensus       236 ----~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          236 ----DFDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             ----CCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ----CCCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                0011111    1234678999999999999999999999965

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.5e-46  Score=347.06  Aligned_cols=263  Identities=22%  Similarity=0.365  Sum_probs=201.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      .++|++.+.||+|+||+||+|...+++.||+|+.....     ...+.+|++++++++||||+++++++.+.+..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            46799999999999999999999889999999754322     3567899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++ +|.+.+..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++......
T Consensus       100 ~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A          100 FMEK-DLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             CCSE-EHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             CCCC-CHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            9986 67666632    34558999999999999999999999  77999999999999999999999999999876432


Q ss_pred             CCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh----
Q 016917          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK----  305 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----  305 (380)
                      .  .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+...................    
T Consensus       173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          173 V--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             C--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             c--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence            2  12234567899999999876 5689999999999999999999999987654332111111110000000000    


Q ss_pred             ---------hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          306 ---------ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       306 ---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                               ......+.......++++.+|+.+||+.||.+|||++|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                     000011111122345678999999999999999999999975

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.4e-46  Score=342.12  Aligned_cols=257  Identities=26%  Similarity=0.434  Sum_probs=199.2

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECC----CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      ..++|++.+.||+|+||.||+|....    +..||+|......    .+.+.+|+.++++++||||+++++++. .+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            45678889999999999999998643    4579999865432    345788999999999999999999985 45679


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +||||+++++|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++..
T Consensus        92 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHEEECCCCCEEECccccccc
Confidence            99999999999998842    23468899999999999999999999  7799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......   +....+...        
T Consensus       166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i~~~--------  233 (281)
T 1mp8_A          166 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIENG--------  233 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHTT--------
T ss_pred             cCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHHHcC--------
Confidence            6543221 2233456778999999999999999999999999999996 99999865432   222222111        


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                           .....+..+++++.+++.+||+.||.+|||+.++++.|+++++++
T Consensus       234 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          234 -----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                 112344556688999999999999999999999999999998764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.6e-46  Score=347.32  Aligned_cols=263  Identities=16%  Similarity=0.200  Sum_probs=213.5

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC-CCChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP-GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      .++|++.+.||+|+||.||+|.. .+++.||+|... ....+.+.+|+++++.+ +||||+++++++...+..++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            45788999999999999999995 578999999754 33445688999999999 9999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc-----eEEccccccccc
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI-----AKVADAGLRNFL  227 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~-----~kl~DFgla~~~  227 (380)
                       +++|.+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.     +||+|||+++..
T Consensus        88 -~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           88 -GPSLEDLFDL----CDRTFSLKTVLMIAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             -CCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence             8899998842    24578999999999999999999999  67999999999999998887     999999999876


Q ss_pred             CCCCCC-----CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc
Q 016917          228 GRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  302 (380)
Q Consensus       228 ~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (380)
                      ......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  240 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP  240 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence            443221     123456799999999999999999999999999999999999999998654443333332221111000


Q ss_pred             hhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      .     +.    ....++ ++.+++..||+.||.+||++.++++.|+++.++.
T Consensus       241 ~-----~~----~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          241 I-----EV----LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             H-----HH----HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             H-----HH----HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            0     00    011123 7999999999999999999999999999988774

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.8e-46  Score=339.61  Aligned_cols=264  Identities=17%  Similarity=0.222  Sum_probs=215.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC-CCChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP-GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      .++|++.+.||+|+||.||+|.. .+++.||+|... ....+.+.+|+.+++.+ +|+|++++++++......++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            46789999999999999999995 578999999754 33456788999999999 7999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc-----eEEccccccccc
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI-----AKVADAGLRNFL  227 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~-----~kl~DFgla~~~  227 (380)
                       +++|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.     +||+|||++...
T Consensus        89 -~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           89 -GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             -CCCHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence             8899999842    23458999999999999999999999  77999999999999987765     999999999876


Q ss_pred             CCCCCC-----CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc
Q 016917          228 GRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  302 (380)
Q Consensus       228 ~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (380)
                      ......     .......||..|+|||.+.+..++.++|||||||++|||++|+.||..............+........
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  241 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence            543221     123456789999999999999999999999999999999999999988665444333333222211111


Q ss_pred             hhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      ..         .....+++++.+++.+||+.||.+|||++++++.|++++++.
T Consensus       242 ~~---------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~  285 (298)
T 1csn_A          242 LR---------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  285 (298)
T ss_dssp             HH---------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HH---------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence            11         111234578999999999999999999999999999998764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=354.68  Aligned_cols=247  Identities=23%  Similarity=0.342  Sum_probs=205.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|... +++.||+|...      ......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            457889999999999999999964 58899999743      33456788999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+.+|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++....
T Consensus        94 ~e~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQ-----QNVHFKEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             ECCCTTEEHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            99999999999883     34568999999999999999999999  779999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCccceeccccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ..   .......||+.|+|||++.+   ..|+.++|||||||++|||++|+.||.................         
T Consensus       167 ~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---------  234 (384)
T 4fr4_A          167 RE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---------  234 (384)
T ss_dssp             TT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---------
T ss_pred             CC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---------
Confidence            32   22345679999999999864   4689999999999999999999999986554333222222111         


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCC-HHHHHH
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-MSDVVT  346 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~~ll~  346 (380)
                           ....++..+++++.+++.+||+.||.+||+ ++++++
T Consensus       235 -----~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          235 -----TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -----CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -----cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                 112344556688999999999999999998 666654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=343.48  Aligned_cols=247  Identities=24%  Similarity=0.318  Sum_probs=196.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC-----------------------------hHHHHHHHHHHh
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----------------------------TQEFIDEVCFLA  125 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----------------------------~~~~~~E~~~l~  125 (380)
                      .++|++.+.||+|+||.||+|.. .+++.||+|......                             .+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46799999999999999999995 468899999743221                             246889999999


Q ss_pred             cCCCCceeeeccceec--CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 016917          126 SIQHRNLVTLLGYCQE--NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF  203 (380)
Q Consensus       126 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDi  203 (380)
                      +++||||+++++++.+  .+..++||||+++++|.+++      ....+++..+..++.|++.||.|||+  ++|+||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP------TLKPLSEDQARFYFQDLIKGIEYLHY--QKIIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS------CSSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCC
Confidence            9999999999999976  56889999999999998765      34568999999999999999999999  67999999


Q ss_pred             CCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCC---CCcchhhHHHHHHHHHHHcCCCCCC
Q 016917          204 KTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASS  280 (380)
Q Consensus       204 kp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~DvwSlG~il~el~tg~~p~~  280 (380)
                      ||+|||++.++.+||+|||++........  ......||+.|+|||.+.+..   ++.++|||||||++|+|++|+.||.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            99999999999999999999987654221  123457899999999988765   3788999999999999999999997


Q ss_pred             CCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          281 SLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....   ......+..            .....+.....++++.+++.+||+.||++|||+.+++++
T Consensus       242 ~~~~---~~~~~~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          242 DERI---MCLHSKIKS------------QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             CSSH---HHHHHHHHH------------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CccH---HHHHHHHhc------------ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            5431   111111110            001111122345779999999999999999999999865

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-47  Score=352.96  Aligned_cols=266  Identities=25%  Similarity=0.372  Sum_probs=212.2

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEE------CCCcEEEEEeCCCC----ChHHHHHHHHHHhcC-CCCceeeeccceec
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGA----PTQEFIDEVCFLASI-QHRNLVTLLGYCQE  141 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  141 (380)
                      ....++|++.+.||+|+||.||+|..      .++..||+|.....    ..+.+.+|+.+++++ +||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            34567899999999999999999995      24568999985432    345788999999999 89999999999999


Q ss_pred             CCeeEEEEEeecCCCccccccCCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 016917          142 NNLQFLIYEYIPNGSVSIHLYGPSQV------------------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF  203 (380)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDi  203 (380)
                      .+..++||||+++|+|.+++......                  ....+++..++.++.|++.||.|||+  ++|+||||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Di  198 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDL  198 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEETTC
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCC
Confidence            99999999999999999998543211                  01347899999999999999999999  77999999


Q ss_pred             CCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCC
Q 016917          204 KTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL  282 (380)
Q Consensus       204 kp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~  282 (380)
                      ||+|||++.++.+||+|||++................+|..|+|||.+.+..++.++|||||||++|||+| |..||...
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999999987654332222334456788999999999999999999999999999998 99999865


Q ss_pred             CCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          283 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      ...  ......+.             .......+..+++++.+++.+||+.||.+|||+.+++++|+.++...
T Consensus       279 ~~~--~~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          279 PVD--ANFYKLIQ-------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CCS--HHHHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CcH--HHHHHHHh-------------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            432  11111111             11122334455688999999999999999999999999999988654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=342.52  Aligned_cols=270  Identities=20%  Similarity=0.310  Sum_probs=211.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC----CChHHHHHHHHHHhcCCCCceeeeccceecCC--eeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENN--LQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|... +++.||+|....    ...+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            356889999999999999999965 589999998653    34567889999999999999999999987654  77999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----CCCCceEEcccccc
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLR  224 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili----~~~~~~kl~DFgla  224 (380)
                      |||+++++|.+++....  ....+++..++.++.|++.||.|||+  ++|+||||||+|||+    +.++.+||+|||++
T Consensus        88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EeCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            99999999999985431  22348999999999999999999999  779999999999999    78888999999999


Q ss_pred             cccCCCCCCCCCccccCccceecccccc--------cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCc-ccHHHHHH
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKE--------FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-QDLVELVQ  295 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~-~~~~~~~~  295 (380)
                      +......   ......+|..|+|||++.        +..++.++|||||||++|||++|+.||........ ......+.
T Consensus       164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             EECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             eecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            8765432   223456899999999886        57889999999999999999999999976543222 12222221


Q ss_pred             hhhcccchh---hhc--------ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          296 NSRDFSNLL---KIL--------DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       296 ~~~~~~~~~---~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                      .........   ...        .-......+...++.+.+++.+||+.||++|||++|++++..+-.
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            111110000   000        001112456788899999999999999999999999999987544

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.8e-46  Score=339.34  Aligned_cols=248  Identities=26%  Similarity=0.439  Sum_probs=196.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC-------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|... +..||+|.....       ..+.+.+|+++++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            467888999999999999999975 889999975432       235688999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---eEecCCCCCCeeeCC--------CCceE
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR---VVHKDFKTANVLVDE--------DFIAK  217 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~---ivHrDikp~Nili~~--------~~~~k  217 (380)
                      |||+++++|.+++.      ...+++..++.++.|++.||.|||+  ++   |+||||||+|||++.        ++.+|
T Consensus        85 ~e~~~~~~L~~~~~------~~~~~~~~~~~i~~~l~~~l~~lH~--~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k  156 (271)
T 3dtc_A           85 MEFARGGPLNRVLS------GKRIPPDILVNWAVQIARGMNYLHD--EAIVPIIHRDLKSSNILILQKVENGDLSNKILK  156 (271)
T ss_dssp             EECCTTEEHHHHHT------SSCCCHHHHHHHHHHHHHHHHHHHH--SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred             EEcCCCCCHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHh--CCCCceeecCCchHHEEEecccccccccCcceE
Confidence            99999999998882      4568999999999999999999999  66   899999999999986        67899


Q ss_pred             EcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhh
Q 016917          218 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS  297 (380)
Q Consensus       218 l~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  297 (380)
                      |+|||++.......    .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......   ....     
T Consensus       157 l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~-----  224 (271)
T 3dtc_A          157 ITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL---AVAY-----  224 (271)
T ss_dssp             ECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHH-----
T ss_pred             EccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH-----
Confidence            99999998654422    22456889999999999999999999999999999999999999764321   1100     


Q ss_pred             hcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                             ...........+..+++.+.+++.+||+.||.+|||+.+++++|+++
T Consensus       225 -------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          225 -------GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -------hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                   11111222334455668899999999999999999999999999753

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-46  Score=339.12  Aligned_cols=256  Identities=28%  Similarity=0.423  Sum_probs=211.9

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeec
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      .++|++.+.||+|+||.||+|...++..||+|.....  ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            4578889999999999999999988899999986543  45678999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                      +++|.+++..    ....+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++........ 
T Consensus        87 ~~~L~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  159 (267)
T 3t9t_A           87 HGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  159 (267)
T ss_dssp             TCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCcHHHHHhh----CcccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence            9999998842    23568899999999999999999999  7799999999999999999999999999986643211 


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                      .......++..|+|||++.+..++.++||||||+++|+|++ |+.||.....   ......+..             ...
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~i~~-------------~~~  223 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDIST-------------GFR  223 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHT-------------TCC
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHHHHHHhc-------------CCc
Confidence            11233456778999999999999999999999999999999 8999876432   111111111             111


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      ...+...++++.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            223334567899999999999999999999999999998764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.3e-45  Score=342.28  Aligned_cols=245  Identities=20%  Similarity=0.309  Sum_probs=202.1

Q ss_pred             CCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC---CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      |...+.||+|+||.||+|... +|+.||+|...   ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            566678999999999999975 79999999743   33456788999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG  234 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~  234 (380)
                      ++|.+++.      ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.......  .
T Consensus       127 ~~L~~~l~------~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~  196 (321)
T 2c30_A          127 GALTDIVS------QVRLNEEQIATVCEAVLQALAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P  196 (321)
T ss_dssp             CBHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--C
T ss_pred             CCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--c
Confidence            99999873      3468999999999999999999999  779999999999999999999999999988765422  1


Q ss_pred             CCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       235 ~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ......+....         .+.  ..
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~~~~~~~~---------~~~--~~  262 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSP---------PPK--LK  262 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSS---------CCC--CT
T ss_pred             ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCC---------CCC--cC
Confidence            23456789999999999999999999999999999999999999975432   11111111110         000  11


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .+...++++.+++.+||+.||++|||+.+++++
T Consensus       263 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          263 NSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            122345779999999999999999999999975

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=348.92  Aligned_cols=258  Identities=24%  Similarity=0.417  Sum_probs=203.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCc----EEEEEeCC----CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRP----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      .++|++.+.||+|+||.||+|... ++.    +|++|...    ....+.+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            467899999999999999999954 343    45777643    334567899999999999999999999998765 78


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +|++|+.+|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++..
T Consensus        93 ~v~~~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEECCCSSCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             EEEEecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhh--CCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            99999999999998842    24568899999999999999999999  6799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ..............+|..|+|||.+.+..|+.++|||||||++|||++ |..||......   .....+           
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~-----------  232 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSIL-----------  232 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH-----------
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHH-----------
Confidence            754433333444567888999999999999999999999999999999 99999865432   222211           


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                        ........+..++.++.+++.+||+.||.+|||+.++++.|+++...+.
T Consensus       233 --~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  281 (327)
T 3lzb_A          233 --EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ  281 (327)
T ss_dssp             --HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred             --HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence              1122233445566789999999999999999999999999999987653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.4e-46  Score=348.07  Aligned_cols=265  Identities=25%  Similarity=0.441  Sum_probs=213.9

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC--------CCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeeeccceec
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQE  141 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~  141 (380)
                      ..++|++.+.||+|+||.||+|...        ++..||+|......    .+.+.+|+++++++ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            4567889999999999999999863        46789999876543    24578899999999 89999999999999


Q ss_pred             CCeeEEEEEeecCCCccccccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 016917          142 NNLQFLIYEYIPNGSVSIHLYGPSQV-----------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (380)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili  210 (380)
                      .+..++||||+++|+|.+++......           ....+++..++.++.|++.||.|||+  ++|+||||||+|||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLV  190 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCccceEEE
Confidence            99999999999999999998643221           12358899999999999999999999  779999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCccc
Q 016917          211 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQD  289 (380)
Q Consensus       211 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~  289 (380)
                      +.++.+||+|||++................+|..|+|||++.+..++.++||||||+++|||++ |..||.....   .+
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---HH
Confidence            9999999999999987655333223344567788999999998899999999999999999999 9999976432   11


Q ss_pred             HHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcc
Q 016917          290 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  357 (380)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~  357 (380)
                      ....+..             ......+..+++++.+++.+||+.||.+|||+.++++.|++++.....
T Consensus       268 ~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          268 LFKLLKE-------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             HHHHHHH-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             HHHHHhc-------------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence            1111111             111233445667899999999999999999999999999999876443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-45  Score=343.15  Aligned_cols=266  Identities=24%  Similarity=0.370  Sum_probs=208.4

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcC--CCCceeeeccceecC----CeeE
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI--QHRNLVTLLGYCQEN----NLQF  146 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~~~  146 (380)
                      ....++|++.+.||+|+||.||+|+.. +..||+|.........+..|.+++..+  +||||+++++++...    ...+
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  111 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY  111 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence            344568999999999999999999986 899999987666666677777777665  899999999998876    7889


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCeeeCCCCceEEcc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL------SPRVVHKDFKTANVLVDEDFIAKVAD  220 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~ivHrDikp~Nili~~~~~~kl~D  220 (380)
                      +||||+++|+|.+++.      ...+++..++.++.|++.||.|||+.      .++|+||||||+|||++.++.+||+|
T Consensus       112 lv~e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          112 LITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             EEECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEeccCCCcHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence            9999999999999983      34688999999999999999999983      12799999999999999999999999


Q ss_pred             cccccccCCCCCC--CCCccccCccceecccccccCCCCcc------hhhHHHHHHHHHHHcC----------CCCCCCC
Q 016917          221 AGLRNFLGRTDVA--GPSSQVTADEIFLASEVKEFRRFSEK------SDVYSFGVFLLELVSG----------REASSSL  282 (380)
Q Consensus       221 Fgla~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~------~DvwSlG~il~el~tg----------~~p~~~~  282 (380)
                      ||++.........  .......||..|+|||++.+..++..      +|||||||++|||++|          ..||...
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            9999766442221  12234578999999999988776665      9999999999999999          6666654


Q ss_pred             CCCCcccHHHHHHhhhcccchhhhcccccccCCC-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          283 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFT-----NEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      ......  .........        .......++     ..+++++.+++.+||+.||.+|||+.+++++|+++.+..
T Consensus       266 ~~~~~~--~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          266 VPSDPS--YEDMREIVC--------IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             SCSSCC--HHHHHHHHT--------TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cCCCCc--hhhhHHHHh--------hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            332211  111111110        011111222     367889999999999999999999999999999988653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.7e-46  Score=364.09  Aligned_cols=258  Identities=26%  Similarity=0.448  Sum_probs=208.1

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +..++|++.+.||+|+||.||+|..+.+..||+|.....  ..+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            445678888999999999999999988888999986643  45679999999999999999999999876 668999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++|+|.+++...   ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++......
T Consensus       260 ~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          260 MSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             CTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             hcCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            9999999998421   23458899999999999999999999  779999999999999999999999999998765422


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      . .......+|..|+|||.+.+..++.++|||||||++|||++ |+.||.....   .+....+             ...
T Consensus       335 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i-------------~~~  397 (452)
T 1fmk_A          335 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQV-------------ERG  397 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHH-------------HTT
T ss_pred             e-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHH-------------HcC
Confidence            1 12233456788999999999999999999999999999999 9999976432   1111111             111


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      .+...+..+++.+.+++.+||+.||++|||++++++.|+.+...
T Consensus       398 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            22344556778899999999999999999999999999988744

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.9e-46  Score=337.31  Aligned_cols=250  Identities=27%  Similarity=0.437  Sum_probs=203.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCCh----------HHHHHHHHHHhcCCCCceeeeccceecCCe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT----------QEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~----------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  144 (380)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.......          +.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            46788899999999999999996 5789999998543221          56889999999999999999999997665 


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeeCCCCc-----eE
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR--VVHKDFKTANVLVDEDFI-----AK  217 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~--ivHrDikp~Nili~~~~~-----~k  217 (380)
                       ++||||+++|+|.+.+..    ....+++..++.++.|++.||.|||+  .+  |+||||||+|||++.++.     +|
T Consensus        97 -~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQN--QNPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHT--SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             -eEEEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHh--CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence             699999999999888742    34568999999999999999999999  66  999999999999988776     99


Q ss_pred             EcccccccccCCCCCCCCCccccCccceeccccc--ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH
Q 016917          218 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK--EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  295 (380)
Q Consensus       218 l~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~  295 (380)
                      |+|||++.....     ......+|..|+|||++  ....++.++|||||||++|||++|+.||.......... .... 
T Consensus       170 l~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~-  242 (287)
T 4f0f_A          170 VADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-INMI-  242 (287)
T ss_dssp             ECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-HHHH-
T ss_pred             eCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-HHHH-
Confidence            999999875433     23445688999999998  44567899999999999999999999998654321110 1111 


Q ss_pred             hhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                                 .........+..+++++.+++.+||+.||.+|||+.++++.|+++
T Consensus       243 -----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          243 -----------REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             -----------HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             -----------hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                       111222344556678899999999999999999999999999764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-46  Score=345.57  Aligned_cols=243  Identities=21%  Similarity=0.315  Sum_probs=204.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|+.. +++.||+|....      ...+.+.+|..+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            457889999999999999999965 689999997532      3456688899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus        85 ~e~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           85 MDYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             ECCCCSCBHHHHHH-----HTSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EeCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            99999999999983     34568899999999999999999999  679999999999999999999999999998754


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ..     .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.....   ......+.            .
T Consensus       158 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~------------~  217 (318)
T 1fot_A          158 DV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTYEKIL------------N  217 (318)
T ss_dssp             SC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHH------------H
T ss_pred             Cc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH------------h
Confidence            32     2345789999999999999999999999999999999999999976432   11111111            1


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                      ..  ..++...++++.+++.+||+.||.+||     ++++++++
T Consensus       218 ~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          218 AE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            11  123445567899999999999999999     88888865

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.4e-46  Score=348.75  Aligned_cols=245  Identities=18%  Similarity=0.257  Sum_probs=204.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|.. .+++.||+|...      ......+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36789999999999999999996 578999999753      23345788999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+ +|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++....
T Consensus        88 ~E~~-~g~l~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           88 IEYA-GGELFDYIV-----EKKRMTEDEGRRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             ECCC-CEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EECC-CCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            9999 678888773     34568999999999999999999999  679999999999999999999999999998765


Q ss_pred             CCCCCCCCccccCccceecccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      ...   ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........                ...+
T Consensus       160 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i  220 (336)
T 3h4j_B          160 DGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKV  220 (336)
T ss_dssp             TSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCC
T ss_pred             CCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHH
Confidence            432   2234568999999999998877 7899999999999999999999976442211                0001


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      .. .....+...++++.+++.+||+.||.+|||++|++++-
T Consensus       221 ~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          221 NS-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             CS-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred             Hc-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence            11 11234445667899999999999999999999999763

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.8e-46  Score=353.57  Aligned_cols=248  Identities=19%  Similarity=0.274  Sum_probs=199.4

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcC-CCCceeeeccceecCCeeE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  146 (380)
                      ..++|++.++||+|+||.||+|+.+ +++.||+|+...      ...+.+..|..++.++ +||||+++++++.+.+..|
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            4567999999999999999999965 578899997432      2334578899999877 8999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +||||+++|+|..++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       130 lV~E~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEcCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            9999999999998883     34678999999999999999999999  6799999999999999999999999999986


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcc--cHHHHHHhhhcccchh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ--DLVELVQNSRDFSNLL  304 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~  304 (380)
                      ....  .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.........  ...+.+..        
T Consensus       203 ~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~--------  272 (396)
T 4dc2_A          203 GLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--------  272 (396)
T ss_dssp             CCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH--------
T ss_pred             cccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH--------
Confidence            3221  12345567999999999999999999999999999999999999999754322111  00010000        


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM  341 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~  341 (380)
                      .+...  ...++...++++.+|+.+||+.||.+||++
T Consensus       273 ~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          273 VILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             HHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            00111  123455567889999999999999999996

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7.6e-47  Score=354.65  Aligned_cols=248  Identities=20%  Similarity=0.291  Sum_probs=200.7

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcC-CCCceeeeccceecCCee
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  145 (380)
                      ...++|++.+.||+|+||.||+|+.+ +++.||+|+...      .....+..|..+++.+ +||||+++++++.+.+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            45678999999999999999999965 589999997542      3445678899999988 799999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      |+||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       100 ~lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NILl~~~g~ikL~DFG~a~  172 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQ-----KSRRFDEARARFYAAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCK  172 (353)
T ss_dssp             EEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCCHHHEEECCCCCEEEcccccee
Confidence            99999999999998883     34668999999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ......  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.....   .+....+..         
T Consensus       173 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~---------  238 (353)
T 3txo_A          173 EGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEAILN---------  238 (353)
T ss_dssp             CSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH---------
T ss_pred             ecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---HHHHHHHHc---------
Confidence            543221  223456799999999999999999999999999999999999999976432   112211111         


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCH------HHHHHH
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM------SDVVTE  347 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~------~~ll~~  347 (380)
                         .  ...++...++++.+++.+||+.||.+||++      ++++++
T Consensus       239 ---~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          239 ---D--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             ---C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             ---C--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence               1  113344566789999999999999999998      777764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.5e-46  Score=342.11  Aligned_cols=260  Identities=25%  Similarity=0.387  Sum_probs=203.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC-ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      .++|++.+.||+|+||.||+|... ++.||+|..... ..+.+.+|++++++++||||+++++++.+  ..++||||+++
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~   83 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG   83 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence            356888899999999999999985 788999987544 35678999999999999999999999874  37899999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCCeeeCCCCc-eEEcccccccccCCCCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS-PRVVHKDFKTANVLVDEDFI-AKVADAGLRNFLGRTDV  232 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-~~ivHrDikp~Nili~~~~~-~kl~DFgla~~~~~~~~  232 (380)
                      |+|.+++....  ....+++..++.++.|++.||.|||+.+ ++|+||||||+|||++.++. +||+|||++......  
T Consensus        84 ~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           84 GSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             CBHHHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCHHHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999985432  2235788899999999999999999843 47999999999999988876 799999998765432  


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                         .....||..|+|||++.+..++.++||||||+++|||++|+.||.......    ........          ....
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~----------~~~~  222 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVH----------NGTR  222 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHH----------TTCC
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHh----------cCCC
Confidence               223458899999999999999999999999999999999999997644321    11111000          0111


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcccc
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT  359 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~~~  359 (380)
                      ...+..+++.+.+++.+||+.||.+|||+.++++.|+.+.+......
T Consensus       223 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  269 (307)
T 2eva_A          223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD  269 (307)
T ss_dssp             CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred             CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence            22334456779999999999999999999999999999887654433

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.7e-46  Score=339.66  Aligned_cols=259  Identities=26%  Similarity=0.455  Sum_probs=211.5

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +..++|++.+.||+|+||.||+|...++..||+|.....  ..+.+.+|+++++.++||||+++++++.. +..++||||
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            345678889999999999999999888889999975533  56778999999999999999999999874 457999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++...   ....+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++.......
T Consensus        89 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           89 MENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             CTTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             CCCCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            9999999998421   12368899999999999999999999  679999999999999999999999999998765432


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      .. ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....   .+....+..             .
T Consensus       164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~-------------~  226 (279)
T 1qpc_A          164 YT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLER-------------G  226 (279)
T ss_dssp             EE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHT-------------T
T ss_pred             cc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHHHHhc-------------c
Confidence            21 2233456778999999998899999999999999999999 8999876432   111111111             1


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      .....+..+++++.+++.+||+.||++|||+.++++.|+++....
T Consensus       227 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            112233455678999999999999999999999999999988653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.5e-47  Score=345.21  Aligned_cols=261  Identities=25%  Similarity=0.438  Sum_probs=216.4

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ...++|++.+.||+|+||.||+|... ++..||+|.....  ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            35667888999999999999999965 4889999986544  34678899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++++|.+++...   ....+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++......
T Consensus        90 ~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           90 FMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             CCTTEEHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHHH--HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             cCCCCcHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHHH--CCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            99999999998432   34568999999999999999999999  67999999999999999999999999999876542


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      .. .......+|..|+|||.+.+..++.++||||||+++|+|++ |..||......   ...+.+.             .
T Consensus       165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~~-------------~  227 (288)
T 3kfa_A          165 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLE-------------K  227 (288)
T ss_dssp             SS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHH-------------T
T ss_pred             cc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh-------------c
Confidence            21 12233456778999999999999999999999999999999 99998765432   2222211             1


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                      ......+..+++++.+++.+||+.||.+|||+.++++.|+++..+..
T Consensus       228 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          228 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            12223445566889999999999999999999999999999987754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-46  Score=347.71  Aligned_cols=251  Identities=20%  Similarity=0.242  Sum_probs=204.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC--hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      .++|++.+.||+|+||.||+|... ++..+|+|......  ...+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            357889999999999999999965 58899999865443  345789999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC--CCceEEcccccccccCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~--~~~~kl~DFgla~~~~~~  230 (380)
                      ++|+|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.  ++.+||+|||++......
T Consensus        84 ~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           84 SGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            99999998832    23468999999999999999999999  67999999999999987  789999999999876442


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      .   ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.....   ......+......      ....
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~------~~~~  225 (321)
T 1tki_A          158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMNAEYT------FDEE  225 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCCC------CCHH
T ss_pred             C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHcCCCC------CChh
Confidence            2   22345689999999999998899999999999999999999999976432   1122111111100      0001


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      .+    ...++++.+++.+||+.||.+|||+.|++++-
T Consensus       226 ~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          226 AF----KEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             HH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             hh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence            11    12356799999999999999999999999863

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1e-46  Score=349.53  Aligned_cols=269  Identities=23%  Similarity=0.378  Sum_probs=215.1

Q ss_pred             HHHHHHhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccce
Q 016917           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYC  139 (380)
Q Consensus        70 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~  139 (380)
                      +++....++|++.+.||+|+||.||+|...      ++..||+|......    ...+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344455678999999999999999999854      36789999876443    23578899999999999999999999


Q ss_pred             ecCCeeEEEEEeecCCCccccccCCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC
Q 016917          140 QENNLQFLIYEYIPNGSVSIHLYGPSQ-----VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF  214 (380)
Q Consensus       140 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~  214 (380)
                      .+.+..++||||+++|+|.+++.....     .....+++..++.++.|++.||.|||+  ++|+||||||+||+++.++
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTC
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCCccCCCccceEEEcCCC
Confidence            999999999999999999998843211     112456889999999999999999999  6799999999999999999


Q ss_pred             ceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHH
Q 016917          215 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVEL  293 (380)
Q Consensus       215 ~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~  293 (380)
                      .+||+|||++................+|..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .+....
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~  252 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRF  252 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHHHHH
Confidence            999999999987644332222233456788999999999999999999999999999999 8899876432   111111


Q ss_pred             HHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          294 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                      +..             ......+..+++.+.+++.+||+.||.+|||+.+++++|++.+....
T Consensus       253 ~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~  302 (322)
T 1p4o_A          253 VME-------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF  302 (322)
T ss_dssp             HHT-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred             HHc-------------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCC
Confidence            111             11123344566789999999999999999999999999998876543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.1e-46  Score=341.07  Aligned_cols=260  Identities=24%  Similarity=0.337  Sum_probs=199.1

Q ss_pred             CCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      ++|++.+.||+|+||.||+|...+++.||+|+....     ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            468889999999999999999988999999975432     235688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++ +|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CSE-EHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cCC-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            986 88777732    23568899999999999999999999  779999999999999999999999999987654321


Q ss_pred             CCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc-----ccchhh
Q 016917          232 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-----FSNLLK  305 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  305 (380)
                        .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......  ..+.........     ......
T Consensus       155 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          155 --RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             --cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHCCCChhhchhhhc
Confidence              112344678899999998764 5899999999999999999999999764321  111111111000     000000


Q ss_pred             --hcc-------cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          306 --ILD-------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       306 --~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                        ..+       +..+..+....++++.+++.+||+.||++|||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence              000       011112223456789999999999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.5e-46  Score=335.68  Aligned_cols=252  Identities=25%  Similarity=0.367  Sum_probs=204.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecC--CeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN--NLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|+.. +..||+|......     .+.+.+|+.++++++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            457888999999999999999986 8889999855332     34688999999999999999999999876  788999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++|+|.+++...   ....+++..++.++.|++.||.|||+.+..|+||||||+||+++.++.++|+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            9999999999999532   2235899999999999999999999832339999999999999999999999998865432


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCc---chhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSE---KSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      .       ....+|+.|+|||.+.+..++.   ++|||||||++|||++|+.||......   ...            ..
T Consensus       165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~------------~~  222 (271)
T 3kmu_A          165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM---EIG------------MK  222 (271)
T ss_dssp             C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH---HHH------------HH
T ss_pred             c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH---HHH------------HH
Confidence            2       2346788999999998765554   799999999999999999999754321   111            11


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhh
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  353 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~  353 (380)
                      ..........+..+++++.+++.+||+.||++|||++++++.|+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          223 VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            111122234455567889999999999999999999999999998865

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.9e-46  Score=345.28  Aligned_cols=248  Identities=21%  Similarity=0.292  Sum_probs=202.2

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC---------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      +.|++.+.||+|+||.||+|... ++..||+|.....         ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45888999999999999999965 6889999964321         3467899999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC----ceEEcccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADAG  222 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~----~~kl~DFg  222 (380)
                      +||||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++    .+||+|||
T Consensus        91 lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           91 LILELVAGGELFDFLA-----EKESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEECCCSCBHHHHHT-----TSSCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCCCHHHHHH-----hcCCcCHHHHHHHHHHHHHHHHHHHH--CCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            9999999999999983     34568999999999999999999999  6799999999999998877    89999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  302 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (380)
                      ++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....   ......+.... .. 
T Consensus       164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~-~~-  235 (326)
T 2y0a_A          164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANVSAVN-YE-  235 (326)
T ss_dssp             TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHTC-CC-
T ss_pred             CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHHHhcC-CC-
Confidence            998764322   22345689999999999999999999999999999999999999975432   11111111100 00 


Q ss_pred             hhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                          .....    ....++.+.+++.+||+.||.+|||+.+++++
T Consensus       236 ----~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          236 ----FEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             ----CCHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ----cCccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                00001    11234678999999999999999999999985

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.3e-46  Score=361.93  Aligned_cols=260  Identities=22%  Similarity=0.268  Sum_probs=207.7

Q ss_pred             HHHHHHHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceec
Q 016917           69 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQE  141 (380)
Q Consensus        69 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  141 (380)
                      ..++....++|++.++||+|+||+||+|+.+ +++.||+|+...      .....+.+|..++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            3445556788999999999999999999965 478999997542      233458899999999999999999999999


Q ss_pred             CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccc
Q 016917          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (380)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DF  221 (380)
                      .+..|+||||+++|+|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~----~~~~l~e~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSK----FEDRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHH----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeeEcCCCCEEEcch
Confidence            9999999999999999999842    24568999999999999999999999  67999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCccccCccceecccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh
Q 016917          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  296 (380)
Q Consensus       222 gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  296 (380)
                      |+++....... .......||+.|+|||++.     ...|+.++|||||||++|||++|+.||.....   .+....+..
T Consensus       220 Gla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~  295 (437)
T 4aw2_A          220 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMN  295 (437)
T ss_dssp             TTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHT
T ss_pred             hhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---hHHHHhhhh
Confidence            99976644221 1123457999999999987     46789999999999999999999999986432   111111111


Q ss_pred             hhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 016917          297 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE  347 (380)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~~ll~~  347 (380)
                      ...     ..    ..+......++++.+|+.+||..+|++  ||++++++++
T Consensus       296 ~~~-----~~----~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          296 HKE-----RF----QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHH-----HC----CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ccc-----cc----cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            000     00    001111235678999999999998888  9999999876

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-46  Score=348.06  Aligned_cols=267  Identities=25%  Similarity=0.395  Sum_probs=211.9

Q ss_pred             CCCCCeeccCCceEEEEEEEC-----CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceec--CCeeEE
Q 016917           79 FSDKNLIGEGKFGEVYKGLLQ-----DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFL  147 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  147 (380)
                      |++.+.||+|+||.||++.+.     +++.||+|+.....    .+.+.+|++++++++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488899999999999998743     57899999866543    3457899999999999999999999987  467899


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+++|+|.+++.      ...+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++...
T Consensus       113 v~e~~~~~~L~~~l~------~~~~~~~~~~~i~~~l~~~l~~LH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLP------RHSIGLAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EECCCTTCBHHHHGG------GSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEecccCCcHHHHHh------hCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEEcCCCCEEECCccccccc
Confidence            999999999999983      2348999999999999999999999  67999999999999999999999999999876


Q ss_pred             CCCCC-CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH---Hhhhcccch
Q 016917          228 GRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV---QNSRDFSNL  303 (380)
Q Consensus       228 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~  303 (380)
                      ..... ........+|..|+|||.+.+..++.++||||||+++|+|++|..||......    .....   ........+
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK----FLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh----hhhhhcccccchhHHHH
Confidence            54321 12233455788899999999999999999999999999999999998643210    00000   000011112


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcc
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  357 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~  357 (380)
                      ...+........+..+++++.+++.+||+.||.+|||+.++++.|+++.++..+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  314 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG  314 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence            223333334455666778899999999999999999999999999999877654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=350.88  Aligned_cols=251  Identities=20%  Similarity=0.304  Sum_probs=198.0

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--C---hHHHHHHHHHHhcCCC--CceeeeccceecCCeeEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--P---TQEFIDEVCFLASIQH--RNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~---~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l  147 (380)
                      ..++|++.+.||+|+||.||++...+++.||+|.....  .   .+.+.+|+.++++++|  |||+++++++...+..++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            34568999999999999999999888999999975422  2   2467889999999976  999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||| +.+++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++ ++.+||+|||+++..
T Consensus        87 v~e-~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~--~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           87 VME-CGNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEC-CCSEEHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEe-CCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            999 56779999883     34668899999999999999999999  6799999999999997 578999999999877


Q ss_pred             CCCCCCCCCccccCccceeccccccc-----------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEF-----------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  296 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  296 (380)
                      .............||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....     ...    
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~----  228 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QIS----  228 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHH----
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHH----
Confidence            54333333345679999999999865           6789999999999999999999999975332     111    


Q ss_pred             hhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          297 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                           .+....+......++...++++.+++.+||+.||.+|||+.+++++.
T Consensus       229 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          229 -----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             -----HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -----HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence                 11122222233344444557899999999999999999999999874

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.7e-47  Score=360.81  Aligned_cols=256  Identities=21%  Similarity=0.277  Sum_probs=206.4

Q ss_pred             HHHHHHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecC
Q 016917           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQEN  142 (380)
Q Consensus        70 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  142 (380)
                      .++....++|++.+.||+|+||+||+|+.+ +++.||+|...      ......+.+|..+++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344455678999999999999999999965 58899999753      23345588999999999999999999999999


Q ss_pred             CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFg  222 (380)
                      +..|+||||+++|+|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~------~~~~~e~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEeCCCCCcHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeeECCCCCEEEeccc
Confidence            99999999999999999883      3458899999999999999999999  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccCC----CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR----FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR  298 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  298 (380)
                      +++....... .......||+.|+|||++.+..    |+.++|||||||++|||++|+.||.....   ......+....
T Consensus       214 ~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~  289 (410)
T 3v8s_A          214 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMNHK  289 (410)
T ss_dssp             TCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTHH
T ss_pred             eeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh---hhHHHHHHhcc
Confidence            9987654221 1123567999999999998765    88999999999999999999999985432   11111111110


Q ss_pred             cccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 016917          299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER--RPSMSDVVTE  347 (380)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~~ll~~  347 (380)
                      .          ....+.....++++.+|+.+||+.+|.+  ||++++++++
T Consensus       290 ~----------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          290 N----------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             H----------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             c----------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            0          0001111235578999999999999988  9999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-46  Score=337.63  Aligned_cols=258  Identities=25%  Similarity=0.386  Sum_probs=209.9

Q ss_pred             CCCCCCC-eeccCCceEEEEEEEC---CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           77 KNFSDKN-LIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        77 ~~~~~~~-~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      ++|.+.+ .||+|+||.||+|...   ++..||+|......    .+.+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4555555 8999999999999853   57789999865532    34578999999999999999999999 45568999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++++|.+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            999999999998842    34568999999999999999999999  679999999999999999999999999998764


Q ss_pred             CCCC-CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          229 RTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       229 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      .... ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||......   +....+..          
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i~~----------  228 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQ----------  228 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHT----------
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHhc----------
Confidence            3221 122334456888999999998899999999999999999998 99999765431   12211111          


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcc
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  357 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~  357 (380)
                         ......+..+++++.+++.+||+.||.+||++.+++++|++++.....
T Consensus       229 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          229 ---GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             ---CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence               112234556678899999999999999999999999999999876543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.5e-46  Score=357.33  Aligned_cols=250  Identities=19%  Similarity=0.222  Sum_probs=202.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      .++|++.+.||+|+||.||+|.. .+++.+|+|......     .+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            45689999999999999999985 468899999754332     345789999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCceEEcccccccc
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNF  226 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~---~~~~~kl~DFgla~~  226 (380)
                      ||+++|+|.+.+.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++   .++.+||+|||++..
T Consensus        90 E~~~gg~L~~~i~-----~~~~~~e~~~~~i~~qil~aL~~lH~--~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           90 DLVTGGELFEDIV-----AREYYSEADASHCIQQILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             CCCBCCBHHHHHH-----HCSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EeCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            9999999998883     34668999999999999999999999  7799999999999998   567899999999987


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      .....  .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.....   ......+.....       
T Consensus       163 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~-------  230 (444)
T 3soa_A          163 VEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRLYQQIKAGAY-------  230 (444)
T ss_dssp             CCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHTCC-------
T ss_pred             ecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhCCC-------
Confidence            65422  122346799999999999999999999999999999999999999975431   112221111110       


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         .........+++++.+++.+||+.||.+|||+.|++++
T Consensus       231 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          231 ---DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             ---CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence               00011112345779999999999999999999999985

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.8e-46  Score=339.41  Aligned_cols=260  Identities=20%  Similarity=0.259  Sum_probs=199.1

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ++|++.+.||+|+||+||+|... +++.||+|.....     ....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57889999999999999999964 6889999974322     23567899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |++++ +.+.+.    .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~~~-l~~~~~----~~~~~l~~~~~~~~~~ql~~~l~~lH~--~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQD-LKKYFD----SCNGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEE-HHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCCC-HHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            99874 444442    234668999999999999999999999  67999999999999999999999999999876432


Q ss_pred             CCCCCCccccCccceecccccccCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc------cch
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF------SNL  303 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~  303 (380)
                      .  .......+|..|+|||++.+.. ++.++|||||||++|||++|..||.....  ..+....+......      ...
T Consensus       155 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~  230 (292)
T 3o0g_A          155 V--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             C--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTG
T ss_pred             c--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhh
Confidence            2  2234456899999999987765 79999999999999999998888654321  11222221111100      000


Q ss_pred             hhhccc---------ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 LKILDE---------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....+.         ..........++++.+++.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            100000         00112223456789999999999999999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.1e-46  Score=346.88  Aligned_cols=279  Identities=24%  Similarity=0.305  Sum_probs=204.8

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHh--cCCCCceeeecccee-----cCCeeEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLA--SIQHRNLVTLLGYCQ-----ENNLQFL  147 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~-----~~~~~~l  147 (380)
                      ..++|++.+.||+|+||.||+|+. +++.||+|+......+.+..|.+++.  .++||||+++++.+.     .....++
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            456889999999999999999987 58899999987666677777766654  589999999997542     3346789


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCeEecCCCCCCeeeCCCCceEEcc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-------SPRVVHKDFKTANVLVDEDFIAKVAD  220 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------~~~ivHrDikp~Nili~~~~~~kl~D  220 (380)
                      ||||+++|+|.+++.      ....++..+..++.|++.||.|||+.       .++|+||||||+|||++.++.+||+|
T Consensus        90 v~e~~~~g~L~~~l~------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLS------LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEecCCCCcHHHHHh------hcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            999999999999983      23448888999999999999999983       11799999999999999999999999


Q ss_pred             cccccccCCCCC------CCCCccccCccceeccccccc-------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC-C
Q 016917          221 AGLRNFLGRTDV------AGPSSQVTADEIFLASEVKEF-------RRFSEKSDVYSFGVFLLELVSGREASSSLSPD-S  286 (380)
Q Consensus       221 Fgla~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~-~  286 (380)
                      ||++..+.....      ........||..|+|||++.+       ..++.++|||||||++|||++|..||...... .
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            999987654321      112234569999999999876       46678999999999999999997776543321 1


Q ss_pred             cccHHHH-HHhhhcccchhhh-cccccccC------CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhccc
Q 016917          287 SQDLVEL-VQNSRDFSNLLKI-LDERLWST------FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL  358 (380)
Q Consensus       287 ~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~~  358 (380)
                      ....... ............. ........      ....+++++.+++.+||+.||++|||+.++++.|++++....+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence            1111110 0000000011100 01111111      12347788999999999999999999999999999999776544


Q ss_pred             cc
Q 016917          359 TT  360 (380)
Q Consensus       359 ~~  360 (380)
                      ..
T Consensus       324 ~~  325 (336)
T 3g2f_A          324 KS  325 (336)
T ss_dssp             --
T ss_pred             cc
Confidence            33

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3e-46  Score=349.42  Aligned_cols=249  Identities=23%  Similarity=0.339  Sum_probs=204.5

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC------CCChHHHHHHHHHHhcC-CCCceeeeccceecCCe
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNL  144 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  144 (380)
                      ....++|++.+.||+|+||.||+|+.+ +++.||+|...      ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999965 68899999754      23456678899999876 99999999999999999


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .|+||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        93 ~~lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             EEEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence            999999999999999883     34568999999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      +......  .......||+.|+|||++.+..|+.++|||||||++|||++|..||.....   ......+...       
T Consensus       166 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~~-------  233 (345)
T 1xjd_A          166 KENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSIRMD-------  233 (345)
T ss_dssp             BCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC-------
T ss_pred             hhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHhC-------
Confidence            8643211  223456799999999999999999999999999999999999999976432   1122111110       


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHH-HHHHH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS-DVVTE  347 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-~ll~~  347 (380)
                             ...++...++++.+++.+||+.||.+||++. +++++
T Consensus       234 -------~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          234 -------NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             -------CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence                   1123444567899999999999999999997 66543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8e-47  Score=351.22  Aligned_cols=282  Identities=27%  Similarity=0.367  Sum_probs=211.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-----CCCcEEEEEeCCCCCh---HHHHHHHHHHhcCCCCceeeecccee--cCCee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAPT---QEFIDEVCFLASIQHRNLVTLLGYCQ--ENNLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  145 (380)
                      .++|++.+.||+|+||.||+|+.     .++..||+|.......   +.+.+|++++++++||||+++++++.  +.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            45788899999999999999984     4678999998665543   35789999999999999999999886  55678


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++||||+++++|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.
T Consensus       102 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQR----HRARLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEEECCTTCBHHHHHHH----HGGGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             EEEEeecCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChhhEEECCCCCEEEcccccce
Confidence            999999999999999842    23458999999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCC-CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH---Hhhhccc
Q 016917          226 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV---QNSRDFS  301 (380)
Q Consensus       226 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~  301 (380)
                      ....... ........+|..|+|||.+.+..++.++||||||+++|+|++|..||......    .....   .......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~~  251 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE----FLRMMGCERDVPALS  251 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHCC----CCHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch----hhhhcccccccccHH
Confidence            7643221 11233456788899999999999999999999999999999999997643210    00000   0000011


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcccccccCCCCc
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTP  367 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~~~~~~~~~~~  367 (380)
                      .+............+..+++++.+++.+||+.||.+|||+.+++++|+.+..............+|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~p  317 (327)
T 3lxl_A          252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHP  317 (327)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----------------
T ss_pred             HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccccccccCc
Confidence            122222333334556677788999999999999999999999999999998876655544443333

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.6e-46  Score=337.97  Aligned_cols=260  Identities=27%  Similarity=0.450  Sum_probs=195.5

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      +..++|++.+.||+|+||.||+|....  .+|+|......     .+.+.+|++++++++||||++++++.. .+..++|
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv   97 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV   97 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEE
Confidence            446789999999999999999998653  59999754322     245889999999999999999999654 4567999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++++|.+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++....
T Consensus        98 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           98 TQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             EECCCEEEHHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             EEecCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCcccccCccceEEECCCCCEEEccceeccccc
Confidence            999999999988842    34568999999999999999999999  679999999999999999999999999998665


Q ss_pred             CCCCCCCCccccCccceecccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ............||..|+|||.+.   +..++.++||||||+++|+|++|+.||.....  .......+.......    
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~----  245 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLSP----  245 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHHHHHTSCCC----
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHHhcccccCc----
Confidence            433233334556899999999986   66789999999999999999999999976442  112222221111100    


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhh
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  353 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~  353 (380)
                           ........+++++.+++.+||+.||.+|||+.++++.|+++.+
T Consensus       246 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          246 -----DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             -----CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -----chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                 0112334556789999999999999999999999999998865

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-45  Score=343.33  Aligned_cols=266  Identities=26%  Similarity=0.466  Sum_probs=208.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECC-----CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      ..+|+..+.||+|+||.||+|....     +..||+|......    ...+.+|+.++++++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            4567778999999999999998542     2469999865432    235788999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +||||+++|+|.+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++..
T Consensus       123 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          123 IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            99999999999998842    23568999999999999999999999  6799999999999999999999999999987


Q ss_pred             cCCCCC-CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          227 LGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       227 ~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ...... ........+|..|+|||.+.+..++.++|||||||++|||++ |..||.....   .+....+..        
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~~--------  265 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAIND--------  265 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHT--------
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHC--------
Confidence            654221 112223446778999999999999999999999999999999 9999975432   111111111        


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcccccccC
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMG  363 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~~~~~~~  363 (380)
                           ......+..+++.+.+++.+||+.||.+||++.++++.|++++......+....
T Consensus       266 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~~~~~  319 (333)
T 1mqb_A          266 -----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD  319 (333)
T ss_dssp             -----TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGSBCC
T ss_pred             -----CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhhhcC
Confidence                 111233445667899999999999999999999999999999987666555443

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.4e-46  Score=350.28  Aligned_cols=251  Identities=20%  Similarity=0.210  Sum_probs=194.5

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC--CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      .++|++.+.||+|+||.||+++.. +++.||+|....  ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   98 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA   98 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence            457999999999999999999965 789999997543  34567889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc--eEEcccccccccCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--AKVADAGLRNFLGRT  230 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~--~kl~DFgla~~~~~~  230 (380)
                      ++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.  +||+|||+++.....
T Consensus        99 ~~~~L~~~l~-----~~~~~~~~~~~~i~~ql~~~L~~LH~--~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           99 SGGELYERIC-----NAGRFSEDEARFFFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            9999998883     34568999999999999999999999  77999999999999987765  999999998754221


Q ss_pred             CCCCCCccccCccceecccccccCCCCcc-hhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEK-SDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                         .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.......  ..........         ..
T Consensus       172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~---------~~  237 (361)
T 3uc3_A          172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRIL---------SV  237 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHH---------TT
T ss_pred             ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHh---------cC
Confidence               22334568999999999988888766 899999999999999999998654322  1222111111         11


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....+.....++++.+|+.+||+.||.+|||+.+++++
T Consensus       238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            11111122345779999999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.8e-46  Score=342.71  Aligned_cols=267  Identities=22%  Similarity=0.391  Sum_probs=203.1

Q ss_pred             HHHHHHhCCCCCCCeeccCCceEEEEEEEC----CCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeecccee
Q 016917           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQ  140 (380)
Q Consensus        70 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~  140 (380)
                      .++....++|.+.+.||+|+||.||+|...    ++..||+|......     .+.+.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            444455677889999999999999999853    34589999865332     245789999999999999999999987


Q ss_pred             cCC-----eeEEEEEeecCCCccccccCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC
Q 016917          141 ENN-----LQFLIYEYIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF  214 (380)
Q Consensus       141 ~~~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~  214 (380)
                      ..+     ..++||||+++|+|.+++..... .....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN--RNFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCSGGGEEECTTS
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCC
Confidence            654     34999999999999988743221 234668999999999999999999999  6799999999999999999


Q ss_pred             ceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHH
Q 016917          215 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVEL  293 (380)
Q Consensus       215 ~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~  293 (380)
                      .+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .....
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~  261 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDY  261 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHH
Confidence            999999999987654333333344567888999999999999999999999999999999 88898765432   22221


Q ss_pred             HHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          294 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      ...             ......+..+++++.+++.+||+.||.+|||+.+++++|++++++
T Consensus       262 ~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          262 LLH-------------GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             HHT-------------TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHc-------------CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            111             111233445567899999999999999999999999999998865

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.9e-46  Score=348.30  Aligned_cols=243  Identities=20%  Similarity=0.266  Sum_probs=204.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|+.. +++.||+|...      ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            357889999999999999999965 68999999753      23456788999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus       120 ~e~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          120 MEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EECCTTCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EcCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCccceEEECCCCCEEEcccccceecc
Confidence            99999999999883     34568999999999999999999999  779999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ..     .....||+.|+|||++.+..|+.++|||||||++|||++|..||.....   ......+..            
T Consensus       193 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~------------  252 (350)
T 1rdq_E          193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVS------------  252 (350)
T ss_dssp             SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH------------
T ss_pred             CC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---HHHHHHHHc------------
Confidence            32     2345789999999999999999999999999999999999999975432   111111111            


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~~ll~~  347 (380)
                      .  ...++...++++.+++.+||+.||.+||+     +++++++
T Consensus       253 ~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          253 G--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             C--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             C--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            1  11334455678999999999999999998     8888765

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.2e-46  Score=345.01  Aligned_cols=272  Identities=23%  Similarity=0.373  Sum_probs=215.8

Q ss_pred             cCHHHHHHHhCCCCCCCeeccCCceEEEEEEE------CCCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeee
Q 016917           67 FQMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTL  135 (380)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l  135 (380)
                      +....+....++|++.+.||+|+||.||+|..      .+++.||+|......    ...+.+|+.+++++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            34455556678899999999999999999984      346789999865433    23578899999999 79999999


Q ss_pred             ccceecCC-eeEEEEEeecCCCccccccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 016917          136 LGYCQENN-LQFLIYEYIPNGSVSIHLYGPSQV-----------SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDF  203 (380)
Q Consensus       136 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDi  203 (380)
                      ++++...+ ..++||||+++|+|.+++......           ....+++..++.++.|++.||.|||+  ++|+||||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~di  174 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDL  174 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH--TTCCCSCC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh--CCcccccC
Confidence            99987654 589999999999999998543221           02237899999999999999999999  67999999


Q ss_pred             CCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCC
Q 016917          204 KTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSL  282 (380)
Q Consensus       204 kp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~  282 (380)
                      ||+||+++.++.+||+|||++................+|..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987654332222334557788999999999999999999999999999998 99999765


Q ss_pred             CCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          283 SPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      ...  ......+..             ......+...++++.+++.+||+.||.+|||+.+++++|+++++..
T Consensus       255 ~~~--~~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          255 KID--EEFCRRLKE-------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CCS--HHHHHHHHH-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             chh--HHHHHHhcc-------------CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            432  111111111             1112233445678999999999999999999999999999998654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.7e-46  Score=349.37  Aligned_cols=268  Identities=16%  Similarity=0.177  Sum_probs=206.3

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECC------CcEEEEEeCCCCChH--------------HHHHHHHHHhcCCCCceee
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAPTQ--------------EFIDEVCFLASIQHRNLVT  134 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~--------------~~~~E~~~l~~l~h~niv~  134 (380)
                      ..++|++.+.||+|+||.||+|....      ++.||+|........              ....|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35579999999999999999999754      478999986544321              2334555677788999999


Q ss_pred             eccceecC----CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 016917          135 LLGYCQEN----NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (380)
Q Consensus       135 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili  210 (380)
                      +++++...    ...++||||+ +++|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~--~~iiHrDlkp~Nill  185 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHE--HEYVHGDIKASNLLL  185 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeEEecCCHHHEEE
Confidence            99998764    4579999999 8899998842    33668999999999999999999999  679999999999999


Q ss_pred             C--CCCceEEcccccccccCCCCCC-----CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 016917          211 D--EDFIAKVADAGLRNFLGRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (380)
Q Consensus       211 ~--~~~~~kl~DFgla~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~  283 (380)
                      +  .++.+||+|||+++.+......     .......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            8  8899999999999876543221     12234559999999999999999999999999999999999999998543


Q ss_pred             CCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          284 PDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      ..  ........... ...+....+..+.   ...+++++.+++..||+.||.+||++.++++.|++++++.
T Consensus       266 ~~--~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          266 KD--PKYVRDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             TC--HHHHHHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cC--HHHHHHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            22  11111111111 1122222222221   1234577999999999999999999999999999998764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.9e-46  Score=349.61  Aligned_cols=249  Identities=20%  Similarity=0.263  Sum_probs=202.5

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      .++|++.+.||+|+||.||+|..+ ++..||+|......     .+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999964 68999999854322     245788999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---CceEEcccccccc
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVADAGLRNF  226 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~---~~~kl~DFgla~~  226 (380)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.+   +.+||+|||++..
T Consensus       108 e~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          108 DLVTGGELFEDIV-----AREFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             CCCCSCBHHHHHT-----TCSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             ecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            9999999998883     34568999999999999999999999  679999999999999764   4599999999987


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      .....   ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.....   ......+..... .     
T Consensus       181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~i~~~~~-~-----  248 (362)
T 2bdw_A          181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKAGAY-D-----  248 (362)
T ss_dssp             CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCC-C-----
T ss_pred             ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCCC-C-----
Confidence            65422   22346789999999999999999999999999999999999999976432   112221111100 0     


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                          ........+++++.+++.+||+.||.+|||+.+++++
T Consensus       249 ----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          249 ----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ----CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                0000112345779999999999999999999999876

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.2e-46  Score=349.04  Aligned_cols=265  Identities=22%  Similarity=0.347  Sum_probs=212.0

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECC------CcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeeeccceecC
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQEN  142 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  142 (380)
                      ...++|++.+.||+|+||.||+|....      ...||+|......    .+.+.+|+.+++.+ +||||+++++++...
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            446789999999999999999999642      2479999865442    34588999999999 899999999999999


Q ss_pred             CeeEEEEEeecCCCccccccCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQ---------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED  213 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~  213 (380)
                      +..++||||+++|+|.+++.....         .....+++..++.++.|++.||.|||+  ++|+||||||+|||++.+
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGCEEEGG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCcccceEEECCC
Confidence            999999999999999998843211         013457899999999999999999999  779999999999999999


Q ss_pred             CceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHH
Q 016917          214 FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVE  292 (380)
Q Consensus       214 ~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~  292 (380)
                      +.+||+|||++................+|..|+|||.+.+..++.++|||||||++|||++ |..||......  .....
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~  278 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--SKFYK  278 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--HHHHH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--HHHHH
Confidence            9999999999987644332222234456778999999999999999999999999999998 99999765432  11111


Q ss_pred             HHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          293 LVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      ...             .......+..+++++.+++.+||+.||.+|||+.++++.|+++..+.
T Consensus       279 ~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          279 LVK-------------DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HHH-------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHh-------------cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            111             11112233445678999999999999999999999999999887653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6e-46  Score=353.46  Aligned_cols=249  Identities=20%  Similarity=0.307  Sum_probs=196.7

Q ss_pred             CCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCC--CCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQ--HRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  149 (380)
                      +.|++.+.||+|+||.||+|...+++.||+|.....     ..+.+.+|+.++++++  ||||+++++++...+..|+||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            458999999999999999999888999999975432     1356889999999996  599999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      | +.+++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++ ++.+||+|||+++....
T Consensus       136 E-~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          136 E-CGNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             E-CCSEEHHHHHH-----HCSSCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             e-cCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            9 56789999884     33567888999999999999999999  6799999999999996 57899999999987754


Q ss_pred             CCCCCCCccccCccceeccccccc-----------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEF-----------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR  298 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  298 (380)
                      ...........||+.|+|||++.+           ..|+.++|||||||++|||++|+.||.....     ...      
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~------  275 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QIS------  275 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHH------
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHH------
Confidence            332223345679999999999865           4689999999999999999999999975431     111      


Q ss_pred             cccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                         .+..+++......++...+.++.+++.+||+.||.+|||+.+++++-
T Consensus       276 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          276 ---KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             ---HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ---HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence               11122222222233444457799999999999999999999999763

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.3e-45  Score=332.32  Aligned_cols=266  Identities=17%  Similarity=0.226  Sum_probs=209.8

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC-CCChHHHHHHHHHHhcCCCCceeeeccce-ecCCeeEEEEEe
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVTLLGYC-QENNLQFLIYEY  151 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~  151 (380)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|... ....+.+.+|+++++.++|++++..+..+ ...+..++||||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence            346799999999999999999995 578899999733 33445688999999999988777666655 667788999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCceEEcccccccccC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili---~~~~~~kl~DFgla~~~~  228 (380)
                      + +++|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||+   +.++.+||+|||++....
T Consensus        87 ~-~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           87 L-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             C-CCBHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             c-CCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9 8899998842    24568999999999999999999999  679999999999999   788999999999998765


Q ss_pred             CCCCC-----CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          229 RTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       229 ~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      .....     .......+|..|+|||.+.+..++.++|||||||++|+|++|+.||..............+.........
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            43221     1234567899999999999999999999999999999999999999886655554444333222111110


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                      .         .....+++++.+++.+||+.||++|||+.++++.|++++++..
T Consensus       240 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          240 E---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             H---------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             h---------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            0         0112234679999999999999999999999999999998753

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.6e-46  Score=341.10  Aligned_cols=259  Identities=23%  Similarity=0.357  Sum_probs=207.9

Q ss_pred             HhCCCCCCC-eeccCCceEEEEEEE---CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCee
Q 016917           75 ATKNFSDKN-LIGEGKFGEVYKGLL---QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        75 ~~~~~~~~~-~ig~G~~g~V~~~~~---~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      ..++|++.+ .||+|+||.||+|..   .++..||+|......     .+.+.+|+++++.++||||+++++++ ..+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            345677777 999999999999963   346789999865332     45688999999999999999999999 55678


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++||||+++++|.+++.     ....+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++.
T Consensus        93 ~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             EEEEECCTTEEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCCHHHHHH-----hCcCCCHHHHHHHHHHHHHHHHHHHh--CCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            99999999999999983     34568899999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCC-CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          226 FLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       226 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      ....... ........++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....   .+....+.        
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~--------  234 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLE--------  234 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHH--------
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH--------
Confidence            7644221 112223446788999999998899999999999999999999 9999986542   11111111        


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcc
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  357 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~  357 (380)
                           .......+..+++++.+++.+||+.||.+|||+.++++.|++++.....
T Consensus       235 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  283 (291)
T 1xbb_A          235 -----KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  283 (291)
T ss_dssp             -----TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             -----cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence                 1112234455678899999999999999999999999999999877654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.4e-45  Score=345.26  Aligned_cols=253  Identities=20%  Similarity=0.280  Sum_probs=201.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  147 (380)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|.....      ..+.+.+|..+++++ +||||+++++++.+.+..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            456888999999999999999965 5889999975432      124477899999888 89999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             EECCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            999999999998883     34568999999999999999999999  67999999999999999999999999999864


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCccc--HHHHHHhhhcccchhh
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD--LVELVQNSRDFSNLLK  305 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~  305 (380)
                      ....  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||..........  .......        .
T Consensus       161 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------~  230 (345)
T 3a8x_A          161 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--------V  230 (345)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH--------H
T ss_pred             cCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH--------H
Confidence            3211  22345679999999999999999999999999999999999999997543221110  0000000        0


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCH------HHHHHH
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM------SDVVTE  347 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~------~~ll~~  347 (380)
                      +...  ...++...++++.+++.+||+.||.+||++      .+++++
T Consensus       231 i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          231 ILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             HHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             HHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            0111  123445566889999999999999999996      566554

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2e-46  Score=344.39  Aligned_cols=268  Identities=26%  Similarity=0.386  Sum_probs=209.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-----CCCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecC--Ce
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN--NL  144 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  144 (380)
                      .+.|++.+.||+|+||.||+|++     .+++.||+|.....    ..+.+.+|+++++.++||||+++++++...  +.
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            34578889999999999999983     46889999985432    346788999999999999999999999876  66


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .++||||+++|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       100 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPK----NKNKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HTTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEEeCCCCcHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHhhc--CCcccCCCchheEEEcCCCCEEECccccc
Confidence            8999999999999998832    33568999999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCC-CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh---hhcc
Q 016917          225 NFLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN---SRDF  300 (380)
Q Consensus       225 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~  300 (380)
                      ........ ........+|..|+|||.+.+..++.++||||||+++|+|++|..|+.....    ........   ....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTV  249 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccCH
Confidence            87654321 1223445678889999999999999999999999999999999988543210    00000000   0000


Q ss_pred             cchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhh
Q 016917          301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  353 (380)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~  353 (380)
                      ...............+..+++++.+++.+||+.||.+|||+.++++.|+++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            11111222222334556677889999999999999999999999999998763

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.8e-46  Score=338.57  Aligned_cols=255  Identities=29%  Similarity=0.421  Sum_probs=202.6

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC-ChHHHHHHHHHHhcCCCCceeeeccceec-CCeeEEEEEee
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYEYI  152 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  152 (380)
                      ..++|++.+.||+|+||.||+|... +..||+|..... ..+.+.+|+.++++++||||+++++++.. .+..++||||+
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            4567899999999999999999875 889999986544 45678999999999999999999998654 45789999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++...   ....+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++......  
T Consensus        98 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           98 AKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             TTEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            999999988421   12337888999999999999999999  77999999999999999999999999998765432  


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                         .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   .+....+             ....
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~-------------~~~~  231 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV-------------EKGY  231 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHH-------------TTTC
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH-------------hcCC
Confidence               123356778999999999999999999999999999998 9999976542   1222111             1111


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                      ....+..+++++.+++.+||+.||.+|||+.++++.|+++...+.
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~  276 (278)
T 1byg_A          232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL  276 (278)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhhc
Confidence            223445566889999999999999999999999999999887654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-45  Score=334.31  Aligned_cols=257  Identities=24%  Similarity=0.402  Sum_probs=205.3

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-C---CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCee-EEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-D---GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ-FLI  148 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv  148 (380)
                      .|...+.||+|+||.||+|... +   +..+|+|......    .+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            3555689999999999999843 2   2379999865433    24678999999999999999999999766554 999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+.+|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++....
T Consensus       102 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            999999999999843    34567899999999999999999999  679999999999999999999999999998764


Q ss_pred             CCCC--CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCC-CCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          229 RTDV--AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       229 ~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ....  ........+|..|+|||.+.+..++.++||||||+++|+|++|..| |.....   .+....+...        
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~~~--------  244 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---FDLTHFLAQG--------  244 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG---GGHHHHHHTT--------
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH---HHHHHHhhcC--------
Confidence            4321  2233455678899999999999999999999999999999996555 443322   2222222111        


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                           .....+..+++.+.+++.+||+.||.+|||+.++++.|+++++...
T Consensus       245 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          245 -----RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             -----CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence                 1123344456789999999999999999999999999999987644

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.2e-45  Score=340.11  Aligned_cols=264  Identities=21%  Similarity=0.336  Sum_probs=188.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      .++|++.+.||+|+||.||+|.. .+++.||+|....    ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            45789999999999999999995 4689999997432    234678899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          151 YIPNGSVSIHLYGPSQ-VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      |+++ +|.+++..... .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.....
T Consensus        84 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           84 FMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             CCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             ecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            9984 88887743211 123458899999999999999999999  7799999999999999999999999999987643


Q ss_pred             CCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc--cc----
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF--SN----  302 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~----  302 (380)
                      ..  .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......   +....+......  ..    
T Consensus       161 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          161 PV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             CC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCTTTCGG
T ss_pred             Cc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhHhhh
Confidence            21  12234568899999999876 46899999999999999999999999865421   111111111000  00    


Q ss_pred             hhhh--ccc------------ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          303 LLKI--LDE------------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       303 ~~~~--~~~------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....  ..+            ......+...++++.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            0000  000            00011112345679999999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.5e-45  Score=335.23  Aligned_cols=257  Identities=26%  Similarity=0.436  Sum_probs=205.3

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECC----CcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      ..++|++.+.||+|+||.||+|....    +..||+|.....    ..+.+.+|+.+++.++||||+++++++.++ ..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            34578888999999999999998532    346999987654    235688899999999999999999998754 468


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +||||+++++|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++..
T Consensus        89 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           89 IIMELYPYGELGHYLER----NKNSLKVLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEECCTTCBHHHHHHH----HTTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEecCCCCCHHHHHHh----ccccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            99999999999998842    23458899999999999999999999  7799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ...... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......   +....+...        
T Consensus       163 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~~~~--------  230 (281)
T 3cc6_A          163 IEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVLEKG--------  230 (281)
T ss_dssp             C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHHHHT--------
T ss_pred             cccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHHhcC--------
Confidence            654221 11233456788999999999999999999999999999998 99999754432   222222111        


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                           .....+..+++.+.+++.+||+.||.+|||+.++++.|+++.+.+
T Consensus       231 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          231 -----DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence                 112233445678999999999999999999999999999987654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.1e-45  Score=335.07  Aligned_cols=258  Identities=26%  Similarity=0.446  Sum_probs=203.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECC----CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccce-ecCCeeE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYC-QENNLQF  146 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~  146 (380)
                      ..+|++.+.||+|+||.||+|....    ...+|+|......    .+.+.+|+.++++++||||+++++++ ..++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3458888999999999999998542    2368999765432    34678999999999999999999985 4566789


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +||||+++|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++..
T Consensus       104 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEECCCCCEEECccccccc
Confidence            99999999999999842    34567899999999999999999999  7799999999999999999999999999987


Q ss_pred             cCCCCC--CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          227 LGRTDV--AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       227 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      ......  ........+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......   +........      
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~~~~~------  248 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLLQG------  248 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHHHHHTT------
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHHhcC------
Confidence            654322  122334567788999999999999999999999999999999 55566544322   111111111      


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                             .....+..+++.+.+++.+||+.||.+|||+.++++.|++++...
T Consensus       249 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          249 -------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             -------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                   111223445578999999999999999999999999999988653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.4e-45  Score=342.86  Aligned_cols=250  Identities=21%  Similarity=0.350  Sum_probs=195.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC----CChHHHHHHHHHHhcCCCCceeeeccceecCC-------
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENN-------  143 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  143 (380)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|+...    ...+.+.+|++++++++||||+++++++.+.+       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            356888999999999999999975 789999997532    23456889999999999999999999885443       


Q ss_pred             --------------------------------------------------eeEEEEEeecCCCccccccCCCCCCCCCCC
Q 016917          144 --------------------------------------------------LQFLIYEYIPNGSVSIHLYGPSQVSRQKLE  173 (380)
Q Consensus       144 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  173 (380)
                                                                        ..++||||+++++|.+++....  ......
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~  162 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDRE  162 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGSC
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--Cccchh
Confidence                                                              3799999999999999986542  234456


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC----------CCCccccCcc
Q 016917          174 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA----------GPSSQVTADE  243 (380)
Q Consensus       174 ~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~----------~~~~~~~~~~  243 (380)
                      +..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.........          .......||+
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             hHHHHHHHHHHHHHHHHHHh--CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            77789999999999999999  77999999999999999999999999999877543211          1233457999


Q ss_pred             ceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHH
Q 016917          244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEF  323 (380)
Q Consensus       244 ~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  323 (380)
                      .|+|||.+.+..++.++|||||||++|||++|..|+..        ...........          .........++++
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~~~~~~~~----------~~~~~~~~~~~~~  302 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRIITDVRNL----------KFPLLFTQKYPQE  302 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHHHHHHHTT----------CCCHHHHHHCHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHHHHHhhcc----------CCCcccccCChhH
Confidence            99999999999999999999999999999998765321        11111111000          0011123445778


Q ss_pred             HHHHhHccCCCCCCCCCHHHHHHH
Q 016917          324 IQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       324 ~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .+++.+||+.||++|||+.+++++
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHccCCCCcCCCHHHHhhc
Confidence            999999999999999999999875

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.9e-45  Score=331.24  Aligned_cols=251  Identities=21%  Similarity=0.314  Sum_probs=203.9

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      .++|++.+.||+|+||.||+|... +++.||+|....    ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            457889999999999999999965 689999997432    234678899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           86 YCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             CCTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ecCCCcHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            999999999883     34568899999999999999999999  77999999999999999999999999999866433


Q ss_pred             CCCCCCccccCccceecccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ..........++..|+|||.+.+..+ +.++||||||+++|+|++|..||........ ....+ ....           
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~-~~~~-----------  225 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-KEKK-----------  225 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHH-HTTC-----------
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHh-hhcc-----------
Confidence            22223345678999999999988776 7789999999999999999999986543211 11111 1000           


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       .........++.+.+++.+||+.||.+|||+++++++
T Consensus       226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          226 -TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             -TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence             0011112345778999999999999999999999874

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-45  Score=348.31  Aligned_cols=250  Identities=19%  Similarity=0.259  Sum_probs=203.9

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      .++|++.+.||+|+||.||+|... +++.||+|......   ...+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            357899999999999999999964 68899999865442   34678999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC--CCceEEcccccccccCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGR  229 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~--~~~~kl~DFgla~~~~~  229 (380)
                      +++|+|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.  ++.+||+|||++.....
T Consensus       130 ~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          130 LSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            999999998842    23468999999999999999999999  77999999999999974  57899999999987654


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ..   ......+|+.|+|||++.+..++.++|||||||++|||++|..||.....   ......+....          .
T Consensus       204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~~~----------~  267 (387)
T 1kob_A          204 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRCD----------W  267 (387)
T ss_dssp             TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHCC----------C
T ss_pred             Cc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC----------C
Confidence            22   22345789999999999999999999999999999999999999986432   11111111100          0


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..........++++.+++.+||+.||.+|||+.+++++
T Consensus       268 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          268 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            01111223456789999999999999999999999986

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.3e-45  Score=343.17  Aligned_cols=246  Identities=18%  Similarity=0.252  Sum_probs=195.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE----CCCcEEEEEeCCCC-------ChHHHHHHHHHHhcCCCCceeeeccceecCCe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPGA-------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  144 (380)
                      .++|++.+.||+|+||.||+|+.    .+++.||+|.....       ....+.+|+++++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            45789999999999999999996    47899999975532       23457789999999999999999999999999


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .|+||||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLE-----REGIFMEDTACFYLAEISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEEECCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEeCCCCCcHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            999999999999998883     34568899999999999999999999  67999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      +......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ......+..        
T Consensus       169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~--------  235 (327)
T 3a62_A          169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KKTIDKILK--------  235 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH--------
T ss_pred             cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHh--------
Confidence            7643221  123345789999999999999999999999999999999999999976432   111111111        


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                          .  ...++...++++.+++.+||+.||.+||     ++.+++++
T Consensus       236 ----~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          236 ----C--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ----T--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ----C--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                0  1123445567899999999999999999     77788775

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.3e-45  Score=346.15  Aligned_cols=248  Identities=19%  Similarity=0.282  Sum_probs=204.1

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC------CCChHHHHHHHHHHhcC-CCCceeeeccceecCCee
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  145 (380)
                      ...++|++.+.||+|+||.||+|+.+ +++.||+|...      ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            45678999999999999999999975 47899999754      23456688999999988 899999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      |+||||+++|+|.+++.     ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        97 ~lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG~a~  169 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQ-----QVGRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK  169 (353)
T ss_dssp             EEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence            99999999999999883     34568999999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ......  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.....   ......+..         
T Consensus       170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~---------  235 (353)
T 2i0e_A          170 ENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIME---------  235 (353)
T ss_dssp             CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH---------
T ss_pred             ccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---HHHHHHHHh---------
Confidence            643211  223456799999999999999999999999999999999999999976432   111111111         


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  347 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~~ll~~  347 (380)
                         .  ...++...++++.+++.+||+.||.+||+     +++++++
T Consensus       236 ---~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          236 ---H--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             ---C--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             ---C--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               1  11344556688999999999999999996     4666654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-45  Score=348.23  Aligned_cols=257  Identities=26%  Similarity=0.460  Sum_probs=196.0

Q ss_pred             CCCCCCeeccCCceEEEEEEEC--C--CcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeecccee-cCCeeEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ--D--GMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQ-ENNLQFLI  148 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~--~--~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv  148 (380)
                      .|++.+.||+|+||.||+|...  +  +..||+|.....    ..+.+.+|+.++++++||||+++++++. ..+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3566789999999999999853  2  246899976532    2356889999999999999999999865 45678999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus       170 ~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCccchheEEECCCCCEEEeecccccccc
Confidence            999999999999842    33457889999999999999999999  779999999999999999999999999998764


Q ss_pred             CCCCC--CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          229 RTDVA--GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       229 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      .....  .......+|..|+|||.+.+..++.++|||||||++|||++ |.+||......   +....+....       
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~~~~~~-------  313 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLLQGR-------  313 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHHHHTTC-------
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHHHHcCC-------
Confidence            43221  12234457788999999999999999999999999999999 67777765432   2222211111       


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                            ....+..+++.+.+++.+||+.||++|||+.++++.|++++....
T Consensus       314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence                  122344556789999999999999999999999999999886644

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=346.07  Aligned_cols=260  Identities=13%  Similarity=0.155  Sum_probs=212.6

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEE------ECCCcEEEEEeCCCCChHHHHHHHHHHhcCC---CCceeeeccceecCCe
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGL------LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNL  144 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~  144 (380)
                      ...++|++.+.||+|+||.||+|.      ..+++.||+|........++..|.++++.++   |+||+++++++...+.
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~  141 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG  141 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence            345678888999999999999994      4568899999988888888999999999887   8999999999999999


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-----------C
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-----------D  213 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~-----------~  213 (380)
                      .++||||+++|+|.+++..........+++..++.++.|++.||.|||+  ++|+||||||+|||++.           +
T Consensus       142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~--~~ivHrDiKp~NIll~~~~~~~~~~~~~~  219 (365)
T 3e7e_A          142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDDEDDLS  219 (365)
T ss_dssp             EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECGGGTCC------C
T ss_pred             cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEecccccCcccccccc
Confidence            9999999999999999854333345679999999999999999999999  67999999999999998           8


Q ss_pred             CceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHH
Q 016917          214 FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL  293 (380)
Q Consensus       214 ~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~  293 (380)
                      +.+||+|||+++.+.............||..|+|||++.+..|+.++|||||||++|||++|+.||........      
T Consensus       220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------  293 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------  293 (365)
T ss_dssp             TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------
T ss_pred             CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------
Confidence            99999999999765432222233456789999999999999999999999999999999999999864332100      


Q ss_pred             HHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCC-CCHHHHHHHHHhhhhhhc
Q 016917          294 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR-PSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-pt~~~ll~~L~~~~~~~~  356 (380)
                              ..    .... ...  ..++.+.+++..|++.+|.+| |+++++.+.|++++.+..
T Consensus       294 --------~~----~~~~-~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~  342 (365)
T 3e7e_A          294 --------KP----EGLF-RRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY  342 (365)
T ss_dssp             --------EE----CSCC-TTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             --------ee----chhc-ccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence                    00    0000 011  124668899999999999998 588888899998887643

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.7e-45  Score=340.86  Aligned_cols=261  Identities=27%  Similarity=0.464  Sum_probs=208.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcE--EEEEeCCC----CChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGML--VAIKKRPG----APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~--vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  147 (380)
                      .++|++.+.||+|+||.||+|+.. ++..  +++|....    ...+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            357888999999999999999954 5554  48886432    2345688999999999 89999999999999999999


Q ss_pred             EEEeecCCCccccccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCce
Q 016917          148 IYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  216 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~  216 (380)
                      ||||+++|+|.+++.....           .....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCccceEEEcCCCeE
Confidence            9999999999999854321           123468999999999999999999999  779999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHH
Q 016917          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQ  295 (380)
Q Consensus       217 kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~  295 (380)
                      ||+|||++......   .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......   .....  
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~--  253 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEK--  253 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH--
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HHHHH--
Confidence            99999998754321   12233456778999999999999999999999999999998 99999765421   11111  


Q ss_pred             hhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcc
Q 016917          296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  357 (380)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~  357 (380)
                                 +........+..+++++.+++.+||+.||.+|||+.++++.|.+++++...
T Consensus       254 -----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          254 -----------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             -----------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             -----------hhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence                       111112233445668899999999999999999999999999999987543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.7e-45  Score=342.63  Aligned_cols=253  Identities=19%  Similarity=0.292  Sum_probs=202.1

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC--------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP--------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      .+.|++.+.||+|+||.||+|..+ +++.||+|...        ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            346899999999999999999964 68999999742        224677899999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc---eEEccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVADAGL  223 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~---~kl~DFgl  223 (380)
                      +||||+++++|.+.+.... .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999987774221 123457899999999999999999999  77999999999999986554   99999999


Q ss_pred             ccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      +........  ......||+.|+|||++.+..|+.++|||||||++|+|++|..||....    ......+.....    
T Consensus       180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~~~~~----  249 (351)
T 3c0i_A          180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGIIKGKY----  249 (351)
T ss_dssp             CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHHHTCC----
T ss_pred             eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHHcCCC----
Confidence            987654321  1234578999999999999999999999999999999999999997632    112211111100    


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                        ...+..+.    ..++++.+++.+||+.||++|||+.+++++
T Consensus       250 --~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          250 --KMNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             --CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --CCCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              00011111    234679999999999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.5e-46  Score=366.94  Aligned_cols=259  Identities=26%  Similarity=0.443  Sum_probs=212.7

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCC--CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ++..++|++.+.||+|+||.||+|.+..+..||||+...  ...+.+.+|+++|++++||||+++++++.+ +..++|||
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            344567888899999999999999998888899998654  345789999999999999999999999876 66899999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++|+|.+++...   ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       342 ~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          342 YMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             CCTTEEHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             hhcCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            99999999998421   23458899999999999999999999  77999999999999999999999999999876532


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      .. .......++..|+|||++.+..++.++|||||||+||||++ |+.||.....   .+....+.             .
T Consensus       417 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i~-------------~  479 (535)
T 2h8h_A          417 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVE-------------R  479 (535)
T ss_dssp             HH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHHH-------------T
T ss_pred             ce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH-------------c
Confidence            11 11223456778999999999999999999999999999999 9999976432   11111111             1


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      ..+...+..+++++.+||.+||+.||++|||++++++.|+.++..
T Consensus       480 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          480 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            122234556678899999999999999999999999999987744

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.6e-45  Score=340.07  Aligned_cols=265  Identities=22%  Similarity=0.388  Sum_probs=211.9

Q ss_pred             HHHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhc--CCCCceeeeccceecCC----ee
Q 016917           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLAS--IQHRNLVTLLGYCQENN----LQ  145 (380)
Q Consensus        72 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~  145 (380)
                      .....++|++.+.||+|+||.||+|+.. ++.||+|.........+.+|.+++..  ++||||+++++++...+    ..
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  115 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL  115 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence            3445678999999999999999999984 89999999877777788899999887  79999999999998765    78


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCeEecCCCCCCeeeCCCCceE
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH--------SLSPRVVHKDFKTANVLVDEDFIAK  217 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~ivHrDikp~Nili~~~~~~k  217 (380)
                      ++||||+++|+|.+++.      ...+++..++.++.|++.||.|||        +  ++|+||||||+|||++.++.+|
T Consensus       116 ~lv~e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK--PAIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             EEEECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB--CEEECSCCSGGGEEECTTSCEE
T ss_pred             EEEEeecCCCcHHHHHh------ccCccHHHHHHHHHHHHHHHHHHHHHHhhhccc--CCeeeCCCCHHHEEECCCCCEE
Confidence            99999999999999983      245889999999999999999999        6  7799999999999999999999


Q ss_pred             EcccccccccCCCCCC--CCCccccCccceecccccccC------CCCcchhhHHHHHHHHHHHcC----------CCCC
Q 016917          218 VADAGLRNFLGRTDVA--GPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSG----------REAS  279 (380)
Q Consensus       218 l~DFgla~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~------~~~~~~DvwSlG~il~el~tg----------~~p~  279 (380)
                      |+|||++.........  .......+|..|+|||.+.+.      .++.++|||||||++|||++|          ..||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            9999999776442211  123445789999999998765      334789999999999999999          6787


Q ss_pred             CCCCCCCcccHHHHHHhhhcccchhhhcccccccCC-----CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          280 SSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      ......... .......         +.........     +..+++.+.+++.+||+.||.+|||+.+++++|+++.++
T Consensus       268 ~~~~~~~~~-~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          268 YDLVPSDPS-VEEMRKV---------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             TTTSCSSCC-HHHHHHH---------HTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cccCcCccc-HHHHHHH---------HHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            665432211 1111110         0111111122     236778899999999999999999999999999998866


Q ss_pred             h
Q 016917          355 E  355 (380)
Q Consensus       355 ~  355 (380)
                      .
T Consensus       338 ~  338 (342)
T 1b6c_B          338 E  338 (342)
T ss_dssp             T
T ss_pred             h
Confidence            4

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=345.26  Aligned_cols=251  Identities=18%  Similarity=0.207  Sum_probs=189.9

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ..++|++.+.||+|+||.||+|... +++.||+|..... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  130 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV  130 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence            3457899999999999999999965 5789999985443 4456788999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEcccccccccCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNFLGR  229 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~---~~~~kl~DFgla~~~~~  229 (380)
                      ++|+|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.   ++.+||+|||+++....
T Consensus       131 ~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          131 TGGELFDRIV-----EKGYYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CSCBHHHHHT-----TCSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             CCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            9999999883     34568999999999999999999999  67999999999999975   88999999999987643


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||++|..||......  ......+....          .
T Consensus       204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~i~~~~----------~  268 (349)
T 2w4o_A          204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFRRILNCE----------Y  268 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHHHHHTTC----------C
T ss_pred             cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHHHHHhCC----------C
Confidence            22   223456899999999999999999999999999999999999999754321  11111111100          0


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..........+.++.+++.+||+.||++|||+.+++++
T Consensus       269 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          269 YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00111223455779999999999999999999999975

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.5e-45  Score=354.08  Aligned_cols=245  Identities=22%  Similarity=0.292  Sum_probs=205.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|.+.+.||+|+||.||+|... +|+.||+|+...      .....+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            467889999999999999999965 789999997542      2345788999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++....
T Consensus        95 ~E~~~gg~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           95 MEYVSGGELFDYIC-----KNGRLDEKESRRLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EECCSSEEHHHHTT-----SSSSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            99999999999983     34668999999999999999999999  779999999999999999999999999998765


Q ss_pred             CCCCCCCCccccCccceecccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      ...   ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....   ..+...+..           
T Consensus       168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~-----------  230 (476)
T 2y94_A          168 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLFKKICD-----------  230 (476)
T ss_dssp             TTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHHHHHHT-----------
T ss_pred             ccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHHHHHhc-----------
Confidence            432   2334578999999999998876 6899999999999999999999976432   112211111           


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       ..  ...+...++++.+++.+||+.||.+|||+.+++++
T Consensus       231 -~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          231 -GI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             -TC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -CC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence             10  12233455779999999999999999999999975

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.4e-44  Score=329.38  Aligned_cols=265  Identities=17%  Similarity=0.226  Sum_probs=212.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC-CCChHHHHHHHHHHhcCCCCceeeeccce-ecCCeeEEEEEee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVTLLGYC-QENNLQFLIYEYI  152 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~  152 (380)
                      .++|++.+.||+|+||.||+|+. .+++.||+|... ....+.+.+|+.+++.++|++++..+..+ ...+..++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            46789999999999999999995 678999999743 33446789999999999988766666555 5677889999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCceEEcccccccccCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~---~~~~~kl~DFgla~~~~~  229 (380)
                       +++|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++   .++.+||+|||++.....
T Consensus        88 -~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           88 -GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             -CCCHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence             8899998842    24568999999999999999999999  6799999999999994   788999999999987654


Q ss_pred             CCCC-----CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          230 TDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       230 ~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ....     .......+|..|+|||.+.+..++.++|||||||++|||++|+.||..............+..........
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence            3221     12345678999999999999999999999999999999999999998766554444443332221110000


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                               ..+..+++++.+++.+||+.||.+|||+.++++.|+++..+..
T Consensus       241 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          241 ---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             ---------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ---------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence                     1112345779999999999999999999999999999987743

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.9e-46  Score=343.91  Aligned_cols=248  Identities=21%  Similarity=0.273  Sum_probs=181.8

Q ss_pred             CCeeccCCceEEEEEEEC-CCcEEEEEeCCCCChHHHHHHHHHHhcCC-CCceeeeccceecCCeeEEEEEeecCCCccc
Q 016917           82 KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSI  159 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  159 (380)
                      .+.||+|+||.||+|... +++.||+|+........+.+|+.+++.+. ||||+++++++.+.+..++||||+++|+|.+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~   95 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE   95 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence            378999999999999964 68999999987666778889999999996 9999999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC---ceEEcccccccccCCCCCCCCC
Q 016917          160 HLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---IAKVADAGLRNFLGRTDVAGPS  236 (380)
Q Consensus       160 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~---~~kl~DFgla~~~~~~~~~~~~  236 (380)
                      ++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++   .+||+|||+++......  ...
T Consensus        96 ~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~  166 (325)
T 3kn6_A           96 RIK-----KKKHFSETEASYIMRKLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPL  166 (325)
T ss_dssp             HHH-----HCSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Ccc
Confidence            883     34678999999999999999999999  7799999999999997665   89999999998654322  122


Q ss_pred             ccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCc-ccHHHHHHhhhcccchhhhccccccc--
Q 016917          237 SQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-QDLVELVQNSRDFSNLLKILDERLWS--  313 (380)
Q Consensus       237 ~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~--  313 (380)
                      ....+|..|+|||++.+..|+.++|||||||++|+|++|..||........ ....+.......         .....  
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~---------~~~~~~~  237 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK---------GDFSFEG  237 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT---------TCCCCCS
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc---------CCCCCCc
Confidence            345678999999999999999999999999999999999999986543211 111111111111         00000  


Q ss_pred             CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       314 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .....+++++.+++.+||+.||.+|||+++++++
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            0012345789999999999999999999999865

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-45  Score=365.92  Aligned_cols=249  Identities=25%  Similarity=0.396  Sum_probs=201.7

Q ss_pred             eeccCCceEEEEEEEC---CCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCC
Q 016917           84 LIGEGKFGEVYKGLLQ---DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGS  156 (380)
Q Consensus        84 ~ig~G~~g~V~~~~~~---~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  156 (380)
                      .||+|+||.||+|..+   ++..||||.....    ..+.+.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999853   4567999986542    45679999999999999999999999976 56899999999999


Q ss_pred             ccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC-CCC
Q 016917          157 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-AGP  235 (380)
Q Consensus       157 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~-~~~  235 (380)
                      |.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus       422 L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          422 LHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             HHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             HHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            9999842    34568999999999999999999999  6799999999999999999999999999987643221 112


Q ss_pred             CccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccC
Q 016917          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST  314 (380)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (380)
                      .....+|..|+|||++.+..++.++|||||||++|||++ |+.||......   +....+.             ...+..
T Consensus       496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i~-------------~~~~~~  559 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIE-------------QGKRME  559 (613)
T ss_dssp             ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHHH-------------TTCCCC
T ss_pred             ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH-------------cCCCCC
Confidence            223345678999999999999999999999999999998 99999875432   1222211             112234


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      .+..+++++.+++.+||+.||++||++.++++.|+.+....
T Consensus       560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            55667788999999999999999999999999999887653

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.5e-45  Score=341.14  Aligned_cols=265  Identities=23%  Similarity=0.346  Sum_probs=208.8

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE------CCCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCe
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  144 (380)
                      ..++|++.+.||+|+||.||+|..      .++..||+|......    ...+.+|+.++++++||||+++++++...+.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            456899999999999999999983      346789999875432    3457889999999999999999999999999


Q ss_pred             eEEEEEeecCCCccccccCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQ--VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVA  219 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~---~~~~kl~  219 (380)
                      .++||||+++++|.+++.....  .....+++..++.++.|++.||.|||+  .+|+||||||+|||++.   +..+||+
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeecCcCCHhHEEEecCCCcceEEEC
Confidence            9999999999999999854322  122458899999999999999999999  67999999999999984   4569999


Q ss_pred             ccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhh
Q 016917          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSR  298 (380)
Q Consensus       220 DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  298 (380)
                      |||++................+|..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ......+... 
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~-  261 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVTSG-  261 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHTT-
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHHHHhcC-
Confidence            9999876544333333345567889999999999999999999999999999998 9999876432   1112111111 


Q ss_pred             cccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcc
Q 016917          299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMN  357 (380)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~  357 (380)
                                  .....+..+++.+.+++.+||+.||.+|||+.+++++|+.+..+...
T Consensus       262 ------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~  308 (327)
T 2yfx_A          262 ------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  308 (327)
T ss_dssp             ------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             ------------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence                        11223445567899999999999999999999999999998876543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.8e-45  Score=348.08  Aligned_cols=274  Identities=20%  Similarity=0.307  Sum_probs=214.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC----CChHHHHHHHHHHhcCCCCceeeeccceecCC--eeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENN--LQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|... +++.||+|....    ...+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            356889999999999999999965 589999998653    34567889999999999999999999987654  67999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----CCCCceEEcccccc
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGLR  224 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili----~~~~~~kl~DFgla  224 (380)
                      |||+++|+|.+++....  ....+++..++.++.|++.||.|||+  ++|+||||||+|||+    +.++.+||+|||++
T Consensus        88 ~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             ECCCTTEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EecCCCCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHH--CCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            99999999999985331  22348999999999999999999999  779999999999999    77888999999999


Q ss_pred             cccCCCCCCCCCccccCccceeccccccc--------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCc-ccHHHHHH
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEF--------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS-QDLVELVQ  295 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~-~~~~~~~~  295 (380)
                      +.......   .....||..|+|||++.+        ..++.++|||||||++|||++|+.||........ .+....+.
T Consensus       164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             EECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             eEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            87654321   234568999999999865        5678899999999999999999999976543222 22222222


Q ss_pred             hhhcccch---hhhc--------ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          296 NSRDFSNL---LKIL--------DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       296 ~~~~~~~~---~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                      ........   ....        +.......+...+..+.+++.+||+.||++|||+.++++.+.+++++..
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~~  312 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMV  312 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCEE
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhceE
Confidence            11111000   0000        0011224557888999999999999999999999999999999988753

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.8e-45  Score=337.33  Aligned_cols=259  Identities=21%  Similarity=0.272  Sum_probs=196.5

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ++|++.+.||+|+||.||+|... +++.||+|+.....     .+.+.+|++++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57889999999999999999965 58999999754332     2457789999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++......
T Consensus        83 ~~~~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDR-----YQRGVPEHLVKSITWQTLQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHH-----TSSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eCCCchHHHHHh-----hhcCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            999999988773     34568899999999999999999999  67999999999999999999999999999876532


Q ss_pred             CCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc--cchh---
Q 016917          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF--SNLL---  304 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~---  304 (380)
                      ..  ......+|..|+|||.+.+ ..++.++||||||+++|+|++|..||......+.   ...+......  ....   
T Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  230 (311)
T 4agu_A          156 SD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQVF  230 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHHHH
T ss_pred             cc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhccccccccccc
Confidence            21  1234568889999999876 6789999999999999999999999976543211   1111110000  0000   


Q ss_pred             ---------hhccccccc---CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          305 ---------KILDERLWS---TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       305 ---------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                               ...++....   ......++++.+++.+||+.||.+|||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence                     000000000   0002345679999999999999999999999976

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.9e-46  Score=350.43  Aligned_cols=268  Identities=21%  Similarity=0.240  Sum_probs=205.2

Q ss_pred             ccCHHHHHHHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC--ChHHHHHHHHHHhcCC-----CCceeeecc
Q 016917           66 RFQMEELSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA--PTQEFIDEVCFLASIQ-----HRNLVTLLG  137 (380)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~-----h~niv~l~~  137 (380)
                      .+...+.....++|++.+.||+|+||.||+|+. .+++.||+|.....  ....+..|.++++.+.     ||||+++++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            344444445567899999999999999999996 46889999987643  2345778999999886     999999999


Q ss_pred             ceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-----
Q 016917          138 YCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-----  212 (380)
Q Consensus       138 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~-----  212 (380)
                      ++...+..++||||+ +++|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.     
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLRK--MSLTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCTTCCE
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCcccEEEccccccc
Confidence            999999999999999 88999888432   23458899999999999999999999  77999999999999975     


Q ss_pred             --------------------CCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHH
Q 016917          213 --------------------DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLEL  272 (380)
Q Consensus       213 --------------------~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el  272 (380)
                                          ++.+||+|||++......     .....||+.|+|||++.+..|+.++|||||||++|+|
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                789999999999865432     2345689999999999999999999999999999999


Q ss_pred             HcCCCCCCCCCCCCcccHHHHHHhhhc-cc--ch--------hhhcc-cccccCCC--------------------HHHH
Q 016917          273 VSGREASSSLSPDSSQDLVELVQNSRD-FS--NL--------LKILD-ERLWSTFT--------------------NEGM  320 (380)
Q Consensus       273 ~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~--~~--------~~~~~-~~~~~~~~--------------------~~~~  320 (380)
                      ++|+.||......   +....+..... ..  ..        ....+ .......+                    ...+
T Consensus       253 l~g~~pf~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (360)
T 3llt_A          253 YTGSLLFRTHEHM---EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH  329 (360)
T ss_dssp             HHSSCSCCCSSHH---HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred             HHCCCCCCCCcHH---HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence            9999999865422   11111111100 00  00        00000 00000000                    0112


Q ss_pred             HHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          321 EEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       321 ~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      +.+.+|+.+||+.||.+|||+.|++++
T Consensus       330 ~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          330 ELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            668899999999999999999999864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.7e-45  Score=347.37  Aligned_cols=265  Identities=18%  Similarity=0.216  Sum_probs=202.0

Q ss_pred             hCCCCCCCeeccC--CceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           76 TKNFSDKNLIGEG--KFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        76 ~~~~~~~~~ig~G--~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      .++|++.+.||+|  +||.||+|+.. +++.||+|.....     ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4578999999999  99999999965 6899999975422     23457789999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+++|+|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++...
T Consensus       104 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            99999999999988432   23568999999999999999999999  67999999999999999999999999987654


Q ss_pred             CCCC-----CCCCCccccCccceeccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc-
Q 016917          228 GRTD-----VAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-  299 (380)
Q Consensus       228 ~~~~-----~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-  299 (380)
                      ....     .........||..|+|||++.+  ..|+.++|||||||++|||++|+.||........  .......... 
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~  256 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPC  256 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC-------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCc
Confidence            3211     1122334578899999999987  6799999999999999999999999986543221  1110000000 


Q ss_pred             --------ccc-------------hhhhc---------ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 --------FSN-------------LLKIL---------DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 --------~~~-------------~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                              ...             .....         ........+...++++.+|+.+||+.||++|||+.+++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                    000             00000         0000112334456789999999999999999999999976

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.4e-46  Score=346.28  Aligned_cols=253  Identities=19%  Similarity=0.310  Sum_probs=202.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEeec
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      .++|++.+.||+|+||.||+|..+ +++.||+|...... ....+|++++.++ +||||+++++++.+.+..|+||||++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~   99 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK   99 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence            456889999999999999999965 68899999865433 2345788888887 79999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC----CceEEcccccccccCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED----FIAKVADAGLRNFLGR  229 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~----~~~kl~DFgla~~~~~  229 (380)
                      +|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||+.++    +.+||+|||++.....
T Consensus       100 gg~L~~~i~-----~~~~~~~~~~~~~~~qi~~al~~lH~--~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A          100 GGELLDKIL-----RQKFFSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             SCBHHHHHH-----TCTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             CCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            999999883     34568999999999999999999999  679999999999998433    3599999999987643


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ..  .......+|+.|+|||++.+..|+.++|||||||++|||++|..||..............+.....          
T Consensus       173 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~----------  240 (342)
T 2qr7_A          173 EN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF----------  240 (342)
T ss_dssp             TT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC----------
T ss_pred             CC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc----------
Confidence            22  123345689999999999988899999999999999999999999986543333233222221110          


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      ..........++++.+++.+||+.||++|||+.+++++-
T Consensus       241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence            011112234567899999999999999999999999763

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-45  Score=344.40  Aligned_cols=260  Identities=20%  Similarity=0.192  Sum_probs=199.4

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC--------CCChHHHHHHHHHHhcCCCCceeeeccceecCC
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP--------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN  143 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  143 (380)
                      ....++|++.+.||+|+||.||+|.. .++..||+|...        ....+.+.+|++++++++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            34567899999999999999999996 468899999743        334567889999999999999999999999999


Q ss_pred             eeEEEEEeecCCCccccccCCCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHH
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQV-----------------------------------SRQKLEFKHRLSIALGAAKGL  188 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~-----------------------------------~~~~~~~~~~~~i~~~i~~~l  188 (380)
                      ..++||||+++|+|.+++......                                   ....+++..++.++.|++.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999888421100                                   022345677889999999999


Q ss_pred             HHHhcCCCCeEecCCCCCCeeeCCCC--ceEEcccccccccCCCCC--CCCCccccCccceeccccccc--CCCCcchhh
Q 016917          189 AHLHSLSPRVVHKDFKTANVLVDEDF--IAKVADAGLRNFLGRTDV--AGPSSQVTADEIFLASEVKEF--RRFSEKSDV  262 (380)
Q Consensus       189 ~~LH~~~~~ivHrDikp~Nili~~~~--~~kl~DFgla~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv  262 (380)
                      .|||+  ++|+||||||+|||++.++  .+||+|||++........  ........+|+.|+|||.+.+  ..++.++||
T Consensus       182 ~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di  259 (345)
T 3hko_A          182 HYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA  259 (345)
T ss_dssp             HHHHH--TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred             HHHHH--CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence            99999  6799999999999998776  899999999986543221  112345668999999999875  678999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHH
Q 016917          263 YSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS  342 (380)
Q Consensus       263 wSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~  342 (380)
                      |||||++|||++|+.||......   +....+.....          ..........++++.+++.+||+.||.+|||+.
T Consensus       260 wslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  326 (345)
T 3hko_A          260 WSAGVLLHLLLMGAVPFPGVNDA---DTISQVLNKKL----------CFENPNYNVLSPLARDLLSNLLNRNVDERFDAM  326 (345)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCC----------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred             HHHHHHHHHHHHCCCCCCCCChH---HHHHHHHhccc----------ccCCcccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence            99999999999999999765421   11111110000          000011123457799999999999999999999


Q ss_pred             HHHHH
Q 016917          343 DVVTE  347 (380)
Q Consensus       343 ~ll~~  347 (380)
                      +++++
T Consensus       327 ~~l~h  331 (345)
T 3hko_A          327 RALQH  331 (345)
T ss_dssp             HHHHS
T ss_pred             HHhcC
Confidence            99975

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=343.71  Aligned_cols=264  Identities=16%  Similarity=0.158  Sum_probs=198.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC----CCcEEEEEeCCCCC--------------hHHHHHHHHHHhcCCCCceeeecc
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPGAP--------------TQEFIDEVCFLASIQHRNLVTLLG  137 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  137 (380)
                      .++|++.+.||+|+||.||+|...    ++..+|+|......              ...+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467899999999999999999975    57889999754432              123567888899999999999999


Q ss_pred             ceec----CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC
Q 016917          138 YCQE----NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED  213 (380)
Q Consensus       138 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~  213 (380)
                      ++..    ....++||||+ +++|.+++.     ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISG-----QNGTFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCB-----GGGBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEESS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCcCHHHEEEccC
Confidence            9887    77889999999 889999983     33478999999999999999999999  679999999999999887


Q ss_pred             C--ceEEcccccccccCCCCCC-----CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 016917          214 F--IAKVADAGLRNFLGRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS  286 (380)
Q Consensus       214 ~--~~kl~DFgla~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~  286 (380)
                      +  .+||+|||+++.+......     .......||..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  9999999999876432211     11245578999999999999999999999999999999999999996432211


Q ss_pred             cccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhh
Q 016917          287 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  353 (380)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~  353 (380)
                      .  .......... ..........   .....+++++.+++.+||+.||++|||++++++.|+++..
T Consensus       268 ~--~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          268 V--AVQTAKTNLL-DELPQSVLKW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             H--HHHHHHHHHH-HTTTHHHHHH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             H--HHHHHHHhhc-ccccHHHHhh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            1  1111110000 0000000000   0011345689999999999999999999999999987654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.9e-45  Score=347.45  Aligned_cols=243  Identities=21%  Similarity=0.268  Sum_probs=192.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHH-HhcCCCCceeeeccceecCCeeEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCF-LASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|....      .....+..|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            457899999999999999999965 578999997432      223345667766 577899999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus       117 v~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          117 VLDYINGGELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            999999999998883     34568899999999999999999999  77999999999999999999999999999864


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      ....  .......||+.|+|||++.+..|+.++|||||||++|||++|..||.....   ......+.            
T Consensus       190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~------------  252 (373)
T 2r5t_A          190 IEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNIL------------  252 (373)
T ss_dssp             BCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---HHHHHHHH------------
T ss_pred             ccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHH------------
Confidence            3221  223456799999999999999999999999999999999999999975432   11111111            


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV  344 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~l  344 (380)
                      ...  ..++...++++.+++.+||+.||.+||++.+.
T Consensus       253 ~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~  287 (373)
T 2r5t_A          253 NKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDD  287 (373)
T ss_dssp             HSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred             hcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence            111  12334456789999999999999999998643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.2e-46  Score=354.31  Aligned_cols=260  Identities=22%  Similarity=0.240  Sum_probs=205.3

Q ss_pred             CHHHHHHHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeecccee
Q 016917           68 QMEELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQ  140 (380)
Q Consensus        68 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~  140 (380)
                      ...+.....++|++.+.||+|+||.||+|+.+ +++.||+|+....      ..+.+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34455556788999999999999999999964 6899999986432      2344788999999999999999999999


Q ss_pred             cCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcc
Q 016917          141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  220 (380)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~D  220 (380)
                      +.+..|+||||+++|+|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++++||+|
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~----~~~~l~~~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSK----FGERIPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH----HSSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccCHHHeeecCCCCEEEee
Confidence            99999999999999999999832    23468999999999999999999999  6799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCccceecccccc-------cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHH
Q 016917          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKE-------FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL  293 (380)
Q Consensus       221 Fgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~-------~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~  293 (380)
                      ||+++....... .......||+.|+|||++.       +..|+.++|||||||++|||++|+.||.....   ......
T Consensus       206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~  281 (412)
T 2vd5_A          206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST---AETYGK  281 (412)
T ss_dssp             CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHH
T ss_pred             chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH---HHHHHH
Confidence            999987644221 1123457999999999987       35789999999999999999999999976432   111111


Q ss_pred             HHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCC---CCHHHHHHH
Q 016917          294 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR---PSMSDVVTE  347 (380)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---pt~~~ll~~  347 (380)
                      +......      .   .....+...++++.+++.+||. +|.+|   |++++++++
T Consensus       282 i~~~~~~------~---~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          282 IVHYKEH------L---SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHTHHHH------C---CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHhcccC------c---CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            1110000      0   0011123456789999999999 99998   588888765

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=343.76  Aligned_cols=239  Identities=21%  Similarity=0.311  Sum_probs=200.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----------ChHHHHHHHHHHhcCCCCceeeeccceecCC
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----------PTQEFIDEVCFLASIQHRNLVTLLGYCQENN  143 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  143 (380)
                      .++|++.+.||+|+||.||+|.. .++..||+|.....           ..+.+.+|++++++++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            45799999999999999999995 56889999974432           2345778999999999999999999999999


Q ss_pred             eeEEEEEeecCC-CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 016917          144 LQFLIYEYIPNG-SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       144 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFg  222 (380)
                      ..++||||+.+| +|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFID-----RHPRLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHH-----TCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEEeCCCCccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence            999999999777 8888883     34568999999999999999999999  679999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                      ++.......   ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......                
T Consensus       176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------  236 (335)
T 3dls_A          176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------  236 (335)
T ss_dssp             TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred             cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence            998765432   2334678999999999988877 78999999999999999999999752210                


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                           ....  ...+..+++++.+++.+||+.||++|||+.+++++
T Consensus       237 -----~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 -----VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0000  11222345779999999999999999999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=338.86  Aligned_cols=261  Identities=23%  Similarity=0.278  Sum_probs=197.9

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC--------CChHHHHHHHHHHhcCC---CCceeeeccceecC
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG--------APTQEFIDEVCFLASIQ---HRNLVTLLGYCQEN  142 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  142 (380)
                      ..++|++.+.||+|+||+||+|.. .+++.||+|....        .....+.+|+++++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999995 5689999997431        12346778888877764   99999999999765


Q ss_pred             C-----eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceE
Q 016917          143 N-----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  217 (380)
Q Consensus       143 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~k  217 (380)
                      .     ..++||||+.+ +|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQ-DLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCCC-BHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhhc-CHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEE
Confidence            4     47999999974 898888432   23448999999999999999999999  6799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhh
Q 016917          218 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS  297 (380)
Q Consensus       218 l~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  297 (380)
                      |+|||++......   .......+|+.|+|||++.+..++.++|||||||++|||++|+.||......   +....+...
T Consensus       161 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~  234 (308)
T 3g33_A          161 LADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDL  234 (308)
T ss_dssp             ECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHHHHHHHH
T ss_pred             EeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHH
Confidence            9999999866432   2234567899999999999999999999999999999999999999764421   111111111


Q ss_pred             hcccchhh----------hccc---ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          298 RDFSNLLK----------ILDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       298 ~~~~~~~~----------~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ........          ...+   ..........++++.+++.+||+.||.+|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            10000000          0000   00000112345779999999999999999999999975

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.2e-45  Score=333.79  Aligned_cols=245  Identities=27%  Similarity=0.382  Sum_probs=201.0

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      ..++|++.+.||+|+||.||+|... ++..||+|....      .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3467889999999999999999854 577899997532      234568899999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||++...
T Consensus        87 v~e~~~~~~l~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             EECCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHT--TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             EEecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            999999999998883     34568899999999999999999999  77999999999999999999999999998654


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      ...    ......++..|+|||.+.+..++.++||||||+++|+|++|..||.....   ......+..           
T Consensus       160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~-----------  221 (279)
T 3fdn_A          160 PSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKRISR-----------  221 (279)
T ss_dssp             ------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHH-----------
T ss_pred             Ccc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH---HHHHHHHHh-----------
Confidence            332    12345688899999999999999999999999999999999999975432   111111110           


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         ....++...++++.+++.+||+.||.+|||+.+++++
T Consensus       222 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          222 ---VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ---TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ---CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               1123344456789999999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.2e-45  Score=359.42  Aligned_cols=251  Identities=20%  Similarity=0.312  Sum_probs=207.4

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      ..++|++.+.||+|+||.||+|+.+ +++.||+|+..      ......+.+|+++++.++||||+++++++.+.+..|+
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3456888999999999999999965 68999999753      2345568899999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+++|+|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++...
T Consensus       262 VmEy~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH~--~gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EECCCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence            99999999999888532   23458999999999999999999999  67999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCccc-HHHHHHhhhcccchhhh
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQD-LVELVQNSRDFSNLLKI  306 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  306 (380)
                      ....   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.......... ....+..          
T Consensus       337 ~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----------  403 (576)
T 2acx_A          337 PEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----------  403 (576)
T ss_dssp             CTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH----------
T ss_pred             ccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc----------
Confidence            4422   2234579999999999999999999999999999999999999998754322111 1111110          


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                          ....++...++++.+|+.+||+.||.+||     ++++++++
T Consensus       404 ----~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          404 ----VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             ----ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                11234445668899999999999999999     77888865

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-45  Score=351.23  Aligned_cols=261  Identities=23%  Similarity=0.340  Sum_probs=189.6

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCC-CCceeeeccceecC--Cee
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQ-HRNLVTLLGYCQEN--NLQ  145 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~  145 (380)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|+....     ....+.+|+.+++.+. ||||+++++++...  ...
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            457899999999999999999995 56899999975432     2345778999999997 99999999998754  368


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      |+||||+++ +|..++.      ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++
T Consensus        87 ~lv~e~~~~-~L~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           87 YLVFDYMET-DLHAVIR------ANILEPVHKQYVVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEECCSE-EHHHHHH------HTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEecccCc-CHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            999999984 7887773      3468889999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCC-------------------CCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 016917          226 FLGRTDV-------------------AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPD  285 (380)
Q Consensus       226 ~~~~~~~-------------------~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~  285 (380)
                      .......                   ........||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            6543111                   112234679999999999876 67899999999999999999999999865421


Q ss_pred             CcccHHHHHHhhhcccchhh---hc------------------ccccc------------cCCCHHHHHHHHHHHhHccC
Q 016917          286 SSQDLVELVQNSRDFSNLLK---IL------------------DERLW------------STFTNEGMEEFIQLIVRCLD  332 (380)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~---~~------------------~~~~~------------~~~~~~~~~~l~~li~~cl~  332 (380)
                         +....+...........   +.                  .....            ......+++++.+|+.+||+
T Consensus       238 ---~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          238 ---NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             ---HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             ---HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence               11111111111000000   00                  00000            00111345679999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 016917          333 PSSERRPSMSDVVTE  347 (380)
Q Consensus       333 ~dp~~Rpt~~~ll~~  347 (380)
                      .||.+|||++|++++
T Consensus       315 ~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          315 FNPNKRISANDALKH  329 (388)
T ss_dssp             SSGGGSCCHHHHTTS
T ss_pred             cCcccCCCHHHHhCC
Confidence            999999999999987

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.1e-45  Score=342.03  Aligned_cols=275  Identities=17%  Similarity=0.205  Sum_probs=210.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECC---------CcEEEEEeCCCCChHHHHHHHHHHhcCCCCceee------------
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQD---------GMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVT------------  134 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~------------  134 (380)
                      .++|++.+.||+|+||.||+|....         ++.||+|.....  +.+.+|++++++++||||++            
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  118 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA  118 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence            4679999999999999999999653         789999986543  56889999999999999998            


Q ss_pred             ---eccceec-CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 016917          135 ---LLGYCQE-NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (380)
Q Consensus       135 ---l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili  210 (380)
                         +++++.. .+..++||||+ +++|.+++...   ....+++..++.++.|++.||.|||+  ++|+||||||+|||+
T Consensus       119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLHE--NEYVHGNVTAENIFV  192 (352)
T ss_dssp             CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCGGGEEE
T ss_pred             ccchhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEE
Confidence               4555554 67889999999 99999998422   23678999999999999999999999  679999999999999


Q ss_pred             CCCC--ceEEcccccccccCCCCCC-----CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 016917          211 DEDF--IAKVADAGLRNFLGRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (380)
Q Consensus       211 ~~~~--~~kl~DFgla~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~  283 (380)
                      +.++  .+||+|||++.........     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  9999999999876543211     12234578999999999999999999999999999999999999998654


Q ss_pred             CCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc-cccccc
Q 016917          284 PDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM-NLTTVM  362 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~-~~~~~~  362 (380)
                      ... ............  .........   ......++++.+++.+||+.||.+|||++++++.|++++++.. ...+..
T Consensus       273 ~~~-~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~  346 (352)
T 2jii_A          273 PNT-EDIMKQKQKFVD--KPGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPI  346 (352)
T ss_dssp             TCH-HHHHHHHHHHHH--SCCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCC
T ss_pred             cCH-HHHHHHHHhccC--Chhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccc
Confidence            221 111111111100  000000000   0011234779999999999999999999999999999987743 334444


Q ss_pred             CC
Q 016917          363 GE  364 (380)
Q Consensus       363 ~~  364 (380)
                      .+
T Consensus       347 dw  348 (352)
T 2jii_A          347 GL  348 (352)
T ss_dssp             CC
T ss_pred             cC
Confidence            33

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.6e-45  Score=336.02  Aligned_cols=262  Identities=20%  Similarity=0.247  Sum_probs=194.8

Q ss_pred             CCCCCC-CeeccCCceEEEEEEE-CCCcEEEEEeCCC---CChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEE
Q 016917           77 KNFSDK-NLIGEGKFGEVYKGLL-QDGMLVAIKKRPG---APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        77 ~~~~~~-~~ig~G~~g~V~~~~~-~~~~~vavK~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      +.|++. +.||+|+||.||+|.. .+++.||+|....   ...+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            457774 7899999999999994 5789999997533   3456789999999885 79999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc---eEEccccccccc
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVADAGLRNFL  227 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~---~kl~DFgla~~~  227 (380)
                      |+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.   +||+|||++...
T Consensus        92 ~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           92 KMRGGSILSHIH-----KRRHFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             CCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             cCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            999999999883     34568899999999999999999999  67999999999999988765   999999998765


Q ss_pred             CCCCC-----CCCCccccCccceeccccccc-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhh
Q 016917          228 GRTDV-----AGPSSQVTADEIFLASEVKEF-----RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS  297 (380)
Q Consensus       228 ~~~~~-----~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  297 (380)
                      .....     ........||..|+|||++.+     ..++.++|||||||++|||++|+.||......+...........
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            42211     111223458999999999875     56899999999999999999999999876543211000000000


Q ss_pred             hcccchhhhcccccccCCCH----HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          298 RDFSNLLKILDERLWSTFTN----EGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ........+....  ..++.    ..++++.+++.+||+.||.+|||+.+++++
T Consensus       245 ~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          245 CQNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0000000000000  11121    245679999999999999999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.5e-45  Score=342.93  Aligned_cols=244  Identities=27%  Similarity=0.396  Sum_probs=197.5

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      +.|+..+.||+|+||.||+|.. .+++.||+|+.....      .+.+.+|++++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            3488889999999999999995 578999999754321      245789999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+. |+|.+.+.    .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.....
T Consensus       134 e~~~-g~l~~~l~----~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9997 47776663    234568899999999999999999999  6799999999999999999999999999986543


Q ss_pred             CCCCCCCccccCccceecccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          230 TDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                            .....||+.|+|||++.   ...++.++|||||||++|||++|+.||.....      .........       
T Consensus       207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~-------  267 (348)
T 1u5q_A          207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-------  267 (348)
T ss_dssp             ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHH-------
T ss_pred             ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHh-------
Confidence                  23456899999999984   56789999999999999999999999875432      111111000       


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                        .......+..+++.+.+++.+||+.||++|||+++++++.
T Consensus       268 --~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          268 --NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             --SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             --cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence              0011112234557799999999999999999999999764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.9e-44  Score=335.32  Aligned_cols=257  Identities=18%  Similarity=0.255  Sum_probs=202.9

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCChHHHHHHHHHHhcCC-CCceeeeccceec--CCeeEEEEEe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQE--NNLQFLIYEY  151 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~  151 (380)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.......+.+.+|++++++++ ||||+++++++.+  ....++||||
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~  114 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  114 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence            35689999999999999999985 578999999988888889999999999997 9999999999987  6678999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEcccccccccCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRT  230 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~-~~kl~DFgla~~~~~~  230 (380)
                      +++++|.+++        ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++ .+||+|||++......
T Consensus       115 ~~~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          115 VNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             CCCCCHHHHG--------GGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             cCchhHHHHH--------HhCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            9999998877        237888999999999999999999  6799999999999999776 8999999999876442


Q ss_pred             CCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc-
Q 016917          231 DVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD-  308 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  308 (380)
                      .   ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ...+... ............++ 
T Consensus       185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~-~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRI-AKVLGTEDLYDYIDK  259 (330)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHH-HHHHCHHHHHHHHHH
T ss_pred             C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHH-HHhcCCchhhhHHHH
Confidence            2   2334568889999999877 67899999999999999999999999654321 1111111 11000000000000 


Q ss_pred             ----------------------cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ----------------------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ----------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                                            .......+...++++.+|+.+||+.||++|||+++++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                                  000111122356789999999999999999999999975

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.9e-45  Score=365.70  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=200.1

Q ss_pred             CeeccCCceEEEEEEE---CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLL---QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~---~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      +.||+|+||.||+|.+   ..+..||||+....     ..+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999964   34678999986532     24678999999999999999999999975 457899999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC-C
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-A  233 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~-~  233 (380)
                      |+|.+++.     ....+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+++.+..... .
T Consensus       454 g~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~yLH~--~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            99999983     34568899999999999999999999  6799999999999999999999999999987654322 1


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                      .......+|..|+|||++.+..++.++|||||||++|||++ |+.||......   +....+             .....
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i-------------~~~~~  590 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAML-------------EKGER  590 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH-------------HTTCC
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH-------------HcCCC
Confidence            22233456788999999999999999999999999999998 99999865421   111111             11222


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      ...+..+++++.+++..||+.||++|||+.++++.|+++..+
T Consensus       591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            344556778899999999999999999999999999988754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.3e-45  Score=353.15  Aligned_cols=248  Identities=23%  Similarity=0.262  Sum_probs=196.2

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|...      ......+.+|+.+++.++||||+++++++...+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            346789999999999999999995 468999999743      2334567789999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+++|+|.+++.     ....+++..+..++.|++.||.|||+. ++|+||||||+|||++.++.+||+|||+++..
T Consensus       226 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~-~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          226 VMEYANGGELFFHLS-----RERVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             EECCCSSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EEeeCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHhhc-CCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            999999999998883     345789999999999999999999961 46999999999999999999999999999864


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      ....  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.....   ......+..           
T Consensus       300 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~-----------  363 (446)
T 4ejn_A          300 IKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILM-----------  363 (446)
T ss_dssp             CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH-----------
T ss_pred             cCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHHHh-----------
Confidence            3221  223456799999999999999999999999999999999999999976432   111111111           


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                       .  ...++...++++.+++.+||+.||.+||     ++++++++
T Consensus       364 -~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          364 -E--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             -C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -C--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence             0  1123445567899999999999999999     99999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.7e-44  Score=354.73  Aligned_cols=254  Identities=22%  Similarity=0.301  Sum_probs=206.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|+...      ...+.+..|.+++++++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            356888899999999999999975 689999997532      3446688999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++|+|.+++..... ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~--~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHH--cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999988854321 24568999999999999999999999  679999999999999999999999999998765


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ....  ......||+.|+|||++.+..|+.++|||||||++|||++|+.||........  ..+......         .
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~---------~  407 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVL---------E  407 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHH---------H
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHh---------h
Confidence            4221  22345799999999999999999999999999999999999999987543211  111111110         0


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM-----SDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~~ll~~  347 (380)
                      .  ...++...++++.+++.+||+.||.+||++     ++++++
T Consensus       408 ~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          408 Q--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             C--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             c--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence            0  113445566889999999999999999975     566543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-45  Score=337.60  Aligned_cols=243  Identities=25%  Similarity=0.305  Sum_probs=189.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC--Ch---HHHHHHHHHHhcC-CCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA--PT---QEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~---~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|++.++||+|+||+||+|... +++.||+|+....  ..   .....|+..+.++ +||||+++++++.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            357899999999999999999975 7899999975432  11   2344555555444 899999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+ +++|.+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++....
T Consensus       136 ~e~~-~~~L~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          136 TELC-GPSLQQHCEA----WGASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EECC-CCBHHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             Eecc-CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            9999 5688877732    23568999999999999999999999  679999999999999999999999999988764


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ...   ......||+.|+|||++.+ .++.++|||||||++|||++|..|+....      ....+..            
T Consensus       209 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------~~~~~~~------------  266 (311)
T 3p1a_A          209 TAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------GWQQLRQ------------  266 (311)
T ss_dssp             ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------HHHHHTT------------
T ss_pred             cCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHhc------------
Confidence            422   2334568999999999886 79999999999999999999977654321      1111110            


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ......++...++++.+++.+||+.||++|||+.+++++
T Consensus       267 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          267 GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            000011122345779999999999999999999999974

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.5e-45  Score=353.59  Aligned_cols=257  Identities=20%  Similarity=0.283  Sum_probs=191.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecC------C
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQEN------N  143 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  143 (380)
                      .++|++.+.||+|+||.||+|.. .+++.||+|+....     ..+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46799999999999999999995 46889999986432     245678999999999999999999998654      4


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      ..|+||||++++ +.+.+.       ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            569999999875 544441       237889999999999999999999  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh-cccc
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-DFSN  302 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~  302 (380)
                      ++.....   .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+  .+...+.... ....
T Consensus       211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~i~~~lg~p~~~  285 (464)
T 3ttj_A          211 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPE  285 (464)
T ss_dssp             C-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHH
T ss_pred             eeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHH
Confidence            9876432   22345678999999999999999999999999999999999999998654211  1111111000 0000


Q ss_pred             --------hh---------------hhcccccccCC---CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          303 --------LL---------------KILDERLWSTF---TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       303 --------~~---------------~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                              ..               ...........   ....++++.+|+.+||+.||++|||++|++++
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                    00               00000000000   11236789999999999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7.6e-45  Score=337.05  Aligned_cols=249  Identities=20%  Similarity=0.271  Sum_probs=202.5

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC---------ChHHHHHHHHHHhcCCCCceeeeccceecCCee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      .++|++.+.||+|+||.||+|... ++..||+|.....         ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            346888999999999999999965 6889999964321         356789999999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC----ceEEccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADA  221 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~----~~kl~DF  221 (380)
                      ++||||+++++|.+++.     ....+++..++.++.|++.||.|||+  .+|+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~lH~--~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLA-----QKESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHH-----TCSCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999983     34568899999999999999999999  6799999999999999887    7999999


Q ss_pred             ccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc
Q 016917          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       222 gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                      |++.......   ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||.....   ......+.....  
T Consensus       164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~--  235 (321)
T 2a2a_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANITSVSY--  235 (321)
T ss_dssp             TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHTTCC--
T ss_pred             ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhccc--
Confidence            9998765422   22345689999999999999999999999999999999999999975432   111111111000  


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                          ...+..    ....++.+.+++.+||+.||++|||+.+++++
T Consensus       236 ----~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          236 ----DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             ----CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ----ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                000111    11234678999999999999999999999975

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7e-45  Score=344.01  Aligned_cols=243  Identities=22%  Similarity=0.299  Sum_probs=193.0

Q ss_pred             CCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecCCCc
Q 016917           82 KNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  157 (380)
                      .+.||+|+||.||+|.. .++..||+|......   .+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            46799999999999995 468999999865543   45688999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee--CCCCceEEcccccccccCCCCCCCC
Q 016917          158 SIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGRTDVAGP  235 (380)
Q Consensus       158 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili--~~~~~~kl~DFgla~~~~~~~~~~~  235 (380)
                      .+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+|||+  +.++.+||+|||+++.......   
T Consensus       174 ~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---  244 (373)
T 2x4f_A          174 FDRIID----ESYNLTELDTILFMKQICEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---  244 (373)
T ss_dssp             HHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred             HHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence            888742    23468899999999999999999999  679999999999999  6678999999999987654322   


Q ss_pred             CccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh-hhcccchhhhcccccccC
Q 016917          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN-SRDFSNLLKILDERLWST  314 (380)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  314 (380)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||.....   .+....+.. ....       ...    
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~-------~~~----  310 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---AETLNNILACRWDL-------EDE----  310 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCCCS-------CSG----
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCC-------Chh----
Confidence            2344689999999999999999999999999999999999999976432   111111111 1000       000    


Q ss_pred             CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       315 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .....++++.+|+.+||+.||.+|||+.+++++
T Consensus       311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          311 EFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            112345779999999999999999999999985

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.7e-45  Score=335.98  Aligned_cols=249  Identities=21%  Similarity=0.389  Sum_probs=199.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECC-C-------cEEEEEeCCCC---ChHHHHHHHHHHhcCCCCceeeeccceecCCe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQD-G-------MLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~-~-------~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  144 (380)
                      .++|++.+.||+|+||.||+|.... +       ..||+|.....   ..+.+.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4578889999999999999998542 3       47999986433   34668899999999999999999999999999


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc--------e
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--------A  216 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~--------~  216 (380)
                      .++||||+++|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.        +
T Consensus        87 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKK----NKNCINILWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CEEEEECCCCCCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHhh--CCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999842    23448899999999999999999999  77999999999999988876        9


Q ss_pred             EEcccccccccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCC-CCCCCCCCcccHHHHH
Q 016917          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREA-SSSLSPDSSQDLVELV  294 (380)
Q Consensus       217 kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p-~~~~~~~~~~~~~~~~  294 (380)
                      ||+|||++.....      .....++..|+|||.+.+ ..++.++|||||||++|||++|..| |.....   .......
T Consensus       161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~  231 (289)
T 4fvq_A          161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS---QRKLQFY  231 (289)
T ss_dssp             EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHH
T ss_pred             eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch---HHHHHHh
Confidence            9999999875432      223456778999999987 6789999999999999999996544 433221   1111111


Q ss_pred             HhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      ..               ....+...++++.+++.+||+.||.+|||+.+++++|++++.-
T Consensus       232 ~~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          232 ED---------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HT---------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             hc---------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            10               0112222345689999999999999999999999999988853

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.4e-44  Score=343.43  Aligned_cols=252  Identities=17%  Similarity=0.228  Sum_probs=192.9

Q ss_pred             CCCCCC-CeeccCCceEEEEEEEC-CCcEEEEEeCCCCChHHHHHHHHHHh-cCCCCceeeeccceec----CCeeEEEE
Q 016917           77 KNFSDK-NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLA-SIQHRNLVTLLGYCQE----NNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~~lv~  149 (380)
                      ++|.+. +.||+|+||+||+|... +++.||+|+...  ...+.+|++++. ..+||||+++++++..    .+..|+||
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~  138 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM  138 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEE
Confidence            345555 68999999999999964 688999998753  356778988874 4589999999998865    56789999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEcccccccc
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNF  226 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~---~~~~kl~DFgla~~  226 (380)
                      ||+++|+|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.   ++.+||+|||+++.
T Consensus       139 E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          139 ECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             ECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EeCCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            999999999998432   23468999999999999999999999  67999999999999987   78999999999986


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcc-cHHHHHHhhhcccchhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ-DLVELVQNSRDFSNLLK  305 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~  305 (380)
                      .....   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||......... .....+.... .     
T Consensus       214 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~-~-----  284 (400)
T 1nxk_A          214 TTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-Y-----  284 (400)
T ss_dssp             CC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC-C-----
T ss_pred             cCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc-c-----
Confidence            54321   223556899999999999999999999999999999999999999865543221 1222111110 0     


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                          .........+++++.+|+.+||+.||.+|||+.+++++-
T Consensus       285 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          285 ----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             ----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             ----cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence                000011123557799999999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1e-44  Score=334.45  Aligned_cols=259  Identities=17%  Similarity=0.205  Sum_probs=199.0

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      ..++|++.+.||+|+||.||+|... +++.||+|......      .+.+.+|+.++++++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3578999999999999999999965 68899999865331      2567899999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+++++|.+++.     ....+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++...
T Consensus       112 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          112 DMRLINGVDLAAMLR-----RQGPLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEECCCCEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEEecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            999999999999883     33568899999999999999999999  67999999999999999999999999998766


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||......   .....+....         
T Consensus       185 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~---------  251 (309)
T 2h34_A          185 TDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHINQAI---------  251 (309)
T ss_dssp             -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHHSCC---------
T ss_pred             ccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhccCC---------
Confidence            44221 1223456889999999999999999999999999999999999999754311   1111111000         


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHHHhhhhhh
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTLDKE  355 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~~ll~~L~~~~~~~  355 (380)
                        ......+..+++++.+++.+||+.||++|| +++++++.|++.+...
T Consensus       252 --~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          252 --PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             --CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             --CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence              001122344557799999999999999999 9999999999887654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.3e-45  Score=337.97  Aligned_cols=257  Identities=19%  Similarity=0.261  Sum_probs=193.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC------hHHHHHHHHHHhcCCCCceeeeccceecCCe----
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNL----  144 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  144 (380)
                      .++|++.+.||+|+||.||+|.. .+++.||+|......      ...+.+|++++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            45789999999999999999995 578999999865432      2357889999999999999999999876543    


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .|+||||+++++|.+++.     ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            499999999999999983     34568999999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCC-CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          225 NFLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       225 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      ......... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......      ............
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~  237 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI  237 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCC
Confidence            876543221 2233456899999999999999999999999999999999999999764321      111110000000


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHH-HHHHhhh
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV-TELDRTL  352 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll-~~L~~~~  352 (380)
                             ........+++++.+++.+||+.||.+||+..+++ +.+.+..
T Consensus       238 -------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          238 -------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             -------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence                   00001122457799999999999999999776665 4444443

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=340.59  Aligned_cols=259  Identities=20%  Similarity=0.292  Sum_probs=193.7

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCCh----HHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      ++|++.+.||+|+||.||+|... +++.||+|.......    ..+.+|+++++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            47888999999999999999965 788999997543322    2345799999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++ +|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           82 LDK-DLKQYLDD----CGNIINMHNVKLFLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             CSE-EHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             ccc-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            985 78777732    24568899999999999999999999  779999999999999999999999999987654321


Q ss_pred             CCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc---ccchhhhc
Q 016917          232 VAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD---FSNLLKIL  307 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  307 (380)
                        .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||......   +....+.....   ........
T Consensus       155 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~  229 (324)
T 3mtl_A          155 --KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGIL  229 (324)
T ss_dssp             ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGG
T ss_pred             --cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHhchhhh
Confidence              12234567899999999876 57899999999999999999999999865432   11111111100   00000000


Q ss_pred             cc---------cc----ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          308 DE---------RL----WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       308 ~~---------~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..         ..    ........++++.+|+.+||+.||.+|||++|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00         00    001112345778999999999999999999999985

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=9.8e-45  Score=329.86  Aligned_cols=251  Identities=22%  Similarity=0.332  Sum_probs=204.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCChHHHHHHHHHHhcCCCCceeeeccceec-------------
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQE-------------  141 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------------  141 (380)
                      ..+|++.+.||+|+||.||+|... +++.||+|...... +.+.+|++++++++||||+++++++..             
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   88 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS   88 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence            456889999999999999999975 78999999865443 567899999999999999999998754             


Q ss_pred             ---CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEE
Q 016917          142 ---NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV  218 (380)
Q Consensus       142 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl  218 (380)
                         ....++||||+++++|.+++...   ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           89 RSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             CCEEEEEEEEECCCCSCBHHHHHHHG---GGSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEE
T ss_pred             ccCcceEEEEEeccCCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHEEEcCCCCEEE
Confidence               44579999999999999998432   23568899999999999999999999  67999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh
Q 016917          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR  298 (380)
Q Consensus       219 ~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  298 (380)
                      +|||++.......   ......+++.|+|||.+.+..++.++||||||+++|+|++|..|+...        ....... 
T Consensus       164 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~~~-  231 (284)
T 2a19_B          164 GDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFTDL-  231 (284)
T ss_dssp             CCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHHHH-
T ss_pred             Ccchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHHHh-
Confidence            9999988765432   223456889999999999999999999999999999999998875321        0000000 


Q ss_pred             cccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                              ..    ...+...+..+.+++.+||+.||.+|||+.+++++|..+.+...
T Consensus       232 --------~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          232 --------RD----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             --------HT----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             --------hc----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence                    00    11223345678999999999999999999999999988876543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.6e-44  Score=328.78  Aligned_cols=249  Identities=20%  Similarity=0.261  Sum_probs=201.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      .++|++.+.||+|+||.||+|... ++..||+|.....     ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467899999999999999999964 5889999975322     2345778999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc---eEEcccccccc
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVADAGLRNF  226 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~---~kl~DFgla~~  226 (380)
                      ||+++++|.+.+.     ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.   +||+|||++..
T Consensus        85 e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           85 DLVTGGELFEDIV-----AREFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             CCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            9999999988873     34568999999999999999999999  77999999999999976654   99999999977


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      .....   ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||.....   ......+.....       
T Consensus       158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~-------  224 (284)
T 3kk8_A          158 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKAGAY-------  224 (284)
T ss_dssp             CCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCC-------
T ss_pred             cccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---hHHHHHHHhccc-------
Confidence            65422   12345689999999999999999999999999999999999999976432   111111111100       


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         ..........++++.+++.+||+.||++|||+.+++++
T Consensus       225 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          225 ---DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             ---CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ---cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence               00011112345779999999999999999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.8e-44  Score=327.24  Aligned_cols=244  Identities=21%  Similarity=0.294  Sum_probs=200.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC---CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      .++|++.+.||+|+||.||+|... ++..+|+|+..   ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            346889999999999999999965 47789999743   34567899999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCceEEcccccccccC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili---~~~~~~kl~DFgla~~~~  228 (380)
                      +++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||+   +.++.+||+|||++....
T Consensus        88 ~~~~~L~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           88 CTGGELFERVV-----HKRVFRESDAARIMKDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             cCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999988873     34568999999999999999999999  779999999999999   788999999999998765


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ...   ......+|+.|+|||.+.+. ++.++||||||+++|+|++|+.||.....   ......+....          
T Consensus       161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~----------  223 (277)
T 3f3z_A          161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD---SEVMLKIREGT----------  223 (277)
T ss_dssp             TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCC----------
T ss_pred             Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCC----------
Confidence            422   23345688999999998754 89999999999999999999999976432   11111111100          


Q ss_pred             cccccCCCH----HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTN----EGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~----~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                          ...+.    .+++++.+++.+||+.||.+|||+.+++++
T Consensus       224 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          224 ----FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             ----CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ----CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                01111    235779999999999999999999999975

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-45  Score=343.56  Aligned_cols=255  Identities=20%  Similarity=0.325  Sum_probs=193.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCC------
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN------  143 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  143 (380)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|+.....     .+.+.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46789999999999999999996 568999999864321     345788999999999999999999987653      


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      ..|+||||+ +++|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~------~~~l~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMK------HEKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence            459999999 779988873      2468899999999999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc--
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF--  300 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--  300 (380)
                      ++.....     .....+|+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..   +....+......  
T Consensus       175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~~~  246 (367)
T 1cm8_A          175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGTPP  246 (367)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCC
T ss_pred             ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCC
Confidence            9875432     334578999999999877 68999999999999999999999999865421   111111110000  


Q ss_pred             cchh------------hhc---ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 SNLL------------KIL---DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 ~~~~------------~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....            ..+   ............++.+.+|+.+||+.||.+|||+.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0000            000   0011112223456789999999999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=326.50  Aligned_cols=247  Identities=23%  Similarity=0.336  Sum_probs=183.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|.. .+++.||+|....      ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35688999999999999999996 5789999997532      2346788999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++++|.+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EECCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            999999999998842    23568999999999999999999999  679999999999999999999999999988764


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ....  ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........   .            .....
T Consensus       164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~------------~~~~~  226 (278)
T 3cok_A          164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---L------------NKVVL  226 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCS
T ss_pred             CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---H------------HHHhh
Confidence            3221  12345688899999999999999999999999999999999999986543211   0            00000


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..  ...+...+.++.+++.+||+.||++|||+.+++++
T Consensus       227 ~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          227 AD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             SC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            00  12334456789999999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=341.87  Aligned_cols=270  Identities=27%  Similarity=0.417  Sum_probs=209.4

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-----CCCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCC--e
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-----QDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENN--L  144 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~  144 (380)
                      ..++|++.+.||+|+||.||+|..     .+++.||+|......   .+.+.+|++++++++||||+++++++...+  .
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            345688899999999999999984     368899999865443   346889999999999999999999886543  6


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .++||||+++++|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++
T Consensus       119 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHH----STTSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             eEEEEECCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            7999999999999999842    23458899999999999999999999  77999999999999999999999999999


Q ss_pred             cccCCCCC-CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc----
Q 016917          225 NFLGRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD----  299 (380)
Q Consensus       225 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----  299 (380)
                      ........ ........++..|+|||.+.+..++.++||||||+++|||++|..||.....    ...........    
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~~  268 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQMI  268 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhhh
Confidence            87654321 1112334567789999999988999999999999999999999988763210    00000000000    


Q ss_pred             ccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          300 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      ...+...+........+..+++++.+++.+||+.||.+|||+.++++.|+++.++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            0011112222222344556778899999999999999999999999999988754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.1e-44  Score=334.14  Aligned_cols=263  Identities=24%  Similarity=0.353  Sum_probs=199.1

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|.. .++..||+|.....      ....+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            45789999999999999999995 57899999975432      234578999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++++|.+++.... .....+++..++.++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhc-ccccCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999998884321 124568899999999999999999999  779999999999999999999999999988664


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ...  .......++..|+|||.+.+..++.++||||||+++|+|++|+.||......    ..........         
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~---------  252 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQ---------  252 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHHT---------
T ss_pred             CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhhc---------
Confidence            322  1123456888999999999999999999999999999999999999754321    1111111110         


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                      ..........+++++.+++.+||+.||.+|||+.++++.|+++.....
T Consensus       253 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          253 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence            000111123455789999999999999999999999999999886644

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-45  Score=342.08  Aligned_cols=252  Identities=23%  Similarity=0.272  Sum_probs=202.9

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE----CCCcEEEEEeCCC-------CChHHHHHHHHHHhcC-CCCceeeeccceecCC
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKKRPG-------APTQEFIDEVCFLASI-QHRNLVTLLGYCQENN  143 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~-------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  143 (380)
                      .++|++.+.||+|+||.||+|+.    .+++.||+|....       ...+.+.+|+++++.+ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46799999999999999999997    3689999997542       2345677899999999 6999999999999999


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      ..++||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       133 ~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLS-----QRERFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eEEEEeecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence            9999999999999999983     34568899999999999999999999  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCccceeccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                      ++....... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||........  ..........  
T Consensus       206 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~--  280 (355)
T 1vzo_A          206 SKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILK--  280 (355)
T ss_dssp             EEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHH--
T ss_pred             CeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhc--
Confidence            986543221 12234578999999999885  3578999999999999999999999986543222  1111111110  


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHHH
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTEL  348 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~L  348 (380)
                               ....++...++.+.+++.+||+.||.+||     ++.+++++.
T Consensus       281 ---------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          281 ---------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ---------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                     01234455667899999999999999999     899988764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.3e-43  Score=344.95  Aligned_cols=264  Identities=19%  Similarity=0.236  Sum_probs=212.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC-CCChHHHHHHHHHHhcCCC-CceeeeccceecCCeeEEEEEee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP-GAPTQEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      .++|++.+.||+|+||.||+|.. .+++.||||+.. ......+..|+++++.++| +++..+..++...+..++||||+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            46799999999999999999995 568999999743 3344568899999999976 56666666777888899999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCceEEcccccccccCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili---~~~~~~kl~DFgla~~~~~  229 (380)
                       +++|.+++..    ....+++..++.++.||+.||.|||+  ++|+||||||+|||+   +.++.+||+|||+++....
T Consensus        86 -g~sL~~ll~~----~~~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           86 -GPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             -CCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence             8899998842    24568999999999999999999999  679999999999999   5889999999999987654


Q ss_pred             CCCC-----CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          230 TDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       230 ~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ....     .......||..|+|||.+.+..++.++|||||||+||||++|+.||..............+..........
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE  238 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence            3221     12336679999999999999999999999999999999999999998876544444333332221111111


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      .     +    +..+++++.+++..||+.||++||++.++++.|++++.+.
T Consensus       239 ~-----l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          239 A-----L----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             H-----H----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             H-----H----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            1     1    1123467999999999999999999999999999988764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.4e-44  Score=327.78  Aligned_cols=244  Identities=20%  Similarity=0.296  Sum_probs=203.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|... ++..||+|...      ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            457889999999999999999965 57889999753      23456788999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++....
T Consensus        93 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           93 LEFAPRGELYKELQ-----KHGRFDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             ECCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EEeCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            99999999998883     33568899999999999999999999  779999999999999999999999999987654


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ..    ......++..|+|||.+.+..++.++||||||+++|+|++|..||......   .....+.            .
T Consensus       166 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~------------~  226 (284)
T 2vgo_A          166 SL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---ETHRRIV------------N  226 (284)
T ss_dssp             SS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHH------------T
T ss_pred             cc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh---HHHHHHh------------c
Confidence            32    123456889999999999999999999999999999999999999754321   1111111            0


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .  ...++...++++.+++.+||+.||.+|||+.+++++
T Consensus       227 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          227 V--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             T--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             c--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            0  112344456789999999999999999999999975

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.1e-44  Score=336.98  Aligned_cols=262  Identities=19%  Similarity=0.281  Sum_probs=197.5

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceec--------
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE--------  141 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  141 (380)
                      .++|++.+.||+|+||.||+|.. .+++.||+|+....     ....+.+|+++++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            35789999999999999999996 57899999975322     23467899999999999999999999876        


Q ss_pred             CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccc
Q 016917          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (380)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DF  221 (380)
                      .+..++||||+++ +|.+.+.    .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~----~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHH----CTTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCC-CHHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence            4568999999986 6665553    233568999999999999999999999  77999999999999999999999999


Q ss_pred             ccccccCCCCC--CCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh
Q 016917          222 GLRNFLGRTDV--AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR  298 (380)
Q Consensus       222 gla~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  298 (380)
                      |++........  ........+|+.|+|||++.+ ..++.++|||||||++|||++|..||......   .....+....
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~  245 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLC  245 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHH
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Confidence            99987653221  222345578999999998876 46899999999999999999999999865422   1111111110


Q ss_pred             ---cccchhhhcccccc----------cCCCH-----HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          299 ---DFSNLLKILDERLW----------STFTN-----EGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       299 ---~~~~~~~~~~~~~~----------~~~~~-----~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         ..............          .....     ..++++.+|+.+||+.||.+|||++|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence               00000000000000          00000     013568999999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.6e-44  Score=344.41  Aligned_cols=251  Identities=19%  Similarity=0.299  Sum_probs=192.0

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC-----------ChHHHHHHHHHHhcCCCCceeeeccceec
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA-----------PTQEFIDEVCFLASIQHRNLVTLLGYCQE  141 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~  141 (380)
                      ...++|.+.+.||+|+||.||+|.. .+++.||+|.....           ....+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3467899999999999999999995 45789999974321           12347899999999999999999999864


Q ss_pred             CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---CceEE
Q 016917          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKV  218 (380)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~---~~~kl  218 (380)
                       +..++||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.+   +.+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTS-----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -CceEEEEEcCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCCCcceEEE
Confidence             45799999999999998883     44678999999999999999999999  679999999999999654   45999


Q ss_pred             cccccccccCCCCCCCCCccccCccceeccccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH
Q 016917          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  295 (380)
Q Consensus       219 ~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~  295 (380)
                      +|||+++......   ......||+.|+|||++.+   ..|+.++|||||||++|+|++|..||......  ..+...+.
T Consensus       284 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~i~  358 (419)
T 3i6u_A          284 TDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQIT  358 (419)
T ss_dssp             CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHHHHH
T ss_pred             eecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHHHHh
Confidence            9999998765422   2334678999999999853   67889999999999999999999999864322  12222221


Q ss_pred             hhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .... ..     .+..+    ...++.+.+++.+||+.||++|||+++++++
T Consensus       359 ~~~~-~~-----~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          359 SGKY-NF-----IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             TTCC-CC-----CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cCCC-CC-----Cchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            1110 00     00001    1235679999999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4e-44  Score=329.32  Aligned_cols=246  Identities=26%  Similarity=0.394  Sum_probs=204.5

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC----CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      ..|++.+.||+|+||.||+|.. .+++.||+|...    ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            4588899999999999999985 468899999743    23456789999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++.......
T Consensus       102 ~~~~~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          102 LGGGSALDLLE------PGPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CTTEEHHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             CCCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            99999999883      3568899999999999999999999  679999999999999999999999999998765422


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                        .......++..|+|||.+.+..++.++||||||+++|+|++|..||......   .....+..             ..
T Consensus       174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~-------------~~  235 (303)
T 3a7i_A          174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFLIPK-------------NN  235 (303)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHH-------------SC
T ss_pred             --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHHhhc-------------CC
Confidence              1234456889999999999999999999999999999999999999754321   11111110             11


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                      ....+..++..+.+++.+||+.||.+|||+.+++++.
T Consensus       236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            1223334557799999999999999999999999864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-44  Score=349.71  Aligned_cols=264  Identities=20%  Similarity=0.295  Sum_probs=182.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceec-----CCe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE-----NNL  144 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  144 (380)
                      .++|++.+.||+|+||.||+|... +++.||+|+....     ..+.+.+|+++|+.++||||+++++++..     .+.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            367999999999999999999954 6899999975432     23467899999999999999999999843     357


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .|+||||+. ++|.+++.     ....+++..+..++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus       132 ~~lv~e~~~-~~L~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~--~~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFR-----TPVYLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEEECCCS-EEHHHHHH-----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeccc-cchhhhcc-----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcCCCCCChhhEEECCCCCEeecccccc
Confidence            899999985 58888773     34568999999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCC-------------------------CCCccccCccceeccccc-ccCCCCcchhhHHHHHHHHHHHc----
Q 016917          225 NFLGRTDVA-------------------------GPSSQVTADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVS----  274 (380)
Q Consensus       225 ~~~~~~~~~-------------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~~DvwSlG~il~el~t----  274 (380)
                      +........                         .......||+.|+|||++ .+..|+.++|||||||++|||++    
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence            876432111                         122345789999999976 56679999999999999999999    


Q ss_pred             -------CCCCCCCCCCCCc-----------------ccHHHHHHhhhccc---chh-----------hhcccc---ccc
Q 016917          275 -------GREASSSLSPDSS-----------------QDLVELVQNSRDFS---NLL-----------KILDER---LWS  313 (380)
Q Consensus       275 -------g~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~---~~~-----------~~~~~~---~~~  313 (380)
                             |+++|.+......                 .+....+.......   .+.           ..+...   ...
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                   5666654331000                 00000000000000   000           000000   000


Q ss_pred             CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       314 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ......++++.+|+.+||+.||++|||++|++++
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            1112335779999999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-44  Score=330.07  Aligned_cols=250  Identities=22%  Similarity=0.328  Sum_probs=195.1

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC----CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      ++|++.+.||+|+||.||+|.. .++..+|+|...    ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            4688889999999999999996 468899999743    33457789999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCceEEcccccccccC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili---~~~~~~kl~DFgla~~~~  228 (380)
                      +++|+|.+++.... .....+++..++.++.|++.||.|||+  ++|+||||||+|||+   +.++.+||+|||++....
T Consensus       102 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQ-ARGKALSEGYVAELMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhh-hcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            99999998874321 123568999999999999999999999  779999999999999   456789999999998764


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ...   ......+|..|+|||.+. ..++.++||||||+++|||++|+.||......   ..........          
T Consensus       179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~----------  241 (285)
T 3is5_A          179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---EVQQKATYKE----------  241 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCC----------
T ss_pred             Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---HHHhhhccCC----------
Confidence            322   233456899999999986 57899999999999999999999999764321   1111111000          


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ... .......++++.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          242 PNY-AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CCC-CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ccc-ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000 00111134678999999999999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=6.7e-45  Score=338.61  Aligned_cols=262  Identities=21%  Similarity=0.278  Sum_probs=192.8

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      ...++|++.+.||+|+||+||+|.. .+++.||+|......     .+.+.+|++++++++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            3456799999999999999999995 478899999865332     2356789999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee-----CCCCceEEcccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV-----DEDFIAKVADAG  222 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili-----~~~~~~kl~DFg  222 (380)
                      ||||+++ +|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||+     +.++.+||+|||
T Consensus       111 v~e~~~~-~L~~~~~-----~~~~~~~~~~~~i~~ql~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMD-----KNPDVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEECCSE-EHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEecCCC-CHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            9999985 8888883     34568999999999999999999999  679999999999999     455569999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc-
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF-  300 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-  300 (380)
                      ++.......  .......+|..|+|||++.+. .++.++|||||||++|||++|..||......  ..+.......... 
T Consensus       183 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~  258 (329)
T 3gbz_A          183 LARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--DQLFKIFEVLGLPD  258 (329)
T ss_dssp             HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCC
T ss_pred             CccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--HHHHHHHHHhCCCc
Confidence            998764321  122344678899999998874 5899999999999999999999999764321  1111111110000 


Q ss_pred             -cc---hhhh----------cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 -SN---LLKI----------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 -~~---~~~~----------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       ..   ....          ....+....+...++++.+|+.+||+.||.+|||++|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence             00   0000          00000000111245778999999999999999999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.9e-44  Score=326.83  Aligned_cols=256  Identities=21%  Similarity=0.278  Sum_probs=202.5

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC---------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      ++|++.+.||+|+||.||+|... +++.||+|.....         ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46888999999999999999965 6899999963321         3567899999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC----ceEEcccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADAG  222 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~----~~kl~DFg  222 (380)
                      +||||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++    .+||+|||
T Consensus        85 lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           85 LILELVSGGELFDFLA-----EKESLTEDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEeecCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            9999999999999883     34568999999999999999999999  6799999999999998877    89999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  302 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (380)
                      ++.......   ......++..|+|||.+.+..++.++||||||+++|+|++|..||.....   ......+.....   
T Consensus       158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~---  228 (283)
T 3bhy_A          158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---QETLTNISAVNY---  228 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTTCC---
T ss_pred             cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HHHHHHhHhccc---
Confidence            998764322   12345688999999999999999999999999999999999999976432   111111111000   


Q ss_pred             hhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--HHhhhhhh
Q 016917          303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRTLDKE  355 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~--L~~~~~~~  355 (380)
                         ......    ....++.+.+++.+||+.||.+|||+.+++++  +..+..+.
T Consensus       229 ---~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          229 ---DFDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             ---CCCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             ---CCcchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence               000001    11234678999999999999999999999974  44544443

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=324.78  Aligned_cols=249  Identities=20%  Similarity=0.258  Sum_probs=197.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC-------CChHHHHHHHHHHhcCCCCceeeeccce--ecCCee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-------APTQEFIDEVCFLASIQHRNLVTLLGYC--QENNLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~  145 (380)
                      .++|++.+.||+|+||.||+|.. .++..||+|....       .....+.+|++++++++||||+++++++  .+.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            46899999999999999999996 4688999997543       2345688999999999999999999998  455678


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++||||++++ |.+.+..   .....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDS---VPEKRFPVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEECCSEE-HHHHHHH---STTCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEehhccCC-HHHHHHh---CcccccCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEcCCCcEEeecccccc
Confidence            9999999886 5555532   234568999999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCccceecccccccCC--CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      ...............++..|+|||++.+..  ++.++||||||+++|||++|+.||.....   ......+...      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~~~------  228 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI---YKLFENIGKG------  228 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHC------
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHHHhcC------
Confidence            765433223334556899999999987644  37899999999999999999999975431   1111111100      


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                              ....+..+++.+.+++.+||+.||.+|||+.+++++
T Consensus       229 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          229 --------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             --------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                    112334556789999999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.2e-44  Score=351.33  Aligned_cols=248  Identities=22%  Similarity=0.324  Sum_probs=201.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC-----CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      .++|++.+.||+|+||+||+|... +++.||+|...     ......+.+|++++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            356889999999999999999965 78999999742     345677899999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCceEEcccccccc
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNF  226 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~---~~~~~kl~DFgla~~  226 (380)
                      ||+.+|+|.+.+.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++   .++.+||+|||++..
T Consensus       101 e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          101 ELYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             CCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            9999999988873     34568999999999999999999999  6799999999999995   456899999999987


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      .....   ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.....   .+....+......      
T Consensus       174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~------  240 (486)
T 3mwu_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVETGKYA------  240 (486)
T ss_dssp             BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCC------
T ss_pred             CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCC------
Confidence            64422   2334578999999999876 599999999999999999999999976432   1122211111100      


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..    .+....+++++.+++.+||+.||.+|||+.+++++
T Consensus       241 ~~----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          241 FD----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             SC----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CC----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00    01112345779999999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.9e-44  Score=328.22  Aligned_cols=247  Identities=25%  Similarity=0.391  Sum_probs=194.8

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC-----CChHHHHHHHHHHhcCCCCceeeeccceec----CCeeE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQF  146 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  146 (380)
                      +.|++.+.||+|+||.||+|.. .++..||+|....     ...+.+.+|+.+++.++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            3467788999999999999996 4678899997432     223568899999999999999999998764    45689


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCceEEccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRN  225 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~-~~~~~kl~DFgla~  225 (380)
                      +||||+++++|.+++.     ....+++..++.++.|++.||.|||+.+.+|+||||||+|||++ .++.+||+|||++.
T Consensus       106 lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEecCCCCHHHHHH-----HccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            9999999999999983     34668899999999999999999999322399999999999997 78999999999997


Q ss_pred             ccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      .....    ......+++.|+|||.+. ..++.++||||||+++|+|++|+.||.....  ............       
T Consensus       181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~-------  246 (290)
T 1t4h_A          181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGV-------  246 (290)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTC-------
T ss_pred             ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHHHHhccC-------
Confidence            54332    233456889999999887 4599999999999999999999999975432  111111111110       


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                           ....++...++++.+++.+||+.||.+|||+.+++++
T Consensus       247 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          247 -----KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -----CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                 0111222334679999999999999999999999875

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.3e-45  Score=345.01  Aligned_cols=265  Identities=20%  Similarity=0.276  Sum_probs=197.7

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCChHHHHHHHHHHhcCCCCceeeeccceec----------
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQE----------  141 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  141 (380)
                      ....++|++.+.||+|+||.||+|.. .+++.||+|+.... .....+|+++++.++||||+++++++..          
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence            34567899999999999999999995 57899999975433 2233479999999999999999999843          


Q ss_pred             ----------------------------CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 016917          142 ----------------------------NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS  193 (380)
Q Consensus       142 ----------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~  193 (380)
                                                  ....++||||+++ +|.+.+.... .....+++..+..++.|++.||.|||+
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~  159 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFI-RSGRSIPMNLISIYIYQLFRAVGFIHS  159 (383)
T ss_dssp             ----------------------------CCEEEEEECCCSE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                                        3347899999985 7666653211 234678999999999999999999999


Q ss_pred             CCCCeEecCCCCCCeeeC-CCCceEEcccccccccCCCCCCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHH
Q 016917          194 LSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLE  271 (380)
Q Consensus       194 ~~~~ivHrDikp~Nili~-~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~e  271 (380)
                        .+|+||||||+|||++ .++.+||+|||+++......   ......+|..|+|||.+.+. .|+.++|||||||++||
T Consensus       160 --~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          160 --LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             --TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             --CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence              7799999999999997 68899999999998764432   23345678899999998765 58999999999999999


Q ss_pred             HHcCCCCCCCCCCCCcccHHHHHHhhhc--ccchh------------hhcccccccCCCHHHHHHHHHHHhHccCCCCCC
Q 016917          272 LVSGREASSSLSPDSSQDLVELVQNSRD--FSNLL------------KILDERLWSTFTNEGMEEFIQLIVRCLDPSSER  337 (380)
Q Consensus       272 l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  337 (380)
                      |++|+.||......  ..+...+.....  ...+.            ..........++...++++.+|+.+||+.||.+
T Consensus       235 ll~g~~pf~~~~~~--~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  312 (383)
T 3eb0_A          235 LILGKPLFSGETSI--DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL  312 (383)
T ss_dssp             HHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred             HHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence            99999999864421  111111111000  00000            000111112234456678999999999999999


Q ss_pred             CCCHHHHHHH
Q 016917          338 RPSMSDVVTE  347 (380)
Q Consensus       338 Rpt~~~ll~~  347 (380)
                      |||+.|++++
T Consensus       313 R~t~~e~l~h  322 (383)
T 3eb0_A          313 RINPYEAMAH  322 (383)
T ss_dssp             SCCHHHHHTS
T ss_pred             CCCHHHHhcC
Confidence            9999999965

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-44  Score=335.96  Aligned_cols=261  Identities=20%  Similarity=0.301  Sum_probs=196.6

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC--------hHHHHHHHHHHhcCCCCceeeeccceecCCee
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      ..++|++.+.||+|+||.||+|... +++.||+|......        ...+.+|+++++.++||||+++++++...+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            4568999999999999999999964 68999999865321        24578999999999999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++||||+++ +|.+++..    ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.
T Consensus        88 ~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             EEEEECCSE-EHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             EEEEEcCCC-CHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            999999986 77777732    23457888899999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc----
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF----  300 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----  300 (380)
                      ......  .......+|+.|+|||++.+. .++.++|||||||++|||++|.+||.....   .+....+......    
T Consensus       161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~~~  235 (346)
T 1ua2_A          161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEE  235 (346)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTT
T ss_pred             eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCChh
Confidence            764322  123345689999999998654 589999999999999999999999876432   1111111111100    


Q ss_pred             --cchhhhcc---cccccCC-----CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 --SNLLKILD---ERLWSTF-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 --~~~~~~~~---~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                        .......+   .......     ....++++.+++.+||+.||.+|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence              00000000   0000011     12345789999999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.6e-45  Score=341.84  Aligned_cols=267  Identities=18%  Similarity=0.280  Sum_probs=198.3

Q ss_pred             CHHHHHHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC--------------hHHHHHHHHHHhcCCCCcee
Q 016917           68 QMEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP--------------TQEFIDEVCFLASIQHRNLV  133 (380)
Q Consensus        68 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~h~niv  133 (380)
                      ...++....++|++.+.||+|+||.||+|...++..||+|+.....              .+.+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            4567777889999999999999999999998889999999743211              15688999999999999999


Q ss_pred             eecccee-----cCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 016917          134 TLLGYCQ-----ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (380)
Q Consensus       134 ~l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Ni  208 (380)
                      ++++++.     .....++||||+++ +|.+.+.    .....+++..+..++.|++.||.|||+  ++|+||||||+||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NI  165 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH----DQRIVISPQHIQYFMYHILLGLHVLHE--AGVVHRDLHPGNI  165 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHH----CTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCCC-CHHHHHH----hcccCCCHHHHHHHHHHHHHHHHHHHH--CcCEecCCChHHE
Confidence            9999984     33468999999985 7777764    234568999999999999999999999  6799999999999


Q ss_pred             eeCCCCceEEcccccccccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCc
Q 016917          209 LVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSS  287 (380)
Q Consensus       209 li~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~  287 (380)
                      |++.++.+||+|||++.......   ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||......  
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--  240 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--  240 (362)
T ss_dssp             EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--
T ss_pred             EEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH--
Confidence            99999999999999997543322   2334568889999999876 67899999999999999999999999864421  


Q ss_pred             ccHHHHHHhhhcccch-----------hhhccc-------ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          288 QDLVELVQNSRDFSNL-----------LKILDE-------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       288 ~~~~~~~~~~~~~~~~-----------~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       +....+.........           ......       ..+.......++.+.+++.+||+.||.+|||+.+++++
T Consensus       241 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          241 -NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             -HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence             111111110000000           000000       00111122345779999999999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.4e-44  Score=353.86  Aligned_cols=248  Identities=23%  Similarity=0.346  Sum_probs=202.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|... +++.||+|...      ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            356889999999999999999965 78999999743      23456789999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCceEEccccccc
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRN  225 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili---~~~~~~kl~DFgla~  225 (380)
                      |||+.+|+|.+.+.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||+   +.++.+||+|||++.
T Consensus       105 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          105 GEVYTGGELFDEII-----SRKRFSEVDAARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             ECCCCSCBHHHHHH-----TCSCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            99999999998883     34568999999999999999999999  679999999999999   567899999999998


Q ss_pred             ccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ......   ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.....   .+....+......     
T Consensus       178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~-----  245 (484)
T 3nyv_A          178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---YDILKKVEKGKYT-----  245 (484)
T ss_dssp             HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCC-----
T ss_pred             Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCCCC-----
Confidence            764322   2345578999999999876 699999999999999999999999986432   1112211111000     


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                           ...+....+++++.+++.+||+.||.+|||+.+++++
T Consensus       246 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          246 -----FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             -----CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence                 0001112345779999999999999999999999976

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.4e-45  Score=343.99  Aligned_cols=261  Identities=20%  Similarity=0.259  Sum_probs=202.1

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      .++|++.+.||+|+||.||+|... ++..||+|......    .+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            457899999999999999999965 68899999854332    3467899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      |+++++|.+++.     ....+++..+..++.|++.||.|||+  + +|+||||||+|||++.++.+||+|||++.....
T Consensus       112 ~~~~~~L~~~l~-----~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          112 HMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             CCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             CCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            999999999983     34568899999999999999999998  4 699999999999999999999999999876532


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH---------------
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV---------------  294 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------  294 (380)
                      .    ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...............               
T Consensus       185 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          185 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             H----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             c----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence            1    123456889999999999999999999999999999999999999765422111000000               


Q ss_pred             --------Hhhhcccch----hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          295 --------QNSRDFSNL----LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       295 --------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                              .........    ..+............++.++.+|+.+||+.||.+|||+.+++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                    000000000    00111111111122356789999999999999999999999976

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.5e-44  Score=351.79  Aligned_cols=248  Identities=23%  Similarity=0.392  Sum_probs=199.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC----------------CChHHHHHHHHHHhcCCCCceeeeccc
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----------------APTQEFIDEVCFLASIQHRNLVTLLGY  138 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~----------------~~~~~~~~E~~~l~~l~h~niv~l~~~  138 (380)
                      .++|++.+.||+|+||+||+|... ++..||+|....                ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            467999999999999999999965 578999997432                224568899999999999999999999


Q ss_pred             eecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC---c
Q 016917          139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF---I  215 (380)
Q Consensus       139 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~---~  215 (380)
                      +.+.+..++||||+++|+|.+.+.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++   .
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQII-----NRHKFDECDAANIMKQILSGICYLHK--HNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESSTTCCSS
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCcHHHEEEecCCCCcc
Confidence            999999999999999999988883     34668999999999999999999999  6799999999999998775   6


Q ss_pred             eEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH
Q 016917          216 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ  295 (380)
Q Consensus       216 ~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~  295 (380)
                      +||+|||++.......   ......||+.|+|||++. ..|+.++|||||||++|+|++|..||.....   ......+.
T Consensus       188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~  260 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND---QDIIKKVE  260 (504)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH
T ss_pred             EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH
Confidence            9999999998765422   234456899999999987 4699999999999999999999999986442   12222221


Q ss_pred             hhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .....      .....+    ..+++++.+++.+||+.||.+|||+++++++
T Consensus       261 ~~~~~------~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          261 KGKYY------FDFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HCCCC------CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCCC------CCcccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11100      000011    1234779999999999999999999999976

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=333.57  Aligned_cols=262  Identities=19%  Similarity=0.265  Sum_probs=202.7

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC---ChHHHHHHHHHHhcCCCCceeeecccee----cCCeeE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQ----ENNLQF  146 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~  146 (380)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|.....   ..+.+.+|+++++.++||||+++++++.    .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            456799999999999999999996 57899999975433   3456889999999999999999999986    345789


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +||||+++|+|.+++.... .....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLK-DKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            9999999999998884321 134668999999999999999999999  6799999999999999999999999999876


Q ss_pred             cCCCCCCC-------CCccccCccceecccccccCC---CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh
Q 016917          227 LGRTDVAG-------PSSQVTADEIFLASEVKEFRR---FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  296 (380)
Q Consensus       227 ~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~---~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  296 (380)
                      ........       ......+|..|+|||.+.+..   ++.++||||||+++|||++|+.||....... ........ 
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~-  261 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVALAVQ-  261 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHHHHH-
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhHHhh-
Confidence            53211000       012334688999999987554   6899999999999999999999986321110 11111111 


Q ss_pred             hhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhh
Q 016917          297 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  353 (380)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~  353 (380)
                                  .....+.+...++++.+++.+||+.||.+|||+.+++++|+.+..
T Consensus       262 ------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          262 ------------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             ------------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             ------------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                        111122233456789999999999999999999999999988764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.2e-43  Score=334.81  Aligned_cols=251  Identities=20%  Similarity=0.345  Sum_probs=201.5

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC-----------hHHHHHHHHHHhcC-CCCceeeecccee
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----------TQEFIDEVCFLASI-QHRNLVTLLGYCQ  140 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l-~h~niv~l~~~~~  140 (380)
                      ...++|++.+.||+|+||.||+|... +|+.||||+.....           .+.+.+|+.+++++ +||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            34467899999999999999999975 78999999754322           34577899999999 7999999999999


Q ss_pred             cCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcc
Q 016917          141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  220 (380)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~D  220 (380)
                      ..+..++||||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~--~gi~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLT-----EKVALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECC
T ss_pred             eCCEEEEEEEeCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEEe
Confidence            9999999999999999999883     34568999999999999999999999  6799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCccceeccccccc------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH
Q 016917          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  294 (380)
Q Consensus       221 Fgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~  294 (380)
                      ||++..+....   ......||+.|+|||++.+      ..++.++|||||||++|+|++|..||.....   ......+
T Consensus       244 fG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~~~i  317 (365)
T 2y7j_A          244 FGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILMLRMI  317 (365)
T ss_dssp             CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH
T ss_pred             cCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HHHHHHH
Confidence            99988765432   2334678999999999864      3688999999999999999999999975431   1111111


Q ss_pred             HhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..... .     .....+    ...++.+.+++.+||+.||++|||+.+++++
T Consensus       318 ~~~~~-~-----~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          318 MEGQY-Q-----FSSPEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHTCC-C-----CCHHHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhCCC-C-----CCCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11100 0     000001    1234679999999999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.9e-44  Score=361.25  Aligned_cols=248  Identities=19%  Similarity=0.292  Sum_probs=205.2

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC------CCChHHHHHHHHHHhcC-CCCceeeeccceecCCee
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  145 (380)
                      ...++|++.+.||+|+||.||+|+.+ +++.||+|+..      ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            44567999999999999999999964 67889999753      33456678899999988 799999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      |+||||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       418 ~lV~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~--~gIiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQ-----QVGRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             EEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             EEEEeCcCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeccCChhhEEEcCCCcEEEeecceee
Confidence            99999999999999883     34568999999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ......  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.   .++...+.          
T Consensus       491 ~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~~~~~i~----------  555 (674)
T 3pfq_A          491 ENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIM----------  555 (674)
T ss_dssp             ECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----------
T ss_pred             ccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---HHHHHHHH----------
Confidence            643221  224456799999999999999999999999999999999999999986432   11221111          


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHHH
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM-----SDVVTE  347 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~~ll~~  347 (380)
                        ...  ..++...++++.+|+.+||+.||.+||++     ++++++
T Consensus       556 --~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          556 --EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             --SSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             --hCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence              111  23455667889999999999999999998     666653

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.2e-44  Score=328.77  Aligned_cols=248  Identities=22%  Similarity=0.304  Sum_probs=201.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC---ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA---PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|.....   ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            356888999999999999999965 6899999975432   345688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCceEEcccccccccC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili---~~~~~~kl~DFgla~~~~  228 (380)
                      +++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+||++   +.++.+||+|||++....
T Consensus        88 ~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           88 VSGGELFDRIL-----ERGVYTEKDASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             CCCccHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999998883     34568899999999999999999999  679999999999999   788999999999987543


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ..    ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.....   ......+....          
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~----------  223 (304)
T 2jam_A          161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLFEKIKEGY----------  223 (304)
T ss_dssp             CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHCC----------
T ss_pred             CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCC----------
Confidence            21    22345688999999999999999999999999999999999999976432   11111111110          


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...........++++.+++.+||+.||.+|||+.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          224 YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            000112223456789999999999999999999999975

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.7e-44  Score=329.64  Aligned_cols=258  Identities=25%  Similarity=0.357  Sum_probs=197.5

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC--CCc--EEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ--DGM--LVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~--~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      .++|++.+.||+|+||.||+|.+.  ++.  .||+|.....      ..+.+.+|++++++++||||+++++++...+ .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            457889999999999999999853  233  6899975432      2356889999999999999999999998765 7


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++|+||+++++|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEEECCTTCBHHHHHHH----HGGGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeEecccCCCHHHHHHh----ccCCcCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEEcCCCCEEEccccccc
Confidence            899999999999998842    23568899999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCCC-CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          226 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       226 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      ........ .......+|..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ......+.        
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~--------  238 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKID--------  238 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHH--------
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHHHHHH--------
Confidence            76443211 12234456778999999998899999999999999999999 9999976532   11111111        


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                          ........+..+++++.+++.+||+.||.+|||+.++++.|.++....
T Consensus       239 ----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          239 ----KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             ----TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             ----ccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence                111112334456688999999999999999999999999998877543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.9e-44  Score=359.70  Aligned_cols=259  Identities=26%  Similarity=0.435  Sum_probs=206.8

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEECC----CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCe
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL  144 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  144 (380)
                      ....++|++.+.||+|+||.||+|....    +..||+|......    .+.+.+|+.++++++||||+++++++.+ +.
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~  464 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP  464 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cc
Confidence            3345668888999999999999998642    4679999865433    2568899999999999999999999854 56


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .++||||+++|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       465 ~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHH----TTTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             eEEEEEcCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchHhEEEeCCCCEEEEecCCC
Confidence            8999999999999998842    23458899999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      +........ ......+|..|+|||++.+..++.++|||||||++|||++ |..||.....   .+....+..       
T Consensus       539 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~~i~~-------  607 (656)
T 2j0j_A          539 RYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIEN-------  607 (656)
T ss_dssp             CSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHH-------
T ss_pred             eecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHc-------
Confidence            876543221 2233456788999999999999999999999999999997 9999976432   112211111       


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                            ......+..+++.+.+++.+||+.||.+|||+.++++.|+++++++
T Consensus       608 ------~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          608 ------GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             ------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence                  1122345566788999999999999999999999999999988653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.2e-44  Score=327.74  Aligned_cols=246  Identities=19%  Similarity=0.300  Sum_probs=203.1

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|... +++.+|+|.....      ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            456888999999999999999965 5788999974322      235678899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++++|.+++.     ....+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++....
T Consensus        94 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           94 LELCRRRSLLELHK-----RRKALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EECCTTCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            99999999998873     34568899999999999999999999  679999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ...  .......++..|+|||.+.+..++.++||||||+++|+|++|+.||......   +....+..            
T Consensus       167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~------------  229 (294)
T 2rku_A          167 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYLRIKK------------  229 (294)
T ss_dssp             STT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHT------------
T ss_pred             cCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhh------------
Confidence            322  1233456888999999999999999999999999999999999999764321   11111100            


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .  ....+...++.+.+++.+||+.||++|||+++++++
T Consensus       230 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          230 N--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             T--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             c--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0  012334455779999999999999999999999975

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.4e-43  Score=321.11  Aligned_cols=246  Identities=22%  Similarity=0.281  Sum_probs=196.2

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      ..++|++.+.||+|+||.||+|... +++.||+|...      ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            3467899999999999999999965 78999999753      2345578899999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++...
T Consensus        89 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           89 VMEYVSGGELFDYIC-----KHGRVEEMEARRLFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EEECCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--HCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             EEeccCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            999999999999883     34568899999999999999999999  67999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCccceecccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      ....   ......++..|+|||.+.+..+ +.++||||||+++|+|++|..||.....   ......+...         
T Consensus       162 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~---------  226 (276)
T 2h6d_A          162 SDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PTLFKKIRGG---------  226 (276)
T ss_dssp             CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC---------
T ss_pred             CCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhhcC---------
Confidence            4422   1234468889999999988776 6899999999999999999999975331   1111111110         


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                           ....+...+.++.+++.+||+.||.+|||+.+++++
T Consensus       227 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          227 -----VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -----cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                 012333455779999999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2e-44  Score=343.44  Aligned_cols=262  Identities=22%  Similarity=0.289  Sum_probs=195.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcCCCCceeeeccceecCC------eeEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENN------LQFLIY  149 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  149 (380)
                      ..+|++.+.||+|+||.||+|+...+..+|+|+..... ....+|+++++.++||||+++++++...+      ..++||
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~-~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~  117 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL  117 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc-chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence            34688999999999999999998777779998753321 22347999999999999999999985433      378999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCceEEcccccccccC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLG  228 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~-~~~~~kl~DFgla~~~~  228 (380)
                      ||++++.+..... . ......+++..+..++.|++.||.|||+  .+|+||||||+|||++ .++.+||+|||+++...
T Consensus       118 e~~~~~l~~~~~~-~-~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          118 EYVPETVYRASRH-Y-AKLKQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             ECCSEEHHHHHHH-H-HHTTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eccCccHHHHHHH-H-HhhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            9998754433221 0 1134678899999999999999999999  7799999999999998 79999999999998764


Q ss_pred             CCCCCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh--cccchhh
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR--DFSNLLK  305 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~  305 (380)
                      ...   ......+|+.|+|||++.+. .|+.++|||||||++|||++|+.||.+....  ..+...+....  ....+..
T Consensus       194 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          194 AGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             TTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHH
T ss_pred             CCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHh
Confidence            322   23355789999999998765 5899999999999999999999999865421  11222111100  0000000


Q ss_pred             ------------hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          306 ------------ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       306 ------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                                  .........++...++++.+|+.+||+.||.+|||+.+++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                        000011112233456789999999999999999999999976

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2e-44  Score=336.31  Aligned_cols=246  Identities=19%  Similarity=0.301  Sum_probs=203.5

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|.+.+.||+|+||.||++... +++.+|+|.....      ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467889999999999999999965 5788999975322      245678899999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++++|.+++.     ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++....
T Consensus       120 ~e~~~~~~L~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHK-----RRKALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            99999999998873     34568999999999999999999999  679999999999999999999999999998764


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ...  .......++..|+|||++.+..++.++||||||+++|+|++|+.||.....   .+....+...           
T Consensus       193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~-----------  256 (335)
T 2owb_A          193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KETYLRIKKN-----------  256 (335)
T ss_dssp             STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHT-----------
T ss_pred             cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHHhcC-----------
Confidence            322  123345688999999999999999999999999999999999999975431   1111111100           


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         ....+..+++++.+++.+||+.||++|||+.+++++
T Consensus       257 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          257 ---EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               012333455779999999999999999999999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=9.4e-44  Score=348.70  Aligned_cols=247  Identities=24%  Similarity=0.395  Sum_probs=197.3

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC-----CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      +.|++.+.||+|+||.||+|... ++..||+|...     ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46889999999999999999965 68899999743     2345678999999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEccccccccc
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNFL  227 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~---~~~~kl~DFgla~~~  227 (380)
                      |+++|+|.+.+.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.   ++.+||+|||++...
T Consensus       117 ~~~~g~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          117 CYKGGELFDEII-----HRMKFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             CCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             cCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            999999988873     34568899999999999999999999  77999999999999976   456999999999876


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                      ....   ......||+.|+|||++. ..|+.++|||||||++|+|++|..||.....   ......+.....      ..
T Consensus       190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~------~~  256 (494)
T 3lij_A          190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILRKVEKGKY------TF  256 (494)
T ss_dssp             BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCC------CC
T ss_pred             CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCC------CC
Confidence            5432   233456899999999986 5699999999999999999999999986442   122221111110      00


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....+    ..+++++.+++.+||+.||.+|||+.+++++
T Consensus       257 ~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          257 DSPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CSGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             Cchhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            11111    1345679999999999999999999999976

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.2e-44  Score=339.80  Aligned_cols=255  Identities=22%  Similarity=0.336  Sum_probs=181.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecC------C
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN------N  143 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  143 (380)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|+.....     .+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46799999999999999999995 568999999865432     34677899999999999999999998653      5


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      ..++|+||+ +++|.+++.      ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             eEEEEeccc-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            679999998 678888873      2568999999999999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc--
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF--  300 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--  300 (380)
                      ++.....     .....+|..|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..   +....+......  
T Consensus       179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~  250 (367)
T 2fst_X          179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPG  250 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCC
T ss_pred             ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCC
Confidence            9865432     234578999999999877 68899999999999999999999999865421   111111110000  


Q ss_pred             -cchhhhccc-------cc-------ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 -SNLLKILDE-------RL-------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 -~~~~~~~~~-------~~-------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       .....+...       .+       ........++.+.+|+.+||+.||.+|||+.+++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence             000000000       00       000011235678999999999999999999999976

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.6e-44  Score=325.80  Aligned_cols=244  Identities=23%  Similarity=0.350  Sum_probs=196.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|... +++.||+|.....     ....+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            456888999999999999999965 7899999975432     234678899999998 999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---------------
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---------------  213 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~---------------  213 (380)
                      |||+++++|.+++..... ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHh--CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999843211 12568999999999999999999999  779999999999999844               


Q ss_pred             ----CceEEcccccccccCCCCCCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcc
Q 016917          214 ----FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ  288 (380)
Q Consensus       214 ----~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~  288 (380)
                          ..+||+|||++......      ....+|..|+|||.+.+. .++.++|||||||++|+|++|.+|+....     
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----  235 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-----  235 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred             cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence                47999999998876442      233588899999998766 56689999999999999999987754321     


Q ss_pred             cHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          289 DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       ....+..             ......+..+++++.+++.+||+.||++|||+.+++++
T Consensus       236 -~~~~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          236 -QWHEIRQ-------------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             -HHHHHHT-------------TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -HHHHHHc-------------CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence             1111111             11123344456789999999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.6e-44  Score=345.81  Aligned_cols=196  Identities=21%  Similarity=0.322  Sum_probs=162.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecC-----Ce
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NL  144 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  144 (380)
                      .++|++.+.||+|+||.||+|.. .+++.||+|+.....     .+.+.+|+++++.++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46799999999999999999995 468899999865421     24678999999999999999999998765     56


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .|+||||+++ +|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~~-~L~~~~~-----~~~~l~~~~~~~i~~qil~aL~~LH~--~givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIADS-DLKKLFK-----TPIFLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCSE-EHHHHHH-----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCCc-CHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            8999999875 8888883     34568999999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCC--------------------CCCccccCccceeccccc-ccCCCCcchhhHHHHHHHHHHHcCCCCC
Q 016917          225 NFLGRTDVA--------------------GPSSQVTADEIFLASEVK-EFRRFSEKSDVYSFGVFLLELVSGREAS  279 (380)
Q Consensus       225 ~~~~~~~~~--------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~~DvwSlG~il~el~tg~~p~  279 (380)
                      +........                    .......||+.|+|||++ .+..|+.++|||||||++|||++|..||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            876442211                    123566789999999985 5667999999999999999999855444

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.7e-44  Score=336.15  Aligned_cols=261  Identities=21%  Similarity=0.348  Sum_probs=196.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      .++|++.+.||+|+||.||+|... +++.||+|+.....     .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            457888999999999999999965 58999999753322     234678999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++++|.+++.     ....+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.....
T Consensus       104 e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          104 EFVDHTILDDLEL-----FPNGLDYQVVQKYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             ECCSEEHHHHHHH-----STTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecCCcchHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHH--CCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            9999998887762     34568999999999999999999999  6799999999999999999999999999976643


Q ss_pred             CCCCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc--------
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF--------  300 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------  300 (380)
                      ..  .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||......  .............        
T Consensus       177 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~  252 (331)
T 4aaa_A          177 PG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI--DQLYHIMMCLGNLIPRHQELF  252 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHHHHH
T ss_pred             Cc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhhhHh
Confidence            22  122345688899999998875 7899999999999999999999999765421  1111111100000        


Q ss_pred             ---cchhhhccccccc-----CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 ---SNLLKILDERLWS-----TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 ---~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         ........+....     .....+++++.+++.+||+.||.+|||+.|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence               0000000000000     0112345789999999999999999999999976

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.1e-45  Score=331.16  Aligned_cols=252  Identities=23%  Similarity=0.359  Sum_probs=200.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeecccee--cCCeeEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQ--ENNLQFL  147 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l  147 (380)
                      .++|++.+.||+|+||.||+|... +++.||+|.....     ..+.+.+|+.++++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            457889999999999999999965 6889999975432     2345789999999999999999999874  4678899


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCCeeeCCCCceEEcccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR-----VVHKDFKTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-----ivHrDikp~Nili~~~~~~kl~DFg  222 (380)
                      ||||+++++|.+++.... .....+++..++.++.|++.||.|||+  .+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHR--RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH--HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHhc--ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999884321 123458999999999999999999999  66     9999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  302 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (380)
                      ++........  ......++..|+|||.+.+..++.++||||||+++|+|++|..||.....   .+....+..      
T Consensus       162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~~------  230 (279)
T 2w5a_A          162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIRE------  230 (279)
T ss_dssp             HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH------
T ss_pred             hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHHhh------
Confidence            9876543211  11234678899999999998999999999999999999999999986532   111111111      


Q ss_pred             hhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                             ......+..+++++.+++.+||+.||.+|||+.++++++
T Consensus       231 -------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          231 -------GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             -------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             -------cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence                   111233445567899999999999999999999999865

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1e-43  Score=330.27  Aligned_cols=254  Identities=16%  Similarity=0.205  Sum_probs=200.9

Q ss_pred             HHHhCCCCCC-CeeccCCceEEEEEEEC-CCcEEEEEeCCC-----CChHHHHHHHHHHhcC-CCCceeeeccceecCCe
Q 016917           73 SLATKNFSDK-NLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG-----APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNL  144 (380)
Q Consensus        73 ~~~~~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  144 (380)
                      ....+.|.+. +.||+|+||.||+|... +++.||+|....     .....+.+|+.+++.+ +||||+++++++.+.+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3345567766 88999999999999965 689999997432     2356788999999999 56999999999999999


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADA  221 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~---~~~~kl~DF  221 (380)
                      .++||||+++|+|.+++..   .....+++..++.++.|++.||.|||+  ++|+||||||+|||++.   ++.+||+||
T Consensus       104 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~--~givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             EEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            9999999999999998843   234668999999999999999999999  67999999999999987   789999999


Q ss_pred             ccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc
Q 016917          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       222 gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                      |++.......   ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||......   .....+...    
T Consensus       179 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~----  248 (327)
T 3lm5_A          179 GMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---ETYLNISQV----  248 (327)
T ss_dssp             GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHT----
T ss_pred             ccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHhc----
Confidence            9998764422   123456899999999999999999999999999999999999999764321   111111110    


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                            ...........+++.+.+++.+||+.||.+|||+++++++
T Consensus       249 ------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          249 ------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             ------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                  0111112223456779999999999999999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.3e-44  Score=335.84  Aligned_cols=263  Identities=20%  Similarity=0.299  Sum_probs=199.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecC-----Cee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  145 (380)
                      .++|++.+.||+|+||.||+|... ++..||+|+.....    .+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            357999999999999999999954 68899999865432    24578999999999999999999998654     468


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++||||+++ +|.+++.      ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.
T Consensus       106 ~iv~e~~~~-~L~~~l~------~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLK------TQHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEECCSE-EHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEcccCc-CHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            999999975 8887772      3458999999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCC-CCCCccccCccceecccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          226 FLGRTDV-AGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       226 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      ....... ........||+.|+|||++. +..++.++|||||||++|+|++|+.||......+.................
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            7654322 22234567999999999865 455899999999999999999999999875532221111100000000000


Q ss_pred             hhhcc--------------cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 LKILD--------------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....+              ...+.......++++.+|+.+||+.||++|||+.+++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000              000001112345779999999999999999999999976

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.6e-45  Score=346.01  Aligned_cols=242  Identities=12%  Similarity=0.108  Sum_probs=185.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC------CChHHHHHHHH---HHhcCCCCceeeec-------cc
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVC---FLASIQHRNLVTLL-------GY  138 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~E~~---~l~~l~h~niv~l~-------~~  138 (380)
                      .++|++.+.||+|+||.||+|.. .+++.||+|....      ...+.+.+|++   +++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35688889999999999999995 5689999997431      22466889994   55566899999998       44


Q ss_pred             eecCC-----------------eeEEEEEeecCCCccccccCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 016917          139 CQENN-----------------LQFLIYEYIPNGSVSIHLYGPSQV--SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV  199 (380)
Q Consensus       139 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~iv  199 (380)
                      +...+                 ..|+||||+ +|+|.+++......  ....+++..++.++.|++.||.|||+  ++|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~iv  228 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLV  228 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH--TTEE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh--CCee
Confidence            44432                 278999999 57999988432111  11234457888899999999999999  6799


Q ss_pred             ecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccC-----------CCCcchhhHHHHHH
Q 016917          200 HKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-----------RFSEKSDVYSFGVF  268 (380)
Q Consensus       200 HrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~DvwSlG~i  268 (380)
                      ||||||+|||++.++.+||+|||+++....     ......| ..|+|||++.+.           .|+.++|||||||+
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            999999999999999999999999986433     1233456 889999999887           89999999999999


Q ss_pred             HHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          269 LLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       269 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      +|||++|+.||........               ...+.      .....+++++.+++.+||+.||.+|||+.+++++
T Consensus       303 l~elltg~~Pf~~~~~~~~---------------~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGG---------------SEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHHHSSCCC------CC---------------SGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHHHCCCCCcccccccc---------------hhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            9999999999976442211               01111      0112345779999999999999999999999964

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=333.89  Aligned_cols=266  Identities=22%  Similarity=0.310  Sum_probs=201.5

Q ss_pred             HHHHHHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCC-----CChHHHHHHHHHHhcCCCCceeeeccceecCC
Q 016917           69 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENN  143 (380)
Q Consensus        69 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  143 (380)
                      ..++.+..++|++.+.||+|+||.||+|..+.  .+|+|....     ...+.+.+|+.++++++||||+++++++.+.+
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            34445567889999999999999999999764  488987543     22355778999999999999999999999999


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      ..++||||+++++|.+++..    ....+++..++.++.|++.||.|||+  .+|+||||||+|||++ ++.+||+|||+
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             ceEEEeecccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChhhEEEe-CCCEEEeecCC
Confidence            99999999999999999842    23468889999999999999999999  6799999999999998 67999999999


Q ss_pred             ccccCCCC---CCCCCccccCccceeccccccc---------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHH
Q 016917          224 RNFLGRTD---VAGPSSQVTADEIFLASEVKEF---------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV  291 (380)
Q Consensus       224 a~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~---------~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~  291 (380)
                      +.......   .........|+..|+|||.+.+         ..++.++||||||+++|||++|+.||......   ...
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~  252 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AII  252 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH
Confidence            87653211   1122334558899999999864         45789999999999999999999999764321   111


Q ss_pred             HHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhccc
Q 016917          292 ELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNL  358 (380)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~~  358 (380)
                      ..+....         .+   ...+..++.++.+++.+||+.||.+|||+.++++.|+++.++....
T Consensus       253 ~~~~~~~---------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~  307 (319)
T 2y4i_B          253 WQMGTGM---------KP---NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL  307 (319)
T ss_dssp             HHHHTTC---------CC---CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred             HHhccCC---------CC---CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence            1111110         00   0111134466899999999999999999999999999998776543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.1e-44  Score=330.80  Aligned_cols=266  Identities=22%  Similarity=0.321  Sum_probs=188.4

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      .+..++|++.+.||+|+||.||+|.. .++..||+|.....    ..+.+.+|+.++++++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            34567899999999999999999994 46889999976532    34567889999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCC---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          148 IYEYIPNGSVSIHLYGPS---QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      ||||+++++|.+++....   ......+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999998884211   1124568999999999999999999999  67999999999999999999999999998


Q ss_pred             cccCCCCC---CCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc
Q 016917          225 NFLGRTDV---AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF  300 (380)
Q Consensus       225 ~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  300 (380)
                      ........   ........+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.......   ......... .
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~-~  244 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLMLTLQND-P  244 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHHHTSS-C
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHHHHhccC-C
Confidence            76543211   112234568899999999876 578999999999999999999999998754321   111111100 0


Q ss_pred             cchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .....   ..........+++++.+++.+||+.||.+|||+.+++++
T Consensus       245 ~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          245 PSLET---GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             CCTTC--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             Ccccc---ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            00000   000011222345679999999999999999999999974

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=327.01  Aligned_cols=251  Identities=25%  Similarity=0.402  Sum_probs=200.6

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC-CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ..++|++.+.||+|+||.||+|... +++.||+|... ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  106 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC  106 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence            4567999999999999999999965 58999999754 344677899999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++++|.+++.    .....+++..++.++.|++.||.|||+  .+++|+||||+||+++.++.+||+|||++....... 
T Consensus       107 ~~~~L~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (314)
T 3com_A          107 GAGSVSDIIR----LRNKTLTEDEIATILQSTLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-  179 (314)
T ss_dssp             TTEEHHHHHH----HHTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred             CCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence            9999999883    134568899999999999999999999  679999999999999999999999999997764422 


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                       .......++..|+|||.+.+..++.++||||||+++|+|++|..||......   ..........           ...
T Consensus       180 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~-----------~~~  244 (314)
T 3com_A          180 -AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM---RAIFMIPTNP-----------PPT  244 (314)
T ss_dssp             -SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSC-----------CCC
T ss_pred             -cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhcCC-----------Ccc
Confidence             1233456889999999999999999999999999999999999999754321   1111000000           001


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...+..+++.+.+++.+||+.||.+|||+.+++++
T Consensus       245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            11233456789999999999999999999999975

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=323.20  Aligned_cols=250  Identities=23%  Similarity=0.397  Sum_probs=197.0

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC---CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeec
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG---APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      +|.....||+|+||.||+|.. .++..||+|....   ...+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            455556899999999999995 5688999997543   235678899999999999999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEcccccccccCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~-~~~~kl~DFgla~~~~~~~~  232 (380)
                      +++|.+++...  .....+++..+..++.|++.||.|||+  ++|+||||||+||+++. ++.+||+|||++....... 
T Consensus       103 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          103 GGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             EEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHh--CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            99999988532  123356788899999999999999999  67999999999999987 8999999999998764322 


Q ss_pred             CCCCccccCccceecccccccCC--CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRR--FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                       .......++..|+|||++.+..  ++.++||||||+++|+|++|+.||.......    ...... .         ...
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~-~---------~~~  242 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AAMFKV-G---------MFK  242 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HHHHHH-H---------HHC
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HHHHhh-c---------ccc
Confidence             1123456889999999987653  8899999999999999999999997533210    000000 0         001


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .....+..+++++.+++.+||+.||++|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1123445566789999999999999999999999864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=337.69  Aligned_cols=257  Identities=20%  Similarity=0.294  Sum_probs=186.8

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC---hHHHHHHHHHHhcCC-CCceeeeccce--------ec
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP---TQEFIDEVCFLASIQ-HRNLVTLLGYC--------QE  141 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~-h~niv~l~~~~--------~~  141 (380)
                      ...+|++.+.||+|+||.||+|.. .+++.||+|......   .+.+.+|+.+++++. ||||+++++++        ..
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            345789999999999999999996 468999999754333   345788999999995 99999999988        34


Q ss_pred             CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeeCCCCceEEc
Q 016917          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR--VVHKDFKTANVLVDEDFIAKVA  219 (380)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~--ivHrDikp~Nili~~~~~~kl~  219 (380)
                      ....++||||+. |+|.+++...  .....+++..++.++.|++.||.|||+  .+  |+||||||+|||++.++.+||+
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKM--ESRGPLSCDTVLKIFYQTCRAVQHMHR--QKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHH--HTTCSCCHHHHHHHHHHHHHHHHHHHT--SSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             CceEEEEEEecC-CCHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCEEEccCCcccEEECCCCCEEEe
Confidence            456799999996 5888877422  124568999999999999999999999  56  9999999999999999999999


Q ss_pred             ccccccccCCCCCC----------CCCccccCccceeccccc---ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 016917          220 DAGLRNFLGRTDVA----------GPSSQVTADEIFLASEVK---EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS  286 (380)
Q Consensus       220 DFgla~~~~~~~~~----------~~~~~~~~~~~~~aPE~~---~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~  286 (380)
                      |||++.........          .......+|+.|+|||++   .+..++.++|||||||++|+|++|+.||.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            99999876542211          111244588999999998   56778999999999999999999999997533210


Q ss_pred             cccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          287 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                            .             .............+..+.+++.+||+.||.+|||+.+++++|..+....
T Consensus       261 ------~-------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          261 ------I-------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             ------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ------h-------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence                  0             0111111112223355889999999999999999999999999887653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.2e-44  Score=327.61  Aligned_cols=252  Identities=21%  Similarity=0.297  Sum_probs=185.7

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCCh-----HHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPT-----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|.......     ..+.++...++.++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            356788999999999999999996 5789999998654322     1233445557888999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      |||+++ +|.+++.... .....+++..++.++.|++.||.|||+  + +|+||||||+||+++.++.+||+|||++...
T Consensus        85 ~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH--HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999975 7766663211 134678999999999999999999998  5 7999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCccceeccccc----ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVK----EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      ....   ......+|+.|+|||.+    .+..++.++|||||||++|+|++|+.||......     .....        
T Consensus       161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~--------  224 (290)
T 3fme_A          161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLK--------  224 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHH--------
T ss_pred             cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHH--------
Confidence            4422   12334688899999995    5667899999999999999999999999753321     11111        


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       ...........+..+++++.+++.+||+.||++|||+.+++++
T Consensus       225 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          225 -QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             -HHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             -HHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence             0111111111223456789999999999999999999999984

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.4e-43  Score=333.56  Aligned_cols=271  Identities=23%  Similarity=0.249  Sum_probs=191.2

Q ss_pred             HHHHHHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC--CCChHHHHHHHHHHhcCCCCceeeeccceecCCe--
Q 016917           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP--GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNL--  144 (380)
Q Consensus        70 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  144 (380)
                      .......++|++.+.||+|+||.||+|... ++..||+|+..  ........++++.++.++||||+++++++...+.  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            445567789999999999999999999964 68999999743  3344567788888999999999999999865333  


Q ss_pred             -----eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEE
Q 016917          145 -----QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKV  218 (380)
Q Consensus       145 -----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~-~~~~kl  218 (380)
                           .++||||++++ |...+... ......+++..+..++.|++.||.|||.++++|+||||||+|||++. ++.+||
T Consensus        96 ~~~~~~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDT-LHRCCRNY-YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             TTCEEEEEEEECCSCB-HHHHHHHH-HTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred             ccceeEEEEeeccccc-HHHHHHHH-hhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence                 78999999874 43333111 02345678899999999999999999933378999999999999996 899999


Q ss_pred             cccccccccCCCCCCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhh
Q 016917          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS  297 (380)
Q Consensus       219 ~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  297 (380)
                      +|||++.......   ......+|..|+|||++.+. .++.++|||||||++|||++|+.||......  ..........
T Consensus       174 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~  248 (360)
T 3e3p_A          174 CDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHEIVRVL  248 (360)
T ss_dssp             CCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHH
T ss_pred             eeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHHHHHHc
Confidence            9999998765432   23345689999999998665 4899999999999999999999999865421  1111111110


Q ss_pred             hcc-cchhhhc----------------ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          298 RDF-SNLLKIL----------------DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       298 ~~~-~~~~~~~----------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ... .......                ........+...++++.+|+.+||+.||.+|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            000 0000000                0011122233457889999999999999999999999976

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2e-43  Score=330.92  Aligned_cols=264  Identities=17%  Similarity=0.213  Sum_probs=203.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC------h--------------HHHHHHHHHHhcCCCCceeee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP------T--------------QEFIDEVCFLASIQHRNLVTL  135 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~------~--------------~~~~~E~~~l~~l~h~niv~l  135 (380)
                      .++|++.+.||+|+||.||+|.. ++..||+|......      .              +.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 89999999743211      1              778999999999999999999


Q ss_pred             ccceecCCeeEEEEEeecCCCccccccCC---CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC
Q 016917          136 LGYCQENNLQFLIYEYIPNGSVSIHLYGP---SQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE  212 (380)
Q Consensus       136 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~  212 (380)
                      ++++.+.+..++||||+++|+|.+++...   .......+++..++.++.|++.||.|||+ .++|+||||||+||+++.
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDK  187 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TSCEECCCCCGGGEEECT
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc-cCCEeecCCChHhEEEcC
Confidence            99999999999999999999999983210   11125678999999999999999999997 145999999999999999


Q ss_pred             CCceEEcccccccccCCCCCCCCCccccCccceecccccccC-CCCc-chhhHHHHHHHHHHHcCCCCCCCCCCCCcccH
Q 016917          213 DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSE-KSDVYSFGVFLLELVSGREASSSLSPDSSQDL  290 (380)
Q Consensus       213 ~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~  290 (380)
                      ++.+||+|||++......    ......++..|+|||.+.+. .++. ++|||||||++|||++|..||......  ...
T Consensus       188 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~  261 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VEL  261 (348)
T ss_dssp             TSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHH
T ss_pred             CCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH
Confidence            999999999999876442    23445688999999999877 6766 999999999999999999999865431  122


Q ss_pred             HHHHHhhh-cccchh----hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          291 VELVQNSR-DFSNLL----KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       291 ~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...+.... ......    ...............++++.+++.+||+.||.+|||+.+++++
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            22221110 000000    0000000001113456789999999999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.9e-43  Score=336.59  Aligned_cols=261  Identities=18%  Similarity=0.256  Sum_probs=201.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC--hHHHHHHHHHHhcCC--------CCceeeecccee----
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP--TQEFIDEVCFLASIQ--------HRNLVTLLGYCQ----  140 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~--------h~niv~l~~~~~----  140 (380)
                      .++|++.+.||+|+||+||+|.. .+++.||+|......  .+.+.+|+.+++.++        |+||+++++++.    
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            46799999999999999999985 468899999876442  356788999999885        788999999987    


Q ss_pred             cCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCeeeCCCC-----
Q 016917          141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDF-----  214 (380)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~ivHrDikp~Nili~~~~-----  214 (380)
                      .....++||||+.+ ++.+.+..   .....+++..++.++.|++.||.|||+  + +|+||||||+|||++.++     
T Consensus       116 ~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          116 NGTHICMVFEVLGH-HLLKWIIK---SNYQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TEEEEEEEECCCCC-BHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCceEEEEEeccCc-cHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHeeEeccchhhhh
Confidence            56678999999955 55555532   123568999999999999999999999  6 799999999999999775     


Q ss_pred             --------------------------------------------ceEEcccccccccCCCCCCCCCccccCccceecccc
Q 016917          215 --------------------------------------------IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV  250 (380)
Q Consensus       215 --------------------------------------------~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~  250 (380)
                                                                  .+||+|||++......     .....+|..|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999876432     234568999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH---hhhc-ccc--------hhhhccc---------
Q 016917          251 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ---NSRD-FSN--------LLKILDE---------  309 (380)
Q Consensus       251 ~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~-~~~--------~~~~~~~---------  309 (380)
                      +.+..|+.++|||||||++|||++|+.||................   .... ...        .......         
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            999999999999999999999999999998766543322211111   1000 000        0000000         


Q ss_pred             ----------ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 ----------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ----------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                                ......+...++.+.+|+.+||+.||++|||+.|++++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                      00113467788899999999999999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=333.64  Aligned_cols=252  Identities=27%  Similarity=0.422  Sum_probs=195.6

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC--CCChHHHHHHHHHHhcC-CCCceeeeccceec------CC
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP--GAPTQEFIDEVCFLASI-QHRNLVTLLGYCQE------NN  143 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~  143 (380)
                      ...++|++.+.||+|+||.||+|.. .+++.||+|...  ....+.+.+|+.+++++ +||||+++++++..      .+
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            3467799999999999999999996 478999999743  34567789999999998 89999999999976      46


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      ..++||||+++++|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  175 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGV  175 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence            789999999999999988432   23568899999999999999999999  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCccceecccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR  298 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  298 (380)
                      +.......  .......++..|+|||.+.     +..++.++|||||||++|+|++|..||......   .....+..  
T Consensus       176 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~--  248 (326)
T 2x7f_A          176 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPR--  248 (326)
T ss_dssp             TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHH--
T ss_pred             ceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHhhc--
Confidence            88764321  1223456899999999986     567899999999999999999999999754321   11111100  


Q ss_pred             cccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          299 DFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                                .......+..+++.+.+++.+||..||.+|||+.+++++
T Consensus       249 ----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          249 ----------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             ----------SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ----------CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                      000011123345779999999999999999999999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.7e-44  Score=329.40  Aligned_cols=253  Identities=20%  Similarity=0.303  Sum_probs=196.9

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCC--CCceeeeccceecCCee
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQ--HRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~  145 (380)
                      ....++|++.+.||+|+||.||+|...+++.||+|.....     ..+.+.+|++++++++  ||||+++++++...+..
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            3445679999999999999999999888999999975432     2356789999999996  59999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++||| +.+++|.+++.     ....+++..++.++.|++.||.|||+  ++|+||||||+|||+++ +.+||+|||++.
T Consensus       104 ~lv~e-~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~  174 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVD-GMLKLIDFGIAN  174 (313)
T ss_dssp             EEEEC-CCSEEHHHHHH-----HCSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred             EEEEe-cCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEEEC-CeEEEeeccccc
Confidence            99999 56779999883     34568899999999999999999999  67999999999999964 899999999998


Q ss_pred             ccCCCCCCCCCccccCccceeccccccc-----------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEF-----------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  294 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~  294 (380)
                      ...............++..|+|||.+.+           ..++.++||||||+++|||++|+.||......     ... 
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~-  248 (313)
T 3cek_A          175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISK-  248 (313)
T ss_dssp             C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHH-
T ss_pred             cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHH-
Confidence            7654333223345568999999999875           47889999999999999999999999754321     111 


Q ss_pred             HhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 016917          295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL  348 (380)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L  348 (380)
                              +....+......++...++++.+++.+||+.||.+|||+.+++++-
T Consensus       249 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          249 --------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             --------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             --------HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence                    1111222222233444457899999999999999999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.5e-44  Score=343.52  Aligned_cols=259  Identities=18%  Similarity=0.231  Sum_probs=198.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC--hHHHHHHHHHHhcC------CCCceeeeccceecCCeeE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASI------QHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~  146 (380)
                      ..+|++.+.||+|+||.||+|... +++.||+|+.....  ...+.+|+.+++.+      +|+||+++++++...+..+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            456899999999999999999854 58899999876543  24567788887766      5789999999999999999


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc--eEEcccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI--AKVADAGLR  224 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~--~kl~DFgla  224 (380)
                      +||||+. ++|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.  +||+|||++
T Consensus       176 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          176 MTFELLS-MNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALHK--NRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEECCCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH--HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEeccC-CCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            9999996 5888877432   23458999999999999999999999  67999999999999999887  999999999


Q ss_pred             cccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc-----
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-----  299 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----  299 (380)
                      ......     .....+|+.|+|||++.+..|+.++|||||||++|||++|.+||......+  .+.........     
T Consensus       250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~--~l~~i~~~~~~p~~~~  322 (429)
T 3kvw_A          250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD--QLACMIELLGMPSQKL  322 (429)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHH
T ss_pred             eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCHHH
Confidence            764332     234578999999999999999999999999999999999999998654221  11111110000     


Q ss_pred             ---ccchhhhccccc------------------------------------ccCCCHHHHHHHHHHHhHccCCCCCCCCC
Q 016917          300 ---FSNLLKILDERL------------------------------------WSTFTNEGMEEFIQLIVRCLDPSSERRPS  340 (380)
Q Consensus       300 ---~~~~~~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt  340 (380)
                         .......++...                                    ....+...++++.+|+.+||+.||++|||
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt  402 (429)
T 3kvw_A          323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT  402 (429)
T ss_dssp             HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence               000000000000                                    00011122567899999999999999999


Q ss_pred             HHHHHHH
Q 016917          341 MSDVVTE  347 (380)
Q Consensus       341 ~~~ll~~  347 (380)
                      +.|++++
T Consensus       403 a~e~L~H  409 (429)
T 3kvw_A          403 PGQALRH  409 (429)
T ss_dssp             HHHHHTS
T ss_pred             HHHHhCC
Confidence            9999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.6e-43  Score=334.75  Aligned_cols=256  Identities=20%  Similarity=0.289  Sum_probs=189.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCC------
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENN------  143 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  143 (380)
                      .++|++.+.||+|+||.||+|... +++.||+|+....     ..+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            467999999999999999999954 6889999985432     1245788999999999999999999987654      


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      ..++||||+++ +|.+.+.       ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ceEEEEEcCCC-CHHHHHh-------hccCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEEEeec
Confidence            78999999976 6766662       347889999999999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc--cc
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD--FS  301 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~  301 (380)
                      +.......   ......+|+.|+|||++.+..|+.++|||||||++|+|++|+.||......   +....+.....  ..
T Consensus       174 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          174 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTPCP  247 (371)
T ss_dssp             -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHC-CCCCCH
T ss_pred             cccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence            98654321   223457899999999999999999999999999999999999999865421   11111100000  00


Q ss_pred             -----------------------chhhhcccccccC---CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 -----------------------NLLKILDERLWST---FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 -----------------------~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                                             .............   .+...++++.+|+.+||+.||.+|||+++++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                                   0000000000000   012346789999999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.8e-44  Score=344.32  Aligned_cols=261  Identities=25%  Similarity=0.305  Sum_probs=194.1

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCChHHHHHHHHHHhcCCCCceeeeccceec------CCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQE------NNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~lv~  149 (380)
                      .+|++.+.||+|+||.||+|... +++.||+|+.... .....+|+++++.++||||+++++++..      ....++||
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~  132 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL  132 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence            35888999999999999999975 6899999976433 2234579999999999999999998843      22467899


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CceEEcccccccccC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLG  228 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~-~~~kl~DFgla~~~~  228 (380)
                      ||+++ ++.+.+... ......+++..+..++.|++.||.|||+  .+|+||||||+|||++.+ +.+||+|||+++...
T Consensus       133 e~~~~-~l~~~~~~~-~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          133 DYVPE-TVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             ECCCE-EHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             hcccc-cHHHHHHHH-hhccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            99986 454444211 1234678999999999999999999999  779999999999999965 678999999998764


Q ss_pred             CCCCCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh--cccchhh
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR--DFSNLLK  305 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~  305 (380)
                      ...   ......+|+.|+|||++.+. .|+.++|||||||++|||++|+.||.+...  ...+.+.+....  ..+.+..
T Consensus       209 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          209 RGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             TTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCSCCHHHHHH
T ss_pred             cCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHHHh
Confidence            322   23345789999999998764 799999999999999999999999986432  122222221100  0000000


Q ss_pred             hc------------ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          306 IL------------DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       306 ~~------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..            ...+...++...++++.+|+.+||+.||.+|||+.|++++
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            00            0000111333456789999999999999999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3e-44  Score=339.75  Aligned_cols=250  Identities=12%  Similarity=0.021  Sum_probs=178.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC------hHHHHHHH---HHHhcCCCCceeeecc-------ce
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------TQEFIDEV---CFLASIQHRNLVTLLG-------YC  139 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~E~---~~l~~l~h~niv~l~~-------~~  139 (380)
                      .+|++.+.||+|+||.||+|... +++.||+|......      .+.+.+|+   ..|+. +||||++++.       ++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            34888899999999999999964 78999999855432      23466774   45555 7999888553       33


Q ss_pred             ecC-----------------CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCC
Q 016917          140 QEN-----------------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR------LSIALGAAKGLAHLHSLSP  196 (380)
Q Consensus       140 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~  196 (380)
                      ...                 ...|+||||++ |+|.+++...    ...+.+..+      ..++.|++.||.|||+  +
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~--~  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL----DFVYVFRGDEGILALHILTAQLIRLAANLQS--K  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH----HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH--T
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh----ccccchhhhhhhhhHHHHHHHHHHHHHHHHH--C
Confidence            222                 34799999999 7999998432    223344445      6778999999999999  6


Q ss_pred             CeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceeccccccc--CCCCcchhhHHHHHHHHHHHc
Q 016917          197 RVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVS  274 (380)
Q Consensus       197 ~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DvwSlG~il~el~t  274 (380)
                      +|+||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..|+.++|||||||++|||++
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence            7999999999999999999999999999866431     114456689999999987  789999999999999999999


Q ss_pred             CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          275 GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       275 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      |+.||....+.....        .....................+++++.+++.+||+.||++|||+.+++++
T Consensus       289 g~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          289 LFLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             SSCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            999998764332110        00000001111111112223556889999999999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.4e-43  Score=323.18  Aligned_cols=250  Identities=20%  Similarity=0.309  Sum_probs=201.4

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC------------hHHHHHHHHHHhcCC-CCceeeecccee
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP------------TQEFIDEVCFLASIQ-HRNLVTLLGYCQ  140 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~-h~niv~l~~~~~  140 (380)
                      ..++|++.+.||+|+||.||+|... +++.||+|......            .+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3567999999999999999999965 68899999854322            245778999999995 999999999999


Q ss_pred             cCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcc
Q 016917          141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  220 (380)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~D  220 (380)
                      ..+..++||||+++++|.+++.     ....+++..++.++.|++.||.|||+  .+++||||||+||+++.++.+||+|
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECC
T ss_pred             cCCeEEEEEeccCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEcCCCcEEEec
Confidence            9999999999999999999983     34568999999999999999999999  6799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCccceecccccc------cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH
Q 016917          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKE------FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  294 (380)
Q Consensus       221 Fgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~  294 (380)
                      ||++.......   ......++..|+|||++.      ...++.++||||||+++|+|++|..||.....   ......+
T Consensus       168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~  241 (298)
T 1phk_A          168 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLRMI  241 (298)
T ss_dssp             CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH
T ss_pred             ccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HHHHHHH
Confidence            99998764422   223456888999999875      45688999999999999999999999975431   1111111


Q ss_pred             HhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....          ...........++.+.+++.+||+.||.+|||+.+++++
T Consensus       242 ~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          242 MSGN----------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HHTC----------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             hcCC----------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            1100          000011113456789999999999999999999999874

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.2e-43  Score=329.06  Aligned_cols=249  Identities=19%  Similarity=0.302  Sum_probs=195.5

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC-----------hHHHHHHHHHHhcCCCCceeeeccceecCC
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQHRNLVTLLGYCQENN  143 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  143 (380)
                      .++|++.+.||+|+||.||+|... +++.||+|......           ...+.+|++++++++||||+++++++...+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            456899999999999999999964 57899999754321           234789999999999999999999987665


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc---eEEcc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVAD  220 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~---~kl~D  220 (380)
                       .++||||+++++|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.   +||+|
T Consensus        89 -~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             -EEEEEECCTTEETHHHHS-----TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             -eEEEEecCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence             799999999999998883     34568899999999999999999999  67999999999999987654   99999


Q ss_pred             cccccccCCCCCCCCCccccCccceecccccc---cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhh
Q 016917          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS  297 (380)
Q Consensus       221 Fgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  297 (380)
                      ||++.......   ......+|..|+|||++.   ...++.++|||||||++|+|++|..||......  ..+...+...
T Consensus       161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~  235 (322)
T 2ycf_A          161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQITSG  235 (322)
T ss_dssp             CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--SCHHHHHHHT
T ss_pred             Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--HHHHHHHHhC
Confidence            99998764321   122446888999999864   567899999999999999999999999765432  1222222111


Q ss_pred             hcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      . ...     .+..+    ...++++.+++.+||+.||.+|||+.+++++
T Consensus       236 ~-~~~-----~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          236 K-YNF-----IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             C-CCC-----CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             c-ccc-----Cchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            1 000     00011    1234678999999999999999999999864

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.4e-43  Score=326.76  Aligned_cols=261  Identities=19%  Similarity=0.269  Sum_probs=201.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE--CCCcEEEEEeCCCCC--hHHHHHHHHHHhcCCCC------ceeeeccceecCCee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL--QDGMLVAIKKRPGAP--TQEFIDEVCFLASIQHR------NLVTLLGYCQENNLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~~  145 (380)
                      .++|++.+.||+|+||.||+|..  .+++.||+|......  .+.+.+|+++++.++|+      +++++++++...+..
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            45799999999999999999986  368899999876443  35678899999888655      599999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-------------
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-------------  212 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~-------------  212 (380)
                      ++||||+ +++|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.             
T Consensus        93 ~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEcCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            9999999 77998888432   22467899999999999999999999  67999999999999987             


Q ss_pred             ------CCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 016917          213 ------DFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS  286 (380)
Q Consensus       213 ------~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~  286 (380)
                            ++.+||+|||++......     .....+|..|+|||++.+..++.++|||||||++|||++|..||......+
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                  668999999999864332     234578999999999999999999999999999999999999998654321


Q ss_pred             cccHHHHHHhhhcccchh--------------------------hhccc-ccccCCCHHHHHHHHHHHhHccCCCCCCCC
Q 016917          287 SQDLVELVQNSRDFSNLL--------------------------KILDE-RLWSTFTNEGMEEFIQLIVRCLDPSSERRP  339 (380)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~--------------------------~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp  339 (380)
                      ..................                          ....+ ......+...++++.+++.+||+.||.+||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            111111110000000000                          00000 001123445678899999999999999999


Q ss_pred             CHHHHHHH
Q 016917          340 SMSDVVTE  347 (380)
Q Consensus       340 t~~~ll~~  347 (380)
                      |+.|++++
T Consensus       322 t~~ell~h  329 (339)
T 1z57_A          322 TLREALKH  329 (339)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999875

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.8e-43  Score=325.24  Aligned_cols=261  Identities=23%  Similarity=0.315  Sum_probs=199.3

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE--CCCcEEEEEeCC-----CCChHHHHHHHHHHhcC---CCCceeeecccee----
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL--QDGMLVAIKKRP-----GAPTQEFIDEVCFLASI---QHRNLVTLLGYCQ----  140 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~--~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~----  140 (380)
                      ..++|++.+.||+|+||.||+|..  .+++.||+|...     ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            346799999999999999999997  467899999643     22234577788777766   8999999999987    


Q ss_pred             -cCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEc
Q 016917          141 -ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  219 (380)
Q Consensus       141 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~  219 (380)
                       .....++||||++ |+|.+++...   ....+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~--~gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHHHeEEcCCCCEEEe
Confidence             5567899999998 5888887432   23458899999999999999999999  679999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc
Q 016917          220 DAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD  299 (380)
Q Consensus       220 DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  299 (380)
                      |||++.......   ......++..|+|||++.+..++.++|||||||++|+|++|+.||......   +....+.....
T Consensus       163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~  236 (326)
T 1blx_A          163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIG  236 (326)
T ss_dssp             SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHC
T ss_pred             cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcC
Confidence            999998664322   223456888999999999999999999999999999999999999865421   11111111100


Q ss_pred             ccchhh----------hc---ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 FSNLLK----------IL---DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 ~~~~~~----------~~---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ......          ..   .......+....++.+.+++.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000000          00   0001112233456789999999999999999999999964

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.8e-43  Score=334.27  Aligned_cols=266  Identities=19%  Similarity=0.282  Sum_probs=181.7

Q ss_pred             CCC-CCeeccCCceEEEEEEEC---CCcEEEEEeCCCC-ChHHHHHHHHHHhcCCCCceeeecccee--cCCeeEEEEEe
Q 016917           79 FSD-KNLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQ--ENNLQFLIYEY  151 (380)
Q Consensus        79 ~~~-~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~  151 (380)
                      |++ .++||+|+||.||+|..+   ++..||+|..... ....+.+|++++++++||||+++++++.  .....++||||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~  101 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY  101 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEEC
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeC
Confidence            555 458999999999999965   5789999987644 3567889999999999999999999994  46789999999


Q ss_pred             ecCCCccccccCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----CCCCceEEccccc
Q 016917          152 IPNGSVSIHLYGPS----QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV----DEDFIAKVADAGL  223 (380)
Q Consensus       152 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili----~~~~~~kl~DFgl  223 (380)
                      +++ +|.+++....    ......+++..++.++.|++.||.|||+  ++|+||||||+|||+    +.++.+||+|||+
T Consensus       102 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  178 (405)
T 3rgf_A          102 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGF  178 (405)
T ss_dssp             CSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred             CCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence            975 6666653111    1122358999999999999999999999  679999999999999    6778999999999


Q ss_pred             ccccCCCCC-CCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCc------ccHHHHHH
Q 016917          224 RNFLGRTDV-AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSS------QDLVELVQ  295 (380)
Q Consensus       224 a~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~------~~~~~~~~  295 (380)
                      ++....... ........||+.|+|||++.+. .|+.++|||||||++|||++|+.||........      .+....+.
T Consensus       179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~  258 (405)
T 3rgf_A          179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  258 (405)
T ss_dssp             CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred             ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence            987654221 1223456789999999998874 589999999999999999999999976543210      01111111


Q ss_pred             hhhcc------cchhh---------hcccccccC---------CCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          296 NSRDF------SNLLK---------ILDERLWST---------FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       296 ~~~~~------~~~~~---------~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .....      ..+..         .+.......         .....++++.+|+.+||+.||.+|||++|++++
T Consensus       259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            10000      00000         000000000         001114678999999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.2e-43  Score=332.65  Aligned_cols=254  Identities=20%  Similarity=0.329  Sum_probs=193.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCee----
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ----  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  145 (380)
                      .++|.+.+.||+|+||.||+|... +++.||+|+.....     ...+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467889999999999999999954 68999999865432     34678899999999999999999999877654    


Q ss_pred             --EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          146 --FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       146 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                        ++||||+.+ +|.+.+       ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus       121 ~~~lv~e~~~~-~l~~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          121 DFYLVMPFMQT-DLQKIM-------GMEFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCEEEEECCCE-EHHHHT-------TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEEccccc-cHHHHh-------hcCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence              999999984 777666       2348899999999999999999999  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc-
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS-  301 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-  301 (380)
                      +......     .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......   +....+....... 
T Consensus       191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~  262 (371)
T 4exu_A          191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPG  262 (371)
T ss_dssp             C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCC
T ss_pred             ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCc
Confidence            9865432     234567899999999887 78899999999999999999999999864421   1111111100000 


Q ss_pred             -chhh------------hccccc---ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 -NLLK------------ILDERL---WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 -~~~~------------~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       ....            ......   ........++++.+|+.+||+.||.+|||+.+++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence             0000            000000   001112345789999999999999999999999976

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-43  Score=325.72  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=197.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC---CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG---APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      .++|++.+.||+|+||.||+|... ++..||+|....   ...+.+.+|+++++.++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            457889999999999999999975 588999997543   3456788999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++++|.+++..    ....+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++.......
T Consensus        98 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           98 CPGGAVDAIMLE----LDRGLTEPQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             CTTEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             CCCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            999999988732    24568999999999999999999999  679999999999999999999999999875432111


Q ss_pred             CCCCCccccCccceeccccc-----ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          232 VAGPSSQVTADEIFLASEVK-----EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~-----~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                        .......++..|+|||.+     .+..++.++||||||+++|+|++|..||......   ..........        
T Consensus       172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~--------  238 (302)
T 2j7t_A          172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSD--------  238 (302)
T ss_dssp             --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSC--------
T ss_pred             --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHHHhccC--------
Confidence              112334688899999987     4677899999999999999999999999865421   1111110000        


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         ......+..++.++.+++.+||+.||.+|||+.+++++
T Consensus       239 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          239 ---PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             ---CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             ---CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence               00112234456789999999999999999999999874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=9e-43  Score=327.35  Aligned_cols=254  Identities=20%  Similarity=0.326  Sum_probs=194.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCe-----
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL-----  144 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  144 (380)
                      .++|.+.+.||+|+||.||+|.. .+|+.||+|......     .+.+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            35788999999999999999996 468999999864322     3457889999999999999999999987654     


Q ss_pred             -eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          145 -QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       145 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                       .++||||++ ++|.+++.       ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEeECCCCcEEEeeccc
Confidence             499999997 47877662       348899999999999999999999  6799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc-
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS-  301 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-  301 (380)
                      +......     .....+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||......   +....+....... 
T Consensus       173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~  244 (353)
T 3coi_A          173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPG  244 (353)
T ss_dssp             TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCBCC
T ss_pred             ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCC
Confidence            9865432     234567899999999876 67899999999999999999999999865421   1111111100000 


Q ss_pred             -chh------------hhccc---ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 -NLL------------KILDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 -~~~------------~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       ...            ..+..   ..........++++.+++.+||+.||.+|||+.+++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             000            00000   00112233556889999999999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.6e-43  Score=329.80  Aligned_cols=260  Identities=22%  Similarity=0.304  Sum_probs=195.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecC-----Cee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  145 (380)
                      .++|++.+.||+|+||.||+|... +++.||+|......    ...+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            457889999999999999999965 68899999865433    23567899999999999999999987654     678


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++||||+.+ +|.+++.      ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++.
T Consensus        90 ~lv~e~~~~-~L~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           90 YIIQELMQT-DLHRVIS------TQMLSDDHIQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEECCCSE-EHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeccCc-cHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            999999974 8887772      3468899999999999999999999  679999999999999999999999999998


Q ss_pred             ccCCCCCC--------CCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh
Q 016917          226 FLGRTDVA--------GPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  296 (380)
Q Consensus       226 ~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  296 (380)
                      ........        .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||......   .....+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~  237 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR---HQLLLIFG  237 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHH
Confidence            76532211        11233568999999998754 67899999999999999999999999865421   11111110


Q ss_pred             hhcc---cc---------hhhhccc------ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          297 SRDF---SN---------LLKILDE------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       297 ~~~~---~~---------~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....   ..         .......      ..........++++.+++.+||+.||++|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000   00         0000000      00000112345779999999999999999999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=324.37  Aligned_cols=260  Identities=20%  Similarity=0.309  Sum_probs=190.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeecccee-----------
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQ-----------  140 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  140 (380)
                      .++|++.+.||+|+||.||+|... +++.||+|......   .+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            357889999999999999999965 48999999765443   346789999999999999999998873           


Q ss_pred             ---cCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCce
Q 016917          141 ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIA  216 (380)
Q Consensus       141 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~-~~~~~  216 (380)
                         ..+..++||||++ |+|.+++.      ...+++..+..++.|++.||.|||+  ++|+||||||+|||++ +++.+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE------QGPLLEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh------cCCccHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCeE
Confidence               4467899999998 58988872      3568899999999999999999999  6799999999999997 56799


Q ss_pred             EEcccccccccCCCCC-CCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH
Q 016917          217 KVADAGLRNFLGRTDV-AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  294 (380)
Q Consensus       217 kl~DFgla~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~  294 (380)
                      ||+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||......   .....+
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~  237 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---EQMQLI  237 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHH
Confidence            9999999987643211 122334567888999998765 67899999999999999999999999865421   111111


Q ss_pred             Hhhhccc------chhhh----ccccc------ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          295 QNSRDFS------NLLKI----LDERL------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       295 ~~~~~~~------~~~~~----~~~~~------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .......      .+...    .....      .......+++++.+++.+||+.||++|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            1100000      00000    00000      001112345789999999999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.7e-42  Score=329.01  Aligned_cols=200  Identities=23%  Similarity=0.262  Sum_probs=168.8

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC--hHHHHHHHHHHhcCC-CC-----ceeeeccceecCCee
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-HR-----NLVTLLGYCQENNLQ  145 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~  145 (380)
                      ..++|++.+.||+|+||+||+|... +++.||+|+.....  ...+..|+.+++.++ |+     +|+++++++...+..
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  131 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL  131 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence            3568999999999999999999965 67899999876442  345677888888774 44     599999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC--CCCceEEccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGL  223 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~--~~~~~kl~DFgl  223 (380)
                      ++||||+++ +|.+++...   ....+++..+..++.|++.||.|||.+..+|+||||||+|||++  .++.+||+|||+
T Consensus       132 ~lv~e~~~~-~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          132 CLVFEMLSY-NLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEECCCC-BHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEecCCC-CHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            999999965 888888432   22458899999999999999999996547899999999999995  478899999999


Q ss_pred             ccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLS  283 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~  283 (380)
                      +......     .....+|+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus       208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9876432     234578999999999999999999999999999999999999998654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.4e-42  Score=328.10  Aligned_cols=259  Identities=17%  Similarity=0.233  Sum_probs=198.6

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC--hHHHHHHHHHHhcCC-----------CCceeeeccceec
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-----------HRNLVTLLGYCQE  141 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  141 (380)
                      .++|++.+.||+|+||.||+|.. .+++.||+|......  .+.+.+|+.++++++           ||||+++++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            46799999999999999999995 568999999876442  356788999998876           8999999999876


Q ss_pred             CC----eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCeeeC-----
Q 016917          142 NN----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVD-----  211 (380)
Q Consensus       142 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~ivHrDikp~Nili~-----  211 (380)
                      .+    ..++||||+ +++|.+++...   ....+++..+..++.|++.||.|||+  + +|+||||||+|||++     
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChHHeEEeccCCC
Confidence            54    789999999 88998888432   23458899999999999999999999  6 799999999999994     


Q ss_pred             -CCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccH
Q 016917          212 -EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL  290 (380)
Q Consensus       212 -~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~  290 (380)
                       ..+.+||+|||++......     .....+|+.|+|||++.+..++.++|||||||++|||++|..||...........
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             4458999999999876432     2344689999999999999999999999999999999999999986553322211


Q ss_pred             HHHH----Hhhhcccc-----------------------------hhhhcccccccCCCHHHHHHHHHHHhHccCCCCCC
Q 016917          291 VELV----QNSRDFSN-----------------------------LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSER  337 (380)
Q Consensus       291 ~~~~----~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  337 (380)
                      ...+    ........                             +....  .....++...++++.+|+.+||+.||.+
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL--TEKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH--HHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhh--hhcccCCcchHHHHHHHHHHHhccCccc
Confidence            1111    10000000                             00000  0112466788899999999999999999


Q ss_pred             CCCHHHHHHH
Q 016917          338 RPSMSDVVTE  347 (380)
Q Consensus       338 Rpt~~~ll~~  347 (380)
                      |||+.+++++
T Consensus       325 Rpt~~ell~h  334 (373)
T 1q8y_A          325 RADAGGLVNH  334 (373)
T ss_dssp             CBCHHHHHTC
T ss_pred             cCCHHHHhhC
Confidence            9999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.2e-42  Score=317.16  Aligned_cols=249  Identities=21%  Similarity=0.313  Sum_probs=200.0

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC-----CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      ..++|++.+.||+|+||.||+|... +++.||+|...     ....+.+.+|++++++++||||+++++++...+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3467999999999999999999965 68899999743     33466789999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---CceEEccccccc
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED---FIAKVADAGLRN  225 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~---~~~kl~DFgla~  225 (380)
                      |||+++++|.+.+.     ....+++..++.++.|++.||.|||+  ++++||||||+||+++.+   +.+||+|||++.
T Consensus       100 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A          100 GELYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             ECCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            99999999988873     34568899999999999999999999  679999999999999754   479999999988


Q ss_pred             ccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ......   ......++..|+|||.+.+ .++.++||||||+++|+|++|..||.....   .+....+......     
T Consensus       173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~-----  240 (287)
T 2wei_A          173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVETGKYA-----  240 (287)
T ss_dssp             TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCC-----
T ss_pred             eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCC-----
Confidence            764422   1233457888999999876 489999999999999999999999976432   1111111111000     


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       .+    .......++++.+++.+||+.||++|||+.+++++
T Consensus       241 -~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          241 -FD----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             -CC----SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -CC----chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence             00    00012345779999999999999999999999974

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.9e-43  Score=324.22  Aligned_cols=256  Identities=21%  Similarity=0.315  Sum_probs=178.3

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCC----hHHHHHHHH-HHhcCCCCceeeeccceecCCeeEEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAP----TQEFIDEVC-FLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      ..++|++.+.||+|+||.||+|... +++.||+|......    ...+..|.. +++.++||||+++++++...+..++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            3567889999999999999999964 68999999865432    223455555 77788999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      |||+++ +|.+++..........+++..+..++.|++.||.|||+  + +|+||||||+|||++.++.+||+|||++...
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH--HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc--cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            999986 67666532111235678899999999999999999999  6 7999999999999999999999999999876


Q ss_pred             CCCCCCCCCccccCccceeccccc----ccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVK----EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      ....   ......+|..|+|||.+    .+..++.++|||||||++|+|++|+.||......     .+...      ..
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~------~~  242 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----FDQLT------QV  242 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C------CC
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----HHHHH------HH
Confidence            4422   12234688899999998    4667899999999999999999999999754321     00000      00


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .....+.+.......+++++.+++.+||+.||.+|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            00000111111223455789999999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6.8e-43  Score=320.41  Aligned_cols=251  Identities=23%  Similarity=0.378  Sum_probs=191.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceec-----------
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQE-----------  141 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----------  141 (380)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.....  ..+.+.+|+.++++++||||+++++++.+           
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            35688899999999999999996 47899999986432  23567899999999999999999998754           


Q ss_pred             --CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEc
Q 016917          142 --NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVA  219 (380)
Q Consensus       142 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~  219 (380)
                        .+..++||||+++|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHS----ENLNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHH----SCGGGCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhc----cccccchHHHHHHHHHHHHHHHHHHh--CCeecccCCHHhEEEcCCCCEEEe
Confidence              4567999999999999999842    23457788999999999999999999  679999999999999999999999


Q ss_pred             ccccccccCCCCC------------CCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 016917          220 DAGLRNFLGRTDV------------AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDS  286 (380)
Q Consensus       220 DFgla~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~  286 (380)
                      |||++........            ........++..|+|||++.+. .++.++|||||||++|+|++   ||...    
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~----  231 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG----  231 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----
Confidence            9999987643210            1122345688899999998765 68999999999999999998   44321    


Q ss_pred             cccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          287 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       .+..........       ........++...++.+.+++.+||+.||.+|||+.+++++
T Consensus       232 -~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          232 -MERVNILKKLRS-------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             -HHHHHHHHHHHS-------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -hhHHHHHHhccc-------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence             111111111110       11112233445566789999999999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1e-42  Score=335.82  Aligned_cols=255  Identities=19%  Similarity=0.250  Sum_probs=189.5

Q ss_pred             CCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEeecCCC
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPNGS  156 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~  156 (380)
                      .|...+.||+|+||+||.+...+|+.||+|.......+.+.+|+.+++++ +||||+++++++.+.+..++||||+. |+
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs   94 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN   94 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence            34556889999999998877778999999987666667788999999876 89999999999999999999999996 59


Q ss_pred             ccccccCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-------------CceEEccc
Q 016917          157 VSIHLYGPSQVSR--QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED-------------FIAKVADA  221 (380)
Q Consensus       157 L~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~-------------~~~kl~DF  221 (380)
                      |.+++........  ....+..++.++.|++.||.|||+  .+|+||||||+|||++.+             +.+||+||
T Consensus        95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF  172 (434)
T 2rio_A           95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF  172 (434)
T ss_dssp             HHHHHHTC------------CCHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred             HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence            9998854322111  111233457799999999999999  679999999999999654             48999999


Q ss_pred             ccccccCCCCCC--CCCccccCccceeccccccc-------CCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHH
Q 016917          222 GLRNFLGRTDVA--GPSSQVTADEIFLASEVKEF-------RRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLV  291 (380)
Q Consensus       222 gla~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~  291 (380)
                      |++.........  .......||+.|+|||++.+       ..++.++|||||||++|||++ |..||......    ..
T Consensus       173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----~~  248 (434)
T 2rio_A          173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR----ES  248 (434)
T ss_dssp             TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH----HH
T ss_pred             ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh----HH
Confidence            999877543211  12234578999999999875       678999999999999999999 99999654321    11


Q ss_pred             HHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          292 ELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .........        +......+...++++.+++.+||+.||.+|||+.+++++
T Consensus       249 ~i~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          249 NIIRGIFSL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             HHHHTCCCC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHhcCCCCc--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            111111111        111112345678899999999999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.8e-42  Score=323.23  Aligned_cols=252  Identities=18%  Similarity=0.237  Sum_probs=173.4

Q ss_pred             hCCCCCCC-eeccCCceEEEEEEEC-CCcEEEEEeCCCCChHHHHHHH-HHHhcCCCCceeeeccceec----CCeeEEE
Q 016917           76 TKNFSDKN-LIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEV-CFLASIQHRNLVTLLGYCQE----NNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~-~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~----~~~~~lv  148 (380)
                      .++|++.+ .||+|+||.||+|... +++.||+|+....  ....+|+ ..++.++||||+++++++..    ....++|
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  104 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII  104 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence            45788754 6999999999999965 6899999986543  2233343 44667799999999999875    4558999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEccccccc
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRN  225 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~---~~~~kl~DFgla~  225 (380)
                      |||+++|+|.+++...   ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.   ++.+||+|||++.
T Consensus       105 ~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~--~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          105 MECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EeccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            9999999999998532   23468999999999999999999999  77999999999999976   4569999999998


Q ss_pred             ccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      .....    ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.............   ...      .
T Consensus       180 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~------~  246 (336)
T 3fhr_A          180 ETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRI------R  246 (336)
T ss_dssp             EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             ecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhh------h
Confidence            65432    1234567889999999998899999999999999999999999997654322110000   000      0


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .............+++++.+++.+||+.||.+|||+.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            000001111123456789999999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.6e-42  Score=323.78  Aligned_cols=258  Identities=18%  Similarity=0.259  Sum_probs=197.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CC-cEEEEEeCCCC--ChHHHHHHHHHHhcCCCCc------eeeeccceecCCee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DG-MLVAIKKRPGA--PTQEFIDEVCFLASIQHRN------LVTLLGYCQENNLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~-~~vavK~~~~~--~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~  145 (380)
                      .++|++.+.||+|+||.||+|... ++ ..||+|.....  ..+.+.+|+++++.++|++      ++.+++++...+..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            467999999999999999999964 34 68999987643  2456778999999887655      89999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---------------
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV---------------  210 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili---------------  210 (380)
                      ++||||+ ++++.+++..   .....+++..+..++.|++.||.|||+  ++|+||||||+|||+               
T Consensus        98 ~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKE---NNFQPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEecc-CCChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecccccccccccccc
Confidence            9999999 4566666532   123468999999999999999999999  679999999999999               


Q ss_pred             ----CCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 016917          211 ----DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS  286 (380)
Q Consensus       211 ----~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~  286 (380)
                          +.++.+||+|||++......     .....||..|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                56789999999999864332     234578999999999999999999999999999999999999998654221


Q ss_pred             cccHHHHHHhhh-cccc-hh-hh------cc-------------------c--ccccCCCHHHHHHHHHHHhHccCCCCC
Q 016917          287 SQDLVELVQNSR-DFSN-LL-KI------LD-------------------E--RLWSTFTNEGMEEFIQLIVRCLDPSSE  336 (380)
Q Consensus       287 ~~~~~~~~~~~~-~~~~-~~-~~------~~-------------------~--~~~~~~~~~~~~~l~~li~~cl~~dp~  336 (380)
                         ....+.... .... .. ..      ..                   .  ..........+.++.+|+.+||+.||.
T Consensus       247 ---~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          247 ---HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             ---HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             ---HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence               111111100 0000 00 00      00                   0  001122334567899999999999999


Q ss_pred             CCCCHHHHHHH
Q 016917          337 RRPSMSDVVTE  347 (380)
Q Consensus       337 ~Rpt~~~ll~~  347 (380)
                      +|||+.+++++
T Consensus       324 ~Rpt~~e~l~h  334 (355)
T 2eu9_A          324 QRITLAEALLH  334 (355)
T ss_dssp             TSCCHHHHTTS
T ss_pred             hCcCHHHHhcC
Confidence            99999999865

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=333.14  Aligned_cols=251  Identities=20%  Similarity=0.219  Sum_probs=188.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEEEeecC
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      ..+|+..+.||+|+||+|+.....+++.||||+........+.+|+++++.+ +||||+++++++.+.+..|+||||+. 
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-  101 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-  101 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence            3458888999999999977666678999999998766666778999999999 79999999999999999999999997 


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-----CCceEEcccccccccCC
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-----DFIAKVADAGLRNFLGR  229 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~-----~~~~kl~DFgla~~~~~  229 (380)
                      |+|.+++....    .......++.++.|++.||.|||+  .+|+||||||+|||++.     ...+||+|||+++....
T Consensus       102 g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          102 ATLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             EEHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHHH--TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CCHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHHH--CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            48888885332    223334457899999999999999  67999999999999953     23678999999987654


Q ss_pred             CCC-CCCCccccCccceecccccc---cCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          230 TDV-AGPSSQVTADEIFLASEVKE---FRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       230 ~~~-~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ... ........||+.|+|||++.   +..++.++|||||||++|||++ |..||......    ..........     
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~~~~~~~~~~-----  246 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----QANILLGACS-----  246 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----HHHHHTTCCC-----
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----HHHHHhccCC-----
Confidence            321 12234567999999999987   4567889999999999999999 88898543211    1111100000     


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                           ..........+..+.+++.+||+.||.+|||+.+++++
T Consensus       247 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          247 -----LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             -----CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                 00011223456778999999999999999999999954

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=320.08  Aligned_cols=242  Identities=24%  Similarity=0.357  Sum_probs=191.1

Q ss_pred             HHHHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC---------hHHHHHHHHHHhcC----CCCceeeecc
Q 016917           72 LSLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP---------TQEFIDEVCFLASI----QHRNLVTLLG  137 (380)
Q Consensus        72 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l----~h~niv~l~~  137 (380)
                      .....++|++.+.||+|+||.||+|.. .+++.||+|......         ...+.+|+.+++++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            344567899999999999999999985 568899999865432         22355789988888    8999999999


Q ss_pred             ceecCCeeEEEEEe-ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCc
Q 016917          138 YCQENNLQFLIYEY-IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFI  215 (380)
Q Consensus       138 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~-~~~~  215 (380)
                      ++...+..++|+|| +.+++|.+++.     ....+++..++.++.|++.||.|||+  .+|+||||||+||+++ .++.
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYIT-----EKGPLGEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--HTEECCCCSGGGEEEETTTTE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChhhEEEeCCCCe
Confidence            99999999999999 78899999883     34568999999999999999999999  6799999999999999 8899


Q ss_pred             eEEcccccccccCCCCCCCCCccccCccceecccccccCCCC-cchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH
Q 016917          216 AKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS-EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  294 (380)
Q Consensus       216 ~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~  294 (380)
                      +||+|||++.......    .....++..|+|||++.+..+. .++||||||+++|||++|+.||....        +..
T Consensus       179 ~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~  246 (312)
T 2iwi_A          179 AKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------EIL  246 (312)
T ss_dssp             EEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHH
T ss_pred             EEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------HHh
Confidence            9999999998765432    2345688899999998877775 48999999999999999999986421        000


Q ss_pred             HhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .             .  ...++..++.++.+++.+||+.||++|||+.+++++
T Consensus       247 ~-------------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          247 E-------------A--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             H-------------T--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             h-------------h--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0             0  112334456789999999999999999999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.8e-43  Score=326.46  Aligned_cols=241  Identities=23%  Similarity=0.354  Sum_probs=198.0

Q ss_pred             HHHhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC---------ChHHHHHHHHHHhcCC--CCceeeecccee
Q 016917           73 SLATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---------PTQEFIDEVCFLASIQ--HRNLVTLLGYCQ  140 (380)
Q Consensus        73 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~--h~niv~l~~~~~  140 (380)
                      ....++|++.+.||+|+||.||+|.. .+++.||+|.....         ..+.+.+|+.++++++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            34567899999999999999999995 56889999974322         2245678999999996  599999999999


Q ss_pred             cCCeeEEEEEeecC-CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCceEE
Q 016917          141 ENNLQFLIYEYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKV  218 (380)
Q Consensus       141 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~-~~~~~kl  218 (380)
                      ..+..++|+|++.+ ++|.+++.     ....+++..++.++.|++.||.|||+  ++|+||||||+|||++ +++.+||
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEE
T ss_pred             cCCcEEEEEEcCCCCccHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHH--CCcEeCCCCHHHEEEeCCCCCEEE
Confidence            99999999999976 78998883     34568899999999999999999999  7799999999999999 7899999


Q ss_pred             cccccccccCCCCCCCCCccccCccceecccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhh
Q 016917          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS  297 (380)
Q Consensus       219 ~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~  297 (380)
                      +|||++.......    .....+|..|+|||++.+..+ +.++|||||||++|||++|+.||....        ..... 
T Consensus       192 ~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~~~~~-  258 (320)
T 3a99_A          192 IDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIRG-  258 (320)
T ss_dssp             CCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHHHC-
T ss_pred             eeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------hhhcc-
Confidence            9999998765422    234568999999999887776 678999999999999999999986421        00000 


Q ss_pred             hcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                                    ...++..+++++.+++.+||+.||++|||+++++++
T Consensus       259 --------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          259 --------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             --------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                          011223345779999999999999999999999875

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.5e-41  Score=306.60  Aligned_cols=230  Identities=13%  Similarity=0.035  Sum_probs=183.1

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCCh------HHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT------QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|... +++.||+|.......      +.+.+|+.++.+++||||+++++++...+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367999999999999999999965 589999998654422      5688999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++++|.+++..      . .....+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+++|.     
T Consensus       110 ~e~~~g~~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH~--~givH~Dikp~NIll~~~g~~kl~~~~~-----  175 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT------S-PSPVGAIRAMQSLAAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPAT-----  175 (286)
T ss_dssp             EECCCEEEHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEETTSCEEECSCCC-----
T ss_pred             EEecCCCCHHHHHhc------C-CChHHHHHHHHHHHHHHHHHHH--CCCccCCCCcccEEEcCCCCEEEEeccc-----
Confidence            999999999999832      1 2455678899999999999999  7799999999999999999999985542     


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                                       ++       .++.++|||||||++|||++|+.||..........            .......
T Consensus       176 -----------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~  219 (286)
T 3uqc_A          176 -----------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTA  219 (286)
T ss_dssp             -----------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTT
T ss_pred             -----------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhc
Confidence                             22       36889999999999999999999998765422100            0000000


Q ss_pred             ccc--ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          309 ERL--WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       309 ~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                      ...  .......+++++.+++.+||+.||++| |+.++++.|.++.....
T Consensus       220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            000  011223455779999999999999999 99999999998876544

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=312.91  Aligned_cols=250  Identities=19%  Similarity=0.281  Sum_probs=177.4

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCCh-----HHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT-----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      ..++|++.+.||+|+||.||+|... +++.||+|.......     +.+.++..+++.++||||+++++++...+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3457888899999999999999965 689999998654322     1233445568888999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSP-RVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      |||+ ++.+.....    .....+++..+..++.|++.||.|||+  + +|+||||||+||+++.++.+||+|||++...
T Consensus       103 ~e~~-~~~~~~l~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          103 MELM-GTCAEKLKK----RMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             ECCC-SEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             Eecc-CCcHHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            9999 444443331    124568899999999999999999998  4 6999999999999999999999999998766


Q ss_pred             CCCCCCCCCccccCccceecccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  302 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (380)
                      ....   ......++..|+|||.+.     +..++.++|||||||++|||++|+.||......  ...........    
T Consensus       176 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~----  246 (318)
T 2dyl_A          176 VDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTKVLQEE----  246 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHHHSC----
T ss_pred             cCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHHHHhccC----
Confidence            4322   123446888999999984     567899999999999999999999999754321  11111111100    


Q ss_pred             hhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                             .........+++++.+++.+||+.||.+|||+.+++++
T Consensus       247 -------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          247 -------PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             -------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -------CCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                   00011112345779999999999999999999999975

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.7e-41  Score=334.70  Aligned_cols=268  Identities=19%  Similarity=0.249  Sum_probs=202.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceec------CCe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE------NNL  144 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  144 (380)
                      .++|++.+.||+|+||.||+|.. .++..||+|......    .+.+.+|++++++++||||+++++++..      ++.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36899999999999999999996 468999999865432    3457889999999999999999998765      677


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc---eEEccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFI---AKVADA  221 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~---~kl~DF  221 (380)
                      .++||||+++|+|.+++....  ....+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.   +||+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs--~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHH--TTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEeecCCCceeEEEccc
Confidence            899999999999999985432  23357888899999999999999999  77999999999999987664   999999


Q ss_pred             ccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhh----
Q 016917          222 GLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS----  297 (380)
Q Consensus       222 gla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~----  297 (380)
                      |++.......   ......+|..|+|||.+.+..++.++|||||||++|+|++|..||......     ..+....    
T Consensus       169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~  240 (676)
T 3qa8_A          169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKS  240 (676)
T ss_dssp             CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC---
T ss_pred             cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhccc
Confidence            9998765432   223457899999999999999999999999999999999999999753210     0000000    


Q ss_pred             ----hcccchhhh--ccc--ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHH-----HHHHHHhhhhhh
Q 016917          298 ----RDFSNLLKI--LDE--RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD-----VVTELDRTLDKE  355 (380)
Q Consensus       298 ----~~~~~~~~~--~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~-----ll~~L~~~~~~~  355 (380)
                          .........  ...  ......+...++.+.+++.+||+.||++|||+.+     +.+.++.+++..
T Consensus       241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence                000000000  000  1112345567899999999999999999999988     556677766654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.9e-40  Score=334.86  Aligned_cols=239  Identities=21%  Similarity=0.308  Sum_probs=192.8

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC--CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCe-----
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ--DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNL-----  144 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  144 (380)
                      .++|++.+.||+|+||.||+|...  +++.||+|......    ...+.+|++++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            468999999999999999999965  58999999865432    2357889999999999999999999987655     


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .|+||||+++++|.+++.       ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.+ .+||+|||++
T Consensus       159 ~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~--~giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHS--IGLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             eEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH--CCCeecccChHHeEEeCC-cEEEEecccc
Confidence            699999999999988762       268999999999999999999999  679999999999999986 8999999999


Q ss_pred             cccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      +.....      ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.........                
T Consensus       229 ~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------------  285 (681)
T 2pzi_A          229 SRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------------  285 (681)
T ss_dssp             EETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----------------
T ss_pred             hhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc----------------
Confidence            876442      345689999999998765 489999999999999999999887643211100                


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHHHhhhhh
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTLDK  354 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~~ll~~L~~~~~~  354 (380)
                         .    .......++.+.+++.+||+.||.+|| +++++.+.|..++.+
T Consensus       286 ---~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          286 ---E----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             ---T----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             ---c----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence               0    000112346789999999999999999 566666777776654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3e-40  Score=303.03  Aligned_cols=227  Identities=18%  Similarity=0.247  Sum_probs=178.3

Q ss_pred             CCCCCC-CeeccCCceEEEEEEE-CCCcEEEEEeCCCCChHHHHHHHHHH-hcCCCCceeeeccceec----CCeeEEEE
Q 016917           77 KNFSDK-NLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFL-ASIQHRNLVTLLGYCQE----NNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~-~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~  149 (380)
                      ++|.+. +.||+|+||.||+|.. .+++.||+|....  ...+.+|++++ +.++||||+++++++..    .+..++||
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~   94 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM   94 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence            456666 7799999999999996 5688999998753  45677899888 56699999999999876    67789999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEcccccccc
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRNF  226 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~---~~~~kl~DFgla~~  226 (380)
                      ||+++|+|.+++...   ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.   ++.+||+|||++..
T Consensus        95 e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           95 ECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             CCCCSCBHHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             eecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            999999999988432   23468999999999999999999999  77999999999999998   78999999999865


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      ..                        +..|+.++|||||||++|||++|+.||.........            ......
T Consensus       170 ~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~~~~~~  213 (299)
T 3m2w_A          170 TT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMKTR  213 (299)
T ss_dssp             CT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSCCS
T ss_pred             cc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------HHHHHH
Confidence            32                        145678999999999999999999999764421100            000000


Q ss_pred             cccccccCCC----HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          307 LDERLWSTFT----NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       307 ~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .... ....+    ..+++++.+++.+||+.||.+|||+.+++++
T Consensus       214 ~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          214 IRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             SCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             Hhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            0000 01111    2345789999999999999999999999985

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.1e-40  Score=311.05  Aligned_cols=241  Identities=17%  Similarity=0.156  Sum_probs=183.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC-----------ChHHHHHHHHHHhcCC----------------
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----------PTQEFIDEVCFLASIQ----------------  128 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~----------------  128 (380)
                      .++|++.+.||+|+||+||+|+. +++.||+|.....           ..+.+.+|+.+++.++                
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            45688899999999999999998 6899999974422           2267889999998886                


Q ss_pred             ----------CCceeeeccceec-------------CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHH
Q 016917          129 ----------HRNLVTLLGYCQE-------------NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA  185 (380)
Q Consensus       129 ----------h~niv~l~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~  185 (380)
                                ||||+++++++.+             .+..|+||||+++|++.+.+.      ...+++..+..++.|++
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~------~~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR------TKLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT------TTCCCHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH------hcCCCHHHHHHHHHHHH
Confidence                      6666666666665             778999999999997766662      25578999999999999


Q ss_pred             HHHHHHh-cCCCCeEecCCCCCCeeeCCCC--------------------ceEEcccccccccCCCCCCCCCccccCccc
Q 016917          186 KGLAHLH-SLSPRVVHKDFKTANVLVDEDF--------------------IAKVADAGLRNFLGRTDVAGPSSQVTADEI  244 (380)
Q Consensus       186 ~~l~~LH-~~~~~ivHrDikp~Nili~~~~--------------------~~kl~DFgla~~~~~~~~~~~~~~~~~~~~  244 (380)
                      .||.||| +  .+|+||||||+|||++.++                    .+||+|||+++....       ....||+.
T Consensus       172 ~aL~~lH~~--~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~  242 (336)
T 2vuw_A          172 ASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDV  242 (336)
T ss_dssp             HHHHHHHHH--HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCC
T ss_pred             HHHHHHHHh--CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeec
Confidence            9999999 8  6799999999999999887                    899999999987643       23478999


Q ss_pred             eecccccccCCCCcchhhHHHHHH-HHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHH
Q 016917          245 FLASEVKEFRRFSEKSDVYSFGVF-LLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEF  323 (380)
Q Consensus       245 ~~aPE~~~~~~~~~~~DvwSlG~i-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  323 (380)
                      |+|||++.+.. +.++||||+|++ .+++++|..||.....  .....+.+.....       .............++++
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~-------~~~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQMT-------FKTKCNTPAMKQIKRKI  312 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHTCC-------CSSCCCSHHHHHHHHHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhhhc-------cCcccchhhhhhcCHHH
Confidence            99999998776 899999998777 7888899988742100  0000000000000       00111112234678999


Q ss_pred             HHHHhHccCCCCCCCCCHHHHH-HH
Q 016917          324 IQLIVRCLDPSSERRPSMSDVV-TE  347 (380)
Q Consensus       324 ~~li~~cl~~dp~~Rpt~~~ll-~~  347 (380)
                      .+|+.+||+.|     |++|++ ++
T Consensus       313 ~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHhccC-----CHHHHHhcC
Confidence            99999999977     999988 54

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-40  Score=318.70  Aligned_cols=240  Identities=12%  Similarity=0.066  Sum_probs=177.3

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC------CChHHHHHHHHHHhcCCC-Cceeeeccc-----------
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG------APTQEFIDEVCFLASIQH-RNLVTLLGY-----------  138 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~h-~niv~l~~~-----------  138 (380)
                      .|...+.||+|+||.||+|.. .+++.||||+...      ...+.+.+|+.+++.++| +|......+           
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            466778999999999999994 5789999997542      224568899999999977 332211111           


Q ss_pred             ----------eec-----CCeeEEEEEeecCCCccccccCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 016917          139 ----------CQE-----NNLQFLIYEYIPNGSVSIHLYGPS--QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHK  201 (380)
Q Consensus       139 ----------~~~-----~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHr  201 (380)
                                +..     ....+++|+++ +++|.+++....  ......+++..++.++.|++.||.|||+  ++|+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~iiHr  235 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHT  235 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH--TTEECS
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccC
Confidence                      111     12346677765 568887773110  1124557788899999999999999999  779999


Q ss_pred             CCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceeccccc----------ccCCCCcchhhHHHHHHHHH
Q 016917          202 DFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK----------EFRRFSEKSDVYSFGVFLLE  271 (380)
Q Consensus       202 Dikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~DvwSlG~il~e  271 (380)
                      ||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..|+.++|||||||++||
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            99999999999999999999998865432     233456 889999998          56678999999999999999


Q ss_pred             HHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          272 LVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       272 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      |++|+.||........               ...++..      ....++++.+++.+||+.||++|||+.+++++
T Consensus       310 lltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          310 IWCADLPNTDDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHSSCCCCTTGGGSC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHCCCCCCCcchhhh---------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            9999999976442211               1111110      11234779999999999999999998888643

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.9e-32  Score=270.25  Aligned_cols=181  Identities=17%  Similarity=0.049  Sum_probs=125.8

Q ss_pred             eccCCceEEEEEE-ECCCcEEEEEeCCCC-------------ChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEEE
Q 016917           85 IGEGKFGEVYKGL-LQDGMLVAIKKRPGA-------------PTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        85 ig~G~~g~V~~~~-~~~~~~vavK~~~~~-------------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      .+.|++|.+..++ ...|..+++|.+...             ..+++.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4556666665554 345788999974322             124588999999999 7999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||++|++|.+.+..     ...++..   .|+.||+.||.|+|+  +|||||||||+|||++.++.+||+|||+|+....
T Consensus       322 Eyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~--~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          322 EKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEK--QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             ECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHH--TTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             ecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHH--CCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            99999999999943     3445543   478999999999999  7799999999999999999999999999987644


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCC
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA  278 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p  278 (380)
                      ..  ......+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus       392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            22  22345679999999999986 467789999999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=4e-29  Score=246.43  Aligned_cols=182  Identities=19%  Similarity=0.192  Sum_probs=142.1

Q ss_pred             CCCeeccCCceEEEEEEECCCcEEEEEeCCCCC-----------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           81 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP-----------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        81 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ..+.||+|+||.||+|.. .+..+++|+.....           .+.+.+|++++++++||||+++..++...+..|+||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            357899999999999954 46788888633221           234789999999999999997666666777789999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++++|.+++..             +..++.|++.||.|||+  ++|+||||||+|||++.  .+||+|||+++....
T Consensus       419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~--~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK--NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH--TTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH--CcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            99999999999832             45789999999999999  77999999999999998  999999999987754


Q ss_pred             CCCCC-----CCccccCccceeccccccc--CCCCcchhhHHHHHHHHHHHcCCCCCC
Q 016917          230 TDVAG-----PSSQVTADEIFLASEVKEF--RRFSEKSDVYSFGVFLLELVSGREASS  280 (380)
Q Consensus       230 ~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~DvwSlG~il~el~tg~~p~~  280 (380)
                      .....     ......||+.|+|||++..  ..|+..+|+||...-..+...++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            22111     1235678999999999987  678889999999998888888776653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.3e-25  Score=203.55  Aligned_cols=151  Identities=17%  Similarity=0.065  Sum_probs=119.3

Q ss_pred             HHHHHHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC---------------------hHHHHHHHHHHhcC
Q 016917           69 MEELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---------------------TQEFIDEVCFLASI  127 (380)
Q Consensus        69 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------~~~~~~E~~~l~~l  127 (380)
                      ...+......|++.+.||+|+||.||+|...+|+.||+|......                     ...+.+|+++++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            334444555677779999999999999999779999999864321                     34578999999999


Q ss_pred             CCCceeeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 016917          128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTAN  207 (380)
Q Consensus       128 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~N  207 (380)
                      +  | +++.+++.. +..++||||+++++|.+ +..           .....++.|++.||.|||+  .+|+||||||+|
T Consensus       162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~--~giiHrDlkp~N  223 (282)
T 1zar_A          162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYH--RGIVHGDLSQYN  223 (282)
T ss_dssp             T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHH--TTEECSCCSTTS
T ss_pred             c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHH--CCCEeCCCCHHH
Confidence            9  5 666665544 45699999999999988 411           1234689999999999999  779999999999


Q ss_pred             eeeCCCCceEEcccccccccCCCCCCCCCccccCccceeccccccc
Q 016917          208 VLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF  253 (380)
Q Consensus       208 ili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  253 (380)
                      ||++ ++.+||+|||++.....               ++|||.+..
T Consensus       224 ILl~-~~~vkl~DFG~a~~~~~---------------~~a~e~l~r  253 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQSVEVGE---------------EGWREILER  253 (282)
T ss_dssp             EEEE-TTEEEECCCTTCEETTS---------------TTHHHHHHH
T ss_pred             EEEE-CCcEEEEECCCCeECCC---------------CCHHHHHHH
Confidence            9999 99999999999875322               678887653

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=3.1e-21  Score=172.57  Aligned_cols=133  Identities=18%  Similarity=0.101  Sum_probs=101.4

Q ss_pred             CCCCCeeccCCceEEEEEEE-CCCcE--EEEEeCCCCC---------------------------hHHHHHHHHHHhcCC
Q 016917           79 FSDKNLIGEGKFGEVYKGLL-QDGML--VAIKKRPGAP---------------------------TQEFIDEVCFLASIQ  128 (380)
Q Consensus        79 ~~~~~~ig~G~~g~V~~~~~-~~~~~--vavK~~~~~~---------------------------~~~~~~E~~~l~~l~  128 (380)
                      |++.+.||+|+||.||+|.. .+|..  ||+|......                           ...+.+|+.+++.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            66788999999999999997 67888  9999743221                           025778999999998


Q ss_pred             CCce--eeeccceecCCeeEEEEEeecC-C----CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCeEe
Q 016917          129 HRNL--VTLLGYCQENNLQFLIYEYIPN-G----SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH-SLSPRVVH  200 (380)
Q Consensus       129 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~ivH  200 (380)
                      |+++  +..++.    +..++||||+.+ |    +|.+....        .++.....++.|++.||.||| +  .+|+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~--~givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQE--AELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHT--SCEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHH--CCEEe
Confidence            7754  333332    346899999943 4    44433311        123356789999999999999 8  67999


Q ss_pred             cCCCCCCeeeCCCCceEEccccccccc
Q 016917          201 KDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       201 rDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      |||||+|||++.  .++|+|||+|...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  8999999998754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=1.2e-18  Score=162.52  Aligned_cols=142  Identities=13%  Similarity=0.040  Sum_probs=96.5

Q ss_pred             HHHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC-----------------ChHHHHHHHHHHhcCCCCceee
Q 016917           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----------------PTQEFIDEVCFLASIQHRNLVT  134 (380)
Q Consensus        72 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~  134 (380)
                      +.....-|++.+.||+|++|.||+|...+|+.||||+....                 .......+..+.....|+|+.+
T Consensus        90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r  169 (397)
T 4gyi_A           90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA  169 (397)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            33333348999999999999999999889999999964321                 0112222222222223444444


Q ss_pred             eccceecC------CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 016917          135 LLGYCQEN------NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANV  208 (380)
Q Consensus       135 l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Ni  208 (380)
                      ++......      ...+|||||++|++|......           .....++.|++.+|.+||+  .|||||||||.||
T Consensus       170 L~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~--~gIVHrDLKp~NI  236 (397)
T 4gyi_A          170 LYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAK--HGLIHGDFNEFNI  236 (397)
T ss_dssp             HHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSE
T ss_pred             HHhcCCCCCeeeeccCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHE
Confidence            43322111      123799999999888665411           1224678999999999999  6799999999999


Q ss_pred             eeCCCC----------ceEEcccccccc
Q 016917          209 LVDEDF----------IAKVADAGLRNF  226 (380)
Q Consensus       209 li~~~~----------~~kl~DFgla~~  226 (380)
                      |+++++          .+.|+||+-+-.
T Consensus       237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          237 LIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             EEeCCCCcccccccccceEEEEeCCccc
Confidence            998776          389999986543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.37  E-value=9.2e-13  Score=117.57  Aligned_cols=141  Identities=13%  Similarity=0.077  Sum_probs=110.9

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCC---CChHHHHHHHHHHhcCC-CCceeeeccceecCCeeEEEE
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG---APTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  149 (380)
                      .....|++...++.|+.+.||++... +..+++|....   .....+.+|.++++.+. +.++.++++++...+..|+||
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            34457888888888999999999854 67899998653   34456889999999884 678889999998888999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS----------------------------------  195 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------  195 (380)
                      ||++|.+|.+.+..          ......++.+++.++..||+..                                  
T Consensus        90 e~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           90 SEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             ECCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            99999888765311          0112367889999999999820                                  


Q ss_pred             -----------------------CCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          196 -----------------------PRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       196 -----------------------~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                                             ..++|+|++|.|||++++..+.|+||+.+.
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                   348999999999999876667799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.31  E-value=2.3e-12  Score=114.50  Aligned_cols=127  Identities=18%  Similarity=0.182  Sum_probs=97.1

Q ss_pred             ccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcCCCCc--eeeeccceecCCeeEEEEEeecCCCccccccC
Q 016917           86 GEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRN--LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG  163 (380)
Q Consensus        86 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  163 (380)
                      +.|..+.||++...+|..+++|.........+..|..+++.+.+.+  +.+++++....+..++||||++|.++.  ...
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~  106 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH  106 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc
Confidence            4566699999987778889999866555566889999999885433  566888888777889999999998874  210


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------------
Q 016917          164 PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS------------------------------------------------  195 (380)
Q Consensus       164 ~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------------  195 (380)
                              ..   ...++.+++..+..||+..                                                
T Consensus       107 --------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (264)
T 1nd4_A          107 --------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK  175 (264)
T ss_dssp             --------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred             --------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence                    01   1256778888888888732                                                


Q ss_pred             --------CCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          196 --------PRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       196 --------~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                              ..++|+|++|.|||+++++.+.|+|||.+.
T Consensus       176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                    129999999999999887667799999865

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.19  E-value=7.8e-11  Score=110.03  Aligned_cols=138  Identities=14%  Similarity=0.239  Sum_probs=105.1

Q ss_pred             CCCeeccCCceEEEEEEECCCcEEEEEeCC--CCC----hHHHHHHHHHHhcCC--CCceeeeccceecC---CeeEEEE
Q 016917           81 DKNLIGEGKFGEVYKGLLQDGMLVAIKKRP--GAP----TQEFIDEVCFLASIQ--HRNLVTLLGYCQEN---NLQFLIY  149 (380)
Q Consensus        81 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~--~~~----~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  149 (380)
                      ..+.|+.|.++.||+....+ ..+++|+..  ...    ...+.+|..+++.+.  +.++++++.++.+.   +..|+||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            45678999999999998764 578888765  322    346788999999886  45688888888766   4579999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL-----------------------------------  194 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----------------------------------  194 (380)
                      ||++|..+.+..       ...++......++.+++..|..||+.                                   
T Consensus       121 e~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          121 EFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             ECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             EecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            999998775422       12356777888999999999999973                                   


Q ss_pred             ---------------------CCCeEecCCCCCCeeeCCCCc--eEEcccccccc
Q 016917          195 ---------------------SPRVVHKDFKTANVLVDEDFI--AKVADAGLRNF  226 (380)
Q Consensus       195 ---------------------~~~ivHrDikp~Nili~~~~~--~kl~DFgla~~  226 (380)
                                           ...++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 146999999999999997753  68999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.99  E-value=1e-10  Score=106.58  Aligned_cols=185  Identities=19%  Similarity=0.208  Sum_probs=116.5

Q ss_pred             CCeeccCCceEEEEEEECCCcEEEEEeCCCC-ChHHHHHHHHHHhcC-CCCc--eeeeccceecCC---eeEEEEEeecC
Q 016917           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASI-QHRN--LVTLLGYCQENN---LQFLIYEYIPN  154 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~e~~~~  154 (380)
                      .+.++.|.+..||++.    ..+++|..... ....+.+|.++++.+ .+..  +.+.+......+   ..|+||++++|
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            4668999999999864    46888875433 345678899999887 3322  445554443333   34899999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL----------------------------------------  194 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----------------------------------------  194 (380)
                      .++.+...       ..++..++..++.+++..+..||+.                                        
T Consensus       101 ~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A          101 VPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             EECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             eECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            88764321       2345666677777777777777751                                        


Q ss_pred             ----------------CCCeEecCCCCCCeeeCC--CCceEEcccccccccCCCC-CCCCCcc--ccCcc-------ce-
Q 016917          195 ----------------SPRVVHKDFKTANVLVDE--DFIAKVADAGLRNFLGRTD-VAGPSSQ--VTADE-------IF-  245 (380)
Q Consensus       195 ----------------~~~ivHrDikp~Nili~~--~~~~kl~DFgla~~~~~~~-~~~~~~~--~~~~~-------~~-  245 (380)
                                      ...++|+|++|.||++++  +..+.++||+.+..-.... .......  ..+..       .| 
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                            124799999999999998  5568899999876532210 0000000  00000       01 


Q ss_pred             -ec-ccccccCCCCcchhhHHHHHHHHHHHcCCCCC
Q 016917          246 -LA-SEVKEFRRFSEKSDVYSFGVFLLELVSGREAS  279 (380)
Q Consensus       246 -~a-PE~~~~~~~~~~~DvwSlG~il~el~tg~~p~  279 (380)
                       .. |+...  ......+.|++|.++|.+.+|..+|
T Consensus       254 ~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             11 11111  1122368999999999999998653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.54  E-value=1.4e-07  Score=84.09  Aligned_cols=133  Identities=22%  Similarity=0.231  Sum_probs=94.8

Q ss_pred             eeccCCce-EEEEEEEC-CCcEEEEEeCCCCChHHHHHHHHHHhcCC-CCceeeeccceecCCeeEEEEEeecCCCcccc
Q 016917           84 LIGEGKFG-EVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIH  160 (380)
Q Consensus        84 ~ig~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  160 (380)
                      .+..|..+ .||+.... ++..+++|..+......+..|...|+.+. +-.+.+.++++.+.+..++|||+++|.++.+.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~  110 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV  110 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence            34455554 68988754 46679999877666677889999998884 44477888888888999999999998776543


Q ss_pred             ccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------------
Q 016917          161 LYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS---------------------------------------------  195 (380)
Q Consensus       161 l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------  195 (380)
                      ...         .......+..+++..|.-||...                                             
T Consensus       111 ~~~---------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          111 LEE---------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHH---------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccC---------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            310         01112234555666666666431                                             


Q ss_pred             -----------CCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          196 -----------PRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       196 -----------~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                                 ..++|+|+.+.|||+++++.+-|+||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                       137999999999999988777899998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.49  E-value=2.9e-07  Score=83.75  Aligned_cols=134  Identities=16%  Similarity=0.142  Sum_probs=88.8

Q ss_pred             CCeeccCCceEEEEEEECCCcEEEEEeCCCC-ChHHHHHHHHHHhcCCCC---ceeeecccee-cCCeeEEEEEeecCCC
Q 016917           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHR---NLVTLLGYCQ-ENNLQFLIYEYIPNGS  156 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~g~  156 (380)
                      .+.++.|....||+.    +..+++|..... ....+..|.++|+.+.+.   .+.+.+.++. ..+..++|||+++|..
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            356888998999988    566888874322 235678999999998642   3566666663 4556789999999987


Q ss_pred             ccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 016917          157 VSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL------------------------------------------  194 (380)
Q Consensus       157 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------------------------------------------  194 (380)
                      +.....       ..++......++.+++..|..||+.                                          
T Consensus       100 l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A          100 LGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             CHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             Cchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            765221       1122333333444444444444432                                          


Q ss_pred             ----------------CCCeEecCCCCCCeeeCC---CCc-eEEcccccccc
Q 016917          195 ----------------SPRVVHKDFKTANVLVDE---DFI-AKVADAGLRNF  226 (380)
Q Consensus       195 ----------------~~~ivHrDikp~Nili~~---~~~-~kl~DFgla~~  226 (380)
                                      ...++|+|++|.|||++.   ++. +.|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            135699999999999987   355 58999997654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.38  E-value=1e-06  Score=81.71  Aligned_cols=77  Identities=9%  Similarity=0.021  Sum_probs=55.8

Q ss_pred             Cee-ccCCceEEEEEEEC-------CCcEEEEEeCCCCC------hHHHHHHHHHHhcCC-C--CceeeeccceecC---
Q 016917           83 NLI-GEGKFGEVYKGLLQ-------DGMLVAIKKRPGAP------TQEFIDEVCFLASIQ-H--RNLVTLLGYCQEN---  142 (380)
Q Consensus        83 ~~i-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~------~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~---  142 (380)
                      +.| +.|....+|+....       ++..+++|......      ...+..|..+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            557 88889999998754       26678899865432      246788999888873 2  3567777776654   


Q ss_pred             CeeEEEEEeecCCCccc
Q 016917          143 NLQFLIYEYIPNGSVSI  159 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~  159 (380)
                      +..++||||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            45689999999877664

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.22  E-value=1.1e-05  Score=73.96  Aligned_cols=141  Identities=18%  Similarity=0.264  Sum_probs=79.5

Q ss_pred             CeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcCC--CCceeeecc------ceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ--HRNLVTLLG------YCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~e~~~~  154 (380)
                      +.|+.|..+.||++...++ .+++|.... .......|..+++.|.  .-.+.+++.      +....+..++||+|++|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G  115 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG  115 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECS-CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence            4466677889999987655 488888665 3344555666666553  112334433      12345677999999998


Q ss_pred             CCccc--------------ccc----CCCCCC-----CCCCCHHH-------------------------------HHHH
Q 016917          155 GSVSI--------------HLY----GPSQVS-----RQKLEFKH-------------------------------RLSI  180 (380)
Q Consensus       155 g~L~~--------------~l~----~~~~~~-----~~~~~~~~-------------------------------~~~i  180 (380)
                      ..+..              .++    ......     .....|..                               ...+
T Consensus       116 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (346)
T 2q83_A          116 RPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGF  195 (346)
T ss_dssp             BCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHH
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHH
Confidence            66531              000    000000     00111211                               0011


Q ss_pred             HHHHHHHHHHHhc-----------CCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          181 ALGAAKGLAHLHS-----------LSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       181 ~~~i~~~l~~LH~-----------~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ...+..++.+|++           ....++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       196 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          196 IEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1223345666652           23679999999999999888889999998764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.03  E-value=1.4e-05  Score=72.64  Aligned_cols=75  Identities=19%  Similarity=0.159  Sum_probs=60.9

Q ss_pred             CCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcCC---CCceeeeccceecCCeeEEEEEeecCCCc
Q 016917           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ---HRNLVTLLGYCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g~L  157 (380)
                      .+.|+.|....+|+.... +..+++|.........+..|.+.|+.|.   ...+++.+.++...+..++||||+++..+
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            467899999999999864 6678899866555667889999888873   35788888888877889999999998765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.99  E-value=1.5e-05  Score=75.11  Aligned_cols=72  Identities=14%  Similarity=0.077  Sum_probs=48.0

Q ss_pred             CCeeccCCceEEEEEEEC-CCcEEEEEeCCCC----------ChHHHHHHHHHHhcCCC--C-ceeeeccceecCCeeEE
Q 016917           82 KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----------PTQEFIDEVCFLASIQH--R-NLVTLLGYCQENNLQFL  147 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----------~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l  147 (380)
                      .+.||.|.++.||++... ++..+++|.....          ..+.+..|.++++.+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999743 4678999963321          23456789888887732  3 34455544  3344589


Q ss_pred             EEEeecCC
Q 016917          148 IYEYIPNG  155 (380)
Q Consensus       148 v~e~~~~g  155 (380)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.87  E-value=4.8e-05  Score=68.22  Aligned_cols=77  Identities=17%  Similarity=0.184  Sum_probs=55.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC---hHHHHHHHHHHhcCCC---CceeeeccceecCCeeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---TQEFIDEVCFLASIQH---RNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ........+|.|..+.||+.+..+|+.+.+|..+...   ...+..|...|+.|..   -.+++.+++.    ..++|||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e   90 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME   90 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence            3445567799999999999999999999999855332   3457889998887732   2344555432    2378999


Q ss_pred             eecCCCc
Q 016917          151 YIPNGSV  157 (380)
Q Consensus       151 ~~~~g~L  157 (380)
                      |++++..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9987654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.75  E-value=0.00041  Score=62.97  Aligned_cols=142  Identities=11%  Similarity=0.046  Sum_probs=78.8

Q ss_pred             CeeccCCceEEEEEEECCCcEEEEEeCCC-CChHHHHHHHHHHhcCCCC--ceeeeccc------eecCCeeEEEEEeec
Q 016917           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPG-APTQEFIDEVCFLASIQHR--NLVTLLGY------CQENNLQFLIYEYIP  153 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e~~~  153 (380)
                      +.|+.|....+|+....++ .+++|.... ...+.+..|..+++.+...  .+.+++..      ....+..+++++|++
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~  106 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE  106 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence            4567788899999987655 577887654 3445677788888776321  23333322      122456789999999


Q ss_pred             CCCcccc--------------cc----CCCCCCCCCC---CHHHHHH------------HHHHHHHHHHHHhc-----CC
Q 016917          154 NGSVSIH--------------LY----GPSQVSRQKL---EFKHRLS------------IALGAAKGLAHLHS-----LS  195 (380)
Q Consensus       154 ~g~L~~~--------------l~----~~~~~~~~~~---~~~~~~~------------i~~~i~~~l~~LH~-----~~  195 (380)
                      |..+...              ++    ..........   .|.....            +...+...+.++..     ..
T Consensus       107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~  186 (322)
T 2ppq_A          107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP  186 (322)
T ss_dssp             CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred             CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence            8664321              00    0000000001   1111000            00113344555542     12


Q ss_pred             CCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          196 PRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       196 ~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      .+++|+|+.+.|||++++..+.++||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            469999999999999987666899998654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.68  E-value=8.4e-05  Score=68.07  Aligned_cols=142  Identities=10%  Similarity=0.017  Sum_probs=72.6

Q ss_pred             CeeccCCceE-EEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcCC--CCceeeeccceecCCeeEEEEEeecCCCccc
Q 016917           83 NLIGEGKFGE-VYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ--HRNLVTLLGYCQENNLQFLIYEYIPNGSVSI  159 (380)
Q Consensus        83 ~~ig~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  159 (380)
                      +.|+.|.... +|+....++..+++|..+......+..|..+++.+.  .-.+.+++.+....+  +++||++.+..+.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~~  101 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFTE  101 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHHH
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchHH
Confidence            4465555554 667765446778888765443244566777777663  223556666544433  68999987655433


Q ss_pred             cccCCC---------------------CCCCCCCCHHHHH--------------------HHHHHHHHHHHHH----hcC
Q 016917          160 HLYGPS---------------------QVSRQKLEFKHRL--------------------SIALGAAKGLAHL----HSL  194 (380)
Q Consensus       160 ~l~~~~---------------------~~~~~~~~~~~~~--------------------~i~~~i~~~l~~L----H~~  194 (380)
                      ++....                     ......+......                    .....+...+..+    ...
T Consensus       102 ~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~  181 (333)
T 3csv_A          102 VINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEG  181 (333)
T ss_dssp             HHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCS
T ss_pred             HhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccC
Confidence            221100                     0000111111000                    0001111222222    112


Q ss_pred             CCCeEecCCCCCCeeeCCC----CceEEcccccccc
Q 016917          195 SPRVVHKDFKTANVLVDED----FIAKVADAGLRNF  226 (380)
Q Consensus       195 ~~~ivHrDikp~Nili~~~----~~~kl~DFgla~~  226 (380)
                      ...++|+|+.+.|||++.+    +.+.++||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            2579999999999999874    6789999997754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.54  E-value=0.00023  Score=67.63  Aligned_cols=73  Identities=21%  Similarity=0.247  Sum_probs=50.5

Q ss_pred             CCeeccCCceEEEEEEECC--------CcEEEEEeCCCCCh-HHHHHHHHHHhcCCCCce-eeeccceecCCeeEEEEEe
Q 016917           82 KNLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGAPT-QEFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  151 (380)
                      .+.|+.|....+|++...+        +..+++|+...... ..+..|..+++.+...++ .++++.+.+    .+|+||
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            3568888889999998653        47899998744233 667789998888743233 556665442    289999


Q ss_pred             ecCCCcc
Q 016917          152 IPNGSVS  158 (380)
Q Consensus       152 ~~~g~L~  158 (380)
                      ++|-.+.
T Consensus       154 l~G~~l~  160 (429)
T 1nw1_A          154 IPSRPLS  160 (429)
T ss_dssp             CCEEECC
T ss_pred             eCCcccC
Confidence            9865543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.52  E-value=0.00018  Score=68.27  Aligned_cols=79  Identities=19%  Similarity=0.125  Sum_probs=45.6

Q ss_pred             CCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccC---CCCcchhhHHHHHHHHHH
Q 016917          196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR---RFSEKSDVYSFGVFLLEL  272 (380)
Q Consensus       196 ~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DvwSlG~il~el  272 (380)
                      ..++|+|++|.|||++.++ +.++||+.+..-.....-. .....-...|.+|+.....   .-....++.+....+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            6799999999999998876 9999999876432100000 0000001234555543311   112234556777788887


Q ss_pred             HcCC
Q 016917          273 VSGR  276 (380)
Q Consensus       273 ~tg~  276 (380)
                      +++.
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.43  E-value=0.0011  Score=60.22  Aligned_cols=74  Identities=9%  Similarity=0.138  Sum_probs=50.1

Q ss_pred             CeeccCCceEEEEEEECCCcEEEEEeCCC--CChHHHHHHHHHHhcCCC--Cceeeeccc-----eecCCeeEEEEEeec
Q 016917           83 NLIGEGKFGEVYKGLLQDGMLVAIKKRPG--APTQEFIDEVCFLASIQH--RNLVTLLGY-----CQENNLQFLIYEYIP  153 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~h--~niv~l~~~-----~~~~~~~~lv~e~~~  153 (380)
                      ..++ |....||+....+|..+++|....  .....+..|..+++.+..  -.+++.+..     ....+..++||++++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            4566 888899998877777899998653  345667788888877732  224444443     122456688999998


Q ss_pred             CCCc
Q 016917          154 NGSV  157 (380)
Q Consensus       154 ~g~L  157 (380)
                      |..+
T Consensus       111 G~~~  114 (328)
T 1zyl_A          111 GRQF  114 (328)
T ss_dssp             CEEC
T ss_pred             CCCC
Confidence            8654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.37  E-value=0.00054  Score=63.83  Aligned_cols=139  Identities=15%  Similarity=0.137  Sum_probs=79.4

Q ss_pred             CeeccCCceEEEEEEEC--------CCcEEEEEeCCCC--ChHHHHHHHHHHhcCC-CCceeeeccceecCCeeEEEEEe
Q 016917           83 NLIGEGKFGEVYKGLLQ--------DGMLVAIKKRPGA--PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +.|..|-...+|++...        ++..+++|+....  ......+|..+++.+. +.-..++++.+.+    .+||||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            56777888899999864        2478999986432  3455678999888773 2223566666544    289999


Q ss_pred             ecCCCcccc-c----------------cCCCCCCCCCC--CHHHHHHHHHHHH-------------------HHHHH---
Q 016917          152 IPNGSVSIH-L----------------YGPSQVSRQKL--EFKHRLSIALGAA-------------------KGLAH---  190 (380)
Q Consensus       152 ~~~g~L~~~-l----------------~~~~~~~~~~~--~~~~~~~i~~~i~-------------------~~l~~---  190 (380)
                      ++|..+... +                +..........  .+.++..+..++-                   ..+..   
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            998665421 1                11100001111  1233333333221                   11222   


Q ss_pred             -HhcC--CCCeEecCCCCCCeeeCCC----CceEEccccccc
Q 016917          191 -LHSL--SPRVVHKDFKTANVLVDED----FIAKVADAGLRN  225 (380)
Q Consensus       191 -LH~~--~~~ivHrDikp~Nili~~~----~~~kl~DFgla~  225 (380)
                       |...  ...++|+|+.+.|||++.+    +.+.++||..+.
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence             2221  2358999999999999876    789999998765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.37  E-value=0.00039  Score=58.79  Aligned_cols=101  Identities=13%  Similarity=0.090  Sum_probs=63.7

Q ss_pred             CccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCCCC
Q 016917          156 SVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP  235 (380)
Q Consensus       156 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~  235 (380)
                      +|.+.|.    .....+++.++|.++.|.+.+|.-+-.. +.-..+=+.|..|++..+|.|...+ +.+.          
T Consensus        34 SL~eIL~----~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           34 SLEEILR----LYNQPINEEQAWAVCYQCCGSLRAAARR-RQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             cHHHHHH----HcCCCcCHHHHHHHHHHHHHHHHhhhhc-ccCCceecCCcceEEecCCceeccc-cccc----------
Confidence            5666663    3567899999999999999998876210 1111233456889999999887664 1111          


Q ss_pred             CccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCC
Q 016917          236 SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE  277 (380)
Q Consensus       236 ~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~  277 (380)
                          .....+.+||... ...+.+.=|||||+++|.-+--..
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence                0111266887753 345678889999999999886443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.35  E-value=0.0009  Score=64.01  Aligned_cols=72  Identities=14%  Similarity=0.055  Sum_probs=46.4

Q ss_pred             CeeccCCceEEEEEEECC-CcEEEEEeCCCCChH--HHHHHHHHHhcCCCCce-eeeccceecCCeeEEEEEeecCCCcc
Q 016917           83 NLIGEGKFGEVYKGLLQD-GMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYIPNGSVS  158 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~--~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~  158 (380)
                      +.|+.|-...+|++...+ +..+++|+.......  .-..|..+++.|...++ .++++.+. +   .+|+||++|-.+.
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~l~  189 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYALS  189 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEECC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCccCC
Confidence            567788889999998765 478889975432211  12578888888854444 56666653 2   2599999875553

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.34  E-value=0.00055  Score=61.65  Aligned_cols=69  Identities=9%  Similarity=0.017  Sum_probs=42.9

Q ss_pred             CCeeccCCceEEEEEEECCCcEEEEEeCCCCCh--HHHHHHHHHHhcCCCCce-eeeccceecCCeeEEEEEee-cCCCc
Q 016917           82 KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPT--QEFIDEVCFLASIQHRNL-VTLLGYCQENNLQFLIYEYI-PNGSV  157 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~L  157 (380)
                      .+.|+.|....+|++     ..+++|+......  .....|..+++.+...++ .++++...+  .-++++||+ ++.++
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQTM   95 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCEEC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCccC
Confidence            678989999999998     4588887554321  123567777776632122 455544332  346899999 65444

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.98  E-value=0.0047  Score=56.57  Aligned_cols=67  Identities=10%  Similarity=0.111  Sum_probs=42.8

Q ss_pred             cCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcCC---CCceeeeccc------eecCCeeEEEEEeecCCCc
Q 016917           87 EGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ---HRNLVTLLGY------CQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        87 ~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~~g~L  157 (380)
                      .|....||+....+| .+++|+......   ..|...++.|.   -|++++.+..      ....+..++||+|++|..+
T Consensus        33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~---~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~  108 (339)
T 3i1a_A           33 ADTNAFAYQADSESK-SYFIKLKYGYHD---EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG  108 (339)
T ss_dssp             SCSSCEEEEEECSSC-EEEEEEEECSSC---CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred             CccccceEEEEeCCC-CEEEEEecCccc---hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence            333678999997777 889997544332   35666666552   1224454432      2335677999999998765

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.93  E-value=0.0014  Score=60.68  Aligned_cols=71  Identities=15%  Similarity=0.112  Sum_probs=42.9

Q ss_pred             CeeccCCceEEEEEEECC---------CcEEEEEeCCCCChH--HHHHHHHHHhcCCCCc-eeeeccceecCCeeEEEEE
Q 016917           83 NLIGEGKFGEVYKGLLQD---------GMLVAIKKRPGAPTQ--EFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~--~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e  150 (380)
                      ..|+.|....+|++...+         +..+++|+.......  ....|.++++.+...+ ..++++..  .  -++|||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e  114 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE  114 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence            567788888999998654         268889986543221  2357888887774223 34555443  2  268999


Q ss_pred             eecCCCc
Q 016917          151 YIPNGSV  157 (380)
Q Consensus       151 ~~~~g~L  157 (380)
                      |++|..+
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987554

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.72  E-value=0.024  Score=53.50  Aligned_cols=72  Identities=8%  Similarity=-0.005  Sum_probs=46.6

Q ss_pred             CeeccCCceEEEEEEECC--------CcEEEEEeCCCCCh--HHHHHHHHHHhcCC-CCceeeeccceecCCeeEEEEEe
Q 016917           83 NLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGAPT--QEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~--~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +.+..|-...+|+....+        +..+++|+......  -.-.+|..+++.+. +.-..++++.+.  +  ++|+||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~ef  151 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIEEF  151 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEEC
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEEEE
Confidence            567778888999998653        57899998654321  12357888887773 222345554332  2  689999


Q ss_pred             ecCCCcc
Q 016917          152 IPNGSVS  158 (380)
Q Consensus       152 ~~~g~L~  158 (380)
                      ++|..|.
T Consensus       152 I~G~~l~  158 (424)
T 3mes_A          152 IDGEPLT  158 (424)
T ss_dssp             CCSEECC
T ss_pred             eCCccCC
Confidence            9986653

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=95.38  E-value=0.023  Score=33.38  Aligned_cols=30  Identities=17%  Similarity=0.108  Sum_probs=20.4

Q ss_pred             cchhhHHHHHHHHHHHHHHHHHHHHHHHHh
Q 016917            3 VTLAAIFGAAAGAVALMGIIFFLSWFCLYR   32 (380)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r   32 (380)
                      .+-+.+.++++++++.+++++++.+++.+|
T Consensus         8 ls~GaIAGiVvG~v~gv~li~~l~~~~~rr   37 (38)
T 2k1k_A            8 LTGGEIVAVIFGLLLGAALLLGILVFRSRR   37 (38)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence            345678888888887777666666555433

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=95.21  E-value=0.05  Score=32.93  Aligned_cols=27  Identities=15%  Similarity=0.150  Sum_probs=10.4

Q ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHhcC
Q 016917            8 IFGAAAGAVALMGIIFFLSWFCLYRNR   34 (380)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~r~~   34 (380)
                      +++.+++.++++++++++.|++.+||+
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr   38 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKS   38 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence            333333333333333344444443433

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=95.00  E-value=0.043  Score=33.27  Aligned_cols=26  Identities=12%  Similarity=0.097  Sum_probs=10.5

Q ss_pred             hHHHHHHHHHHHHHHHHHHHHHHHHhc
Q 016917            7 AIFGAAAGAVALMGIIFFLSWFCLYRN   33 (380)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~r~   33 (380)
                      +..+++.|++++++++ ++.|++.+||
T Consensus        13 IA~gVVgGv~~~~ii~-~~~~~~~RRr   38 (44)
T 2ks1_B           13 IATGMVGALLLLLVVA-LGIGLFMRRR   38 (44)
T ss_dssp             STHHHHHHHHHHHHHH-HHHHHHHHTT
T ss_pred             EEeehhHHHHHHHHHH-HHHHHHhhhh
Confidence            3344444444444333 3333433333

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=93.47  E-value=0.21  Score=30.15  Aligned_cols=12  Identities=33%  Similarity=0.592  Sum_probs=6.6

Q ss_pred             hhhHHHHHHHHH
Q 016917            5 LAAIFGAAAGAV   16 (380)
Q Consensus         5 ~~~~~~~~~~~~   16 (380)
                      ...+++.++|++
T Consensus        11 ~~~Ia~~vVGvl   22 (44)
T 2jwa_A           11 LTSIISAVVGIL   22 (44)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             ccchHHHHHHHH
Confidence            445666666633

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.29  E-value=0.085  Score=49.31  Aligned_cols=28  Identities=21%  Similarity=0.311  Sum_probs=24.0

Q ss_pred             eEecCCCCCCeee------CCCCceEEccccccc
Q 016917          198 VVHKDFKTANVLV------DEDFIAKVADAGLRN  225 (380)
Q Consensus       198 ivHrDikp~Nili------~~~~~~kl~DFgla~  225 (380)
                      ++|+|+.+.|||+      +++..+.++||..|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            5799999999999      456789999998765

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.13  E-value=1.2  Score=37.32  Aligned_cols=116  Identities=9%  Similarity=0.062  Sum_probs=76.2

Q ss_pred             CCCceeeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 016917          128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTAN  207 (380)
Q Consensus       128 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~N  207 (380)
                      .||+.+.. ..-.+.+.+.+.++  ...+...+-      .-...+...+++++.+++....+++.    -+|--+.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~--~~~~~~~f~------~ik~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYD--INDNHTPFD------NIKSFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEEC--CCTTSEEGG------GGGGSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEE--cCcccCCHH------HHHhcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecce
Confidence            56777765 34445555444444  333333332      23556788899999999988866664    5788899999


Q ss_pred             eeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 016917          208 VLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASS  280 (380)
Q Consensus       208 ili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~  280 (380)
                      ++++.++.+++.--|+...+.+                   .     .++...=.-.+=|++..+++++..|.
T Consensus       110 L~f~~~~~p~i~~RGik~~l~P-------------------~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVVDP-------------------L-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTTBSC-------------------C-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccCCCC-------------------C-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999998876543321                   1     11222223457788889999886654

>2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B

Probab=90.00  E-value=0.49  Score=26.67  Aligned_cols=29  Identities=21%  Similarity=0.369  Sum_probs=20.9

Q ss_pred             CccchhhHHHHHHHHHHHHHHHHHHHHHH
Q 016917            1 MSVTLAAIFGAAAGAVALMGIIFFLSWFC   29 (380)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   29 (380)
                      |..+.+.+.|++++.++..+++.+..|++
T Consensus         2 ~~L~~gaIaGIVvgdi~~t~~i~~~vy~~   30 (33)
T 2l34_A            2 STVSPGVLAGIVVGDLVLTVLIALAVYFL   30 (33)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccCcceEEeEeHHHHHHHHHHHHHHhhe
Confidence            45677889999988887766666555554

>2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens}

Probab=89.56  E-value=1.2  Score=28.11  Aligned_cols=28  Identities=18%  Similarity=0.288  Sum_probs=14.4

Q ss_pred             chhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 016917            4 TLAAIFGAAAGAVALMGIIFFLSWFCLY   31 (380)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~   31 (380)
                      .+.++++.+++.++++++++++.|-|..
T Consensus         8 p~WiIi~svl~GLLLL~Lii~~LwK~GF   35 (54)
T 2l8s_A            8 PLWVILLSAFAGLLLLMLLILALWKIGF   35 (54)
T ss_dssp             CTHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHHHHHHHHHHcCc
Confidence            3445555555555555555555555533

>2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens}

Probab=89.48  E-value=1.5  Score=27.70  Aligned_cols=29  Identities=14%  Similarity=0.361  Sum_probs=14.9

Q ss_pred             cchhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 016917            3 VTLAAIFGAAAGAVALMGIIFFLSWFCLY   31 (380)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   31 (380)
                      +.+.++++.+++.++++++++++.|-|..
T Consensus        10 vp~wiIi~svl~GLllL~li~~~LwK~GF   38 (54)
T 2knc_A           10 IPIWWVLVGVLGGLLLLTILVLAMWKVGF   38 (54)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHHHHHHHHHHHHHHcCc
Confidence            34455555555555555555555555533

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.51  E-value=2.3  Score=35.72  Aligned_cols=113  Identities=10%  Similarity=0.079  Sum_probs=70.9

Q ss_pred             CCCceeeeccceecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCC
Q 016917          128 QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA-HLHSLSPRVVHKDFKTA  206 (380)
Q Consensus       128 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~-~LH~~~~~ivHrDikp~  206 (380)
                      .||++..  ..-.+.+.+.+.++.-++  ...+-      .-...+...+++++.+++.... +++.    -+|--+.|+
T Consensus        48 ~~~~f~~--~I~~~eD~~~i~y~~~~~--~~~f~------~i~~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCIVR--DIDVSEDEVKVVIKPPSS--FLTFA------AIRKTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPE  113 (219)
T ss_dssp             SCSSSEE--EEEECSSEEEEEEECCTT--CEEHH------HHHTSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGG
T ss_pred             cCCCCCe--EEEEeCCEEEEEEEcCcc--cCcHH------HHHhcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCc
Confidence            4677722  222455555554443322  22221      2245677888999999888776 6654    678889999


Q ss_pred             CeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchh-hHHHHHHHHHHHcCCCCC
Q 016917          207 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSD-VYSFGVFLLELVSGREAS  279 (380)
Q Consensus       207 Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D-vwSlG~il~el~tg~~p~  279 (380)
                      |++++.++.+++.-.|+-..+.                   |.     ..+ ..| .-.+=|++..++.++..|
T Consensus       114 NL~f~~~~~p~i~hRGi~~~lp-------------------P~-----e~~-ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKESLP-------------------PD-----EWD-DERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             GEEECTTCCEEESCCEETTTBS-------------------SC-----SCC-HHHHHHHHHHHHHHHTTCSSCH
T ss_pred             eEEEeCCCcEEEEEcCCcccCC-------------------CC-----CCC-HHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999999999888754321                   11     111 123 334777888888887543

>2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens}

Probab=83.25  E-value=1.6  Score=28.49  Aligned_cols=7  Identities=14%  Similarity=-0.036  Sum_probs=2.6

Q ss_pred             HHHHHHH
Q 016917           21 IIFFLSW   27 (380)
Q Consensus        21 ~~~~~~~   27 (380)
                      ++.+.++
T Consensus        23 ~~glcI~   29 (70)
T 2klu_A           23 FIGLGIF   29 (70)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            3333334

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	380
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-56
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-56
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-54
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-54
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-54
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-53
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-52
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-51
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-51
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-51
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-51
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-50
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-50
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-49
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-49
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-48
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-48
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-47
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-47
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-47
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-47
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-46
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-46
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-46
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-45
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-45
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-45
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-43
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-40
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-37
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-37
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-36
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-36
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-36
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-36
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-35
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-34
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-32
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-31
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-31
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-30
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	9e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-27
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-24
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-17

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 9e-59
 Identities = 71/289 (24%), Positives = 130/289 (44%), Gaps = 28/289 (9%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT----QEFIDEVCFL 124
           ++  +     +    IG G FG VYKG       VA+K     APT    Q F +EV  L
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVL 58

Query: 125 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
              +H N++  +GY     L  ++ ++    S+  HL+        K E    + IA   
Sbjct: 59  RKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHII----ETKFEMIKLIDIARQT 113

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
           A+G+ +LH+    ++H+D K+ N+ + ED   K+ D GL     R   +    Q++   +
Sbjct: 114 AQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171

Query: 245 FLASEV---KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 301
           ++A EV   ++   +S +SDVY+FG+ L EL++G+   S+++      ++ +V       
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSP 229

Query: 302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR 350
           +L K+              +   +L+  CL    + RP    ++  ++ 
Sbjct: 230 DLSKVRSNCP---------KAMKRLMAECLKKKRDERPLFPQILASIEL 269

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 1e-56
 Identities = 73/279 (26%), Positives = 123/279 (44%), Gaps = 24/279 (8%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
              +    IG G+FG V+ G   +   VAIK  +      ++FI+E   +  + H  LV 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L G C E     L++E++ +G     L    +  R     +  L + L   +G+A+L   
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-- 118

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
              V+H+D    N LV E+ + KV+D G+  F+        +      + + + EV  F 
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-WASPEVFSFS 177

Query: 255 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 314
           R+S KSDV+SFGV + E+ S  +      P  ++   E+V+   D S   ++   RL S 
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK-----IPYENRSNSEVVE---DISTGFRLYKPRLAS- 228

Query: 315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
                     Q++  C     E RP+ S ++ +L    +
Sbjct: 229 ------THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 2e-56
 Identities = 72/275 (26%), Positives = 117/275 (42%), Gaps = 24/275 (8%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           +       +G G+FGEV+ G       VA+K  K+       F+ E   +  +QH+ LV 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L     +  + ++I EY+ NGS+   L  P   S  KL     L +A   A+G+A +   
Sbjct: 73  LYAVVTQEPI-YIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
           +   +H+D + AN+LV +    K+AD GL   +   +             + A E   + 
Sbjct: 129 N--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYG 185

Query: 255 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 314
            F+ KSDV+SFG+ L E+V+         P       E++QN          L+      
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI-----PYPGMTNPEVIQN----------LERGYRMV 230

Query: 315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
             +   EE  QL+  C     E RP+   + + L+
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  179 bits (456), Expect = 1e-54
 Identities = 68/293 (23%), Positives = 128/293 (43%), Gaps = 24/293 (8%)

Query: 65  RRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD-GMLVAIK--KRPGAPTQEFIDEV 121
                ++  +   + + K+ +G G++GEVY+G+ +   + VA+K  K      +EF+ E 
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 64

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
             +  I+H NLV LLG C      ++I E++  G++  +L    + +RQ++     L +A
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR---ECNRQEVSAVVLLYMA 121

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
              +  + +L       +H+D    N LV E+ + KVAD GL   +   D     +    
Sbjct: 122 TQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKF 178

Query: 242 DEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS 301
              + A E   + +FS KSDV++FGV L E+ +                        D S
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG---------------MSPYPGIDLS 223

Query: 302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 354
            + ++L++           E+  +L+  C   +   RPS +++    +    +
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  178 bits (453), Expect = 4e-54
 Identities = 68/312 (21%), Positives = 126/312 (40%), Gaps = 41/312 (13%)

Query: 67  FQMEELSLATKNFSDK---------NLIGEGKFGEVYKGLL----QDGMLVAIKKRPGAP 113
           F  E+ + A + F+ +          +IG G+FGEV  G L    +  + VAIK      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 114 T----QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSR 169
           T    ++F+ E   +    H N++ L G   ++    +I E++ NGS    L    + + 
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGS----LDSFLRQND 122

Query: 170 QKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR 229
            +      + +  G A G+ +L       VH+D    N+LV+ + + KV+D GL  FL  
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 230 TDVAGPSSQVTAD---EIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS 286
                  +          + A E  ++R+F+  SDV+S+G+ + E++S  E         
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW----- 235

Query: 287 SQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVT 346
                          +++  +++        +      QL++ C       RP    +V 
Sbjct: 236 ----------DMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 347 ELDRTLDKEMNL 358
            LD+ +    +L
Sbjct: 286 TLDKMIRNPNSL 297

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 9e-54
 Identities = 64/274 (23%), Positives = 119/274 (43%), Gaps = 24/274 (8%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           K+ +    +G G+FG V  G  +    VAIK  K       EFI+E   + ++ H  LV 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L G C +    F+I EY+ NG +  +L       R + + +  L +     + + +L   
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLR----EMRHRFQTQQLLEMCKDVCEAMEYLE-- 117

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
           S + +H+D    N LV++  + KV+D GL  ++   +             +   EV  + 
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PVRWSPPEVLMYS 176

Query: 255 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 314
           +FS KSD+++FGV + E+ S  +      P       E  ++    +  L++    L S 
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAEH---IAQGLRLYRPHLAS- 227

Query: 315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
                 E+   ++  C    ++ RP+   +++ +
Sbjct: 228 ------EKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-53
 Identities = 76/288 (26%), Positives = 118/288 (40%), Gaps = 30/288 (10%)

Query: 71  ELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQH 129
            L++  K       IG+G+FG+V  G    G  VA+K  +  A  Q F+ E   +  ++H
Sbjct: 3   ALNM--KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRH 59

Query: 130 RNLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
            NLV LLG   +E    +++ EY+  GS+  +L       R  L     L  +L   + +
Sbjct: 60  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAM 116

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
            +L       VH+D    NVLV ED +AKV+D GL      T   G          + A 
Sbjct: 117 EYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-----WTAP 169

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 308
           E    ++FS KSDV+SFG+ L E+ S         P     L ++V        + K   
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVP------RVEKGYK 218

Query: 309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM 356
                           +++  C    +  RPS   +  +L+     E+
Sbjct: 219 MDAPDGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 9e-52
 Identities = 60/301 (19%), Positives = 122/301 (40%), Gaps = 36/301 (11%)

Query: 82  KNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFID--EVCFLASIQHRNLVTLLGYC 139
           +  IG+G+FGEV++G    G  VA+K       + +    E+     ++H N++  +   
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 140 QENNLQ----FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL- 194
            ++N      +L+ +Y  +GS+  +L      +R  +  +  + +AL  A GLAHLH   
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 195 -----SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG---------RTDVAGPSSQVT 240
                 P + H+D K+ N+LV ++    +AD GL                   G    + 
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM- 179

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 300
           A E+   S   +     +++D+Y+ G+   E+     +   +  D      +LV +    
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC-SIGGIHEDYQLPYYDLVPSDPSV 238

Query: 301 SNLLKILDERL------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 354
             + K++ E+           + E +    +++  C   +   R +   +   L +   +
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298

Query: 355 E 355
           E
Sbjct: 299 E 299

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 1e-51
 Identities = 69/275 (25%), Positives = 115/275 (41%), Gaps = 24/275 (8%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVT 134
           ++   +  +G+G FGEV+ G       VAIK  K      + F+ E   +  ++H  LV 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
           L     E  + +++ EY+  GS+   L G    + + L     + +A   A G+A++   
Sbjct: 77  LYAVVSEEPI-YIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVE-- 130

Query: 195 SPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFR 254
               VH+D + AN+LV E+ + KVAD GL   +   +           + + A E   + 
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYG 189

Query: 255 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 314
           RF+ KSDV+SFG+ L EL +         P       E          +L  ++      
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV-----PYPGMVNRE----------VLDQVERGYRMP 234

Query: 315 FTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD 349
              E  E    L+ +C     E RP+   +   L+
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 1e-51
 Identities = 71/294 (24%), Positives = 129/294 (43%), Gaps = 31/294 (10%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQDG-----MLVAIKKRPGAPTQ----EFIDEVCFLASIQ 128
             + + +IG G+FGEVYKG+L+       + VAIK      T+    +F+ E   +    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
           H N++ L G   +     +I EY+ NG++   L         +      + +  G A G+
Sbjct: 68  HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGM 123

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-FLA 247
            +L +     VH+D    N+LV+ + + KV+D GL   L     A  ++      I + A
Sbjct: 124 KYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 307
            E   +R+F+  SDV+SFG+ + E+++  E                         ++K +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE---------------RPYWELSNHEVMKAI 226

Query: 308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTV 361
           ++        +      QL+++C      RRP  +D+V+ LD+ +    +L T+
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 280

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 2e-51
 Identities = 54/306 (17%), Positives = 112/306 (36%), Gaps = 44/306 (14%)

Query: 72  LSLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK-----RPGAPTQEFIDEVCFLA 125
           + L   +F   + +G G  G V+K      G+++A K      +P     + I E+  L 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR-NQIIRELQVLH 59

Query: 126 SIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 185
                 +V   G    +    +  E++  GS+   L         ++  +    +++   
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVI 114

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 245
           KGL +L     +++H+D K +N+LV+     K+ D G+   L  +     ++       +
Sbjct: 115 KGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSY 169

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGR---------------------------EA 278
           ++ E  +   +S +SD++S G+ L+E+  GR                             
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229

Query: 279 SSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 338
             +     S   ++       F  L  I++E      +     EF   + +CL  +   R
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 289

Query: 339 PSMSDV 344
             +  +
Sbjct: 290 ADLKQL 295

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (435), Expect = 2e-51
 Identities = 66/277 (23%), Positives = 116/277 (41%), Gaps = 32/277 (11%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQ 128
            K FSD   IG G FG VY    +++  +VAIKK      +     Q+ I EV FL  ++
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
           H N +   G     +  +L+ EY    +  +         ++ L+     ++  GA +GL
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-----HKKPLQEVEIAAVTHGALQGL 128

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
           A+LHS    ++H+D K  N+L+ E  + K+ D G  + +   +    +    A E+ LA 
Sbjct: 129 AYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAM 186

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 308
           +     ++  K DV+S G+  +EL   +       P  + + +           L  I  
Sbjct: 187 DEG---QYDGKVDVWSLGITCIELAERK------PPLFNMNAMSA---------LYHIAQ 228

Query: 309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
               +  +    E F   +  CL    + RP+   ++
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 8e-51
 Identities = 68/304 (22%), Positives = 113/304 (37%), Gaps = 40/304 (13%)

Query: 78  NFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKK-RPGAPTQE---FIDEVCFLASI 127
             S    +G G FG+V +            M VA+K  +P A   E    + E+  L+ +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 128 -QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY-------------GPSQVSRQKLE 173
             H N+V LLG C       +I EY   G +   L                 +     L+
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 174 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
            +  LS +   AKG+A L S     +H+D    N+L+    I K+ D GL   +      
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 293
                      ++A E      ++ +SDV+S+G+FL EL S   +     P  S+     
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----- 256

Query: 294 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD 353
                      K++ E            E   ++  C D    +RP+   +V  +++ + 
Sbjct: 257 ---------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

Query: 354 KEMN 357
           +  N
Sbjct: 308 ESTN 311

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  168 bits (427), Expect = 3e-50
 Identities = 71/312 (22%), Positives = 112/312 (35%), Gaps = 46/312 (14%)

Query: 68  QMEELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKK----RPGAPTQEF 117
           ++  L     N      IGEG FG V++         +   +VA+K            +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG-------------- 163
             E   +A   + N+V LLG C       L++EY+  G ++  L                
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 164 -----PSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV 218
                 S      L    +L IA   A G+A+L     + VH+D  T N LV E+ + K+
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKI 181

Query: 219 ADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREA 278
           AD GL   +   D             ++  E   + R++ +SDV+++GV L E+ S    
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG-- 239

Query: 279 SSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERR 338
              L P       E++           + D  +          E   L+  C       R
Sbjct: 240 ---LQPYYGMAHEEVIY---------YVRDGNI-LACPENCPLELYNLMRLCWSKLPADR 286

Query: 339 PSMSDVVTELDR 350
           PS   +   L R
Sbjct: 287 PSFCSIHRILQR 298

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 5e-50
 Identities = 67/288 (23%), Positives = 115/288 (39%), Gaps = 31/288 (10%)

Query: 70  EELSLATKNFSDKNL-IGEGKFGEVYKGLLQ---DGMLVAIKK----RPGAPTQEFIDEV 121
           ++L L   N    ++ +G G FG V +G+ +     + VAIK        A T+E + E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
             +  + +  +V L+G CQ   L  L+ E    G +   L G     R+++   +   + 
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK----REEIPVSNVAELL 115

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
              + G+ +L       VH+D    NVL+     AK++D GL   LG  D    +     
Sbjct: 116 HQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 242 DEI-FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 300
             + + A E   FR+FS +SDV+S+GV + E +S  +           +++  ++  +  
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ--KPYKKMKGPEVMAFIEQGKRM 231

Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
                            E   E   L+  C     E RP    V   +
Sbjct: 232 E-------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 1e-49
 Identities = 62/279 (22%), Positives = 112/279 (40%), Gaps = 30/279 (10%)

Query: 78  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 131
           ++     IG G +G   K     DG ++  K+        A  Q  + EV  L  ++H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 132 LVTLLGYC--QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
           +V        + N   +++ EY   G ++  +   ++  RQ L+ +  L +       L 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALK 123

Query: 190 HLHSLS---PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFL 246
             H  S     V+H+D K ANV +D     K+ D GL   L        +   T    ++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTP--YYM 181

Query: 247 ASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI 306
           + E      ++EKSD++S G  L EL +         P ++    EL         + + 
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAG------KIREG 229

Query: 307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
              R+   ++    +E  ++I R L+     RPS+ +++
Sbjct: 230 KFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEIL 264

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 2e-49
 Identities = 70/312 (22%), Positives = 125/312 (40%), Gaps = 34/312 (10%)

Query: 57  IELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGA 112
           +   + +A +  +   S    +F    +IG G FG VY G L D     +  A+K     
Sbjct: 9   LNPELVQAVQHVVIGPSSLIVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 66

Query: 113 PTQ----EFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYEYIPNGSVSIHLYGPSQV 167
                  +F+ E   +    H N+++LLG C        ++  Y+ +G     L    + 
Sbjct: 67  TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD----LRNFIRN 122

Query: 168 SRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL 227
                  K  +   L  AKG+  L S   + VH+D    N ++DE F  KVAD GL   +
Sbjct: 123 ETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180

Query: 228 GRTDVAGP--SSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPD 285
              +       +       ++A E  + ++F+ KSDV+SFGV L EL++         P 
Sbjct: 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PY 235

Query: 286 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
              +  ++           ++L             +   +++++C  P +E RPS S++V
Sbjct: 236 PDVNTFDITVYLL---QGRRLLQPEYCP-------DPLYEVMLKCWHPKAEMRPSFSELV 285

Query: 346 TELDRTLDKEMN 357
           + +       + 
Sbjct: 286 SRISAIFSTFIG 297

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 4e-48
 Identities = 71/298 (23%), Positives = 129/298 (43%), Gaps = 39/298 (13%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLLQDG---MLVAIKKRPGAPT----QEFIDEVCFLASI-Q 128
            +   +++IGEG FG+V K  ++     M  AIK+     +    ++F  E+  L  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 129 HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLEFKHR 177
           H N++ LLG C+     +L  EY P+G++   L           +  +  +   L  +  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
           L  A   A+G+ +L     + +H+D    N+LV E+++AK+AD GL +      V     
Sbjct: 130 LHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGL-SRGQEVYVKKTMG 186

Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 297
           ++     ++A E   +  ++  SDV+S+GV L E+VS        +P       EL +  
Sbjct: 187 RLPVR--WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAELYEK- 238

Query: 298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 355
                L +               +E   L+ +C       RPS + ++  L+R L++ 
Sbjct: 239 -----LPQGYRLEKPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 9e-48
 Identities = 68/301 (22%), Positives = 125/301 (41%), Gaps = 31/301 (10%)

Query: 79  FSDKNLIGEGKFGEVYKGLLQD-----GMLVAIKKRPGAPT----QEFIDEVCFLASIQH 129
           F    ++G G FG VYKGL         + VAIK+   A +    +E +DE   +AS+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            ++  LLG C  + +  LI + +P G     L    +  +  +  ++ L+  +  AKG+ 
Sbjct: 71  PHVCRLLGICLTSTV-QLITQLMPFGC----LLDYVREHKDNIGSQYLLNWCVQIAKGMN 125

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +L     R+VH+D    NVLV      K+ D GL   LG  +    +        ++A E
Sbjct: 126 YLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 309
               R ++ +SDV+S+GV + EL++                     +    S +  IL++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFG---------------SKPYDGIPASEISSILEK 228

Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTTVMGEGTPTV 369
                       +   ++V+C    ++ RP   +++ E  +          + G+    +
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288

Query: 370 T 370
            
Sbjct: 289 P 289

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-47
 Identities = 58/274 (21%), Positives = 109/274 (39%), Gaps = 27/274 (9%)

Query: 77  KNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK----KRPGAPTQEFIDEVCFLASIQHRN 131
           +++     +GEG +GEV           VA+K    KR     +    E+C    + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           +V   G+ +E N+Q+L  EY   G +   +          +              G+ +L
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYL 119

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 251
           H +   + H+D K  N+L+DE    K++D GL       +     +++     ++A E+ 
Sbjct: 120 HGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 252 EFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 310
           + R F +E  DV+S G+ L  +++G        P  S       +  + + N  K +D  
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEKKTYLNPWKKID-- 233

Query: 311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
                        + L+ + L  +   R ++ D+
Sbjct: 234 ----------SAPLALLHKILVENPSARITIPDI 257

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 3e-47
 Identities = 67/280 (23%), Positives = 114/280 (40%), Gaps = 31/280 (11%)

Query: 84  LIGEGKFGEVYKGLL----QDGMLVAIKKRPGAPTQE----FIDEVCFLASIQHRNLVTL 135
            IGEG+FG+V++G+        + VAIK      +      F+ E   +    H ++V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 136 LGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS 195
           +G   EN + ++I E    G     L    QV +  L+    +  A   +  LA+L S  
Sbjct: 74  IGVITENPV-WIIMELCTLGE----LRSFLQVRKYSLDLASLILYAYQLSTALAYLES-- 126

Query: 196 PRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRR 255
            R VH+D    NVLV  +   K+ D GL  ++  +     S      + ++A E   FRR
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRR 185

Query: 256 FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTF 315
           F+  SDV+ FGV + E++          P       +++        +       +    
Sbjct: 186 FTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGR------IENGERLPMPPNC 234

Query: 316 TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 355
                     L+ +C      RRP  +++  +L   L++E
Sbjct: 235 P----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 5e-47
 Identities = 76/299 (25%), Positives = 126/299 (42%), Gaps = 41/299 (13%)

Query: 78  NFSDKNLIGEGKFGEVYKGLL--------QDGMLVAIKKRPGAPTQ----EFIDEVCFLA 125
                  +GEG FG+V                  VA+K      T+    + I E+  + 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 126 SI-QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHL-----------YGPSQVSRQKLE 173
            I +H+N++ LLG C ++   ++I EY   G++  +L           Y PS    ++L 
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 174 FKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA 233
            K  +S A   A+G+ +L S   + +H+D    NVLV ED + K+AD GL   +   D  
Sbjct: 134 SKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVEL 293
             ++       ++A E    R ++ +SDV+SFGV L E+ +        SP     + E 
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-----SPYPGVPVEE- 245

Query: 294 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
                    L K+L E       +    E   ++  C      +RP+   +V +LDR +
Sbjct: 246 ---------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 5e-47
 Identities = 62/300 (20%), Positives = 124/300 (41%), Gaps = 32/300 (10%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAPTQ----EFID 119
           +E  +A +  +    +G+G FG VY+G+       +    VAIK    A +     EF++
Sbjct: 13  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 72

Query: 120 EVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLY-----GPSQVSRQKLEF 174
           E   +      ++V LLG   +     +I E +  G +  +L        +         
Sbjct: 73  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132

Query: 175 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 234
              + +A   A G+A+L++   + VH+D    N +V EDF  K+ D G+   +  TD   
Sbjct: 133 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190

Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 294
              +      +++ E  +   F+  SDV+SFGV L E+ +  E      P       +++
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPYQGLSNEQVL 245

Query: 295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK 354
           +          +++  L     +   +   +L+  C   + + RPS  ++++ +   ++ 
Sbjct: 246 R---------FVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 9e-47
 Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 42/288 (14%)

Query: 65  RRFQMEELSLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------RPGAPTQEF 117
           R++ +E       +F     +G+GKFG VY     Q   ++A+K              + 
Sbjct: 1   RQWALE-------DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53

Query: 118 IDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 177
             EV   + ++H N++ L GY  +    +LI EY P G+V   L         K + +  
Sbjct: 54  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRT 108

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
            +     A  L++ HS   RV+H+D K  N+L+      K+AD G       +      +
Sbjct: 109 ATYITELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRT 162

Query: 238 QVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS 297
            +     +L  E+ E R   EK D++S GV   E + G+       P  +    E  +  
Sbjct: 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYK-- 214

Query: 298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
                  +I       TF +   E    LI R L  +  +RP + +V+
Sbjct: 215 -------RISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-46
 Identities = 60/277 (21%), Positives = 104/277 (37%), Gaps = 32/277 (11%)

Query: 81  DKNLIGEGKFGEVYKGLLQD---GMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNL 132
           +   +G G FG V KG  Q       VA+K         A   E + E   +  + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           V ++G C+  +   L+ E    G ++ +L        + ++ K+ + +    + G+ +L 
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLE 124

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIFLASEVK 251
                 VH+D    NVL+     AK++D GL +      +     +       + A E  
Sbjct: 125 E--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 311
            + +FS KSDV+SFGV + E  S  +      P       E+            +L++  
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQK-----PYRGMKGSEV----------TAMLEKGE 227

Query: 312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
                     E   L+  C     E RP  + V   L
Sbjct: 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 4e-46
 Identities = 60/272 (22%), Positives = 113/272 (41%), Gaps = 35/272 (12%)

Query: 85  IGEGKFGEVYKGLL-QDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
           IG G F  VYKGL  +  + VA  +        +  Q F +E   L  +QH N+V     
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 139 CQE----NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
            +          L+ E + +G++  +L        + ++ K   S      KGL  LH+ 
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 195 SPRVVHKDFKTANVLV-DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEF 253
           +P ++H+D K  N+ +       K+ D GL      +     +  V     F+A E+ E 
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE- 186

Query: 254 RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS 313
            ++ E  DVY+FG+ +LE+ +             Q+  ++ +         ++      +
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSE-----YPYSECQNAAQIYR---------RVTSGVKPA 232

Query: 314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVV 345
           +F    + E  ++I  C+  + + R S+ D++
Sbjct: 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 4e-46
 Identities = 61/271 (22%), Positives = 109/271 (40%), Gaps = 31/271 (11%)

Query: 83  NLIGEGKFGEVYKG-LLQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRNLVTLLGY 138
             +G+G FG+VYK    +  +L A K    +     ++++ E+  LAS  H N+V LL  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRV 198
               N  +++ E+   G+V   +        + L       +       L +LH    ++
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLE----LERPLTESQIQVVCKQTLDALNYLHDN--KI 131

Query: 199 VHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQV----TADEIFLASEVKEFR 254
           +H+D K  N+L   D   K+AD G+     RT     S        A E+ +    K+ R
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD-R 190

Query: 255 RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWST 314
            +  K+DV+S G+ L+E+           P    + + +         LLKI      + 
Sbjct: 191 PYDYKADVWSLGITLIEMAEIE------PPHHELNPMRV---------LLKIAKSEPPTL 235

Query: 315 FTNEGM-EEFIQLIVRCLDPSSERRPSMSDV 344
                    F   + +CL+ + + R + S +
Sbjct: 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-45
 Identities = 64/301 (21%), Positives = 103/301 (34%), Gaps = 45/301 (14%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQD------GMLVAIKKRPGAPTQ----EFIDEVCFLASI 127
           N     ++G G FG+V              + VA+K              + E+  +  +
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 128 -QHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYG------------------PSQVS 168
             H N+V LLG C  +   +LI+EY   G +  +L                      +  
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 169 RQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG 228
              L F+  L  A   AKG+  L       VH+D    NVLV    + K+ D GL   + 
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ 288
                           ++A E      ++ KSDV+S+G+ L E+ S         P    
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-----PYPGI 270

Query: 289 DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
            +           N  K++             EE   ++  C    S +RPS  ++ + L
Sbjct: 271 PVDA---------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

Query: 349 D 349
            
Sbjct: 322 G 322

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 5e-45
 Identities = 53/273 (19%), Positives = 110/273 (40%), Gaps = 28/273 (10%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRN 131
            K ++    IG+G  G VY  + +  G  VAI+    +     +  I+E+  +   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           +V  L      +  +++ EY+  GS++  +          ++     ++     + L  L
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFL 132

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 251
           HS   +V+H+D K+ N+L+  D   K+ D G    +         S +     ++A EV 
Sbjct: 133 HSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVV 188

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 311
             + +  K D++S G+  +E++ G        P  +++ +  +             +   
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPLRALYL--------IATNGTP 234

Query: 312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
                 +    F   + RCLD   E+R S  ++
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 5e-45
 Identities = 64/283 (22%), Positives = 107/283 (37%), Gaps = 32/283 (11%)

Query: 77  KNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKK------RPGAPTQEFIDEVCFLAS 126
           K+      +G+G FG V +G         + VA+K              +FI EV  + S
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 186
           + HRNL+ L G      +  ++ E  P GS    L    +  +           A+  A+
Sbjct: 68  LDHRNLIRLYGVVLTPPM-KMVTELAPLGS----LLDRLRKHQGHFLLGTLSRYAVQVAE 122

Query: 187 GLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVTADEIF 245
           G+ +L   S R +H+D    N+L+    + K+ D GL R      D             +
Sbjct: 123 GMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 305
            A E  + R FS  SD + FGV L E+ +  +      P    +  +++          K
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILH---------K 226

Query: 306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTEL 348
           I  E        +  ++   ++V+C     E RP+   +   L
Sbjct: 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  151 bits (382), Expect = 4e-43
 Identities = 57/273 (20%), Positives = 102/273 (37%), Gaps = 28/273 (10%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRNLV 133
           ++     +G G FG V++      G   A K       +  +    E+  ++ ++H  LV
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            L    +++N   +IYE++  G +   +         K+     +       KGL H+H 
Sbjct: 87  NLHDAFEDDNEMVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 194 LSPRVVHKDFKTANVLV--DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 251
                VH D K  N++         K+ D GL   L            T    F A EV 
Sbjct: 143 N--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL 311
           E +     +D++S GV    L+SG       SP   ++  E ++N +   +    +D+  
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVK---SCDWNMDDSA 248

Query: 312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           +S  +    E+    I + L      R ++   
Sbjct: 249 FSGIS----EDGKDFIRKLLLADPNTRMTIHQA 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 1e-42
 Identities = 46/274 (16%), Positives = 94/274 (34%), Gaps = 31/274 (11%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHR 130
           +F    ++GEG F  V     L      AIK                  E   ++ + H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
             V L    Q++   +    Y  NG +  ++           +              L +
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEY 123

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 250
           LH     ++H+D K  N+L++ED   ++ D G    L        ++       +++ E+
Sbjct: 124 LHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER 310
              +   + SD+++ G  + +LV+G        P  + +   + Q         KI+   
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQ---------KIIKLE 226

Query: 311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
               F  +   +   L+ + L   + +R    ++
Sbjct: 227 Y--DFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (365), Expect = 3e-41
 Identities = 67/298 (22%), Positives = 113/298 (37%), Gaps = 39/298 (13%)

Query: 78  NFSDKNLIGEGKFGEVYKGL------LQDGMLVAIKK----RPGAPTQEFIDEVCFLASI 127
                  +G G FG+V +              VA+K        +  +  + E+  L  I
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 128 QHR-NLVTLLGYC-QENNLQFLIYEYIPNGSVSIHLYG-----------PSQVSRQKLEF 174
            H  N+V LLG C +      +I E+   G++S +L             P  + +  L  
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 175 KHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAG 234
           +H +  +   AKG+  L S   + +H+D    N+L+ E  + K+ D GL   + +     
Sbjct: 134 EHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 235 PSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV 294
                     ++A E    R ++ +SDV+SFGV L E+ S        SP     + E  
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEE- 245

Query: 295 QNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL 352
                     + L E       +    E  Q ++ C      +RP+ S++V  L   L
Sbjct: 246 --------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  142 bits (360), Expect = 1e-40
 Identities = 52/284 (18%), Positives = 103/284 (36%), Gaps = 37/284 (13%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPT------------QEFIDEVCFL 124
           N+  K ++G G    V + +        A+K                   +  + EV  L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 125 ASIQ-HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALG 183
             +  H N++ L    + N   FL+++ +  G +  +L       +  L  K    I   
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRA 118

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGP---SSQVT 240
             + +  LH L   +VH+D K  N+L+D+D   K+ D G    L   +       +    
Sbjct: 119 LLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 300
           A EI   S       + ++ D++S GV +  L++G        P   +  + +++     
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQMLMLRMIMSG 230

Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           +      +   +S       +    L+ R L    ++R +  + 
Sbjct: 231 NYQFGSPEWDDYS-------DTVKDLVSRFLVVQPQKRYTAEEA 267

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 1e-40
 Identities = 53/277 (19%), Positives = 101/277 (36%), Gaps = 31/277 (11%)

Query: 77  KNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQH 129
           K   +K      +G G+FG V++ +          K  K  G        E+  L   +H
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
           RN++ L    +      +I+E+I    +   +      S  +L  +  +S      + L 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQ 116

Query: 190 HLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLA 247
            LHS    + H D +  N++         K+ + G    L   D             + A
Sbjct: 117 FLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE---YYA 171

Query: 248 SEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL 307
            EV +    S  +D++S G  +  L+SG    +    +++Q ++E + N+          
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGI---NPFLAETNQQIIENIMNAE------YTF 222

Query: 308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           DE  +   +     E +  + R L    + R + S+ 
Sbjct: 223 DEEAFKEIS----IEAMDFVDRLLVKERKSRMTASEA 255

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  141 bits (357), Expect = 2e-39
 Identities = 56/267 (20%), Positives = 103/267 (38%), Gaps = 28/267 (10%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK---KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYC 139
            +G G FG V++ +    G +   K              +E+  +  + H  L+ L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 140 QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVV 199
           ++     LI E++  G +   +         K+     ++    A +GL H+H     +V
Sbjct: 96  EDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACEGLKHMHEH--SIV 149

Query: 200 HKDFKTANVLVD--EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           H D K  N++ +  +    K+ D GL   L   ++       TA   F A E+ +     
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVG 206

Query: 258 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 317
             +D+++ GV    L+SG       SP + +D +E +QN +         DE  +S+ + 
Sbjct: 207 FYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVK---RCDWEFDEDAFSSVS- 256

Query: 318 EGMEEFIQLIVRCLDPSSERRPSMSDV 344
               E    I   L     +R ++ D 
Sbjct: 257 ---PEAKDFIKNLLQKEPRKRLTVHDA 280

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-38
 Identities = 63/285 (22%), Positives = 102/285 (35%), Gaps = 25/285 (8%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 131
           NF     IGEG +G VYK      G +VA+KK              I E+  L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           +V LL      N  +L++E++                   +      S      +GLA  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFC 118

Query: 192 HSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVK 251
           H  S RV+H+D K  N+L++ +   K+AD GL    G   V   + +V          + 
Sbjct: 119 H--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILL 175

Query: 252 EFRRFSEKSDVYSFGVFLLELVSGREASSSLSP------------DSSQDLVELVQNSRD 299
             + +S   D++S G    E+V+ R      S                + +   V +  D
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 300 FSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           +         + +S       E+   L+ + L     +R S    
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  137 bits (345), Expect = 1e-37
 Identities = 55/281 (19%), Positives = 99/281 (35%), Gaps = 38/281 (13%)

Query: 72  LSLATKNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIK---------KRPGAPTQEFIDEV 121
           L++   +FS   +IG G FGEVY       G + A+K         K+           +
Sbjct: 1   LTM--NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 58

Query: 122 CFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
             +++     +V +       +    I + +  G +  HL                   A
Sbjct: 59  SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMRFYA 113

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTA 241
                GL H+H  +  VV++D K AN+L+DE    +++D GL     +            
Sbjct: 114 AEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVG 167

Query: 242 DEIFLASEV-KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 300
              ++A EV ++   +   +D +S G  L +L+ G           ++D  E+ + +   
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHEIDRMTLTM 224

Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 341
                     L  +F+     E   L+   L     RR   
Sbjct: 225 -------AVELPDSFS----PELRSLLEGLLQRDVNRRLGC 254

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  134 bits (338), Expect = 2e-37
 Identities = 58/284 (20%), Positives = 99/284 (34%), Gaps = 25/284 (8%)

Query: 78  NFSDKNLIGEGKFGEVYKGLLQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRNL 132
            +     IGEG +G VYK     G   A+KK              I E+  L  ++H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 133 VTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLH 192
           V L           L++E++        L     V    LE     S  L    G+A+ H
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQ-----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 193 SLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 252
               RV+H+D K  N+L++ +   K+AD GL    G       + ++          +  
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVTLWYRAPDVLMG 174

Query: 253 FRRFSEKSDVYSFGVFLLELVSGR------------EASSSLSPDSSQDLVELVQNSRDF 300
            +++S   D++S G    E+V+G                  +    +      V     +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 301 SNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
                + +   W +F     E  I L+ + L     +R +    
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 3e-37
 Identities = 60/287 (20%), Positives = 110/287 (38%), Gaps = 27/287 (9%)

Query: 78  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLL 136
           +++D  +IG G FG VY+  L   G LVAIKK      +    E+  +  + H N+V L 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLR 79

Query: 137 GYCQENNLQ------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
            +   +  +       L+ +Y+P     +  +     ++Q L   +         + LA+
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAY 137

Query: 191 LHSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +H  S  + H+D K  N+L+D D  + K+ D G    L R +     S + +        
Sbjct: 138 IH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPEL 193

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDS------------SQDLVELVQNS 297
           +     ++   DV+S G  L EL+ G+      S               +++ +  +  +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
                  +I        F      E I L  R L+ +   R +  + 
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (337), Expect = 3e-37
 Identities = 46/283 (16%), Positives = 89/283 (31%), Gaps = 27/283 (9%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIKK-RPGAPTQEFIDEVCFLASIQHRNLVTLLGYC-Q 140
            IG G FG++Y G  +  G  VAIK         +   E      +Q    +  + +C  
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 73

Query: 141 ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVH 200
           E +   ++ E +      +  +       +K   K  L +A      + ++HS     +H
Sbjct: 74  EGDYNVMVMELLGPSLEDLFNF-----CSRKFSLKTVLLLADQMISRIEYIHSK--NFIH 126

Query: 201 KDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI-----FLASEVKE 252
           +D K  N L+    +  +  + D GL                    +     + +     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW 312
               S + D+ S G  L+    G      L   + +   E +   +     +    E L 
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----MSTPIEVLC 241

Query: 313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 355
             +      EF   +  C     + +P  S +         ++
Sbjct: 242 KGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 1e-36
 Identities = 57/283 (20%), Positives = 102/283 (36%), Gaps = 30/283 (10%)

Query: 83  NLIGEGKFGEVYKG-LLQDGMLVAIKK--------RPGAPTQEFIDEVCFLASIQHRNLV 133
           + +GEG+F  VYK        +VAIKK              +  + E+  L  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 134 TLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
            LL      +   L+++++      I      + +   L   H  +  L   +GL +LH 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVII-----KDNSLVLTPSHIKAYMLMTLQGLEYLH- 117

Query: 194 LSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV-KE 252
               ++H+D K  N+L+DE+ + K+AD GL    G  + A     VT    + A E+   
Sbjct: 118 -QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR--WYRAPELLFG 174

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV-----------QNSRDFS 301
            R +    D+++ G  L EL+         S       +                S    
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
              K           +   ++ + LI      +   R + +  
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 1e-36
 Identities = 55/290 (18%), Positives = 112/290 (38%), Gaps = 25/290 (8%)

Query: 76  TKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLASIQHR 130
              +++ + IGEG +G V       + + VAIKK          Q  + E+  L   +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           N++ +    +   ++ +   Y+    +   LY    +  Q L   H         +GL +
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY--KLLKTQHLSNDHICYFLYQILRGLKY 124

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT-DVAGPSSQVTADEIFLASE 249
           +HS    V+H+D K +N+L++     K+ D GL        D  G  ++  A   + A E
Sbjct: 125 IHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 250 V-KEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD 308
           +    + +++  D++S G  L E++S R            + +  +  S    +L  I++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 309 ERL--------------WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
            +               W+        + + L+ + L  +  +R  +   
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (334), Expect = 2e-36
 Identities = 54/281 (19%), Positives = 97/281 (34%), Gaps = 35/281 (12%)

Query: 76  TKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIKK----RPGAPTQEFIDEVCFLAS 126
            ++  D     +++G G F EV      +   LVAIK               +E+  L  
Sbjct: 4   AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK 63

Query: 127 IQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAK 186
           I+H N+V L    +     +LI + +  G +   +       +     +    +      
Sbjct: 64  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-----EKGFYTERDASRLIFQVLD 118

Query: 187 GLAHLHSLSPRVVHKDFKTANVLV---DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
            + +LH     +VH+D K  N+L    DED    ++D GL        V    S      
Sbjct: 119 AVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGTP 173

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNL 303
            ++A EV   + +S+  D +S GV    L+ G        P   ++  +L +        
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQ---ILKA 224

Query: 304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
               D   W   +    +     I   ++   E+R +    
Sbjct: 225 EYEFDSPYWDDIS----DSAKDFIRHLMEKDPEKRFTCEQA 261

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  130 bits (328), Expect = 4e-36
 Identities = 54/292 (18%), Positives = 116/292 (39%), Gaps = 39/292 (13%)

Query: 77  KNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLA 125
            + SD+     ++G G   EV+    L+    VA+K       R  +    F  E    A
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 126 SIQHRNLVTLLGYCQENN----LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIA 181
           ++ H  +V +    +       L +++ EY+   ++   ++     +   +  K  + + 
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVI 117

Query: 182 LGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL-RNFLGRTDVAGPSSQVT 240
             A + L   H     ++H+D K AN+++      KV D G+ R      +    ++ V 
Sbjct: 118 ADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175

Query: 241 ADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF 300
               +L+ E         +SDVYS G  L E+++G        P +    V +       
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQ---- 225

Query: 301 SNLLKILDERLWSTFTNEGM-EEFIQLIVRCLDPSSERRP-SMSDVVTELDR 350
                + ++ +  +  +EG+  +   ++++ L  + E R  + +++  +L R
Sbjct: 226 ----HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 2e-35
 Identities = 61/274 (22%), Positives = 106/274 (38%), Gaps = 34/274 (12%)

Query: 78  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK-------RPGAPTQEFIDEVCFLASIQH 129
           +F    ++G+G FG+V+     +     AIK                 +++     + +H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
             L  +    Q     F + EY+  G +  H+      S  K +       A     GL 
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQ 117

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
            LH  S  +V++D K  N+L+D+D   K+AD G+       D    +   T D  ++A E
Sbjct: 118 FLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPD--YIAPE 173

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 309
           +   ++++   D +SFGV L E++ G+      SP   QD  EL  + R           
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIR----------- 216

Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD 343
                +     +E   L+V+      E+R  +  
Sbjct: 217 MDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRG 250

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 4e-35
 Identities = 57/291 (19%), Positives = 99/291 (34%), Gaps = 26/291 (8%)

Query: 75  ATKNFSDKNLIGEGKFGEVYKG--LLQDGMLVAIKKRPGAPTQE--------FIDEVCFL 124
           A + +     IGEG +G+V+K   L   G  VA+K+      +E         +  +  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 125 ASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVS-IHLYGPSQVSRQKLEFKHRLSIALG 183
            + +H N+V L   C  +         +    V         +V    +  +    +   
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 184 AAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADE 243
             +GL  LHS   RVVH+D K  N+LV      K+AD GL             + V    
Sbjct: 125 LLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTL 179

Query: 244 IFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLV----------EL 293
            + A EV     ++   D++S G    E+   +      S       +          + 
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

Query: 294 VQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
            ++             +    F  +  E    L+++CL  +  +R S    
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  128 bits (322), Expect = 5e-35
 Identities = 45/291 (15%), Positives = 97/291 (33%), Gaps = 27/291 (9%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRP-GAPTQEFIDEVCFLASIQHRNLVT 134
            ++     IGEG FG +++G  L +   VAIK  P  +   +  DE      +     + 
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64

Query: 135 LLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL 194
            + Y  +  L  ++   +   S+   L     +  +K   K     A      +  +H  
Sbjct: 65  NVYYFGQEGLHNVLVIDLLGPSLEDLL----DLCGRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 195 SPRVVHKDFKTANVLVDEDFI-----AKVADAGLRNFLGRTDVAGPSSQVTADEI----- 244
              +V++D K  N L+            V D G+  F                 +     
Sbjct: 121 --SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL 304
           +++      R  S + D+ + G   +  + G      L   +++   E +   +  + L 
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238

Query: 305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE 355
           ++     +        EEF + +    + + +  P    +     + L++ 
Sbjct: 239 ELCAG--FP-------EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 1e-34
 Identities = 58/292 (19%), Positives = 106/292 (36%), Gaps = 40/292 (13%)

Query: 67  FQMEELSLATKNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK---------RPGAPTQE 116
           F+ E +      +     +G G+F  V K      G+  A K          R G   ++
Sbjct: 3   FRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59

Query: 117 FIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKH 176
              EV  L  IQH N++TL    +      LI E +  G +   L       ++ L  + 
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA-----EKESLTEEE 114

Query: 177 RLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED----FIAKVADAGLRNFLGRTDV 232
                     G+ +LH  S ++ H D K  N+++ +        K+ D GL + +   + 
Sbjct: 115 ATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN- 171

Query: 233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVE 292
                 +     F+A E+  +     ++D++S GV    L+SG         D+ Q+ + 
Sbjct: 172 --EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG---DTKQETLA 226

Query: 293 LVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
            V             ++  +S  +          I R L    ++R ++ D 
Sbjct: 227 NVSAVN------YEFEDEYFSNTS----ALAKDFIRRLLVKDPKKRMTIQDS 268

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  126 bits (317), Expect = 4e-34
 Identities = 54/271 (19%), Positives = 106/271 (39%), Gaps = 36/271 (13%)

Query: 77  KNFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
           ++F     +G G FG V+      +G   A+K             +   DE   L+ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
             ++ + G  Q+    F+I +YI  G +   L        Q+         A      L 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALE 118

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +LH  S  ++++D K  N+L+D++   K+ D G   ++           +     ++A E
Sbjct: 119 YLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPE 171

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 309
           V   + +++  D +SFG+ + E+++G       +P    + ++  +         KIL+ 
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYE---------KILNA 216

Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPS 340
            L   F     E+   L+ R +     +R  
Sbjct: 217 EL--RFPPFFNEDVKDLLSRLITRDLSQRLG 245

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 1e-33
 Identities = 43/267 (16%), Positives = 89/267 (33%), Gaps = 22/267 (8%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASI-QHRNLVTLLGYCQ- 140
           ++G G  G+V +    +     A+K     P  +   EV       Q  ++V ++   + 
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP--KARREVELHWRASQCPHIVRIVDVYEN 76

Query: 141 ---ENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPR 197
                    ++ E +  G +   +        Q    +    I     + + +LHS+   
Sbjct: 77  LYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHSI--N 131

Query: 198 VVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFS 257
           + H+D K  N+L        +       F   T      +       ++A EV    ++ 
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 191

Query: 258 EKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTN 317
           +  D++S GV +  L+ G     S    +    ++       +           WS  + 
Sbjct: 192 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE-----FPNPEWSEVS- 245

Query: 318 EGMEEFIQLIVRCLDPSSERRPSMSDV 344
              EE   LI   L     +R ++++ 
Sbjct: 246 ---EEVKMLIRNLLKTEPTQRMTITEF 269

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 9e-32
 Identities = 53/294 (18%), Positives = 98/294 (33%), Gaps = 29/294 (9%)

Query: 78  NFSDKNLIGEGKFGEVYKG-LLQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHRN 131
            +     IG+G FGEV+K    + G  VA+KK              + E+  L  ++H N
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 132 LVTLLGYCQENNLQFLIYE---YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGL 188
           +V L+  C+     +   +   Y+        L G       K        +      GL
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130

Query: 189 AHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR---TDVAGPSSQVTADEIF 245
            ++H    +++H+D K ANVL+  D + K+AD GL         +     +++V      
Sbjct: 131 YYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 246 LASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK 305
               +   R +    D++  G  + E+ +        +      L+  +  S        
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 306 ILDERLWSTFTNEGM---------------EEFIQLIVRCLDPSSERRPSMSDV 344
           + +  L+                          + LI + L     +R    D 
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 2e-31
 Identities = 52/287 (18%), Positives = 99/287 (34%), Gaps = 27/287 (9%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 130
           + +     IGEG +G V+K    +   +VA+K+              + E+C L  ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 131 NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAH 190
           N+V L      +    L++E+                    L+ +   S      KGL  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-----CNGDLDPEIVKSFLFQLLKGLGF 116

Query: 191 LHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 250
            H  S  V+H+D K  N+L++ +   K+A+ GL    G   V   S++V          +
Sbjct: 117 CH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVL 173

Query: 251 KEFRRFSEKSDVYSFGVFLLELVSGR-------------EASSSLSPDSSQDLVELVQNS 297
              + +S   D++S G    EL +               +    L    +++    +   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 298 RDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
            D+                 +       L+   L  +  +R S  + 
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 7e-31
 Identities = 49/294 (16%), Positives = 111/294 (37%), Gaps = 39/294 (13%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 130
             + D   +G G +G V   +  + G  VAIKK     +     +    E+  L  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 131 NLVTLLGYCQENNLQ------FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
           N++ LL     +         +L+  ++      +          +KL       +    
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-------KHEKLGEDRIQFLVYQM 130

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
            KGL ++H+    ++H+D K  N+ V+ED   K+ D GL            +  V     
Sbjct: 131 LKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWY 184

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE--------------ASSSLSPDSSQDL 290
                +  + R+++  D++S G  + E+++G+                  + +P +    
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244

Query: 291 VELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
                 ++++   L  L+++ +++         + L+ + L   +E+R +  + 
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 9e-31
 Identities = 60/272 (22%), Positives = 96/272 (35%), Gaps = 33/272 (12%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQH 129
            +F    L+G+G FG+V        G   A+K                + E   L + +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 130 RNLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
             L  L    Q ++    + EY   G +  HL        +    +            L 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALE 119

Query: 190 HLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASE 249
           +LHS    VV++D K  N+++D+D   K+ D GL            +   T +  +LA E
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE--YLAPE 175

Query: 250 VKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 309
           V E   +    D +  GV + E++ GR       P  +QD   L +          IL E
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFE---------LILME 220

Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSM 341
            +   F      E   L+   L    ++R   
Sbjct: 221 EI--RFPRTLSPEAKSLLAGLLKKDPKQRLGG 250

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 2e-30
 Identities = 57/275 (20%), Positives = 96/275 (34%), Gaps = 47/275 (17%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIKK---------RPGAPTQEFIDEVCFLASIQ--HRN 131
           L+G G FG VY G+ + D + VAIK                     EV  L  +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 132 LVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHL 191
           ++ LL + +  +   LI E                  R  L+ +   S      + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVRHC 126

Query: 192 HSLSPRVVHKDFKTANVLVDED-FIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEV 250
           H+    V+H+D K  N+L+D +    K+ D G    L  T      +      ++   E 
Sbjct: 127 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEW 180

Query: 251 KEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE 309
             + R+    + V+S G+ L ++V G        P               F +  +I+  
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGD------IP---------------FEHDEEIIRG 219

Query: 310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDV 344
           ++   F      E   LI  CL      RP+  ++
Sbjct: 220 QV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  109 bits (273), Expect = 9e-28
 Identities = 46/293 (15%), Positives = 108/293 (36%), Gaps = 38/293 (12%)

Query: 78  NFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTL 135
           ++     +G GK+ EV++ + + +   V +K       ++   E+  L +++   N++TL
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 95

Query: 136 LGYCQE--NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHS 193
               ++  +    L++E++ N               Q L             K L + HS
Sbjct: 96  ADIVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS 147

Query: 194 LSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKE 252
           +   ++H+D K  NV++D E    ++ D GL  F         + +V +        + +
Sbjct: 148 M--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVD 203

Query: 253 FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDL----------------VELVQN 296
           ++ +    D++S G  L  ++  +E       +  Q +                   ++ 
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263

Query: 297 SRDFSNLLKILDERLWSTFTNEGM-----EEFIQLIVRCLDPSSERRPSMSDV 344
              F+++L     + W  F +         E +  + + L    + R +  + 
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-27
 Identities = 56/308 (18%), Positives = 120/308 (38%), Gaps = 43/308 (13%)

Query: 67  FQMEELSLATKNFSDK----NLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQE 116
           F  +EL+       ++    + +G G +G V      + G+ VA+KK     +     + 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 117 FIDEVCFLASIQHRNLVTLLGYCQENN-----LQFLIYEYIPNGSVSIHLYGPSQVSRQK 171
              E+  L  ++H N++ LL                +  ++    ++      + V  QK
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN------NIVKCQK 117

Query: 172 LEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD 231
           L   H   +     +GL ++H  S  ++H+D K +N+ V+ED   K+ D GL        
Sbjct: 118 LTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175

Query: 232 VAGPSSQV-TADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE------------- 277
               +++   A EI L      +  +++  D++S G  + EL++GR              
Sbjct: 176 TGYVATRWYRAPEIML-----NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

Query: 278 -ASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSE 336
                 +P +        +++R++   L  + +  ++          + L+ + L   S+
Sbjct: 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 290

Query: 337 RRPSMSDV 344
           +R + +  
Sbjct: 291 KRITAAQA 298

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  108 bits (270), Expect = 4e-27
 Identities = 57/308 (18%), Positives = 111/308 (36%), Gaps = 38/308 (12%)

Query: 39  TSETGSSEPSVQPGRNVGIELSIREARRFQMEELSLATKNFSDKNLIGEGKFGEVYKGL- 97
            ++ GS + SV+       E  +++          L    F     +G G FG V     
Sbjct: 5   AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL--DQFDRIKTLGTGSFGRVMLVKH 62

Query: 98  LQDGMLVAIKK------RPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY 151
            + G   A+K             +  ++E   L ++    LV L    ++N+  +++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122

Query: 152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD 211
           +  G +  HL         +    H    A        +LHSL   ++++D K  N+L+D
Sbjct: 123 VAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLID 175

Query: 212 EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLE 271
           +    +V D G         V G +  +      LA E+   + +++  D ++ GV + E
Sbjct: 176 QQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230

Query: 272 LVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCL 331
           + +G        P  +   +++ +              R  S F+     +   L+   L
Sbjct: 231 MAAGY------PPFFADQPIQIYEKIVSG-------KVRFPSHFS----SDLKDLLRNLL 273

Query: 332 DPSSERRP 339
                +R 
Sbjct: 274 QVDLTKRF 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 1e-26
 Identities = 58/286 (20%), Positives = 98/286 (34%), Gaps = 35/286 (12%)

Query: 70  EELSLATKNFSDKNLIGEGKFGEVYKGLL----QDGMLVAIKK-------RPGAPTQEFI 118
           E++ +  +NF    ++G G +G+V+          G L A+K        +    T+   
Sbjct: 19  EKVGI--ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 76

Query: 119 DEVCFLASIQHR-NLVTLLGYCQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHR 177
            E   L  I+    LVTL    Q      LI +YI  G +  HL       R++      
Sbjct: 77  TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-----QRERFTEHEV 131

Query: 178 LSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSS 237
                     L HLH L   ++++D K  N+L+D +    + D GL       +      
Sbjct: 132 QIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 189

Query: 238 QVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN 296
                E      V+       +  D +S GV + EL++G    +     +SQ   E+ + 
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRR 247

Query: 297 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS 342
                      +       +         LI R L    ++R    
Sbjct: 248 ILKS-------EPPYPQEMS----ALAKDLIQRLLMKDPKKRLGCG 282

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  100 bits (249), Expect = 2e-24
 Identities = 44/307 (14%), Positives = 92/307 (29%), Gaps = 47/307 (15%)

Query: 84  LIGEGKFGEVYKGL-LQDGMLVAIK--KRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQ 140
            +G G F  V+    + +   VA+K  +     T+   DE+  L  +   +         
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 141 ENNLQFLIYEYIPNGSVSI-----------HLYGPSQVSRQKLEFKHRLSIALGAAKGLA 189
            + L+ L +      +               L    +   + +   +   I+     GL 
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 190 HLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLAS 248
           ++H     ++H D K  NVL++  D    +    + +           +       + + 
Sbjct: 140 YMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP 198

Query: 249 EVKEFRRFSEKSDVYSFGVFLLELVSGR---EASSSLSPDSSQD---------------L 290
           EV     +   +D++S    + EL++G    E     S     D               L
Sbjct: 199 EVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL 258

Query: 291 VELVQNSRDFSNLLKILDE-------------RLWSTFTNEGMEEFIQLIVRCLDPSSER 337
           +   + +R F N   +L                    F+ +  +E    +   L     +
Sbjct: 259 LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318

Query: 338 RPSMSDV 344
           R     +
Sbjct: 319 RADAGGL 325

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.9 bits (245), Expect = 7e-24
 Identities = 58/305 (19%), Positives = 105/305 (34%), Gaps = 50/305 (16%)

Query: 77  KNFSDKNLIGEGKFGEVYKGL-LQDGMLVAIKK-----RPGAPTQEFIDEVCFLASIQHR 130
           K + +   IG G  G V           VAIKK     +     +    E+  +  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 131 NLVTLLGYC------QENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGA 184
           N+++LL         +E    +L+ E +      +         + +L+ +    +    
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--------QMELDHERMSYLLYQM 128

Query: 185 AKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEI 244
             G+ HLHS    ++H+D K +N++V  D   K+ D GL    G +      +       
Sbjct: 129 LCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRY 183

Query: 245 FLASEVKEFRRFSEKSDVYSFGVFLLELVSGR----------------EASSSLSPDSSQ 288
           + A EV     + E  D++S G  + E+V  +                E   +  P+  +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243

Query: 289 DLVELVQN---------SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP 339
            L   V+N            F  L         S        +   L+ + L     +R 
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303

Query: 340 SMSDV 344
           S+ D 
Sbjct: 304 SVDDA 308

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 76.7 bits (188), Expect = 4e-17
 Identities = 34/211 (16%), Positives = 63/211 (29%), Gaps = 47/211 (22%)

Query: 83  NLIGEGKFGEVYKGLLQDGMLVAIKK-RPGAPT------------QEFIDEVCFLASIQH 129
            L+GEGK   V+    +      +K  + G  +              F       A  + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 130 RNLVTLLGYCQENNLQF----LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAA 185
           R L  L G        +    ++ E I    +                 ++   +     
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV------------RVENPDEVLDMIL 113

Query: 186 KGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIF 245
           + +A  +     +VH D    NVLV E+ I  + D            +    +    E  
Sbjct: 114 EEVAKFY--HRGIVHGDLSQYNVLVSEEGI-WIIDFPQ---------SVEVGEEGWRE-I 160

Query: 246 LASEVKEF-----RRFSEKSDVYSFGVFLLE 271
           L  +V+       R +  + D+ S    +L+
Sbjct: 161 LERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	380
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.54
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.48
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.72
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.38
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.91
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.71

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=407.11  Aligned_cols=255  Identities=27%  Similarity=0.426  Sum_probs=203.1

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCC--CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeec
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      .++|++.+.||+|+||+||+|...++..||||+...  ...+++.+|++++++++||||++++|++..++..++||||++
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            356888899999999999999998889999998653  345779999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                      +|+|.+++..    ....+++..++.++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++....... 
T Consensus        84 ~g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-  156 (263)
T d1sm2a_          84 HGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  156 (263)
T ss_dssp             TCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             CCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhc--cceeecccchhheeecCCCCeEecccchheeccCCCc-
Confidence            9999998843    34568899999999999999999999  7799999999999999999999999999987754322 


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG-REASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                      .......||..|+|||++.+..|+.++|||||||++|||+|+ .+||....   ..+....+..             ...
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~~i~~-------------~~~  220 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDIST-------------GFR  220 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHHHHHH-------------TCC
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHHHHHHh-------------cCC
Confidence            223345688999999999999999999999999999999995 44444322   1122222221             122


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhh
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  353 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~  353 (380)
                      ...+..+++++.+++.+||+.||++|||+++++++|+++.+
T Consensus       221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            23445566889999999999999999999999999998865

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-57  Score=408.30  Aligned_cols=250  Identities=21%  Similarity=0.297  Sum_probs=205.2

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      ++|++.+.||+|+||+||+|+.+ +|+.||+|+....    ..+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57899999999999999999964 6899999974322    335688999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++|+|.+++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||+++++.+||+|||+|+......
T Consensus        85 ~~gg~L~~~l~-----~~~~l~e~~~~~i~~qi~~al~ylH~--~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          85 CSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHH--cCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            99999999983     45678999999999999999999999  679999999999999999999999999998875444


Q ss_pred             CCCCCccccCccceecccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      .........||+.|+|||++.+..| +.++|||||||++|||++|+.||.......  .........            .
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~~~~~~------------~  223 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEK------------K  223 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHHHHHTT------------C
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHHHHHhcC------------C
Confidence            3344456789999999999988887 567999999999999999999997644221  111111111            1


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .........++++.+|+.+||+.||++|||++|++++
T Consensus       224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1111123445778999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-57  Score=410.31  Aligned_cols=260  Identities=25%  Similarity=0.426  Sum_probs=204.7

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCC-----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      +..++|++.+.||+|+||+||+|+.+  ..||||....     ...+.|.+|++++++++||||+++++++.+ +..++|
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence            44578999999999999999999865  3599998542     234578899999999999999999998765 457999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++|+|.+++..    ....+++..+..++.|++.||+|||+  ++||||||||+|||++.++.+||+|||+|+...
T Consensus        82 ~Ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          82 TQWCEGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EECCCEEEHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             EecCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHhc--CCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            999999999998842    34568999999999999999999999  779999999999999999999999999998775


Q ss_pred             CCCCCCCCccccCccceeccccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ............||+.|+|||++.+   ..|+.++|||||||++|||+||+.||......  ......+........   
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~--~~~~~~~~~~~~~p~---  230 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYLSPD---  230 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHHTSCCCC---
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCc---
Confidence            5443334456679999999999864   35899999999999999999999999865421  112222221111111   


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhh
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  353 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~  353 (380)
                            ....+..+++++.+++.+||+.||.+|||+++++++|+.+.+
T Consensus       231 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         231 ------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             ------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                  123344566889999999999999999999999999987764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.3e-57  Score=411.00  Aligned_cols=262  Identities=25%  Similarity=0.460  Sum_probs=205.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECC-C---cEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQD-G---MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~-~---~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      .++|++.+.||+|+||+||+|..+. +   ..||||......    .+.|.+|+++|++++||||++++|++..++..++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            3567788999999999999999642 2   368999865432    3468899999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+++|+|.+++..    ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++++||+|||+++.+
T Consensus       105 v~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EEECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEecCCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhh--CCCccCccccceEEECCCCcEEECCcccceEc
Confidence            9999999999988742    34568999999999999999999999  77999999999999999999999999999877


Q ss_pred             CCCCCC---CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          228 GRTDVA---GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       228 ~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      ......   .......+|+.|+|||.+.+..|+.++|||||||++|||+| |+.||.....   .+....+.        
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~--------  247 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIE--------  247 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHH--------
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHHH--------
Confidence            543221   12233567899999999999999999999999999999998 8999986542   12222221        


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhcccc
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLT  359 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~~~  359 (380)
                           ...+.+.+..+++++.+|+.+||+.||++|||+.++++.|+++++.+-+++
T Consensus       248 -----~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~slk  298 (299)
T d1jpaa_         248 -----QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK  298 (299)
T ss_dssp             -----TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGT
T ss_pred             -----cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhhCC
Confidence                 122334556677889999999999999999999999999999998765554

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-57  Score=413.28  Aligned_cols=260  Identities=25%  Similarity=0.412  Sum_probs=215.6

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC--CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      +..++|++.+.||+|+||+||+|.++ +++.||||+...  ...+++.+|+++|++++||||+++++++.+++..++|||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            44567888899999999999999965 588999998653  346779999999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++|+|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        94 ~~~~g~l~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          94 FMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             CCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             cccCcchHHHhhhc---cccchHHHHHHHHHHHHHHHHHHHHH--CCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            99999999988432   34678999999999999999999999  77999999999999999999999999999876543


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      .. .......++..|+|||++.+..|+.++|||||||++|||++|..||.....  .....             +.+...
T Consensus       169 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~-------------~~i~~~  232 (287)
T d1opja_         169 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVY-------------ELLEKD  232 (287)
T ss_dssp             SS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHH-------------HHHHTT
T ss_pred             Cc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHH-------------HHHhcC
Confidence            22 122334578889999999999999999999999999999997776543221  11111             122222


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      .....+..+++++.+|+.+||+.||++|||++++++.|+.+.++
T Consensus       233 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            33455566778899999999999999999999999999888755

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-56  Score=395.19  Aligned_cols=252  Identities=25%  Similarity=0.423  Sum_probs=214.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCC--CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeec
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRP--GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      .++|++.++||+|+||+||+|++++++.||||..+  ....+++.+|++++++++||||++++|++.+++..++||||++
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            36899999999999999999999888899999743  3456789999999999999999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                      +|+|.+++.    .....+++..+..++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++........
T Consensus        83 ~g~l~~~~~----~~~~~~~~~~~~~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          83 NGCLLNYLR----EMRHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             TEEHHHHHH----SGGGCCCHHHHHHHHHHHHHHHHHHHH--TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             CCcHHHhhh----ccccCCcHHHHHHHHHHHHHHHHHHhh--cCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            999988873    235568899999999999999999999  77999999999999999999999999999877553322


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                       ......+|..|+|||.+.+..|+.++|||||||++|||+| |+.||.....   .+....+.             ...+
T Consensus       157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~i~-------------~~~~  219 (258)
T d1k2pa_         157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIA-------------QGLR  219 (258)
T ss_dssp             -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHH-------------TTCC
T ss_pred             -eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHHHHH-------------hCCC
Confidence             2334678999999999999999999999999999999998 8999976542   12222111             1122


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHh
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDR  350 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~  350 (380)
                      ...|..+++++.+|+.+||+.||++|||+++++++|.+
T Consensus       220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            34455666889999999999999999999999999854

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-57  Score=405.63  Aligned_cols=257  Identities=25%  Similarity=0.418  Sum_probs=210.3

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCC--CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG--APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +..++|++.+.||+|+||.||+|..+++..||||+...  ...+.+.+|++++++++||||++++|++.+ +..++||||
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            34567888999999999999999998889999998643  346679999999999999999999998865 457899999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +++|+|.+++..   .....+++..++.++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+|+......
T Consensus        89 ~~~g~L~~~~~~---~~~~~l~~~~~~~i~~qi~~gl~~lH~--~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          89 MENGSLVDFLKT---PSGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             CTTCBHHHHTTS---HHHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             CCCCcHHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccchhheeeecccceeeccccceEEccCCc
Confidence            999999987742   233458999999999999999999999  779999999999999999999999999998875533


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                      . .......+|..|+|||++.+..|+.++|||||||++|||+||..|+.....  ..+....+.             ...
T Consensus       164 ~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i~-------------~~~  227 (272)
T d1qpca_         164 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLE-------------RGY  227 (272)
T ss_dssp             E-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH-------------TTC
T ss_pred             c-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHHHH-------------hcC
Confidence            2 223345688899999999999999999999999999999996655443221  111222111             112


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhh
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTL  352 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~  352 (380)
                      +...+..+++++.+|+.+||+.||++|||++++++.|+...
T Consensus       228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence            23445566788999999999999999999999999998765

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-56  Score=399.10  Aligned_cols=243  Identities=26%  Similarity=0.380  Sum_probs=207.0

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||+||+|+.+ +++.||+|+..      ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46888999999999999999964 68899999743      344567889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+|.....
T Consensus        86 Ey~~~g~L~~~l~-----~~~~l~e~~~~~i~~qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            9999999999883     44678999999999999999999999  7799999999999999999999999999986643


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      .    ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.....   .+....+...            
T Consensus       159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~------------  219 (263)
T d2j4za1         159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKRISRV------------  219 (263)
T ss_dssp             C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTT------------
T ss_pred             C----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH---HHHHHHHHcC------------
Confidence            2    23456799999999999999999999999999999999999999975432   1122111110            


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                        ...++...++++.+|+.+||+.||++|||++|++++
T Consensus       220 --~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         220 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             --CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence              113445566889999999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-56  Score=403.11  Aligned_cols=247  Identities=22%  Similarity=0.359  Sum_probs=206.7

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC---CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP---GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ++|++.+.||+|+||+||+|.. .+|+.||+|+..   ....+.+.+|++++++++||||+++++++.+.+..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4699999999999999999995 568999999743   344567899999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++|+|.+++.      ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+|+.+.... 
T Consensus       100 ~gg~L~~~~~------~~~l~~~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-  170 (293)
T d1yhwa1         100 AGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (293)
T ss_dssp             TTCBHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             CCCcHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence            9999998762      3468999999999999999999999  779999999999999999999999999998765432 


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                       .......||+.|+|||++.+..|+.++|||||||++|||++|+.||......   +........           ....
T Consensus       171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~~~~~-----------~~~~  235 (293)
T d1yhwa1         171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLIATN-----------GTPE  235 (293)
T ss_dssp             -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHH-----------CSCC
T ss_pred             -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH---HHHHHHHhC-----------CCCC
Confidence             2234567999999999999999999999999999999999999999754321   111111110           0111


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...+..+++++++|+.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            23344566889999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=399.76  Aligned_cols=263  Identities=26%  Similarity=0.450  Sum_probs=207.2

Q ss_pred             CCCCCCCeeccCCceEEEEEEECCC-----cEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQDG-----MLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~~-----~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      +.|+..++||+|+||.||+|.++..     ..||||+.....    ...|.+|++++++++||||++++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4677889999999999999986532     479999865433    2358899999999999999999999999999999


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ||||+.+|++.+.+.    .....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.+
T Consensus        87 v~e~~~~~~l~~~~~----~~~~~~~~~~~~~i~~~i~~gl~~lH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          87 ITEYMENGALDKFLR----EKDGEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEECCTTEEHHHHHH----HTTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEecccCcchhhhh----cccccccHHHHHHHHHHHHHhhhhccc--cccccCccccceEEECCCCeEEEcccchhhcc
Confidence            999999999888763    234678999999999999999999999  77999999999999999999999999999877


Q ss_pred             CCCCC-CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          228 GRTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       228 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      ..... ........||..|+|||++.+..|+.++|||||||++|||++|..|+.....  ..+...             .
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~-------------~  225 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMK-------------A  225 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHH-------------H
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHH-------------H
Confidence            54322 1223345689999999999999999999999999999999997666543321  111221             1


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhccccc
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEMNLTT  360 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~~~~~  360 (380)
                      +....+.+.+..+++++.+|+.+||+.||++|||+.++++.|+++++.+.++++
T Consensus       226 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~l~~  279 (283)
T d1mqba_         226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT  279 (283)
T ss_dssp             HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGS
T ss_pred             HhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcccccc
Confidence            222233455666778899999999999999999999999999999887666554

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-56  Score=402.95  Aligned_cols=247  Identities=17%  Similarity=0.223  Sum_probs=204.9

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||+||+|.. .+++.||+|+..      ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            4689999999999999999996 468999999743      344567899999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++     ...+.+++..+..++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+|+.+..
T Consensus        88 Ey~~gg~L~~~~-----~~~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHH-----HHHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhh-----hccCCCCHHHHHHHHHHHHHHHHhhcc--ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence            999999999887     345678999999999999999999999  7799999999999999999999999999988765


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ...........||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.   ......+.            ..
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~------------~~  225 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKII------------KL  225 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH------------TT
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---HHHHHHHH------------cC
Confidence            4433344556799999999999999999999999999999999999999986432   11111111            11


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                        ...++...++++.+|+.+||+.||++|||++|++++
T Consensus       226 --~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         226 --EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             --CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             --CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence              113444566789999999999999999999998764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-56  Score=409.67  Aligned_cols=259  Identities=25%  Similarity=0.382  Sum_probs=209.6

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECC-C-----cEEEEEeCCC----CChHHHHHHHHHHhcC-CCCceeeeccceecC
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQD-G-----MLVAIKKRPG----APTQEFIDEVCFLASI-QHRNLVTLLGYCQEN  142 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~-~-----~~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  142 (380)
                      +..++|++.++||+|+||+||+|+... +     ..||+|....    .....+.+|+.++.++ +||||+++++++.+.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            344678889999999999999998542 2     3689997532    3345688999999998 899999999999999


Q ss_pred             CeeEEEEEeecCCCccccccCCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQ------------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFK  204 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~------------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDik  204 (380)
                      +..++||||+++|+|.+++.....                  .....+++..++.++.|++.||+|||+  ++|+|||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~--~~IiHRDlK  191 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLA  191 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEETTCS
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCc
Confidence            999999999999999999854321                  112458899999999999999999999  779999999


Q ss_pred             CCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 016917          205 TANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLS  283 (380)
Q Consensus       205 p~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~  283 (380)
                      |+|||++.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||+| |..||.+..
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987655433323334567999999999999999999999999999999998 899998654


Q ss_pred             CCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHH
Q 016917          284 PDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELD  349 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~  349 (380)
                      ..  ..+...+             ....+.+.+..+++++.+|+.+||+.||++|||++|++++|.
T Consensus       272 ~~--~~~~~~~-------------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         272 VD--ANFYKLI-------------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CS--HHHHHHH-------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH--HHHHHHH-------------hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            32  1122222             222233455667788999999999999999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=401.24  Aligned_cols=252  Identities=23%  Similarity=0.364  Sum_probs=193.6

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceec--CCeeEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQE--NNLQFLI  148 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  148 (380)
                      ++|++.+.||+|+||+||+|+. .+|+.||+|......     .+.+.+|++++++++||||+++++++.+  ++..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            4688999999999999999996 468999999754332     2457899999999999999999998854  4568999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---CCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS---PRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      |||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        84 mEy~~~g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          84 MEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EECCTTEEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EecCCCCcHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999884321 13457899999999999999999999832   249999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      .+.....  ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.....   .++...+..         
T Consensus       163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~~~i~~---------  228 (269)
T d2java1         163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIRE---------  228 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH---------
T ss_pred             ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHHHHHHc---------
Confidence            7754221  23356789999999999999999999999999999999999999976432   122221111         


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                          ......+..+++++.+|+.+||+.||++|||++|++++
T Consensus       229 ----~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         229 ----GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             ----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                11123444566889999999999999999999999864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-55  Score=395.27  Aligned_cols=255  Identities=25%  Similarity=0.385  Sum_probs=208.4

Q ss_pred             CCCCCCC-eeccCCceEEEEEEEC---CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           77 KNFSDKN-LIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        77 ~~~~~~~-~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      ++|.+.+ +||+|+||.||+|.++   ++..||||......    .+.+.+|+++|++++||||++++|++..+ ..|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence            3455556 4999999999999854   35579999865432    34688999999999999999999998754 57999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++|+|.+++.    ..+..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus        87 mE~~~~g~L~~~l~----~~~~~l~~~~~~~i~~qi~~gL~ylH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          87 MEMAGGGPLHKFLV----GKREEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EECCTTEEHHHHHT----TCTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCcHHHHhh----ccccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCcCchhheeeccCCceeeccchhhhccc
Confidence            99999999999873    234578999999999999999999999  779999999999999999999999999998875


Q ss_pred             CCCC-CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          229 RTDV-AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       229 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      .... ........||+.|+|||++.+..|+.++|||||||++|||+| |+.||.....   .+....+.           
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~i~-----------  226 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIE-----------  226 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHH-----------
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHHHHH-----------
Confidence            5332 223345568899999999999999999999999999999998 8999986542   12222221           


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                        ...+...+..+++++.+|+.+||+.||++|||+.++++.|+.....
T Consensus       227 --~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         227 --QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             --TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --cCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence              1222345666778899999999999999999999999999876543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-56  Score=411.59  Aligned_cols=263  Identities=19%  Similarity=0.264  Sum_probs=204.3

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ..++|++.+.||+|+||+||+|.. .+|+.||+|+...    ...+.+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            356799999999999999999996 4689999997432    23456889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|.+++.     ....+++..+..++.|++.||.|||+. ++|+||||||+|||++.++.+||+|||+|+...+
T Consensus        84 Ey~~gg~L~~~l~-----~~~~l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             ECCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EcCCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            9999999999983     345689999999999999999999972 3699999999999999999999999999987643


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh-------------
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN-------------  296 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-------------  296 (380)
                      ..    .....||+.|+|||++.+..|+.++||||+||++|||++|+.||...+.............             
T Consensus       158 ~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         158 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             HT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             Cc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            21    2356899999999999999999999999999999999999999986543211100000000             


Q ss_pred             ----------hhcccchhhhc---ccccccCCC-HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          297 ----------SRDFSNLLKIL---DERLWSTFT-NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       297 ----------~~~~~~~~~~~---~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                                ........+..   ........+ ...+.++.+|+.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                      00000000000   000001111 1245779999999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-55  Score=393.56  Aligned_cols=248  Identities=23%  Similarity=0.365  Sum_probs=201.5

Q ss_pred             CeeccCCceEEEEEEEC---CCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeecC
Q 016917           83 NLIGEGKFGEVYKGLLQ---DGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIPN  154 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  154 (380)
                      ++||+|+||+||+|.++   .++.||||+.....     .+.+.+|+++|++++||||+++++++..+ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            57999999999999854   34689999854322     35689999999999999999999998654 56899999999


Q ss_pred             CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC-C
Q 016917          155 GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV-A  233 (380)
Q Consensus       155 g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~-~  233 (380)
                      |+|.+++.     ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus        92 g~L~~~l~-----~~~~l~~~~~~~i~~qi~~gl~ylH~--~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHh-----hccCCCHHHHHHHHHHHHHHHhhHHh--CCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            99999883     44668999999999999999999999  7799999999999999999999999999987654322 2


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLW  312 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (380)
                      .......||+.|+|||.+.+..|+.++|||||||++|||+| |+.||.....   .+....+.             ...+
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~-------------~~~~  228 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLE-------------KGER  228 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHH-------------TTCC
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHHHH-------------cCCC
Confidence            22344568999999999999999999999999999999998 8999986542   12222221             1223


Q ss_pred             cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          313 STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       313 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                      ...+..+++++.+|+.+||+.||.+|||++++++.|+....+
T Consensus       229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            345566778899999999999999999999999888776543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.6e-55  Score=400.55  Aligned_cols=242  Identities=26%  Similarity=0.389  Sum_probs=199.4

Q ss_pred             CCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      .|+..+.||+|+||.||+|+. .+++.||||......      .+.+.+|+++|++++||||+++++++.+.+..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            488899999999999999995 568899999754322      2357889999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+++|+|..++     .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+|..... 
T Consensus        96 ~~~~g~l~~~~-----~~~~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          96 YCLGSASDLLE-----VHKKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             CCSEEHHHHHH-----HHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             ecCCCchHHHH-----HhCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            99999987665     234678999999999999999999999  7799999999999999999999999999986543 


Q ss_pred             CCCCCCccccCccceeccccccc---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEF---RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                           .....||+.|+|||++.+   ..|+.++|||||||++|||++|..||.....   .+....+.            
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---~~~~~~i~------------  227 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIA------------  227 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH------------
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHH------------
Confidence                 234579999999999864   4689999999999999999999999975432   11111111            


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ........+..+++++.+|+.+||+.||.+|||++|++++
T Consensus       228 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             HSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             hCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            1111112233456789999999999999999999999874

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-55  Score=397.50  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=203.9

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC---CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG---APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      +.|++.+.||+|+||+||+|+. .++..||+|+...   ...+.+.+|+++|++++||||+++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            3588899999999999999996 4688999997543   33467889999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++|+|.+++.    .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        92 ~~g~L~~~~~----~~~~~l~e~~~~~i~~qi~~gL~ylH~--~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-  164 (288)
T d2jfla1          92 AGGAVDAVML----ELERPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-  164 (288)
T ss_dssp             TTEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred             CCCcHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence            9999998873    234568999999999999999999999  679999999999999999999999999987653311 


Q ss_pred             CCCCccccCccceecccccc-----cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhc
Q 016917          233 AGPSSQVTADEIFLASEVKE-----FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKIL  307 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (380)
                       .......||+.|+|||++.     +..|+.++|||||||++|||++|+.||......   +....+....         
T Consensus       165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~~~i~~~~---------  231 (288)
T d2jfla1         165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLLKIAKSE---------  231 (288)
T ss_dssp             -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHHHHSC---------
T ss_pred             -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHHHHHcCC---------
Confidence             1123457899999999973     567899999999999999999999999865432   1221111110         


Q ss_pred             ccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          308 DERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                        ......+..+++++.+|+.+||+.||++|||++|++++
T Consensus       232 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         232 --PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             --CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             --CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              11123344566889999999999999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-55  Score=390.36  Aligned_cols=244  Identities=25%  Similarity=0.386  Sum_probs=194.7

Q ss_pred             CCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceec----CCeeEEEE
Q 016917           80 SDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE----NNLQFLIY  149 (380)
Q Consensus        80 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  149 (380)
                      +..++||+|+||+||+|... ++..||+|.....     ..+.+.+|+++|++++||||+++++++.+    ....|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            56678999999999999964 6889999974321     23468899999999999999999999864    45679999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCceEEcccccccccC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD-EDFIAKVADAGLRNFLG  228 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~-~~~~~kl~DFgla~~~~  228 (380)
                      ||+++|+|.+++.     ....+++..+..++.|++.||+|||+.+.+|+||||||+|||++ +++.+||+|||+++...
T Consensus        92 E~~~~g~L~~~l~-----~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHh-----ccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999883     44678999999999999999999999433499999999999996 57899999999998643


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ..    ......||+.|+|||++.+ .|+.++|||||||++|||++|+.||.....  ...+...+.....         
T Consensus       167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~~~i~~~~~---------  230 (270)
T d1t4ha_         167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVK---------  230 (270)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCC---------
T ss_pred             CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHHHHHHcCCC---------
Confidence            32    2345679999999999875 699999999999999999999999975432  1112221111110         


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                         ...++...++++.+++.+||+.||++|||++|++++
T Consensus       231 ---~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         231 ---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             ---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ---CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence               111223345679999999999999999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-55  Score=392.01  Aligned_cols=257  Identities=26%  Similarity=0.442  Sum_probs=201.0

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECC----CcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQD----GMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      ..++|++.+.||+|+||.||+|.+..    +..||+|......    .+.+.+|++++++++||||+++++++.+ +..+
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~   83 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW   83 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCE
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEE
Confidence            34578889999999999999998642    3578999865433    2458899999999999999999999964 5689


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNF  226 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~  226 (380)
                      +||||+++|+|.+++.    .....+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||+++.
T Consensus        84 iv~E~~~~g~l~~~~~----~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQ----VRKYSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEEECCTTEEHHHHHH----HTTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEeccCCcHHhhhh----ccCCCCCHHHHHHHHHHHHHHhhhhcc--cCeeccccchhheeecCCCcEEEccchhhee
Confidence            9999999999988763    234568999999999999999999999  7799999999999999999999999999987


Q ss_pred             cCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          227 LGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ...... .......+|+.|+|||++.+..|+.++|||||||++|||++ |.+||......   +....+..         
T Consensus       158 ~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~i~~---------  224 (273)
T d1mp8a_         158 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIEN---------  224 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHT---------
T ss_pred             ccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHHHHc---------
Confidence            654322 22334568899999999999999999999999999999998 88998865432   22222221         


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                          ....+.+..+++++.+|+.+||+.||++|||+.+++++|+++++++
T Consensus       225 ----~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         225 ----GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                1123455667788999999999999999999999999999988663

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-55  Score=394.15  Aligned_cols=256  Identities=26%  Similarity=0.419  Sum_probs=205.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeec
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      .++|++.+.||+|+||.||+|..+++..||||.+...  ..+.|.+|+.++++++||||+++++++.+ +..++||||++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            4578999999999999999999988889999986543  45679999999999999999999999865 55799999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDVA  233 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~~  233 (380)
                      +|+|..++..   .....+++..++.++.||+.||.|||+  ++|+||||||+|||++.++++||+|||+++....... 
T Consensus        95 ~g~l~~~~~~---~~~~~l~~~~~~~i~~~i~~gl~~LH~--~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-  168 (285)
T d1fmka3          95 KGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  168 (285)
T ss_dssp             TCBHHHHHSH---HHHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCchhhhhhh---cccccchHHHHHHHHHHHHHHHHHHhh--hheecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence            9999888743   233568999999999999999999999  6799999999999999999999999999987654322 


Q ss_pred             CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccccc
Q 016917          234 GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERLWS  313 (380)
Q Consensus       234 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (380)
                      .......+|+.|+|||++....++.++|||||||++|||++|..|+.....  ..+....+.             .....
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~-------------~~~~~  233 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVE-------------RGYRM  233 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH-------------TTCCC
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHH-------------hcCCC
Confidence            223345689999999999999999999999999999999997766554332  111222211             12223


Q ss_pred             CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhh
Q 016917          314 TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  353 (380)
Q Consensus       314 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~  353 (380)
                      +.+..+++++.+++.+||+.||++|||++++++.|+..+.
T Consensus       234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            4556677889999999999999999999999998887664

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-54  Score=395.62  Aligned_cols=257  Identities=25%  Similarity=0.421  Sum_probs=207.8

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCc----EEEEEeCCC----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGM----LVAIKKRPG----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  147 (380)
                      .+|++.++||+|+||+||+|.+. +|+    +||+|....    ...+.+.+|++++++++||||++++|++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46899999999999999999864 333    689987542    3456799999999999999999999999875 4678


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      ++||+.+|+|.+++.    .....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~gl~yLH~--~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVR----EHKDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHH----HTSSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCccccccc----ccccCCCHHHHHHHHHHHHHHHHHHHH--cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence            899999999988774    245678999999999999999999999  67999999999999999999999999999887


Q ss_pred             CCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhh
Q 016917          228 GRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKI  306 (380)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (380)
                      .............||..|+|||++.+..|+.++|||||||++|||+| |..||......   ++...+.           
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~i~-----------  227 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILE-----------  227 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHHHH-----------
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH-----------
Confidence            65444434445568999999999999999999999999999999998 78888765432   2222222           


Q ss_pred             cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhhc
Q 016917          307 LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKEM  356 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~~  356 (380)
                        ...+...+..+++++.+|+.+||+.||.+|||+.+++++|..+.....
T Consensus       228 --~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~  275 (317)
T d1xkka_         228 --KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  275 (317)
T ss_dssp             --HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHH
T ss_pred             --cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhChH
Confidence              222334556677889999999999999999999999999998876543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-54  Score=395.13  Aligned_cols=264  Identities=26%  Similarity=0.399  Sum_probs=213.5

Q ss_pred             HHHHhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceec
Q 016917           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQE  141 (380)
Q Consensus        72 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~  141 (380)
                      ++...++|++.+.||+|+||+||+|+.+      ++..||||+.....    .+++.+|++++++++||||+++++++..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            4445667999999999999999999854      35789999876443    3468899999999999999999999999


Q ss_pred             CCeeEEEEEeecCCCccccccCCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 016917          142 NNLQFLIYEYIPNGSVSIHLYGPSQ-------------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKD  202 (380)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrD  202 (380)
                      .+..++||||+++|+|.+++.....                   .....+++..++.++.|++.||+|||+  ++|||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~--~~ivHrD  165 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRD  165 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSC
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc--CCeEeeE
Confidence            9999999999999999998843211                   123458899999999999999999999  7799999


Q ss_pred             CCCCCeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCC-CCCCC
Q 016917          203 FKTANVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR-EASSS  281 (380)
Q Consensus       203 ikp~Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~-~p~~~  281 (380)
                      |||+|||++.++.+||+|||+++...............+++.|+|||.+.+..|+.++|||||||++|||++|. +||..
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            99999999999999999999998775544334444566888999999999999999999999999999999986 56765


Q ss_pred             CCCCCcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhh
Q 016917          282 LSPDSSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  353 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~  353 (380)
                      ...   .+....+.             .......+..+++++.+|+.+||+.||++|||+.|+++.|+++++
T Consensus       246 ~~~---~e~~~~v~-------------~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         246 MAH---EEVIYYVR-------------DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             SCH---HHHHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCH---HHHHHHHH-------------cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            432   11222111             111234455667889999999999999999999999999998763

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-54  Score=395.47  Aligned_cols=248  Identities=20%  Similarity=0.276  Sum_probs=191.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      +.|++.+.||+|+||+||+|+.+ +++.||+|.....    ....+.+|+++|++++||||+++++++.+++..|+||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            45899999999999999999965 6899999975432    234577899999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCceEEcccccccccC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLG  228 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~---~~~~~kl~DFgla~~~~  228 (380)
                      +++|+|.+++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||+.   +++.+||+|||+++...
T Consensus        89 ~~gg~L~~~l~-----~~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          89 VSGGELFDRIV-----EKGFYTERDASRLIFQVLDAVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCSCBHHHHHH-----TCSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             cCCCcHHHhhh-----cccCCCHHHHHHHHHHHHHHHHhhhh--ceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999999983     35678999999999999999999999  7799999999999994   57899999999998764


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ...   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.....   .+....+....          
T Consensus       162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~~~~----------  225 (307)
T d1a06a_         162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKLFEQILKAE----------  225 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHTTC----------
T ss_pred             CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHhccC----------
Confidence            432   23346799999999999999999999999999999999999999976432   11222111111          


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...........++++.+|+.+||+.||.+|||++|++++
T Consensus       226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            111122334566789999999999999999999999985

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=386.50  Aligned_cols=254  Identities=29%  Similarity=0.417  Sum_probs=203.6

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC-ChHHHHHHHHHHhcCCCCceeeeccceec-CCeeEEEEEee
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-PTQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYEYI  152 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  152 (380)
                      ..++|++.+.||+|+||.||+|+.+ |..||||+.+.. ..+.+.+|++++++++||||++++|++.+ .+..++||||+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            3456788899999999999999985 778999987544 45679999999999999999999998854 46689999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++|+|.+++...   ....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.....  
T Consensus        84 ~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~al~ylH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--  156 (262)
T d1byga_          84 AKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  156 (262)
T ss_dssp             TTEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHhhcccccc--CceeccccchHhheecCCCCEeecccccceecCCC--
Confidence            999999998421   23458999999999999999999999  77999999999999999999999999999865432  


Q ss_pred             CCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          233 AGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                         .....+|..|+|||++.+..|+.++|||||||++|||+| |+.||.....   .+....+.             ...
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i~-------------~~~  217 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVE-------------KGY  217 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHT-------------TTC
T ss_pred             ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHH-------------cCC
Confidence               233457788999999999999999999999999999998 6777765432   22332222             223


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      +.+++..+++++.+|+.+||+.||.+|||+.+++++|+++...+
T Consensus       218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~  261 (262)
T d1byga_         218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  261 (262)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence            34566667788999999999999999999999999999886543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-54  Score=390.73  Aligned_cols=268  Identities=24%  Similarity=0.362  Sum_probs=205.5

Q ss_pred             HHHHHHhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeeeccc
Q 016917           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGY  138 (380)
Q Consensus        70 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~  138 (380)
                      ..+++..++|++.+.||+|+||.||+|...      +++.||+|......    .+.+.+|..++.++ +|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            444455678999999999999999999853      24689999875433    23567788877776 68999999998


Q ss_pred             eec-CCeeEEEEEeecCCCccccccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 016917          139 CQE-NNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTA  206 (380)
Q Consensus       139 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~  206 (380)
                      +.. ++..++||||+++|+|.+++.....           .....+++..++.++.|++.||.|||+  ++|+||||||+
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~ivHrDlKp~  163 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAAR  163 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh--CCCcCCcCCcc
Confidence            765 4568999999999999999854321           123458899999999999999999999  77999999999


Q ss_pred             CeeeCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCC-CCCCCCCCC
Q 016917          207 NVLVDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR-EASSSLSPD  285 (380)
Q Consensus       207 Nili~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~-~p~~~~~~~  285 (380)
                      |||+++++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||+||. +||......
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998776544444445667999999999999999999999999999999999875 577654321


Q ss_pred             CcccHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhh
Q 016917          286 SSQDLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDK  354 (380)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~  354 (380)
                        ......+             ........+..+++++.+++.+||+.||++|||++|++++|+++++.
T Consensus       244 --~~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         244 --EEFCRRL-------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             --HHHHHHH-------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHHH-------------hcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence              1112211             12222344555678899999999999999999999999999998864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-53  Score=390.10  Aligned_cols=246  Identities=23%  Similarity=0.271  Sum_probs=208.2

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEE
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|+..      ....+.+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            45789999999999999999996 578999999753      33456788999999999999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++|+|.+++     .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.+|.+||+|||+|+...
T Consensus        84 ~ey~~gg~L~~~~-----~~~~~~~e~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          84 MEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHH-----HHHSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eeccCCCchhhhh-----hcccCCcHHHHHHHHHHHhhhhhhhhh--cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence            9999999999888     345678999999999999999999999  779999999999999999999999999998654


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ...  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.   ..+...+..            
T Consensus       157 ~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~~i~~------------  219 (337)
T d1o6la_         157 SDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILM------------  219 (337)
T ss_dssp             CTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH------------
T ss_pred             cCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHHHHHhc------------
Confidence            322  223456799999999999999999999999999999999999999986542   112211111            


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~~ll~~  347 (380)
                      .  ...++..+++++.+||.+||+.||.+||+     ++++++|
T Consensus       220 ~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         220 E--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            0  12345556788999999999999999995     7888875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.2e-53  Score=393.46  Aligned_cols=249  Identities=20%  Similarity=0.268  Sum_probs=205.8

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      ++|++.+.||+|+||.||+|.. .+|+.||+|......   ...+.+|+++|++++||||+++++++.+++..|+||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            4689999999999999999996 579999999865433   345778999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC--CCCceEEcccccccccCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~--~~~~~kl~DFgla~~~~~~  230 (380)
                      ++|+|.+.+.    .....+++..+..++.||+.||.|||+  ++|+||||||+|||++  .++.+||+|||+|......
T Consensus       109 ~gg~L~~~~~----~~~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         109 SGGELFDRIA----AEDYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCBHHHHTT----CTTCCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCChHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            9999988773    234568999999999999999999999  7799999999999997  6789999999999887543


Q ss_pred             CCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      .   ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+...   .+....+...          +..
T Consensus       183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~----------~~~  246 (352)
T d1koba_         183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRC----------DWE  246 (352)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHC----------CCC
T ss_pred             C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhC----------CCC
Confidence            2   23456789999999999999999999999999999999999999976432   1111111111          011


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ........+++++.+|+.+||+.||.+|||+.|++++
T Consensus       247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1122233456789999999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.6e-53  Score=394.54  Aligned_cols=250  Identities=21%  Similarity=0.266  Sum_probs=205.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC---hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP---TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|+.....   .+.+.+|+++|++++||||+++++++.+.+..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35799999999999999999996 468999999865443   34578999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC--CCCceEEcccccccccCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD--EDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~--~~~~~kl~DFgla~~~~~  229 (380)
                      +++|+|.+++..    ....+++..+..++.||+.||.|||+  ++|+||||||+|||++  .++.+||+|||+++.+..
T Consensus       105 ~~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         105 MSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh--cCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            999999988832    34568999999999999999999999  7799999999999995  467899999999987654


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      ..   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+...   .+....+.....          
T Consensus       179 ~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~----------  242 (350)
T d1koaa2         179 KQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKSCDW----------  242 (350)
T ss_dssp             TS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCC----------
T ss_pred             cc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCC----------
Confidence            22   23456789999999999999999999999999999999999999975432   122221111110          


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .........+++++.+|+.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00011112345779999999999999999999999986

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-53  Score=385.58  Aligned_cols=248  Identities=21%  Similarity=0.275  Sum_probs=203.4

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC---------CChHHHHHHHHHHhcCCCCceeeeccceecCCeeE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG---------APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQF  146 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  146 (380)
                      ++|++.+.||+|+||+||+|+. .+|+.||+|....         ...+.+.+|+++|++++||||+++++++.+.+..|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4689999999999999999996 5689999996421         12467899999999999999999999999999999


Q ss_pred             EEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC----ceEEcccc
Q 016917          147 LIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF----IAKVADAG  222 (380)
Q Consensus       147 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~----~~kl~DFg  222 (380)
                      +||||+++|+|.+++.     ....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++    .+||+|||
T Consensus        90 iv~E~~~gg~L~~~i~-----~~~~l~~~~~~~~~~qi~~al~yLH~--~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          90 LILELVAGGELFDFLA-----EKESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCccccchhc-----cccccchhHHHHHHHHHHHHHHhhhh--cceeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999883     34578999999999999999999999  7799999999999998776    59999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  302 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (380)
                      ++.......   ......+|+.|+|||++.+..|+.++|||||||++|||++|+.||.+...   .+....+....    
T Consensus       163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~~~~----  232 (293)
T d1jksa_         163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANVSAVN----  232 (293)
T ss_dssp             TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHTTC----
T ss_pred             hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH---HHHHHHHHhcC----
Confidence            998775432   23345788999999999999999999999999999999999999986432   11111111110    


Q ss_pred             hhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                            .......+...++++.+|+.+||+.||.+|||++|++++
T Consensus       233 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         233 ------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             ------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  000001112345678999999999999999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.4e-53  Score=387.46  Aligned_cols=242  Identities=22%  Similarity=0.309  Sum_probs=205.6

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||+||+|+. .+|+.||+|+..      ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5789999999999999999996 568999999753      344567899999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+++|+|...+     .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+|+....
T Consensus        84 E~~~gg~l~~~~-----~~~~~~~~~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLL-----RKSQRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHH-----HHTSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCccccccc-----cccccccccHHHHHHHHHHHhhhhhcc--CcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            999999998887     345667888899999999999999999  7799999999999999999999999999987654


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      .     .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.....   .+....+..            .
T Consensus       157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i~~------------~  216 (316)
T d1fota_         157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTYEKILN------------A  216 (316)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHH------------C
T ss_pred             c-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH---HHHHHHHHc------------C
Confidence            2     2346799999999999999999999999999999999999999986432   111111111            1


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                        ...++...++++.+++.+||+.||.+|+     |+++++++
T Consensus       217 --~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         217 --ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence              1134445667899999999999999996     89999875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-53  Score=384.64  Aligned_cols=262  Identities=27%  Similarity=0.433  Sum_probs=210.5

Q ss_pred             HHhCCCCCCCeeccCCceEEEEEEECC--------CcEEEEEeCCCCCh----HHHHHHHHHHhcC-CCCceeeecccee
Q 016917           74 LATKNFSDKNLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGAPT----QEFIDEVCFLASI-QHRNLVTLLGYCQ  140 (380)
Q Consensus        74 ~~~~~~~~~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~----~~~~~E~~~l~~l-~h~niv~l~~~~~  140 (380)
                      +..++|++.+.||+|+||.||+|+...        +..||||+......    .++.+|...+.++ +||||+++++++.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            345678888999999999999998432        24799998755432    4577888888888 8999999999999


Q ss_pred             cCCeeEEEEEeecCCCccccccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 016917          141 ENNLQFLIYEYIPNGSVSIHLYGPSQ-----------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVL  209 (380)
Q Consensus       141 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nil  209 (380)
                      +++..++||||+++|+|.+++.....           .....+++..++.++.|++.||+|||+  ++||||||||+|||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~--~~ivHrDiKp~NiL  167 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVL  167 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh--CCEEeeeeccccee
Confidence            99999999999999999999854432           124568999999999999999999999  77999999999999


Q ss_pred             eCCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcc
Q 016917          210 VDEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQ  288 (380)
Q Consensus       210 i~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~  288 (380)
                      ++.++.+||+|||+++...............+|+.|+|||.+.+..|+.++|||||||++|||++ |.+||.....   .
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~  244 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---E  244 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---H
Confidence            99999999999999998766555555566778999999999999999999999999999999998 6888875442   1


Q ss_pred             cHHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhh
Q 016917          289 DLVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLD  353 (380)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~  353 (380)
                      .....+             ........+..+++++.+|+.+||+.||++|||+.|+++.|++++.
T Consensus       245 ~~~~~i-------------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         245 ELFKLL-------------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HHHHHH-------------HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHH-------------HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            122211             1222334455567889999999999999999999999999988763

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=383.66  Aligned_cols=258  Identities=27%  Similarity=0.461  Sum_probs=208.1

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCc--EEEEEeCCC----CChHHHHHHHHHHhcC-CCCceeeeccceecCCeeEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGM--LVAIKKRPG----APTQEFIDEVCFLASI-QHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  148 (380)
                      ++|++.++||+|+||.||+|+++ ++.  .||||....    ...+.+.+|+++|+++ +||||+++++++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            57888899999999999999965 344  477776432    2445789999999999 799999999999999999999


Q ss_pred             EEeecCCCccccccCCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceE
Q 016917          149 YEYIPNGSVSIHLYGPS-----------QVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAK  217 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~k  217 (380)
                      |||+++|+|.+++....           ......+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+|
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~--~~iiHrDlkp~NIL~~~~~~~k  167 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAK  167 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc--CCccccccccceEEEcCCCceE
Confidence            99999999999985432           1234678999999999999999999999  7799999999999999999999


Q ss_pred             EcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCC-CCCCCCCCCcccHHHHHHh
Q 016917          218 VADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGRE-ASSSLSPDSSQDLVELVQN  296 (380)
Q Consensus       218 l~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~-p~~~~~~~~~~~~~~~~~~  296 (380)
                      |+|||+++......   ......+|..|+|||.+.+..|+.++|||||||++|||++|.. ||.....   .++..    
T Consensus       168 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~----  237 (309)
T d1fvra_         168 IADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYE----  237 (309)
T ss_dssp             ECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH----
T ss_pred             Eccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHH----
Confidence            99999997654322   2234468889999999999999999999999999999999765 5654331   11111    


Q ss_pred             hhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          297 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                               .+....+...+..+++++.+|+.+||+.||++|||+++++++|++++++.
T Consensus       238 ---------~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         238 ---------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             ---------HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ---------HHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence                     11222234555667789999999999999999999999999999998764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-53  Score=381.20  Aligned_cols=254  Identities=25%  Similarity=0.347  Sum_probs=198.0

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC--C--CcEEEEEeCCCC------ChHHHHHHHHHHhcCCCCceeeeccceecCCee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ--D--GMLVAIKKRPGA------PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~--~--~~~vavK~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      .++|++.+.||+|+||.||+|+..  +  ...||||+....      ..+.|.+|+++|++++||||++++|++.++ ..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence            356888999999999999999853  2  247899975432      235689999999999999999999999764 67


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ++||||+++|++.+.+.    .....+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~lv~e~~~~~~l~~~~~----~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLR----KHQGHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEEECCTTCBHHHHHH----HHGGGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             heeeeeecCcchhhhhh----cccCCCCHHHHHHHHHHHHHHHHHhhh--CCEeeeeecHHHhccccccceeeccchhhh
Confidence            89999999999988773    234568999999999999999999999  779999999999999999999999999999


Q ss_pred             ccCCCCCC-CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHhhhcccch
Q 016917          226 FLGRTDVA-GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVS-GREASSSLSPDSSQDLVELVQNSRDFSNL  303 (380)
Q Consensus       226 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  303 (380)
                      ........ .......+|..|+|||.+.+..++.++|||||||++|||+| |..||......   +....+         
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~~i---------  227 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKI---------  227 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH---------
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHHHH---------
Confidence            87553322 22334567889999999999999999999999999999998 89999764321   111111         


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhh
Q 016917          304 LKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRT  351 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~  351 (380)
                         .....+.+.+..+++++.+|+.+||+.||++|||++++.+.|.+.
T Consensus       228 ---~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         228 ---DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ---HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence               112223344556678899999999999999999999999888764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=384.46  Aligned_cols=264  Identities=24%  Similarity=0.383  Sum_probs=214.1

Q ss_pred             HhCCCCCCCeeccCCceEEEEEEE------CCCcEEEEEeCCCCC----hHHHHHHHHHHhcC-CCCceeeeccceecCC
Q 016917           75 ATKNFSDKNLIGEGKFGEVYKGLL------QDGMLVAIKKRPGAP----TQEFIDEVCFLASI-QHRNLVTLLGYCQENN  143 (380)
Q Consensus        75 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  143 (380)
                      ..++|++.++||+|+||.||+|+.      .+++.||||+.....    ...+.+|+++++++ +||||+++++++.+.+
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            345788889999999999999985      245689999865432    33578999999999 6999999999999999


Q ss_pred             eeEEEEEeecCCCccccccCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQ-------------VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLV  210 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili  210 (380)
                      ..++||||+++|+|.+++.....             .....+++..+..++.|++.||+|||+  ++++||||||+|||+
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~--~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILL  178 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccccccccc
Confidence            99999999999999998854321             123468899999999999999999999  679999999999999


Q ss_pred             CCCCceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCCCCccc
Q 016917          211 DEDFIAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSG-REASSSLSPDSSQD  289 (380)
Q Consensus       211 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg-~~p~~~~~~~~~~~  289 (380)
                      +.++.+|++|||+++...............+|+.|+|||++.+..++.++|||||||++|||+|+ .+||......  ..
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--~~  256 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--SK  256 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--HH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--HH
Confidence            99999999999999987654443344556789999999999999999999999999999999995 5555443321  11


Q ss_pred             HHHHHHhhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          290 LVELVQNSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      +             .+++....+...+..+++++.+|+.+||+.||++|||++++++.|++.+.+.
T Consensus       257 ~-------------~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~  309 (311)
T d1t46a_         257 F-------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (311)
T ss_dssp             H-------------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             H-------------HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence            1             1222223333445556788999999999999999999999999999888664

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.4e-52  Score=390.35  Aligned_cols=247  Identities=21%  Similarity=0.275  Sum_probs=201.5

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCC------CChHHHHH---HHHHHhcCCCCceeeeccceecCCee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG------APTQEFID---EVCFLASIQHRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~  145 (380)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|....      .....+.+   |+.+++.++||||+++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            467999999999999999999964 689999997532      12223333   46778888999999999999999999


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      |+||||+++|+|.+++.     ....+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+|+
T Consensus        83 ~ivmE~~~gg~L~~~l~-----~~~~~~e~~~~~~~~qi~~aL~ylH~--~~iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEEECCCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEEecCCCcHHHHHH-----hcccccHHHHHHHHHHHHHHHHHHHH--CCccceeeccceeEEcCCCcEEEeeeceee
Confidence            99999999999999883     45667899999999999999999999  779999999999999999999999999998


Q ss_pred             ccCCCCCCCCCccccCccceecccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ......    .....||+.|+|||++. +..|+.++|||||||+||||+||+.||........   .........     
T Consensus       156 ~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~~~~~~-----  223 (364)
T d1omwa3         156 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLT-----  223 (364)
T ss_dssp             ECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHHHHHSSS-----
T ss_pred             ecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccc-----
Confidence            765432    34557999999999986 45789999999999999999999999987543322   111111110     


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  347 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~~ll~~  347 (380)
                            ....++..+++++.+||.+||+.||.+|||     +++++++
T Consensus       224 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         224 ------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             ------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                  112334456678999999999999999999     6888865

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=376.21  Aligned_cols=253  Identities=26%  Similarity=0.450  Sum_probs=203.2

Q ss_pred             CCeeccCCceEEEEEEECCC----cEEEEEeCCCC-C---hHHHHHHHHHHhcCCCCceeeeccceec-CCeeEEEEEee
Q 016917           82 KNLIGEGKFGEVYKGLLQDG----MLVAIKKRPGA-P---TQEFIDEVCFLASIQHRNLVTLLGYCQE-NNLQFLIYEYI  152 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~~~----~~vavK~~~~~-~---~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  152 (380)
                      .++||+|+||+||+|+...+    ..||||+.+.. .   .+++.+|+++|++++||||++++|++.. ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999996432    36899976532 2   3468999999999999999999999865 56889999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      ++|+|.+++..    ......+..++.++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~--~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcc--cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            99999998842    34556788899999999999999999  7799999999999999999999999999987754332


Q ss_pred             C--CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcccc
Q 016917          233 A--GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDER  310 (380)
Q Consensus       233 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (380)
                      .  .......||..|+|||.+.+..++.++||||||+++|||+||+.||.....  ..+....+...             
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~~g-------------  250 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQG-------------  250 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTT-------------
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcC-------------
Confidence            2  233446789999999999999999999999999999999998888764331  11111211111             


Q ss_pred             cccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          311 LWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       311 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      .+...+..+++++.+|+.+||+.||++|||+.|++++|+++++..
T Consensus       251 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~  295 (311)
T d1r0pa_         251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  295 (311)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence            122344556688999999999999999999999999999998663

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-52  Score=381.02  Aligned_cols=264  Identities=22%  Similarity=0.358  Sum_probs=203.1

Q ss_pred             CCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHH--hcCCCCceeeeccceecCC----eeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFL--ASIQHRNLVTLLGYCQENN----LQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l--~~l~h~niv~l~~~~~~~~----~~~lv~e  150 (380)
                      ++|.+.+.||+|+||+||+|+. +|+.||||+........+..|.+++  ..++||||+++++++.+.+    ..++|||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            3566778999999999999997 5889999988766666666666554  5679999999999997543    5799999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSL------SPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      |+++|+|.+++.      +..+++..++.++.|++.||.|+|+.      .++|+||||||+|||++.++.+||+|||++
T Consensus        82 y~~~g~L~~~l~------~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          82 YHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             CCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cccCCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999993      34688999999999999999999973      358999999999999999999999999999


Q ss_pred             cccCCCCC--CCCCccccCccceecccccccC------CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcc--------
Q 016917          225 NFLGRTDV--AGPSSQVTADEIFLASEVKEFR------RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQ--------  288 (380)
Q Consensus       225 ~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~------~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~--------  288 (380)
                      +.......  ........||+.|+|||++.+.      .++.++|||||||+||||+||..||.........        
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            87754322  2233456799999999998764      3677999999999999999999887543321110        


Q ss_pred             cHHHHHHhhhcccchhhhcccccccCC-----CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          289 DLVELVQNSRDFSNLLKILDERLWSTF-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      ........        ...+...++..     +.+....+.+++.+||+.||++|||+.|+++.|+++.+++
T Consensus       236 ~~~~~~~~--------~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         236 PSVEEMRK--------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             CCHHHHHH--------HHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             chHHHHHH--------HHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence            00111111        11112222222     2345677999999999999999999999999999988664

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.3e-52  Score=387.33  Aligned_cols=242  Identities=20%  Similarity=0.269  Sum_probs=205.3

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC------CCChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP------GAPTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIY  149 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  149 (380)
                      ++|++.+.||+|+||.||+|+. .+|+.||+|+..      ....+.+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4689999999999999999996 468999999743      344567889999999999999999999999999999999


Q ss_pred             EeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCC
Q 016917          150 EYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGR  229 (380)
Q Consensus       150 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~  229 (380)
                      ||+.+|+|..++.     ....+++..+..++.||+.||.|||+  ++||||||||+|||++.++.+||+|||+|+.+..
T Consensus       121 e~~~~g~l~~~l~-----~~~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHh-----hcCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            9999999998883     44578999999999999999999999  6799999999999999999999999999987653


Q ss_pred             CCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccc
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDE  309 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (380)
                      .     .....||+.|+|||++.+..|+.++|||||||++|||+||+.||.....   ......+..            .
T Consensus       194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i~~------------~  253 (350)
T d1rdqe_         194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVS------------G  253 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH------------C
T ss_pred             c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---HHHHHHHhc------------C
Confidence            2     2346799999999999999999999999999999999999999975431   111111111            1


Q ss_pred             ccccCCCHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 016917          310 RLWSTFTNEGMEEFIQLIVRCLDPSSERRP-----SMSDVVTE  347 (380)
Q Consensus       310 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~~ll~~  347 (380)
                        ...++..+++++.+++.+||+.||.+|+     |++++++|
T Consensus       254 --~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         254 --KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence              1123445667899999999999999994     89999874

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.8e-52  Score=374.13  Aligned_cols=248  Identities=21%  Similarity=0.314  Sum_probs=203.8

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC------------hHHHHHHHHHHhcCC-CCceeeeccceecC
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------------TQEFIDEVCFLASIQ-HRNLVTLLGYCQEN  142 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  142 (380)
                      ++|++.+.||+|+||+||+|+. .+++.||+|+.....            .+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5788999999999999999996 578999999743321            124788999999996 99999999999999


Q ss_pred             CeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccc
Q 016917          143 NLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAG  222 (380)
Q Consensus       143 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFg  222 (380)
                      +..|+||||+++|+|.+++.     ....+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~-----~~~~l~e~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH--cCCcccccccceEEEcCCCCeEEccch
Confidence            99999999999999999983     45678999999999999999999999  779999999999999999999999999


Q ss_pred             cccccCCCCCCCCCccccCccceeccccccc------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHh
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEF------RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQN  296 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~  296 (380)
                      +++.+....   ......||+.|+|||.+.+      ..|+.++||||+||++|||++|+.||.....   ......+..
T Consensus       156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~~~~~~i~~  229 (277)
T d1phka_         156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLRMIMS  229 (277)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH
T ss_pred             heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---HHHHHHHHh
Confidence            998875432   2345679999999998753      3578899999999999999999999986542   111111111


Q ss_pred             hhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          297 SRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..          ..........+++++.+|+.+||+.||++|||++|++++
T Consensus       230 ~~----------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         230 GN----------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             TC----------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             CC----------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            11          011112233566889999999999999999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.2e-52  Score=374.05  Aligned_cols=256  Identities=20%  Similarity=0.270  Sum_probs=198.9

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC------hHHHHHHHHHHhcCCCCceeeeccceecCC----ee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP------TQEFIDEVCFLASIQHRNLVTLLGYCQENN----LQ  145 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  145 (380)
                      ++|++.+.||+|+||+||+|.. .+++.||+|......      .+.+.+|+++++.++||||+++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            5699999999999999999995 578999999854322      235789999999999999999999987543    47


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      |+||||+++|+|.+++     .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++..+++|||.+.
T Consensus        87 ~lvmE~~~g~~L~~~~-----~~~~~l~~~~~~~i~~qi~~al~~lH~--~~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEECCCEEEHHHHH-----HHHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEECCCCCEehhhh-----cccCCCCHHHHHHHHHHHHHHHHHHHh--CCccCccccCcccccCccccceeehhhhhh
Confidence            9999999999999887     345678999999999999999999999  779999999999999999999999999987


Q ss_pred             ccCCCC-CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh
Q 016917          226 FLGRTD-VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL  304 (380)
Q Consensus       226 ~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (380)
                      ...... .........||+.|+|||++.+..|+.++|||||||++|||+||+.||.....      .+........    
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~----  229 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVRE----  229 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHC----
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhc----
Confidence            654322 22234456799999999999999999999999999999999999999975432      1111111100    


Q ss_pred             hhcccccccCCCHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHHHhhh
Q 016917          305 KILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRP-SMSDVVTELDRTL  352 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~~ll~~L~~~~  352 (380)
                         +..........+++++.+++.+||+.||.+|| |++++++.|.++.
T Consensus       230 ---~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         230 ---DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             ---CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ---CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence               00011122234557899999999999999999 8999998887764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=384.13  Aligned_cols=266  Identities=23%  Similarity=0.371  Sum_probs=215.0

Q ss_pred             HHHHhCCCCCCCeeccCCceEEEEEEEC------CCcEEEEEeCCCCCh----HHHHHHHHHHhcCCCCceeeeccceec
Q 016917           72 LSLATKNFSDKNLIGEGKFGEVYKGLLQ------DGMLVAIKKRPGAPT----QEFIDEVCFLASIQHRNLVTLLGYCQE  141 (380)
Q Consensus        72 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~  141 (380)
                      +++..++|++.+.||+|+||.||+|.++      ++..||||+......    ..+.+|++++++++||||+++++++..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            4445567888999999999999999853      357899998764332    347899999999999999999999999


Q ss_pred             CCeeEEEEEeecCCCccccccCCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCce
Q 016917          142 NNLQFLIYEYIPNGSVSIHLYGPSQ-----VSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIA  216 (380)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~  216 (380)
                      .+..++||||+++|+|.+++.....     .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~--~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTCCE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeeceEcCCceeecCCceE
Confidence            9999999999999999988743211     122456889999999999999999999  779999999999999999999


Q ss_pred             EEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCC-CCCCCCCCCCcccHHHHHH
Q 016917          217 KVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGR-EASSSLSPDSSQDLVELVQ  295 (380)
Q Consensus       217 kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~-~p~~~~~~~~~~~~~~~~~  295 (380)
                      ||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+||. +||.....   .+....+.
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~---~~~~~~i~  249 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFVM  249 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHHHH
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH
Confidence            999999998775544333344556889999999999999999999999999999999985 66655332   11122111


Q ss_pred             hhhcccchhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          296 NSRDFSNLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                                   ...+...+..+++.+.+++.+||+.||++|||+++++++|++.++..
T Consensus       250 -------------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         250 -------------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             -------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             -------------hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence                         11123445566788999999999999999999999999998877643

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=377.25  Aligned_cols=254  Identities=21%  Similarity=0.285  Sum_probs=195.0

Q ss_pred             CCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC--------hHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEee
Q 016917           82 KNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP--------TQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      +++||+|+||+||+|.. .+|+.||||+.....        .+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            47899999999999995 568999999754321        235789999999999999999999999999999999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTDV  232 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~~  232 (380)
                      .++++....     .....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        83 ~~~~~~~~~-----~~~~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-  154 (299)
T d1ua2a_          83 ETDLEVIIK-----DNSLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-  154 (299)
T ss_dssp             SEEHHHHHT-----TCCSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred             cchHHhhhh-----hcccCCCHHHHHHHHHHHHHHHHHhhc--cceecccCCcceEEecCCCccccccCccccccCCCc-
Confidence            998777655     245668888999999999999999999  779999999999999999999999999998765432 


Q ss_pred             CCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc------cchhh
Q 016917          233 AGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF------SNLLK  305 (380)
Q Consensus       233 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~  305 (380)
                       .......||+.|+|||++.+ ..|+.++|||||||++|||++|..||......   +....+......      .....
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH---HHHHHHHHhcCCCChhhccchhc
Confidence             22334578999999998864 46799999999999999999999999764421   111111111000      00000


Q ss_pred             hccc---ccccCC-----CHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          306 ILDE---RLWSTF-----TNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       306 ~~~~---~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....   ......     ....++++.+|+.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            0000   000001     11345779999999999999999999999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-52  Score=379.95  Aligned_cols=245  Identities=23%  Similarity=0.344  Sum_probs=203.7

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC------CCChHHHHHHHHHHh-cCCCCceeeeccceecCCeeEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP------GAPTQEFIDEVCFLA-SIQHRNLVTLLGYCQENNLQFLI  148 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~------~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  148 (380)
                      ++|++.+.||+|+||+||+|+.. +++.||+|+..      ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            47889999999999999999964 68999999853      344556777777765 68999999999999999999999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccC
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLG  228 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~  228 (380)
                      |||+++|+|.+++.     ....+++..+..++.||+.||.|||+  ++|+||||||+|||+++++.+||+|||+++...
T Consensus        82 mEy~~~g~L~~~i~-----~~~~~~e~~~~~~~~qi~~al~ylH~--~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence            99999999999983     45668999999999999999999999  679999999999999999999999999998654


Q ss_pred             CCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhcc
Q 016917          229 RTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILD  308 (380)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (380)
                      ...  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+...   .++...+...           
T Consensus       155 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~~~-----------  218 (320)
T d1xjda_         155 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSIRMD-----------  218 (320)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC-----------
T ss_pred             ccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHcC-----------
Confidence            322  223456799999999999999999999999999999999999999986432   1222211110           


Q ss_pred             cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHH-HHHHH
Q 016917          309 ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMS-DVVTE  347 (380)
Q Consensus       309 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-~ll~~  347 (380)
                         ...++..+++++.+|+.+||+.||.+|||+. +++++
T Consensus       219 ---~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         219 ---NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ---CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence               1234445678899999999999999999995 67653

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=379.19  Aligned_cols=249  Identities=20%  Similarity=0.254  Sum_probs=203.0

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCCh--HHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEeec
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPT--QEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      ++|++.+.||+|+||+||+|... +++.||+|..+....  ..+.+|+++|+.++||||+++++++.+.+..|+||||++
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~   84 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence            57899999999999999999965 688999998665543  357799999999999999999999999999999999999


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC--CceEEcccccccccCCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDED--FIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~--~~~kl~DFgla~~~~~~~  231 (380)
                      +|+|.+++..    ....+++..+..++.||+.||.|||+  .+|+||||||+|||++.+  ..+||+|||+++......
T Consensus        85 gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~--~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          85 GLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             CCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH--cCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            9999998832    23468999999999999999999999  679999999999999854  589999999998764322


Q ss_pred             CCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhhhccccc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLKILDERL  311 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (380)
                         ......+|+.|+|||...+..|+.++|||||||++|+|++|..||.....   .+....+.....      ......
T Consensus       159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~~~~~i~~~~~------~~~~~~  226 (321)
T d1tkia_         159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMNAEY------TFDEEA  226 (321)
T ss_dssp             ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCC------CCCHHH
T ss_pred             ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCC------CCChhh
Confidence               23345688999999999999999999999999999999999999986432   122221111100      000111


Q ss_pred             ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          312 WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       312 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      +    ..+++++.+|+.+||+.||++|||++|++++
T Consensus       227 ~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         227 F----KEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             H----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             c----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1    1235678999999999999999999999985

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=381.25  Aligned_cols=251  Identities=18%  Similarity=0.216  Sum_probs=199.0

Q ss_pred             hCCCCCCC-eeccCCceEEEEEEE-CCCcEEEEEeCCCCChHHHHHHHHHHhc-CCCCceeeeccceec----CCeeEEE
Q 016917           76 TKNFSDKN-LIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLAS-IQHRNLVTLLGYCQE----NNLQFLI  148 (380)
Q Consensus        76 ~~~~~~~~-~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~lv  148 (380)
                      .++|.+.+ .||+|+||+||+|+. .+++.||||+...  ...+.+|++++.+ .+||||+++++++.+    ....|+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv   87 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   87 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence            35788765 599999999999996 5689999998743  4567889998755 589999999999865    4678999


Q ss_pred             EEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEccccccc
Q 016917          149 YEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE---DFIAKVADAGLRN  225 (380)
Q Consensus       149 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~---~~~~kl~DFgla~  225 (380)
                      ||||+||+|.+++...   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.   ++.+||+|||+|+
T Consensus        88 mEy~~gg~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH~--~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          88 MECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EECCCSEEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EECCCCCcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHHH--cCCccccccccccccccccccccccccccceee
Confidence            9999999999998432   23568999999999999999999999  77999999999999975   5679999999998


Q ss_pred             ccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          226 FLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ......   ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.........   +..        .
T Consensus       163 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~--------~  228 (335)
T d2ozaa1         163 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKT--------R  228 (335)
T ss_dssp             ECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------C
T ss_pred             eccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHH--------H
Confidence            765432   23456799999999999999999999999999999999999999976543221110   000        0


Q ss_pred             hccccc--ccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          306 ILDERL--WSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       306 ~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      +.....  .......+++++.+|+.+||+.||++|||+.|++++
T Consensus       229 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            000111  011112456789999999999999999999999985

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-51  Score=372.79  Aligned_cols=261  Identities=25%  Similarity=0.338  Sum_probs=199.8

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC-----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ++|++.+.||+|+||+||+|.. .+++.||+|+...     ...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            4788999999999999999996 5789999997532     235678899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      |+.++.+.....    .....+++..+..++.|++.||+|||+  ++||||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~~~~~~~~~~~~----~~~~~l~e~~~~~~~~qil~~L~yLH~--~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQDLKKFMDA----SALTGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEEHHHHHHH----TTTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCchhhhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhc--CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence            998754443321    234668999999999999999999999  77999999999999999999999999999876542


Q ss_pred             CCCCCCccccCccceecccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc-----hh
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN-----LL  304 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~  304 (380)
                      .  .......||+.|+|||.+....+ +.++|||||||++|+|++|+.||...+..  ..+............     ..
T Consensus       156 ~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         156 V--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             S--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGG
T ss_pred             c--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--HHHHHHHHhcCCCchhhccccc
Confidence            2  22345578999999998777665 78999999999999999999999764321  111111111100000     00


Q ss_pred             hhcc--ccc--c-----cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          305 KILD--ERL--W-----STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       305 ~~~~--~~~--~-----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...+  ...  .     .......++++.+|+.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0000  000  0     00111344778999999999999999999999976

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.2e-51  Score=369.26  Aligned_cols=260  Identities=23%  Similarity=0.343  Sum_probs=201.2

Q ss_pred             CCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEEe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYEY  151 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  151 (380)
                      ++|++.++||+|+||+||+|+.++++.||+|+....     ..+.+.+|+.+|++++||||+++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            578899999999999999999999999999985432     245789999999999999999999999999999999999


Q ss_pred             ecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCCC
Q 016917          152 IPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRTD  231 (380)
Q Consensus       152 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~~  231 (380)
                      +.++++....     .....+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+|++|||++.......
T Consensus        82 ~~~~~~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLD-----VCEGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHH-----TSTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHH-----hhcCCcchhhhHHHHHHHHHHHHHhcc--CcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            9887776665     345779999999999999999999999  679999999999999999999999999998765432


Q ss_pred             CCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh-----cccchhh
Q 016917          232 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR-----DFSNLLK  305 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  305 (380)
                      .  ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......  +.+........     .......
T Consensus       155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         155 R--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             c--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCChhhccchhh
Confidence            2  22344678889999998765 5689999999999999999999999764321  11111111000     0000000


Q ss_pred             ---------hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          306 ---------ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       306 ---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                               .........+....++++.+|+.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                     001111122333456789999999999999999999999865

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=371.04  Aligned_cols=237  Identities=23%  Similarity=0.363  Sum_probs=194.8

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCC---------ChHHHHHHHHHHhcCC--CCceeeeccceecCCe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGA---------PTQEFIDEVCFLASIQ--HRNLVTLLGYCQENNL  144 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  144 (380)
                      ++|++.+.||+|+||+||+|+. .+++.||+|.....         ....+.+|+.++++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5799999999999999999996 47899999974321         1234678999999986  8999999999999999


Q ss_pred             eEEEEEeecC-CCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEcccc
Q 016917          145 QFLIYEYIPN-GSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-DFIAKVADAG  222 (380)
Q Consensus       145 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~-~~~~kl~DFg  222 (380)
                      .++||||+.+ +++.+++     .....+++..+..++.|++.||.|||+  ++|+||||||+|||++. ++.+||+|||
T Consensus        84 ~~lv~e~~~~~~~l~~~~-----~~~~~l~e~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFI-----TERGALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEECCSSEEEHHHHH-----HHHCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEeccCcchHHHHH-----hccCCCCHHHHHHHHHHHHHHHHHHHH--CCCccccCcccceEEecCCCeEEECccc
Confidence            9999999976 4666666     245678999999999999999999999  77999999999999985 4799999999


Q ss_pred             cccccCCCCCCCCCccccCccceecccccccCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhccc
Q 016917          223 LRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRF-SEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFS  301 (380)
Q Consensus       223 la~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  301 (380)
                      +|+.....    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....        +... .    
T Consensus       157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~i~~-~----  219 (273)
T d1xwsa_         157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIR-G----  219 (273)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHHH-C----
T ss_pred             cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------HHhh-c----
Confidence            99875442    2345679999999999988776 567899999999999999999997421        0000 0    


Q ss_pred             chhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 NLLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                                ...++...++++.+|+.+||+.||++|||++|++++
T Consensus       220 ----------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         220 ----------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             ----------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                      012233455789999999999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-50  Score=368.16  Aligned_cols=260  Identities=23%  Similarity=0.307  Sum_probs=197.9

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CC-CcEEEEEeCC-----CCChHHHHHHHHHHhcC---CCCceeeeccceec----
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QD-GMLVAIKKRP-----GAPTQEFIDEVCFLASI---QHRNLVTLLGYCQE----  141 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~-~~~vavK~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  141 (380)
                      .++|++.+.||+|+||+||+|+. ++ ++.||||+..     ......+.+|+++++.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999996 34 5679999742     22344577888877765   79999999999853    


Q ss_pred             -CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcc
Q 016917          142 -NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVAD  220 (380)
Q Consensus       142 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~D  220 (380)
                       ....+++|||++++++.....    .....+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~--~~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH----SCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhh----ccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecCCCccEEEEcCCCCeeecc
Confidence             346799999999887654432    245668899999999999999999999  6799999999999999999999999


Q ss_pred             cccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhc-
Q 016917          221 AGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRD-  299 (380)
Q Consensus       221 Fgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-  299 (380)
                      ||+++......   ......||+.|+|||++.+..|+.++||||+||++|||++|+.||......   +....+..... 
T Consensus       160 fg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~  233 (305)
T d1blxa_         160 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGL  233 (305)
T ss_dssp             CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCC
T ss_pred             hhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCC
Confidence            99988654322   234567999999999999999999999999999999999999999865421   11111111100 


Q ss_pred             -----ccch----hhh---cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 -----FSNL----LKI---LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 -----~~~~----~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                           +...    ...   ........+....++.+.+|+.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                 0000    000   00011112333456789999999999999999999999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=363.70  Aligned_cols=265  Identities=18%  Similarity=0.244  Sum_probs=197.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC-----CCChHHHHHHHHHHhcCCCCceeeeccceec--------
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP-----GAPTQEFIDEVCFLASIQHRNLVTLLGYCQE--------  141 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  141 (380)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+..     ......+.+|+++|++++||||+++++.+..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36789999999999999999996 578999999743     2234568899999999999999999998754        


Q ss_pred             CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccc
Q 016917          142 NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADA  221 (380)
Q Consensus       142 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DF  221 (380)
                      .+..++||||+.++++....     .....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~-----~~~~~~~~~~~~~i~~qil~~l~~lH~--~~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS-----NVLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT-----CTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCCCccchhh-----hcccccccHHHHHHHHHHHHHHHHhcc--CCEEecCcCchheeecCCCcEEeeec
Confidence            34579999999987766554     345678899999999999999999999  77999999999999999999999999


Q ss_pred             ccccccCCCCC--CCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhh
Q 016917          222 GLRNFLGRTDV--AGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSR  298 (380)
Q Consensus       222 gla~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~  298 (380)
                      |+++.......  ........||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.................
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~  241 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  241 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99987654322  2233456799999999998765 68999999999999999999999997644221111111111000


Q ss_pred             cccchhhhccc--------ccccCCC-------HHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          299 DFSNLLKILDE--------RLWSTFT-------NEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       299 ~~~~~~~~~~~--------~~~~~~~-------~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ...........        ......+       ...++++.+|+.+||+.||++|||++|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            00000000000        0000000       0123567899999999999999999999976

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6.7e-48  Score=350.45  Aligned_cols=264  Identities=17%  Similarity=0.239  Sum_probs=212.3

Q ss_pred             hCCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCC-CCChHHHHHHHHHHhcCCC-CceeeeccceecCCeeEEEEEee
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRP-GAPTQEFIDEVCFLASIQH-RNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      .++|++.+.||+|+||+||+|+.. +|+.||+|..+ ....+.+.+|++.++.++| +|++.+++++......++||||+
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence            367999999999999999999954 68899999753 3344568889999999965 89999999999999999999998


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-----CCceEEccccccccc
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDE-----DFIAKVADAGLRNFL  227 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~-----~~~~kl~DFgla~~~  227 (380)
                       +++|.+++.    .....++...+..++.|++.||.|||+  ++|+||||||+|||++.     ++.+||+|||+|+..
T Consensus        84 -~~~l~~~~~----~~~~~~~~~~~~~i~~q~~~~l~~lH~--~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          84 -GPSLEDLLD----LCGRKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             -CCBHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             -CCCHHHHHH----hhccchhhHHHHHHHHHHHHHHHHHHH--CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence             578888773    234568999999999999999999999  77999999999999964     578999999999876


Q ss_pred             CCCCCC-----CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc
Q 016917          228 GRTDVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  302 (380)
Q Consensus       228 ~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (380)
                      ......     .......||+.|+|||++.+..|+.++|||||||++|||++|+.||..............+........
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            543211     123456799999999999999999999999999999999999999987665444333333222221111


Q ss_pred             hhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                      ..+         .+..+++++.+++..|++.+|++||+++.+.+.|++++++.
T Consensus       237 ~~~---------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         237 LRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hHH---------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            111         11234467999999999999999999999999999988764

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=368.30  Aligned_cols=266  Identities=25%  Similarity=0.310  Sum_probs=196.6

Q ss_pred             CCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCCChHHHHHHHHHHhcCCCCceeeeccceec------CCeeEEEEE
Q 016917           78 NFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGAPTQEFIDEVCFLASIQHRNLVTLLGYCQE------NNLQFLIYE  150 (380)
Q Consensus        78 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~lv~e  150 (380)
                      +|+..++||+|+||+||+|+.. +|+.||||+..... ....+|+++|++++||||+++++++..      ....++|||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E   99 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD   99 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence            5778899999999999999964 68999999864332 234579999999999999999999853      335789999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEcccccccccCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGR  229 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~-~~kl~DFgla~~~~~  229 (380)
                      |++++.+......  ......+++..+..++.|++.||+|||+  ++|+||||||+|||++.++ .+||+|||++.....
T Consensus       100 y~~~~~~~~l~~~--~~~~~~l~~~~~~~i~~qil~aL~yLH~--~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~  175 (350)
T d1q5ka_         100 YVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  175 (350)
T ss_dssp             CCSEEHHHHHHHH--HHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred             ccCCccHHHHHhh--hhccCCCCHHHHHHHHHHHHHHHHHHHh--cCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence            9987644433211  1235678999999999999999999999  7799999999999999775 899999999987654


Q ss_pred             CCCCCCCccccCccceeccccccc-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhh--hcccchhhh
Q 016917          230 TDVAGPSSQVTADEIFLASEVKEF-RRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS--RDFSNLLKI  306 (380)
Q Consensus       230 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  306 (380)
                      ..   ......|+..|+|||.+.+ ..|+.++||||+||++|||++|+.||......  ..+.......  .........
T Consensus       176 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~--~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         176 GE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             TS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHH
T ss_pred             Cc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH--HHHHHHHHHhCCChHHhhhhh
Confidence            32   2344578999999998765 57899999999999999999999999765421  1111111100  000000000


Q ss_pred             ------------cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH--HHhhhh
Q 016917          307 ------------LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE--LDRTLD  353 (380)
Q Consensus       307 ------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~--L~~~~~  353 (380)
                                  .............++++.+|+.+||+.||++|||+.|++++  ++++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence                        00001111223456789999999999999999999999975  445443

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-48  Score=352.78  Aligned_cols=263  Identities=17%  Similarity=0.221  Sum_probs=200.8

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCC-CCChHHHHHHHHHHhcCCCCc-eeeeccceecCCeeEEEEEeec
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRP-GAPTQEFIDEVCFLASIQHRN-LVTLLGYCQENNLQFLIYEYIP  153 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~-~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~  153 (380)
                      ++|++.+.||+|+||.||+|+. .+|+.||||... ....+++..|+++++.++|+| |+.+.+++.+.+..++||||+.
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~   86 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG   86 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence            4699999999999999999996 568999999743 234456889999999998766 4555556677888899999995


Q ss_pred             CCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCceEEcccccccccCCC
Q 016917          154 NGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVD---EDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       154 ~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~---~~~~~kl~DFgla~~~~~~  230 (380)
                      + ++.+.+.    .....+++..+..++.|++.||+|||+  ++|+||||||+|||++   .+..+||+|||+|+.....
T Consensus        87 ~-~l~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          87 P-SLEDLFN----FCSRKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             C-BHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             C-chhhhhh----hccCCCcHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            5 5555442    234678999999999999999999999  7799999999999985   4557999999999887543


Q ss_pred             CCC-----CCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchhh
Q 016917          231 DVA-----GPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLLK  305 (380)
Q Consensus       231 ~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (380)
                      ...     .......||+.|+|||.+.+..|+.++|||||||++|||++|+.||........................  
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--  237 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI--  237 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH--
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh--
Confidence            321     1234567999999999999999999999999999999999999999876544333222211111100000  


Q ss_pred             hcccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 016917          306 ILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTELDRTLDKE  355 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~L~~~~~~~  355 (380)
                             ......+++++.+++..||+.||++||+++++.+.|+.+..+.
T Consensus       238 -------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         238 -------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             -------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             -------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                   0112234577999999999999999999999999998876653

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.1e-48  Score=358.73  Aligned_cols=257  Identities=19%  Similarity=0.256  Sum_probs=200.5

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCChHHHHHHHHHHhcCC-CCceeeeccceec--CCeeEEEEEee
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAPTQEFIDEVCFLASIQ-HRNLVTLLGYCQE--NNLQFLIYEYI  152 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~~  152 (380)
                      ++|++.++||+|+||+||+|+. .+++.||+|+.+....+++.+|+++|++++ ||||+++++++..  ....++||||+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~  114 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  114 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence            4799999999999999999996 578999999988888889999999999995 9999999999874  45689999999


Q ss_pred             cCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEcccccccccCCCC
Q 016917          153 PNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF-IAKVADAGLRNFLGRTD  231 (380)
Q Consensus       153 ~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~-~~kl~DFgla~~~~~~~  231 (380)
                      .+++|....        +.+++..+..++.||+.||.|||+  ++|+||||||+|||++.++ .+||+|||+|.......
T Consensus       115 ~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~--~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         115 NNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             CSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             CCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhh--cccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999987654        358899999999999999999999  6799999999999998654 69999999998765432


Q ss_pred             CCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH--h---------hhc
Q 016917          232 VAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQ--N---------SRD  299 (380)
Q Consensus       232 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~---------~~~  299 (380)
                         ......+|+.|+|||.+.+. .|+.++||||+||++|||++|+.||......... ......  .         ...
T Consensus       185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~-~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         185 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTT
T ss_pred             ---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH-HHHHHHHHCCchhhhhhhhcc
Confidence               23456789999999998765 5799999999999999999999999865432111 110000  0         000


Q ss_pred             cc---chhhhcc--------cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          300 FS---NLLKILD--------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       300 ~~---~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ..   .......        ...........++++.+|+.+||+.||++|||++|++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00   0000000        001111223456789999999999999999999999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-49  Score=364.23  Aligned_cols=263  Identities=20%  Similarity=0.280  Sum_probs=194.2

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC----hHHHHHHHHHHhcCCCCceeeeccceecCC----eeEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP----TQEFIDEVCFLASIQHRNLVTLLGYCQENN----LQFL  147 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l  147 (380)
                      .+|++.+.||+|+||+||+|.. .+|+.||||+.....    .+.+.+|+++|++++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            4688999999999999999985 579999999865433    236788999999999999999999986543    2345


Q ss_pred             EEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccccccc
Q 016917          148 IYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFL  227 (380)
Q Consensus       148 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~  227 (380)
                      +++|+.+|+|.+++.      ...+++..+..++.|++.||+|||+  ++|+||||||+|||+++++.+||+|||++...
T Consensus        88 l~~~~~~g~L~~~l~------~~~l~~~~i~~i~~qil~al~yLH~--~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          88 LVTHLMGADLYKLLK------TQHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEECCCEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEeecCCchhhhhh------cCCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            556677899999883      3468999999999999999999999  77999999999999999999999999999876


Q ss_pred             CCCCC-CCCCccccCccceecccccc-cCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccchh-
Q 016917          228 GRTDV-AGPSSQVTADEIFLASEVKE-FRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSNLL-  304 (380)
Q Consensus       228 ~~~~~-~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  304 (380)
                      ..... ........||+.|+|||++. +..|+.++||||+||++|||++|+.||......+.................. 
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            44322 22335567999999999984 4567899999999999999999999997654221111110000000000000 


Q ss_pred             -------hh---ccc---ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          305 -------KI---LDE---RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       305 -------~~---~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                             ..   ...   ..+.......++++.+|+.+||+.||.+|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   00   000   00000111234678999999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=362.56  Aligned_cols=256  Identities=20%  Similarity=0.331  Sum_probs=191.7

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecCC------
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQENN------  143 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  143 (380)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+.....     .+.+.+|+++|+.++||||+++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            45799999999999999999996 469999999865432     245788999999999999999999987654      


Q ss_pred             eeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEccccc
Q 016917          144 LQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGL  223 (380)
Q Consensus       144 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgl  223 (380)
                      ..|+||||+ +++|....      ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+|++|||+
T Consensus        97 ~~~lv~e~~-~~~l~~~~------~~~~l~~~~~~~~~~qi~~aL~~LH~--~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLM------KHEKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHH------HHCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHH------HhccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCcchhhcccccccccccccc
Confidence            469999999 44666554      34568999999999999999999999  7799999999999999999999999999


Q ss_pred             ccccCCCCCCCCCccccCccceecccccccC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc-c
Q 016917          224 RNFLGRTDVAGPSSQVTADEIFLASEVKEFR-RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF-S  301 (380)
Q Consensus       224 a~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~  301 (380)
                      ++.....     .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||........  +.......... .
T Consensus       168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~  240 (346)
T d1cm8a_         168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPA  240 (346)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCH
T ss_pred             eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHHHHhccCCCcH
Confidence            9876442     3456789999999998764 568999999999999999999999986542111  11111000000 0


Q ss_pred             c------------hhhh---cccccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          302 N------------LLKI---LDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       302 ~------------~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      .            ....   .............++++.+|+.+||+.||.+|||++|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0            0000   00011112223455778999999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=358.25  Aligned_cols=250  Identities=22%  Similarity=0.263  Sum_probs=202.0

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC----CCcEEEEEeCCC-------CChHHHHHHHHHHhcCCC-CceeeeccceecCCe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ----DGMLVAIKKRPG-------APTQEFIDEVCFLASIQH-RNLVTLLGYCQENNL  144 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~-------~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  144 (380)
                      ++|++.+.||+|+||+||+|...    +|+.||+|....       ...+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999842    478999997532       234568899999999966 899999999999999


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .+++|||+.+|+|.+++     .....+++.....++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~v~e~~~~~~L~~~i-----~~~~~~~e~~~~~~~~Qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         104 LHLILDYINGGELFTHL-----SQRERFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEECCCCSCBHHHHH-----HHHSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeeeecccccHHHHHH-----HhcccccHHHHHHHHHHHHHHHHHhhc--CCEEeccCCccceeecCCCCEEEeeccch
Confidence            99999999999999988     345567888999999999999999999  67999999999999999999999999999


Q ss_pred             cccCCCCCCCCCccccCccceecccccccC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFR--RFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN  302 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  302 (380)
                      +.+..... .......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||...........  .......   
T Consensus       177 ~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--i~~~~~~---  250 (322)
T d1vzoa_         177 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRILK---  250 (322)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHHHH---
T ss_pred             hhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhccc---
Confidence            87644222 223456788999999998765  468899999999999999999999987654332211  1111111   


Q ss_pred             hhhhcccccccCCCHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHHH
Q 016917          303 LLKILDERLWSTFTNEGMEEFIQLIVRCLDPSSERRPS-----MSDVVTE  347 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~~ll~~  347 (380)
                              ....++..+++++.+++.+||+.||.+|||     ++|++++
T Consensus       251 --------~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         251 --------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             --------CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                    112344566788999999999999999994     7888864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-48  Score=351.49  Aligned_cols=260  Identities=20%  Similarity=0.256  Sum_probs=203.0

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCC-----CChHHHHHHHHHHhcCCCCceeeeccceecCCeeEEEEE
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPG-----APTQEFIDEVCFLASIQHRNLVTLLGYCQENNLQFLIYE  150 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  150 (380)
                      ++|++.++||+|+||+||+|+. .+++.||||+.+.     .....+.+|+.+++.++||||+++++++.+....++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999995 5788999997432     224578899999999999999999999999999999999


Q ss_pred             eecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccccccCCC
Q 016917          151 YIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLRNFLGRT  230 (380)
Q Consensus       151 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla~~~~~~  230 (380)
                      ++.++++..++     ...+.+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||.++.....
T Consensus        82 ~~~~~~l~~~~-----~~~~~~~~~~~~~~~~q~~~aL~~lH~--~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFD-----SCNGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHH-----HTTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             ecccccccccc-----ccccccchhHHHHHHHHHHHHHHHhhc--CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            99998888776     345677899999999999999999999  77999999999999999999999999999876543


Q ss_pred             CCCCCCccccCccceecccccccCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcc------cch
Q 016917          231 DVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDF------SNL  303 (380)
Q Consensus       231 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~  303 (380)
                      ..  ......++..|+|||.+.+.. ++.++|||||||++|||++|+.||.....  ..+....+......      ...
T Consensus       155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  230 (292)
T d1unla_         155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTG
T ss_pred             Cc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhh
Confidence            22  233445778899999987665 58999999999999999999999754332  12222222111110      000


Q ss_pred             hhhcc---------cccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          304 LKILD---------ERLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       304 ~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                      ....+         ...........++++.+|+.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000         011112333456789999999999999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=356.10  Aligned_cols=256  Identities=20%  Similarity=0.298  Sum_probs=187.9

Q ss_pred             CCCCCCCeeccCCceEEEEEEEC-CCcEEEEEeCCCC-----ChHHHHHHHHHHhcCCCCceeeeccceec------CCe
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPGA-----PTQEFIDEVCFLASIQHRNLVTLLGYCQE------NNL  144 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  144 (380)
                      ++|++.++||+|+||+||+|... +|+.||||+....     ..+.+.+|+.++++++||||+++++++..      .+.
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999965 6999999985432     12357899999999999999999999853      467


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .|+||||+.++.+...        ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+|++|||++
T Consensus        97 ~~iv~Ey~~~~l~~~~--------~~~~~~~~i~~~~~qil~gl~~LH~--~giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI--------QMELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEECCSEEHHHHH--------TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eEEEEeccchHHHHhh--------hcCCCHHHHHHHHHHHHHHHHHhhh--cccccccCCccccccccccceeeechhhh
Confidence            8999999987655433        2457899999999999999999999  77999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhh-------
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNS-------  297 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-------  297 (380)
                      +.....   .......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+....  ........       
T Consensus       167 ~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~--~~~i~~~~~~~~~~~  241 (355)
T d2b1pa1         167 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCPEF  241 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHH
T ss_pred             hccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH--HHHHHHhccCCCHHH
Confidence            765432   223455789999999999999999999999999999999999999976532111  11000000       


Q ss_pred             ---------------hccc--chhhhccccccc---CCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          298 ---------------RDFS--NLLKILDERLWS---TFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       298 ---------------~~~~--~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                                     ....  ............   ......++++.+|+.+||+.||++|||++|+|++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                           0000  000011111111   1123467889999999999999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-47  Score=352.57  Aligned_cols=256  Identities=20%  Similarity=0.298  Sum_probs=192.4

Q ss_pred             hCCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC-----hHHHHHHHHHHhcCCCCceeeeccceecC-----Ce
Q 016917           76 TKNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP-----TQEFIDEVCFLASIQHRNLVTLLGYCQEN-----NL  144 (380)
Q Consensus        76 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  144 (380)
                      .++|++.++||+|+||+||+|+. .+|+.||||+.....     .+.+.+|+++|++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            35799999999999999999995 579999999865432     23578999999999999999999998532     34


Q ss_pred             eEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEcccccc
Q 016917          145 QFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKVADAGLR  224 (380)
Q Consensus       145 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl~DFgla  224 (380)
                      .+++++|+.+|+|.+++.      .+.+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~i~~~~~gg~L~~~~~------~~~l~e~~~~~i~~qil~aL~~LH~--~giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhcc------cccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCCccccccccccccccccchh
Confidence            467778888999999882      3468999999999999999999999  77999999999999999999999999998


Q ss_pred             cccCCCCCCCCCccccCccceecccccccCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHhhhcccc-
Q 016917          225 NFLGRTDVAGPSSQVTADEIFLASEVKEFRR-FSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELVQNSRDFSN-  302 (380)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  302 (380)
                      ......     .....|+..|+|||...+.. ++.++|||||||++|+|++|+.||.+.+..   .....+........ 
T Consensus       169 ~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~---~~~~~i~~~~~~~~~  240 (348)
T d2gfsa1         169 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGA  240 (348)
T ss_dssp             -CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCH
T ss_pred             cccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCh
Confidence            765432     34456888999999877654 588999999999999999999999865421   11111111100000 


Q ss_pred             -hh---------hhcc---cccc---cCCCHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 016917          303 -LL---------KILD---ERLW---STFTNEGMEEFIQLIVRCLDPSSERRPSMSDVVTE  347 (380)
Q Consensus       303 -~~---------~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~ll~~  347 (380)
                       ..         ....   ....   .......++++.+|+.+||+.||.+|||++|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence             00         0000   0000   00011245778999999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.4e-42  Score=319.28  Aligned_cols=263  Identities=17%  Similarity=0.195  Sum_probs=190.6

Q ss_pred             CCCCCCCeeccCCceEEEEEEE-CCCcEEEEEeCCCCC--hHHHHHHHHHHhcCC-----------CCceeeeccceec-
Q 016917           77 KNFSDKNLIGEGKFGEVYKGLL-QDGMLVAIKKRPGAP--TQEFIDEVCFLASIQ-----------HRNLVTLLGYCQE-  141 (380)
Q Consensus        77 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~-  141 (380)
                      ++|++.++||+|+||+||+|+. .+|+.||||+.....  .+.+.+|+.+++.++           |+||+++++++.. 
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            4599999999999999999996 579999999876542  356778999888775           5789999988754 


Q ss_pred             -CCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC------
Q 016917          142 -NNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDF------  214 (380)
Q Consensus       142 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~------  214 (380)
                       ....+++++++..+.......  .......+.+..+..++.|++.||.|||+. .+|+||||||+|||++.++      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~i~~qil~al~~lh~~-~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALI--KKYEHRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHH--HHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeeccccccccccc--ccccccCCcHHHHHHHHHHHHHHHHHHhhh-cCcccccCChhHeeeeccCcccccc
Confidence             355667777765544322221  123456778899999999999999999973 5699999999999997654      


Q ss_pred             ceEEcccccccccCCCCCCCCCccccCccceecccccccCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH
Q 016917          215 IAKVADAGLRNFLGRTDVAGPSSQVTADEIFLASEVKEFRRFSEKSDVYSFGVFLLELVSGREASSSLSPDSSQDLVELV  294 (380)
Q Consensus       215 ~~kl~DFgla~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DvwSlG~il~el~tg~~p~~~~~~~~~~~~~~~~  294 (380)
                      .++++|||.+.....     ......||+.|+|||++.+..|+.++||||+||++++|++|+.||...............
T Consensus       170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         170 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence            499999999876533     234567999999999999999999999999999999999999999865432222111111


Q ss_pred             Hhh-hcc-----------cchhhhcc---------c----------ccccCCCHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 016917          295 QNS-RDF-----------SNLLKILD---------E----------RLWSTFTNEGMEEFIQLIVRCLDPSSERRPSMSD  343 (380)
Q Consensus       295 ~~~-~~~-----------~~~~~~~~---------~----------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~~  343 (380)
                      ... ...           .......+         .          .....+....++++.+|+.+||+.||.+|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            000 000           00000000         0          0122345678899999999999999999999999


Q ss_pred             HHHH
Q 016917          344 VVTE  347 (380)
Q Consensus       344 ll~~  347 (380)
                      +|++
T Consensus       325 ~L~H  328 (362)
T d1q8ya_         325 LVNH  328 (362)
T ss_dssp             HHTC
T ss_pred             HhcC
Confidence            9986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.5e-25  Score=189.40  Aligned_cols=159  Identities=17%  Similarity=0.105  Sum_probs=115.7

Q ss_pred             CCCCeeccCCceEEEEEEECCCcEEEEEeCCCCC---------------------hHHHHHHHHHHhcCCCCceeeeccc
Q 016917           80 SDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPGAP---------------------TQEFIDEVCFLASIQHRNLVTLLGY  138 (380)
Q Consensus        80 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------~~~~~~E~~~l~~l~h~niv~l~~~  138 (380)
                      .+.++||+|+||+||+|...+|+.||||......                     ......|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            3568899999999999998889999999633110                     0123467888999999999888765


Q ss_pred             eecCCeeEEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEE
Q 016917          139 CQENNLQFLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLSPRVVHKDFKTANVLVDEDFIAKV  218 (380)
Q Consensus       139 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDikp~Nili~~~~~~kl  218 (380)
                      ..    .+++|||++++.+.+.            +......++.|++.++.|||+  .+|+||||||+|||+++++ ++|
T Consensus        83 ~~----~~lvme~~~~~~~~~l------------~~~~~~~i~~ql~~~l~~lH~--~giiHrDiKP~NILv~~~~-~~l  143 (191)
T d1zara2          83 EG----NAVLMELIDAKELYRV------------RVENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVSEEG-IWI  143 (191)
T ss_dssp             ET----TEEEEECCCCEEGGGC------------CCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEETTE-EEE
T ss_pred             cC----CEEEEEeeccccccch------------hhHHHHHHHHHHHHHHHHHhh--CCEEEccCChhheeeeCCC-EEE
Confidence            32    3799999988655432            222345789999999999999  6799999999999999654 899


Q ss_pred             cccccccccCCCCCCCCCccccCccceecc------cccccCCCCcchhhHHHHHH
Q 016917          219 ADAGLRNFLGRTDVAGPSSQVTADEIFLAS------EVKEFRRFSEKSDVYSFGVF  268 (380)
Q Consensus       219 ~DFgla~~~~~~~~~~~~~~~~~~~~~~aP------E~~~~~~~~~~~DvwSlG~i  268 (380)
                      +|||+|........          ..|...      +.+ .+.|+.++|+||..--
T Consensus       144 iDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         144 IDFPQSVEVGEEGW----------REILERDVRNIITYF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCCTTCEETTSTTH----------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred             EECCCcccCCCCCc----------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence            99999876543211          011111      111 3578899999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.54  E-value=9.7e-08  Score=82.51  Aligned_cols=145  Identities=14%  Similarity=0.093  Sum_probs=96.8

Q ss_pred             HHHHHHhCCCCCCCeeccCCceEEEEEEECCCcEEEEEeCCC---CChHHHHHHHHHHhcCC-CCceeeeccceecCCee
Q 016917           70 EELSLATKNFSDKNLIGEGKFGEVYKGLLQDGMLVAIKKRPG---APTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQ  145 (380)
Q Consensus        70 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  145 (380)
                      .++......|+..+..+.++.+.||+.... +..+++|+...   .....+.+|...+..+. +--+.+++.+...++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            344445567776665555556789998754 55667776442   23445778888887763 43467778888888889


Q ss_pred             EEEEEeecCCCccccccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------
Q 016917          146 FLIYEYIPNGSVSIHLYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS------------------------------  195 (380)
Q Consensus       146 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------  195 (380)
                      ++||++++|..+.......       ..   ...++.+++..+..||+..                              
T Consensus        86 ~lv~~~l~G~~~~~~~~~~-------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE-------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC-------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             EEEEEeccccccccccccc-------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence            9999999987765433110       01   1224455555566666421                              


Q ss_pred             ---------------------------CCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          196 ---------------------------PRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       196 ---------------------------~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                                                 ..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                       237899999999999987777799998765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.48  E-value=1.4e-07  Score=80.98  Aligned_cols=129  Identities=19%  Similarity=0.174  Sum_probs=89.6

Q ss_pred             eeccCC-ceEEEEEEECCCcEEEEEeCCCCChHHHHHHHHHHhcCC--CCceeeeccceecCCeeEEEEEeecCCCcccc
Q 016917           84 LIGEGK-FGEVYKGLLQDGMLVAIKKRPGAPTQEFIDEVCFLASIQ--HRNLVTLLGYCQENNLQFLIYEYIPNGSVSIH  160 (380)
Q Consensus        84 ~ig~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  160 (380)
                      .+..|. .+.||+....++..+++|.........+..|...++.+.  .-.+.+++.+..+++..++||++++|.++...
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~   96 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSS   96 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTS
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccc
Confidence            344454 368999998888889999877776667888998888773  33467778888888888999999988665432


Q ss_pred             ccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------------
Q 016917          161 LYGPSQVSRQKLEFKHRLSIALGAAKGLAHLHSLS---------------------------------------------  195 (380)
Q Consensus       161 l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------  195 (380)
                      .          ...   ...+.++...|.-||+..                                             
T Consensus        97 ~----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          97 H----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             C----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             c----------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            1          011   111223333444444311                                             


Q ss_pred             -----------CCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          196 -----------PRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       196 -----------~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                                 ..++|+|+.|.|||++++..+-|+||+.+.
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                       237999999999999987777899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.72  E-value=4.9e-05  Score=69.15  Aligned_cols=73  Identities=15%  Similarity=0.099  Sum_probs=47.5

Q ss_pred             CCeeccCCceEEEEEEEC-CCcEEEEEeCCC----------CChHHHHHHHHHHhcC-CC--CceeeeccceecCCeeEE
Q 016917           82 KNLIGEGKFGEVYKGLLQ-DGMLVAIKKRPG----------APTQEFIDEVCFLASI-QH--RNLVTLLGYCQENNLQFL  147 (380)
Q Consensus        82 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~----------~~~~~~~~E~~~l~~l-~h--~niv~l~~~~~~~~~~~l  147 (380)
                      .+.||.|....||++... +++.+++|...+          ...++...|.+.|+.+ .+  ..+++++.+.  ....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            357899999999999854 467889995221          1334556788888766 22  3466666553  344578


Q ss_pred             EEEeecCCC
Q 016917          148 IYEYIPNGS  156 (380)
Q Consensus       148 v~e~~~~g~  156 (380)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.38  E-value=0.00014  Score=64.25  Aligned_cols=68  Identities=12%  Similarity=0.188  Sum_probs=45.8

Q ss_pred             ceEEEEEEECCCcEEEEEeCCCC--ChHHHHHHHHHHhcCCCCc--ee---eecc--ceecCCeeEEEEEeecCCCc
Q 016917           90 FGEVYKGLLQDGMLVAIKKRPGA--PTQEFIDEVCFLASIQHRN--LV---TLLG--YCQENNLQFLIYEYIPNGSV  157 (380)
Q Consensus        90 ~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~h~n--iv---~l~~--~~~~~~~~~lv~e~~~~g~L  157 (380)
                      --.||+++..+|..+++|...+.  ..+++..|...+..|...+  ++   ..-+  .....+..+.++++++|..+
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            35899999999999999986543  4567888988887774211  11   2111  22345667889999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.91  E-value=0.0026  Score=55.35  Aligned_cols=157  Identities=13%  Similarity=0.018  Sum_probs=82.2

Q ss_pred             CHHHHHHHhCCCCCCCe-----eccCCceEEEEEEECCCcEEEEEeCCC-CChHHHHHHHHHHhcCCC-----Cceeeec
Q 016917           68 QMEELSLATKNFSDKNL-----IGEGKFGEVYKGLLQDGMLVAIKKRPG-APTQEFIDEVCFLASIQH-----RNLVTLL  136 (380)
Q Consensus        68 ~~~~~~~~~~~~~~~~~-----ig~G~~g~V~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~h-----~niv~l~  136 (380)
                      +.+++.....+|.+.+.     |..|---+.|+.+..+|+ +++|+... ...+++..|++++..|..     |..+...
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~   82 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK   82 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceec
Confidence            44566666677876443     345666788999887665 78887543 344566677777777632     2222211


Q ss_pred             -c--ceecCCeeEEEEEeecCCCcccccc------------------CCCCCCCCCC------------------CHHHH
Q 016917          137 -G--YCQENNLQFLIYEYIPNGSVSIHLY------------------GPSQVSRQKL------------------EFKHR  177 (380)
Q Consensus       137 -~--~~~~~~~~~lv~e~~~~g~L~~~l~------------------~~~~~~~~~~------------------~~~~~  177 (380)
                       |  +....+....++.+..+........                  ..........                  .....
T Consensus        83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (316)
T d2ppqa1          83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL  162 (316)
T ss_dssp             TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred             CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence             1  1122334556677666543322110                  0000000000                  00111


Q ss_pred             HHHHHHHHHHHHHHhc--CCCCeEecCCCCCCeeeCCCCceEEccccccc
Q 016917          178 LSIALGAAKGLAHLHS--LSPRVVHKDFKTANVLVDEDFIAKVADAGLRN  225 (380)
Q Consensus       178 ~~i~~~i~~~l~~LH~--~~~~ivHrDikp~Nili~~~~~~kl~DFgla~  225 (380)
                      ...+......+.-.+.  ...++||+|+.+.|++++++...-+.||+.+.
T Consensus       163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            1222223333333332  23579999999999999998877899999765

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.71  E-value=0.0043  Score=55.84  Aligned_cols=72  Identities=17%  Similarity=0.175  Sum_probs=48.1

Q ss_pred             CeeccCCceEEEEEEECC--------CcEEEEEeCCCC-ChHHHHHHHHHHhcCC-CCceeeeccceecCCeeEEEEEee
Q 016917           83 NLIGEGKFGEVYKGLLQD--------GMLVAIKKRPGA-PTQEFIDEVCFLASIQ-HRNLVTLLGYCQENNLQFLIYEYI  152 (380)
Q Consensus        83 ~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  152 (380)
                      +.|+.|-.-.+|++...+        ...|.+++.... ......+|..+++.+. +.-..++++++.+    .+|+||+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi  123 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI  123 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence            568888889999998643        356777775432 3334567888888774 3223466666643    5789999


Q ss_pred             cCCCcc
Q 016917          153 PNGSVS  158 (380)
Q Consensus       153 ~~g~L~  158 (380)
                      +|..+.
T Consensus       124 ~g~~l~  129 (395)
T d1nw1a_         124 PSRPLS  129 (395)
T ss_dssp             CEEECC
T ss_pred             ccccCC
Confidence            875543